primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
103720386,10372038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, QD",,,,,,,21081.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Arthropathy,,2020,Q1,6,F,20140710.0,20200313.0,20140808,20200325,EXP,,US-SA-2014SA103264,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20200325.0,,CN,US,US,2020,Q1,Elderly
103720386,10372038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, QD",,,,,,,21081.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cataract,,2020,Q1,6,F,20140710.0,20200313.0,20140808,20200325,EXP,,US-SA-2014SA103264,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20200325.0,,CN,US,US,2020,Q1,Elderly
103720386,10372038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, QD",,,,,,,21081.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Foot operation,,2020,Q1,6,F,20140710.0,20200313.0,20140808,20200325,EXP,,US-SA-2014SA103264,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20200325.0,,CN,US,US,2020,Q1,Elderly
103720386,10372038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, QD",,,,,,,21081.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gait disturbance,,2020,Q1,6,F,20140710.0,20200313.0,20140808,20200325,EXP,,US-SA-2014SA103264,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20200325.0,,CN,US,US,2020,Q1,Elderly
103720386,10372038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 IU, QD",,,,,,,21081.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dispensing issue,,2020,Q1,6,F,20140710.0,20200313.0,20140808,20200325,EXP,,US-SA-2014SA103264,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20200325.0,,CN,US,US,2020,Q1,Elderly
103786043,10378604,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 DF,QD",,,,,,,21081.0,35.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 DF,QD",,,,,,,21081.0,35.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoaesthesia,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 DF,QD",,,,,,,21081.0,35.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Impaired driving ability,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 DF,QD",,,,,,,21081.0,35.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Nephrectomy,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 DF,QD",,,,,,,21081.0,35.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Surgery,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 DF,QD",,,,,,,21081.0,35.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Vascular operation,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoaesthesia,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Impaired driving ability,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Nephrectomy,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Surgery,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
103786043,10378604,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Vascular operation,,2020,Q1,3,F,2019.0,20200306.0,20140812,20200319,EXP,,US-SA-2014SA107531,SANOFI AVENTIS,,56.0,YR,A,M,Y,98.8,KG,20200320.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Back pain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Brain neoplasm,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetic coma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Dizziness,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Drug ineffective,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Exostosis,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Gait inability,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Glaucoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hospitalisation,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoaesthesia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Ligament sprain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Lower limb fracture,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Mobility decreased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Nausea,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Neoplasm malignant,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Perirenal haematoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Pneumonia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Presyncope,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Product administration error,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Renal impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Road traffic accident,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Visual impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,,,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Vomiting,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Back pain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Brain neoplasm,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetic coma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Dizziness,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Drug ineffective,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Exostosis,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Gait inability,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Glaucoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hospitalisation,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoaesthesia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Ligament sprain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Lower limb fracture,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Mobility decreased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Nausea,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Neoplasm malignant,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Perirenal haematoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Pneumonia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Presyncope,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Product administration error,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Renal impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Road traffic accident,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Visual impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 DF,HS",,,,, A4798,,,75.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Vomiting,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Back pain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Brain neoplasm,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Diabetic coma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dizziness,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Drug ineffective,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Exostosis,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Fall,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Gait inability,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glaucoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hospitalisation,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoaesthesia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Ligament sprain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Lower limb fracture,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Mobility decreased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Nausea,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Neoplasm malignant,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Perirenal haematoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Pneumonia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Presyncope,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product administration error,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Renal impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Road traffic accident,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Visual impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,,,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Back pain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Brain neoplasm,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Diabetic coma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dizziness,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Drug ineffective,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Exostosis,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Fall,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Gait inability,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glaucoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hospitalisation,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoaesthesia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Ligament sprain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Lower limb fracture,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Mobility decreased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Nausea,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Neoplasm malignant,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Perirenal haematoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Pneumonia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Presyncope,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product administration error,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Renal impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Road traffic accident,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Visual impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 DF,BID",,,,, A4798,,,42.0,DF,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Back pain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Brain neoplasm,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetic coma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Dizziness,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Drug ineffective,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Exostosis,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Gait inability,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Glaucoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hospitalisation,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoaesthesia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Ligament sprain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Lower limb fracture,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Mobility decreased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Nausea,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Neoplasm malignant,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Perirenal haematoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Pneumonia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Presyncope,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Product administration error,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Renal impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Road traffic accident,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Visual impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"90 DF,QD",,,,,,,,90.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Vomiting,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Back pain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Brain neoplasm,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetic coma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Dizziness,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Drug ineffective,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Exostosis,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gait inability,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Glaucoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hospitalisation,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoaesthesia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Ligament sprain,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Lower limb fracture,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Mobility decreased,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Nausea,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Neoplasm malignant,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Perirenal haematoma,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Pneumonia,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Presyncope,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product administration error,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Renal impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Road traffic accident,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Visual impairment,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
108851864,10885186,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU,HS",,,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Vomiting,,2020,Q1,4,F,2009.0,20200220.0,20150304,20200302,EXP,,US-SA-2014SA070989,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200302.0,,CN,US,US,2020,Q1,Adult
111151912,11115191,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,LATENCY: 52 MONTHS,,,,,,,,,,,,2020,Q1,Pemphigoid,,2020,Q1,2,F,20150126.0,20200214.0,20150515,20200221,EXP,,ES-ASTRAZENECA-2015SE43885,ASTRAZENECA,,80.0,YR,,M,Y,,,20200221.0,,HP,ES,ES,2020,Q1,Elderly
115597852,11559785,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,2,F,20130923.0,20200326.0,20150928,20200331,EXP,,US-ASTRAZENECA-2015SE91416,ASTRAZENECA,,21892.0,DY,,F,Y,96.6,KG,20200331.0,,,US,US,2020,Q1,Elderly
115597852,11559785,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Adenocarcinoma pancreas,,2020,Q1,2,F,20130923.0,20200326.0,20150928,20200331,EXP,,US-ASTRAZENECA-2015SE91416,ASTRAZENECA,,21892.0,DY,,F,Y,96.6,KG,20200331.0,,,US,US,2020,Q1,Elderly
115597852,11559785,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Emotional disorder,,2020,Q1,2,F,20130923.0,20200326.0,20150928,20200331,EXP,,US-ASTRAZENECA-2015SE91416,ASTRAZENECA,,21892.0,DY,,F,Y,96.6,KG,20200331.0,,,US,US,2020,Q1,Elderly
115597852,11559785,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Nephropathy,,2020,Q1,2,F,20130923.0,20200326.0,20150928,20200331,EXP,,US-ASTRAZENECA-2015SE91416,ASTRAZENECA,,21892.0,DY,,F,Y,96.6,KG,20200331.0,,,US,US,2020,Q1,Elderly
115597852,11559785,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,2,F,20130923.0,20200326.0,20150928,20200331,EXP,,US-ASTRAZENECA-2015SE91416,ASTRAZENECA,,21892.0,DY,,F,Y,96.6,KG,20200331.0,,,US,US,2020,Q1,Elderly
115597852,11559785,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Septic shock,,2020,Q1,2,F,20130923.0,20200326.0,20150928,20200331,EXP,,US-ASTRAZENECA-2015SE91416,ASTRAZENECA,,21892.0,DY,,F,Y,96.6,KG,20200331.0,,,US,US,2020,Q1,Elderly
115597852,11559785,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Stress,,2020,Q1,2,F,20130923.0,20200326.0,20150928,20200331,EXP,,US-ASTRAZENECA-2015SE91416,ASTRAZENECA,,21892.0,DY,,F,Y,96.6,KG,20200331.0,,,US,US,2020,Q1,Elderly
118990423,11899042,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, 1X/DAY (AT BEDTIME)",,,,,,,,35.0,IU,,QD,2020,Q1,Urinary tract infection,,2020,Q1,3,F,,20200214.0,20160108,20200218,PER,,US-PFIZER INC-2015478101,PFIZER,,65.0,YR,,F,Y,,,20200218.0,,MD,US,US,2020,Q1,Elderly
119137522,11913752,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,, 9F437A,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,, 9F437A,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Breast cancer female,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,, 9F437A,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,, 9F437A,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Intentional product use issue,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Breast cancer female,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Intentional product use issue,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Breast cancer female,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Intentional product use issue,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Breast cancer female,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
119137522,11913752,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Intentional product use issue,,2020,Q1,2,F,2015.0,20200302.0,20160113,20200310,EXP,,US-SA-2016SA002902,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20200310.0,,CN,US,US,2020,Q1,Elderly
120810746,12081074,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,6,F,,20200108.0,20160216,20200116,EXP,,CA-TEVA-634645USA,TEVA,YANG A.,70.0,YR,,F,Y,,,20200116.0,,MD,CA,CA,2020,Q1,Elderly
120810746,12081074,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,DAILY AT BED TIME,,,,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,6,F,,20200108.0,20160216,20200116,EXP,,CA-TEVA-634645USA,TEVA,YANG A.,70.0,YR,,F,Y,,,20200116.0,,MD,CA,CA,2020,Q1,Elderly
121790172,12179017,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 DF, QD",,,,, 5F068A,,206538.0,32.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Blood pressure increased,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 DF, QD",,,,, 5F068A,,206538.0,32.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Dyspnoea,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 DF, QD",,,,, 5F068A,,206538.0,32.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 DF, QD",,,,, 5F068A,,206538.0,32.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Headache,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 DF, QD",,,,, 5F068A,,206538.0,32.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 DF, QD",,,,, 5F068A,,206538.0,32.0,DF,SOLUTION FOR INJECTION,QD,2020,Q1,Sleep apnoea syndrome,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood pressure increased,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Headache,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Sleep apnoea syndrome,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Blood pressure increased,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Headache,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
121790172,12179017,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Sleep apnoea syndrome,,2020,Q1,2,F,201602.0,20200130.0,20160314,20200210,PER,,US-SA-2016SA035487,SANOFI AVENTIS,,61.0,YR,A,F,Y,63.5,KG,20200210.0,,CN,US,US,2020,Q1,Adult
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose decreased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyspepsia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Eye haemorrhage,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Goitre,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoacusis,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoglycaemia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inability to afford medication,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Myocardial infarction,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Optic neuropathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Retinopathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Thyroid disorder,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Tooth infection,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Toothache,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Unevaluable event,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Visual impairment,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID  (AM + PM)",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose decreased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyspepsia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Eye haemorrhage,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Goitre,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoacusis,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoglycaemia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inability to afford medication,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Myocardial infarction,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Optic neuropathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Retinopathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Thyroid disorder,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Tooth infection,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Toothache,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Unevaluable event,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Visual impairment,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F425A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose decreased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyspepsia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Eye haemorrhage,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Goitre,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoacusis,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoglycaemia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inability to afford medication,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Myocardial infarction,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Optic neuropathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Retinopathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Thyroid disorder,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Tooth infection,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Toothache,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Unevaluable event,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Visual impairment,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, A5952,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose decreased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyspepsia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Eye haemorrhage,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Goitre,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoacusis,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoglycaemia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inability to afford medication,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Myocardial infarction,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Optic neuropathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Retinopathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Thyroid disorder,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Tooth infection,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Toothache,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Unevaluable event,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Visual impairment,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,, 5F432A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose decreased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspepsia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Eye haemorrhage,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Goitre,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoacusis,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Inability to afford medication,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Myocardial infarction,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Optic neuropathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Retinopathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Thyroid disorder,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Tooth infection,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Toothache,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Unevaluable event,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Visual impairment,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Vomiting,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose decreased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyspepsia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Eye haemorrhage,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Goitre,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoacusis,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoglycaemia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inability to afford medication,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Myocardial infarction,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Optic neuropathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Retinopathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Thyroid disorder,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Tooth infection,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Toothache,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Unevaluable event,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Visual impairment,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, BID",,,,, 7F003A,,21081.0,45.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose decreased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Dyspepsia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Eye haemorrhage,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Goitre,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoacusis,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Inability to afford medication,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Myocardial infarction,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Optic neuropathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Retinopathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Thyroid disorder,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Tooth infection,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Toothache,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Unevaluable event,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Visual impairment,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Vomiting,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose decreased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyspepsia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Eye haemorrhage,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Goitre,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoacusis,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoglycaemia,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inability to afford medication,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Myocardial infarction,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Optic neuropathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Retinopathy,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Thyroid disorder,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Tooth infection,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Toothache,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Unevaluable event,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Visual impairment,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
123621348,12362134,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,8,F,2009.0,20200227.0,20160512,20200306,EXP,,US-SA-2016SA089762,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
124440172,12444017,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,2,F,,20200109.0,20160607,20200117,PER,,US-SA-2016SA078521,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200117.0,,CN,US,US,2020,Q1,Adult
124440172,12444017,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dose omission,,2020,Q1,2,F,,20200109.0,20160607,20200117,PER,,US-SA-2016SA078521,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200117.0,,CN,US,US,2020,Q1,Adult
124440172,12444017,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Skin discolouration,,2020,Q1,2,F,,20200109.0,20160607,20200117,PER,,US-SA-2016SA078521,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200117.0,,CN,US,US,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Adverse drug reaction,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Condition aggravated,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Gait inability,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Headache,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Hypoaesthesia,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Lower respiratory tract infection,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Pharyngitis,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
1267068513,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Toothache,,2020,Q1,13,F,,20200306.0,20160822,20200312,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200312.0,,MD,CA,CA,2020,Q1,Adult
128264192,12826419,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Cholecystitis,,2020,Q1,2,F,20160923.0,20200227.0,20161006,20200305,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-080557,BRISTOL MYERS SQUIBB,,38.0,YR,,M,Y,81.0,KG,20200305.0,,HP,US,US,2020,Q1,Adult
129459694,12945969,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,15.0,IU,,QD,2020,Q1,Ovarian endometrioid carcinoma,,2020,Q1,4,F,20160822.0,20200129.0,20161116,20200131,EXP,,US-ASTRAZENECA-2016SF21403,ASTRAZENECA,,26916.0,DY,,F,Y,80.7,KG,20200131.0,,MD,US,US,2020,Q1,Elderly
131155053,13115505,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Cholecystitis,,2020,Q1,3,F,20160923.0,20200305.0,20170113,20200306,EXP,,US-SEATTLE GENETICS-2016SGN01555,SEATTLE GENETICS,,38.0,YR,,M,Y,81.0,KG,20200306.0,,MD,US,US,2020,Q1,Adult
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Anaemia,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Blood pressure systolic increased,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Diarrhoea,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Fall,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Hyperglycaemia,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Hypoglycaemia,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Hypotension,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Injection site mass,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Injection site pain,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Metastases to liver,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Nausea,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Pneumonia,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Renal failure,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Skin lesion,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1327014116,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q1,Urinary tract infection,,2020,Q1,16,F,2015.0,20200318.0,20170224,20200326,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200326.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Acute kidney injury,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Anaemia,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Ascites,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Cardiac failure,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Cardiac failure acute,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Fall,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Fluid overload,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Gout,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Hepatic cirrhosis,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Hepatic encephalopathy,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Inflammatory marker increased,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Leukocytosis,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Mental status changes,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1332210420,13322104,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,D,,,,,12.0,DF,,QD,2020,Q1,Sepsis,,2020,Q1,20,F,20160106.0,20200309.0,20170308,20200309,EXP,,PHHO2017US000680,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200309.0,,HP,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Abdominal pain,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Alanine aminotransferase increased,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Aspartate aminotransferase increased,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Atelectasis,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Blood pressure systolic decreased,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Body temperature increased,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Burning sensation,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Cardiac output decreased,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Cellulitis,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Chest pain,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Chills,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Clostridium difficile colitis,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Colitis,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Condition aggravated,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Confusional state,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Diabetic foot,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Dizziness,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Dizziness postural,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Erythema,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Fall,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Fatigue,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Heart rate increased,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Hepatocellular injury,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Hypertension,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Hypotension,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Hypoxia,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,International normalised ratio increased,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Klebsiella infection,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Musculoskeletal pain,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Myalgia,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Nausea,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Non-cardiac chest pain,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Osteomyelitis,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Oxygen saturation decreased,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Peripheral swelling,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Pulmonary hypertension,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Pulmonary oedema,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Respiratory failure,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Septic shock,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Sinus tachycardia,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Toe amputation,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Transaminases increased,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Urinary tract infection,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Wound,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
1377846919,13778469,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,U,,,,,,,,2020,Q1,Wound drainage,,2020,Q1,19,F,20160408.0,20200303.0,20170721,20200314,EXP,,US-ACTELION-A-NJ2016-138553,ACTELION,,71.0,YR,,M,Y,117.46,KG,20200314.0,,MD,US,US,2020,Q1,Elderly
138172786,13817278,6,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,18 UNK,,,,,,,,,,INJECTION,,2020,Q1,Localised infection,,2020,Q1,6,F,20170605.0,20200316.0,20170731,20200319,PER,,CN-AMGEN-CHNCT2017113798,AMGEN,,48.0,YR,A,M,Y,56.0,KG,20200318.0,,MD,CN,CN,2020,Q1,Adult
138172786,13817278,6,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,18 UNK,,,,,,,,,,INJECTION,,2020,Q1,Periodontitis,,2020,Q1,6,F,20170605.0,20200316.0,20170731,20200319,PER,,CN-AMGEN-CHNCT2017113798,AMGEN,,48.0,YR,A,M,Y,56.0,KG,20200318.0,,MD,CN,CN,2020,Q1,Adult
138556844,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Constipation,,2020,Q1,4,F,2017.0,20200313.0,20170810,20200320,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200320.0,,CN,US,US,2020,Q1,Elderly
138556844,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,4,F,2017.0,20200313.0,20170810,20200320,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200320.0,,CN,US,US,2020,Q1,Elderly
138556844,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Fall,,2020,Q1,4,F,2017.0,20200313.0,20170810,20200320,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200320.0,,CN,US,US,2020,Q1,Elderly
138556844,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hip fracture,,2020,Q1,4,F,2017.0,20200313.0,20170810,20200320,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200320.0,,CN,US,US,2020,Q1,Elderly
138556844,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Product preparation issue,,2020,Q1,4,F,2017.0,20200313.0,20170810,20200320,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200320.0,,CN,US,US,2020,Q1,Elderly
138556844,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Urinary tract infection staphylococcal,,2020,Q1,4,F,2017.0,20200313.0,20170810,20200320,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200320.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Abdominal distension,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Abdominal pain upper,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Asthenia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Cardiac disorder,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dizziness,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyspepsia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Fall,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Flatulence,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Gastrooesophageal reflux disease,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Insomnia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Joint dislocation,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Lymphadenopathy,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Neoplasm,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Nephrolithiasis,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Neuropathy peripheral,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Pain in extremity,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product dispensing error,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product use in unapproved indication,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product use issue,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Rib fracture,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Testicular disorder,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Thrombosis,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vascular compression,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vein disorder,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Weight increased,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Abdominal distension,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Abdominal pain upper,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Asthenia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Cardiac disorder,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dizziness,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyspepsia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Fall,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Flatulence,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Gastrooesophageal reflux disease,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Insomnia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Joint dislocation,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Lymphadenopathy,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Neoplasm,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Nephrolithiasis,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Neuropathy peripheral,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Pain in extremity,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product dispensing error,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product use in unapproved indication,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product use issue,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Rib fracture,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Testicular disorder,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Thrombosis,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vascular compression,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vein disorder,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vomiting,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"40 IU, BID",,,,,,,21081.0,40.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Weight increased,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Abdominal distension,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Abdominal pain upper,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Asthenia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cardiac disorder,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Dizziness,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Dyspepsia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Flatulence,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gastrooesophageal reflux disease,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Insomnia,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Joint dislocation,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Lymphadenopathy,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Neoplasm,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Nephrolithiasis,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Neuropathy peripheral,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Pain in extremity,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dispensing error,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product use in unapproved indication,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product use issue,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Rib fracture,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Testicular disorder,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Thrombosis,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Vascular compression,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Vein disorder,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Vomiting,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144196344,14419634,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Weight increased,,2020,Q1,4,F,2016.0,20200220.0,20180122,20200228,EXP,,US-SA-2018SA012568,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200228.0,,CN,US,US,2020,Q1,Elderly
144413168,14441316,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"25 IU, UNK",,,D,,,,,25.0,IU,INJECTION,,2020,Q1,Concomitant disease progression,,2020,Q1,8,F,201801.0,20200312.0,20180125,20200316,EXP,,PHJP2018JP001589,NOVARTIS,,66.0,YR,,F,Y,,,20200316.0,,,JP,JP,2020,Q1,Elderly
144413168,14441316,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"25 IU, UNK",,,D,,,,,25.0,IU,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,8,F,201801.0,20200312.0,20180125,20200316,EXP,,PHJP2018JP001589,NOVARTIS,,66.0,YR,,F,Y,,,20200316.0,,,JP,JP,2020,Q1,Elderly
144413168,14441316,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"25 IU, UNK",,,D,,,,,25.0,IU,INJECTION,,2020,Q1,Neoplasm progression,,2020,Q1,8,F,201801.0,20200312.0,20180125,20200316,EXP,,PHJP2018JP001589,NOVARTIS,,66.0,YR,,F,Y,,,20200316.0,,,JP,JP,2020,Q1,Elderly
144413168,14441316,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"25 IU, UNK",,,D,,,,,25.0,IU,INJECTION,,2020,Q1,Tumour compression,,2020,Q1,8,F,201801.0,20200312.0,20180125,20200316,EXP,,PHJP2018JP001589,NOVARTIS,,66.0,YR,,F,Y,,,20200316.0,,,JP,JP,2020,Q1,Elderly
144413168,14441316,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"25 IU, UNK",,,D,,,,,25.0,IU,INJECTION,,2020,Q1,Tumour haemorrhage,,2020,Q1,8,F,201801.0,20200312.0,20180125,20200316,EXP,,PHJP2018JP001589,NOVARTIS,,66.0,YR,,F,Y,,,20200316.0,,,JP,JP,2020,Q1,Elderly
144413168,14441316,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"25 IU, UNK",,,D,,,,,25.0,IU,INJECTION,,2020,Q1,Visual field defect,,2020,Q1,8,F,201801.0,20200312.0,20180125,20200316,EXP,,PHJP2018JP001589,NOVARTIS,,66.0,YR,,F,Y,,,20200316.0,,,JP,JP,2020,Q1,Elderly
1457669015,14576690,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,15,F,20170812.0,20200129.0,20180227,20200216,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,,,20200216.0,,HP,DE,DE,2020,Q1,Elderly
1457669015,14576690,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypothyroidism,,2020,Q1,15,F,20170812.0,20200129.0,20180227,20200216,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,,,20200216.0,,HP,DE,DE,2020,Q1,Elderly
1457669015,14576690,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Lipase increased,,2020,Q1,15,F,20170812.0,20200129.0,20180227,20200216,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,,,20200216.0,,HP,DE,DE,2020,Q1,Elderly
1457669015,14576690,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Malignant neoplasm progression,,2020,Q1,15,F,20170812.0,20200129.0,20180227,20200216,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,,,20200216.0,,HP,DE,DE,2020,Q1,Elderly
1457669015,14576690,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Metastases to pancreas,,2020,Q1,15,F,20170812.0,20200129.0,20180227,20200216,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,,,20200216.0,,HP,DE,DE,2020,Q1,Elderly
1457669015,14576690,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Nausea,,2020,Q1,15,F,20170812.0,20200129.0,20180227,20200216,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,,,20200216.0,,HP,DE,DE,2020,Q1,Elderly
1457669015,14576690,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Vulvovaginal candidiasis,,2020,Q1,15,F,20170812.0,20200129.0,20180227,20200216,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-100377,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,,,20200216.0,,HP,DE,DE,2020,Q1,Elderly
146026019,14602601,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,DF,INJECTION,QD,2020,Q1,Cerebral infarction,,2020,Q1,9,F,20171211.0,20200121.0,20180306,20200129,EXP,,JP-ASTRAZENECA-2018SE27337,ASTRAZENECA,,29149.0,DY,,M,Y,60.0,KG,20200129.0,,,JP,JP,2020,Q1,Elderly
146026019,14602601,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,DF,INJECTION,QD,2020,Q1,Diverticulum intestinal haemorrhagic,,2020,Q1,9,F,20171211.0,20200121.0,20180306,20200129,EXP,,JP-ASTRAZENECA-2018SE27337,ASTRAZENECA,,29149.0,DY,,M,Y,60.0,KG,20200129.0,,,JP,JP,2020,Q1,Elderly
146026019,14602601,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,DF,INJECTION,QD,2020,Q1,Duodenal ulcer,,2020,Q1,9,F,20171211.0,20200121.0,20180306,20200129,EXP,,JP-ASTRAZENECA-2018SE27337,ASTRAZENECA,,29149.0,DY,,M,Y,60.0,KG,20200129.0,,,JP,JP,2020,Q1,Elderly
146026019,14602601,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,DF,INJECTION,QD,2020,Q1,Haemoglobin decreased,,2020,Q1,9,F,20171211.0,20200121.0,20180306,20200129,EXP,,JP-ASTRAZENECA-2018SE27337,ASTRAZENECA,,29149.0,DY,,M,Y,60.0,KG,20200129.0,,,JP,JP,2020,Q1,Elderly
146026019,14602601,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,DF,INJECTION,QD,2020,Q1,Influenza,,2020,Q1,9,F,20171211.0,20200121.0,20180306,20200129,EXP,,JP-ASTRAZENECA-2018SE27337,ASTRAZENECA,,29149.0,DY,,M,Y,60.0,KG,20200129.0,,,JP,JP,2020,Q1,Elderly
146026019,14602601,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,DF,INJECTION,QD,2020,Q1,Muscular weakness,,2020,Q1,9,F,20171211.0,20200121.0,20180306,20200129,EXP,,JP-ASTRAZENECA-2018SE27337,ASTRAZENECA,,29149.0,DY,,M,Y,60.0,KG,20200129.0,,,JP,JP,2020,Q1,Elderly
146026019,14602601,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,DF,INJECTION,QD,2020,Q1,Vascular device infection,,2020,Q1,9,F,20171211.0,20200121.0,20180306,20200129,EXP,,JP-ASTRAZENECA-2018SE27337,ASTRAZENECA,,29149.0,DY,,M,Y,60.0,KG,20200129.0,,,JP,JP,2020,Q1,Elderly
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Abdominal pain,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Blood growth hormone increased,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Bone pain,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Depression,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Dizziness,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Dysuria,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Headache,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Hypertension,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Malaise,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Neoplasm progression,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Pain,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146027662,14602766,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Thyroid disorder,,2020,Q1,2,F,201607.0,20200128.0,20180306,20200204,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,72.0,KG,20200204.0,,CN,CO,CO,2020,Q1,Adult
146441917,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q1,Alanine aminotransferase increased,,2020,Q1,7,F,201803.0,20200205.0,20180315,20200219,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200219.0,,MD,US,US,2020,Q1,Young Adult
146441917,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q1,Aspartate aminotransferase increased,,2020,Q1,7,F,201803.0,20200205.0,20180315,20200219,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200219.0,,MD,US,US,2020,Q1,Young Adult
146441917,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q1,Blood alkaline phosphatase increased,,2020,Q1,7,F,201803.0,20200205.0,20180315,20200219,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200219.0,,MD,US,US,2020,Q1,Young Adult
146441917,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q1,Blood bilirubin increased,,2020,Q1,7,F,201803.0,20200205.0,20180315,20200219,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200219.0,,MD,US,US,2020,Q1,Young Adult
146441917,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q1,Catheter site pain,,2020,Q1,7,F,201803.0,20200205.0,20180315,20200219,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200219.0,,MD,US,US,2020,Q1,Young Adult
146441917,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q1,Diarrhoea,,2020,Q1,7,F,201803.0,20200205.0,20180315,20200219,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200219.0,,MD,US,US,2020,Q1,Young Adult
146441917,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q1,Headache,,2020,Q1,7,F,201803.0,20200205.0,20180315,20200219,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200219.0,,MD,US,US,2020,Q1,Young Adult
146441917,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q1,Pain in jaw,,2020,Q1,7,F,201803.0,20200205.0,20180315,20200219,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200219.0,,MD,US,US,2020,Q1,Young Adult
146441917,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q1,Pulmonary hypertension,,2020,Q1,7,F,201803.0,20200205.0,20180315,20200219,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200219.0,,MD,US,US,2020,Q1,Young Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dry mouth,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Influenza,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Intentional product misuse,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Ketoacidosis,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Memory impairment,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product dose omission,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146616102,14661610,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"125 IU, BID",,,,, 7F508B,,206538.0,125.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vision blurred,,2020,Q1,2,F,,20200117.0,20180320,20200127,EXP,,US-SA-2018SA081731,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
146632089,14663208,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Cutaneous,"TOTAL DAILY DOSE 50 INTERNATIONAL UNIT, QOD",,,,,,,,,,,QOD,2020,Q1,Drug-induced liver injury,,2020,Q1,9,F,20180308.0,20200316.0,20180321,20200318,EXP,,AU-009507513-1803AUS006266,MERCK,,67.0,YR,,M,Y,87.45,KG,20200318.0,,MD,AU,AU,2020,Q1,Elderly
146632089,14663208,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Cutaneous,"TOTAL DAILY DOSE 50 INTERNATIONAL UNIT, QOD",,,,,,,,,,,QOD,2020,Q1,Non-cardiac chest pain,,2020,Q1,9,F,20180308.0,20200316.0,20180321,20200318,EXP,,AU-009507513-1803AUS006266,MERCK,,67.0,YR,,M,Y,87.45,KG,20200318.0,,MD,AU,AU,2020,Q1,Elderly
146632089,14663208,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Cutaneous,"TOTAL DAILY DOSE 50 INTERNATIONAL UNIT, QOD",,,,,,,,,,,QOD,2020,Q1,Vertigo positional,,2020,Q1,9,F,20180308.0,20200316.0,20180321,20200318,EXP,,AU-009507513-1803AUS006266,MERCK,,67.0,YR,,M,Y,87.45,KG,20200318.0,,MD,AU,AU,2020,Q1,Elderly
146997987,14699798,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,7,F,20110627.0,20200131.0,20180330,20200204,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20200204.0,,LW,US,US,2020,Q1,Adult
146997987,14699798,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,7,F,20110627.0,20200131.0,20180330,20200204,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20200204.0,,LW,US,US,2020,Q1,Adult
146997987,14699798,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Gastrooesophageal reflux disease,,2020,Q1,7,F,20110627.0,20200131.0,20180330,20200204,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20200204.0,,LW,US,US,2020,Q1,Adult
147005006,14700500,37,C,GLARGINE,,2,,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,6,F,20110627.0,20200120.0,20180330,20200128,EXP,,US-ASTRAZENECA-2018SE37662,ASTRAZENECA,,13644.0,DY,,F,Y,70.3,KG,20200128.0,,,US,US,2020,Q1,Elderly
147005006,14700500,37,C,GLARGINE,,2,,,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,6,F,20110627.0,20200120.0,20180330,20200128,EXP,,US-ASTRAZENECA-2018SE37662,ASTRAZENECA,,13644.0,DY,,F,Y,70.3,KG,20200128.0,,,US,US,2020,Q1,Elderly
147005006,14700500,37,C,GLARGINE,,2,,,,,,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,6,F,20110627.0,20200120.0,20180330,20200128,EXP,,US-ASTRAZENECA-2018SE37662,ASTRAZENECA,,13644.0,DY,,F,Y,70.3,KG,20200128.0,,,US,US,2020,Q1,Elderly
147005006,14700500,37,C,GLARGINE,,2,,,,,,,,,,,,,,2020,Q1,Renal injury,,2020,Q1,6,F,20110627.0,20200120.0,20180330,20200128,EXP,,US-ASTRAZENECA-2018SE37662,ASTRAZENECA,,13644.0,DY,,F,Y,70.3,KG,20200128.0,,,US,US,2020,Q1,Elderly
1472727810,14727278,51,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Cellulitis,,2020,Q1,10,F,20180329.0,20200311.0,20180406,20200319,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,45.0,YR,,M,Y,95.0,KG,20200319.0,,CN,JP,JP,2020,Q1,Adult
1472727810,14727278,51,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Cytomegalovirus infection,,2020,Q1,10,F,20180329.0,20200311.0,20180406,20200319,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,45.0,YR,,M,Y,95.0,KG,20200319.0,,CN,JP,JP,2020,Q1,Adult
1472727810,14727278,51,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Neutrophil count decreased,,2020,Q1,10,F,20180329.0,20200311.0,20180406,20200319,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,45.0,YR,,M,Y,95.0,KG,20200319.0,,CN,JP,JP,2020,Q1,Adult
1472727810,14727278,51,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Pancreatitis acute,,2020,Q1,10,F,20180329.0,20200311.0,20180406,20200319,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,45.0,YR,,M,Y,95.0,KG,20200319.0,,CN,JP,JP,2020,Q1,Adult
1472727810,14727278,51,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Pneumocystis jirovecii pneumonia,,2020,Q1,10,F,20180329.0,20200311.0,20180406,20200319,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,45.0,YR,,M,Y,95.0,KG,20200319.0,,CN,JP,JP,2020,Q1,Adult
1472727810,14727278,51,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,White blood cell count decreased,,2020,Q1,10,F,20180329.0,20200311.0,20180406,20200319,EXP,,JP-GLAXOSMITHKLINE-JP2018JPN056741,GLAXOSMITHKLINE,,45.0,YR,,M,Y,95.0,KG,20200319.0,,CN,JP,JP,2020,Q1,Adult
147300735,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,5,F,20151024.0,20200120.0,20180406,20200124,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20200124.0,,CN,US,US,2020,Q1,Young Adult
147300735,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,5,F,20151024.0,20200120.0,20180406,20200124,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20200124.0,,CN,US,US,2020,Q1,Young Adult
147300735,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2020,Q1,End stage renal disease,,2020,Q1,5,F,20151024.0,20200120.0,20180406,20200124,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20200124.0,,CN,US,US,2020,Q1,Young Adult
147300735,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2020,Q1,Gastrooesophageal reflux disease,,2020,Q1,5,F,20151024.0,20200120.0,20180406,20200124,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20200124.0,,CN,US,US,2020,Q1,Young Adult
147300735,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2020,Q1,Nephrogenic anaemia,,2020,Q1,5,F,20151024.0,20200120.0,20180406,20200124,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20200124.0,,CN,US,US,2020,Q1,Young Adult
147300735,14730073,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNITS/ML,,,,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,5,F,20151024.0,20200120.0,20180406,20200124,EXP,,US-PFIZER INC-2018136913,PFIZER,,29.0,YR,,F,Y,,,20200124.0,,CN,US,US,2020,Q1,Young Adult
1475225310,14752253,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE DAILY (ALSO REPORTED STARTED 11 YEARS AGO APROX)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q1,Arterial occlusive disease,,2020,Q1,10,F,201803.0,20200219.0,20180412,20200227,EXP,,CO-ASTELLAS-2018US017683,ASTELLAS,,58.0,YR,,M,Y,,,20200227.0,,CN,CO,CO,2020,Q1,Adult
1475225310,14752253,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE DAILY (ALSO REPORTED STARTED 11 YEARS AGO APROX)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q1,Asthma,,2020,Q1,10,F,201803.0,20200219.0,20180412,20200227,EXP,,CO-ASTELLAS-2018US017683,ASTELLAS,,58.0,YR,,M,Y,,,20200227.0,,CN,CO,CO,2020,Q1,Adult
1475225310,14752253,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE DAILY (ALSO REPORTED STARTED 11 YEARS AGO APROX)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q1,Diabetic foot,,2020,Q1,10,F,201803.0,20200219.0,20180412,20200227,EXP,,CO-ASTELLAS-2018US017683,ASTELLAS,,58.0,YR,,M,Y,,,20200227.0,,CN,CO,CO,2020,Q1,Adult
1475225310,14752253,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE DAILY (ALSO REPORTED STARTED 11 YEARS AGO APROX)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q1,Diabetic foot infection,,2020,Q1,10,F,201803.0,20200219.0,20180412,20200227,EXP,,CO-ASTELLAS-2018US017683,ASTELLAS,,58.0,YR,,M,Y,,,20200227.0,,CN,CO,CO,2020,Q1,Adult
1475225310,14752253,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE DAILY (ALSO REPORTED STARTED 11 YEARS AGO APROX)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q1,Diabetic retinopathy,,2020,Q1,10,F,201803.0,20200219.0,20180412,20200227,EXP,,CO-ASTELLAS-2018US017683,ASTELLAS,,58.0,YR,,M,Y,,,20200227.0,,CN,CO,CO,2020,Q1,Adult
1475225310,14752253,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE DAILY (ALSO REPORTED STARTED 11 YEARS AGO APROX)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q1,Hydronephrosis,,2020,Q1,10,F,201803.0,20200219.0,20180412,20200227,EXP,,CO-ASTELLAS-2018US017683,ASTELLAS,,58.0,YR,,M,Y,,,20200227.0,,CN,CO,CO,2020,Q1,Adult
1475225310,14752253,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE DAILY (ALSO REPORTED STARTED 11 YEARS AGO APROX)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q1,Pneumonia influenzal,,2020,Q1,10,F,201803.0,20200219.0,20180412,20200227,EXP,,CO-ASTELLAS-2018US017683,ASTELLAS,,58.0,YR,,M,Y,,,20200227.0,,CN,CO,CO,2020,Q1,Adult
1475225310,14752253,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNITS, ONCE DAILY (ALSO REPORTED STARTED 11 YEARS AGO APROX)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q1,Pulmonary oedema,,2020,Q1,10,F,201803.0,20200219.0,20180412,20200227,EXP,,CO-ASTELLAS-2018US017683,ASTELLAS,,58.0,YR,,M,Y,,,20200227.0,,CN,CO,CO,2020,Q1,Adult
147729908,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q1,Bronchitis,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
147729908,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q1,Colitis,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
147729908,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q1,Coronary artery disease,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
147729908,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q1,Dehydration,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
147729908,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q1,Quadriplegia,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
147729908,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q1,Bronchitis,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
147729908,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q1,Colitis,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
147729908,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q1,Coronary artery disease,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
147729908,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q1,Dehydration,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
147729908,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q1,Quadriplegia,,2020,Q1,8,F,20180411.0,20200115.0,20180418,20200120,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200120.0,,HP,DE,DE,2020,Q1,Adult
148298492,14829849,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,U,,,,,,,,2020,Q1,Cholecystitis acute,,2020,Q1,2,F,20170913.0,20200204.0,20180430,20200215,EXP,,PHHO2017US016770,NOVARTIS,,77.0,YR,,F,Y,,,20200215.0,,HP,US,US,2020,Q1,Elderly
148981423,14898142,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"50 IU, QD",,,N,, 7F607A,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Dry eye,,2020,Q1,3,F,20171220.0,20200102.0,20180515,20200108,PER,,US-SA-2018SA041996,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200108.0,,CN,US,US,2020,Q1,Adult
148981423,14898142,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"50 IU, QD",,,N,, 7F607A,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,3,F,20171220.0,20200102.0,20180515,20200108,PER,,US-SA-2018SA041996,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200108.0,,CN,US,US,2020,Q1,Adult
148981423,14898142,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"50 IU, QD",,,N,, 7F607A,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,20171220.0,20200102.0,20180515,20200108,PER,,US-SA-2018SA041996,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200108.0,,CN,US,US,2020,Q1,Adult
148981423,14898142,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"50 IU, QD",,,N,, 7F607A,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,3,F,20171220.0,20200102.0,20180515,20200108,PER,,US-SA-2018SA041996,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200108.0,,CN,US,US,2020,Q1,Adult
148981423,14898142,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"50 IU, QD",,,N,, 7F607A,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Visual impairment,,2020,Q1,3,F,20171220.0,20200102.0,20180515,20200108,PER,,US-SA-2018SA041996,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200108.0,,CN,US,US,2020,Q1,Adult
149030382,14903038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"UNK UNK, QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Abdominal discomfort,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
149030382,14903038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"UNK UNK, QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
149030382,14903038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"UNK UNK, QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Eye disorder,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
149030382,14903038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"UNK UNK, QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Foot fracture,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
149030382,14903038,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"UNK UNK, QD",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hypertension,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
149030382,14903038,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Abdominal discomfort,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
149030382,14903038,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
149030382,14903038,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Eye disorder,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
149030382,14903038,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Foot fracture,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
149030382,14903038,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypertension,,2020,Q1,2,F,,20200306.0,20180516,20200313,EXP,,US-SA-2017SA119532,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200313.0,,CN,US,US,2020,Q1,Elderly
151068512,15106851,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 IU, QD",,,D,, 8F5221A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Device difficult to use,,2020,Q1,2,F,,20200107.0,20180704,20200113,PER,,US-SA-2018SA177365,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20200113.0,,CN,US,US,2020,Q1,Elderly
151068512,15106851,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 IU, QD",,,D,, 8F5221A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hospitalisation,,2020,Q1,2,F,,20200107.0,20180704,20200113,PER,,US-SA-2018SA177365,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20200113.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, 7F4747A,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hip arthroplasty,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, 7F4747A,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Joint swelling,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, 7F4747A,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Post procedural infection,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, 7F4747A,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Product use issue,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, 7F4747A,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Walking aid user,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, 7F4747A,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Weight increased,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"?DOSE DEPENDS ON SUGAR LEVEL, SOMETIME DAILY, PRN",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hip arthroplasty,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"?DOSE DEPENDS ON SUGAR LEVEL, SOMETIME DAILY, PRN",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Joint swelling,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"?DOSE DEPENDS ON SUGAR LEVEL, SOMETIME DAILY, PRN",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Post procedural infection,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"?DOSE DEPENDS ON SUGAR LEVEL, SOMETIME DAILY, PRN",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Product use issue,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"?DOSE DEPENDS ON SUGAR LEVEL, SOMETIME DAILY, PRN",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Walking aid user,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"?DOSE DEPENDS ON SUGAR LEVEL, SOMETIME DAILY, PRN",,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Weight increased,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (20 UNITS IN THE MORNING AND 20 UNITS AT NIGHT A TOTAL OF 40 UNITS), BID",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hip arthroplasty,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (20 UNITS IN THE MORNING AND 20 UNITS AT NIGHT A TOTAL OF 40 UNITS), BID",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Joint swelling,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (20 UNITS IN THE MORNING AND 20 UNITS AT NIGHT A TOTAL OF 40 UNITS), BID",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Post procedural infection,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (20 UNITS IN THE MORNING AND 20 UNITS AT NIGHT A TOTAL OF 40 UNITS), BID",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product use issue,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (20 UNITS IN THE MORNING AND 20 UNITS AT NIGHT A TOTAL OF 40 UNITS), BID",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Walking aid user,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
151208812,15120881,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (20 UNITS IN THE MORNING AND 20 UNITS AT NIGHT A TOTAL OF 40 UNITS), BID",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Weight increased,,2020,Q1,2,F,,20200228.0,20180709,20200309,PER,,US-SA-2018SA174018,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20200309.0,,CN,US,US,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Blister,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Cholecystitis,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Cholelithiasis,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Condition aggravated,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Dermatitis exfoliative,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Electrolyte imbalance,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Erythema,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Hyperthyroidism,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Multiple organ dysfunction syndrome,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Respiratory disorder,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Restlessness,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
1518334320,15183343,130,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Toxic epidermal necrolysis,,2020,Q1,20,F,20010704.0,20200304.0,20180723,20200318,EXP,,GB-MYLANLABS-2018M1053534,MYLAN,,73.0,YR,,F,Y,69.0,KG,20200318.0,,HP,FR,DE,2020,Q1,Elderly
152061217,15206121,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hyponatraemia,,2020,Q1,7,F,20180628.0,20200323.0,20180727,20200331,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-068971,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200331.0,,HP,US,US,2020,Q1,Elderly
152061217,15206121,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Squamous cell carcinoma,,2020,Q1,7,F,20180628.0,20200323.0,20180727,20200331,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-068971,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200331.0,,HP,US,US,2020,Q1,Elderly
152140985,15214098,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"53 IU, QD",,,,, 8F786B,,206538.0,53.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Contusion,,2020,Q1,5,F,20200210.0,20200318.0,20180730,20200323,PER,,US-SA-2018SA193002,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20200323.0,,CN,US,US,2020,Q1,Elderly
152140985,15214098,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"53 IU, QD",,,,, 8F786B,,206538.0,53.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cough,,2020,Q1,5,F,20200210.0,20200318.0,20180730,20200323,PER,,US-SA-2018SA193002,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20200323.0,,CN,US,US,2020,Q1,Elderly
152140985,15214098,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"53 IU, QD",,,,, 8F786B,,206538.0,53.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hospitalisation,,2020,Q1,5,F,20200210.0,20200318.0,20180730,20200323,PER,,US-SA-2018SA193002,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20200323.0,,CN,US,US,2020,Q1,Elderly
1524542414,15245424,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q1,Anaemia,Anaemia,2020,Q1,14,F,20180605.0,20200224.0,20180806,20200303,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200303.0,,MD,PL,PL,2020,Q1,Elderly
1524542414,15245424,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q1,Febrile neutropenia,Febrile neutropenia,2020,Q1,14,F,20180605.0,20200224.0,20180806,20200303,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200303.0,,MD,PL,PL,2020,Q1,Elderly
1524542414,15245424,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q1,Neutropenia,Neutropenia,2020,Q1,14,F,20180605.0,20200224.0,20180806,20200303,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200303.0,,MD,PL,PL,2020,Q1,Elderly
1524542414,15245424,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q1,Thrombocytopenia,,2020,Q1,14,F,20180605.0,20200224.0,20180806,20200303,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200303.0,,MD,PL,PL,2020,Q1,Elderly
1541683710,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2020,Q1,Death,,2020,Q1,10,F,20180905.0,20191113.0,20180924,20200114,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20200114.0,,HP,DE,DE,2020,Q1,Elderly
1541683710,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2020,Q1,Endophthalmitis,,2020,Q1,10,F,20180905.0,20191113.0,20180924,20200114,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20200114.0,,HP,DE,DE,2020,Q1,Elderly
1541683710,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2020,Q1,Hypophysitis,,2020,Q1,10,F,20180905.0,20191113.0,20180924,20200114,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20200114.0,,HP,DE,DE,2020,Q1,Elderly
1541683710,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2020,Q1,Pancytopenia,,2020,Q1,10,F,20180905.0,20191113.0,20180924,20200114,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20200114.0,,HP,DE,DE,2020,Q1,Elderly
1541683710,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2020,Q1,Staphylococcal infection,,2020,Q1,10,F,20180905.0,20191113.0,20180924,20200114,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20200114.0,,HP,DE,DE,2020,Q1,Elderly
1541683710,15416837,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 INTERNATIONAL UNIT,,,U,,,,,10.0,IU,INJECTION,,2020,Q1,Type 3 diabetes mellitus,,2020,Q1,10,F,20180905.0,20191113.0,20180924,20200114,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-085915,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20200114.0,,HP,DE,DE,2020,Q1,Elderly
154529016,15452901,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Dry mouth,,2020,Q1,6,F,20171107.0,20200107.0,20181001,20200107,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088509,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
154529016,15452901,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Fall,,2020,Q1,6,F,20171107.0,20200107.0,20181001,20200107,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088509,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
154529016,15452901,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,6,F,20171107.0,20200107.0,20181001,20200107,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088509,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
154529016,15452901,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,6,F,20171107.0,20200107.0,20181001,20200107,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088509,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
154529016,15452901,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Malignant neoplasm progression,,2020,Q1,6,F,20171107.0,20200107.0,20181001,20200107,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088509,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
154529016,15452901,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Nasal injury,,2020,Q1,6,F,20171107.0,20200107.0,20181001,20200107,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088509,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
154529016,15452901,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,6,F,20171107.0,20200107.0,20181001,20200107,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-088509,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,,,20200107.0,,MD,DE,DE,2020,Q1,Elderly
155538292,15553829,1,PS,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,"29 IU, QD",,,,, 8F080A,,208673.0,29.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Injection site pain,,2020,Q1,2,F,,20191217.0,20181026,20200131,PER,,US-SA-2018SA292833,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20200131.0,,CN,US,US,2020,Q1,Adult
155538292,15553829,1,PS,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Unknown,"29 IU, QD",,,,, 8F080A,,208673.0,29.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Pancreatitis,,2020,Q1,2,F,,20191217.0,20181026,20200131,PER,,US-SA-2018SA292833,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20200131.0,,CN,US,US,2020,Q1,Adult
155621942,15562194,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, BID",,,,,,,,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Bipolar disorder,,2020,Q1,2,F,,20200107.0,20181029,20200114,EXP,,US-SA-2018SA295252,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20200114.0,,MD,US,US,2020,Q1,Adult
155621942,15562194,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, BID",,,,,,,,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,,20200107.0,20181029,20200114,EXP,,US-SA-2018SA295252,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20200114.0,,MD,US,US,2020,Q1,Adult
155621942,15562194,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, BID",,,,,,,,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product dose omission,,2020,Q1,2,F,,20200107.0,20181029,20200114,EXP,,US-SA-2018SA295252,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20200114.0,,MD,US,US,2020,Q1,Adult
155621942,15562194,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Bipolar disorder,,2020,Q1,2,F,,20200107.0,20181029,20200114,EXP,,US-SA-2018SA295252,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20200114.0,,MD,US,US,2020,Q1,Adult
155621942,15562194,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,,20200107.0,20181029,20200114,EXP,,US-SA-2018SA295252,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20200114.0,,MD,US,US,2020,Q1,Adult
155621942,15562194,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dose omission,,2020,Q1,2,F,,20200107.0,20181029,20200114,EXP,,US-SA-2018SA295252,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20200114.0,,MD,US,US,2020,Q1,Adult
156147248,15614724,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hypothyroidism,,2020,Q1,8,F,20180731.0,20200108.0,20181113,20200117,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-087388,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20200117.0,,HP,DE,DE,2020,Q1,Elderly
156147248,15614724,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Pain,,2020,Q1,8,F,20180731.0,20200108.0,20181113,20200117,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-087388,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20200117.0,,HP,DE,DE,2020,Q1,Elderly
156545806,15654580,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q1,Intentional product use issue,,2020,Q1,6,F,20181116.0,20190418.0,20181126,20200323,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-109108,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
156545806,15654580,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q1,Malignant neoplasm progression,,2020,Q1,6,F,20181116.0,20190418.0,20181126,20200323,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-109108,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
156545806,15654580,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q1,Pruritus,,2020,Q1,6,F,20181116.0,20190418.0,20181126,20200323,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-109108,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
156545806,15654580,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, BID",,,U,,,,,1.0,DF,,BID,2020,Q1,Renal failure,,2020,Q1,6,F,20181116.0,20190418.0,20181126,20200323,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-109108,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
156566432,15656643,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"BEFORE BREAKFAST - 40 IU AND AT BEDTIME - 25 IU, BID",,,,,,,,,,,Q12H,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,20181119.0,20200107.0,20181126,20200109,EXP,,ZA-SAKK-2018SA253187AA,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20200109.0,,CN,ZA,ZA,2020,Q1,Adult
156566432,15656643,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"BEFORE BREAKFAST - 40 IU AND AT BEDTIME - 25 IU, BID",,,,,,,,,,,Q12H,2020,Q1,Diarrhoea,,2020,Q1,2,F,20181119.0,20200107.0,20181126,20200109,EXP,,ZA-SAKK-2018SA253187AA,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20200109.0,,CN,ZA,ZA,2020,Q1,Adult
156566432,15656643,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"BEFORE BREAKFAST - 40 IU AND AT BEDTIME - 25 IU, BID",,,,,,,,,,,Q12H,2020,Q1,Off label use,,2020,Q1,2,F,20181119.0,20200107.0,20181126,20200109,EXP,,ZA-SAKK-2018SA253187AA,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20200109.0,,CN,ZA,ZA,2020,Q1,Adult
156566432,15656643,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"23 IU, BID (BREAKFAST AND NIGHT TIME DOSE)",,,,,,,,23.0,IU,,Q12H,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,20181119.0,20200107.0,20181126,20200109,EXP,,ZA-SAKK-2018SA253187AA,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20200109.0,,CN,ZA,ZA,2020,Q1,Adult
156566432,15656643,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"23 IU, BID (BREAKFAST AND NIGHT TIME DOSE)",,,,,,,,23.0,IU,,Q12H,2020,Q1,Diarrhoea,,2020,Q1,2,F,20181119.0,20200107.0,20181126,20200109,EXP,,ZA-SAKK-2018SA253187AA,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20200109.0,,CN,ZA,ZA,2020,Q1,Adult
156566432,15656643,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"23 IU, BID (BREAKFAST AND NIGHT TIME DOSE)",,,,,,,,23.0,IU,,Q12H,2020,Q1,Off label use,,2020,Q1,2,F,20181119.0,20200107.0,20181126,20200109,EXP,,ZA-SAKK-2018SA253187AA,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20200109.0,,CN,ZA,ZA,2020,Q1,Adult
156738832,15673883,7,C,Insulin glargine,INSULIN GLARGINE,1,,"100U/ML VIAL INJ, INJ. 50U AT BEDTIME",,,,,,,,,,,,2020,Q1,Alanine aminotransferase increased,,2020,Q1,2,F,20181121.0,20200312.0,20181129,20200326,EXP,,US-TESAROUBC-2018-TSO2019-US,GLAXOSMITHKLINE,,52.0,YR,,F,Y,104.31,KG,20200326.0,,MD,US,US,2020,Q1,Adult
156738832,15673883,7,C,Insulin glargine,INSULIN GLARGINE,1,,"100U/ML VIAL INJ, INJ. 50U AT BEDTIME",,,,,,,,,,,,2020,Q1,Aspartate aminotransferase increased,,2020,Q1,2,F,20181121.0,20200312.0,20181129,20200326,EXP,,US-TESAROUBC-2018-TSO2019-US,GLAXOSMITHKLINE,,52.0,YR,,F,Y,104.31,KG,20200326.0,,MD,US,US,2020,Q1,Adult
156738832,15673883,7,C,Insulin glargine,INSULIN GLARGINE,1,,"100U/ML VIAL INJ, INJ. 50U AT BEDTIME",,,,,,,,,,,,2020,Q1,Blood bilirubin increased,,2020,Q1,2,F,20181121.0,20200312.0,20181129,20200326,EXP,,US-TESAROUBC-2018-TSO2019-US,GLAXOSMITHKLINE,,52.0,YR,,F,Y,104.31,KG,20200326.0,,MD,US,US,2020,Q1,Adult
156738832,15673883,7,C,Insulin glargine,INSULIN GLARGINE,1,,"100U/ML VIAL INJ, INJ. 50U AT BEDTIME",,,,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,2,F,20181121.0,20200312.0,20181129,20200326,EXP,,US-TESAROUBC-2018-TSO2019-US,GLAXOSMITHKLINE,,52.0,YR,,F,Y,104.31,KG,20200326.0,,MD,US,US,2020,Q1,Adult
156793932,15679393,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD (AT NIGHT)",,,U,,,,,1.0,DF,INJECTION,QD,2020,Q1,Alanine aminotransferase increased,,2020,Q1,2,F,20181121.0,20200311.0,20181203,20200317,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111802,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,104.3,KG,20200317.0,,MD,US,US,2020,Q1,Adult
156793932,15679393,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD (AT NIGHT)",,,U,,,,,1.0,DF,INJECTION,QD,2020,Q1,Aspartate aminotransferase increased,,2020,Q1,2,F,20181121.0,20200311.0,20181203,20200317,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111802,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,104.3,KG,20200317.0,,MD,US,US,2020,Q1,Adult
156793932,15679393,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD (AT NIGHT)",,,U,,,,,1.0,DF,INJECTION,QD,2020,Q1,Blood bilirubin increased,,2020,Q1,2,F,20181121.0,20200311.0,20181203,20200317,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111802,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,104.3,KG,20200317.0,,MD,US,US,2020,Q1,Adult
156793932,15679393,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD (AT NIGHT)",,,U,,,,,1.0,DF,INJECTION,QD,2020,Q1,Chills,,2020,Q1,2,F,20181121.0,20200311.0,20181203,20200317,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111802,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,104.3,KG,20200317.0,,MD,US,US,2020,Q1,Adult
156793932,15679393,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD (AT NIGHT)",,,U,,,,,1.0,DF,INJECTION,QD,2020,Q1,Cholangitis,,2020,Q1,2,F,20181121.0,20200311.0,20181203,20200317,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111802,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,104.3,KG,20200317.0,,MD,US,US,2020,Q1,Adult
156793932,15679393,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD (AT NIGHT)",,,U,,,,,1.0,DF,INJECTION,QD,2020,Q1,Pyrexia,,2020,Q1,2,F,20181121.0,20200311.0,20181203,20200317,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111802,BRISTOL MYERS SQUIBB,,52.0,YR,,F,Y,104.3,KG,20200317.0,,MD,US,US,2020,Q1,Adult
1572525112,15725251,50,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY (DAILY AT BED TIME)",,,U,,,,,,,SOLUTION,QD,2020,Q1,Anaphylactic reaction,,2020,Q1,12,F,,20200121.0,20181215,20200130,EXP,,CA-AUROBINDO-AUR-APL-2018-059432,AUROBINDO,,70.0,YR,,F,Y,,,20200130.0,,HP,CA,CA,2020,Q1,Elderly
1572525112,15725251,50,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY (DAILY AT BED TIME)",,,U,,,,,,,SOLUTION,QD,2020,Q1,Drug ineffective,,2020,Q1,12,F,,20200121.0,20181215,20200130,EXP,,CA-AUROBINDO-AUR-APL-2018-059432,AUROBINDO,,70.0,YR,,F,Y,,,20200130.0,,HP,CA,CA,2020,Q1,Elderly
1572525112,15725251,50,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY (DAILY AT BED TIME)",,,U,,,,,,,SOLUTION,QD,2020,Q1,Drug intolerance,,2020,Q1,12,F,,20200121.0,20181215,20200130,EXP,,CA-AUROBINDO-AUR-APL-2018-059432,AUROBINDO,,70.0,YR,,F,Y,,,20200130.0,,HP,CA,CA,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Arthritis,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Blood pressure increased,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Brain natriuretic peptide abnormal,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Disease progression,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Dysphagia,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Fall,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Haemoglobin decreased,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Pulmonary arterial hypertension,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Rib fracture,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Scratch,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Syncope,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
1573911716,15739117,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,16,F,20181209.0,20200323.0,20181219,20200325,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200325.0,,HP,SE,SE,2020,Q1,Elderly
157515319,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2020,Q1,Cerebral haemorrhage,,2020,Q1,9,F,20180115.0,20200203.0,20181221,20200205,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20200205.0,,HP,DE,DE,2020,Q1,Elderly
157515319,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2020,Q1,Gamma-glutamyltransferase increased,,2020,Q1,9,F,20180115.0,20200203.0,20181221,20200205,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20200205.0,,HP,DE,DE,2020,Q1,Elderly
157515319,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2020,Q1,Malignant neoplasm progression,,2020,Q1,9,F,20180115.0,20200203.0,20181221,20200205,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20200205.0,,HP,DE,DE,2020,Q1,Elderly
157515319,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2020,Q1,Metastases to central nervous system,,2020,Q1,9,F,20180115.0,20200203.0,20181221,20200205,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20200205.0,,HP,DE,DE,2020,Q1,Elderly
157515319,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2020,Q1,Metastatic malignant melanoma,,2020,Q1,9,F,20180115.0,20200203.0,20181221,20200205,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20200205.0,,HP,DE,DE,2020,Q1,Elderly
157515319,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2020,Q1,Partial seizures,,2020,Q1,9,F,20180115.0,20200203.0,20181221,20200205,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20200205.0,,HP,DE,DE,2020,Q1,Elderly
157515319,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2020,Q1,Renal failure,,2020,Q1,9,F,20180115.0,20200203.0,20181221,20200205,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20200205.0,,HP,DE,DE,2020,Q1,Elderly
157515319,15751531,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,D,,,,,30.0,IU,,QD,2020,Q1,Urinary tract infection,,2020,Q1,9,F,20180115.0,20200203.0,20181221,20200205,EXP,,PHHY2018DE189162,NOVARTIS,,73.0,YR,,M,Y,117.0,KG,20200205.0,,HP,DE,DE,2020,Q1,Elderly
157603513,15760351,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,,,2020,Q1,Hepatic enzyme increased,,2020,Q1,3,F,20181217.0,20200213.0,20181226,20200225,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201812008367,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20200225.0,,MD,JP,JP,2020,Q1,Adult
157603513,15760351,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,,,2020,Q1,Ultrasound biliary tract abnormal,,2020,Q1,3,F,20181217.0,20200213.0,20181226,20200225,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201812008367,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20200225.0,,MD,JP,JP,2020,Q1,Adult
157603513,15760351,3,SS,Insulin Glargine,INSULIN GLARGINE,1,,UNK,,,Y,U,,,,,,,,2020,Q1,Hepatic enzyme increased,,2020,Q1,3,F,20181217.0,20200213.0,20181226,20200225,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201812008367,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20200225.0,,MD,JP,JP,2020,Q1,Adult
157603513,15760351,3,SS,Insulin Glargine,INSULIN GLARGINE,1,,UNK,,,Y,U,,,,,,,,2020,Q1,Ultrasound biliary tract abnormal,,2020,Q1,3,F,20181217.0,20200213.0,20181226,20200225,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201812008367,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20200225.0,,MD,JP,JP,2020,Q1,Adult
157662614,15766261,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,4,F,20180731.0,20191230.0,20181227,20200106,EXP,,ES-SAKK-2018SA221479AA,SANOFI AVENTIS,,73.0,YR,E,M,Y,62.0,KG,20200106.0,,CN,ES,ES,2020,Q1,Elderly
157662614,15766261,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gastric cancer,,2020,Q1,4,F,20180731.0,20191230.0,20181227,20200106,EXP,,ES-SAKK-2018SA221479AA,SANOFI AVENTIS,,73.0,YR,E,M,Y,62.0,KG,20200106.0,,CN,ES,ES,2020,Q1,Elderly
157662614,15766261,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,20180731.0,20191230.0,20181227,20200106,EXP,,ES-SAKK-2018SA221479AA,SANOFI AVENTIS,,73.0,YR,E,M,Y,62.0,KG,20200106.0,,CN,ES,ES,2020,Q1,Elderly
157662614,15766261,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Pancreatic carcinoma,,2020,Q1,4,F,20180731.0,20191230.0,20181227,20200106,EXP,,ES-SAKK-2018SA221479AA,SANOFI AVENTIS,,73.0,YR,E,M,Y,62.0,KG,20200106.0,,CN,ES,ES,2020,Q1,Elderly
157662614,15766261,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,21 IU,,,,, 9F404A,,206538.0,21.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,4,F,20180731.0,20191230.0,20181227,20200106,EXP,,ES-SAKK-2018SA221479AA,SANOFI AVENTIS,,73.0,YR,E,M,Y,62.0,KG,20200106.0,,CN,ES,ES,2020,Q1,Elderly
157662614,15766261,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,21 IU,,,,, 9F404A,,206538.0,21.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Gastric cancer,,2020,Q1,4,F,20180731.0,20191230.0,20181227,20200106,EXP,,ES-SAKK-2018SA221479AA,SANOFI AVENTIS,,73.0,YR,E,M,Y,62.0,KG,20200106.0,,CN,ES,ES,2020,Q1,Elderly
157662614,15766261,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,21 IU,,,,, 9F404A,,206538.0,21.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,20180731.0,20191230.0,20181227,20200106,EXP,,ES-SAKK-2018SA221479AA,SANOFI AVENTIS,,73.0,YR,E,M,Y,62.0,KG,20200106.0,,CN,ES,ES,2020,Q1,Elderly
157662614,15766261,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,21 IU,,,,, 9F404A,,206538.0,21.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Pancreatic carcinoma,,2020,Q1,4,F,20180731.0,20191230.0,20181227,20200106,EXP,,ES-SAKK-2018SA221479AA,SANOFI AVENTIS,,73.0,YR,E,M,Y,62.0,KG,20200106.0,,CN,ES,ES,2020,Q1,Elderly
157864702,15786470,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 U, BID",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 U, BID",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Diabetic foot infection,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 U, BID",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Disability,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 U, BID",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hospitalisation,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 U, BID",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 U, BID",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Injection site pain,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, BID",,,,,,,206538.0,80.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, BID",,,,,,,206538.0,80.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Diabetic foot infection,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, BID",,,,,,,206538.0,80.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Disability,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, BID",,,,,,,206538.0,80.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hospitalisation,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, BID",,,,,,,206538.0,80.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157864702,15786470,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, BID",,,,,,,206538.0,80.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Injection site pain,,2020,Q1,2,F,20170614.0,20200130.0,20190103,20200206,EXP,,US-SA-2018SA387445,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20200206.0,,CN,US,US,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Bronchitis,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Cerumen impaction,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Chronic graft versus host disease,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Constipation,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Dermal cyst,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Duodenal ulcer,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Febrile neutropenia,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Neutropenia,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Papule,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Patella fracture,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
157887949,15788794,105,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q1,Pulmonary artery thrombosis,,2020,Q1,9,F,20170321.0,20200214.0,20190104,20200227,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200227.0,,MD,JP,JP,2020,Q1,Adult
1580112614,15801126,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q1,Myocarditis,,2020,Q1,14,F,20190102.0,20200228.0,20190109,20200306,EXP,,CO-ROCHE-2241275,ROCHE,,83.0,YR,,F,Y,56.5,KG,20200306.0,,MD,CO,CO,2020,Q1,Elderly
158015972,15801597,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"85 IU, QD",,,,,,,,85.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Haematological malignancy,,2020,Q1,2,F,2017.0,20200114.0,20190109,20200122,EXP,,US-SA-2019SA004965,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200122.0,,CN,US,US,2020,Q1,Elderly
158015972,15801597,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"85 IU, QD",,,,,,,,85.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Malaise,,2020,Q1,2,F,2017.0,20200114.0,20190109,20200122,EXP,,US-SA-2019SA004965,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200122.0,,CN,US,US,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Acidosis,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Cardiac disorder,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Carotid artery stenosis,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haematuria,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hyperkalaemia,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypertension,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypomagnesaemia,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Nausea,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Overdose,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pyelonephritis,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Serum sickness,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
1584403510,15844035,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Underdose,,2020,Q1,10,F,20181126.0,20200113.0,20190118,20200129,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,83.3,KG,20200129.0,,MD,FR,FR,2020,Q1,Elderly
158478169,15847816,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,9,F,2014.0,20200122.0,20190121,20200129,EXP,,PHHY2019DE011566,NOVARTIS,,54.0,YR,,F,Y,78.0,KG,20200129.0,,CN,DE,DE,2020,Q1,Adult
158478169,15847816,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,,,,,,,,,2020,Q1,Arthritis,,2020,Q1,9,F,2014.0,20200122.0,20190121,20200129,EXP,,PHHY2019DE011566,NOVARTIS,,54.0,YR,,F,Y,78.0,KG,20200129.0,,CN,DE,DE,2020,Q1,Adult
158478169,15847816,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,,,,,,,,,2020,Q1,Asthma,,2020,Q1,9,F,2014.0,20200122.0,20190121,20200129,EXP,,PHHY2019DE011566,NOVARTIS,,54.0,YR,,F,Y,78.0,KG,20200129.0,,CN,DE,DE,2020,Q1,Adult
158478169,15847816,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,,,,,,,,,2020,Q1,Chronic sinusitis,,2020,Q1,9,F,2014.0,20200122.0,20190121,20200129,EXP,,PHHY2019DE011566,NOVARTIS,,54.0,YR,,F,Y,78.0,KG,20200129.0,,CN,DE,DE,2020,Q1,Adult
158478169,15847816,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,,,,,,,,,2020,Q1,Cough,,2020,Q1,9,F,2014.0,20200122.0,20190121,20200129,EXP,,PHHY2019DE011566,NOVARTIS,,54.0,YR,,F,Y,78.0,KG,20200129.0,,CN,DE,DE,2020,Q1,Adult
158478169,15847816,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,,,,,,,,,2020,Q1,Intraductal proliferative breast lesion,,2020,Q1,9,F,2014.0,20200122.0,20190121,20200129,EXP,,PHHY2019DE011566,NOVARTIS,,54.0,YR,,F,Y,78.0,KG,20200129.0,,CN,DE,DE,2020,Q1,Adult
158478169,15847816,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,,,,,,,,,2020,Q1,Sleep apnoea syndrome,,2020,Q1,9,F,2014.0,20200122.0,20190121,20200129,EXP,,PHHY2019DE011566,NOVARTIS,,54.0,YR,,F,Y,78.0,KG,20200129.0,,CN,DE,DE,2020,Q1,Adult
158478169,15847816,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,,,,,,,,,2020,Q1,Snoring,,2020,Q1,9,F,2014.0,20200122.0,20190121,20200129,EXP,,PHHY2019DE011566,NOVARTIS,,54.0,YR,,F,Y,78.0,KG,20200129.0,,CN,DE,DE,2020,Q1,Adult
158478169,15847816,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,,,,,,,,,2020,Q1,Upper respiratory tract infection,,2020,Q1,9,F,2014.0,20200122.0,20190121,20200129,EXP,,PHHY2019DE011566,NOVARTIS,,54.0,YR,,F,Y,78.0,KG,20200129.0,,CN,DE,DE,2020,Q1,Adult
158845953,15884595,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"4 IU, DAILY",200.0,IU,Y,,,,205692.0,4.0,IU,,QD,2020,Q1,Drug-induced liver injury,,2020,Q1,3,F,20190104.0,20200108.0,20190129,20200116,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201901011364,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20200116.0,,CN,JP,JP,2020,Q1,Elderly
159535676,15953567,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,6,F,,20200306.0,20190212,20200316,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200316.0,,MD,CA,CA,2020,Q1,Adult
159535676,15953567,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Condition aggravated,,2020,Q1,6,F,,20200306.0,20190212,20200316,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200316.0,,MD,CA,CA,2020,Q1,Adult
159535676,15953567,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,6,F,,20200306.0,20190212,20200316,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200316.0,,MD,CA,CA,2020,Q1,Adult
159535676,15953567,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Gait inability,,2020,Q1,6,F,,20200306.0,20190212,20200316,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200316.0,,MD,CA,CA,2020,Q1,Adult
159535676,15953567,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Headache,,2020,Q1,6,F,,20200306.0,20190212,20200316,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200316.0,,MD,CA,CA,2020,Q1,Adult
159535676,15953567,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Hypoaesthesia,,2020,Q1,6,F,,20200306.0,20190212,20200316,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200316.0,,MD,CA,CA,2020,Q1,Adult
159535676,15953567,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Lower respiratory tract infection,,2020,Q1,6,F,,20200306.0,20190212,20200316,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200316.0,,MD,CA,CA,2020,Q1,Adult
159535676,15953567,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Pharyngitis,,2020,Q1,6,F,,20200306.0,20190212,20200316,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200316.0,,MD,CA,CA,2020,Q1,Adult
159535676,15953567,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Toothache,,2020,Q1,6,F,,20200306.0,20190212,20200316,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200316.0,,MD,CA,CA,2020,Q1,Adult
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Dyskinesia,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Dyspnoea,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoacusis,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Knee arthroplasty,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Neoplasm,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Pruritus,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Rash,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Surgery,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Vocal cord disorder,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Weight increased,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyskinesia,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dyspnoea,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoacusis,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Knee arthroplasty,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Neoplasm,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Pruritus,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Rash,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Surgery,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Vocal cord disorder,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160067763,16006776,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 U, BID",,,Y,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Weight increased,,2020,Q1,3,F,20180615.0,20200225.0,20190226,20200303,EXP,,US-SA-2019SA028112,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Appendicitis perforated,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetic neuropathy,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gait disturbance,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Grip strength decreased,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoaesthesia,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dose omission,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Stress,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Unevaluable event,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Appendicitis perforated,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Diabetic neuropathy,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Fall,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Gait disturbance,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Grip strength decreased,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoaesthesia,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product dose omission,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Stress,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160068002,16006800,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,TAKES 30 UNITS OF TOUJEO IN THE MORNING,,,,, 7F688A,,206538.0,30.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Unevaluable event,,2020,Q1,2,F,20170118.0,20191227.0,20190226,20200103,EXP,,US-SA-2018SA024029,SANOFI AVENTIS,,61.0,YR,A,F,Y,80.0,KG,20200103.0,,CN,US,US,2020,Q1,Adult
160247835,16024783,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,5,F,2007.0,20200127.0,20190301,20200203,EXP,,US-ASTRAZENECA-2018SF64731,ASTRAZENECA,,53.0,YR,,M,Y,102.1,KG,20200204.0,,,US,US,2020,Q1,Adult
160247835,16024783,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,End stage renal disease,,2020,Q1,5,F,2007.0,20200127.0,20190301,20200203,EXP,,US-ASTRAZENECA-2018SF64731,ASTRAZENECA,,53.0,YR,,M,Y,102.1,KG,20200204.0,,,US,US,2020,Q1,Adult
160247835,16024783,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,5,F,2007.0,20200127.0,20190301,20200203,EXP,,US-ASTRAZENECA-2018SF64731,ASTRAZENECA,,53.0,YR,,M,Y,102.1,KG,20200204.0,,,US,US,2020,Q1,Adult
160247835,16024783,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Renal injury,,2020,Q1,5,F,2007.0,20200127.0,20190301,20200203,EXP,,US-ASTRAZENECA-2018SF64731,ASTRAZENECA,,53.0,YR,,M,Y,102.1,KG,20200204.0,,,US,US,2020,Q1,Adult
160271415,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q1,Cellulitis,,2020,Q1,5,F,20181224.0,20200306.0,20190303,20200313,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20200313.0,,HP,DE,DE,2020,Q1,Adult
160271415,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q1,Lymphangitis,,2020,Q1,5,F,20181224.0,20200306.0,20190303,20200313,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20200313.0,,HP,DE,DE,2020,Q1,Adult
160271415,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q1,Necrosis,,2020,Q1,5,F,20181224.0,20200306.0,20190303,20200313,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20200313.0,,HP,DE,DE,2020,Q1,Adult
160271415,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q1,Soft tissue infection,,2020,Q1,5,F,20181224.0,20200306.0,20190303,20200313,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20200313.0,,HP,DE,DE,2020,Q1,Adult
160379063,16037906,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 DOSAGE FORM,,,U,U,,,,18.0,DF,,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,3,F,,20200125.0,20190305,20200130,EXP,,PT-MYLANLABS-2019M1018999,MYLAN,,52.0,YR,,F,Y,51.0,KG,20200130.0,,HP,PT,PT,2020,Q1,Adult
160379063,16037906,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 DOSAGE FORM,,,U,U,,,,18.0,DF,,,2020,Q1,Drug ineffective,,2020,Q1,3,F,,20200125.0,20190305,20200130,EXP,,PT-MYLANLABS-2019M1018999,MYLAN,,52.0,YR,,F,Y,51.0,KG,20200130.0,,HP,PT,PT,2020,Q1,Adult
160379063,16037906,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 DOSAGE FORM,,,U,U,,,,18.0,DF,,,2020,Q1,Hyperlactacidaemia,,2020,Q1,3,F,,20200125.0,20190305,20200130,EXP,,PT-MYLANLABS-2019M1018999,MYLAN,,52.0,YR,,F,Y,51.0,KG,20200130.0,,HP,PT,PT,2020,Q1,Adult
160379063,16037906,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 DOSAGE FORM,,,U,U,,,,18.0,DF,,,2020,Q1,Lactic acidosis,,2020,Q1,3,F,,20200125.0,20190305,20200130,EXP,,PT-MYLANLABS-2019M1018999,MYLAN,,52.0,YR,,F,Y,51.0,KG,20200130.0,,HP,PT,PT,2020,Q1,Adult
160406282,16040628,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),HIGH-DOSE INSULIN (TITRATED TO 10 U/KG/H),,,D,,,,,,,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20200309.0,20190306,20200317,EXP,,SE-MYLANLABS-2018M1059042,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",28.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Young Adult
160406282,16040628,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),HIGH-DOSE INSULIN (TITRATED TO 10 U/KG/H),,,D,,,,,,,INJECTION,,2020,Q1,Drug interaction,,2020,Q1,2,F,,20200309.0,20190306,20200317,EXP,,SE-MYLANLABS-2018M1059042,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",28.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Young Adult
160406282,16040628,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),HIGH-DOSE INSULIN (TITRATED TO 10 U/KG/H),,,D,,,,,,,INJECTION,,2020,Q1,Intentional overdose,,2020,Q1,2,F,,20200309.0,20190306,20200317,EXP,,SE-MYLANLABS-2018M1059042,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",28.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Young Adult
160406282,16040628,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),HIGH-DOSE INSULIN (TITRATED TO 10 U/KG/H),,,D,,,,,,,INJECTION,,2020,Q1,Shock,,2020,Q1,2,F,,20200309.0,20190306,20200317,EXP,,SE-MYLANLABS-2018M1059042,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",28.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Young Adult
160406282,16040628,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),HIGH-DOSE INSULIN (TITRATED TO 10 U/KG/H),,,D,,,,,,,INJECTION,,2020,Q1,Suicide attempt,,2020,Q1,2,F,,20200309.0,20190306,20200317,EXP,,SE-MYLANLABS-2018M1059042,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",28.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Young Adult
160406282,16040628,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),HIGH-DOSE INSULIN (TITRATED TO 10 U/KG/H),,,D,,,,,,,INJECTION,,2020,Q1,Toxicity to various agents,,2020,Q1,2,F,,20200309.0,20190306,20200317,EXP,,SE-MYLANLABS-2018M1059042,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",28.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Young Adult
160562792,16056279,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,78 IU AND 30 IU,,,,, A7099,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blindness,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,78 IU AND 30 IU,,,,, A7099,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose fluctuation,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,78 IU AND 30 IU,,,,, A7099,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Diabetic retinopathy,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,78 IU AND 30 IU,,,,, A7099,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Disability,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,78 IU AND 30 IU,,,,, A7099,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,78 IU AND 30 IU,,,,, A7099,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Retinal disorder,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,, A7099,,,100.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blindness,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,, A7099,,,100.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose fluctuation,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,, A7099,,,100.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetic retinopathy,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,, A7099,,,100.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Disability,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,, A7099,,,100.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,, A7099,,,100.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Retinal disorder,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blindness,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose fluctuation,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetic retinopathy,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Disability,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
160562792,16056279,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Retinal disorder,,2020,Q1,2,F,,20200227.0,20190311,20200306,EXP,,US-SA-2019SA058757,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200306.0,,CN,US,US,2020,Q1,Elderly
1606856613,16068566,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 INTERNATIONAL UNIT, UNKNOWN",,,D,,,,,12.0,IU,INJECTION,,2020,Q1,Bacteraemia,,2020,Q1,13,F,20181102.0,20200220.0,20190313,20200224,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201903003891,ELI LILLY AND CO,,68.0,YR,,F,Y,68.0,KG,20200224.0,,MD,IL,IL,2020,Q1,Elderly
1606856613,16068566,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 INTERNATIONAL UNIT, UNKNOWN",,,D,,,,,12.0,IU,INJECTION,,2020,Q1,Dysphagia,,2020,Q1,13,F,20181102.0,20200220.0,20190313,20200224,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201903003891,ELI LILLY AND CO,,68.0,YR,,F,Y,68.0,KG,20200224.0,,MD,IL,IL,2020,Q1,Elderly
1606856613,16068566,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 INTERNATIONAL UNIT, UNKNOWN",,,D,,,,,12.0,IU,INJECTION,,2020,Q1,Fatigue,,2020,Q1,13,F,20181102.0,20200220.0,20190313,20200224,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201903003891,ELI LILLY AND CO,,68.0,YR,,F,Y,68.0,KG,20200224.0,,MD,IL,IL,2020,Q1,Elderly
1606856613,16068566,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 INTERNATIONAL UNIT, UNKNOWN",,,D,,,,,12.0,IU,INJECTION,,2020,Q1,Vomiting,,2020,Q1,13,F,20181102.0,20200220.0,20190313,20200224,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201903003891,ELI LILLY AND CO,,68.0,YR,,F,Y,68.0,KG,20200224.0,,MD,IL,IL,2020,Q1,Elderly
1606856613,16068566,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 INTERNATIONAL UNIT, UNKNOWN",,,D,,,,,3.0,IU,INJECTION,,2020,Q1,Bacteraemia,,2020,Q1,13,F,20181102.0,20200220.0,20190313,20200224,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201903003891,ELI LILLY AND CO,,68.0,YR,,F,Y,68.0,KG,20200224.0,,MD,IL,IL,2020,Q1,Elderly
1606856613,16068566,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 INTERNATIONAL UNIT, UNKNOWN",,,D,,,,,3.0,IU,INJECTION,,2020,Q1,Dysphagia,,2020,Q1,13,F,20181102.0,20200220.0,20190313,20200224,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201903003891,ELI LILLY AND CO,,68.0,YR,,F,Y,68.0,KG,20200224.0,,MD,IL,IL,2020,Q1,Elderly
1606856613,16068566,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 INTERNATIONAL UNIT, UNKNOWN",,,D,,,,,3.0,IU,INJECTION,,2020,Q1,Fatigue,,2020,Q1,13,F,20181102.0,20200220.0,20190313,20200224,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201903003891,ELI LILLY AND CO,,68.0,YR,,F,Y,68.0,KG,20200224.0,,MD,IL,IL,2020,Q1,Elderly
1606856613,16068566,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"3 INTERNATIONAL UNIT, UNKNOWN",,,D,,,,,3.0,IU,INJECTION,,2020,Q1,Vomiting,,2020,Q1,13,F,20181102.0,20200220.0,20190313,20200224,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201903003891,ELI LILLY AND CO,,68.0,YR,,F,Y,68.0,KG,20200224.0,,MD,IL,IL,2020,Q1,Elderly
160929464,16092946,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,FORM STRENGTH: 100 UNT/ML 3ML SOLOSTAR; ADMINISTER AT THE SAME TIME EACH DAY AS DIRECTED.,,,,,,,,36.0,IU,INJECTION,BID,2020,Q1,Rectal haemorrhage,,2020,Q1,4,F,20160317.0,20200113.0,20190320,20200115,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-012423",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,104.33,KG,20200116.0,,CN,US,US,2020,Q1,Elderly
161042234,16104223,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, QD",,,U,,,,,,,INJECTION,QD,2020,Q1,Dyspnoea,,2020,Q1,4,F,20190310.0,20200306.0,20190322,20200312,EXP,,JP-SAKK-2019SA073913AA,SANOFI AVENTIS,,79.0,YR,E,M,Y,61.0,KG,20200312.0,,MD,JP,JP,2020,Q1,Elderly
161042234,16104223,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, QD",,,U,,,,,,,INJECTION,QD,2020,Q1,Interstitial lung disease,,2020,Q1,4,F,20190310.0,20200306.0,20190322,20200312,EXP,,JP-SAKK-2019SA073913AA,SANOFI AVENTIS,,79.0,YR,E,M,Y,61.0,KG,20200312.0,,MD,JP,JP,2020,Q1,Elderly
161042234,16104223,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, QD",,,U,,,,,,,INJECTION,QD,2020,Q1,Pyrexia,,2020,Q1,4,F,20190310.0,20200306.0,20190322,20200312,EXP,,JP-SAKK-2019SA073913AA,SANOFI AVENTIS,,79.0,YR,E,M,Y,61.0,KG,20200312.0,,MD,JP,JP,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Acute kidney injury,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Arrhythmia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Atrial fibrillation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Bradycardia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Dehydration,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Dizziness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Haematocrit increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Haemoglobin increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Heart rate irregular,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Hypotension,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Hypovolaemia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Left atrial dilatation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Mucosal dryness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Presyncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Skin disorder,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q1,Syncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Heart rate irregular,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161236887,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Syncope,,2020,Q1,7,F,2018.0,20200226.0,20190327,20200303,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200303.0,,CN,NL,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Acute kidney injury,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Arrhythmia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Atrial fibrillation,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Bradycardia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Dehydration,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Dizziness,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Haematocrit increased,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Haemoglobin increased,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Hypotension,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Hypovolaemia,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Left atrial dilatation,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Mucosal dryness,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Oedema peripheral,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Presyncope,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Pulmonary congestion,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Renal disorder,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Skin disorder,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161298284,16129828,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"26 IU, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Syncope,,2020,Q1,4,F,,20191204.0,20190328,20200106,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20200106.0,,MD,PT,PT,2020,Q1,Elderly
161310602,16131060,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 IU/ML,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Application site warmth,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 IU/ML,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 IU/ML,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Incorrect dose administered,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 IU/ML,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Intentional product misuse,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 IU/ML,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Unevaluable event,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 IU/ML,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,22 IU,,,,,,,206538.0,22.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Application site warmth,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,22 IU,,,,,,,206538.0,22.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,22 IU,,,,,,,206538.0,22.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Incorrect dose administered,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,22 IU,,,,,,,206538.0,22.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Intentional product misuse,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,22 IU,,,,,,,206538.0,22.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Unevaluable event,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161310602,16131060,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,22 IU,,,,,,,206538.0,22.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,2,F,20190308.0,20200107.0,20190328,20200110,EXP,,MX-SA-2019SA079370,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20200110.0,,CN,MX,MX,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Acute kidney injury,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Arrhythmia,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Atrial fibrillation,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Bradycardia,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Dehydration,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Dizziness,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Haematocrit increased,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Haemoglobin increased,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Hypotension,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Hypovolaemia,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Left atrial dilatation,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Mucosal dryness,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Oedema peripheral,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Presyncope,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Pulmonary congestion,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Pulmonary oedema,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Renal disorder,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Skin disorder,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Syncope,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Acute kidney injury,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Arrhythmia,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Atrial fibrillation,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Bradycardia,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Dehydration,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Dizziness,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Haematocrit increased,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Haemoglobin increased,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Hypotension,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Hypovolaemia,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Left atrial dilatation,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Mucosal dryness,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Oedema peripheral,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Presyncope,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Pulmonary congestion,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Pulmonary oedema,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Renal disorder,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Skin disorder,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161477355,16147735,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,26.0,IU,,QD,2020,Q1,Syncope,,2020,Q1,5,F,2018.0,20191204.0,20190402,20200110,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20200110.0,,MD,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Acute kidney injury,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Arrhythmia,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Atrial fibrillation,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Bradycardia,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Dehydration,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Dizziness,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Haematocrit increased,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Haemoglobin increased,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Hypotension,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Hypovolaemia,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Left atrial dilatation,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Mucosal dryness,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Oedema peripheral,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Presyncope,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Pulmonary congestion,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Renal disorder,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Skin disorder,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161548648,16154864,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, DAILY",,,U,U,,,,26.0,IU,,QD,2020,Q1,Syncope,,2020,Q1,8,F,2018.0,20200107.0,20190403,20200113,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200113.0,,CN,PT,PT,2020,Q1,Elderly
161629973,16162997,3,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,8 INTERNATIONAL UNIT/DAY,,,U,,,,,8.0,IU,,,2020,Q1,Diabetic ketosis,,2020,Q1,3,F,20190305.0,20200113.0,20190405,20200123,EXP,,JP-009507513-1903JPN001641J,MERCK,,58.0,YR,,M,Y,55.0,KG,20200123.0,,CN,JP,JP,2020,Q1,Adult
161629973,16162997,3,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,8 INTERNATIONAL UNIT/DAY,,,U,,,,,8.0,IU,,,2020,Q1,Hepatic function abnormal,,2020,Q1,3,F,20190305.0,20200113.0,20190405,20200123,EXP,,JP-009507513-1903JPN001641J,MERCK,,58.0,YR,,M,Y,55.0,KG,20200123.0,,CN,JP,JP,2020,Q1,Adult
161629973,16162997,3,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,8 INTERNATIONAL UNIT/DAY,,,U,,,,,8.0,IU,,,2020,Q1,Jaundice cholestatic,,2020,Q1,3,F,20190305.0,20200113.0,20190405,20200123,EXP,,JP-009507513-1903JPN001641J,MERCK,,58.0,YR,,M,Y,55.0,KG,20200123.0,,CN,JP,JP,2020,Q1,Adult
161629973,16162997,3,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,8 INTERNATIONAL UNIT/DAY,,,U,,,,,8.0,IU,,,2020,Q1,Type 1 diabetes mellitus,,2020,Q1,3,F,20190305.0,20200113.0,20190405,20200123,EXP,,JP-009507513-1903JPN001641J,MERCK,,58.0,YR,,M,Y,55.0,KG,20200123.0,,CN,JP,JP,2020,Q1,Adult
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Acute kidney injury,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Arrhythmia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Atrial fibrillation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Bradycardia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Dehydration,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Dizziness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Haematocrit increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Haemoglobin increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Hypotension,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Hypovolaemia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Left atrial dilatation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Mucosal dryness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Oedema peripheral,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Presyncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Pulmonary congestion,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Renal disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Skin disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, 1X/DAY",,,U,,,,,26.0,IU,,QD,2020,Q1,Syncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
1616373312,16163733,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,12,F,2018.0,20200110.0,20190405,20200120,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLEMIA - A CASE OF EMPAGLIFLOZIN IATROGENESIS?. PORTUGUESE DIABETES JOURNAL. 2019;14 (1) SUPPL:44:74",71.0,YR,,M,Y,,,20200120.0,,MD,PT,PT,2020,Q1,Elderly
161726202,16172620,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS ONCE DAILY IN THE AFTERNOON AND 30 UNITS ONCE NIGHTLY, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Back injury,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS ONCE DAILY IN THE AFTERNOON AND 30 UNITS ONCE NIGHTLY, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS ONCE DAILY IN THE AFTERNOON AND 30 UNITS ONCE NIGHTLY, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Fall,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS ONCE DAILY IN THE AFTERNOON AND 30 UNITS ONCE NIGHTLY, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Gait inability,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS ONCE DAILY IN THE AFTERNOON AND 30 UNITS ONCE NIGHTLY, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS ONCE DAILY IN THE AFTERNOON AND 30 UNITS ONCE NIGHTLY, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Joint injury,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS ONCE DAILY IN THE AFTERNOON AND 30 UNITS ONCE NIGHTLY, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Limb injury,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS ONCE DAILY IN THE AFTERNOON AND 30 UNITS ONCE NIGHTLY, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product dose omission,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNITS ONCE DAILY IN THE AFTERNOON AND 30 UNITS ONCE NIGHTLY, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q1,Road traffic accident,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"130 IU, QD",,,,,,,,130.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Back injury,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"130 IU, QD",,,,,,,,130.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"130 IU, QD",,,,,,,,130.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"130 IU, QD",,,,,,,,130.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gait inability,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"130 IU, QD",,,,,,,,130.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"130 IU, QD",,,,,,,,130.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Joint injury,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"130 IU, QD",,,,,,,,130.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Limb injury,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"130 IU, QD",,,,,,,,130.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dose omission,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
161726202,16172620,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"130 IU, QD",,,,,,,,130.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Road traffic accident,,2020,Q1,2,F,20161025.0,20200312.0,20190409,20200319,EXP,,US-SA-2019SA042811,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200319.0,,CN,US,US,2020,Q1,Adult
1625331214,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q1,Bronchitis,,2020,Q1,14,F,20190404.0,20200129.0,20190429,20200210,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ;:-.",74.0,YR,,M,Y,70.0,KG,20200210.0,,MD,JP,JP,2020,Q1,Elderly
1625331214,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q1,Interstitial lung disease,,2020,Q1,14,F,20190404.0,20200129.0,20190429,20200210,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ;:-.",74.0,YR,,M,Y,70.0,KG,20200210.0,,MD,JP,JP,2020,Q1,Elderly
1625331214,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q1,Myasthenia gravis,,2020,Q1,14,F,20190404.0,20200129.0,20190429,20200210,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ;:-.",74.0,YR,,M,Y,70.0,KG,20200210.0,,MD,JP,JP,2020,Q1,Elderly
1625331214,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q1,Myositis,,2020,Q1,14,F,20190404.0,20200129.0,20190429,20200210,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ;:-.",74.0,YR,,M,Y,70.0,KG,20200210.0,,MD,JP,JP,2020,Q1,Elderly
1625331214,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q1,Platelet count decreased,,2020,Q1,14,F,20190404.0,20200129.0,20190429,20200210,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ;:-.",74.0,YR,,M,Y,70.0,KG,20200210.0,,MD,JP,JP,2020,Q1,Elderly
1625331214,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q1,Pneumonia staphylococcal,,2020,Q1,14,F,20190404.0,20200129.0,20190429,20200210,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ;:-.",74.0,YR,,M,Y,70.0,KG,20200210.0,,MD,JP,JP,2020,Q1,Elderly
1625331214,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q1,Pyrexia,,2020,Q1,14,F,20190404.0,20200129.0,20190429,20200210,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ;:-.",74.0,YR,,M,Y,70.0,KG,20200210.0,,MD,JP,JP,2020,Q1,Elderly
162598492,16259849,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 MILLIGRAM, QD",,,Y,U,,,,36.0,MG,INJECTION,QD,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,2,F,201712.0,20200107.0,20190501,20200110,EXP,,CZ-MYLANLABS-2019M1040729,MYLAN,VYKOUPILOVA D.. THE ACHIEVEMENT OF A TARGETED DIABETES CONTROL WITH A FIXED COMBINATION OF BASAL INSULIN AND GLP-1 AGONIST (DEGLUDEC + LIRAGLUTIDE).. KAZUISTIKY V DIABETOLOGII. 2018;3:13-14,72.0,YR,,F,Y,,,20200110.0,,MD,CZ,CZ,2020,Q1,Elderly
162598492,16259849,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 MILLIGRAM, QD",,,Y,U,,,,36.0,MG,INJECTION,QD,2020,Q1,Drug ineffective,,2020,Q1,2,F,201712.0,20200107.0,20190501,20200110,EXP,,CZ-MYLANLABS-2019M1040729,MYLAN,VYKOUPILOVA D.. THE ACHIEVEMENT OF A TARGETED DIABETES CONTROL WITH A FIXED COMBINATION OF BASAL INSULIN AND GLP-1 AGONIST (DEGLUDEC + LIRAGLUTIDE).. KAZUISTIKY V DIABETOLOGII. 2018;3:13-14,72.0,YR,,F,Y,,,20200110.0,,MD,CZ,CZ,2020,Q1,Elderly
162598492,16259849,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 MILLIGRAM, QD",,,Y,U,,,,36.0,MG,INJECTION,QD,2020,Q1,Weight increased,,2020,Q1,2,F,201712.0,20200107.0,20190501,20200110,EXP,,CZ-MYLANLABS-2019M1040729,MYLAN,VYKOUPILOVA D.. THE ACHIEVEMENT OF A TARGETED DIABETES CONTROL WITH A FIXED COMBINATION OF BASAL INSULIN AND GLP-1 AGONIST (DEGLUDEC + LIRAGLUTIDE).. KAZUISTIKY V DIABETOLOGII. 2018;3:13-14,72.0,YR,,F,Y,,,20200110.0,,MD,CZ,CZ,2020,Q1,Elderly
162598492,16259849,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 U DAILY,,,Y,U,,,,,,INJECTION,QD,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,2,F,201712.0,20200107.0,20190501,20200110,EXP,,CZ-MYLANLABS-2019M1040729,MYLAN,VYKOUPILOVA D.. THE ACHIEVEMENT OF A TARGETED DIABETES CONTROL WITH A FIXED COMBINATION OF BASAL INSULIN AND GLP-1 AGONIST (DEGLUDEC + LIRAGLUTIDE).. KAZUISTIKY V DIABETOLOGII. 2018;3:13-14,72.0,YR,,F,Y,,,20200110.0,,MD,CZ,CZ,2020,Q1,Elderly
162598492,16259849,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 U DAILY,,,Y,U,,,,,,INJECTION,QD,2020,Q1,Drug ineffective,,2020,Q1,2,F,201712.0,20200107.0,20190501,20200110,EXP,,CZ-MYLANLABS-2019M1040729,MYLAN,VYKOUPILOVA D.. THE ACHIEVEMENT OF A TARGETED DIABETES CONTROL WITH A FIXED COMBINATION OF BASAL INSULIN AND GLP-1 AGONIST (DEGLUDEC + LIRAGLUTIDE).. KAZUISTIKY V DIABETOLOGII. 2018;3:13-14,72.0,YR,,F,Y,,,20200110.0,,MD,CZ,CZ,2020,Q1,Elderly
162598492,16259849,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 U DAILY,,,Y,U,,,,,,INJECTION,QD,2020,Q1,Weight increased,,2020,Q1,2,F,201712.0,20200107.0,20190501,20200110,EXP,,CZ-MYLANLABS-2019M1040729,MYLAN,VYKOUPILOVA D.. THE ACHIEVEMENT OF A TARGETED DIABETES CONTROL WITH A FIXED COMBINATION OF BASAL INSULIN AND GLP-1 AGONIST (DEGLUDEC + LIRAGLUTIDE).. KAZUISTIKY V DIABETOLOGII. 2018;3:13-14,72.0,YR,,F,Y,,,20200110.0,,MD,CZ,CZ,2020,Q1,Elderly
162598492,16259849,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,2,F,201712.0,20200107.0,20190501,20200110,EXP,,CZ-MYLANLABS-2019M1040729,MYLAN,VYKOUPILOVA D.. THE ACHIEVEMENT OF A TARGETED DIABETES CONTROL WITH A FIXED COMBINATION OF BASAL INSULIN AND GLP-1 AGONIST (DEGLUDEC + LIRAGLUTIDE).. KAZUISTIKY V DIABETOLOGII. 2018;3:13-14,72.0,YR,,F,Y,,,20200110.0,,MD,CZ,CZ,2020,Q1,Elderly
162598492,16259849,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,201712.0,20200107.0,20190501,20200110,EXP,,CZ-MYLANLABS-2019M1040729,MYLAN,VYKOUPILOVA D.. THE ACHIEVEMENT OF A TARGETED DIABETES CONTROL WITH A FIXED COMBINATION OF BASAL INSULIN AND GLP-1 AGONIST (DEGLUDEC + LIRAGLUTIDE).. KAZUISTIKY V DIABETOLOGII. 2018;3:13-14,72.0,YR,,F,Y,,,20200110.0,,MD,CZ,CZ,2020,Q1,Elderly
162598492,16259849,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2020,Q1,Weight increased,,2020,Q1,2,F,201712.0,20200107.0,20190501,20200110,EXP,,CZ-MYLANLABS-2019M1040729,MYLAN,VYKOUPILOVA D.. THE ACHIEVEMENT OF A TARGETED DIABETES CONTROL WITH A FIXED COMBINATION OF BASAL INSULIN AND GLP-1 AGONIST (DEGLUDEC + LIRAGLUTIDE).. KAZUISTIKY V DIABETOLOGII. 2018;3:13-14,72.0,YR,,F,Y,,,20200110.0,,MD,CZ,CZ,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Arthritis,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Brain natriuretic peptide abnormal,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Disease progression,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Dysphagia,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Fall,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Pulmonary arterial hypertension,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Rib fracture,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Scratch,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
1626837213,16268372,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,13,F,20181209.0,20200310.0,20190503,20200319,EXP,,SE-AUROBINDO-AUR-APL-2019-001014,AUROBINDO,,82.0,YR,,M,Y,80.0,KG,20200319.0,,HP,SE,SE,2020,Q1,Elderly
162784608,16278460,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,29 UNITS,,,,,,,,,,INJECTION,,2020,Q1,Anaemia,,2020,Q1,8,F,20190417.0,20200226.0,20190506,20200303,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20200303.0,,HP,US,US,2020,Q1,Elderly
162784608,16278460,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,29 UNITS,,,,,,,,,,INJECTION,,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,8,F,20190417.0,20200226.0,20190506,20200303,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20200303.0,,HP,US,US,2020,Q1,Elderly
162784608,16278460,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,29 UNITS,,,,,,,,,,INJECTION,,2020,Q1,Hepatic failure,,2020,Q1,8,F,20190417.0,20200226.0,20190506,20200303,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20200303.0,,HP,US,US,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood cholesterol increased,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood triglycerides increased,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Drug abuse,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypertension,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Intentional product misuse,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Medication error,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Overdose,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162785085,16278508,16,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,5,F,,20200127.0,20190506,20200203,EXP,,ES-MYLANLABS-2017M1073678,MYLAN,,72.0,YR,,M,Y,,,20200203.0,,PH,ES,ES,2020,Q1,Elderly
162849512,16284951,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, HS DAILY AT BED TIME",81552.0,IU,,, 8F5856A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, HS DAILY AT BED TIME",81552.0,IU,,, 8F5856A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cardiac disorder,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, HS DAILY AT BED TIME",81552.0,IU,,, 8F5856A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Haemorrhage,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, HS DAILY AT BED TIME",81552.0,IU,,, 8F5856A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Myocardial infarction,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, HS DAILY AT BED TIME",81552.0,IU,,, 8F5856A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dose omission,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, HS DAILY AT BED TIME",81552.0,IU,,, 8F5856A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Sepsis,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, HS DAILY AT BED TIME",81552.0,IU,,, 8F5856A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Wound,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU, HS DAILY AT BED TIME",81552.0,IU,,, 8F5856A,,,42.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Wrong technique in product usage process,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD",81552.0,IU,,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD",81552.0,IU,,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cardiac disorder,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD",81552.0,IU,,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Haemorrhage,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD",81552.0,IU,,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Myocardial infarction,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD",81552.0,IU,,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dose omission,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD",81552.0,IU,,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Sepsis,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD",81552.0,IU,,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Wound,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD",81552.0,IU,,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Wrong technique in product usage process,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, HS",81552.0,IU,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, HS",81552.0,IU,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cardiac disorder,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, HS",81552.0,IU,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Haemorrhage,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, HS",81552.0,IU,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Myocardial infarction,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, HS",81552.0,IU,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dose omission,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, HS",81552.0,IU,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Sepsis,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, HS",81552.0,IU,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Wound,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, HS",81552.0,IU,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Wrong technique in product usage process,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",81552.0,IU,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",81552.0,IU,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cardiac disorder,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",81552.0,IU,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Haemorrhage,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",81552.0,IU,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Myocardial infarction,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",81552.0,IU,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product dose omission,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",81552.0,IU,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Sepsis,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",81552.0,IU,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Wound,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162849512,16284951,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",81552.0,IU,,,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Wrong technique in product usage process,,2020,Q1,2,F,20150826.0,20200225.0,20190508,20200303,EXP,,US-SA-2015SA133500,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
162986613,16298661,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Diabetes mellitus,,2020,Q1,3,F,2011.0,20200122.0,20190510,20200129,EXP,,CZ-AUROBINDO-AUR-APL-2019-024858,AUROBINDO,,80.0,YR,,M,Y,85.0,KG,20200129.0,,HP,CZ,CZ,2020,Q1,Elderly
162986613,16298661,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,3,F,2011.0,20200122.0,20190510,20200129,EXP,,CZ-AUROBINDO-AUR-APL-2019-024858,AUROBINDO,,80.0,YR,,M,Y,85.0,KG,20200129.0,,HP,CZ,CZ,2020,Q1,Elderly
162986613,16298661,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,3,F,2011.0,20200122.0,20190510,20200129,EXP,,CZ-AUROBINDO-AUR-APL-2019-024858,AUROBINDO,,80.0,YR,,M,Y,85.0,KG,20200129.0,,HP,CZ,CZ,2020,Q1,Elderly
162986613,16298661,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Palpitations,,2020,Q1,3,F,2011.0,20200122.0,20190510,20200129,EXP,,CZ-AUROBINDO-AUR-APL-2019-024858,AUROBINDO,,80.0,YR,,M,Y,85.0,KG,20200129.0,,HP,CZ,CZ,2020,Q1,Elderly
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Abdominal pain,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Atelectasis,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Blood creatinine increased,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Bronchial wall thickening,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Cardiac failure,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Cardiac failure acute,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Chronic obstructive pulmonary disease,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Circulatory collapse,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Diverticulum,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Fall,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Fluid overload,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Hospitalisation,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Immobile,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Localised oedema,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Myocardial ischaemia,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Nasopharyngitis,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Oxygen consumption increased,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Pericardial effusion,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Peripheral swelling,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Pleuritic pain,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Pulmonary arterial hypertension,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Pulmonary arterial pressure increased,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Pulmonary hypertension,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Pulmonary oedema,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Rales,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Respiratory failure,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Right ventricular failure,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Syncope,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Troponin increased,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163011617,16301161,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Weight increased,,2020,Q1,7,F,20181128.0,20200310.0,20190510,20200319,EXP,,US-ACTELION-A-NJ2018-183083,ACTELION,,61.0,YR,,F,Y,94.79,KG,20200319.0,,HP,US,US,2020,Q1,Adult
163080212,16308021,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,8.0,IU,INJECTION,QD,2020,Q1,Death,,2020,Q1,2,F,20160523.0,20200108.0,20190514,20200112,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-021575",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,68.0,KG,20200112.0,,CN,US,US,2020,Q1,Elderly
163080212,16308021,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,8.0,IU,INJECTION,QD,2020,Q1,Gastrointestinal haemorrhage,,2020,Q1,2,F,20160523.0,20200108.0,20190514,20200112,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-021575",BOEHRINGER INGELHEIM,,78.0,YR,,M,Y,68.0,KG,20200112.0,,CN,US,US,2020,Q1,Elderly
163143374,16314337,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q1,Blood cholesterol increased,,2020,Q1,4,F,,20200122.0,20190515,20200130,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201802011945,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20200130.0,,CN,ES,ES,2020,Q1,Elderly
163143374,16314337,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q1,Blood triglycerides increased,,2020,Q1,4,F,,20200122.0,20190515,20200130,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201802011945,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20200130.0,,CN,ES,ES,2020,Q1,Elderly
163143374,16314337,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q1,Fatigue,,2020,Q1,4,F,,20200122.0,20190515,20200130,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201802011945,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20200130.0,,CN,ES,ES,2020,Q1,Elderly
163143374,16314337,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,,20200122.0,20190515,20200130,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201802011945,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20200130.0,,CN,ES,ES,2020,Q1,Elderly
163143374,16314337,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q1,Hypertension,,2020,Q1,4,F,,20200122.0,20190515,20200130,EXP,,ES-ELI_LILLY_AND_COMPANY-ES201802011945,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20200130.0,,CN,ES,ES,2020,Q1,Elderly
163154934,16315493,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, QD",,,,, 9F5995A,,21081.0,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Device operational issue,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, QD",,,,, 9F5995A,,21081.0,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, QD",,,,, 9F5995A,,21081.0,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, QD",,,,, 9F5995A,,21081.0,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gastrointestinal disorder,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, QD",,,,, 9F5995A,,21081.0,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Injection site pain,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, QD",,,,, 9F5995A,,21081.0,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Limb injury,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"22 IU, QD",,,,, 9F5995A,,21081.0,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Rotator cuff syndrome,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,, 9F5995A,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Device operational issue,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,, 9F5995A,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,, 9F5995A,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,, 9F5995A,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gastrointestinal disorder,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,, 9F5995A,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Injection site pain,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,, 9F5995A,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Limb injury,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163154934,16315493,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,, 9F5995A,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Rotator cuff syndrome,,2020,Q1,4,F,20190904.0,20200210.0,20190515,20200218,PER,,US-SA-2019SA125218,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Adult
163156712,16315671,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Diabetes mellitus,,2020,Q1,2,F,201805.0,20190507.0,20190515,20200117,EXP,,PHHY2019CZ108904,NOVARTIS,ZAK P. SUCCESSFUL USE OF A FIXED-RATIO COMBINATION OF BASAL INSULIN AND GLP-1 RA IN A PATIENT WITH TYPE 2 DIABETES LASTING FOR NEARLY A QUARTER OF A CENTURY. KAZUISTIKY V DIABETOLOGII. 2019;1:10-2,80.0,YR,,M,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
163237863,16323786,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Blood cholesterol increased,,2020,Q1,3,F,,20200124.0,20190517,20200131,EXP,,ES-ASTRAZENECA-2018SE27035,ASTRAZENECA,,72.0,YR,,M,Y,,,20200131.0,,PH,ES,ES,2020,Q1,Elderly
163237863,16323786,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Blood triglycerides increased,,2020,Q1,3,F,,20200124.0,20190517,20200131,EXP,,ES-ASTRAZENECA-2018SE27035,ASTRAZENECA,,72.0,YR,,M,Y,,,20200131.0,,PH,ES,ES,2020,Q1,Elderly
163237863,16323786,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Fatigue,,2020,Q1,3,F,,20200124.0,20190517,20200131,EXP,,ES-ASTRAZENECA-2018SE27035,ASTRAZENECA,,72.0,YR,,M,Y,,,20200131.0,,PH,ES,ES,2020,Q1,Elderly
163237863,16323786,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,,20200124.0,20190517,20200131,EXP,,ES-ASTRAZENECA-2018SE27035,ASTRAZENECA,,72.0,YR,,M,Y,,,20200131.0,,PH,ES,ES,2020,Q1,Elderly
163237863,16323786,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Hypertension,,2020,Q1,3,F,,20200124.0,20190517,20200131,EXP,,ES-ASTRAZENECA-2018SE27035,ASTRAZENECA,,72.0,YR,,M,Y,,,20200131.0,,PH,ES,ES,2020,Q1,Elderly
163237863,16323786,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Overdose,,2020,Q1,3,F,,20200124.0,20190517,20200131,EXP,,ES-ASTRAZENECA-2018SE27035,ASTRAZENECA,,72.0,YR,,M,Y,,,20200131.0,,PH,ES,ES,2020,Q1,Elderly
163237863,16323786,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Treatment noncompliance,,2020,Q1,3,F,,20200124.0,20190517,20200131,EXP,,ES-ASTRAZENECA-2018SE27035,ASTRAZENECA,,72.0,YR,,M,Y,,,20200131.0,,PH,ES,ES,2020,Q1,Elderly
163469283,16346928,18,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Accelerated hypertension,,2020,Q1,3,F,,20200122.0,20190523,20200128,EXP,,ES-AUROBINDO-AUR-APL-2018-013491,AUROBINDO,,72.0,YR,,M,Y,,,20200128.0,,PH,ES,ES,2020,Q1,Elderly
163469283,16346928,18,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Blood cholesterol increased,,2020,Q1,3,F,,20200122.0,20190523,20200128,EXP,,ES-AUROBINDO-AUR-APL-2018-013491,AUROBINDO,,72.0,YR,,M,Y,,,20200128.0,,PH,ES,ES,2020,Q1,Elderly
163469283,16346928,18,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Blood triglycerides increased,,2020,Q1,3,F,,20200122.0,20190523,20200128,EXP,,ES-AUROBINDO-AUR-APL-2018-013491,AUROBINDO,,72.0,YR,,M,Y,,,20200128.0,,PH,ES,ES,2020,Q1,Elderly
163469283,16346928,18,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Fatigue,,2020,Q1,3,F,,20200122.0,20190523,20200128,EXP,,ES-AUROBINDO-AUR-APL-2018-013491,AUROBINDO,,72.0,YR,,M,Y,,,20200128.0,,PH,ES,ES,2020,Q1,Elderly
163469283,16346928,18,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,,20200122.0,20190523,20200128,EXP,,ES-AUROBINDO-AUR-APL-2018-013491,AUROBINDO,,72.0,YR,,M,Y,,,20200128.0,,PH,ES,ES,2020,Q1,Elderly
163469283,16346928,18,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hypertension,,2020,Q1,3,F,,20200122.0,20190523,20200128,EXP,,ES-AUROBINDO-AUR-APL-2018-013491,AUROBINDO,,72.0,YR,,M,Y,,,20200128.0,,PH,ES,ES,2020,Q1,Elderly
163469283,16346928,18,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Overdose,,2020,Q1,3,F,,20200122.0,20190523,20200128,EXP,,ES-AUROBINDO-AUR-APL-2018-013491,AUROBINDO,,72.0,YR,,M,Y,,,20200128.0,,PH,ES,ES,2020,Q1,Elderly
163469283,16346928,18,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Treatment noncompliance,,2020,Q1,3,F,,20200122.0,20190523,20200128,EXP,,ES-AUROBINDO-AUR-APL-2018-013491,AUROBINDO,,72.0,YR,,M,Y,,,20200128.0,,PH,ES,ES,2020,Q1,Elderly
163492603,16349260,4,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,UNK (IN MORNING),,,,,,,,,,,,2020,Q1,Hepatic function abnormal,,2020,Q1,3,F,2019.0,20200313.0,20190523,20200326,EXP,,JP-NOVOPROD-663454,NOVO NORDISK,"NAOTO SEKI, ET AL. A CASE OF TYPE 2 DIABETES MELLITUS IN WHOM HEPATIC DYSFUNCTION OCCURRED POSSIBLY DUE TO LIRAGLUTIDE. THE 57TH KANTO-KOSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY. 2020",87.0,YR,,M,Y,,,20200326.0,,MD,JP,JP,2020,Q1,Elderly
163788512,16378851,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, BID",,,D,, 8F5929A,,,36.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,,20200113.0,20190531,20200121,PER,,US-SA-2019SA142560,SANOFI AVENTIS,,56.0,YR,A,M,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
163788512,16378851,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, BID",,,D,, 8F5929A,,,36.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Product storage error,,2020,Q1,2,F,,20200113.0,20190531,20200121,PER,,US-SA-2019SA142560,SANOFI AVENTIS,,56.0,YR,A,M,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
163788512,16378851,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, BID",,,D,, 8F5929A,,,36.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Wrong technique in device usage process,,2020,Q1,2,F,,20200113.0,20190531,20200121,PER,,US-SA-2019SA142560,SANOFI AVENTIS,,56.0,YR,A,M,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
163881483,16388148,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT /ML, 14 UNIT UNDER SKIN NIGHTLY",,,,,,,,,,,,2020,Q1,Bacteraemia,,2020,Q1,3,F,20180206.0,20191001.0,20190604,20200124,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20200124.0,,MD,US,US,2020,Q1,Elderly
163881483,16388148,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT /ML, 14 UNIT UNDER SKIN NIGHTLY",,,,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,3,F,20180206.0,20191001.0,20190604,20200124,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20200124.0,,MD,US,US,2020,Q1,Elderly
163881483,16388148,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT /ML, 14 UNIT UNDER SKIN NIGHTLY",,,,,,,,,,,,2020,Q1,Vascular device infection,,2020,Q1,3,F,20180206.0,20191001.0,20190604,20200124,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20200124.0,,MD,US,US,2020,Q1,Elderly
163927172,16392717,20,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood cholesterol increased,,2020,Q1,2,F,,20200122.0,20190605,20200129,EXP,,ES-GLAXOSMITHKLINE-ES2018033236,GLAXOSMITHKLINE,,72.0,YR,,M,Y,,,20200129.0,,PH,ES,ES,2020,Q1,Elderly
163927172,16392717,20,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood triglycerides increased,,2020,Q1,2,F,,20200122.0,20190605,20200129,EXP,,ES-GLAXOSMITHKLINE-ES2018033236,GLAXOSMITHKLINE,,72.0,YR,,M,Y,,,20200129.0,,PH,ES,ES,2020,Q1,Elderly
163927172,16392717,20,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,2,F,,20200122.0,20190605,20200129,EXP,,ES-GLAXOSMITHKLINE-ES2018033236,GLAXOSMITHKLINE,,72.0,YR,,M,Y,,,20200129.0,,PH,ES,ES,2020,Q1,Elderly
163927172,16392717,20,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,,20200122.0,20190605,20200129,EXP,,ES-GLAXOSMITHKLINE-ES2018033236,GLAXOSMITHKLINE,,72.0,YR,,M,Y,,,20200129.0,,PH,ES,ES,2020,Q1,Elderly
163927172,16392717,20,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypertension,,2020,Q1,2,F,,20200122.0,20190605,20200129,EXP,,ES-GLAXOSMITHKLINE-ES2018033236,GLAXOSMITHKLINE,,72.0,YR,,M,Y,,,20200129.0,,PH,ES,ES,2020,Q1,Elderly
163927172,16392717,20,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Overdose,,2020,Q1,2,F,,20200122.0,20190605,20200129,EXP,,ES-GLAXOSMITHKLINE-ES2018033236,GLAXOSMITHKLINE,,72.0,YR,,M,Y,,,20200129.0,,PH,ES,ES,2020,Q1,Elderly
163927172,16392717,20,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,2,F,,20200122.0,20190605,20200129,EXP,,ES-GLAXOSMITHKLINE-ES2018033236,GLAXOSMITHKLINE,,72.0,YR,,M,Y,,,20200129.0,,PH,ES,ES,2020,Q1,Elderly
163963305,16396330,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q1,Bleeding varicose vein,,2020,Q1,5,F,20190528.0,20200305.0,20190605,20200311,EXP,,MX-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-053490,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,78.0,KG,20200311.0,,HP,MX,MX,2020,Q1,Elderly
163963305,16396330,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q1,Portal vein thrombosis,,2020,Q1,5,F,20190528.0,20200305.0,20190605,20200311,EXP,,MX-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-053490,BRISTOL MYERS SQUIBB,,80.0,YR,,F,Y,78.0,KG,20200311.0,,HP,MX,MX,2020,Q1,Elderly
163991002,16399100,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD (EVERY NIGHT)",,,,, 8F00AA,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Disability,,2020,Q1,2,F,201703.0,20200225.0,20190606,20200304,EXP,,US-SA-2019SA151299,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Adult
163991002,16399100,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD (EVERY NIGHT)",,,,, 8F00AA,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Dyspnoea,,2020,Q1,2,F,201703.0,20200225.0,20190606,20200304,EXP,,US-SA-2019SA151299,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Adult
163991002,16399100,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD (EVERY NIGHT)",,,,, 8F00AA,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Impaired work ability,,2020,Q1,2,F,201703.0,20200225.0,20190606,20200304,EXP,,US-SA-2019SA151299,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Adult
163991002,16399100,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD (EVERY NIGHT)",,,,, 8F00AA,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Intentional product misuse,,2020,Q1,2,F,201703.0,20200225.0,20190606,20200304,EXP,,US-SA-2019SA151299,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Adult
163991002,16399100,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, QD (EVERY NIGHT)",,,,, 8F00AA,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Neuroendocrine carcinoma metastatic,,2020,Q1,2,F,201703.0,20200225.0,20190606,20200304,EXP,,US-SA-2019SA151299,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Adult
164138713,16413871,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Cerebrovascular accident,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Dysphemia,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Hypoacusis,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Localised infection,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 IU, BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Memory impairment,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 IU, QD",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cerebrovascular accident,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 IU, QD",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Dysphemia,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 IU, QD",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoacusis,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 IU, QD",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 IU, QD",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Localised infection,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164138713,16413871,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 IU, QD",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Memory impairment,,2020,Q1,3,F,20190603.0,20200224.0,20190611,20200303,EXP,,US-SA-2019SA154771,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Elderly
164226063,16422606,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, ASKQ,,,,,,,2020,Q1,Blood cholesterol increased,,2020,Q1,3,F,,20200126.0,20190612,20200204,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-TEVA-2019-ES-1060874,TEVA,,72.0,YR,,M,Y,,,20200204.0,,PH,ES,ES,2020,Q1,Elderly
164226063,16422606,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, ASKQ,,,,,,,2020,Q1,Blood triglycerides increased,,2020,Q1,3,F,,20200126.0,20190612,20200204,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-TEVA-2019-ES-1060874,TEVA,,72.0,YR,,M,Y,,,20200204.0,,PH,ES,ES,2020,Q1,Elderly
164226063,16422606,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, ASKQ,,,,,,,2020,Q1,Fatigue,,2020,Q1,3,F,,20200126.0,20190612,20200204,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-TEVA-2019-ES-1060874,TEVA,,72.0,YR,,M,Y,,,20200204.0,,PH,ES,ES,2020,Q1,Elderly
164226063,16422606,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, ASKQ,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,,20200126.0,20190612,20200204,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-TEVA-2019-ES-1060874,TEVA,,72.0,YR,,M,Y,,,20200204.0,,PH,ES,ES,2020,Q1,Elderly
164226063,16422606,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, ASKQ,,,,,,,2020,Q1,Hypertension,,2020,Q1,3,F,,20200126.0,20190612,20200204,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-TEVA-2019-ES-1060874,TEVA,,72.0,YR,,M,Y,,,20200204.0,,PH,ES,ES,2020,Q1,Elderly
164226063,16422606,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, ASKQ,,,,,,,2020,Q1,Overdose,,2020,Q1,3,F,,20200126.0,20190612,20200204,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-TEVA-2019-ES-1060874,TEVA,,72.0,YR,,M,Y,,,20200204.0,,PH,ES,ES,2020,Q1,Elderly
164226063,16422606,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, ASKQ,,,,,,,2020,Q1,Treatment noncompliance,,2020,Q1,3,F,,20200126.0,20190612,20200204,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-TEVA-2019-ES-1060874,TEVA,,72.0,YR,,M,Y,,,20200204.0,,PH,ES,ES,2020,Q1,Elderly
164248062,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Anhedonia,,2020,Q1,2,F,201001.0,20200320.0,20190613,20200327,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,,,20200327.0,,CN,US,US,2020,Q1,Adult
164248062,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Anxiety,,2020,Q1,2,F,201001.0,20200320.0,20190613,20200327,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,,,20200327.0,,CN,US,US,2020,Q1,Adult
164248062,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Chronic kidney disease,,2020,Q1,2,F,201001.0,20200320.0,20190613,20200327,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,,,20200327.0,,CN,US,US,2020,Q1,Adult
164248062,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Economic problem,,2020,Q1,2,F,201001.0,20200320.0,20190613,20200327,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,,,20200327.0,,CN,US,US,2020,Q1,Adult
164248062,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Emotional distress,,2020,Q1,2,F,201001.0,20200320.0,20190613,20200327,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,,,20200327.0,,CN,US,US,2020,Q1,Adult
164248062,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Pain,,2020,Q1,2,F,201001.0,20200320.0,20190613,20200327,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,,,20200327.0,,CN,US,US,2020,Q1,Adult
164288413,16428841,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2020,Q1,Cellulitis,,2020,Q1,3,F,2018.0,20200120.0,20190613,20200127,EXP,,PHHY2019GB134083,NOVARTIS,,85.0,YR,,M,Y,,,20200127.0,,HP,GB,GB,2020,Q1,Elderly
164288413,16428841,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2020,Q1,Labelled drug-drug interaction medication error,,2020,Q1,3,F,2018.0,20200120.0,20190613,20200127,EXP,,PHHY2019GB134083,NOVARTIS,,85.0,YR,,M,Y,,,20200127.0,,HP,GB,GB,2020,Q1,Elderly
164305473,16430547,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Blood cholesterol increased,,2020,Q1,3,F,,20200127.0,20190614,20200210,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-210400,RANBAXY,,72.0,YR,,M,Y,,,20200210.0,,HP,NL,ES,2020,Q1,Elderly
164305473,16430547,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Blood triglycerides increased,,2020,Q1,3,F,,20200127.0,20190614,20200210,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-210400,RANBAXY,,72.0,YR,,M,Y,,,20200210.0,,HP,NL,ES,2020,Q1,Elderly
164305473,16430547,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,3,F,,20200127.0,20190614,20200210,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-210400,RANBAXY,,72.0,YR,,M,Y,,,20200210.0,,HP,NL,ES,2020,Q1,Elderly
164305473,16430547,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,,20200127.0,20190614,20200210,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-210400,RANBAXY,,72.0,YR,,M,Y,,,20200210.0,,HP,NL,ES,2020,Q1,Elderly
164305473,16430547,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypertension,,2020,Q1,3,F,,20200127.0,20190614,20200210,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-210400,RANBAXY,,72.0,YR,,M,Y,,,20200210.0,,HP,NL,ES,2020,Q1,Elderly
164305473,16430547,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Overdose,,2020,Q1,3,F,,20200127.0,20190614,20200210,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-210400,RANBAXY,,72.0,YR,,M,Y,,,20200210.0,,HP,NL,ES,2020,Q1,Elderly
164305473,16430547,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Treatment noncompliance,,2020,Q1,3,F,,20200127.0,20190614,20200210,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-210400,RANBAXY,,72.0,YR,,M,Y,,,20200210.0,,HP,NL,ES,2020,Q1,Elderly
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Adverse drug reaction,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Arthralgia,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Condition aggravated,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Drug ineffective,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Gait inability,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Headache,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Hypoaesthesia,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Lower respiratory tract infection,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Pharyngitis,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
164449024,16444902,8,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Toothache,,2020,Q1,4,F,,20200311.0,20190618,20200319,EXP,2019-087650,CA-AUROBINDO-AUR-APL-2019-033840,AUROBINDO,,42.0,YR,,F,Y,,,20200319.0,,HP,CA,CA,2020,Q1,Adult
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Arthritis,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Brain natriuretic peptide abnormal,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Disease progression,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Dysphagia,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Fall,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Pulmonary arterial hypertension,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Rib fracture,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Scratch,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Syncope,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
1645458112,16454581,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,12,F,20181209.0,20200306.0,20190619,20200316,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20200316.0,,MD,SE,SE,2020,Q1,Elderly
164648342,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood cholesterol increased,,2020,Q1,2,F,,20200124.0,20190621,20200207,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20200207.0,,PH,ES,ES,2020,Q1,Elderly
164648342,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood triglycerides increased,,2020,Q1,2,F,,20200124.0,20190621,20200207,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20200207.0,,PH,ES,ES,2020,Q1,Elderly
164648342,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,2,F,,20200124.0,20190621,20200207,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20200207.0,,PH,ES,ES,2020,Q1,Elderly
164648342,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,,20200124.0,20190621,20200207,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20200207.0,,PH,ES,ES,2020,Q1,Elderly
164648342,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypertension,,2020,Q1,2,F,,20200124.0,20190621,20200207,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20200207.0,,PH,ES,ES,2020,Q1,Elderly
164648342,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Overdose,,2020,Q1,2,F,,20200124.0,20190621,20200207,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20200207.0,,PH,ES,ES,2020,Q1,Elderly
164648342,16464834,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,2,F,,20200124.0,20190621,20200207,EXP,,ES-SYNTHON BV-IN51PV19_48906,SYNTHON,,72.0,YR,,M,Y,,,20200207.0,,PH,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Abdominal discomfort,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Asphyxia,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Circulatory collapse,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Depressed mood,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Exostosis,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Gait disturbance,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hyperhidrosis,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hypotension,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Malaise,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Muscle spasms,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Nausea,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Pain in extremity,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Product selection error,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Skin ulcer,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164819742,16481974,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,,,,,206538.0,40.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Thirst,,2020,Q1,2,F,20190411.0,20200117.0,20190627,20200124,EXP,,ES-SA-2019SA104599,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20200124.0,,CN,ES,ES,2020,Q1,Elderly
164826673,16482667,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood cholesterol increased,,2020,Q1,3,F,,20200122.0,20190627,20200127,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-ACCORD-135166,ACCORD,,72.0,YR,,M,Y,,,20200127.0,,PH,ES,ES,2020,Q1,Elderly
164826673,16482667,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood triglycerides increased,,2020,Q1,3,F,,20200122.0,20190627,20200127,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-ACCORD-135166,ACCORD,,72.0,YR,,M,Y,,,20200127.0,,PH,ES,ES,2020,Q1,Elderly
164826673,16482667,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,3,F,,20200122.0,20190627,20200127,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-ACCORD-135166,ACCORD,,72.0,YR,,M,Y,,,20200127.0,,PH,ES,ES,2020,Q1,Elderly
164826673,16482667,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,,20200122.0,20190627,20200127,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-ACCORD-135166,ACCORD,,72.0,YR,,M,Y,,,20200127.0,,PH,ES,ES,2020,Q1,Elderly
164826673,16482667,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypertension,,2020,Q1,3,F,,20200122.0,20190627,20200127,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-ACCORD-135166,ACCORD,,72.0,YR,,M,Y,,,20200127.0,,PH,ES,ES,2020,Q1,Elderly
164826673,16482667,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Overdose,,2020,Q1,3,F,,20200122.0,20190627,20200127,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-ACCORD-135166,ACCORD,,72.0,YR,,M,Y,,,20200127.0,,PH,ES,ES,2020,Q1,Elderly
164826673,16482667,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,3,F,,20200122.0,20190627,20200127,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,ES-ACCORD-135166,ACCORD,,72.0,YR,,M,Y,,,20200127.0,,PH,ES,ES,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Acidosis,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Cardiac disorder,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Carotid artery stenosis,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Diabetes mellitus,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Fluid overload,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Haematuria,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hyperkalaemia,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hypertension,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hypomagnesaemia,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Nausea,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Pyelonephritis,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Serum sickness,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165219736,16521973,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Underdose,,2020,Q1,6,F,20181122.0,20200229.0,20190702,20200309,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20200309.0,,MD,FR,FR,2020,Q1,Elderly
165318994,16531899,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, TWICE DAILY (30 UNITS IN THE MORNING AND 30 UNITS IN THE NIGHT)",,,,,,,,30.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Bladder prolapse,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165318994,16531899,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, TWICE DAILY (30 UNITS IN THE MORNING AND 30 UNITS IN THE NIGHT)",,,,,,,,30.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Chills,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165318994,16531899,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, TWICE DAILY (30 UNITS IN THE MORNING AND 30 UNITS IN THE NIGHT)",,,,,,,,30.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Pyrexia,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165318994,16531899,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, TWICE DAILY (30 UNITS IN THE MORNING AND 30 UNITS IN THE NIGHT)",,,,,,,,30.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Urinary tract infection,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165318994,16531899,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, TWICE DAILY (30 UNITS IN THE MORNING AND 30 UNITS IN THE NIGHT)",,,,,,,,30.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Vomiting,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165318994,16531899,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Bladder prolapse,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165318994,16531899,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Chills,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165318994,16531899,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Pyrexia,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165318994,16531899,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Urinary tract infection,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165318994,16531899,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,25.0,IU,FORMULATION UNKNOWN,Q12H,2020,Q1,Vomiting,,2020,Q1,4,F,20190514.0,20200124.0,20190705,20200205,EXP,,CO-ASTELLAS-2019US022631,ASTELLAS,,63.0,YR,,F,Y,,,20200205.0,,CN,CO,CO,2020,Q1,Adult
165379875,16537987,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,5,F,,20200108.0,20190708,20200122,PER,,US-SA-2019SA178942,SANOFI AVENTIS,,14.0,YR,T,M,Y,,,20200122.0,,HP,US,US,2020,Q1,Youth
165379875,16537987,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,5,F,,20200108.0,20190708,20200122,PER,,US-SA-2019SA178942,SANOFI AVENTIS,,14.0,YR,T,M,Y,,,20200122.0,,HP,US,US,2020,Q1,Youth
165684819,16568481,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Anaemia,,2020,Q1,9,F,20190610.0,20200213.0,20190712,20200221,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,95.1,KG,20200221.0,,MD,FR,FR,2020,Q1,Elderly
165684819,16568481,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Angina pectoris,,2020,Q1,9,F,20190610.0,20200213.0,20190712,20200221,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,95.1,KG,20200221.0,,MD,FR,FR,2020,Q1,Elderly
165684819,16568481,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,9,F,20190610.0,20200213.0,20190712,20200221,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,95.1,KG,20200221.0,,MD,FR,FR,2020,Q1,Elderly
165684819,16568481,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,9,F,20190610.0,20200213.0,20190712,20200221,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,95.1,KG,20200221.0,,MD,FR,FR,2020,Q1,Elderly
165684819,16568481,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Skin ulcer,,2020,Q1,9,F,20190610.0,20200213.0,20190712,20200221,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,95.1,KG,20200221.0,,MD,FR,FR,2020,Q1,Elderly
165684819,16568481,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Tooth abscess,,2020,Q1,9,F,20190610.0,20200213.0,20190712,20200221,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,95.1,KG,20200221.0,,MD,FR,FR,2020,Q1,Elderly
165684819,16568481,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Urinary tract infection,,2020,Q1,9,F,20190610.0,20200213.0,20190712,20200221,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,95.1,KG,20200221.0,,MD,FR,FR,2020,Q1,Elderly
166237902,16623790,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2020,Q1,Arthralgia,,2020,Q1,2,F,,20200128.0,20190724,20200207,EXP,,CA-AUROBINDO-AUR-APL-2019-041708,AUROBINDO,,42.0,YR,,F,Y,,,20200207.0,,HP,CA,CA,2020,Q1,Adult
166237902,16623790,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2020,Q1,Condition aggravated,,2020,Q1,2,F,,20200128.0,20190724,20200207,EXP,,CA-AUROBINDO-AUR-APL-2019-041708,AUROBINDO,,42.0,YR,,F,Y,,,20200207.0,,HP,CA,CA,2020,Q1,Adult
166237902,16623790,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20200128.0,20190724,20200207,EXP,,CA-AUROBINDO-AUR-APL-2019-041708,AUROBINDO,,42.0,YR,,F,Y,,,20200207.0,,HP,CA,CA,2020,Q1,Adult
166237902,16623790,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2020,Q1,Gait inability,,2020,Q1,2,F,,20200128.0,20190724,20200207,EXP,,CA-AUROBINDO-AUR-APL-2019-041708,AUROBINDO,,42.0,YR,,F,Y,,,20200207.0,,HP,CA,CA,2020,Q1,Adult
166237902,16623790,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2020,Q1,Headache,,2020,Q1,2,F,,20200128.0,20190724,20200207,EXP,,CA-AUROBINDO-AUR-APL-2019-041708,AUROBINDO,,42.0,YR,,F,Y,,,20200207.0,,HP,CA,CA,2020,Q1,Adult
166237902,16623790,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2020,Q1,Hypoaesthesia,,2020,Q1,2,F,,20200128.0,20190724,20200207,EXP,,CA-AUROBINDO-AUR-APL-2019-041708,AUROBINDO,,42.0,YR,,F,Y,,,20200207.0,,HP,CA,CA,2020,Q1,Adult
166237902,16623790,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2020,Q1,Lower respiratory tract infection,,2020,Q1,2,F,,20200128.0,20190724,20200207,EXP,,CA-AUROBINDO-AUR-APL-2019-041708,AUROBINDO,,42.0,YR,,F,Y,,,20200207.0,,HP,CA,CA,2020,Q1,Adult
166237902,16623790,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2020,Q1,Pharyngitis,,2020,Q1,2,F,,20200128.0,20190724,20200207,EXP,,CA-AUROBINDO-AUR-APL-2019-041708,AUROBINDO,,42.0,YR,,F,Y,,,20200207.0,,HP,CA,CA,2020,Q1,Adult
166237902,16623790,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, ONCE A DAY",,,U,U,,,,,,SOLUTION,QD,2020,Q1,Toothache,,2020,Q1,2,F,,20200128.0,20190724,20200207,EXP,,CA-AUROBINDO-AUR-APL-2019-041708,AUROBINDO,,42.0,YR,,F,Y,,,20200207.0,,HP,CA,CA,2020,Q1,Adult
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Abdominal pain upper,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Amylase increased,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Blood creatine phosphokinase MB increased,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Blood creatine phosphokinase increased,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Bronchitis,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Chest pain,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Connective tissue disorder,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dry eye,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dry mouth,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dry skin,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Embolism,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Headache,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Myocardial infarction,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Nausea,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pain,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Prescribed underdose,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166619024,16661902,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,4,F,20190212.0,20200224.0,20190802,20200229,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200229.0,,MD,DE,DE,2020,Q1,Elderly
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Acute lymphocytic leukaemia recurrent,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Bone pain,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Catheter site infection,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Deep vein thrombosis,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Dry mouth,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Herpes virus infection,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Meningitis staphylococcal,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Muscle spasms,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Neck pain,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Night sweats,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Pulmonary embolism,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Sinusitis,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166710764,16671076,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Tremor,,2020,Q1,4,F,201902.0,20200224.0,20190805,20200226,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20200226.0,,CN,US,US,2020,Q1,Adult
166739922,16673992,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Diarrhoea,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Gastroenteritis,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Loss of consciousness,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Malaise,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Renal failure,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Vomiting,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, 9F150A,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diarrhoea,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, 9F150A,,,,,SOLUTION FOR INJECTION,,2020,Q1,Gastroenteritis,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, 9F150A,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, 9F150A,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, 9F150A,,,,,SOLUTION FOR INJECTION,,2020,Q1,Loss of consciousness,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, 9F150A,,,,,SOLUTION FOR INJECTION,,2020,Q1,Malaise,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, 9F150A,,,,,SOLUTION FOR INJECTION,,2020,Q1,Renal failure,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,Y,, 9F150A,,,,,SOLUTION FOR INJECTION,,2020,Q1,Vomiting,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED,,,Y,, 9F150A,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED,,,Y,, 9F150A,,,,,,,2020,Q1,Gastroenteritis,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED,,,Y,, 9F150A,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED,,,Y,, 9F150A,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED,,,Y,, 9F150A,,,,,,,2020,Q1,Loss of consciousness,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED,,,Y,, 9F150A,,,,,,,2020,Q1,Malaise,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED,,,Y,, 9F150A,,,,,,,2020,Q1,Renal failure,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166739922,16673992,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE REDUCED,,,Y,, 9F150A,,,,,,,2020,Q1,Vomiting,,2020,Q1,2,F,201902.0,20200217.0,20190806,20200227,EXP,,ES-BAUSCH-BL-2019-021832,BAUSCH AND LOMB,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,34 INTERNATIONAL UNIT,,,Y,U, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Diarrhoea,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,34 INTERNATIONAL UNIT,,,Y,U, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Gastroenteritis,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,34 INTERNATIONAL UNIT,,,Y,U, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,34 INTERNATIONAL UNIT,,,Y,U, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,34 INTERNATIONAL UNIT,,,Y,U, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Loss of consciousness,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,34 INTERNATIONAL UNIT,,,Y,U, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Malaise,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,34 INTERNATIONAL UNIT,,,Y,U, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Renal failure,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,34 INTERNATIONAL UNIT,,,Y,U, 9F150A,,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Vomiting,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Diarrhoea,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Gastroenteritis,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Loss of consciousness,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Malaise,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Renal failure,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
166808802,16680880,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Vomiting,,2020,Q1,2,F,201902.0,20200215.0,20190808,20200226,EXP,,ES-AUROBINDO-AUR-APL-2019-046319,AUROBINDO,,56.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
1670542710,16705427,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4 UNIT,,,U,,,,,4.0,DF,,,2020,Q1,Blood glucose increased,,2020,Q1,10,F,20190411.0,20200217.0,20190815,20200220,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-066927,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,49.1,KG,20200220.0,,MD,JP,JP,2020,Q1,Adult
1670542710,16705427,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4 UNIT,,,U,,,,,4.0,DF,,,2020,Q1,Hypophysitis,,2020,Q1,10,F,20190411.0,20200217.0,20190815,20200220,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-066927,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,49.1,KG,20200220.0,,MD,JP,JP,2020,Q1,Adult
1670542710,16705427,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4 UNIT,,,U,,,,,4.0,DF,,,2020,Q1,Impaired insulin secretion,,2020,Q1,10,F,20190411.0,20200217.0,20190815,20200220,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-066927,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,49.1,KG,20200220.0,,MD,JP,JP,2020,Q1,Adult
1670542710,16705427,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4 UNIT,,,U,,,,,4.0,DF,,,2020,Q1,Prescribed overdose,,2020,Q1,10,F,20190411.0,20200217.0,20190815,20200220,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-066927,BRISTOL MYERS SQUIBB,,54.0,YR,,M,Y,49.1,KG,20200220.0,,MD,JP,JP,2020,Q1,Adult
167056046,16705604,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,INJECTION,QD,2020,Q1,Cholangitis,,2020,Q1,6,F,20190604.0,20200207.0,20190815,20200218,PER,,JP-AMGEN-JPNCT2019129859,AMGEN,,67.0,YR,E,F,Y,45.0,KG,20200218.0,,MD,JP,JP,2020,Q1,Elderly
167056046,16705604,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,INJECTION,QD,2020,Q1,Cholangitis acute,,2020,Q1,6,F,20190604.0,20200207.0,20190815,20200218,PER,,JP-AMGEN-JPNCT2019129859,AMGEN,,67.0,YR,E,F,Y,45.0,KG,20200218.0,,MD,JP,JP,2020,Q1,Elderly
167056046,16705604,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,INJECTION,QD,2020,Q1,Diarrhoea,,2020,Q1,6,F,20190604.0,20200207.0,20190815,20200218,PER,,JP-AMGEN-JPNCT2019129859,AMGEN,,67.0,YR,E,F,Y,45.0,KG,20200218.0,,MD,JP,JP,2020,Q1,Elderly
167056046,16705604,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,INJECTION,QD,2020,Q1,Dyspnoea,,2020,Q1,6,F,20190604.0,20200207.0,20190815,20200218,PER,,JP-AMGEN-JPNCT2019129859,AMGEN,,67.0,YR,E,F,Y,45.0,KG,20200218.0,,MD,JP,JP,2020,Q1,Elderly
167056046,16705604,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,INJECTION,QD,2020,Q1,Erythema,,2020,Q1,6,F,20190604.0,20200207.0,20190815,20200218,PER,,JP-AMGEN-JPNCT2019129859,AMGEN,,67.0,YR,E,F,Y,45.0,KG,20200218.0,,MD,JP,JP,2020,Q1,Elderly
167056046,16705604,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,INJECTION,QD,2020,Q1,Neutrophil count decreased,,2020,Q1,6,F,20190604.0,20200207.0,20190815,20200218,PER,,JP-AMGEN-JPNCT2019129859,AMGEN,,67.0,YR,E,F,Y,45.0,KG,20200218.0,,MD,JP,JP,2020,Q1,Elderly
167056046,16705604,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,INJECTION,QD,2020,Q1,Oropharyngeal discomfort,,2020,Q1,6,F,20190604.0,20200207.0,20190815,20200218,PER,,JP-AMGEN-JPNCT2019129859,AMGEN,,67.0,YR,E,F,Y,45.0,KG,20200218.0,,MD,JP,JP,2020,Q1,Elderly
167056046,16705604,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,INJECTION,QD,2020,Q1,Pruritus,,2020,Q1,6,F,20190604.0,20200207.0,20190815,20200218,PER,,JP-AMGEN-JPNCT2019129859,AMGEN,,67.0,YR,E,F,Y,45.0,KG,20200218.0,,MD,JP,JP,2020,Q1,Elderly
167281034,16728103,44,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION,,2020,Q1,Anaphylactic reaction,,2020,Q1,4,F,,20200204.0,20190822,20200212,EXP,,CA-AUROBINDO-AUR-APL-2019-054279,AUROBINDO,,70.0,YR,,F,Y,,,20200212.0,,HP,CA,CA,2020,Q1,Elderly
167281034,16728103,44,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION,,2020,Q1,Drug intolerance,,2020,Q1,4,F,,20200204.0,20190822,20200212,EXP,,CA-AUROBINDO-AUR-APL-2019-054279,AUROBINDO,,70.0,YR,,F,Y,,,20200212.0,,HP,CA,CA,2020,Q1,Elderly
167364012,16736401,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, QD",,,D,, 9F217A,,206538.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20191223.0,20190823,20200106,PER,,US-SA-2019SA234314,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200106.0,,CN,US,US,2020,Q1,Elderly
167364012,16736401,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, QD",,,D,, 9F217A,,206538.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Product quality issue,,2020,Q1,2,F,,20191223.0,20190823,20200106,PER,,US-SA-2019SA234314,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200106.0,,CN,US,US,2020,Q1,Elderly
167364012,16736401,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, QD",,,D,, 9F217A,,206538.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Wrong technique in device usage process,,2020,Q1,2,F,,20191223.0,20190823,20200106,PER,,US-SA-2019SA234314,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200106.0,,CN,US,US,2020,Q1,Elderly
167364012,16736401,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCREASED DOSE,,,D,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20191223.0,20190823,20200106,PER,,US-SA-2019SA234314,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200106.0,,CN,US,US,2020,Q1,Elderly
167364012,16736401,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCREASED DOSE,,,D,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Product quality issue,,2020,Q1,2,F,,20191223.0,20190823,20200106,PER,,US-SA-2019SA234314,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200106.0,,CN,US,US,2020,Q1,Elderly
167364012,16736401,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INCREASED DOSE,,,D,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Wrong technique in device usage process,,2020,Q1,2,F,,20191223.0,20190823,20200106,PER,,US-SA-2019SA234314,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200106.0,,CN,US,US,2020,Q1,Elderly
167520212,16752021,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU,,,,, 9F6005A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hypoacusis,,2020,Q1,2,F,20170913.0,20200311.0,20190828,20200319,EXP,,US-SA-2019SA237378,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200319.0,,CN,US,US,2020,Q1,Elderly
167520212,16752021,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU,,,,, 9F6005A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Rehabilitation therapy,,2020,Q1,2,F,20170913.0,20200311.0,20190828,20200319,EXP,,US-SA-2019SA237378,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200319.0,,CN,US,US,2020,Q1,Elderly
167520212,16752021,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU,,,,, 9F6005A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Road traffic accident,,2020,Q1,2,F,20170913.0,20200311.0,20190828,20200319,EXP,,US-SA-2019SA237378,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200319.0,,CN,US,US,2020,Q1,Elderly
167520212,16752021,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,26 IU,,,,, 9F6005A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Seizure,,2020,Q1,2,F,20170913.0,20200311.0,20190828,20200319,EXP,,US-SA-2019SA237378,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200319.0,,CN,US,US,2020,Q1,Elderly
167520212,16752021,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNK,,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoacusis,,2020,Q1,2,F,20170913.0,20200311.0,20190828,20200319,EXP,,US-SA-2019SA237378,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200319.0,,CN,US,US,2020,Q1,Elderly
167520212,16752021,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNK,,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Rehabilitation therapy,,2020,Q1,2,F,20170913.0,20200311.0,20190828,20200319,EXP,,US-SA-2019SA237378,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200319.0,,CN,US,US,2020,Q1,Elderly
167520212,16752021,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNK,,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Road traffic accident,,2020,Q1,2,F,20170913.0,20200311.0,20190828,20200319,EXP,,US-SA-2019SA237378,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200319.0,,CN,US,US,2020,Q1,Elderly
167520212,16752021,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNK,,,,,,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Seizure,,2020,Q1,2,F,20170913.0,20200311.0,20190828,20200319,EXP,,US-SA-2019SA237378,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200319.0,,CN,US,US,2020,Q1,Elderly
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Acute respiratory failure,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Aphasia,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Aspergillus infection,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Bacterial sepsis,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Cytokine release syndrome,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Encephalopathy,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypogammaglobulinaemia,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Infection,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Lip disorder,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Mycobacterium abscessus infection,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Neurotoxicity,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
167730334,16773033,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,4,F,2019.0,20200206.0,20190904,20200210,EXP,,US-GILEAD-2019-0426068,GILEAD,,52.0,YR,A,F,Y,112.0,KG,20200210.0,,MD,US,US,2020,Q1,Adult
168145782,16814578,30,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,INJECTION,,2020,Q1,Constipation,,2020,Q1,2,F,20180320.0,20200122.0,20190917,20200203,EXP,,JP-UCBSA-2018049766,UCB,,77.0,YR,,M,Y,55.0,KG,20200203.0,,MD,JP,JP,2020,Q1,Elderly
168145782,16814578,30,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,INJECTION,,2020,Q1,Death,,2020,Q1,2,F,20180320.0,20200122.0,20190917,20200203,EXP,,JP-UCBSA-2018049766,UCB,,77.0,YR,,M,Y,55.0,KG,20200203.0,,MD,JP,JP,2020,Q1,Elderly
168145782,16814578,30,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,INJECTION,,2020,Q1,Decubitus ulcer,,2020,Q1,2,F,20180320.0,20200122.0,20190917,20200203,EXP,,JP-UCBSA-2018049766,UCB,,77.0,YR,,M,Y,55.0,KG,20200203.0,,MD,JP,JP,2020,Q1,Elderly
168145782,16814578,30,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,INJECTION,,2020,Q1,Diabetes mellitus,,2020,Q1,2,F,20180320.0,20200122.0,20190917,20200203,EXP,,JP-UCBSA-2018049766,UCB,,77.0,YR,,M,Y,55.0,KG,20200203.0,,MD,JP,JP,2020,Q1,Elderly
168145782,16814578,30,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,INJECTION,,2020,Q1,Hyponatraemia,,2020,Q1,2,F,20180320.0,20200122.0,20190917,20200203,EXP,,JP-UCBSA-2018049766,UCB,,77.0,YR,,M,Y,55.0,KG,20200203.0,,MD,JP,JP,2020,Q1,Elderly
168145782,16814578,30,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,INJECTION,,2020,Q1,Skin candida,,2020,Q1,2,F,20180320.0,20200122.0,20190917,20200203,EXP,,JP-UCBSA-2018049766,UCB,,77.0,YR,,M,Y,55.0,KG,20200203.0,,MD,JP,JP,2020,Q1,Elderly
168145782,16814578,30,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,INJECTION,,2020,Q1,Urinary tract infection,,2020,Q1,2,F,20180320.0,20200122.0,20190917,20200203,EXP,,JP-UCBSA-2018049766,UCB,,77.0,YR,,M,Y,55.0,KG,20200203.0,,MD,JP,JP,2020,Q1,Elderly
168193526,16819352,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Encephalopathy,,2020,Q1,6,F,20190911.0,20200108.0,20190917,20200113,EXP,,US-GILEAD-2019-0428171,GILEAD,,58.0,YR,A,F,Y,70.6,KG,20200113.0,,MD,US,US,2020,Q1,Adult
168193526,16819352,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Somnolence,,2020,Q1,6,F,20190911.0,20200108.0,20190917,20200113,EXP,,US-GILEAD-2019-0428171,GILEAD,,58.0,YR,A,F,Y,70.6,KG,20200113.0,,MD,US,US,2020,Q1,Adult
168210762,16821076,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, UNKNOWN,,,1.0,DF,,,2020,Q1,Abdominal pain upper,,2020,Q1,2,F,20190710.0,20200113.0,20190918,20200121,EXP,IT-MINISAL02-572511,IT-TEVA-2019-IT-1107604,TEVA,,51.0,YR,,M,Y,,,20200121.0,,MD,IT,IT,2020,Q1,Adult
168210762,16821076,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, UNKNOWN,,,1.0,DF,,,2020,Q1,Asthenia,,2020,Q1,2,F,20190710.0,20200113.0,20190918,20200121,EXP,IT-MINISAL02-572511,IT-TEVA-2019-IT-1107604,TEVA,,51.0,YR,,M,Y,,,20200121.0,,MD,IT,IT,2020,Q1,Adult
168210762,16821076,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, UNKNOWN,,,1.0,DF,,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,20190710.0,20200113.0,20190918,20200121,EXP,IT-MINISAL02-572511,IT-TEVA-2019-IT-1107604,TEVA,,51.0,YR,,M,Y,,,20200121.0,,MD,IT,IT,2020,Q1,Adult
168210762,16821076,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,, UNKNOWN,,,1.0,DF,,,2020,Q1,Nausea,,2020,Q1,2,F,20190710.0,20200113.0,20190918,20200121,EXP,IT-MINISAL02-572511,IT-TEVA-2019-IT-1107604,TEVA,,51.0,YR,,M,Y,,,20200121.0,,MD,IT,IT,2020,Q1,Adult
168288762,16828876,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,INJECTION,,2020,Q1,Dysphagia,,2020,Q1,2,F,20190825.0,20200219.0,20190919,20200304,EXP,,US-JNJFOC-20190925116,JOHNSON AND JOHNSON,,80.0,YR,,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
168288762,16828876,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,INJECTION,,2020,Q1,Hospitalisation,,2020,Q1,2,F,20190825.0,20200219.0,20190919,20200304,EXP,,US-JNJFOC-20190925116,JOHNSON AND JOHNSON,,80.0,YR,,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
168288762,16828876,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNITS UNDER THE SKIN AT BEDTIME,,,,,,,,,,INJECTION,,2020,Q1,Viral infection,,2020,Q1,2,F,20190825.0,20200219.0,20190919,20200304,EXP,,US-JNJFOC-20190925116,JOHNSON AND JOHNSON,,80.0,YR,,M,Y,,,20200304.0,,CN,US,US,2020,Q1,Elderly
168321083,16832108,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",,,Y,U,,,,1.0,DF,,QD,2020,Q1,Abdominal pain upper,,2020,Q1,3,F,20190710.0,20200109.0,20190920,20200120,EXP,,IT-AUROBINDO-AUR-APL-2019-060191,AUROBINDO,,51.0,YR,,M,Y,,,20200120.0,,MD,IT,IT,2020,Q1,Adult
168321083,16832108,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",,,Y,U,,,,1.0,DF,,QD,2020,Q1,Asthenia,,2020,Q1,3,F,20190710.0,20200109.0,20190920,20200120,EXP,,IT-AUROBINDO-AUR-APL-2019-060191,AUROBINDO,,51.0,YR,,M,Y,,,20200120.0,,MD,IT,IT,2020,Q1,Adult
168321083,16832108,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",,,Y,U,,,,1.0,DF,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,3,F,20190710.0,20200109.0,20190920,20200120,EXP,,IT-AUROBINDO-AUR-APL-2019-060191,AUROBINDO,,51.0,YR,,M,Y,,,20200120.0,,MD,IT,IT,2020,Q1,Adult
168321083,16832108,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",,,Y,U,,,,1.0,DF,,QD,2020,Q1,Nausea,,2020,Q1,3,F,20190710.0,20200109.0,20190920,20200120,EXP,,IT-AUROBINDO-AUR-APL-2019-060191,AUROBINDO,,51.0,YR,,M,Y,,,20200120.0,,MD,IT,IT,2020,Q1,Adult
168420872,16842087,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION,,2020,Q1,Hypoglycaemic unconsciousness,,2020,Q1,2,F,,20200124.0,20190923,20200203,EXP,,CA-AUROBINDO-AUR-APL-2019-060923,AUROBINDO,,53.0,YR,,F,Y,93.0,KG,20200203.0,,CN,CA,CA,2020,Q1,Adult
168786952,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Decreased appetite,,2020,Q1,2,F,20190301.0,20200324.0,20191002,20200331,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20200331.0,,MD,IT,IT,2020,Q1,Adult
168786952,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diarrhoea,,2020,Q1,2,F,20190301.0,20200324.0,20191002,20200331,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20200331.0,,MD,IT,IT,2020,Q1,Adult
168786952,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Nausea,,2020,Q1,2,F,20190301.0,20200324.0,20191002,20200331,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20200331.0,,MD,IT,IT,2020,Q1,Adult
168786952,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Pancreatic atrophy,,2020,Q1,2,F,20190301.0,20200324.0,20191002,20200331,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20200331.0,,MD,IT,IT,2020,Q1,Adult
168786952,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Pancreatic duct stenosis,,2020,Q1,2,F,20190301.0,20200324.0,20191002,20200331,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20200331.0,,MD,IT,IT,2020,Q1,Adult
168786952,16878695,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",2320.0,IU,,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Weight decreased,,2020,Q1,2,F,20190301.0,20200324.0,20191002,20200331,EXP,IT-MINISAL02-557219,IT-SA-2019SA170038,SANOFI AVENTIS,,64.0,YR,A,M,Y,72.0,KG,20200331.0,,MD,IT,IT,2020,Q1,Adult
168787894,16878789,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION (EXCEPT SYRUP),QD,2020,Q1,Acute kidney injury,,2020,Q1,4,F,20190819.0,20200305.0,20191002,20200311,EXP,,ES-INTERCEPT-CT2019001598,INTERCEPT PHARMACEUTICALS,,61.0,YR,,F,Y,64.0,KG,20200311.0,,MD,ES,ES,2020,Q1,Adult
168787894,16878789,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION (EXCEPT SYRUP),QD,2020,Q1,Acute on chronic liver failure,,2020,Q1,4,F,20190819.0,20200305.0,20191002,20200311,EXP,,ES-INTERCEPT-CT2019001598,INTERCEPT PHARMACEUTICALS,,61.0,YR,,F,Y,64.0,KG,20200311.0,,MD,ES,ES,2020,Q1,Adult
168787894,16878789,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION (EXCEPT SYRUP),QD,2020,Q1,Bile duct stone,,2020,Q1,4,F,20190819.0,20200305.0,20191002,20200311,EXP,,ES-INTERCEPT-CT2019001598,INTERCEPT PHARMACEUTICALS,,61.0,YR,,F,Y,64.0,KG,20200311.0,,MD,ES,ES,2020,Q1,Adult
168787894,16878789,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION (EXCEPT SYRUP),QD,2020,Q1,Cholangitis,,2020,Q1,4,F,20190819.0,20200305.0,20191002,20200311,EXP,,ES-INTERCEPT-CT2019001598,INTERCEPT PHARMACEUTICALS,,61.0,YR,,F,Y,64.0,KG,20200311.0,,MD,ES,ES,2020,Q1,Adult
168787894,16878789,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,SOLUTION (EXCEPT SYRUP),QD,2020,Q1,Hepatic encephalopathy,,2020,Q1,4,F,20190819.0,20200305.0,20191002,20200311,EXP,,ES-INTERCEPT-CT2019001598,INTERCEPT PHARMACEUTICALS,,61.0,YR,,F,Y,64.0,KG,20200311.0,,MD,ES,ES,2020,Q1,Adult
168825512,16882551,3,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,Y,,,,,8.0,IU,,,2020,Q1,Angina pectoris,,2020,Q1,2,F,20181104.0,20200129.0,20191003,20200204,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-104902",BOEHRINGER INGELHEIM,,64.0,YR,,M,Y,106.7,KG,20200204.0,,MD,JP,JP,2020,Q1,Adult
169356412,16935641,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML, QD",,,,,,,,,,,,2020,Q1,Psychotic disorder,,2020,Q1,2,F,20190922.0,20200306.0,20191018,20200316,EXP,,US-VERTEX PHARMACEUTICALS-2019-009932,VERTEX,,40.0,YR,,M,Y,57.0,KG,20200316.0,,MD,US,US,2020,Q1,Adult
169385034,16938503,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,4,F,20190903.0,20200217.0,20191019,20200221,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200221.0,,HP,US,US,2020,Q1,Adult
169385034,16938503,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,4,F,20190903.0,20200217.0,20191019,20200221,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200221.0,,HP,US,US,2020,Q1,Adult
169385034,16938503,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,4,F,20190903.0,20200217.0,20191019,20200221,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200221.0,,HP,US,US,2020,Q1,Adult
169443262,16944326,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Lung disorder,,2020,Q1,2,F,20190904.0,20200120.0,20191022,20200120,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-100455,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,51.0,KG,20200120.0,,PH,JP,JP,2020,Q1,Elderly
169471562,16947156,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"100UNIT/ML, INJECT 32 (THIRTY TWO) UNITS UNDER THE SKIN EVERY MORNING",,,U,,,,,,,,,2020,Q1,Auditory disorder,,2020,Q1,2,F,20190830.0,20200108.0,20191022,20200109,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098649,BRISTOL MYERS SQUIBB,,74.0,YR,,F,Y,85.26,KG,20200109.0,,MD,US,US,2020,Q1,Elderly
169471562,16947156,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"100UNIT/ML, INJECT 32 (THIRTY TWO) UNITS UNDER THE SKIN EVERY MORNING",,,U,,,,,,,,,2020,Q1,Middle ear effusion,,2020,Q1,2,F,20190830.0,20200108.0,20191022,20200109,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-098649,BRISTOL MYERS SQUIBB,,74.0,YR,,F,Y,85.26,KG,20200109.0,,MD,US,US,2020,Q1,Elderly
169538935,16953893,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Colitis ulcerative,,2020,Q1,5,F,20191217.0,20200204.0,20191023,20200212,EXP,,CA-TAKEDA-2019TUS059000,TAKEDA,,73.0,YR,,F,Y,,,20200212.0,,CN,CA,CA,2020,Q1,Elderly
169538935,16953893,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Off label use,,2020,Q1,5,F,20191217.0,20200204.0,20191023,20200212,EXP,,CA-TAKEDA-2019TUS059000,TAKEDA,,73.0,YR,,F,Y,,,20200212.0,,CN,CA,CA,2020,Q1,Elderly
169610133,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q1,Decreased appetite,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q1,Hypoglycaemia,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q1,Weight decreased,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q1,Decreased appetite,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q1,Hypoglycaemia,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q1,Weight decreased,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q1,Decreased appetite,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q1,Hypoglycaemia,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
169610133,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q1,Weight decreased,,2020,Q1,3,F,20181221.0,20200219.0,20191025,20200227,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20200227.0,,CN,ES,ES,2020,Q1,Adult
1696951021,16969510,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,DF,INJECTION,,2020,Q1,Heart injury,,2020,Q1,21,F,20191021.0,20200309.0,20191029,20200312,EXP,,CN-EISAI MEDICAL RESEARCH-EC-2019-064326,EISAI,,62.0,YR,,M,Y,69.0,KG,20200312.0,,MD,CN,CN,2020,Q1,Adult
169752102,16975210,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Angiofibroma,,2020,Q1,2,F,2019.0,20200120.0,20191030,20200122,EXP,,FR-ABBVIE-19K-056-2977460-00,ABBVIE,,69.0,YR,,M,Y,93.0,KG,20200122.0,,CN,FR,FR,2020,Q1,Elderly
169752102,16975210,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Leiomyoma,,2020,Q1,2,F,2019.0,20200120.0,20191030,20200122,EXP,,FR-ABBVIE-19K-056-2977460-00,ABBVIE,,69.0,YR,,M,Y,93.0,KG,20200122.0,,CN,FR,FR,2020,Q1,Elderly
169752102,16975210,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Prostatectomy,,2020,Q1,2,F,2019.0,20200120.0,20191030,20200122,EXP,,FR-ABBVIE-19K-056-2977460-00,ABBVIE,,69.0,YR,,M,Y,93.0,KG,20200122.0,,CN,FR,FR,2020,Q1,Elderly
169752102,16975210,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Prostatic adenoma,,2020,Q1,2,F,2019.0,20200120.0,20191030,20200122,EXP,,FR-ABBVIE-19K-056-2977460-00,ABBVIE,,69.0,YR,,M,Y,93.0,KG,20200122.0,,CN,FR,FR,2020,Q1,Elderly
169802742,16980274,6,C,TOUJEO/ GLARGINE,,2,Subcutaneous,SINCE 6 MONTHS AGO,,,,,,,,36.0,IU,,QD,2020,Q1,Deep vein thrombosis,,2020,Q1,2,F,20191002.0,20200102.0,20191031,20200110,EXP,,US-ASTRAZENECA-2019SF51688,ASTRAZENECA,,17207.0,DY,,M,Y,100.7,KG,20200110.0,,CN,US,US,2020,Q1,Elderly
169802742,16980274,6,C,TOUJEO/ GLARGINE,,2,Subcutaneous,SINCE 6 MONTHS AGO,,,,,,,,36.0,IU,,QD,2020,Q1,Headache,,2020,Q1,2,F,20191002.0,20200102.0,20191031,20200110,EXP,,US-ASTRAZENECA-2019SF51688,ASTRAZENECA,,17207.0,DY,,M,Y,100.7,KG,20200110.0,,CN,US,US,2020,Q1,Elderly
169802742,16980274,6,C,TOUJEO/ GLARGINE,,2,Subcutaneous,SINCE 6 MONTHS AGO,,,,,,,,36.0,IU,,QD,2020,Q1,Malaise,,2020,Q1,2,F,20191002.0,20200102.0,20191031,20200110,EXP,,US-ASTRAZENECA-2019SF51688,ASTRAZENECA,,17207.0,DY,,M,Y,100.7,KG,20200110.0,,CN,US,US,2020,Q1,Elderly
169802742,16980274,6,C,TOUJEO/ GLARGINE,,2,Subcutaneous,SINCE 6 MONTHS AGO,,,,,,,,36.0,IU,,QD,2020,Q1,Pain,,2020,Q1,2,F,20191002.0,20200102.0,20191031,20200110,EXP,,US-ASTRAZENECA-2019SF51688,ASTRAZENECA,,17207.0,DY,,M,Y,100.7,KG,20200110.0,,CN,US,US,2020,Q1,Elderly
169802742,16980274,6,C,TOUJEO/ GLARGINE,,2,Subcutaneous,SINCE 6 MONTHS AGO,,,,,,,,36.0,IU,,QD,2020,Q1,Pulmonary embolism,,2020,Q1,2,F,20191002.0,20200102.0,20191031,20200110,EXP,,US-ASTRAZENECA-2019SF51688,ASTRAZENECA,,17207.0,DY,,M,Y,100.7,KG,20200110.0,,CN,US,US,2020,Q1,Elderly
169802742,16980274,6,C,TOUJEO/ GLARGINE,,2,Subcutaneous,SINCE 6 MONTHS AGO,,,,,,,,36.0,IU,,QD,2020,Q1,Thirst,,2020,Q1,2,F,20191002.0,20200102.0,20191031,20200110,EXP,,US-ASTRAZENECA-2019SF51688,ASTRAZENECA,,17207.0,DY,,M,Y,100.7,KG,20200110.0,,CN,US,US,2020,Q1,Elderly
169990182,16999018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 U, QD",,,Y,U,,,,22.0,DF,INJECTION,QD,2020,Q1,Abdominal pain,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
169990182,16999018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 U, QD",,,Y,U,,,,22.0,DF,INJECTION,QD,2020,Q1,Appendicitis,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
169990182,16999018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 U, QD",,,Y,U,,,,22.0,DF,INJECTION,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
169990182,16999018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 U, QD",,,Y,U,,,,22.0,DF,INJECTION,QD,2020,Q1,Peritoneal abscess,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
169990182,16999018,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 U, QD",,,Y,U,,,,22.0,DF,INJECTION,QD,2020,Q1,Pyrexia,,2020,Q1,2,F,201706.0,20200116.0,20191106,20200129,EXP,,PHJP2017JP035137,NOVARTIS,,55.0,YR,,F,Y,74.6,KG,20200129.0,,CN,COUNTRY NOT SPECIFIED,JP,2020,Q1,Adult
170046394,17004639,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2020,Q1,Ascites,,2020,Q1,4,F,20190925.0,20200117.0,20191107,20200131,EXP,,JP-ROCHE-2460132,ROCHE,,58.0,YR,,M,Y,72.0,KG,20200131.0,,PH,JP,JP,2020,Q1,Adult
170046394,17004639,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2020,Q1,Gastric hypomotility,,2020,Q1,4,F,20190925.0,20200117.0,20191107,20200131,EXP,,JP-ROCHE-2460132,ROCHE,,58.0,YR,,M,Y,72.0,KG,20200131.0,,PH,JP,JP,2020,Q1,Adult
170046394,17004639,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2020,Q1,Lung disorder,,2020,Q1,4,F,20190925.0,20200117.0,20191107,20200131,EXP,,JP-ROCHE-2460132,ROCHE,,58.0,YR,,M,Y,72.0,KG,20200131.0,,PH,JP,JP,2020,Q1,Adult
170046394,17004639,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,4,F,20190925.0,20200117.0,20191107,20200131,EXP,,JP-ROCHE-2460132,ROCHE,,58.0,YR,,M,Y,72.0,KG,20200131.0,,PH,JP,JP,2020,Q1,Adult
170046394,17004639,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2020,Q1,Platelet count decreased,,2020,Q1,4,F,20190925.0,20200117.0,20191107,20200131,EXP,,JP-ROCHE-2460132,ROCHE,,58.0,YR,,M,Y,72.0,KG,20200131.0,,PH,JP,JP,2020,Q1,Adult
170046394,17004639,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE IS UNCERTAIN.,,,,,,,,,,,,2020,Q1,Small cell lung cancer,,2020,Q1,4,F,20190925.0,20200117.0,20191107,20200131,EXP,,JP-ROCHE-2460132,ROCHE,,58.0,YR,,M,Y,72.0,KG,20200131.0,,PH,JP,JP,2020,Q1,Adult
170086712,17008671,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,2,F,,20200225.0,20191108,20200302,EXP,GB-MHRA-EYC 00210654,GB-ELI_LILLY_AND_COMPANY-GB201911002346,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20200302.0,,MD,GB,GB,2020,Q1,Adult
170162085,17016208,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"16 IU, 1X/DAY",,,,,,,,16.0,IU,,QD,2020,Q1,Asthenia,,2020,Q1,5,F,20120711.0,20200313.0,20191111,20200318,EXP,,NL-PFIZER INC-2019481997,PFIZER,,78.0,YR,,F,Y,,,20200318.0,,MD,NL,NL,2020,Q1,Elderly
170162085,17016208,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"16 IU, 1X/DAY",,,,,,,,16.0,IU,,QD,2020,Q1,Confusional state,,2020,Q1,5,F,20120711.0,20200313.0,20191111,20200318,EXP,,NL-PFIZER INC-2019481997,PFIZER,,78.0,YR,,F,Y,,,20200318.0,,MD,NL,NL,2020,Q1,Elderly
170162085,17016208,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"16 IU, 1X/DAY",,,,,,,,16.0,IU,,QD,2020,Q1,Cystitis,,2020,Q1,5,F,20120711.0,20200313.0,20191111,20200318,EXP,,NL-PFIZER INC-2019481997,PFIZER,,78.0,YR,,F,Y,,,20200318.0,,MD,NL,NL,2020,Q1,Elderly
170162085,17016208,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"16 IU, 1X/DAY",,,,,,,,16.0,IU,,QD,2020,Q1,Hip fracture,,2020,Q1,5,F,20120711.0,20200313.0,20191111,20200318,EXP,,NL-PFIZER INC-2019481997,PFIZER,,78.0,YR,,F,Y,,,20200318.0,,MD,NL,NL,2020,Q1,Elderly
170162085,17016208,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"16 IU, 1X/DAY",,,,,,,,16.0,IU,,QD,2020,Q1,Off label use,,2020,Q1,5,F,20120711.0,20200313.0,20191111,20200318,EXP,,NL-PFIZER INC-2019481997,PFIZER,,78.0,YR,,F,Y,,,20200318.0,,MD,NL,NL,2020,Q1,Elderly
170162085,17016208,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"16 IU, 1X/DAY",,,,,,,,16.0,IU,,QD,2020,Q1,Postoperative delirium,,2020,Q1,5,F,20120711.0,20200313.0,20191111,20200318,EXP,,NL-PFIZER INC-2019481997,PFIZER,,78.0,YR,,F,Y,,,20200318.0,,MD,NL,NL,2020,Q1,Elderly
170232443,17023244,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,QN,,,,,,,,6.0,DF,,QD,2020,Q1,Pneumonia,,2020,Q1,3,F,20190926.0,20200111.0,20191112,20200115,EXP,,CN-ABBVIE-19P-035-2989891-00,ABBVIE,,73.0,YR,,M,Y,86.0,KG,20200115.0,,MD,CN,CN,2020,Q1,Elderly
170232443,17023244,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,QN,,,,,,,,10.0,IU,,QD,2020,Q1,Pneumonia,,2020,Q1,3,F,20190926.0,20200111.0,20191112,20200115,EXP,,CN-ABBVIE-19P-035-2989891-00,ABBVIE,,73.0,YR,,M,Y,86.0,KG,20200115.0,,MD,CN,CN,2020,Q1,Elderly
170232443,17023244,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,QN,,,,,,,,12.0,DF,,QD,2020,Q1,Pneumonia,,2020,Q1,3,F,20190926.0,20200111.0,20191112,20200115,EXP,,CN-ABBVIE-19P-035-2989891-00,ABBVIE,,73.0,YR,,M,Y,86.0,KG,20200115.0,,MD,CN,CN,2020,Q1,Elderly
170255612,17025561,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,2,F,,20200228.0,20191113,20200304,EXP,GB-MHRA-EYC 00210654,GB-SA-2019SA310040,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200304.0,,MD,GB,GB,2020,Q1,Adult
170255612,17025561,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Withdrawal syndrome,,2020,Q1,2,F,,20200228.0,20191113,20200304,EXP,GB-MHRA-EYC 00210654,GB-SA-2019SA310040,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20200304.0,,MD,GB,GB,2020,Q1,Adult
170282952,17028295,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,2,F,,20200225.0,20191113,20200304,EXP,GB-MHRA-EYC 00210654,GB-NOVOPROD-694712,NOVO NORDISK,,57.0,YR,,F,Y,,,20200304.0,,MD,GB,GB,2020,Q1,Adult
170615444,17061544,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,Y,U,,,,,,INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,4,F,,20200124.0,20191121,20200206,EXP,,CZ-MYLANLABS-2019M1111280,MYLAN,MAULE P.. TRESIBA. POMUE NAM JETE DALI BAZALNI ANALOG?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):53-55,69.0,YR,,M,Y,,,20200206.0,,MD,CZ,CZ,2020,Q1,Elderly
170745002,17074500,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Haemorrhagic stroke,,2020,Q1,2,F,,20200121.0,20191126,20200127,EXP,,RO-ELI_LILLY_AND_COMPANY-RO201911010018,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20200127.0,,CN,RO,RO,2020,Q1,Adult
170889993,17088999,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, QD",,,U,,,,,1.0,DF,,QD,2020,Q1,Tubulointerstitial nephritis,,2020,Q1,3,F,20191018.0,20200205.0,20191128,20200211,EXP,,JP-009507513-1911JPN002530J,MERCK,,79.0,YR,,F,Y,47.0,KG,20200211.0,,CN,JP,JP,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Diabetes mellitus,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Drug hypersensitivity,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Dyspepsia,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Muscle spasms,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170947555,17094755,16,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),48 UNITS,,,U,,,,,,,,,2020,Q1,Neutrophilia,,2020,Q1,5,F,201604.0,20200107.0,20191130,20200117,EXP,,CZ-AUROBINDO-AUR-APL-2019-075426,AUROBINDO,TOMANEK P. PRVN? ZKUSENOST S T??DENN? HLADOVKOU U OB?ZN? DIABETI?KY 2. TYPU S V?ZNAMNOU INZULINOREZISTENC?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,,F,Y,,,20200117.0,,HP,CZ,CZ,2020,Q1,Elderly
170996264,17099626,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Pleural effusion,,2020,Q1,4,F,20191112.0,20200109.0,20191202,20200123,EXP,,NVSC2019CN041826,NOVARTIS,,50.0,YR,,F,Y,53.0,KG,20200123.0,,MD,CN,CN,2020,Q1,Adult
170998192,17099819,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS ONCE DAILY,,,,,,,,,,,QD,2020,Q1,Herpes zoster,,2020,Q1,2,F,20191114.0,20200108.0,20191202,20200121,EXP,,US-ROCHE-2482986,ROCHE,,45.0,YR,,M,Y,79.45,KG,20200121.0,,CN,US,US,2020,Q1,Adult
170998192,17099819,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 UNITS ONCE DAILY,,,,,,,,,,,QD,2020,Q1,Multiple sclerosis relapse,,2020,Q1,2,F,20191114.0,20200108.0,20191202,20200121,EXP,,US-ROCHE-2482986,ROCHE,,45.0,YR,,M,Y,79.45,KG,20200121.0,,CN,US,US,2020,Q1,Adult
171040153,17104015,3,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,,,2020,Q1,Oedematous pancreatitis,,2020,Q1,3,F,,20200129.0,20191203,20200211,EXP,,CZ-AUROBINDO-AUR-APL-2019-076276,AUROBINDO,MAULE P. TRESIBA POMUE NAM JETE DALI BAZALNI ANALOG?. KAZUISTIKY V DIABETOLOGII. 2019;17(3):53-55,69.0,YR,,M,Y,,,20200211.0,,MD,CZ,CZ,2020,Q1,Elderly
171040262,17104026,5,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),300 U/ML,,,U,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200131.0,20191203,20200212,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20200212.0,,MD,CZ,CZ,2020,Q1,Adult
171040262,17104026,5,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),300 U/ML,,,U,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,,20200131.0,20191203,20200212,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20200212.0,,MD,CZ,CZ,2020,Q1,Adult
171040262,17104026,5,C,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),300 U/ML,,,U,,,,,,,,,2020,Q1,Weight increased,,2020,Q1,2,F,,20200131.0,20191203,20200212,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20200212.0,,MD,CZ,CZ,2020,Q1,Adult
171113692,17111369,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, HS (AT BEDTIME)",,,U,,,,21081.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Peripheral swelling,,2020,Q1,2,F,20191102.0,20200113.0,20191204,20200116,EXP,,ZA-SA-2019SA334597,SANOFI AVENTIS,,39.0,YR,A,F,Y,,,20200116.0,,CN,ZA,ZA,2020,Q1,Adult
171113692,17111369,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, HS (AT BEDTIME)",,,U,,,,21081.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Rash,,2020,Q1,2,F,20191102.0,20200113.0,20191204,20200116,EXP,,ZA-SA-2019SA334597,SANOFI AVENTIS,,39.0,YR,A,F,Y,,,20200116.0,,CN,ZA,ZA,2020,Q1,Adult
171113692,17111369,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"10 IU, HS (AT BEDTIME)",,,U,,,,21081.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Weight increased,,2020,Q1,2,F,20191102.0,20200113.0,20191204,20200116,EXP,,ZA-SA-2019SA334597,SANOFI AVENTIS,,39.0,YR,A,F,Y,,,20200116.0,,CN,ZA,ZA,2020,Q1,Adult
171120122,17112012,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Duodenal ulcer,,2020,Q1,2,F,20191007.0,20200225.0,20191204,20200228,EXP,,JP-GILEAD-2019-0439459,GILEAD,,71.0,YR,E,F,Y,43.0,KG,20200228.0,,MD,JP,JP,2020,Q1,Elderly
171120122,17112012,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Hepatocellular carcinoma,,2020,Q1,2,F,20191007.0,20200225.0,20191204,20200228,EXP,,JP-GILEAD-2019-0439459,GILEAD,,71.0,YR,E,F,Y,43.0,KG,20200228.0,,MD,JP,JP,2020,Q1,Elderly
171204272,17120427,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,INJECTION,QD,2020,Q1,Hepatic function abnormal,,2020,Q1,2,F,20190621.0,20200107.0,20191206,20200115,EXP,,JP-ASTRAZENECA-2019SF73177,ASTRAZENECA,,24608.0,DY,,M,Y,45.0,KG,20200115.0,,,JP,JP,2020,Q1,Elderly
171205502,17120550,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",14436.0,IU,Y,U, D004690C,,205692.0,18.0,IU,INJECTION,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,2,F,20191115.0,20200109.0,20191206,20200123,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201911014062,ELI LILLY AND CO,,76.0,YR,,F,Y,67.0,KG,20200123.0,,CN,JP,JP,2020,Q1,Elderly
171205502,17120550,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",14436.0,IU,Y,U, D004690C,,205692.0,18.0,IU,INJECTION,QD,2020,Q1,Product dose omission,,2020,Q1,2,F,20191115.0,20200109.0,20191206,20200123,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201911014062,ELI LILLY AND CO,,76.0,YR,,F,Y,67.0,KG,20200123.0,,CN,JP,JP,2020,Q1,Elderly
171227513,17122751,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Biopsy thyroid gland,,2020,Q1,3,F,20190711.0,20200124.0,20191206,20200205,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200205.0,,MD,DE,DE,2020,Q1,Adult
171227513,17122751,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Bronchitis,,2020,Q1,3,F,20190711.0,20200124.0,20191206,20200205,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200205.0,,MD,DE,DE,2020,Q1,Adult
171227513,17122751,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Catheterisation cardiac,,2020,Q1,3,F,20190711.0,20200124.0,20191206,20200205,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200205.0,,MD,DE,DE,2020,Q1,Adult
171227513,17122751,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Magnetic resonance imaging liver abnormal,,2020,Q1,3,F,20190711.0,20200124.0,20191206,20200205,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200205.0,,MD,DE,DE,2020,Q1,Adult
171227513,17122751,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,3,F,20190711.0,20200124.0,20191206,20200205,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200205.0,,MD,DE,DE,2020,Q1,Adult
171227513,17122751,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Thyroid mass,,2020,Q1,3,F,20190711.0,20200124.0,20191206,20200205,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200205.0,,MD,DE,DE,2020,Q1,Adult
171227513,17122751,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Transplant evaluation,,2020,Q1,3,F,20190711.0,20200124.0,20191206,20200205,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200205.0,,MD,DE,DE,2020,Q1,Adult
171250463,17125046,9,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,"3 U, QD",,,D,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Depressed level of consciousness,,2020,Q1,3,F,201909.0,20200214.0,20191206,20200221,EXP,,JP-009507513-1912JPN000143J,MERCK,,59.0,YR,,M,Y,58.0,KG,20200221.0,,CN,JP,JP,2020,Q1,Adult
171250463,17125046,9,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,"3 U, QD",,,D,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Fall,,2020,Q1,3,F,201909.0,20200214.0,20191206,20200221,EXP,,JP-009507513-1912JPN000143J,MERCK,,59.0,YR,,M,Y,58.0,KG,20200221.0,,CN,JP,JP,2020,Q1,Adult
171250463,17125046,9,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,"3 U, QD",,,D,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Haemoptysis,,2020,Q1,3,F,201909.0,20200214.0,20191206,20200221,EXP,,JP-009507513-1912JPN000143J,MERCK,,59.0,YR,,M,Y,58.0,KG,20200221.0,,CN,JP,JP,2020,Q1,Adult
171250463,17125046,9,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,"3 U, QD",,,D,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,"Hallucination, visual",,2020,Q1,3,F,201909.0,20200214.0,20191206,20200221,EXP,,JP-009507513-1912JPN000143J,MERCK,,59.0,YR,,M,Y,58.0,KG,20200221.0,,CN,JP,JP,2020,Q1,Adult
171250463,17125046,9,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,"3 U, QD",,,D,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Respiratory failure,,2020,Q1,3,F,201909.0,20200214.0,20191206,20200221,EXP,,JP-009507513-1912JPN000143J,MERCK,,59.0,YR,,M,Y,58.0,KG,20200221.0,,CN,JP,JP,2020,Q1,Adult
171250463,17125046,9,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,"3 U, QD",,,D,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Respiratory tract haemorrhage,,2020,Q1,3,F,201909.0,20200214.0,20191206,20200221,EXP,,JP-009507513-1912JPN000143J,MERCK,,59.0,YR,,M,Y,58.0,KG,20200221.0,,CN,JP,JP,2020,Q1,Adult
171250463,17125046,9,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,"3 U, QD",,,D,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Vascular rupture,,2020,Q1,3,F,201909.0,20200214.0,20191206,20200221,EXP,,JP-009507513-1912JPN000143J,MERCK,,59.0,YR,,M,Y,58.0,KG,20200221.0,,CN,JP,JP,2020,Q1,Adult
171294392,17129439,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 IU,,,Y,," 9F150A, 9F375A",,,34.0,IU,INJECTION,,2020,Q1,Diarrhoea,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 IU,,,Y,," 9F150A, 9F375A",,,34.0,IU,INJECTION,,2020,Q1,Gastroenteritis,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 IU,,,Y,," 9F150A, 9F375A",,,34.0,IU,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 IU,,,Y,," 9F150A, 9F375A",,,34.0,IU,INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 IU,,,Y,," 9F150A, 9F375A",,,34.0,IU,INJECTION,,2020,Q1,Loss of consciousness,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 IU,,,Y,," 9F150A, 9F375A",,,34.0,IU,INJECTION,,2020,Q1,Malaise,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 IU,,,Y,," 9F150A, 9F375A",,,34.0,IU,INJECTION,,2020,Q1,Renal failure,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,34 IU,,,Y,," 9F150A, 9F375A",,,34.0,IU,INJECTION,,2020,Q1,Vomiting,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Diarrhoea,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Gastroenteritis,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Loss of consciousness,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Malaise,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Renal failure,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171294392,17129439,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,,,,,,,INJECTION,,2020,Q1,Vomiting,,2020,Q1,2,F,201902.0,20200307.0,20191209,20200316,EXP,,ES-MYLANLABS-2019M1119514,MYLAN,,56.0,YR,,F,Y,,,20200316.0,,CN,ES,ES,2020,Q1,Adult
171419802,17141980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Arthritis,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Dysphagia,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Fall,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Scratch,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171419802,17141980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2020,Q1,Tachycardia,,2020,Q1,2,F,20181209.0,20200130.0,20191211,20200206,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20200206.0,,CN,SE,SE,2020,Q1,Elderly
171538702,17153870,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Agitation,,2020,Q1,2,F,201912.0,20200106.0,20191213,20200109,EXP,,US-GILEAD-2019-0442515,GILEAD,,61.0,YR,A,M,Y,,,20200109.0,,HP,US,US,2020,Q1,Adult
171538702,17153870,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Aphasia,,2020,Q1,2,F,201912.0,20200106.0,20191213,20200109,EXP,,US-GILEAD-2019-0442515,GILEAD,,61.0,YR,A,M,Y,,,20200109.0,,HP,US,US,2020,Q1,Adult
171538702,17153870,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,2,F,201912.0,20200106.0,20191213,20200109,EXP,,US-GILEAD-2019-0442515,GILEAD,,61.0,YR,A,M,Y,,,20200109.0,,HP,US,US,2020,Q1,Adult
171538702,17153870,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Confusional state,,2020,Q1,2,F,201912.0,20200106.0,20191213,20200109,EXP,,US-GILEAD-2019-0442515,GILEAD,,61.0,YR,A,M,Y,,,20200109.0,,HP,US,US,2020,Q1,Adult
171538702,17153870,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Cytokine release syndrome,,2020,Q1,2,F,201912.0,20200106.0,20191213,20200109,EXP,,US-GILEAD-2019-0442515,GILEAD,,61.0,YR,A,M,Y,,,20200109.0,,HP,US,US,2020,Q1,Adult
171538702,17153870,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Ileus,,2020,Q1,2,F,201912.0,20200106.0,20191213,20200109,EXP,,US-GILEAD-2019-0442515,GILEAD,,61.0,YR,A,M,Y,,,20200109.0,,HP,US,US,2020,Q1,Adult
171538702,17153870,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Neurotoxicity,,2020,Q1,2,F,201912.0,20200106.0,20191213,20200109,EXP,,US-GILEAD-2019-0442515,GILEAD,,61.0,YR,A,M,Y,,,20200109.0,,HP,US,US,2020,Q1,Adult
171538702,17153870,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Tremor,,2020,Q1,2,F,201912.0,20200106.0,20191213,20200109,EXP,,US-GILEAD-2019-0442515,GILEAD,,61.0,YR,A,M,Y,,,20200109.0,,HP,US,US,2020,Q1,Adult
171728242,17172824,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Acute myocardial infarction,,2020,Q1,2,F,20191213.0,20200206.0,20191218,20200208,EXP,,US-TAKEDA-2019TUS071567,TAKEDA,,61.0,YR,,F,Y,133.79,KG,20200208.0,,MD,US,US,2020,Q1,Adult
171728242,17172824,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Asthma,,2020,Q1,2,F,20191213.0,20200206.0,20191218,20200208,EXP,,US-TAKEDA-2019TUS071567,TAKEDA,,61.0,YR,,F,Y,133.79,KG,20200208.0,,MD,US,US,2020,Q1,Adult
171728242,17172824,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,2,F,20191213.0,20200206.0,20191218,20200208,EXP,,US-TAKEDA-2019TUS071567,TAKEDA,,61.0,YR,,F,Y,133.79,KG,20200208.0,,MD,US,US,2020,Q1,Adult
171728242,17172824,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,2,F,20191213.0,20200206.0,20191218,20200208,EXP,,US-TAKEDA-2019TUS071567,TAKEDA,,61.0,YR,,F,Y,133.79,KG,20200208.0,,MD,US,US,2020,Q1,Adult
171829482,17182948,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2020,Q1,Vitamin B1 deficiency,,2020,Q1,2,F,20191016.0,20200114.0,20191220,20200122,EXP,,US-CELGENEUS-USA-20191205924,CELGENE,,78.0,YR,,M,Y,90.0,KG,20200122.0,,MD,US,US,2020,Q1,Elderly
171865573,17186557,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q1,Hepatitis,,2020,Q1,3,F,20191210.0,20191227.0,20191220,20200102,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-119566,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,62.0,KG,20200102.0,,HP,CN,CN,2020,Q1,Elderly
171954352,17195435,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,2,F,,20200103.0,20191224,20200109,EXP,,US-TEVA-2019-US-1156678,TEVA,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
171954352,17195435,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Cardiac arrest,,2020,Q1,2,F,,20200103.0,20191224,20200109,EXP,,US-TEVA-2019-US-1156678,TEVA,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
171954352,17195435,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Cardiomegaly,,2020,Q1,2,F,,20200103.0,20191224,20200109,EXP,,US-TEVA-2019-US-1156678,TEVA,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
171954352,17195435,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Cardiopulmonary failure,,2020,Q1,2,F,,20200103.0,20191224,20200109,EXP,,US-TEVA-2019-US-1156678,TEVA,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
171954352,17195435,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,2,F,,20200103.0,20191224,20200109,EXP,,US-TEVA-2019-US-1156678,TEVA,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
171954352,17195435,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Pericardial effusion,,2020,Q1,2,F,,20200103.0,20191224,20200109,EXP,,US-TEVA-2019-US-1156678,TEVA,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
171954352,17195435,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,2,F,,20200103.0,20191224,20200109,EXP,,US-TEVA-2019-US-1156678,TEVA,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
171954582,17195458,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 U,,,,,,,,8.0,DF,INJECTION,,2020,Q1,Cholangitis,,2020,Q1,2,F,20190717.0,20200312.0,20191224,20200318,EXP,,NVSJ2019JP005737,NOVARTIS,,77.0,YR,,F,Y,45.0,KG,20200318.0,,MD,JP,JP,2020,Q1,Elderly
171954582,17195458,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 U,,,,,,,,8.0,DF,INJECTION,,2020,Q1,Hepatic enzyme increased,,2020,Q1,2,F,20190717.0,20200312.0,20191224,20200318,EXP,,NVSJ2019JP005737,NOVARTIS,,77.0,YR,,F,Y,45.0,KG,20200318.0,,MD,JP,JP,2020,Q1,Elderly
171954582,17195458,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 U,,,,,,,,8.0,DF,INJECTION,,2020,Q1,Liver disorder,,2020,Q1,2,F,20190717.0,20200312.0,20191224,20200318,EXP,,NVSJ2019JP005737,NOVARTIS,,77.0,YR,,F,Y,45.0,KG,20200318.0,,MD,JP,JP,2020,Q1,Elderly
172046432,17204643,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Confusional state,,2020,Q1,2,F,20190725.0,20200212.0,20191226,20200221,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20200221.0,,HP,CA,CA,2020,Q1,Elderly
172046432,17204643,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,2,F,20190725.0,20200212.0,20191226,20200221,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20200221.0,,HP,CA,CA,2020,Q1,Elderly
172046432,17204643,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Hot flush,,2020,Q1,2,F,20190725.0,20200212.0,20191226,20200221,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20200221.0,,HP,CA,CA,2020,Q1,Elderly
172046432,17204643,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Kidney infection,,2020,Q1,2,F,20190725.0,20200212.0,20191226,20200221,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20200221.0,,HP,CA,CA,2020,Q1,Elderly
172046432,17204643,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Off label use,,2020,Q1,2,F,20190725.0,20200212.0,20191226,20200221,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20200221.0,,HP,CA,CA,2020,Q1,Elderly
172046432,17204643,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Sleep apnoea syndrome,,2020,Q1,2,F,20190725.0,20200212.0,20191226,20200221,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20200221.0,,HP,CA,CA,2020,Q1,Elderly
172049972,17204997,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Asthenia,,2020,Q1,2,F,2018.0,20191219.0,20191227,20200103,EXP,,TR-ASTELLAS-2019US051023,ASTELLAS,,82.0,YR,,M,Y,,,20200103.0,,MD,TR,TR,2020,Q1,Elderly
172049972,17204997,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Fatigue,,2020,Q1,2,F,2018.0,20191219.0,20191227,20200103,EXP,,TR-ASTELLAS-2019US051023,ASTELLAS,,82.0,YR,,M,Y,,,20200103.0,,MD,TR,TR,2020,Q1,Elderly
172049972,17204997,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Malignant neoplasm progression,,2020,Q1,2,F,2018.0,20191219.0,20191227,20200103,EXP,,TR-ASTELLAS-2019US051023,ASTELLAS,,82.0,YR,,M,Y,,,20200103.0,,MD,TR,TR,2020,Q1,Elderly
172049972,17204997,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Oedema peripheral,,2020,Q1,2,F,2018.0,20191219.0,20191227,20200103,EXP,,TR-ASTELLAS-2019US051023,ASTELLAS,,82.0,YR,,M,Y,,,20200103.0,,MD,TR,TR,2020,Q1,Elderly
172185822,17218582,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Abdominal pain,,2020,Q1,2,F,,20200102.0,20191231,20200117,EXP,,US-ZYDUS-045009,ZYDUS PHARM,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING?LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200117.0,,HP,US,US,2020,Q1,Adult
172185822,17218582,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Atrial fibrillation,Atrial fibrillation,2020,Q1,2,F,,20200102.0,20191231,20200117,EXP,,US-ZYDUS-045009,ZYDUS PHARM,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING?LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200117.0,,HP,US,US,2020,Q1,Adult
172185822,17218582,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Confusional state,,2020,Q1,2,F,,20200102.0,20191231,20200117,EXP,,US-ZYDUS-045009,ZYDUS PHARM,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING?LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200117.0,,HP,US,US,2020,Q1,Adult
172185822,17218582,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,2,F,,20200102.0,20191231,20200117,EXP,,US-ZYDUS-045009,ZYDUS PHARM,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING?LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200117.0,,HP,US,US,2020,Q1,Adult
172185822,17218582,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Lactic acidosis,Lactic acidosis,2020,Q1,2,F,,20200102.0,20191231,20200117,EXP,,US-ZYDUS-045009,ZYDUS PHARM,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING?LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200117.0,,HP,US,US,2020,Q1,Adult
172185822,17218582,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,2,F,,20200102.0,20191231,20200117,EXP,,US-ZYDUS-045009,ZYDUS PHARM,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING?LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200117.0,,HP,US,US,2020,Q1,Adult
172185822,17218582,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Toxicity to various agents,Toxicity to various agents,2020,Q1,2,F,,20200102.0,20191231,20200117,EXP,,US-ZYDUS-045009,ZYDUS PHARM,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING?LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200117.0,,HP,US,US,2020,Q1,Adult
172185822,17218582,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,2,F,,20200102.0,20191231,20200117,EXP,,US-ZYDUS-045009,ZYDUS PHARM,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN-ASSOCIATED LACTIC ACIDOSIS PRESENTING?LIKE ACUTE MESENTERIC ISCHEMIA. J-EMERG-MED 2019;57(5):720-722.",60.0,YR,,F,Y,,,20200117.0,,HP,US,US,2020,Q1,Adult
172213322,17221332,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,CUTANEOUS SOLUTION,QD,2020,Q1,Blood pressure increased,,2020,Q1,2,F,20191128.0,20200116.0,20191231,20200122,EXP,,"RU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-122353",BOEHRINGER INGELHEIM,,62.0,YR,,F,Y,68.0,KG,20200123.0,,MD,RU,RU,2020,Q1,Adult
172213322,17221332,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,CUTANEOUS SOLUTION,QD,2020,Q1,Ketosis,,2020,Q1,2,F,20191128.0,20200116.0,20191231,20200122,EXP,,"RU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-122353",BOEHRINGER INGELHEIM,,62.0,YR,,F,Y,68.0,KG,20200123.0,,MD,RU,RU,2020,Q1,Adult
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Anaemia,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Cold sweat,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Constipation,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Death,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Delirium,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Femur fracture,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Gastric ulcer,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Hypotension,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Memory impairment,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Neuropathy peripheral,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Pain,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236093,17223609,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,18.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Urinary tract infection,,2020,Q1,3,F,20191206.0,20200205.0,20200102,20200212,EXP,,CO-ASTELLAS-2019US052017,ASTELLAS,,81.0,YR,,M,Y,,,20200212.0,,CN,CO,CO,2020,Q1,Elderly
172236781,17223678,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,20.0,IU,,QD,2020,Q1,Acute myocardial infarction,,2020,Q1,1,I,,20191222.0,20200102,20200102,EXP,,US-USP-000075,USPHARMA,"SAEED M, GIL GS, LOPEZ PD, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019 DEC 17. DOI:10.1097/MJT.0000000000000699",54.0,YR,A,,Y,,,20200102.0,,MD,US,US,2020,Q1,Adult
172236781,17223678,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT BEDTIME,,,,,,,,20.0,IU,,QD,2020,Q1,Product use in unapproved indication,,2020,Q1,1,I,,20191222.0,20200102,20200102,EXP,,US-USP-000075,USPHARMA,"SAEED M, GIL GS, LOPEZ PD, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019 DEC 17. DOI:10.1097/MJT.0000000000000699",54.0,YR,A,,Y,,,20200102.0,,MD,US,US,2020,Q1,Adult
172270041,17227004,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,32.0,IU,,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20191227.0,20200103,20200103,EXP,,"IE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-122581",BOEHRINGER INGELHEIM,"FINUCANE F, RAFEY M, BUTT A, COFFEY B, REDDINGTON L, DEVITT A, ET AL. PROLONGED ACIDOSIS IS A FEATURE OF SGLT2I-INDUCED EUGLYCAEMIC DIABETIC KETOACIDOSIS. ENDOCRINOLOGY, DIABETES AND METABOLISM CASE REPORTS. 2019;2019:1:19-0087.",59.0,YR,,F,Y,,,20200103.0,,HP,IE,IE,2020,Q1,Adult
172273771,17227377,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20191223.0,20200103,20200103,EXP,,US-LUPIN PHARMACEUTICALS INC.-2019-08853,LUPIN,,57.0,YR,,F,Y,,,20200103.0,,HP,US,US,2020,Q1,Adult
172328281,17232828,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, Q.H.S.",,,,,,,,,,,QD,2020,Q1,Pruritus,,2020,Q1,1,I,20191211.0,20191224.0,20200103,20200103,PER,,US-IGSA-SR10009649,GRIFOLS,,46.0,YR,,F,Y,78.0,KG,20200103.0,,HP,US,US,2020,Q1,Adult
172328281,17232828,30,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, Q.H.S.",,,,,,,,,,,QD,2020,Q1,Rash,,2020,Q1,1,I,20191211.0,20191224.0,20200103,20200103,PER,,US-IGSA-SR10009649,GRIFOLS,,46.0,YR,,F,Y,78.0,KG,20200103.0,,HP,US,US,2020,Q1,Adult
172384601,17238460,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2020,Q1,Dizziness,,2020,Q1,1,I,20190918.0,20200103.0,20200106,20200106,EXP,,ES-MYLANLABS-2020M1001216,MYLAN,,75.0,YR,,M,Y,,,20200106.0,,CN,ES,ES,2020,Q1,Elderly
172384601,17238460,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2020,Q1,Eye swelling,,2020,Q1,1,I,20190918.0,20200103.0,20200106,20200106,EXP,,ES-MYLANLABS-2020M1001216,MYLAN,,75.0,YR,,M,Y,,,20200106.0,,CN,ES,ES,2020,Q1,Elderly
172384601,17238460,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2020,Q1,Malaise,,2020,Q1,1,I,20190918.0,20200103.0,20200106,20200106,EXP,,ES-MYLANLABS-2020M1001216,MYLAN,,75.0,YR,,M,Y,,,20200106.0,,CN,ES,ES,2020,Q1,Elderly
172384601,17238460,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2020,Q1,Peripheral swelling,,2020,Q1,1,I,20190918.0,20200103.0,20200106,20200106,EXP,,ES-MYLANLABS-2020M1001216,MYLAN,,75.0,YR,,M,Y,,,20200106.0,,CN,ES,ES,2020,Q1,Elderly
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Cardio-respiratory arrest,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Confusional state,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Gallbladder oedema,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Gastroenteritis,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Intestinal angioedema,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Oedematous pancreatitis,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Renal impairment,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Retroperitoneal oedema,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172405121,17240512,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20191226.0,20200107,20200107,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172410871,17241087,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 UNITS SUBCUTANEOUSLY AT BEDTIME,,,,,,,,,,,,2020,Q1,Acute myocardial infarction,,2020,Q1,1,I,,20191224.0,20200107,20200107,EXP,,US-ALVOGEN-2020-ALVOGEN-102297,ALVOGEN,"SAEED M, GIL GS, LOPEZ PD, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019 DEC 17",54.0,YR,,M,Y,,,20200107.0,,MD,US,US,2020,Q1,Adult
172432862,17243286,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2020,Q1,Cholecystitis,,2020,Q1,2,F,,20200106.0,20200107,20200109,EXP,,NL-PFIZER INC-2019526226,PFIZER,,72.0,YR,,F,Y,100.0,KG,20200109.0,,CN,NL,NL,2020,Q1,Elderly
172432862,17243286,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2020,Q1,Cholelithiasis,,2020,Q1,2,F,,20200106.0,20200107,20200109,EXP,,NL-PFIZER INC-2019526226,PFIZER,,72.0,YR,,F,Y,100.0,KG,20200109.0,,CN,NL,NL,2020,Q1,Elderly
172432862,17243286,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION IN PRE-FILLED PEN,,2020,Q1,Peritonitis,,2020,Q1,2,F,,20200106.0,20200107,20200109,EXP,,NL-PFIZER INC-2019526226,PFIZER,,72.0,YR,,F,Y,100.0,KG,20200109.0,,CN,NL,NL,2020,Q1,Elderly
172442041,17244204,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,28.0,IU,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442041,17244204,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,28.0,IU,,QD,2020,Q1,Postprandial hypoglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442041,17244204,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,32.0,IU,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442041,17244204,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,32.0,IU,,QD,2020,Q1,Postprandial hypoglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442041,17244204,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,30.0,IU,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442041,17244204,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,30.0,IU,,QD,2020,Q1,Postprandial hypoglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442041,17244204,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442041,17244204,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q1,Postprandial hypoglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442041,17244204,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,28.0,IU,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442041,17244204,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,28.0,IU,,,2020,Q1,Postprandial hypoglycaemia,,2020,Q1,1,I,201902.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066817,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442061,17244206,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"32 IU, QD",,,,,,,,32.0,IU,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201905.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066815,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442061,17244206,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"32 IU, QD",,,,,,,,32.0,IU,,QD,2020,Q1,Postprandial hypoglycaemia,,2020,Q1,1,I,201905.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066815,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442061,17244206,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD, STARTED IN /JUN/2019",,,,,,,,30.0,IU,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201905.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066815,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442061,17244206,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"30 IU, QD, STARTED IN /JUN/2019",,,,,,,,30.0,IU,,QD,2020,Q1,Postprandial hypoglycaemia,,2020,Q1,1,I,201905.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066815,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442061,17244206,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,,,,,,28.0,IU,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201905.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066815,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442061,17244206,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,,,,,,28.0,IU,,QD,2020,Q1,Postprandial hypoglycaemia,,2020,Q1,1,I,201905.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066815,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442061,17244206,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, QD",,,,,,,,26.0,IU,,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,201905.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066815,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172442061,17244206,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, QD",,,,,,,,26.0,IU,,QD,2020,Q1,Postprandial hypoglycaemia,,2020,Q1,1,I,201905.0,20191226.0,20200107,20200107,EXP,,IT-BAUSCH-BL-2019-066815,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20200107.0,,MD,IT,IT,2020,Q1,Adult
172450252,17245025,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, UNK",,,,,,,,100.0,IU,,,2020,Q1,Rash,,2020,Q1,2,F,,20200123.0,20200108,20200219,PER,,US-ALEXION PHARMACEUTICALS INC.-A201919468,ALEXION,,40.0,YR,,M,Y,126.8,KG,20200219.0,,CN,US,US,2020,Q1,Adult
172457161,17245716,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,,,,,21081.0,1.0,DF,,QD,2020,Q1,Dizziness,,2020,Q1,1,I,20191123.0,20191231.0,20200108,20200108,EXP,IT-MINISAL02-596823,IT-SA-2020SA000671,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200108.0,,MD,IT,IT,2020,Q1,Elderly
172457161,17245716,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,,,,,21081.0,1.0,DF,,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,20191123.0,20191231.0,20200108,20200108,EXP,IT-MINISAL02-596823,IT-SA-2020SA000671,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200108.0,,MD,IT,IT,2020,Q1,Elderly
172457161,17245716,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,,,,,21081.0,1.0,DF,,QD,2020,Q1,Hyperinsulinaemic hypoglycaemia,,2020,Q1,1,I,20191123.0,20191231.0,20200108,20200108,EXP,IT-MINISAL02-596823,IT-SA-2020SA000671,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200108.0,,MD,IT,IT,2020,Q1,Elderly
172457161,17245716,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,,,,,21081.0,1.0,DF,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20191123.0,20191231.0,20200108,20200108,EXP,IT-MINISAL02-596823,IT-SA-2020SA000671,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200108.0,,MD,IT,IT,2020,Q1,Elderly
172457181,17245718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD (IN EVENING)",,,U,,,,21081.0,48.0,IU,,QD,2020,Q1,Insulin resistance,,2020,Q1,1,I,,20191231.0,20200108,20200108,EXP,,CZ-SA-2020SA000701,SANOFI AVENTIS,TOMANEK P.;. FIRST EXPERIENCE WITH A THREE-DAY FASTING IN AN OBESE TYPE 2 DIABETIC PATIENT WITH SIGNIFICANT INSULIN RESISTANCE. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,E,F,Y,,,20200108.0,,HP,CZ,CZ,2020,Q1,Elderly
172457181,17245718,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 IU, QD (IN EVENING)",,,U,,,,21081.0,48.0,IU,,QD,2020,Q1,Weight increased,,2020,Q1,1,I,,20191231.0,20200108,20200108,EXP,,CZ-SA-2020SA000701,SANOFI AVENTIS,TOMANEK P.;. FIRST EXPERIENCE WITH A THREE-DAY FASTING IN AN OBESE TYPE 2 DIABETIC PATIENT WITH SIGNIFICANT INSULIN RESISTANCE. KAZUISTIKY V DIABETOLOGII. 2019;17(3):30-32,66.0,YR,E,F,Y,,,20200108.0,,HP,CZ,CZ,2020,Q1,Elderly
172466283,17246628,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Blood glucose decreased,,2020,Q1,3,F,201912.0,20200120.0,20200108,20200127,PER,,US-EISAI MEDICAL RESEARCH-EC-2019-067480,EISAI,,66.0,YR,,F,Y,89.3,KG,20200127.0,,CN,US,US,2020,Q1,Elderly
172466283,17246628,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Essential hypertension,,2020,Q1,3,F,201912.0,20200120.0,20200108,20200127,PER,,US-EISAI MEDICAL RESEARCH-EC-2019-067480,EISAI,,66.0,YR,,F,Y,89.3,KG,20200127.0,,CN,US,US,2020,Q1,Elderly
172466283,17246628,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Toothache,,2020,Q1,3,F,201912.0,20200120.0,20200108,20200127,PER,,US-EISAI MEDICAL RESEARCH-EC-2019-067480,EISAI,,66.0,YR,,F,Y,89.3,KG,20200127.0,,CN,US,US,2020,Q1,Elderly
172474133,17247413,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Skin infection,,2020,Q1,3,F,20191227.0,20200116.0,20200108,20200123,EXP,,US-TAKEDA-2019TUS074519,TAKEDA,,63.0,YR,,M,Y,,,20200123.0,,MD,US,US,2020,Q1,Adult
172499585,17249958,16,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,30 UNITS UNDER THE SKIN NIGHTLY,,,,,,,,,,INJECTION,,2020,Q1,Anaemia,,2020,Q1,5,F,20200104.0,20200218.0,20200109,20200226,PER,,US-CELGENEUS-USA-20200101909,CELGENE,,77.0,YR,,M,Y,,,20200226.0,,MD,US,US,2020,Q1,Elderly
172499585,17249958,16,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,30 UNITS UNDER THE SKIN NIGHTLY,,,,,,,,,,INJECTION,,2020,Q1,Platelet count decreased,,2020,Q1,5,F,20200104.0,20200218.0,20200109,20200226,PER,,US-CELGENEUS-USA-20200101909,CELGENE,,77.0,YR,,M,Y,,,20200226.0,,MD,US,US,2020,Q1,Elderly
172499585,17249958,16,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,30 UNITS UNDER THE SKIN NIGHTLY,,,,,,,,,,INJECTION,,2020,Q1,White blood cell count decreased,,2020,Q1,5,F,20200104.0,20200218.0,20200109,20200226,PER,,US-CELGENEUS-USA-20200101909,CELGENE,,77.0,YR,,M,Y,,,20200226.0,,MD,US,US,2020,Q1,Elderly
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Cardiac arrest,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Confusional state,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Dehydration,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Gallbladder oedema,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Gastroenteritis,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Intestinal angioedema,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Oedematous pancreatitis,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Renal impairment,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Retroperitoneal oedema,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172501151,17250115,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20191226.0,20200109,20200109,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2078700",ATLAS PHARMACEUTICALS,,60.0,YR,,F,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172505091,17250509,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20191203.0,20200109,20200109,EXP,,US-MALLINCKRODT-T201908742,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",37.0,YR,,M,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172505091,17250509,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,2018.0,20191203.0,20200109,20200109,EXP,,US-MALLINCKRODT-T201908742,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",37.0,YR,,M,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172505091,17250509,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20191203.0,20200109,20200109,EXP,,US-MALLINCKRODT-T201908742,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",37.0,YR,,M,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172505091,17250509,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,2018.0,20191203.0,20200109,20200109,EXP,,US-MALLINCKRODT-T201908742,MALLINCKRODT,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57:1220-413",37.0,YR,,M,Y,,,20200109.0,,MD,US,US,2020,Q1,Adult
172519824,17251982,5,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,10.0,DF,INJECTION,QD,2020,Q1,Acute myeloid leukaemia,,2020,Q1,4,F,20190925.0,20200228.0,20200109,20200313,EXP,,JP-ABBVIE-20K-087-3226106-00,ABBVIE,,61.0,YR,,M,Y,65.0,KG,20200313.0,,MD,JP,JP,2020,Q1,Adult
172519824,17251982,5,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,10.0,DF,INJECTION,QD,2020,Q1,Ascites,,2020,Q1,4,F,20190925.0,20200228.0,20200109,20200313,EXP,,JP-ABBVIE-20K-087-3226106-00,ABBVIE,,61.0,YR,,M,Y,65.0,KG,20200313.0,,MD,JP,JP,2020,Q1,Adult
172519824,17251982,5,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,10.0,DF,INJECTION,QD,2020,Q1,Faeces discoloured,,2020,Q1,4,F,20190925.0,20200228.0,20200109,20200313,EXP,,JP-ABBVIE-20K-087-3226106-00,ABBVIE,,61.0,YR,,M,Y,65.0,KG,20200313.0,,MD,JP,JP,2020,Q1,Adult
172519824,17251982,5,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,10.0,DF,INJECTION,QD,2020,Q1,Graft versus host disease,,2020,Q1,4,F,20190925.0,20200228.0,20200109,20200313,EXP,,JP-ABBVIE-20K-087-3226106-00,ABBVIE,,61.0,YR,,M,Y,65.0,KG,20200313.0,,MD,JP,JP,2020,Q1,Adult
172519824,17251982,5,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,10.0,DF,INJECTION,QD,2020,Q1,Jaundice,,2020,Q1,4,F,20190925.0,20200228.0,20200109,20200313,EXP,,JP-ABBVIE-20K-087-3226106-00,ABBVIE,,61.0,YR,,M,Y,65.0,KG,20200313.0,,MD,JP,JP,2020,Q1,Adult
172532835,17253283,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q1,Ketoacidosis,,2020,Q1,5,F,20191220.0,20200130.0,20200109,20200201,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001322",BOEHRINGER INGELHEIM,,44.0,YR,,M,Y,162.0,KG,20200201.0,,MD,ES,ES,2020,Q1,Adult
172532835,17253283,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q1,Pneumonia staphylococcal,,2020,Q1,5,F,20191220.0,20200130.0,20200109,20200201,EXP,,"ES-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001322",BOEHRINGER INGELHEIM,,44.0,YR,,M,Y,162.0,KG,20200201.0,,MD,ES,ES,2020,Q1,Adult
172539171,17253917,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200109.0,20200109,20200109,EXP,GB-MHRA-EYC 00215409,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-001398",BOEHRINGER INGELHEIM,,86.0,YR,,F,Y,,,20200109.0,,PH,GB,GB,2020,Q1,Elderly
172555591,17255559,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCTANEOUS,,,,,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,1,I,,20200108.0,20200110,20200110,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001393",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200110.0,,HP,CA,CA,2020,Q1,Elderly
172555591,17255559,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCTANEOUS,,,,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,1,I,,20200108.0,20200110,20200110,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001393",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200110.0,,HP,CA,CA,2020,Q1,Elderly
172559821,17255982,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSAGE FORM - SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,1,I,,20200108.0,20200110,20200110,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001380",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200110.0,,HP,CA,CA,2020,Q1,Elderly
172559821,17255982,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSAGE FORM - SOLUTION SUBCUTANEOUS,,,U,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,1,I,,20200108.0,20200110,20200110,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001380",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200110.0,,HP,CA,CA,2020,Q1,Elderly
172580791,17258079,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200106.0,20200110,20200110,EXP,,US-EMD SERONO-9139501,EMD SERONO INC,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019 MAY 01;199(9):.,63.0,YR,,M,Y,,,20200110.0,,HP,US,US,2020,Q1,Adult
172580791,17258079,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200106.0,20200110,20200110,EXP,,US-EMD SERONO-9139501,EMD SERONO INC,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019 MAY 01;199(9):.,63.0,YR,,M,Y,,,20200110.0,,HP,US,US,2020,Q1,Adult
172580791,17258079,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200106.0,20200110,20200110,EXP,,US-EMD SERONO-9139501,EMD SERONO INC,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019 MAY 01;199(9):.,63.0,YR,,M,Y,,,20200110.0,,HP,US,US,2020,Q1,Adult
172580791,17258079,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,1,I,,20200106.0,20200110,20200110,EXP,,US-EMD SERONO-9139501,EMD SERONO INC,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019 MAY 01;199(9):.,63.0,YR,,M,Y,,,20200110.0,,HP,US,US,2020,Q1,Adult
172582032,17258203,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,5 UNIT,,,U,,,,,5.0,DF,,,2020,Q1,Anaemia,,2020,Q1,2,F,20200103.0,20200208.0,20200110,20200218,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000002,VELOXIS PHARMACEUTICALS,,54.0,YR,,F,Y,109.5,KG,20200218.0,,HP,US,US,2020,Q1,Adult
172582032,17258203,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,5 UNIT,,,U,,,,,5.0,DF,,,2020,Q1,Complications of transplant surgery,,2020,Q1,2,F,20200103.0,20200208.0,20200110,20200218,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000002,VELOXIS PHARMACEUTICALS,,54.0,YR,,F,Y,109.5,KG,20200218.0,,HP,US,US,2020,Q1,Adult
172582032,17258203,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,5 UNIT,,,U,,,,,5.0,DF,,,2020,Q1,Leukocytosis,,2020,Q1,2,F,20200103.0,20200208.0,20200110,20200218,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000002,VELOXIS PHARMACEUTICALS,,54.0,YR,,F,Y,109.5,KG,20200218.0,,HP,US,US,2020,Q1,Adult
172594151,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,1,I,2018.0,20191219.0,20200110,20200110,EXP,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200110.0,,MD,TR,TR,2020,Q1,Elderly
172594151,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Asthenia,,2020,Q1,1,I,2018.0,20191219.0,20200110,20200110,EXP,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200110.0,,MD,TR,TR,2020,Q1,Elderly
172594151,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,1,I,2018.0,20191219.0,20200110,20200110,EXP,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200110.0,,MD,TR,TR,2020,Q1,Elderly
172594151,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Lymphadenopathy,,2020,Q1,1,I,2018.0,20191219.0,20200110,20200110,EXP,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200110.0,,MD,TR,TR,2020,Q1,Elderly
172594151,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Malignant neoplasm progression,,2020,Q1,1,I,2018.0,20191219.0,20200110,20200110,EXP,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200110.0,,MD,TR,TR,2020,Q1,Elderly
172594151,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Movement disorder,,2020,Q1,1,I,2018.0,20191219.0,20200110,20200110,EXP,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200110.0,,MD,TR,TR,2020,Q1,Elderly
172594151,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,2018.0,20191219.0,20200110,20200110,EXP,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200110.0,,MD,TR,TR,2020,Q1,Elderly
172598025,17259802,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,LIQUID,QD,2020,Q1,Bacteraemia,,2020,Q1,5,F,20191220.0,20200304.0,20200110,20200318,PER,,US-AMGEN-USACT2019216516,AMGEN,,70.0,YR,E,M,Y,82.0,KG,20200318.0,,MD,US,US,2020,Q1,Elderly
172598025,17259802,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,LIQUID,,2020,Q1,Bacteraemia,,2020,Q1,5,F,20191220.0,20200304.0,20200110,20200318,PER,,US-AMGEN-USACT2019216516,AMGEN,,70.0,YR,E,M,Y,82.0,KG,20200318.0,,MD,US,US,2020,Q1,Elderly
172611112,17261111,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,FORM OF ADMIN: SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,2,F,,20200225.0,20200113,20200303,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001476",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200303.0,,HP,CA,CA,2020,Q1,Elderly
172611112,17261111,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,FORM OF ADMIN: SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,2,F,,20200225.0,20200113,20200303,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001476",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200303.0,,HP,CA,CA,2020,Q1,Elderly
172643123,17264312,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD",,,,, UNKNOWN,,,8.0,IU,,QD,2020,Q1,Blood glucose increased,,2020,Q1,3,F,20191221.0,20200318.0,20200113,20200327,EXP,,CN-NOVOPROD-705692,NOVO NORDISK,,27.0,YR,,F,Y,51.0,KG,20200327.0,,CN,CN,CN,2020,Q1,Young Adult
172643123,17264312,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD",,,,, UNKNOWN,,,8.0,IU,,QD,2020,Q1,Ill-defined disorder,,2020,Q1,3,F,20191221.0,20200318.0,20200113,20200327,EXP,,CN-NOVOPROD-705692,NOVO NORDISK,,27.0,YR,,F,Y,51.0,KG,20200327.0,,CN,CN,CN,2020,Q1,Young Adult
172643123,17264312,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"8 IU, QD",,,,, UNKNOWN,,,8.0,IU,,QD,2020,Q1,Product quality issue,,2020,Q1,3,F,20191221.0,20200318.0,20200113,20200327,EXP,,CN-NOVOPROD-705692,NOVO NORDISK,,27.0,YR,,F,Y,51.0,KG,20200327.0,,CN,CN,CN,2020,Q1,Young Adult
172658561,17265856,6,C,glargine,,2,Parenteral,"17 UNITS, QHS",,,,,,,,,,,QD,2020,Q1,Erythema,,2020,Q1,1,I,20190506.0,20190509.0,20200114,20200114,PER,,US-ALLERGAN-1919856US,ALLERGAN,,46.0,YR,,F,Y,75.3,KG,20200114.0,,PH,US,US,2020,Q1,Adult
172658561,17265856,6,C,glargine,,2,Parenteral,"17 UNITS, QHS",,,,,,,,,,,QD,2020,Q1,Pruritus,,2020,Q1,1,I,20190506.0,20190509.0,20200114,20200114,PER,,US-ALLERGAN-1919856US,ALLERGAN,,46.0,YR,,F,Y,75.3,KG,20200114.0,,PH,US,US,2020,Q1,Adult
172674971,17267497,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hypertension,,2020,Q1,1,I,,20200108.0,20200114,20200114,EXP,,NVSC2020US006689,NOVARTIS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172674971,17267497,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hypothermia,,2020,Q1,1,I,,20200108.0,20200114,20200114,EXP,,NVSC2020US006689,NOVARTIS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172674971,17267497,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hypoxia,,2020,Q1,1,I,,20200108.0,20200114,20200114,EXP,,NVSC2020US006689,NOVARTIS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172674971,17267497,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200108.0,20200114,20200114,EXP,,NVSC2020US006689,NOVARTIS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172674971,17267497,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Product use in unapproved indication,,2020,Q1,1,I,,20200108.0,20200114,20200114,EXP,,NVSC2020US006689,NOVARTIS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172674971,17267497,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Respiratory distress,,2020,Q1,1,I,,20200108.0,20200114,20200114,EXP,,NVSC2020US006689,NOVARTIS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172674971,17267497,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,1,I,,20200108.0,20200114,20200114,EXP,,NVSC2020US006689,NOVARTIS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172674971,17267497,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Tachypnoea,,2020,Q1,1,I,,20200108.0,20200114,20200114,EXP,,NVSC2020US006689,NOVARTIS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172694302,17269430,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Acute myocardial infarction,,2020,Q1,2,F,20200106.0,20200131.0,20200114,20200203,EXP,,CO-ABBVIE-20K-036-3231578-00,ABBVIE,,63.0,YR,,F,Y,65.0,KG,20200203.0,,MD,CO,CO,2020,Q1,Adult
172694302,17269430,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,General physical health deterioration,,2020,Q1,2,F,20200106.0,20200131.0,20200114,20200203,EXP,,CO-ABBVIE-20K-036-3231578-00,ABBVIE,,63.0,YR,,F,Y,65.0,KG,20200203.0,,MD,CO,CO,2020,Q1,Adult
172694302,17269430,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Resuscitation,,2020,Q1,2,F,20200106.0,20200131.0,20200114,20200203,EXP,,CO-ABBVIE-20K-036-3231578-00,ABBVIE,,63.0,YR,,F,Y,65.0,KG,20200203.0,,MD,CO,CO,2020,Q1,Adult
172699182,17269918,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2020,Q1,Cognitive disorder,,2020,Q1,2,F,20190606.0,20200114.0,20200114,20200117,PER,,DE-EISAI MEDICAL RESEARCH-EC-2019-065947,EISAI,,61.0,YR,,M,Y,70.9,KG,20200117.0,,MD,DE,DE,2020,Q1,Adult
172699182,17269918,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2020,Q1,Dysgeusia,,2020,Q1,2,F,20190606.0,20200114.0,20200114,20200117,PER,,DE-EISAI MEDICAL RESEARCH-EC-2019-065947,EISAI,,61.0,YR,,M,Y,70.9,KG,20200117.0,,MD,DE,DE,2020,Q1,Adult
172699182,17269918,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2020,Q1,Dysphonia,,2020,Q1,2,F,20190606.0,20200114.0,20200114,20200117,PER,,DE-EISAI MEDICAL RESEARCH-EC-2019-065947,EISAI,,61.0,YR,,M,Y,70.9,KG,20200117.0,,MD,DE,DE,2020,Q1,Adult
172699182,17269918,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2020,Q1,Neoplasm progression,,2020,Q1,2,F,20190606.0,20200114.0,20200114,20200117,PER,,DE-EISAI MEDICAL RESEARCH-EC-2019-065947,EISAI,,61.0,YR,,M,Y,70.9,KG,20200117.0,,MD,DE,DE,2020,Q1,Adult
172699182,17269918,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2020,Q1,Weight decreased,,2020,Q1,2,F,20190606.0,20200114.0,20200114,20200117,PER,,DE-EISAI MEDICAL RESEARCH-EC-2019-065947,EISAI,,61.0,YR,,M,Y,70.9,KG,20200117.0,,MD,DE,DE,2020,Q1,Adult
172710291,17271029,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2020PRN00010,PRINSTON PHARMACEUTICAL,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172710291,17271029,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Hypertension,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2020PRN00010,PRINSTON PHARMACEUTICAL,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172710291,17271029,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2020PRN00010,PRINSTON PHARMACEUTICAL,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172710291,17271029,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2020PRN00010,PRINSTON PHARMACEUTICAL,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172710291,17271029,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2020PRN00010,PRINSTON PHARMACEUTICAL,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172710291,17271029,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2020PRN00010,PRINSTON PHARMACEUTICAL,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172713412,17271341,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2020,Q1,Acute kidney injury,,2020,Q1,2,F,,20200124.0,20200115,20200130,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001401",BOEHRINGER INGELHEIM,ROGOWICZ-FRONTCZAK A. PACJENTKA Z DMT1 I NIEWYDOLNOSCIA KORY NADNERCZY. DIABETOLOGIA PO DYPLOMIE. 2019;.,41.0,YR,,F,Y,,,20200130.0,,MD,PL,PL,2020,Q1,Adult
172713412,17271341,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2020,Q1,Adrenocortical insufficiency acute,,2020,Q1,2,F,,20200124.0,20200115,20200130,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001401",BOEHRINGER INGELHEIM,ROGOWICZ-FRONTCZAK A. PACJENTKA Z DMT1 I NIEWYDOLNOSCIA KORY NADNERCZY. DIABETOLOGIA PO DYPLOMIE. 2019;.,41.0,YR,,F,Y,,,20200130.0,,MD,PL,PL,2020,Q1,Adult
172713412,17271341,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,2,F,,20200124.0,20200115,20200130,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001401",BOEHRINGER INGELHEIM,ROGOWICZ-FRONTCZAK A. PACJENTKA Z DMT1 I NIEWYDOLNOSCIA KORY NADNERCZY. DIABETOLOGIA PO DYPLOMIE. 2019;.,41.0,YR,,F,Y,,,20200130.0,,MD,PL,PL,2020,Q1,Adult
172713412,17271341,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2020,Q1,Off label use,,2020,Q1,2,F,,20200124.0,20200115,20200130,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001401",BOEHRINGER INGELHEIM,ROGOWICZ-FRONTCZAK A. PACJENTKA Z DMT1 I NIEWYDOLNOSCIA KORY NADNERCZY. DIABETOLOGIA PO DYPLOMIE. 2019;.,41.0,YR,,F,Y,,,20200130.0,,MD,PL,PL,2020,Q1,Adult
172713412,17271341,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,QD,2020,Q1,Urinary tract infection,,2020,Q1,2,F,,20200124.0,20200115,20200130,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-001401",BOEHRINGER INGELHEIM,ROGOWICZ-FRONTCZAK A. PACJENTKA Z DMT1 I NIEWYDOLNOSCIA KORY NADNERCZY. DIABETOLOGIA PO DYPLOMIE. 2019;.,41.0,YR,,F,Y,,,20200130.0,,MD,PL,PL,2020,Q1,Adult
172716321,17271632,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"80 U, QD",,,U,,,,,,,,QD,2020,Q1,Syncope,,2020,Q1,1,I,20191126.0,20200108.0,20200115,20200115,EXP,,US-SA-2020SA010249,SANOFI AVENTIS,,73.0,YR,E,F,Y,106.5,KG,20200115.0,,PH,US,US,2020,Q1,Elderly
172716401,17271640,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Mononeuropathy,,2020,Q1,1,I,,20191025.0,20200115,20200115,EXP,,IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2019-09287,ALKEM,"CHRISTENSEN MMH, BRUUN HAASTRUP M, OHLENSCHLAEGER T, ESBECH P, ET AL.. INTERACTION POTENTIAL BETWEEN CLARITHROMYCIN AND INDIVIDUAL STATINS - A SYSTEMATIC REVIEW. BASIC CLIN PHARMACOL TOXICOL.. 2019;UNK:UNK",42.0,YR,,M,Y,,,20200115.0,,MD,DK,IT,2020,Q1,Adult
172716401,17271640,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Rhabdomyolysis,,2020,Q1,1,I,,20191025.0,20200115,20200115,EXP,,IT-ALKEM LABORATORIES LIMITED-IT-ALKEM-2019-09287,ALKEM,"CHRISTENSEN MMH, BRUUN HAASTRUP M, OHLENSCHLAEGER T, ESBECH P, ET AL.. INTERACTION POTENTIAL BETWEEN CLARITHROMYCIN AND INDIVIDUAL STATINS - A SYSTEMATIC REVIEW. BASIC CLIN PHARMACOL TOXICOL.. 2019;UNK:UNK",42.0,YR,,M,Y,,,20200115.0,,MD,DK,IT,2020,Q1,Adult
172718201,17271820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Cardiac disorder,,2020,Q1,1,I,2018.0,20200103.0,20200115,20200115,EXP,,US-ELI_LILLY_AND_COMPANY-US202001004684,ELI LILLY AND CO,,49.0,YR,,M,Y,,,20200115.0,,CN,US,US,2020,Q1,Adult
172718201,17271820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,General physical health deterioration,,2020,Q1,1,I,2018.0,20200103.0,20200115,20200115,EXP,,US-ELI_LILLY_AND_COMPANY-US202001004684,ELI LILLY AND CO,,49.0,YR,,M,Y,,,20200115.0,,CN,US,US,2020,Q1,Adult
172718201,17271820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Multiple organ dysfunction syndrome,,2020,Q1,1,I,2018.0,20200103.0,20200115,20200115,EXP,,US-ELI_LILLY_AND_COMPANY-US202001004684,ELI LILLY AND CO,,49.0,YR,,M,Y,,,20200115.0,,CN,US,US,2020,Q1,Adult
172718201,17271820,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Overdose,,2020,Q1,1,I,2018.0,20200103.0,20200115,20200115,EXP,,US-ELI_LILLY_AND_COMPANY-US202001004684,ELI LILLY AND CO,,49.0,YR,,M,Y,,,20200115.0,,CN,US,US,2020,Q1,Adult
172722181,17272218,1,PS,"INSULIN (INSULIN GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,45.0,IU,,QD,2020,Q1,Asthenia,,2020,Q1,1,I,20191007.0,,20191223,20191223,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20191219.0,N,PH,US,US,2020,Q1,Elderly
172722181,17272218,1,PS,"INSULIN (INSULIN GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,45.0,IU,,QD,2020,Q1,Confusional state,,2020,Q1,1,I,20191007.0,,20191223,20191223,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20191219.0,N,PH,US,US,2020,Q1,Elderly
172722181,17272218,1,PS,"INSULIN (INSULIN GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,45.0,IU,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20191007.0,,20191223,20191223,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20191219.0,N,PH,US,US,2020,Q1,Elderly
172722701,17272270,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20200106.0,20200115,20200115,EXP,,US-APOTEX-2020AP005904,APOTEX,"GUMMIN DD, MOWRYJB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, HASHEM HA, RYAN ML. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. DOI: 10.1080/15563650.2019.1677022. CLINICAL TOXICOLOGY. 2019;57 (12):1220-1413",37.0,YR,,M,Y,,,20200115.0,,MD,US,US,2020,Q1,Adult
172722701,17272270,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20200106.0,20200115,20200115,EXP,,US-APOTEX-2020AP005904,APOTEX,"GUMMIN DD, MOWRYJB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, HASHEM HA, RYAN ML. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. DOI: 10.1080/15563650.2019.1677022. CLINICAL TOXICOLOGY. 2019;57 (12):1220-1413",37.0,YR,,M,Y,,,20200115.0,,MD,US,US,2020,Q1,Adult
172729941,17272994,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,45.0,DF,,QD,2020,Q1,Asthenia,,2020,Q1,1,I,20191007.0,,20191223,20191223,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20191219.0,N,PH,US,US,2020,Q1,Elderly
172729941,17272994,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,45.0,DF,,QD,2020,Q1,Blood glucose decreased,,2020,Q1,1,I,20191007.0,,20191223,20191223,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20191219.0,N,PH,US,US,2020,Q1,Elderly
172729941,17272994,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,45.0,DF,,QD,2020,Q1,Confusional state,,2020,Q1,1,I,20191007.0,,20191223,20191223,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20191219.0,N,PH,US,US,2020,Q1,Elderly
172729941,17272994,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,45.0,DF,,QD,2020,Q1,Oesophageal adenocarcinoma,,2020,Q1,1,I,20191007.0,,20191223,20191223,DIR,,,FDA-CTU,,73.0,YR,,M,N,,,20191219.0,N,PH,US,US,2020,Q1,Elderly
172738821,17273882,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 INTERNATIONAL UNIT,,,D,,,,,40.0,IU,,,2020,Q1,Burning sensation,,2020,Q1,1,I,,20200107.0,20200115,20200115,EXP,,GR-MYLANLABS-2020M1003699,MYLAN,"ANIFANTAKIS. D, KATSANIKAKI.F, ANIFANTAKIS.A, SYMVOULAKIS E.. RESTLESS LEGS SYNDROME IN PATIENT WITH DIABETES MELLITUS: CAN A CHRONIC DISEASE REDUCE DIAGNOSTIC ACUITY. ARCH INTERN MED. 2005;165:1286-1292",65.0,YR,,F,Y,,,20200115.0,,MD,GR,GR,2020,Q1,Elderly
172738821,17273882,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 INTERNATIONAL UNIT,,,D,,,,,40.0,IU,,,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20200107.0,20200115,20200115,EXP,,GR-MYLANLABS-2020M1003699,MYLAN,"ANIFANTAKIS. D, KATSANIKAKI.F, ANIFANTAKIS.A, SYMVOULAKIS E.. RESTLESS LEGS SYNDROME IN PATIENT WITH DIABETES MELLITUS: CAN A CHRONIC DISEASE REDUCE DIAGNOSTIC ACUITY. ARCH INTERN MED. 2005;165:1286-1292",65.0,YR,,F,Y,,,20200115.0,,MD,GR,GR,2020,Q1,Elderly
172738821,17273882,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 INTERNATIONAL UNIT,,,D,,,,,40.0,IU,,,2020,Q1,Insomnia,,2020,Q1,1,I,,20200107.0,20200115,20200115,EXP,,GR-MYLANLABS-2020M1003699,MYLAN,"ANIFANTAKIS. D, KATSANIKAKI.F, ANIFANTAKIS.A, SYMVOULAKIS E.. RESTLESS LEGS SYNDROME IN PATIENT WITH DIABETES MELLITUS: CAN A CHRONIC DISEASE REDUCE DIAGNOSTIC ACUITY. ARCH INTERN MED. 2005;165:1286-1292",65.0,YR,,F,Y,,,20200115.0,,MD,GR,GR,2020,Q1,Elderly
172738821,17273882,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 INTERNATIONAL UNIT,,,D,,,,,40.0,IU,,,2020,Q1,Restless legs syndrome,,2020,Q1,1,I,,20200107.0,20200115,20200115,EXP,,GR-MYLANLABS-2020M1003699,MYLAN,"ANIFANTAKIS. D, KATSANIKAKI.F, ANIFANTAKIS.A, SYMVOULAKIS E.. RESTLESS LEGS SYNDROME IN PATIENT WITH DIABETES MELLITUS: CAN A CHRONIC DISEASE REDUCE DIAGNOSTIC ACUITY. ARCH INTERN MED. 2005;165:1286-1292",65.0,YR,,F,Y,,,20200115.0,,MD,GR,GR,2020,Q1,Elderly
172741531,17274153,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-BEXIMCO-2020BEX00002,BEXIMCO PHARMACEUTICALS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172741531,17274153,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Hypertension,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-BEXIMCO-2020BEX00002,BEXIMCO PHARMACEUTICALS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172741531,17274153,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-BEXIMCO-2020BEX00002,BEXIMCO PHARMACEUTICALS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172741531,17274153,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-BEXIMCO-2020BEX00002,BEXIMCO PHARMACEUTICALS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172741531,17274153,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-BEXIMCO-2020BEX00002,BEXIMCO PHARMACEUTICALS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172741531,17274153,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,1,I,,20200105.0,20200115,20200115,EXP,,US-BEXIMCO-2020BEX00002,BEXIMCO PHARMACEUTICALS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9),63.0,YR,,M,Y,,,20200114.0,,HP,US,US,2020,Q1,Adult
172755211,17275521,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q1,Infusion site discharge,,2020,Q1,1,I,,20190627.0,20200116,20200116,EXP,,CA-AUROBINDO-AUR-APL-2019-038592,AUROBINDO,,53.0,YR,,F,Y,48.0,KG,20200116.0,,PH,CA,CA,2020,Q1,Adult
172755211,17275521,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q1,Infusion site erythema,,2020,Q1,1,I,,20190627.0,20200116,20200116,EXP,,CA-AUROBINDO-AUR-APL-2019-038592,AUROBINDO,,53.0,YR,,F,Y,48.0,KG,20200116.0,,PH,CA,CA,2020,Q1,Adult
172755211,17275521,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q1,Neutrophil count decreased,,2020,Q1,1,I,,20190627.0,20200116,20200116,EXP,,CA-AUROBINDO-AUR-APL-2019-038592,AUROBINDO,,53.0,YR,,F,Y,48.0,KG,20200116.0,,PH,CA,CA,2020,Q1,Adult
172781371,17278137,2,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,205692.0,,,,,2020,Q1,Drug hypersensitivity,,2020,Q1,1,I,2019.0,20200108.0,20200116,20200116,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202001005217,ELI LILLY AND CO,"NAMIKAWA S, ET AL..A CASE OF A PATIENT WITH TYPE 2 DIABETES MELLITUS WHO EXPERIENCED RED NODULE AT THE INJECTION SITE OF INSULIN AND DULAGLUTIDE.THE 57TH CHUGOKU AND SHIKOKU BRANCH MEETING OF THE JAPAN DIABETES SOCIETY 2019;:80.",79.0,YR,,M,Y,,,20200116.0,,MD,JP,JP,2020,Q1,Elderly
172781371,17278137,2,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,205692.0,,,,,2020,Q1,Injection site nodule,,2020,Q1,1,I,2019.0,20200108.0,20200116,20200116,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202001005217,ELI LILLY AND CO,"NAMIKAWA S, ET AL..A CASE OF A PATIENT WITH TYPE 2 DIABETES MELLITUS WHO EXPERIENCED RED NODULE AT THE INJECTION SITE OF INSULIN AND DULAGLUTIDE.THE 57TH CHUGOKU AND SHIKOKU BRANCH MEETING OF THE JAPAN DIABETES SOCIETY 2019;:80.",79.0,YR,,M,Y,,,20200116.0,,MD,JP,JP,2020,Q1,Elderly
172788773,17278877,4,SS,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,6-0-0-6 UNIT(S) TWO TIMES A DAY,,,,,,,,,,INJECTION,,2020,Q1,Arthralgia,,2020,Q1,3,F,20191203.0,20200309.0,20200116,20200317,EXP,,JP-ASTRAZENECA-2020SE06975,ASTRAZENECA,,42.0,YR,,M,Y,58.0,KG,20200317.0,,MD,JP,JP,2020,Q1,Adult
172788773,17278877,4,SS,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,6-0-0-6 UNIT(S) TWO TIMES A DAY,,,,,,,,,,INJECTION,,2020,Q1,Decreased appetite,,2020,Q1,3,F,20191203.0,20200309.0,20200116,20200317,EXP,,JP-ASTRAZENECA-2020SE06975,ASTRAZENECA,,42.0,YR,,M,Y,58.0,KG,20200317.0,,MD,JP,JP,2020,Q1,Adult
172788773,17278877,4,SS,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,6-0-0-6 UNIT(S) TWO TIMES A DAY,,,,,,,,,,INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,3,F,20191203.0,20200309.0,20200116,20200317,EXP,,JP-ASTRAZENECA-2020SE06975,ASTRAZENECA,,42.0,YR,,M,Y,58.0,KG,20200317.0,,MD,JP,JP,2020,Q1,Adult
172788773,17278877,4,SS,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,6-0-0-6 UNIT(S) TWO TIMES A DAY,,,,,,,,,,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,20191203.0,20200309.0,20200116,20200317,EXP,,JP-ASTRAZENECA-2020SE06975,ASTRAZENECA,,42.0,YR,,M,Y,58.0,KG,20200317.0,,MD,JP,JP,2020,Q1,Adult
172788773,17278877,4,SS,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,6-0-0-6 UNIT(S) TWO TIMES A DAY,,,,,,,,,,INJECTION,,2020,Q1,Malaise,,2020,Q1,3,F,20191203.0,20200309.0,20200116,20200317,EXP,,JP-ASTRAZENECA-2020SE06975,ASTRAZENECA,,42.0,YR,,M,Y,58.0,KG,20200317.0,,MD,JP,JP,2020,Q1,Adult
172788773,17278877,4,SS,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,6-0-0-6 UNIT(S) TWO TIMES A DAY,,,,,,,,,,INJECTION,,2020,Q1,Memory impairment,,2020,Q1,3,F,20191203.0,20200309.0,20200116,20200317,EXP,,JP-ASTRAZENECA-2020SE06975,ASTRAZENECA,,42.0,YR,,M,Y,58.0,KG,20200317.0,,MD,JP,JP,2020,Q1,Adult
172788773,17278877,4,SS,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,6-0-0-6 UNIT(S) TWO TIMES A DAY,,,,,,,,,,INJECTION,,2020,Q1,Pyrexia,,2020,Q1,3,F,20191203.0,20200309.0,20200116,20200317,EXP,,JP-ASTRAZENECA-2020SE06975,ASTRAZENECA,,42.0,YR,,M,Y,58.0,KG,20200317.0,,MD,JP,JP,2020,Q1,Adult
172788773,17278877,4,SS,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Subcutaneous,6-0-0-6 UNIT(S) TWO TIMES A DAY,,,,,,,,,,INJECTION,,2020,Q1,Therapy cessation,,2020,Q1,3,F,20191203.0,20200309.0,20200116,20200317,EXP,,JP-ASTRAZENECA-2020SE06975,ASTRAZENECA,,42.0,YR,,M,Y,58.0,KG,20200317.0,,MD,JP,JP,2020,Q1,Adult
172792081,17279208,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, QD",,,Y,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Anti-insulin antibody positive,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, QD",,,Y,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood insulin increased,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, QD",,,Y,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, QD",,,Y,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, QD",,,Y,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Insulin C-peptide increased,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172792081,17279208,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 IU, QD",,,Y,,,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Insulin autoimmune syndrome,,2020,Q1,1,I,,20200109.0,20200116,20200116,EXP,,CN-SA-2020SA007933,SANOFI AVENTIS,SHEN Y.; SONG X.; REN Y.. INSULIN AUTOIMMUNE SYNDROME INDUCED BY EXOGENOUS INSULIN INJECTION: A FOUR-CASE SERIES. BMC ENDOCRINE DISORDERS. 2019;19 (1):UNK,79.0,YR,E,M,Y,,,20200116.0,,HP,CN,CN,2020,Q1,Elderly
172794671,17279467,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20191121.0,20200109.0,20200116,20200116,EXP,FR-AFSSAPS-LY20192093,FR-FRESENIUS KABI-FK202000384,FRESENIUS KABI,,72.0,YR,,M,Y,87.6,KG,20200116.0,,HP,NL,FR,2020,Q1,Elderly
172794671,17279467,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2020,Q1,Hypokalaemia,,2020,Q1,1,I,20191121.0,20200109.0,20200116,20200116,EXP,FR-AFSSAPS-LY20192093,FR-FRESENIUS KABI-FK202000384,FRESENIUS KABI,,72.0,YR,,M,Y,87.6,KG,20200116.0,,HP,NL,FR,2020,Q1,Elderly
172795402,17279540,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,42 IU,,,,,,,,42.0,IU,,,2020,Q1,Blood glucose decreased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,42 IU,,,,,,,,42.0,IU,,,2020,Q1,Blood glucose increased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,42 IU,,,,,,,,42.0,IU,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,42 IU,,,,,,,,42.0,IU,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"47 IU, HS",,,,,,,,47.0,IU,,QD,2020,Q1,Blood glucose decreased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"47 IU, HS",,,,,,,,47.0,IU,,QD,2020,Q1,Blood glucose increased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"47 IU, HS",,,,,,,,47.0,IU,,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172795402,17279540,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"47 IU, HS",,,,,,,,47.0,IU,,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,,20200110.0,20200116,20200121,PER,,US-SA-2020SA008691,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200121.0,,CN,US,US,2020,Q1,Adult
172801243,17280124,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, UNK",,,,,,,,12.0,DF,INJECTION,,2020,Q1,Cough,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, UNK",,,,,,,,12.0,DF,INJECTION,,2020,Q1,Diabetes mellitus,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, UNK",,,,,,,,12.0,DF,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,31,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, UNK",,,,,,,,12.0,DF,INJECTION,,2020,Q1,Pneumonia mycoplasmal,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,,,,,,24.0,DF,INJECTION,,2020,Q1,Cough,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,,,,,,24.0,DF,INJECTION,,2020,Q1,Diabetes mellitus,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,,,,,,24.0,DF,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,32,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, UNK",,,,,,,,24.0,DF,INJECTION,,2020,Q1,Pneumonia mycoplasmal,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 U, UNK",,,,,,,,28.0,DF,INJECTION,,2020,Q1,Cough,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 U, UNK",,,,,,,,28.0,DF,INJECTION,,2020,Q1,Diabetes mellitus,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 U, UNK",,,,,,,,28.0,DF,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172801243,17280124,33,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 U, UNK",,,,,,,,28.0,DF,INJECTION,,2020,Q1,Pneumonia mycoplasmal,,2020,Q1,3,F,20181114.0,20200210.0,20200117,20200218,EXP,,NVSJ2020JP000455,NOVARTIS,,56.0,YR,,F,Y,78.9,KG,20200218.0,,MD,JP,JP,2020,Q1,Adult
172819061,17281906,10,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Localised infection,,2020,Q1,1,I,20181115.0,,20191229,20191229,DIR,,,FDA-CTU,,59.0,YR,,M,N,85.3,KG,20191218.0,N,MD,US,US,2020,Q1,Adult
172819061,17281906,10,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Therapy cessation,,2020,Q1,1,I,20181115.0,,20191229,20191229,DIR,,,FDA-CTU,,59.0,YR,,M,N,85.3,KG,20191218.0,N,MD,US,US,2020,Q1,Adult
172872442,17287244,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,2,F,,20200205.0,20200120,20200215,EXP,,US-AUROBINDO-AUR-APL-2020-002881,AUROBINDO,METFORMIN: LACTIC ACIDOSIS: CASE REPORT. 2020,63.0,YR,,M,Y,,,20200215.0,,MD,US,US,2020,Q1,Adult
172872442,17287244,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Drug level increased,,2020,Q1,2,F,,20200205.0,20200120,20200215,EXP,,US-AUROBINDO-AUR-APL-2020-002881,AUROBINDO,METFORMIN: LACTIC ACIDOSIS: CASE REPORT. 2020,63.0,YR,,M,Y,,,20200215.0,,MD,US,US,2020,Q1,Adult
172872442,17287244,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,2,F,,20200205.0,20200120,20200215,EXP,,US-AUROBINDO-AUR-APL-2020-002881,AUROBINDO,METFORMIN: LACTIC ACIDOSIS: CASE REPORT. 2020,63.0,YR,,M,Y,,,20200215.0,,MD,US,US,2020,Q1,Adult
172872442,17287244,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,2,F,,20200205.0,20200120,20200215,EXP,,US-AUROBINDO-AUR-APL-2020-002881,AUROBINDO,METFORMIN: LACTIC ACIDOSIS: CASE REPORT. 2020,63.0,YR,,M,Y,,,20200215.0,,MD,US,US,2020,Q1,Adult
172890751,17289075,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200108.0,20200120,20200120,EXP,,US-MYLANLABS-2020M1005341,MYLAN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805,63.0,YR,,M,Y,,,20200120.0,,HP,US,US,2020,Q1,Adult
172890751,17289075,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Confusional state,,2020,Q1,1,I,,20200108.0,20200120,20200120,EXP,,US-MYLANLABS-2020M1005341,MYLAN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805,63.0,YR,,M,Y,,,20200120.0,,HP,US,US,2020,Q1,Adult
172890751,17289075,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,,20200108.0,20200120,20200120,EXP,,US-MYLANLABS-2020M1005341,MYLAN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805,63.0,YR,,M,Y,,,20200120.0,,HP,US,US,2020,Q1,Adult
172890751,17289075,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200108.0,20200120,20200120,EXP,,US-MYLANLABS-2020M1005341,MYLAN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805,63.0,YR,,M,Y,,,20200120.0,,HP,US,US,2020,Q1,Adult
172890751,17289075,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Lethargy,,2020,Q1,1,I,,20200108.0,20200120,20200120,EXP,,US-MYLANLABS-2020M1005341,MYLAN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805,63.0,YR,,M,Y,,,20200120.0,,HP,US,US,2020,Q1,Adult
172890751,17289075,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,1,I,,20200108.0,20200120,20200120,EXP,,US-MYLANLABS-2020M1005341,MYLAN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805,63.0,YR,,M,Y,,,20200120.0,,HP,US,US,2020,Q1,Adult
172890751,17289075,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,,20200108.0,20200120,20200120,EXP,,US-MYLANLABS-2020M1005341,MYLAN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805,63.0,YR,,M,Y,,,20200120.0,,HP,US,US,2020,Q1,Adult
172890751,17289075,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Respiratory distress,,2020,Q1,1,I,,20200108.0,20200120,20200120,EXP,,US-MYLANLABS-2020M1005341,MYLAN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805,63.0,YR,,M,Y,,,20200120.0,,HP,US,US,2020,Q1,Adult
172890751,17289075,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,,20200108.0,20200120,20200120,EXP,,US-MYLANLABS-2020M1005341,MYLAN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805,63.0,YR,,M,Y,,,20200120.0,,HP,US,US,2020,Q1,Adult
172921391,17292139,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE, 0-0-0-12, INJEKTIONS-/INFUSIONSL?SUNG",,,,,,,,12.0,IU,,QD,2020,Q1,Renal impairment,,2020,Q1,1,I,20171218.0,20191209.0,20200121,20200121,PER,,DE-BAYER-2019-222535,BAYER,,65.0,YR,E,M,Y,80.0,KG,20200121.0,,HP,NL,DE,2020,Q1,Elderly
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Cholelithiasis,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Food intolerance,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Headache,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Malaise,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Pituitary enlargement,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Vision blurred,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172933823,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,3,F,,20200220.0,20200121,20200228,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200228.0,,CN,CO,CO,2020,Q1,Adult
172947601,17294760,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200101.0,20200121,20200121,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK045301,GLENMARK,"RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS.. 2019 INTERNATIONAL CONFERENCE OF THE AMERICAN THORACIC SOCIETY , ATS. 2019;199(9)",63.0,YR,,M,Y,,,20200121.0,,MD,US,US,2020,Q1,Adult
172947601,17294760,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Drug level increased,,2020,Q1,1,I,,20200101.0,20200121,20200121,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK045301,GLENMARK,"RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS.. 2019 INTERNATIONAL CONFERENCE OF THE AMERICAN THORACIC SOCIETY , ATS. 2019;199(9)",63.0,YR,,M,Y,,,20200121.0,,MD,US,US,2020,Q1,Adult
172947601,17294760,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,,20200101.0,20200121,20200121,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK045301,GLENMARK,"RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS.. 2019 INTERNATIONAL CONFERENCE OF THE AMERICAN THORACIC SOCIETY , ATS. 2019;199(9)",63.0,YR,,M,Y,,,20200121.0,,MD,US,US,2020,Q1,Adult
172947601,17294760,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200101.0,20200121,20200121,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK045301,GLENMARK,"RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS.. 2019 INTERNATIONAL CONFERENCE OF THE AMERICAN THORACIC SOCIETY , ATS. 2019;199(9)",63.0,YR,,M,Y,,,20200121.0,,MD,US,US,2020,Q1,Adult
172955932,17295593,3,C,Insulin-glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,2,F,,20200205.0,20200121,20200212,EXP,,US-TEVA-2020-US-1172381,TEVA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805.,63.0,YR,,M,Y,,,20200212.0,,HP,US,US,2020,Q1,Adult
172955932,17295593,3,C,Insulin-glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,2,F,,20200205.0,20200121,20200212,EXP,,US-TEVA-2020-US-1172381,TEVA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805.,63.0,YR,,M,Y,,,20200212.0,,HP,US,US,2020,Q1,Adult
172955932,17295593,3,C,Insulin-glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,2,F,,20200205.0,20200121,20200212,EXP,,US-TEVA-2020-US-1172381,TEVA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805.,63.0,YR,,M,Y,,,20200212.0,,HP,US,US,2020,Q1,Adult
172955932,17295593,3,C,Insulin-glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2020,Q1,Respiratory distress,,2020,Q1,2,F,,20200205.0,20200121,20200212,EXP,,US-TEVA-2020-US-1172381,TEVA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805.,63.0,YR,,M,Y,,,20200212.0,,HP,US,US,2020,Q1,Adult
172955932,17295593,3,C,Insulin-glargine,INSULIN NOS,1,Unknown,,,,U,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,2,F,,20200205.0,20200121,20200212,EXP,,US-TEVA-2020-US-1172381,TEVA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM-J-RESPIR-CRIT-CARE-MED 2019;199(9): (PLUS POSTER) ABSTR. A4805.,63.0,YR,,M,Y,,,20200212.0,,HP,US,US,2020,Q1,Adult
172983341,17298334,2,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Acute myocardial infarction,,2020,Q1,1,I,,20200109.0,20200122,20200122,EXP,,"US-EVUS PHARMACEUTICALS, LLC-EPL202001-000006",EVUS PHARMACEUTICALS,"SAEED M, GIL G, LOPEZ P, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019;1-3.",54.0,YR,,M,Y,,,20200122.0,,,COUNTRY NOT SPECIFIED,US,2020,Q1,Adult
172983341,17298334,2,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 UNITS AT BEDTIME,,,,,,,,,,,,2020,Q1,Product use in unapproved indication,,2020,Q1,1,I,,20200109.0,20200122,20200122,EXP,,"US-EVUS PHARMACEUTICALS, LLC-EPL202001-000006",EVUS PHARMACEUTICALS,"SAEED M, GIL G, LOPEZ P, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AM J THER. 2019;1-3.",54.0,YR,,M,Y,,,20200122.0,,,COUNTRY NOT SPECIFIED,US,2020,Q1,Adult
172987221,17298722,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2020,Q1,Dehydration,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
172987221,17298722,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
172987221,17298722,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
172987221,17298722,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2020,Q1,Nausea,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
172987221,17298722,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION,,2020,Q1,Vomiting,,2020,Q1,1,I,,20200113.0,20200121,20200121,EXP,,CA-JNJFOC-20200125688,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,79.0,KG,20200121.0,,PH,CA,CA,2020,Q1,Adult
172995613,17299561,19,C,INSULIN GLARGINE INJECTION,,2,Subcutaneous,FREQUENCY: QN,,,,,,,,6.0,DF,,,2020,Q1,Neutropenia,,2020,Q1,3,F,20200111.0,20200224.0,20200121,20200303,EXP,,CN-ABBVIE-20P-035-3230426-00,ABBVIE,,74.0,YR,,M,Y,90.0,KG,20200303.0,,MD,CN,CN,2020,Q1,Elderly
172995613,17299561,19,C,INSULIN GLARGINE INJECTION,,2,Subcutaneous,FREQUENCY: QN,,,,,,,,6.0,DF,,,2020,Q1,Thrombocytopenia,,2020,Q1,3,F,20200111.0,20200224.0,20200121,20200303,EXP,,CN-ABBVIE-20P-035-3230426-00,ABBVIE,,74.0,YR,,M,Y,90.0,KG,20200303.0,,MD,CN,CN,2020,Q1,Elderly
173010363,17301036,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,INJECTION,QD,2020,Q1,Cellulitis,,2020,Q1,3,F,20170906.0,20200225.0,20200122,20200306,EXP,,JP-JNJFOC-20200128660,JOHNSON AND JOHNSON,"N K, R Y, S I, M M, PRIVACY. 2-C-17 A CASE OF PROLONGED KETOSIS NOTED DURING TREATMENT FOR EUGLYCAEMIC KETOACIDOSIS DUE TO SGLT2 INHIBITORS. JAPAN DIABETES SOCIETY THE 57TH ANNUAL MEETING OF CHUGOKU SHIKOKU REGION ASSOCIATION. 2019;12.6,7;89:.",64.0,YR,,M,Y,,,20200306.0,,MD,JP,JP,2020,Q1,Adult
173010363,17301036,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,INJECTION,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,3,F,20170906.0,20200225.0,20200122,20200306,EXP,,JP-JNJFOC-20200128660,JOHNSON AND JOHNSON,"N K, R Y, S I, M M, PRIVACY. 2-C-17 A CASE OF PROLONGED KETOSIS NOTED DURING TREATMENT FOR EUGLYCAEMIC KETOACIDOSIS DUE TO SGLT2 INHIBITORS. JAPAN DIABETES SOCIETY THE 57TH ANNUAL MEETING OF CHUGOKU SHIKOKU REGION ASSOCIATION. 2019;12.6,7;89:.",64.0,YR,,M,Y,,,20200306.0,,MD,JP,JP,2020,Q1,Adult
173010363,17301036,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,INJECTION,QD,2020,Q1,Cellulitis,,2020,Q1,3,F,20170906.0,20200225.0,20200122,20200306,EXP,,JP-JNJFOC-20200128660,JOHNSON AND JOHNSON,"N K, R Y, S I, M M, PRIVACY. 2-C-17 A CASE OF PROLONGED KETOSIS NOTED DURING TREATMENT FOR EUGLYCAEMIC KETOACIDOSIS DUE TO SGLT2 INHIBITORS. JAPAN DIABETES SOCIETY THE 57TH ANNUAL MEETING OF CHUGOKU SHIKOKU REGION ASSOCIATION. 2019;12.6,7;89:.",64.0,YR,,M,Y,,,20200306.0,,MD,JP,JP,2020,Q1,Adult
173010363,17301036,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,INJECTION,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,3,F,20170906.0,20200225.0,20200122,20200306,EXP,,JP-JNJFOC-20200128660,JOHNSON AND JOHNSON,"N K, R Y, S I, M M, PRIVACY. 2-C-17 A CASE OF PROLONGED KETOSIS NOTED DURING TREATMENT FOR EUGLYCAEMIC KETOACIDOSIS DUE TO SGLT2 INHIBITORS. JAPAN DIABETES SOCIETY THE 57TH ANNUAL MEETING OF CHUGOKU SHIKOKU REGION ASSOCIATION. 2019;12.6,7;89:.",64.0,YR,,M,Y,,,20200306.0,,MD,JP,JP,2020,Q1,Adult
173033231,17303323,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200110.0,20200122,20200122,EXP,,US-BAUSCH-BL-2020-000954,BAUSCH AND LOMB,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE.. 2019;199(9):.,63.0,YR,,M,Y,,,20200122.0,,MD,US,US,2020,Q1,Adult
173033231,17303323,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Drug level increased,,2020,Q1,1,I,,20200110.0,20200122,20200122,EXP,,US-BAUSCH-BL-2020-000954,BAUSCH AND LOMB,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE.. 2019;199(9):.,63.0,YR,,M,Y,,,20200122.0,,MD,US,US,2020,Q1,Adult
173033231,17303323,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,,20200110.0,20200122,20200122,EXP,,US-BAUSCH-BL-2020-000954,BAUSCH AND LOMB,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE.. 2019;199(9):.,63.0,YR,,M,Y,,,20200122.0,,MD,US,US,2020,Q1,Adult
173033231,17303323,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200110.0,20200122,20200122,EXP,,US-BAUSCH-BL-2020-000954,BAUSCH AND LOMB,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE.. 2019;199(9):.,63.0,YR,,M,Y,,,20200122.0,,MD,US,US,2020,Q1,Adult
173051061,17305106,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,,20200113.0,20200122,20200122,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173051061,17305106,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Flatulence,,2020,Q1,1,I,,20200113.0,20200122,20200122,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173051061,17305106,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,,20200113.0,20200122,20200122,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173051061,17305106,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,,20200113.0,20200122,20200122,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173051061,17305106,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Flatulence,,2020,Q1,1,I,,20200113.0,20200122,20200122,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173051061,17305106,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 INTERNATIONAL UNIT,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,,20200113.0,20200122,20200122,EXP,,ES-AUROBINDO-AUR-APL-2020-003168,AUROBINDO,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173064071,17306407,1,PS,"INSULIN (INSULIN ,GLARGINE, HUM AN 100 IUNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,Y,D,,,,34.0,IU,,BID,2020,Q1,Confusional state,,2020,Q1,1,I,20191206.0,,20200106,20200106,DIR,,,FDA-CTU,,69.0,YR,,M,N,97.98,KG,20200102.0,N,PH,US,US,2020,Q1,Elderly
173064071,17306407,1,PS,"INSULIN (INSULIN ,GLARGINE, HUM AN 100 IUNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,Y,D,,,,34.0,IU,,BID,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20191206.0,,20200106,20200106,DIR,,,FDA-CTU,,69.0,YR,,M,N,97.98,KG,20200102.0,N,PH,US,US,2020,Q1,Elderly
173064071,17306407,1,PS,"INSULIN (INSULIN ,GLARGINE, HUM AN 100 IUNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,Y,D,,,,34.0,IU,,BID,2020,Q1,Loss of consciousness,,2020,Q1,1,I,20191206.0,,20200106,20200106,DIR,,,FDA-CTU,,69.0,YR,,M,N,97.98,KG,20200102.0,N,PH,US,US,2020,Q1,Elderly
173064071,17306407,1,PS,"INSULIN (INSULIN ,GLARGINE, HUM AN 100 IUNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,Y,D,,,,34.0,IU,,BID,2020,Q1,Tremor,,2020,Q1,1,I,20191206.0,,20200106,20200106,DIR,,,FDA-CTU,,69.0,YR,,M,N,97.98,KG,20200102.0,N,PH,US,US,2020,Q1,Elderly
173064071,17306407,1,PS,"INSULIN (INSULIN ,GLARGINE, HUM AN 100 IUNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,,,,Y,D,,,,34.0,IU,,BID,2020,Q1,Vision blurred,,2020,Q1,1,I,20191206.0,,20200106,20200106,DIR,,,FDA-CTU,,69.0,YR,,M,N,97.98,KG,20200102.0,N,PH,US,US,2020,Q1,Elderly
173077101,17307710,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200108.0,20200123,20200123,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-233646,RANBAXY,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9):NO PAGINATION,63.0,YR,,M,Y,,,20200123.0,,HP,US,US,2020,Q1,Adult
173077101,17307710,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Drug level above therapeutic,,2020,Q1,1,I,,20200108.0,20200123,20200123,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-233646,RANBAXY,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9):NO PAGINATION,63.0,YR,,M,Y,,,20200123.0,,HP,US,US,2020,Q1,Adult
173077101,17307710,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200108.0,20200123,20200123,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-233646,RANBAXY,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9):NO PAGINATION,63.0,YR,,M,Y,,,20200123.0,,HP,US,US,2020,Q1,Adult
173077101,17307710,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,,20200108.0,20200123,20200123,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-233646,RANBAXY,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9):NO PAGINATION,63.0,YR,,M,Y,,,20200123.0,,HP,US,US,2020,Q1,Adult
173077101,17307710,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200108.0,20200123,20200123,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-233646,RANBAXY,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9):NO PAGINATION,63.0,YR,,M,Y,,,20200123.0,,HP,US,US,2020,Q1,Adult
173077101,17307710,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,1,I,,20200108.0,20200123,20200123,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-233646,RANBAXY,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED. 2019;199(9):NO PAGINATION,63.0,YR,,M,Y,,,20200123.0,,HP,US,US,2020,Q1,Adult
173078131,17307813,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,2019.0,20200113.0,20200123,20200123,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173078131,17307813,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Flatulence,,2020,Q1,1,I,2019.0,20200113.0,20200123,20200123,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173078131,17307813,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INCREASE 1 IU OF TOUJEO IF THE BASAL GLYCAEMIA GOES ABOVE 130 MG / DL,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,2019.0,20200113.0,20200123,20200123,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173078131,17307813,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,2019.0,20200113.0,20200123,20200123,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173078131,17307813,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Flatulence,,2020,Q1,1,I,2019.0,20200113.0,20200123,20200123,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173078131,17307813,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,26.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,2019.0,20200113.0,20200123,20200123,EXP,,ES-BAUSCH-BL-2020-001358,BAUSCH AND LOMB,,72.0,YR,,F,Y,70.0,KG,20200123.0,,CN,ES,ES,2020,Q1,Elderly
173080842,17308084,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,2,F,,20200303.0,20200123,20200310,EXP,,US-DRREDDYS-USA/USA/20/0118566,DR REDDYS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9).,63.0,YR,,M,Y,,,20200310.0,,MD,US,US,2020,Q1,Adult
173080842,17308084,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Drug level increased,,2020,Q1,2,F,,20200303.0,20200123,20200310,EXP,,US-DRREDDYS-USA/USA/20/0118566,DR REDDYS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9).,63.0,YR,,M,Y,,,20200310.0,,MD,US,US,2020,Q1,Adult
173080842,17308084,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Hypotension,,2020,Q1,2,F,,20200303.0,20200123,20200310,EXP,,US-DRREDDYS-USA/USA/20/0118566,DR REDDYS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9).,63.0,YR,,M,Y,,,20200310.0,,MD,US,US,2020,Q1,Adult
173080842,17308084,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,2,F,,20200303.0,20200123,20200310,EXP,,US-DRREDDYS-USA/USA/20/0118566,DR REDDYS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199(9).,63.0,YR,,M,Y,,,20200310.0,,MD,US,US,2020,Q1,Adult
173083692,17308369,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 UL (BEFORE DINNER),,,D,,,,,6.0,UL,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 UL (BEFORE DINNER),,,D,,,,,6.0,UL,INJECTION,,2020,Q1,Glycosylated haemoglobin abnormal,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 UL (BEFORE DINNER),,,D,,,,,6.0,UL,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),10 UL (BEFORE BREAKFAST),,,D,,,,,10.0,UL,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),10 UL (BEFORE BREAKFAST),,,D,,,,,10.0,UL,INJECTION,,2020,Q1,Glycosylated haemoglobin abnormal,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),10 UL (BEFORE BREAKFAST),,,D,,,,,10.0,UL,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 U (BEFORE DINNER),,,D,,,,,,,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 U (BEFORE DINNER),,,D,,,,,,,INJECTION,,2020,Q1,Glycosylated haemoglobin abnormal,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 U (BEFORE DINNER),,,D,,,,,,,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 U (MORNING),,,D,,,,,,,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 U (MORNING),,,D,,,,,,,INJECTION,,2020,Q1,Glycosylated haemoglobin abnormal,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 U (MORNING),,,D,,,,,,,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 U (BEFORE DINNER),,,D,,,,,,,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 U (BEFORE DINNER),,,D,,,,,,,INJECTION,,2020,Q1,Glycosylated haemoglobin abnormal,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 U (BEFORE DINNER),,,D,,,,,,,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),10 U (BEFORE BREAKFAST),,,D,,,,,,,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),10 U (BEFORE BREAKFAST),,,D,,,,,,,INJECTION,,2020,Q1,Glycosylated haemoglobin abnormal,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173083692,17308369,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),10 U (BEFORE BREAKFAST),,,D,,,,,,,INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,,20200122.0,20200123,20200127,EXP,,PL-MYLANLABS-2020M1007661,MYLAN,"DZIDA G, GAJDA P, PASTERCZYK K. PROFILES OF PATIENTS WHO ARE ADVISED TO USE HUMAN INSULIN - PART II. MEDYCYNA FAKTOW. 2019;1:35-7",66.0,YR,,F,Y,,,20200127.0,,HP,PL,PL,2020,Q1,Elderly
173101171,17310117,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 U,,,Y,U,,,,,,,,2020,Q1,Erectile dysfunction,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173101171,17310117,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 U,,,Y,U,,,,,,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173101171,17310117,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 U,,,Y,U,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173101171,17310117,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 U,,,Y,U,,,,,,,,2020,Q1,Weight decreased,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173101171,17310117,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 U,,,Y,U,,,,,,,,2020,Q1,Weight increased,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173101171,17310117,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 UNK,,,Y,U,,,,,,,,2020,Q1,Erectile dysfunction,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173101171,17310117,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 UNK,,,Y,U,,,,,,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173101171,17310117,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 UNK,,,Y,U,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173101171,17310117,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 UNK,,,Y,U,,,,,,,,2020,Q1,Weight decreased,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173101171,17310117,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,6 UNK,,,Y,U,,,,,,,,2020,Q1,Weight increased,,2020,Q1,1,I,201701.0,20200117.0,20200123,20200123,EXP,,PT-MYLANLABS-2020M1006881,MYLAN,"QUINTAL V, MOITA L, PEREIRA I. PO 157: DIABETES MELLITUS: THE IMPORTANCE OF LIFESTYLE.. REVISTA PORTUGESA MEDICINA GERAL E FAMILIAR. 2019;35(SUP 3):83",54.0,YR,,M,Y,,,20200123.0,,HP,PT,PT,2020,Q1,Adult
173124101,17312410,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Gastric disorder,,2020,Q1,1,I,,20190627.0,20200123,20200123,PER,,US-NOVOPROD-670944,NOVO NORDISK,,73.0,YR,,F,Y,68.0,KG,20200124.0,,CN,US,US,2020,Q1,Elderly
173124101,17312410,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Memory impairment,,2020,Q1,1,I,,20190627.0,20200123,20200123,PER,,US-NOVOPROD-670944,NOVO NORDISK,,73.0,YR,,F,Y,68.0,KG,20200124.0,,CN,US,US,2020,Q1,Elderly
173124101,17312410,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Urticaria,,2020,Q1,1,I,,20190627.0,20200123,20200123,PER,,US-NOVOPROD-670944,NOVO NORDISK,,73.0,YR,,F,Y,68.0,KG,20200124.0,,CN,US,US,2020,Q1,Elderly
173156492,17315649,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Expired product administered,,2020,Q1,2,F,,20200121.0,20200124,20200129,PER,,US-SA-2020SA015634,SANOFI AVENTIS,,27.0,YR,A,F,Y,,,20200129.0,,CN,US,US,2020,Q1,Young Adult
173156492,17315649,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Product dose omission,,2020,Q1,2,F,,20200121.0,20200124,20200129,PER,,US-SA-2020SA015634,SANOFI AVENTIS,,27.0,YR,A,F,Y,,,20200129.0,,CN,US,US,2020,Q1,Young Adult
173231101,17323110,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q1,Confusional state,,2020,Q1,1,I,,20200120.0,20200127,20200127,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-003414",BOEHRINGER INGELHEIM,"NOLAN B, VARADARAJAN S, FOURLANOS S, NEOH S. BEWARE KETOACIDOSIS WITH SGLT2 INHIBITORS IN LATENT AUTOIMMUNE DIABETES. THE AMERICAN JOURNAL OF MEDICINE.",56.0,YR,,F,Y,,,20200127.0,,MD,AU,AU,2020,Q1,Adult
173231101,17323110,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200120.0,20200127,20200127,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-003414",BOEHRINGER INGELHEIM,"NOLAN B, VARADARAJAN S, FOURLANOS S, NEOH S. BEWARE KETOACIDOSIS WITH SGLT2 INHIBITORS IN LATENT AUTOIMMUNE DIABETES. THE AMERICAN JOURNAL OF MEDICINE.",56.0,YR,,F,Y,,,20200127.0,,MD,AU,AU,2020,Q1,Adult
173231101,17323110,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q1,Nausea,,2020,Q1,1,I,,20200120.0,20200127,20200127,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-003414",BOEHRINGER INGELHEIM,"NOLAN B, VARADARAJAN S, FOURLANOS S, NEOH S. BEWARE KETOACIDOSIS WITH SGLT2 INHIBITORS IN LATENT AUTOIMMUNE DIABETES. THE AMERICAN JOURNAL OF MEDICINE.",56.0,YR,,F,Y,,,20200127.0,,MD,AU,AU,2020,Q1,Adult
173231101,17323110,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q1,Vomiting,,2020,Q1,1,I,,20200120.0,20200127,20200127,EXP,,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-003414",BOEHRINGER INGELHEIM,"NOLAN B, VARADARAJAN S, FOURLANOS S, NEOH S. BEWARE KETOACIDOSIS WITH SGLT2 INHIBITORS IN LATENT AUTOIMMUNE DIABETES. THE AMERICAN JOURNAL OF MEDICINE.",56.0,YR,,F,Y,,,20200127.0,,MD,AU,AU,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Atelectasis,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Blood glucose increased,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Cardiomegaly,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Cerebral ischaemia,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Cerebral ventricle dilatation,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Hydrocephalus,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Intraventricular haemorrhage,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Pneumocephalus,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Prescribed underdose,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Spinal osteoarthritis,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173236353,17323635,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,3,F,20200116.0,20200317.0,20200127,20200323,EXP,,US-BIOGEN-2020BI00830949,BIOGEN,,51.0,YR,,F,Y,,,20200323.0,,HP,US,US,2020,Q1,Adult
173245681,17324568,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Acanthosis nigricans,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Ketosis-prone diabetes mellitus,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Lethargy,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Nausea,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Nocturia,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, INCREASED UP TO 30 U (0.4 U/KG)",,,,,,,206538.0,30.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Acanthosis nigricans,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, INCREASED UP TO 30 U (0.4 U/KG)",,,,,,,206538.0,30.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, INCREASED UP TO 30 U (0.4 U/KG)",,,,,,,206538.0,30.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, INCREASED UP TO 30 U (0.4 U/KG)",,,,,,,206538.0,30.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Ketosis-prone diabetes mellitus,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, INCREASED UP TO 30 U (0.4 U/KG)",,,,,,,206538.0,30.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Lethargy,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, INCREASED UP TO 30 U (0.4 U/KG)",,,,,,,206538.0,30.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Nausea,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, INCREASED UP TO 30 U (0.4 U/KG)",,,,,,,206538.0,30.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Nocturia,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173245681,17324568,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, INCREASED UP TO 30 U (0.4 U/KG)",,,,,,,206538.0,30.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,1,I,,20200117.0,20200127,20200127,EXP,,KR-SA-2020SA016753,SANOFI AVENTIS,HWANG W.B.; KIM J.H.; CHO S.M.. TWO CASES OF KETOSIS-PRONE DIABETES MELLITUS IN KOREAN ADOLESCENTS. ANNALS OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM. 2019;24 (4):257-261,13.0,YR,T,M,Y,76.5,KG,20200127.0,,MD,KR,KR,2020,Q1,Child
173251001,17325100,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,28.0,IU,,,2020,Q1,Drug interaction,,2020,Q1,1,I,20190809.0,20200122.0,20200127,20200127,EXP,ES-AEMPS-590838,ES-ACCORD-170820,ACCORD,,89.0,YR,E,F,Y,,,20200127.0,,MD,ES,ES,2020,Q1,Elderly
173251001,17325100,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,28.0,IU,,,2020,Q1,Haematuria,,2020,Q1,1,I,20190809.0,20200122.0,20200127,20200127,EXP,ES-AEMPS-590838,ES-ACCORD-170820,ACCORD,,89.0,YR,E,F,Y,,,20200127.0,,MD,ES,ES,2020,Q1,Elderly
173257291,17325729,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, UNKNOWN",,,,, F375A,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Asphyxia,,2020,Q1,1,I,,20200120.0,20200127,20200127,EXP,,NVSC2020ES014691,NOVARTIS,,82.0,YR,,F,Y,80.0,KG,20200127.0,,HP,ES,ES,2020,Q1,Elderly
173257291,17325729,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, UNKNOWN",,,,, F375A,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Asthenia,,2020,Q1,1,I,,20200120.0,20200127,20200127,EXP,,NVSC2020ES014691,NOVARTIS,,82.0,YR,,F,Y,80.0,KG,20200127.0,,HP,ES,ES,2020,Q1,Elderly
173257291,17325729,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, UNKNOWN",,,,, F375A,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Dose calculation error,,2020,Q1,1,I,,20200120.0,20200127,20200127,EXP,,NVSC2020ES014691,NOVARTIS,,82.0,YR,,F,Y,80.0,KG,20200127.0,,HP,ES,ES,2020,Q1,Elderly
173257291,17325729,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, UNKNOWN",,,,, F375A,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Nasopharyngitis,,2020,Q1,1,I,,20200120.0,20200127,20200127,EXP,,NVSC2020ES014691,NOVARTIS,,82.0,YR,,F,Y,80.0,KG,20200127.0,,HP,ES,ES,2020,Q1,Elderly
173257291,17325729,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, UNKNOWN",,,,, F375A,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Pain,,2020,Q1,1,I,,20200120.0,20200127,20200127,EXP,,NVSC2020ES014691,NOVARTIS,,82.0,YR,,F,Y,80.0,KG,20200127.0,,HP,ES,ES,2020,Q1,Elderly
173291341,17329134,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20200113.0,20200127,20200127,EXP,,US-GENUS_LIFESCIENCES-USA-POI0580202000132,GENUS LIFESCIENCES,GUMMIN D. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2019;57(12):1220-1413.,37.0,YR,,M,Y,,,20200124.0,,MD,US,US,2020,Q1,Adult
173295482,17329548,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"50 IU, QD",,,,, 9F6338A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Eye disorder,,2020,Q1,2,F,,20200211.0,20200127,20200218,PER,,US-SA-2020SA019850,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Elderly
173295482,17329548,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"50 IU, QD",,,,, 9F6338A,,21081.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,2,F,,20200211.0,20200127,20200218,PER,,US-SA-2020SA019850,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200218.0,,CN,US,US,2020,Q1,Elderly
173301871,17330187,2,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Abdominal pain,,2020,Q1,1,I,20191228.0,,20200127,20200127,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.7,KG,20200127.0,N,PH,US,US,2020,Q1,Adult
173301871,17330187,2,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,1,I,20191228.0,,20200127,20200127,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.7,KG,20200127.0,N,PH,US,US,2020,Q1,Adult
173301871,17330187,2,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Pancreatitis,,2020,Q1,1,I,20191228.0,,20200127,20200127,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.7,KG,20200127.0,N,PH,US,US,2020,Q1,Adult
173301871,17330187,2,C,Insuline glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,20191228.0,,20200127,20200127,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.7,KG,20200127.0,N,PH,US,US,2020,Q1,Adult
173322981,17332298,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,202001.0,20200122.0,20200127,20200127,EXP,,US-ELI_LILLY_AND_COMPANY-US202001010441,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200127.0,,CN,US,US,2020,Q1,Adult
173372051,17337205,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,1,I,,20200121.0,20200129,20200129,EXP,,CA-AUROBINDO-AUR-APL-2020-004054,AUROBINDO,,70.0,YR,,F,Y,,,20200129.0,,HP,CA,CA,2020,Q1,Elderly
173372051,17337205,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,,20200121.0,20200129,20200129,EXP,,CA-AUROBINDO-AUR-APL-2020-004054,AUROBINDO,,70.0,YR,,F,Y,,,20200129.0,,HP,CA,CA,2020,Q1,Elderly
173372051,17337205,10,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Nerve block,,2020,Q1,1,I,,20200121.0,20200129,20200129,EXP,,CA-AUROBINDO-AUR-APL-2020-004054,AUROBINDO,,70.0,YR,,F,Y,,,20200129.0,,HP,CA,CA,2020,Q1,Elderly
173386701,17338670,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,21081.0,,,,,2020,Q1,Ichthyosis,,2020,Q1,1,I,,20200121.0,20200129,20200129,EXP,,GB-SA-2020SA018957,SANOFI AVENTIS,SRIKURGAN L.;  LINDLEY R.;  GOUGH A.. CAN INSULIN REALLY DO THIS TO SKIN? AN EXTREME FORM OF INSULIN-INDUCED LIPODYSTROPHY. PRACTICAL DIABETES INTERNATIONAL. 2008;25:6:(245),59.0,YR,A,M,Y,,,20200129.0,,HP,GB,GB,2020,Q1,Adult
173386701,17338670,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,21081.0,,,,,2020,Q1,Injection site discolouration,,2020,Q1,1,I,,20200121.0,20200129,20200129,EXP,,GB-SA-2020SA018957,SANOFI AVENTIS,SRIKURGAN L.;  LINDLEY R.;  GOUGH A.. CAN INSULIN REALLY DO THIS TO SKIN? AN EXTREME FORM OF INSULIN-INDUCED LIPODYSTROPHY. PRACTICAL DIABETES INTERNATIONAL. 2008;25:6:(245),59.0,YR,A,M,Y,,,20200129.0,,HP,GB,GB,2020,Q1,Adult
173386701,17338670,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,21081.0,,,,,2020,Q1,Lipodystrophy acquired,,2020,Q1,1,I,,20200121.0,20200129,20200129,EXP,,GB-SA-2020SA018957,SANOFI AVENTIS,SRIKURGAN L.;  LINDLEY R.;  GOUGH A.. CAN INSULIN REALLY DO THIS TO SKIN? AN EXTREME FORM OF INSULIN-INDUCED LIPODYSTROPHY. PRACTICAL DIABETES INTERNATIONAL. 2008;25:6:(245),59.0,YR,A,M,Y,,,20200129.0,,HP,GB,GB,2020,Q1,Adult
173386701,17338670,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,21081.0,,,,,2020,Q1,Skin hypertrophy,,2020,Q1,1,I,,20200121.0,20200129,20200129,EXP,,GB-SA-2020SA018957,SANOFI AVENTIS,SRIKURGAN L.;  LINDLEY R.;  GOUGH A.. CAN INSULIN REALLY DO THIS TO SKIN? AN EXTREME FORM OF INSULIN-INDUCED LIPODYSTROPHY. PRACTICAL DIABETES INTERNATIONAL. 2008;25:6:(245),59.0,YR,A,M,Y,,,20200129.0,,HP,GB,GB,2020,Q1,Adult
173386701,17338670,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,21081.0,,,,,2020,Q1,Skin plaque,,2020,Q1,1,I,,20200121.0,20200129,20200129,EXP,,GB-SA-2020SA018957,SANOFI AVENTIS,SRIKURGAN L.;  LINDLEY R.;  GOUGH A.. CAN INSULIN REALLY DO THIS TO SKIN? AN EXTREME FORM OF INSULIN-INDUCED LIPODYSTROPHY. PRACTICAL DIABETES INTERNATIONAL. 2008;25:6:(245),59.0,YR,A,M,Y,,,20200129.0,,HP,GB,GB,2020,Q1,Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Anaemia,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Blood iron decreased,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Blood thyroid stimulating hormone increased,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Condition aggravated,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Extra dose administered,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Insulin C-peptide increased,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173473762,17347376,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,21081.0,,,,,2020,Q1,Lipoatrophy,,2020,Q1,2,F,,20200221.0,20200130,20200302,EXP,,PL-SA-2020SA020070,SANOFI AVENTIS,"DZIURA M., WASIKOWA R.. LIPOATROPHY AFTER USE OF LONG ACTING INSULIN GLARGINE ANALOGUE IN A 32-YEAR-OLD PATIENT WITH TYPE 1 DIABETES. PEDIATRIC ENDOCRINOLOGY, DIABETES AND METABOLISM. 2008;14:1:61-63",32.0,YR,A,F,Y,,,20200302.0,,HP,PL,PL,2020,Q1,Young Adult
173495702,17349570,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"55 IU, HS",,,,, 9F357A,,206538.0,55.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetes mellitus,,2020,Q1,2,F,,20200128.0,20200130,20200205,PER,,US-SA-2020SA021990,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
173495702,17349570,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"55 IU, HS",,,,, 9F357A,,206538.0,55.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Weight decreased,,2020,Q1,2,F,,20200128.0,20200130,20200205,PER,,US-SA-2020SA021990,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
173495702,17349570,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus,,2020,Q1,2,F,,20200128.0,20200130,20200205,PER,,US-SA-2020SA021990,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
173495702,17349570,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Weight decreased,,2020,Q1,2,F,,20200128.0,20200130,20200205,PER,,US-SA-2020SA021990,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Abdominal pain,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Blood immunoglobulin E increased,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Diarrhoea,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Drug hypersensitivity,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Skin test positive,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Type I hypersensitivity,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173497222,17349722,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,,,2020,Q1,Urticaria,,2020,Q1,2,F,,20200124.0,20200130,20200205,EXP,,CA-AUROBINDO-AUR-APL-2019-077306,AUROBINDO,,62.0,YR,,M,Y,,,20200205.0,,CN,CA,CA,2020,Q1,Adult
173506931,17350693,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,ROUTE: INGESTION AND PARENTERAL,,,D,,,,,,,,,2020,Q1,Completed suicide,Completed suicide,2020,Q1,1,I,,20200122.0,20200130,20200130,EXP,,US-ALVOGEN-2020-ALVOGEN-102562,ALVOGEN,"GUMMIN DD, MOWRY JB, SPYKER DA, BROOKS DE, BEUHLER MC, RIVERS LJ, ET AL. 2018 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 36TH ANNUAL REPORT. CLIN TOXICOL (PHILA). 2019 DEC;57(12):1220-1413.",37.0,YR,,M,Y,,,20200130.0,,MD,US,US,2020,Q1,Adult
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Abdominal pain,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Aphonia,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Asthenia,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Blood creatinine abnormal,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose decreased,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Blood potassium decreased,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Blood urea abnormal,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Glossodynia,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Haemorrhage,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Immunodeficiency,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Nosocomial infection,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Penis disorder,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Pneumonia,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Respiratory distress,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Unevaluable event,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Urethral operation,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Urine abnormality,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173509184,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q1,Weight decreased,,2020,Q1,4,F,20191220.0,20200312.0,20200130,20200315,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200315.0,,CN,CO,CO,2020,Q1,Elderly
173518901,17351890,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 INTERNATIONAL UNIT, DAILY",,,,U, UNK,,,12.0,IU,,QD,2020,Q1,Insulin autoimmune syndrome,,2020,Q1,1,I,,20200120.0,20200130,20200130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202001013266,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20200130.0,,HP,CN,CN,2020,Q1,Elderly
173553734,17355373,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,6 UNITS,,,,,,,,,,,QD,2020,Q1,Diarrhoea,,2020,Q1,4,F,2019.0,20200310.0,20200131,20200318,EXP,,"IL-IPSEN BIOPHARMACEUTICALS, INC.-2020-01985",IPSEN,,84.0,YR,E,M,Y,,,20200318.0,,HP,IL,IL,2020,Q1,Elderly
173553734,17355373,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,6 UNITS,,,,,,,,,,,QD,2020,Q1,Oedema peripheral,,2020,Q1,4,F,2019.0,20200310.0,20200131,20200318,EXP,,"IL-IPSEN BIOPHARMACEUTICALS, INC.-2020-01985",IPSEN,,84.0,YR,E,M,Y,,,20200318.0,,HP,IL,IL,2020,Q1,Elderly
173553734,17355373,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,6 UNITS,,,,,,,,,,,QD,2020,Q1,Weight decreased,,2020,Q1,4,F,2019.0,20200310.0,20200131,20200318,EXP,,"IL-IPSEN BIOPHARMACEUTICALS, INC.-2020-01985",IPSEN,,84.0,YR,E,M,Y,,,20200318.0,,HP,IL,IL,2020,Q1,Elderly
173560281,17356028,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,140.0,IU,UNKNOWN,,2020,Q1,Hyperkalaemia,,2020,Q1,1,I,,20200121.0,20200131,20200131,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-00359,HIKMA,"CAMPBELL T, LIEBMAN S. PLANT-BASED DIETARY APPROACH TO STAGE 3 CHRONIC KIDNEY DISEASE WITH HYPERPHOSPHATAEMIAKIDNEY DISEASE WITH HYPERPHOSPHATAEMIA. BMJ CASE REP; DOI:10.1136/BCR-2019-232080. 2019;12:232080:.",69.0,YR,,,Y,,,20200131.0,,MD,US,US,2020,Q1,Elderly
173560281,17356028,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,140.0,IU,UNKNOWN,,2020,Q1,Hyperphosphataemia,,2020,Q1,1,I,,20200121.0,20200131,20200131,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-00359,HIKMA,"CAMPBELL T, LIEBMAN S. PLANT-BASED DIETARY APPROACH TO STAGE 3 CHRONIC KIDNEY DISEASE WITH HYPERPHOSPHATAEMIAKIDNEY DISEASE WITH HYPERPHOSPHATAEMIA. BMJ CASE REP; DOI:10.1136/BCR-2019-232080. 2019;12:232080:.",69.0,YR,,,Y,,,20200131.0,,MD,US,US,2020,Q1,Elderly
173560281,17356028,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,140.0,IU,UNKNOWN,,2020,Q1,Weight increased,,2020,Q1,1,I,,20200121.0,20200131,20200131,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-00359,HIKMA,"CAMPBELL T, LIEBMAN S. PLANT-BASED DIETARY APPROACH TO STAGE 3 CHRONIC KIDNEY DISEASE WITH HYPERPHOSPHATAEMIAKIDNEY DISEASE WITH HYPERPHOSPHATAEMIA. BMJ CASE REP; DOI:10.1136/BCR-2019-232080. 2019;12:232080:.",69.0,YR,,,Y,,,20200131.0,,MD,US,US,2020,Q1,Elderly
173601961,17360196,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS Q12H SCH,,,,,,,,,,,,2020,Q1,Asthenia,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS Q12H SCH,,,,,,,,,,,,2020,Q1,Blood pressure decreased,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS Q12H SCH,,,,,,,,,,,,2020,Q1,Chills,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS Q12H SCH,,,,,,,,,,,,2020,Q1,Feeling cold,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS Q12H SCH,,,,,,,,,,,,2020,Q1,Speech disorder,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173601961,17360196,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS Q12H SCH,,,,,,,,,,,,2020,Q1,Tremor,,2020,Q1,1,I,20200117.0,20200122.0,20200203,20200203,EXP,,US-ACCORD-170771,ACCORD,,50.0,YR,,M,Y,117.93,KG,20200203.0,,HP,US,US,2020,Q1,Adult
173607194,17360719,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IN THE EVENING,,,Y,,,,,,,INJECTION,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,4,F,20200113.0,20200325.0,20200203,20200330,EXP,,JP-ASTRAZENECA-2020SE13889,ASTRAZENECA,,16464.0,DY,,F,Y,42.0,KG,20200330.0,,,JP,JP,2020,Q1,Elderly
173607194,17360719,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 IN THE EVENING,,,Y,,,,,,,INJECTION,,2020,Q1,Influenza,,2020,Q1,4,F,20200113.0,20200325.0,20200203,20200330,EXP,,JP-ASTRAZENECA-2020SE13889,ASTRAZENECA,,16464.0,DY,,F,Y,42.0,KG,20200330.0,,,JP,JP,2020,Q1,Elderly
173635112,17363511,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Aphasia,,2020,Q1,2,F,20160304.0,20200217.0,20200203,20200221,EXP,,US-GILEAD-2018-0344642,GILEAD,,64.0,YR,A,F,Y,88.0,KG,20200221.0,,HP,US,US,2020,Q1,Adult
173635112,17363511,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Confusional state,,2020,Q1,2,F,20160304.0,20200217.0,20200203,20200221,EXP,,US-GILEAD-2018-0344642,GILEAD,,64.0,YR,A,F,Y,88.0,KG,20200221.0,,HP,US,US,2020,Q1,Adult
173635112,17363511,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Depressed level of consciousness,,2020,Q1,2,F,20160304.0,20200217.0,20200203,20200221,EXP,,US-GILEAD-2018-0344642,GILEAD,,64.0,YR,A,F,Y,88.0,KG,20200221.0,,HP,US,US,2020,Q1,Adult
173635112,17363511,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Somnolence,,2020,Q1,2,F,20160304.0,20200217.0,20200203,20200221,EXP,,US-GILEAD-2018-0344642,GILEAD,,64.0,YR,A,F,Y,88.0,KG,20200221.0,,HP,US,US,2020,Q1,Adult
173639881,17363988,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,, UNK,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,1,I,2014.0,20200122.0,20200204,20200204,EXP,,DE-AUROBINDO-AUR-APL-2020-004374,AUROBINDO,,54.0,YR,,F,Y,78.0,KG,20200204.0,,CN,DE,DE,2020,Q1,Adult
173639881,17363988,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,, UNK,,,,,,,2020,Q1,Arthritis,,2020,Q1,1,I,2014.0,20200122.0,20200204,20200204,EXP,,DE-AUROBINDO-AUR-APL-2020-004374,AUROBINDO,,54.0,YR,,F,Y,78.0,KG,20200204.0,,CN,DE,DE,2020,Q1,Adult
173639881,17363988,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,, UNK,,,,,,,2020,Q1,Asthma,,2020,Q1,1,I,2014.0,20200122.0,20200204,20200204,EXP,,DE-AUROBINDO-AUR-APL-2020-004374,AUROBINDO,,54.0,YR,,F,Y,78.0,KG,20200204.0,,CN,DE,DE,2020,Q1,Adult
173639881,17363988,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,, UNK,,,,,,,2020,Q1,Chronic sinusitis,,2020,Q1,1,I,2014.0,20200122.0,20200204,20200204,EXP,,DE-AUROBINDO-AUR-APL-2020-004374,AUROBINDO,,54.0,YR,,F,Y,78.0,KG,20200204.0,,CN,DE,DE,2020,Q1,Adult
173639881,17363988,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,, UNK,,,,,,,2020,Q1,Cough,,2020,Q1,1,I,2014.0,20200122.0,20200204,20200204,EXP,,DE-AUROBINDO-AUR-APL-2020-004374,AUROBINDO,,54.0,YR,,F,Y,78.0,KG,20200204.0,,CN,DE,DE,2020,Q1,Adult
173639881,17363988,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,, UNK,,,,,,,2020,Q1,Intraductal proliferative breast lesion,,2020,Q1,1,I,2014.0,20200122.0,20200204,20200204,EXP,,DE-AUROBINDO-AUR-APL-2020-004374,AUROBINDO,,54.0,YR,,F,Y,78.0,KG,20200204.0,,CN,DE,DE,2020,Q1,Adult
173639881,17363988,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,, UNK,,,,,,,2020,Q1,Sleep apnoea syndrome,,2020,Q1,1,I,2014.0,20200122.0,20200204,20200204,EXP,,DE-AUROBINDO-AUR-APL-2020-004374,AUROBINDO,,54.0,YR,,F,Y,78.0,KG,20200204.0,,CN,DE,DE,2020,Q1,Adult
173639881,17363988,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,, UNK,,,,,,,2020,Q1,Snoring,,2020,Q1,1,I,2014.0,20200122.0,20200204,20200204,EXP,,DE-AUROBINDO-AUR-APL-2020-004374,AUROBINDO,,54.0,YR,,F,Y,78.0,KG,20200204.0,,CN,DE,DE,2020,Q1,Adult
173639881,17363988,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,, UNK,,,,,,,2020,Q1,Upper respiratory tract infection,,2020,Q1,1,I,2014.0,20200122.0,20200204,20200204,EXP,,DE-AUROBINDO-AUR-APL-2020-004374,AUROBINDO,,54.0,YR,,F,Y,78.0,KG,20200204.0,,CN,DE,DE,2020,Q1,Adult
173644111,17364411,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,35.0,IU,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,20180420.0,20200129.0,20200204,20200204,EXP,FR-AFSSAPS-RE20200043,FR-ABBVIE-20K-056-3262002-00,ABBVIE,,74.0,YR,,M,Y,72.0,KG,20200204.0,,MD,FR,FR,2020,Q1,Elderly
173658561,17365856,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Blood loss anaemia,,2020,Q1,1,I,,20200116.0,20200204,20200204,EXP,,US-BAYER-2020-011594,BAYER,"PATEL H, MEHERSHAHI S, SHAIKH DH, MAKKER J, NAYUDU S, REMY P, CHILIMURI S. THALIDOMIDE FOR THE TREATMENT OF ANGIODYSPLASIA-RELATED RECURRENT GASTROINTESTINAL HEMORRHAGE: IS LOW DOSE A SAFE AND VIABLE OPTION?. CLINICAL CASE REPORTS. 2019;7:12:2363-2367",75.0,YR,E,F,Y,,,20200204.0,,HP,US,US,2020,Q1,Elderly
173658561,17365856,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Gastrointestinal vascular malformation haemorrhagic,,2020,Q1,1,I,,20200116.0,20200204,20200204,EXP,,US-BAYER-2020-011594,BAYER,"PATEL H, MEHERSHAHI S, SHAIKH DH, MAKKER J, NAYUDU S, REMY P, CHILIMURI S. THALIDOMIDE FOR THE TREATMENT OF ANGIODYSPLASIA-RELATED RECURRENT GASTROINTESTINAL HEMORRHAGE: IS LOW DOSE A SAFE AND VIABLE OPTION?. CLINICAL CASE REPORTS. 2019;7:12:2363-2367",75.0,YR,E,F,Y,,,20200204.0,,HP,US,US,2020,Q1,Elderly
173658561,17365856,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Labelled drug-drug interaction medication error,,2020,Q1,1,I,,20200116.0,20200204,20200204,EXP,,US-BAYER-2020-011594,BAYER,"PATEL H, MEHERSHAHI S, SHAIKH DH, MAKKER J, NAYUDU S, REMY P, CHILIMURI S. THALIDOMIDE FOR THE TREATMENT OF ANGIODYSPLASIA-RELATED RECURRENT GASTROINTESTINAL HEMORRHAGE: IS LOW DOSE A SAFE AND VIABLE OPTION?. CLINICAL CASE REPORTS. 2019;7:12:2363-2367",75.0,YR,E,F,Y,,,20200204.0,,HP,US,US,2020,Q1,Elderly
173659532,17365953,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,205692.0,,,INJECTION,,2020,Q1,Tremor,,2020,Q1,2,F,,20200121.0,20200204,20200220,EXP,,US-ELI_LILLY_AND_COMPANY-US202001010314,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20200220.0,,CN,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Hypertension,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Hypophagia,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Hypothermia,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Respiratory distress,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Tachycardia,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173666061,17366606,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200121.0,20200204,20200204,EXP,,"US-ATLAS PHARMACEUTICALS, LLC-2079787",ATLAS PHARMACEUTICALS,"RAOOF S.ET.AL. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AM J RESPIR CRIT CARE MED, 2019, 199:A4805.",63.0,YR,,M,Y,,,20200204.0,,HP,US,US,2020,Q1,Adult
173712501,17371250,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Influenza,,2020,Q1,1,I,20200113.0,20200127.0,20200205,20200205,PER,,NVSC2020US029628,NOVARTIS,,31.0,YR,,F,Y,54.3,KG,20200205.0,,CN,GB,US,2020,Q1,Young Adult
173745692,17374569,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Arterial insufficiency,,2020,Q1,2,F,20190824.0,20200207.0,20200205,20200213,PER,,BR-AMGEN-BRACT2020017638,AMGEN,,65.0,YR,E,M,Y,,,20200213.0,,MD,BR,BR,2020,Q1,Elderly
173747691,17374769,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:PM;?,,,,,,,,15.0,DF,,,2020,Q1,Fall,,2020,Q1,1,I,20191011.0,,20200122,20200122,DIR,,,FDA-CTU,,67.0,YR,,M,N,54.0,KG,20200121.0,N,PH,US,US,2020,Q1,Elderly
173747691,17374769,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:PM;?,,,,,,,,15.0,DF,,,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,20191011.0,,20200122,20200122,DIR,,,FDA-CTU,,67.0,YR,,M,N,54.0,KG,20200121.0,N,PH,US,US,2020,Q1,Elderly
173747691,17374769,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:PM;?,,,,,,,,15.0,DF,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20191011.0,,20200122,20200122,DIR,,,FDA-CTU,,67.0,YR,,M,N,54.0,KG,20200121.0,N,PH,US,US,2020,Q1,Elderly
173747691,17374769,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:PM;?,,,,,,,,15.0,DF,,,2020,Q1,Hypophagia,,2020,Q1,1,I,20191011.0,,20200122,20200122,DIR,,,FDA-CTU,,67.0,YR,,M,N,54.0,KG,20200121.0,N,PH,US,US,2020,Q1,Elderly
173747691,17374769,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNIT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:PM;?,,,,,,,,15.0,DF,,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,20191011.0,,20200122,20200122,DIR,,,FDA-CTU,,67.0,YR,,M,N,54.0,KG,20200121.0,N,PH,US,US,2020,Q1,Elderly
173749581,17374958,3,C,Glargine,,2,,,,,,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173749581,17374958,3,C,Glargine,,2,,,,,,,,,,,,,,2020,Q1,Mental status changes,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173749581,17374958,3,C,Glargine,,2,,,,,,,,,,,,,,2020,Q1,Myocardial infarction,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173749581,17374958,3,C,Glargine,,2,,,,,,,,,,,,,,2020,Q1,Therapy cessation,,2020,Q1,1,I,20200107.0,,20200204,20200204,DIR,,,FDA-CTU,,55.0,YR,,F,N,71.1,KG,20200204.0,N,HP,US,US,2020,Q1,Adult
173752111,17375211,1,PS,"INSULIN (INSULIN GLARGINE,HUMAN 100 UNIT/ML INJ SOLOSTAR,3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:30 UNITS;?,,,,,,,,30.0,IU,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20191010.0,,20200121,20200121,DIR,,,FDA-CTU,,68.0,YR,,M,N,73.0,KG,20200113.0,N,PH,US,US,2020,Q1,Elderly
173752111,17375211,1,PS,"INSULIN (INSULIN GLARGINE,HUMAN 100 UNIT/ML INJ SOLOSTAR,3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:30 UNITS;?,,,,,,,,30.0,IU,,QD,2020,Q1,Sedation,,2020,Q1,1,I,20191010.0,,20200121,20200121,DIR,,,FDA-CTU,,68.0,YR,,M,N,73.0,KG,20200113.0,N,PH,US,US,2020,Q1,Elderly
173752111,17375211,2,SS,"INSULIN (INSULIN GLARGINE,HUMAN 100 UNIT/ML INJ SOLOSTAR,3ML)",INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20191010.0,,20200121,20200121,DIR,,,FDA-CTU,,68.0,YR,,M,N,73.0,KG,20200113.0,N,PH,US,US,2020,Q1,Elderly
173752111,17375211,2,SS,"INSULIN (INSULIN GLARGINE,HUMAN 100 UNIT/ML INJ SOLOSTAR,3ML)",INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Sedation,,2020,Q1,1,I,20191010.0,,20200121,20200121,DIR,,,FDA-CTU,,68.0,YR,,M,N,73.0,KG,20200113.0,N,PH,US,US,2020,Q1,Elderly
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypertension,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypophagia,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypothermia,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Leukocytosis,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Respiratory distress,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Tachycardia,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173770941,17377094,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200123.0,20200206,20200206,EXP,,US-SCIEGEN PHARMACEUTICALS INC-2020SCILIT00020,SCIEGEN,"RAOOF S.ET.AL.,;METFORMIN ASSOCIATED LACTIC ACIDOSIS.;AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE;2019;;199:A4805.",63.0,YR,E,M,Y,,,20200206.0,,HP,US,US,2020,Q1,Adult
173774891,17377489,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,QD,2020,Q1,Faeces discoloured,,2020,Q1,1,I,20191217.0,20200129.0,20200206,20200206,PER,,US-JNJFOC-20200151112,JOHNSON AND JOHNSON,,64.0,YR,,M,Y,198.85,KG,20200206.0,,CN,US,US,2020,Q1,Adult
173774891,17377489,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,QD,2020,Q1,Localised infection,,2020,Q1,1,I,20191217.0,20200129.0,20200206,20200206,PER,,US-JNJFOC-20200151112,JOHNSON AND JOHNSON,,64.0,YR,,M,Y,198.85,KG,20200206.0,,CN,US,US,2020,Q1,Adult
173774891,17377489,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,QD,2020,Q1,Pain in extremity,,2020,Q1,1,I,20191217.0,20200129.0,20200206,20200206,PER,,US-JNJFOC-20200151112,JOHNSON AND JOHNSON,,64.0,YR,,M,Y,198.85,KG,20200206.0,,CN,US,US,2020,Q1,Adult
173774891,17377489,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,QD,2020,Q1,Wound,,2020,Q1,1,I,20191217.0,20200129.0,20200206,20200206,PER,,US-JNJFOC-20200151112,JOHNSON AND JOHNSON,,64.0,YR,,M,Y,198.85,KG,20200206.0,,CN,US,US,2020,Q1,Adult
173825871,17382587,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,2018.0,20200114.0,20200206,20200206,EXP,,US-ENDO PHARMACEUTICALS INC-2020-000992,ENDO,,37.0,YR,,M,Y,,,20200206.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Bronchospasm,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Death,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Deep vein thrombosis,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Muscular weakness,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Pneumocystis jirovecii pneumonia,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Pneumonia,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173882871,17388287,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q1,Pulmonary embolism,,2020,Q1,1,I,20191025.0,20191015.0,20200207,20200207,EXP,,US-PFIZER INC-2019451106,PFIZER,,59.0,YR,,F,Y,,,20200207.0,,MD,US,US,2020,Q1,Adult
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Arthritis,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Dysphagia,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Fall,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Rib fracture,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Scratch,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Subarachnoid haemorrhage,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Syncope,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173912771,17391277,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Tachycardia,,2020,Q1,1,I,20181209.0,20200205.0,20200207,20200207,EXP,,SE-TEVA-2020-SE-1182497,TEVA,,82.0,YR,,M,Y,80.0,KG,20200207.0,,HP,SE,SE,2020,Q1,Elderly
173933231,17393323,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200131.0,20200207,20200207,EXP,,JP-ASTRAZENECA-2020SE18034,ASTRAZENECA,,50.0,YR,,M,Y,,,20200207.0,,,JP,JP,2020,Q1,Adult
173933241,17393324,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q1,Arthralgia,,2020,Q1,1,I,,20200127.0,20200208,20200208,EXP,,CA-ROCHE-2535919,ROCHE,,42.0,YR,,F,Y,,,20200208.0,,HP,CA,CA,2020,Q1,Adult
173933241,17393324,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200127.0,20200208,20200208,EXP,,CA-ROCHE-2535919,ROCHE,,42.0,YR,,F,Y,,,20200208.0,,HP,CA,CA,2020,Q1,Adult
173933241,17393324,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q1,Drug ineffective,,2020,Q1,1,I,,20200127.0,20200208,20200208,EXP,,CA-ROCHE-2535919,ROCHE,,42.0,YR,,F,Y,,,20200208.0,,HP,CA,CA,2020,Q1,Adult
173933241,17393324,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q1,Gait inability,,2020,Q1,1,I,,20200127.0,20200208,20200208,EXP,,CA-ROCHE-2535919,ROCHE,,42.0,YR,,F,Y,,,20200208.0,,HP,CA,CA,2020,Q1,Adult
173933241,17393324,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q1,Headache,,2020,Q1,1,I,,20200127.0,20200208,20200208,EXP,,CA-ROCHE-2535919,ROCHE,,42.0,YR,,F,Y,,,20200208.0,,HP,CA,CA,2020,Q1,Adult
173933241,17393324,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q1,Hypoaesthesia,,2020,Q1,1,I,,20200127.0,20200208,20200208,EXP,,CA-ROCHE-2535919,ROCHE,,42.0,YR,,F,Y,,,20200208.0,,HP,CA,CA,2020,Q1,Adult
173933241,17393324,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q1,Lower respiratory tract infection,,2020,Q1,1,I,,20200127.0,20200208,20200208,EXP,,CA-ROCHE-2535919,ROCHE,,42.0,YR,,F,Y,,,20200208.0,,HP,CA,CA,2020,Q1,Adult
173933241,17393324,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q1,Pharyngitis,,2020,Q1,1,I,,20200127.0,20200208,20200208,EXP,,CA-ROCHE-2535919,ROCHE,,42.0,YR,,F,Y,,,20200208.0,,HP,CA,CA,2020,Q1,Adult
173933241,17393324,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q1,Toothache,,2020,Q1,1,I,,20200127.0,20200208,20200208,EXP,,CA-ROCHE-2535919,ROCHE,,42.0,YR,,F,Y,,,20200208.0,,HP,CA,CA,2020,Q1,Adult
173934441,17393444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNITS ONCE A DAY,,,,,,,,100.0,IU,,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201908.0,20200203.0,20200208,20200208,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-US-006258",BOEHRINGER INGELHEIM,,73.0,YR,,F,Y,,,20200208.0,,CN,US,US,2020,Q1,Elderly
173934441,17393444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNITS ONCE A DAY,,,,,,,,100.0,IU,,QD,2020,Q1,Drug ineffective,,2020,Q1,1,I,201908.0,20200203.0,20200208,20200208,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-US-006258",BOEHRINGER INGELHEIM,,73.0,YR,,F,Y,,,20200208.0,,CN,US,US,2020,Q1,Elderly
173945611,17394561,7,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,7,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Cytokine release syndrome,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,7,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Intestinal perforation,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,7,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Neutropenia,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,7,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Pneumonitis,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173945611,17394561,7,C,insuline glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Sepsis,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-BAXTER-2020BAX002710,BAXTER,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173952482,17395248,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Blood pressure increased,,2020,Q1,2,F,,20200227.0,20200210,20200311,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002001378,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200311.0,,MD,JP,JP,2020,Q1,Elderly
173952482,17395248,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Cardiac failure,,2020,Q1,2,F,,20200227.0,20200210,20200311,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002001378,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200311.0,,MD,JP,JP,2020,Q1,Elderly
173952482,17395248,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200227.0,20200210,20200311,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002001378,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200311.0,,MD,JP,JP,2020,Q1,Elderly
173952482,17395248,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Nausea,,2020,Q1,2,F,,20200227.0,20200210,20200311,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002001378,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20200311.0,,MD,JP,JP,2020,Q1,Elderly
173956251,17395625,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Off label use,,2020,Q1,1,I,,20191111.0,20200210,20200210,EXP,,ES-MYLANLABS-2019M1109101,MYLAN,"MORGADO-CARRASCO D, COMBALIA A, FUSTA-NOVELL X, MASCARO J AND IRANZO P. AGGRESSIVE EROSIVE LICHEN PLANUS ASSOCIATED WITH HEPATITIS C RESPONDING TO SOFOSBUVIR/LEDIPASVIR TREATMENT. INDIAN JOURNAL OF DERMATOLOGY, VENEREOLOGY AND LEPROLOGY. 2019;58(3):326-329",80.0,YR,,F,Y,,,20200210.0,,HP,ES,ES,2020,Q1,Elderly
173956251,17395625,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pancytopenia,,2020,Q1,1,I,,20191111.0,20200210,20200210,EXP,,ES-MYLANLABS-2019M1109101,MYLAN,"MORGADO-CARRASCO D, COMBALIA A, FUSTA-NOVELL X, MASCARO J AND IRANZO P. AGGRESSIVE EROSIVE LICHEN PLANUS ASSOCIATED WITH HEPATITIS C RESPONDING TO SOFOSBUVIR/LEDIPASVIR TREATMENT. INDIAN JOURNAL OF DERMATOLOGY, VENEREOLOGY AND LEPROLOGY. 2019;58(3):326-329",80.0,YR,,F,Y,,,20200210.0,,HP,ES,ES,2020,Q1,Elderly
173956251,17395625,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Product use in unapproved indication,,2020,Q1,1,I,,20191111.0,20200210,20200210,EXP,,ES-MYLANLABS-2019M1109101,MYLAN,"MORGADO-CARRASCO D, COMBALIA A, FUSTA-NOVELL X, MASCARO J AND IRANZO P. AGGRESSIVE EROSIVE LICHEN PLANUS ASSOCIATED WITH HEPATITIS C RESPONDING TO SOFOSBUVIR/LEDIPASVIR TREATMENT. INDIAN JOURNAL OF DERMATOLOGY, VENEREOLOGY AND LEPROLOGY. 2019;58(3):326-329",80.0,YR,,F,Y,,,20200210.0,,HP,ES,ES,2020,Q1,Elderly
173956541,17395654,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, QD",,,U,,,,,34.0,IU,,QD,2020,Q1,Cerebral haemorrhage,,2020,Q1,1,I,20190818.0,20200203.0,20200210,20200210,EXP,IT-MINISAL02-586960,NVSC2020IT027691,NOVARTIS,,77.0,YR,,M,Y,,,20200210.0,,HP,IT,IT,2020,Q1,Elderly
173956541,17395654,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, QD",,,U,,,,,34.0,IU,,QD,2020,Q1,Haematuria,,2020,Q1,1,I,20190818.0,20200203.0,20200210,20200210,EXP,IT-MINISAL02-586960,NVSC2020IT027691,NOVARTIS,,77.0,YR,,M,Y,,,20200210.0,,HP,IT,IT,2020,Q1,Elderly
173956541,17395654,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, QD",,,U,,,,,34.0,IU,,QD,2020,Q1,Medication error,,2020,Q1,1,I,20190818.0,20200203.0,20200210,20200210,EXP,IT-MINISAL02-586960,NVSC2020IT027691,NOVARTIS,,77.0,YR,,M,Y,,,20200210.0,,HP,IT,IT,2020,Q1,Elderly
173956541,17395654,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, QD",,,U,,,,,34.0,IU,,QD,2020,Q1,Overdose,,2020,Q1,1,I,20190818.0,20200203.0,20200210,20200210,EXP,IT-MINISAL02-586960,NVSC2020IT027691,NOVARTIS,,77.0,YR,,M,Y,,,20200210.0,,HP,IT,IT,2020,Q1,Elderly
173974531,17397453,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,1,I,,20200204.0,20200210,20200210,EXP,,CA-PFIZER INC-2020056292,PFIZER,,64.0,YR,,F,Y,,,20200210.0,,PH,CA,CA,2020,Q1,Adult
173974531,17397453,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200204.0,20200210,20200210,EXP,,CA-PFIZER INC-2020056292,PFIZER,,64.0,YR,,F,Y,,,20200210.0,,PH,CA,CA,2020,Q1,Adult
173974531,17397453,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Erythema,,2020,Q1,1,I,,20200204.0,20200210,20200210,EXP,,CA-PFIZER INC-2020056292,PFIZER,,64.0,YR,,F,Y,,,20200210.0,,PH,CA,CA,2020,Q1,Adult
173974531,17397453,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Rash,,2020,Q1,1,I,,20200204.0,20200210,20200210,EXP,,CA-PFIZER INC-2020056292,PFIZER,,64.0,YR,,F,Y,,,20200210.0,,PH,CA,CA,2020,Q1,Adult
173988701,17398870,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,205692.0,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,201911.0,20200130.0,20200210,20200210,EXP,HR-HALMED-2020-00170,HR-ELI_LILLY_AND_COMPANY-HR202001014485,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20200210.0,,CN,HR,HR,2020,Q1,Elderly
173988701,17398870,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,205692.0,,,,,2020,Q1,Nausea,,2020,Q1,1,I,201911.0,20200130.0,20200210,20200210,EXP,HR-HALMED-2020-00170,HR-ELI_LILLY_AND_COMPANY-HR202001014485,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20200210.0,,CN,HR,HR,2020,Q1,Elderly
173988701,17398870,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,205692.0,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,201911.0,20200130.0,20200210,20200210,EXP,HR-HALMED-2020-00170,HR-ELI_LILLY_AND_COMPANY-HR202001014485,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20200210.0,,CN,HR,HR,2020,Q1,Elderly
173988833,17398883,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Autoimmune pancreatitis,,2020,Q1,3,F,20191226.0,20200304.0,20200210,20200310,EXP,,JP-EISAI MEDICAL RESEARCH-EC-2020-069786,EISAI,,77.0,YR,,M,Y,57.0,KG,20200310.0,,MD,JP,JP,2020,Q1,Elderly
173989191,17398919,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Cytokine release syndrome,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Intestinal perforation,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Neutropenia,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Pneumonitis,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
173989191,17398919,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Sepsis,,2020,Q1,1,I,20180125.0,20200131.0,20200210,20200210,EXP,,US-FRESENIUS KABI-FK202001276,FRESENIUS KABI,,47.0,YR,,M,Y,76.7,KG,20200210.0,,MD,US,US,2020,Q1,Adult
174011091,17401109,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32,,,Y,,,,21081.0,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,201911.0,20200204.0,20200211,20200211,EXP,HR-HALMED-2020-00170,HR-SA-2020SA030690,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200211.0,,MD,HR,HR,2020,Q1,Elderly
174011091,17401109,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32,,,Y,,,,21081.0,,,,,2020,Q1,Nausea,,2020,Q1,1,I,201911.0,20200204.0,20200211,20200211,EXP,HR-HALMED-2020-00170,HR-SA-2020SA030690,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200211.0,,MD,HR,HR,2020,Q1,Elderly
174011091,17401109,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32,,,Y,,,,21081.0,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,201911.0,20200204.0,20200211,20200211,EXP,HR-HALMED-2020-00170,HR-SA-2020SA030690,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200211.0,,MD,HR,HR,2020,Q1,Elderly
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Abdominal discomfort,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Asthenia,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Ketonuria,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Metabolic disorder,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Nausea,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,INJECTION,QD,2020,Q1,Vomiting,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Abdominal discomfort,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Asthenia,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Ketonuria,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Metabolic disorder,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Nausea,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174015901,17401590,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,INJECTION,QD,2020,Q1,Vomiting,,2020,Q1,1,I,,20200204.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1014226,MYLAN,,59.0,YR,,M,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174031091,17403109,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Haemorrhage intracranial,,2020,Q1,1,I,20191127.0,20200131.0,20200211,20200211,EXP,,NL-JNJFOC-20200207766,JOHNSON AND JOHNSON,,74.0,YR,,F,Y,,,20200211.0,,HP,NL,NL,2020,Q1,Elderly
174031091,17403109,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Hydrocephalus,,2020,Q1,1,I,20191127.0,20200131.0,20200211,20200211,EXP,,NL-JNJFOC-20200207766,JOHNSON AND JOHNSON,,74.0,YR,,F,Y,,,20200211.0,,HP,NL,NL,2020,Q1,Elderly
174038931,17403893,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"66 IU, UNK",,,,, 9F404A,,,66.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Daydreaming,,2020,Q1,1,I,,20200210.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1015970,MYLAN,,60.0,YR,,F,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174038931,17403893,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"66 IU, UNK",,,,, 9F404A,,,66.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Disorientation,,2020,Q1,1,I,,20200210.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1015970,MYLAN,,60.0,YR,,F,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174038931,17403893,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"66 IU, UNK",,,,, 9F404A,,,66.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Vitamin B12 deficiency,,2020,Q1,1,I,,20200210.0,20200211,20200211,EXP,,ES-MYLANLABS-2020M1015970,MYLAN,,60.0,YR,,F,Y,,,20200211.0,,CN,ES,ES,2020,Q1,Adult
174062271,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,1,I,202001.0,20200203.0,20200212,20200212,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200212.0,,HP,US,US,2020,Q1,Elderly
174062271,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q1,Contusion,,2020,Q1,1,I,202001.0,20200203.0,20200212,20200212,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200212.0,,HP,US,US,2020,Q1,Elderly
174062271,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,202001.0,20200203.0,20200212,20200212,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200212.0,,HP,US,US,2020,Q1,Elderly
174062271,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q1,Ear infection,,2020,Q1,1,I,202001.0,20200203.0,20200212,20200212,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200212.0,,HP,US,US,2020,Q1,Elderly
174062271,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q1,Fall,,2020,Q1,1,I,202001.0,20200203.0,20200212,20200212,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200212.0,,HP,US,US,2020,Q1,Elderly
174062271,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q1,Musculoskeletal chest pain,,2020,Q1,1,I,202001.0,20200203.0,20200212,20200212,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200212.0,,HP,US,US,2020,Q1,Elderly
174062271,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q1,Pain in extremity,,2020,Q1,1,I,202001.0,20200203.0,20200212,20200212,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200212.0,,HP,US,US,2020,Q1,Elderly
174062271,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q1,Rib fracture,,2020,Q1,1,I,202001.0,20200203.0,20200212,20200212,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200212.0,,HP,US,US,2020,Q1,Elderly
174075751,17407575,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Parainfluenzae virus infection,,2020,Q1,1,I,,20200203.0,20200212,20200212,EXP,,AU-BAUSCH-BL-2020-003762,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20200212.0,,CN,AU,AU,2020,Q1,Elderly
174075751,17407575,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,1,I,,20200203.0,20200212,20200212,EXP,,AU-BAUSCH-BL-2020-003762,BAUSCH AND LOMB,,65.0,YR,,M,Y,,,20200212.0,,CN,AU,AU,2020,Q1,Elderly
174076481,17407648,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),300 U/ML,,,U,,,,,300.0,DF,,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037024,NOVARTIS,,54.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Adult
174076481,17407648,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),300 U/ML,,,U,,,,,300.0,DF,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037024,NOVARTIS,,54.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Adult
174076481,17407648,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),300 U/ML,,,U,,,,,300.0,DF,,,2020,Q1,Weight increased,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037024,NOVARTIS,,54.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Adult
174076821,17407682,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,,,2020,Q1,Oedematous pancreatitis,,2020,Q1,1,I,,20200210.0,20200212,20200212,EXP,,NVSC2020CZ037017,NOVARTIS,,69.0,YR,,M,Y,,,20200212.0,,HP,CZ,CZ,2020,Q1,Elderly
174080231,17408023,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Blood cholesterol increased,,2020,Q1,1,I,,20200205.0,20200212,20200212,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,NVSC2020ES032584,NOVARTIS,,72.0,YR,,M,Y,,,20200212.0,,HP,ES,ES,2020,Q1,Elderly
174080231,17408023,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Blood triglycerides increased,,2020,Q1,1,I,,20200205.0,20200212,20200212,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,NVSC2020ES032584,NOVARTIS,,72.0,YR,,M,Y,,,20200212.0,,HP,ES,ES,2020,Q1,Elderly
174080231,17408023,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Fatigue,,2020,Q1,1,I,,20200205.0,20200212,20200212,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,NVSC2020ES032584,NOVARTIS,,72.0,YR,,M,Y,,,20200212.0,,HP,ES,ES,2020,Q1,Elderly
174080231,17408023,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200205.0,20200212,20200212,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,NVSC2020ES032584,NOVARTIS,,72.0,YR,,M,Y,,,20200212.0,,HP,ES,ES,2020,Q1,Elderly
174080231,17408023,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Hypertension,,2020,Q1,1,I,,20200205.0,20200212,20200212,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,NVSC2020ES032584,NOVARTIS,,72.0,YR,,M,Y,,,20200212.0,,HP,ES,ES,2020,Q1,Elderly
174080231,17408023,15,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Overdose,,2020,Q1,1,I,,20200205.0,20200212,20200212,EXP,ES-EMA-DD-20190524-TANEJA_C-170028,NVSC2020ES032584,NOVARTIS,,72.0,YR,,M,Y,,,20200212.0,,HP,ES,ES,2020,Q1,Elderly
174087403,17408740,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,3,F,20200201.0,20200217.0,20200212,20200226,EXP,,NVSC2020JP028745,NOVARTIS,,60.0,YR,,M,Y,,,20200226.0,,HP,JP,JP,2020,Q1,Adult
174087403,17408740,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,3,F,20200201.0,20200217.0,20200212,20200226,EXP,,NVSC2020JP028745,NOVARTIS,,60.0,YR,,M,Y,,,20200226.0,,HP,JP,JP,2020,Q1,Adult
174093353,17409335,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,3,F,20200116.0,20200222.0,20200212,20200302,EXP,,US-ROCHE-2544298,ROCHE,,87.0,YR,,M,Y,92.6,KG,20200302.0,,MD,US,US,2020,Q1,Elderly
174093353,17409335,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Angina pectoris,,2020,Q1,3,F,20200116.0,20200222.0,20200212,20200302,EXP,,US-ROCHE-2544298,ROCHE,,87.0,YR,,M,Y,92.6,KG,20200302.0,,MD,US,US,2020,Q1,Elderly
174093353,17409335,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,3,F,20200116.0,20200222.0,20200212,20200302,EXP,,US-ROCHE-2544298,ROCHE,,87.0,YR,,M,Y,92.6,KG,20200302.0,,MD,US,US,2020,Q1,Elderly
174093353,17409335,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Myocardial infarction,,2020,Q1,3,F,20200116.0,20200222.0,20200212,20200302,EXP,,US-ROCHE-2544298,ROCHE,,87.0,YR,,M,Y,92.6,KG,20200302.0,,MD,US,US,2020,Q1,Elderly
174093353,17409335,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Sepsis,,2020,Q1,3,F,20200116.0,20200222.0,20200212,20200302,EXP,,US-ROCHE-2544298,ROCHE,,87.0,YR,,M,Y,92.6,KG,20200302.0,,MD,US,US,2020,Q1,Elderly
174126421,17412642,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Intentional self-injury,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Overdose,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Pneumonia aspiration,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174126421,17412642,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Vomiting,,2020,Q1,1,I,,20200210.0,20200213,20200213,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-008134",BOEHRINGER INGELHEIM,TANAKA H. UTILITY OF METFORMIN AND ITS PROPER USE. -.,48.0,YR,,M,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Adult
174131521,17413152,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Blood glucose decreased,,2020,Q1,1,I,,20200205.0,20200213,20200213,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002005254,ELI LILLY AND CO,"MATSUI M, ET AL..A CASE OF A PATIENT WITH TYPE 1 DIABETES MELLITUS WHO ATTEMPTED SUICIDE BY INJECTING INSULIN LISPRO 3600 IU.THE 57TH MEETING OF JAPAN DIABETES SOCIETY IN KANTO KOSHINETSU 2020;:104.",20.0,YR,,F,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Youth
174131521,17413152,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Blood potassium decreased,,2020,Q1,1,I,,20200205.0,20200213,20200213,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002005254,ELI LILLY AND CO,"MATSUI M, ET AL..A CASE OF A PATIENT WITH TYPE 1 DIABETES MELLITUS WHO ATTEMPTED SUICIDE BY INJECTING INSULIN LISPRO 3600 IU.THE 57TH MEETING OF JAPAN DIABETES SOCIETY IN KANTO KOSHINETSU 2020;:104.",20.0,YR,,F,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Youth
174131521,17413152,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Depression,,2020,Q1,1,I,,20200205.0,20200213,20200213,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002005254,ELI LILLY AND CO,"MATSUI M, ET AL..A CASE OF A PATIENT WITH TYPE 1 DIABETES MELLITUS WHO ATTEMPTED SUICIDE BY INJECTING INSULIN LISPRO 3600 IU.THE 57TH MEETING OF JAPAN DIABETES SOCIETY IN KANTO KOSHINETSU 2020;:104.",20.0,YR,,F,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Youth
174131521,17413152,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200205.0,20200213,20200213,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002005254,ELI LILLY AND CO,"MATSUI M, ET AL..A CASE OF A PATIENT WITH TYPE 1 DIABETES MELLITUS WHO ATTEMPTED SUICIDE BY INJECTING INSULIN LISPRO 3600 IU.THE 57TH MEETING OF JAPAN DIABETES SOCIETY IN KANTO KOSHINETSU 2020;:104.",20.0,YR,,F,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Youth
174131521,17413152,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Intentional product misuse,,2020,Q1,1,I,,20200205.0,20200213,20200213,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002005254,ELI LILLY AND CO,"MATSUI M, ET AL..A CASE OF A PATIENT WITH TYPE 1 DIABETES MELLITUS WHO ATTEMPTED SUICIDE BY INJECTING INSULIN LISPRO 3600 IU.THE 57TH MEETING OF JAPAN DIABETES SOCIETY IN KANTO KOSHINETSU 2020;:104.",20.0,YR,,F,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Youth
174131521,17413152,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q1,Suicide attempt,,2020,Q1,1,I,,20200205.0,20200213,20200213,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002005254,ELI LILLY AND CO,"MATSUI M, ET AL..A CASE OF A PATIENT WITH TYPE 1 DIABETES MELLITUS WHO ATTEMPTED SUICIDE BY INJECTING INSULIN LISPRO 3600 IU.THE 57TH MEETING OF JAPAN DIABETES SOCIETY IN KANTO KOSHINETSU 2020;:104.",20.0,YR,,F,Y,,,20200213.0,,MD,JP,JP,2020,Q1,Youth
174134441,17413444,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20190228.0,20200213,20200213,EXP,,CA-ASTRAZENECA-2019SE34391,ASTRAZENECA,,78.0,YR,,M,Y,121.0,KG,20200213.0,,PH,CA,CA,2020,Q1,Elderly
174142181,17414218,15,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Myasthenia gravis,,2020,Q1,1,I,20191010.0,20200206.0,20200213,20200213,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-011886,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,81.6,KG,20200213.0,,PH,JP,JP,2020,Q1,Elderly
174156611,17415661,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,35.0,IU,UNKNOWN,QD,2020,Q1,Diverticulitis,,2020,Q1,1,I,20180719.0,20200131.0,20200213,20200213,EXP,,US-FRESENIUS KABI-FK202001289,FRESENIUS KABI,,75.0,YR,,M,Y,89.17,KG,20200213.0,,HP,US,US,2020,Q1,Elderly
174178901,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood cholesterol increased,,2020,Q1,1,I,,20180226.0,20200213,20200213,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200214.0,,PH,ES,ES,2020,Q1,Elderly
174178901,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood triglycerides increased,,2020,Q1,1,I,,20180226.0,20200213,20200213,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200214.0,,PH,ES,ES,2020,Q1,Elderly
174178901,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Fatigue,,2020,Q1,1,I,,20180226.0,20200213,20200213,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200214.0,,PH,ES,ES,2020,Q1,Elderly
174178901,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20180226.0,20200213,20200213,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200214.0,,PH,ES,ES,2020,Q1,Elderly
174178901,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Hypertension,,2020,Q1,1,I,,20180226.0,20200213,20200213,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200214.0,,PH,ES,ES,2020,Q1,Elderly
174178901,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Off label use,,2020,Q1,1,I,,20180226.0,20200213,20200213,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200214.0,,PH,ES,ES,2020,Q1,Elderly
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Abdominal pain,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Blood growth hormone increased,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Bone pain,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Depression,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Dysuria,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Headache,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypertension,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Malaise,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Neoplasm progression,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Pelvic pain,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174194271,17419427,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Thyroid disorder,,2020,Q1,1,I,201607.0,20200204.0,20200214,20200214,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,72.0,KG,20200214.0,,CN,CO,CO,2020,Q1,Adult
174196921,17419692,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20200212.0,20200214,20200214,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-008239",BOEHRINGER INGELHEIM,,46.0,YR,,F,Y,75.0,KG,20200214.0,,PH,CA,CA,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Amnesia,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Anaemia,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Blood creatinine increased,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Blood glucose increased,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Diarrhoea,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Drug ineffective,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Hemiplegia,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Human polyomavirus infection,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Hypoacusis,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Hypoaesthesia,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Inflammation,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Malnutrition,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Monoplegia,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Pain,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Renal disorder,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Renal impairment,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Tremor,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Viral infection,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174212863,17421286,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15 UNITS IN NIGHT,,,,,,,,,,FORMULATION UNKNOWN,,2020,Q1,Vomiting,,2020,Q1,3,F,2015.0,20200310.0,20200214,20200318,EXP,,CO-ASTELLAS-2019US024573,ASTELLAS,,63.0,YR,,F,Y,54.0,KG,20200318.0,,CN,CO,CO,2020,Q1,Adult
174225441,17422544,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,35.0,IU,,,2020,Q1,Lactic acidosis,Lactic acidosis,2020,Q1,1,I,20200118.0,20200206.0,20200215,20200215,EXP,ES-AEMPS-594411,ES-ZYDUS-047502,ZYDUS PHARM,,81.0,YR,E,F,Y,,,20200215.0,,PH,ES,ES,2020,Q1,Elderly
174225441,17422544,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,35.0,IU,,,2020,Q1,Urinary tract infection,Urinary tract infection,2020,Q1,1,I,20200118.0,20200206.0,20200215,20200215,EXP,ES-AEMPS-594411,ES-ZYDUS-047502,ZYDUS PHARM,,81.0,YR,E,F,Y,,,20200215.0,,PH,ES,ES,2020,Q1,Elderly
174231181,17423118,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ )",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 DF/ML;OTHER FREQUENCY:AM;?,,,Y,N,,,,20.0,DF,,,2020,Q1,Cognitive disorder,,2020,Q1,1,I,20200103.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231181,17423118,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ )",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 DF/ML;OTHER FREQUENCY:AM;?,,,Y,N,,,,20.0,DF,,,2020,Q1,Dizziness,,2020,Q1,1,I,20200103.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231181,17423118,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ )",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 DF/ML;OTHER FREQUENCY:AM;?,,,Y,N,,,,20.0,DF,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200103.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231181,17423118,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ )",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 DF/ML;OTHER FREQUENCY:AM;?,,,Y,N,,,,20.0,DF,,,2020,Q1,Hypophagia,,2020,Q1,1,I,20200103.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231181,17423118,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ )",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 DF/ML;OTHER FREQUENCY:AM;?,,,Y,N,,,,20.0,DF,,,2020,Q1,Incorrect dose administered,,2020,Q1,1,I,20200103.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231181,17423118,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ )",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 DF/ML;OTHER FREQUENCY:AM;?,,,Y,N,,,,20.0,DF,,,2020,Q1,Leukocytosis,,2020,Q1,1,I,20200103.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231181,17423118,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ )",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 DF/ML;OTHER FREQUENCY:AM;?,,,Y,N,,,,20.0,DF,,,2020,Q1,Malaise,,2020,Q1,1,I,20200103.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231181,17423118,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ )",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 DF/ML;OTHER FREQUENCY:AM;?,,,Y,N,,,,20.0,DF,,,2020,Q1,Tachycardia,,2020,Q1,1,I,20200103.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231581,17423158,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:BEDTIME ;?,,,,,,,,20.0,IU,,HS,2020,Q1,Asthenia,,2020,Q1,1,I,20200110.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231581,17423158,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:BEDTIME ;?,,,,,,,,20.0,IU,,HS,2020,Q1,Blood glucose fluctuation,,2020,Q1,1,I,20200110.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231581,17423158,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:BEDTIME ;?,,,,,,,,20.0,IU,,HS,2020,Q1,Dizziness,,2020,Q1,1,I,20200110.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174231581,17423158,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:BEDTIME ;?,,,,,,,,20.0,IU,,HS,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200110.0,,20200130,20200130,DIR,,,FDA-CTU,,63.0,YR,,M,N,,,20200129.0,N,PH,US,US,2020,Q1,Adult
174251151,17425115,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN DOSE WAS 46 UNITS/DAY,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN DOSE WAS 46 UNITS/DAY,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Lipohypertrophy,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN DOSE WAS 46 UNITS/DAY,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Secondary amyloidosis,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,REDUCED TO 24 UNITS/DAY,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,REDUCED TO 24 UNITS/DAY,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Lipohypertrophy,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174251151,17425115,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,REDUCED TO 24 UNITS/DAY,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Secondary amyloidosis,,2020,Q1,1,I,,20200207.0,20200217,20200217,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,NAGASE T.; IWAYA K.; KOGURE K.; ZAKO T.; MISUMI Y.; KIKUCHI M.; ET AL. INSULIN-DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019;UNK:UNK,81.0,YR,E,M,Y,,,20200217.0,,HP,JP,JP,2020,Q1,Elderly
174288851,17428885,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 U, UNK",,,U,U,,,,18.0,DF,,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,,20180910.0,20200218,20200218,EXP,,PHHY2018PT100687,NOVARTIS,,52.0,YR,,F,Y,51.0,KG,20200218.0,,HP,PT,PT,2020,Q1,Adult
174288851,17428885,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 U, UNK",,,U,U,,,,18.0,DF,,,2020,Q1,Hyperlactacidaemia,,2020,Q1,1,I,,20180910.0,20200218,20200218,EXP,,PHHY2018PT100687,NOVARTIS,,52.0,YR,,F,Y,51.0,KG,20200218.0,,HP,PT,PT,2020,Q1,Adult
174288851,17428885,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 U, UNK",,,U,U,,,,18.0,DF,,,2020,Q1,Lactic acidosis,,2020,Q1,1,I,,20180910.0,20200218,20200218,EXP,,PHHY2018PT100687,NOVARTIS,,52.0,YR,,F,Y,51.0,KG,20200218.0,,HP,PT,PT,2020,Q1,Adult
174293231,17429323,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNITS AT NIGHT,,,U,,,,,,,,,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200209.0,20200218,20200218,EXP,,AU-ASTRAZENECA-2020SE22770,ASTRAZENECA,,61.0,YR,,M,Y,,,20200218.0,,HP,AU,AU,2020,Q1,Adult
174293755,17429375,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UI/ML, 22 UI, QD",,,,,,,,,,,,2020,Q1,Breast cellulitis,,2020,Q1,5,F,20200205.0,20200309.0,20200218,20200323,EXP,,NVSC2020US035444,NOVARTIS,,48.0,YR,,F,Y,105.4,KG,20200323.0,,HP,US,US,2020,Q1,Adult
174293755,17429375,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UI/ML, 22 UI, QD",,,,,,,,,,,,2020,Q1,Ureterolithiasis,,2020,Q1,5,F,20200205.0,20200309.0,20200218,20200323,EXP,,NVSC2020US035444,NOVARTIS,,48.0,YR,,F,Y,105.4,KG,20200323.0,,HP,US,US,2020,Q1,Adult
174370861,17437086,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200211.0,20200219,20200219,EXP,,CA-TEVA-2020-CA-1185671,TEVA,,70.0,YR,,F,Y,,,20200219.0,,HP,CA,CA,2020,Q1,Elderly
174370861,17437086,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Neoplasm progression,,2020,Q1,1,I,,20200211.0,20200219,20200219,EXP,,CA-TEVA-2020-CA-1185671,TEVA,,70.0,YR,,F,Y,,,20200219.0,,HP,CA,CA,2020,Q1,Elderly
174382241,17438224,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 IE,,,U,,,,,,,,,2020,Q1,Cough,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013704,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,80.0,KG,20200220.0,,PH,DE,DE,2020,Q1,Elderly
174382241,17438224,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 IE,,,U,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013704,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,80.0,KG,20200220.0,,PH,DE,DE,2020,Q1,Elderly
174382241,17438224,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 IE,,,U,,,,,,,,,2020,Q1,Melaena,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013704,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,80.0,KG,20200220.0,,PH,DE,DE,2020,Q1,Elderly
174382241,17438224,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,450 IE,,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200214.0,20200220,20200220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013704,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,80.0,KG,20200220.0,,PH,DE,DE,2020,Q1,Elderly
174409761,17440976,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,18 UNIT,,,U,,,,,18.0,DF,,,2020,Q1,Anticoagulation drug level above therapeutic,,2020,Q1,1,I,20200203.0,20200206.0,20200220,20200220,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-013893,BRISTOL MYERS SQUIBB,,73.0,YR,,F,Y,68.1,KG,20200220.0,,HP,US,US,2020,Q1,Elderly
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Anxiety,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Depression,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Dry mouth,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Feeling abnormal,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Increased insulin requirement,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Paraesthesia,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Temperature intolerance,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174426612,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Vertigo,,2020,Q1,2,F,20190304.0,20200306.0,20200220,20200312,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200312.0,,HP,US,US,2020,Q1,Youth
174431942,17443194,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,40 UNITS AT BED TIME,,,U,,,,,,,,,2020,Q1,Neutrophilia,,2020,Q1,2,F,20200212.0,20200228.0,20200221,20200312,EXP,,US-AUROBINDO-AUR-APL-2020-009007,AUROBINDO,,32.0,YR,,M,Y,37.73,KG,20200312.0,,HP,US,US,2020,Q1,Young Adult
174431942,17443194,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,40 UNITS AT BED TIME,,,U,,,,,,,,,2020,Q1,Suicidal ideation,,2020,Q1,2,F,20200212.0,20200228.0,20200221,20200312,EXP,,US-AUROBINDO-AUR-APL-2020-009007,AUROBINDO,,32.0,YR,,M,Y,37.73,KG,20200312.0,,HP,US,US,2020,Q1,Young Adult
174512271,17451227,1,PS,INSULIN (INSULIN GLARGINE. HUMAN 100UNT/ML INJ),INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:35 UNITS;OTHER FREQUENCY:AM;?,,,Y,, 02/01/22,20220201.0,,,,,,2020,Q1,Diarrhoea,,2020,Q1,1,I,20191216.0,,20200210,20200210,DIR,,,FDA-CTU,,73.0,YR,,M,N,89.0,KG,20200207.0,N,PH,US,US,2020,Q1,Elderly
174516221,17451622,1,PS,Insulin Glargine,INSULIN GLARGINE,1,,,,,,Y,,,,,,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200201.0,,20200221,20200221,DIR,,,FDA-CTU,,56.0,YR,,M,N,160.0,KG,20200221.0,N,,US,US,2020,Q1,Adult
174516321,17451632,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q1,Erythema,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,DE-GLAXOSMITHKLINE-DE2020027578,GLAXOSMITHKLINE,,82.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174516321,17451632,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q1,Peripheral swelling,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,DE-GLAXOSMITHKLINE-DE2020027578,GLAXOSMITHKLINE,,82.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174516321,17451632,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,DE-GLAXOSMITHKLINE-DE2020027578,GLAXOSMITHKLINE,,82.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174516321,17451632,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,DE-GLAXOSMITHKLINE-DE2020027578,GLAXOSMITHKLINE,,82.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174516321,17451632,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q1,Rash,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,DE-GLAXOSMITHKLINE-DE2020027578,GLAXOSMITHKLINE,,82.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174516321,17451632,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q1,Skin irritation,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,DE-GLAXOSMITHKLINE-DE2020027578,GLAXOSMITHKLINE,,82.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174516321,17451632,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q1,Urticaria,,2020,Q1,1,I,,20200217.0,20200224,20200224,EXP,,DE-GLAXOSMITHKLINE-DE2020027578,GLAXOSMITHKLINE,,82.0,YR,,M,Y,,,20200224.0,,MD,DE,DE,2020,Q1,Elderly
174523581,17452358,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNITS AT BEDTIME,,,D,,,,,,,INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200210.0,20200224,20200224,EXP,,BAUSCH-BL-2020-004447,BAUSCH AND LOMB,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MEDICAL JOURNAL ARMED FORCES INDIA. 2018 FEB 03;76:109-111. DOI:HTTPS://DOI.ORG/10.1016/J.MJAFI.2017.11.006",35.0,YR,,F,Y,,,20200224.0,,HP,COUNTRY NOT SPECIFIED,,2020,Q1,Adult
174523581,17452358,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNITS AT BEDTIME,,,D,,,,,,,INJECTION,,2020,Q1,Maternal exposure during pregnancy,,2020,Q1,1,I,,20200210.0,20200224,20200224,EXP,,BAUSCH-BL-2020-004447,BAUSCH AND LOMB,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MEDICAL JOURNAL ARMED FORCES INDIA. 2018 FEB 03;76:109-111. DOI:HTTPS://DOI.ORG/10.1016/J.MJAFI.2017.11.006",35.0,YR,,F,Y,,,20200224.0,,HP,COUNTRY NOT SPECIFIED,,2020,Q1,Adult
174523581,17452358,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNITS AT BEDTIME,,,D,,,,,,,INJECTION,,2020,Q1,Normal newborn,,2020,Q1,1,I,,20200210.0,20200224,20200224,EXP,,BAUSCH-BL-2020-004447,BAUSCH AND LOMB,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MEDICAL JOURNAL ARMED FORCES INDIA. 2018 FEB 03;76:109-111. DOI:HTTPS://DOI.ORG/10.1016/J.MJAFI.2017.11.006",35.0,YR,,F,Y,,,20200224.0,,HP,COUNTRY NOT SPECIFIED,,2020,Q1,Adult
174544261,17454426,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q1,Kaposi's sarcoma,,2020,Q1,1,I,,20200213.0,20200225,20200225,EXP,,US-APOTEX-2020AP007976,APOTEX,"AHMED M, DENICOLA R. GASTRIC KAPOSI^S SARCOMA IN A PATIENT WITH APLASTIC ANEMIA. DOI: 10.14309/01.AJG.0000597548.92525.7B. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2019;114:S1121-S1122",70.0,YR,,M,Y,,,20200225.0,,HP,US,US,2020,Q1,Elderly
174555291,17455529,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK MG, NACH SCHEMA",,,U,,,,,,,,,2020,Q1,Erythema,,2020,Q1,1,I,,20200213.0,20200225,20200225,EXP,,DE-AUROBINDO-AUR-APL-2020-009190,AUROBINDO,,82.0,YR,,M,Y,,,20200225.0,,MD,DE,DE,2020,Q1,Elderly
174555291,17455529,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK MG, NACH SCHEMA",,,U,,,,,,,,,2020,Q1,Peripheral swelling,,2020,Q1,1,I,,20200213.0,20200225,20200225,EXP,,DE-AUROBINDO-AUR-APL-2020-009190,AUROBINDO,,82.0,YR,,M,Y,,,20200225.0,,MD,DE,DE,2020,Q1,Elderly
174555291,17455529,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK MG, NACH SCHEMA",,,U,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,1,I,,20200213.0,20200225,20200225,EXP,,DE-AUROBINDO-AUR-APL-2020-009190,AUROBINDO,,82.0,YR,,M,Y,,,20200225.0,,MD,DE,DE,2020,Q1,Elderly
174555291,17455529,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK MG, NACH SCHEMA",,,U,,,,,,,,,2020,Q1,Pyrexia,,2020,Q1,1,I,,20200213.0,20200225,20200225,EXP,,DE-AUROBINDO-AUR-APL-2020-009190,AUROBINDO,,82.0,YR,,M,Y,,,20200225.0,,MD,DE,DE,2020,Q1,Elderly
174555291,17455529,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK MG, NACH SCHEMA",,,U,,,,,,,,,2020,Q1,Rash,,2020,Q1,1,I,,20200213.0,20200225,20200225,EXP,,DE-AUROBINDO-AUR-APL-2020-009190,AUROBINDO,,82.0,YR,,M,Y,,,20200225.0,,MD,DE,DE,2020,Q1,Elderly
174555291,17455529,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK MG, NACH SCHEMA",,,U,,,,,,,,,2020,Q1,Skin irritation,,2020,Q1,1,I,,20200213.0,20200225,20200225,EXP,,DE-AUROBINDO-AUR-APL-2020-009190,AUROBINDO,,82.0,YR,,M,Y,,,20200225.0,,MD,DE,DE,2020,Q1,Elderly
174555291,17455529,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK MG, NACH SCHEMA",,,U,,,,,,,,,2020,Q1,Urticaria,,2020,Q1,1,I,,20200213.0,20200225,20200225,EXP,,DE-AUROBINDO-AUR-APL-2020-009190,AUROBINDO,,82.0,YR,,M,Y,,,20200225.0,,MD,DE,DE,2020,Q1,Elderly
174582811,17458281,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),100 U/ML,,,U,,,,,100.0,DF,,,2020,Q1,Hepatitis E,,2020,Q1,1,I,2018.0,20200214.0,20200225,20200225,EXP,,NVSC2020CZ051250,NOVARTIS,,50.0,YR,,M,Y,,,20200225.0,,HP,CZ,CZ,2020,Q1,Adult
174582811,17458281,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),100 U/ML,,,U,,,,,100.0,DF,,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,2018.0,20200214.0,20200225,20200225,EXP,,NVSC2020CZ051250,NOVARTIS,,50.0,YR,,M,Y,,,20200225.0,,HP,CZ,CZ,2020,Q1,Adult
174624571,17462457,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,U,,,,,450.0,IU,,,2020,Q1,Cough,,2020,Q1,1,I,,20200214.0,20200226,20200226,EXP,,DE-AUROBINDO-AUR-APL-2020-009279,AUROBINDO,,72.0,YR,,M,Y,80.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174624571,17462457,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,U,,,,,450.0,IU,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200214.0,20200226,20200226,EXP,,DE-AUROBINDO-AUR-APL-2020-009279,AUROBINDO,,72.0,YR,,M,Y,80.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174624571,17462457,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,U,,,,,450.0,IU,,,2020,Q1,Melaena,,2020,Q1,1,I,,20200214.0,20200226,20200226,EXP,,DE-AUROBINDO-AUR-APL-2020-009279,AUROBINDO,,72.0,YR,,M,Y,80.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174624571,17462457,4,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,450 INTERNATIONAL UNIT,,,U,,,,,450.0,IU,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200214.0,20200226,20200226,EXP,,DE-AUROBINDO-AUR-APL-2020-009279,AUROBINDO,,72.0,YR,,M,Y,80.0,KG,20200226.0,,PH,DE,DE,2020,Q1,Elderly
174630602,17463060,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,16.0,IU,INJECTION,QD,2020,Q1,Vulval abscess,,2020,Q1,2,F,20190620.0,20200313.0,20200226,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-011257",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,70.6,KG,20200320.0,,MD,JP,JP,2020,Q1,Elderly
174630602,17463060,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,16.0,IU,INJECTION,QD,2020,Q1,Vulval cellulitis,,2020,Q1,2,F,20190620.0,20200313.0,20200226,20200320,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-011257",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,70.6,KG,20200320.0,,MD,JP,JP,2020,Q1,Elderly
174669661,17466966,6,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Acute myocardial infarction,,2020,Q1,1,I,20200214.0,20200218.0,20200227,20200227,EXP,,CO-BAXTER-2020BAX003868,BAXTER,,78.0,YR,,F,Y,58.0,KG,20200227.0,,HP,CO,CO,2020,Q1,Elderly
174688561,17468856,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 U/ML, QD",,,,,,,,,,,QD,2020,Q1,Urinary tract infection,,2020,Q1,1,I,20181115.0,20190607.0,20200227,20200227,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004330",AEGERION,,47.0,YR,,F,Y,51.6,KG,20200227.0,,HP,US,US,2020,Q1,Adult
174689311,17468931,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U/ML, QD",,,,,,,,,,,QD,2020,Q1,Angina pectoris,,2020,Q1,1,I,20190407.0,20190906.0,20200227,20200227,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004480",AEGERION,,48.0,YR,,F,Y,49.6,KG,20200227.0,,HP,US,US,2020,Q1,Adult
174689311,17468931,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U/ML, QD",,,,,,,,,,,QD,2020,Q1,Vaginal haemorrhage,,2020,Q1,1,I,20190407.0,20190906.0,20200227,20200227,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004480",AEGERION,,48.0,YR,,F,Y,49.6,KG,20200227.0,,HP,US,US,2020,Q1,Adult
174716131,17471613,7,SS,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,"12 UNIT, AT BEDTIME",,,U,,,,,,,INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,,20200213.0,20200228,20200228,EXP,,SD-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-238449,RANBAXY,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MED-J-ARMED-FORCES-INDIA. 2020;75:109-111",35.0,YR,,F,Y,,,20200228.0,,HP,SD,SD,2020,Q1,Adult
174716131,17471613,7,SS,GLARGINE INSULIN,INSULIN GLARGINE,1,Unknown,"12 UNIT, AT BEDTIME",,,U,,,,,,,INJECTION,,2020,Q1,Exposure during pregnancy,,2020,Q1,1,I,,20200213.0,20200228,20200228,EXP,,SD-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-238449,RANBAXY,"DEY M, SAHOO I, CHAWLA S, RAJPUT M. PREGNANCY WITH PRIOR CORONARY ARTERY DISEASE: SPECIFIC CONCERNS. MED-J-ARMED-FORCES-INDIA. 2020;75:109-111",35.0,YR,,F,Y,,,20200228.0,,HP,SD,SD,2020,Q1,Adult
174720841,17472084,2,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DAILY",,,Y,U,,,,,,,QD,2020,Q1,Cutaneous amyloidosis,,2020,Q1,1,I,,20200210.0,20200228,20200228,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202002003606,ELI LILLY AND CO,"TACHIBANA M, ET AL.A CASE OF INSULIN BALL, CLINICALLY MIMICKING EPIDERMAL CYST.JAPANESE JOURNAL OF DIAGNOSTIC PATHOLOGY 2019;364:315-319.",55.0,YR,,M,Y,,,20200228.0,,MD,JP,JP,2020,Q1,Adult
174732791,17473279,2,SS,insulin glargine,INSULIN GLARGINE,1,,UNKNOWN,,,D,,,,,,,,,2020,Q1,Completed suicide,,2020,Q1,1,I,,20200218.0,20200228,20200228,EXP,,US-TORRENT-00010000,TORRENT,,37.0,YR,A,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Adult
174732791,17473279,2,SS,insulin glargine,INSULIN GLARGINE,1,,UNKNOWN,,,D,,,,,,,,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200218.0,20200228,20200228,EXP,,US-TORRENT-00010000,TORRENT,,37.0,YR,A,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Adult
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Arrhythmia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Atrial fibrillation,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Bradycardia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Dehydration,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Dizziness,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Haematocrit increased,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Haemoglobin increased,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Hypotension,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Hypovolaemia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Left atrial dilatation,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Mucosal dryness,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Presyncope,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Pulmonary congestion,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Renal disorder,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Skin disorder,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,U,,,,,26.0,IU,,QD,2020,Q1,Syncope,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Atrial fibrillation,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Bradycardia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Dizziness,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haematocrit increased,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Haemoglobin increased,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Hypovolaemia,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Left atrial dilatation,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Mucosal dryness,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Presyncope,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Pulmonary congestion,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Renal disorder,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Skin disorder,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174760861,17476086,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Syncope,,2020,Q1,1,I,,20200222.0,20200228,20200228,EXP,,PT-MYLANLABS-2020M1021094,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?.. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1):47-122:1-2",71.0,YR,,M,Y,,,20200228.0,,MD,PT,PT,2020,Q1,Elderly
174764411,17476441,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Altered state of consciousness,,2020,Q1,1,I,20200210.0,20200224.0,20200228,20200228,EXP,,US-PFIZER INC-2020083164,PFIZER,,11.0,YR,,F,Y,68.1,KG,20200228.0,,MD,US,US,2020,Q1,Child
174764411,17476441,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Seizure,,2020,Q1,1,I,20200210.0,20200224.0,20200228,20200228,EXP,,US-PFIZER INC-2020083164,PFIZER,,11.0,YR,,F,Y,68.1,KG,20200228.0,,MD,US,US,2020,Q1,Child
174801331,17480133,57,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,UNKNOWN,QD,2020,Q1,Confusional state,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,57,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,UNKNOWN,QD,2020,Q1,Fall,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,57,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,UNKNOWN,QD,2020,Q1,Osteomyelitis,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,57,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,UNKNOWN,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,57,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,UNKNOWN,QD,2020,Q1,Somnolence,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,58,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,40.0,IU,UNKNOWN,QD,2020,Q1,Confusional state,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,58,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,40.0,IU,UNKNOWN,QD,2020,Q1,Fall,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,58,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,40.0,IU,UNKNOWN,QD,2020,Q1,Osteomyelitis,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,58,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,40.0,IU,UNKNOWN,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,58,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,40.0,IU,UNKNOWN,QD,2020,Q1,Somnolence,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (INTERNATIONAL UNIT (50 IU, 1 IN 1 D)",,,,,,,,,,UNKNOWN,,2020,Q1,Confusional state,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (INTERNATIONAL UNIT (50 IU, 1 IN 1 D)",,,,,,,,,,UNKNOWN,,2020,Q1,Fall,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (INTERNATIONAL UNIT (50 IU, 1 IN 1 D)",,,,,,,,,,UNKNOWN,,2020,Q1,Osteomyelitis,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (INTERNATIONAL UNIT (50 IU, 1 IN 1 D)",,,,,,,,,,UNKNOWN,,2020,Q1,Pneumonia,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174801331,17480133,59,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU (INTERNATIONAL UNIT (50 IU, 1 IN 1 D)",,,,,,,,,,UNKNOWN,,2020,Q1,Somnolence,,2020,Q1,1,I,20180807.0,20200218.0,20200228,20200228,EXP,,US-FRESENIUS KABI-FK202002028,FRESENIUS KABI,,75.0,YR,,M,Y,,,20200228.0,,MD,US,US,2020,Q1,Elderly
174819261,17481926,14,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Altered state of consciousness,,2020,Q1,1,I,20200210.0,20200220.0,20200302,20200302,EXP,,US-BAXTER-2020BAX004462,BAXTER,,11.0,YR,,F,Y,68.1,KG,20200302.0,,MD,US,US,2020,Q1,Child
174819261,17481926,14,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Seizure,,2020,Q1,1,I,20200210.0,20200220.0,20200302,20200302,EXP,,US-BAXTER-2020BAX004462,BAXTER,,11.0,YR,,F,Y,68.1,KG,20200302.0,,MD,US,US,2020,Q1,Child
174822061,17482206,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,,, 9F375A,,,34.0,IU,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200217.0,20200302,20200302,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202002008484,ELI LILLY AND CO,,57.0,YR,,F,Y,95.4,KG,20200302.0,,CN,ES,ES,2020,Q1,Adult
174822061,17482206,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,,, 9F375A,,,,,,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200217.0,20200302,20200302,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202002008484,ELI LILLY AND CO,,57.0,YR,,F,Y,95.4,KG,20200302.0,,CN,ES,ES,2020,Q1,Adult
174838381,17483838,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q1,Kaposi's sarcoma,,2020,Q1,1,I,,20200219.0,20200302,20200302,EXP,,US-MYLANLABS-2020M1021204,MYLAN,"AHMED M, DENICOLA R. GASTRIC KAPOSI^S SARCOMA IN A PATIENT WITH APLASTIC ANEMIA. AM-J-GASTROENTEROL 2019;114 (SUPPL.):S1121-S1122 ABSTR. 2004.",70.0,YR,,M,Y,,,20200302.0,,MD,US,US,2020,Q1,Elderly
174848951,17484895,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,,QD,2020,Q1,Keratitis fungal,,2020,Q1,1,I,,20200220.0,20200302,20200302,EXP,,JP-NOVOPROD-715485,NOVO NORDISK,,69.0,YR,,M,Y,61.0,KG,20200302.0,,MD,JP,JP,2020,Q1,Elderly
174849482,17484948,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Hepatitis acute,,2020,Q1,2,F,20200114.0,20200320.0,20200302,20200330,EXP,,ES-NOVOPROD-714601,NOVO NORDISK,,63.0,YR,,F,Y,,,20200330.0,,MD,ES,ES,2020,Q1,Adult
174849482,17484948,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,2,F,20200114.0,20200320.0,20200302,20200330,EXP,,ES-NOVOPROD-714601,NOVO NORDISK,,63.0,YR,,F,Y,,,20200330.0,,MD,ES,ES,2020,Q1,Adult
174849482,17484948,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hepatitis acute,,2020,Q1,2,F,20200114.0,20200320.0,20200302,20200330,EXP,,ES-NOVOPROD-714601,NOVO NORDISK,,63.0,YR,,F,Y,,,20200330.0,,MD,ES,ES,2020,Q1,Adult
174849482,17484948,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Pruritus,,2020,Q1,2,F,20200114.0,20200320.0,20200302,20200330,EXP,,ES-NOVOPROD-714601,NOVO NORDISK,,63.0,YR,,F,Y,,,20200330.0,,MD,ES,ES,2020,Q1,Adult
174860142,17486014,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,U,, UNKNOWN,,,,,,QD,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,2,F,,20200305.0,20200303,20200317,EXP,PL-EMA-DD-20200214-GONUGUNTLA_N1-134423,PL-LUPIN PHARMACEUTICALS INC.-2020-01113,LUPIN,,62.0,YR,,M,Y,81.0,KG,20200317.0,,CN,GB,PL,2020,Q1,Adult
174860142,17486014,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 UNIT, QD",,,U,, UNKNOWN,,,,,,QD,2020,Q1,Pulmonary tuberculosis,,2020,Q1,2,F,,20200305.0,20200303,20200317,EXP,PL-EMA-DD-20200214-GONUGUNTLA_N1-134423,PL-LUPIN PHARMACEUTICALS INC.-2020-01113,LUPIN,,62.0,YR,,M,Y,81.0,KG,20200317.0,,CN,GB,PL,2020,Q1,Adult
174863381,17486338,5,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, PRN",,,N,U,,,205692.0,,,INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,202002.0,20200225.0,20200303,20200303,PER,,US-ELI_LILLY_AND_COMPANY-US202002013378,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Youth
174863381,17486338,5,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, PRN",,,N,U,,,205692.0,,,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,202002.0,20200225.0,20200303,20200303,PER,,US-ELI_LILLY_AND_COMPANY-US202002013378,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20200303.0,,CN,US,US,2020,Q1,Youth
174868051,17486805,12,C,GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Fall,,2020,Q1,1,I,20200126.0,20200225.0,20200303,20200303,EXP,,AU-GLAXOSMITHKLINE-AU2020APC034526,GLAXOSMITHKLINE,,72.0,YR,,F,Y,,,20200303.0,,HP,AU,AU,2020,Q1,Elderly
174868051,17486805,12,C,GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q1,Hip fracture,,2020,Q1,1,I,20200126.0,20200225.0,20200303,20200303,EXP,,AU-GLAXOSMITHKLINE-AU2020APC034526,GLAXOSMITHKLINE,,72.0,YR,,F,Y,,,20200303.0,,HP,AU,AU,2020,Q1,Elderly
174871063,17487106,12,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,,,,,,,,QD,2020,Q1,Acute kidney injury,,2020,Q1,3,F,20200221.0,20200316.0,20200303,20200330,EXP,,JP-ROCHE-2560400,ROCHE,,66.0,YR,,F,Y,60.5,KG,20200330.0,,MD,JP,JP,2020,Q1,Elderly
174871063,17487106,12,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,,,,,,,,QD,2020,Q1,Decreased appetite,,2020,Q1,3,F,20200221.0,20200316.0,20200303,20200330,EXP,,JP-ROCHE-2560400,ROCHE,,66.0,YR,,F,Y,60.5,KG,20200330.0,,MD,JP,JP,2020,Q1,Elderly
174871063,17487106,12,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,,,,,,,,QD,2020,Q1,Dehydration,,2020,Q1,3,F,20200221.0,20200316.0,20200303,20200330,EXP,,JP-ROCHE-2560400,ROCHE,,66.0,YR,,F,Y,60.5,KG,20200330.0,,MD,JP,JP,2020,Q1,Elderly
174871063,17487106,12,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,,,,,,,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,3,F,20200221.0,20200316.0,20200303,20200330,EXP,,JP-ROCHE-2560400,ROCHE,,66.0,YR,,F,Y,60.5,KG,20200330.0,,MD,JP,JP,2020,Q1,Elderly
174881491,17488149,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:10 UNITS;?,,,,,,,,10.0,IU,,QD,2020,Q1,Lethargy,,2020,Q1,1,I,20180109.0,,20200220,20200220,DIR,,,FDA-CTU,,59.0,YR,,M,N,102.0,KG,20180316.0,N,PH,US,US,2020,Q1,Adult
174910222,17491022,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, 1X/DAY (60 UNITS)",,,,,,,,60.0,IU,,QD,2020,Q1,Gingival hypertrophy,,2020,Q1,2,F,,20200309.0,20200303,20200311,EXP,,US-PFIZER INC-2020092112,PFIZER,"GOLOB DEEB, J.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6 (1):10.1016/J.OMSC.2020.100143",52.0,YR,,M,Y,,,20200311.0,,HP,US,US,2020,Q1,Adult
174910222,17491022,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, 1X/DAY (60 UNITS)",,,,,,,,60.0,IU,,QD,2020,Q1,Periodontitis,,2020,Q1,2,F,,20200309.0,20200303,20200311,EXP,,US-PFIZER INC-2020092112,PFIZER,"GOLOB DEEB, J.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6 (1):10.1016/J.OMSC.2020.100143",52.0,YR,,M,Y,,,20200311.0,,HP,US,US,2020,Q1,Adult
174918531,17491853,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,U,,,,,,,,2020,Q1,Arrhythmia,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,U,,,,,,,,2020,Q1,Arthritis,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,U,,,,,,,,2020,Q1,Asthma,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,U,,,,,,,,2020,Q1,Chronic sinusitis,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,U,,,,,,,,2020,Q1,Cough,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,U,,,,,,,,2020,Q1,Intraductal proliferative breast lesion,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,U,,,,,,,,2020,Q1,Sleep apnoea syndrome,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,U,,,,,,,,2020,Q1,Snoring,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174918531,17491853,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 300 E/ML48 (IN THE NIGHT)",,,U,U,,,,,,,,2020,Q1,Upper respiratory tract infection,,2020,Q1,1,I,2014.0,20200226.0,20200303,20200303,EXP,,DE-MYLANLABS-2020M1022691,MYLAN,,54.0,YR,,F,Y,78.0,KG,20200303.0,,MD,DE,DE,2020,Q1,Adult
174926741,17492674,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,60.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Gingival disorder,,2020,Q1,1,I,,20200302.0,20200304,20200304,EXP,,US-ASTELLAS-2020US008348,ASTELLAS,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):100143",52.0,YR,,M,Y,,,20200304.0,,HP,US,US,2020,Q1,Adult
174926741,17492674,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,60.0,IU,FORMULATION UNKNOWN,QD,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200302.0,20200304,20200304,EXP,,US-ASTELLAS-2020US008348,ASTELLAS,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):100143",52.0,YR,,M,Y,,,20200304.0,,HP,US,US,2020,Q1,Adult
174929161,17492916,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Aspiration,,2020,Q1,1,I,20191127.0,20200221.0,20200303,20200303,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,,F,Y,,,20200303.0,,MD,NL,NL,2020,Q1,Elderly
174929161,17492916,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hydrocephalus,,2020,Q1,1,I,20191127.0,20200221.0,20200303,20200303,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,,F,Y,,,20200303.0,,MD,NL,NL,2020,Q1,Elderly
174929161,17492916,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,20191127.0,20200221.0,20200303,20200303,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,,F,Y,,,20200303.0,,MD,NL,NL,2020,Q1,Elderly
174929161,17492916,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,1,I,20191127.0,20200221.0,20200303,20200303,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,,F,Y,,,20200303.0,,MD,NL,NL,2020,Q1,Elderly
174929161,17492916,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Pulseless electrical activity,,2020,Q1,1,I,20191127.0,20200221.0,20200303,20200303,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,,F,Y,,,20200303.0,,MD,NL,NL,2020,Q1,Elderly
174929161,17492916,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Respiratory failure,,2020,Q1,1,I,20191127.0,20200221.0,20200303,20200303,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,,F,Y,,,20200303.0,,MD,NL,NL,2020,Q1,Elderly
174929801,17492980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 UNIT,,,,,,,,,,,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20190520.0,20190604.0,20200304,20200304,EXP,,CN-GLAXOSMITHKLINE-2019-TSO02178-CN,GLAXOSMITHKLINE,,57.0,YR,,F,Y,55.0,KG,20200304.0,,MD,CN,CN,2020,Q1,Adult
174930761,17493076,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,1,I,,20200227.0,20200304,20200304,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-011736",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200304.0,,HP,CA,CA,2020,Q1,Elderly
174930761,17493076,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,1,I,,20200227.0,20200304,20200304,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-011736",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200304.0,,HP,CA,CA,2020,Q1,Elderly
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Abdominal discomfort,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Asthenia,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Ketonuria,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Metabolic disorder,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Nausea,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Vomiting,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Abdominal discomfort,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Asthenia,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Ketonuria,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Metabolic acidosis,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Metabolic disorder,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Nausea,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174959081,17495908,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Vomiting,,2020,Q1,1,I,,20200228.0,20200304,20200304,EXP,,NVSC2020ES058209,NOVARTIS,,59.0,YR,,M,Y,,,20200304.0,,HP,ES,ES,2020,Q1,Adult
174990981,17499098,4,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Kaposi's sarcoma,,2020,Q1,1,I,,20200219.0,20200305,20200305,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-239051,RANBAXY,"AHMED M, DENICOLA R. GASTRIC KAPOSIS SARCOMA IN A PATIENT WITH APLASTIC ANEMIA. AM J GASTROENTEROL. 2019;114 (SUPPL.):S1121-S1122",70.0,YR,,M,Y,,,20200305.0,,MD,US,US,2020,Q1,Elderly
174999861,17499986,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Anaphylactic reaction,,2020,Q1,1,I,,20200227.0,20200304,20200304,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-011701",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200305.0,,HP,CA,CA,2020,Q1,Elderly
174999861,17499986,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Drug intolerance,,2020,Q1,1,I,,20200227.0,20200304,20200304,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-011701",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200305.0,,HP,CA,CA,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Anaemia,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Ascites,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Cardiac failure,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Cardiac failure acute,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Fall,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Fluid overload,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Gout,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Hepatic cirrhosis,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Hepatic encephalopathy,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Inflammatory marker increased,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Leukocytosis,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Mental status changes,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175011491,17501149,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 U, QD",,,U,,,,,12.0,DF,,QD,2020,Q1,Sepsis,,2020,Q1,1,I,20160106.0,20170106.0,20200305,20200305,PER,,PHHO2017US017683,NOVARTIS,,73.0,YR,,M,Y,107.3,KG,20200305.0,,MD,US,US,2020,Q1,Elderly
175019901,17501990,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200129.0,20200227.0,20200305,20200305,EXP,IT-MINISAL02-606784,IT-SA-2020SA052992,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20200305.0,,MD,IT,IT,2020,Q1,Adult
175019901,17501990,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Sopor,,2020,Q1,1,I,20200129.0,20200227.0,20200305,20200305,EXP,IT-MINISAL02-606784,IT-SA-2020SA052992,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20200305.0,,MD,IT,IT,2020,Q1,Adult
175024931,17502493,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Kaposi's sarcoma,,2020,Q1,1,I,,20200224.0,20200305,20200305,EXP,,US-TEVA-2020-US-1193459,TEVA,"AHMED M, DENICOLA R. GASTRIC KAPOSI^S SARCOMA IN A PATIENT WITH APLASTIC ANEMIA. AM-J-GASTROENTEROL 2019;114 (SUPPL.):S1121-S1122 ABSTR. 2004.",70.0,YR,,M,Y,,,20200305.0,,MD,US,US,2020,Q1,Elderly
175074112,17507411,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 60 UNITS QD",,,U,,,,,,,,QD,2020,Q1,Gingival hypertrophy,,2020,Q1,2,F,,20200302.0,20200306,20200306,EXP,,NVSC2020US062198,NOVARTIS,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):1-6",52.0,YR,,M,Y,,,20200306.0,,HP,US,US,2020,Q1,Adult
175074112,17507411,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, 60 UNITS QD",,,U,,,,,,,,QD,2020,Q1,Periodontitis,,2020,Q1,2,F,,20200302.0,20200306,20200306,EXP,,NVSC2020US062198,NOVARTIS,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):1-6",52.0,YR,,M,Y,,,20200306.0,,HP,US,US,2020,Q1,Adult
175085131,17508513,5,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Brain cancer metastatic,,2020,Q1,1,I,20191209.0,,20200225,20200225,DIR,,,FDA-CTU,,57.0,YR,,F,N,67.9,KG,20200225.0,N,CN,US,US,2020,Q1,Adult
175085131,17508513,5,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Drug ineffective,,2020,Q1,1,I,20191209.0,,20200225,20200225,DIR,,,FDA-CTU,,57.0,YR,,F,N,67.9,KG,20200225.0,N,CN,US,US,2020,Q1,Adult
175085131,17508513,5,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Seizure,,2020,Q1,1,I,20191209.0,,20200225,20200225,DIR,,,FDA-CTU,,57.0,YR,,F,N,67.9,KG,20200225.0,N,CN,US,US,2020,Q1,Adult
175094041,17509404,1,PS,INSULIN (INSULIN GLARGINE. HUMAN 100UNT/ML INJ),INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:10 UNITS;?,,,D,D,,,,10.0,IU,,BID,2020,Q1,Diabetic ketoacidosis,,2020,Q1,1,I,20190818.0,,20200225,20200225,DIR,,,FDA-CTU,,49.0,YR,,F,N,31.3,KG,20200205.0,N,PH,US,US,2020,Q1,Adult
175094041,17509404,1,PS,INSULIN (INSULIN GLARGINE. HUMAN 100UNT/ML INJ),INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:10 UNITS;?,,,D,D,,,,10.0,IU,,BID,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,20190818.0,,20200225,20200225,DIR,,,FDA-CTU,,49.0,YR,,F,N,31.3,KG,20200205.0,N,PH,US,US,2020,Q1,Adult
175097171,17509717,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:55 UNITS;?,,,D,D,,,,55.0,IU,,BID,2020,Q1,Abscess limb,,2020,Q1,1,I,20200130.0,,20200225,20200225,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20200224.0,N,PH,US,US,2020,Q1,Adult
175097171,17509717,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:55 UNITS;?,,,D,D,,,,55.0,IU,,BID,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20200130.0,,20200225,20200225,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20200224.0,N,PH,US,US,2020,Q1,Adult
175097171,17509717,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:55 UNITS;?,,,D,D,,,,55.0,IU,,BID,2020,Q1,Diabetic foot,,2020,Q1,1,I,20200130.0,,20200225,20200225,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20200224.0,N,PH,US,US,2020,Q1,Adult
175097171,17509717,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:55 UNITS;?,,,D,D,,,,55.0,IU,,BID,2020,Q1,Peripheral ischaemia,,2020,Q1,1,I,20200130.0,,20200225,20200225,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20200224.0,N,PH,US,US,2020,Q1,Adult
175097171,17509717,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;OTHER DOSE:55 UNITS;?,,,D,D,,,,55.0,IU,,BID,2020,Q1,Toe amputation,,2020,Q1,1,I,20200130.0,,20200225,20200225,DIR,,,FDA-CTU,,61.0,YR,,M,N,,,20200224.0,N,PH,US,US,2020,Q1,Adult
175098541,17509854,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,3-6 UNITS,,,,,,,,,,,,2020,Q1,Thrombocytopenia,,2020,Q1,1,I,20190825.0,20190903.0,20200306,20200306,EXP,,US-ABBVIE-19P-163-2911916-00,ABBVIE,,54.0,YR,,M,Y,90.6,KG,20200306.0,,MD,US,US,2020,Q1,Adult
175112431,17511243,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,205692.0,,,,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,2018.0,20200224.0,20200306,20200306,EXP,,SK-ELI_LILLY_AND_COMPANY-SK202002011783,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20200306.0,,MD,SK,SK,2020,Q1,Elderly
175117131,17511713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 9F472A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Dysstasia,,2020,Q1,1,I,,20200227.0,20200306,20200306,EXP,,ES-BAUSCH-BL-2020-006482,BAUSCH AND LOMB,,60.0,YR,,F,Y,71.0,KG,20200306.0,,CN,ES,ES,2020,Q1,Adult
175117131,17511713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 9F472A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Feeling abnormal,,2020,Q1,1,I,,20200227.0,20200306,20200306,EXP,,ES-BAUSCH-BL-2020-006482,BAUSCH AND LOMB,,60.0,YR,,F,Y,71.0,KG,20200306.0,,CN,ES,ES,2020,Q1,Adult
175117131,17511713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 9F472A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200227.0,20200306,20200306,EXP,,ES-BAUSCH-BL-2020-006482,BAUSCH AND LOMB,,60.0,YR,,F,Y,71.0,KG,20200306.0,,CN,ES,ES,2020,Q1,Adult
175117131,17511713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 9F472A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hyperhidrosis,,2020,Q1,1,I,,20200227.0,20200306,20200306,EXP,,ES-BAUSCH-BL-2020-006482,BAUSCH AND LOMB,,60.0,YR,,F,Y,71.0,KG,20200306.0,,CN,ES,ES,2020,Q1,Adult
175117131,17511713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 9F472A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,,20200227.0,20200306,20200306,EXP,,ES-BAUSCH-BL-2020-006482,BAUSCH AND LOMB,,60.0,YR,,F,Y,71.0,KG,20200306.0,,CN,ES,ES,2020,Q1,Adult
175117131,17511713,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 9F472A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Thirst,,2020,Q1,1,I,,20200227.0,20200306,20200306,EXP,,ES-BAUSCH-BL-2020-006482,BAUSCH AND LOMB,,60.0,YR,,F,Y,71.0,KG,20200306.0,,CN,ES,ES,2020,Q1,Adult
175119681,17511968,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, DAILY",,,Y,U,,,205692.0,10.0,IU,SOLUTION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200129.0,20200224.0,20200307,20200307,EXP,IT-MINISAL02-606784,IT-ELI_LILLY_AND_COMPANY-IT202002011769,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20200307.0,,MD,IT,IT,2020,Q1,Adult
175119681,17511968,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, DAILY",,,Y,U,,,205692.0,10.0,IU,SOLUTION,QD,2020,Q1,Sopor,,2020,Q1,1,I,20200129.0,20200224.0,20200307,20200307,EXP,IT-MINISAL02-606784,IT-ELI_LILLY_AND_COMPANY-IT202002011769,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20200307.0,,MD,IT,IT,2020,Q1,Adult
175121661,17512166,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,66 IU,,,,, 9F404A,,,66.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Daydreaming,,2020,Q1,1,I,,20200304.0,20200308,20200308,EXP,,NVSC2020ES062765,NOVARTIS,,60.0,YR,,F,Y,,,20200308.0,,HP,ES,ES,2020,Q1,Adult
175121661,17512166,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,66 IU,,,,, 9F404A,,,66.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Disorientation,,2020,Q1,1,I,,20200304.0,20200308,20200308,EXP,,NVSC2020ES062765,NOVARTIS,,60.0,YR,,F,Y,,,20200308.0,,HP,ES,ES,2020,Q1,Adult
175121661,17512166,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,66 IU,,,,, 9F404A,,,66.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Vitamin B12 deficiency,,2020,Q1,1,I,,20200304.0,20200308,20200308,EXP,,NVSC2020ES062765,NOVARTIS,,60.0,YR,,F,Y,,,20200308.0,,HP,ES,ES,2020,Q1,Adult
175133141,17513314,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Cyanosis,,2020,Q1,1,I,20200210.0,20200227.0,20200306,20200306,EXP,,US-JAZZ-2020-US-003057,JAZZ,,11.0,YR,,F,Y,68.1,KG,20200306.0,,HP,US,US,2020,Q1,Child
175133141,17513314,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Irregular breathing,,2020,Q1,1,I,20200210.0,20200227.0,20200306,20200306,EXP,,US-JAZZ-2020-US-003057,JAZZ,,11.0,YR,,F,Y,68.1,KG,20200306.0,,HP,US,US,2020,Q1,Child
175133141,17513314,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Loss of consciousness,,2020,Q1,1,I,20200210.0,20200227.0,20200306,20200306,EXP,,US-JAZZ-2020-US-003057,JAZZ,,11.0,YR,,F,Y,68.1,KG,20200306.0,,HP,US,US,2020,Q1,Child
175133141,17513314,9,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Seizure,,2020,Q1,1,I,20200210.0,20200227.0,20200306,20200306,EXP,,US-JAZZ-2020-US-003057,JAZZ,,11.0,YR,,F,Y,68.1,KG,20200306.0,,HP,US,US,2020,Q1,Child
175136191,17513619,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, DAILY",,,Y,,,,205692.0,38.0,IU,,QD,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201808.0,20200224.0,20200306,20200306,EXP,,SK-ELI_LILLY_AND_COMPANY-SK202002011787,ELI LILLY AND CO,,47.0,YR,,M,Y,100.0,KG,20200306.0,,MD,SK,SK,2020,Q1,Adult
175136191,17513619,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"38 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,205692.0,38.0,IU,,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201808.0,20200224.0,20200306,20200306,EXP,,SK-ELI_LILLY_AND_COMPANY-SK202002011787,ELI LILLY AND CO,,47.0,YR,,M,Y,100.0,KG,20200306.0,,MD,SK,SK,2020,Q1,Adult
175136191,17513619,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"54 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,205692.0,54.0,IU,,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201808.0,20200224.0,20200306,20200306,EXP,,SK-ELI_LILLY_AND_COMPANY-SK202002011787,ELI LILLY AND CO,,47.0,YR,,M,Y,100.0,KG,20200306.0,,MD,SK,SK,2020,Q1,Adult
175136191,17513619,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"35 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,205692.0,35.0,IU,,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201808.0,20200224.0,20200306,20200306,EXP,,SK-ELI_LILLY_AND_COMPANY-SK202002011787,ELI LILLY AND CO,,47.0,YR,,M,Y,100.0,KG,20200306.0,,MD,SK,SK,2020,Q1,Adult
175136191,17513619,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"36 INTERNATIONAL UNIT, DAILY",,,Y,,,,205692.0,36.0,IU,,QD,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201808.0,20200224.0,20200306,20200306,EXP,,SK-ELI_LILLY_AND_COMPANY-SK202002011787,ELI LILLY AND CO,,47.0,YR,,M,Y,100.0,KG,20200306.0,,MD,SK,SK,2020,Q1,Adult
175136191,17513619,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"34 INTERNATIONAL UNIT, DAILY",,,Y,,,,205692.0,34.0,IU,,QD,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201808.0,20200224.0,20200306,20200306,EXP,,SK-ELI_LILLY_AND_COMPANY-SK202002011787,ELI LILLY AND CO,,47.0,YR,,M,Y,100.0,KG,20200306.0,,MD,SK,SK,2020,Q1,Adult
175177221,17517722,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Alopecia,,2020,Q1,1,I,20190415.0,,20200309,20200309,DIR,,,FDA-CTU,,50.0,YR,,M,N,72.0,KG,20200309.0,Y,CN,US,US,2020,Q1,Adult
175177221,17517722,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Nail dystrophy,,2020,Q1,1,I,20190415.0,,20200309,20200309,DIR,,,FDA-CTU,,50.0,YR,,M,N,72.0,KG,20200309.0,Y,CN,US,US,2020,Q1,Adult
175203032,17520303,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Dehydration,,2020,Q1,2,F,,20200227.0,20200309,20200312,EXP,,IQ-ELI_LILLY_AND_COMPANY-IQ202003000137,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20200312.0,,MD,IQ,IQ,2020,Q1,Adult
175203032,17520303,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Impaired gastric emptying,,2020,Q1,2,F,,20200227.0,20200309,20200312,EXP,,IQ-ELI_LILLY_AND_COMPANY-IQ202003000137,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20200312.0,,MD,IQ,IQ,2020,Q1,Adult
175203032,17520303,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Ketosis,,2020,Q1,2,F,,20200227.0,20200309,20200312,EXP,,IQ-ELI_LILLY_AND_COMPANY-IQ202003000137,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20200312.0,,MD,IQ,IQ,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Abdominal pain,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Alanine aminotransferase decreased,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Blood creatinine increased,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Cardiorenal syndrome,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Cellulitis,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Chronic kidney disease,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Hypervolaemia,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Hypotension,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Impaired gastric emptying,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Implant site infection,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Lethargy,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Nausea,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Necrotising fasciitis,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Renal failure,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Septic shock,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175232761,17523276,74,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 U, TID",,,D,,,,,16.0,DF,,TID,2020,Q1,Vomiting,,2020,Q1,1,I,20171218.0,20171219.0,20200310,20200310,PER,,PHHY2017US194786,NOVARTIS,,59.0,YR,,M,Y,147.6,KG,20200310.0,,MD,US,US,2020,Q1,Adult
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Cataract,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Decreased appetite,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Dizziness,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Gastrointestinal disorder,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Malaise,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Visual impairment,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, QD",,,,, 9F165A,,,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Cataract,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Decreased appetite,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Dizziness,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Gastrointestinal disorder,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Malaise,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Visual impairment,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175234461,17523446,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, BID (40-0-20IU, BID)",,,,, 9F404A,,,40.0,IU,SOLUTION FOR INJECTION,BID,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200306.0,20200310,20200310,EXP,,NVSC2020ES065067,NOVARTIS,,68.0,YR,,M,Y,81.0,KG,20200310.0,,HP,ES,ES,2020,Q1,Elderly
175243761,17524376,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Cholecystectomy,,2020,Q1,1,I,20200123.0,,20200310,20200310,DIR,,,FDA-CTU,,64.0,YR,,F,N,109.35,KG,20200310.0,N,PH,US,US,2020,Q1,Adult
175243761,17524376,2,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q1,Cholecystitis acute,,2020,Q1,1,I,20200123.0,,20200310,20200310,DIR,,,FDA-CTU,,64.0,YR,,F,N,109.35,KG,20200310.0,N,PH,US,US,2020,Q1,Adult
175287391,17528739,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,INJECTION,QD,2020,Q1,Weight decreased,,2020,Q1,1,I,,20200304.0,20200311,20200311,EXP,,"PL-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-012848",BOEHRINGER INGELHEIM,"CICHOCKA E, GUMPRECHT J. EXCESS WEIGHT LOSS IN A PATIENT WITH TYPE 2 DIABETES MELLITUS TREATED WITH AN SLGT-2 INHIBITOR. ENDOKRYNOLOGIA POLSKA. 2019;70:6:522-523.",62.0,YR,,M,Y,,,20200311.0,,HP,PL,PL,2020,Q1,Adult
175313601,17531360,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,20160404.0,20180702.0,20200311,20200311,EXP,,US-ASTRAZENECA-2018SE85712,ASTRAZENECA,,16672.0,DY,,F,Y,113.4,KG,20200311.0,,,US,US,2020,Q1,Elderly
175313601,17531360,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Renal failure,,2020,Q1,1,I,20160404.0,20180702.0,20200311,20200311,EXP,,US-ASTRAZENECA-2018SE85712,ASTRAZENECA,,16672.0,DY,,F,Y,113.4,KG,20200311.0,,,US,US,2020,Q1,Elderly
175313601,17531360,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Renal tubular necrosis,,2020,Q1,1,I,20160404.0,20180702.0,20200311,20200311,EXP,,US-ASTRAZENECA-2018SE85712,ASTRAZENECA,,16672.0,DY,,F,Y,113.4,KG,20200311.0,,,US,US,2020,Q1,Elderly
175321411,17532141,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Cellulitis,,2020,Q1,1,I,20200130.0,20200302.0,20200311,20200311,EXP,,CO-BAXTER-2020BAX004882,BAXTER,,84.0,YR,,F,Y,,,20200311.0,,HP,CO,CO,2020,Q1,Elderly
175321411,17532141,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Device physical property issue,,2020,Q1,1,I,20200130.0,20200302.0,20200311,20200311,EXP,,CO-BAXTER-2020BAX004882,BAXTER,,84.0,YR,,F,Y,,,20200311.0,,HP,CO,CO,2020,Q1,Elderly
175321411,17532141,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Peritonitis,,2020,Q1,1,I,20200130.0,20200302.0,20200311,20200311,EXP,,CO-BAXTER-2020BAX004882,BAXTER,,84.0,YR,,F,Y,,,20200311.0,,HP,CO,CO,2020,Q1,Elderly
175321411,17532141,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Sepsis,,2020,Q1,1,I,20200130.0,20200302.0,20200311,20200311,EXP,,CO-BAXTER-2020BAX004882,BAXTER,,84.0,YR,,F,Y,,,20200311.0,,HP,CO,CO,2020,Q1,Elderly
175321411,17532141,6,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q1,Septic shock,,2020,Q1,1,I,20200130.0,20200302.0,20200311,20200311,EXP,,CO-BAXTER-2020BAX004882,BAXTER,,84.0,YR,,F,Y,,,20200311.0,,HP,CO,CO,2020,Q1,Elderly
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Abdominal hernia,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Anaemia,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Animal bite,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Asthenia,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Atelectasis,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Blood albumin decreased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Blood chloride increased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Blood creatinine increased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Blood phosphorus increased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Blood urea increased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Carbon dioxide decreased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Cellulitis,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Chromaturia,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Chronic obstructive pulmonary disease,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Dehydration,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Dysuria,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Fatigue,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Fluid intake reduced,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Gait disturbance,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Glomerular filtration rate decreased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Gouty tophus,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Grip strength decreased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Haematocrit decreased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Hyperkalaemia,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Hypokinesia,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Hypotension,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Hypovolaemia,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Influenza like illness,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Leukocytosis,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Lymphocyte count decreased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Malaise,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Muscular weakness,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Mycobacterium chelonae infection,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Neutrophil count increased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Oedema peripheral,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Pain in extremity,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Pancreatitis acute,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Red cell distribution width increased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Sepsis,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Skin discolouration,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Skin lesion,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Systemic infection,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Tendon injury,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Tremor,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Urinary tract infection,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Urine odour abnormal,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Weight decreased,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Wound,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Wound haemorrhage,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175329571,17532957,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 U, QD (100 UNIT/ML, 3 ML SOLOSTAR",,,,,,,,5.0,DF,INJECTION,QD,2020,Q1,Wound secretion,,2020,Q1,1,I,201806.0,20190111.0,20200312,20200312,PER,,PHHY2019US016120,NOVARTIS,,61.0,YR,,M,Y,70.12,KG,20200312.0,,MD,US,US,2020,Q1,Adult
175362371,17536237,10,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Altered state of consciousness,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,10,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Cyanosis,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,10,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Drooling,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,10,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Irregular breathing,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,10,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Seizure,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175362371,17536237,10,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q1,Somnolence,,2020,Q1,1,I,20200210.0,20200228.0,20200313,20200313,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01201,HIKMA,,11.0,YR,,F,Y,68.0,KG,20200312.0,,HP,US,US,2020,Q1,Child
175390871,17539087,10,C,insulin glargine U100,,2,,,,,,,,,,,,,,2020,Q1,Abdominal pain upper,,2020,Q1,1,I,20200309.0,,20200312,20200312,DIR,,,FDA-CTU,,72.0,YR,,F,N,91.1,KG,20200312.0,N,PH,US,US,2020,Q1,Elderly
175390871,17539087,10,C,insulin glargine U100,,2,,,,,,,,,,,,,,2020,Q1,Amylase increased,,2020,Q1,1,I,20200309.0,,20200312,20200312,DIR,,,FDA-CTU,,72.0,YR,,F,N,91.1,KG,20200312.0,N,PH,US,US,2020,Q1,Elderly
175390871,17539087,10,C,insulin glargine U100,,2,,,,,,,,,,,,,,2020,Q1,Fatigue,,2020,Q1,1,I,20200309.0,,20200312,20200312,DIR,,,FDA-CTU,,72.0,YR,,F,N,91.1,KG,20200312.0,N,PH,US,US,2020,Q1,Elderly
175390871,17539087,10,C,insulin glargine U100,,2,,,,,,,,,,,,,,2020,Q1,Lipase increased,,2020,Q1,1,I,20200309.0,,20200312,20200312,DIR,,,FDA-CTU,,72.0,YR,,F,N,91.1,KG,20200312.0,N,PH,US,US,2020,Q1,Elderly
175411941,17541194,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,12.0,IU,,QD,2020,Q1,Haemolytic anaemia,,2020,Q1,1,I,20160212.0,20200311.0,20200313,20200313,EXP,PT-INFARMED-T202002-692,PT-SA-2020SA064948,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20200313.0,,PH,PT,PT,2020,Q1,Adult
175427081,17542708,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q1,Hyponatraemia,,2020,Q1,1,I,20190612.0,20200306.0,20200315,20200315,EXP,,NVSC2020ES069633,NOVARTIS,,77.0,YR,,M,Y,,,20200315.0,,CN,FR,ES,2020,Q1,Elderly
175432821,17543282,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,1.0,DF,UNKNOWN,,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200303.0,20200316,20200316,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01290,HIKMA,"GOLOB DEEB J, LYONS D, LASKIN D, DEEP G. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES; DOI: 10.1016/J.OMSC.2020.100143. 2020;6(1):1-6.",52.0,YR,,M,Y,,,20200313.0,,MD,US,US,2020,Q1,Adult
175432821,17543282,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,1.0,DF,UNKNOWN,,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200303.0,20200316,20200316,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-01290,HIKMA,"GOLOB DEEB J, LYONS D, LASKIN D, DEEP G. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES; DOI: 10.1016/J.OMSC.2020.100143. 2020;6(1):1-6.",52.0,YR,,M,Y,,,20200313.0,,MD,US,US,2020,Q1,Adult
175447811,17544781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 IU, 0-0-1-0",,,,,,,,2.0,IU,,,2020,Q1,C-reactive protein increased,,2020,Q1,1,I,,20200305.0,20200316,20200316,EXP,DE-BFARM-20002595,DE-ACCORD-175873,ACCORD,,76.0,YR,E,M,Y,53.0,KG,20200316.0,,MD,DE,DE,2020,Q1,Elderly
175447811,17544781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 IU, 0-0-1-0",,,,,,,,2.0,IU,,,2020,Q1,Cough,,2020,Q1,1,I,,20200305.0,20200316,20200316,EXP,DE-BFARM-20002595,DE-ACCORD-175873,ACCORD,,76.0,YR,E,M,Y,53.0,KG,20200316.0,,MD,DE,DE,2020,Q1,Elderly
175447811,17544781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 IU, 0-0-1-0",,,,,,,,2.0,IU,,,2020,Q1,Leukopenia,,2020,Q1,1,I,,20200305.0,20200316,20200316,EXP,DE-BFARM-20002595,DE-ACCORD-175873,ACCORD,,76.0,YR,E,M,Y,53.0,KG,20200316.0,,MD,DE,DE,2020,Q1,Elderly
175447811,17544781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 IU, 0-0-1-0",,,,,,,,2.0,IU,,,2020,Q1,Oropharyngeal pain,,2020,Q1,1,I,,20200305.0,20200316,20200316,EXP,DE-BFARM-20002595,DE-ACCORD-175873,ACCORD,,76.0,YR,E,M,Y,53.0,KG,20200316.0,,MD,DE,DE,2020,Q1,Elderly
175447811,17544781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 IU, 0-0-1-0",,,,,,,,2.0,IU,,,2020,Q1,Productive cough,,2020,Q1,1,I,,20200305.0,20200316,20200316,EXP,DE-BFARM-20002595,DE-ACCORD-175873,ACCORD,,76.0,YR,E,M,Y,53.0,KG,20200316.0,,MD,DE,DE,2020,Q1,Elderly
175456581,17545658,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 IE, NACH SCHEMA",,,,,,,,,,,,2020,Q1,Cough,,2020,Q1,1,I,,20200306.0,20200316,20200316,EXP,,DE-MYLANLABS-2020M1026513,MYLAN,,72.0,YR,,M,Y,80.0,KG,20200316.0,,PH,DE,DE,2020,Q1,Elderly
175456581,17545658,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 IE, NACH SCHEMA",,,,,,,,,,,,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200306.0,20200316,20200316,EXP,,DE-MYLANLABS-2020M1026513,MYLAN,,72.0,YR,,M,Y,80.0,KG,20200316.0,,PH,DE,DE,2020,Q1,Elderly
175456581,17545658,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 IE, NACH SCHEMA",,,,,,,,,,,,2020,Q1,Melaena,,2020,Q1,1,I,,20200306.0,20200316,20200316,EXP,,DE-MYLANLABS-2020M1026513,MYLAN,,72.0,YR,,M,Y,80.0,KG,20200316.0,,PH,DE,DE,2020,Q1,Elderly
175456581,17545658,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 IE, NACH SCHEMA",,,,,,,,,,,,2020,Q1,Oedema peripheral,,2020,Q1,1,I,,20200306.0,20200316,20200316,EXP,,DE-MYLANLABS-2020M1026513,MYLAN,,72.0,YR,,M,Y,80.0,KG,20200316.0,,PH,DE,DE,2020,Q1,Elderly
175460951,17546095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 IU,,,U,U,,,,18.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 IU,,,U,U,,,,18.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 IU,,,U,U,,,,18.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,U,U,,,,24.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,U,U,,,,24.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,U,U,,,,24.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,U,U,,,,12.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,U,U,,,,12.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,U,U,,,,12.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,U,U,,,,32.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,U,U,,,,32.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175460951,17546095,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,U,U,,,,32.0,IU,SOLUTION FOR INJECTION/INFUSION,QD,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200309.0,20200316,20200316,EXP,,"SK-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-013559",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,,,20200316.0,,MD,SK,SK,2020,Q1,Elderly
175471981,17547198,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200302.0,20200316,20200316,EXP,,"US-SILVERGATE PHARMACEUTICALS, INC.-2020SIL00013",SILVERGATE,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES.. 2020;6(1)",52.0,YR,,M,Y,,,20200316.0,,HP,US,US,2020,Q1,Adult
175471981,17547198,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200302.0,20200316,20200316,EXP,,"US-SILVERGATE PHARMACEUTICALS, INC.-2020SIL00013",SILVERGATE,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES.. 2020;6(1)",52.0,YR,,M,Y,,,20200316.0,,HP,US,US,2020,Q1,Adult
175471981,17547198,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200302.0,20200316,20200316,EXP,,"US-SILVERGATE PHARMACEUTICALS, INC.-2020SIL00013",SILVERGATE,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES.. 2020;6(1)",52.0,YR,,M,Y,,,20200316.0,,HP,US,US,2020,Q1,Adult
175473841,17547384,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200302.0,20200316,20200316,EXP,,"US-OXFORD PHARMACEUTICALS, LLC-2020OXF00032",OXFORD PHARMACEUTICALS,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020;6(1)",52.0,YR,,M,Y,,,20200316.0,,HP,US,US,2020,Q1,Adult
175473841,17547384,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200302.0,20200316,20200316,EXP,,"US-OXFORD PHARMACEUTICALS, LLC-2020OXF00032",OXFORD PHARMACEUTICALS,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020;6(1)",52.0,YR,,M,Y,,,20200316.0,,HP,US,US,2020,Q1,Adult
175473841,17547384,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200302.0,20200316,20200316,EXP,,"US-OXFORD PHARMACEUTICALS, LLC-2020OXF00032",OXFORD PHARMACEUTICALS,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020;6(1)",52.0,YR,,M,Y,,,20200316.0,,HP,US,US,2020,Q1,Adult
175474051,17547405,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200302.0,20200316,20200316,EXP,,US-EPIC PHARMA LLC-2020EPC00097,EPIC PHARM,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL MAXILLOFAC SURG CASES.. 2020;6(1)",52.0,YR,,M,Y,,,20200316.0,,HP,US,US,2020,Q1,Adult
175474051,17547405,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200302.0,20200316,20200316,EXP,,US-EPIC PHARMA LLC-2020EPC00097,EPIC PHARM,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL MAXILLOFAC SURG CASES.. 2020;6(1)",52.0,YR,,M,Y,,,20200316.0,,HP,US,US,2020,Q1,Adult
175474051,17547405,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200302.0,20200316,20200316,EXP,,US-EPIC PHARMA LLC-2020EPC00097,EPIC PHARM,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL MAXILLOFAC SURG CASES.. 2020;6(1)",52.0,YR,,M,Y,,,20200316.0,,HP,US,US,2020,Q1,Adult
175482461,17548246,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,CA-AUROBINDO-AUR-APL-2020-013439,AUROBINDO,,18.0,YR,,F,Y,56.0,KG,20200317.0,,PH,CA,CA,2020,Q1,Youth
175482461,17548246,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q1,Hyperglycaemia,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,CA-AUROBINDO-AUR-APL-2020-013439,AUROBINDO,,18.0,YR,,F,Y,56.0,KG,20200317.0,,PH,CA,CA,2020,Q1,Youth
175482461,17548246,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q1,Increased insulin requirement,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,CA-AUROBINDO-AUR-APL-2020-013439,AUROBINDO,,18.0,YR,,F,Y,56.0,KG,20200317.0,,PH,CA,CA,2020,Q1,Youth
175485232,17548523,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNIT,,,U,,,,,100.0,DF,,,2020,Q1,Kidney transplant rejection,,2020,Q1,2,F,20200304.0,20200320.0,20200317,20200330,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000248,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,63.9,KG,20200330.0,,HP,US,US,2020,Q1,Adult
175490991,17549099,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Aspiration,,2020,Q1,1,I,20191127.0,20200304.0,20200317,20200317,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20200317.0,,CN,US,NL,2020,Q1,Elderly
175490991,17549099,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Hydrocephalus,,2020,Q1,1,I,20191127.0,20200304.0,20200317,20200317,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20200317.0,,CN,US,NL,2020,Q1,Elderly
175490991,17549099,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,20191127.0,20200304.0,20200317,20200317,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20200317.0,,CN,US,NL,2020,Q1,Elderly
175490991,17549099,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,1,I,20191127.0,20200304.0,20200317,20200317,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20200317.0,,CN,US,NL,2020,Q1,Elderly
175490991,17549099,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Pulseless electrical activity,,2020,Q1,1,I,20191127.0,20200304.0,20200317,20200317,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20200317.0,,CN,US,NL,2020,Q1,Elderly
175490991,17549099,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q1,Respiratory failure,,2020,Q1,1,I,20191127.0,20200304.0,20200317,20200317,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20200317.0,,CN,US,NL,2020,Q1,Elderly
175492291,17549229,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 UNITS, QD",,,,,,,,,,,QD,2020,Q1,Gingival disorder,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-01415,LUPIN,,52.0,YR,,M,Y,,,20200317.0,,HP,US,US,2020,Q1,Adult
175492291,17549229,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 UNITS, QD",,,,,,,,,,,QD,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-01415,LUPIN,,52.0,YR,,M,Y,,,20200317.0,,HP,US,US,2020,Q1,Adult
175508581,17550858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION OF 1 U/KG/H, 5U KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Cardiac arrest,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028962,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",60.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508581,17550858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION OF 1 U/KG/H, 5U KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Cardiac dysfunction,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028962,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",60.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508581,17550858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION OF 1 U/KG/H, 5U KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028962,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",60.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508581,17550858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION OF 1 U/KG/H, 5U KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Intentional overdose,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028962,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",60.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508581,17550858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION OF 1 U/KG/H, 5U KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Non-cardiogenic pulmonary oedema,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028962,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",60.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508581,17550858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION OF 1 U/KG/H, 5U KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Respiratory failure,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028962,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",60.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508581,17550858,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION OF 1 U/KG/H, 5U KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028962,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",60.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508611,17550861,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY AN INITIAL INFUSION RATE OF 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Cardiac dysfunction,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028922,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",62.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508611,17550861,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY AN INITIAL INFUSION RATE OF 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028922,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",62.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508611,17550861,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY AN INITIAL INFUSION RATE OF 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Intentional overdose,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028922,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",62.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508611,17550861,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY AN INITIAL INFUSION RATE OF 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Non-cardiogenic pulmonary oedema,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028922,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",62.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508611,17550861,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY AN INITIAL INFUSION RATE OF 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028922,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",62.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508661,17550866,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Cardiac dysfunction,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028927,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",58.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508661,17550866,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028927,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",58.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508661,17550866,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Intentional overdose,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028927,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",58.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508661,17550866,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Non-cardiogenic pulmonary oedema,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028927,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",58.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508661,17550866,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Respiratory failure,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028927,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",58.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175508661,17550866,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"LOADING DOSE: 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200309.0,20200317,20200317,EXP,,SE-MYLANLABS-2020M1028927,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",58.0,YR,,F,Y,,,20200317.0,,MD,SE,SE,2020,Q1,Adult
175522981,17552298,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12-36 IU MORNING,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Blood pressure increased,,2020,Q1,1,I,2014.0,20200306.0,20200317,20200317,EXP,,SK-BAUSCH-BL-2020-007470,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20200317.0,,MD,SK,SK,2020,Q1,Adult
175522981,17552298,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12-36 IU MORNING,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q1,Weight increased,,2020,Q1,1,I,2014.0,20200306.0,20200317,20200317,EXP,,SK-BAUSCH-BL-2020-007470,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20200317.0,,MD,SK,SK,2020,Q1,Adult
175528191,17552819,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,STRENGTH : 60 IU,,,U,,,,,1.0,DF,,,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200309.0,20200318,20200318,EXP,,US-ACCORD-176057,ACCORD,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):ARTICLE NUMBER 100143. DOI:10.1016/J.OMSC.2020.100143",52.0,YR,,M,Y,,,20200318.0,,MD,US,US,2020,Q1,Adult
175530311,17553031,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q1,Dyspnoea,,2020,Q1,1,I,,20200310.0,20200317,20200317,EXP,,"ID-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-014186",BOEHRINGER INGELHEIM,,71.0,YR,,F,Y,,,20200317.0,,MD,ID,ID,2020,Q1,Elderly
175548041,17554804,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q1,Erythema multiforme,,2020,Q1,1,I,20190610.0,20200305.0,20200318,20200318,EXP,ES-EMA-DD-20200304-GANGAL_S-133417,ES-ACCORD-175314,ACCORD,,73.0,YR,E,F,Y,,,20200318.0,,HP,ES,ES,2020,Q1,Elderly
175548041,17554804,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q1,Pyrexia,,2020,Q1,1,I,20190610.0,20200305.0,20200318,20200318,EXP,ES-EMA-DD-20200304-GANGAL_S-133417,ES-ACCORD-175314,ACCORD,,73.0,YR,E,F,Y,,,20200318.0,,HP,ES,ES,2020,Q1,Elderly
175568821,17556882,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Cardiac dysfunction,,2020,Q1,1,I,,20200309.0,20200318,20200318,EXP,,SE-MYLANLABS-2020M1028906,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",49.0,YR,,M,Y,,,20200318.0,,MD,SE,SE,2020,Q1,Adult
175568821,17556882,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200309.0,20200318,20200318,EXP,,SE-MYLANLABS-2020M1028906,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",49.0,YR,,M,Y,,,20200318.0,,MD,SE,SE,2020,Q1,Adult
175568821,17556882,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Intentional overdose,,2020,Q1,1,I,,20200309.0,20200318,20200318,EXP,,SE-MYLANLABS-2020M1028906,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",49.0,YR,,M,Y,,,20200318.0,,MD,SE,SE,2020,Q1,Adult
175568821,17556882,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Non-cardiogenic pulmonary oedema,,2020,Q1,1,I,,20200309.0,20200318,20200318,EXP,,SE-MYLANLABS-2020M1028906,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",49.0,YR,,M,Y,,,20200318.0,,MD,SE,SE,2020,Q1,Adult
175568821,17556882,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Respiratory failure,,2020,Q1,1,I,,20200309.0,20200318,20200318,EXP,,SE-MYLANLABS-2020M1028906,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",49.0,YR,,M,Y,,,20200318.0,,MD,SE,SE,2020,Q1,Adult
175568821,17556882,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"LOADING DOSE OF 1 U/KG FOLLOWED BY INFUSION AT 1 U/KG/H, 5 U/KG/H AND THEN 10 U/KG/H",,,U,U,,,,,,INJECTION,,2020,Q1,Toxicity to various agents,,2020,Q1,1,I,,20200309.0,20200318,20200318,EXP,,SE-MYLANLABS-2020M1028906,MYLAN,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J. THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY. CLIN-TOXICOL-(PHILA) 2020;NULL:NULL.",49.0,YR,,M,Y,,,20200318.0,,MD,SE,SE,2020,Q1,Adult
175582691,17558269,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,1.0,DF,,,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200309.0,20200319,20200319,EXP,,US-DRREDDYS-USA/USA/20/0120775,DR REDDYS,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):ARTICLE NUMBER 100143. DOI:10.1016/J.OMSC.2020.100143",52.0,YR,A,M,Y,,,20200319.0,,MD,US,US,2020,Q1,Adult
175615122,17561512,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU INTERNATIONAL UNIT(S), QD  (60UNITS 1X/DAY)",,,,,,,,,,,,2020,Q1,Gingival hypertrophy,,2020,Q1,2,F,,20200309.0,20200319,20200323,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK046513,GLENMARK,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6:1-6",52.0,YR,,M,Y,,,20200323.0,,MD,US,US,2020,Q1,Adult
175615122,17561512,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU INTERNATIONAL UNIT(S), QD  (60UNITS 1X/DAY)",,,,,,,,,,,,2020,Q1,Periodontitis,,2020,Q1,2,F,,20200309.0,20200319,20200323,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK046513,GLENMARK,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6:1-6",52.0,YR,,M,Y,,,20200323.0,,MD,US,US,2020,Q1,Adult
175615122,17561512,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU INTERNATIONAL UNIT(S), QD  (60UNITS 1X/DAY)",,,,,,,,,,,,2020,Q1,Product use in unapproved indication,,2020,Q1,2,F,,20200309.0,20200319,20200323,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK046513,GLENMARK,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6:1-6",52.0,YR,,M,Y,,,20200323.0,,MD,US,US,2020,Q1,Adult
175615321,17561532,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 UNIT, QD",,,U,,,,,60.0,DF,,QD,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200309.0,20200319,20200319,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000252,VELOXIS PHARMACEUTICALS,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES.. 2020;6(1):1-5",52.0,YR,,M,Y,,,20200319.0,,MD,US,US,2020,Q1,Adult
175615321,17561532,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 UNIT, QD",,,U,,,,,60.0,DF,,QD,2020,Q1,Off label use,,2020,Q1,1,I,,20200309.0,20200319,20200319,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000252,VELOXIS PHARMACEUTICALS,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES.. 2020;6(1):1-5",52.0,YR,,M,Y,,,20200319.0,,MD,US,US,2020,Q1,Adult
175615321,17561532,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 UNIT, QD",,,U,,,,,60.0,DF,,QD,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200309.0,20200319,20200319,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000252,VELOXIS PHARMACEUTICALS,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES.. 2020;6(1):1-5",52.0,YR,,M,Y,,,20200319.0,,MD,US,US,2020,Q1,Adult
175615321,17561532,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 UNIT, QD",,,U,,,,,60.0,DF,,QD,2020,Q1,Tooth loss,,2020,Q1,1,I,,20200309.0,20200319,20200319,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000252,VELOXIS PHARMACEUTICALS,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES.. 2020;6(1):1-5",52.0,YR,,M,Y,,,20200319.0,,MD,US,US,2020,Q1,Adult
175618671,17561867,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,20200301.0,20200310.0,20200319,20200319,EXP,IT-MINISAL02-610154,IT-TEVA-2020-IT-1202394,TEVA,,61.0,YR,,M,Y,,,20200319.0,,MD,IT,IT,2020,Q1,Adult
175618671,17561867,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2020,Q1,Sopor,,2020,Q1,1,I,20200301.0,20200310.0,20200319,20200319,EXP,IT-MINISAL02-610154,IT-TEVA-2020-IT-1202394,TEVA,,61.0,YR,,M,Y,,,20200319.0,,MD,IT,IT,2020,Q1,Adult
175634211,17563421,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Arthralgia,,2020,Q1,1,I,,20200311.0,20200320,20200320,EXP,000733189,CA-ACCORD-176019,ACCORD,,34.0,YR,,F,Y,,,20200320.0,,PH,CA,CA,2020,Q1,Young Adult
175634211,17563421,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Blood creatine phosphokinase increased,,2020,Q1,1,I,,20200311.0,20200320,20200320,EXP,000733189,CA-ACCORD-176019,ACCORD,,34.0,YR,,F,Y,,,20200320.0,,PH,CA,CA,2020,Q1,Young Adult
175634211,17563421,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Mobility decreased,,2020,Q1,1,I,,20200311.0,20200320,20200320,EXP,000733189,CA-ACCORD-176019,ACCORD,,34.0,YR,,F,Y,,,20200320.0,,PH,CA,CA,2020,Q1,Young Adult
175634211,17563421,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Myalgia,,2020,Q1,1,I,,20200311.0,20200320,20200320,EXP,000733189,CA-ACCORD-176019,ACCORD,,34.0,YR,,F,Y,,,20200320.0,,PH,CA,CA,2020,Q1,Young Adult
175634211,17563421,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Pain,,2020,Q1,1,I,,20200311.0,20200320,20200320,EXP,000733189,CA-ACCORD-176019,ACCORD,,34.0,YR,,F,Y,,,20200320.0,,PH,CA,CA,2020,Q1,Young Adult
175634211,17563421,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q1,Rhabdomyolysis,,2020,Q1,1,I,,20200311.0,20200320,20200320,EXP,000733189,CA-ACCORD-176019,ACCORD,,34.0,YR,,F,Y,,,20200320.0,,PH,CA,CA,2020,Q1,Young Adult
175676431,17567643,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q1,Blindness transient,,2020,Q1,1,I,,20200311.0,20200320,20200320,EXP,,CA-NOVOPROD-719299,NOVO NORDISK,,66.0,YR,,M,Y,,,20200320.0,,MD,CA,CA,2020,Q1,Elderly
175677792,17567779,11,C,"Insulin, glargine, human rec. anlogl",,2,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Hypokalaemia,,2020,Q1,2,F,20190228.0,20200327.0,20200320,20200330,EXP,,US-PFIZER INC-2019096689,PFIZER,,81.0,YR,,F,Y,64.85,KG,20200330.0,,HP,US,US,2020,Q1,Elderly
175677792,17567779,11,C,"Insulin, glargine, human rec. anlogl",,2,Subcutaneous,UNK,,,,,,,,,,,,2020,Q1,Osteomyelitis,,2020,Q1,2,F,20190228.0,20200327.0,20200320,20200330,EXP,,US-PFIZER INC-2019096689,PFIZER,,81.0,YR,,F,Y,64.85,KG,20200330.0,,HP,US,US,2020,Q1,Elderly
175679181,17567918,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200309.0,20200320,20200320,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00089,JUBILANT,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020",52.0,YR,,M,Y,,,20200320.0,,HP,US,US,2020,Q1,Adult
175679181,17567918,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200309.0,20200320,20200320,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00089,JUBILANT,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020",52.0,YR,,M,Y,,,20200320.0,,HP,US,US,2020,Q1,Adult
175679181,17567918,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 U, 1X/DAY",,,,,,,,,,,QD,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200309.0,20200320,20200320,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00089,JUBILANT,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020",52.0,YR,,M,Y,,,20200320.0,,HP,US,US,2020,Q1,Adult
175680011,17568001,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"64 INTERNATIONAL UNIT, UNKNOWN",,,,, 9F150A,,,64.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200122.0,20200320,20200320,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202003009126,ELI LILLY AND CO,,57.0,YR,,M,Y,97.0,KG,20200320.0,,CN,ES,ES,2020,Q1,Adult
175680341,17568034,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,20200301.0,20200312.0,20200320,20200320,EXP,IT-MINISAL02-610154,IT-PURDUE PHARMA-GBR-2020-0075748,PURDUE,,61.0,YR,,M,Y,,,20200319.0,,MD,IT,IT,2020,Q1,Adult
175680341,17568034,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U,,,,,,,,2020,Q1,Sopor,,2020,Q1,1,I,20200301.0,20200312.0,20200320,20200320,EXP,IT-MINISAL02-610154,IT-PURDUE PHARMA-GBR-2020-0075748,PURDUE,,61.0,YR,,M,Y,,,20200319.0,,MD,IT,IT,2020,Q1,Adult
175716311,17571631,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,,2020,Q1,Abdominal pain,,2020,Q1,1,I,20200202.0,20200310.0,20200323,20200323,EXP,DE-AMK-240133,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200323.0,,PH,DE,DE,2020,Q1,Elderly
175716311,17571631,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,,2020,Q1,Abdominal pain upper,,2020,Q1,1,I,20200202.0,20200310.0,20200323,20200323,EXP,DE-AMK-240133,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200323.0,,PH,DE,DE,2020,Q1,Elderly
175716311,17571631,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,,2020,Q1,Agranulocytosis,,2020,Q1,1,I,20200202.0,20200310.0,20200323,20200323,EXP,DE-AMK-240133,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200323.0,,PH,DE,DE,2020,Q1,Elderly
175716311,17571631,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,,2020,Q1,Bone marrow failure,,2020,Q1,1,I,20200202.0,20200310.0,20200323,20200323,EXP,DE-AMK-240133,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200323.0,,PH,DE,DE,2020,Q1,Elderly
175716311,17571631,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,,2020,Q1,Candida infection,,2020,Q1,1,I,20200202.0,20200310.0,20200323,20200323,EXP,DE-AMK-240133,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200323.0,,PH,DE,DE,2020,Q1,Elderly
175716311,17571631,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,,2020,Q1,Leukopenia,,2020,Q1,1,I,20200202.0,20200310.0,20200323,20200323,EXP,DE-AMK-240133,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200323.0,,PH,DE,DE,2020,Q1,Elderly
175716311,17571631,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,,2020,Q1,Petechiae,,2020,Q1,1,I,20200202.0,20200310.0,20200323,20200323,EXP,DE-AMK-240133,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200323.0,,PH,DE,DE,2020,Q1,Elderly
175716311,17571631,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,,2020,Q1,Thrombocytopenia,,2020,Q1,1,I,20200202.0,20200310.0,20200323,20200323,EXP,DE-AMK-240133,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200323.0,,PH,DE,DE,2020,Q1,Elderly
175716311,17571631,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,,2020,Q1,Umbilical hernia,,2020,Q1,1,I,20200202.0,20200310.0,20200323,20200323,EXP,DE-AMK-240133,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200323.0,,PH,DE,DE,2020,Q1,Elderly
175746341,17574634,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q1,Concomitant disease progression,,2020,Q1,1,I,20180527.0,20200312.0,20200324,20200324,EXP,,JP-RECORDATI RARE DISEASES-2081909,RECORDATI,,67.0,YR,,F,Y,,,20200324.0,,MD,JP,JP,2020,Q1,Elderly
175746341,17574634,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,20180527.0,20200312.0,20200324,20200324,EXP,,JP-RECORDATI RARE DISEASES-2081909,RECORDATI,,67.0,YR,,F,Y,,,20200324.0,,MD,JP,JP,2020,Q1,Elderly
175746341,17574634,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q1,Neoplasm progression,,2020,Q1,1,I,20180527.0,20200312.0,20200324,20200324,EXP,,JP-RECORDATI RARE DISEASES-2081909,RECORDATI,,67.0,YR,,F,Y,,,20200324.0,,MD,JP,JP,2020,Q1,Elderly
175746341,17574634,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q1,Tumour compression,,2020,Q1,1,I,20180527.0,20200312.0,20200324,20200324,EXP,,JP-RECORDATI RARE DISEASES-2081909,RECORDATI,,67.0,YR,,F,Y,,,20200324.0,,MD,JP,JP,2020,Q1,Elderly
175746341,17574634,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q1,Tumour haemorrhage,,2020,Q1,1,I,20180527.0,20200312.0,20200324,20200324,EXP,,JP-RECORDATI RARE DISEASES-2081909,RECORDATI,,67.0,YR,,F,Y,,,20200324.0,,MD,JP,JP,2020,Q1,Elderly
175746341,17574634,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q1,Visual field defect,,2020,Q1,1,I,20180527.0,20200312.0,20200324,20200324,EXP,,JP-RECORDATI RARE DISEASES-2081909,RECORDATI,,67.0,YR,,F,Y,,,20200324.0,,MD,JP,JP,2020,Q1,Elderly
175758951,17575895,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,,,2020,Q1,Injection site abscess,,2020,Q1,1,I,,20200312.0,20200324,20200324,EXP,,US-ELI_LILLY_AND_COMPANY-US202003010189,ELI LILLY AND CO,TATIANA S SOUZA.CASE REPORT: CUTANEOUS NONTUBERCULOUS MYCOBACTERIAL ABSCESSES ASSOCIATED WITH INSULIN INJECTIONS.JOURNAL OF DRUGS IN DER DERMATOLOGY 2010;9:1439 - 1442.,60.0,YR,,F,Y,,,20200324.0,,MD,US,US,2020,Q1,Adult
175760261,17576026,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK UNK, 1X/DAY (3 UNITS IN EVENING)",,,,,,,,,,,QD,2020,Q1,Bradycardia,,2020,Q1,1,I,,20200317.0,20200324,20200324,EXP,,JP-PFIZER INC-2020117631,PFIZER,"SHIROMA, M.. DIFFERENTIATION OF BRADYCARDIA WITH SHOCK. JOURNAL OF GENERALIST MEDICINE. 2020;30(3):374-378",81.0,YR,,M,Y,,,20200324.0,,MD,JP,JP,2020,Q1,Elderly
175760261,17576026,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK UNK, 1X/DAY (3 UNITS IN EVENING)",,,,,,,,,,,QD,2020,Q1,Hyperkalaemia,,2020,Q1,1,I,,20200317.0,20200324,20200324,EXP,,JP-PFIZER INC-2020117631,PFIZER,"SHIROMA, M.. DIFFERENTIATION OF BRADYCARDIA WITH SHOCK. JOURNAL OF GENERALIST MEDICINE. 2020;30(3):374-378",81.0,YR,,M,Y,,,20200324.0,,MD,JP,JP,2020,Q1,Elderly
175760931,17576093,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),LOADING DOSE: 1 U/KG,,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009254,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",14.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Youth
175760931,17576093,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),LOADING DOSE: 1 U/KG,,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009254,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",14.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Youth
175760931,17576093,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),LOADING DOSE: 1 U/KG,,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Non-cardiogenic pulmonary oedema,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009254,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",14.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Youth
175760931,17576093,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),LOADING DOSE: 1 U/KG,,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Off label use,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009254,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",14.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Youth
175769581,17576958,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),LOADING DOSE: 1 U/KG FOLLOWED BY AN INFUSION OF 1 U/KG/H AND THEN 5 U/KG/H,,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),LOADING DOSE: 1 U/KG FOLLOWED BY AN INFUSION OF 1 U/KG/H AND THEN 5 U/KG/H,,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),LOADING DOSE: 1 U/KG FOLLOWED BY AN INFUSION OF 1 U/KG/H AND THEN 5 U/KG/H,,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Non-cardiogenic pulmonary oedema,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),LOADING DOSE: 1 U/KG FOLLOWED BY AN INFUSION OF 1 U/KG/H AND THEN 5 U/KG/H,,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Off label use,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),LOADING DOSE: 1 U/KG FOLLOWED BY AN INFUSION OF 1 U/KG/H AND THEN 5 U/KG/H,,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Respiratory failure,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,2,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"INFUSION OF 1 U/KG/H, UNKNOWN",,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,2,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"INFUSION OF 1 U/KG/H, UNKNOWN",,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,2,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"INFUSION OF 1 U/KG/H, UNKNOWN",,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Non-cardiogenic pulmonary oedema,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,2,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"INFUSION OF 1 U/KG/H, UNKNOWN",,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Off label use,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,2,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"INFUSION OF 1 U/KG/H, UNKNOWN",,,U,U,,,205692.0,1.0,DF,,,2020,Q1,Respiratory failure,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,3,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"5 U/KG/H, UNKNOWN",,,U,U,,,205692.0,5.0,DF,,,2020,Q1,Condition aggravated,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,3,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"5 U/KG/H, UNKNOWN",,,U,U,,,205692.0,5.0,DF,,,2020,Q1,Incorrect route of product administration,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,3,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"5 U/KG/H, UNKNOWN",,,U,U,,,205692.0,5.0,DF,,,2020,Q1,Non-cardiogenic pulmonary oedema,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,3,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"5 U/KG/H, UNKNOWN",,,U,U,,,205692.0,5.0,DF,,,2020,Q1,Off label use,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175769581,17576958,3,SS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"5 U/KG/H, UNKNOWN",,,U,U,,,205692.0,5.0,DF,,,2020,Q1,Respiratory failure,,2020,Q1,1,I,,20200318.0,20200324,20200324,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009268,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J.THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY.CLIN-TOXICOL-(PHILA) 2020;:.",77.0,YR,,F,Y,,,20200324.0,,MD,SE,SE,2020,Q1,Elderly
175808483,17580848,9,SS,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"2 IU, 1 TIME DAILY (EVENING)",,,U,U,,,,2.0,IU,,QD,2020,Q1,Hyperglycaemic hyperosmolar nonketotic syndrome,,2020,Q1,3,F,20190330.0,20200310.0,20200325,20200326,EXP,,JP-FERRINGPH-2019FE07768,FERRING,,63.0,YR,,F,Y,70.0,KG,20200326.0,,HP,JP,JP,2020,Q1,Adult
175808483,17580848,9,SS,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"2 IU, 1 TIME DAILY (EVENING)",,,U,U,,,,2.0,IU,,QD,2020,Q1,Hyponatraemia,,2020,Q1,3,F,20190330.0,20200310.0,20200325,20200326,EXP,,JP-FERRINGPH-2019FE07768,FERRING,,63.0,YR,,F,Y,70.0,KG,20200326.0,,HP,JP,JP,2020,Q1,Adult
175808483,17580848,9,SS,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"2 IU, 1 TIME DAILY (EVENING)",,,U,U,,,,2.0,IU,,QD,2020,Q1,Intentional dose omission,,2020,Q1,3,F,20190330.0,20200310.0,20200325,20200326,EXP,,JP-FERRINGPH-2019FE07768,FERRING,,63.0,YR,,F,Y,70.0,KG,20200326.0,,HP,JP,JP,2020,Q1,Adult
175818531,17581853,8,C,Insulin glargine,INSULIN GLARGINE,1,,60 UNITS ONCE DAILY,,,,,,,,,,,,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200312.0,20200325,20200325,EXP,,US-CONCORD BIOTECH LIMITED-CBL202003-000026,CONCORD BIOTECH,"DEEB J, LYONS D, LASKIN D, DEEB G. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6:.",52.0,YR,,M,Y,,,20200325.0,,HP,US,US,2020,Q1,Adult
175818531,17581853,8,C,Insulin glargine,INSULIN GLARGINE,1,,60 UNITS ONCE DAILY,,,,,,,,,,,,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200312.0,20200325,20200325,EXP,,US-CONCORD BIOTECH LIMITED-CBL202003-000026,CONCORD BIOTECH,"DEEB J, LYONS D, LASKIN D, DEEB G. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6:.",52.0,YR,,M,Y,,,20200325.0,,HP,US,US,2020,Q1,Adult
175819981,17581998,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Abortion spontaneous,,2020,Q1,1,I,20190302.0,20200317.0,20200325,20200325,EXP,FR-AFSSAPS-MP20200272,FR-MYLANLABS-2020M1030637,MYLAN,,39.0,YR,,F,Y,,,20200325.0,,MD,FR,FR,2020,Q1,Adult
175819981,17581998,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Maternal exposure during pregnancy,,2020,Q1,1,I,20190302.0,20200317.0,20200325,20200325,EXP,FR-AFSSAPS-MP20200272,FR-MYLANLABS-2020M1030637,MYLAN,,39.0,YR,,F,Y,,,20200325.0,,MD,FR,FR,2020,Q1,Adult
175840681,17584068,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"60 UNITS, QD",,,,, UNKNOWN,,,,,,,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200311.0,20200326,20200326,EXP,US-MLMSERVICE-20200303-2194138-1,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-00803,ALKEM,,52.0,YR,,M,Y,,,20200326.0,,HP,GB,US,2020,Q1,Adult
175848681,17584868,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Blood insulin abnormal,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Diabetes mellitus inadequate control,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Drug ineffective,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Insulin C-peptide abnormal,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175848681,17584868,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q1,Treatment noncompliance,,2020,Q1,1,I,201908.0,20200319.0,20200326,20200326,EXP,,PT-SA-2020SA072050,SANOFI AVENTIS,"ROS?RIO F.,  FORTUNATO F.,  BRANCO P., ADRAG?O T.. A CASE OF HYPOGLYCEMIA THAT DEFIES DIAGNOSTIC ALGORITHMS - THE IMPORTANCE OF DETAILS. REVISTA PORTUGUESA DE DIABETES. 2020;15(1):86-93",43.0,YR,A,F,Y,,,20200326.0,,HP,PT,PT,2020,Q1,Adult
175851861,17585186,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 U, DAILY (AT NIGHT)",,,,,,,,46.0,IU,INJECTION,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,201909.0,20200317.0,20200326,20200326,EXP,,US-ELI_LILLY_AND_COMPANY-US202003008058,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20200326.0,,CN,US,US,2020,Q1,Adult
175851861,17585186,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 U, DAILY (AT NIGHT)",,,,,,,,46.0,IU,INJECTION,QD,2020,Q1,Injection site pain,,2020,Q1,1,I,201909.0,20200317.0,20200326,20200326,EXP,,US-ELI_LILLY_AND_COMPANY-US202003008058,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20200326.0,,CN,US,US,2020,Q1,Adult
175851861,17585186,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"46 U, DAILY (AT NIGHT)",,,,,,,,46.0,IU,INJECTION,QD,2020,Q1,Pneumonia,,2020,Q1,1,I,201909.0,20200317.0,20200326,20200326,EXP,,US-ELI_LILLY_AND_COMPANY-US202003008058,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20200326.0,,CN,US,US,2020,Q1,Adult
175852431,17585243,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,Neutrophil count decreased,,2020,Q1,1,I,20200319.0,20200320.0,20200326,20200326,EXP,,NVSC2020DE080769,NOVARTIS,,66.0,YR,,M,Y,,,20200326.0,,HP,DE,DE,2020,Q1,Elderly
175852431,17585243,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q1,White blood cell count decreased,,2020,Q1,1,I,20200319.0,20200320.0,20200326,20200326,EXP,,NVSC2020DE080769,NOVARTIS,,66.0,YR,,M,Y,,,20200326.0,,HP,DE,DE,2020,Q1,Elderly
175861391,17586139,3,C,LANTUS (GLARGINE) INSULIN,,2,,,,,,,,,,,,,,2020,Q1,Blood creatinine increased,,2020,Q1,1,I,20200101.0,,20200324,20200324,DIR,,,FDA-CTU,,72.0,YR,,M,N,103.87,KG,20200324.0,N,PH,US,US,2020,Q1,Elderly
175861391,17586139,3,C,LANTUS (GLARGINE) INSULIN,,2,,,,,,,,,,,,,,2020,Q1,Therapy cessation,,2020,Q1,1,I,20200101.0,,20200324,20200324,DIR,,,FDA-CTU,,72.0,YR,,M,N,103.87,KG,20200324.0,N,PH,US,US,2020,Q1,Elderly
175870951,17587095,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Aspiration,,2020,Q1,1,I,20191127.0,20200319.0,20200326,20200326,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,CN,US,NL,2020,Q1,Elderly
175870951,17587095,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Hydrocephalus,,2020,Q1,1,I,20191127.0,20200319.0,20200326,20200326,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,CN,US,NL,2020,Q1,Elderly
175870951,17587095,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Hypotension,,2020,Q1,1,I,20191127.0,20200319.0,20200326,20200326,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,CN,US,NL,2020,Q1,Elderly
175870951,17587095,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Pneumonia,,2020,Q1,1,I,20191127.0,20200319.0,20200326,20200326,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,CN,US,NL,2020,Q1,Elderly
175870951,17587095,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Pulseless electrical activity,,2020,Q1,1,I,20191127.0,20200319.0,20200326,20200326,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,CN,US,NL,2020,Q1,Elderly
175870951,17587095,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q1,Respiratory failure,,2020,Q1,1,I,20191127.0,20200319.0,20200326,20200326,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,CN,US,NL,2020,Q1,Elderly
175871411,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q1,Abdominal pain,,2020,Q1,1,I,20200202.0,20200319.0,20200326,20200326,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200326.0,,PH,DE,DE,2020,Q1,Elderly
175871411,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q1,Abdominal pain upper,,2020,Q1,1,I,20200202.0,20200319.0,20200326,20200326,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200326.0,,PH,DE,DE,2020,Q1,Elderly
175871411,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q1,Agranulocytosis,,2020,Q1,1,I,20200202.0,20200319.0,20200326,20200326,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200326.0,,PH,DE,DE,2020,Q1,Elderly
175871411,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q1,Bone marrow failure,,2020,Q1,1,I,20200202.0,20200319.0,20200326,20200326,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200326.0,,PH,DE,DE,2020,Q1,Elderly
175871411,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q1,Candida infection,,2020,Q1,1,I,20200202.0,20200319.0,20200326,20200326,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200326.0,,PH,DE,DE,2020,Q1,Elderly
175871411,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q1,Leukopenia,,2020,Q1,1,I,20200202.0,20200319.0,20200326,20200326,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200326.0,,PH,DE,DE,2020,Q1,Elderly
175871411,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q1,Petechiae,,2020,Q1,1,I,20200202.0,20200319.0,20200326,20200326,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200326.0,,PH,DE,DE,2020,Q1,Elderly
175871411,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q1,Thrombocytopenia,,2020,Q1,1,I,20200202.0,20200319.0,20200326,20200326,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200326.0,,PH,DE,DE,2020,Q1,Elderly
175871411,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q1,Umbilical hernia,,2020,Q1,1,I,20200202.0,20200319.0,20200326,20200326,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200326.0,,PH,DE,DE,2020,Q1,Elderly
175873351,17587335,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 IU,,,U,,,,,18.0,IU,INJECTION,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 IU,,,U,,,,,18.0,IU,INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 IU,,,U,,,,,18.0,IU,INJECTION,,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,U,,,,,24.0,IU,INJECTION,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,U,,,,,24.0,IU,INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,U,,,,,24.0,IU,INJECTION,,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,U,,,,,12.0,IU,INJECTION,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,U,,,,,12.0,IU,INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,U,,,,,12.0,IU,INJECTION,,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,U,,,,,32.0,IU,INJECTION,,2020,Q1,Diabetic metabolic decompensation,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,U,,,,,32.0,IU,INJECTION,,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175873351,17587335,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,U,,,,,32.0,IU,INJECTION,,2020,Q1,Weight increased,,2020,Q1,1,I,201905.0,20200319.0,20200326,20200326,EXP,,SK-MYLANLABS-2020M1031886,MYLAN,,74.0,YR,,F,Y,,,20200326.0,,MD,SK,SK,2020,Q1,Elderly
175886611,17588661,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q1,Cholangitis,,2020,Q1,1,I,20190717.0,20200312.0,20200327,20200327,EXP,,JP-RECORDATI RARE DISEASES-2082053,RECORDATI,,77.0,YR,,F,Y,45.0,KG,20200327.0,,MD,JP,JP,2020,Q1,Elderly
175886611,17588661,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q1,Hepatic enzyme increased,,2020,Q1,1,I,20190717.0,20200312.0,20200327,20200327,EXP,,JP-RECORDATI RARE DISEASES-2082053,RECORDATI,,77.0,YR,,F,Y,45.0,KG,20200327.0,,MD,JP,JP,2020,Q1,Elderly
175886611,17588661,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q1,Liver disorder,,2020,Q1,1,I,20190717.0,20200312.0,20200327,20200327,EXP,,JP-RECORDATI RARE DISEASES-2082053,RECORDATI,,77.0,YR,,F,Y,45.0,KG,20200327.0,,MD,JP,JP,2020,Q1,Elderly
175895331,17589533,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"90 IU, QD",,,D,,,,206538.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Blood glucose decreased,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175895331,17589533,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"90 IU, QD",,,D,,,,206538.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Brain death,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175895331,17589533,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"90 IU, QD",,,D,,,,206538.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Intentional overdose,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175895331,17589533,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"90 IU, QD",,,D,,,,206538.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Loss of consciousness,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175895331,17589533,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"90 IU, QD",,,D,,,,206538.0,90.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Unresponsive to stimuli,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175895331,17589533,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"180 IU, TOTAL WITHIN 45 TO 60 MINUTES",,,D,,,,206538.0,180.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Blood glucose decreased,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175895331,17589533,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"180 IU, TOTAL WITHIN 45 TO 60 MINUTES",,,D,,,,206538.0,180.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Brain death,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175895331,17589533,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"180 IU, TOTAL WITHIN 45 TO 60 MINUTES",,,D,,,,206538.0,180.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Intentional overdose,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175895331,17589533,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"180 IU, TOTAL WITHIN 45 TO 60 MINUTES",,,D,,,,206538.0,180.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Loss of consciousness,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175895331,17589533,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"180 IU, TOTAL WITHIN 45 TO 60 MINUTES",,,D,,,,206538.0,180.0,IU,SOLUTION FOR INJECTION,,2020,Q1,Unresponsive to stimuli,,2020,Q1,1,I,,20200323.0,20200327,20200327,EXP,,US-SA-2020SA073254,SANOFI AVENTIS,SHAH V.N.; FORLENZA G.P.. SUICIDE VIA INTENTIONAL INSULIN OVERDOSE THROUGH FIRST COMMERCIAL HYBRID CLOSED-LOOP. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020;UNK:UNK,51.0,YR,A,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Adult
175902271,17590227,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"75 UNITS, TWICE DAILY",,,U,U,,,,,,,,2020,Q1,Acute kidney injury,,2020,Q1,1,I,,20200317.0,20200327,20200327,EXP,,US-MYLANLABS-2020M1032368,MYLAN,"HARRISON DS, GIANG J, DARLING JM. AN INTERACTION BETWEEN GLECAPREVIR, PIBRENTASVIR, AND COLCHICINE CAUSING RHABDOMYOLYSIS IN A PATIENT WITH CHRONIC RENAL DISEASE. CLIN-LIV-DIS 2020;15(1):17-20.",69.0,YR,,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Elderly
175902271,17590227,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"75 UNITS, TWICE DAILY",,,U,U,,,,,,,,2020,Q1,Drug interaction,,2020,Q1,1,I,,20200317.0,20200327,20200327,EXP,,US-MYLANLABS-2020M1032368,MYLAN,"HARRISON DS, GIANG J, DARLING JM. AN INTERACTION BETWEEN GLECAPREVIR, PIBRENTASVIR, AND COLCHICINE CAUSING RHABDOMYOLYSIS IN A PATIENT WITH CHRONIC RENAL DISEASE. CLIN-LIV-DIS 2020;15(1):17-20.",69.0,YR,,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Elderly
175902271,17590227,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"75 UNITS, TWICE DAILY",,,U,U,,,,,,,,2020,Q1,Rhabdomyolysis,,2020,Q1,1,I,,20200317.0,20200327,20200327,EXP,,US-MYLANLABS-2020M1032368,MYLAN,"HARRISON DS, GIANG J, DARLING JM. AN INTERACTION BETWEEN GLECAPREVIR, PIBRENTASVIR, AND COLCHICINE CAUSING RHABDOMYOLYSIS IN A PATIENT WITH CHRONIC RENAL DISEASE. CLIN-LIV-DIS 2020;15(1):17-20.",69.0,YR,,M,Y,,,20200327.0,,HP,US,US,2020,Q1,Elderly
175928581,17592858,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20180904.0,20200327,20200327,EXP,,TH-JNJFOC-20180903642,JOHNSON AND JOHNSON,"THEWJITCHAROEN Y, WANOTHAYAROJ E, TAMMAWIWAT C, MALIDAENG A, YENSEUNG N, NAKASATIEN S, ET AL. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I-ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT-OF-CARE BLOOD KETONE TESTING. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY: CASE REPORTS 2018;10:8-10.",22.0,YR,,F,Y,,,20200327.0,,HP,TH,TH,2020,Q1,Youth
175928581,17592858,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q1,Off label use,,2020,Q1,1,I,,20180904.0,20200327,20200327,EXP,,TH-JNJFOC-20180903642,JOHNSON AND JOHNSON,"THEWJITCHAROEN Y, WANOTHAYAROJ E, TAMMAWIWAT C, MALIDAENG A, YENSEUNG N, NAKASATIEN S, ET AL. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I-ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT-OF-CARE BLOOD KETONE TESTING. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY: CASE REPORTS 2018;10:8-10.",22.0,YR,,F,Y,,,20200327.0,,HP,TH,TH,2020,Q1,Youth
175928581,17592858,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q1,Product use in unapproved indication,,2020,Q1,1,I,,20180904.0,20200327,20200327,EXP,,TH-JNJFOC-20180903642,JOHNSON AND JOHNSON,"THEWJITCHAROEN Y, WANOTHAYAROJ E, TAMMAWIWAT C, MALIDAENG A, YENSEUNG N, NAKASATIEN S, ET AL. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I-ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT-OF-CARE BLOOD KETONE TESTING. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY: CASE REPORTS 2018;10:8-10.",22.0,YR,,F,Y,,,20200327.0,,HP,TH,TH,2020,Q1,Youth
175928581,17592858,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20180904.0,20200327,20200327,EXP,,TH-JNJFOC-20180903642,JOHNSON AND JOHNSON,"THEWJITCHAROEN Y, WANOTHAYAROJ E, TAMMAWIWAT C, MALIDAENG A, YENSEUNG N, NAKASATIEN S, ET AL. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I-ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT-OF-CARE BLOOD KETONE TESTING. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY: CASE REPORTS 2018;10:8-10.",22.0,YR,,F,Y,,,20200327.0,,HP,TH,TH,2020,Q1,Youth
175928581,17592858,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q1,Off label use,,2020,Q1,1,I,,20180904.0,20200327,20200327,EXP,,TH-JNJFOC-20180903642,JOHNSON AND JOHNSON,"THEWJITCHAROEN Y, WANOTHAYAROJ E, TAMMAWIWAT C, MALIDAENG A, YENSEUNG N, NAKASATIEN S, ET AL. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I-ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT-OF-CARE BLOOD KETONE TESTING. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY: CASE REPORTS 2018;10:8-10.",22.0,YR,,F,Y,,,20200327.0,,HP,TH,TH,2020,Q1,Youth
175928581,17592858,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q1,Product use in unapproved indication,,2020,Q1,1,I,,20180904.0,20200327,20200327,EXP,,TH-JNJFOC-20180903642,JOHNSON AND JOHNSON,"THEWJITCHAROEN Y, WANOTHAYAROJ E, TAMMAWIWAT C, MALIDAENG A, YENSEUNG N, NAKASATIEN S, ET AL. A SINGLE CENTER RETROSPECTIVE ANALYSIS OF SGLT2I-ASSOCIATED DIABETIC KETOACIDOSIS IN BANGKOK: THE ROLE OF POINT-OF-CARE BLOOD KETONE TESTING. JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY: CASE REPORTS 2018;10:8-10.",22.0,YR,,F,Y,,,20200327.0,,HP,TH,TH,2020,Q1,Youth
175928851,17592885,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,66.0,IU,UNKNOWN,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20181113.0,20200327,20200327,EXP,,CA-JNJFOC-20181122846,JOHNSON AND JOHNSON,"LANE S, PASKAR D, HAMED S, GOFFI A. WHEN GUIDELINES FAIL: EUGLYCEMIC DIABETIC KETOACIDOSIS AFTER BARIATRIC SURGERY IN A PATIENT TAKING A SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR: A CASE REPORT. A+A PRACTICE 2018;11/2:46-48.",42.0,YR,,F,Y,,,20200327.0,,MD,CA,CA,2020,Q1,Adult
175928851,17592885,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,33.0,IU,UNKNOWN,QD,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20181113.0,20200327,20200327,EXP,,CA-JNJFOC-20181122846,JOHNSON AND JOHNSON,"LANE S, PASKAR D, HAMED S, GOFFI A. WHEN GUIDELINES FAIL: EUGLYCEMIC DIABETIC KETOACIDOSIS AFTER BARIATRIC SURGERY IN A PATIENT TAKING A SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR: A CASE REPORT. A+A PRACTICE 2018;11/2:46-48.",42.0,YR,,F,Y,,,20200327.0,,MD,CA,CA,2020,Q1,Adult
175930791,17593079,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q1,Euglycaemic diabetic ketoacidosis,,2020,Q1,1,I,,20181112.0,20200327,20200327,EXP,,GR-JNJFOC-20181116173,JOHNSON AND JOHNSON,"PRODROMIADOU E, KONTRAFOURI P, KOURTI E, TSAKANIKAS A, KARAOLIA M, NTZIORA F, ET AL. EUGLYCEMIC DIABETIC KETOACIDOSIS IN PATIENT WITH DIABETES MELLITUS DURING ADMINISTRATION OF SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITORS. 2018.",65.0,YR,,F,Y,,,20200327.0,,MD,GR,GR,2020,Q1,Elderly
175931961,17593196,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Acute kidney injury,Acute kidney injury,2020,Q1,1,I,,20200316.0,20200327,20200327,EXP,,US-UMEDICA-000007,UMEDICA LABS,,69.0,YR,E,F,Y,,,20200327.0,,HP,US,US,2020,Q1,Elderly
175931961,17593196,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Drug eruption,Drug eruption,2020,Q1,1,I,,20200316.0,20200327,20200327,EXP,,US-UMEDICA-000007,UMEDICA LABS,,69.0,YR,E,F,Y,,,20200327.0,,HP,US,US,2020,Q1,Elderly
175931961,17593196,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Hypothyroidism,Hypothyroidism,2020,Q1,1,I,,20200316.0,20200327,20200327,EXP,,US-UMEDICA-000007,UMEDICA LABS,,69.0,YR,E,F,Y,,,20200327.0,,HP,US,US,2020,Q1,Elderly
175931961,17593196,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Lupus-like syndrome,Lupus-like syndrome,2020,Q1,1,I,,20200316.0,20200327,20200327,EXP,,US-UMEDICA-000007,UMEDICA LABS,,69.0,YR,E,F,Y,,,20200327.0,,HP,US,US,2020,Q1,Elderly
175931961,17593196,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q1,Tubulointerstitial nephritis,Tubulointerstitial nephritis,2020,Q1,1,I,,20200316.0,20200327,20200327,EXP,,US-UMEDICA-000007,UMEDICA LABS,,69.0,YR,E,F,Y,,,20200327.0,,HP,US,US,2020,Q1,Elderly
175986181,17598618,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 UNITS,,,U,U,,,,,,,,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200318.0,20200330,20200330,EXP,,US-MYLANLABS-2020M1032967,MYLAN,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL-MAXILLOFAC-SURG-CASES 2020;6:NO. 1.",52.0,YR,,M,Y,,,20200330.0,,HP,US,US,2020,Q1,Adult
175986181,17598618,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 UNITS,,,U,U,,,,,,,,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200318.0,20200330,20200330,EXP,,US-MYLANLABS-2020M1032967,MYLAN,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL-MAXILLOFAC-SURG-CASES 2020;6:NO. 1.",52.0,YR,,M,Y,,,20200330.0,,HP,US,US,2020,Q1,Adult
175992411,17599241,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 UNITS QD,,,,,,,,,,,,2020,Q1,Bone loss,,2020,Q1,1,I,,20200323.0,20200330,20200330,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP004065,STRIDES,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):1-6",52.0,YR,,M,Y,,,20200330.0,,HP,US,US,2020,Q1,Adult
175992411,17599241,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 UNITS QD,,,,,,,,,,,,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200323.0,20200330,20200330,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP004065,STRIDES,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):1-6",52.0,YR,,M,Y,,,20200330.0,,HP,US,US,2020,Q1,Adult
175992411,17599241,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 UNITS QD,,,,,,,,,,,,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200323.0,20200330,20200330,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP004065,STRIDES,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):1-6",52.0,YR,,M,Y,,,20200330.0,,HP,US,US,2020,Q1,Adult
175992411,17599241,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 UNITS QD,,,,,,,,,,,,2020,Q1,Tooth loss,,2020,Q1,1,I,,20200323.0,20200330,20200330,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP004065,STRIDES,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):1-6",52.0,YR,,M,Y,,,20200330.0,,HP,US,US,2020,Q1,Adult
175996511,17599651,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,20200115.0,20200324.0,20200330,20200330,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-025402,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,77.0,KG,20200330.0,,CN,DE,DE,2020,Q1,Elderly
175996511,17599651,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q1,Eye movement disorder,,2020,Q1,1,I,20200115.0,20200324.0,20200330,20200330,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-025402,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,77.0,KG,20200330.0,,CN,DE,DE,2020,Q1,Elderly
175996511,17599651,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q1,Movement disorder,,2020,Q1,1,I,20200115.0,20200324.0,20200330,20200330,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-025402,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,77.0,KG,20200330.0,,CN,DE,DE,2020,Q1,Elderly
175996511,17599651,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q1,Seizure,,2020,Q1,1,I,20200115.0,20200324.0,20200330,20200330,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-025402,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,77.0,KG,20200330.0,,CN,DE,DE,2020,Q1,Elderly
175998841,17599884,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,D,,,,,60.0,IU,,,2020,Q1,Gingival hypertrophy,,2020,Q1,1,I,,20200318.0,20200330,20200330,EXP,,US-APOTEX-2020AP009171,APOTEX,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. DOI: 10.1016/J.OMSC.2020.100143. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):100143:1-6",52.0,YR,,M,Y,,,20200330.0,,HP,US,US,2020,Q1,Adult
175998841,17599884,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,D,,,,,60.0,IU,,,2020,Q1,Periodontitis,,2020,Q1,1,I,,20200318.0,20200330,20200330,EXP,,US-APOTEX-2020AP009171,APOTEX,"DEEB JG, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. DOI: 10.1016/J.OMSC.2020.100143. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):100143:1-6",52.0,YR,,M,Y,,,20200330.0,,HP,US,US,2020,Q1,Adult
175999861,17599986,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,Y,,,,21081.0,10.0,IU,,QD,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20191201.0,20200324.0,20200330,20200330,EXP,IT-MINISAL02-602355,IT-SA-2020SA074722,SANOFI AVENTIS,,48.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
175999861,17599986,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,Y,,,,21081.0,10.0,IU,,QD,2020,Q1,Syncope,,2020,Q1,1,I,20191201.0,20200324.0,20200330,20200330,EXP,IT-MINISAL02-602355,IT-SA-2020SA074722,SANOFI AVENTIS,,48.0,YR,A,F,Y,,,20200330.0,,MD,IT,IT,2020,Q1,Adult
176000601,17600060,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Acute myeloid leukaemia,,2020,Q1,1,I,20190815.0,20190826.0,20200330,20200330,EXP,,JP-CELGENEUS-JPN-20190808789,CELGENE,,73.0,YR,,M,Y,50.0,KG,20200330.0,,HP,JP,JP,2020,Q1,Elderly
176000601,17600060,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q1,Febrile neutropenia,,2020,Q1,1,I,20190815.0,20190826.0,20200330,20200330,EXP,,JP-CELGENEUS-JPN-20190808789,CELGENE,,73.0,YR,,M,Y,50.0,KG,20200330.0,,HP,JP,JP,2020,Q1,Elderly
176003511,17600351,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"55 IU, QD",,,U,,,,21081.0,55.0,IU,,QD,2020,Q1,Accident,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"55 IU, QD",,,U,,,,21081.0,55.0,IU,,QD,2020,Q1,Biliary colic,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"55 IU, QD",,,U,,,,21081.0,55.0,IU,,QD,2020,Q1,Blood glucose increased,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"55 IU, QD",,,U,,,,21081.0,55.0,IU,,QD,2020,Q1,Cholelithiasis,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"55 IU, QD",,,U,,,,21081.0,55.0,IU,,QD,2020,Q1,Fatigue,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"55 IU, QD",,,U,,,,21081.0,55.0,IU,,QD,2020,Q1,Gait disturbance,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176003511,17600351,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"55 IU, QD",,,U,,,,21081.0,55.0,IU,,QD,2020,Q1,Hepatic pain,,2020,Q1,1,I,,20200326.0,20200330,20200330,EXP,,CA-SA-2020SA076395,SANOFI AVENTIS,,59.0,YR,A,F,Y,,,20200330.0,,CN,CA,CA,2020,Q1,Adult
176004521,17600452,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,205692.0,15.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,20200115.0,20200324.0,20200330,20200330,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200330.0,,CN,DE,DE,2020,Q1,Elderly
176004521,17600452,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,205692.0,15.0,IU,,QD,2020,Q1,Eye movement disorder,,2020,Q1,1,I,20200115.0,20200324.0,20200330,20200330,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200330.0,,CN,DE,DE,2020,Q1,Elderly
176004521,17600452,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,205692.0,15.0,IU,,QD,2020,Q1,Movement disorder,,2020,Q1,1,I,20200115.0,20200324.0,20200330,20200330,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200330.0,,CN,DE,DE,2020,Q1,Elderly
176004521,17600452,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,205692.0,15.0,IU,,QD,2020,Q1,Seizure,,2020,Q1,1,I,20200115.0,20200324.0,20200330,20200330,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200330.0,,CN,DE,DE,2020,Q1,Elderly
176011241,17601124,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Posterior reversible encephalopathy syndrome,,2020,Q1,1,I,,20200326.0,20200331,20200331,EXP,,US-DRREDDYS-USA/USA/20/0121287,DR REDDYS,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68. DOI: 10.1159/000505907.",41.0,YR,A,F,Y,,,20200331.0,,MD,US,US,2020,Q1,Adult
176011241,17601124,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q1,Serotonin syndrome,,2020,Q1,1,I,,20200326.0,20200331,20200331,EXP,,US-DRREDDYS-USA/USA/20/0121287,DR REDDYS,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68. DOI: 10.1159/000505907.",41.0,YR,A,F,Y,,,20200331.0,,MD,US,US,2020,Q1,Adult
176014671,17601467,8,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNK,,,,,,,2020,Q1,Lupus-like syndrome,,2020,Q1,1,I,,20200319.0,20200331,20200331,EXP,,"US-RICONPHARMA, LLC-2020RIC000001",RICONPHARMA,,69.0,YR,,F,Y,,,20200331.0,,HP,US,US,2020,Q1,Elderly
176014671,17601467,8,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNK,,,,,,,2020,Q1,Tubulointerstitial nephritis,,2020,Q1,1,I,,20200319.0,20200331,20200331,EXP,,"US-RICONPHARMA, LLC-2020RIC000001",RICONPHARMA,,69.0,YR,,F,Y,,,20200331.0,,HP,US,US,2020,Q1,Elderly
176074341,17607434,3,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q1,Drug interaction,,2020,Q1,1,I,20200115.0,20200324.0,20200331,20200331,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20200331.0,,CN,DE,DE,2020,Q1,Elderly
176074341,17607434,3,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q1,Eye movement disorder,,2020,Q1,1,I,20200115.0,20200324.0,20200331,20200331,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20200331.0,,CN,DE,DE,2020,Q1,Elderly
176074341,17607434,3,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q1,Movement disorder,,2020,Q1,1,I,20200115.0,20200324.0,20200331,20200331,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20200331.0,,CN,DE,DE,2020,Q1,Elderly
176074341,17607434,3,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q1,Seizure,,2020,Q1,1,I,20200115.0,20200324.0,20200331,20200331,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20200331.0,,CN,DE,DE,2020,Q1,Elderly
176082771,17608277,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,66.0,IU,,QD,2020,Q1,Hiccups,,2020,Q1,1,I,,20200220.0,20200331,20200331,PER,,US-ASTRAZENECA-2020SE26349,ASTRAZENECA,,68.0,YR,,M,Y,131.5,KG,20200331.0,,HP,US,US,2020,Q1,Elderly
176104491,17610449,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;?,,,Y,D,,,,22.0,DF,,HS,2020,Q1,Depressed level of consciousness,,2020,Q1,1,I,20200313.0,,20200330,20200330,DIR,,,FDA-CTU,,86.0,YR,,M,N,,,20200325.0,N,PH,US,US,2020,Q1,Elderly
176104491,17610449,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;?,,,Y,D,,,,22.0,DF,,HS,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,1,I,20200313.0,,20200330,20200330,DIR,,,FDA-CTU,,86.0,YR,,M,N,,,20200325.0,N,PH,US,US,2020,Q1,Elderly
176104491,17610449,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;?,,,Y,D,,,,22.0,DF,,HS,2020,Q1,Hypoglycaemia,,2020,Q1,1,I,20200313.0,,20200330,20200330,DIR,,,FDA-CTU,,86.0,YR,,M,N,,,20200325.0,N,PH,US,US,2020,Q1,Elderly
176104491,17610449,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;?,,,Y,D,,,,22.0,DF,,HS,2020,Q1,Hypophagia,,2020,Q1,1,I,20200313.0,,20200330,20200330,DIR,,,FDA-CTU,,86.0,YR,,M,N,,,20200325.0,N,PH,US,US,2020,Q1,Elderly
176104491,17610449,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;?,,,Y,D,,,,22.0,DF,,HS,2020,Q1,Infection,,2020,Q1,1,I,20200313.0,,20200330,20200330,DIR,,,FDA-CTU,,86.0,YR,,M,N,,,20200325.0,N,PH,US,US,2020,Q1,Elderly
176104491,17610449,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;?,,,Y,D,,,,22.0,DF,,HS,2020,Q1,Insulinoma,,2020,Q1,1,I,20200313.0,,20200330,20200330,DIR,,,FDA-CTU,,86.0,YR,,M,N,,,20200325.0,N,PH,US,US,2020,Q1,Elderly
176104491,17610449,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;?,,,Y,D,,,,22.0,DF,,HS,2020,Q1,Radius fracture,,2020,Q1,1,I,20200313.0,,20200330,20200330,DIR,,,FDA-CTU,,86.0,YR,,M,N,,,20200325.0,N,PH,US,US,2020,Q1,Elderly
176104491,17610449,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER STRENGTH:100 UNT/ML;?,,,Y,D,,,,22.0,DF,,HS,2020,Q1,Somnolence,,2020,Q1,1,I,20200313.0,,20200330,20200330,DIR,,,FDA-CTU,,86.0,YR,,M,N,,,20200325.0,N,PH,US,US,2020,Q1,Elderly
76405522,7640552,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Foot fracture,,2020,Q1,2,F,2010.0,20200127.0,20101026,20200205,EXP,,US-SANOFI-AVENTIS-2010SA063974,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
76405522,7640552,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,2010.0,20200127.0,20101026,20200205,EXP,,US-SANOFI-AVENTIS-2010SA063974,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
76405522,7640552,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q1,Non-Hodgkin's lymphoma,,2020,Q1,2,F,2010.0,20200127.0,20101026,20200205,EXP,,US-SANOFI-AVENTIS-2010SA063974,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
76405522,7640552,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, C767,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Foot fracture,,2020,Q1,2,F,2010.0,20200127.0,20101026,20200205,EXP,,US-SANOFI-AVENTIS-2010SA063974,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
76405522,7640552,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, C767,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,2010.0,20200127.0,20101026,20200205,EXP,,US-SANOFI-AVENTIS-2010SA063974,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
76405522,7640552,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, C767,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Non-Hodgkin's lymphoma,,2020,Q1,2,F,2010.0,20200127.0,20101026,20200205,EXP,,US-SANOFI-AVENTIS-2010SA063974,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
76405522,7640552,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, BID",,,,,,,21081.0,75.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Foot fracture,,2020,Q1,2,F,2010.0,20200127.0,20101026,20200205,EXP,,US-SANOFI-AVENTIS-2010SA063974,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
76405522,7640552,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, BID",,,,,,,21081.0,75.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Inappropriate schedule of product administration,,2020,Q1,2,F,2010.0,20200127.0,20101026,20200205,EXP,,US-SANOFI-AVENTIS-2010SA063974,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
76405522,7640552,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU, BID",,,,,,,21081.0,75.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q1,Non-Hodgkin's lymphoma,,2020,Q1,2,F,2010.0,20200127.0,20101026,20200205,EXP,,US-SANOFI-AVENTIS-2010SA063974,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20200205.0,,CN,US,US,2020,Q1,Elderly
93482823,9348282,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, QD",,,,, 4F829A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Aphonia,,2020,Q1,3,F,201405.0,20200115.0,20130614,20200123,EXP,,US-SANOFI-AVENTIS-2013SA059316,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Elderly
93482823,9348282,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, QD",,,,, 4F829A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Atrioventricular block,,2020,Q1,3,F,201405.0,20200115.0,20130614,20200123,EXP,,US-SANOFI-AVENTIS-2013SA059316,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Elderly
93482823,9348282,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, QD",,,,, 4F829A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Glycosylated haemoglobin increased,,2020,Q1,3,F,201405.0,20200115.0,20130614,20200123,EXP,,US-SANOFI-AVENTIS-2013SA059316,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Elderly
93482823,9348282,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, QD",,,,, 4F829A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Hyperglycaemia,,2020,Q1,3,F,201405.0,20200115.0,20130614,20200123,EXP,,US-SANOFI-AVENTIS-2013SA059316,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Elderly
93482823,9348282,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, QD",,,,, 4F829A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Injection site pain,,2020,Q1,3,F,201405.0,20200115.0,20130614,20200123,EXP,,US-SANOFI-AVENTIS-2013SA059316,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Elderly
93482823,9348282,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, QD",,,,, 4F829A,,21081.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q1,Myocardial infarction,,2020,Q1,3,F,201405.0,20200115.0,20130614,20200123,EXP,,US-SANOFI-AVENTIS-2013SA059316,SANOFI AVENTIS,,82.0,YR,E,M,Y,,,20200123.0,,CN,US,US,2020,Q1,Elderly
103112764,10311276,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, HS",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, HS",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cardiac failure,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, HS",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, HS",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Malaise,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, HS",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, HS",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Peripheral swelling,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, HS",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, HS",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Weight increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, HS",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Wrong technique in device usage process,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cardiac failure,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Malaise,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Peripheral swelling,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Weight increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,,,,,21081.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Wrong technique in device usage process,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,, 8F5700A,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,, 8F5700A,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cardiac failure,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,, 8F5700A,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,, 8F5700A,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Malaise,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,, 8F5700A,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,, 8F5700A,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Peripheral swelling,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,, 8F5700A,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,, 8F5700A,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Weight increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,, 8F5700A,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Wrong technique in device usage process,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, HS",,,,, 3F650A,,21081.0,14.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, HS",,,,, 3F650A,,21081.0,14.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cardiac failure,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, HS",,,,, 3F650A,,21081.0,14.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, HS",,,,, 3F650A,,21081.0,14.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Malaise,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, HS",,,,, 3F650A,,21081.0,14.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, HS",,,,, 3F650A,,21081.0,14.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Peripheral swelling,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, HS",,,,, 3F650A,,21081.0,14.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, HS",,,,, 3F650A,,21081.0,14.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Weight increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, HS",,,,, 3F650A,,21081.0,14.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Wrong technique in device usage process,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, HS",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, HS",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cardiac failure,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, HS",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, HS",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Malaise,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, HS",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, HS",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Peripheral swelling,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, HS",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, HS",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Weight increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 IU, HS",,,,,,,21081.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Wrong technique in device usage process,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cardiac failure,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Malaise,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Peripheral swelling,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Weight increased,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
103112764,10311276,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,,,,,21081.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Wrong technique in device usage process,,2020,Q2,4,F,20140615.0,20200413.0,20140717,20200416,EXP,,US-SA-2014SA091715,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20200416.0,,CN,US,US,2020,Q2,Elderly
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Ankle fracture,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blindness,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Fall,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Gait disturbance,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Limb injury,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Pain in extremity,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Post procedural complication,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Road traffic accident,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, BID",,,D,,,,21081.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Vision blurred,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Ankle fracture,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blindness,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Fall,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Gait disturbance,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Limb injury,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Pain in extremity,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Post procedural complication,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Road traffic accident,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 IU,,,D,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Vision blurred,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Ankle fracture,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Blindness,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Fall,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Gait disturbance,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Limb injury,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Pain in extremity,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Post procedural complication,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Road traffic accident,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104020082,10402008,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,(20-70 IU),,,D,,,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q2,Vision blurred,,2020,Q2,2,F,20120129.0,20200514.0,20140822,20200521,EXP,,US-SA-2014SA111632,SANOFI AVENTIS,,47.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
104431444,10443144,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, 8F5609A,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Back injury,,2020,Q2,4,F,20100818.0,20200413.0,20140909,20200417,EXP,,US-SA-2014SA121444,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200417.0,,CN,US,US,2020,Q2,Adult
104431444,10443144,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, 8F5609A,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebral thrombosis,,2020,Q2,4,F,20100818.0,20200413.0,20140909,20200417,EXP,,US-SA-2014SA121444,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200417.0,,CN,US,US,2020,Q2,Adult
104431444,10443144,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, 8F5609A,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Chronic obstructive pulmonary disease,,2020,Q2,4,F,20100818.0,20200413.0,20140909,20200417,EXP,,US-SA-2014SA121444,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200417.0,,CN,US,US,2020,Q2,Adult
104431444,10443144,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, 8F5609A,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Generalised tonic-clonic seizure,,2020,Q2,4,F,20100818.0,20200413.0,20140909,20200417,EXP,,US-SA-2014SA121444,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200417.0,,CN,US,US,2020,Q2,Adult
104431444,10443144,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, 8F5609A,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,4,F,20100818.0,20200413.0,20140909,20200417,EXP,,US-SA-2014SA121444,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200417.0,,CN,US,US,2020,Q2,Adult
104431444,10443144,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, 8F5609A,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hypoaesthesia,,2020,Q2,4,F,20100818.0,20200413.0,20140909,20200417,EXP,,US-SA-2014SA121444,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200417.0,,CN,US,US,2020,Q2,Adult
104431444,10443144,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, 8F5609A,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Myocardial infarction,,2020,Q2,4,F,20100818.0,20200413.0,20140909,20200417,EXP,,US-SA-2014SA121444,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200417.0,,CN,US,US,2020,Q2,Adult
104431444,10443144,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,,, 8F5609A,,21081.0,36.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Road traffic accident,,2020,Q2,4,F,20100818.0,20200413.0,20140909,20200417,EXP,,US-SA-2014SA121444,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20200417.0,,CN,US,US,2020,Q2,Adult
109982195,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2020,Q2,Diabetic coma,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
109982195,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2020,Q2,Myocardial infarction,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
109982195,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
109982195,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
109982195,10998219,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (300 UNIT/ ML (1.5 ML) INSULIN PEN),,,,,,,,,,,,2020,Q2,Steroid diabetes,,2020,Q2,5,F,20050414.0,20200415.0,20150408,20200423,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20200423.0,,HP,US,US,2020,Q2,Adult
112216934,11221693,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"37 UNITS AM AND 37 UNITS PM,BID",,,,,,,,37.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Arthritis,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"37 UNITS AM AND 37 UNITS PM,BID",,,,,,,,37.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose decreased,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"37 UNITS AM AND 37 UNITS PM,BID",,,,,,,,37.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"37 UNITS AM AND 37 UNITS PM,BID",,,,,,,,37.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Eye disorder,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"37 UNITS AM AND 37 UNITS PM,BID",,,,,,,,37.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Incorrect dose administered,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"37 UNITS AM AND 37 UNITS PM,BID",,,,,,,,37.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Myocardial infarction,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"37 UNITS AM AND 37 UNITS PM,BID",,,,,,,,37.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"37 UNITS AM AND 37 UNITS PM,BID",,,,,,,,37.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Wrong product administered,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS IN THE AM AND 35 UNITS IN THE PM,BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Arthritis,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS IN THE AM AND 35 UNITS IN THE PM,BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose decreased,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS IN THE AM AND 35 UNITS IN THE PM,BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS IN THE AM AND 35 UNITS IN THE PM,BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Eye disorder,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS IN THE AM AND 35 UNITS IN THE PM,BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Incorrect dose administered,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS IN THE AM AND 35 UNITS IN THE PM,BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Myocardial infarction,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS IN THE AM AND 35 UNITS IN THE PM,BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 UNITS IN THE AM AND 35 UNITS IN THE PM,BID",,,,,,,,35.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Wrong product administered,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,QD",,,U,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Arthritis,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,QD",,,U,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,QD",,,U,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,QD",,,U,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Eye disorder,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,QD",,,U,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Incorrect dose administered,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,QD",,,U,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Myocardial infarction,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,QD",,,U,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Off label use,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112216934,11221693,3,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,QD",,,U,,,,21081.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Wrong product administered,,2020,Q2,4,F,2005.0,20200511.0,20150626,20200520,EXP,,US-SA-2015SA090365,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20200520.0,,CN,US,US,2020,Q2,Elderly
112809634,11280963,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,4,F,20120822.0,20200506.0,20150717,20200508,PER,,US-JNJFOC-20150708053,JOHNSON AND JOHNSON,,70.0,YR,,M,Y,,,20200508.0,,CN,US,US,2020,Q2,Elderly
116125543,11612554,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,INJECTION,,2020,Q2,Internal haemorrhage,,2020,Q2,3,F,20141114.0,20200622.0,20151008,20200625,PER,,US-JNJFOC-20150907724,JOHNSON AND JOHNSON,,55.0,YR,,M,Y,,,20200625.0,,CN,US,US,2020,Q2,Adult
116125543,11612554,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,INJECTION,,2020,Q2,Lower gastrointestinal haemorrhage,,2020,Q2,3,F,20141114.0,20200622.0,20151008,20200625,PER,,US-JNJFOC-20150907724,JOHNSON AND JOHNSON,,55.0,YR,,M,Y,,,20200625.0,,CN,US,US,2020,Q2,Adult
119378512,11937851,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Depression,,2020,Q2,2,F,20120115.0,20200520.0,20160122,20200525,EXP,,US-ASTRAZENECA-2016SE04367,ASTRAZENECA,,24451.0,DY,,M,Y,,,20200525.0,,,US,US,2020,Q2,Elderly
119378512,11937851,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pancreatic carcinoma,,2020,Q2,2,F,20120115.0,20200520.0,20160122,20200525,EXP,,US-ASTRAZENECA-2016SE04367,ASTRAZENECA,,24451.0,DY,,M,Y,,,20200525.0,,,US,US,2020,Q2,Elderly
119378512,11937851,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Suicidal ideation,,2020,Q2,2,F,20120115.0,20200520.0,20160122,20200525,EXP,,US-ASTRAZENECA-2016SE04367,ASTRAZENECA,,24451.0,DY,,M,Y,,,20200525.0,,,US,US,2020,Q2,Elderly
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Bronchiectasis,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Cough,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Decreased appetite,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Fatigue,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Influenza,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Memory impairment,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Product dose omission,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Sleep apnoea syndrome,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
123208163,12320816,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,,BID,2020,Q2,Throat irritation,,2020,Q2,3,F,201505.0,20200612.0,20160429,20200617,EXP,,US-ROCHE-1603102,ROCHE,,64.0,YR,,M,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Cardiac failure congestive,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Constipation,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Coxsackie virus test positive,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Dizziness,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Dyspnoea,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Dyspnoea exertional,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Fatigue,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Gait disturbance,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,General physical health deterioration,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Hypotension,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Muscle spasms,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Platelet count decreased,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Pneumonia,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Pulmonary oedema,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Weight decreased,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
126976746,12697674,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"62 U, HS",,,U,U,,,,62.0,DF,,,2020,Q2,Weight increased,,2020,Q2,6,F,20160608.0,20200413.0,20160830,20200415,PER,,PHEH2016US021655,NOVARTIS,,64.0,YR,,M,Y,119.2,KG,20200415.0,,CN,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Atrial tachycardia,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Chronic obstructive pulmonary disease,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Cough,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Hypertonic bladder,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Nail hypertrophy,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Oxygen saturation decreased,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131318488,13131848,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,8,F,20160322.0,20200612.0,20170119,20200624,EXP,,US-ACTELION-A-US2017-148361,ACTELION,,77.0,YR,,M,Y,,,20200624.0,,HP,US,US,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Abscess,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,C-reactive protein increased,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Chills,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Cough,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Dysphonia,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Folliculitis,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Hypokinesia,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Joint swelling,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Nasopharyngitis,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Nausea,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Oral mucosal erythema,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Osteoarthritis,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Osteomyelitis,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Pain,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Peripheral swelling,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Psoriatic arthropathy,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Red blood cell sedimentation rate increased,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Respiratory tract congestion,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Rheumatoid arthritis,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Sinus congestion,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Tooth abscess,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
131841207,13184120,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Wound,,2020,Q2,7,F,20180307.0,20200513.0,20170203,20200515,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-095616,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20200515.0,,PH,CA,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Anaemia,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Blood pressure systolic increased,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Diarrhoea,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Fall,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Hyperglycaemia,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Hypoglycaemia,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Hypotension,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Injection site mass,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Injection site pain,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Metastases to liver,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Nausea,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Pneumonia,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Renal failure,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Skin lesion,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
1327014117,13270141,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU,,,U,,,,,300.0,IU,,,2020,Q2,Urinary tract infection,,2020,Q2,17,F,2015.0,20200520.0,20170224,20200524,EXP,,PHHY2016CA137746,NOVARTIS,,82.0,YR,,F,Y,,,20200525.0,,CN,COUNTRY NOT SPECIFIED,CA,2020,Q2,Elderly
134909236,13490923,7,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Autoimmune hepatitis,,2020,Q2,6,F,20160531.0,20200615.0,20170427,20200619,EXP,,JP-009507513-1704JPN001956J,MERCK,,69.0,YR,,M,Y,53.0,KG,20200619.0,,CN,JP,JP,2020,Q2,Elderly
134909236,13490923,7,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Drug-induced liver injury,,2020,Q2,6,F,20160531.0,20200615.0,20170427,20200619,EXP,,JP-009507513-1704JPN001956J,MERCK,,69.0,YR,,M,Y,53.0,KG,20200619.0,,CN,JP,JP,2020,Q2,Elderly
134909236,13490923,7,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Eosinophil count increased,,2020,Q2,6,F,20160531.0,20200615.0,20170427,20200619,EXP,,JP-009507513-1704JPN001956J,MERCK,,69.0,YR,,M,Y,53.0,KG,20200619.0,,CN,JP,JP,2020,Q2,Elderly
134909236,13490923,7,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,6,F,20160531.0,20200615.0,20170427,20200619,EXP,,JP-009507513-1704JPN001956J,MERCK,,69.0,YR,,M,Y,53.0,KG,20200619.0,,CN,JP,JP,2020,Q2,Elderly
137683466,13768346,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Myoclonus,,2020,Q2,6,F,,20200608.0,20170719,20200611,EXP,,US-PFIZER INC-2017306608,PFIZER,"IBRAHIM, H.. TREATMENT OF GABAPENTIN TOXICITY WITH PERITONEAL DIALYSIS: ASSESSMENT OF GABAPENTIN CLEARANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2017;70(6):878-880",54.0,YR,,F,Y,67.4,KG,20200611.0,,MD,US,US,2020,Q2,Adult
137683466,13768346,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,6,F,,20200608.0,20170719,20200611,EXP,,US-PFIZER INC-2017306608,PFIZER,"IBRAHIM, H.. TREATMENT OF GABAPENTIN TOXICITY WITH PERITONEAL DIALYSIS: ASSESSMENT OF GABAPENTIN CLEARANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2017;70(6):878-880",54.0,YR,,F,Y,67.4,KG,20200611.0,,MD,US,US,2020,Q2,Adult
137683466,13768346,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Toxicity to various agents,,2020,Q2,6,F,,20200608.0,20170719,20200611,EXP,,US-PFIZER INC-2017306608,PFIZER,"IBRAHIM, H.. TREATMENT OF GABAPENTIN TOXICITY WITH PERITONEAL DIALYSIS: ASSESSMENT OF GABAPENTIN CLEARANCE. AMERICAN JOURNAL OF KIDNEY DISEASES. 2017;70(6):878-880",54.0,YR,,F,Y,67.4,KG,20200611.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Gallbladder disorder,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hepatic enzyme increased,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hypersensitivity,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Jaundice,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Joint injury,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Malaise,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"70 IU, QD",,,,,,,21081.0,70.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product dose omission,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,30 DF,,,,,,,21081.0,30.0,DF,SOLUTION FOR INJECTION,,2020,Q2,Gallbladder disorder,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,30 DF,,,,,,,21081.0,30.0,DF,SOLUTION FOR INJECTION,,2020,Q2,Hepatic enzyme increased,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,30 DF,,,,,,,21081.0,30.0,DF,SOLUTION FOR INJECTION,,2020,Q2,Hypersensitivity,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,30 DF,,,,,,,21081.0,30.0,DF,SOLUTION FOR INJECTION,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,30 DF,,,,,,,21081.0,30.0,DF,SOLUTION FOR INJECTION,,2020,Q2,Jaundice,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,30 DF,,,,,,,21081.0,30.0,DF,SOLUTION FOR INJECTION,,2020,Q2,Joint injury,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,30 DF,,,,,,,21081.0,30.0,DF,SOLUTION FOR INJECTION,,2020,Q2,Malaise,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,30 DF,,,,,,,21081.0,30.0,DF,SOLUTION FOR INJECTION,,2020,Q2,Product dose omission,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Gallbladder disorder,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Hepatic enzyme increased,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Hypersensitivity,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Jaundice,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Joint injury,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Malaise,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
137915843,13791584,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Product dose omission,,2020,Q2,3,F,,20200422.0,20170725,20200430,EXP,,US-SA-2017SA134862,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20200430.0,,MD,US,US,2020,Q2,Adult
138427532,13842753,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pancreatic carcinoma,,2020,Q2,2,F,20121228.0,20200528.0,20170808,20200603,EXP,,US-ASTRAZENECA-2017SE78985,ASTRAZENECA,,18173.0,DY,,M,Y,99.8,KG,20200603.0,,,US,US,2020,Q2,Elderly
138556846,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Constipation,,2020,Q2,6,F,2017.0,20200506.0,20170810,20200512,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Elderly
138556846,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Drug intolerance,,2020,Q2,6,F,2017.0,20200506.0,20170810,20200512,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Elderly
138556846,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,6,F,2017.0,20200506.0,20170810,20200512,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Elderly
138556846,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Femur fracture,,2020,Q2,6,F,2017.0,20200506.0,20170810,20200512,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Elderly
138556846,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hip fracture,,2020,Q2,6,F,2017.0,20200506.0,20170810,20200512,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Elderly
138556846,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Postoperative wound infection,,2020,Q2,6,F,2017.0,20200506.0,20170810,20200512,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Elderly
138556846,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Product preparation error,,2020,Q2,6,F,2017.0,20200506.0,20170810,20200512,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Elderly
138556846,13855684,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Urinary tract infection staphylococcal,,2020,Q2,6,F,2017.0,20200506.0,20170810,20200512,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,E,F,Y,,,20200512.0,,CN,US,US,2020,Q2,Elderly
144483317,14448331,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,7,F,20120427.0,20200603.0,20180126,20200604,EXP,,FR-009507513-1801FRA009509,MERCK,"LEPELLEY M, LOGEROT S, FONROSE X, VILLIER C. PHARMACOKINETIC DRUG INTERACTION BETWEEN MICONAZOLE MUCOADHESIVE TABLET AND TACROLIMUS: ABOUT 3 CASE-REPORTS IN TRANSPLANT PATIENTS. THERAPIE. 2017;72(4):475-82",65.0,YR,,M,Y,,,20200604.0,,MD,FR,FR,2020,Q2,Elderly
144483317,14448331,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Drug level increased,,2020,Q2,7,F,20120427.0,20200603.0,20180126,20200604,EXP,,FR-009507513-1801FRA009509,MERCK,"LEPELLEY M, LOGEROT S, FONROSE X, VILLIER C. PHARMACOKINETIC DRUG INTERACTION BETWEEN MICONAZOLE MUCOADHESIVE TABLET AND TACROLIMUS: ABOUT 3 CASE-REPORTS IN TRANSPLANT PATIENTS. THERAPIE. 2017;72(4):475-82",65.0,YR,,M,Y,,,20200604.0,,MD,FR,FR,2020,Q2,Elderly
144483317,14448331,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,7,F,20120427.0,20200603.0,20180126,20200604,EXP,,FR-009507513-1801FRA009509,MERCK,"LEPELLEY M, LOGEROT S, FONROSE X, VILLIER C. PHARMACOKINETIC DRUG INTERACTION BETWEEN MICONAZOLE MUCOADHESIVE TABLET AND TACROLIMUS: ABOUT 3 CASE-REPORTS IN TRANSPLANT PATIENTS. THERAPIE. 2017;72(4):475-82",65.0,YR,,M,Y,,,20200604.0,,MD,FR,FR,2020,Q2,Elderly
144483317,14448331,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Overdose,,2020,Q2,7,F,20120427.0,20200603.0,20180126,20200604,EXP,,FR-009507513-1801FRA009509,MERCK,"LEPELLEY M, LOGEROT S, FONROSE X, VILLIER C. PHARMACOKINETIC DRUG INTERACTION BETWEEN MICONAZOLE MUCOADHESIVE TABLET AND TACROLIMUS: ABOUT 3 CASE-REPORTS IN TRANSPLANT PATIENTS. THERAPIE. 2017;72(4):475-82",65.0,YR,,M,Y,,,20200604.0,,MD,FR,FR,2020,Q2,Elderly
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Blood alkaline phosphatase increased,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Blood bilirubin increased,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Catheter site pain,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Cholelithiasis,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Diarrhoea,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Headache,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Pain in jaw,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
146441918,14644191,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,25 MG,,,,,,,,25.0,MG,,,2020,Q2,Pulmonary hypertension,,2020,Q2,8,F,201803.0,20200416.0,20180315,20200429,EXP,,US-ACTELION-A-NJ2018-169052,ACTELION,,34.0,YR,,M,Y,,,20200429.0,,MD,US,US,2020,Q2,Young Adult
1476418710,14764187,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q2,Interstitial lung disease,,2020,Q2,10,F,20180319.0,20200618.0,20180416,20200622,EXP,,JP-PFIZER INC-2018146989,PFIZER,,71.0,YR,,M,Y,50.0,KG,20200622.0,,MD,JP,JP,2020,Q2,Elderly
149067413,14906741,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, HS",,,,, 1F860A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Arterial occlusive disease,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, HS",,,,, 1F860A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Device issue,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, HS",,,,, 1F860A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Drug ineffective,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, HS",,,,, 1F860A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Extra dose administered,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, HS",,,,, 1F860A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hyperglycaemia,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, HS",,,,, 1F860A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Injection site induration,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, HS",,,,, 1F860A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Pain in extremity,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, HS",,,,, 1F860A,,21081.0,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU, QD",,,,, 7F4958A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Arterial occlusive disease,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU, QD",,,,, 7F4958A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Device issue,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU, QD",,,,, 7F4958A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Drug ineffective,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU, QD",,,,, 7F4958A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Extra dose administered,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU, QD",,,,, 7F4958A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hyperglycaemia,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU, QD",,,,, 7F4958A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Injection site induration,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU, QD",,,,, 7F4958A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Pain in extremity,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"30 IU, QD",,,,, 7F4958A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 IU, QD (ONCE DAILY IN THE MORNING)",,,,, 8F5547A,,21081.0,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Arterial occlusive disease,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 IU, QD (ONCE DAILY IN THE MORNING)",,,,, 8F5547A,,21081.0,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Device issue,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 IU, QD (ONCE DAILY IN THE MORNING)",,,,, 8F5547A,,21081.0,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Drug ineffective,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 IU, QD (ONCE DAILY IN THE MORNING)",,,,, 8F5547A,,21081.0,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Extra dose administered,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 IU, QD (ONCE DAILY IN THE MORNING)",,,,, 8F5547A,,21081.0,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hyperglycaemia,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 IU, QD (ONCE DAILY IN THE MORNING)",,,,, 8F5547A,,21081.0,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Injection site induration,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 IU, QD (ONCE DAILY IN THE MORNING)",,,,, 8F5547A,,21081.0,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Pain in extremity,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"32 IU, QD (ONCE DAILY IN THE MORNING)",,,,, 8F5547A,,21081.0,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, QD",,,,, 9F6438A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Arterial occlusive disease,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, QD",,,,, 9F6438A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Device issue,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, QD",,,,, 9F6438A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Drug ineffective,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, QD",,,,, 9F6438A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Extra dose administered,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, QD",,,,, 9F6438A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hyperglycaemia,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, QD",,,,, 9F6438A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Injection site induration,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, QD",,,,, 9F6438A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Pain in extremity,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
149067413,14906741,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 IU, QD",,,,, 9F6438A,,21081.0,30.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,3,F,,20200511.0,20180517,20200519,PER,,US-SANOFI-AVENTIS-2012SA027975,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Elderly
150105366,15010536,14,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,50 IU (INTERNATIONAL UNIT),,,,,,,,50.0,IU,INJECTION,QD,2020,Q2,Systemic inflammatory response syndrome,,2020,Q2,6,F,20180607.0,20200430.0,20180614,20200504,EXP,,US-CELGENEUS-USA-20180603839,CELGENE,,79.0,YR,,F,Y,103.0,KG,20200504.0,,MD,US,US,2020,Q2,Elderly
150774833,15077483,8,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,30 IU (INTERNATIONAL UNIT),,,,,,,,30.0,IU,UNKNOWN,QD,2020,Q2,Febrile neutropenia,,2020,Q2,3,F,20180618.0,20200430.0,20180627,20200501,EXP,,US-CELGENEUS-USA-20180608870,CELGENE,,60.0,YR,,M,Y,139.0,KG,20200501.0,,HP,US,US,2020,Q2,Adult
151171122,15117112,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD",,,D,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Death,,2020,Q2,2,F,,20180627.0,20180706,20200430,EXP,,SD-SA-2018SA176355,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200430.0,,CN,SD,SD,2020,Q2,Elderly
151440952,15144095,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,70.0,IU,,QD,2020,Q2,Peripheral arterial occlusive disease,,2020,Q2,2,F,20180502.0,20200324.0,20180713,20200401,EXP,,US-ASTRAZENECA-2018SE62595,ASTRAZENECA,,18680.0,DY,,F,Y,,,20200401.0,,MD,US,US,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Arthralgia,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Blindness,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Chest discomfort,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Corneal opacity,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Erythema,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Eye pain,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Malaise,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Mouth ulceration,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Multiple organ dysfunction syndrome,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Oropharyngeal pain,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Pharyngeal ulceration,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Rash erythematous,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Sepsis,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Skin exfoliation,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Tachycardia,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Toxic epidermal necrolysis,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Ulcerative keratitis,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
151586353,15158635,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"36 IU, QD",,,U,U,,,,36.0,IU,,QD,2020,Q2,Visual impairment,,2020,Q2,3,F,2018.0,20200622.0,20180718,20200625,EXP,DK-DKMA-WBS-0009361,PHHY2018DK047647,NOVARTIS,,72.0,YR,,M,Y,,,20200625.0,,CN,DK,DK,2020,Q2,Elderly
152029562,15202956,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35-45 UNITS, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Arterial thrombosis,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35-45 UNITS, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Atrioventricular block,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35-45 UNITS, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetes mellitus,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35-45 UNITS, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Hypertension,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35-45 UNITS, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Renal disorder,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35-45 UNITS, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Urinary incontinence,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Arterial thrombosis,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Atrioventricular block,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetes mellitus,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Hypertension,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Renal disorder,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
152029562,15202956,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"35 U, QD",,,,, 8F5153A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Urinary incontinence,,2020,Q2,2,F,,20200415.0,20180726,20200421,EXP,,US-SA-2018SA158016,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20200421.0,,CN,US,US,2020,Q2,Elderly
1524542416,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q2,Anaemia,,2020,Q2,16,F,20180605.0,20200604.0,20180806,20200611,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200611.0,,MD,PL,PL,2020,Q2,Elderly
1524542416,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q2,Febrile neutropenia,,2020,Q2,16,F,20180605.0,20200604.0,20180806,20200611,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200611.0,,MD,PL,PL,2020,Q2,Elderly
1524542416,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q2,Neutropenia,,2020,Q2,16,F,20180605.0,20200604.0,20180806,20200611,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200611.0,,MD,PL,PL,2020,Q2,Elderly
1524542416,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q2,Thrombocytopenia,,2020,Q2,16,F,20180605.0,20200604.0,20180806,20200611,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200611.0,,MD,PL,PL,2020,Q2,Elderly
152551974,15255197,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,4,F,,20200622.0,20180808,20200625,EXP,,US-PFIZER INC-2018312628,PFIZER,"STRICKLAND, S. THE SAMPLE THAT WOULD NOT CLOT. CLINICA CHIMICA ACTA. 2018;485:272-274",68.0,YR,,F,Y,,,20200625.0,,MD,US,US,2020,Q2,Elderly
152551974,15255197,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Haematemesis,,2020,Q2,4,F,,20200622.0,20180808,20200625,EXP,,US-PFIZER INC-2018312628,PFIZER,"STRICKLAND, S. THE SAMPLE THAT WOULD NOT CLOT. CLINICA CHIMICA ACTA. 2018;485:272-274",68.0,YR,,F,Y,,,20200625.0,,MD,US,US,2020,Q2,Elderly
152551974,15255197,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Increased tendency to bruise,,2020,Q2,4,F,,20200622.0,20180808,20200625,EXP,,US-PFIZER INC-2018312628,PFIZER,"STRICKLAND, S. THE SAMPLE THAT WOULD NOT CLOT. CLINICA CHIMICA ACTA. 2018;485:272-274",68.0,YR,,F,Y,,,20200625.0,,MD,US,US,2020,Q2,Elderly
152551974,15255197,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,International normalised ratio fluctuation,,2020,Q2,4,F,,20200622.0,20180808,20200625,EXP,,US-PFIZER INC-2018312628,PFIZER,"STRICKLAND, S. THE SAMPLE THAT WOULD NOT CLOT. CLINICA CHIMICA ACTA. 2018;485:272-274",68.0,YR,,F,Y,,,20200625.0,,MD,US,US,2020,Q2,Elderly
152551974,15255197,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Vitamin K deficiency,,2020,Q2,4,F,,20200622.0,20180808,20200625,EXP,,US-PFIZER INC-2018312628,PFIZER,"STRICKLAND, S. THE SAMPLE THAT WOULD NOT CLOT. CLINICA CHIMICA ACTA. 2018;485:272-274",68.0,YR,,F,Y,,,20200625.0,,MD,US,US,2020,Q2,Elderly
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Abdominal pain upper,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Asthenia,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Dehydration,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Drug hypersensitivity,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Gastrointestinal infection,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Headache,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Heat stroke,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Hyponatraemia,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Hypotension,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Lung disorder,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Myalgia,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Sepsis,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Syncope,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Thrombocytopenia,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
1534719111,15347191,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,U,,,,,,,,2020,Q2,Vomiting,,2020,Q2,11,F,20180827.0,20200512.0,20180904,20200524,EXP,,IL-ACTELION-A-CH2018-178371,ACTELION,,27.0,YR,,F,Y,79.0,KG,20200524.0,,MD,IL,IL,2020,Q2,Young Adult
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Gait disturbance,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Gallbladder disorder,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Gallbladder rupture,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Gastrointestinal disorder,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Hypoacusis,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Pain,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Renal disorder,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Seizure,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Sepsis,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Staphylococcal infection,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,, 7F745A,,206538.0,,,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Gait disturbance,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Gallbladder disorder,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Gallbladder rupture,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Gastrointestinal disorder,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Hypoacusis,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Pain,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Renal disorder,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Seizure,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Sepsis,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Staphylococcal infection,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QOD",,,,, 7F745A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QOD,2020,Q2,Unevaluable event,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Gait disturbance,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Gallbladder disorder,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Gallbladder rupture,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Gastrointestinal disorder,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hypoacusis,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Pain,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Renal disorder,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Seizure,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Sepsis,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Staphylococcal infection,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154093434,15409343,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,,, 9F213A,,206538.0,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,4,F,201805.0,20200508.0,20180920,20200515,EXP,,US-SA-2018SA243768,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20200515.0,,CN,US,US,2020,Q2,Elderly
154180902,15418090,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Blood loss anaemia,,2020,Q2,2,F,20160529.0,20200408.0,20180924,20200414,EXP,,US-BAYER-2018-106622,BAYER,,69.0,YR,E,F,Y,,,20200414.0,,HP,US,US,2020,Q2,Elderly
154254144,15425414,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 U, QD (IF BLOOD SUGAR IS } 80)",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Anaemia,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 U, QD (IF BLOOD SUGAR IS } 80)",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 U, QD (IF BLOOD SUGAR IS } 80)",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Hospitalisation,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 U, QD (IF BLOOD SUGAR IS } 80)",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Internal haemorrhage,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 U, QD (IF BLOOD SUGAR IS } 80)",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Movement disorder,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 U, QD (IF BLOOD SUGAR IS } 80)",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Osteoporosis,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 U, QD (IF BLOOD SUGAR IS } 80)",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Product dose omission,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 U, QD (IF BLOOD SUGAR IS } 80)",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Visual impairment,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Anaemia,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Hospitalisation,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Internal haemorrhage,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Movement disorder,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Osteoporosis,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Product dose omission,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Visual impairment,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Anaemia,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Hospitalisation,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Internal haemorrhage,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Movement disorder,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Osteoporosis,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Product dose omission,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
154254144,15425414,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QD",,,,, 8F5235A,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Visual impairment,,2020,Q2,4,F,201803.0,20200413.0,20180925,20200415,EXP,,US-SAKK-2018SA236443AA,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20200415.0,,CN,US,US,2020,Q2,Elderly
155797813,15579781,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blindness,,2020,Q2,3,F,,20200218.0,20181102,20200527,EXP,,US-SAKK-2018SA301578AA,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200527.0,,CN,US,US,2020,Q2,Elderly
155797813,15579781,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Off label use,,2020,Q2,3,F,,20200218.0,20181102,20200527,EXP,,US-SAKK-2018SA301578AA,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200527.0,,CN,US,US,2020,Q2,Elderly
155797813,15579781,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, QD",,,,,,,21081.0,100.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Visual impairment,,2020,Q2,3,F,,20200218.0,20181102,20200527,EXP,,US-SAKK-2018SA301578AA,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200527.0,,CN,US,US,2020,Q2,Elderly
155797813,15579781,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blindness,,2020,Q2,3,F,,20200218.0,20181102,20200527,EXP,,US-SAKK-2018SA301578AA,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200527.0,,CN,US,US,2020,Q2,Elderly
155797813,15579781,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,3,F,,20200218.0,20181102,20200527,EXP,,US-SAKK-2018SA301578AA,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200527.0,,CN,US,US,2020,Q2,Elderly
155797813,15579781,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Visual impairment,,2020,Q2,3,F,,20200218.0,20181102,20200527,EXP,,US-SAKK-2018SA301578AA,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20200527.0,,CN,US,US,2020,Q2,Elderly
155844842,15584484,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,,, 8F5694A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product use issue,,2020,Q2,2,F,,20200420.0,20181105,20200428,PER,,US-SA-2018SA301284,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20200428.0,,CN,US,US,2020,Q2,Adult
155844842,15584484,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,,, 8F5694A,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Visual impairment,,2020,Q2,2,F,,20200420.0,20181105,20200428,PER,,US-SA-2018SA301284,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20200428.0,,CN,US,US,2020,Q2,Adult
155844842,15584484,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, BID",,,,,,,,65.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Product use issue,,2020,Q2,2,F,,20200420.0,20181105,20200428,PER,,US-SA-2018SA301284,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20200428.0,,CN,US,US,2020,Q2,Adult
155844842,15584484,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, BID",,,,,,,,65.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Visual impairment,,2020,Q2,2,F,,20200420.0,20181105,20200428,PER,,US-SA-2018SA301284,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20200428.0,,CN,US,US,2020,Q2,Adult
155983332,15598333,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, QD",,,,,,,206538.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,2,F,,20200403.0,20181108,20200408,EXP,,US-SAKK-2018SA304165AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20200408.0,,CN,US,US,2020,Q2,Elderly
155996362,15599636,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 IU, BID",,,,,,,,70.0,IU,,BID,2020,Q2,Metastases to liver,,2020,Q2,2,F,201702.0,20200603.0,20181108,20200612,EXP,,US-NOVOPROD-630528,NOVO NORDISK,,67.0,YR,,M,Y,118.37,KG,20200612.0,,LW,US,US,2020,Q2,Elderly
155996362,15599636,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 IU, BID",,,,,,,,70.0,IU,,BID,2020,Q2,Metastases to lung,,2020,Q2,2,F,201702.0,20200603.0,20181108,20200612,EXP,,US-NOVOPROD-630528,NOVO NORDISK,,67.0,YR,,M,Y,118.37,KG,20200612.0,,LW,US,US,2020,Q2,Elderly
155996362,15599636,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 IU, BID",,,,,,,,70.0,IU,,BID,2020,Q2,Pancreatic carcinoma metastatic,,2020,Q2,2,F,201702.0,20200603.0,20181108,20200612,EXP,,US-NOVOPROD-630528,NOVO NORDISK,,67.0,YR,,M,Y,118.37,KG,20200612.0,,LW,US,US,2020,Q2,Elderly
156574213,15657421,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Bronchitis,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
156574213,15657421,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Cardiac disorder,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
156574213,15657421,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Diabetic foot,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
156574213,15657421,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
156574213,15657421,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Pneumonia,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
156574213,15657421,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,70 UNITS  IN THE MORNING AND 65 UNITS AT,,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Bronchitis,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
156574213,15657421,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,70 UNITS  IN THE MORNING AND 65 UNITS AT,,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Cardiac disorder,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
156574213,15657421,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,70 UNITS  IN THE MORNING AND 65 UNITS AT,,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Diabetic foot,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
156574213,15657421,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,70 UNITS  IN THE MORNING AND 65 UNITS AT,,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
156574213,15657421,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,70 UNITS  IN THE MORNING AND 65 UNITS AT,,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Pneumonia,,2020,Q2,3,F,,20200514.0,20181126,20200521,EXP,,US-SAKK-2018SA316353AA,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
157132235,15713223,61,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION,,2020,Q2,Anaphylactic reaction,,2020,Q2,5,F,,20200413.0,20181212,20200427,EXP,,CA-GLENMARK PHARMACEUTICALS-2016GMK038565,GLENMARK,,70.0,YR,,F,Y,,,20200424.0,,HP,CA,CA,2020,Q2,Elderly
157132235,15713223,61,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION,,2020,Q2,Drug intolerance,,2020,Q2,5,F,,20200413.0,20181212,20200427,EXP,,CA-GLENMARK PHARMACEUTICALS-2016GMK038565,GLENMARK,,70.0,YR,,F,Y,,,20200424.0,,HP,CA,CA,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Arthritis,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Blood pressure increased,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Brain natriuretic peptide abnormal,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Disease progression,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Fall,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Haemoglobin decreased,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Headache,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Pericardial effusion,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Rib fracture,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Scratch,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Syncope,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
1573911719,15739117,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,U,,,,,,,,2020,Q2,Tachycardia,,2020,Q2,19,F,20181209.0,20200602.0,20181219,20200611,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20200611.0,,HP,SE,SE,2020,Q2,Elderly
158884293,15888429,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,3,F,20160607.0,20200417.0,20190130,20200423,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-005513,BRISTOL MYERS SQUIBB,,93.0,YR,,F,Y,71.66,KG,20200423.0,,HP,US,US,2020,Q2,Elderly
158884293,15888429,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Anticoagulation drug level below therapeutic,,2020,Q2,3,F,20160607.0,20200417.0,20190130,20200423,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-005513,BRISTOL MYERS SQUIBB,,93.0,YR,,F,Y,71.66,KG,20200423.0,,HP,US,US,2020,Q2,Elderly
158884293,15888429,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,3,F,20160607.0,20200417.0,20190130,20200423,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-005513,BRISTOL MYERS SQUIBB,,93.0,YR,,F,Y,71.66,KG,20200423.0,,HP,US,US,2020,Q2,Elderly
158884293,15888429,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Transient ischaemic attack,,2020,Q2,3,F,20160607.0,20200417.0,20190130,20200423,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-005513,BRISTOL MYERS SQUIBB,,93.0,YR,,F,Y,71.66,KG,20200423.0,,HP,US,US,2020,Q2,Elderly
159076362,15907636,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Asthma,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Atrial fibrillation,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Back pain,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Fibromyalgia,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Intentional product use issue,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Meniscus injury,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Myocardial infarction,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Patellofemoral pain syndrome,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Asthma,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Atrial fibrillation,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Back pain,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Fibromyalgia,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Intentional product use issue,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Meniscus injury,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Myocardial infarction,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159076362,15907636,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Patellofemoral pain syndrome,,2020,Q2,2,F,201806.0,20200406.0,20190204,20200409,EXP,,US-SA-2019SA026308,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
159467066,15946706,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,,QD,2020,Q2,Arteriovenous graft site stenosis,,2020,Q2,6,F,20190123.0,20200624.0,20190211,20200626,EXP,,FR-ABBVIE-19P-056-2656750-00,ABBVIE,,65.0,YR,,F,Y,,,20200625.0,,MD,FR,FR,2020,Q2,Elderly
159881112,15988111,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, BID",,,U,,,,,,,,BID,2020,Q2,Haemorrhagic stroke,,2020,Q2,2,F,20181227.0,20190213.0,20190220,20200505,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-016407,BRISTOL MYERS SQUIBB,,82.0,YR,,F,Y,,,20200505.0,,MD,US,US,2020,Q2,Elderly
159881112,15988111,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, BID",,,U,,,,,,,,BID,2020,Q2,Off label use,,2020,Q2,2,F,20181227.0,20190213.0,20190220,20200505,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-016407,BRISTOL MYERS SQUIBB,,82.0,YR,,F,Y,,,20200505.0,,MD,US,US,2020,Q2,Elderly
159881112,15988111,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, BID",,,U,,,,,,,,BID,2020,Q2,Weight decreased,,2020,Q2,2,F,20181227.0,20190213.0,20190220,20200505,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-016407,BRISTOL MYERS SQUIBB,,82.0,YR,,F,Y,,,20200505.0,,MD,US,US,2020,Q2,Elderly
160102413,16010241,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,,QD,2020,Q2,Appendicitis,,2020,Q2,3,F,201710.0,20200402.0,20190225,20200408,EXP,,GT-SA-2019SA049041,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20200408.0,,CN,GT,GT,2020,Q2,Young Adult
160102413,16010241,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,,,,,,18.0,IU,,QD,2020,Q2,Renal failure,,2020,Q2,3,F,201710.0,20200402.0,20190225,20200408,EXP,,GT-SA-2019SA049041,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20200408.0,,CN,GT,GT,2020,Q2,Young Adult
160129553,16012955,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,3,F,2011.0,20200403.0,20190227,20200406,EXP,,US-PFIZER INC-2019088083,PFIZER,,60.0,YR,,M,Y,,,20200406.0,,LW,US,US,2020,Q2,Adult
160129553,16012955,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,3,F,2011.0,20200403.0,20190227,20200406,EXP,,US-PFIZER INC-2019088083,PFIZER,,60.0,YR,,M,Y,,,20200406.0,,LW,US,US,2020,Q2,Adult
160129553,16012955,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,End stage renal disease,,2020,Q2,3,F,2011.0,20200403.0,20190227,20200406,EXP,,US-PFIZER INC-2019088083,PFIZER,,60.0,YR,,M,Y,,,20200406.0,,LW,US,US,2020,Q2,Adult
160271416,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q2,Cellulitis,,2020,Q2,6,F,20181225.0,20200420.0,20190303,20200423,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20200423.0,,HP,DE,DE,2020,Q2,Adult
160271416,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q2,Lymphangitis,,2020,Q2,6,F,20181225.0,20200420.0,20190303,20200423,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20200423.0,,HP,DE,DE,2020,Q2,Adult
160271416,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q2,Necrosis,,2020,Q2,6,F,20181225.0,20200420.0,20190303,20200423,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20200423.0,,HP,DE,DE,2020,Q2,Adult
160271416,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q2,Soft tissue infection,,2020,Q2,6,F,20181225.0,20200420.0,20190303,20200423,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20200423.0,,HP,DE,DE,2020,Q2,Adult
160408152,16040815,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, Q12H",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,2,F,,20200422.0,20190306,20200501,EXP,,US-SA-2019SA057452,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20200501.0,,MD,US,US,2020,Q2,Adult
160408152,16040815,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, Q12H",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Hypertension,,2020,Q2,2,F,,20200422.0,20190306,20200501,EXP,,US-SA-2019SA057452,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20200501.0,,MD,US,US,2020,Q2,Adult
160408152,16040815,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, Q12H",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,2,F,,20200422.0,20190306,20200501,EXP,,US-SA-2019SA057452,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20200501.0,,MD,US,US,2020,Q2,Adult
160408152,16040815,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, Q12H",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Product dose omission,,2020,Q2,2,F,,20200422.0,20190306,20200501,EXP,,US-SA-2019SA057452,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20200501.0,,MD,US,US,2020,Q2,Adult
160458892,16045889,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160458892,16045889,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hospitalisation,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160458892,16045889,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Limb injury,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160458892,16045889,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Off label use,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160458892,16045889,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, QD",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Toe amputation,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160458892,16045889,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160458892,16045889,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Hospitalisation,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160458892,16045889,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Limb injury,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160458892,16045889,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160458892,16045889,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Toe amputation,,2020,Q2,2,F,201901.0,20200116.0,20190307,20200521,EXP,,US-SA-2019SA058202,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Acute myocardial infarction,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Asthenia,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Cardiac failure acute,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Chills,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Constipation,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Diabetic foot,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypophagia,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Lumbar vertebral fracture,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Myocardial ischaemia,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,N-terminal prohormone brain natriuretic peptide increased,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Neuropathic arthropathy,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160684734,16068473,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,White blood cell count increased,,2020,Q2,4,F,20161209.0,20200407.0,20190313,20200414,EXP,,US-BAUSCH-BL-2019-006772,BAUSCH AND LOMB,,65.0,YR,,M,Y,106.9,KG,20200414.0,,MD,US,US,2020,Q2,Elderly
160784962,16078496,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Cerebrovascular accident,,2020,Q2,2,F,201806.0,20200511.0,20190315,20200519,EXP,,US-SA-2019SA068745,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Young Adult
160784962,16078496,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, Q12H",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,2,F,201806.0,20200511.0,20190315,20200519,EXP,,US-SA-2019SA068745,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Young Adult
160914063,16091406,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,Y,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,Y,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Epistaxis,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,Y,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Ingrowing nail,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,Y,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,Y,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Skin ulcer,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,Y,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Toe amputation,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,Y,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Weight decreased,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Epistaxis,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Ingrowing nail,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Off label use,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Skin ulcer,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Toe amputation,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160914063,16091406,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Weight decreased,,2020,Q2,3,F,20190312.0,20200428.0,20190319,20200505,EXP,,US-SA-2019SA069901,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200505.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"84 IU,QD",,,,,,,206538.0,84.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Balance disorder,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"84 IU,QD",,,,,,,206538.0,84.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"84 IU,QD",,,,,,,206538.0,84.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hypoaesthesia,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"84 IU,QD",,,,,,,206538.0,84.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"84 IU,QD",,,,,,,206538.0,84.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"84 IU,QD",,,,,,,206538.0,84.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Oedema peripheral,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"84 IU,QD",,,,,,,206538.0,84.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Off label use,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"84 IU,QD",,,,,,,206538.0,84.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Peripheral swelling,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Balance disorder,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Hypoaesthesia,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Neuropathy peripheral,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Oedema peripheral,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"70 IU, BID",,,,,,,206538.0,70.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Peripheral swelling,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"95 IU, BID",,,,,,,206538.0,95.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Balance disorder,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"95 IU, BID",,,,,,,206538.0,95.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"95 IU, BID",,,,,,,206538.0,95.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Hypoaesthesia,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"95 IU, BID",,,,,,,206538.0,95.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"95 IU, BID",,,,,,,206538.0,95.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Neuropathy peripheral,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"95 IU, BID",,,,,,,206538.0,95.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Oedema peripheral,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"95 IU, BID",,,,,,,206538.0,95.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
160963142,16096314,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"95 IU, BID",,,,,,,206538.0,95.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Peripheral swelling,,2020,Q2,2,F,201707.0,20200413.0,20190320,20200420,EXP,,US-SA-2017SA157012,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Adult
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Acute kidney injury,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Arrhythmia,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Atrial fibrillation,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Bradycardia,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Dehydration,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Dizziness,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Drug interaction,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Haematocrit increased,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Haemoglobin increased,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Hypotension,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Hypovolaemia,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Left atrial dilatation,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Mucosal dryness,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Oedema peripheral,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Presyncope,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Pulmonary congestion,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Renal disorder,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Skin disorder,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 IU, UNK",,,U,U,,,,26.0,IU,,,2020,Q2,Syncope,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Arrhythmia,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Atrial fibrillation,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Bradycardia,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Dehydration,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Dizziness,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Drug interaction,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Haematocrit increased,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Haemoglobin increased,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Hypotension,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Hypovolaemia,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Left atrial dilatation,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Mucosal dryness,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Presyncope,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Pulmonary congestion,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Renal disorder,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Skin disorder,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161022955,16102295,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE 26 UNITS,,,U,U, UNK,,,,,,,2020,Q2,Syncope,,2020,Q2,5,F,2018.0,20200413.0,20190321,20200418,EXP,,PHHY2019PT063216,NOVARTIS,,71.0,YR,,M,Y,,,20200418.0,,HP,PT,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Acute kidney injury,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Arrhythmia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Atrial fibrillation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Bradycardia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Dehydration,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Dizziness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Haematocrit increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Haemoglobin increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Heart rate irregular,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Hypotension,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Hypovolaemia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Left atrial dilatation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Mucosal dryness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Oedema peripheral,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Presyncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Pulmonary congestion,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Renal disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Skin disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 INTERNATIONAL UNIT, QD",,,D,,,,,26.0,IU,,QD,2020,Q2,Syncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Arrhythmia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Atrial fibrillation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Bradycardia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Dehydration,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Haematocrit increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Haemoglobin increased,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Heart rate irregular,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Hypovolaemia,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Left atrial dilatation,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Mucosal dryness,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Presyncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Pulmonary congestion,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Renal disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Skin disorder,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161236888,16123688,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Syncope,,2020,Q2,8,F,2018.0,20200401.0,20190327,20200415,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,,71.0,YR,,M,Y,,,20200415.0,,CN,NL,PT,2020,Q2,Elderly
161526327,16152632,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 10 -12 UNIT(S),,,,,,,,1.0,DF,,BID,2020,Q2,Acute coronary syndrome,,2020,Q2,7,F,20190318.0,20200416.0,20190403,20200422,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-030496,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,65.0,KG,20200422.0,,HP,US,US,2020,Q2,Elderly
161526327,16152632,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 10 -12 UNIT(S),,,,,,,,1.0,DF,,BID,2020,Q2,Cerebrovascular accident,,2020,Q2,7,F,20190318.0,20200416.0,20190403,20200422,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-030496,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,65.0,KG,20200422.0,,HP,US,US,2020,Q2,Elderly
161526327,16152632,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 10 -12 UNIT(S),,,,,,,,1.0,DF,,BID,2020,Q2,Diplopia,,2020,Q2,7,F,20190318.0,20200416.0,20190403,20200422,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-030496,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,65.0,KG,20200422.0,,HP,US,US,2020,Q2,Elderly
161526327,16152632,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 10 -12 UNIT(S),,,,,,,,1.0,DF,,BID,2020,Q2,IIIrd nerve disorder,,2020,Q2,7,F,20190318.0,20200416.0,20190403,20200422,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-030496,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,65.0,KG,20200422.0,,HP,US,US,2020,Q2,Elderly
161526327,16152632,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 10 -12 UNIT(S),,,,,,,,1.0,DF,,BID,2020,Q2,Myocarditis,,2020,Q2,7,F,20190318.0,20200416.0,20190403,20200422,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-030496,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,65.0,KG,20200422.0,,HP,US,US,2020,Q2,Elderly
161526327,16152632,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 10 -12 UNIT(S),,,,,,,,1.0,DF,,BID,2020,Q2,VIth nerve paralysis,,2020,Q2,7,F,20190318.0,20200416.0,20190403,20200422,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-030496,BRISTOL MYERS SQUIBB,,75.0,YR,,M,Y,65.0,KG,20200422.0,,HP,US,US,2020,Q2,Elderly
161551262,16155126,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,D,,,,206538.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Disability,,2020,Q2,2,F,,20200415.0,20190403,20200423,EXP,,US-SA-2019SA089939,SANOFI AVENTIS,,46.0,YR,A,F,Y,,,20200423.0,,MD,US,US,2020,Q2,Adult
161551262,16155126,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IU, BID",,,D,,,,206538.0,100.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,2,F,,20200415.0,20190403,20200423,EXP,,US-SA-2019SA089939,SANOFI AVENTIS,,46.0,YR,A,F,Y,,,20200423.0,,MD,US,US,2020,Q2,Adult
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Acidosis,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,C-reactive protein increased,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Food intolerance,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Glycosuria,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Hypophosphataemia,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Ketonuria,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Leukocytosis,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Nausea,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Neutrophilia,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161623373,16162337,9,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,3,F,,20200612.0,20190405,20200622,EXP,,PT-AUROBINDO-AUR-APL-2019-017860,AUROBINDO,,70.0,YR,,M,Y,,,20200622.0,,HP,PT,PT,2020,Q2,Elderly
161715262,16171526,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,,,,206538.0,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Angina pectoris,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,,,,206538.0,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Appendicitis perforated,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,,,,206538.0,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Coronary artery thrombosis,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,,,,206538.0,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Foot amputation,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,,,,206538.0,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,,,,206538.0,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Limb operation,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU, QD",,,,,,,206538.0,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Myocardial infarction,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU IN THE MORNING AND 20 IU AT NIGHT, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Angina pectoris,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU IN THE MORNING AND 20 IU AT NIGHT, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Appendicitis perforated,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU IN THE MORNING AND 20 IU AT NIGHT, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Coronary artery thrombosis,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU IN THE MORNING AND 20 IU AT NIGHT, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Foot amputation,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU IN THE MORNING AND 20 IU AT NIGHT, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU IN THE MORNING AND 20 IU AT NIGHT, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Limb operation,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161715262,16171526,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IU IN THE MORNING AND 20 IU AT NIGHT, BID",,,,,,,206538.0,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Myocardial infarction,,2020,Q2,2,F,20171225.0,20200327.0,20190408,20200401,EXP,,US-SA-2019SA092974,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
161809442,16180944,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU IN THE MORNING, 65 IU IN THE EVENING, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Feeling abnormal,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161809442,16180944,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU IN THE MORNING, 65 IU IN THE EVENING, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Hip arthroplasty,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161809442,16180944,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU IN THE MORNING, 65 IU IN THE EVENING, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Myocardial infarction,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161809442,16180944,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU IN THE MORNING, 65 IU IN THE EVENING, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161809442,16180944,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"42 IU IN THE MORNING, 65 IU IN THE EVENING, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Physical disability,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161809442,16180944,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"58 IU IN AM/ 70 IU IN PM, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Feeling abnormal,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161809442,16180944,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"58 IU IN AM/ 70 IU IN PM, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Hip arthroplasty,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161809442,16180944,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"58 IU IN AM/ 70 IU IN PM, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Myocardial infarction,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161809442,16180944,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"58 IU IN AM/ 70 IU IN PM, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161809442,16180944,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"58 IU IN AM/ 70 IU IN PM, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Physical disability,,2020,Q2,2,F,201806.0,20200408.0,20190410,20200416,EXP,,US-SA-2019SA092972,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20200416.0,,MD,US,US,2020,Q2,Elderly
161902252,16190225,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, QD",,,D,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Off label use,,2020,Q2,2,F,,20200519.0,20190412,20200527,EXP,,US-SA-2019SA096955,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20200527.0,,CN,US,US,2020,Q2,Young Adult
161902252,16190225,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU AM AND 11 IU PM,,,D,,,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,2,F,,20200519.0,20190412,20200527,EXP,,US-SA-2019SA096955,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20200527.0,,CN,US,US,2020,Q2,Young Adult
161997668,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2020,Q2,Cutaneous sarcoidosis,,2020,Q2,8,F,20190404.0,20200418.0,20190415,20200422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200422.0,,HP,BR,BR,2020,Q2,Elderly
161997668,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2020,Q2,Epiglottic oedema,,2020,Q2,8,F,20190404.0,20200418.0,20190415,20200422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200422.0,,HP,BR,BR,2020,Q2,Elderly
161997668,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2020,Q2,Sarcoidosis,,2020,Q2,8,F,20190404.0,20200418.0,20190415,20200422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200422.0,,HP,BR,BR,2020,Q2,Elderly
161997668,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Cutaneous sarcoidosis,,2020,Q2,8,F,20190404.0,20200418.0,20190415,20200422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200422.0,,HP,BR,BR,2020,Q2,Elderly
161997668,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Epiglottic oedema,,2020,Q2,8,F,20190404.0,20200418.0,20190415,20200422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200422.0,,HP,BR,BR,2020,Q2,Elderly
161997668,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Sarcoidosis,,2020,Q2,8,F,20190404.0,20200418.0,20190415,20200422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200422.0,,HP,BR,BR,2020,Q2,Elderly
162204833,16220483,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 UNITS,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,3,F,20181116.0,20200413.0,20190421,20200420,PER,,US-JNJFOC-20190411774,JOHNSON AND JOHNSON,,77.0,YR,,M,Y,77.18,KG,20200420.0,,HP,US,US,2020,Q2,Elderly
162204833,16220483,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 UNITS,,,,,,,,,,,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,20181116.0,20200413.0,20190421,20200420,PER,,US-JNJFOC-20190411774,JOHNSON AND JOHNSON,,77.0,YR,,M,Y,77.18,KG,20200420.0,,HP,US,US,2020,Q2,Elderly
162204833,16220483,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 UNITS,,,,,,,,,,,,2020,Q2,Increased tendency to bruise,,2020,Q2,3,F,20181116.0,20200413.0,20190421,20200420,PER,,US-JNJFOC-20190411774,JOHNSON AND JOHNSON,,77.0,YR,,M,Y,77.18,KG,20200420.0,,HP,US,US,2020,Q2,Elderly
162204833,16220483,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 UNITS,,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,3,F,20181116.0,20200413.0,20190421,20200420,PER,,US-JNJFOC-20190411774,JOHNSON AND JOHNSON,,77.0,YR,,M,Y,77.18,KG,20200420.0,,HP,US,US,2020,Q2,Elderly
162486162,16248616,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,2,F,,20200520.0,20190429,20200602,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-206430,RANBAXY,,52.0,YR,,M,Y,,,20200602.0,,HP,US,US,2020,Q2,Adult
162548152,16254815,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,,QD,2020,Q2,Blindness,,2020,Q2,2,F,2018.0,20200508.0,20190430,20200514,EXP,,EC-SA-2019SA116369,SANOFI AVENTIS,,38.0,YR,A,F,Y,81.5,KG,20200514.0,,CN,EC,EC,2020,Q2,Adult
162548152,16254815,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,,QD,2020,Q2,Condition aggravated,,2020,Q2,2,F,2018.0,20200508.0,20190430,20200514,EXP,,EC-SA-2019SA116369,SANOFI AVENTIS,,38.0,YR,A,F,Y,81.5,KG,20200514.0,,CN,EC,EC,2020,Q2,Adult
162548152,16254815,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,,QD,2020,Q2,Decreased appetite,,2020,Q2,2,F,2018.0,20200508.0,20190430,20200514,EXP,,EC-SA-2019SA116369,SANOFI AVENTIS,,38.0,YR,A,F,Y,81.5,KG,20200514.0,,CN,EC,EC,2020,Q2,Adult
162548152,16254815,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,,QD,2020,Q2,Gastritis,,2020,Q2,2,F,2018.0,20200508.0,20190430,20200514,EXP,,EC-SA-2019SA116369,SANOFI AVENTIS,,38.0,YR,A,F,Y,81.5,KG,20200514.0,,CN,EC,EC,2020,Q2,Adult
162548152,16254815,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,,,,,26.0,IU,,QD,2020,Q2,Weight decreased,,2020,Q2,2,F,2018.0,20200508.0,20190430,20200514,EXP,,EC-SA-2019SA116369,SANOFI AVENTIS,,38.0,YR,A,F,Y,81.5,KG,20200514.0,,CN,EC,EC,2020,Q2,Adult
162902843,16290284,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, BID",,,,,,,206538.0,15.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, BID",,,,,,,206538.0,15.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Cerebrovascular accident,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, BID",,,,,,,206538.0,15.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Impaired work ability,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, BID",,,,,,,206538.0,15.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, BID",,,,,,,206538.0,15.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Memory impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, BID",,,,,,,206538.0,15.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Product dose omission,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, BID",,,,,,,206538.0,15.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Visual impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, BID",,,,,,,206538.0,25.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, BID",,,,,,,206538.0,25.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Cerebrovascular accident,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, BID",,,,,,,206538.0,25.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Impaired work ability,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, BID",,,,,,,206538.0,25.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, BID",,,,,,,206538.0,25.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Memory impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, BID",,,,,,,206538.0,25.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Product dose omission,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, BID",,,,,,,206538.0,25.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Visual impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,206538.0,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,206538.0,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,206538.0,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Impaired work ability,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,206538.0,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,206538.0,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Memory impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,206538.0,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product dose omission,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 IU, QD",,,,,,,206538.0,45.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Visual impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Impaired work ability,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Memory impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product dose omission,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,206538.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Visual impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Impaired work ability,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Memory impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product dose omission,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
162902843,16290284,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, QD",,,,,,,206538.0,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Visual impairment,,2020,Q2,3,F,20161015.0,20200324.0,20190509,20200406,EXP,,US-SA-2018SA210267,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20200406.0,,CN,US,US,2020,Q2,Adult
163074012,16307401,11,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,2,F,20170508.0,20200325.0,20190514,20200402,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-021604",BOEHRINGER INGELHEIM,,74.0,YR,,M,Y,93.44,KG,20200402.0,,CN,US,US,2020,Q2,Elderly
163074012,16307401,11,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,2,F,20170508.0,20200325.0,20190514,20200402,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-021604",BOEHRINGER INGELHEIM,,74.0,YR,,M,Y,93.44,KG,20200402.0,,CN,US,US,2020,Q2,Elderly
163209825,16320982,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,UNKNOWN,QD,2020,Q2,Emphysema,,2020,Q2,5,F,20181009.0,20200522.0,20190516,20200528,EXP,,JP-CELGENEUS-JPN-20190504896,CELGENE,,73.0,YR,,M,Y,51.0,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
163209825,16320982,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,UNKNOWN,QD,2020,Q2,Haemoglobin decreased,,2020,Q2,5,F,20181009.0,20200522.0,20190516,20200528,EXP,,JP-CELGENEUS-JPN-20190504896,CELGENE,,73.0,YR,,M,Y,51.0,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
163209825,16320982,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,UNKNOWN,QD,2020,Q2,Interstitial lung disease,,2020,Q2,5,F,20181009.0,20200522.0,20190516,20200528,EXP,,JP-CELGENEUS-JPN-20190504896,CELGENE,,73.0,YR,,M,Y,51.0,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
163209825,16320982,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,UNKNOWN,QD,2020,Q2,Muscular weakness,,2020,Q2,5,F,20181009.0,20200522.0,20190516,20200528,EXP,,JP-CELGENEUS-JPN-20190504896,CELGENE,,73.0,YR,,M,Y,51.0,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
163209825,16320982,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,UNKNOWN,QD,2020,Q2,Pneumonia bacterial,,2020,Q2,5,F,20181009.0,20200522.0,20190516,20200528,EXP,,JP-CELGENEUS-JPN-20190504896,CELGENE,,73.0,YR,,M,Y,51.0,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
163209825,16320982,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,UNKNOWN,QD,2020,Q2,Stomatitis,,2020,Q2,5,F,20181009.0,20200522.0,20190516,20200528,EXP,,JP-CELGENEUS-JPN-20190504896,CELGENE,,73.0,YR,,M,Y,51.0,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
163209825,16320982,4,C,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,10 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,UNKNOWN,QD,2020,Q2,Tachycardia,,2020,Q2,5,F,20181009.0,20200522.0,20190516,20200528,EXP,,JP-CELGENEUS-JPN-20190504896,CELGENE,,73.0,YR,,M,Y,51.0,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
163621184,16362118,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"100 E/ML, QD",,,,,,,,,,,QD,2020,Q2,Ankle fracture,,2020,Q2,4,F,2018.0,20200616.0,20190528,20200622,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,73.0,YR,E,M,Y,,,20200621.0,,CN,NL,NL,2020,Q2,Elderly
163621184,16362118,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"100 E/ML, QD",,,,,,,,,,,QD,2020,Q2,Herpes zoster,,2020,Q2,4,F,2018.0,20200616.0,20190528,20200622,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,73.0,YR,E,M,Y,,,20200621.0,,CN,NL,NL,2020,Q2,Elderly
163621184,16362118,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"100 E/ML, QD",,,,,,,,,,,QD,2020,Q2,Impaired healing,,2020,Q2,4,F,2018.0,20200616.0,20190528,20200622,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,73.0,YR,E,M,Y,,,20200621.0,,CN,NL,NL,2020,Q2,Elderly
163621184,16362118,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"100 E/ML, QD",,,,,,,,,,,QD,2020,Q2,Influenza like illness,Influenza like illness,2020,Q2,4,F,2018.0,20200616.0,20190528,20200622,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,73.0,YR,E,M,Y,,,20200621.0,,CN,NL,NL,2020,Q2,Elderly
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Asthenia,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Cellulitis,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Erythema,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Fatigue,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,General physical health deterioration,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Hepatitis,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Inflammation,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Intentional product use issue,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Oedema peripheral,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Pain in extremity,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Portal vein phlebitis,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Product availability issue,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Product packaging quantity issue,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Product use in unapproved indication,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Splenitis,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Urinary tract infection,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163783619,16378361,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,3.0,IU,FORMULATION UNKNOWN,Q8H,2020,Q2,Weight decreased,,2020,Q2,9,F,20140221.0,20200604.0,20190531,20200615,EXP,,CO-ASTELLAS-2019US023103,ASTELLAS,,51.0,YR,,M,Y,47.0,KG,20200615.0,,CN,CO,CO,2020,Q2,Adult
163881484,16388148,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT /ML, 14 UNIT UNDER SKIN NIGHTLY",,,,,,,,,,,,2020,Q2,Bacteraemia,,2020,Q2,4,F,20180206.0,20200602.0,20190604,20200615,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,93.3,KG,20200615.0,,MD,US,US,2020,Q2,Elderly
163881484,16388148,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT /ML, 14 UNIT UNDER SKIN NIGHTLY",,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,4,F,20180206.0,20200602.0,20190604,20200615,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,93.3,KG,20200615.0,,MD,US,US,2020,Q2,Elderly
163881484,16388148,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT /ML, 14 UNIT UNDER SKIN NIGHTLY",,,,,,,,,,,,2020,Q2,Vascular device infection,,2020,Q2,4,F,20180206.0,20200602.0,20190604,20200615,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,93.3,KG,20200615.0,,MD,US,US,2020,Q2,Elderly
165634939,16563493,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,"25 UNITS INTO SKIN, TWICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q12H,2020,Q2,Arthralgia,,2020,Q2,9,F,201905.0,20200327.0,20190712,20200407,EXP,,US-ASTELLAS-2019US021312,ASTELLAS,,79.0,YR,,M,Y,120.0,KG,20200407.0,,CN,US,US,2020,Q2,Elderly
165634939,16563493,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,"25 UNITS INTO SKIN, TWICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q12H,2020,Q2,Cardiac disorder,,2020,Q2,9,F,201905.0,20200327.0,20190712,20200407,EXP,,US-ASTELLAS-2019US021312,ASTELLAS,,79.0,YR,,M,Y,120.0,KG,20200407.0,,CN,US,US,2020,Q2,Elderly
165634939,16563493,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,"25 UNITS INTO SKIN, TWICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q12H,2020,Q2,Dyspnoea,,2020,Q2,9,F,201905.0,20200327.0,20190712,20200407,EXP,,US-ASTELLAS-2019US021312,ASTELLAS,,79.0,YR,,M,Y,120.0,KG,20200407.0,,CN,US,US,2020,Q2,Elderly
165634939,16563493,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,"25 UNITS INTO SKIN, TWICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q12H,2020,Q2,Fatigue,,2020,Q2,9,F,201905.0,20200327.0,20190712,20200407,EXP,,US-ASTELLAS-2019US021312,ASTELLAS,,79.0,YR,,M,Y,120.0,KG,20200407.0,,CN,US,US,2020,Q2,Elderly
165634939,16563493,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,"25 UNITS INTO SKIN, TWICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q12H,2020,Q2,Headache,,2020,Q2,9,F,201905.0,20200327.0,20190712,20200407,EXP,,US-ASTELLAS-2019US021312,ASTELLAS,,79.0,YR,,M,Y,120.0,KG,20200407.0,,CN,US,US,2020,Q2,Elderly
165634939,16563493,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,"25 UNITS INTO SKIN, TWICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q12H,2020,Q2,Hot flush,,2020,Q2,9,F,201905.0,20200327.0,20190712,20200407,EXP,,US-ASTELLAS-2019US021312,ASTELLAS,,79.0,YR,,M,Y,120.0,KG,20200407.0,,CN,US,US,2020,Q2,Elderly
165634939,16563493,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,"25 UNITS INTO SKIN, TWICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q12H,2020,Q2,Influenza,,2020,Q2,9,F,201905.0,20200327.0,20190712,20200407,EXP,,US-ASTELLAS-2019US021312,ASTELLAS,,79.0,YR,,M,Y,120.0,KG,20200407.0,,CN,US,US,2020,Q2,Elderly
165634939,16563493,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,"25 UNITS INTO SKIN, TWICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q12H,2020,Q2,Nausea,,2020,Q2,9,F,201905.0,20200327.0,20190712,20200407,EXP,,US-ASTELLAS-2019US021312,ASTELLAS,,79.0,YR,,M,Y,120.0,KG,20200407.0,,CN,US,US,2020,Q2,Elderly
165634939,16563493,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intradermal,"25 UNITS INTO SKIN, TWICE DAILY",,,,,,,,,,FORMULATION UNKNOWN,Q12H,2020,Q2,Pneumocystis jirovecii pneumonia,,2020,Q2,9,F,201905.0,20200327.0,20190712,20200407,EXP,,US-ASTELLAS-2019US021312,ASTELLAS,,79.0,YR,,M,Y,120.0,KG,20200407.0,,CN,US,US,2020,Q2,Elderly
1656848113,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,13,F,20190610.0,20200616.0,20190712,20200619,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,97.1,KG,20200619.0,,MD,FR,FR,2020,Q2,Elderly
1656848113,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Angina pectoris,,2020,Q2,13,F,20190610.0,20200616.0,20190712,20200619,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,97.1,KG,20200619.0,,MD,FR,FR,2020,Q2,Elderly
1656848113,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Cytomegalovirus test positive,,2020,Q2,13,F,20190610.0,20200616.0,20190712,20200619,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,97.1,KG,20200619.0,,MD,FR,FR,2020,Q2,Elderly
1656848113,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Endocarditis,,2020,Q2,13,F,20190610.0,20200616.0,20190712,20200619,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,97.1,KG,20200619.0,,MD,FR,FR,2020,Q2,Elderly
1656848113,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,13,F,20190610.0,20200616.0,20190712,20200619,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,97.1,KG,20200619.0,,MD,FR,FR,2020,Q2,Elderly
1656848113,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,13,F,20190610.0,20200616.0,20190712,20200619,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,97.1,KG,20200619.0,,MD,FR,FR,2020,Q2,Elderly
1656848113,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Skin ulcer,,2020,Q2,13,F,20190610.0,20200616.0,20190712,20200619,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,97.1,KG,20200619.0,,MD,FR,FR,2020,Q2,Elderly
1656848113,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Tooth abscess,,2020,Q2,13,F,20190610.0,20200616.0,20190712,20200619,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,97.1,KG,20200619.0,,MD,FR,FR,2020,Q2,Elderly
1656848113,16568481,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Urinary tract infection,,2020,Q2,13,F,20190610.0,20200616.0,20190712,20200619,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,97.1,KG,20200619.0,,MD,FR,FR,2020,Q2,Elderly
166100862,16610086,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Asthenia,,2020,Q2,2,F,20190926.0,20200604.0,20190722,20200609,EXP,,US-ABBVIE-19K-163-2834238-00,ABBVIE,,83.0,YR,,M,Y,,,20200609.0,,CN,US,US,2020,Q2,Elderly
166100862,16610086,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Diabetes mellitus,,2020,Q2,2,F,20190926.0,20200604.0,20190722,20200609,EXP,,US-ABBVIE-19K-163-2834238-00,ABBVIE,,83.0,YR,,M,Y,,,20200609.0,,CN,US,US,2020,Q2,Elderly
166100862,16610086,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,2,F,20190926.0,20200604.0,20190722,20200609,EXP,,US-ABBVIE-19K-163-2834238-00,ABBVIE,,83.0,YR,,M,Y,,,20200609.0,,CN,US,US,2020,Q2,Elderly
166100862,16610086,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,2,F,20190926.0,20200604.0,20190722,20200609,EXP,,US-ABBVIE-19K-163-2834238-00,ABBVIE,,83.0,YR,,M,Y,,,20200609.0,,CN,US,US,2020,Q2,Elderly
166100862,16610086,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,2,F,20190926.0,20200604.0,20190722,20200609,EXP,,US-ABBVIE-19K-163-2834238-00,ABBVIE,,83.0,YR,,M,Y,,,20200609.0,,CN,US,US,2020,Q2,Elderly
166100862,16610086,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,2,F,20190926.0,20200604.0,20190722,20200609,EXP,,US-ABBVIE-19K-163-2834238-00,ABBVIE,,83.0,YR,,M,Y,,,20200609.0,,CN,US,US,2020,Q2,Elderly
166100862,16610086,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Intestinal obstruction,,2020,Q2,2,F,20190926.0,20200604.0,20190722,20200609,EXP,,US-ABBVIE-19K-163-2834238-00,ABBVIE,,83.0,YR,,M,Y,,,20200609.0,,CN,US,US,2020,Q2,Elderly
166100862,16610086,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Nipple pain,,2020,Q2,2,F,20190926.0,20200604.0,20190722,20200609,EXP,,US-ABBVIE-19K-163-2834238-00,ABBVIE,,83.0,YR,,M,Y,,,20200609.0,,CN,US,US,2020,Q2,Elderly
166100862,16610086,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Visual impairment,,2020,Q2,2,F,20190926.0,20200604.0,20190722,20200609,EXP,,US-ABBVIE-19K-163-2834238-00,ABBVIE,,83.0,YR,,M,Y,,,20200609.0,,CN,US,US,2020,Q2,Elderly
166599686,16659968,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Malaise,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,6,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,6,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,6,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,6,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Malaise,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,6,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
166599686,16659968,6,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,6,F,20190720.0,20200403.0,20190802,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-003558",BOEHRINGER INGELHEIM,,74.0,YR,,F,Y,49.7,KG,20200406.0,,MD,JP,JP,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Acidosis,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,C-reactive protein increased,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Food intolerance,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Glycosuria,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Hypophosphataemia,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Ketonuria,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Leukocytosis,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Nausea,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Neutrophilia,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167421763,16742176,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,,,2020,Q2,Vomiting,,2020,Q2,3,F,,20200616.0,20190826,20200624,EXP,,PT-MYLANLABS-2019M1078474,MYLAN,"PEREIRA F G, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A R, ET.AL.. EUGLICAEMIC DIABETIC KETOACIDOSIS: SGLT2 INHIBITORS MAY BE GUILTY.. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1SUPPL):47-122",70.0,YR,,M,Y,,,20200624.0,,HP,PT,PT,2020,Q2,Elderly
167741912,16774191,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD (EVERY NIGHT)",,,,, 9F311A,,,,,,QD,2020,Q2,Blood glucose increased,,2020,Q2,2,F,20200422.0,20200622.0,20190905,20200629,EXP,,PHHY2019GR150244,NOVARTIS,,61.0,YR,,F,Y,,,20200629.0,,HP,GR,GR,2020,Q2,Adult
167741912,16774191,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD (EVERY NIGHT)",,,,, 9F311A,,,,,,QD,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20200422.0,20200622.0,20190905,20200629,EXP,,PHHY2019GR150244,NOVARTIS,,61.0,YR,,F,Y,,,20200629.0,,HP,GR,GR,2020,Q2,Adult
167905672,16790567,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, HS",,,,, 9F476A,,206538.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blindness,,2020,Q2,2,F,200101.0,20200511.0,20190910,20200519,EXP,,US-SA-2019SA067846,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Adult
167905672,16790567,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, HS",,,,, 9F476A,,206538.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Heart valve replacement,,2020,Q2,2,F,200101.0,20200511.0,20190910,20200519,EXP,,US-SA-2019SA067846,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Adult
167905672,16790567,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, HS",,,,, 9F476A,,206538.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Macular degeneration,,2020,Q2,2,F,200101.0,20200511.0,20190910,20200519,EXP,,US-SA-2019SA067846,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Adult
167905672,16790567,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, HS",,,,, 9F476A,,206538.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Multiple use of single-use product,,2020,Q2,2,F,200101.0,20200511.0,20190910,20200519,EXP,,US-SA-2019SA067846,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Adult
167905672,16790567,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"16 IU, HS",,,,, 9F476A,,206538.0,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product storage error,,2020,Q2,2,F,200101.0,20200511.0,20190910,20200519,EXP,,US-SA-2019SA067846,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20200519.0,,CN,US,US,2020,Q2,Adult
168103207,16810320,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,7,F,,20200601.0,20190916,20200603,EXP,,US-PFIZER INC-2019389734,PFIZER,,69.0,YR,,F,Y,117.9,KG,20200603.0,,CN,US,US,2020,Q2,Elderly
168103207,16810320,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,7,F,,20200601.0,20190916,20200603,EXP,,US-PFIZER INC-2019389734,PFIZER,,69.0,YR,,F,Y,117.9,KG,20200603.0,,CN,US,US,2020,Q2,Elderly
168103207,16810320,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,7,F,,20200601.0,20190916,20200603,EXP,,US-PFIZER INC-2019389734,PFIZER,,69.0,YR,,F,Y,117.9,KG,20200603.0,,CN,US,US,2020,Q2,Elderly
168225663,16822566,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 IU, 1X/DAY, (AT BEDTIME)",,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Depression,,2020,Q2,3,F,,20200403.0,20190918,20200408,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20200408.0,,HP,US,US,2020,Q2,Adult
168666902,16866690,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q2,Anaphylactic reaction,,2020,Q2,2,F,,20200331.0,20190930,20200406,EXP,,PHHY2019CA225974,NOVARTIS,,70.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Elderly
168666902,16866690,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION,,2020,Q2,Drug intolerance,,2020,Q2,2,F,,20200331.0,20190930,20200406,EXP,,PHHY2019CA225974,NOVARTIS,,70.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Arthritis,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Blood pressure increased,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Brain natriuretic peptide abnormal,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Disease progression,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Dysphagia,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Fall,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Haemoglobin decreased,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Headache,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Pericardial effusion,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Rib fracture,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Scratch,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Subarachnoid haemorrhage,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Syncope,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169075708,16907570,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Tachycardia,,2020,Q2,8,F,20181209.0,20200612.0,20191011,20200624,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20200624.0,,HP,SE,SE,2020,Q2,Elderly
169356413,16935641,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UNIT/ML, QD",,,,,,,,,,,,2020,Q2,Psychotic disorder,,2020,Q2,3,F,20190922.0,20200409.0,20191018,20200415,EXP,,US-VERTEX PHARMACEUTICALS-2019-009932,VERTEX,,40.0,YR,,M,Y,57.0,KG,20200415.0,,MD,US,US,2020,Q2,Adult
169414035,16941403,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Brain neoplasm,,2020,Q2,5,F,201908.0,20200508.0,20191021,20200518,EXP,,US-JNJFOC-20191027547,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,,,20200518.0,,CN,US,US,2020,Q2,Elderly
169414035,16941403,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Melanoma recurrent,,2020,Q2,5,F,201908.0,20200508.0,20191021,20200518,EXP,,US-JNJFOC-20191027547,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,,,20200518.0,,CN,US,US,2020,Q2,Elderly
169414035,16941403,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Metastases to central nervous system,,2020,Q2,5,F,201908.0,20200508.0,20191021,20200518,EXP,,US-JNJFOC-20191027547,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,,,20200518.0,,CN,US,US,2020,Q2,Elderly
169414035,16941403,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Pulmonary mass,,2020,Q2,5,F,201908.0,20200508.0,20191021,20200518,EXP,,US-JNJFOC-20191027547,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,,,20200518.0,,CN,US,US,2020,Q2,Elderly
169517262,16951726,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,16 TO 32 IU IN EVENING,,,Y,,,,205692.0,,,,QD,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,2,F,201509.0,20200513.0,20191023,20200522,EXP,,SK-ELI_LILLY_AND_COMPANY-SK201910007297,ELI LILLY AND CO,,70.0,YR,,M,Y,83.0,KG,20200522.0,,MD,SK,SK,2020,Q2,Elderly
169517262,16951726,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,16 TO 32 IU IN EVENING,,,Y,,,,205692.0,,,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,201509.0,20200513.0,20191023,20200522,EXP,,SK-ELI_LILLY_AND_COMPANY-SK201910007297,ELI LILLY AND CO,,70.0,YR,,M,Y,83.0,KG,20200522.0,,MD,SK,SK,2020,Q2,Elderly
169517262,16951726,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"34 IU, HS",,,Y,,,,205692.0,32.0,IU,,QD,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,2,F,201509.0,20200513.0,20191023,20200522,EXP,,SK-ELI_LILLY_AND_COMPANY-SK201910007297,ELI LILLY AND CO,,70.0,YR,,M,Y,83.0,KG,20200522.0,,MD,SK,SK,2020,Q2,Elderly
169517262,16951726,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"34 IU, HS",,,Y,,,,205692.0,32.0,IU,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,201509.0,20200513.0,20191023,20200522,EXP,,SK-ELI_LILLY_AND_COMPANY-SK201910007297,ELI LILLY AND CO,,70.0,YR,,M,Y,83.0,KG,20200522.0,,MD,SK,SK,2020,Q2,Elderly
169517262,16951726,3,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,Y,,,,205692.0,,,,,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,2,F,201509.0,20200513.0,20191023,20200522,EXP,,SK-ELI_LILLY_AND_COMPANY-SK201910007297,ELI LILLY AND CO,,70.0,YR,,M,Y,83.0,KG,20200522.0,,MD,SK,SK,2020,Q2,Elderly
169517262,16951726,3,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,Y,,,,205692.0,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,201509.0,20200513.0,20191023,20200522,EXP,,SK-ELI_LILLY_AND_COMPANY-SK201910007297,ELI LILLY AND CO,,70.0,YR,,M,Y,83.0,KG,20200522.0,,MD,SK,SK,2020,Q2,Elderly
169538936,16953893,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Colitis ulcerative,,2020,Q2,6,F,20191217.0,20200423.0,20191023,20200427,EXP,,CA-TAKEDA-2019TUS059000,TAKEDA,,73.0,YR,,F,Y,,,20200427.0,,CN,CA,CA,2020,Q2,Elderly
169538936,16953893,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,6,F,20191217.0,20200423.0,20191023,20200427,EXP,,CA-TAKEDA-2019TUS059000,TAKEDA,,73.0,YR,,F,Y,,,20200427.0,,CN,CA,CA,2020,Q2,Elderly
1696951023,16969510,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,DF,INJECTION,,2020,Q2,Heart injury,,2020,Q2,23,F,20191021.0,20200427.0,20191029,20200430,EXP,,CN-EISAI MEDICAL RESEARCH-EC-2019-064326,EISAI,,62.0,YR,A,M,Y,69.0,KG,20200430.0,,MD,CN,CN,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Blood pressure increased,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Crying,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Cystitis,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Gastrointestinal disorder,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Generalised tonic-clonic seizure,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hypersomnia,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Oropharyngeal pain,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Screaming,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Seizure,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170794355,17079435,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Urinary tract infection,,2020,Q2,5,F,20190124.0,20200428.0,20191127,20200430,EXP,,US-UCBSA-2019003987,UCB,,47.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Adult
170996265,17099626,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,5,F,20191112.0,20200509.0,20191202,20200512,EXP,,NVSC2019CN041826,NOVARTIS,,50.0,YR,,F,Y,53.0,KG,20200512.0,,MD,CN,CN,2020,Q2,Adult
171224402,17122440,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,13.0,IU,,QD,2020,Q2,Fournier's gangrene,,2020,Q2,2,F,20180211.0,20200515.0,20191206,20200522,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-118313",BOEHRINGER INGELHEIM,,48.0,YR,,F,Y,,,20200522.0,,CN,US,US,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase abnormal,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Biopsy thyroid gland,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Bronchitis,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Catheterisation cardiac,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Dialysis,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Disseminated intravascular coagulation,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Fascial operation,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Hepatic failure,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Hepatic infarction,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Lactic acidosis,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Liver transplant,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Magnetic resonance imaging liver abnormal,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Multiple organ dysfunction syndrome,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Pulmonary embolism,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Pulmonary oedema,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Tachycardia,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Thyroid mass,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Transplant evaluation,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171227516,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q2,Transplant failure,,2020,Q2,6,F,20190711.0,20200609.0,20191206,20200619,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200619.0,,HP,DE,DE,2020,Q2,Adult
171246082,17124608,1,PS,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"40 IU, QD",,,D,,,,208673.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Memory impairment,,2020,Q2,2,F,,20200414.0,20191206,20200420,PER,,US-SA-2019SA337695,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Elderly
171246082,17124608,1,PS,INSULIN GLARGINE/LIXISENATIDE,INSULIN GLARGINE\LIXISENATIDE,1,Subcutaneous,"40 IU, QD",,,D,,,,208673.0,40.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product dose omission,,2020,Q2,2,F,,20200414.0,20191206,20200420,PER,,US-SA-2019SA337695,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20200420.0,,CN,US,US,2020,Q2,Elderly
171516906,17151690,7,C,recombinant insulin glargine,,2,Subcutaneous,8-10 IU,,,,,,,,,,INJECTION,QD,2020,Q2,Haemoptysis,,2020,Q2,6,F,20191130.0,20200609.0,20191213,20200611,EXP,,CN-CELGENEUS-CHN-20191202475,CELGENE,,53.0,YR,,M,Y,70.0,KG,20200611.0,,MD,CN,CN,2020,Q2,Adult
171730313,17173031,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10-24 IU,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,3,F,20191210.0,20200513.0,20191218,20200520,EXP,,US-ABBVIE-19P-163-3191358-00,ABBVIE,,16.0,YR,,M,Y,70.0,KG,20200520.0,,MD,US,US,2020,Q2,Youth
172021393,17202139,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172021393,17202139,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hot flush,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172021393,17202139,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172021393,17202139,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Syncope,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172021393,17202139,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,White blood cell count decreased,,2020,Q2,3,F,20191214.0,20200430.0,20191226,20200504,EXP,,US-PFIZER INC-2019552689,PFIZER,,65.0,YR,,F,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
172047452,17204745,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,INJECTION,,2020,Q2,Organising pneumonia,,2020,Q2,2,F,20190130.0,20200408.0,20191226,20200421,PER,,JP-AMGEN-JPNCT2019214409,AMGEN,,70.0,YR,E,M,Y,,,20200420.0,,HP,JP,JP,2020,Q2,Elderly
172439452,17243945,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, 1/DAY",,,Y,,,,,22.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,QD,2020,Q2,Behaviour disorder,,2020,Q2,2,F,2019.0,20200602.0,20200107,20200612,EXP,FR-AFSSAPS-AN20191444,FR-JNJFOC-20200106420,JOHNSON AND JOHNSON,,64.0,YR,,F,Y,63.0,KG,20200612.0,,MD,FR,FR,2020,Q2,Adult
172439452,17243945,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, 1/DAY",,,Y,,,,,22.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,QD,2020,Q2,Coma,,2020,Q2,2,F,2019.0,20200602.0,20200107,20200612,EXP,FR-AFSSAPS-AN20191444,FR-JNJFOC-20200106420,JOHNSON AND JOHNSON,,64.0,YR,,F,Y,63.0,KG,20200612.0,,MD,FR,FR,2020,Q2,Adult
172439452,17243945,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, 1/DAY",,,Y,,,,,22.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,QD,2020,Q2,Magnetic resonance imaging brain abnormal,,2020,Q2,2,F,2019.0,20200602.0,20200107,20200612,EXP,FR-AFSSAPS-AN20191444,FR-JNJFOC-20200106420,JOHNSON AND JOHNSON,,64.0,YR,,F,Y,63.0,KG,20200612.0,,MD,FR,FR,2020,Q2,Adult
172439452,17243945,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, 1/DAY",,,Y,,,,,22.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,QD,2020,Q2,Pyrexia,,2020,Q2,2,F,2019.0,20200602.0,20200107,20200612,EXP,FR-AFSSAPS-AN20191444,FR-JNJFOC-20200106420,JOHNSON AND JOHNSON,,64.0,YR,,F,Y,63.0,KG,20200612.0,,MD,FR,FR,2020,Q2,Adult
172594152,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Asthenia,,2020,Q2,2,F,2018.0,20191227.0,20200110,20200605,PER,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200605.0,,MD,TR,TR,2020,Q2,Elderly
172594152,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,2,F,2018.0,20191227.0,20200110,20200605,PER,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200605.0,,MD,TR,TR,2020,Q2,Elderly
172594152,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Malignant neoplasm progression,,2020,Q2,2,F,2018.0,20191227.0,20200110,20200605,PER,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200605.0,,MD,TR,TR,2020,Q2,Elderly
172594152,17259415,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,2,F,2018.0,20191227.0,20200110,20200605,PER,,"TR-TOLMAR, INC.-19TR019766",TOLMAR,,82.0,YR,,M,Y,,,20200605.0,,MD,TR,TR,2020,Q2,Elderly
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cholelithiasis,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Food intolerance,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Malaise,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Photophobia,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pituitary enlargement,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Vision blurred,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172933824,17293382,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,4,F,,20200421.0,20200121,20200424,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,,M,Y,104.0,KG,20200424.0,,CN,CO,CO,2020,Q2,Adult
172961902,17296190,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2020,Q2,Injury,,2020,Q2,2,F,202001.0,20200330.0,20200121,20200409,EXP,,US-JNJFOC-20200125824,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
172961902,17296190,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,,QD,2020,Q2,Surgery,,2020,Q2,2,F,202001.0,20200330.0,20200121,20200409,EXP,,US-JNJFOC-20200125824,JOHNSON AND JOHNSON,,61.0,YR,,F,Y,,,20200409.0,,CN,US,US,2020,Q2,Adult
172995615,17299561,16,C,INSULIN GLARGINE INJECTION,,2,Subcutaneous,NIGHTLY,,,,,,,,12.0,DF,,QD,2020,Q2,Neutropenia,,2020,Q2,5,F,20200111.0,20200417.0,20200121,20200424,EXP,,CN-ABBVIE-20P-035-3230426-00,ABBVIE,,74.0,YR,,M,Y,90.0,KG,20200424.0,,MD,CN,CN,2020,Q2,Elderly
172995615,17299561,16,C,INSULIN GLARGINE INJECTION,,2,Subcutaneous,NIGHTLY,,,,,,,,12.0,DF,,QD,2020,Q2,Thrombocytopenia,,2020,Q2,5,F,20200111.0,20200417.0,20200121,20200424,EXP,,CN-ABBVIE-20P-035-3230426-00,ABBVIE,,74.0,YR,,M,Y,90.0,KG,20200424.0,,MD,CN,CN,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Abdominal pain,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Aphonia,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Asthenia,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Blood creatinine abnormal,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose decreased,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Blood potassium decreased,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Blood urea abnormal,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Glossodynia,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Haemorrhage,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Immunodeficiency,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Nosocomial infection,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Penis disorder,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Pneumonia,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Respiratory distress,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Unevaluable event,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Urethral operation,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Urine abnormality,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
173509185,17350918,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q2,Weight decreased,,2020,Q2,5,F,20191220.0,20200312.0,20200130,20200423,EXP,,CO-ABBVIE-20K-036-3253636-00,ABBVIE,,72.0,YR,,M,Y,62.0,KG,20200423.0,,CN,CO,CO,2020,Q2,Elderly
174050302,17405030,4,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,U,,,,,24.0,IU,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,2,F,,20200401.0,20200212,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,"SONODA K, UCHIDA J, TAKAHASHI H. A CASE OF EUGLYCAEMIC DIABETIC KETOACIDOSIS TRIGGERED BY POSTOPERATIVE ORAL ADMINISTRATION OF SGLT2 INHIBITOR. CONGRESS TITLE: THE 658TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2020 MAR 14;.",7.0,DEC,,F,Y,,,20200406.0,,MD,JP,JP,2020,Q2,Child
174050302,17405030,4,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,U,,,,,24.0,IU,,,2020,Q2,Lumbar spinal stenosis,,2020,Q2,2,F,,20200401.0,20200212,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,"SONODA K, UCHIDA J, TAKAHASHI H. A CASE OF EUGLYCAEMIC DIABETIC KETOACIDOSIS TRIGGERED BY POSTOPERATIVE ORAL ADMINISTRATION OF SGLT2 INHIBITOR. CONGRESS TITLE: THE 658TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2020 MAR 14;.",7.0,DEC,,F,Y,,,20200406.0,,MD,JP,JP,2020,Q2,Child
174050302,17405030,5,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,2,F,,20200401.0,20200212,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,"SONODA K, UCHIDA J, TAKAHASHI H. A CASE OF EUGLYCAEMIC DIABETIC KETOACIDOSIS TRIGGERED BY POSTOPERATIVE ORAL ADMINISTRATION OF SGLT2 INHIBITOR. CONGRESS TITLE: THE 658TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2020 MAR 14;.",7.0,DEC,,F,Y,,,20200406.0,,MD,JP,JP,2020,Q2,Child
174050302,17405030,5,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Lumbar spinal stenosis,,2020,Q2,2,F,,20200401.0,20200212,20200406,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-007047",BOEHRINGER INGELHEIM,"SONODA K, UCHIDA J, TAKAHASHI H. A CASE OF EUGLYCAEMIC DIABETIC KETOACIDOSIS TRIGGERED BY POSTOPERATIVE ORAL ADMINISTRATION OF SGLT2 INHIBITOR. CONGRESS TITLE: THE 658TH KANTO REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2020 MAR 14;.",7.0,DEC,,F,Y,,,20200406.0,,MD,JP,JP,2020,Q2,Child
174076822,17407682,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,,,2020,Q2,Oedematous pancreatitis,,2020,Q2,2,F,,20200424.0,20200212,20200429,EXP,,NVSC2020CZ037017,NOVARTIS,,69.0,YR,,M,Y,,,20200429.0,,HP,CZ,CZ,2020,Q2,Elderly
174327972,17432797,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Febrile neutropenia,,2020,Q2,2,F,20181003.0,20200320.0,20200218,20200401,EXP,,AU-ROCHE-2552472,ROCHE,,38.0,YR,,F,Y,,,20200401.0,,MD,AU,AU,2020,Q2,Adult
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Anxiety,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Depression,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Dry mouth,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Feeling abnormal,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Increased insulin requirement,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Paraesthesia,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Temperature intolerance,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174426613,17442661,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Vertigo,,2020,Q2,3,F,20190304.0,20200616.0,20200220,20200618,PER,,NVSC2020US046127,NOVARTIS,,16.0,YR,,F,Y,59.9,KG,20200618.0,,HP,US,US,2020,Q2,Youth
174630603,17463060,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,16.0,IU,INJECTION,QD,2020,Q2,Vulval abscess,,2020,Q2,3,F,20190620.0,20200528.0,20200226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-011257",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,70.6,KG,20200601.0,,MD,JP,JP,2020,Q2,Elderly
174630603,17463060,8,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,16.0,IU,INJECTION,QD,2020,Q2,Vulval cellulitis,,2020,Q2,3,F,20190620.0,20200528.0,20200226,20200601,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-011257",BOEHRINGER INGELHEIM,,66.0,YR,,F,Y,70.6,KG,20200601.0,,MD,JP,JP,2020,Q2,Elderly
174819262,17481926,15,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Altered state of consciousness,,2020,Q2,2,F,20200210.0,20200512.0,20200302,20200521,EXP,,US-BAXTER-2020BAX004462,BAXTER,,11.0,YR,,F,Y,68.1,KG,20200521.0,,MD,US,US,2020,Q2,Child
174819262,17481926,15,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Seizure,,2020,Q2,2,F,20200210.0,20200512.0,20200302,20200521,EXP,,US-BAXTER-2020BAX004462,BAXTER,,11.0,YR,,F,Y,68.1,KG,20200521.0,,MD,US,US,2020,Q2,Child
174910223,17491022,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, 1X/DAY (60 UNITS)",,,,,,,,60.0,IU,,QD,2020,Q2,Gingival hypertrophy,,2020,Q2,3,F,,20200513.0,20200303,20200515,EXP,,US-PFIZER INC-2020092112,PFIZER,"GOLOB DEEB, J.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6 (1):10.1016/J.OMSC.2020.100143",52.0,YR,,M,Y,,,20200515.0,,HP,US,US,2020,Q2,Adult
174910223,17491022,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"60 IU, 1X/DAY (60 UNITS)",,,,,,,,60.0,IU,,QD,2020,Q2,Periodontitis,,2020,Q2,3,F,,20200513.0,20200303,20200515,EXP,,US-PFIZER INC-2020092112,PFIZER,"GOLOB DEEB, J.. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6 (1):10.1016/J.OMSC.2020.100143",52.0,YR,,M,Y,,,20200515.0,,HP,US,US,2020,Q2,Adult
175231603,17523160,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,INJECTION,,2020,Q2,Decreased appetite,,2020,Q2,3,F,20200301.0,20200330.0,20200310,20200403,EXP,,JP-OTSUKA-2020_006803,OTSUKA,,63.0,YR,,M,Y,46.8,KG,20200403.0,,MD,JP,JP,2020,Q2,Adult
175231603,17523160,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,INJECTION,,2020,Q2,Hypernatraemia,,2020,Q2,3,F,20200301.0,20200330.0,20200310,20200403,EXP,,JP-OTSUKA-2020_006803,OTSUKA,,63.0,YR,,M,Y,46.8,KG,20200403.0,,MD,JP,JP,2020,Q2,Adult
175231603,17523160,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,INJECTION,,2020,Q2,Osmotic demyelination syndrome,,2020,Q2,3,F,20200301.0,20200330.0,20200310,20200403,EXP,,JP-OTSUKA-2020_006803,OTSUKA,,63.0,YR,,M,Y,46.8,KG,20200403.0,,MD,JP,JP,2020,Q2,Adult
175271572,17527157,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Acute kidney injury,,2020,Q2,2,F,,20200303.0,20200310,20200403,EXP,,"AT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-012478",BOEHRINGER INGELHEIM,ABRAHAMIAN H. DRUGS AND RENAL FUNCTION. ALLGEMEINE + PLUS. 2020 MAR;.,84.0,YR,,,Y,,,20200403.0,,MD,AT,AT,2020,Q2,Elderly
175271572,17527157,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,C-reactive protein increased,,2020,Q2,2,F,,20200303.0,20200310,20200403,EXP,,"AT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-012478",BOEHRINGER INGELHEIM,ABRAHAMIAN H. DRUGS AND RENAL FUNCTION. ALLGEMEINE + PLUS. 2020 MAR;.,84.0,YR,,,Y,,,20200403.0,,MD,AT,AT,2020,Q2,Elderly
175271572,17527157,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Dehydration,,2020,Q2,2,F,,20200303.0,20200310,20200403,EXP,,"AT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-012478",BOEHRINGER INGELHEIM,ABRAHAMIAN H. DRUGS AND RENAL FUNCTION. ALLGEMEINE + PLUS. 2020 MAR;.,84.0,YR,,,Y,,,20200403.0,,MD,AT,AT,2020,Q2,Elderly
175271572,17527157,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Inflammation,,2020,Q2,2,F,,20200303.0,20200310,20200403,EXP,,"AT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-012478",BOEHRINGER INGELHEIM,ABRAHAMIAN H. DRUGS AND RENAL FUNCTION. ALLGEMEINE + PLUS. 2020 MAR;.,84.0,YR,,,Y,,,20200403.0,,MD,AT,AT,2020,Q2,Elderly
175271572,17527157,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Osteomyelitis,,2020,Q2,2,F,,20200303.0,20200310,20200403,EXP,,"AT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-012478",BOEHRINGER INGELHEIM,ABRAHAMIAN H. DRUGS AND RENAL FUNCTION. ALLGEMEINE + PLUS. 2020 MAR;.,84.0,YR,,,Y,,,20200403.0,,MD,AT,AT,2020,Q2,Elderly
175271572,17527157,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Pyrexia,,2020,Q2,2,F,,20200303.0,20200310,20200403,EXP,,"AT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-012478",BOEHRINGER INGELHEIM,ABRAHAMIAN H. DRUGS AND RENAL FUNCTION. ALLGEMEINE + PLUS. 2020 MAR;.,84.0,YR,,,Y,,,20200403.0,,MD,AT,AT,2020,Q2,Elderly
175271572,17527157,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Renal ischaemia,,2020,Q2,2,F,,20200303.0,20200310,20200403,EXP,,"AT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-012478",BOEHRINGER INGELHEIM,ABRAHAMIAN H. DRUGS AND RENAL FUNCTION. ALLGEMEINE + PLUS. 2020 MAR;.,84.0,YR,,,Y,,,20200403.0,,MD,AT,AT,2020,Q2,Elderly
175344342,17534434,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,75.0,DF,,BID,2020,Q2,Drug interaction,,2020,Q2,2,F,,20200408.0,20200312,20200408,EXP,,US-ABBVIE-20K-163-3309471-00,ABBVIE,"HARRISON D, GIANG J, DARLING J. AN INTERACTION BETWEEN GLECAPREVIR, PIBRENTASVIR, AND COLCHICINE CAUSING RHABDOMYOLYSIS IN A PATIENT WITH CHRONIC RENAL DISEASE. CLINICAL LIVER DISEASE. 2020 JAN 01;15(1):17-20.",69.0,YR,,M,Y,,,20200408.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q2,Elderly
175344342,17534434,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,75.0,DF,,BID,2020,Q2,Rhabdomyolysis,,2020,Q2,2,F,,20200408.0,20200312,20200408,EXP,,US-ABBVIE-20K-163-3309471-00,ABBVIE,"HARRISON D, GIANG J, DARLING J. AN INTERACTION BETWEEN GLECAPREVIR, PIBRENTASVIR, AND COLCHICINE CAUSING RHABDOMYOLYSIS IN A PATIENT WITH CHRONIC RENAL DISEASE. CLINICAL LIVER DISEASE. 2020 JAN 01;15(1):17-20.",69.0,YR,,M,Y,,,20200408.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q2,Elderly
175355117,17535511,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2020,Q2,Acute respiratory distress syndrome,,2020,Q2,7,F,20191223.0,20200616.0,20200312,20200623,EXP,,US-ABBVIE-19P-163-3211425-00,ABBVIE,,62.0,YR,,M,Y,86.0,KG,20200623.0,,MD,US,US,2020,Q2,Adult
175355117,17535511,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2020,Q2,Multiple organ dysfunction syndrome,,2020,Q2,7,F,20191223.0,20200616.0,20200312,20200623,EXP,,US-ABBVIE-19P-163-3211425-00,ABBVIE,,62.0,YR,,M,Y,86.0,KG,20200623.0,,MD,US,US,2020,Q2,Adult
175355117,17535511,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2020,Q2,Perirectal abscess,,2020,Q2,7,F,20191223.0,20200616.0,20200312,20200623,EXP,,US-ABBVIE-19P-163-3211425-00,ABBVIE,,62.0,YR,,M,Y,86.0,KG,20200623.0,,MD,US,US,2020,Q2,Adult
175355117,17535511,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2020,Q2,Pneumonia klebsiella,,2020,Q2,7,F,20191223.0,20200616.0,20200312,20200623,EXP,,US-ABBVIE-19P-163-3211425-00,ABBVIE,,62.0,YR,,M,Y,86.0,KG,20200623.0,,MD,US,US,2020,Q2,Adult
175355117,17535511,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2020,Q2,Septic shock,,2020,Q2,7,F,20191223.0,20200616.0,20200312,20200623,EXP,,US-ABBVIE-19P-163-3211425-00,ABBVIE,,62.0,YR,,M,Y,86.0,KG,20200623.0,,MD,US,US,2020,Q2,Adult
175453533,17545353,11,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Differentiation syndrome,,2020,Q2,3,F,20200216.0,20200331.0,20200316,20200402,EXP,,ES-CELGENEUS-ESP-20200301108,CELGENE,,80.0,YR,,F,Y,,,20200402.0,,MD,ES,ES,2020,Q2,Elderly
175453533,17545353,11,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Renal failure,,2020,Q2,3,F,20200216.0,20200331.0,20200316,20200402,EXP,,ES-CELGENEUS-ESP-20200301108,CELGENE,,80.0,YR,,F,Y,,,20200402.0,,MD,ES,ES,2020,Q2,Elderly
175471333,17547133,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Abdominal pain upper,,2020,Q2,3,F,20191224.0,20200401.0,20200316,20200406,EXP,,CA-ACTELION-A-US2020-200321,ACTELION,,59.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Adult
175471333,17547133,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,3,F,20191224.0,20200401.0,20200316,20200406,EXP,,CA-ACTELION-A-US2020-200321,ACTELION,,59.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Adult
175471333,17547133,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hospitalisation,,2020,Q2,3,F,20191224.0,20200401.0,20200316,20200406,EXP,,CA-ACTELION-A-US2020-200321,ACTELION,,59.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Adult
175471333,17547133,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,3,F,20191224.0,20200401.0,20200316,20200406,EXP,,CA-ACTELION-A-US2020-200321,ACTELION,,59.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Adult
175471333,17547133,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Malaise,,2020,Q2,3,F,20191224.0,20200401.0,20200316,20200406,EXP,,CA-ACTELION-A-US2020-200321,ACTELION,,59.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Adult
175471333,17547133,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pain in extremity,,2020,Q2,3,F,20191224.0,20200401.0,20200316,20200406,EXP,,CA-ACTELION-A-US2020-200321,ACTELION,,59.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Adult
175482462,17548246,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,,20200404.0,20200317,20200410,EXP,,CA-AUROBINDO-AUR-APL-2020-013439,AUROBINDO,,18.0,YR,,F,Y,56.0,KG,20200410.0,,PH,CA,CA,2020,Q2,Youth
175482462,17548246,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200404.0,20200317,20200410,EXP,,CA-AUROBINDO-AUR-APL-2020-013439,AUROBINDO,,18.0,YR,,F,Y,56.0,KG,20200410.0,,PH,CA,CA,2020,Q2,Youth
175482462,17548246,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q2,Increased insulin requirement,,2020,Q2,2,F,,20200404.0,20200317,20200410,EXP,,CA-AUROBINDO-AUR-APL-2020-013439,AUROBINDO,,18.0,YR,,F,Y,56.0,KG,20200410.0,,PH,CA,CA,2020,Q2,Youth
175485234,17548523,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 UNIT,,,U,,,,,100.0,DF,,,2020,Q2,Acute kidney injury,,2020,Q2,4,F,20200203.0,20200529.0,20200317,20200608,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000248,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,63.9,KG,20200608.0,,HP,US,US,2020,Q2,Adult
175539604,17553960,18,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Blood pressure increased,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,18,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Diabetic nephropathy,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,18,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hypertension,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,18,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Oedema,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,18,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Oedema peripheral,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,18,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Protein urine present,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175539604,17553960,18,C,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,4,F,20191119.0,20200529.0,20200317,20200605,EXP,,JP-BEH-2020114465,CSL BEHRING,,36.0,YR,A,M,Y,95.6,KG,20200605.0,,MD,JP,JP,2020,Q2,Adult
175544232,17554423,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,,,,,1.0,DF,,QD,2020,Q2,Gingival hypertrophy,,2020,Q2,2,F,,20200330.0,20200318,20200407,EXP,,US-AUROBINDO-AUR-APL-2020-013137,AUROBINDO,,52.0,YR,,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
175544232,17554423,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"1 DOSAGE FORM, ONCE A DAY",,,U,,,,,1.0,DF,,QD,2020,Q2,Periodontitis,,2020,Q2,2,F,,20200330.0,20200318,20200407,EXP,,US-AUROBINDO-AUR-APL-2020-013137,AUROBINDO,,52.0,YR,,M,Y,,,20200407.0,,MD,US,US,2020,Q2,Adult
175548042,17554804,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q2,Erythema multiforme,,2020,Q2,2,F,20190610.0,20200520.0,20200318,20200530,EXP,ES-EMA-DD-20200304-GANGAL_S-133417,ES-ACCORD-175314,ACCORD,,73.0,YR,E,F,Y,,,20200530.0,,HP,ES,ES,2020,Q2,Elderly
175548042,17554804,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q2,Pyrexia,,2020,Q2,2,F,20190610.0,20200520.0,20200318,20200530,EXP,ES-EMA-DD-20200304-GANGAL_S-133417,ES-ACCORD-175314,ACCORD,,73.0,YR,E,F,Y,,,20200530.0,,HP,ES,ES,2020,Q2,Elderly
175548042,17554804,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q2,Toxic skin eruption,,2020,Q2,2,F,20190610.0,20200520.0,20200318,20200530,EXP,ES-EMA-DD-20200304-GANGAL_S-133417,ES-ACCORD-175314,ACCORD,,73.0,YR,E,F,Y,,,20200530.0,,HP,ES,ES,2020,Q2,Elderly
175573823,17557382,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 UNIT, QD",,,U,,,,,30.0,DF,,QD,2020,Q2,Kidney transplant rejection,,2020,Q2,3,F,20200305.0,20200324.0,20200318,20200402,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000249,VELOXIS PHARMACEUTICALS,,67.0,YR,,M,Y,76.9,KG,20200402.0,,HP,US,US,2020,Q2,Elderly
175582693,17558269,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,1.0,DF,,,2020,Q2,Periodontitis,,2020,Q2,3,F,,20200626.0,20200319,20200630,EXP,,US-DRREDDYS-USA/USA/20/0120775,DR REDDYS,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6(1):ARTICLE NUMBER 100143. DOI:10.1016/J.OMSC.2020.100143",52.0,YR,A,M,Y,,,20200630.0,,MD,US,US,2020,Q2,Adult
175608633,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175608633,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2020,Q2,Gastrointestinal disorder,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175608633,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2020,Q2,Product administration error,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175608633,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175608633,17560863,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,INJECTION,,2020,Q2,Urinary tract disorder,,2020,Q2,3,F,,20200424.0,20200319,20200427,EXP,,PT-MYLANLABS-2020M1028430,MYLAN,,61.0,YR,,M,Y,,,20200427.0,,HP,PT,PT,2020,Q2,Adult
175615123,17561512,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU INTERNATIONAL UNIT(S), OD",,,,,,,,,,,QD,2020,Q2,Gingival hypertrophy,,2020,Q2,3,F,,20200513.0,20200319,20200521,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK046513,GLENMARK,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6 (1):1-6",52.0,YR,,M,Y,,,20200521.0,,MD,US,US,2020,Q2,Adult
175615123,17561512,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU INTERNATIONAL UNIT(S), OD",,,,,,,,,,,QD,2020,Q2,Periodontitis,,2020,Q2,3,F,,20200513.0,20200319,20200521,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK046513,GLENMARK,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT.. ORAL AND MAXILLOFACIAL SURGERY CASES. 2020;6 (1):1-6",52.0,YR,,M,Y,,,20200521.0,,MD,US,US,2020,Q2,Adult
175623033,17562303,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,3,F,,20200326.0,20200319,20200401,EXP,,US-PFIZER INC-2020115287,PFIZER,"MALIK, M.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. NEUROLOGY. 2020;12:10.1159/000505907",41.0,YR,,F,Y,,,20200401.0,,MD,US,US,2020,Q2,Adult
175623033,17562303,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Posterior reversible encephalopathy syndrome,,2020,Q2,3,F,,20200326.0,20200319,20200401,EXP,,US-PFIZER INC-2020115287,PFIZER,"MALIK, M.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. NEUROLOGY. 2020;12:10.1159/000505907",41.0,YR,,F,Y,,,20200401.0,,MD,US,US,2020,Q2,Adult
175623033,17562303,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Serotonin syndrome,,2020,Q2,3,F,,20200326.0,20200319,20200401,EXP,,US-PFIZER INC-2020115287,PFIZER,"MALIK, M.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. NEUROLOGY. 2020;12:10.1159/000505907",41.0,YR,,F,Y,,,20200401.0,,MD,US,US,2020,Q2,Adult
175699474,17569947,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Liver transplant,,2020,Q2,4,F,20200218.0,20200504.0,20200323,20200506,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023877,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,86.0,KG,20200506.0,,HP,DE,DE,2020,Q2,Elderly
175699474,17569947,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Liver transplant rejection,,2020,Q2,4,F,20200218.0,20200504.0,20200323,20200506,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023877,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,86.0,KG,20200506.0,,HP,DE,DE,2020,Q2,Elderly
175700806,17570080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Gastrointestinal disorder,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Genitourinary symptom,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Product administration error,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Treatment noncompliance,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Urinary tract disorder,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, WAS RESTARTED",,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, WAS RESTARTED",,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, WAS RESTARTED",,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Gastrointestinal disorder,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, WAS RESTARTED",,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Genitourinary symptom,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, WAS RESTARTED",,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Product administration error,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, WAS RESTARTED",,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, WAS RESTARTED",,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Treatment noncompliance,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175700806,17570080,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, WAS RESTARTED",,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Urinary tract disorder,,2020,Q2,6,F,,20200502.0,20200323,20200514,EXP,,PT-AUROBINDO-AUR-APL-2020-014210,AUROBINDO,,61.0,YR,,M,Y,,,20200514.0,,HP,PT,PT,2020,Q2,Adult
175784932,17578493,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q2,Condition aggravated,,2020,Q2,2,F,,20200327.0,20200324,20200402,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009271,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J..THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY..CLIN-TOXICOL-(PHILA) 2020;:.",68.0,YR,,M,Y,,,20200402.0,,MD,SE,SE,2020,Q2,Elderly
175784932,17578493,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q2,Incorrect route of product administration,,2020,Q2,2,F,,20200327.0,20200324,20200402,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009271,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J..THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY..CLIN-TOXICOL-(PHILA) 2020;:.",68.0,YR,,M,Y,,,20200402.0,,MD,SE,SE,2020,Q2,Elderly
175784932,17578493,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q2,Non-cardiogenic pulmonary oedema,,2020,Q2,2,F,,20200327.0,20200324,20200402,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009271,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J..THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY..CLIN-TOXICOL-(PHILA) 2020;:.",68.0,YR,,M,Y,,,20200402.0,,MD,SE,SE,2020,Q2,Elderly
175784932,17578493,1,PS,Insulin glargine,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q2,Off label use,,2020,Q2,2,F,,20200327.0,20200324,20200402,EXP,,SE-ELI_LILLY_AND_COMPANY-SE202003009271,ELI LILLY AND CO,"LINDEMAN E, ALEBRING J, JOHANSSON A, AHLNER J, KUGELBERG FC, NORDMARK GRASS J..THE UNKNOWN KNOWN: NON-CARDIOGENIC PULMONARY EDEMA IN AMLODIPINE POISONING, A COHORT STUDY..CLIN-TOXICOL-(PHILA) 2020;:.",68.0,YR,,M,Y,,,20200402.0,,MD,SE,SE,2020,Q2,Elderly
175849912,17584991,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNKNOWN,,,U,,,,,,,,,2020,Q2,Posterior reversible encephalopathy syndrome,,2020,Q2,2,F,,20200326.0,20200326,20200403,EXP,,US-TORRENT-00010125,TORRENT,,41.0,YR,A,F,Y,,,20200403.0,,MD,US,US,2020,Q2,Adult
175849912,17584991,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNKNOWN,,,U,,,,,,,,,2020,Q2,Serotonin syndrome,,2020,Q2,2,F,,20200326.0,20200326,20200403,EXP,,US-TORRENT-00010125,TORRENT,,41.0,YR,A,F,Y,,,20200403.0,,MD,US,US,2020,Q2,Adult
175935383,17593538,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Bone density decreased,,2020,Q2,3,F,201908.0,20200506.0,20200327,20200602,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200602.0,,LW,US,US,2020,Q2,Adult
175935383,17593538,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,3,F,201908.0,20200506.0,20200327,20200602,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200602.0,,LW,US,US,2020,Q2,Adult
175935383,17593538,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Osteopenia,,2020,Q2,3,F,201908.0,20200506.0,20200327,20200602,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200602.0,,LW,US,US,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Oxygen consumption increased,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Oxygen saturation decreased,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Pulmonary arterial hypertension,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Pulmonary oedema,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Pulmonary veno-occlusive disease,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Right ventricular failure,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175946004,17594600,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK,,,,,,,,,,,,2020,Q2,Right-to-left cardiac shunt,,2020,Q2,4,F,2020.0,20200505.0,20200327,20200515,EXP,,CA-ACTELION-A-CH2020-203225,ACTELION,,60.0,YR,,F,Y,82.0,KG,20200515.0,,MD,CA,CA,2020,Q2,Adult
175996519,17599651,14,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Drug interaction,,2020,Q2,9,F,20200115.0,20200604.0,20200330,20200609,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-025402,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,77.0,KG,20200609.0,,HP,DE,DE,2020,Q2,Elderly
175996519,17599651,14,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Eye movement disorder,,2020,Q2,9,F,20200115.0,20200604.0,20200330,20200609,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-025402,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,77.0,KG,20200609.0,,HP,DE,DE,2020,Q2,Elderly
175996519,17599651,14,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Movement disorder,,2020,Q2,9,F,20200115.0,20200604.0,20200330,20200609,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-025402,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,77.0,KG,20200609.0,,HP,DE,DE,2020,Q2,Elderly
175996519,17599651,14,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Oculogyric crisis,,2020,Q2,9,F,20200115.0,20200604.0,20200330,20200609,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-025402,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,77.0,KG,20200609.0,,HP,DE,DE,2020,Q2,Elderly
175996519,17599651,14,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Seizure,,2020,Q2,9,F,20200115.0,20200604.0,20200330,20200609,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-025402,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,77.0,KG,20200609.0,,HP,DE,DE,2020,Q2,Elderly
1760743416,17607434,7,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Drug interaction,,2020,Q2,16,F,20200115.0,20200604.0,20200331,20200610,EXP,,DE-PFIZER INC-2020134407,PFIZER,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
1760743416,17607434,7,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Eye movement disorder,,2020,Q2,16,F,20200115.0,20200604.0,20200331,20200610,EXP,,DE-PFIZER INC-2020134407,PFIZER,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
1760743416,17607434,7,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Movement disorder,,2020,Q2,16,F,20200115.0,20200604.0,20200331,20200610,EXP,,DE-PFIZER INC-2020134407,PFIZER,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
1760743416,17607434,7,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Oculogyric crisis,,2020,Q2,16,F,20200115.0,20200604.0,20200331,20200610,EXP,,DE-PFIZER INC-2020134407,PFIZER,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
1760743416,17607434,7,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Seizure,,2020,Q2,16,F,20200115.0,20200604.0,20200331,20200610,EXP,,DE-PFIZER INC-2020134407,PFIZER,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
176077921,17607792,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Posterior reversible encephalopathy syndrome,,2020,Q2,1,I,,20200326.0,20200401,20200401,EXP,,US-HETERO-HET2020US00371,HETERO,,41.0,YR,,F,Y,,,20200401.0,,HP,IN,US,2020,Q2,Adult
176077921,17607792,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Serotonin syndrome,,2020,Q2,1,I,,20200326.0,20200401,20200401,EXP,,US-HETERO-HET2020US00371,HETERO,,41.0,YR,,F,Y,,,20200401.0,,HP,IN,US,2020,Q2,Adult
176082381,17608238,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS SUBCUTANEOUS DAILY,,,,, UNKNOWN,,,50.0,IU,,QD,2020,Q2,Pneumonia,,2020,Q2,1,I,20200323.0,20200325.0,20200401,20200401,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-US-016591",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,,,20200401.0,,CN,US,US,2020,Q2,Elderly
176086034,17608603,5,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,4,F,20200115.0,20200516.0,20200401,20200520,EXP,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,69.0,YR,E,M,Y,77.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
176086034,17608603,5,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,,QD,2020,Q2,Eye movement disorder,,2020,Q2,4,F,20200115.0,20200516.0,20200401,20200520,EXP,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,69.0,YR,E,M,Y,77.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
176086034,17608603,5,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,,QD,2020,Q2,Movement disorder,,2020,Q2,4,F,20200115.0,20200516.0,20200401,20200520,EXP,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,69.0,YR,E,M,Y,77.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
176086034,17608603,5,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,,QD,2020,Q2,Off label use,,2020,Q2,4,F,20200115.0,20200516.0,20200401,20200520,EXP,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,69.0,YR,E,M,Y,77.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
176086034,17608603,5,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,,QD,2020,Q2,Seizure,,2020,Q2,4,F,20200115.0,20200516.0,20200401,20200520,EXP,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,69.0,YR,E,M,Y,77.0,KG,20200520.0,,PH,DE,DE,2020,Q2,Elderly
176105972,17610597,17,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Pneumonia,,2020,Q2,2,F,20200325.0,20200408.0,20200401,20200410,EXP,,MX-CELGENEUS-MEX-20200310414,CELGENE,,68.0,YR,,M,Y,,,20200410.0,,HP,MX,MX,2020,Q2,Elderly
176116491,17611649,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2020,Q2,Injury,,2020,Q2,1,I,202001.0,20200113.0,20200401,20200401,EXP,,US-BAYER-2020-011537,BAYER,,61.0,YR,A,F,Y,,,20200401.0,,HP,US,US,2020,Q2,Adult
176116491,17611649,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,,,,,,14.0,IU,,QD,2020,Q2,Surgery,,2020,Q2,1,I,202001.0,20200113.0,20200401,20200401,EXP,,US-BAYER-2020-011537,BAYER,,61.0,YR,A,F,Y,,,20200401.0,,HP,US,US,2020,Q2,Adult
176124861,17612486,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Asthenia,,2020,Q2,1,I,20170624.0,20200319.0,20200401,20200401,EXP,,IT-BAUSCH-BL-2020-008687,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20200401.0,,MD,IT,IT,2020,Q2,Elderly
176124861,17612486,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Bradycardia,,2020,Q2,1,I,20170624.0,20200319.0,20200401,20200401,EXP,,IT-BAUSCH-BL-2020-008687,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20200401.0,,MD,IT,IT,2020,Q2,Elderly
176124861,17612486,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Hypotension,,2020,Q2,1,I,20170624.0,20200319.0,20200401,20200401,EXP,,IT-BAUSCH-BL-2020-008687,BAUSCH AND LOMB,,73.0,YR,,M,Y,,,20200401.0,,MD,IT,IT,2020,Q2,Elderly
176142971,17614297,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,,20200327.0,20200402,20200402,EXP,,US-DRREDDYS-USA/USA/20/0121439,DR REDDYS,"SELAMET U, HANNA RM, SISK A, ABDELNOUR L, GHOBRY L, KURTZ I. ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT. SAGE OPEN MEDICAL CASE REPORTS. 2020;8. DOI: 10.1177/2050313X20910029.",69.0,YR,E,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
176142971,17614297,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2020,Q2,Diabetic nephropathy,,2020,Q2,1,I,,20200327.0,20200402,20200402,EXP,,US-DRREDDYS-USA/USA/20/0121439,DR REDDYS,"SELAMET U, HANNA RM, SISK A, ABDELNOUR L, GHOBRY L, KURTZ I. ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT. SAGE OPEN MEDICAL CASE REPORTS. 2020;8. DOI: 10.1177/2050313X20910029.",69.0,YR,E,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
176142971,17614297,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2020,Q2,Hypersensitivity,,2020,Q2,1,I,,20200327.0,20200402,20200402,EXP,,US-DRREDDYS-USA/USA/20/0121439,DR REDDYS,"SELAMET U, HANNA RM, SISK A, ABDELNOUR L, GHOBRY L, KURTZ I. ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT. SAGE OPEN MEDICAL CASE REPORTS. 2020;8. DOI: 10.1177/2050313X20910029.",69.0,YR,E,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
176142971,17614297,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2020,Q2,Kidney fibrosis,,2020,Q2,1,I,,20200327.0,20200402,20200402,EXP,,US-DRREDDYS-USA/USA/20/0121439,DR REDDYS,"SELAMET U, HANNA RM, SISK A, ABDELNOUR L, GHOBRY L, KURTZ I. ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT. SAGE OPEN MEDICAL CASE REPORTS. 2020;8. DOI: 10.1177/2050313X20910029.",69.0,YR,E,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
176142971,17614297,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2020,Q2,Lupus-like syndrome,,2020,Q2,1,I,,20200327.0,20200402,20200402,EXP,,US-DRREDDYS-USA/USA/20/0121439,DR REDDYS,"SELAMET U, HANNA RM, SISK A, ABDELNOUR L, GHOBRY L, KURTZ I. ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT. SAGE OPEN MEDICAL CASE REPORTS. 2020;8. DOI: 10.1177/2050313X20910029.",69.0,YR,E,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
176142971,17614297,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2020,Q2,Renal tubular necrosis,,2020,Q2,1,I,,20200327.0,20200402,20200402,EXP,,US-DRREDDYS-USA/USA/20/0121439,DR REDDYS,"SELAMET U, HANNA RM, SISK A, ABDELNOUR L, GHOBRY L, KURTZ I. ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT. SAGE OPEN MEDICAL CASE REPORTS. 2020;8. DOI: 10.1177/2050313X20910029.",69.0,YR,E,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
176142971,17614297,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2020,Q2,Tubulointerstitial nephritis,,2020,Q2,1,I,,20200327.0,20200402,20200402,EXP,,US-DRREDDYS-USA/USA/20/0121439,DR REDDYS,"SELAMET U, HANNA RM, SISK A, ABDELNOUR L, GHOBRY L, KURTZ I. ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT. SAGE OPEN MEDICAL CASE REPORTS. 2020;8. DOI: 10.1177/2050313X20910029.",69.0,YR,E,F,Y,,,20200402.0,,MD,US,US,2020,Q2,Elderly
176150884,17615088,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q2,Drug interaction,,2020,Q2,4,F,20200115.0,20200515.0,20200402,20200525,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200525.0,,CN,DE,DE,2020,Q2,Elderly
176150884,17615088,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q2,Eye movement disorder,,2020,Q2,4,F,20200115.0,20200515.0,20200402,20200525,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200525.0,,CN,DE,DE,2020,Q2,Elderly
176150884,17615088,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q2,Movement disorder,,2020,Q2,4,F,20200115.0,20200515.0,20200402,20200525,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200525.0,,CN,DE,DE,2020,Q2,Elderly
176150884,17615088,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q2,Off label use,,2020,Q2,4,F,20200115.0,20200515.0,20200402,20200525,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200525.0,,CN,DE,DE,2020,Q2,Elderly
176150884,17615088,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q2,Seizure,,2020,Q2,4,F,20200115.0,20200515.0,20200402,20200525,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200525.0,,CN,DE,DE,2020,Q2,Elderly
176191941,17619194,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Anaphylactic reaction,,2020,Q2,1,I,,20200330.0,20200402,20200402,EXP,,NVSC2020CA089906,NOVARTIS,,64.0,YR,,F,Y,,,20200403.0,,HP,COUNTRY NOT SPECIFIED,CA,2020,Q2,Adult
176191941,17619194,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200330.0,20200402,20200402,EXP,,NVSC2020CA089906,NOVARTIS,,64.0,YR,,F,Y,,,20200403.0,,HP,COUNTRY NOT SPECIFIED,CA,2020,Q2,Adult
176191941,17619194,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Erythema,,2020,Q2,1,I,,20200330.0,20200402,20200402,EXP,,NVSC2020CA089906,NOVARTIS,,64.0,YR,,F,Y,,,20200403.0,,HP,COUNTRY NOT SPECIFIED,CA,2020,Q2,Adult
176191941,17619194,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Rash,,2020,Q2,1,I,,20200330.0,20200402,20200402,EXP,,NVSC2020CA089906,NOVARTIS,,64.0,YR,,F,Y,,,20200403.0,,HP,COUNTRY NOT SPECIFIED,CA,2020,Q2,Adult
176196353,17619635,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJ 300E/ML PEN 1.5ML,,,,,,,,,,INJECTION,QD,2020,Q2,Abdominal pain,,2020,Q2,3,F,201911.0,20200422.0,20200403,20200423,EXP,,NL-ABBVIE-19K-114-2997106-00,ABBVIE,,61.0,YR,,F,Y,,,20200423.0,,MD,NL,NL,2020,Q2,Adult
176196353,17619635,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJ 300E/ML PEN 1.5ML,,,,,,,,,,INJECTION,QD,2020,Q2,Cholecystectomy,,2020,Q2,3,F,201911.0,20200422.0,20200403,20200423,EXP,,NL-ABBVIE-19K-114-2997106-00,ABBVIE,,61.0,YR,,F,Y,,,20200423.0,,MD,NL,NL,2020,Q2,Adult
176196353,17619635,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,INJ 300E/ML PEN 1.5ML,,,,,,,,,,INJECTION,QD,2020,Q2,Stress,,2020,Q2,3,F,201911.0,20200422.0,20200403,20200423,EXP,,NL-ABBVIE-19K-114-2997106-00,ABBVIE,,61.0,YR,,F,Y,,,20200423.0,,MD,NL,NL,2020,Q2,Adult
176212231,17621223,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200402.0,20200403,20200403,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-028189,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20200403.0,,PH,US,US,2020,Q2,Elderly
176232464,17623246,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IU IN THE EVENING,,,,,,,21081.0,15.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,4,F,20200115.0,20200520.0,20200403,20200525,EXP,DE-BFARM-20003581,DE-SA-2020SA081110,SANOFI AVENTIS,,69.0,YR,E,M,Y,77.0,KG,20200525.0,,HP,DE,DE,2020,Q2,Elderly
176232464,17623246,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IU IN THE EVENING,,,,,,,21081.0,15.0,IU,,QD,2020,Q2,Eye movement disorder,,2020,Q2,4,F,20200115.0,20200520.0,20200403,20200525,EXP,DE-BFARM-20003581,DE-SA-2020SA081110,SANOFI AVENTIS,,69.0,YR,E,M,Y,77.0,KG,20200525.0,,HP,DE,DE,2020,Q2,Elderly
176232464,17623246,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IU IN THE EVENING,,,,,,,21081.0,15.0,IU,,QD,2020,Q2,Movement disorder,,2020,Q2,4,F,20200115.0,20200520.0,20200403,20200525,EXP,DE-BFARM-20003581,DE-SA-2020SA081110,SANOFI AVENTIS,,69.0,YR,E,M,Y,77.0,KG,20200525.0,,HP,DE,DE,2020,Q2,Elderly
176232464,17623246,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IU IN THE EVENING,,,,,,,21081.0,15.0,IU,,QD,2020,Q2,Off label use,,2020,Q2,4,F,20200115.0,20200520.0,20200403,20200525,EXP,DE-BFARM-20003581,DE-SA-2020SA081110,SANOFI AVENTIS,,69.0,YR,E,M,Y,77.0,KG,20200525.0,,HP,DE,DE,2020,Q2,Elderly
176232464,17623246,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IU IN THE EVENING,,,,,,,21081.0,15.0,IU,,QD,2020,Q2,Seizure,,2020,Q2,4,F,20200115.0,20200520.0,20200403,20200525,EXP,DE-BFARM-20003581,DE-SA-2020SA081110,SANOFI AVENTIS,,69.0,YR,E,M,Y,77.0,KG,20200525.0,,HP,DE,DE,2020,Q2,Elderly
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Dehydration,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Glycosuria,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Oedema,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Peripheral swelling,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Polydipsia,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Product dose omission,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Treatment noncompliance,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Weight decreased,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176243001,17624300,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Weight increased,,2020,Q2,1,I,,20200330.0,20200403,20200403,EXP,,PT-SA-2020SA078382,SANOFI AVENTIS,LIZ C; CUNHA J; LIRA S.. INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE. NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):43-46,14.0,YR,T,F,Y,,,20200403.0,,HP,PT,PT,2020,Q2,Youth
176244661,17624466,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 IU/3ML,,,,,,,,,,,,2020,Q2,Pleural effusion,,2020,Q2,1,I,20181005.0,20181010.0,20200403,20200403,EXP,,DE-ABBVIE-18P-062-3121660-00,ABBVIE,,68.0,YR,,M,Y,86.0,KG,20200403.0,,MD,DE,DE,2020,Q2,Elderly
176253861,17625386,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Posterior reversible encephalopathy syndrome,,2020,Q2,1,I,,20200326.0,20200403,20200403,EXP,,US-AUROBINDO-AUR-APL-2020-016294,AUROBINDO,,41.0,YR,,F,Y,,,20200404.0,,HP,US,US,2020,Q2,Adult
176253861,17625386,4,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Serotonin syndrome,,2020,Q2,1,I,,20200326.0,20200403,20200403,EXP,,US-AUROBINDO-AUR-APL-2020-016294,AUROBINDO,,41.0,YR,,F,Y,,,20200404.0,,HP,US,US,2020,Q2,Adult
176254351,17625435,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,,20200327.0,20200403,20200403,EXP,,US-AUROBINDO-AUR-APL-2020-016296,AUROBINDO,,69.0,YR,,F,Y,,,20200404.0,,HP,US,US,2020,Q2,Elderly
176254351,17625435,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Diabetic nephropathy,,2020,Q2,1,I,,20200327.0,20200403,20200403,EXP,,US-AUROBINDO-AUR-APL-2020-016296,AUROBINDO,,69.0,YR,,F,Y,,,20200404.0,,HP,US,US,2020,Q2,Elderly
176254351,17625435,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Hypersensitivity,,2020,Q2,1,I,,20200327.0,20200403,20200403,EXP,,US-AUROBINDO-AUR-APL-2020-016296,AUROBINDO,,69.0,YR,,F,Y,,,20200404.0,,HP,US,US,2020,Q2,Elderly
176254351,17625435,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Kidney fibrosis,,2020,Q2,1,I,,20200327.0,20200403,20200403,EXP,,US-AUROBINDO-AUR-APL-2020-016296,AUROBINDO,,69.0,YR,,F,Y,,,20200404.0,,HP,US,US,2020,Q2,Elderly
176254351,17625435,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Lupus-like syndrome,,2020,Q2,1,I,,20200327.0,20200403,20200403,EXP,,US-AUROBINDO-AUR-APL-2020-016296,AUROBINDO,,69.0,YR,,F,Y,,,20200404.0,,HP,US,US,2020,Q2,Elderly
176254351,17625435,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Renal tubular necrosis,,2020,Q2,1,I,,20200327.0,20200403,20200403,EXP,,US-AUROBINDO-AUR-APL-2020-016296,AUROBINDO,,69.0,YR,,F,Y,,,20200404.0,,HP,US,US,2020,Q2,Elderly
176254351,17625435,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Tubulointerstitial nephritis,,2020,Q2,1,I,,20200327.0,20200403,20200403,EXP,,US-AUROBINDO-AUR-APL-2020-016296,AUROBINDO,,69.0,YR,,F,Y,,,20200404.0,,HP,US,US,2020,Q2,Elderly
176288792,17628879,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Posterior reversible encephalopathy syndrome,,2020,Q2,2,F,,20200402.0,20200406,20200414,EXP,,US-ACCORD-178113,ACCORD,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68.",41.0,YR,,F,Y,,,20200414.0,,MD,US,US,2020,Q2,Adult
176288792,17628879,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Serotonin syndrome,,2020,Q2,2,F,,20200402.0,20200406,20200414,EXP,,US-ACCORD-178113,ACCORD,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68.",41.0,YR,,F,Y,,,20200414.0,,MD,US,US,2020,Q2,Adult
176297182,17629718,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,60 UNITS,,,U,,,,,,,,,2020,Q2,Gingival hypertrophy,,2020,Q2,2,F,,20200413.0,20200406,20200420,EXP,,US-TEVA-2020-US-1218169,TEVA,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL-MAXILLOFAC-SURG-CASES 2020;6:NO. 1.",52.0,YR,,M,Y,,,20200420.0,,HP,US,US,2020,Q2,Adult
176297182,17629718,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,60 UNITS,,,U,,,,,,,,,2020,Q2,Periodontitis,,2020,Q2,2,F,,20200413.0,20200406,20200420,EXP,,US-TEVA-2020-US-1218169,TEVA,"GOLOB DEEB J, LYONS DJ, LASKIN DM, DEEB GR. SEVERE DRUG-INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL-MAXILLOFAC-SURG-CASES 2020;6:NO. 1.",52.0,YR,,M,Y,,,20200420.0,,HP,US,US,2020,Q2,Adult
176322301,17632230,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Arthralgia,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091875,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176322301,17632230,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Blood creatine phosphokinase increased,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091875,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176322301,17632230,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Mobility decreased,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091875,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176322301,17632230,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Myalgia,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091875,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176322301,17632230,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Myositis,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091875,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176322301,17632230,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Pain,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091875,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176322301,17632230,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q2,Rhabdomyolysis,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091875,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176341661,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Arthralgia,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176341661,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood creatine phosphokinase increased,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176341661,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Mobility decreased,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176341661,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Myalgia,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176341661,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Pain,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176341661,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Rhabdomyolysis,,2020,Q2,1,I,,20200330.0,20200406,20200406,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20200406.0,,HP,CA,CA,2020,Q2,Young Adult
176356521,17635652,8,I,insulin glargine,INSULIN GLARGINE,1,,15 IE ABENDS,,,,, UNKNOWN,,,15.0,IU,,,2020,Q2,Drug interaction,,2020,Q2,1,I,20200115.0,20200401.0,20200407,20200407,EXP,DE-BFARM-20003581,DE-TEVA-2020-DE-1219947,TEVA,,69.0,YR,,M,Y,77.0,KG,20200407.0,,CN,DE,DE,2020,Q2,Elderly
176356521,17635652,8,I,insulin glargine,INSULIN GLARGINE,1,,15 IE ABENDS,,,,, UNKNOWN,,,15.0,IU,,,2020,Q2,Eye movement disorder,,2020,Q2,1,I,20200115.0,20200401.0,20200407,20200407,EXP,DE-BFARM-20003581,DE-TEVA-2020-DE-1219947,TEVA,,69.0,YR,,M,Y,77.0,KG,20200407.0,,CN,DE,DE,2020,Q2,Elderly
176356521,17635652,8,I,insulin glargine,INSULIN GLARGINE,1,,15 IE ABENDS,,,,, UNKNOWN,,,15.0,IU,,,2020,Q2,Movement disorder,,2020,Q2,1,I,20200115.0,20200401.0,20200407,20200407,EXP,DE-BFARM-20003581,DE-TEVA-2020-DE-1219947,TEVA,,69.0,YR,,M,Y,77.0,KG,20200407.0,,CN,DE,DE,2020,Q2,Elderly
176356521,17635652,8,I,insulin glargine,INSULIN GLARGINE,1,,15 IE ABENDS,,,,, UNKNOWN,,,15.0,IU,,,2020,Q2,Off label use,,2020,Q2,1,I,20200115.0,20200401.0,20200407,20200407,EXP,DE-BFARM-20003581,DE-TEVA-2020-DE-1219947,TEVA,,69.0,YR,,M,Y,77.0,KG,20200407.0,,CN,DE,DE,2020,Q2,Elderly
176356521,17635652,8,I,insulin glargine,INSULIN GLARGINE,1,,15 IE ABENDS,,,,, UNKNOWN,,,15.0,IU,,,2020,Q2,Seizure,,2020,Q2,1,I,20200115.0,20200401.0,20200407,20200407,EXP,DE-BFARM-20003581,DE-TEVA-2020-DE-1219947,TEVA,,69.0,YR,,M,Y,77.0,KG,20200407.0,,CN,DE,DE,2020,Q2,Elderly
176357388,17635738,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Drug interaction,,2020,Q2,8,F,20200115.0,20200608.0,20200406,20200616,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,68.0,YR,,M,Y,77.0,KG,20200616.0,,CN,DE,DE,2020,Q2,Elderly
176357388,17635738,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Movement disorder,,2020,Q2,8,F,20200115.0,20200608.0,20200406,20200616,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,68.0,YR,,M,Y,77.0,KG,20200616.0,,CN,DE,DE,2020,Q2,Elderly
176357388,17635738,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Oculogyric crisis,,2020,Q2,8,F,20200115.0,20200608.0,20200406,20200616,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,68.0,YR,,M,Y,77.0,KG,20200616.0,,CN,DE,DE,2020,Q2,Elderly
176357388,17635738,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Seizure,,2020,Q2,8,F,20200115.0,20200608.0,20200406,20200616,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,68.0,YR,,M,Y,77.0,KG,20200616.0,,CN,DE,DE,2020,Q2,Elderly
176382831,17638283,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,1,I,20181106.0,20200325.0,20200407,20200407,EXP,IT-MINISAL02-538310,IT-JNJFOC-20200343241,JOHNSON AND JOHNSON,,82.0,YR,,M,Y,,,20200407.0,,PH,IT,IT,2020,Q2,Elderly
176382831,17638283,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,20181106.0,20200325.0,20200407,20200407,EXP,IT-MINISAL02-538310,IT-JNJFOC-20200343241,JOHNSON AND JOHNSON,,82.0,YR,,M,Y,,,20200407.0,,PH,IT,IT,2020,Q2,Elderly
176382831,17638283,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Melaena,,2020,Q2,1,I,20181106.0,20200325.0,20200407,20200407,EXP,IT-MINISAL02-538310,IT-JNJFOC-20200343241,JOHNSON AND JOHNSON,,82.0,YR,,M,Y,,,20200407.0,,PH,IT,IT,2020,Q2,Elderly
176394451,17639445,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,20200301.0,20200310.0,20200407,20200407,EXP,IT-MINISAL02-610154,IT-JNJFOC-20200315359,JOHNSON AND JOHNSON,,61.0,YR,,M,Y,,,20200407.0,,MD,IT,IT,2020,Q2,Adult
176394451,17639445,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Sopor,,2020,Q2,1,I,20200301.0,20200310.0,20200407,20200407,EXP,IT-MINISAL02-610154,IT-JNJFOC-20200315359,JOHNSON AND JOHNSON,,61.0,YR,,M,Y,,,20200407.0,,MD,IT,IT,2020,Q2,Adult
176398362,17639836,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2020,Q2,Acute kidney injury,,2020,Q2,2,F,20191126.0,20200408.0,20200407,20200417,EXP,FR-AFSSAPS-GR20200479,FR-EMD SERONO-E2B_90076385,EMD SERONO INC,,80.0,YR,,F,Y,60.0,KG,20200417.0,,PH,FR,FR,2020,Q2,Elderly
176398362,17639836,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2020,Q2,Bradycardia,,2020,Q2,2,F,20191126.0,20200408.0,20200407,20200417,EXP,FR-AFSSAPS-GR20200479,FR-EMD SERONO-E2B_90076385,EMD SERONO INC,,80.0,YR,,F,Y,60.0,KG,20200417.0,,PH,FR,FR,2020,Q2,Elderly
176398362,17639836,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2020,Q2,Cognitive disorder,,2020,Q2,2,F,20191126.0,20200408.0,20200407,20200417,EXP,FR-AFSSAPS-GR20200479,FR-EMD SERONO-E2B_90076385,EMD SERONO INC,,80.0,YR,,F,Y,60.0,KG,20200417.0,,PH,FR,FR,2020,Q2,Elderly
176398362,17639836,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2020,Q2,Lactic acidosis,,2020,Q2,2,F,20191126.0,20200408.0,20200407,20200417,EXP,FR-AFSSAPS-GR20200479,FR-EMD SERONO-E2B_90076385,EMD SERONO INC,,80.0,YR,,F,Y,60.0,KG,20200417.0,,PH,FR,FR,2020,Q2,Elderly
176398362,17639836,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2020,Q2,Orthostatic hypotension,,2020,Q2,2,F,20191126.0,20200408.0,20200407,20200417,EXP,FR-AFSSAPS-GR20200479,FR-EMD SERONO-E2B_90076385,EMD SERONO INC,,80.0,YR,,F,Y,60.0,KG,20200417.0,,PH,FR,FR,2020,Q2,Elderly
176398362,17639836,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,QD,2020,Q2,Overdose,,2020,Q2,2,F,20191126.0,20200408.0,20200407,20200417,EXP,FR-AFSSAPS-GR20200479,FR-EMD SERONO-E2B_90076385,EMD SERONO INC,,80.0,YR,,F,Y,60.0,KG,20200417.0,,PH,FR,FR,2020,Q2,Elderly
1764090014,17640900,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,100.0,DF,INJECTION,,2020,Q2,Ascites,,2020,Q2,14,F,20200306.0,20200625.0,20200407,20200630,PER,,CO-EISAI MEDICAL RESEARCH-EC-2020-072240,EISAI,,72.0,YR,E,M,Y,72.2,KG,20200630.0,,MD,CO,CO,2020,Q2,Elderly
1764090014,17640900,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,100.0,DF,INJECTION,,2020,Q2,Bronchitis,,2020,Q2,14,F,20200306.0,20200625.0,20200407,20200630,PER,,CO-EISAI MEDICAL RESEARCH-EC-2020-072240,EISAI,,72.0,YR,E,M,Y,72.2,KG,20200630.0,,MD,CO,CO,2020,Q2,Elderly
1764090014,17640900,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,100.0,DF,INJECTION,,2020,Q2,Oesophageal varices haemorrhage,,2020,Q2,14,F,20200306.0,20200625.0,20200407,20200630,PER,,CO-EISAI MEDICAL RESEARCH-EC-2020-072240,EISAI,,72.0,YR,E,M,Y,72.2,KG,20200630.0,,MD,CO,CO,2020,Q2,Elderly
176481982,17648198,3,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,3,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,3,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Gastrointestinal disorder,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,3,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Genitourinary symptom,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,3,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Product administration error,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,3,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,3,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Treatment noncompliance,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176481982,17648198,3,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Urinary tract disorder,,2020,Q2,2,F,,20200406.0,20200408,20200416,EXP,,PT-EMD SERONO-9152906,EMD SERONO INC,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. EMPODERAMENTO E TERAPEUTICA INDIVIDUALIZADA:UMA ALIANCA DE SUCESSO NA DIABETES. 2020;15(1):79.",61.0,YR,,M,Y,,,20200416.0,,HP,PT,PT,2020,Q2,Adult
176484391,17648439,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100U/ML 24 UNITS IN 1 MORNING DOSE,,,,,,,,,,,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,1,I,201509.0,20200401.0,20200408,20200408,EXP,,CZ-EMD SERONO-9155967,EMD SERONO INC,UNKNOWN. JEDNOU JE EFEKTIVNEJSI NEZ DVAKRAT?!. DIABETOLOGIE. 2020;21-22.,57.0,YR,,M,Y,103.0,KG,20200408.0,,MD,CZ,CZ,2020,Q2,Adult
176484391,17648439,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100U/ML 24 UNITS IN 1 MORNING DOSE,,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201509.0,20200401.0,20200408,20200408,EXP,,CZ-EMD SERONO-9155967,EMD SERONO INC,UNKNOWN. JEDNOU JE EFEKTIVNEJSI NEZ DVAKRAT?!. DIABETOLOGIE. 2020;21-22.,57.0,YR,,M,Y,103.0,KG,20200408.0,,MD,CZ,CZ,2020,Q2,Adult
176484391,17648439,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100U/ML IN 2 MORNING DOSES,,,,,,,,,,,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,1,I,201509.0,20200401.0,20200408,20200408,EXP,,CZ-EMD SERONO-9155967,EMD SERONO INC,UNKNOWN. JEDNOU JE EFEKTIVNEJSI NEZ DVAKRAT?!. DIABETOLOGIE. 2020;21-22.,57.0,YR,,M,Y,103.0,KG,20200408.0,,MD,CZ,CZ,2020,Q2,Adult
176484391,17648439,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100U/ML IN 2 MORNING DOSES,,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201509.0,20200401.0,20200408,20200408,EXP,,CZ-EMD SERONO-9155967,EMD SERONO INC,UNKNOWN. JEDNOU JE EFEKTIVNEJSI NEZ DVAKRAT?!. DIABETOLOGIE. 2020;21-22.,57.0,YR,,M,Y,103.0,KG,20200408.0,,MD,CZ,CZ,2020,Q2,Adult
176484391,17648439,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,TITRATED UP TO 28 UNITS OF GLARGINE 100U/ML DAILY (10-0-18 J.S.C).,,,,,,,,,,,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,1,I,201509.0,20200401.0,20200408,20200408,EXP,,CZ-EMD SERONO-9155967,EMD SERONO INC,UNKNOWN. JEDNOU JE EFEKTIVNEJSI NEZ DVAKRAT?!. DIABETOLOGIE. 2020;21-22.,57.0,YR,,M,Y,103.0,KG,20200408.0,,MD,CZ,CZ,2020,Q2,Adult
176484391,17648439,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,TITRATED UP TO 28 UNITS OF GLARGINE 100U/ML DAILY (10-0-18 J.S.C).,,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201509.0,20200401.0,20200408,20200408,EXP,,CZ-EMD SERONO-9155967,EMD SERONO INC,UNKNOWN. JEDNOU JE EFEKTIVNEJSI NEZ DVAKRAT?!. DIABETOLOGIE. 2020;21-22.,57.0,YR,,M,Y,103.0,KG,20200408.0,,MD,CZ,CZ,2020,Q2,Adult
176484971,17648497,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Posterior reversible encephalopathy syndrome,,2020,Q2,1,I,,20200326.0,20200408,20200408,EXP,,US-BAUSCH-BL-2020-009496,BAUSCH AND LOMB,"MALIK M, MAJEED M, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020 FEB 12;12:63-68. DOI:10.1159/000505907",41.0,YR,,F,Y,,,20200408.0,,MD,US,US,2020,Q2,Adult
176488121,17648812,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Pyelonephritis,,2020,Q2,1,I,,20200408.0,20200409,20200409,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-029733,BRISTOL MYERS SQUIBB,,23.0,YR,,F,Y,60.0,KG,20200409.0,,CN,CA,CA,2020,Q2,Youth
176488121,17648812,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Weight increased,,2020,Q2,1,I,,20200408.0,20200409,20200409,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-029733,BRISTOL MYERS SQUIBB,,23.0,YR,,F,Y,60.0,KG,20200409.0,,CN,CA,CA,2020,Q2,Youth
176490982,17649098,6,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q2,Colitis,,2020,Q2,2,F,20200324.0,20200409.0,20200408,20200415,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-026124,BRISTOL MYERS SQUIBB,,72.0,YR,,F,Y,84.0,KG,20200415.0,,HP,CA,CA,2020,Q2,Elderly
176514393,17651439,6,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q2,Drug interaction,,2020,Q2,3,F,20200115.0,20200518.0,20200409,20200521,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,69.0,YR,E,M,Y,77.0,KG,20200521.0,,CN,DE,DE,2020,Q2,Elderly
176514393,17651439,6,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q2,Eye movement disorder,,2020,Q2,3,F,20200115.0,20200518.0,20200409,20200521,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,69.0,YR,E,M,Y,77.0,KG,20200521.0,,CN,DE,DE,2020,Q2,Elderly
176514393,17651439,6,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q2,Movement disorder,,2020,Q2,3,F,20200115.0,20200518.0,20200409,20200521,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,69.0,YR,E,M,Y,77.0,KG,20200521.0,,CN,DE,DE,2020,Q2,Elderly
176514393,17651439,6,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q2,Off label use,,2020,Q2,3,F,20200115.0,20200518.0,20200409,20200521,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,69.0,YR,E,M,Y,77.0,KG,20200521.0,,CN,DE,DE,2020,Q2,Elderly
176514393,17651439,6,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q2,Seizure,,2020,Q2,3,F,20200115.0,20200518.0,20200409,20200521,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,69.0,YR,E,M,Y,77.0,KG,20200521.0,,CN,DE,DE,2020,Q2,Elderly
176549771,17654977,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,6 INTERNATIONAL UNIT,,,Y,, D101439CJ,,205692.0,6.0,IU,INJECTION,,2020,Q2,Anaphylactic reaction,,2020,Q2,1,I,20200324.0,20200324.0,20200410,20200410,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202003011334,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20200410.0,,PH,JP,JP,2020,Q2,Adult
176562981,17656298,5,C,GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2020,Q2,Diabetic ketosis,,2020,Q2,1,I,20181020.0,20191002.0,20200410,20200410,EXP,,CN-ASTRAZENECA-2020SE49165,ASTRAZENECA,,8666.0,DY,,M,Y,,,20200410.0,,MD,CN,CN,2020,Q2,Elderly
176576641,17657664,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,21081.0,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,,20200407.0,20200411,20200411,EXP,,DE-SA-2020SA089710,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200411.0,,PH,DE,DE,2020,Q2,Elderly
176576641,17657664,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,21081.0,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200407.0,20200411,20200411,EXP,,DE-SA-2020SA089710,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200411.0,,PH,DE,DE,2020,Q2,Elderly
176576641,17657664,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,21081.0,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200407.0,20200411,20200411,EXP,,DE-SA-2020SA089710,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200411.0,,PH,DE,DE,2020,Q2,Elderly
176576641,17657664,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,21081.0,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200407.0,20200411,20200411,EXP,,DE-SA-2020SA089710,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200411.0,,PH,DE,DE,2020,Q2,Elderly
176576641,17657664,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,21081.0,,,,,2020,Q2,Sedation,,2020,Q2,1,I,,20200407.0,20200411,20200411,EXP,,DE-SA-2020SA089710,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20200411.0,,PH,DE,DE,2020,Q2,Elderly
176578802,17657880,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,,,,,24.0,DF,,QD,2020,Q2,Blood glucose increased,,2020,Q2,2,F,201901.0,20200407.0,20200411,20200430,EXP,,NVSC2020CZ097042,NOVARTIS,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200430.0,,HP,CZ,CZ,2020,Q2,Elderly
176578802,17657880,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,,,,,24.0,DF,,QD,2020,Q2,Condition aggravated,,2020,Q2,2,F,201901.0,20200407.0,20200411,20200430,EXP,,NVSC2020CZ097042,NOVARTIS,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200430.0,,HP,CZ,CZ,2020,Q2,Elderly
176578802,17657880,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,,,,,24.0,DF,,QD,2020,Q2,Drug intolerance,,2020,Q2,2,F,201901.0,20200407.0,20200411,20200430,EXP,,NVSC2020CZ097042,NOVARTIS,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200430.0,,HP,CZ,CZ,2020,Q2,Elderly
176591261,17659126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cellulitis,,2020,Q2,1,I,20190825.0,20200406.0,20200413,20200413,EXP,AU-TGA-0000476350,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-018480",BOEHRINGER INGELHEIM,,42.0,YR,,F,Y,,,20200413.0,,HP,AU,AU,2020,Q2,Adult
176591261,17659126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Deep vein thrombosis,,2020,Q2,1,I,20190825.0,20200406.0,20200413,20200413,EXP,AU-TGA-0000476350,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-018480",BOEHRINGER INGELHEIM,,42.0,YR,,F,Y,,,20200413.0,,HP,AU,AU,2020,Q2,Adult
176591261,17659126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,20190825.0,20200406.0,20200413,20200413,EXP,AU-TGA-0000476350,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-018480",BOEHRINGER INGELHEIM,,42.0,YR,,F,Y,,,20200413.0,,HP,AU,AU,2020,Q2,Adult
176591261,17659126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20190825.0,20200406.0,20200413,20200413,EXP,AU-TGA-0000476350,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-018480",BOEHRINGER INGELHEIM,,42.0,YR,,F,Y,,,20200413.0,,HP,AU,AU,2020,Q2,Adult
176591261,17659126,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,1,I,20190825.0,20200406.0,20200413,20200413,EXP,AU-TGA-0000476350,"AU-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-018480",BOEHRINGER INGELHEIM,,42.0,YR,,F,Y,,,20200413.0,,HP,AU,AU,2020,Q2,Adult
176595621,17659562,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 INTERNATIONAL UNIT PER MILLILITRE (16-0-0-0),,,U,, UNKNOWN,,,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-01603,LUPIN,,80.0,YR,,F,Y,,,20200413.0,,CN,NL,DE,2020,Q2,Elderly
176595621,17659562,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 INTERNATIONAL UNIT PER MILLILITRE (16-0-0-0),,,U,, UNKNOWN,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-01603,LUPIN,,80.0,YR,,F,Y,,,20200413.0,,CN,NL,DE,2020,Q2,Elderly
176595621,17659562,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 INTERNATIONAL UNIT PER MILLILITRE (16-0-0-0),,,U,, UNKNOWN,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-01603,LUPIN,,80.0,YR,,F,Y,,,20200413.0,,CN,NL,DE,2020,Q2,Elderly
176595621,17659562,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 INTERNATIONAL UNIT PER MILLILITRE (16-0-0-0),,,U,, UNKNOWN,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-01603,LUPIN,,80.0,YR,,F,Y,,,20200413.0,,CN,NL,DE,2020,Q2,Elderly
176595621,17659562,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,300 INTERNATIONAL UNIT PER MILLILITRE (16-0-0-0),,,U,, UNKNOWN,,,,,,,2020,Q2,Sedation,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-01603,LUPIN,,80.0,YR,,F,Y,,,20200413.0,,CN,NL,DE,2020,Q2,Elderly
176610591,17661059,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Posterior reversible encephalopathy syndrome,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,US-CPL-001715,CADILA,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68.",41.0,YR,,F,Y,,,20200413.0,,MD,US,US,2020,Q2,Adult
176610591,17661059,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Serotonin syndrome,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,US-CPL-001715,CADILA,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68.",41.0,YR,,F,Y,,,20200413.0,,MD,US,US,2020,Q2,Adult
176620791,17662079,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,1,I,200803.0,20200407.0,20200413,20200413,EXP,,SK-EMD SERONO-9156661,EMD SERONO INC,UNKNOWN. USE OF NFI PROTOCOL IN PATIENT WITH DIABETES MELLITUS TYPE 2 FOR 30 YEARS. KAZUISTIKY V DIABETOLOGII. 2020;18(1):27-30.,64.0,YR,,M,Y,77.0,KG,20200413.0,,MD,SK,SK,2020,Q2,Adult
176620791,17662079,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q2,Diabetic vascular disorder,,2020,Q2,1,I,200803.0,20200407.0,20200413,20200413,EXP,,SK-EMD SERONO-9156661,EMD SERONO INC,UNKNOWN. USE OF NFI PROTOCOL IN PATIENT WITH DIABETES MELLITUS TYPE 2 FOR 30 YEARS. KAZUISTIKY V DIABETOLOGII. 2020;18(1):27-30.,64.0,YR,,M,Y,77.0,KG,20200413.0,,MD,SK,SK,2020,Q2,Adult
176620791,17662079,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q2,Weight increased,,2020,Q2,1,I,200803.0,20200407.0,20200413,20200413,EXP,,SK-EMD SERONO-9156661,EMD SERONO INC,UNKNOWN. USE OF NFI PROTOCOL IN PATIENT WITH DIABETES MELLITUS TYPE 2 FOR 30 YEARS. KAZUISTIKY V DIABETOLOGII. 2020;18(1):27-30.,64.0,YR,,M,Y,77.0,KG,20200413.0,,MD,SK,SK,2020,Q2,Adult
176620791,17662079,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSAGE MODIFIED,,,D,,,,,,,,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,1,I,200803.0,20200407.0,20200413,20200413,EXP,,SK-EMD SERONO-9156661,EMD SERONO INC,UNKNOWN. USE OF NFI PROTOCOL IN PATIENT WITH DIABETES MELLITUS TYPE 2 FOR 30 YEARS. KAZUISTIKY V DIABETOLOGII. 2020;18(1):27-30.,64.0,YR,,M,Y,77.0,KG,20200413.0,,MD,SK,SK,2020,Q2,Adult
176620791,17662079,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSAGE MODIFIED,,,D,,,,,,,,,2020,Q2,Diabetic vascular disorder,,2020,Q2,1,I,200803.0,20200407.0,20200413,20200413,EXP,,SK-EMD SERONO-9156661,EMD SERONO INC,UNKNOWN. USE OF NFI PROTOCOL IN PATIENT WITH DIABETES MELLITUS TYPE 2 FOR 30 YEARS. KAZUISTIKY V DIABETOLOGII. 2020;18(1):27-30.,64.0,YR,,M,Y,77.0,KG,20200413.0,,MD,SK,SK,2020,Q2,Adult
176620791,17662079,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,DOSAGE MODIFIED,,,D,,,,,,,,,2020,Q2,Weight increased,,2020,Q2,1,I,200803.0,20200407.0,20200413,20200413,EXP,,SK-EMD SERONO-9156661,EMD SERONO INC,UNKNOWN. USE OF NFI PROTOCOL IN PATIENT WITH DIABETES MELLITUS TYPE 2 FOR 30 YEARS. KAZUISTIKY V DIABETOLOGII. 2020;18(1):27-30.,64.0,YR,,M,Y,77.0,KG,20200413.0,,MD,SK,SK,2020,Q2,Adult
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Dehydration,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Glycosuria,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Oedema,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Peripheral swelling,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Polydipsia,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Product dose omission,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Treatment noncompliance,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Weight decreased,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629122,17662912,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,,,,,205692.0,,,,,2020,Q2,Weight increased,,2020,Q2,2,F,,20200409.0,20200413,20200422,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202004002609,ELI LILLY AND CO,"LIZ C, CUNHA J, LIRA S..INSULIN-INDUCED EDEMA IN A PEDIATRIC PATIENT - CLINICAL CASE..NASCER E CRESCER - BIRTH AND GROWTH MEDICAL JOURNAL. 2020;29(1):463-46.DOI:10.25753/BIRTHGROWTHMJ.V29.I1.15709",14.0,YR,,F,Y,51.5,KG,20200422.0,,HP,PT,PT,2020,Q2,Youth
176629401,17662940,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,QD,2020,Q2,Dehydration,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-018288",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176629401,17662940,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-018288",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176629401,17662940,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-018288",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176629401,17662940,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,QD,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-018288",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176629401,17662940,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,QD,2020,Q2,Sedation,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-018288",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176631551,17663155,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"300 IU/ML, 16-0-0-0",,,U,U,,,205692.0,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202004001444,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176631551,17663155,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"300 IU/ML, 16-0-0-0",,,U,U,,,205692.0,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202004001444,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176631551,17663155,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"300 IU/ML, 16-0-0-0",,,U,U,,,205692.0,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202004001444,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176631551,17663155,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"300 IU/ML, 16-0-0-0",,,U,U,,,205692.0,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202004001444,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176631551,17663155,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"300 IU/ML, 16-0-0-0",,,U,U,,,205692.0,,,,,2020,Q2,Sedation,,2020,Q2,1,I,,20200402.0,20200413,20200413,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202004001444,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20200413.0,,PH,DE,DE,2020,Q2,Elderly
176633721,17663372,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,300 (IE/ML) (16-0-0-0),,,U,U,,,,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,DE-AUROBINDO-AUR-APL-2020-017583,AUROBINDO,,80.0,YR,,F,Y,,,20200414.0,,PH,DE,DE,2020,Q2,Elderly
176633721,17663372,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,300 (IE/ML) (16-0-0-0),,,U,U,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,DE-AUROBINDO-AUR-APL-2020-017583,AUROBINDO,,80.0,YR,,F,Y,,,20200414.0,,PH,DE,DE,2020,Q2,Elderly
176633721,17663372,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,300 (IE/ML) (16-0-0-0),,,U,U,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,DE-AUROBINDO-AUR-APL-2020-017583,AUROBINDO,,80.0,YR,,F,Y,,,20200414.0,,PH,DE,DE,2020,Q2,Elderly
176633721,17663372,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,300 (IE/ML) (16-0-0-0),,,U,U,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,DE-AUROBINDO-AUR-APL-2020-017583,AUROBINDO,,80.0,YR,,F,Y,,,20200414.0,,PH,DE,DE,2020,Q2,Elderly
176633721,17663372,5,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,300 (IE/ML) (16-0-0-0),,,U,U,,,,,,,,2020,Q2,Sedation,,2020,Q2,1,I,,20200406.0,20200413,20200413,EXP,,DE-AUROBINDO-AUR-APL-2020-017583,AUROBINDO,,80.0,YR,,F,Y,,,20200414.0,,PH,DE,DE,2020,Q2,Elderly
176650604,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q2,Drug interaction,,2020,Q2,4,F,20200115.0,20200520.0,20200414,20200527,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200527.0,,PH,DE,DE,2020,Q2,Elderly
176650604,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q2,Eye movement disorder,,2020,Q2,4,F,20200115.0,20200520.0,20200414,20200527,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200527.0,,PH,DE,DE,2020,Q2,Elderly
176650604,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q2,Movement disorder,,2020,Q2,4,F,20200115.0,20200520.0,20200414,20200527,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200527.0,,PH,DE,DE,2020,Q2,Elderly
176650604,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q2,Seizure,,2020,Q2,4,F,20200115.0,20200520.0,20200414,20200527,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200527.0,,PH,DE,DE,2020,Q2,Elderly
176669661,17666966,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,U,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Mental status changes,,2020,Q2,1,I,20170706.0,20190429.0,20200414,20200414,PER,,US-ASTELLAS-2019US018950,ASTELLAS,,66.0,YR,,M,Y,,,20200414.0,,MD,US,US,2020,Q2,Elderly
176669701,17666970,37,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,U,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Diabetes mellitus,,2020,Q2,1,I,20170516.0,20190429.0,20200414,20200414,PER,,US-ASTELLAS-2019US018922,ASTELLAS,,50.0,YR,,F,Y,,,20200414.0,,MD,US,US,2020,Q2,Adult
176676541,17667654,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200401.0,20200414,20200414,EXP,,US-DEXPHARM-20200314,DEXCEL,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68. DOI: 10.1159/000505907.",41.0,YR,A,F,Y,,,20200414.0,,HP,US,US,2020,Q2,Adult
176676541,17667654,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Posterior reversible encephalopathy syndrome,,2020,Q2,1,I,,20200401.0,20200414,20200414,EXP,,US-DEXPHARM-20200314,DEXCEL,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68. DOI: 10.1159/000505907.",41.0,YR,A,F,Y,,,20200414.0,,HP,US,US,2020,Q2,Adult
176676541,17667654,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Serotonin syndrome,,2020,Q2,1,I,,20200401.0,20200414,20200414,EXP,,US-DEXPHARM-20200314,DEXCEL,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68. DOI: 10.1159/000505907.",41.0,YR,A,F,Y,,,20200414.0,,HP,US,US,2020,Q2,Adult
176692231,17669223,17,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cerebrospinal fluid leakage,,2020,Q2,1,I,,,20200414,20200414,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200413.0,N,,US,US,2020,Q2,Adult
176692231,17669223,17,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Disease progression,,2020,Q2,1,I,,,20200414,20200414,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200413.0,N,,US,US,2020,Q2,Adult
176692231,17669223,17,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,1,I,,,20200414,20200414,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200413.0,N,,US,US,2020,Q2,Adult
176692231,17669223,17,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,,20200414,20200414,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200413.0,N,,US,US,2020,Q2,Adult
176692231,17669223,17,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hemiparesis,,2020,Q2,1,I,,,20200414,20200414,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200413.0,N,,US,US,2020,Q2,Adult
176692231,17669223,17,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,,,20200414,20200414,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200413.0,N,,US,US,2020,Q2,Adult
176692231,17669223,17,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Transplant,,2020,Q2,1,I,,,20200414,20200414,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200413.0,N,,US,US,2020,Q2,Adult
176692231,17669223,17,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Vision blurred,,2020,Q2,1,I,,,20200414,20200414,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200413.0,N,,US,US,2020,Q2,Adult
176753191,17675319,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,EVERY PM,,,,,,,,100.0,IU,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200127.0,,20200415,20200415,DIR,,,FDA-CTU,,69.0,YR,,M,N,,,20200229.0,N,PH,US,US,2020,Q2,Elderly
176759741,17675974,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 IU/ML, TOTAL",,,Y,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200413.0,20200416,20200416,EXP,,RU-SA-2020SA097568,SANOFI AVENTIS,,58.0,YR,A,F,Y,105.0,KG,20200416.0,,HP,RU,RU,2020,Q2,Adult
176764751,17676475,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200413.0,20200416,20200416,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202004005021,ELI LILLY AND CO,,78.0,YR,,M,Y,82.0,KG,20200416.0,,CN,CN,CN,2020,Q2,Elderly
176766841,17676684,2,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,,,2020,Q2,Cerebrovascular accident,,2020,Q2,1,I,,20200407.0,20200416,20200416,EXP,,CZ-EMD SERONO-9156668,EMD SERONO INC,UNKNOWN. MATERNALLY INHERITED DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2020;18(1):11-13.,35.0,YR,,F,Y,,,20200416.0,,HP,CZ,CZ,2020,Q2,Adult
176766841,17676684,2,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,Y,,,,,,,,,2020,Q2,Lactic acidosis,,2020,Q2,1,I,,20200407.0,20200416,20200416,EXP,,CZ-EMD SERONO-9156668,EMD SERONO INC,UNKNOWN. MATERNALLY INHERITED DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII. 2020;18(1):11-13.,35.0,YR,,F,Y,,,20200416.0,,HP,CZ,CZ,2020,Q2,Adult
176772982,17677298,21,C,INSULIN GLARGINE INJECTION,,2,Subcutaneous,,,,,,,,,10.0,IU,,,2020,Q2,Pneumonia,,2020,Q2,2,F,20190715.0,20200417.0,20200416,20200424,EXP,,CN-ABBVIE-19P-035-2871296-00,ABBVIE,,73.0,YR,,M,Y,85.0,KG,20200424.0,,MD,CN,CN,2020,Q2,Elderly
176772982,17677298,22,C,INSULIN GLARGINE INJECTION,,2,Subcutaneous,,,,,,,,,12.0,DF,,,2020,Q2,Pneumonia,,2020,Q2,2,F,20190715.0,20200417.0,20200416,20200424,EXP,,CN-ABBVIE-19P-035-2871296-00,ABBVIE,,73.0,YR,,M,Y,85.0,KG,20200424.0,,MD,CN,CN,2020,Q2,Elderly
176773601,17677360,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"94 IU, QD",,,U,U,,,,94.0,IU,,QD,2020,Q2,Pneumonia,,2020,Q2,1,I,,20200407.0,20200416,20200416,EXP,,CA-NOVOPROD-722812,NOVO NORDISK,,71.0,YR,,F,Y,95.0,KG,20200416.0,,HP,CA,CA,2020,Q2,Elderly
176802041,17680204,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100UNT/ML INJ)",INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200130.0,,20200417,20200417,DIR,,,FDA-CTU,,72.0,YR,,F,N,,,20200306.0,N,PH,US,US,2020,Q2,Elderly
176803002,17680300,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 UNIT, BID",,,U,,,,,20.0,DF,,BID,2020,Q2,Confusional state,,2020,Q2,2,F,202002.0,20200427.0,20200417,20200504,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023491,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,93.6,KG,20200504.0,,HP,US,US,2020,Q2,Elderly
176803002,17680300,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 UNIT, BID",,,U,,,,,20.0,DF,,BID,2020,Q2,Encephalopathy,,2020,Q2,2,F,202002.0,20200427.0,20200417,20200504,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023491,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,93.6,KG,20200504.0,,HP,US,US,2020,Q2,Elderly
176803002,17680300,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 UNIT, BID",,,U,,,,,20.0,DF,,BID,2020,Q2,Hepatotoxicity,,2020,Q2,2,F,202002.0,20200427.0,20200417,20200504,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023491,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,93.6,KG,20200504.0,,HP,US,US,2020,Q2,Elderly
176803002,17680300,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 UNIT, BID",,,U,,,,,20.0,DF,,BID,2020,Q2,Muscular weakness,,2020,Q2,2,F,202002.0,20200427.0,20200417,20200504,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023491,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,93.6,KG,20200504.0,,HP,US,US,2020,Q2,Elderly
176819711,17681971,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hepatic angiosarcoma,,2020,Q2,1,I,201511.0,20200403.0,20200418,20200418,EXP,,US-ROCHE-2579607,ROCHE,,63.0,YR,,M,Y,88.53,KG,20200418.0,,MD,US,US,2020,Q2,Adult
176819711,17681971,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Intentional product use issue,,2020,Q2,1,I,201511.0,20200403.0,20200418,20200418,EXP,,US-ROCHE-2579607,ROCHE,,63.0,YR,,M,Y,88.53,KG,20200418.0,,MD,US,US,2020,Q2,Adult
176819711,17681971,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,1,I,201511.0,20200403.0,20200418,20200418,EXP,,US-ROCHE-2579607,ROCHE,,63.0,YR,,M,Y,88.53,KG,20200418.0,,MD,US,US,2020,Q2,Adult
176821231,17682123,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Posterior reversible encephalopathy syndrome,,2020,Q2,1,I,,20200407.0,20200418,20200418,EXP,,US-EMCURE PHARMACEUTICALS LTD-2020-EPL-000431,EMCURE,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME.. CASE REP NEUROL. 2020;12(1):63-68",41.0,YR,,F,Y,,,20200418.0,,MD,US,US,2020,Q2,Adult
176821231,17682123,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Serotonin syndrome,,2020,Q2,1,I,,20200407.0,20200418,20200418,EXP,,US-EMCURE PHARMACEUTICALS LTD-2020-EPL-000431,EMCURE,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME.. CASE REP NEUROL. 2020;12(1):63-68",41.0,YR,,F,Y,,,20200418.0,,MD,US,US,2020,Q2,Adult
176839021,17683902,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (EVENING)",,,U,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,1,I,2008.0,20200414.0,20200420,20200420,EXP,,SK-SA-2020SA099240,SANOFI AVENTIS,LEJAVOV? J. HICKMAN D.. FIRST EXPERIENCE WITH THE USE OF NFI (NATURAL FOOD INTERACTION) PROTOCOL IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN SLOVAKIA. CASE REPORTS IN DIABETOLOGY. 2020;1:20-30,64.0,YR,A,M,Y,,,20200420.0,,MD,SK,SK,2020,Q2,Adult
176839021,17683902,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (EVENING)",,,U,,,,206538.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Weight increased,,2020,Q2,1,I,2008.0,20200414.0,20200420,20200420,EXP,,SK-SA-2020SA099240,SANOFI AVENTIS,LEJAVOV? J. HICKMAN D.. FIRST EXPERIENCE WITH THE USE OF NFI (NATURAL FOOD INTERACTION) PROTOCOL IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN SLOVAKIA. CASE REPORTS IN DIABETOLOGY. 2020;1:20-30,64.0,YR,A,M,Y,,,20200420.0,,MD,SK,SK,2020,Q2,Adult
176840471,17684047,18,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cerebrospinal fluid leakage,,2020,Q2,1,I,,,20200417,20200417,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200417.0,N,MD,US,US,2020,Q2,Adult
176840471,17684047,18,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Disease progression,,2020,Q2,1,I,,,20200417,20200417,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200417.0,N,MD,US,US,2020,Q2,Adult
176840471,17684047,18,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Dizziness,,2020,Q2,1,I,,,20200417,20200417,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200417.0,N,MD,US,US,2020,Q2,Adult
176840471,17684047,18,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,,20200417,20200417,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200417.0,N,MD,US,US,2020,Q2,Adult
176840471,17684047,18,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hemiparesis,,2020,Q2,1,I,,,20200417,20200417,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200417.0,N,MD,US,US,2020,Q2,Adult
176840471,17684047,18,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,,,20200417,20200417,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200417.0,N,MD,US,US,2020,Q2,Adult
176840471,17684047,18,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Vision blurred,,2020,Q2,1,I,,,20200417,20200417,DIR,,,FDA-CTU,,48.0,YR,,F,N,99.3,KG,20200417.0,N,MD,US,US,2020,Q2,Adult
176841901,17684190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,Y,,,,206538.0,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,1,I,,20200414.0,20200420,20200420,EXP,,SK-SA-2020SA099575,SANOFI AVENTIS,SKRIPOVA D.. MULTIFACTORY EFFECT OF EMPAGLIFLOSIN IN A POLYMORBIDAL PATIENT WITH DIABETES MELLITUS. INTERNAL MEDICINE. 2020;S1:8-9,58.0,YR,A,F,Y,,,20200420.0,,MD,SK,SK,2020,Q2,Adult
176841901,17684190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,REDUCTION OF INSULIN DOSE TO 0.4 IU/KG/DAY,,,Y,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,1,I,,20200414.0,20200420,20200420,EXP,,SK-SA-2020SA099575,SANOFI AVENTIS,SKRIPOVA D.. MULTIFACTORY EFFECT OF EMPAGLIFLOSIN IN A POLYMORBIDAL PATIENT WITH DIABETES MELLITUS. INTERNAL MEDICINE. 2020;S1:8-9,58.0,YR,A,F,Y,,,20200420.0,,MD,SK,SK,2020,Q2,Adult
176875361,17687536,3,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,,20200413.0,20200421,20200421,EXP,,US-EMCURE PHARMACEUTICALS LTD-2020-EPL-000448,EMCURE,,76.0,YR,,F,Y,,,20200421.0,,HP,US,US,2020,Q2,Elderly
176875361,17687536,3,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Crystal nephropathy,,2020,Q2,1,I,,20200413.0,20200421,20200421,EXP,,US-EMCURE PHARMACEUTICALS LTD-2020-EPL-000448,EMCURE,,76.0,YR,,F,Y,,,20200421.0,,HP,US,US,2020,Q2,Elderly
176888331,17688833,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, UNKNOWN",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Fatigue,,2020,Q2,1,I,,20200415.0,20200421,20200421,EXP,,NVSC2020ES105522,NOVARTIS,,72.0,YR,,F,Y,70.0,KG,20200421.0,,HP,ES,ES,2020,Q2,Elderly
176888331,17688833,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, UNKNOWN",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Flatulence,,2020,Q2,1,I,,20200415.0,20200421,20200421,EXP,,NVSC2020ES105522,NOVARTIS,,72.0,YR,,F,Y,70.0,KG,20200421.0,,HP,ES,ES,2020,Q2,Elderly
176888331,17688833,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, UNKNOWN",,,,,,,,26.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,,20200415.0,20200421,20200421,EXP,,NVSC2020ES105522,NOVARTIS,,72.0,YR,,F,Y,70.0,KG,20200421.0,,HP,ES,ES,2020,Q2,Elderly
176906671,17690667,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"62 INTERNATIONAL UNIT, ONCE A DAY (EVERY MORNING, 300UNITS/ML)",,,U,,,,,62.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose fluctuation,,2020,Q2,1,I,20190706.0,20200413.0,20200421,20200421,EXP,,GB-AUROBINDO-AUR-APL-2020-019872,AUROBINDO,,69.0,YR,,M,Y,,,20200422.0,,PH,GB,GB,2020,Q2,Elderly
176906671,17690667,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"62 INTERNATIONAL UNIT, ONCE A DAY (EVERY MORNING, 300UNITS/ML)",,,U,,,,,62.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hypophagia,,2020,Q2,1,I,20190706.0,20200413.0,20200421,20200421,EXP,,GB-AUROBINDO-AUR-APL-2020-019872,AUROBINDO,,69.0,YR,,M,Y,,,20200422.0,,PH,GB,GB,2020,Q2,Elderly
176906671,17690667,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"62 INTERNATIONAL UNIT, ONCE A DAY (EVERY MORNING, 300UNITS/ML)",,,U,,,,,62.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Vomiting,,2020,Q2,1,I,20190706.0,20200413.0,20200421,20200421,EXP,,GB-AUROBINDO-AUR-APL-2020-019872,AUROBINDO,,69.0,YR,,M,Y,,,20200422.0,,PH,GB,GB,2020,Q2,Elderly
176916191,17691619,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"OM, 300UNITS/ML (UNIT DOSE: 62 IU)",,,,, UNKNOWN,,,62.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose fluctuation,,2020,Q2,1,I,20190706.0,20200416.0,20200422,20200422,EXP,GB-MHRA-MIDB-85CE4964-284F-4F47-98DB-665CEBB5D9FE,GB-TEVA-2020-GB-1226033,TEVA,,69.0,YR,,M,Y,,,20200422.0,,PH,GB,GB,2020,Q2,Elderly
176916191,17691619,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"OM, 300UNITS/ML (UNIT DOSE: 62 IU)",,,,, UNKNOWN,,,62.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypophagia,,2020,Q2,1,I,20190706.0,20200416.0,20200422,20200422,EXP,GB-MHRA-MIDB-85CE4964-284F-4F47-98DB-665CEBB5D9FE,GB-TEVA-2020-GB-1226033,TEVA,,69.0,YR,,M,Y,,,20200422.0,,PH,GB,GB,2020,Q2,Elderly
176916191,17691619,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"OM, 300UNITS/ML (UNIT DOSE: 62 IU)",,,,, UNKNOWN,,,62.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Vomiting,,2020,Q2,1,I,20190706.0,20200416.0,20200422,20200422,EXP,GB-MHRA-MIDB-85CE4964-284F-4F47-98DB-665CEBB5D9FE,GB-TEVA-2020-GB-1226033,TEVA,,69.0,YR,,M,Y,,,20200422.0,,PH,GB,GB,2020,Q2,Elderly
176949411,17694941,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (4 U/DAY)",,,U,U,,,,1.0,DF,,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,20200115.0,20200413.0,20200422,20200422,EXP,,IT-NOVOPROD-723528,NOVO NORDISK,,44.0,YR,,M,Y,,,20200422.0,,MD,IT,IT,2020,Q2,Adult
176949411,17694941,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (4 U/DAY)",,,U,U,,,,1.0,DF,,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200115.0,20200413.0,20200422,20200422,EXP,,IT-NOVOPROD-723528,NOVO NORDISK,,44.0,YR,,M,Y,,,20200422.0,,MD,IT,IT,2020,Q2,Adult
176949411,17694941,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (4 U/DAY)",,,U,U,,,,1.0,DF,,QD,2020,Q2,Loss of consciousness,,2020,Q2,1,I,20200115.0,20200413.0,20200422,20200422,EXP,,IT-NOVOPROD-723528,NOVO NORDISK,,44.0,YR,,M,Y,,,20200422.0,,MD,IT,IT,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,43 INTERNATIONAL UNIT,,,Y,U, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176967901,17696790,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,40 INTERNATIONAL UNIT,,,Y,U, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200413.0,20200423,20200423,EXP,,ES-AUROBINDO-AUR-APL-2020-019892,AUROBINDO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
176998053,17699805,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q2,Hospitalisation,,2020,Q2,3,F,20200416.0,20200618.0,20200423,20200629,EXP,,GB-MYLANLABS-2020M1040444,MYLAN,,36.0,YR,,F,Y,,,20200629.0,,PH,GB,GB,2020,Q2,Adult
176998053,17699805,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q2,Intentional overdose,,2020,Q2,3,F,20200416.0,20200618.0,20200423,20200629,EXP,,GB-MYLANLABS-2020M1040444,MYLAN,,36.0,YR,,F,Y,,,20200629.0,,PH,GB,GB,2020,Q2,Adult
176998053,17699805,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q2,Neutrophil count increased,,2020,Q2,3,F,20200416.0,20200618.0,20200423,20200629,EXP,,GB-MYLANLABS-2020M1040444,MYLAN,,36.0,YR,,F,Y,,,20200629.0,,PH,GB,GB,2020,Q2,Adult
176998053,17699805,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q2,Schizophrenia,,2020,Q2,3,F,20200416.0,20200618.0,20200423,20200629,EXP,,GB-MYLANLABS-2020M1040444,MYLAN,,36.0,YR,,F,Y,,,20200629.0,,PH,GB,GB,2020,Q2,Adult
176998053,17699805,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q2,Syncope,,2020,Q2,3,F,20200416.0,20200618.0,20200423,20200629,EXP,,GB-MYLANLABS-2020M1040444,MYLAN,,36.0,YR,,F,Y,,,20200629.0,,PH,GB,GB,2020,Q2,Adult
176998053,17699805,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q2,White blood cell count increased,,2020,Q2,3,F,20200416.0,20200618.0,20200423,20200629,EXP,,GB-MYLANLABS-2020M1040444,MYLAN,,36.0,YR,,F,Y,,,20200629.0,,PH,GB,GB,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177002131,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200414.0,20200423,20200423,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200423.0,,CN,ES,ES,2020,Q2,Adult
177033843,17703384,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 UNITS/VIAL, ONCE A DAY",,,U,,,,,,,,QD,2020,Q2,Blood glucose increased,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177033843,17703384,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 UNITS/VIAL, ONCE A DAY",,,U,,,,,,,,QD,2020,Q2,Condition aggravated,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177033843,17703384,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 UNITS/VIAL, ONCE A DAY",,,U,,,,,,,,QD,2020,Q2,Drug intolerance,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177033843,17703384,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 UNITS/VIAL, ONCE A DAY",,,U,,,,,,,,QD,2020,Q2,Mass,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177033843,17703384,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 UNITS/VIAL, ONCE A DAY",,,U,,,,,,,,QD,2020,Q2,Necrosis,,2020,Q2,3,F,201901.0,20200511.0,20200423,20200522,EXP,,CZ-AUROBINDO-AUR-APL-2020-019965,AUROBINDO,HALCIAKOVA K. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200522.0,,MD,CZ,CZ,2020,Q2,Elderly
177040602,17704060,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, DAILY",,,Y,,,,205692.0,4.0,IU,INJECTION,QD,2020,Q2,Drug eruption,,2020,Q2,2,F,20200218.0,20200611.0,20200424,20200615,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202004007252,ELI LILLY AND CO,,57.0,YR,,M,Y,75.0,KG,20200615.0,,PH,JP,JP,2020,Q2,Adult
177044212,17704421,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q2,Upper gastrointestinal haemorrhage,,2020,Q2,2,F,20191027.0,20200420.0,20200424,20200429,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-032858,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,127.3,KG,20200429.0,,HP,US,US,2020,Q2,Elderly
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177077151,17707715,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,," 9F404A,0F517A",,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200415.0,20200424,20200424,EXP,,ES-BAUSCH-BL-2020-011565,BAUSCH AND LOMB,,39.0,YR,,F,Y,70.0,KG,20200424.0,,CN,ES,ES,2020,Q2,Adult
177092741,17709274,2,SS,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q2,Cerebrovascular accident,,2020,Q2,1,I,,20200417.0,20200426,20200426,EXP,,CZ-AUROBINDO-AUR-APL-2020-020504,AUROBINDO,MATERNALLY INHERITED DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII.. 2020;18(1):11-13,35.0,YR,,F,Y,,,20200427.0,,HP,CZ,CZ,2020,Q2,Adult
177092741,17709274,2,SS,Insuline Glargine,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q2,Lactic acidosis,,2020,Q2,1,I,,20200417.0,20200426,20200426,EXP,,CZ-AUROBINDO-AUR-APL-2020-020504,AUROBINDO,MATERNALLY INHERITED DIABETES MELLITUS. KAZUISTIKY V DIABETOLOGII.. 2020;18(1):11-13,35.0,YR,,F,Y,,,20200427.0,,HP,CZ,CZ,2020,Q2,Adult
177101632,17710163,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Gait inability,,2020,Q2,2,F,,20200504.0,20200427,20200511,PER,,US-SA-2020SA104706,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177101632,17710163,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product dose omission,,2020,Q2,2,F,,20200504.0,20200427,20200511,PER,,US-SA-2020SA104706,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177101632,17710163,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, QD",,,,,,,21081.0,50.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product storage error,,2020,Q2,2,F,,20200504.0,20200427,20200511,PER,,US-SA-2020SA104706,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20200511.0,,CN,US,US,2020,Q2,Elderly
177102541,17710254,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,,20200417.0,20200427,20200427,EXP,DE-BFARM-20004271,DE-ACCORD-179740,ACCORD,,80.0,YR,E,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177102541,17710254,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200417.0,20200427,20200427,EXP,DE-BFARM-20004271,DE-ACCORD-179740,ACCORD,,80.0,YR,E,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177102541,17710254,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200417.0,20200427,20200427,EXP,DE-BFARM-20004271,DE-ACCORD-179740,ACCORD,,80.0,YR,E,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177102541,17710254,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200417.0,20200427,20200427,EXP,DE-BFARM-20004271,DE-ACCORD-179740,ACCORD,,80.0,YR,E,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177102541,17710254,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 IE/ML, 16-0-0-0",,,U,,,,,,,,,2020,Q2,Sedation,,2020,Q2,1,I,,20200417.0,20200427,20200427,EXP,DE-BFARM-20004271,DE-ACCORD-179740,ACCORD,,80.0,YR,E,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177135971,17713597,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 IU/ML 16-0-0-0,,,U,, UNKNOWN,,,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,,20200422.0,20200427,20200427,EXP,DE-ADRED-04523-01,DE-PFIZER INC-2020162747,PFIZER,,80.0,YR,,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177135971,17713597,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 IU/ML 16-0-0-0,,,U,, UNKNOWN,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200422.0,20200427,20200427,EXP,DE-ADRED-04523-01,DE-PFIZER INC-2020162747,PFIZER,,80.0,YR,,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177135971,17713597,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 IU/ML 16-0-0-0,,,U,, UNKNOWN,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200422.0,20200427,20200427,EXP,DE-ADRED-04523-01,DE-PFIZER INC-2020162747,PFIZER,,80.0,YR,,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177135971,17713597,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 IU/ML 16-0-0-0,,,U,, UNKNOWN,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200422.0,20200427,20200427,EXP,DE-ADRED-04523-01,DE-PFIZER INC-2020162747,PFIZER,,80.0,YR,,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177135971,17713597,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 IU/ML 16-0-0-0,,,U,, UNKNOWN,,,,,,,2020,Q2,Sedation,,2020,Q2,1,I,,20200422.0,20200427,20200427,EXP,DE-ADRED-04523-01,DE-PFIZER INC-2020162747,PFIZER,,80.0,YR,,F,Y,,,20200427.0,,PH,DE,DE,2020,Q2,Elderly
177138311,17713831,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",40.0,IU,,, 9BGA040,,,10.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,20200404.0,20200424.0,20200427,20200427,EXP,,CN-BAYER-2020-070743,BAYER,,76.0,YR,E,F,Y,52.0,KG,20200427.0,,HP,CN,CN,2020,Q2,Elderly
177138311,17713831,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",40.0,IU,,, 9BGA040,,,10.0,IU,,QD,2020,Q2,Hypoglycaemic coma,,2020,Q2,1,I,20200404.0,20200424.0,20200427,20200427,EXP,,CN-BAYER-2020-070743,BAYER,,76.0,YR,E,F,Y,52.0,KG,20200427.0,,HP,CN,CN,2020,Q2,Elderly
177138311,17713831,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",40.0,IU,,, 9BGA040,,,10.0,IU,,QD,2020,Q2,Hypoxic-ischaemic encephalopathy,,2020,Q2,1,I,20200404.0,20200424.0,20200427,20200427,EXP,,CN-BAYER-2020-070743,BAYER,,76.0,YR,E,F,Y,52.0,KG,20200427.0,,HP,CN,CN,2020,Q2,Elderly
177138311,17713831,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 U, QD",40.0,IU,,, 9BGA040,,,10.0,IU,,QD,2020,Q2,Unresponsive to stimuli,,2020,Q2,1,I,20200404.0,20200424.0,20200427,20200427,EXP,,CN-BAYER-2020-070743,BAYER,,76.0,YR,E,F,Y,52.0,KG,20200427.0,,HP,CN,CN,2020,Q2,Elderly
177159182,17715918,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cardiovascular disorder,,2020,Q2,2,F,201912.0,20200423.0,20200428,20200429,EXP,,FR-ABBVIE-20K-056-3381314-00,ABBVIE,,83.0,YR,,M,Y,,,20200429.0,,MD,FR,FR,2020,Q2,Elderly
177159182,17715918,9,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Internal haemorrhage,,2020,Q2,2,F,201912.0,20200423.0,20200428,20200429,EXP,,FR-ABBVIE-20K-056-3381314-00,ABBVIE,,83.0,YR,,M,Y,,,20200429.0,,MD,FR,FR,2020,Q2,Elderly
177182505,17718250,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IE ABENDS,,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Drug interaction,,2020,Q2,5,F,20200115.0,20200608.0,20200428,20200610,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
177182505,17718250,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IE ABENDS,,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Eye movement disorder,,2020,Q2,5,F,20200115.0,20200608.0,20200428,20200610,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
177182505,17718250,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IE ABENDS,,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Movement disorder,,2020,Q2,5,F,20200115.0,20200608.0,20200428,20200610,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
177182505,17718250,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IE ABENDS,,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Oculogyric crisis,,2020,Q2,5,F,20200115.0,20200608.0,20200428,20200610,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
177182505,17718250,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IE ABENDS,,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Off label use,,2020,Q2,5,F,20200115.0,20200608.0,20200428,20200610,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
177182505,17718250,5,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IE ABENDS,,,,,,,,15.0,IU,INJECTION,QD,2020,Q2,Seizure,,2020,Q2,5,F,20200115.0,20200608.0,20200428,20200610,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,68.0,YR,,M,Y,77.0,KG,20200610.0,,HP,DE,DE,2020,Q2,Elderly
177227051,17722705,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q2,Amyloidosis,,2020,Q2,1,I,,20200423.0,20200429,20200429,EXP,,US-SA-2020SA106039,SANOFI AVENTIS,"SAMLASKA C.; REBER S.; MURRY T.. INSULIN-DERIVED AMYLOIDOSIS: THE INSULIN BALL, AMYLOIDOMA. JAAD CASE REPORTS. 2020;6(4):351-353",51.0,YR,A,M,Y,,,20200429.0,,HP,US,US,2020,Q2,Adult
177283981,17728398,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"12 INTERNATIONAL UNIT, EVERY NIGHT",,,,,,,,12.0,IU,,QD,2020,Q2,Road traffic accident,,2020,Q2,1,I,202003.0,20200323.0,20200430,20200430,PER,,US-VERTEX PHARMACEUTICALS-2020-006909,VERTEX,,17.0,YR,,F,Y,,,20200430.0,,CN,US,US,2020,Q2,Youth
177306241,17730624,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 INTERNATIONAL UNIT PER MILLILITRE, 1-0-1-0",,,U,U,,,,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,,20200427.0,20200430,20200430,EXP,,DE-MYLANLABS-2020M1042428,MYLAN,,80.0,YR,,F,Y,,,20200430.0,,PH,DE,DE,2020,Q2,Elderly
177306241,17730624,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 INTERNATIONAL UNIT PER MILLILITRE, 1-0-1-0",,,U,U,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200427.0,20200430,20200430,EXP,,DE-MYLANLABS-2020M1042428,MYLAN,,80.0,YR,,F,Y,,,20200430.0,,PH,DE,DE,2020,Q2,Elderly
177306241,17730624,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 INTERNATIONAL UNIT PER MILLILITRE, 1-0-1-0",,,U,U,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200427.0,20200430,20200430,EXP,,DE-MYLANLABS-2020M1042428,MYLAN,,80.0,YR,,F,Y,,,20200430.0,,PH,DE,DE,2020,Q2,Elderly
177306241,17730624,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 INTERNATIONAL UNIT PER MILLILITRE, 1-0-1-0",,,U,U,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200427.0,20200430,20200430,EXP,,DE-MYLANLABS-2020M1042428,MYLAN,,80.0,YR,,F,Y,,,20200430.0,,PH,DE,DE,2020,Q2,Elderly
177306241,17730624,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"300 INTERNATIONAL UNIT PER MILLILITRE, 1-0-1-0",,,U,U,,,,,,,,2020,Q2,Sedation,,2020,Q2,1,I,,20200427.0,20200430,20200430,EXP,,DE-MYLANLABS-2020M1042428,MYLAN,,80.0,YR,,F,Y,,,20200430.0,,PH,DE,DE,2020,Q2,Elderly
177316191,17731619,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Abdominal pain,,2020,Q2,1,I,20200228.0,20200428.0,20200501,20200501,EXP,,CO-ABBVIE-20K-036-3385051-00,ABBVIE,,66.0,YR,,M,Y,62.0,KG,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177316191,17731619,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Adenoma benign,,2020,Q2,1,I,20200228.0,20200428.0,20200501,20200501,EXP,,CO-ABBVIE-20K-036-3385051-00,ABBVIE,,66.0,YR,,M,Y,62.0,KG,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177316191,17731619,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Constipation,,2020,Q2,1,I,20200228.0,20200428.0,20200501,20200501,EXP,,CO-ABBVIE-20K-036-3385051-00,ABBVIE,,66.0,YR,,M,Y,62.0,KG,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177316191,17731619,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Defaecation disorder,,2020,Q2,1,I,20200228.0,20200428.0,20200501,20200501,EXP,,CO-ABBVIE-20K-036-3385051-00,ABBVIE,,66.0,YR,,M,Y,62.0,KG,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177316191,17731619,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Diarrhoea haemorrhagic,,2020,Q2,1,I,20200228.0,20200428.0,20200501,20200501,EXP,,CO-ABBVIE-20K-036-3385051-00,ABBVIE,,66.0,YR,,M,Y,62.0,KG,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177316191,17731619,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Duodenogastric reflux,,2020,Q2,1,I,20200228.0,20200428.0,20200501,20200501,EXP,,CO-ABBVIE-20K-036-3385051-00,ABBVIE,,66.0,YR,,M,Y,62.0,KG,20200430.0,,CN,CO,CO,2020,Q2,Elderly
177318771,17731877,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 U, QD",,,,,,,,,,,QD,2020,Q2,Pneumonia,,2020,Q2,1,I,,20200421.0,20200501,20200501,PER,,GR-AMGEN-GRCSP2020065638,AMGEN,XANTHOPOULOS A.; IAKOVIS N.; CHAMAIDI A.ET AL.. RECURRENT ACUTE CORONARY SYNDROMES IN A PATIENT WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA. CASE REPORTS IN CARDIOLOGY. 2020;2020:1-5,53.0,YR,A,M,Y,,,20200501.0,,HP,GR,GR,2020,Q2,Adult
177318771,17731877,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 U, QD",,,,,,,,,,,QD,2020,Q2,Sepsis,,2020,Q2,1,I,,20200421.0,20200501,20200501,PER,,GR-AMGEN-GRCSP2020065638,AMGEN,XANTHOPOULOS A.; IAKOVIS N.; CHAMAIDI A.ET AL.. RECURRENT ACUTE CORONARY SYNDROMES IN A PATIENT WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA. CASE REPORTS IN CARDIOLOGY. 2020;2020:1-5,53.0,YR,A,M,Y,,,20200501.0,,HP,GR,GR,2020,Q2,Adult
177400861,17740086,4,C,glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,13.0,IU,,,2020,Q2,Death,,2020,Q2,1,I,20200307.0,20200430.0,20200504,20200504,EXP,,CO-BAXTER-2020BAX009427,BAXTER,,70.0,YR,,F,Y,60.0,KG,20200504.0,,HP,CO,CO,2020,Q2,Elderly
177420721,17742072,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE FORM: SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Anaphylactic reaction,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022487",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200505.0,,HP,CA,CA,2020,Q2,Elderly
177420721,17742072,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSAGE FORM: SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Drug intolerance,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022487",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200505.0,,HP,CA,CA,2020,Q2,Elderly
177421301,17742130,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSAGE FORM: SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Anaphylactic reaction,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022399",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200505.0,,HP,CA,CA,2020,Q2,Elderly
177421301,17742130,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSAGE FORM: SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Drug intolerance,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022399",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200505.0,,HP,CA,CA,2020,Q2,Elderly
177425572,17742557,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Anaphylactic reaction,,2020,Q2,2,F,,20200501.0,20200505,20200509,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022116",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200509.0,,HP,CA,CA,2020,Q2,Elderly
177425572,17742557,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Drug intolerance,,2020,Q2,2,F,,20200501.0,20200505,20200509,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022116",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200509.0,,HP,CA,CA,2020,Q2,Elderly
177443721,17744372,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Adverse drug reaction,,2020,Q2,1,I,20181130.0,20200428.0,20200504,20200504,PER,,US-AMGEN-USACT2020070889,AMGEN,,65.0,YR,E,M,Y,,,20200504.0,,MD,US,US,2020,Q2,Elderly
177449391,17744939,10,C,Glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Rash,,2020,Q2,1,I,,20200504.0,20200504,20200504,EXP,,US-ANIPHARMA-2020-US-008277,ANI,"SELAMET U, HANNA RM, SISK A ET AL.ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT..SAGE OPEN MEDICAL CASE REPORTS.2020;8.",69.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Elderly
177449391,17744939,10,C,Glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Systemic lupus erythematosus,,2020,Q2,1,I,,20200504.0,20200504,20200504,EXP,,US-ANIPHARMA-2020-US-008277,ANI,"SELAMET U, HANNA RM, SISK A ET AL.ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT..SAGE OPEN MEDICAL CASE REPORTS.2020;8.",69.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Elderly
177449391,17744939,10,C,Glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Tubulointerstitial nephritis,,2020,Q2,1,I,,20200504.0,20200504,20200504,EXP,,US-ANIPHARMA-2020-US-008277,ANI,"SELAMET U, HANNA RM, SISK A ET AL.ACUTE INTERSTITIAL NEPHRITIS AND DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS DUE TO CHLORTHALIDONE AND AMIODARONE: A CASE REPORT..SAGE OPEN MEDICAL CASE REPORTS.2020;8.",69.0,YR,,F,Y,,,20200504.0,,HP,US,US,2020,Q2,Elderly
177454251,17745425,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q2,Adverse drug reaction,,2020,Q2,1,I,,20200428.0,20200505,20200505,EXP,,CA-ROCHE-2592299,ROCHE,,42.0,YR,,F,Y,,,20200505.0,,MD,CA,CA,2020,Q2,Adult
177454251,17745425,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q2,Arthralgia,,2020,Q2,1,I,,20200428.0,20200505,20200505,EXP,,CA-ROCHE-2592299,ROCHE,,42.0,YR,,F,Y,,,20200505.0,,MD,CA,CA,2020,Q2,Adult
177454251,17745425,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200428.0,20200505,20200505,EXP,,CA-ROCHE-2592299,ROCHE,,42.0,YR,,F,Y,,,20200505.0,,MD,CA,CA,2020,Q2,Adult
177454251,17745425,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q2,Gait inability,,2020,Q2,1,I,,20200428.0,20200505,20200505,EXP,,CA-ROCHE-2592299,ROCHE,,42.0,YR,,F,Y,,,20200505.0,,MD,CA,CA,2020,Q2,Adult
177454251,17745425,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,20200428.0,20200505,20200505,EXP,,CA-ROCHE-2592299,ROCHE,,42.0,YR,,F,Y,,,20200505.0,,MD,CA,CA,2020,Q2,Adult
177454251,17745425,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q2,Hypoaesthesia,,2020,Q2,1,I,,20200428.0,20200505,20200505,EXP,,CA-ROCHE-2592299,ROCHE,,42.0,YR,,F,Y,,,20200505.0,,MD,CA,CA,2020,Q2,Adult
177454251,17745425,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q2,Lower respiratory tract infection,,2020,Q2,1,I,,20200428.0,20200505,20200505,EXP,,CA-ROCHE-2592299,ROCHE,,42.0,YR,,F,Y,,,20200505.0,,MD,CA,CA,2020,Q2,Adult
177454251,17745425,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q2,Pharyngitis,,2020,Q2,1,I,,20200428.0,20200505,20200505,EXP,,CA-ROCHE-2592299,ROCHE,,42.0,YR,,F,Y,,,20200505.0,,MD,CA,CA,2020,Q2,Adult
177454251,17745425,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q2,Toothache,,2020,Q2,1,I,,20200428.0,20200505,20200505,EXP,,CA-ROCHE-2592299,ROCHE,,42.0,YR,,F,Y,,,20200505.0,,MD,CA,CA,2020,Q2,Adult
177472171,17747217,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,INJECTION,,2020,Q2,Gastrointestinal disorder,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,INJECTION,,2020,Q2,Product administration error,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,INJECTION,,2020,Q2,Urinary tract disorder,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,WAS RESTARTED,,,D,,,,,,,INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,WAS RESTARTED,,,D,,,,,,,INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,WAS RESTARTED,,,D,,,,,,,INJECTION,,2020,Q2,Gastrointestinal disorder,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,WAS RESTARTED,,,D,,,,,,,INJECTION,,2020,Q2,Product administration error,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177472171,17747217,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,WAS RESTARTED,,,D,,,,,,,INJECTION,,2020,Q2,Urinary tract disorder,,2020,Q2,1,I,,20200429.0,20200505,20200505,EXP,,PT-MYLANLABS-2020M1043727,MYLAN,"CANENTO P, JACINTO N, RIO L, JACINTO C. EMPOWERMENT AND INDIVIDUALIZED THERAPY: A SUCCESSFUL ALLIANCE IN DIABETES. REVISTA PORTUGUESA DE DIABETES. 2020;15 (1):50-85",61.0,YR,,M,Y,,,20200505.0,,HP,PT,PT,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Confusional state,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Crying,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Depressed mood,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Diarrhoea,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Dyskinesia,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Gait disturbance,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Impaired gastric emptying,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Limb discomfort,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Limb operation,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Memory impairment,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Mood altered,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Muscle rigidity,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Muscular weakness,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,On and off phenomenon,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Panic reaction,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Procedural pain,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Protein total increased,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Serum ferritin increased,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Sleep disorder due to a general medical condition,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Stoma site erythema,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Stoma site infection,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Stress,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Therapeutic response shortened,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Transferrin decreased,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Tremor,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Urinary tract infection,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177488643,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,3,F,20191117.0,20200617.0,20200506,20200622,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20200622.0,,CN,NL,NL,2020,Q2,Adult
177504651,17750465,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q2,Arthralgia,,2020,Q2,1,I,,20200428.0,20200506,20200506,EXP,,CA-ROCHE-2591985,ROCHE,,42.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Adult
177504651,17750465,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200428.0,20200506,20200506,EXP,,CA-ROCHE-2591985,ROCHE,,42.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Adult
177504651,17750465,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200428.0,20200506,20200506,EXP,,CA-ROCHE-2591985,ROCHE,,42.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Adult
177504651,17750465,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q2,Gait inability,,2020,Q2,1,I,,20200428.0,20200506,20200506,EXP,,CA-ROCHE-2591985,ROCHE,,42.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Adult
177504651,17750465,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q2,Headache,,2020,Q2,1,I,,20200428.0,20200506,20200506,EXP,,CA-ROCHE-2591985,ROCHE,,42.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Adult
177504651,17750465,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q2,Hypoaesthesia,,2020,Q2,1,I,,20200428.0,20200506,20200506,EXP,,CA-ROCHE-2591985,ROCHE,,42.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Adult
177504651,17750465,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q2,Lower respiratory tract infection,,2020,Q2,1,I,,20200428.0,20200506,20200506,EXP,,CA-ROCHE-2591985,ROCHE,,42.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Adult
177504651,17750465,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q2,Pharyngitis,,2020,Q2,1,I,,20200428.0,20200506,20200506,EXP,,CA-ROCHE-2591985,ROCHE,,42.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Adult
177504651,17750465,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,QD,2020,Q2,Toothache,,2020,Q2,1,I,,20200428.0,20200506,20200506,EXP,,CA-ROCHE-2591985,ROCHE,,42.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Adult
177508143,17750814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,36.0,IU,,,2020,Q2,Blood potassium increased,,2020,Q2,3,F,,20200525.0,20200506,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022588",BOEHRINGER INGELHEIM,"TANAKA S, FUJISHIRO M, TAKUBO M, KUSHIMOTO M, IKEDA J, OGAWA K, ET AL.. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020;9:201.",57.0,YR,,F,Y,49.0,KG,20200528.0,,HP,JP,JP,2020,Q2,Adult
177508143,17750814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,36.0,IU,,,2020,Q2,Blood sodium decreased,,2020,Q2,3,F,,20200525.0,20200506,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022588",BOEHRINGER INGELHEIM,"TANAKA S, FUJISHIRO M, TAKUBO M, KUSHIMOTO M, IKEDA J, OGAWA K, ET AL.. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020;9:201.",57.0,YR,,F,Y,49.0,KG,20200528.0,,HP,JP,JP,2020,Q2,Adult
177508143,17750814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,36.0,IU,,,2020,Q2,Hyperkalaemia,,2020,Q2,3,F,,20200525.0,20200506,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022588",BOEHRINGER INGELHEIM,"TANAKA S, FUJISHIRO M, TAKUBO M, KUSHIMOTO M, IKEDA J, OGAWA K, ET AL.. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020;9:201.",57.0,YR,,F,Y,49.0,KG,20200528.0,,HP,JP,JP,2020,Q2,Adult
177508143,17750814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,36.0,IU,,,2020,Q2,Hyponatraemia,,2020,Q2,3,F,,20200525.0,20200506,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022588",BOEHRINGER INGELHEIM,"TANAKA S, FUJISHIRO M, TAKUBO M, KUSHIMOTO M, IKEDA J, OGAWA K, ET AL.. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020;9:201.",57.0,YR,,F,Y,49.0,KG,20200528.0,,HP,JP,JP,2020,Q2,Adult
177508143,17750814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,36.0,IU,,,2020,Q2,Metabolic acidosis,,2020,Q2,3,F,,20200525.0,20200506,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022588",BOEHRINGER INGELHEIM,"TANAKA S, FUJISHIRO M, TAKUBO M, KUSHIMOTO M, IKEDA J, OGAWA K, ET AL.. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020;9:201.",57.0,YR,,F,Y,49.0,KG,20200528.0,,HP,JP,JP,2020,Q2,Adult
177508143,17750814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,36.0,IU,,,2020,Q2,Renal tubular acidosis,,2020,Q2,3,F,,20200525.0,20200506,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022588",BOEHRINGER INGELHEIM,"TANAKA S, FUJISHIRO M, TAKUBO M, KUSHIMOTO M, IKEDA J, OGAWA K, ET AL.. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020;9:201.",57.0,YR,,F,Y,49.0,KG,20200528.0,,HP,JP,JP,2020,Q2,Adult
177508143,17750814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,36.0,IU,,,2020,Q2,Respiratory alkalosis,,2020,Q2,3,F,,20200525.0,20200506,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022588",BOEHRINGER INGELHEIM,"TANAKA S, FUJISHIRO M, TAKUBO M, KUSHIMOTO M, IKEDA J, OGAWA K, ET AL.. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020;9:201.",57.0,YR,,F,Y,49.0,KG,20200528.0,,HP,JP,JP,2020,Q2,Adult
177508143,17750814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,36.0,IU,,,2020,Q2,Urine sodium increased,,2020,Q2,3,F,,20200525.0,20200506,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022588",BOEHRINGER INGELHEIM,"TANAKA S, FUJISHIRO M, TAKUBO M, KUSHIMOTO M, IKEDA J, OGAWA K, ET AL.. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020;9:201.",57.0,YR,,F,Y,49.0,KG,20200528.0,,HP,JP,JP,2020,Q2,Adult
177508143,17750814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,36.0,IU,,,2020,Q2,Visual impairment,,2020,Q2,3,F,,20200525.0,20200506,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022588",BOEHRINGER INGELHEIM,"TANAKA S, FUJISHIRO M, TAKUBO M, KUSHIMOTO M, IKEDA J, OGAWA K, ET AL.. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020;9:201.",57.0,YR,,F,Y,49.0,KG,20200528.0,,HP,JP,JP,2020,Q2,Adult
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Acute respiratory distress syndrome,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Embolism,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Encephalopathy,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Osteonecrosis,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Peripheral artery occlusion,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Peripheral ischaemia,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Post procedural complication,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Pulmonary oedema,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177510601,17751060,15,C,Insulin glargine 100 u/ml,,2,,,,,,,,,,,,,,2020,Q2,Rhabdomyolysis,,2020,Q2,1,I,20200101.0,,20200506,20200506,DIR,,,FDA-CTU,,66.0,YR,,F,N,92.0,KG,20200506.0,N,MD,US,US,2020,Q2,Elderly
177515313,17751531,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Cogwheel rigidity,,2020,Q2,3,F,,20200608.0,20200506,20200618,EXP,,US-INFO-001000,INFORLIFE,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,,M,Y,,,20200618.0,,PH,US,US,2020,Q2,Elderly
177515313,17751531,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,3,F,,20200608.0,20200506,20200618,EXP,,US-INFO-001000,INFORLIFE,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,,M,Y,,,20200618.0,,PH,US,US,2020,Q2,Elderly
177515313,17751531,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Drug level increased,,2020,Q2,3,F,,20200608.0,20200506,20200618,EXP,,US-INFO-001000,INFORLIFE,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,,M,Y,,,20200618.0,,PH,US,US,2020,Q2,Elderly
177515313,17751531,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Dystonia,,2020,Q2,3,F,,20200608.0,20200506,20200618,EXP,,US-INFO-001000,INFORLIFE,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,,M,Y,,,20200618.0,,PH,US,US,2020,Q2,Elderly
177515313,17751531,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Resting tremor,,2020,Q2,3,F,,20200608.0,20200506,20200618,EXP,,US-INFO-001000,INFORLIFE,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,,M,Y,,,20200618.0,,PH,US,US,2020,Q2,Elderly
177519581,17751958,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSAGE FORM: SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Anaphylactic reaction,,2020,Q2,1,I,,20200429.0,20200506,20200506,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022401",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Elderly
177519581,17751958,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSAGE FORM: SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Drug intolerance,,2020,Q2,1,I,,20200429.0,20200506,20200506,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-022401",BOEHRINGER INGELHEIM,,70.0,YR,,F,Y,,,20200506.0,,HP,CA,CA,2020,Q2,Elderly
177548411,17754841,8,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,,20200422.0,20200507,20200507,EXP,,US-APPCO PHARMA LLC-2083578,APPCO PHARMA,,69.0,YR,,F,Y,,,20200507.0,,HP,US,US,2020,Q2,Elderly
177548411,17754841,8,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Contraindicated product administered,,2020,Q2,1,I,,20200422.0,20200507,20200507,EXP,,US-APPCO PHARMA LLC-2083578,APPCO PHARMA,,69.0,YR,,F,Y,,,20200507.0,,HP,US,US,2020,Q2,Elderly
177548411,17754841,8,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Lupus-like syndrome,,2020,Q2,1,I,,20200422.0,20200507,20200507,EXP,,US-APPCO PHARMA LLC-2083578,APPCO PHARMA,,69.0,YR,,F,Y,,,20200507.0,,HP,US,US,2020,Q2,Elderly
177548411,17754841,8,C,Glargine insulin,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q2,Tubulointerstitial nephritis,,2020,Q2,1,I,,20200422.0,20200507,20200507,EXP,,US-APPCO PHARMA LLC-2083578,APPCO PHARMA,,69.0,YR,,F,Y,,,20200507.0,,HP,US,US,2020,Q2,Elderly
177559492,17755949,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q2,2,F,20200415.0,20200527.0,20200507,20200603,EXP,,US-VERTEX PHARMACEUTICALS-2020-010150,VERTEX,,67.0,YR,,F,Y,81.0,KG,20200603.0,,HP,US,US,2020,Q2,Elderly
177567031,17756703,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,20130725.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02148,HIKMA,,33.0,YR,,M,Y,72.0,KG,20200504.0,,MD,US,US,2020,Q2,Young Adult
177567031,17756703,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Intra-abdominal haematoma,,2020,Q2,1,I,20130725.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02148,HIKMA,,33.0,YR,,M,Y,72.0,KG,20200504.0,,MD,US,US,2020,Q2,Young Adult
177567031,17756703,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Transplant rejection,,2020,Q2,1,I,20130725.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02148,HIKMA,,33.0,YR,,M,Y,72.0,KG,20200504.0,,MD,US,US,2020,Q2,Young Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Bronchopulmonary aspergillosis,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Febrile neutropenia,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Fungal infection,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Pneumonia,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Sepsis,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Syncope,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Tachycardia,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Upper respiratory tract infection,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177568641,17756864,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,White blood cell count decreased,,2020,Q2,1,I,20180504.0,20200425.0,20200507,20200507,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02083,HIKMA,,64.0,YR,,M,Y,65.3,KG,20200505.0,,HP,US,US,2020,Q2,Adult
177578452,17757845,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Tubo-ovarian abscess,,2020,Q2,2,F,20200402.0,20200508.0,20200507,20200513,EXP,,US-CELGENEUS-USA-20200406122,CELGENE,,65.0,YR,,F,Y,,,20200513.0,,HP,US,US,2020,Q2,Elderly
177586182,17758618,4,C,Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Psoriasis,,2020,Q2,2,F,201809.0,20200520.0,20200507,20200524,PER,,US-CELGENEUS-USA-20200501066,CELGENE,,47.0,YR,,F,Y,,,20200524.0,,HP,US,US,2020,Q2,Adult
177586182,17758618,4,C,Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Rash,,2020,Q2,2,F,201809.0,20200520.0,20200507,20200524,PER,,US-CELGENEUS-USA-20200501066,CELGENE,,47.0,YR,,F,Y,,,20200524.0,,HP,US,US,2020,Q2,Adult
177614821,17761482,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,U,U,,,,,,,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177614821,17761482,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,U,U,,,,,,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177614821,17761482,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,U,U,,,,,,,QD,2020,Q2,Drug intolerance,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177614821,17761482,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,U,U,,,,,,,QD,2020,Q2,Mass,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177614821,17761482,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD",,,U,U,,,,,,,QD,2020,Q2,Necrosis,,2020,Q2,1,I,201901.0,20200504.0,20200508,20200508,EXP,,CZ-MYLANLABS-2020M1045101,MYLAN,HALCIAKOVA K.. INTENSIFICATION OF DIABETES TREATMENT WITH DULAGLUTIDE.. KAZUISTIKY V DIABETOLOGII. 2020;18(1):37-8,66.0,YR,,M,Y,103.0,KG,20200508.0,,HP,CZ,CZ,2020,Q2,Elderly
177614841,17761484,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"OM, 300UNITS/ML",,,,,,,,62.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose fluctuation,,2020,Q2,1,I,20190706.0,20200504.0,20200508,20200508,EXP,GB-MHRA-MIDB-85CE4964-284F-4F47-98DB-665CEBB5D9FE,GB-MYLANLABS-2020M1045078,MYLAN,,69.0,YR,,M,Y,,,20200508.0,,PH,GB,GB,2020,Q2,Elderly
177614841,17761484,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"OM, 300UNITS/ML",,,,,,,,62.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Hypophagia,,2020,Q2,1,I,20190706.0,20200504.0,20200508,20200508,EXP,GB-MHRA-MIDB-85CE4964-284F-4F47-98DB-665CEBB5D9FE,GB-MYLANLABS-2020M1045078,MYLAN,,69.0,YR,,M,Y,,,20200508.0,,PH,GB,GB,2020,Q2,Elderly
177614841,17761484,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"OM, 300UNITS/ML",,,,,,,,62.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Vomiting,,2020,Q2,1,I,20190706.0,20200504.0,20200508,20200508,EXP,GB-MHRA-MIDB-85CE4964-284F-4F47-98DB-665CEBB5D9FE,GB-MYLANLABS-2020M1045078,MYLAN,,69.0,YR,,M,Y,,,20200508.0,,PH,GB,GB,2020,Q2,Elderly
177625531,17762553,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, UNK",,,Y,," 9F150A, 9F375A",,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Diarrhoea,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, UNK",,,Y,," 9F150A, 9F375A",,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Gastroenteritis,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, UNK",,,Y,," 9F150A, 9F375A",,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, UNK",,,Y,," 9F150A, 9F375A",,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, UNK",,,Y,," 9F150A, 9F375A",,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Loss of consciousness,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, UNK",,,Y,," 9F150A, 9F375A",,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Malaise,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, UNK",,,Y,," 9F150A, 9F375A",,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Renal failure,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, UNK",,,Y,," 9F150A, 9F375A",,,34.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Vomiting,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Diarrhoea,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Gastroenteritis,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Loss of consciousness,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Malaise,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Renal failure,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177625531,17762553,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Vomiting,,2020,Q2,1,I,201902.0,20190729.0,20200508,20200508,EXP,,PHHY2019ES175951,NOVARTIS,,56.0,YR,,F,Y,,,20200508.0,,HP,ES,ES,2020,Q2,Adult
177632871,17763287,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Acute myocardial infarction,,2020,Q2,1,I,20200501.0,20200507.0,20200509,20200509,EXP,,CO-ABBVIE-20K-036-3398104-00,ABBVIE,,61.0,YR,,M,Y,55.0,KG,20200509.0,,CN,CO,CO,2020,Q2,Adult
177632871,17763287,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Coronary artery disease,,2020,Q2,1,I,20200501.0,20200507.0,20200509,20200509,EXP,,CO-ABBVIE-20K-036-3398104-00,ABBVIE,,61.0,YR,,M,Y,55.0,KG,20200509.0,,CN,CO,CO,2020,Q2,Adult
177632871,17763287,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,20200501.0,20200507.0,20200509,20200509,EXP,,CO-ABBVIE-20K-036-3398104-00,ABBVIE,,61.0,YR,,M,Y,55.0,KG,20200509.0,,CN,CO,CO,2020,Q2,Adult
177650461,17765046,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,,,,,,,,QD,2020,Q2,Acute kidney injury,,2020,Q2,1,I,,20200426.0,20200511,20200511,EXP,,US-PBT-000305,PANACEA BIOTEC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,E,,Y,,,20200511.0,,HP,US,US,2020,Q2,Elderly
177650461,17765046,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,,,,,,,,QD,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200426.0,20200511,20200511,EXP,,US-PBT-000305,PANACEA BIOTEC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,E,,Y,,,20200511.0,,HP,US,US,2020,Q2,Elderly
177650461,17765046,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,,,,,,,,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200426.0,20200511,20200511,EXP,,US-PBT-000305,PANACEA BIOTEC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,E,,Y,,,20200511.0,,HP,US,US,2020,Q2,Elderly
177650461,17765046,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,,,,,,,,QD,2020,Q2,Dystonia,,2020,Q2,1,I,,20200426.0,20200511,20200511,EXP,,US-PBT-000305,PANACEA BIOTEC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,E,,Y,,,20200511.0,,HP,US,US,2020,Q2,Elderly
177650461,17765046,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,,,,,,,,QD,2020,Q2,Hydronephrosis,,2020,Q2,1,I,,20200426.0,20200511,20200511,EXP,,US-PBT-000305,PANACEA BIOTEC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,E,,Y,,,20200511.0,,HP,US,US,2020,Q2,Elderly
177650461,17765046,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,,,,,,,,QD,2020,Q2,Nephrolithiasis,,2020,Q2,1,I,,20200426.0,20200511,20200511,EXP,,US-PBT-000305,PANACEA BIOTEC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,E,,Y,,,20200511.0,,HP,US,US,2020,Q2,Elderly
177650461,17765046,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,,,,,,,,QD,2020,Q2,Pyelonephritis,,2020,Q2,1,I,,20200426.0,20200511,20200511,EXP,,US-PBT-000305,PANACEA BIOTEC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,E,,Y,,,20200511.0,,HP,US,US,2020,Q2,Elderly
177650461,17765046,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,,,,,,,,QD,2020,Q2,Resting tremor,,2020,Q2,1,I,,20200426.0,20200511,20200511,EXP,,US-PBT-000305,PANACEA BIOTEC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12. DOI: 10.1097/01.NPR.0000660368.67226.AD.",69.0,YR,E,,Y,,,20200511.0,,HP,US,US,2020,Q2,Elderly
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Brugada syndrome,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Confusional state,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Coordination abnormal,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Dizziness postural,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Fall,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Hypovolaemia,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Nausea,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Toxicity to various agents,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Tremor,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177688651,17768865,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Vomiting,,2020,Q2,1,I,,20200429.0,20200512,20200512,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02196,HIKMA,"SCHNEIR A, MASOM C. LITHIUM TOXICITY FROM THE ADDITION OF AN ACE INHIBITOR WITH AN UNEXPECTED TYPE I BRUGADA PATTERN ECG: CASE FILES OF THE MEDICAL TOXICOLOGY FELLOWSHIP AT THE UNIVERSITY OF CALIFORNIA, SAN DIEGO. JOURNAL OF MEDICAL TOXICOLOGY; DOI: 10.1007/S13181-020-00773-9. 2020;.",48.0,YR,,F,Y,,,20200508.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Adult
177701583,17770158,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Cogwheel rigidity,,2020,Q2,3,F,,20200608.0,20200512,20200611,EXP,,US-PFIZER INC-2020185959,PFIZER,"CHAPPELL, K.. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45 (5):11-12",69.0,YR,,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
177701583,17770158,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,3,F,,20200608.0,20200512,20200611,EXP,,US-PFIZER INC-2020185959,PFIZER,"CHAPPELL, K.. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45 (5):11-12",69.0,YR,,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
177701583,17770158,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Dystonia,,2020,Q2,3,F,,20200608.0,20200512,20200611,EXP,,US-PFIZER INC-2020185959,PFIZER,"CHAPPELL, K.. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45 (5):11-12",69.0,YR,,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
177701583,17770158,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,3,F,,20200608.0,20200512,20200611,EXP,,US-PFIZER INC-2020185959,PFIZER,"CHAPPELL, K.. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45 (5):11-12",69.0,YR,,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
177701583,17770158,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Product use issue,,2020,Q2,3,F,,20200608.0,20200512,20200611,EXP,,US-PFIZER INC-2020185959,PFIZER,"CHAPPELL, K.. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45 (5):11-12",69.0,YR,,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
177701583,17770158,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Tremor,,2020,Q2,3,F,,20200608.0,20200512,20200611,EXP,,US-PFIZER INC-2020185959,PFIZER,"CHAPPELL, K.. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45 (5):11-12",69.0,YR,,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
177706452,17770645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,U,,,,,,,,2020,Q2,Cerebrovascular accident,,2020,Q2,2,F,,20200512.0,20200512,20200518,EXP,,CZ-MYLANLABS-2020M1045544,MYLAN,,35.0,YR,,F,Y,,,20200518.0,,MD,CZ,CZ,2020,Q2,Adult
177706452,17770645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,Y,U,,,,,,,,2020,Q2,Lactic acidosis,,2020,Q2,2,F,,20200512.0,20200512,20200518,EXP,,CZ-MYLANLABS-2020M1045544,MYLAN,,35.0,YR,,F,Y,,,20200518.0,,MD,CZ,CZ,2020,Q2,Adult
177719372,17771937,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Other,"22 UNIT, QHS",,,U,,,,,22.0,DF,,,2020,Q2,Lactic acidosis,,2020,Q2,2,F,20200426.0,20200508.0,20200512,20200518,EXP,,US-SA-2020SA115033,SANOFI AVENTIS,,60.0,YR,A,M,Y,,,20200518.0,,MD,US,US,2020,Q2,Adult
177719372,17771937,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Other,"22 UNIT, QHS",,,U,,,,,22.0,DF,,,2020,Q2,Septic shock,,2020,Q2,2,F,20200426.0,20200508.0,20200512,20200518,EXP,,US-SA-2020SA115033,SANOFI AVENTIS,,60.0,YR,A,M,Y,,,20200518.0,,MD,US,US,2020,Q2,Adult
177719372,17771937,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Other,"22 UNIT, QHS",,,U,,,,,22.0,DF,,,2020,Q2,Transaminases increased,,2020,Q2,2,F,20200426.0,20200508.0,20200512,20200518,EXP,,US-SA-2020SA115033,SANOFI AVENTIS,,60.0,YR,A,M,Y,,,20200518.0,,MD,US,US,2020,Q2,Adult
177724672,17772467,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Arrhythmia,,2020,Q2,2,F,201911.0,20200522.0,20200512,20200528,EXP,,NVSC2020MX128035,NOVARTIS,,64.0,YR,,M,Y,82.0,KG,20200528.0,,MD,MX,MX,2020,Q2,Adult
177724672,17772467,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Malaise,,2020,Q2,2,F,201911.0,20200522.0,20200512,20200528,EXP,,NVSC2020MX128035,NOVARTIS,,64.0,YR,,M,Y,82.0,KG,20200528.0,,MD,MX,MX,2020,Q2,Adult
177724672,17772467,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Product use in unapproved indication,,2020,Q2,2,F,201911.0,20200522.0,20200512,20200528,EXP,,NVSC2020MX128035,NOVARTIS,,64.0,YR,,M,Y,82.0,KG,20200528.0,,MD,MX,MX,2020,Q2,Adult
177744211,17774421,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, QD",,,U,,,,,34.0,IU,UNKNOWN,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201907.0,20200505.0,20200513,20200513,EXP,,IT-BAUSCH-BL-2020-013602,BAUSCH AND LOMB,,40.0,YR,,M,Y,94.4,KG,20200513.0,,CN,IT,IT,2020,Q2,Adult
177746031,17774603,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Product dose omission,,2020,Q2,1,I,20191214.0,20191214.0,20200513,20200513,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-015087,ACADIA PHARMACEUTICALS,,83.0,YR,,M,Y,,,20200513.0,,MD,US,US,2020,Q2,Elderly
177781981,17778198,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,1,I,20120822.0,20150706.0,20200513,20200513,EXP,,US-BAYER-2015-378084,BAYER,,70.0,YR,E,M,Y,,,20200513.0,,HP,US,US,2020,Q2,Elderly
177781981,17778198,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,1,I,20120822.0,20150706.0,20200513,20200513,EXP,,US-BAYER-2015-378084,BAYER,,70.0,YR,E,M,Y,,,20200513.0,,HP,US,US,2020,Q2,Elderly
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Bile duct stone,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Blood glucose increased,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Cholangitis,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Cholecystitis acute,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Enterococcus test positive,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Hyperbilirubinaemia,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Hyponatraemia,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Liver function test increased,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177786662,17778666,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS NIGHTLY AS NEEDED,,,,,,,,,,,,2020,Q2,Vascular device infection,,2020,Q2,2,F,202004.0,20200515.0,20200513,20200521,EXP,,US-VERTEX PHARMACEUTICALS-2020-010571,VERTEX,,45.0,YR,,F,Y,,,20200521.0,,CN,US,US,2020,Q2,Adult
177793241,17779324,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 UNITS OF INSULIN GLARGINE U-300, ONCE DAILY.",,,U,,,,,,,,,2020,Q2,Hyperkalaemia,Hyperkalaemia,2020,Q2,1,I,,20200504.0,20200514,20200514,EXP,,JP-INVENTIA-000032,INVENTIA HEALTHCARE,,57.0,YR,A,F,Y,49.0,KG,20200513.0,,HP,JP,JP,2020,Q2,Adult
177793241,17779324,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 UNITS OF INSULIN GLARGINE U-300, ONCE DAILY.",,,U,,,,,,,,,2020,Q2,Hyponatraemia,Hyponatraemia,2020,Q2,1,I,,20200504.0,20200514,20200514,EXP,,JP-INVENTIA-000032,INVENTIA HEALTHCARE,,57.0,YR,A,F,Y,49.0,KG,20200513.0,,HP,JP,JP,2020,Q2,Adult
177793241,17779324,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 UNITS OF INSULIN GLARGINE U-300, ONCE DAILY.",,,U,,,,,,,,,2020,Q2,Metabolic acidosis,Metabolic acidosis,2020,Q2,1,I,,20200504.0,20200514,20200514,EXP,,JP-INVENTIA-000032,INVENTIA HEALTHCARE,,57.0,YR,A,F,Y,49.0,KG,20200513.0,,HP,JP,JP,2020,Q2,Adult
177793241,17779324,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 UNITS OF INSULIN GLARGINE U-300, ONCE DAILY.",,,U,,,,,,,,,2020,Q2,Renal tubular acidosis,,2020,Q2,1,I,,20200504.0,20200514,20200514,EXP,,JP-INVENTIA-000032,INVENTIA HEALTHCARE,,57.0,YR,A,F,Y,49.0,KG,20200513.0,,HP,JP,JP,2020,Q2,Adult
177793241,17779324,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"36 UNITS OF INSULIN GLARGINE U-300, ONCE DAILY.",,,U,,,,,,,,,2020,Q2,Respiratory alkalosis,Respiratory alkalosis,2020,Q2,1,I,,20200504.0,20200514,20200514,EXP,,JP-INVENTIA-000032,INVENTIA HEALTHCARE,,57.0,YR,A,F,Y,49.0,KG,20200513.0,,HP,JP,JP,2020,Q2,Adult
177802041,17780204,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,22 U,,,,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,2011.0,20200504.0,20200513,20200513,EXP,,GB-NOVOPROD-727818,NOVO NORDISK,"HARVEY, JOHN N CRONIN, MICHAEL ARKWRIGHT, PETER. INSULIN HYPERSENSITIVITY IN TYPE 1 DIABETES: INVESTIGATION AND TREATMENT WITH IMMUNODEPLETION. PRACTICAL DIABETES. 2020;37(2):59-61",12.0,YR,,F,Y,99.7,KG,20200513.0,,HP,GB,GB,2020,Q2,Child
177802041,17780204,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,22 U,,,,,,,,,,,,2020,Q2,Drug hypersensitivity,,2020,Q2,1,I,2011.0,20200504.0,20200513,20200513,EXP,,GB-NOVOPROD-727818,NOVO NORDISK,"HARVEY, JOHN N CRONIN, MICHAEL ARKWRIGHT, PETER. INSULIN HYPERSENSITIVITY IN TYPE 1 DIABETES: INVESTIGATION AND TREATMENT WITH IMMUNODEPLETION. PRACTICAL DIABETES. 2020;37(2):59-61",12.0,YR,,F,Y,99.7,KG,20200513.0,,HP,GB,GB,2020,Q2,Child
177802041,17780204,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,22 U,,,,,,,,,,,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,2011.0,20200504.0,20200513,20200513,EXP,,GB-NOVOPROD-727818,NOVO NORDISK,"HARVEY, JOHN N CRONIN, MICHAEL ARKWRIGHT, PETER. INSULIN HYPERSENSITIVITY IN TYPE 1 DIABETES: INVESTIGATION AND TREATMENT WITH IMMUNODEPLETION. PRACTICAL DIABETES. 2020;37(2):59-61",12.0,YR,,F,Y,99.7,KG,20200513.0,,HP,GB,GB,2020,Q2,Child
177805781,17780578,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"25 IU, QD",,,Y,U,,,,25.0,IU,INJECTION,QD,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,1,I,,20200506.0,20200513,20200513,EXP,,SK-MYLANLABS-2020M1045923,MYLAN,SKRIPOVA D.. MULTIFACTORY EFFECT OF EMPAGLIFLOSIN IN A POLYMORBIDAL PATIENT WITH DIABETES MELLITUS.. INTERNAL MEDICINE.. 2020;S1:8-9,58.0,YR,,F,Y,,,20200513.0,,MD,SK,SK,2020,Q2,Adult
177805781,17780578,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,REDUCTION OF INSULIN DOSE TO 0.4 IU/KG/DAY,,,Y,U,,,,,,INJECTION,,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,1,I,,20200506.0,20200513,20200513,EXP,,SK-MYLANLABS-2020M1045923,MYLAN,SKRIPOVA D.. MULTIFACTORY EFFECT OF EMPAGLIFLOSIN IN A POLYMORBIDAL PATIENT WITH DIABETES MELLITUS.. INTERNAL MEDICINE.. 2020;S1:8-9,58.0,YR,,F,Y,,,20200513.0,,MD,SK,SK,2020,Q2,Adult
177805931,17780593,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (EVENING)",,,Y,,,,,20.0,IU,INJECTION,QD,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,1,I,2008.0,20200506.0,20200513,20200513,EXP,,SK-MYLANLABS-2020M1045921,MYLAN,LEJAVOV? J. HICKMAN D.. FIRST EXPERIENCE WITH THE USE OF NFI (NATURAL FOOD INTERACTION) PROTOCOL IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN SLOVAKIA.. CASE REPORTS IN DIABETOLOGY.. 2020;1:20-30,64.0,YR,,M,Y,,,20200513.0,,MD,SK,SK,2020,Q2,Adult
177805931,17780593,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (EVENING)",,,Y,,,,,20.0,IU,INJECTION,QD,2020,Q2,Weight increased,,2020,Q2,1,I,2008.0,20200506.0,20200513,20200513,EXP,,SK-MYLANLABS-2020M1045921,MYLAN,LEJAVOV? J. HICKMAN D.. FIRST EXPERIENCE WITH THE USE OF NFI (NATURAL FOOD INTERACTION) PROTOCOL IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN SLOVAKIA.. CASE REPORTS IN DIABETOLOGY.. 2020;1:20-30,64.0,YR,,M,Y,,,20200513.0,,MD,SK,SK,2020,Q2,Adult
177830031,17783003,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,2020.0,20200506.0,20200514,20200514,PER,DE-BFARM-20003581,DE-AMGEN-DEUSP2020075015,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20200514.0,,CN,DE,DE,2020,Q2,Elderly
177830031,17783003,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Eye movement disorder,,2020,Q2,1,I,2020.0,20200506.0,20200514,20200514,PER,DE-BFARM-20003581,DE-AMGEN-DEUSP2020075015,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20200514.0,,CN,DE,DE,2020,Q2,Elderly
177830031,17783003,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Movement disorder,,2020,Q2,1,I,2020.0,20200506.0,20200514,20200514,PER,DE-BFARM-20003581,DE-AMGEN-DEUSP2020075015,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20200514.0,,CN,DE,DE,2020,Q2,Elderly
177830031,17783003,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Off label use,,2020,Q2,1,I,2020.0,20200506.0,20200514,20200514,PER,DE-BFARM-20003581,DE-AMGEN-DEUSP2020075015,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20200514.0,,CN,DE,DE,2020,Q2,Elderly
177830031,17783003,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Seizure,,2020,Q2,1,I,2020.0,20200506.0,20200514,20200514,PER,DE-BFARM-20003581,DE-AMGEN-DEUSP2020075015,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20200514.0,,CN,DE,DE,2020,Q2,Elderly
177886061,17788606,15,SS,Insulin glargine,INSULIN GLARGINE,1,Oral,UNK,,,D,,,,,,,,,2020,Q2,Completed suicide,,2020,Q2,1,I,,20200504.0,20200515,20200515,EXP,,US-AUROBINDO-AUR-APL-2020-023191,AUROBINDO,,48.0,YR,,M,Y,,,20200515.0,,MD,US,US,2020,Q2,Adult
177886061,17788606,16,SS,Insulin glargine,INSULIN GLARGINE,1,Parenteral,UNK,,,D,,,,,,,,,2020,Q2,Completed suicide,,2020,Q2,1,I,,20200504.0,20200515,20200515,EXP,,US-AUROBINDO-AUR-APL-2020-023191,AUROBINDO,,48.0,YR,,M,Y,,,20200515.0,,MD,US,US,2020,Q2,Adult
177933361,17793336,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 UNITS OF, U-300 ONCE-DAILY",,,,,,,,,,,QD,2020,Q2,Hyponatraemia,,2020,Q2,1,I,,20200505.0,20200515,20200515,EXP,,JP-AMNEAL PHARMACEUTICALS-2020-AMRX-01348,AMNEAL,,57.0,YR,,F,Y,49.0,KG,20200515.0,,MD,JP,JP,2020,Q2,Adult
177933361,17793336,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 UNITS OF, U-300 ONCE-DAILY",,,,,,,,,,,QD,2020,Q2,Renal tubular acidosis,,2020,Q2,1,I,,20200505.0,20200515,20200515,EXP,,JP-AMNEAL PHARMACEUTICALS-2020-AMRX-01348,AMNEAL,,57.0,YR,,F,Y,49.0,KG,20200515.0,,MD,JP,JP,2020,Q2,Adult
177944302,17794430,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,MELAS syndrome,,2020,Q2,2,F,,20200513.0,20200516,20200521,EXP,,CZ-AUROBINDO-AUR-APL-2020-024219,AUROBINDO,,35.0,YR,,F,Y,,,20200521.0,,HP,CZ,CZ,2020,Q2,Adult
177957101,17795710,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 INTERNATIONAL UNIT, QD, 36 UNITS OF INSULIN GLARGINE U-300 ONCE-DAILY",,,,,,,,36.0,IU,,QD,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,,20200506.0,20200516,20200516,EXP,,JP-LUPIN PHARMACEUTICALS INC.-2020-02190,LUPIN,,57.0,YR,,F,Y,49.0,KG,20200516.0,,HP,JP,JP,2020,Q2,Adult
177957101,17795710,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 INTERNATIONAL UNIT, QD, 36 UNITS OF INSULIN GLARGINE U-300 ONCE-DAILY",,,,,,,,36.0,IU,,QD,2020,Q2,Hyponatraemia,,2020,Q2,1,I,,20200506.0,20200516,20200516,EXP,,JP-LUPIN PHARMACEUTICALS INC.-2020-02190,LUPIN,,57.0,YR,,F,Y,49.0,KG,20200516.0,,HP,JP,JP,2020,Q2,Adult
177957101,17795710,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"36 INTERNATIONAL UNIT, QD, 36 UNITS OF INSULIN GLARGINE U-300 ONCE-DAILY",,,,,,,,36.0,IU,,QD,2020,Q2,Renal tubular acidosis,,2020,Q2,1,I,,20200506.0,20200516,20200516,EXP,,JP-LUPIN PHARMACEUTICALS INC.-2020-02190,LUPIN,,57.0,YR,,F,Y,49.0,KG,20200516.0,,HP,JP,JP,2020,Q2,Adult
177964601,17796460,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,U-300 ONCE-DAILY,,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,,20200504.0,20200518,20200518,EXP,,JP-CPL-001730,CADILA,"TAKUBO M, TANAKA S, KUSHIMOTO M, IKEDA J, OGAWA K, SUZUKI Y, ET AL. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020 APR 23;9(4).",57.0,YR,,F,Y,49.0,KG,20200518.0,,HP,JP,JP,2020,Q2,Adult
177964601,17796460,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,U-300 ONCE-DAILY,,,,,,,,,,,,2020,Q2,Hyponatraemia,,2020,Q2,1,I,,20200504.0,20200518,20200518,EXP,,JP-CPL-001730,CADILA,"TAKUBO M, TANAKA S, KUSHIMOTO M, IKEDA J, OGAWA K, SUZUKI Y, ET AL. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS (BASEL). 2020 APR 23;9(4).",57.0,YR,,F,Y,49.0,KG,20200518.0,,HP,JP,JP,2020,Q2,Adult
177974131,17797413,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Rash,,2020,Q2,1,I,20200513.0,,20200515,20200515,DIR,,,FDA-CTU,,58.0,YR,,M,N,137.0,KG,20200515.0,N,PH,US,US,2020,Q2,Adult
177974131,17797413,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Staphylococcal infection,,2020,Q2,1,I,20200513.0,,20200515,20200515,DIR,,,FDA-CTU,,58.0,YR,,M,N,137.0,KG,20200515.0,N,PH,US,US,2020,Q2,Adult
177974131,17797413,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Stevens-Johnson syndrome,,2020,Q2,1,I,20200513.0,,20200515,20200515,DIR,,,FDA-CTU,,58.0,YR,,M,N,137.0,KG,20200515.0,N,PH,US,US,2020,Q2,Adult
177974131,17797413,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Toxic shock syndrome,,2020,Q2,1,I,20200513.0,,20200515,20200515,DIR,,,FDA-CTU,,58.0,YR,,M,N,137.0,KG,20200515.0,N,PH,US,US,2020,Q2,Adult
178011992,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q2,Cogwheel rigidity,,2020,Q2,2,F,,20200608.0,20200519,20200611,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
178011992,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q2,Drug interaction,,2020,Q2,2,F,,20200608.0,20200519,20200611,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
178011992,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q2,Drug level increased,,2020,Q2,2,F,,20200608.0,20200519,20200611,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
178011992,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q2,Dystonia,,2020,Q2,2,F,,20200608.0,20200519,20200611,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
178011992,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q2,Tremor,,2020,Q2,2,F,,20200608.0,20200519,20200611,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200611.0,,PH,US,US,2020,Q2,Elderly
178017101,17801710,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Coronavirus test positive,,2020,Q2,1,I,20200514.0,,20200518,20200518,DIR,,,FDA-CTU,,43.0,YR,,F,N,85.7,KG,20200518.0,N,PH,US,US,2020,Q2,Adult
178017101,17801710,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,20200514.0,,20200518,20200518,DIR,,,FDA-CTU,,43.0,YR,,F,N,85.7,KG,20200518.0,N,PH,US,US,2020,Q2,Adult
178017601,17801760,6,C,insulin glargine 12 Units SC QHS,,2,,,,,,,,,,,,,,2020,Q2,Clinical trial participant,,2020,Q2,1,I,20200517.0,,20200518,20200518,DIR,,,FDA-CTU,,53.0,YR,,M,N,87.66,KG,20200518.0,Y,PH,US,US,2020,Q2,Adult
178017601,17801760,6,C,insulin glargine 12 Units SC QHS,,2,,,,,,,,,,,,,,2020,Q2,Differential white blood cell count abnormal,,2020,Q2,1,I,20200517.0,,20200518,20200518,DIR,,,FDA-CTU,,53.0,YR,,M,N,87.66,KG,20200518.0,Y,PH,US,US,2020,Q2,Adult
178017601,17801760,6,C,insulin glargine 12 Units SC QHS,,2,,,,,,,,,,,,,,2020,Q2,Leukopenia,,2020,Q2,1,I,20200517.0,,20200518,20200518,DIR,,,FDA-CTU,,53.0,YR,,M,N,87.66,KG,20200518.0,Y,PH,US,US,2020,Q2,Adult
178017601,17801760,6,C,insulin glargine 12 Units SC QHS,,2,,,,,,,,,,,,,,2020,Q2,Lymphocyte percentage increased,,2020,Q2,1,I,20200517.0,,20200518,20200518,DIR,,,FDA-CTU,,53.0,YR,,M,N,87.66,KG,20200518.0,Y,PH,US,US,2020,Q2,Adult
178017601,17801760,6,C,insulin glargine 12 Units SC QHS,,2,,,,,,,,,,,,,,2020,Q2,Neutrophil percentage decreased,,2020,Q2,1,I,20200517.0,,20200518,20200518,DIR,,,FDA-CTU,,53.0,YR,,M,N,87.66,KG,20200518.0,Y,PH,US,US,2020,Q2,Adult
178017601,17801760,6,C,insulin glargine 12 Units SC QHS,,2,,,,,,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,1,I,20200517.0,,20200518,20200518,DIR,,,FDA-CTU,,53.0,YR,,M,N,87.66,KG,20200518.0,Y,PH,US,US,2020,Q2,Adult
178018091,17801809,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200518.0,,20200518,20200518,DIR,,,FDA-CTU,,72.0,YR,,M,N,69.4,KG,20200518.0,N,PH,US,US,2020,Q2,Elderly
178025781,17802578,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Aspiration,,2020,Q2,1,I,20191127.0,20200515.0,20200519,20200519,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20200519.0,,HP,COUNTRY NOT SPECIFIED,NL,2020,Q2,Elderly
178025781,17802578,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Hydrocephalus,,2020,Q2,1,I,20191127.0,20200515.0,20200519,20200519,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20200519.0,,HP,COUNTRY NOT SPECIFIED,NL,2020,Q2,Elderly
178025781,17802578,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20191127.0,20200515.0,20200519,20200519,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20200519.0,,HP,COUNTRY NOT SPECIFIED,NL,2020,Q2,Elderly
178025781,17802578,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Pneumonia,,2020,Q2,1,I,20191127.0,20200515.0,20200519,20200519,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20200519.0,,HP,COUNTRY NOT SPECIFIED,NL,2020,Q2,Elderly
178025781,17802578,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Pulseless electrical activity,,2020,Q2,1,I,20191127.0,20200515.0,20200519,20200519,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20200519.0,,HP,COUNTRY NOT SPECIFIED,NL,2020,Q2,Elderly
178025781,17802578,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20191127.0,20200515.0,20200519,20200519,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20200519.0,,HP,COUNTRY NOT SPECIFIED,NL,2020,Q2,Elderly
178026381,17802638,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Bacteraemia,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,COVID-19,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cardiac arrest,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Disease complication,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pneumonia pseudomonal,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026381,17802638,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200518.0,,20200519,20200519,DIR,,,FDA-CTU,,60.0,YR,,F,N,90.0,KG,20200519.0,N,PH,US,US,2020,Q2,Adult
178026781,17802678,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Leukocytosis,,2020,Q2,1,I,20200510.0,,20200518,20200518,DIR,,,FDA-CTU,,69.0,YR,,M,N,99.7,KG,20200512.0,N,PH,US,US,2020,Q2,Elderly
178026781,17802678,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pneumatosis intestinalis,,2020,Q2,1,I,20200510.0,,20200518,20200518,DIR,,,FDA-CTU,,69.0,YR,,M,N,99.7,KG,20200512.0,N,PH,US,US,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Abdominal pain upper,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Acidosis,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Dyspnoea,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Fatigue,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Feeling abnormal,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Hyperhidrosis,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Hypotension,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Lactic acidosis,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Renal impairment,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178037151,17803715,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, QD, 29 U",,,,,,,,,,,QD,2020,Q2,Vomiting,,2020,Q2,1,I,,20200512.0,20200519,20200519,EXP,,PT-MYLANLABS-2020M1048333,MYLAN,"SANTOS M, GARCA M, COTA P, AVILA P, SANTOS A.. METFORMIN-ASSOCIATED LACTIC ACIDOSIS, WITH ACUTE KIDNEY INJURY DUE TO IATROGENIC HYPOTENSION.. MEDICINA INTERNA ? CONGRESSO NACIONAL. 2019;25CNMI19",76.0,YR,,M,Y,,,20200519.0,,MD,PT,PT,2020,Q2,Elderly
178042971,17804297,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNIT NIGHTLY (BEDTIME),,,,,,,,,,,,2020,Q2,Invasive breast carcinoma,,2020,Q2,1,I,20200428.0,20200513.0,20200519,20200519,PER,,US-AMGEN-USACT2020078712,AMGEN,,74.0,YR,E,F,Y,102.95,KG,20200519.0,,MD,US,US,2020,Q2,Elderly
178067901,17806790,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood alkaline phosphatase increased,,2020,Q2,1,I,20200519.0,,20200519,20200519,DIR,,,FDA-CTU,,49.0,YR,,F,N,87.8,KG,20200519.0,Y,PH,US,US,2020,Q2,Adult
178067901,17806790,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood pressure decreased,,2020,Q2,1,I,20200519.0,,20200519,20200519,DIR,,,FDA-CTU,,49.0,YR,,F,N,87.8,KG,20200519.0,Y,PH,US,US,2020,Q2,Adult
178067901,17806790,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Body temperature increased,,2020,Q2,1,I,20200519.0,,20200519,20200519,DIR,,,FDA-CTU,,49.0,YR,,F,N,87.8,KG,20200519.0,Y,PH,US,US,2020,Q2,Adult
178071491,17807149,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,MELAS syndrome,,2020,Q2,1,I,,20200513.0,20200520,20200520,EXP,,CZ-MYLANLABS-2020M1048514,MYLAN,"GOLDMANNOVA D, KRYSTYNIK O, CIBICKOVA L, KARASEK D.. MATERNALNE DEDICNY DIABETES MELLITUS.. KAZUISTIKY V DIABETOLOGII.. 2020;11-13.",35.0,YR,,F,Y,,,20200520.0,,HP,CZ,CZ,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Abdominal discomfort,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Asthenia,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Ketonuria,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Metabolic disorder,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Nausea,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"18 IU, HS",,,Y,,,,206538.0,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Vomiting,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Abdominal discomfort,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Asthenia,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Ketonuria,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Metabolic disorder,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Nausea,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178091901,17809190,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, HS",,,Y,,,,206538.0,10.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Vomiting,,2020,Q2,1,I,,20181205.0,20200520,20200520,EXP,,ES-SAKK-2018SA334374AA,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Adult
178094511,17809451,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 INTERNATIONAL UNIT, QD (1X / DAY)",,,,,,,,16.0,IU,,QD,2020,Q2,Dolichocolon,,2020,Q2,1,I,20190701.0,20200514.0,20200520,20200520,EXP,,ES-MYLANLABS-2020M1049025,MYLAN,,66.0,YR,,F,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Elderly
178094511,17809451,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"16 INTERNATIONAL UNIT, QD (1X / DAY)",,,,,,,,16.0,IU,,QD,2020,Q2,Pneumatosis intestinalis,,2020,Q2,1,I,20190701.0,20200514.0,20200520,20200520,EXP,,ES-MYLANLABS-2020M1049025,MYLAN,,66.0,YR,,F,Y,,,20200520.0,,CN,ES,ES,2020,Q2,Elderly
178105551,17810555,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 IU, QD",,,U,,,,21081.0,120.0,IU,,QD,2020,Q2,Myocardial infarction,,2020,Q2,1,I,,20200518.0,20200521,20200521,EXP,,CA-SA-2020SA128569,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20200521.0,,CN,CA,CA,2020,Q2,Adult
178109621,17810962,19,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200516.0,,20200520,20200520,DIR,,,FDA-CTU,,69.0,YR,,M,N,134.5,KG,20200520.0,Y,PH,US,US,2020,Q2,Elderly
178109621,17810962,19,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200516.0,,20200520,20200520,DIR,,,FDA-CTU,,69.0,YR,,M,N,134.5,KG,20200520.0,Y,PH,US,US,2020,Q2,Elderly
178109621,17810962,19,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood urea increased,,2020,Q2,1,I,20200516.0,,20200520,20200520,DIR,,,FDA-CTU,,69.0,YR,,M,N,134.5,KG,20200520.0,Y,PH,US,US,2020,Q2,Elderly
178110121,17811012,16,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200518.0,,20200520,20200520,DIR,,,FDA-CTU,,35.0,YR,,M,N,272.7,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178110121,17811012,16,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200518.0,,20200520,20200520,DIR,,,FDA-CTU,,35.0,YR,,M,N,272.7,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178110121,17811012,16,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200518.0,,20200520,20200520,DIR,,,FDA-CTU,,35.0,YR,,M,N,272.7,KG,20200520.0,N,PH,US,US,2020,Q2,Adult
178110201,17811020,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200519.0,,20200520,20200520,DIR,,,FDA-CTU,,72.0,YR,,M,N,69.0,KG,20200520.0,N,PH,US,US,2020,Q2,Elderly
178110561,17811056,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Platelet count decreased,,2020,Q2,1,I,20200517.0,,20200520,20200520,DIR,,,FDA-CTU,,71.0,YR,,M,N,107.0,KG,20200520.0,Y,PH,AF,AF,2020,Q2,Elderly
178154271,17815427,13,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Body temperature increased,,2020,Q2,1,I,20200519.0,,20200521,20200521,DIR,,,FDA-CTU,,69.0,YR,,M,N,111.6,KG,20200521.0,Y,PH,US,US,2020,Q2,Elderly
178154271,17815427,13,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,20200519.0,,20200521,20200521,DIR,,,FDA-CTU,,69.0,YR,,M,N,111.6,KG,20200521.0,Y,PH,US,US,2020,Q2,Elderly
178157211,17815721,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 U, DAILY",,,U,,,,205692.0,16.0,IU,,QD,2020,Q2,Blood potassium increased,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178157211,17815721,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 U, DAILY",,,U,,,,205692.0,16.0,IU,,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178157211,17815721,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 U, DAILY",,,U,,,,205692.0,16.0,IU,,QD,2020,Q2,Injection site swelling,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178157211,17815721,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 U, DAILY",,,U,,,,205692.0,16.0,IU,,QD,2020,Q2,Intentional overdose,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178157211,17815721,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 U, DAILY",,,U,,,,205692.0,16.0,IU,,QD,2020,Q2,Suicide attempt,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178157211,17815721,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1200 U, SINGLE",,,U,,,,205692.0,1200.0,IU,,,2020,Q2,Blood potassium increased,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178157211,17815721,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1200 U, SINGLE",,,U,,,,205692.0,1200.0,IU,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178157211,17815721,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1200 U, SINGLE",,,U,,,,205692.0,1200.0,IU,,,2020,Q2,Injection site swelling,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178157211,17815721,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1200 U, SINGLE",,,U,,,,205692.0,1200.0,IU,,,2020,Q2,Intentional overdose,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178157211,17815721,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1200 U, SINGLE",,,U,,,,205692.0,1200.0,IU,,,2020,Q2,Suicide attempt,,2020,Q2,1,I,,20200511.0,20200522,20200522,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202005005425,ELI LILLY AND CO,"MIYAKUNI Y, ET AL..A CASE INVOLVING MASSIVE INSULIN OVERDOSE: DIRECT AND INDIRECT CONDITIONS REQUIRING EXTENDED MANAGEMENT OF SERUM POTASSIUM..AMERICAN JOURNAL OF CASE REPORTS 2020;21:.",23.0,YR,,M,Y,65.0,KG,20200522.0,,MD,JP,JP,2020,Q2,Youth
178163611,17816361,9,C,INSULIN GLARGINE BS (BIOSIMILAR 2),,2,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2020,Q2,Encephalopathy,,2020,Q2,1,I,2019.0,20200515.0,20200522,20200522,EXP,,JP-ASTRAZENECA-2020SE65567,ASTRAZENECA,,70.0,YR,,M,Y,,,20200522.0,,PH,JP,JP,2020,Q2,Elderly
178163611,17816361,9,C,INSULIN GLARGINE BS (BIOSIMILAR 2),,2,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2020,Q2,Paraneoplastic neurological syndrome,,2020,Q2,1,I,2019.0,20200515.0,20200522,20200522,EXP,,JP-ASTRAZENECA-2020SE65567,ASTRAZENECA,,70.0,YR,,M,Y,,,20200522.0,,PH,JP,JP,2020,Q2,Elderly
178170021,17817002,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200521.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,M,N,73.4,KG,20200522.0,Y,PH,US,US,2020,Q2,Elderly
178170021,17817002,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Clinical trial participant,,2020,Q2,1,I,20200521.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,M,N,73.4,KG,20200522.0,Y,PH,US,US,2020,Q2,Elderly
178170021,17817002,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,1,I,20200521.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,M,N,73.4,KG,20200522.0,Y,PH,US,US,2020,Q2,Elderly
178170021,17817002,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Renal replacement therapy,,2020,Q2,1,I,20200521.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,M,N,73.4,KG,20200522.0,Y,PH,US,US,2020,Q2,Elderly
178170021,17817002,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200521.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,M,N,73.4,KG,20200522.0,Y,PH,US,US,2020,Q2,Elderly
178170021,17817002,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Shock,,2020,Q2,1,I,20200521.0,,20200522,20200522,DIR,,,FDA-CTU,,69.0,YR,,M,N,73.4,KG,20200522.0,Y,PH,US,US,2020,Q2,Elderly
178174012,17817401,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 IU,,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 IU,,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 IU,,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Weight increased,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,,,,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,,,,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 IU,,,,,,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Weight increased,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 IU,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Weight increased,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178174012,17817401,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Weight increased,,2020,Q2,2,F,201905.0,20200525.0,20200522,20200529,EXP,,NVSC2020SK137255,NOVARTIS,,74.0,YR,,F,Y,,,20200529.0,,HP,SK,SK,2020,Q2,Elderly
178190031,17819003,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,10.0,IU,UNKNOWN,,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200513.0,20200523,20200523,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02363,HIKMA,"CHAPPELL K, SHAH S, CUTSHALL T, SANDS C. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER; DOI: 10.1097/01.NPR.0000660368.67226.AD. 2020 MAY 01;45(5):11-12.",69.0,YR,,M,Y,,,20200521.0,,PH,US,US,2020,Q2,Elderly
178190031,17819003,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,10.0,IU,UNKNOWN,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200513.0,20200523,20200523,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02363,HIKMA,"CHAPPELL K, SHAH S, CUTSHALL T, SANDS C. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER; DOI: 10.1097/01.NPR.0000660368.67226.AD. 2020 MAY 01;45(5):11-12.",69.0,YR,,M,Y,,,20200521.0,,PH,US,US,2020,Q2,Elderly
178190031,17819003,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,10.0,IU,UNKNOWN,,2020,Q2,Drug level increased,,2020,Q2,1,I,,20200513.0,20200523,20200523,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02363,HIKMA,"CHAPPELL K, SHAH S, CUTSHALL T, SANDS C. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER; DOI: 10.1097/01.NPR.0000660368.67226.AD. 2020 MAY 01;45(5):11-12.",69.0,YR,,M,Y,,,20200521.0,,PH,US,US,2020,Q2,Elderly
178190031,17819003,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,10.0,IU,UNKNOWN,,2020,Q2,Dystonia,,2020,Q2,1,I,,20200513.0,20200523,20200523,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02363,HIKMA,"CHAPPELL K, SHAH S, CUTSHALL T, SANDS C. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER; DOI: 10.1097/01.NPR.0000660368.67226.AD. 2020 MAY 01;45(5):11-12.",69.0,YR,,M,Y,,,20200521.0,,PH,US,US,2020,Q2,Elderly
178190031,17819003,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,10.0,IU,UNKNOWN,,2020,Q2,Resting tremor,,2020,Q2,1,I,,20200513.0,20200523,20200523,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-02363,HIKMA,"CHAPPELL K, SHAH S, CUTSHALL T, SANDS C. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER; DOI: 10.1097/01.NPR.0000660368.67226.AD. 2020 MAY 01;45(5):11-12.",69.0,YR,,M,Y,,,20200521.0,,PH,US,US,2020,Q2,Elderly
178192371,17819237,15,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20170213.0,20200515.0,20200523,20200523,EXP,FR-AFSSAPS-RN20170270,FR-ACCORD-182828,ACCORD,,77.0,YR,,F,Y,79.0,KG,20200523.0,,MD,FR,FR,2020,Q2,Elderly
178205811,17820581,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, ONCE A DAY (NIGHTLY)",,,,,,,,10.0,IU,,QD,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200514.0,20200525,20200525,EXP,,US-AUROBINDO-AUR-APL-2020-025131,AUROBINDO,,69.0,YR,,M,Y,,,20200525.0,,HP,US,US,2020,Q2,Elderly
178205811,17820581,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, ONCE A DAY (NIGHTLY)",,,,,,,,10.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200514.0,20200525,20200525,EXP,,US-AUROBINDO-AUR-APL-2020-025131,AUROBINDO,,69.0,YR,,M,Y,,,20200525.0,,HP,US,US,2020,Q2,Elderly
178205811,17820581,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, ONCE A DAY (NIGHTLY)",,,,,,,,10.0,IU,,QD,2020,Q2,Drug level increased,,2020,Q2,1,I,,20200514.0,20200525,20200525,EXP,,US-AUROBINDO-AUR-APL-2020-025131,AUROBINDO,,69.0,YR,,M,Y,,,20200525.0,,HP,US,US,2020,Q2,Elderly
178205811,17820581,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, ONCE A DAY (NIGHTLY)",,,,,,,,10.0,IU,,QD,2020,Q2,Dystonia,,2020,Q2,1,I,,20200514.0,20200525,20200525,EXP,,US-AUROBINDO-AUR-APL-2020-025131,AUROBINDO,,69.0,YR,,M,Y,,,20200525.0,,HP,US,US,2020,Q2,Elderly
178205811,17820581,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, ONCE A DAY (NIGHTLY)",,,,,,,,10.0,IU,,QD,2020,Q2,Tremor,,2020,Q2,1,I,,20200514.0,20200525,20200525,EXP,,US-AUROBINDO-AUR-APL-2020-025131,AUROBINDO,,69.0,YR,,M,Y,,,20200525.0,,HP,US,US,2020,Q2,Elderly
178207351,17820735,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,D,,,,,32.0,IU,,,2020,Q2,Cerebral haemorrhage,,2020,Q2,1,I,20191021.0,20200113.0,20200525,20200525,EXP,IT-MINISAL02-583429,NVSC2020IT007740,NOVARTIS,,67.0,YR,,M,Y,,,20200525.0,,HP,IT,IT,2020,Q2,Elderly
178207351,17820735,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,D,,,,,32.0,IU,,,2020,Q2,Loss of consciousness,,2020,Q2,1,I,20191021.0,20200113.0,20200525,20200525,EXP,IT-MINISAL02-583429,NVSC2020IT007740,NOVARTIS,,67.0,YR,,M,Y,,,20200525.0,,HP,IT,IT,2020,Q2,Elderly
178207351,17820735,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,D,,,,,32.0,IU,,,2020,Q2,Neurological symptom,,2020,Q2,1,I,20191021.0,20200113.0,20200525,20200525,EXP,IT-MINISAL02-583429,NVSC2020IT007740,NOVARTIS,,67.0,YR,,M,Y,,,20200525.0,,HP,IT,IT,2020,Q2,Elderly
178207351,17820735,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,D,,,,,32.0,IU,,,2020,Q2,Respiratory arrest,,2020,Q2,1,I,20191021.0,20200113.0,20200525,20200525,EXP,IT-MINISAL02-583429,NVSC2020IT007740,NOVARTIS,,67.0,YR,,M,Y,,,20200525.0,,HP,IT,IT,2020,Q2,Elderly
178230781,17823078,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200522.0,,20200524,20200524,DIR,,,FDA-CTU,,68.0,YR,,M,N,99.5,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178230781,17823078,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Haemodialysis,,2020,Q2,1,I,20200522.0,,20200524,20200524,DIR,,,FDA-CTU,,68.0,YR,,M,N,99.5,KG,20200524.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,6,C,INSULIN GLARGINE SUBCUTANEOUS,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hypopnoea,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,6,C,INSULIN GLARGINE SUBCUTANEOUS,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Infusion related reaction,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,6,C,INSULIN GLARGINE SUBCUTANEOUS,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Rash,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,6,C,INSULIN GLARGINE SUBCUTANEOUS,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Rash pruritic,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,6,C,INSULIN GLARGINE SUBCUTANEOUS,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Respiratory distress,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231811,17823181,6,C,INSULIN GLARGINE SUBCUTANEOUS,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Wheezing,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,75.0,YR,,F,N,82.6,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231881,17823188,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,60.0,YR,,F,N,143.0,KG,20200525.0,N,PH,US,US,2020,Q2,Adult
178231881,17823188,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200522.0,,20200525,20200525,DIR,,,FDA-CTU,,60.0,YR,,F,N,143.0,KG,20200525.0,N,PH,US,US,2020,Q2,Adult
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Anxiety,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Encephalopathy,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Respiratory distress,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178231951,17823195,3,C,Insulin lispro + insulin glargine,,2,,,,,,,,,,,,,,2020,Q2,Unresponsive to stimuli,,2020,Q2,1,I,20200524.0,,20200525,20200525,DIR,,,FDA-CTU,,68.0,YR,,F,N,76.0,KG,20200525.0,N,PH,US,US,2020,Q2,Elderly
178232201,17823220,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acidosis,,2020,Q2,1,I,20200514.0,,20200522,20200522,DIR,,,FDA-CTU,,60.0,YR,,M,N,103.0,KG,20200522.0,Y,PH,US,US,2020,Q2,Adult
178232201,17823220,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200514.0,,20200522,20200522,DIR,,,FDA-CTU,,60.0,YR,,M,N,103.0,KG,20200522.0,Y,PH,US,US,2020,Q2,Adult
178247021,17824702,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, 1X/DAY AT NIGHT",,,,,,,,,,,QD,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200512.0,20200526,20200526,EXP,,"US-RISING PHARMACEUTICALS, INC.-2020RIS00226",UNIQUE PHARMACEUTICALS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020;5:11-12",69.0,YR,,M,Y,,,20200526.0,,PH,US,US,2020,Q2,Elderly
178247021,17824702,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, 1X/DAY AT NIGHT",,,,,,,,,,,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200512.0,20200526,20200526,EXP,,"US-RISING PHARMACEUTICALS, INC.-2020RIS00226",UNIQUE PHARMACEUTICALS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020;5:11-12",69.0,YR,,M,Y,,,20200526.0,,PH,US,US,2020,Q2,Elderly
178247021,17824702,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, 1X/DAY AT NIGHT",,,,,,,,,,,QD,2020,Q2,Dystonia,,2020,Q2,1,I,,20200512.0,20200526,20200526,EXP,,"US-RISING PHARMACEUTICALS, INC.-2020RIS00226",UNIQUE PHARMACEUTICALS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020;5:11-12",69.0,YR,,M,Y,,,20200526.0,,PH,US,US,2020,Q2,Elderly
178247021,17824702,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, 1X/DAY AT NIGHT",,,,,,,,,,,QD,2020,Q2,Resting tremor,,2020,Q2,1,I,,20200512.0,20200526,20200526,EXP,,"US-RISING PHARMACEUTICALS, INC.-2020RIS00226",UNIQUE PHARMACEUTICALS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020;5:11-12",69.0,YR,,M,Y,,,20200526.0,,PH,US,US,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Acute respiratory distress syndrome,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Cholestasis,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Hepatic failure,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Hypothermia,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Intentional overdose,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Multiple organ dysfunction syndrome,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Pneumonia aspiration,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Seizure,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Shock,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282471,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q2,Toxicity to various agents,,2020,Q2,1,I,,20200518.0,20200527,20200527,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200527.0,,HP,FR,FR,2020,Q2,Elderly
178282581,17828258,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Arthralgia,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240118,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178282581,17828258,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Blood creatine phosphokinase increased,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240118,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178282581,17828258,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Mobility decreased,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240118,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178282581,17828258,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Myalgia,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240118,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178282581,17828258,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Myositis,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240118,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178282581,17828258,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240118,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178282581,17828258,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Rhabdomyolysis,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240118,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178282891,17828289,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatine phosphokinase increased,,2020,Q2,1,I,20200512.0,,20200526,20200526,DIR,,,FDA-CTU,,81.0,YR,,F,N,62.0,KG,20200526.0,N,MD,US,US,2020,Q2,Elderly
178300101,17830010,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Arthralgia,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240109,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178300101,17830010,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatine phosphokinase increased,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240109,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178300101,17830010,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Mobility decreased,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240109,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178300101,17830010,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Myalgia,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240109,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178300101,17830010,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pain,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240109,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178300101,17830010,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Rhabdomyolysis,,2020,Q2,1,I,,20200520.0,20200527,20200527,EXP,,CA-TEVA-2020-CA-1240109,TEVA,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178308251,17830825,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Arthralgia,,2020,Q2,1,I,,20200525.0,20200527,20200527,EXP,,CA-PFIZER INC-2020208244,PFIZER,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178308251,17830825,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood creatine phosphokinase increased,,2020,Q2,1,I,,20200525.0,20200527,20200527,EXP,,CA-PFIZER INC-2020208244,PFIZER,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178308251,17830825,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Mobility decreased,,2020,Q2,1,I,,20200525.0,20200527,20200527,EXP,,CA-PFIZER INC-2020208244,PFIZER,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178308251,17830825,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Myalgia,,2020,Q2,1,I,,20200525.0,20200527,20200527,EXP,,CA-PFIZER INC-2020208244,PFIZER,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178308251,17830825,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Pain,,2020,Q2,1,I,,20200525.0,20200527,20200527,EXP,,CA-PFIZER INC-2020208244,PFIZER,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178308251,17830825,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Rhabdomyolysis,,2020,Q2,1,I,,20200525.0,20200527,20200527,EXP,,CA-PFIZER INC-2020208244,PFIZER,,34.0,YR,,F,Y,,,20200527.0,,PH,CA,CA,2020,Q2,Young Adult
178333381,17833338,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4050 IU, TOTAL (9 1.5-ML PENS AT 300 UNITS/ML)",,,D,,,,206538.0,4050.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4050 IU, TOTAL (9 1.5-ML PENS AT 300 UNITS/ML)",,,D,,,,206538.0,4050.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Depressed level of consciousness,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4050 IU, TOTAL (9 1.5-ML PENS AT 300 UNITS/ML)",,,D,,,,206538.0,4050.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypophagia,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4050 IU, TOTAL (9 1.5-ML PENS AT 300 UNITS/ML)",,,D,,,,206538.0,4050.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Intentional overdose,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4050 IU, TOTAL (9 1.5-ML PENS AT 300 UNITS/ML)",,,D,,,,206538.0,4050.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Nausea,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q2,Depressed level of consciousness,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q2,Hypophagia,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q2,Intentional overdose,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178333381,17833338,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,206538.0,,,SOLUTION FOR INJECTION,,2020,Q2,Nausea,,2020,Q2,1,I,,20200520.0,20200528,20200528,EXP,,AU-SA-2020SA131031,SANOFI AVENTIS,"ENDALL R., MCCALLUM R., BURGESS J.. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1?6",45.0,YR,A,F,Y,,,20200528.0,,HP,AU,AU,2020,Q2,Adult
178334331,17833433,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200519.0,,20200527,20200527,DIR,,,FDA-CTU,,57.0,YR,,M,N,73.0,KG,20200527.0,Y,PH,US,US,2020,Q2,Adult
178334331,17833433,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200519.0,,20200527,20200527,DIR,,,FDA-CTU,,57.0,YR,,M,N,73.0,KG,20200527.0,Y,PH,US,US,2020,Q2,Adult
178334901,17833490,12,C,"Insulin (glargine, regular)",,2,,,,,,,,,,,,,,2020,Q2,Acidosis,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,76.0,YR,,F,N,62.5,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178334901,17833490,12,C,"Insulin (glargine, regular)",,2,,,,,,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,76.0,YR,,F,N,62.5,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178334901,17833490,12,C,"Insulin (glargine, regular)",,2,,,,,,,,,,,,,,2020,Q2,Cough,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,76.0,YR,,F,N,62.5,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178334901,17833490,12,C,"Insulin (glargine, regular)",,2,,,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,76.0,YR,,F,N,62.5,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178334901,17833490,12,C,"Insulin (glargine, regular)",,2,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,76.0,YR,,F,N,62.5,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178334901,17833490,12,C,"Insulin (glargine, regular)",,2,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,76.0,YR,,F,N,62.5,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178334901,17833490,12,C,"Insulin (glargine, regular)",,2,,,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,1,I,20200524.0,,20200527,20200527,DIR,,,FDA-CTU,,76.0,YR,,F,N,62.5,KG,20200527.0,Y,PH,US,US,2020,Q2,Elderly
178335101,17833510,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200526.0,,20200527,20200527,DIR,,,FDA-CTU,,50.0,YR,,M,N,116.0,KG,20200527.0,N,PH,US,US,2020,Q2,Adult
178336101,17833610,14,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,20200522.0,,20200527,20200527,DIR,,,FDA-CTU,,69.0,YR,,M,N,112.5,KG,20200527.0,N,PH,US,US,2020,Q2,Elderly
178336101,17833610,14,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,1,I,20200522.0,,20200527,20200527,DIR,,,FDA-CTU,,69.0,YR,,M,N,112.5,KG,20200527.0,N,PH,US,US,2020,Q2,Elderly
178336101,17833610,14,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Ventricular tachycardia,,2020,Q2,1,I,20200522.0,,20200527,20200527,DIR,,,FDA-CTU,,69.0,YR,,M,N,112.5,KG,20200527.0,N,PH,US,US,2020,Q2,Elderly
178338251,17833825,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q2,Jaundice,,2020,Q2,1,I,20200415.0,20200511.0,20200528,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,,M,Y,,,20200528.0,,MD,JP,JP,2020,Q2,Elderly
178338251,17833825,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q2,Lymphadenopathy,,2020,Q2,1,I,20200415.0,20200511.0,20200528,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,,M,Y,,,20200528.0,,MD,JP,JP,2020,Q2,Elderly
178338251,17833825,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q2,Metastases to peritoneum,,2020,Q2,1,I,20200415.0,20200511.0,20200528,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,,M,Y,,,20200528.0,,MD,JP,JP,2020,Q2,Elderly
178338251,17833825,4,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q2,Pancreatitis acute,,2020,Q2,1,I,20200415.0,20200511.0,20200528,20200528,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-NB-024254",BOEHRINGER INGELHEIM,,74.0,YR,,M,Y,,,20200528.0,,MD,JP,JP,2020,Q2,Elderly
178345971,17834597,8,C,insulin glargine 5 units bid,,2,,,,,,,,,,,,,,2020,Q2,Bradycardia,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178345971,17834597,8,C,insulin glargine 5 units bid,,2,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178345971,17834597,8,C,insulin glargine 5 units bid,,2,,,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178345971,17834597,8,C,insulin glargine 5 units bid,,2,,,,,,,,,,,,,,2020,Q2,Inflammatory marker increased,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178345971,17834597,8,C,insulin glargine 5 units bid,,2,,,,,,,,,,,,,,2020,Q2,Ventricular fibrillation,,2020,Q2,1,I,20200521.0,,20200528,20200528,DIR,,,FDA-CTU,,38.0,YR,,F,N,71.7,KG,20200528.0,Y,PH,US,US,2020,Q2,Adult
178354611,17835461,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Drug eruption,,2020,Q2,1,I,20200302.0,20200521.0,20200528,20200528,EXP,,JP-OTSUKA-2020_012783,OTSUKA,,85.0,YR,,M,Y,52.1,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
178354611,17835461,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Incorrect dose administered,,2020,Q2,1,I,20200302.0,20200521.0,20200528,20200528,EXP,,JP-OTSUKA-2020_012783,OTSUKA,,85.0,YR,,M,Y,52.1,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
178354611,17835461,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Stevens-Johnson syndrome,,2020,Q2,1,I,20200302.0,20200521.0,20200528,20200528,EXP,,JP-OTSUKA-2020_012783,OTSUKA,,85.0,YR,,M,Y,52.1,KG,20200528.0,,PH,JP,JP,2020,Q2,Elderly
178358763,17835876,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Alanine aminotransferase abnormal,,2020,Q2,3,F,20200519.0,20200627.0,20200528,20200630,EXP,,US-GILEAD-2020-0468482,GILEAD,,49.0,YR,A,F,Y,87.8,KG,20200630.0,,PH,US,US,2020,Q2,Adult
178358763,17835876,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Blood alkaline phosphatase increased,,2020,Q2,3,F,20200519.0,20200627.0,20200528,20200630,EXP,,US-GILEAD-2020-0468482,GILEAD,,49.0,YR,A,F,Y,87.8,KG,20200630.0,,PH,US,US,2020,Q2,Adult
178358763,17835876,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hypotension,,2020,Q2,3,F,20200519.0,20200627.0,20200528,20200630,EXP,,US-GILEAD-2020-0468482,GILEAD,,49.0,YR,A,F,Y,87.8,KG,20200630.0,,PH,US,US,2020,Q2,Adult
178389551,17838955,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200527.0,,20200528,20200528,DIR,,,FDA-CTU,,63.0,YR,,M,N,88.1,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178389551,17838955,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Ischaemic hepatitis,,2020,Q2,1,I,20200527.0,,20200528,20200528,DIR,,,FDA-CTU,,63.0,YR,,M,N,88.1,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178389551,17838955,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,1,I,20200527.0,,20200528,20200528,DIR,,,FDA-CTU,,63.0,YR,,M,N,88.1,KG,20200528.0,N,PH,US,US,2020,Q2,Adult
178390041,17839004,13,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,White blood cell count decreased,,2020,Q2,1,I,20200528.0,,20200528,20200528,DIR,,,FDA-CTU,,82.0,YR,,F,N,122.4,KG,20200528.0,N,PH,US,US,2020,Q2,Elderly
178397901,17839790,15,C,"Insulin (glargine, lispro and regular)",,2,,,,,,,,,,,,,,2020,Q2,Dialysis,,2020,Q2,1,I,20200524.0,,20200529,20200529,DIR,,,FDA-CTU,,81.0,YR,,F,N,88.6,KG,20200529.0,Y,PH,US,US,2020,Q2,Elderly
178397901,17839790,15,C,"Insulin (glargine, lispro and regular)",,2,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200524.0,,20200529,20200529,DIR,,,FDA-CTU,,81.0,YR,,F,N,88.6,KG,20200529.0,Y,PH,US,US,2020,Q2,Elderly
178397901,17839790,15,C,"Insulin (glargine, lispro and regular)",,2,,,,,,,,,,,,,,2020,Q2,Tachypnoea,,2020,Q2,1,I,20200524.0,,20200529,20200529,DIR,,,FDA-CTU,,81.0,YR,,F,N,88.6,KG,20200529.0,Y,PH,US,US,2020,Q2,Elderly
178403591,17840359,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Palatal oedema,,2020,Q2,1,I,20200402.0,20200525.0,20200529,20200529,EXP,IT-MINISAL02-619167,IT-MYLANLABS-2020M1051925,MYLAN,,82.0,YR,,M,Y,,,20200529.0,,MD,IT,IT,2020,Q2,Elderly
178406281,17840628,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Palatal oedema,,2020,Q2,1,I,20200402.0,20200526.0,20200529,20200529,EXP,IT-MINISAL02-619167,IT-PFIZER INC-2020210291,PFIZER,,82.0,YR,,M,Y,,,20200529.0,,MD,IT,IT,2020,Q2,Elderly
178414271,17841427,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200516.0,20200520.0,20200529,20200529,EXP,,US-GILEAD-2020-0468705,GILEAD,,69.0,YR,E,M,Y,135.56,KG,20200529.0,,PH,US,US,2020,Q2,Elderly
178414271,17841427,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200516.0,20200520.0,20200529,20200529,EXP,,US-GILEAD-2020-0468705,GILEAD,,69.0,YR,E,M,Y,135.56,KG,20200529.0,,PH,US,US,2020,Q2,Elderly
178414271,17841427,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood urea increased,,2020,Q2,1,I,20200516.0,20200520.0,20200529,20200529,EXP,,US-GILEAD-2020-0468705,GILEAD,,69.0,YR,E,M,Y,135.56,KG,20200529.0,,PH,US,US,2020,Q2,Elderly
178417562,17841756,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Acute respiratory failure,,2020,Q2,2,F,20200524.0,20200611.0,20200529,20200616,EXP,,US-GILEAD-2020-0468849,GILEAD,,68.0,YR,E,F,Y,76.0,KG,20200616.0,,PH,US,US,2020,Q2,Elderly
178417562,17841756,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,COVID-19,,2020,Q2,2,F,20200524.0,20200611.0,20200529,20200616,EXP,,US-GILEAD-2020-0468849,GILEAD,,68.0,YR,E,F,Y,76.0,KG,20200616.0,,PH,US,US,2020,Q2,Elderly
178426251,17842625,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Asthenia,,2020,Q2,1,I,,20200520.0,20200529,20200529,EXP,,CA-ROCHE-2605397,ROCHE,,30.0,YR,,F,Y,,,20200529.0,,HP,CA,CA,2020,Q2,Young Adult
178426251,17842625,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Disability assessment scale score increased,,2020,Q2,1,I,,20200520.0,20200529,20200529,EXP,,CA-ROCHE-2605397,ROCHE,,30.0,YR,,F,Y,,,20200529.0,,HP,CA,CA,2020,Q2,Young Adult
178426251,17842625,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200520.0,20200529,20200529,EXP,,CA-ROCHE-2605397,ROCHE,,30.0,YR,,F,Y,,,20200529.0,,HP,CA,CA,2020,Q2,Young Adult
178426251,17842625,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Drug intolerance,,2020,Q2,1,I,,20200520.0,20200529,20200529,EXP,,CA-ROCHE-2605397,ROCHE,,30.0,YR,,F,Y,,,20200529.0,,HP,CA,CA,2020,Q2,Young Adult
178426251,17842625,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Inflammation,,2020,Q2,1,I,,20200520.0,20200529,20200529,EXP,,CA-ROCHE-2605397,ROCHE,,30.0,YR,,F,Y,,,20200529.0,,HP,CA,CA,2020,Q2,Young Adult
178426251,17842625,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Red blood cell sedimentation rate increased,,2020,Q2,1,I,,20200520.0,20200529,20200529,EXP,,CA-ROCHE-2605397,ROCHE,,30.0,YR,,F,Y,,,20200529.0,,HP,CA,CA,2020,Q2,Young Adult
178426251,17842625,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Spinal disorder,,2020,Q2,1,I,,20200520.0,20200529,20200529,EXP,,CA-ROCHE-2605397,ROCHE,,30.0,YR,,F,Y,,,20200529.0,,HP,CA,CA,2020,Q2,Young Adult
178426251,17842625,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Therapy non-responder,,2020,Q2,1,I,,20200520.0,20200529,20200529,EXP,,CA-ROCHE-2605397,ROCHE,,30.0,YR,,F,Y,,,20200529.0,,HP,CA,CA,2020,Q2,Young Adult
178435061,17843506,10,C,INSULIN GLARGINE(GENETICAL RECOMBINATION),INSULIN GLARGINE,1,Other,,,,,,,,,,,,,2020,Q2,Blood creatine phosphokinase increased,,2020,Q2,1,I,20200508.0,20200522.0,20200531,20200531,EXP,,JP-UCBSA-2020021796,UCB,,67.0,YR,,M,Y,56.9,KG,20200531.0,,MD,JP,JP,2020,Q2,Elderly
178436821,17843682,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,USE AS DIRECTED,,,,,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,20200124.0,20200526.0,20200531,20200531,EXP,GB-MHRA-TPP21122275C7118796YC1589360339776,"GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-026572",BOEHRINGER INGELHEIM,,57.0,YR,,M,Y,124.0,KG,20200601.0,,PH,GB,GB,2020,Q2,Adult
178437241,17843724,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Palatal oedema,,2020,Q2,1,I,20200402.0,20200521.0,20200531,20200531,EXP,,IT-AUROBINDO-AUR-APL-2020-026399,AUROBINDO,,82.0,YR,,M,Y,,,20200601.0,,MD,IT,IT,2020,Q2,Elderly
178446582,17844658,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2020,Q2,COVID-19,,2020,Q2,2,F,20200506.0,20200618.0,20200601,20200622,EXP,,CO-ABBVIE-20K-036-3425828-00,ABBVIE,,53.0,YR,,F,Y,73.0,KG,20200622.0,,CN,CO,CO,2020,Q2,Adult
178446582,17844658,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2020,Q2,Fluid overload,,2020,Q2,2,F,20200506.0,20200618.0,20200601,20200622,EXP,,CO-ABBVIE-20K-036-3425828-00,ABBVIE,,53.0,YR,,F,Y,73.0,KG,20200622.0,,CN,CO,CO,2020,Q2,Adult
178446582,17844658,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2020,Q2,Malaise,,2020,Q2,2,F,20200506.0,20200618.0,20200601,20200622,EXP,,CO-ABBVIE-20K-036-3425828-00,ABBVIE,,53.0,YR,,F,Y,73.0,KG,20200622.0,,CN,CO,CO,2020,Q2,Adult
178446582,17844658,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2020,Q2,Pneumonia,,2020,Q2,2,F,20200506.0,20200618.0,20200601,20200622,EXP,,CO-ABBVIE-20K-036-3425828-00,ABBVIE,,53.0,YR,,F,Y,73.0,KG,20200622.0,,CN,CO,CO,2020,Q2,Adult
178457481,17845748,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200430.0,20200601,20200601,EXP,,US-INDOCO-000099,INDOCO,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12.",69.0,YR,,M,Y,,,20200601.0,,PH,US,US,2020,Q2,Elderly
178457481,17845748,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200430.0,20200601,20200601,EXP,,US-INDOCO-000099,INDOCO,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12.",69.0,YR,,M,Y,,,20200601.0,,PH,US,US,2020,Q2,Elderly
178457481,17845748,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Dystonia,,2020,Q2,1,I,,20200430.0,20200601,20200601,EXP,,US-INDOCO-000099,INDOCO,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12.",69.0,YR,,M,Y,,,20200601.0,,PH,US,US,2020,Q2,Elderly
178457481,17845748,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Resting tremor,,2020,Q2,1,I,,20200430.0,20200601,20200601,EXP,,US-INDOCO-000099,INDOCO,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020 MAY;45(5):11-12.",69.0,YR,,M,Y,,,20200601.0,,PH,US,US,2020,Q2,Elderly
178471074,17847107,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Gastrointestinal disorder,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Genitourinary symptom,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Product administration error,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Therapeutic product effect incomplete,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471074,17847107,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Urinary tract disorder,,2020,Q2,4,F,,20200622.0,20200601,20200626,EXP,,NVSC2020PT074359,NOVARTIS,,61.0,YR,,M,Y,,,20200626.0,,HP,PT,PT,2020,Q2,Adult
178471721,17847172,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Anion gap abnormal,,2020,Q2,1,I,,20200528.0,20200601,20200601,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-027106",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,,,20200601.0,,PH,CA,CA,2020,Q2,Elderly
178471721,17847172,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Blood creatinine abnormal,,2020,Q2,1,I,,20200528.0,20200601,20200601,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-027106",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,,,20200601.0,,PH,CA,CA,2020,Q2,Elderly
178471721,17847172,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Blood glucose abnormal,,2020,Q2,1,I,,20200528.0,20200601,20200601,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-027106",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,,,20200601.0,,PH,CA,CA,2020,Q2,Elderly
178471721,17847172,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Glucose urine present,,2020,Q2,1,I,,20200528.0,20200601,20200601,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-027106",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,,,20200601.0,,PH,CA,CA,2020,Q2,Elderly
178471721,17847172,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,,20200528.0,20200601,20200601,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-027106",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,,,20200601.0,,PH,CA,CA,2020,Q2,Elderly
178471721,17847172,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,SOLUTION SUBCUTANEOUS,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,,20200528.0,20200601,20200601,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-027106",BOEHRINGER INGELHEIM,,69.0,YR,,M,Y,,,20200601.0,,PH,CA,CA,2020,Q2,Elderly
178477751,17847775,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200521.0,20200601,20200601,EXP,,ES-NOVOPROD-730530,NOVO NORDISK,,29.0,YR,,M,Y,71.0,KG,20200601.0,,CN,ES,ES,2020,Q2,Young Adult
178477751,17847775,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Multiple injuries,,2020,Q2,1,I,,20200521.0,20200601,20200601,EXP,,ES-NOVOPROD-730530,NOVO NORDISK,,29.0,YR,,M,Y,71.0,KG,20200601.0,,CN,ES,ES,2020,Q2,Young Adult
178480281,17848028,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200524.0,20200527.0,20200601,20200601,EXP,,US-GILEAD-2020-0469174,GILEAD,,76.0,YR,E,F,Y,62.5,KG,20200601.0,,PH,US,US,2020,Q2,Elderly
178480323,17848032,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Bilirubin conjugated increased,,2020,Q2,3,F,20200514.0,20200612.0,20200601,20200624,EXP,,US-GILEAD-2020-0468530,GILEAD,,57.0,YR,A,M,Y,91.4,KG,20200624.0,,PH,US,US,2020,Q2,Adult
178480323,17848032,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,3,F,20200514.0,20200612.0,20200601,20200624,EXP,,US-GILEAD-2020-0468530,GILEAD,,57.0,YR,A,M,Y,91.4,KG,20200624.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cardiac arrest,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Liver function test increased,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480442,17848044,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,2,F,20200523.0,20200610.0,20200601,20200615,EXP,,US-GILEAD-2020-0469503,GILEAD,,45.0,YR,A,M,Y,145.0,KG,20200615.0,,PH,US,US,2020,Q2,Adult
178480771,17848077,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Platelet count increased,,2020,Q2,1,I,20200516.0,20200520.0,20200601,20200601,EXP,,US-GILEAD-2020-0468738,GILEAD,,71.0,YR,E,M,Y,107.0,KG,20200601.0,,PH,US,US,2020,Q2,Elderly
178486192,17848619,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS OF THE DRUG IN A YELLOW SYRINGE PEN (10-40),,,D,,,,,,,,QD,2020,Q2,Blood glucose increased,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS OF THE DRUG IN A YELLOW SYRINGE PEN (10-40),,,D,,,,,,,,QD,2020,Q2,Decreased appetite,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS OF THE DRUG IN A YELLOW SYRINGE PEN (10-40),,,D,,,,,,,,QD,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS OF THE DRUG IN A YELLOW SYRINGE PEN (10-40),,,D,,,,,,,,QD,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS OF THE DRUG IN A YELLOW SYRINGE PEN (10-40),,,D,,,,,,,,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS OF THE DRUG IN A YELLOW SYRINGE PEN (10-40),,,D,,,,,,,,QD,2020,Q2,Nausea,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS OF THE DRUG IN A YELLOW SYRINGE PEN (10-40),,,D,,,,,,,,QD,2020,Q2,Treatment noncompliance,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486192,17848619,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS OF THE DRUG IN A YELLOW SYRINGE PEN (10-40),,,D,,,,,,,,QD,2020,Q2,Weight decreased,,2020,Q2,2,F,2018.0,20200603.0,20200602,20200609,EXP,,RU-EMD SERONO-9165390,EMD SERONO INC,"MARKOVA T, MKRTUMYAN A. CLINICAL EXPERIENCE OF LONG-TERM OBSERVATION OF THE EFFICACY OF A FIXED COMBINATION OF INSULIN GLARGINE AND GLP-1RA LIXISENATIDE IN PATIENTS WITH TYPE 2 DM WHO DID NOT REACH THE TARGET GLYCEMIA VALUES WITH THE USE OF ORAL ANTIDIABETIC DRUGS. FARMATEKA. 2020;27(4):119-123. DOI:10.18565/PHARMATECA",63.0,YR,,F,Y,,,20200609.0,,MD,RU,RU,2020,Q2,Adult
178486451,17848645,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,1,I,,20200528.0,20200602,20200602,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-042333,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200602.0,,HP,CA,CA,2020,Q2,Elderly
178486451,17848645,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q2,Asthenia,,2020,Q2,1,I,,20200528.0,20200602,20200602,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-042333,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200602.0,,HP,CA,CA,2020,Q2,Elderly
178486451,17848645,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q2,Fatigue,,2020,Q2,1,I,,20200528.0,20200602,20200602,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-042333,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200602.0,,HP,CA,CA,2020,Q2,Elderly
178486451,17848645,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q2,Gastrointestinal haemorrhage,,2020,Q2,1,I,,20200528.0,20200602,20200602,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-042333,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200602.0,,HP,CA,CA,2020,Q2,Elderly
178486451,17848645,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,,20200528.0,20200602,20200602,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-042333,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20200602.0,,HP,CA,CA,2020,Q2,Elderly
178492091,17849209,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood culture positive,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,International normalised ratio increased,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178492091,17849209,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Staphylococcal infection,,2020,Q2,1,I,20200531.0,,20200601,20200601,DIR,,,FDA-CTU,,80.0,YR,,M,N,83.5,KG,20200601.0,N,MD,US,US,2020,Q2,Elderly
178493681,17849368,19,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200527.0,,20200601,20200601,DIR,,,FDA-CTU,,70.0,YR,,M,N,101.7,KG,20200601.0,Y,HP,US,US,2020,Q2,Elderly
178493681,17849368,19,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Haemodialysis,,2020,Q2,1,I,20200527.0,,20200601,20200601,DIR,,,FDA-CTU,,70.0,YR,,M,N,101.7,KG,20200601.0,Y,HP,US,US,2020,Q2,Elderly
178493681,17849368,19,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200527.0,,20200601,20200601,DIR,,,FDA-CTU,,70.0,YR,,M,N,101.7,KG,20200601.0,Y,HP,US,US,2020,Q2,Elderly
178493681,17849368,19,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Therapy cessation,,2020,Q2,1,I,20200527.0,,20200601,20200601,DIR,,,FDA-CTU,,70.0,YR,,M,N,101.7,KG,20200601.0,Y,HP,US,US,2020,Q2,Elderly
178494481,17849448,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2020,Q2,Palatal oedema,,2020,Q2,1,I,20200402.0,20200526.0,20200602,20200602,EXP,IT-MINISAL02-619167,IT-TEVA-2020-IT-1242763,TEVA,,82.0,YR,,M,Y,,,20200602.0,,MD,IT,IT,2020,Q2,Elderly
178508171,17850817,3,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,1,I,20200529.0,,20200602,20200602,DIR,,,FDA-CTU,,71.0,YR,,M,N,98.6,KG,20200602.0,N,PH,US,US,2020,Q2,Elderly
178545661,17854566,13,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cholecystitis,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,13,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cholelithiasis,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,13,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,13,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,13,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178545661,17854566,13,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Renal failure,,2020,Q2,1,I,20200531.0,,20200602,20200602,DIR,,,FDA-CTU,,76.0,YR,,M,N,80.8,KG,20200602.0,Y,HP,US,US,2020,Q2,Elderly
178557481,17855748,9,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200602.0,,20200603,20200603,DIR,,,FDA-CTU,,55.0,YR,,M,N,99.0,KG,20200603.0,N,PH,US,US,2020,Q2,Adult
178562011,17856201,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200521.0,20200522.0,20200603,20200603,EXP,,US-GILEAD-2020-0468990,GILEAD,,69.0,YR,E,M,Y,73.4,KG,20200603.0,,PH,US,US,2020,Q2,Elderly
178562011,17856201,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,COVID-19,,2020,Q2,1,I,20200521.0,20200522.0,20200603,20200603,EXP,,US-GILEAD-2020-0468990,GILEAD,,69.0,YR,E,M,Y,73.4,KG,20200603.0,,PH,US,US,2020,Q2,Elderly
178562011,17856201,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200521.0,20200522.0,20200603,20200603,EXP,,US-GILEAD-2020-0468990,GILEAD,,69.0,YR,E,M,Y,73.4,KG,20200603.0,,PH,US,US,2020,Q2,Elderly
178562011,17856201,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Shock,,2020,Q2,1,I,20200521.0,20200522.0,20200603,20200603,EXP,,US-GILEAD-2020-0468990,GILEAD,,69.0,YR,E,M,Y,73.4,KG,20200603.0,,PH,US,US,2020,Q2,Elderly
178571031,17857103,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200514.0,20200522.0,20200603,20200603,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,103.0,KG,20200603.0,,PH,US,US,2020,Q2,Adult
178589901,17858990,13,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200530.0,,20200603,20200603,DIR,,,FDA-CTU,,67.0,YR,,F,N,135.0,KG,20200603.0,Y,PH,US,US,2020,Q2,Elderly
178589901,17858990,13,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Therapy cessation,,2020,Q2,1,I,20200530.0,,20200603,20200603,DIR,,,FDA-CTU,,67.0,YR,,F,N,135.0,KG,20200603.0,Y,PH,US,US,2020,Q2,Elderly
178600791,17860079,7,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200526.0,,20200604,20200604,DIR,,,FDA-CTU,,27.0,YR,,F,N,176.3,KG,20200604.0,Y,PH,US,US,2020,Q2,Young Adult
178600791,17860079,7,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200526.0,,20200604,20200604,DIR,,,FDA-CTU,,27.0,YR,,F,N,176.3,KG,20200604.0,Y,PH,US,US,2020,Q2,Young Adult
178600791,17860079,7,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Haemodialysis,,2020,Q2,1,I,20200526.0,,20200604,20200604,DIR,,,FDA-CTU,,27.0,YR,,F,N,176.3,KG,20200604.0,Y,PH,US,US,2020,Q2,Young Adult
178604482,17860448,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Drug reaction with eosinophilia and systemic symptoms,,2020,Q2,2,F,,20200529.0,20200604,20200605,EXP,,CA-APOTEX-2020AP011625,APOTEX,,73.0,YR,,M,Y,95.0,KG,20200605.0,,CN,CA,CA,2020,Q2,Elderly
178614451,17861445,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Cellulitis,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178614451,17861445,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Deep vein thrombosis,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178614451,17861445,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Intentional product use issue,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178614451,17861445,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Off label use,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178614451,17861445,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,,QD,2020,Q2,Peripheral swelling,,2020,Q2,1,I,20200515.0,20200521.0,20200604,20200604,EXP,,US-ROCHE-2607417,ROCHE,,78.0,YR,,M,Y,72.0,KG,20200604.0,,MD,US,US,2020,Q2,Elderly
178633231,17863323,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"THREE TIMES PRE MEAL, DAILY",,,U,,,,,,,,QD,2020,Q2,Oedema,,2020,Q2,1,I,,20200525.0,20200604,20200604,EXP,,TR-ELI_LILLY_AND_COMPANY-TR202005010465,ELI LILLY AND CO,"H.Y.KOSTEK, N.KOROGLU, F.O.COMLEK, E.DILEK, F.TUTUNCULER.INSULIN-INDUCED OEDEMA: A RARE COMPLICATION IN A PATIENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020;VOL. 16:N1.DOI:DOI: 10.22141/2224-0721.16.1.2020.199132",9.0,YR,,M,Y,36.0,KG,20200604.0,,MD,TR,TR,2020,Q2,Child
178633231,17863323,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"THREE TIMES PRE MEAL, DAILY",,,U,,,,,,,,QD,2020,Q2,Precocious puberty,,2020,Q2,1,I,,20200525.0,20200604,20200604,EXP,,TR-ELI_LILLY_AND_COMPANY-TR202005010465,ELI LILLY AND CO,"H.Y.KOSTEK, N.KOROGLU, F.O.COMLEK, E.DILEK, F.TUTUNCULER.INSULIN-INDUCED OEDEMA: A RARE COMPLICATION IN A PATIENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020;VOL. 16:N1.DOI:DOI: 10.22141/2224-0721.16.1.2020.199132",9.0,YR,,M,Y,36.0,KG,20200604.0,,MD,TR,TR,2020,Q2,Child
178633231,17863323,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"THREE TIMES PRE MEAL, DAILY",,,U,,,,,,,,QD,2020,Q2,Weight increased,,2020,Q2,1,I,,20200525.0,20200604,20200604,EXP,,TR-ELI_LILLY_AND_COMPANY-TR202005010465,ELI LILLY AND CO,"H.Y.KOSTEK, N.KOROGLU, F.O.COMLEK, E.DILEK, F.TUTUNCULER.INSULIN-INDUCED OEDEMA: A RARE COMPLICATION IN A PATIENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020;VOL. 16:N1.DOI:DOI: 10.22141/2224-0721.16.1.2020.199132",9.0,YR,,M,Y,36.0,KG,20200604.0,,MD,TR,TR,2020,Q2,Child
178634131,17863413,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE MEALS,,,U,, UNKNOWN,,,18.0,IU,,QD,2020,Q2,Feeling abnormal,,2020,Q2,1,I,,20200601.0,20200605,20200605,PER,,US-DRREDDYS-USA/USA/20/0123649,DR REDDYS,"PATEL K, STUMMER L, PATEL K. STIFF-PERSON SYNDROME IN A PATIENT WITH COMORBID BIPOLAR AND PANIC DISORDERS: A CASE REPORT AND LITERATURE REVIEW. MENT HEALTH CLIN. 2020;10(3):95-99. DOI: 10.9740/MHC.2020.05.095.",58.0,YR,A,F,Y,,,20200605.0,,PH,US,US,2020,Q2,Adult
178634131,17863413,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE MEALS,,,U,, UNKNOWN,,,18.0,IU,,QD,2020,Q2,Sedation,,2020,Q2,1,I,,20200601.0,20200605,20200605,PER,,US-DRREDDYS-USA/USA/20/0123649,DR REDDYS,"PATEL K, STUMMER L, PATEL K. STIFF-PERSON SYNDROME IN A PATIENT WITH COMORBID BIPOLAR AND PANIC DISORDERS: A CASE REPORT AND LITERATURE REVIEW. MENT HEALTH CLIN. 2020;10(3):95-99. DOI: 10.9740/MHC.2020.05.095.",58.0,YR,A,F,Y,,,20200605.0,,PH,US,US,2020,Q2,Adult
178665111,17866511,3,C,insulin glargine,INSULIN GLARGINE,1,Unknown,AT NIGHT,,,,,,,,15.0,IU,,,2020,Q2,Acute myocardial infarction,,2020,Q2,1,I,20200528.0,20200528.0,20200605,20200605,EXP,,CO-BAXTER-2020BAX011255,BAXTER,,68.0,YR,,M,Y,,,20200605.0,,HP,CO,CO,2020,Q2,Elderly
178678911,17867891,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q2,Diarrhoea,,2020,Q2,1,I,202005.0,20200601.0,20200605,20200605,EXP,,US-BAUSCH-BL-2020-016125,BAUSCH AND LOMB,,87.0,YR,,F,Y,,,20200605.0,,HP,US,US,2020,Q2,Elderly
178678911,17867891,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q2,Hepatic cirrhosis,,2020,Q2,1,I,202005.0,20200601.0,20200605,20200605,EXP,,US-BAUSCH-BL-2020-016125,BAUSCH AND LOMB,,87.0,YR,,F,Y,,,20200605.0,,HP,US,US,2020,Q2,Elderly
178678911,17867891,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q2,Somnolence,,2020,Q2,1,I,202005.0,20200601.0,20200605,20200605,EXP,,US-BAUSCH-BL-2020-016125,BAUSCH AND LOMB,,87.0,YR,,F,Y,,,20200605.0,,HP,US,US,2020,Q2,Elderly
178681921,17868192,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Transaminases increased,,2020,Q2,1,I,20200519.0,20200527.0,20200605,20200605,EXP,,US-GILEAD-2020-0469449,GILEAD,,57.0,YR,A,M,Y,73.0,KG,20200605.0,,PH,US,US,2020,Q2,Adult
178682052,17868205,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Pyrexia,,2020,Q2,2,F,20200519.0,20200612.0,20200605,20200618,EXP,,US-GILEAD-2020-0469507,GILEAD,,69.0,YR,E,M,Y,112.5,KG,20200618.0,,PH,US,US,2020,Q2,Elderly
178682052,17868205,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Ventricular tachycardia,,2020,Q2,2,F,20200519.0,20200612.0,20200605,20200618,EXP,,US-GILEAD-2020-0469507,GILEAD,,69.0,YR,E,M,Y,112.5,KG,20200618.0,,PH,US,US,2020,Q2,Elderly
178682971,17868297,3,C,insulin glargine U-300,,2,Unknown,"36 UNIT, QD",,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200526.0,20200606,20200606,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249099,RANBAXY,,57.0,YR,,F,Y,49.0,KG,20200606.0,,HP,JP,JP,2020,Q2,Adult
178682971,17868297,3,C,insulin glargine U-300,,2,Unknown,"36 UNIT, QD",,,,,,,,,,,,2020,Q2,Hyponatraemia,,2020,Q2,1,I,,20200526.0,20200606,20200606,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249099,RANBAXY,,57.0,YR,,F,Y,49.0,KG,20200606.0,,HP,JP,JP,2020,Q2,Adult
178682971,17868297,3,C,insulin glargine U-300,,2,Unknown,"36 UNIT, QD",,,,,,,,,,,,2020,Q2,Renal tubular acidosis,,2020,Q2,1,I,,20200526.0,20200606,20200606,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249099,RANBAXY,,57.0,YR,,F,Y,49.0,KG,20200606.0,,HP,JP,JP,2020,Q2,Adult
178686631,17868663,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD (300 IE/ML, 16-0-0-0)",,,U,U, UNKNOWN,,,,,,QD,2020,Q2,Dehydration,,2020,Q2,1,I,,20200603.0,20200606,20200606,EXP,,NVSC2020DE156225,NOVARTIS,,80.0,YR,,F,Y,,,20200607.0,,HP,DE,DE,2020,Q2,Elderly
178686631,17868663,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD (300 IE/ML, 16-0-0-0)",,,U,U, UNKNOWN,,,,,,QD,2020,Q2,General physical health deterioration,,2020,Q2,1,I,,20200603.0,20200606,20200606,EXP,,NVSC2020DE156225,NOVARTIS,,80.0,YR,,F,Y,,,20200607.0,,HP,DE,DE,2020,Q2,Elderly
178686631,17868663,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD (300 IE/ML, 16-0-0-0)",,,U,U, UNKNOWN,,,,,,QD,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200603.0,20200606,20200606,EXP,,NVSC2020DE156225,NOVARTIS,,80.0,YR,,F,Y,,,20200607.0,,HP,DE,DE,2020,Q2,Elderly
178686631,17868663,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD (300 IE/ML, 16-0-0-0)",,,U,U, UNKNOWN,,,,,,QD,2020,Q2,Pyrexia,,2020,Q2,1,I,,20200603.0,20200606,20200606,EXP,,NVSC2020DE156225,NOVARTIS,,80.0,YR,,F,Y,,,20200607.0,,HP,DE,DE,2020,Q2,Elderly
178686631,17868663,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD (300 IE/ML, 16-0-0-0)",,,U,U, UNKNOWN,,,,,,QD,2020,Q2,Sedation,,2020,Q2,1,I,,20200603.0,20200606,20200606,EXP,,NVSC2020DE156225,NOVARTIS,,80.0,YR,,F,Y,,,20200607.0,,HP,DE,DE,2020,Q2,Elderly
178704241,17870424,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS/NIGHT,,,,,,,,,,,,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200601.0,20200608,20200608,EXP,,US-MYLANLABS-2020M1054413,MYLAN,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE-PRACT 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200608.0,,PH,US,US,2020,Q2,Elderly
178704241,17870424,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS/NIGHT,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200601.0,20200608,20200608,EXP,,US-MYLANLABS-2020M1054413,MYLAN,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE-PRACT 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200608.0,,PH,US,US,2020,Q2,Elderly
178704241,17870424,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS/NIGHT,,,,,,,,,,,,2020,Q2,Dystonia,,2020,Q2,1,I,,20200601.0,20200608,20200608,EXP,,US-MYLANLABS-2020M1054413,MYLAN,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE-PRACT 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200608.0,,PH,US,US,2020,Q2,Elderly
178704241,17870424,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS/NIGHT,,,,,,,,,,,,2020,Q2,Resting tremor,,2020,Q2,1,I,,20200601.0,20200608,20200608,EXP,,US-MYLANLABS-2020M1054413,MYLAN,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE-PRACT 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200608.0,,PH,US,US,2020,Q2,Elderly
178707771,17870777,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4050 UNITS OF HIGH CONCENTRATION,,,U,U,,,,,,,,2020,Q2,Intentional overdose,,2020,Q2,1,I,,20200605.0,20200608,20200608,EXP,,NVSC2020AU157797,NOVARTIS,"ENDALL R, MCCALLUM R, BURGESS J. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS.. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1-6",45.0,YR,,F,Y,,,20200608.0,,HP,AU,AU,2020,Q2,Adult
178707771,17870777,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4050 UNITS OF HIGH CONCENTRATION,,,U,U,,,,,,,,2020,Q2,Suicide attempt,,2020,Q2,1,I,,20200605.0,20200608,20200608,EXP,,NVSC2020AU157797,NOVARTIS,"ENDALL R, MCCALLUM R, BURGESS J. CASE REPORT: HIGH-CONCENTRATION INSULIN GLARGINE OVERDOSE COMPLICATED BY HEPATIC STEATOSIS.. JOURNAL OF THE ENDOCRINE SOCIETY. 2020;4(5):1-6",45.0,YR,,F,Y,,,20200608.0,,HP,AU,AU,2020,Q2,Adult
178712301,17871230,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNIT, QD",,,U,, UNKNOWN,,,,,,QD,2020,Q2,Candida infection,,2020,Q2,1,I,,20200527.0,20200608,20200608,EXP,,SA-LUPIN PHARMACEUTICALS INC.-2020-02674,LUPIN,,53.0,YR,,F,Y,,,20200608.0,,HP,SA,SA,2020,Q2,Adult
178712301,17871230,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNIT, QD",,,U,, UNKNOWN,,,,,,QD,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200527.0,20200608,20200608,EXP,,SA-LUPIN PHARMACEUTICALS INC.-2020-02674,LUPIN,,53.0,YR,,F,Y,,,20200608.0,,HP,SA,SA,2020,Q2,Adult
178712301,17871230,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNIT, QD",,,U,, UNKNOWN,,,,,,QD,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,,20200527.0,20200608,20200608,EXP,,SA-LUPIN PHARMACEUTICALS INC.-2020-02674,LUPIN,,53.0,YR,,F,Y,,,20200608.0,,HP,SA,SA,2020,Q2,Adult
178712301,17871230,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNIT, QD",,,U,, UNKNOWN,,,,,,QD,2020,Q2,Oral candidiasis,,2020,Q2,1,I,,20200527.0,20200608,20200608,EXP,,SA-LUPIN PHARMACEUTICALS INC.-2020-02674,LUPIN,,53.0,YR,,F,Y,,,20200608.0,,HP,SA,SA,2020,Q2,Adult
178712301,17871230,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 UNIT, QD",,,U,, UNKNOWN,,,,,,QD,2020,Q2,Treatment noncompliance,,2020,Q2,1,I,,20200527.0,20200608,20200608,EXP,,SA-LUPIN PHARMACEUTICALS INC.-2020-02674,LUPIN,,53.0,YR,,F,Y,,,20200608.0,,HP,SA,SA,2020,Q2,Adult
178716361,17871636,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,12.0,IU,,QD,2020,Q2,Immune-mediated myositis,,2020,Q2,1,I,,20200604.0,20200608,20200608,EXP,,CZ-BAUSCH-BL-2020-016306,BAUSCH AND LOMB,SVARKO J. STATINY INDUKOVANA NEKROTIZUJICI AUTOIMUNITNI MYOPATIE JAKO NEOBVYKLA PRICINA EXTREMNICH HODNOT KARDIALNICH MARKERU U PACIENTA SE SVALOVOU SLABOSTI A OTOKY. CESKA REVMATOLOGIE. 2020 JAN;52-60.,75.0,YR,,,Y,,,20200608.0,,MD,CZ,CZ,2020,Q2,Elderly
178717791,17871779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, QD",,,U,,,,,,,,QD,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200602.0,20200608,20200608,EXP,,NVSC2020US158259,NOVARTIS,"CHAPPELL KB, SHAH SP, CUTSHALL T. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACTITIONER. 2020;45(5):11-2",69.0,YR,,M,Y,,,20200608.0,,HP,US,US,2020,Q2,Elderly
178717791,17871779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, QD",,,U,,,,,,,,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200602.0,20200608,20200608,EXP,,NVSC2020US158259,NOVARTIS,"CHAPPELL KB, SHAH SP, CUTSHALL T. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACTITIONER. 2020;45(5):11-2",69.0,YR,,M,Y,,,20200608.0,,HP,US,US,2020,Q2,Elderly
178717791,17871779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, QD",,,U,,,,,,,,QD,2020,Q2,Dystonia,,2020,Q2,1,I,,20200602.0,20200608,20200608,EXP,,NVSC2020US158259,NOVARTIS,"CHAPPELL KB, SHAH SP, CUTSHALL T. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACTITIONER. 2020;45(5):11-2",69.0,YR,,M,Y,,,20200608.0,,HP,US,US,2020,Q2,Elderly
178717791,17871779,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, QD",,,U,,,,,,,,QD,2020,Q2,Resting tremor,,2020,Q2,1,I,,20200602.0,20200608,20200608,EXP,,NVSC2020US158259,NOVARTIS,"CHAPPELL KB, SHAH SP, CUTSHALL T. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACTITIONER. 2020;45(5):11-2",69.0,YR,,M,Y,,,20200608.0,,HP,US,US,2020,Q2,Elderly
178722302,17872230,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Drug ineffective,,2020,Q2,2,F,,20200610.0,20200608,20200624,EXP,,IT-ASTELLAS-2020US018994,ASTELLAS,"BASILE G, CRISTOFARO G, GIOVANNI LOCATELLO L, VELLERE I, PICCICA M, BRESCI S, ET AL... REFRACTORY MUCOCUTANEOUS LEISHMANIASIS RESOLVED WITH COMBINATION TREATMENT BASED ON INTRAVENOUS PENTAMIDINE, ORAL AZOLE, AEROSOLIZED LIPOSOMAL AMPHOTERICIN B AND INTRALESIONAL MEGLUMINE ANTIMONIATE.. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES.. 2020;NO INFORMATION:NO INFORMATION",65.0,YR,,M,Y,,,20200624.0,,CN,GB,IT,2020,Q2,Elderly
178722302,17872230,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Dysphonia,,2020,Q2,2,F,,20200610.0,20200608,20200624,EXP,,IT-ASTELLAS-2020US018994,ASTELLAS,"BASILE G, CRISTOFARO G, GIOVANNI LOCATELLO L, VELLERE I, PICCICA M, BRESCI S, ET AL... REFRACTORY MUCOCUTANEOUS LEISHMANIASIS RESOLVED WITH COMBINATION TREATMENT BASED ON INTRAVENOUS PENTAMIDINE, ORAL AZOLE, AEROSOLIZED LIPOSOMAL AMPHOTERICIN B AND INTRALESIONAL MEGLUMINE ANTIMONIATE.. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES.. 2020;NO INFORMATION:NO INFORMATION",65.0,YR,,M,Y,,,20200624.0,,CN,GB,IT,2020,Q2,Elderly
178722302,17872230,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Dyspnoea,,2020,Q2,2,F,,20200610.0,20200608,20200624,EXP,,IT-ASTELLAS-2020US018994,ASTELLAS,"BASILE G, CRISTOFARO G, GIOVANNI LOCATELLO L, VELLERE I, PICCICA M, BRESCI S, ET AL... REFRACTORY MUCOCUTANEOUS LEISHMANIASIS RESOLVED WITH COMBINATION TREATMENT BASED ON INTRAVENOUS PENTAMIDINE, ORAL AZOLE, AEROSOLIZED LIPOSOMAL AMPHOTERICIN B AND INTRALESIONAL MEGLUMINE ANTIMONIATE.. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES.. 2020;NO INFORMATION:NO INFORMATION",65.0,YR,,M,Y,,,20200624.0,,CN,GB,IT,2020,Q2,Elderly
178722302,17872230,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q2,Off label use,,2020,Q2,2,F,,20200610.0,20200608,20200624,EXP,,IT-ASTELLAS-2020US018994,ASTELLAS,"BASILE G, CRISTOFARO G, GIOVANNI LOCATELLO L, VELLERE I, PICCICA M, BRESCI S, ET AL... REFRACTORY MUCOCUTANEOUS LEISHMANIASIS RESOLVED WITH COMBINATION TREATMENT BASED ON INTRAVENOUS PENTAMIDINE, ORAL AZOLE, AEROSOLIZED LIPOSOMAL AMPHOTERICIN B AND INTRALESIONAL MEGLUMINE ANTIMONIATE.. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES.. 2020;NO INFORMATION:NO INFORMATION",65.0,YR,,M,Y,,,20200624.0,,CN,GB,IT,2020,Q2,Elderly
178722441,17872244,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,1,I,20200607.0,,20200608,20200608,DIR,,,FDA-CTU,,74.0,YR,,M,N,100.8,KG,20200608.0,N,PH,US,US,2020,Q2,Elderly
178729802,17872980,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2020,Q2,Eczema asteatotic,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,INJECTION,QD,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,INJECTION,QD,2020,Q2,Eczema asteatotic,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,INJECTION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,INJECTION,QD,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,8.0,IU,INJECTION,QD,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,8.0,IU,INJECTION,QD,2020,Q2,Eczema asteatotic,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,8.0,IU,INJECTION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,8.0,IU,INJECTION,QD,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q2,Eczema asteatotic,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,6.0,IU,INJECTION,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,6.0,IU,INJECTION,,2020,Q2,Eczema asteatotic,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,6.0,IU,INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,6.0,IU,INJECTION,,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q2,Eczema asteatotic,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,3.0,IU,INJECTION,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,3.0,IU,INJECTION,,2020,Q2,Eczema asteatotic,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,3.0,IU,INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178729802,17872980,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,3.0,IU,INJECTION,,2020,Q2,Peripheral venous disease,,2020,Q2,2,F,20190507.0,20200620.0,20200608,20200625,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200625.0,,MD,JP,JP,2020,Q2,Elderly
178747021,17874702,17,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200529.0,,20200608,20200608,DIR,,,FDA-CTU,,68.0,YR,,F,N,101.0,KG,20200608.0,N,PH,US,US,2020,Q2,Elderly
178747021,17874702,17,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Aspartate aminotransferase increased,,2020,Q2,1,I,20200529.0,,20200608,20200608,DIR,,,FDA-CTU,,68.0,YR,,F,N,101.0,KG,20200608.0,N,PH,US,US,2020,Q2,Elderly
178747021,17874702,17,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Bacterial infection,,2020,Q2,1,I,20200529.0,,20200608,20200608,DIR,,,FDA-CTU,,68.0,YR,,F,N,101.0,KG,20200608.0,N,PH,US,US,2020,Q2,Elderly
178747021,17874702,17,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200529.0,,20200608,20200608,DIR,,,FDA-CTU,,68.0,YR,,F,N,101.0,KG,20200608.0,N,PH,US,US,2020,Q2,Elderly
178747021,17874702,17,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Respiratory failure,,2020,Q2,1,I,20200529.0,,20200608,20200608,DIR,,,FDA-CTU,,68.0,YR,,F,N,101.0,KG,20200608.0,N,PH,US,US,2020,Q2,Elderly
178747021,17874702,17,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,White blood cell count increased,,2020,Q2,1,I,20200529.0,,20200608,20200608,DIR,,,FDA-CTU,,68.0,YR,,F,N,101.0,KG,20200608.0,N,PH,US,US,2020,Q2,Elderly
178759012,17875901,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 U,,,,,,,,,,,QD,2020,Q2,Blood creatinine increased,,2020,Q2,2,F,20200603.0,20200609.0,20200609,20200612,EXP,,ES-ROCHE-2616155,ROCHE,,71.0,YR,,M,Y,88.5,KG,20200612.0,,MD,ES,ES,2020,Q2,Elderly
178760781,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,202005.0,20200528.0,20200609,20200609,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200609.0,,MD,US,US,2020,Q2,Elderly
178760781,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,202005.0,20200528.0,20200609,20200609,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200609.0,,MD,US,US,2020,Q2,Elderly
178760781,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Insomnia,,2020,Q2,1,I,202005.0,20200528.0,20200609,20200609,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200609.0,,MD,US,US,2020,Q2,Elderly
178760781,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Somnolence,,2020,Q2,1,I,202005.0,20200528.0,20200609,20200609,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200609.0,,MD,US,US,2020,Q2,Elderly
178760781,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Syncope,,2020,Q2,1,I,202005.0,20200528.0,20200609,20200609,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200609.0,,MD,US,US,2020,Q2,Elderly
178762121,17876212,7,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Creatinine renal clearance decreased,,2020,Q2,1,I,20200608.0,,20200609,20200609,DIR,,,FDA-CTU,,66.0,YR,,M,N,82.9,KG,20200609.0,N,PH,US,US,2020,Q2,Elderly
178777341,17877734,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200601.0,20200609,20200609,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006000937,ELI LILLY AND CO,,29.0,YR,,M,Y,71.0,KG,20200609.0,,CN,ES,ES,2020,Q2,Young Adult
178777341,17877734,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q2,Multiple injuries,,2020,Q2,1,I,,20200601.0,20200609,20200609,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006000937,ELI LILLY AND CO,,29.0,YR,,M,Y,71.0,KG,20200609.0,,CN,ES,ES,2020,Q2,Young Adult
178789651,17878965,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Asthenia,,2020,Q2,1,I,,20200603.0,20200610,20200610,EXP,,CA-TEVA-2020-CA-1246406,TEVA,,30.0,YR,,F,Y,,,20200610.0,,HP,CA,CA,2020,Q2,Young Adult
178789651,17878965,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Disability assessment scale score increased,,2020,Q2,1,I,,20200603.0,20200610,20200610,EXP,,CA-TEVA-2020-CA-1246406,TEVA,,30.0,YR,,F,Y,,,20200610.0,,HP,CA,CA,2020,Q2,Young Adult
178789651,17878965,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200603.0,20200610,20200610,EXP,,CA-TEVA-2020-CA-1246406,TEVA,,30.0,YR,,F,Y,,,20200610.0,,HP,CA,CA,2020,Q2,Young Adult
178789651,17878965,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Drug intolerance,,2020,Q2,1,I,,20200603.0,20200610,20200610,EXP,,CA-TEVA-2020-CA-1246406,TEVA,,30.0,YR,,F,Y,,,20200610.0,,HP,CA,CA,2020,Q2,Young Adult
178789651,17878965,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Inflammation,,2020,Q2,1,I,,20200603.0,20200610,20200610,EXP,,CA-TEVA-2020-CA-1246406,TEVA,,30.0,YR,,F,Y,,,20200610.0,,HP,CA,CA,2020,Q2,Young Adult
178789651,17878965,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Red blood cell sedimentation rate increased,,2020,Q2,1,I,,20200603.0,20200610,20200610,EXP,,CA-TEVA-2020-CA-1246406,TEVA,,30.0,YR,,F,Y,,,20200610.0,,HP,CA,CA,2020,Q2,Young Adult
178789651,17878965,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Spinal disorder,,2020,Q2,1,I,,20200603.0,20200610,20200610,EXP,,CA-TEVA-2020-CA-1246406,TEVA,,30.0,YR,,F,Y,,,20200610.0,,HP,CA,CA,2020,Q2,Young Adult
178789651,17878965,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Therapy non-responder,,2020,Q2,1,I,,20200603.0,20200610,20200610,EXP,,CA-TEVA-2020-CA-1246406,TEVA,,30.0,YR,,F,Y,,,20200610.0,,HP,CA,CA,2020,Q2,Young Adult
178791741,17879174,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hepatotoxicity,,2020,Q2,1,I,20200603.0,,20200609,20200609,DIR,,,FDA-CTU,,67.0,YR,,F,N,83.2,KG,20200609.0,N,PH,US,US,2020,Q2,Elderly
178791741,17879174,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Nephropathy toxic,,2020,Q2,1,I,20200603.0,,20200609,20200609,DIR,,,FDA-CTU,,67.0,YR,,F,N,83.2,KG,20200609.0,N,PH,US,US,2020,Q2,Elderly
178794942,17879494,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200605.0,20200610,20200617,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-02613,LUPIN,,59.0,YR,,F,Y,,,20200617.0,,PH,US,US,2020,Q2,Adult
178794942,17879494,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INTENSIFIED),,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200605.0,20200610,20200617,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-02613,LUPIN,,59.0,YR,,F,Y,,,20200617.0,,PH,US,US,2020,Q2,Adult
178796071,17879607,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Drug interaction,,2020,Q2,1,I,2020.0,20200603.0,20200610,20200610,PER,,DE-AMGEN-DEUSP2020090159,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20200610.0,,PH,DE,DE,2020,Q2,Elderly
178796071,17879607,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Eye movement disorder,,2020,Q2,1,I,2020.0,20200603.0,20200610,20200610,PER,,DE-AMGEN-DEUSP2020090159,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20200610.0,,PH,DE,DE,2020,Q2,Elderly
178796071,17879607,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Movement disorder,,2020,Q2,1,I,2020.0,20200603.0,20200610,20200610,PER,,DE-AMGEN-DEUSP2020090159,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20200610.0,,PH,DE,DE,2020,Q2,Elderly
178796071,17879607,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q2,Seizure,,2020,Q2,1,I,2020.0,20200603.0,20200610,20200610,PER,,DE-AMGEN-DEUSP2020090159,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20200610.0,,PH,DE,DE,2020,Q2,Elderly
178800971,17880097,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,,20200531.0,20200610,20200610,EXP,,ES-NOVOPROD-731900,NOVO NORDISK,,54.0,YR,,F,Y,,,20200610.0,,CN,ES,ES,2020,Q2,Adult
178800971,17880097,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200531.0,20200610,20200610,EXP,,ES-NOVOPROD-731900,NOVO NORDISK,,54.0,YR,,F,Y,,,20200610.0,,CN,ES,ES,2020,Q2,Adult
178812571,17881257,14,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200524.0,,20200610,20200610,DIR,,,FDA-CTU,,73.0,YR,,M,N,99.4,KG,20200610.0,N,PH,US,US,2020,Q2,Elderly
178812571,17881257,14,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200524.0,,20200610,20200610,DIR,,,FDA-CTU,,73.0,YR,,M,N,99.4,KG,20200610.0,N,PH,US,US,2020,Q2,Elderly
178812571,17881257,14,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Renal tubular injury,,2020,Q2,1,I,20200524.0,,20200610,20200610,DIR,,,FDA-CTU,,73.0,YR,,M,N,99.4,KG,20200610.0,N,PH,US,US,2020,Q2,Elderly
178822152,17882215,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,U,U,,,,12.0,IU,INJECTION,QD,2020,Q2,Immune-mediated myositis,,2020,Q2,2,F,,20200622.0,20200610,20200630,EXP,,CZ-MYLANLABS-2020M1055310,MYLAN,"?VARKO, J., ET AL.. STATINY INDUKOVAN? NEKROTIZUJ?C? AUTOIMUNITN? MYOPATIE JAKO NEOBVYKL? PR?CINA EXTR?MN?CH HODNOT KARDI?LN?CH MARKERU U PACIENTA SE SVALOVOU SLABOST? A OTOKY [STATIN?LNDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WLTH MUSCLE WEAKNESS AND SWELLING].. CESK? REVMATOLOGIE.. 2020;52-60",75.0,YR,,,Y,,,20200630.0,,MD,CZ,CZ,2020,Q2,Elderly
178829412,17882941,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,12.0,IU,,QD,2020,Q2,Immune-mediated myositis,,2020,Q2,2,F,,20200616.0,20200610,20200624,EXP,,CZ-AUROBINDO-AUR-APL-2020-027986,AUROBINDO,SVARKO J.ET AL.. STATINY INDUKOVAN? NEKROTIZUJ?C? AUTOIMUNITN? MYOPATIE JAKO NEOBVYKL? PR?CINA EXTR?MN?CH HODNOT KARDI?LN?CH MARKERU U PACIENTA SE SVALOVOU SLABOST? A OTOKY [STATIN?LNDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WLTH MUSCLE WEAKNESS AND SWELLING]. CESK? REVMATOLOGIE. ISSUE. 2020;52-60,75.0,YR,,,Y,,,20200624.0,,MD,CZ,CZ,2020,Q2,Elderly
178837191,17883719,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,,20200602.0,20200611,20200611,EXP,,"US-TELIGENT, INC-20200600017",UNKNOWN,SAMARTH P. SHAH. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12,69.0,YR,,M,Y,,,20200611.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Elderly
178837191,17883719,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200602.0,20200611,20200611,EXP,,"US-TELIGENT, INC-20200600017",UNKNOWN,SAMARTH P. SHAH. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12,69.0,YR,,M,Y,,,20200611.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Elderly
178837191,17883719,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200602.0,20200611,20200611,EXP,,"US-TELIGENT, INC-20200600017",UNKNOWN,SAMARTH P. SHAH. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12,69.0,YR,,M,Y,,,20200611.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Elderly
178837191,17883719,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Dystonia,,2020,Q2,1,I,,20200602.0,20200611,20200611,EXP,,"US-TELIGENT, INC-20200600017",UNKNOWN,SAMARTH P. SHAH. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12,69.0,YR,,M,Y,,,20200611.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Elderly
178837191,17883719,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Pyelonephritis,,2020,Q2,1,I,,20200602.0,20200611,20200611,EXP,,"US-TELIGENT, INC-20200600017",UNKNOWN,SAMARTH P. SHAH. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12,69.0,YR,,M,Y,,,20200611.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Elderly
178837191,17883719,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Resting tremor,,2020,Q2,1,I,,20200602.0,20200611,20200611,EXP,,"US-TELIGENT, INC-20200600017",UNKNOWN,SAMARTH P. SHAH. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020;45(5):11-12,69.0,YR,,M,Y,,,20200611.0,,,COUNTRY NOT SPECIFIED,US,2020,Q2,Elderly
178862431,17886243,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,20200526.0,20200604.0,20200611,20200611,EXP,,US-GILEAD-2020-0470876,GILEAD,,27.0,YR,A,F,Y,176.3,KG,20200611.0,,PH,US,US,2020,Q2,Young Adult
178862431,17886243,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,1,I,20200526.0,20200604.0,20200611,20200611,EXP,,US-GILEAD-2020-0470876,GILEAD,,27.0,YR,A,F,Y,176.3,KG,20200611.0,,PH,US,US,2020,Q2,Young Adult
178862461,17886246,15,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Carotid artery stenosis,,2020,Q2,1,I,20190609.0,20200607.0,20200611,20200611,EXP,,CA-CELGENEUS-CAN-20200601965,CELGENE,,73.0,YR,,M,Y,,,20200611.0,,PH,CA,CA,2020,Q2,Elderly
178862461,17886246,15,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Cerebral infarction,,2020,Q2,1,I,20190609.0,20200607.0,20200611,20200611,EXP,,CA-CELGENEUS-CAN-20200601965,CELGENE,,73.0,YR,,M,Y,,,20200611.0,,PH,CA,CA,2020,Q2,Elderly
178862461,17886246,15,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Cerebrovascular accident,,2020,Q2,1,I,20190609.0,20200607.0,20200611,20200611,EXP,,CA-CELGENEUS-CAN-20200601965,CELGENE,,73.0,YR,,M,Y,,,20200611.0,,PH,CA,CA,2020,Q2,Elderly
178862461,17886246,15,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Confusional state,,2020,Q2,1,I,20190609.0,20200607.0,20200611,20200611,EXP,,CA-CELGENEUS-CAN-20200601965,CELGENE,,73.0,YR,,M,Y,,,20200611.0,,PH,CA,CA,2020,Q2,Elderly
178862461,17886246,15,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Depressed level of consciousness,,2020,Q2,1,I,20190609.0,20200607.0,20200611,20200611,EXP,,CA-CELGENEUS-CAN-20200601965,CELGENE,,73.0,YR,,M,Y,,,20200611.0,,PH,CA,CA,2020,Q2,Elderly
178862461,17886246,15,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Fall,,2020,Q2,1,I,20190609.0,20200607.0,20200611,20200611,EXP,,CA-CELGENEUS-CAN-20200601965,CELGENE,,73.0,YR,,M,Y,,,20200611.0,,PH,CA,CA,2020,Q2,Elderly
178862461,17886246,15,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Musculoskeletal chest pain,,2020,Q2,1,I,20190609.0,20200607.0,20200611,20200611,EXP,,CA-CELGENEUS-CAN-20200601965,CELGENE,,73.0,YR,,M,Y,,,20200611.0,,PH,CA,CA,2020,Q2,Elderly
178862461,17886246,15,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q2,Seizure,,2020,Q2,1,I,20190609.0,20200607.0,20200611,20200611,EXP,,CA-CELGENEUS-CAN-20200601965,CELGENE,,73.0,YR,,M,Y,,,20200611.0,,PH,CA,CA,2020,Q2,Elderly
178868341,17886834,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200531.0,20200602.0,20200611,20200611,EXP,,US-ROCHE-2615271,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200611.0,,HP,US,US,2020,Q2,Elderly
178870882,17887088,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q2,Death,,2020,Q2,2,F,20200528.0,20200608.0,20200612,20200615,EXP,,CO-TAKEDA-2020TUS026098,TAKEDA,,72.0,YR,,F,Y,73.0,KG,20200615.0,,HP,CO,CO,2020,Q2,Elderly
178876381,17887638,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Product use issue,,2020,Q2,1,I,20200527.0,20200528.0,20200611,20200611,EXP,,US-GILEAD-2020-0469605,GILEAD,,43.0,YR,A,M,Y,72.0,KG,20200611.0,,MD,US,US,2020,Q2,Adult
178890811,17889081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Abdominal discomfort,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-028981",BOEHRINGER INGELHEIM,"YUEN K, COHAN P, EAST H, GALATI S, MERCADO J, LIM P, ET AL. MIFEPRISTONE TREATMENT IN FOUR CASES OF PRIMARY BILATERAL MACRONODULAR ADRENAL HYPERPLASIA (BMAH). JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. 2019;104: 12:6279-6290.",54.0,YR,,F,Y,,,20200612.0,,MD,US,US,2020,Q2,Adult
178890811,17889081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Fatigue,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-028981",BOEHRINGER INGELHEIM,"YUEN K, COHAN P, EAST H, GALATI S, MERCADO J, LIM P, ET AL. MIFEPRISTONE TREATMENT IN FOUR CASES OF PRIMARY BILATERAL MACRONODULAR ADRENAL HYPERPLASIA (BMAH). JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. 2019;104: 12:6279-6290.",54.0,YR,,F,Y,,,20200612.0,,MD,US,US,2020,Q2,Adult
178890811,17889081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Hyperplasia adrenal,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-028981",BOEHRINGER INGELHEIM,"YUEN K, COHAN P, EAST H, GALATI S, MERCADO J, LIM P, ET AL. MIFEPRISTONE TREATMENT IN FOUR CASES OF PRIMARY BILATERAL MACRONODULAR ADRENAL HYPERPLASIA (BMAH). JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. 2019;104: 12:6279-6290.",54.0,YR,,F,Y,,,20200612.0,,MD,US,US,2020,Q2,Adult
178890811,17889081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Hypertension,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-028981",BOEHRINGER INGELHEIM,"YUEN K, COHAN P, EAST H, GALATI S, MERCADO J, LIM P, ET AL. MIFEPRISTONE TREATMENT IN FOUR CASES OF PRIMARY BILATERAL MACRONODULAR ADRENAL HYPERPLASIA (BMAH). JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. 2019;104: 12:6279-6290.",54.0,YR,,F,Y,,,20200612.0,,MD,US,US,2020,Q2,Adult
178890811,17889081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Hypokalaemia,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-028981",BOEHRINGER INGELHEIM,"YUEN K, COHAN P, EAST H, GALATI S, MERCADO J, LIM P, ET AL. MIFEPRISTONE TREATMENT IN FOUR CASES OF PRIMARY BILATERAL MACRONODULAR ADRENAL HYPERPLASIA (BMAH). JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. 2019;104: 12:6279-6290.",54.0,YR,,F,Y,,,20200612.0,,MD,US,US,2020,Q2,Adult
178895361,17889536,3,C,insulin glargine U-300,,2,,ONCE-DAILY,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200602.0,20200612,20200612,EXP,,JP-MICRO LABS LIMITED-ML2020-01755,MICRO LABS,"TAKUBO M, TANAKA S, KUSHIMOTO M, IKEDA J, OGAWA K, SUZUKI Y, ABE M, ISHIHARA H, FUJISHIRO M. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS-(BASEL). 2020;9(4):2-8.",57.0,YR,,F,Y,49.0,KG,20200612.0,,HP,JP,JP,2020,Q2,Adult
178895361,17889536,3,C,insulin glargine U-300,,2,,ONCE-DAILY,,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,,20200602.0,20200612,20200612,EXP,,JP-MICRO LABS LIMITED-ML2020-01755,MICRO LABS,"TAKUBO M, TANAKA S, KUSHIMOTO M, IKEDA J, OGAWA K, SUZUKI Y, ABE M, ISHIHARA H, FUJISHIRO M. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS-(BASEL). 2020;9(4):2-8.",57.0,YR,,F,Y,49.0,KG,20200612.0,,HP,JP,JP,2020,Q2,Adult
178895361,17889536,3,C,insulin glargine U-300,,2,,ONCE-DAILY,,,,,,,,,,,,2020,Q2,Hyponatraemia,,2020,Q2,1,I,,20200602.0,20200612,20200612,EXP,,JP-MICRO LABS LIMITED-ML2020-01755,MICRO LABS,"TAKUBO M, TANAKA S, KUSHIMOTO M, IKEDA J, OGAWA K, SUZUKI Y, ABE M, ISHIHARA H, FUJISHIRO M. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS-(BASEL). 2020;9(4):2-8.",57.0,YR,,F,Y,49.0,KG,20200612.0,,HP,JP,JP,2020,Q2,Adult
178895361,17889536,3,C,insulin glargine U-300,,2,,ONCE-DAILY,,,,,,,,,,,,2020,Q2,Renal tubular acidosis,,2020,Q2,1,I,,20200602.0,20200612,20200612,EXP,,JP-MICRO LABS LIMITED-ML2020-01755,MICRO LABS,"TAKUBO M, TANAKA S, KUSHIMOTO M, IKEDA J, OGAWA K, SUZUKI Y, ABE M, ISHIHARA H, FUJISHIRO M. HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT. ANTIBIOTICS-(BASEL). 2020;9(4):2-8.",57.0,YR,,F,Y,49.0,KG,20200612.0,,HP,JP,JP,2020,Q2,Adult
178895851,17889585,14,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Angioedema,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,14,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,14,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Ear pruritus,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,14,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Eye irritation,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,14,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Eye pruritus,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178895851,17889585,14,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Throat irritation,,2020,Q2,1,I,20200610.0,,20200612,20200612,DIR,,,FDA-CTU,,33.0,YR,,F,N,136.3,KG,20200612.0,Y,PH,US,US,2020,Q2,Young Adult
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Abdominal pain upper,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,CREST syndrome,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Fall,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hand fracture,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Hiatus hernia,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Injection site bruising,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Pain,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Pelvic fracture,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Rheumatoid arthritis,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Upper limb fracture,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178919861,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Weight increased,,2020,Q2,1,I,,20200605.0,20200612,20200612,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,65.0,YR,,F,Y,96.0,KG,20200612.0,,CN,ES,ES,2020,Q2,Elderly
178926261,17892626,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Product administration error,,2020,Q2,1,I,20200529.0,20200602.0,20200612,20200612,EXP,,US-GILEAD-2020-0470372,GILEAD,,71.0,YR,E,M,Y,98.5,KG,20200612.0,,PH,US,US,2020,Q2,Elderly
178932651,17893265,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200609.0,20200614,20200614,EXP,,DE-ABBVIE-20K-062-3437316-00,ABBVIE,,75.0,YR,,M,Y,,,20200614.0,,PH,DE,DE,2020,Q2,Elderly
178932651,17893265,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,,20200609.0,20200614,20200614,EXP,,DE-ABBVIE-20K-062-3437316-00,ABBVIE,,75.0,YR,,M,Y,,,20200614.0,,PH,DE,DE,2020,Q2,Elderly
178932651,17893265,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200609.0,20200614,20200614,EXP,,DE-ABBVIE-20K-062-3437316-00,ABBVIE,,75.0,YR,,M,Y,,,20200614.0,,PH,DE,DE,2020,Q2,Elderly
178932651,17893265,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,20200609.0,20200614,20200614,EXP,,DE-ABBVIE-20K-062-3437316-00,ABBVIE,,75.0,YR,,M,Y,,,20200614.0,,PH,DE,DE,2020,Q2,Elderly
178932651,17893265,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200609.0,20200614,20200614,EXP,,DE-ABBVIE-20K-062-3437316-00,ABBVIE,,75.0,YR,,M,Y,,,20200614.0,,PH,DE,DE,2020,Q2,Elderly
178945002,17894500,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,N,,,,205692.0,20.0,IU,,QD,2020,Q2,Cerebral infarction,,2020,Q2,2,F,20200602.0,20200617.0,20200615,20200629,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202006001904AA,ELI LILLY AND CO,,89.0,YR,,F,Y,,,20200629.0,,PH,JP,JP,2020,Q2,Elderly
178947871,17894787,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"10 UNIT, NIGHTLY",,,U,,,,,,,,,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200601.0,20200615,20200615,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249585,RANBAXY,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020;MAY; 45 (5):11-12",69.0,YR,,M,Y,,,20200615.0,,PH,US,US,2020,Q2,Elderly
178947871,17894787,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"10 UNIT, NIGHTLY",,,U,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200601.0,20200615,20200615,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249585,RANBAXY,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020;MAY; 45 (5):11-12",69.0,YR,,M,Y,,,20200615.0,,PH,US,US,2020,Q2,Elderly
178947871,17894787,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"10 UNIT, NIGHTLY",,,U,,,,,,,,,2020,Q2,Dystonia,,2020,Q2,1,I,,20200601.0,20200615,20200615,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249585,RANBAXY,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020;MAY; 45 (5):11-12",69.0,YR,,M,Y,,,20200615.0,,PH,US,US,2020,Q2,Elderly
178947871,17894787,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"10 UNIT, NIGHTLY",,,U,,,,,,,,,2020,Q2,Resting tremor,,2020,Q2,1,I,,20200601.0,20200615,20200615,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-249585,RANBAXY,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACT. 2020;MAY; 45 (5):11-12",69.0,YR,,M,Y,,,20200615.0,,PH,US,US,2020,Q2,Elderly
178953241,17895324,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,12.0,IU,,QD,2020,Q2,Immune-mediated myositis,,2020,Q2,1,I,,20200605.0,20200615,20200615,EXP,,"CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-028496",BOEHRINGER INGELHEIM,"J., S, ET AL. STATINY INDUKOVANA NEKROTIZUJICI AUTOIMUNITNI MYOPATIE JAKO NEOBVYKLA PRICINA EXTREMNICH HODNOT KARDIALNICH MARKERU U PACIENTA SE SVALOVOU SLABOSTI A OTOKY [STATIN-LNDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVA. CESKA REVMATOLOGIE. 2020 JAN;52-60.",75.0,YR,,,Y,,,20200615.0,,MD,CZ,CZ,2020,Q2,Elderly
178955711,17895571,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Febrile neutropenia,,2020,Q2,1,I,20200528.0,20200605.0,20200615,20200615,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200615.0,,HP,US,US,2020,Q2,Elderly
178955711,17895571,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Neutrophil count decreased,,2020,Q2,1,I,20200528.0,20200605.0,20200615,20200615,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200615.0,,HP,US,US,2020,Q2,Elderly
178955711,17895571,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Pancytopenia,,2020,Q2,1,I,20200528.0,20200605.0,20200615,20200615,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200615.0,,HP,US,US,2020,Q2,Elderly
178955711,17895571,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,White blood cell count decreased,,2020,Q2,1,I,20200528.0,20200605.0,20200615,20200615,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20200615.0,,HP,US,US,2020,Q2,Elderly
178957342,17895734,23,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 UNITS, EVERY MONRING",10.0,IU,,,,,,5.0,IU,,QD,2020,Q2,Cardio-respiratory arrest,,2020,Q2,2,F,20200609.0,20200615.0,20200615,20200626,EXP,,"US-KARYOPHARM THERAPEUTICS, INC.-2020KPT000647",KARYOPHARM THERAPEUTICS,,47.0,YR,,F,Y,73.0,KG,20200626.0,,HP,US,US,2020,Q2,Adult
178966721,17896672,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200609.0,20200615,20200615,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006004565,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
178966721,17896672,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,,20200609.0,20200615,20200615,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006004565,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
178966721,17896672,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200609.0,20200615,20200615,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006004565,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
178966721,17896672,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,20200609.0,20200615,20200615,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006004565,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
178966721,17896672,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200609.0,20200615,20200615,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006004565,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20200615.0,,PH,DE,DE,2020,Q2,Elderly
178979801,17897980,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200611.0,20200616,20200616,EXP,,DE-UCBSA-2020023556,UCB,,75.0,YR,,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
178979801,17897980,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,,20200611.0,20200616,20200616,EXP,,DE-UCBSA-2020023556,UCB,,75.0,YR,,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
178979801,17897980,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200611.0,20200616,20200616,EXP,,DE-UCBSA-2020023556,UCB,,75.0,YR,,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
178979801,17897980,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,20200611.0,20200616,20200616,EXP,,DE-UCBSA-2020023556,UCB,,75.0,YR,,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
178979801,17897980,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200611.0,20200616,20200616,EXP,,DE-UCBSA-2020023556,UCB,,75.0,YR,,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
178979801,17897980,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Off label use,,2020,Q2,1,I,,20200611.0,20200616,20200616,EXP,,DE-UCBSA-2020023556,UCB,,75.0,YR,,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
178994041,17899404,8,C,insulin glargine 15 units Qbedtime,,2,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,78.0,YR,,F,N,79.0,KG,20200615.0,N,PH,US,US,2020,Q2,Elderly
178994041,17899404,8,C,insulin glargine 15 units Qbedtime,,2,,,,,,,,,,,,,,2020,Q2,Therapy cessation,,2020,Q2,1,I,20200612.0,,20200615,20200615,DIR,,,FDA-CTU,,78.0,YR,,F,N,79.0,KG,20200615.0,N,PH,US,US,2020,Q2,Elderly
178994351,17899435,10,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200613.0,,20200615,20200615,DIR,,,FDA-CTU,,78.0,YR,,F,N,76.2,KG,20200615.0,Y,HP,US,US,2020,Q2,Elderly
179001221,17900122,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200609.0,20200616,20200616,EXP,DE-BFARM-20006189,DE-ACCORD-185363,ACCORD,,75.0,YR,E,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
179001221,17900122,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,,20200609.0,20200616,20200616,EXP,DE-BFARM-20006189,DE-ACCORD-185363,ACCORD,,75.0,YR,E,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
179001221,17900122,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200609.0,20200616,20200616,EXP,DE-BFARM-20006189,DE-ACCORD-185363,ACCORD,,75.0,YR,E,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
179001221,17900122,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,20200609.0,20200616,20200616,EXP,DE-BFARM-20006189,DE-ACCORD-185363,ACCORD,,75.0,YR,E,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
179001221,17900122,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200609.0,20200616,20200616,EXP,DE-BFARM-20006189,DE-ACCORD-185363,ACCORD,,75.0,YR,E,M,Y,,,20200616.0,,PH,DE,DE,2020,Q2,Elderly
179012522,17901252,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNITS,1X/DAY",,,,,,,,24.0,IU,INJECTION,QD,2020,Q2,Cerebrovascular accident,,2020,Q2,2,F,20200523.0,20200611.0,20200616,20200624,EXP,,GB-PFIZER INC-2020228824,PFIZER,,60.0,YR,,M,Y,76.9,KG,20200624.0,,MD,GB,GB,2020,Q2,Adult
179025731,17902573,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,,20200610.0,20200616,20200616,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006005159,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200616.0,,CN,ES,ES,2020,Q2,Adult
179025731,17902573,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200610.0,20200616,20200616,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006005159,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20200616.0,,CN,ES,ES,2020,Q2,Adult
179038411,17903841,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,4050 UNITS OF HIGH CONCENTRATION (9 PENS OF 1.5ML ATAT 300 UNITS/ML),,,,,,,,,,,,2020,Q2,Depressed level of consciousness,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,4050 UNITS OF HIGH CONCENTRATION (9 PENS OF 1.5ML ATAT 300 UNITS/ML),,,,,,,,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,4050 UNITS OF HIGH CONCENTRATION (9 PENS OF 1.5ML ATAT 300 UNITS/ML),,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179038411,17903841,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,4050 UNITS OF HIGH CONCENTRATION (9 PENS OF 1.5ML ATAT 300 UNITS/ML),,,,,,,,,,,,2020,Q2,Suicidal ideation,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,AU-STRIDES ARCOLAB LIMITED-2020SP007039,STRIDES,,45.0,YR,,F,Y,,,20200617.0,,HP,AU,AU,2020,Q2,Adult
179044961,17904496,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS/NIGHT,,,,,,,,,,,,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200608.0,20200616,20200616,EXP,,US-TEVA-2020-US-1510272,TEVA,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE-PRACT 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200617.0,,PH,US,US,2020,Q2,Elderly
179044961,17904496,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS/NIGHT,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200608.0,20200616,20200616,EXP,,US-TEVA-2020-US-1510272,TEVA,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE-PRACT 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200617.0,,PH,US,US,2020,Q2,Elderly
179044961,17904496,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS/NIGHT,,,,,,,,,,,,2020,Q2,Dystonia,,2020,Q2,1,I,,20200608.0,20200616,20200616,EXP,,US-TEVA-2020-US-1510272,TEVA,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE-PRACT 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200617.0,,PH,US,US,2020,Q2,Elderly
179044961,17904496,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS/NIGHT,,,,,,,,,,,,2020,Q2,Resting tremor,,2020,Q2,1,I,,20200608.0,20200616,20200616,EXP,,US-TEVA-2020-US-1510272,TEVA,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE-PRACT 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200617.0,,PH,US,US,2020,Q2,Elderly
179055081,17905508,6,C,insulin glargine 35 units subcut BID,,2,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200616.0,,20200616,20200616,DIR,,,FDA-CTU,,45.0,YR,,M,N,168.2,KG,20200616.0,N,PH,US,US,2020,Q2,Adult
179077561,17907756,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, 0F557A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,ES-MYLANLABS-2020M1056026,MYLAN,,65.0,YR,,M,Y,110.0,KG,20200617.0,,CN,ES,ES,2020,Q2,Elderly
179077561,17907756,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, 0F557A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Intentional product misuse,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,ES-MYLANLABS-2020M1056026,MYLAN,,65.0,YR,,M,Y,110.0,KG,20200617.0,,CN,ES,ES,2020,Q2,Elderly
179077561,17907756,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, 0F557A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product storage error,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,ES-MYLANLABS-2020M1056026,MYLAN,,65.0,YR,,M,Y,110.0,KG,20200617.0,,CN,ES,ES,2020,Q2,Elderly
179077561,17907756,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, 0F557A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Rheumatic disorder,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,ES-MYLANLABS-2020M1056026,MYLAN,,65.0,YR,,M,Y,110.0,KG,20200617.0,,CN,ES,ES,2020,Q2,Elderly
179077561,17907756,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASED THE DOSE BY 2 IU,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,ES-MYLANLABS-2020M1056026,MYLAN,,65.0,YR,,M,Y,110.0,KG,20200617.0,,CN,ES,ES,2020,Q2,Elderly
179077561,17907756,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASED THE DOSE BY 2 IU,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Intentional product misuse,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,ES-MYLANLABS-2020M1056026,MYLAN,,65.0,YR,,M,Y,110.0,KG,20200617.0,,CN,ES,ES,2020,Q2,Elderly
179077561,17907756,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASED THE DOSE BY 2 IU,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Product storage error,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,ES-MYLANLABS-2020M1056026,MYLAN,,65.0,YR,,M,Y,110.0,KG,20200617.0,,CN,ES,ES,2020,Q2,Elderly
179077561,17907756,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INCREASED THE DOSE BY 2 IU,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Rheumatic disorder,,2020,Q2,1,I,,20200609.0,20200617,20200617,EXP,,ES-MYLANLABS-2020M1056026,MYLAN,,65.0,YR,,M,Y,110.0,KG,20200617.0,,CN,ES,ES,2020,Q2,Elderly
179091641,17909164,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Alopecia,,2020,Q2,1,I,2015.0,20200616.0,20200617,20200617,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200617.0,,LW,US,US,2020,Q2,Adult
179091641,17909164,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hair colour changes,,2020,Q2,1,I,2015.0,20200616.0,20200617,20200617,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200617.0,,LW,US,US,2020,Q2,Adult
179091641,17909164,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hair disorder,,2020,Q2,1,I,2015.0,20200616.0,20200617,20200617,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200617.0,,LW,US,US,2020,Q2,Adult
179091641,17909164,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hair texture abnormal,,2020,Q2,1,I,2015.0,20200616.0,20200617,20200617,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200617.0,,LW,US,US,2020,Q2,Adult
179091641,17909164,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Madarosis,,2020,Q2,1,I,2015.0,20200616.0,20200617,20200617,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200617.0,,LW,US,US,2020,Q2,Adult
179091661,17909166,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Alopecia,,2020,Q2,1,I,,20200616.0,20200617,20200617,PER,,US-PFIZER INC-2020235120,PFIZER,,57.0,YR,,F,Y,,,20200617.0,,LW,US,US,2020,Q2,Adult
179091661,17909166,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hair colour changes,,2020,Q2,1,I,,20200616.0,20200617,20200617,PER,,US-PFIZER INC-2020235120,PFIZER,,57.0,YR,,F,Y,,,20200617.0,,LW,US,US,2020,Q2,Adult
179091661,17909166,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hair disorder,,2020,Q2,1,I,,20200616.0,20200617,20200617,PER,,US-PFIZER INC-2020235120,PFIZER,,57.0,YR,,F,Y,,,20200617.0,,LW,US,US,2020,Q2,Adult
179091661,17909166,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hair texture abnormal,,2020,Q2,1,I,,20200616.0,20200617,20200617,PER,,US-PFIZER INC-2020235120,PFIZER,,57.0,YR,,F,Y,,,20200617.0,,LW,US,US,2020,Q2,Adult
179091801,17909180,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,450 INTERNATIONAL UNIT (34-0-0-0),,,,,,,,450.0,IU,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200609.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029158,AUROBINDO,,75.0,YR,,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179091801,17909180,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,450 INTERNATIONAL UNIT (34-0-0-0),,,,,,,,450.0,IU,,,2020,Q2,Fall,,2020,Q2,1,I,,20200609.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029158,AUROBINDO,,75.0,YR,,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179091801,17909180,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,450 INTERNATIONAL UNIT (34-0-0-0),,,,,,,,450.0,IU,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200609.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029158,AUROBINDO,,75.0,YR,,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179091801,17909180,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,450 INTERNATIONAL UNIT (34-0-0-0),,,,,,,,450.0,IU,,,2020,Q2,Headache,,2020,Q2,1,I,,20200609.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029158,AUROBINDO,,75.0,YR,,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179091801,17909180,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,450 INTERNATIONAL UNIT (34-0-0-0),,,,,,,,450.0,IU,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200609.0,20200618,20200618,EXP,,DE-AUROBINDO-AUR-APL-2020-029158,AUROBINDO,,75.0,YR,,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"43 IU, UNKNOWN",,,Y,, 9F404A,,,43.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Aphonia,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose decreased,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Dizziness,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Frequent bowel movements,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Gastrooesophageal reflux disease,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Glycosylated haemoglobin increased,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insomnia,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179101471,17910147,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IU, UNKNOWN",,,Y,, 0F517A,,,40.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Insulin resistance,,2020,Q2,1,I,201905.0,20200615.0,20200617,20200617,EXP,,NVSC2020ES168969,NOVARTIS,,39.0,YR,,F,Y,70.0,KG,20200618.0,,CN,COUNTRY NOT SPECIFIED,ES,2020,Q2,Adult
179104421,17910442,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,20 U AT BEDTIME,,,,,,,,20.0,IU,,QD,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200604.0,20200617,20200617,PER,,US-009507513-2006USA002406,MERCK,,54.0,YR,,F,Y,,,20200617.0,,MD,US,US,2020,Q2,Adult
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Electrolyte imbalance,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Incontinence,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Medication error,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Musculoskeletal chest pain,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Polyuria,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Product monitoring error,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111631,17911163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Therapeutic drug monitoring analysis not performed,,2020,Q2,1,I,,20200611.0,20200618,20200618,EXP,DE-BFARM-20006522,DE-ACCORD-185689,ACCORD,,70.0,YR,E,M,Y,70.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111711,17911171,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,,,,,,,,,2020,Q2,Confusional state,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,DE-BFARM-20006556,DE-ACCORD-185709,ACCORD,,81.0,YR,E,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111711,17911171,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,,,,,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,DE-BFARM-20006556,DE-ACCORD-185709,ACCORD,,81.0,YR,E,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111711,17911171,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,DE-BFARM-20006556,DE-ACCORD-185709,ACCORD,,81.0,YR,E,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111711,17911171,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,DE-BFARM-20006556,DE-ACCORD-185709,ACCORD,,81.0,YR,E,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111711,17911171,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,,,,,,,,,2020,Q2,Muscular weakness,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,DE-BFARM-20006556,DE-ACCORD-185709,ACCORD,,81.0,YR,E,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179111711,17911171,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,,,,,,,,,2020,Q2,Somnolence,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,DE-BFARM-20006556,DE-ACCORD-185709,ACCORD,,81.0,YR,E,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179113671,17911367,13,C,Insulin glargine,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,U,,,,,450.0,IU,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05096-01,DE-TORRENT-00017751,TORRENT,,75.0,YR,E,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179113671,17911367,13,C,Insulin glargine,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,U,,,,,450.0,IU,,,2020,Q2,Fall,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05096-01,DE-TORRENT-00017751,TORRENT,,75.0,YR,E,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179113671,17911367,13,C,Insulin glargine,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,U,,,,,450.0,IU,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05096-01,DE-TORRENT-00017751,TORRENT,,75.0,YR,E,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179113671,17911367,13,C,Insulin glargine,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,U,,,,,450.0,IU,,,2020,Q2,Headache,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05096-01,DE-TORRENT-00017751,TORRENT,,75.0,YR,E,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179113671,17911367,13,C,Insulin glargine,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,U,,,,,450.0,IU,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200612.0,20200618,20200618,EXP,DE-ADRED-05096-01,DE-TORRENT-00017751,TORRENT,,75.0,YR,E,M,Y,,,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179132981,17913298,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"450 UNITS, 0-0-8-0",,,U,,,,205692.0,,,,,2020,Q2,Confusional state,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005668,ELI LILLY AND CO,,81.0,YR,,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179132981,17913298,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"450 UNITS, 0-0-8-0",,,U,,,,205692.0,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005668,ELI LILLY AND CO,,81.0,YR,,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179132981,17913298,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"450 UNITS, 0-0-8-0",,,U,,,,205692.0,,,,,2020,Q2,Fall,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005668,ELI LILLY AND CO,,81.0,YR,,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179132981,17913298,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"450 UNITS, 0-0-8-0",,,U,,,,205692.0,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005668,ELI LILLY AND CO,,81.0,YR,,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179132981,17913298,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"450 UNITS, 0-0-8-0",,,U,,,,205692.0,,,,,2020,Q2,Muscular weakness,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005668,ELI LILLY AND CO,,81.0,YR,,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179132981,17913298,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"450 UNITS, 0-0-8-0",,,U,,,,205692.0,,,,,2020,Q2,Somnolence,,2020,Q2,1,I,20191212.0,20200611.0,20200618,20200618,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202006005668,ELI LILLY AND CO,,81.0,YR,,F,Y,40.0,KG,20200618.0,,PH,DE,DE,2020,Q2,Elderly
179133081,17913308,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Diabetes mellitus inadequate control,,2020,Q2,1,I,,20200609.0,20200618,20200618,EXP,,ID-EMD SERONO-9168550,EMD SERONO INC,"WIDYSANTO J, LUKITO A. EFFECT OF HYPERGLICEMIA ON THE T WAVE INVERSION. JOURNAL OF ARRHYTHMIA. 2019 DEC 01;35 (1):505.",55.0,YR,,F,Y,,,20200618.0,,HP,ID,ID,2020,Q2,Adult
179133081,17913308,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Electrocardiogram T wave inversion,,2020,Q2,1,I,,20200609.0,20200618,20200618,EXP,,ID-EMD SERONO-9168550,EMD SERONO INC,"WIDYSANTO J, LUKITO A. EFFECT OF HYPERGLICEMIA ON THE T WAVE INVERSION. JOURNAL OF ARRHYTHMIA. 2019 DEC 01;35 (1):505.",55.0,YR,,F,Y,,,20200618.0,,HP,ID,ID,2020,Q2,Adult
179133081,17913308,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q2,Treatment noncompliance,,2020,Q2,1,I,,20200609.0,20200618,20200618,EXP,,ID-EMD SERONO-9168550,EMD SERONO INC,"WIDYSANTO J, LUKITO A. EFFECT OF HYPERGLICEMIA ON THE T WAVE INVERSION. JOURNAL OF ARRHYTHMIA. 2019 DEC 01;35 (1):505.",55.0,YR,,F,Y,,,20200618.0,,HP,ID,ID,2020,Q2,Adult
179136561,17913656,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10-0-0-16),,,,,,,,,,,,2020,Q2,Dyspnoea,,2020,Q2,1,I,20200325.0,20200615.0,20200618,20200618,EXP,,DE-MYLANLABS-2020M1057730,MYLAN,,89.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Elderly
179136561,17913656,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10-0-0-16),,,,,,,,,,,,2020,Q2,Product administration error,,2020,Q2,1,I,20200325.0,20200615.0,20200618,20200618,EXP,,DE-MYLANLABS-2020M1057730,MYLAN,,89.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Elderly
179136561,17913656,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (10-0-0-16),,,,,,,,,,,,2020,Q2,Product prescribing error,,2020,Q2,1,I,20200325.0,20200615.0,20200618,20200618,EXP,,DE-MYLANLABS-2020M1057730,MYLAN,,89.0,YR,,F,Y,,,20200618.0,,MD,DE,DE,2020,Q2,Elderly
179140631,17914063,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 UNIT BEFORE SLEEP,,,,,,,,,,,,2020,Q2,Gastrooesophageal cancer,,2020,Q2,1,I,,20200616.0,20200618,20200618,EXP,,JP-GILEAD-2020-0472835,GILEAD,,7.0,DEC,E,M,Y,73.4,KG,20200618.0,,PH,JP,JP,2020,Q2,Child
179146071,17914607,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, 0-0-0-12",,,U,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029549,AUROBINDO,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179146071,17914607,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, 0-0-0-12",,,U,,,,,,,,,2020,Q2,Electrolyte imbalance,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029549,AUROBINDO,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179146071,17914607,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, 0-0-0-12",,,U,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029549,AUROBINDO,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179146071,17914607,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, 0-0-0-12",,,U,,,,,,,,,2020,Q2,Incontinence,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029549,AUROBINDO,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179146071,17914607,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, 0-0-0-12",,,U,,,,,,,,,2020,Q2,Musculoskeletal chest pain,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029549,AUROBINDO,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179146071,17914607,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, 0-0-0-12",,,U,,,,,,,,,2020,Q2,Polyuria,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029549,AUROBINDO,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179146071,17914607,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, 0-0-0-12",,,U,,,,,,,,,2020,Q2,Product monitoring error,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029549,AUROBINDO,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179146071,17914607,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, 0-0-0-12",,,U,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029549,AUROBINDO,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179146071,17914607,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, 0-0-0-12",,,U,,,,,,,,,2020,Q2,Therapeutic drug monitoring analysis not performed,,2020,Q2,1,I,,20200611.0,20200619,20200619,EXP,,DE-AUROBINDO-AUR-APL-2020-029549,AUROBINDO,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179147721,17914772,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Angioedema,,2020,Q2,1,I,20200610.0,20200612.0,20200618,20200618,EXP,,US-GILEAD-2020-0473016,GILEAD,,33.0,YR,A,F,Y,136.3,KG,20200618.0,,PH,US,US,2020,Q2,Young Adult
179147721,17914772,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Eye irritation,,2020,Q2,1,I,20200610.0,20200612.0,20200618,20200618,EXP,,US-GILEAD-2020-0473016,GILEAD,,33.0,YR,A,F,Y,136.3,KG,20200618.0,,PH,US,US,2020,Q2,Young Adult
179147721,17914772,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Pruritus,,2020,Q2,1,I,20200610.0,20200612.0,20200618,20200618,EXP,,US-GILEAD-2020-0473016,GILEAD,,33.0,YR,A,F,Y,136.3,KG,20200618.0,,PH,US,US,2020,Q2,Young Adult
179156852,17915685,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,TABLET,,2020,Q2,Asthma,,2020,Q2,2,F,201611.0,20170116.0,20200619,20200619,EXP,,CO-ROCHE-2622894,ROCHE,,71.0,YR,,F,Y,,,20200619.0,,HP,CO,CO,2020,Q2,Elderly
179156852,17915685,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,TABLET,,2020,Q2,Blood glucose abnormal,,2020,Q2,2,F,201611.0,20170116.0,20200619,20200619,EXP,,CO-ROCHE-2622894,ROCHE,,71.0,YR,,F,Y,,,20200619.0,,HP,CO,CO,2020,Q2,Elderly
179156852,17915685,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,TABLET,,2020,Q2,Hypoglycaemia,,2020,Q2,2,F,201611.0,20170116.0,20200619,20200619,EXP,,CO-ROCHE-2622894,ROCHE,,71.0,YR,,F,Y,,,20200619.0,,HP,CO,CO,2020,Q2,Elderly
179156852,17915685,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,TABLET,,2020,Q2,Infection,,2020,Q2,2,F,201611.0,20170116.0,20200619,20200619,EXP,,CO-ROCHE-2622894,ROCHE,,71.0,YR,,F,Y,,,20200619.0,,HP,CO,CO,2020,Q2,Elderly
179156852,17915685,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,TABLET,,2020,Q2,Respiratory tract infection viral,,2020,Q2,2,F,201611.0,20170116.0,20200619,20200619,EXP,,CO-ROCHE-2622894,ROCHE,,71.0,YR,,F,Y,,,20200619.0,,HP,CO,CO,2020,Q2,Elderly
179156852,17915685,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,TABLET,,2020,Q2,Urinary tract infection,,2020,Q2,2,F,201611.0,20170116.0,20200619,20200619,EXP,,CO-ROCHE-2622894,ROCHE,,71.0,YR,,F,Y,,,20200619.0,,HP,CO,CO,2020,Q2,Elderly
179163812,17916381,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,2,F,,20200615.0,20200619,20200624,EXP,,DE-MYLANLABS-2020M1057701,MYLAN,,70.0,YR,,M,Y,70.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179163812,17916381,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Electrolyte imbalance,,2020,Q2,2,F,,20200615.0,20200619,20200624,EXP,,DE-MYLANLABS-2020M1057701,MYLAN,,70.0,YR,,M,Y,70.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179163812,17916381,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200615.0,20200619,20200624,EXP,,DE-MYLANLABS-2020M1057701,MYLAN,,70.0,YR,,M,Y,70.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179163812,17916381,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Incontinence,,2020,Q2,2,F,,20200615.0,20200619,20200624,EXP,,DE-MYLANLABS-2020M1057701,MYLAN,,70.0,YR,,M,Y,70.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179163812,17916381,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Musculoskeletal chest pain,,2020,Q2,2,F,,20200615.0,20200619,20200624,EXP,,DE-MYLANLABS-2020M1057701,MYLAN,,70.0,YR,,M,Y,70.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179163812,17916381,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Polyuria,,2020,Q2,2,F,,20200615.0,20200619,20200624,EXP,,DE-MYLANLABS-2020M1057701,MYLAN,,70.0,YR,,M,Y,70.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179163812,17916381,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Product monitoring error,,2020,Q2,2,F,,20200615.0,20200619,20200624,EXP,,DE-MYLANLABS-2020M1057701,MYLAN,,70.0,YR,,M,Y,70.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179163812,17916381,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,2,F,,20200615.0,20200619,20200624,EXP,,DE-MYLANLABS-2020M1057701,MYLAN,,70.0,YR,,M,Y,70.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179163812,17916381,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Therapeutic drug monitoring analysis not performed,,2020,Q2,2,F,,20200615.0,20200619,20200624,EXP,,DE-MYLANLABS-2020M1057701,MYLAN,,70.0,YR,,M,Y,70.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179167391,17916739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200616.0,20200619,20200619,EXP,,DE-009507513-2006DEU006111,MERCK,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179167391,17916739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Electrolyte imbalance,,2020,Q2,1,I,,20200616.0,20200619,20200619,EXP,,DE-009507513-2006DEU006111,MERCK,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179167391,17916739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,,20200616.0,20200619,20200619,EXP,,DE-009507513-2006DEU006111,MERCK,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179167391,17916739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Incontinence,,2020,Q2,1,I,,20200616.0,20200619,20200619,EXP,,DE-009507513-2006DEU006111,MERCK,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179167391,17916739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Musculoskeletal chest pain,,2020,Q2,1,I,,20200616.0,20200619,20200619,EXP,,DE-009507513-2006DEU006111,MERCK,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179167391,17916739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Polyuria,,2020,Q2,1,I,,20200616.0,20200619,20200619,EXP,,DE-009507513-2006DEU006111,MERCK,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179167391,17916739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Product monitoring error,,2020,Q2,1,I,,20200616.0,20200619,20200619,EXP,,DE-009507513-2006DEU006111,MERCK,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179167391,17916739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,,20200616.0,20200619,20200619,EXP,,DE-009507513-2006DEU006111,MERCK,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179167391,17916739,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Therapeutic drug monitoring analysis not performed,,2020,Q2,1,I,,20200616.0,20200619,20200619,EXP,,DE-009507513-2006DEU006111,MERCK,,70.0,YR,,M,Y,70.0,KG,20200619.0,,PH,DE,DE,2020,Q2,Elderly
179197911,17919791,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,24.0,IU,,QD,2020,Q2,Pancreatitis acute,,2020,Q2,1,I,20191023.0,20191209.0,20200619,20200619,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-119365",BOEHRINGER INGELHEIM,,63.0,YR,,F,Y,76.0,KG,20200620.0,,MD,CO,CO,2020,Q2,Adult
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Acute respiratory distress syndrome,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Candida infection,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Cardiac failure acute,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Chronic kidney disease,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Ecchymosis,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Erysipelas,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Escherichia infection,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Fungal infection,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Generalised oedema,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Product use in unapproved indication,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Septic shock,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Serratia infection,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Spinal pain,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Subcutaneous haematoma,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Tooth infection,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179198161,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q2,Urosepsis,,2020,Q2,1,I,2019.0,20200601.0,20200619,20200619,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200620.0,,MD,FR,FR,2020,Q2,Elderly
179210761,17921076,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200609.0,20200622,20200622,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02932,LUPIN,,75.0,YR,,M,Y,,,20200622.0,,CN,NL,DE,2020,Q2,Elderly
179210761,17921076,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,,20200609.0,20200622,20200622,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02932,LUPIN,,75.0,YR,,M,Y,,,20200622.0,,CN,NL,DE,2020,Q2,Elderly
179210761,17921076,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200609.0,20200622,20200622,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02932,LUPIN,,75.0,YR,,M,Y,,,20200622.0,,CN,NL,DE,2020,Q2,Elderly
179210761,17921076,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,20200609.0,20200622,20200622,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02932,LUPIN,,75.0,YR,,M,Y,,,20200622.0,,CN,NL,DE,2020,Q2,Elderly
179210761,17921076,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200609.0,20200622,20200622,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-02932,LUPIN,,75.0,YR,,M,Y,,,20200622.0,,CN,NL,DE,2020,Q2,Elderly
179218351,17921835,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200612.0,20200622,20200622,EXP,,DE-009507513-2006DEU005243,MERCK,,75.0,YR,,M,Y,,,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179218351,17921835,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,,20200612.0,20200622,20200622,EXP,,DE-009507513-2006DEU005243,MERCK,,75.0,YR,,M,Y,,,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179218351,17921835,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200612.0,20200622,20200622,EXP,,DE-009507513-2006DEU005243,MERCK,,75.0,YR,,M,Y,,,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179218351,17921835,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,20200612.0,20200622,20200622,EXP,,DE-009507513-2006DEU005243,MERCK,,75.0,YR,,M,Y,,,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179218351,17921835,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,,,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200612.0,20200622,20200622,EXP,,DE-009507513-2006DEU005243,MERCK,,75.0,YR,,M,Y,,,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179250712,17925071,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q2,Cerebrovascular accident,,2020,Q2,2,F,,20200622.0,20200622,20200625,EXP,,NVSC2020CZ097034,NOVARTIS,,35.0,YR,,F,Y,,,20200625.0,,HP,CZ,CZ,2020,Q2,Adult
179250712,17925071,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200622.0,20200622,20200625,EXP,,NVSC2020CZ097034,NOVARTIS,,35.0,YR,,F,Y,,,20200625.0,,HP,CZ,CZ,2020,Q2,Adult
179250712,17925071,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q2,Lactic acidosis,,2020,Q2,2,F,,20200622.0,20200622,20200625,EXP,,NVSC2020CZ097034,NOVARTIS,,35.0,YR,,F,Y,,,20200625.0,,HP,CZ,CZ,2020,Q2,Adult
179250712,17925071,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,Y,,,,,,,,,2020,Q2,MELAS syndrome,,2020,Q2,2,F,,20200622.0,20200622,20200625,EXP,,NVSC2020CZ097034,NOVARTIS,,35.0,YR,,F,Y,,,20200625.0,,HP,CZ,CZ,2020,Q2,Adult
179257901,17925790,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200616.0,20200622,20200622,EXP,DE-ADRED-04340-01,DE-BAUSCH-BL-2020-017790,BAUSCH AND LOMB,,70.0,YR,,M,Y,70.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179257901,17925790,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Electrolyte imbalance,,2020,Q2,1,I,,20200616.0,20200622,20200622,EXP,DE-ADRED-04340-01,DE-BAUSCH-BL-2020-017790,BAUSCH AND LOMB,,70.0,YR,,M,Y,70.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179257901,17925790,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,,20200616.0,20200622,20200622,EXP,DE-ADRED-04340-01,DE-BAUSCH-BL-2020-017790,BAUSCH AND LOMB,,70.0,YR,,M,Y,70.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179257901,17925790,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Incontinence,,2020,Q2,1,I,,20200616.0,20200622,20200622,EXP,DE-ADRED-04340-01,DE-BAUSCH-BL-2020-017790,BAUSCH AND LOMB,,70.0,YR,,M,Y,70.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179257901,17925790,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Musculoskeletal chest pain,,2020,Q2,1,I,,20200616.0,20200622,20200622,EXP,DE-ADRED-04340-01,DE-BAUSCH-BL-2020-017790,BAUSCH AND LOMB,,70.0,YR,,M,Y,70.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179257901,17925790,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Polyuria,,2020,Q2,1,I,,20200616.0,20200622,20200622,EXP,DE-ADRED-04340-01,DE-BAUSCH-BL-2020-017790,BAUSCH AND LOMB,,70.0,YR,,M,Y,70.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179257901,17925790,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Product monitoring error,,2020,Q2,1,I,,20200616.0,20200622,20200622,EXP,DE-ADRED-04340-01,DE-BAUSCH-BL-2020-017790,BAUSCH AND LOMB,,70.0,YR,,M,Y,70.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179257901,17925790,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,,20200616.0,20200622,20200622,EXP,DE-ADRED-04340-01,DE-BAUSCH-BL-2020-017790,BAUSCH AND LOMB,,70.0,YR,,M,Y,70.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179257901,17925790,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Therapeutic drug monitoring analysis not performed,,2020,Q2,1,I,,20200616.0,20200622,20200622,EXP,DE-ADRED-04340-01,DE-BAUSCH-BL-2020-017790,BAUSCH AND LOMB,,70.0,YR,,M,Y,70.0,KG,20200622.0,,PH,DE,DE,2020,Q2,Elderly
179262431,17926243,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200609.0,20200623,20200623,EXP,,US-MICRO LABS LIMITED-ML2020-01805,MICRO LABS,"CHAPPELL K, SHAH S, CUTSHALL T, SANDS C. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS.. THE NURSE PRACTITIONER. 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200623.0,,HP,US,US,2020,Q2,Elderly
179262431,17926243,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200609.0,20200623,20200623,EXP,,US-MICRO LABS LIMITED-ML2020-01805,MICRO LABS,"CHAPPELL K, SHAH S, CUTSHALL T, SANDS C. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS.. THE NURSE PRACTITIONER. 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200623.0,,HP,US,US,2020,Q2,Elderly
179262431,17926243,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Dystonia,,2020,Q2,1,I,,20200609.0,20200623,20200623,EXP,,US-MICRO LABS LIMITED-ML2020-01805,MICRO LABS,"CHAPPELL K, SHAH S, CUTSHALL T, SANDS C. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS.. THE NURSE PRACTITIONER. 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200623.0,,HP,US,US,2020,Q2,Elderly
179262431,17926243,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Tremor,,2020,Q2,1,I,,20200609.0,20200623,20200623,EXP,,US-MICRO LABS LIMITED-ML2020-01805,MICRO LABS,"CHAPPELL K, SHAH S, CUTSHALL T, SANDS C. CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS.. THE NURSE PRACTITIONER. 2020;45(5):11-12.",69.0,YR,,M,Y,,,20200623.0,,HP,US,US,2020,Q2,Elderly
179282371,17928237,3,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Alanine aminotransferase increased,,2020,Q2,1,I,20200616.0,,20200622,20200622,DIR,,,FDA-CTU,,48.0,YR,,M,N,110.9,KG,20200622.0,N,PH,US,US,2020,Q2,Adult
179282371,17928237,3,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Therapy interrupted,,2020,Q2,1,I,20200616.0,,20200622,20200622,DIR,,,FDA-CTU,,48.0,YR,,M,N,110.9,KG,20200622.0,N,PH,US,US,2020,Q2,Adult
179292301,17929230,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2020,Q2,Acquired phimosis,,2020,Q2,1,I,201903.0,20200622.0,20200623,20200623,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-031243",BOEHRINGER INGELHEIM,,77.0,YR,,M,Y,98.0,KG,20200623.0,,MD,DE,DE,2020,Q2,Elderly
179292301,17929230,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,12.0,IU,,QD,2020,Q2,Balanoposthitis,,2020,Q2,1,I,201903.0,20200622.0,20200623,20200623,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-031243",BOEHRINGER INGELHEIM,,77.0,YR,,M,Y,98.0,KG,20200623.0,,MD,DE,DE,2020,Q2,Elderly
179300911,17930091,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (EVENING)",,,U,U,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,1,I,2008.0,20200601.0,20200623,20200623,EXP,,NVSC2020SK154603,NOVARTIS,,64.0,YR,,M,Y,,,20200623.0,,HP,SK,SK,2020,Q2,Adult
179300911,17930091,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (EVENING)",,,U,U,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Metabolic disorder,,2020,Q2,1,I,2008.0,20200601.0,20200623,20200623,EXP,,NVSC2020SK154603,NOVARTIS,,64.0,YR,,M,Y,,,20200623.0,,HP,SK,SK,2020,Q2,Adult
179300911,17930091,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD (EVENING)",,,U,U,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Weight increased,,2020,Q2,1,I,2008.0,20200601.0,20200623,20200623,EXP,,NVSC2020SK154603,NOVARTIS,,64.0,YR,,M,Y,,,20200623.0,,HP,SK,SK,2020,Q2,Adult
179310141,17931014,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,450.0,IU,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,,DE-MYLANLABS-2020M1057240,MYLAN,,75.0,YR,,M,Y,,,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179310141,17931014,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,450.0,IU,,,2020,Q2,Fall,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,,DE-MYLANLABS-2020M1057240,MYLAN,,75.0,YR,,M,Y,,,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179310141,17931014,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,450.0,IU,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,,DE-MYLANLABS-2020M1057240,MYLAN,,75.0,YR,,M,Y,,,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179310141,17931014,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,450.0,IU,,,2020,Q2,Headache,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,,DE-MYLANLABS-2020M1057240,MYLAN,,75.0,YR,,M,Y,,,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179310141,17931014,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 34-0-0-0",,,,,,,,450.0,IU,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,,DE-MYLANLABS-2020M1057240,MYLAN,,75.0,YR,,M,Y,,,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179312901,17931290,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q2,Diabetic ketoacidosis,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,,ES-MYLANLABS-2020M1057177,MYLAN,,54.0,YR,,F,Y,,,20200623.0,,CN,ES,ES,2020,Q2,Adult
179312901,17931290,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,,20200615.0,20200623,20200623,EXP,,ES-MYLANLABS-2020M1057177,MYLAN,,54.0,YR,,F,Y,,,20200623.0,,CN,ES,ES,2020,Q2,Adult
179320911,17932091,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Condition aggravated,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,DE-ADRED-04340-01,DE-PFIZER INC-2020242138,PFIZER,,70.0,YR,,M,Y,70.0,KG,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179320911,17932091,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Electrolyte imbalance,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,DE-ADRED-04340-01,DE-PFIZER INC-2020242138,PFIZER,,70.0,YR,,M,Y,70.0,KG,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179320911,17932091,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,DE-ADRED-04340-01,DE-PFIZER INC-2020242138,PFIZER,,70.0,YR,,M,Y,70.0,KG,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179320911,17932091,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Incontinence,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,DE-ADRED-04340-01,DE-PFIZER INC-2020242138,PFIZER,,70.0,YR,,M,Y,70.0,KG,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179320911,17932091,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Musculoskeletal chest pain,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,DE-ADRED-04340-01,DE-PFIZER INC-2020242138,PFIZER,,70.0,YR,,M,Y,70.0,KG,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179320911,17932091,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Polyuria,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,DE-ADRED-04340-01,DE-PFIZER INC-2020242138,PFIZER,,70.0,YR,,M,Y,70.0,KG,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179320911,17932091,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Product monitoring error,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,DE-ADRED-04340-01,DE-PFIZER INC-2020242138,PFIZER,,70.0,YR,,M,Y,70.0,KG,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179320911,17932091,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,DE-ADRED-04340-01,DE-PFIZER INC-2020242138,PFIZER,,70.0,YR,,M,Y,70.0,KG,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179320911,17932091,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,0-0-0-12,,,,,,,,,,,,2020,Q2,Therapeutic drug monitoring analysis not performed,,2020,Q2,1,I,,20200616.0,20200623,20200623,EXP,DE-ADRED-04340-01,DE-PFIZER INC-2020242138,PFIZER,,70.0,YR,,M,Y,70.0,KG,20200623.0,,PH,DE,DE,2020,Q2,Elderly
179321511,17932151,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,30 INTERNATIONAL UNIT,,,U,U,,,,30.0,IU,,,2020,Q2,Blindness,,2020,Q2,1,I,,20200617.0,20200624,20200624,EXP,,CA-AUROBINDO-AUR-APL-2020-030441,AUROBINDO,,73.0,YR,,F,Y,,,20200624.0,,CN,CA,CA,2020,Q2,Elderly
179321511,17932151,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,30 INTERNATIONAL UNIT,,,U,U,,,,30.0,IU,,,2020,Q2,Blood cholesterol increased,,2020,Q2,1,I,,20200617.0,20200624,20200624,EXP,,CA-AUROBINDO-AUR-APL-2020-030441,AUROBINDO,,73.0,YR,,F,Y,,,20200624.0,,CN,CA,CA,2020,Q2,Elderly
179321511,17932151,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,30 INTERNATIONAL UNIT,,,U,U,,,,30.0,IU,,,2020,Q2,Cataract,,2020,Q2,1,I,,20200617.0,20200624,20200624,EXP,,CA-AUROBINDO-AUR-APL-2020-030441,AUROBINDO,,73.0,YR,,F,Y,,,20200624.0,,CN,CA,CA,2020,Q2,Elderly
179321511,17932151,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,30 INTERNATIONAL UNIT,,,U,U,,,,30.0,IU,,,2020,Q2,Renal failure,,2020,Q2,1,I,,20200617.0,20200624,20200624,EXP,,CA-AUROBINDO-AUR-APL-2020-030441,AUROBINDO,,73.0,YR,,F,Y,,,20200624.0,,CN,CA,CA,2020,Q2,Elderly
179337061,17933706,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE 34-0-0-0,,,U,,,,,,,,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-HETERO-HET2020DE00663,HETERO,,75.0,YR,,M,Y,,,20200624.0,,HP,DE,DE,2020,Q2,Elderly
179337061,17933706,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE 34-0-0-0,,,U,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-HETERO-HET2020DE00663,HETERO,,75.0,YR,,M,Y,,,20200624.0,,HP,DE,DE,2020,Q2,Elderly
179337061,17933706,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE 34-0-0-0,,,U,,,,,,,,,2020,Q2,Fracture,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-HETERO-HET2020DE00663,HETERO,,75.0,YR,,M,Y,,,20200624.0,,HP,DE,DE,2020,Q2,Elderly
179337061,17933706,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE 34-0-0-0,,,U,,,,,,,,,2020,Q2,Headache,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-HETERO-HET2020DE00663,HETERO,,75.0,YR,,M,Y,,,20200624.0,,HP,DE,DE,2020,Q2,Elderly
179337061,17933706,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE 34-0-0-0,,,U,,,,,,,,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-HETERO-HET2020DE00663,HETERO,,75.0,YR,,M,Y,,,20200624.0,,HP,DE,DE,2020,Q2,Elderly
179388731,17938873,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Balance disorder,,2020,Q2,1,I,,20200615.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51571,HIKMA,,75.0,YR,,M,Y,,,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179388731,17938873,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Fall,,2020,Q2,1,I,,20200615.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51571,HIKMA,,75.0,YR,,M,Y,,,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179388731,17938873,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Fracture,,2020,Q2,1,I,,20200615.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51571,HIKMA,,75.0,YR,,M,Y,,,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179388731,17938873,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Headache,,2020,Q2,1,I,,20200615.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51571,HIKMA,,75.0,YR,,M,Y,,,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179388731,17938873,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34-0-0-0 ()",,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q2,Musculoskeletal pain,,2020,Q2,1,I,,20200615.0,20200625,20200625,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-51571,HIKMA,,75.0,YR,,M,Y,,,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179392941,17939294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,450 IU (REPORTED AS 8),,,U,,,,,450.0,IU,,,2020,Q2,Confusional state,,2020,Q2,1,I,20191212.0,20200619.0,20200624,20200624,EXP,,DE-PFIZER INC-2020240585,PFIZER,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179392941,17939294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,450 IU (REPORTED AS 8),,,U,,,,,450.0,IU,,,2020,Q2,Dehydration,,2020,Q2,1,I,20191212.0,20200619.0,20200624,20200624,EXP,,DE-PFIZER INC-2020240585,PFIZER,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179392941,17939294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,450 IU (REPORTED AS 8),,,U,,,,,450.0,IU,,,2020,Q2,Fall,,2020,Q2,1,I,20191212.0,20200619.0,20200624,20200624,EXP,,DE-PFIZER INC-2020240585,PFIZER,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179392941,17939294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,450 IU (REPORTED AS 8),,,U,,,,,450.0,IU,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,20191212.0,20200619.0,20200624,20200624,EXP,,DE-PFIZER INC-2020240585,PFIZER,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179392941,17939294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,450 IU (REPORTED AS 8),,,U,,,,,450.0,IU,,,2020,Q2,Muscular weakness,,2020,Q2,1,I,20191212.0,20200619.0,20200624,20200624,EXP,,DE-PFIZER INC-2020240585,PFIZER,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179392941,17939294,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,450 IU (REPORTED AS 8),,,U,,,,,450.0,IU,,,2020,Q2,Somnolence,,2020,Q2,1,I,20191212.0,20200619.0,20200624,20200624,EXP,,DE-PFIZER INC-2020240585,PFIZER,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179400411,17940041,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"25 IU, QD",,,Y,,,,,25.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,1,I,,20200617.0,20200624,20200624,EXP,,NVSC2020SK175206,NOVARTIS,,58.0,YR,,F,Y,,,20200624.0,,HP,SK,SK,2020,Q2,Adult
179400411,17940041,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,0.4 IU/KG,,,Y,,,,,0.4,IU/KG,SOLUTION FOR INJECTION,QD,2020,Q2,Diabetic metabolic decompensation,,2020,Q2,1,I,,20200617.0,20200624,20200624,EXP,,NVSC2020SK175206,NOVARTIS,,58.0,YR,,F,Y,,,20200624.0,,HP,SK,SK,2020,Q2,Adult
179401091,17940109,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q2,Impaired healing,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057542,MYLAN,,63.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179401091,17940109,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q2,Localised infection,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057542,MYLAN,,63.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179401091,17940109,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q2,Peripheral arterial occlusive disease,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057542,MYLAN,,63.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179401091,17940109,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q2,Ulcer,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057542,MYLAN,,63.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179401091,17940109,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q2,Wound,,2020,Q2,1,I,,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057542,MYLAN,,63.0,YR,,M,Y,,,20200624.0,,MD,DE,DE,2020,Q2,Adult
179401141,17940114,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,U,,,210605.0,450.0,IU,,,2020,Q2,Confusional state,,2020,Q2,1,I,20191212.0,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057526,MYLAN,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179401141,17940114,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,U,,,210605.0,450.0,IU,,,2020,Q2,Dehydration,,2020,Q2,1,I,20191212.0,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057526,MYLAN,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179401141,17940114,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,U,,,210605.0,450.0,IU,,,2020,Q2,Fall,,2020,Q2,1,I,20191212.0,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057526,MYLAN,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179401141,17940114,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,U,,,210605.0,450.0,IU,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,20191212.0,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057526,MYLAN,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179401141,17940114,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,U,,,210605.0,450.0,IU,,,2020,Q2,Muscular weakness,,2020,Q2,1,I,20191212.0,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057526,MYLAN,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179401141,17940114,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,U,,,210605.0,450.0,IU,,,2020,Q2,Somnolence,,2020,Q2,1,I,20191212.0,20200615.0,20200624,20200624,EXP,,DE-MYLANLABS-2020M1057526,MYLAN,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179401511,17940151,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,205692.0,,,INJECTION,,2020,Q2,Cerebral haemorrhage,,2020,Q2,1,I,,20200603.0,20200624,20200624,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202006001788,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20200624.0,,MD,JP,JP,2020,Q2,Elderly
179404322,17940432,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Condition aggravated,,2020,Q2,2,F,,20200618.0,20200624,20200625,EXP,,DE-EMD SERONO-E2B_90078198,EMD SERONO INC,,70.0,YR,,M,Y,70.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179404322,17940432,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Electrolyte imbalance,,2020,Q2,2,F,,20200618.0,20200624,20200625,EXP,,DE-EMD SERONO-E2B_90078198,EMD SERONO INC,,70.0,YR,,M,Y,70.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179404322,17940432,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Hyperglycaemia,,2020,Q2,2,F,,20200618.0,20200624,20200625,EXP,,DE-EMD SERONO-E2B_90078198,EMD SERONO INC,,70.0,YR,,M,Y,70.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179404322,17940432,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Incontinence,,2020,Q2,2,F,,20200618.0,20200624,20200625,EXP,,DE-EMD SERONO-E2B_90078198,EMD SERONO INC,,70.0,YR,,M,Y,70.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179404322,17940432,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Musculoskeletal chest pain,,2020,Q2,2,F,,20200618.0,20200624,20200625,EXP,,DE-EMD SERONO-E2B_90078198,EMD SERONO INC,,70.0,YR,,M,Y,70.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179404322,17940432,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Polyuria,,2020,Q2,2,F,,20200618.0,20200624,20200625,EXP,,DE-EMD SERONO-E2B_90078198,EMD SERONO INC,,70.0,YR,,M,Y,70.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179404322,17940432,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Product monitoring error,,2020,Q2,2,F,,20200618.0,20200624,20200625,EXP,,DE-EMD SERONO-E2B_90078198,EMD SERONO INC,,70.0,YR,,M,Y,70.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179404322,17940432,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Renal impairment,,2020,Q2,2,F,,20200618.0,20200624,20200625,EXP,,DE-EMD SERONO-E2B_90078198,EMD SERONO INC,,70.0,YR,,M,Y,70.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179404322,17940432,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q2,Therapeutic drug monitoring analysis not performed,,2020,Q2,2,F,,20200618.0,20200624,20200625,EXP,,DE-EMD SERONO-E2B_90078198,EMD SERONO INC,,70.0,YR,,M,Y,70.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179409981,17940998,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Cardiac arrest,,2020,Q2,1,I,20200622.0,,20200624,20200624,DIR,,,FDA-CTU,,36.0,YR,,M,N,82.2,KG,20200624.0,N,MD,US,US,2020,Q2,Adult
179409981,17940998,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Hypoxia,,2020,Q2,1,I,20200622.0,,20200624,20200624,DIR,,,FDA-CTU,,36.0,YR,,M,N,82.2,KG,20200624.0,N,MD,US,US,2020,Q2,Adult
179409981,17940998,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Respiratory acidosis,,2020,Q2,1,I,20200622.0,,20200624,20200624,DIR,,,FDA-CTU,,36.0,YR,,M,N,82.2,KG,20200624.0,N,MD,US,US,2020,Q2,Adult
179414861,17941486,4,C,Isulin glargine,,2,,36 UNITS DAILY,,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,,20200624.0,20200624,20200624,EXP,,JP-ANIPHARMA-2020-JP-000191,ANI,"TAKUBO M, TANAKA S, KUSHIMOTO M ET AL.HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT..ANTIBIOTICS.2020;9(4):.",57.0,YR,,F,Y,49.0,KG,20200624.0,,HP,JP,JP,2020,Q2,Adult
179414861,17941486,4,C,Isulin glargine,,2,,36 UNITS DAILY,,,,,,,,,,,,2020,Q2,Hyponatraemia,,2020,Q2,1,I,,20200624.0,20200624,20200624,EXP,,JP-ANIPHARMA-2020-JP-000191,ANI,"TAKUBO M, TANAKA S, KUSHIMOTO M ET AL.HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT..ANTIBIOTICS.2020;9(4):.",57.0,YR,,F,Y,49.0,KG,20200624.0,,HP,JP,JP,2020,Q2,Adult
179414861,17941486,4,C,Isulin glargine,,2,,36 UNITS DAILY,,,,,,,,,,,,2020,Q2,Renal tubular acidosis,,2020,Q2,1,I,,20200624.0,20200624,20200624,EXP,,JP-ANIPHARMA-2020-JP-000191,ANI,"TAKUBO M, TANAKA S, KUSHIMOTO M ET AL.HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT..ANTIBIOTICS.2020;9(4):.",57.0,YR,,F,Y,49.0,KG,20200624.0,,HP,JP,JP,2020,Q2,Adult
179423561,17942356,5,SS,insulin glargine,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,, UNKNOWN,,,,,,,2020,Q2,Confusional state,,2020,Q2,1,I,20191212.0,20200616.0,20200625,20200625,EXP,,DE-TEVA-2020-DE-1790609,TEVA,,81.0,YR,,F,Y,40.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179423561,17942356,5,SS,insulin glargine,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,, UNKNOWN,,,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,20191212.0,20200616.0,20200625,20200625,EXP,,DE-TEVA-2020-DE-1790609,TEVA,,81.0,YR,,F,Y,40.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179423561,17942356,5,SS,insulin glargine,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,, UNKNOWN,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,20191212.0,20200616.0,20200625,20200625,EXP,,DE-TEVA-2020-DE-1790609,TEVA,,81.0,YR,,F,Y,40.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179423561,17942356,5,SS,insulin glargine,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,, UNKNOWN,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,20191212.0,20200616.0,20200625,20200625,EXP,,DE-TEVA-2020-DE-1790609,TEVA,,81.0,YR,,F,Y,40.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179423561,17942356,5,SS,insulin glargine,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,, UNKNOWN,,,,,,,2020,Q2,Muscular weakness,,2020,Q2,1,I,20191212.0,20200616.0,20200625,20200625,EXP,,DE-TEVA-2020-DE-1790609,TEVA,,81.0,YR,,F,Y,40.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179423561,17942356,5,SS,insulin glargine,INSULIN GLARGINE,1,,"450 IE, 0-0-8-0",,,U,, UNKNOWN,,,,,,,2020,Q2,Somnolence,,2020,Q2,1,I,20191212.0,20200616.0,20200625,20200625,EXP,,DE-TEVA-2020-DE-1790609,TEVA,,81.0,YR,,F,Y,40.0,KG,20200625.0,,PH,DE,DE,2020,Q2,Elderly
179424311,17942431,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE,,,U,,,,,,,,,2020,Q2,Confusional state,,2020,Q2,1,I,20191213.0,20200618.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000139,ANI,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424311,17942431,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE,,,U,,,,,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,20191213.0,20200618.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000139,ANI,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424311,17942431,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE,,,U,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,20191213.0,20200618.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000139,ANI,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424311,17942431,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE,,,U,,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,20191213.0,20200618.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000139,ANI,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424311,17942431,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE,,,U,,,,,,,,,2020,Q2,Muscular weakness,,2020,Q2,1,I,20191213.0,20200618.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000139,ANI,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424311,17942431,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,450 IE,,,U,,,,,,,,,2020,Q2,Somnolence,,2020,Q2,1,I,20191213.0,20200618.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000139,ANI,,81.0,YR,,F,Y,40.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 MG BID,,,U,,,,,,,,,2020,Q2,Anaemia,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 MG BID,,,U,,,,,,,,,2020,Q2,Electrolyte imbalance,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 MG BID,,,U,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 MG BID,,,U,,,,,,,,,2020,Q2,Labelled drug-drug interaction medication error,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 MG BID,,,U,,,,,,,,,2020,Q2,Product monitoring error,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179424401,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,60 MG BID,,,U,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,,20200620.0,20200624,20200624,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200624.0,,PH,DE,DE,2020,Q2,Elderly
179437971,17943797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Escherichia infection,,2020,Q2,1,I,201910.0,20200618.0,20200625,20200625,EXP,,US-ROCHE-2627386,ROCHE,,67.0,YR,,F,Y,,,20200625.0,,CN,US,US,2020,Q2,Elderly
179437971,17943797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Sepsis,,2020,Q2,1,I,201910.0,20200618.0,20200625,20200625,EXP,,US-ROCHE-2627386,ROCHE,,67.0,YR,,F,Y,,,20200625.0,,CN,US,US,2020,Q2,Elderly
179437971,17943797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,White blood cell count increased,,2020,Q2,1,I,201910.0,20200618.0,20200625,20200625,EXP,,US-ROCHE-2627386,ROCHE,,67.0,YR,,F,Y,,,20200625.0,,CN,US,US,2020,Q2,Elderly
179445481,17944548,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INFUSION,,,Y,U,,,210605.0,,,INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"KIM AS, HAKEEM R, ABDULLAH A, HOOPER AJ, TCHAN MC, ALAHAKOON TI, ET AL. THERAPEUTIC PLASMA EXCHANGE FOR THE MANAGEMENT OF SEVERE GESTATIONAL HYPERTRIGLYCERIDAEMIC PANCREATITIS DUE TO LIPOPROTEIN LIPASE MUTATION. ENDOCRINOL-DIABETES-METAB-CASE-REP 2020;2020(1):19-0165.",19.0,YR,,F,Y,,,20200625.0,,MD,AU,AU,2020,Q2,Youth
179445481,17944548,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INFUSION,,,Y,U,,,210605.0,,,INJECTION,,2020,Q2,Maternal exposure during pregnancy,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"KIM AS, HAKEEM R, ABDULLAH A, HOOPER AJ, TCHAN MC, ALAHAKOON TI, ET AL. THERAPEUTIC PLASMA EXCHANGE FOR THE MANAGEMENT OF SEVERE GESTATIONAL HYPERTRIGLYCERIDAEMIC PANCREATITIS DUE TO LIPOPROTEIN LIPASE MUTATION. ENDOCRINOL-DIABETES-METAB-CASE-REP 2020;2020(1):19-0165.",19.0,YR,,F,Y,,,20200625.0,,MD,AU,AU,2020,Q2,Youth
179445481,17944548,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INFUSION,,,Y,U,,,210605.0,,,INJECTION,,2020,Q2,Normal newborn,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"KIM AS, HAKEEM R, ABDULLAH A, HOOPER AJ, TCHAN MC, ALAHAKOON TI, ET AL. THERAPEUTIC PLASMA EXCHANGE FOR THE MANAGEMENT OF SEVERE GESTATIONAL HYPERTRIGLYCERIDAEMIC PANCREATITIS DUE TO LIPOPROTEIN LIPASE MUTATION. ENDOCRINOL-DIABETES-METAB-CASE-REP 2020;2020(1):19-0165.",19.0,YR,,F,Y,,,20200625.0,,MD,AU,AU,2020,Q2,Youth
179445481,17944548,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,U,,,210605.0,,,INJECTION,,2020,Q2,Drug ineffective,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"KIM AS, HAKEEM R, ABDULLAH A, HOOPER AJ, TCHAN MC, ALAHAKOON TI, ET AL. THERAPEUTIC PLASMA EXCHANGE FOR THE MANAGEMENT OF SEVERE GESTATIONAL HYPERTRIGLYCERIDAEMIC PANCREATITIS DUE TO LIPOPROTEIN LIPASE MUTATION. ENDOCRINOL-DIABETES-METAB-CASE-REP 2020;2020(1):19-0165.",19.0,YR,,F,Y,,,20200625.0,,MD,AU,AU,2020,Q2,Youth
179445481,17944548,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,U,,,210605.0,,,INJECTION,,2020,Q2,Maternal exposure during pregnancy,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"KIM AS, HAKEEM R, ABDULLAH A, HOOPER AJ, TCHAN MC, ALAHAKOON TI, ET AL. THERAPEUTIC PLASMA EXCHANGE FOR THE MANAGEMENT OF SEVERE GESTATIONAL HYPERTRIGLYCERIDAEMIC PANCREATITIS DUE TO LIPOPROTEIN LIPASE MUTATION. ENDOCRINOL-DIABETES-METAB-CASE-REP 2020;2020(1):19-0165.",19.0,YR,,F,Y,,,20200625.0,,MD,AU,AU,2020,Q2,Youth
179445481,17944548,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,Y,U,,,210605.0,,,INJECTION,,2020,Q2,Normal newborn,,2020,Q2,1,I,,20200616.0,20200625,20200625,EXP,,AU-MYLANLABS-2020M1058456,MYLAN,"KIM AS, HAKEEM R, ABDULLAH A, HOOPER AJ, TCHAN MC, ALAHAKOON TI, ET AL. THERAPEUTIC PLASMA EXCHANGE FOR THE MANAGEMENT OF SEVERE GESTATIONAL HYPERTRIGLYCERIDAEMIC PANCREATITIS DUE TO LIPOPROTEIN LIPASE MUTATION. ENDOCRINOL-DIABETES-METAB-CASE-REP 2020;2020(1):19-0165.",19.0,YR,,F,Y,,,20200625.0,,MD,AU,AU,2020,Q2,Youth
179461101,17946110,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Electrocardiogram T wave inversion,,2020,Q2,1,I,,20200608.0,20200625,20200625,EXP,,"ID-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-028934",BOEHRINGER INGELHEIM,"WIDYSANTO J, LUKITO A. EFFECT OF HYPERGLYCEMIAON THE T WAVE INVERSION. JOURNAL OF ARRHYTHMIA. 2019;35:19-01099.",55.0,YR,,F,Y,,,20200625.0,,MD,ID,ID,2020,Q2,Adult
179461101,17946110,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q2,Hyperglycaemia,,2020,Q2,1,I,,20200608.0,20200625,20200625,EXP,,"ID-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-028934",BOEHRINGER INGELHEIM,"WIDYSANTO J, LUKITO A. EFFECT OF HYPERGLYCEMIAON THE T WAVE INVERSION. JOURNAL OF ARRHYTHMIA. 2019;35:19-01099.",55.0,YR,,F,Y,,,20200625.0,,MD,ID,ID,2020,Q2,Adult
179464841,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179464841,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood pressure increased,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179464841,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Fluid retention,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179464841,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Multiple use of single-use product,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179464841,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q2,Pancreatic disorder,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179464841,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179464841,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood pressure increased,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179464841,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Fluid retention,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179464841,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Multiple use of single-use product,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179464841,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Pancreatic disorder,,2020,Q2,1,I,,20200619.0,20200626,20200626,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179471361,17947136,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Neutrophil count decreased,,2020,Q2,1,I,20200623.0,,20200625,20200625,DIR,,,FDA-CTU,,85.0,YR,,F,N,61.7,KG,20200625.0,N,PH,US,US,2020,Q2,Elderly
179471361,17947136,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Platelet count decreased,,2020,Q2,1,I,20200623.0,,20200625,20200625,DIR,,,FDA-CTU,,85.0,YR,,F,N,61.7,KG,20200625.0,N,PH,US,US,2020,Q2,Elderly
179471361,17947136,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,White blood cell count decreased,,2020,Q2,1,I,20200623.0,,20200625,20200625,DIR,,,FDA-CTU,,85.0,YR,,F,N,61.7,KG,20200625.0,N,PH,US,US,2020,Q2,Elderly
179483191,17948319,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Erythema,,2020,Q2,1,I,20200428.0,20200622.0,20200626,20200626,EXP,,DK-PFIZER INC-2020245395,PFIZER,,39.0,YR,,F,Y,,,20200626.0,,MD,DK,DK,2020,Q2,Adult
179483191,17948319,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Feeling hot,,2020,Q2,1,I,20200428.0,20200622.0,20200626,20200626,EXP,,DK-PFIZER INC-2020245395,PFIZER,,39.0,YR,,F,Y,,,20200626.0,,MD,DK,DK,2020,Q2,Adult
179483191,17948319,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Hypersensitivity,,2020,Q2,1,I,20200428.0,20200622.0,20200626,20200626,EXP,,DK-PFIZER INC-2020245395,PFIZER,,39.0,YR,,F,Y,,,20200626.0,,MD,DK,DK,2020,Q2,Adult
179483191,17948319,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Infusion related reaction,,2020,Q2,1,I,20200428.0,20200622.0,20200626,20200626,EXP,,DK-PFIZER INC-2020245395,PFIZER,,39.0,YR,,F,Y,,,20200626.0,,MD,DK,DK,2020,Q2,Adult
179483191,17948319,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q2,Rash,,2020,Q2,1,I,20200428.0,20200622.0,20200626,20200626,EXP,,DK-PFIZER INC-2020245395,PFIZER,,39.0,YR,,F,Y,,,20200626.0,,MD,DK,DK,2020,Q2,Adult
179488981,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179488981,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Blood pressure increased,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179488981,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Fluid retention,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179488981,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Multiple use of single-use product,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179488981,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q2,Pancreatic disorder,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179488981,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood glucose increased,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179488981,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Blood pressure increased,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179488981,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Fluid retention,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179488981,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Multiple use of single-use product,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179488981,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q2,Pancreatic disorder,,2020,Q2,1,I,,20200621.0,20200626,20200626,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200626.0,,CN,ES,ES,2020,Q2,Adult
179491821,17949182,4,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Extra dose administered,,2020,Q2,1,I,20200625.0,,20200626,20200626,DIR,,,FDA-CTU,,37.0,YR,,F,N,90.3,KG,20200626.0,N,PH,US,US,2020,Q2,Adult
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Acidosis,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Acute kidney injury,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,C-reactive protein increased,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Euglycaemic diabetic ketoacidosis,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Food intolerance,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Glycosuria,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypokalaemia,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Hypophosphataemia,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Ketonuria,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Leukocytosis,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Metabolic acidosis,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Nausea,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Neutrophilia,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179518141,17951814,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q2,Vomiting,,2020,Q2,1,I,,20200612.0,20200627,20200627,EXP,PT-EMA-DD-20200611-AGRAHARI_P-115317,PT-ACCORD-185613,ACCORD,,70.0,YR,,M,Y,,,20200627.0,,HP,PT,PT,2020,Q2,Elderly
179527871,17952787,9,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Cardiac failure congestive,,2020,Q2,1,I,20200530.0,20200619.0,20200626,20200626,EXP,,CO-BAXTER-2020BAX012833,BAXTER,,49.0,YR,,M,Y,65.0,KG,20200626.0,,HP,CO,CO,2020,Q2,Adult
179527871,17952787,9,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,20.0,IU,,QD,2020,Q2,Oedema,,2020,Q2,1,I,20200530.0,20200619.0,20200626,20200626,EXP,,CO-BAXTER-2020BAX012833,BAXTER,,49.0,YR,,M,Y,65.0,KG,20200626.0,,HP,CO,CO,2020,Q2,Adult
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Blood pressure diastolic decreased,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Blood pressure systolic increased,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Body temperature decreased,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Bronchitis,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Cerebrovascular accident,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Cough,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Diarrhoea,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Dizziness,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Fall,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Fatigue,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Hip fracture,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Large intestine polyp,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Pneumonia,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Productive cough,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179535861,17953586,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,,,,,,19.0,DF,,,2020,Q2,Wheezing,,2020,Q2,1,I,,20200615.0,20200628,20200628,EXP,E2B_02975852,CA-ACCORD-185969,ACCORD,,82.0,YR,,F,Y,,,20200629.0,,HP,CA,CA,2020,Q2,Elderly
179569681,17956968,17,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Wrong technique in product usage process,,2020,Q2,1,I,20200627.0,,20200629,20200629,DIR,,,FDA-CTU,,60.0,YR,,M,N,66.9,KG,20200629.0,N,PH,US,US,2020,Q2,Adult
179589601,17958960,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q2,Exposure during pregnancy,,2020,Q2,1,I,20200620.0,20200623.0,20200629,20200629,EXP,,US-FRESENIUS KABI-FK202006367,FRESENIUS KABI,,33.0,YR,,F,Y,,,20200629.0,,HP,US,US,2020,Q2,Young Adult
179589601,17958960,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q2,Hypotension,,2020,Q2,1,I,20200620.0,20200623.0,20200629,20200629,EXP,,US-FRESENIUS KABI-FK202006367,FRESENIUS KABI,,33.0,YR,,F,Y,,,20200629.0,,HP,US,US,2020,Q2,Young Adult
179589601,17958960,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q2,Product use issue,,2020,Q2,1,I,20200620.0,20200623.0,20200629,20200629,EXP,,US-FRESENIUS KABI-FK202006367,FRESENIUS KABI,,33.0,YR,,F,Y,,,20200629.0,,HP,US,US,2020,Q2,Young Adult
179602031,17960203,13,C,Insulin glargine,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Cogwheel rigidity,,2020,Q2,1,I,,20200629.0,20200629,20200629,EXP,,US-ANIPHARMA-2020-US-011606,ANI,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW.CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS..NURSE PRACTITIONER.2020;45(5):11-12.",69.0,YR,,M,Y,,,20200629.0,,PH,US,US,2020,Q2,Elderly
179602031,17960203,13,C,Insulin glargine,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200629.0,20200629,20200629,EXP,,US-ANIPHARMA-2020-US-011606,ANI,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW.CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS..NURSE PRACTITIONER.2020;45(5):11-12.",69.0,YR,,M,Y,,,20200629.0,,PH,US,US,2020,Q2,Elderly
179602031,17960203,13,C,Insulin glargine,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Dystonia,,2020,Q2,1,I,,20200629.0,20200629,20200629,EXP,,US-ANIPHARMA-2020-US-011606,ANI,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW.CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS..NURSE PRACTITIONER.2020;45(5):11-12.",69.0,YR,,M,Y,,,20200629.0,,PH,US,US,2020,Q2,Elderly
179602031,17960203,13,C,Insulin glargine,INSULIN GLARGINE,1,,10 UNITS NIGHTLY,,,,,,,,,,,,2020,Q2,Tremor,,2020,Q2,1,I,,20200629.0,20200629,20200629,EXP,,US-ANIPHARMA-2020-US-011606,ANI,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW.CIPROFLOXACIN-RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS..NURSE PRACTITIONER.2020;45(5):11-12.",69.0,YR,,M,Y,,,20200629.0,,PH,US,US,2020,Q2,Elderly
179608921,17960892,4,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,"450 IE, 0-0-8-0 ()",,,U,,,,,,,,,2020,Q2,Confusional state,,2020,Q2,1,I,20191212.0,20200617.0,20200630,20200630,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252037,RANBAXY,,81.0,YR,,F,Y,40.0,KG,20200630.0,,HP,NL,DE,2020,Q2,Elderly
179608921,17960892,4,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,"450 IE, 0-0-8-0 ()",,,U,,,,,,,,,2020,Q2,Dehydration,,2020,Q2,1,I,20191212.0,20200617.0,20200630,20200630,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252037,RANBAXY,,81.0,YR,,F,Y,40.0,KG,20200630.0,,HP,NL,DE,2020,Q2,Elderly
179608921,17960892,4,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,"450 IE, 0-0-8-0 ()",,,U,,,,,,,,,2020,Q2,Fall,,2020,Q2,1,I,20191212.0,20200617.0,20200630,20200630,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252037,RANBAXY,,81.0,YR,,F,Y,40.0,KG,20200630.0,,HP,NL,DE,2020,Q2,Elderly
179608921,17960892,4,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,"450 IE, 0-0-8-0 ()",,,U,,,,,,,,,2020,Q2,General physical health deterioration,,2020,Q2,1,I,20191212.0,20200617.0,20200630,20200630,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252037,RANBAXY,,81.0,YR,,F,Y,40.0,KG,20200630.0,,HP,NL,DE,2020,Q2,Elderly
179608921,17960892,4,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,"450 IE, 0-0-8-0 ()",,,U,,,,,,,,,2020,Q2,Muscular weakness,,2020,Q2,1,I,20191212.0,20200617.0,20200630,20200630,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252037,RANBAXY,,81.0,YR,,F,Y,40.0,KG,20200630.0,,HP,NL,DE,2020,Q2,Elderly
179608921,17960892,4,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,"450 IE, 0-0-8-0 ()",,,U,,,,,,,,,2020,Q2,Somnolence,,2020,Q2,1,I,20191212.0,20200617.0,20200630,20200630,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252037,RANBAXY,,81.0,YR,,F,Y,40.0,KG,20200630.0,,HP,NL,DE,2020,Q2,Elderly
179611191,17961119,10,C,insulin glargine 30 unit SubQ qHS,,2,,,,,,,,,,,,,,2020,Q2,Glomerular filtration rate decreased,,2020,Q2,1,I,20200629.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,F,N,70.0,KG,20200629.0,N,PH,US,US,2020,Q2,Elderly
179611191,17961119,10,C,insulin glargine 30 unit SubQ qHS,,2,,,,,,,,,,,,,,2020,Q2,Hepatic enzyme increased,,2020,Q2,1,I,20200629.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,F,N,70.0,KG,20200629.0,N,PH,US,US,2020,Q2,Elderly
179611191,17961119,10,C,insulin glargine 30 unit SubQ qHS,,2,,,,,,,,,,,,,,2020,Q2,Renal impairment,,2020,Q2,1,I,20200629.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,F,N,70.0,KG,20200629.0,N,PH,US,US,2020,Q2,Elderly
179611191,17961119,10,C,insulin glargine 30 unit SubQ qHS,,2,,,,,,,,,,,,,,2020,Q2,Therapy cessation,,2020,Q2,1,I,20200629.0,,20200629,20200629,DIR,,,FDA-CTU,,72.0,YR,,F,N,70.0,KG,20200629.0,N,PH,US,US,2020,Q2,Elderly
179619791,17961979,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNIT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER FREQUENCY:BEDTIME ;?,,,Y,D,,,,40.0,IU,,,2020,Q2,Hypoglycaemia,,2020,Q2,1,I,20200123.0,,20200629,20200629,DIR,,,FDA-CTU,,63.0,YR,,M,N,85.0,KG,20200206.0,N,PH,US,US,2020,Q2,Adult
179651021,17965102,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,D,,,,,44.0,IU,,,2020,Q2,Drug interaction,,2020,Q2,1,I,,20200620.0,20200630,20200630,EXP,,CZ-HETERO-HET2020CZ00682,HETERO,"VODICKA M, SLANAR O, PISAR M, SALEK T. ROSUVASTATIN-INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CES. SLOV. FARM. 2020;69:100-102",74.0,YR,,M,Y,,,20200701.0,,HP,CZ,CZ,2020,Q2,Elderly
179651021,17965102,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,D,,,,,44.0,IU,,,2020,Q2,Medication error,,2020,Q2,1,I,,20200620.0,20200630,20200630,EXP,,CZ-HETERO-HET2020CZ00682,HETERO,"VODICKA M, SLANAR O, PISAR M, SALEK T. ROSUVASTATIN-INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CES. SLOV. FARM. 2020;69:100-102",74.0,YR,,M,Y,,,20200701.0,,HP,CZ,CZ,2020,Q2,Elderly
179651021,17965102,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,D,,,,,44.0,IU,,,2020,Q2,Rhabdomyolysis,,2020,Q2,1,I,,20200620.0,20200630,20200630,EXP,,CZ-HETERO-HET2020CZ00682,HETERO,"VODICKA M, SLANAR O, PISAR M, SALEK T. ROSUVASTATIN-INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CES. SLOV. FARM. 2020;69:100-102",74.0,YR,,M,Y,,,20200701.0,,HP,CZ,CZ,2020,Q2,Elderly
179651361,17965136,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q2,Blood creatine phosphokinase increased,,2020,Q2,1,I,20200323.0,20200616.0,20200630,20200630,EXP,,IT-VERTEX PHARMACEUTICALS-2020-013186,VERTEX,,32.0,YR,,M,Y,,,20200630.0,,MD,IT,IT,2020,Q2,Young Adult
179653441,17965344,4,C,Insulin glargine,INSULIN GLARGINE,1,,36 UNITS DAILY,,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,1,I,,20200624.0,20200630,20200630,EXP,,JP-PAIPHARMA-2020-JP-000200,PHARMACEUTICAL ASSOC,"TAKUBO M, TANAKA S, KUSHIMOTO M ET AL.HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT..ANTIBIOTICS.2020;9(4):.",57.0,YR,,F,Y,49.0,KG,20200630.0,,HP,JP,JP,2020,Q2,Adult
179653441,17965344,4,C,Insulin glargine,INSULIN GLARGINE,1,,36 UNITS DAILY,,,,,,,,,,,,2020,Q2,Hyponatraemia,,2020,Q2,1,I,,20200624.0,20200630,20200630,EXP,,JP-PAIPHARMA-2020-JP-000200,PHARMACEUTICAL ASSOC,"TAKUBO M, TANAKA S, KUSHIMOTO M ET AL.HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT..ANTIBIOTICS.2020;9(4):.",57.0,YR,,F,Y,49.0,KG,20200630.0,,HP,JP,JP,2020,Q2,Adult
179653441,17965344,4,C,Insulin glargine,INSULIN GLARGINE,1,,36 UNITS DAILY,,,,,,,,,,,,2020,Q2,Renal tubular acidosis,,2020,Q2,1,I,,20200624.0,20200630,20200630,EXP,,JP-PAIPHARMA-2020-JP-000200,PHARMACEUTICAL ASSOC,"TAKUBO M, TANAKA S, KUSHIMOTO M ET AL.HYPONATREMIA ASSOCIATED WITH PROPHYLACTIC LOW-DOSE TRIMETHOPRIM DURING SYSTEMIC CORTICOSTEROID THERAPY FOR AQP4-POSITIVE OPTIC NEURITIS IN A DIABETIC PATIENT..ANTIBIOTICS.2020;9(4):.",57.0,YR,,F,Y,49.0,KG,20200630.0,,HP,JP,JP,2020,Q2,Adult
78019024,7801902,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,BID (40 UNITS IN MORNING AND 50 UNITS AT NIGHT )",,,,, OF549A,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,BID (40 UNITS IN MORNING AND 50 UNITS AT NIGHT )",,,,, OF549A,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Cardiac failure congestive,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,BID (40 UNITS IN MORNING AND 50 UNITS AT NIGHT )",,,,, OF549A,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Injection site bruising,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,BID (40 UNITS IN MORNING AND 50 UNITS AT NIGHT )",,,,, OF549A,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Myocardial infarction,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,BID (40 UNITS IN MORNING AND 50 UNITS AT NIGHT )",,,,, OF549A,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK,BID (40 UNITS IN MORNING AND 50 UNITS AT NIGHT )",,,,, OF549A,,,,,SOLUTION FOR INJECTION,Q12H,2020,Q2,Product use issue,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"140 IU, QD",,,,,,,,140.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blood glucose increased,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"140 IU, QD",,,,,,,,140.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Cardiac failure congestive,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"140 IU, QD",,,,,,,,140.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Injection site bruising,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"140 IU, QD",,,,,,,,140.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Myocardial infarction,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"140 IU, QD",,,,,,,,140.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Off label use,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"140 IU, QD",,,,,,,,140.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Product use issue,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blood glucose increased,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Cardiac failure congestive,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Injection site bruising,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Myocardial infarction,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Off label use,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
78019024,7801902,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"50 IU, BID",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Product use issue,,2020,Q2,4,F,201001.0,20200427.0,20110207,20200501,EXP,,US-SANOFI-AVENTIS-2011SA007050,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20200501.0,,CN,US,US,2020,Q2,Elderly
94372325,9437232,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU,QD",,,,,,,21081.0,75.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blindness unilateral,,2020,Q2,5,F,,20200406.0,20130802,20200415,EXP,,US-SANOFI-AVENTIS-2013SA077669,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200415.0,,CN,US,US,2020,Q2,Adult
94372325,9437232,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU,QD",,,,,,,21081.0,75.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,5,F,,20200406.0,20130802,20200415,EXP,,US-SANOFI-AVENTIS-2013SA077669,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200415.0,,CN,US,US,2020,Q2,Adult
94372325,9437232,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"75 IU,QD",,,,,,,21081.0,75.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,5,F,,20200406.0,20130802,20200415,EXP,,US-SANOFI-AVENTIS-2013SA077669,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200415.0,,CN,US,US,2020,Q2,Adult
94372325,9437232,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 IU, QD",,,,,,,21081.0,120.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Blindness unilateral,,2020,Q2,5,F,,20200406.0,20130802,20200415,EXP,,US-SANOFI-AVENTIS-2013SA077669,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200415.0,,CN,US,US,2020,Q2,Adult
94372325,9437232,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 IU, QD",,,,,,,21081.0,120.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,5,F,,20200406.0,20130802,20200415,EXP,,US-SANOFI-AVENTIS-2013SA077669,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200415.0,,CN,US,US,2020,Q2,Adult
94372325,9437232,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"120 IU, QD",,,,,,,21081.0,120.0,IU,SOLUTION FOR INJECTION,QD,2020,Q2,Neuropathy peripheral,,2020,Q2,5,F,,20200406.0,20130802,20200415,EXP,,US-SANOFI-AVENTIS-2013SA077669,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200415.0,,CN,US,US,2020,Q2,Adult
94372325,9437232,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, Q12H",,,,,,,21081.0,60.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Blindness unilateral,,2020,Q2,5,F,,20200406.0,20130802,20200415,EXP,,US-SANOFI-AVENTIS-2013SA077669,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200415.0,,CN,US,US,2020,Q2,Adult
94372325,9437232,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, Q12H",,,,,,,21081.0,60.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Inappropriate schedule of product administration,,2020,Q2,5,F,,20200406.0,20130802,20200415,EXP,,US-SANOFI-AVENTIS-2013SA077669,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200415.0,,CN,US,US,2020,Q2,Adult
94372325,9437232,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"60 IU, Q12H",,,,,,,21081.0,60.0,IU,SOLUTION FOR INJECTION,Q12H,2020,Q2,Neuropathy peripheral,,2020,Q2,5,F,,20200406.0,20130802,20200415,EXP,,US-SANOFI-AVENTIS-2013SA077669,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20200415.0,,CN,US,US,2020,Q2,Adult
97389962,9738996,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UKN, UNK",,,,,,,,,,,,2020,Q2,Abdominal pain,,2020,Q2,2,F,20130725.0,20200407.0,20131209,20200413,PER,,PHEH2013US025184,NOVARTIS,,33.0,YR,,M,Y,72.0,KG,20200413.0,,HP,US,US,2020,Q2,Young Adult
97389962,9738996,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UKN, UNK",,,,,,,,,,,,2020,Q2,Blood creatinine increased,,2020,Q2,2,F,20130725.0,20200407.0,20131209,20200413,PER,,PHEH2013US025184,NOVARTIS,,33.0,YR,,M,Y,72.0,KG,20200413.0,,HP,US,US,2020,Q2,Young Adult
97389962,9738996,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UKN, UNK",,,,,,,,,,,,2020,Q2,Hyperkalaemia,,2020,Q2,2,F,20130725.0,20200407.0,20131209,20200413,PER,,PHEH2013US025184,NOVARTIS,,33.0,YR,,M,Y,72.0,KG,20200413.0,,HP,US,US,2020,Q2,Young Adult
97389962,9738996,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UKN, UNK",,,,,,,,,,,,2020,Q2,Intra-abdominal haematoma,,2020,Q2,2,F,20130725.0,20200407.0,20131209,20200413,PER,,PHEH2013US025184,NOVARTIS,,33.0,YR,,M,Y,72.0,KG,20200413.0,,HP,US,US,2020,Q2,Young Adult
97389962,9738996,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UKN, UNK",,,,,,,,,,,,2020,Q2,Kidney transplant rejection,,2020,Q2,2,F,20130725.0,20200407.0,20131209,20200413,PER,,PHEH2013US025184,NOVARTIS,,33.0,YR,,M,Y,72.0,KG,20200413.0,,HP,US,US,2020,Q2,Young Adult
102577057,10257705,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Fibula fracture,,2020,Q3,7,F,20140605.0,20141115.0,20140625,20200714,EXP,,US-NOVOPROD-413487,NOVO NORDISK,,59.0,YR,,F,Y,81.18,KG,20200714.0,,MD,US,US,2020,Q3,Adult
102577057,10257705,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,7,F,20140605.0,20141115.0,20140625,20200714,EXP,,US-NOVOPROD-413487,NOVO NORDISK,,59.0,YR,,F,Y,81.18,KG,20200714.0,,MD,US,US,2020,Q3,Adult
102577057,10257705,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Tibia fracture,,2020,Q3,7,F,20140605.0,20141115.0,20140625,20200714,EXP,,US-NOVOPROD-413487,NOVO NORDISK,,59.0,YR,,F,Y,81.18,KG,20200714.0,,MD,US,US,2020,Q3,Adult
111124102,11112410,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"30 U, QD",,,,,,,,30.0,DF,,QD,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20150502.0,20150504.0,20150514,20200714,EXP,,US-NOVOPROD-448373,NOVO NORDISK,,69.0,YR,,M,Y,112.0,KG,20200714.0,,MD,US,US,2020,Q3,Elderly
111124102,11112410,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20150502.0,20150504.0,20150514,20200714,EXP,,US-NOVOPROD-448373,NOVO NORDISK,,69.0,YR,,M,Y,112.0,KG,20200714.0,,MD,US,US,2020,Q3,Elderly
117041632,11704163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Internal haemorrhage,,2020,Q3,2,F,20141114.0,20200622.0,20151106,20200703,EXP,,US-BAYER-2015-421339,BAYER,,55.0,YR,A,M,Y,,,20200703.0,,CN,US,US,2020,Q3,Adult
117041632,11704163,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Lower gastrointestinal haemorrhage,,2020,Q3,2,F,20141114.0,20200622.0,20151106,20200703,EXP,,US-BAYER-2015-421339,BAYER,,55.0,YR,A,M,Y,,,20200703.0,,CN,US,US,2020,Q3,Adult
120443333,12044333,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,3,F,20140412.0,20200824.0,20160208,20200826,PER,,US-JNJFOC-20160206052,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20200826.0,,CN,US,US,2020,Q3,Elderly
123182982,12318298,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 UNIT, QD AT BEDTIME",,,D,,,,,,,,,2020,Q3,Constipation,,2020,Q3,2,F,20160413.0,20160913.0,20160429,20160921,EXP,,US-JNJFOC-20160420504,PHARMACYCLICS,,69.0,YR,E,M,Y,,,20160921.0,,MD,US,US,2020,Q3,Elderly
123182982,12318298,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 UNIT, QD AT BEDTIME",,,D,,,,,,,,,2020,Q3,Intestinal perforation,,2020,Q3,2,F,20160413.0,20160913.0,20160429,20160921,EXP,,US-JNJFOC-20160420504,PHARMACYCLICS,,69.0,YR,E,M,Y,,,20160921.0,,MD,US,US,2020,Q3,Elderly
125489101,12548910,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,96.0,IU,UNSPECIFIED,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20160426.0,20160630.0,20160712,20160712,EXP,,AU-JNJFOC-20160702550,JANSSEN,,69.0,YR,E,M,Y,,,20160712.0,,MD,AU,AU,2020,Q3,Elderly
125489101,12548910,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,96.0,IU,UNSPECIFIED,,2020,Q3,Prostatitis,,2020,Q3,1,I,20160426.0,20160630.0,20160712,20160712,EXP,,AU-JNJFOC-20160702550,JANSSEN,,69.0,YR,E,M,Y,,,20160712.0,,MD,AU,AU,2020,Q3,Elderly
125489101,12548910,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,34.0,IU,UNSPECIFIED,QD,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20160426.0,20160630.0,20160712,20160712,EXP,,AU-JNJFOC-20160702550,JANSSEN,,69.0,YR,E,M,Y,,,20160712.0,,MD,AU,AU,2020,Q3,Elderly
125489101,12548910,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,34.0,IU,UNSPECIFIED,QD,2020,Q3,Prostatitis,,2020,Q3,1,I,20160426.0,20160630.0,20160712,20160712,EXP,,AU-JNJFOC-20160702550,JANSSEN,,69.0,YR,E,M,Y,,,20160712.0,,MD,AU,AU,2020,Q3,Elderly
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Adverse drug reaction,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Arthralgia,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Gait inability,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Headache,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Hypoaesthesia,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Lower respiratory tract infection,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Pharyngitis,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
1267068515,12670685,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Toothache,,2020,Q3,15,F,,20200720.0,20160822,20200728,PER,,CA-AMGEN-CANSP2015042116,AMGEN,,42.0,YR,A,F,Y,,,20200728.0,,MD,CA,CA,2020,Q3,Adult
127283242,12728324,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HE TAKES IT 4 TIMES A MONTH AT THE MOST,,,,, 6F2974A,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q3,Gastric bypass,,2020,Q3,2,F,201606.0,20200811.0,20160909,20200818,EXP,,US-SA-2016SA162179,SANOFI AVENTIS,,49.0,YR,,M,Y,,,20200818.0,,CN,US,US,2020,Q3,Adult
127283242,12728324,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HE TAKES IT 4 TIMES A MONTH AT THE MOST,,,,, 6F2974A,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,201606.0,20200811.0,20160909,20200818,EXP,,US-SA-2016SA162179,SANOFI AVENTIS,,49.0,YR,,M,Y,,,20200818.0,,CN,US,US,2020,Q3,Adult
127283242,12728324,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HE TAKES IT 4 TIMES A MONTH AT THE MOST,,,,, 6F2974A,,21081.0,,,SOLUTION FOR INJECTION,,2020,Q3,Intentional product misuse,,2020,Q3,2,F,201606.0,20200811.0,20160909,20200818,EXP,,US-SA-2016SA162179,SANOFI AVENTIS,,49.0,YR,,M,Y,,,20200818.0,,CN,US,US,2020,Q3,Adult
127283242,12728324,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Gastric bypass,,2020,Q3,2,F,201606.0,20200811.0,20160909,20200818,EXP,,US-SA-2016SA162179,SANOFI AVENTIS,,49.0,YR,,M,Y,,,20200818.0,,CN,US,US,2020,Q3,Adult
127283242,12728324,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypertension,,2020,Q3,2,F,201606.0,20200811.0,20160909,20200818,EXP,,US-SA-2016SA162179,SANOFI AVENTIS,,49.0,YR,,M,Y,,,20200818.0,,CN,US,US,2020,Q3,Adult
127283242,12728324,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,,,,,21081.0,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product misuse,,2020,Q3,2,F,201606.0,20200811.0,20160909,20200818,EXP,,US-SA-2016SA162179,SANOFI AVENTIS,,49.0,YR,,M,Y,,,20200818.0,,CN,US,US,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Adverse drug reaction,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Arthralgia,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Gait inability,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Headache,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Hypoaesthesia,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Lower respiratory tract infection,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Pharyngitis,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
132200735,13220073,25,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,, UNKNOWN,,,,,,,2020,Q3,Toothache,,2020,Q3,5,F,,20200908.0,20170210,20200911,EXP,,CA-ROCHE-1891879,ROCHE,,42.0,YR,,F,Y,,,20200912.0,,HP,CA,CA,2020,Q3,Adult
134928367,13492836,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE 20 TEA SPOONS,,,D,,,,,,,UNSPECIFIED,,2020,Q3,Laryngeal squamous cell carcinoma,,2020,Q3,7,F,20170412.0,20171103.0,20170427,20171110,EXP,,US-JNJFOC-20170422242,JANSSEN,,61.0,YR,A,M,Y,70.1,KG,20171110.0,,MD,US,US,2020,Q3,Adult
134928367,13492836,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE 20 TEA SPOONS,,,D,,,,,,,UNSPECIFIED,,2020,Q3,Lymphadenopathy,,2020,Q3,7,F,20170412.0,20171103.0,20170427,20171110,EXP,,US-JNJFOC-20170422242,JANSSEN,,61.0,YR,A,M,Y,70.1,KG,20171110.0,,MD,US,US,2020,Q3,Adult
135143966,13514396,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE 3 UNITS UNSPECIFIED,,,D,,,,,,,UNSPECIFIED,,2020,Q3,Eczema,,2020,Q3,6,F,20170421.0,20181018.0,20170504,20181023,EXP,,CN-JNJFOC-20170429222,JANSSEN,,76.0,YR,E,M,Y,80.0,KG,20181023.0,,MD,CN,CN,2020,Q3,Elderly
135143966,13514396,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,,,UNSPECIFIED,,2020,Q3,Eczema,,2020,Q3,6,F,20170421.0,20181018.0,20170504,20181023,EXP,,CN-JNJFOC-20170429222,JANSSEN,,76.0,YR,E,M,Y,80.0,KG,20181023.0,,MD,CN,CN,2020,Q3,Elderly
136243011,13624301,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,6.000 IU QD,,,,,,,,,,,,2020,Q3,Hepatic function abnormal,,2020,Q3,1,I,20161021.0,20161021.0,20170608,20170608,EXP,,JP-ASTRAZENECA-2016SF11826,ASTRAZENECA,,22070.0,DY,,M,Y,,,20170608.0,,MD,JP,JP,2020,Q3,Elderly
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Adverse drug reaction,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Arthralgia,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Condition aggravated,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Gait inability,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Headache,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoaesthesia,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Lower respiratory tract infection,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pharyngitis,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1367540214,13675402,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Toothache,,2020,Q3,14,F,,20200831.0,20170621,20200909,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20200909.0,,CN,CA,CA,2020,Q3,Adult
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Blood calcium decreased,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Blood glucose increased,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,C-reactive protein increased,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Death,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Diarrhoea,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Folate deficiency,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Gastritis,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Haemoglobin decreased,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Hypothyroidism,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Pleural effusion,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
1377990120,13779901,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",258.0,IU,D,,,,,6.0,IU,,QD,2020,Q3,Thrombocytopenia,,2020,Q3,20,F,20170625.0,20200721.0,20170723,20200723,EXP,,PHHY2017DE100273,NOVARTIS,,77.0,YR,,F,Y,50.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
138075783,13807578,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,IU,,QD,2020,Q3,Septic shock,,2020,Q3,3,F,20170720.0,20171003.0,20170728,20171011,EXP,,IT-ABBVIE-17P-083-2051889-00,ABBVIE,,70.0,YR,,M,Y,,,20171011.0,,MD,IT,IT,2020,Q3,Elderly
138407531,13840753,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,100.0,IU,,QD,2020,Q3,Dizziness,,2020,Q3,1,I,20131126.0,20170509.0,20170807,20170807,EXP,,CO-JNJFOC-20170515296,JANSSEN,,68.0,YR,E,M,Y,92.8,KG,20170807.0,,MD,CO,CO,2020,Q3,Elderly
138717165,13871716,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q3,Pleural effusion,,2020,Q3,5,F,20170806.0,20170929.0,20170816,20171006,EXP,,US-JNJFOC-20170812482,PHARMACYCLICS,,66.0,YR,E,M,Y,142.5,KG,20171006.0,,MD,US,US,2020,Q3,Elderly
1394424310,13944243,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,,QD,2020,Q3,Abdominal pain,,2020,Q3,10,F,20170902.0,20181108.0,20170907,20181112,EXP,,JP-ASTRAZENECA-2017SE90841,ASTRAZENECA,,25664.0,DY,,M,Y,,,20181112.0,,MD,JP,JP,2020,Q3,Elderly
1394424310,13944243,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,,QD,2020,Q3,Death,,2020,Q3,10,F,20170902.0,20181108.0,20170907,20181112,EXP,,JP-ASTRAZENECA-2017SE90841,ASTRAZENECA,,25664.0,DY,,M,Y,,,20181112.0,,MD,JP,JP,2020,Q3,Elderly
1394424310,13944243,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,,QD,2020,Q3,Febrile neutropenia,,2020,Q3,10,F,20170902.0,20181108.0,20170907,20181112,EXP,,JP-ASTRAZENECA-2017SE90841,ASTRAZENECA,,25664.0,DY,,M,Y,,,20181112.0,,MD,JP,JP,2020,Q3,Elderly
1394424310,13944243,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,,QD,2020,Q3,Hyperglycaemia,,2020,Q3,10,F,20170902.0,20181108.0,20170907,20181112,EXP,,JP-ASTRAZENECA-2017SE90841,ASTRAZENECA,,25664.0,DY,,M,Y,,,20181112.0,,MD,JP,JP,2020,Q3,Elderly
1394424310,13944243,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,,QD,2020,Q3,Hyponatraemia,,2020,Q3,10,F,20170902.0,20181108.0,20170907,20181112,EXP,,JP-ASTRAZENECA-2017SE90841,ASTRAZENECA,,25664.0,DY,,M,Y,,,20181112.0,,MD,JP,JP,2020,Q3,Elderly
1394424310,13944243,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,6.0,IU,,QD,2020,Q3,Pneumonia aspiration,,2020,Q3,10,F,20170902.0,20181108.0,20170907,20181112,EXP,,JP-ASTRAZENECA-2017SE90841,ASTRAZENECA,,25664.0,DY,,M,Y,,,20181112.0,,MD,JP,JP,2020,Q3,Elderly
140747214,14074721,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,70.0,IU,UNSPECIFIED,,2020,Q3,Diabetic hyperosmolar coma,,2020,Q3,4,F,20170908.0,20171221.0,20171011,20171229,EXP,,CA-JNJFOC-20171002576,JANSSEN,,77.0,YR,E,M,Y,72.7,KG,20171229.0,,MD,CA,CA,2020,Q3,Elderly
142156586,14215658,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,24.0,IU,UNSPECIFIED,QD,2020,Q3,Fluid overload,,2020,Q3,6,F,20170909.0,20180330.0,20171122,20180404,EXP,,MY-JNJFOC-20171114824,JANSSEN,,57.0,YR,A,F,Y,97.0,KG,20180404.0,,MD,MY,MY,2020,Q3,Adult
142156586,14215658,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,24.0,IU,UNSPECIFIED,QD,2020,Q3,Nephrogenic anaemia,,2020,Q3,6,F,20170909.0,20180330.0,20171122,20180404,EXP,,MY-JNJFOC-20171114824,JANSSEN,,57.0,YR,A,F,Y,97.0,KG,20180404.0,,MD,MY,MY,2020,Q3,Adult
142156586,14215658,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,30.0,IU,UNSPECIFIED,,2020,Q3,Fluid overload,,2020,Q3,6,F,20170909.0,20180330.0,20171122,20180404,EXP,,MY-JNJFOC-20171114824,JANSSEN,,57.0,YR,A,F,Y,97.0,KG,20180404.0,,MD,MY,MY,2020,Q3,Adult
142156586,14215658,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,30.0,IU,UNSPECIFIED,,2020,Q3,Nephrogenic anaemia,,2020,Q3,6,F,20170909.0,20180330.0,20171122,20180404,EXP,,MY-JNJFOC-20171114824,JANSSEN,,57.0,YR,A,F,Y,97.0,KG,20180404.0,,MD,MY,MY,2020,Q3,Adult
142618343,14261834,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Anaphylactic reaction,,2020,Q3,3,F,,20200915.0,20171208,20200929,EXP,,CA-APOTEX-2017AP022094,APOTEX,,70.0,YR,,F,Y,,,20200929.0,,CN,CA,CA,2020,Q3,Elderly
142618343,14261834,41,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Drug intolerance,,2020,Q3,3,F,,20200915.0,20171208,20200929,EXP,,CA-APOTEX-2017AP022094,APOTEX,,70.0,YR,,F,Y,,,20200929.0,,CN,CA,CA,2020,Q3,Elderly
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Chronic obstructive pulmonary disease,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Clostridium difficile infection,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Cough,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Feeling abnormal,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Fluid retention,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Haematemesis,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Hypertension,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Lung disorder,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Malaise,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Nasopharyngitis,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Oxygen consumption increased,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Pain,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Pain in jaw,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Pulmonary arterial hypertension,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
1445508010,14455080,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK U, UNK",,,,U,,,,,,,,2020,Q3,Pulmonary oedema,,2020,Q3,10,F,201801.0,20200803.0,20180129,20200817,EXP,,US-ACTELION-A-NJ2017-157388,ACTELION,,58.0,YR,,F,Y,,,20200817.0,,HP,US,US,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Abdominal pain,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Blood growth hormone increased,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Bone pain,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Depression,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Dizziness,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Dysuria,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Headache,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Hypertension,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Hypotension,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Illness,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Neoplasm progression,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Pain,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Product prescribing error,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146027663,14602766,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Thyroid disorder,,2020,Q3,3,F,2002.0,20200624.0,20180306,20200703,EXP,,PHHY2016CO109800,NOVARTIS,,41.0,YR,,F,Y,67.0,KG,20200703.0,,CN,CO,CO,2020,Q3,Adult
146548282,14654828,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,55.0,IU,UNSPECIFIED,QD,2020,Q3,Prostate cancer,,2020,Q3,2,F,20170621.0,20180320.0,20180319,20180327,EXP,,US-JNJFOC-20170928652,JANSSEN,,66.0,YR,E,M,Y,102.0,KG,20180327.0,,MD,US,US,2020,Q3,Elderly
1476418711,14764187,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q3,Interstitial lung disease,,2020,Q3,11,F,20180319.0,20200731.0,20180416,20200806,EXP,,JP-PFIZER INC-2018146989,PFIZER,,71.0,YR,,M,Y,50.0,KG,20200806.0,,MD,JP,JP,2020,Q3,Elderly
147729909,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q3,Bronchitis,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
147729909,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q3,Colitis,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
147729909,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q3,Coronary artery disease,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
147729909,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q3,Dehydration,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
147729909,14772990,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2020,Q3,Quadriplegia,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
147729909,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q3,Bronchitis,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
147729909,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q3,Colitis,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
147729909,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q3,Coronary artery disease,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
147729909,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q3,Dehydration,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
147729909,14772990,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q3,Quadriplegia,,2020,Q3,9,F,20180411.0,20200708.0,20180418,20200709,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-034506,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,80.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Adult
149967713,14996771,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,,,INJECTION,,2020,Q3,Bartholin's cyst,,2020,Q3,3,F,20180516.0,20181022.0,20180611,20181105,EXP,,PL-JNJFOC-20180600199,JANSSEN,,46.0,YR,A,F,Y,65.0,KG,20181105.0,,MD,PL,PL,2020,Q3,Adult
1524542417,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q3,Anaemia,,2020,Q3,17,F,20180605.0,20200821.0,20180806,20200827,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200827.0,,MD,PL,PL,2020,Q3,Elderly
1524542417,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q3,Febrile neutropenia,,2020,Q3,17,F,20180605.0,20200821.0,20180806,20200827,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200827.0,,MD,PL,PL,2020,Q3,Elderly
1524542417,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q3,Neutropenia,,2020,Q3,17,F,20180605.0,20200821.0,20180806,20200827,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200827.0,,MD,PL,PL,2020,Q3,Elderly
1524542417,15245424,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,QD,2020,Q3,Thrombocytopenia,,2020,Q3,17,F,20180605.0,20200821.0,20180806,20200827,EXP,,PL-ABBVIE-18P-129-2407306-00,ABBVIE,,67.0,YR,,M,Y,100.8,KG,20200827.0,,MD,PL,PL,2020,Q3,Elderly
152633242,15263324,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,,,,,,,,,,2020,Q3,Diabetic ketoacidotic hyperglycaemic coma,,2020,Q3,2,F,20180728.0,20180809.0,20180810,20180813,EXP,,FR-ASTRAZENECA-2018SE98377,ASTRAZENECA,,25501.0,DY,,F,Y,63.0,KG,20180813.0,,MD,FR,FR,2020,Q3,Elderly
154126753,15412675,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,U,U,,,,1.0,DF,,QD,2020,Q3,Anaemia,,2020,Q3,3,F,20180719.0,20200730.0,20180921,20200805,EXP,DE-NOVPHSZ-PHHY2018DE103416,PHHY2018DE103416,NOVARTIS,,56.0,YR,,M,Y,,,20200805.0,,MD,DE,DE,2020,Q3,Adult
154126753,15412675,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,U,U,,,,1.0,DF,,QD,2020,Q3,General physical health deterioration,,2020,Q3,3,F,20180719.0,20200730.0,20180921,20200805,EXP,DE-NOVPHSZ-PHHY2018DE103416,PHHY2018DE103416,NOVARTIS,,56.0,YR,,M,Y,,,20200805.0,,MD,DE,DE,2020,Q3,Adult
1543145621,15431456,23,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,, UNK,,,,,,,2020,Q3,Foetal disorder,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,23,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,, UNK,,,,,,,2020,Q3,Foetal exposure during pregnancy,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,23,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,, UNK,,,,,,,2020,Q3,Low birth weight baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,23,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,, UNK,,,,,,,2020,Q3,Neutropenia neonatal,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,23,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,UNK,4060.0,MG,D,, UNK,,,,,,,2020,Q3,Premature baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,, UNK,,,20.0,MG,,QD,2020,Q3,Foetal disorder,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,, UNK,,,20.0,MG,,QD,2020,Q3,Foetal exposure during pregnancy,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,, UNK,,,20.0,MG,,QD,2020,Q3,Low birth weight baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,, UNK,,,20.0,MG,,QD,2020,Q3,Neutropenia neonatal,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
1543145621,15431456,24,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,"20 MILLIGRAM, QD",4060.0,MG,D,, UNK,,,20.0,MG,,QD,2020,Q3,Premature baby,,2020,Q3,21,F,20170914.0,20190716.0,20180926,20190724,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20190724.0,,HP,FR,FR,2020,Q3,Child
154398882,15439888,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q3,International normalised ratio fluctuation,,2020,Q3,2,F,,20200622.0,20180928,20200701,EXP,,US-ACS-001214,ACS DOBFAR,"STRICKLAND SW, BURNS E, PALKIMAS S, BAZYDLO LAL. THE SAMPLE THAT WOULD NOT CLOT. CLINICA CHIMICA ACTA. 2018?485:272?274. DOI:10.1016/J.CCA.2018.06.026.",68.0,YR,,F,Y,,,20200701.0,,MD,US,US,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Altered state of consciousness,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Anaphylactic reaction,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Anaphylactic shock,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Arteriosclerosis,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Cardio-respiratory arrest,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Electrocardiogram ST segment elevation,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Kounis syndrome,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Rash,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Respiratory arrest,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,100 U/ML,,,U,,,,,,,,,2020,Q3,Shock,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Altered state of consciousness,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Anaphylactic reaction,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Anaphylactic shock,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Arteriosclerosis,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Cardio-respiratory arrest,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Electrocardiogram ST segment elevation,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Kounis syndrome,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Rash,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Respiratory arrest,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
155496603,15549660,3,C,Insulin glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Shock,,2020,Q3,3,F,,20200811.0,20181025,20200820,EXP,,PT-AUROBINDO-AUR-APL-2018-051110,AUROBINDO,,73.0,YR,,F,Y,,,20200820.0,,HP,PT,PT,2020,Q3,Elderly
156741423,15674142,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q3,Administration site extravasation,,2020,Q3,3,F,20180617.0,20200910.0,20181130,20200914,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111677,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,79.0,KG,20200914.0,,PH,GB,GB,2020,Q3,Elderly
156741423,15674142,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q3,Blister,,2020,Q3,3,F,20180617.0,20200910.0,20181130,20200914,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111677,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,79.0,KG,20200914.0,,PH,GB,GB,2020,Q3,Elderly
156741423,15674142,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q3,Swelling,,2020,Q3,3,F,20180617.0,20200910.0,20181130,20200914,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111677,BRISTOL MYERS SQUIBB,,81.0,YR,,M,Y,79.0,KG,20200914.0,,PH,GB,GB,2020,Q3,Elderly
156833245,15683324,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,Y,,,,,14.0,IU,,,2020,Q3,Hyponatraemia,,2020,Q3,5,F,201809.0,20200901.0,20181204,20200914,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-192606,RANBAXY,,71.0,YR,,F,Y,,,20200914.0,,HP,NL,FR,2020,Q3,Elderly
156833245,15683324,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,Y,,,,,14.0,IU,,,2020,Q3,Inappropriate antidiuretic hormone secretion,,2020,Q3,5,F,201809.0,20200901.0,20181204,20200914,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2018RR-192606,RANBAXY,,71.0,YR,,F,Y,,,20200914.0,,HP,NL,FR,2020,Q3,Elderly
156891181,15689118,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,58.0,IU,UNKNOWN,QD,2020,Q3,Delirium,,2020,Q3,1,I,20180311.0,20180312.0,20181205,20181205,EXP,,US-JNJFOC-20180317540,JANSSEN,,67.0,YR,E,M,Y,99.6,KG,20181205.0,,MD,US,US,2020,Q3,Elderly
156891181,15689118,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,58.0,IU,UNKNOWN,QD,2020,Q3,Lactic acidosis,,2020,Q3,1,I,20180311.0,20180312.0,20181205,20181205,EXP,,US-JNJFOC-20180317540,JANSSEN,,67.0,YR,E,M,Y,99.6,KG,20181205.0,,MD,US,US,2020,Q3,Elderly
156891181,15689118,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,58.0,IU,UNKNOWN,QD,2020,Q3,Respiratory failure,,2020,Q3,1,I,20180311.0,20180312.0,20181205,20181205,EXP,,US-JNJFOC-20180317540,JANSSEN,,67.0,YR,E,M,Y,99.6,KG,20181205.0,,MD,US,US,2020,Q3,Elderly
156891181,15689118,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,55.0,IU,UNKNOWN,QD,2020,Q3,Delirium,,2020,Q3,1,I,20180311.0,20180312.0,20181205,20181205,EXP,,US-JNJFOC-20180317540,JANSSEN,,67.0,YR,E,M,Y,99.6,KG,20181205.0,,MD,US,US,2020,Q3,Elderly
156891181,15689118,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,55.0,IU,UNKNOWN,QD,2020,Q3,Lactic acidosis,,2020,Q3,1,I,20180311.0,20180312.0,20181205,20181205,EXP,,US-JNJFOC-20180317540,JANSSEN,,67.0,YR,E,M,Y,99.6,KG,20181205.0,,MD,US,US,2020,Q3,Elderly
156891181,15689118,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,55.0,IU,UNKNOWN,QD,2020,Q3,Respiratory failure,,2020,Q3,1,I,20180311.0,20180312.0,20181205,20181205,EXP,,US-JNJFOC-20180317540,JANSSEN,,67.0,YR,E,M,Y,99.6,KG,20181205.0,,MD,US,US,2020,Q3,Elderly
157552747,15755274,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 U, QD",,,U,U,,,,,,,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 U, QD",,,U,U,,,,,,,QD,2020,Q3,Drug ineffective,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 U, QD",,,U,U,,,,,,,QD,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 U, QD",,,U,U,,,,,,,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 U, QD",,,U,U,,,,,,,QD,2020,Q3,Hyperglycaemia,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 U, QD",,,U,U,,,,,,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 U, QD",,,U,U,,,,,,,QD,2020,Q3,Renal impairment,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"26 U, QD",,,U,U,,,,,,,QD,2020,Q3,Weight increased,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,U,U,,,,,,,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,U,U,,,,,,,QD,2020,Q3,Drug ineffective,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,U,U,,,,,,,QD,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,U,U,,,,,,,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,U,U,,,,,,,QD,2020,Q3,Hyperglycaemia,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,U,U,,,,,,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,U,U,,,,,,,QD,2020,Q3,Renal impairment,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 U, QD",,,U,U,,,,,,,QD,2020,Q3,Weight increased,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,U,,,,,,,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,U,,,,,,,QD,2020,Q3,Drug ineffective,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,U,,,,,,,QD,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,U,,,,,,,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,U,,,,,,,QD,2020,Q3,Hyperglycaemia,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,U,,,,,,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,U,,,,,,,QD,2020,Q3,Renal impairment,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157552747,15755274,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 U, QD",,,U,U,,,,,,,QD,2020,Q3,Weight increased,,2020,Q3,7,F,200903.0,20200902.0,20181224,20200904,EXP,,PHHY2018PL190106,NOVARTIS,,70.0,YR,,M,Y,,,20200904.0,,HP,PL,PL,2020,Q3,Elderly
157805042,15780504,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Lactic acidosis,,2020,Q3,2,F,,20200708.0,20190102,20200716,EXP,,IT-BAUSCH-BL-2018-035977,BAUSCH AND LOMB,"GRECO P, REGOLISTI G, MAGGIORE U, FERIOLI E, FANI F, LOCATELLI C, PARENTI E, MACCARI C, FIACCADORI E, GANDOLFINI I. SUSTAINED LOW?EFFICIENCY DIALYSIS FOR METFORMIN?ASSOCIATED LACTIC ACIDOSIS IN PATIENTS WITH ACUTE KIDNEY INJURY. JOURNAL OF NEPHROLOGY. 2018 DEC 06?. DOI:10.1007/S40620?018?00562?2",77.0,YR,,M,Y,,,20200716.0,,MD,IT,IT,2020,Q3,Elderly
157805042,15780504,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Toxicity to various agents,,2020,Q3,2,F,,20200708.0,20190102,20200716,EXP,,IT-BAUSCH-BL-2018-035977,BAUSCH AND LOMB,"GRECO P, REGOLISTI G, MAGGIORE U, FERIOLI E, FANI F, LOCATELLI C, PARENTI E, MACCARI C, FIACCADORI E, GANDOLFINI I. SUSTAINED LOW?EFFICIENCY DIALYSIS FOR METFORMIN?ASSOCIATED LACTIC ACIDOSIS IN PATIENTS WITH ACUTE KIDNEY INJURY. JOURNAL OF NEPHROLOGY. 2018 DEC 06?. DOI:10.1007/S40620?018?00562?2",77.0,YR,,M,Y,,,20200716.0,,MD,IT,IT,2020,Q3,Elderly
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Blood creatine phosphokinase increased,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Bronchitis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Bronchopulmonary aspergillosis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Cerumen impaction,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Chronic graft versus host disease,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Constipation,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Dermal cyst,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Duodenal ulcer,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Encephalitis viral,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Febrile neutropenia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Hepatic enzyme increased,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Insomnia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Neutropenia,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Papule,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Patella fracture,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Pulmonary artery thrombosis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Renal failure,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Sepsis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Stasis dermatitis,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Substance-induced psychotic disorder,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
1578879411,15788794,117,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q3,Transplantation complication,,2020,Q3,11,F,20170321.0,20200820.0,20190104,20200826,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20200826.0,,MD,JP,JP,2020,Q3,Adult
158643975,15864397,22,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,100 DOSAGE FORM (DOSE OF 30 U AT BEDTIME),,,D,,,,,100.0,DF,,,2020,Q3,Blood glucose increased,,2020,Q3,5,F,,20200909.0,20190124,20200917,EXP,,PL-MYLANLABS-2018M1048528,MYLAN,,63.0,YR,,F,Y,86.5,KG,20200917.0,,HP,PL,PL,2020,Q3,Adult
158643975,15864397,22,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,100 DOSAGE FORM (DOSE OF 30 U AT BEDTIME),,,D,,,,,100.0,DF,,,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,,20200909.0,20190124,20200917,EXP,,PL-MYLANLABS-2018M1048528,MYLAN,,63.0,YR,,F,Y,86.5,KG,20200917.0,,HP,PL,PL,2020,Q3,Adult
158643975,15864397,23,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"30 INTERNATIONAL UNIT, QD",,,D,,,,,30.0,IU,,QD,2020,Q3,Blood glucose increased,,2020,Q3,5,F,,20200909.0,20190124,20200917,EXP,,PL-MYLANLABS-2018M1048528,MYLAN,,63.0,YR,,F,Y,86.5,KG,20200917.0,,HP,PL,PL,2020,Q3,Adult
158643975,15864397,23,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"30 INTERNATIONAL UNIT, QD",,,D,,,,,30.0,IU,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,,20200909.0,20190124,20200917,EXP,,PL-MYLANLABS-2018M1048528,MYLAN,,63.0,YR,,F,Y,86.5,KG,20200917.0,,HP,PL,PL,2020,Q3,Adult
159535678,15953567,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Arthralgia,,2020,Q3,8,F,,20200720.0,20190212,20200730,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200730.0,,MD,CA,CA,2020,Q3,Adult
159535678,15953567,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,8,F,,20200720.0,20190212,20200730,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200730.0,,MD,CA,CA,2020,Q3,Adult
159535678,15953567,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,8,F,,20200720.0,20190212,20200730,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200730.0,,MD,CA,CA,2020,Q3,Adult
159535678,15953567,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Gait inability,,2020,Q3,8,F,,20200720.0,20190212,20200730,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200730.0,,MD,CA,CA,2020,Q3,Adult
159535678,15953567,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Headache,,2020,Q3,8,F,,20200720.0,20190212,20200730,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200730.0,,MD,CA,CA,2020,Q3,Adult
159535678,15953567,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Hypoaesthesia,,2020,Q3,8,F,,20200720.0,20190212,20200730,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200730.0,,MD,CA,CA,2020,Q3,Adult
159535678,15953567,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Lower respiratory tract infection,,2020,Q3,8,F,,20200720.0,20190212,20200730,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200730.0,,MD,CA,CA,2020,Q3,Adult
159535678,15953567,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Pharyngitis,,2020,Q3,8,F,,20200720.0,20190212,20200730,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200730.0,,MD,CA,CA,2020,Q3,Adult
159535678,15953567,21,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Toothache,,2020,Q3,8,F,,20200720.0,20190212,20200730,EXP,,CA-PFIZER INC-2015154273,PFIZER,,42.0,YR,,F,Y,,,20200730.0,,MD,CA,CA,2020,Q3,Adult
161268044,16126804,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,Y,,,,,14.0,IU,,,2020,Q3,Hyponatraemia,,2020,Q3,4,F,201809.0,20200831.0,20190328,20200909,EXP,FR-EMA-DD-20181130-HV_A-102030,FR-ACCORD-115172,ACCORD,,71.0,YR,,F,Y,,,20200909.0,,PH,FR,FR,2020,Q3,Elderly
161268044,16126804,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD",,,Y,,,,,14.0,IU,,,2020,Q3,Inappropriate antidiuretic hormone secretion,,2020,Q3,4,F,201809.0,20200831.0,20190328,20200909,EXP,FR-EMA-DD-20181130-HV_A-102030,FR-ACCORD-115172,ACCORD,,71.0,YR,,F,Y,,,20200909.0,,PH,FR,FR,2020,Q3,Elderly
161466514,16146651,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Injection site pain,,2020,Q3,4,F,20170910.0,20190909.0,20190402,20200723,EXP,,JP-CLINIGEN GROUP PLC/ CLINIGEN HEALTHCARE LTD-JP-CLGN-19-00252,CLINIGEN,TAKAHASHI Y. CLINICAL EFFICACY OF DEXRAZOXANE IN THE TREATMENT OF ANTHRACYCLINE?INDUCED EXTRAVASATION. THE 17TH JAPANESE SOCIETY OF MEDICAL ONCOLOGY ANNUAL MEETING.,57.0,YR,,M,Y,70.1,KG,20200723.0,,,COUNTRY NOT SPECIFIED,JP,2020,Q3,Adult
161466514,16146651,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Myelosuppression,,2020,Q3,4,F,20170910.0,20190909.0,20190402,20200723,EXP,,JP-CLINIGEN GROUP PLC/ CLINIGEN HEALTHCARE LTD-JP-CLGN-19-00252,CLINIGEN,TAKAHASHI Y. CLINICAL EFFICACY OF DEXRAZOXANE IN THE TREATMENT OF ANTHRACYCLINE?INDUCED EXTRAVASATION. THE 17TH JAPANESE SOCIETY OF MEDICAL ONCOLOGY ANNUAL MEETING.,57.0,YR,,M,Y,70.1,KG,20200723.0,,,COUNTRY NOT SPECIFIED,JP,2020,Q3,Adult
161466514,16146651,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Staphylococcal sepsis,,2020,Q3,4,F,20170910.0,20190909.0,20190402,20200723,EXP,,JP-CLINIGEN GROUP PLC/ CLINIGEN HEALTHCARE LTD-JP-CLGN-19-00252,CLINIGEN,TAKAHASHI Y. CLINICAL EFFICACY OF DEXRAZOXANE IN THE TREATMENT OF ANTHRACYCLINE?INDUCED EXTRAVASATION. THE 17TH JAPANESE SOCIETY OF MEDICAL ONCOLOGY ANNUAL MEETING.,57.0,YR,,M,Y,70.1,KG,20200723.0,,,COUNTRY NOT SPECIFIED,JP,2020,Q3,Adult
161650694,16165069,52,C,Glargine,INSULIN GLARGINE,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,40.0,IU,UNKNOWN,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,4,F,20190321.0,20200302.0,20190405,20200309,EXP,,US-CELGENEUS-USA-20190401435,CELGENE,,64.0,YR,,F,Y,82.9,KG,20200309.0,,HP,US,US,2020,Q3,Adult
161997669,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2020,Q3,Cutaneous sarcoidosis,,2020,Q3,9,F,20190404.0,20200921.0,20190415,20200928,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200928.0,,HP,BR,BR,2020,Q3,Elderly
161997669,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2020,Q3,Epiglottic oedema,,2020,Q3,9,F,20190404.0,20200921.0,20190415,20200928,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200928.0,,HP,BR,BR,2020,Q3,Elderly
161997669,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2020,Q3,Sarcoidosis,,2020,Q3,9,F,20190404.0,20200921.0,20190415,20200928,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200928.0,,HP,BR,BR,2020,Q3,Elderly
161997669,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Cutaneous sarcoidosis,,2020,Q3,9,F,20190404.0,20200921.0,20190415,20200928,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200928.0,,HP,BR,BR,2020,Q3,Elderly
161997669,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Epiglottic oedema,,2020,Q3,9,F,20190404.0,20200921.0,20190415,20200928,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200928.0,,HP,BR,BR,2020,Q3,Elderly
161997669,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q3,Sarcoidosis,,2020,Q3,9,F,20190404.0,20200921.0,20190415,20200928,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20200928.0,,HP,BR,BR,2020,Q3,Elderly
162066043,16206604,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Body mass index increased,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Latent autoimmune diabetes in adults,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Postprandial hypoglycaemia,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"30 DOSAGE FORM, ONCE A DAY(30 U, QD, IN THE MORNING)",,,,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"30 DOSAGE FORM, ONCE A DAY(30 U, QD, IN THE MORNING)",,,,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2020,Q3,Body mass index increased,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"30 DOSAGE FORM, ONCE A DAY(30 U, QD, IN THE MORNING)",,,,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2020,Q3,Drug ineffective,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"30 DOSAGE FORM, ONCE A DAY(30 U, QD, IN THE MORNING)",,,,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"30 DOSAGE FORM, ONCE A DAY(30 U, QD, IN THE MORNING)",,,,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"30 DOSAGE FORM, ONCE A DAY(30 U, QD, IN THE MORNING)",,,,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2020,Q3,Latent autoimmune diabetes in adults,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162066043,16206604,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"30 DOSAGE FORM, ONCE A DAY(30 U, QD, IN THE MORNING)",,,,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2020,Q3,Postprandial hypoglycaemia,,2020,Q3,3,F,,20200916.0,20190417,20200923,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,,52.0,YR,,F,Y,,,20200923.0,,HP,PT,PT,2020,Q3,Adult
162222192,16222219,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, QN",,,,,,,,4.0,IU,,,2020,Q3,Forearm fracture,,2020,Q3,2,F,20190409.0,20200819.0,20190422,20200828,PER,,CN-AMGEN-CHNCT2019060944,AMGEN,,66.0,YR,E,M,Y,,,20200828.0,,MD,CN,CN,2020,Q3,Elderly
162366032,16236603,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,INJECTION,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,2,F,20181004.0,20200910.0,20190425,20200922,EXP,,US-JNJFOC-20190417427,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,,,20200922.0,,HP,US,US,2020,Q3,Adult
162366032,16236603,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,INJECTION,,2020,Q3,Metabolic encephalopathy,,2020,Q3,2,F,20181004.0,20200910.0,20190425,20200922,EXP,,US-JNJFOC-20190417427,JOHNSON AND JOHNSON,,46.0,YR,A,F,Y,,,20200922.0,,HP,US,US,2020,Q3,Adult
1625331215,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q3,Bronchitis,,2020,Q3,15,F,20190404.0,20200625.0,20190429,20200701,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ?:?.",74.0,YR,,M,Y,70.0,KG,20200701.0,,MD,JP,JP,2020,Q3,Elderly
1625331215,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q3,Interstitial lung disease,,2020,Q3,15,F,20190404.0,20200625.0,20190429,20200701,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ?:?.",74.0,YR,,M,Y,70.0,KG,20200701.0,,MD,JP,JP,2020,Q3,Elderly
1625331215,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q3,Myasthenia gravis,,2020,Q3,15,F,20190404.0,20200625.0,20190429,20200701,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ?:?.",74.0,YR,,M,Y,70.0,KG,20200701.0,,MD,JP,JP,2020,Q3,Elderly
1625331215,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q3,Myositis,,2020,Q3,15,F,20190404.0,20200625.0,20190429,20200701,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ?:?.",74.0,YR,,M,Y,70.0,KG,20200701.0,,MD,JP,JP,2020,Q3,Elderly
1625331215,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q3,Platelet count decreased,,2020,Q3,15,F,20190404.0,20200625.0,20190429,20200701,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ?:?.",74.0,YR,,M,Y,70.0,KG,20200701.0,,MD,JP,JP,2020,Q3,Elderly
1625331215,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q3,Pneumonia staphylococcal,,2020,Q3,15,F,20190404.0,20200625.0,20190429,20200701,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ?:?.",74.0,YR,,M,Y,70.0,KG,20200701.0,,MD,JP,JP,2020,Q3,Elderly
1625331215,16253312,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ON 10/APR/2019, HE RECEIVED MOST RECENT DOSE OF INSULIN GLARGINE",,,Y,, UNKNOWN,,,23.0,IU,,,2020,Q3,Pyrexia,,2020,Q3,15,F,20190404.0,20200625.0,20190429,20200701,EXP,,JP-ROCHE-2309849,ROCHE,"CHOJI T, MORINAGA D, HATTORI T, ET AL. A CASE OF PRIMARY LUNG CANCER WHO DIED OF CONCOMITANT MYASTHENIA GRAVIS AND INTERSTITIAL LUNG DISEASE EARLY AFTER ADMINISTRATION OF ATEZOLIZUMAB. THE 99TH HOKKAIDO MEDICAL CONGRESS, LUNG CANCER AND RESPIRATORY ENDOSCOPY JOINT COMMITTEE (THE 45TH HOKKAIDO BRANCH MEETING OF THE JAPAN LUNG CANCER SOCIETY) ?:?.",74.0,YR,,M,Y,70.0,KG,20200701.0,,MD,JP,JP,2020,Q3,Elderly
162732392,16273239,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Hypoglycaemic unconsciousness,,2020,Q3,2,F,,20200802.0,20190506,20200813,EXP,,CA-APOTEX-2019AP012973,APOTEX,,53.0,YR,,F,Y,93.0,KG,20200813.0,,CN,CA,CA,2020,Q3,Adult
163621186,16362118,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"100 E/ML, QD",,,,,,,,,,,QD,2020,Q3,Ankle fracture,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163621186,16362118,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"100 E/ML, QD",,,,,,,,,,,QD,2020,Q3,Herpes zoster,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163621186,16362118,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"100 E/ML, QD",,,,,,,,,,,QD,2020,Q3,Impaired healing,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163621186,16362118,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"100 E/ML, QD",,,,,,,,,,,QD,2020,Q3,Influenza like illness,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163621186,16362118,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"100 E/ML, QD",,,,,,,,,,,QD,2020,Q3,Musculoskeletal discomfort,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163621186,16362118,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,300E=3ML,,,,,,,,,,,,2020,Q3,Ankle fracture,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163621186,16362118,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,300E=3ML,,,,,,,,,,,,2020,Q3,Herpes zoster,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163621186,16362118,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,300E=3ML,,,,,,,,,,,,2020,Q3,Impaired healing,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163621186,16362118,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,300E=3ML,,,,,,,,,,,,2020,Q3,Influenza like illness,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163621186,16362118,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,300E=3ML,,,,,,,,,,,,2020,Q3,Musculoskeletal discomfort,,2020,Q3,6,F,2018.0,20200811.0,20190528,20200825,PER,,NL-AMGEN-NLDSL2019076993,AMGEN,,72.0,YR,E,M,Y,,,20200825.0,,CN,NL,NL,2020,Q3,Elderly
163699746,16369974,68,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Mucosal inflammation,,2020,Q3,6,F,20190517.0,20191220.0,20190530,20191224,EXP,,IT-ROCHE-2326430,ROCHE,,56.0,YR,,F,Y,67.0,KG,20191225.0,,MD,IT,IT,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Anaemia,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Arthralgia,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Asthenia,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Back pain,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Cardio-respiratory arrest,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Chest pain,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Condition aggravated,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Dizziness,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Dyspnoea,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Fall,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Fatigue,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Feeling abnormal,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Fluid retention,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Gingival discolouration,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Haemoglobin decreased,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Headache,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Hypoaesthesia,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Medical procedure,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Nausea,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Neck pain,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Neuropathy peripheral,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Pain,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Pain in extremity,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Pain in jaw,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Pallor,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Peripheral swelling,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Procedural complication,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Pulmonary mass,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Spinal osteoarthritis,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Transfusion,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164172406,16417240,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,40 UNITS QPM,,,,,,,,,,,QD,2020,Q3,Transient ischaemic attack,,2020,Q3,6,F,201902.0,20200717.0,20190611,20200730,EXP,,US-ACTELION-A-NJ2019-188104,ACTELION,,63.0,YR,,F,Y,98.41,KG,20200730.0,,MD,US,US,2020,Q3,Adult
164248063,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Anhedonia,,2020,Q3,3,F,201001.0,20200723.0,20190613,20200729,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,78.01,KG,20200729.0,,CN,US,US,2020,Q3,Adult
164248063,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Anxiety,,2020,Q3,3,F,201001.0,20200723.0,20190613,20200729,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,78.01,KG,20200729.0,,CN,US,US,2020,Q3,Adult
164248063,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,3,F,201001.0,20200723.0,20190613,20200729,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,78.01,KG,20200729.0,,CN,US,US,2020,Q3,Adult
164248063,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Economic problem,,2020,Q3,3,F,201001.0,20200723.0,20190613,20200729,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,78.01,KG,20200729.0,,CN,US,US,2020,Q3,Adult
164248063,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Emotional distress,,2020,Q3,3,F,201001.0,20200723.0,20190613,20200729,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,78.01,KG,20200729.0,,CN,US,US,2020,Q3,Adult
164248063,16424806,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Pain,,2020,Q3,3,F,201001.0,20200723.0,20190613,20200729,EXP,,US-GILEAD-2019-0413086,GILEAD,,47.0,YR,A,M,Y,78.01,KG,20200729.0,,CN,US,US,2020,Q3,Adult
1656848115,16568481,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,15,F,20190610.0,20200724.0,20190712,20200731,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20200731.0,,MD,FR,FR,2020,Q3,Elderly
1656848115,16568481,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Angina pectoris,,2020,Q3,15,F,20190610.0,20200724.0,20190712,20200731,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20200731.0,,MD,FR,FR,2020,Q3,Elderly
1656848115,16568481,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Cytomegalovirus test positive,,2020,Q3,15,F,20190610.0,20200724.0,20190712,20200731,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20200731.0,,MD,FR,FR,2020,Q3,Elderly
1656848115,16568481,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Endocarditis,,2020,Q3,15,F,20190610.0,20200724.0,20190712,20200731,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20200731.0,,MD,FR,FR,2020,Q3,Elderly
1656848115,16568481,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,15,F,20190610.0,20200724.0,20190712,20200731,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20200731.0,,MD,FR,FR,2020,Q3,Elderly
1656848115,16568481,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,15,F,20190610.0,20200724.0,20190712,20200731,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20200731.0,,MD,FR,FR,2020,Q3,Elderly
1656848115,16568481,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Skin ulcer,,2020,Q3,15,F,20190610.0,20200724.0,20190712,20200731,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20200731.0,,MD,FR,FR,2020,Q3,Elderly
1656848115,16568481,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Tooth abscess,,2020,Q3,15,F,20190610.0,20200724.0,20190712,20200731,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20200731.0,,MD,FR,FR,2020,Q3,Elderly
1656848115,16568481,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,15,F,20190610.0,20200724.0,20190712,20200731,EXP,,PHHY2019FR161521,NOVARTIS,,74.0,YR,,M,Y,88.0,KG,20200731.0,,MD,FR,FR,2020,Q3,Elderly
1670542713,16705427,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4 UNIT,,,U,,,,,4.0,DF,,,2020,Q3,Blood glucose increased,,2020,Q3,13,F,20190411.0,20200911.0,20190815,20200917,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-066927,BRISTOL MYERS SQUIBB,"HORIE M,ET AL. A CASE OF DEPLETION OF INSULIN SECRETION CAPACITY AFTER NIVOLUMAB/IPILIMUMAB ADMINISTRATION IN A PATIENT WITH SLOWLY PROGRESSIVE TYPE 1 DIABETES MELLITUS. THE 57TH CHUGOKU?SHIKOKU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY. 2019?1?B?20",54.0,YR,,M,Y,49.1,KG,20200917.0,,MD,JP,JP,2020,Q3,Adult
1670542713,16705427,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4 UNIT,,,U,,,,,4.0,DF,,,2020,Q3,Hypophysitis,,2020,Q3,13,F,20190411.0,20200911.0,20190815,20200917,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-066927,BRISTOL MYERS SQUIBB,"HORIE M,ET AL. A CASE OF DEPLETION OF INSULIN SECRETION CAPACITY AFTER NIVOLUMAB/IPILIMUMAB ADMINISTRATION IN A PATIENT WITH SLOWLY PROGRESSIVE TYPE 1 DIABETES MELLITUS. THE 57TH CHUGOKU?SHIKOKU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY. 2019?1?B?20",54.0,YR,,M,Y,49.1,KG,20200917.0,,MD,JP,JP,2020,Q3,Adult
1670542713,16705427,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4 UNIT,,,U,,,,,4.0,DF,,,2020,Q3,Impaired insulin secretion,,2020,Q3,13,F,20190411.0,20200911.0,20190815,20200917,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-066927,BRISTOL MYERS SQUIBB,"HORIE M,ET AL. A CASE OF DEPLETION OF INSULIN SECRETION CAPACITY AFTER NIVOLUMAB/IPILIMUMAB ADMINISTRATION IN A PATIENT WITH SLOWLY PROGRESSIVE TYPE 1 DIABETES MELLITUS. THE 57TH CHUGOKU?SHIKOKU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY. 2019?1?B?20",54.0,YR,,M,Y,49.1,KG,20200917.0,,MD,JP,JP,2020,Q3,Adult
1670542713,16705427,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,4 UNIT,,,U,,,,,4.0,DF,,,2020,Q3,Prescribed overdose,,2020,Q3,13,F,20190411.0,20200911.0,20190815,20200917,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-066927,BRISTOL MYERS SQUIBB,"HORIE M,ET AL. A CASE OF DEPLETION OF INSULIN SECRETION CAPACITY AFTER NIVOLUMAB/IPILIMUMAB ADMINISTRATION IN A PATIENT WITH SLOWLY PROGRESSIVE TYPE 1 DIABETES MELLITUS. THE 57TH CHUGOKU?SHIKOKU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY. 2019?1?B?20",54.0,YR,,M,Y,49.1,KG,20200917.0,,MD,JP,JP,2020,Q3,Adult
167375117,16737511,59,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,"40 U, DAILY",,,,,,,,,,UNKNOWN,,2020,Q3,Urinary tract infection,,2020,Q3,7,F,20190812.0,20200828.0,20190823,20200904,PER,,US-CELGENEUS-USA-20190807985,CELGENE,,64.0,YR,,F,Y,82.9,KG,20200904.0,,HP,US,US,2020,Q3,Adult
167405724,16740572,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0.07 ML, 1X/DAY (0.07 MLS (7 UNITS TOTAL) UNDER THE SKIN NIGHTLY)",,,,,,,,0.07,ML,,QD,2020,Q3,Liver disorder,,2020,Q3,4,F,20190306.0,20200904.0,20190826,20200908,PER,,US-PFIZER INC-2019363225,PFIZER,,88.0,YR,,F,Y,56.69,KG,20200908.0,,HP,US,US,2020,Q3,Elderly
167405724,16740572,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"0.07 ML, 1X/DAY (0.07 MLS (7 UNITS TOTAL) UNDER THE SKIN NIGHTLY)",,,,,,,,0.07,ML,,QD,2020,Q3,Product dose omission issue,,2020,Q3,4,F,20190306.0,20200904.0,20190826,20200908,PER,,US-PFIZER INC-2019363225,PFIZER,,88.0,YR,,F,Y,56.69,KG,20200908.0,,HP,US,US,2020,Q3,Elderly
168103208,16810320,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,8,F,,20200714.0,20190916,20200716,EXP,,US-PFIZER INC-2019389734,PFIZER,,69.0,YR,,F,Y,117.9,KG,20200716.0,,CN,US,US,2020,Q3,Elderly
168103208,16810320,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,8,F,,20200714.0,20190916,20200716,EXP,,US-PFIZER INC-2019389734,PFIZER,,69.0,YR,,F,Y,117.9,KG,20200716.0,,CN,US,US,2020,Q3,Elderly
168103208,16810320,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,8,F,,20200714.0,20190916,20200716,EXP,,US-PFIZER INC-2019389734,PFIZER,,69.0,YR,,F,Y,117.9,KG,20200716.0,,CN,US,US,2020,Q3,Elderly
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Anhedonia,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Anxiety,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Decreased activity,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Economic problem,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Emotional distress,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,End stage renal disease,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Fatigue,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Loss of employment,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Loss of personal independence in daily activities,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Mobility decreased,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Pain,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Quality of life decreased,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168378442,16837844,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Social problem,,2020,Q3,2,F,20081008.0,20200712.0,20190923,20200717,EXP,,US-GILEAD-2019-0429262,GILEAD,,38.0,YR,A,M,Y,99.77,KG,20200717.0,,CN,US,US,2020,Q3,Adult
168714301,16871430,7,C,Insulin glargine 22 Units,,2,,,,,,,,,,,,,,2020,Q3,Gastritis erosive,,2020,Q3,1,I,20190729.0,,20190923,20190923,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20190923.0,N,PH,US,US,2020,Q3,Adult
168714301,16871430,7,C,Insulin glargine 22 Units,,2,,,,,,,,,,,,,,2020,Q3,Ulcerative gastritis,,2020,Q3,1,I,20190729.0,,20190923,20190923,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20190923.0,N,PH,US,US,2020,Q3,Adult
168905112,16890511,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12?10 UNIT,,,,,,,,,,UNKNOWN,,2020,Q3,Diabetic foot,,2020,Q3,2,F,20190515.0,20191017.0,20191007,20191030,EXP,,CN-JNJFOC-20190702846,JOHNSON AND JOHNSON,,63.0,YR,,M,Y,64.0,KG,20191030.0,,MD,CN,CN,2020,Q3,Adult
169324972,16932497,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Leukopenia,,2020,Q3,2,F,20190723.0,20200917.0,20191017,20200921,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20200921.0,,MD,PL,PL,2020,Q3,Adult
169324972,16932497,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,2,F,20190723.0,20200917.0,20191017,20200921,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20200921.0,,MD,PL,PL,2020,Q3,Adult
169385035,16938503,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,5,F,20190903.0,20200814.0,20191019,20200817,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200817.0,,HP,US,US,2020,Q3,Adult
169385035,16938503,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,5,F,20190903.0,20200814.0,20191019,20200817,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200817.0,,HP,US,US,2020,Q3,Adult
169385035,16938503,29,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,5,F,20190903.0,20200814.0,20191019,20200817,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20200817.0,,HP,US,US,2020,Q3,Adult
169387556,16938755,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 U/ML, Q24H (!5 UNIT)",,,U,,,,,,,INJECTION,,2020,Q3,Acute respiratory failure,,2020,Q3,6,F,20191010.0,20200810.0,20191020,20200817,EXP,,NVSC2019US004865,NOVARTIS,,70.0,YR,,M,Y,87.08,KG,20200817.0,,CN,US,US,2020,Q3,Elderly
169387556,16938755,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 U/ML, Q24H (!5 UNIT)",,,U,,,,,,,INJECTION,,2020,Q3,Bronchitis,,2020,Q3,6,F,20191010.0,20200810.0,20191020,20200817,EXP,,NVSC2019US004865,NOVARTIS,,70.0,YR,,M,Y,87.08,KG,20200817.0,,CN,US,US,2020,Q3,Elderly
169387556,16938755,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 U/ML, Q24H (!5 UNIT)",,,U,,,,,,,INJECTION,,2020,Q3,Cardiac failure congestive,,2020,Q3,6,F,20191010.0,20200810.0,20191020,20200817,EXP,,NVSC2019US004865,NOVARTIS,,70.0,YR,,M,Y,87.08,KG,20200817.0,,CN,US,US,2020,Q3,Elderly
169387556,16938755,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 U/ML, Q24H (!5 UNIT)",,,U,,,,,,,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,6,F,20191010.0,20200810.0,20191020,20200817,EXP,,NVSC2019US004865,NOVARTIS,,70.0,YR,,M,Y,87.08,KG,20200817.0,,CN,US,US,2020,Q3,Elderly
169387556,16938755,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 U/ML, Q24H (!5 UNIT)",,,U,,,,,,,INJECTION,,2020,Q3,Fluid retention,,2020,Q3,6,F,20191010.0,20200810.0,20191020,20200817,EXP,,NVSC2019US004865,NOVARTIS,,70.0,YR,,M,Y,87.08,KG,20200817.0,,CN,US,US,2020,Q3,Elderly
169387556,16938755,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 U/ML, Q24H (!5 UNIT)",,,U,,,,,,,INJECTION,,2020,Q3,Pneumonia,,2020,Q3,6,F,20191010.0,20200810.0,20191020,20200817,EXP,,NVSC2019US004865,NOVARTIS,,70.0,YR,,M,Y,87.08,KG,20200817.0,,CN,US,US,2020,Q3,Elderly
169387556,16938755,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 U/ML, Q24H (!5 UNIT)",,,U,,,,,,,INJECTION,,2020,Q3,Respiratory failure,,2020,Q3,6,F,20191010.0,20200810.0,20191020,20200817,EXP,,NVSC2019US004865,NOVARTIS,,70.0,YR,,M,Y,87.08,KG,20200817.0,,CN,US,US,2020,Q3,Elderly
169387556,16938755,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 U/ML, Q24H (!5 UNIT)",,,U,,,,,,,INJECTION,,2020,Q3,Swelling,,2020,Q3,6,F,20191010.0,20200810.0,20191020,20200817,EXP,,NVSC2019US004865,NOVARTIS,,70.0,YR,,M,Y,87.08,KG,20200817.0,,CN,US,US,2020,Q3,Elderly
169403944,16940394,11,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,(),,,U,,,,,,,,,2020,Q3,Parkinsonism,,2020,Q3,4,F,201812.0,20200826.0,20191021,20200909,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-224321,RANBAXY,,65.0,YR,,M,Y,88.0,KG,20200909.0,,HP,NL,FR,2020,Q3,Elderly
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase abnormal,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Biopsy thyroid gland,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Bronchitis,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Catheterisation cardiac,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Dialysis,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Disseminated intravascular coagulation,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Fascial operation,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Hepatic infarction,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Lactic acidosis,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Liver transplant,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Liver transplant failure,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Magnetic resonance imaging liver abnormal,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Metastases to liver,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Multiple organ dysfunction syndrome,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Pulmonary embolism,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Pulmonary oedema,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Renal failure,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Tachycardia,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Thyroid mass,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
171227519,17122751,34,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Transplant evaluation,,2020,Q3,9,F,20190711.0,20200817.0,20191206,20200824,EXP,,DE-ACTELION-A-CH2019-193369,ACTELION,,42.0,YR,,F,Y,77.0,KG,20200824.0,,MD,DE,DE,2020,Q3,Adult
172047453,17204745,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,INJECTION,,2020,Q3,Organising pneumonia,,2020,Q3,3,F,20190130.0,20200707.0,20191226,20200714,PER,,JP-AMGEN-JPNCT2019214409,AMGEN,,70.0,YR,E,M,Y,,,20200714.0,,HP,JP,JP,2020,Q3,Elderly
172074813,17207481,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Abscess limb,,2020,Q3,3,F,20191210.0,20200722.0,20191227,20200731,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20200731.0,,CN,JP,JP,2020,Q3,Elderly
172074813,17207481,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Blood pressure decreased,,2020,Q3,3,F,20191210.0,20200722.0,20191227,20200731,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20200731.0,,CN,JP,JP,2020,Q3,Elderly
172074813,17207481,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Cellulitis,,2020,Q3,3,F,20191210.0,20200722.0,20191227,20200731,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20200731.0,,CN,JP,JP,2020,Q3,Elderly
172074813,17207481,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Cerebral infarction,,2020,Q3,3,F,20191210.0,20200722.0,20191227,20200731,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20200731.0,,CN,JP,JP,2020,Q3,Elderly
172074813,17207481,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Erythema,,2020,Q3,3,F,20191210.0,20200722.0,20191227,20200731,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20200731.0,,CN,JP,JP,2020,Q3,Elderly
172074813,17207481,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Immobilisation syndrome,,2020,Q3,3,F,20191210.0,20200722.0,20191227,20200731,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20200731.0,,CN,JP,JP,2020,Q3,Elderly
172074813,17207481,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Pain,,2020,Q3,3,F,20191210.0,20200722.0,20191227,20200731,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20200731.0,,CN,JP,JP,2020,Q3,Elderly
172074813,17207481,16,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,3,F,20191210.0,20200722.0,20191227,20200731,EXP,,NVSJ2019JP006136,NOVARTIS,,81.0,YR,,M,Y,58.4,KG,20200731.0,,CN,JP,JP,2020,Q3,Elderly
173306633,17330663,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,INJECTION,QD,2020,Q3,Lymphocyte count decreased,,2020,Q3,3,F,20200120.0,20200203.0,20200128,20200210,PER,,US-CELGENEUS-USA-20200108615,CELGENE,,60.0,YR,,M,Y,72.8,KG,20200210.0,,MD,US,US,2020,Q3,Adult
173306633,17330663,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,INJECTION,QD,2020,Q3,Neutrophil count decreased,,2020,Q3,3,F,20200120.0,20200203.0,20200128,20200210,PER,,US-CELGENEUS-USA-20200108615,CELGENE,,60.0,YR,,M,Y,72.8,KG,20200210.0,,MD,US,US,2020,Q3,Adult
173306633,17330663,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,INJECTION,QD,2020,Q3,Platelet count decreased,,2020,Q3,3,F,20200120.0,20200203.0,20200128,20200210,PER,,US-CELGENEUS-USA-20200108615,CELGENE,,60.0,YR,,M,Y,72.8,KG,20200210.0,,MD,US,US,2020,Q3,Adult
173306633,17330663,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,25 UNITS,,,,,,,,,,INJECTION,QD,2020,Q3,White blood cell count decreased,,2020,Q3,3,F,20200120.0,20200203.0,20200128,20200210,PER,,US-CELGENEUS-USA-20200108615,CELGENE,,60.0,YR,,M,Y,72.8,KG,20200210.0,,MD,US,US,2020,Q3,Adult
174008455,17400845,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2020,Q3,Ear haemorrhage,,2020,Q3,5,F,2020.0,20200727.0,20200211,20200803,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20200803.0,,HP,US,US,2020,Q3,Elderly
174008455,17400845,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2020,Q3,Off label use,,2020,Q3,5,F,2020.0,20200727.0,20200211,20200803,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20200803.0,,HP,US,US,2020,Q3,Elderly
174062272,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q3,Arthralgia,,2020,Q3,2,F,202001.0,20200203.0,20200212,20200717,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200717.0,,HP,US,US,2020,Q3,Elderly
174062272,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q3,Contusion,,2020,Q3,2,F,202001.0,20200203.0,20200212,20200717,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200717.0,,HP,US,US,2020,Q3,Elderly
174062272,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q3,Dizziness,,2020,Q3,2,F,202001.0,20200203.0,20200212,20200717,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200717.0,,HP,US,US,2020,Q3,Elderly
174062272,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q3,Ear infection,,2020,Q3,2,F,202001.0,20200203.0,20200212,20200717,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200717.0,,HP,US,US,2020,Q3,Elderly
174062272,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,2,F,202001.0,20200203.0,20200212,20200717,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200717.0,,HP,US,US,2020,Q3,Elderly
174062272,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q3,Musculoskeletal chest pain,,2020,Q3,2,F,202001.0,20200203.0,20200212,20200717,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200717.0,,HP,US,US,2020,Q3,Elderly
174062272,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q3,Pain in extremity,,2020,Q3,2,F,202001.0,20200203.0,20200212,20200717,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200717.0,,HP,US,US,2020,Q3,Elderly
174062272,17406227,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2020,Q3,Rib fracture,,2020,Q3,2,F,202001.0,20200203.0,20200212,20200717,EXP,,US-BEH-2020112679,CSL BEHRING,,68.0,YR,E,M,Y,98.87,KG,20200717.0,,HP,US,US,2020,Q3,Elderly
174178902,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood cholesterol increased,,2020,Q3,2,F,,20200203.0,20200213,20200822,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200823.0,,PH,ES,ES,2020,Q3,Elderly
174178902,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood triglycerides increased,,2020,Q3,2,F,,20200203.0,20200213,20200822,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200823.0,,PH,ES,ES,2020,Q3,Elderly
174178902,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Fatigue,,2020,Q3,2,F,,20200203.0,20200213,20200822,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200823.0,,PH,ES,ES,2020,Q3,Elderly
174178902,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hyperglycaemia,,2020,Q3,2,F,,20200203.0,20200213,20200822,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200823.0,,PH,ES,ES,2020,Q3,Elderly
174178902,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,,20200203.0,20200213,20200822,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200823.0,,PH,ES,ES,2020,Q3,Elderly
174178902,17417890,17,SS,Insulin glargine,INSULIN GLARGINE,1,,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Off label use,,2020,Q3,2,F,,20200203.0,20200213,20200822,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20200823.0,,PH,ES,ES,2020,Q3,Elderly
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Abdominal pain,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Blood growth hormone increased,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Bone pain,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Depression,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Dizziness,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Dysuria,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Headache,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Hypertension,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Hypotension,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Illness,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Neoplasm progression,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Off label use,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Pelvic pain,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174194272,17419427,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,12.0,IU,,,2020,Q3,Thyroid disorder,,2020,Q3,2,F,2002.0,20200703.0,20200214,20200712,EXP,,CO-EMD SERONO-9144845,EMD SERONO INC,,45.0,YR,,F,Y,67.0,KG,20200712.0,,CN,CO,CO,2020,Q3,Adult
174226463,17422646,9,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,20.0,IU,,QD,2020,Q3,Erythema multiforme,,2020,Q3,3,F,20190610.0,20200305.0,20200215,20200310,EXP,,ES-AUROBINDO-AUR-APL-2020-007283,AUROBINDO,,73.0,YR,,F,Y,,,20200310.0,,HP,ES,ES,2020,Q3,Elderly
174226463,17422646,9,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,20.0,IU,,QD,2020,Q3,Pyrexia,,2020,Q3,3,F,20190610.0,20200305.0,20200215,20200310,EXP,,ES-AUROBINDO-AUR-APL-2020-007283,AUROBINDO,,73.0,YR,,F,Y,,,20200310.0,,HP,ES,ES,2020,Q3,Elderly
174226463,17422646,9,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,U,U,,,,20.0,IU,,QD,2020,Q3,Toxic skin eruption,,2020,Q3,3,F,20190610.0,20200305.0,20200215,20200310,EXP,,ES-AUROBINDO-AUR-APL-2020-007283,AUROBINDO,,73.0,YR,,F,Y,,,20200310.0,,HP,ES,ES,2020,Q3,Elderly
174226463,17422646,15,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,20.0,IU,,QD,2020,Q3,Erythema multiforme,,2020,Q3,3,F,20190610.0,20200305.0,20200215,20200310,EXP,,ES-AUROBINDO-AUR-APL-2020-007283,AUROBINDO,,73.0,YR,,F,Y,,,20200310.0,,HP,ES,ES,2020,Q3,Elderly
174226463,17422646,15,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,20.0,IU,,QD,2020,Q3,Pyrexia,,2020,Q3,3,F,20190610.0,20200305.0,20200215,20200310,EXP,,ES-AUROBINDO-AUR-APL-2020-007283,AUROBINDO,,73.0,YR,,F,Y,,,20200310.0,,HP,ES,ES,2020,Q3,Elderly
174226463,17422646,15,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,20.0,IU,,QD,2020,Q3,Toxic skin eruption,,2020,Q3,3,F,20190610.0,20200305.0,20200215,20200310,EXP,,ES-AUROBINDO-AUR-APL-2020-007283,AUROBINDO,,73.0,YR,,F,Y,,,20200310.0,,HP,ES,ES,2020,Q3,Elderly
174293757,17429375,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UI/ML, 22 UI, QD",,,,,,,,,,,,2020,Q3,Breast cellulitis,,2020,Q3,7,F,20200205.0,20200702.0,20200218,20200708,EXP,,NVSC2020US035444,NOVARTIS,,48.0,YR,,F,Y,101.0,KG,20200708.0,,HP,US,US,2020,Q3,Adult
174293757,17429375,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UI/ML, 22 UI, QD",,,,,,,,,,,,2020,Q3,Cellulitis,,2020,Q3,7,F,20200205.0,20200702.0,20200218,20200708,EXP,,NVSC2020US035444,NOVARTIS,,48.0,YR,,F,Y,101.0,KG,20200708.0,,HP,US,US,2020,Q3,Adult
174293757,17429375,7,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 UI/ML, 22 UI, QD",,,,,,,,,,,,2020,Q3,Ureterolithiasis,,2020,Q3,7,F,20200205.0,20200702.0,20200218,20200708,EXP,,NVSC2020US035444,NOVARTIS,,48.0,YR,,F,Y,101.0,KG,20200708.0,,HP,US,US,2020,Q3,Adult
174871064,17487106,12,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,,,,,,,,QD,2020,Q3,Acute kidney injury,,2020,Q3,4,F,20200221.0,20200701.0,20200303,20200710,EXP,,JP-ROCHE-2560400,ROCHE,,66.0,YR,,F,Y,60.5,KG,20200710.0,,MD,JP,JP,2020,Q3,Elderly
174871064,17487106,12,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,,,,,,,,QD,2020,Q3,Decreased appetite,,2020,Q3,4,F,20200221.0,20200701.0,20200303,20200710,EXP,,JP-ROCHE-2560400,ROCHE,,66.0,YR,,F,Y,60.5,KG,20200710.0,,MD,JP,JP,2020,Q3,Elderly
174871064,17487106,12,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,,,,,,,,QD,2020,Q3,Dehydration,,2020,Q3,4,F,20200221.0,20200701.0,20200303,20200710,EXP,,JP-ROCHE-2560400,ROCHE,,66.0,YR,,F,Y,60.5,KG,20200710.0,,MD,JP,JP,2020,Q3,Elderly
174871064,17487106,12,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,20 UNITS,,,,,,,,,,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,4,F,20200221.0,20200701.0,20200303,20200710,EXP,,JP-ROCHE-2560400,ROCHE,,66.0,YR,,F,Y,60.5,KG,20200710.0,,MD,JP,JP,2020,Q3,Elderly
175246225,17524622,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,U,,,210605.0,20.0,IU,INJECTION,QD,2020,Q3,Erythema multiforme,,2020,Q3,5,F,20190610.0,20200721.0,20200310,20200727,EXP,,ES-MYLANLABS-2020M1025374,MYLAN,,73.0,YR,,F,Y,,,20200727.0,,CN,ES,ES,2020,Q3,Elderly
175246225,17524622,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,U,,,210605.0,20.0,IU,INJECTION,QD,2020,Q3,Pyrexia,,2020,Q3,5,F,20190610.0,20200721.0,20200310,20200727,EXP,,ES-MYLANLABS-2020M1025374,MYLAN,,73.0,YR,,F,Y,,,20200727.0,,CN,ES,ES,2020,Q3,Elderly
175246225,17524622,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,U,,,210605.0,20.0,IU,INJECTION,QD,2020,Q3,Toxic skin eruption,,2020,Q3,5,F,20190610.0,20200721.0,20200310,20200727,EXP,,ES-MYLANLABS-2020M1025374,MYLAN,,73.0,YR,,F,Y,,,20200727.0,,CN,ES,ES,2020,Q3,Elderly
175355118,17535511,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2020,Q3,Acute respiratory distress syndrome,,2020,Q3,8,F,20191223.0,20200716.0,20200312,20200724,EXP,,US-ABBVIE-19P-163-3211425-00,ABBVIE,,62.0,YR,,M,Y,86.0,KG,20200724.0,,MD,US,US,2020,Q3,Adult
175355118,17535511,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2020,Q3,Multiple organ dysfunction syndrome,,2020,Q3,8,F,20191223.0,20200716.0,20200312,20200724,EXP,,US-ABBVIE-19P-163-3211425-00,ABBVIE,,62.0,YR,,M,Y,86.0,KG,20200724.0,,MD,US,US,2020,Q3,Adult
175355118,17535511,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2020,Q3,Pneumonia klebsiella,,2020,Q3,8,F,20191223.0,20200716.0,20200312,20200724,EXP,,US-ABBVIE-19P-163-3211425-00,ABBVIE,,62.0,YR,,M,Y,86.0,KG,20200724.0,,MD,US,US,2020,Q3,Adult
175355118,17535511,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,10.0,DF,,QD,2020,Q3,Septic shock,,2020,Q3,8,F,20191223.0,20200716.0,20200312,20200724,EXP,,US-ABBVIE-19P-163-3211425-00,ABBVIE,,62.0,YR,,M,Y,86.0,KG,20200724.0,,MD,US,US,2020,Q3,Adult
175411841,17541184,9,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,U,,,,21081.0,60.0,IU,,QD,2020,Q3,Gingival disorder,,2020,Q3,1,I,,20200229.0,20200313,20200313,EXP,,US-SA-2020SA056994,SANOFI AVENTIS,"GOLOB DEEB J., LYONS D.J., LASKIN D.M., DEEB G.R.. SEVERE DRUG?INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020. 2020?6(1):UNKNOWN",52.0,YR,A,M,Y,,,20200313.0,,MD,US,US,2020,Q3,Adult
175411841,17541184,9,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,U,,,,21081.0,60.0,IU,,QD,2020,Q3,Gingival swelling,,2020,Q3,1,I,,20200229.0,20200313,20200313,EXP,,US-SA-2020SA056994,SANOFI AVENTIS,"GOLOB DEEB J., LYONS D.J., LASKIN D.M., DEEB G.R.. SEVERE DRUG?INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020. 2020?6(1):UNKNOWN",52.0,YR,A,M,Y,,,20200313.0,,MD,US,US,2020,Q3,Adult
175411841,17541184,9,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,U,,,,21081.0,60.0,IU,,QD,2020,Q3,Periodontitis,,2020,Q3,1,I,,20200229.0,20200313,20200313,EXP,,US-SA-2020SA056994,SANOFI AVENTIS,"GOLOB DEEB J., LYONS D.J., LASKIN D.M., DEEB G.R.. SEVERE DRUG?INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020. 2020?6(1):UNKNOWN",52.0,YR,A,M,Y,,,20200313.0,,MD,US,US,2020,Q3,Adult
175411841,17541184,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD",,,U,,,,21081.0,1.0,DF,,QD,2020,Q3,Gingival disorder,,2020,Q3,1,I,,20200229.0,20200313,20200313,EXP,,US-SA-2020SA056994,SANOFI AVENTIS,"GOLOB DEEB J., LYONS D.J., LASKIN D.M., DEEB G.R.. SEVERE DRUG?INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020. 2020?6(1):UNKNOWN",52.0,YR,A,M,Y,,,20200313.0,,MD,US,US,2020,Q3,Adult
175411841,17541184,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD",,,U,,,,21081.0,1.0,DF,,QD,2020,Q3,Gingival swelling,,2020,Q3,1,I,,20200229.0,20200313,20200313,EXP,,US-SA-2020SA056994,SANOFI AVENTIS,"GOLOB DEEB J., LYONS D.J., LASKIN D.M., DEEB G.R.. SEVERE DRUG?INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020. 2020?6(1):UNKNOWN",52.0,YR,A,M,Y,,,20200313.0,,MD,US,US,2020,Q3,Adult
175411841,17541184,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD",,,U,,,,21081.0,1.0,DF,,QD,2020,Q3,Periodontitis,,2020,Q3,1,I,,20200229.0,20200313,20200313,EXP,,US-SA-2020SA056994,SANOFI AVENTIS,"GOLOB DEEB J., LYONS D.J., LASKIN D.M., DEEB G.R.. SEVERE DRUG?INDUCED GINGIVAL ENLARGEMENT AND PERIODONTITIS: A CASE SERIES WITH CLINICAL PRESENTATION AND MANAGEMENT. ORAL MAXILLOFAC SURG CASES. 2020. 2020?6(1):UNKNOWN",52.0,YR,A,M,Y,,,20200313.0,,MD,US,US,2020,Q3,Adult
175453536,17545353,12,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Differentiation syndrome,,2020,Q3,6,F,20200216.0,20200922.0,20200316,20200925,EXP,,ES-CELGENEUS-ESP-20200301108,CELGENE,,80.0,YR,,F,Y,66.0,KG,20200925.0,,MD,ES,ES,2020,Q3,Elderly
175453536,17545353,12,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q3,Renal failure,,2020,Q3,6,F,20200216.0,20200922.0,20200316,20200925,EXP,,ES-CELGENEUS-ESP-20200301108,CELGENE,,80.0,YR,,F,Y,66.0,KG,20200925.0,,MD,ES,ES,2020,Q3,Elderly
175548043,17554804,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q3,Erythema multiforme,,2020,Q3,3,F,20190610.0,20200717.0,20200318,20200725,EXP,ES-EMA-DD-20200304-GANGAL_S-133417,ES-ACCORD-175314,ACCORD,,73.0,YR,E,F,Y,,,20200725.0,,HP,ES,ES,2020,Q3,Elderly
175548043,17554804,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q3,Pyrexia,,2020,Q3,3,F,20190610.0,20200717.0,20200318,20200725,EXP,ES-EMA-DD-20200304-GANGAL_S-133417,ES-ACCORD-175314,ACCORD,,73.0,YR,E,F,Y,,,20200725.0,,HP,ES,ES,2020,Q3,Elderly
175548043,17554804,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q3,Toxic skin eruption,,2020,Q3,3,F,20190610.0,20200717.0,20200318,20200725,EXP,ES-EMA-DD-20200304-GANGAL_S-133417,ES-ACCORD-175314,ACCORD,,73.0,YR,E,F,Y,,,20200725.0,,HP,ES,ES,2020,Q3,Elderly
175638162,17563816,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,201802.0,20200709.0,20200320,20200714,EXP,,US-ASTRAZENECA-2020SE38315,ASTRAZENECA,,682.0,MON,,M,Y,115.7,KG,20200714.0,,,US,US,2020,Q3,Elderly
175638162,17563816,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,2,F,201802.0,20200709.0,20200320,20200714,EXP,,US-ASTRAZENECA-2020SE38315,ASTRAZENECA,,682.0,MON,,M,Y,115.7,KG,20200714.0,,,US,US,2020,Q3,Elderly
175638162,17563816,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Renal failure,,2020,Q3,2,F,201802.0,20200709.0,20200320,20200714,EXP,,US-ASTRAZENECA-2020SE38315,ASTRAZENECA,,682.0,MON,,M,Y,115.7,KG,20200714.0,,,US,US,2020,Q3,Elderly
175657712,17565771,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Eosinophilia,,2020,Q3,2,F,,20200612.0,20200320,20200715,PER,,US-ASTRAZENECA-2020SE28482,ASTRAZENECA,,52.0,YR,,F,Y,,,20200715.0,,HP,US,US,2020,Q3,Adult
175657712,17565771,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,2,F,,20200612.0,20200320,20200715,PER,,US-ASTRAZENECA-2020SE28482,ASTRAZENECA,,52.0,YR,,F,Y,,,20200715.0,,HP,US,US,2020,Q3,Adult
175682853,17568285,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,21081.0,20.0,IU,,QD,2020,Q3,Erythema multiforme,,2020,Q3,3,F,20190610.0,20200520.0,20200320,20200528,EXP,,ES-SA-2020SA065161,SANOFI AVENTIS,"GONZ?LEZ?ESTRI?GANA S, DEL R?O?LECHUGA A, ONETO?OTERO J.. FEVER AND DERMAL LESIONS: DOES IT HAVE TO DO WITH THE HEART?. REV ESP CASOS CLIN MED INTERN. 2019?4,3:134?136",73.0,YR,E,F,Y,,,20200528.0,,MD,ES,ES,2020,Q3,Elderly
175682853,17568285,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,21081.0,20.0,IU,,QD,2020,Q3,Pyrexia,,2020,Q3,3,F,20190610.0,20200520.0,20200320,20200528,EXP,,ES-SA-2020SA065161,SANOFI AVENTIS,"GONZ?LEZ?ESTRI?GANA S, DEL R?O?LECHUGA A, ONETO?OTERO J.. FEVER AND DERMAL LESIONS: DOES IT HAVE TO DO WITH THE HEART?. REV ESP CASOS CLIN MED INTERN. 2019?4,3:134?136",73.0,YR,E,F,Y,,,20200528.0,,MD,ES,ES,2020,Q3,Elderly
175682853,17568285,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,21081.0,20.0,IU,,QD,2020,Q3,Rash maculo-papular,,2020,Q3,3,F,20190610.0,20200520.0,20200320,20200528,EXP,,ES-SA-2020SA065161,SANOFI AVENTIS,"GONZ?LEZ?ESTRI?GANA S, DEL R?O?LECHUGA A, ONETO?OTERO J.. FEVER AND DERMAL LESIONS: DOES IT HAVE TO DO WITH THE HEART?. REV ESP CASOS CLIN MED INTERN. 2019?4,3:134?136",73.0,YR,E,F,Y,,,20200528.0,,MD,ES,ES,2020,Q3,Elderly
175682853,17568285,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,21081.0,20.0,IU,,QD,2020,Q3,Rash pruritic,,2020,Q3,3,F,20190610.0,20200520.0,20200320,20200528,EXP,,ES-SA-2020SA065161,SANOFI AVENTIS,"GONZ?LEZ?ESTRI?GANA S, DEL R?O?LECHUGA A, ONETO?OTERO J.. FEVER AND DERMAL LESIONS: DOES IT HAVE TO DO WITH THE HEART?. REV ESP CASOS CLIN MED INTERN. 2019?4,3:134?136",73.0,YR,E,F,Y,,,20200528.0,,MD,ES,ES,2020,Q3,Elderly
175682853,17568285,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,21081.0,20.0,IU,,QD,2020,Q3,Skin exfoliation,,2020,Q3,3,F,20190610.0,20200520.0,20200320,20200528,EXP,,ES-SA-2020SA065161,SANOFI AVENTIS,"GONZ?LEZ?ESTRI?GANA S, DEL R?O?LECHUGA A, ONETO?OTERO J.. FEVER AND DERMAL LESIONS: DOES IT HAVE TO DO WITH THE HEART?. REV ESP CASOS CLIN MED INTERN. 2019?4,3:134?136",73.0,YR,E,F,Y,,,20200528.0,,MD,ES,ES,2020,Q3,Elderly
175682853,17568285,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,21081.0,20.0,IU,,QD,2020,Q3,Skin lesion,,2020,Q3,3,F,20190610.0,20200520.0,20200320,20200528,EXP,,ES-SA-2020SA065161,SANOFI AVENTIS,"GONZ?LEZ?ESTRI?GANA S, DEL R?O?LECHUGA A, ONETO?OTERO J.. FEVER AND DERMAL LESIONS: DOES IT HAVE TO DO WITH THE HEART?. REV ESP CASOS CLIN MED INTERN. 2019?4,3:134?136",73.0,YR,E,F,Y,,,20200528.0,,MD,ES,ES,2020,Q3,Elderly
175682853,17568285,2,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,21081.0,20.0,IU,,QD,2020,Q3,Toxic skin eruption,,2020,Q3,3,F,20190610.0,20200520.0,20200320,20200528,EXP,,ES-SA-2020SA065161,SANOFI AVENTIS,"GONZ?LEZ?ESTRI?GANA S, DEL R?O?LECHUGA A, ONETO?OTERO J.. FEVER AND DERMAL LESIONS: DOES IT HAVE TO DO WITH THE HEART?. REV ESP CASOS CLIN MED INTERN. 2019?4,3:134?136",73.0,YR,E,F,Y,,,20200528.0,,MD,ES,ES,2020,Q3,Elderly
175699476,17569947,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Cholangitis,,2020,Q3,6,F,20200218.0,20200916.0,20200323,20200922,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023877,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,86.0,KG,20200922.0,,HP,DE,DE,2020,Q3,Elderly
175699476,17569947,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Liver transplant,,2020,Q3,6,F,20200218.0,20200916.0,20200323,20200922,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023877,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,86.0,KG,20200922.0,,HP,DE,DE,2020,Q3,Elderly
175699476,17569947,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Liver transplant rejection,,2020,Q3,6,F,20200218.0,20200916.0,20200323,20200922,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-023877,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,86.0,KG,20200922.0,,HP,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Abdominal pain,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Abdominal pain upper,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Agranulocytosis,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Candida infection,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Leukopenia,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Myelosuppression,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Petechiae,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Sepsis,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Thrombocytopenia,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175716313,17571631,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,16.0,IU,UNKNOWN,,2020,Q3,Umbilical hernia,,2020,Q3,3,F,20200202.0,20200629.0,20200323,20200710,EXP,DE-EMA-DD-20200624-B8Q5M4-193914,DE-JNJFOC-20200315361,JOHNSON AND JOHNSON,,78.0,YR,,M,Y,100.0,KG,20200710.0,,PH,DE,DE,2020,Q3,Elderly
175785913,17578591,7,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q3,Erythema multiforme,,2020,Q3,3,F,20190610.0,20200722.0,20200325,20200804,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20200805.0,,HP,NL,ES,2020,Q3,Elderly
175785913,17578591,7,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q3,Pyrexia,,2020,Q3,3,F,20190610.0,20200722.0,20200325,20200804,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20200805.0,,HP,NL,ES,2020,Q3,Elderly
175785913,17578591,7,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q3,Toxic skin eruption,,2020,Q3,3,F,20190610.0,20200722.0,20200325,20200804,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20200805.0,,HP,NL,ES,2020,Q3,Elderly
175785913,17578591,8,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q3,Erythema multiforme,,2020,Q3,3,F,20190610.0,20200722.0,20200325,20200804,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20200805.0,,HP,NL,ES,2020,Q3,Elderly
175785913,17578591,8,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q3,Pyrexia,,2020,Q3,3,F,20190610.0,20200722.0,20200325,20200804,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20200805.0,,HP,NL,ES,2020,Q3,Elderly
175785913,17578591,8,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q3,Toxic skin eruption,,2020,Q3,3,F,20190610.0,20200722.0,20200325,20200804,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20200805.0,,HP,NL,ES,2020,Q3,Elderly
175848755,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Infection in an immunocompromised host,,2020,Q3,5,F,2020.0,20200625.0,20200326,20200703,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20200703.0,,HP,US,US,2020,Q3,Youth
175848755,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Liver transplant rejection,,2020,Q3,5,F,2020.0,20200625.0,20200326,20200703,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20200703.0,,HP,US,US,2020,Q3,Youth
175848755,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Postoperative adhesion,,2020,Q3,5,F,2020.0,20200625.0,20200326,20200703,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20200703.0,,HP,US,US,2020,Q3,Youth
175848755,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Volvulus,,2020,Q3,5,F,2020.0,20200625.0,20200326,20200703,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20200703.0,,HP,US,US,2020,Q3,Youth
175848755,17584875,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,5,F,2020.0,20200625.0,20200326,20200703,EXP,,US-VERTEX PHARMACEUTICALS-2020-006304,VERTEX,,16.0,YR,,M,Y,54.0,KG,20200703.0,,HP,US,US,2020,Q3,Youth
175852436,17585243,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Neutrophil count decreased,,2020,Q3,6,F,20200319.0,20200701.0,20200326,20200703,EXP,,NVSC2020DE080769,NOVARTIS,,66.0,YR,,M,Y,,,20200703.0,,HP,DE,DE,2020,Q3,Elderly
175852436,17585243,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,White blood cell count decreased,,2020,Q3,6,F,20200319.0,20200701.0,20200326,20200703,EXP,,NVSC2020DE080769,NOVARTIS,,66.0,YR,,M,Y,,,20200703.0,,HP,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Abdominal pain,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Abdominal pain upper,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Agranulocytosis,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Candida infection,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Leukopenia,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Myelosuppression,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Petechiae,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Sepsis,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Thrombocytopenia,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175871412,17587141,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 INTERNATIONAL UNIT,,,,,,,,16.0,IU,,,2020,Q3,Umbilical hernia,,2020,Q3,2,F,20200202.0,20200629.0,20200326,20200708,EXP,DE-AMK-240133,DE-MYLANLABS-2020M1031796,MYLAN,,78.0,YR,,M,Y,100.0,KG,20200708.0,,PH,DE,DE,2020,Q3,Elderly
175935384,17593538,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Bone density decreased,,2020,Q3,4,F,201908.0,20200515.0,20200327,20200813,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200813.0,,LW,US,US,2020,Q3,Adult
175935384,17593538,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,4,F,201908.0,20200515.0,20200327,20200813,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200813.0,,LW,US,US,2020,Q3,Adult
175935384,17593538,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Osteopenia,,2020,Q3,4,F,201908.0,20200515.0,20200327,20200813,EXP,,US-GILEAD-2020-0456880,GILEAD,,49.0,YR,A,M,Y,,,20200813.0,,LW,US,US,2020,Q3,Adult
1760045214,17600452,2,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,,15.0,IU,,QD,2020,Q3,Drug interaction,,2020,Q3,14,F,2020.0,20200922.0,20200330,20200928,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200928.0,,CN,DE,DE,2020,Q3,Elderly
1760045214,17600452,2,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,,15.0,IU,,QD,2020,Q3,Eye movement disorder,,2020,Q3,14,F,2020.0,20200922.0,20200330,20200928,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200928.0,,CN,DE,DE,2020,Q3,Elderly
1760045214,17600452,2,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,,15.0,IU,,QD,2020,Q3,Movement disorder,,2020,Q3,14,F,2020.0,20200922.0,20200330,20200928,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200928.0,,CN,DE,DE,2020,Q3,Elderly
1760045214,17600452,2,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,,15.0,IU,,QD,2020,Q3,Muscle spasms,,2020,Q3,14,F,2020.0,20200922.0,20200330,20200928,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200928.0,,CN,DE,DE,2020,Q3,Elderly
1760045214,17600452,2,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,,15.0,IU,,QD,2020,Q3,Oculogyric crisis,,2020,Q3,14,F,2020.0,20200922.0,20200330,20200928,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200928.0,,CN,DE,DE,2020,Q3,Elderly
1760045214,17600452,2,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,,15.0,IU,,QD,2020,Q3,Seizure,,2020,Q3,14,F,2020.0,20200922.0,20200330,20200928,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200928.0,,CN,DE,DE,2020,Q3,Elderly
1760045214,17600452,2,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, EACH EVENING",,,,,,,,15.0,IU,,QD,2020,Q3,Status epilepticus,,2020,Q3,14,F,2020.0,20200922.0,20200330,20200928,EXP,DE-BFARM-20003581,DE-ELI_LILLY_AND_COMPANY-DE202003011545,ELI LILLY AND CO,,69.0,YR,,M,Y,77.0,KG,20200928.0,,CN,DE,DE,2020,Q3,Elderly
176086036,17608603,10,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Drug interaction,,2020,Q3,6,F,201808.0,20200903.0,20200401,20200914,PER,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,68.0,YR,E,M,Y,77.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
176086036,17608603,10,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Eye movement disorder,,2020,Q3,6,F,201808.0,20200903.0,20200401,20200914,PER,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,68.0,YR,E,M,Y,77.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
176086036,17608603,10,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Movement disorder,,2020,Q3,6,F,201808.0,20200903.0,20200401,20200914,PER,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,68.0,YR,E,M,Y,77.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
176086036,17608603,10,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Muscle spasms,,2020,Q3,6,F,201808.0,20200903.0,20200401,20200914,PER,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,68.0,YR,E,M,Y,77.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
176086036,17608603,10,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Oculogyric crisis,,2020,Q3,6,F,201808.0,20200903.0,20200401,20200914,PER,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,68.0,YR,E,M,Y,77.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
176086036,17608603,10,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Off label use,,2020,Q3,6,F,201808.0,20200903.0,20200401,20200914,PER,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,68.0,YR,E,M,Y,77.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
176086036,17608603,10,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Product use issue,,2020,Q3,6,F,201808.0,20200903.0,20200401,20200914,PER,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,68.0,YR,E,M,Y,77.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
176086036,17608603,10,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Seizure,,2020,Q3,6,F,201808.0,20200903.0,20200401,20200914,PER,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,68.0,YR,E,M,Y,77.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
176086036,17608603,10,I,insulin glargine,INSULIN GLARGINE,1,,15 IU IN THE EVENING (15 IE ABENDS),,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Status epilepticus,,2020,Q3,6,F,201808.0,20200903.0,20200401,20200914,PER,DE-BFARM-20003581,DE-DRREDDYS-GER/GER/20/0121251,DR REDDYS,,68.0,YR,E,M,Y,77.0,KG,20200914.0,,MD,DE,DE,2020,Q3,Elderly
176150887,17615088,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Drug interaction,,2020,Q3,7,F,201808.0,20200827.0,20200402,20200908,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200908.0,,CN,DE,DE,2020,Q3,Elderly
176150887,17615088,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Eye movement disorder,,2020,Q3,7,F,201808.0,20200827.0,20200402,20200908,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200908.0,,CN,DE,DE,2020,Q3,Elderly
176150887,17615088,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Movement disorder,,2020,Q3,7,F,201808.0,20200827.0,20200402,20200908,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200908.0,,CN,DE,DE,2020,Q3,Elderly
176150887,17615088,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Muscle spasms,,2020,Q3,7,F,201808.0,20200827.0,20200402,20200908,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200908.0,,CN,DE,DE,2020,Q3,Elderly
176150887,17615088,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Oculogyric crisis,,2020,Q3,7,F,201808.0,20200827.0,20200402,20200908,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200908.0,,CN,DE,DE,2020,Q3,Elderly
176150887,17615088,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Off label use,,2020,Q3,7,F,201808.0,20200827.0,20200402,20200908,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200908.0,,CN,DE,DE,2020,Q3,Elderly
176150887,17615088,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Product use issue,,2020,Q3,7,F,201808.0,20200827.0,20200402,20200908,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200908.0,,CN,DE,DE,2020,Q3,Elderly
176150887,17615088,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Seizure,,2020,Q3,7,F,201808.0,20200827.0,20200402,20200908,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200908.0,,CN,DE,DE,2020,Q3,Elderly
176150887,17615088,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 IU IN THE EVENING)",,,,, UNKNOWN,,,15.0,IU,INJECTION,QD,2020,Q3,Status epilepticus,,2020,Q3,7,F,201808.0,20200827.0,20200402,20200908,EXP,DE-BFARM-20003581,DE-LUPIN PHARMACEUTICALS INC.-2020-01533,LUPIN,,69.0,YR,,M,Y,77.0,KG,20200908.0,,CN,DE,DE,2020,Q3,Elderly
176327844,17632784,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Alopecia,,2020,Q3,4,F,20170301.0,20200710.0,20200406,20200713,PER,,US-PFIZER INC-2020142094,PFIZER,,63.0,YR,,F,Y,,,20200713.0,,LW,US,US,2020,Q3,Adult
176327844,17632784,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hair colour changes,,2020,Q3,4,F,20170301.0,20200710.0,20200406,20200713,PER,,US-PFIZER INC-2020142094,PFIZER,,63.0,YR,,F,Y,,,20200713.0,,LW,US,US,2020,Q3,Adult
176327844,17632784,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hair disorder,,2020,Q3,4,F,20170301.0,20200710.0,20200406,20200713,PER,,US-PFIZER INC-2020142094,PFIZER,,63.0,YR,,F,Y,,,20200713.0,,LW,US,US,2020,Q3,Adult
176327844,17632784,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hair texture abnormal,,2020,Q3,4,F,20170301.0,20200710.0,20200406,20200713,PER,,US-PFIZER INC-2020142094,PFIZER,,63.0,YR,,F,Y,,,20200713.0,,LW,US,US,2020,Q3,Adult
1764090015,17640900,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,100.0,DF,INJECTION,,2020,Q3,Ascites,,2020,Q3,15,F,20200306.0,20200710.0,20200407,20200715,PER,,CO-EISAI MEDICAL RESEARCH-EC-2020-072240,EISAI,,72.0,YR,E,M,Y,72.2,KG,20200715.0,,MD,CO,CO,2020,Q3,Elderly
1764090015,17640900,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,100.0,DF,INJECTION,,2020,Q3,Bronchitis,,2020,Q3,15,F,20200306.0,20200710.0,20200407,20200715,PER,,CO-EISAI MEDICAL RESEARCH-EC-2020-072240,EISAI,,72.0,YR,E,M,Y,72.2,KG,20200715.0,,MD,CO,CO,2020,Q3,Elderly
1764090015,17640900,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,100.0,DF,INJECTION,,2020,Q3,Oesophageal varices haemorrhage,,2020,Q3,15,F,20200306.0,20200710.0,20200407,20200715,PER,,CO-EISAI MEDICAL RESEARCH-EC-2020-072240,EISAI,,72.0,YR,E,M,Y,72.2,KG,20200715.0,,MD,CO,CO,2020,Q3,Elderly
176514395,17651439,7,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q3,Drug interaction,,2020,Q3,5,F,201808.0,20200831.0,20200409,20200910,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,68.0,YR,E,M,Y,77.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
176514395,17651439,7,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q3,Eye movement disorder,,2020,Q3,5,F,201808.0,20200831.0,20200409,20200910,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,68.0,YR,E,M,Y,77.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
176514395,17651439,7,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q3,Movement disorder,,2020,Q3,5,F,201808.0,20200831.0,20200409,20200910,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,68.0,YR,E,M,Y,77.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
176514395,17651439,7,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q3,Muscle spasms,,2020,Q3,5,F,201808.0,20200831.0,20200409,20200910,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,68.0,YR,E,M,Y,77.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
176514395,17651439,7,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q3,Oculogyric crisis,,2020,Q3,5,F,201808.0,20200831.0,20200409,20200910,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,68.0,YR,E,M,Y,77.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
176514395,17651439,7,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q3,Off label use,,2020,Q3,5,F,201808.0,20200831.0,20200409,20200910,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,68.0,YR,E,M,Y,77.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
176514395,17651439,7,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q3,Product use issue,,2020,Q3,5,F,201808.0,20200831.0,20200409,20200910,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,68.0,YR,E,M,Y,77.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
176514395,17651439,7,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q3,Seizure,,2020,Q3,5,F,201808.0,20200831.0,20200409,20200910,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,68.0,YR,E,M,Y,77.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
176514395,17651439,7,I,insulin glargine,INSULIN GLARGINE,1,,"15 INTERNATIONAL UNIT, DAILY",,,,,,,,15.0,IU,INJECTION,,2020,Q3,Status epilepticus,,2020,Q3,5,F,201808.0,20200831.0,20200409,20200910,EXP,DE-BFARM-20003581,DE-TORRENT-00017169,TORRENT,,68.0,YR,E,M,Y,77.0,KG,20200910.0,,CN,DE,DE,2020,Q3,Elderly
1765443712,17654437,28,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY,IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Drug interaction,,2020,Q3,12,F,201808.0,20200922.0,20200410,20200928,EXP,,DE-AUROBINDO-AUR-APL-2020-017224,AUROBINDO,,69.0,YR,,M,Y,77.0,KG,20200929.0,,HP,DE,DE,2020,Q3,Elderly
1765443712,17654437,28,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY,IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Eye movement disorder,,2020,Q3,12,F,201808.0,20200922.0,20200410,20200928,EXP,,DE-AUROBINDO-AUR-APL-2020-017224,AUROBINDO,,69.0,YR,,M,Y,77.0,KG,20200929.0,,HP,DE,DE,2020,Q3,Elderly
1765443712,17654437,28,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY,IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Movement disorder,,2020,Q3,12,F,201808.0,20200922.0,20200410,20200928,EXP,,DE-AUROBINDO-AUR-APL-2020-017224,AUROBINDO,,69.0,YR,,M,Y,77.0,KG,20200929.0,,HP,DE,DE,2020,Q3,Elderly
1765443712,17654437,28,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY,IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Muscle spasms,,2020,Q3,12,F,201808.0,20200922.0,20200410,20200928,EXP,,DE-AUROBINDO-AUR-APL-2020-017224,AUROBINDO,,69.0,YR,,M,Y,77.0,KG,20200929.0,,HP,DE,DE,2020,Q3,Elderly
1765443712,17654437,28,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY,IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Oculogyric crisis,,2020,Q3,12,F,201808.0,20200922.0,20200410,20200928,EXP,,DE-AUROBINDO-AUR-APL-2020-017224,AUROBINDO,,69.0,YR,,M,Y,77.0,KG,20200929.0,,HP,DE,DE,2020,Q3,Elderly
1765443712,17654437,28,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY,IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Off label use,,2020,Q3,12,F,201808.0,20200922.0,20200410,20200928,EXP,,DE-AUROBINDO-AUR-APL-2020-017224,AUROBINDO,,69.0,YR,,M,Y,77.0,KG,20200929.0,,HP,DE,DE,2020,Q3,Elderly
1765443712,17654437,28,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY,IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Product use issue,,2020,Q3,12,F,201808.0,20200922.0,20200410,20200928,EXP,,DE-AUROBINDO-AUR-APL-2020-017224,AUROBINDO,,69.0,YR,,M,Y,77.0,KG,20200929.0,,HP,DE,DE,2020,Q3,Elderly
1765443712,17654437,28,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY,IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Seizure,,2020,Q3,12,F,201808.0,20200922.0,20200410,20200928,EXP,,DE-AUROBINDO-AUR-APL-2020-017224,AUROBINDO,,69.0,YR,,M,Y,77.0,KG,20200929.0,,HP,DE,DE,2020,Q3,Elderly
1765443712,17654437,28,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY,IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Status epilepticus,,2020,Q3,12,F,201808.0,20200922.0,20200410,20200928,EXP,,DE-AUROBINDO-AUR-APL-2020-017224,AUROBINDO,,69.0,YR,,M,Y,77.0,KG,20200929.0,,HP,DE,DE,2020,Q3,Elderly
176650606,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q3,Drug interaction,,2020,Q3,6,F,2020.0,20200828.0,20200414,20200904,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
176650606,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q3,Eye movement disorder,,2020,Q3,6,F,2020.0,20200828.0,20200414,20200904,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
176650606,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q3,Movement disorder,,2020,Q3,6,F,2020.0,20200828.0,20200414,20200904,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
176650606,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q3,Muscle spasms,,2020,Q3,6,F,2020.0,20200828.0,20200414,20200904,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
176650606,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q3,Oculogyric crisis,,2020,Q3,6,F,2020.0,20200828.0,20200414,20200904,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
176650606,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q3,Seizure,,2020,Q3,6,F,2020.0,20200828.0,20200414,20200904,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
176650606,17665060,9,I,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 IU IN THE EVENING,,,,,,,,15.0,IU,INJECTION,,2020,Q3,Status epilepticus,,2020,Q3,6,F,2020.0,20200828.0,20200414,20200904,EXP,DE-BFARM-20003581,DE-ACCORD-178624,ACCORD,,69.0,YR,E,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Alanine aminotransferase increased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Aortic valve incompetence,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Asthenia,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Cardiac index decreased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Decreased appetite,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Dysarthria,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Fall,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Femur fracture,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Haematoma,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Haemoglobin decreased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Hypersomnia,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Hypotension,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Klebsiella test positive,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Lethargy,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Liver function test increased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Muscle strain,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Pain in extremity,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Peripheral swelling,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Renal disorder,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Retroperitoneal haemorrhage,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Skin laceration,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Therapy non-responder,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Urinary retention,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Urinary tract infection,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Urosepsis,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,Weight decreased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177001654,17700165,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,,,,QD,2020,Q3,White blood cell count increased,,2020,Q3,4,F,2020.0,20200715.0,20200423,20200729,EXP,,US-ACTELION-A-US2020-202748,ACTELION,,74.0,YR,,M,Y,105.67,KG,20200729.0,,HP,US,US,2020,Q3,Elderly
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Aphonia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Blood glucose decreased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Dizziness,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Drug ineffective,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Frequent bowel movements,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Gastrooesophageal reflux disease,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Insomnia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,43 IU,,,Y,, 9F404A,,,43.0,IU,,,2020,Q3,Insulin resistance,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Aphonia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Blood glucose decreased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Dizziness,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Drug ineffective,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Frequent bowel movements,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Gastrooesophageal reflux disease,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Insomnia,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177002132,17700213,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,40 IU,,,Y,, 0F517A,,,40.0,IU,,,2020,Q3,Insulin resistance,,2020,Q3,2,F,201905.0,20200715.0,20200423,20200724,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Adult
177262063,17726206,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Aphasia,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
177262063,17726206,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Death,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
177262063,17726206,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
177262063,17726206,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Failure to thrive,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
177262063,17726206,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Small intestinal obstruction,,2020,Q3,3,F,20200421.0,20200508.0,20200429,20200512,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-033677,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,58.1,KG,20200512.0,,HP,US,US,2020,Q3,Adult
177411814,17741181,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,U,U,,,,20.0,IU,,QD,2020,Q3,Erythema multiforme,,2020,Q3,4,F,20190610.0,20200623.0,20200504,20200628,EXP,,NVSC2020ES115050,NOVARTIS,,73.0,YR,,F,Y,,,20200628.0,,HP,ES,ES,2020,Q3,Elderly
177411814,17741181,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,U,U,,,,20.0,IU,,QD,2020,Q3,Pyrexia,,2020,Q3,4,F,20190610.0,20200623.0,20200504,20200628,EXP,,NVSC2020ES115050,NOVARTIS,,73.0,YR,,F,Y,,,20200628.0,,HP,ES,ES,2020,Q3,Elderly
177411814,17741181,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,U,U,,,,20.0,IU,,QD,2020,Q3,Toxic skin eruption,,2020,Q3,4,F,20190610.0,20200623.0,20200504,20200628,EXP,,NVSC2020ES115050,NOVARTIS,,73.0,YR,,F,Y,,,20200628.0,,HP,ES,ES,2020,Q3,Elderly
177630283,17763028,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q3,Intentional overdose,,2020,Q3,3,F,20200416.0,20200625.0,20200508,20200707,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202004011130,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20200707.0,,MD,GB,GB,2020,Q3,Adult
177630283,17763028,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q3,Neutrophil count increased,,2020,Q3,3,F,20200416.0,20200625.0,20200508,20200707,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202004011130,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20200707.0,,MD,GB,GB,2020,Q3,Adult
177630283,17763028,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q3,Schizophrenia,,2020,Q3,3,F,20200416.0,20200625.0,20200508,20200707,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202004011130,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20200707.0,,MD,GB,GB,2020,Q3,Adult
177630283,17763028,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q3,Syncope,,2020,Q3,3,F,20200416.0,20200625.0,20200508,20200707,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202004011130,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20200707.0,,MD,GB,GB,2020,Q3,Adult
177630283,17763028,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q3,White blood cell count increased,,2020,Q3,3,F,20200416.0,20200625.0,20200508,20200707,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202004011130,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20200707.0,,MD,GB,GB,2020,Q3,Adult
177781214,17778121,30,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,20 U (UNIT),,,,,,,,,,,QD,2020,Q3,Pneumonia bacterial,,2020,Q3,4,F,20200430.0,20200707.0,20200513,20200825,EXP,,US-ROCHE-2597569,ROCHE,,49.0,YR,,M,Y,104.0,KG,20200825.0,,MD,US,US,2020,Q3,Adult
178011993,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q3,Cogwheel rigidity,,2020,Q3,3,F,,20200827.0,20200519,20200902,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200902.0,,PH,US,US,2020,Q3,Elderly
178011993,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q3,Drug interaction,,2020,Q3,3,F,,20200827.0,20200519,20200902,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200902.0,,PH,US,US,2020,Q3,Elderly
178011993,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q3,Drug level increased,,2020,Q3,3,F,,20200827.0,20200519,20200902,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200902.0,,PH,US,US,2020,Q3,Elderly
178011993,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q3,Dystonia,,2020,Q3,3,F,,20200827.0,20200519,20200902,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200902.0,,PH,US,US,2020,Q3,Elderly
178011993,17801199,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,NIGHTLY,,,,, UNKNOWN,,,10.0,IU,,,2020,Q3,Tremor,,2020,Q3,3,F,,20200827.0,20200519,20200902,EXP,,US-DRREDDYS-USA/USA/20/0122991,DR REDDYS,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12. DOI:10.1097/01.NPR.0000660368.67226.AD",69.0,YR,E,M,Y,,,20200902.0,,PH,US,US,2020,Q3,Elderly
178165354,17816535,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,50 UNIT,,,,,,,,,,,BID,2020,Q3,Pneumonia staphylococcal,,2020,Q3,4,F,20200510.0,20200702.0,20200522,20200707,EXP,,US-ROCHE-2594802,ROCHE,,66.0,YR,,M,Y,110.4,KG,20200707.0,,MD,US,US,2020,Q3,Elderly
178169582,17816958,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,2,F,20191223.0,20200630.0,20200522,20200702,EXP,,US-PFIZER INC-2020203454,PFIZER,,67.0,YR,,F,Y,66.4,KG,20200702.0,,HP,US,US,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Acute respiratory distress syndrome,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Cholestasis,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Hepatic failure,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Hypothermia,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Intentional overdose,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Multiple organ dysfunction syndrome,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Pneumonia aspiration,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Renal failure,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Seizure,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Shock,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178282472,17828247,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Toxicity to various agents,,2020,Q3,2,F,,20200826.0,20200527,20200902,EXP,,FR-MYLANLABS-2020M1052110,MYLAN,,93.0,YR,,M,Y,,,20200902.0,,HP,FR,FR,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,DOSE REDUCED,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178341135,17834113,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,5,F,2020.0,20200728.0,20200528,20200805,EXP,,ES-BAUSCH-BL-2020-015367,BAUSCH AND LOMB,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178354612,17835461,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Drug eruption,,2020,Q3,2,F,20200302.0,20200812.0,20200528,20200820,EXP,,JP-OTSUKA-2020_012783,OTSUKA,,85.0,YR,,M,Y,52.1,KG,20200820.0,,PH,JP,JP,2020,Q3,Elderly
178354612,17835461,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Incorrect dose administered,,2020,Q3,2,F,20200302.0,20200812.0,20200528,20200820,EXP,,JP-OTSUKA-2020_012783,OTSUKA,,85.0,YR,,M,Y,52.1,KG,20200820.0,,PH,JP,JP,2020,Q3,Elderly
178354612,17835461,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Stevens-Johnson syndrome,,2020,Q3,2,F,20200302.0,20200812.0,20200528,20200820,EXP,,JP-OTSUKA-2020_012783,OTSUKA,,85.0,YR,,M,Y,52.1,KG,20200820.0,,PH,JP,JP,2020,Q3,Elderly
178377208,17837720,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Cytokine release syndrome,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Cytokine release syndrome,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Cytokine release syndrome,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"10,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK; 25,OTHER,DAILY",,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK; 25,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Cytokine release syndrome,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK; 25,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK; 25,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK; 25,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"18,OTHER",,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"18,OTHER",,,,,,,,,,,,2020,Q3,Cytokine release syndrome,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"18,OTHER",,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"18,OTHER",,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"18,OTHER",,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"20,OTHER,DAILY",,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"20,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Cytokine release syndrome,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"20,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"20,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178377208,17837720,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous drip,"20,OTHER,DAILY",,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,8,F,20200327.0,20200819.0,20200528,20200824,EXP,,US-GILEAD-2020-0457166,GILEAD,,73.0,YR,E,M,Y,71.5,KG,20200824.0,,HP,US,US,2020,Q3,Elderly
178446583,17844658,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2020,Q3,COVID-19,,2020,Q3,3,F,20200506.0,20200722.0,20200601,20200723,EXP,,CO-ABBVIE-20K-036-3425828-00,ABBVIE,,53.0,YR,,F,Y,73.0,KG,20200723.0,,CN,CO,CO,2020,Q3,Adult
178446583,17844658,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2020,Q3,Fluid overload,,2020,Q3,3,F,20200506.0,20200722.0,20200601,20200723,EXP,,CO-ABBVIE-20K-036-3425828-00,ABBVIE,,53.0,YR,,F,Y,73.0,KG,20200723.0,,CN,CO,CO,2020,Q3,Adult
178446583,17844658,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2020,Q3,Malaise,,2020,Q3,3,F,20200506.0,20200722.0,20200601,20200723,EXP,,CO-ABBVIE-20K-036-3425828-00,ABBVIE,,53.0,YR,,F,Y,73.0,KG,20200723.0,,CN,CO,CO,2020,Q3,Adult
178446583,17844658,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,8.0,DF,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,2020,Q3,Pneumonia,,2020,Q3,3,F,20200506.0,20200722.0,20200601,20200723,EXP,,CO-ABBVIE-20K-036-3425828-00,ABBVIE,,53.0,YR,,F,Y,73.0,KG,20200723.0,,CN,CO,CO,2020,Q3,Adult
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Intentional product misuse,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE REDUCED",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Intentional product misuse,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Intentional product misuse,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178463274,17846327,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,4,F,2020.0,20200729.0,20200601,20200805,EXP,,ES-MYLANLABS-2020M1052251,MYLAN,,84.0,YR,,F,Y,80.0,KG,20200805.0,,HP,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,36 INTERNATIONAL UNIT,,,Y,U,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178530664,17853066,5,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,Y,U,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,4,F,2020.0,20200624.0,20200603,20200706,EXP,,ES-AUROBINDO-AUR-APL-2020-026536,AUROBINDO,,84.0,YR,,F,Y,80.0,KG,20200706.0,,CN,ES,ES,2020,Q3,Elderly
178563876,17856387,8,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (IN THE EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Drug interaction,,2020,Q3,6,F,20200115.0,20200715.0,20200603,20200717,EXP,DE-BFARM-20003581,NVSC2020DE151448,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200717.0,,PH,DE,DE,2020,Q3,Elderly
178563876,17856387,8,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (IN THE EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Eye movement disorder,,2020,Q3,6,F,20200115.0,20200715.0,20200603,20200717,EXP,DE-BFARM-20003581,NVSC2020DE151448,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200717.0,,PH,DE,DE,2020,Q3,Elderly
178563876,17856387,8,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (IN THE EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Movement disorder,,2020,Q3,6,F,20200115.0,20200715.0,20200603,20200717,EXP,DE-BFARM-20003581,NVSC2020DE151448,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200717.0,,PH,DE,DE,2020,Q3,Elderly
178563876,17856387,8,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (IN THE EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Off label use,,2020,Q3,6,F,20200115.0,20200715.0,20200603,20200717,EXP,DE-BFARM-20003581,NVSC2020DE151448,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200717.0,,PH,DE,DE,2020,Q3,Elderly
178563876,17856387,8,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (IN THE EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Seizure,,2020,Q3,6,F,20200115.0,20200715.0,20200603,20200717,EXP,DE-BFARM-20003581,NVSC2020DE151448,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200717.0,,PH,DE,DE,2020,Q3,Elderly
178571032,17857103,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS Q12 HR,,,,,,,,,,,,2020,Q3,Acidosis,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS Q12 HR,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS Q12 HR,,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS Q12 HR,,,,,,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS Q12 HR,,,,,,,,,,,,2020,Q3,Hypomagnesaemia,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS Q12 HR,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 UNITS Q12 HR,,,,,,,,,,,,2020,Q3,Paralysis,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acidosis,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypomagnesaemia,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
178571032,17857103,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Paralysis,,2020,Q3,2,F,20200513.0,20200910.0,20200603,20200915,EXP,,US-GILEAD-2020-0468777,GILEAD,,60.0,YR,A,M,Y,102.99,KG,20200915.0,,PH,US,US,2020,Q3,Adult
1786046610,17860466,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,INJECTION,,2020,Q3,Back pain,,2020,Q3,10,F,20200522.0,20200710.0,20200604,20200716,PER,,JP-EISAI MEDICAL RESEARCH-EC-2020-075509,EISAI,,66.0,YR,E,M,Y,67.0,KG,20200716.0,,MD,JP,JP,2020,Q3,Elderly
1786046610,17860466,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,INJECTION,,2020,Q3,Musculoskeletal pain,,2020,Q3,10,F,20200522.0,20200710.0,20200604,20200716,PER,,JP-EISAI MEDICAL RESEARCH-EC-2020-075509,EISAI,,66.0,YR,E,M,Y,67.0,KG,20200716.0,,MD,JP,JP,2020,Q3,Elderly
1786046610,17860466,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,14.0,IU,INJECTION,,2020,Q3,Pyrexia,,2020,Q3,10,F,20200522.0,20200710.0,20200604,20200716,PER,,JP-EISAI MEDICAL RESEARCH-EC-2020-075509,EISAI,,66.0,YR,E,M,Y,67.0,KG,20200716.0,,MD,JP,JP,2020,Q3,Elderly
178634132,17863413,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE MEALS,,,U,, UNKNOWN,,,18.0,IU,,QD,2020,Q3,Feeling abnormal,,2020,Q3,2,F,,20200901.0,20200605,20200915,PER,,US-DRREDDYS-USA/USA/20/0123649,DR REDDYS,"PATEL K, STUMMER L, PATEL K. STIFF?PERSON SYNDROME IN A PATIENT WITH COMORBID BIPOLAR AND PANIC DISORDERS: A CASE REPORT AND LITERATURE REVIEW. MENT HEALTH CLIN. 2020?10(3):95?99. DOI: 10.9740/MHC.2020.05.095.",58.0,YR,A,F,Y,,,20200915.0,,PH,US,US,2020,Q3,Adult
178634132,17863413,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE MEALS,,,U,, UNKNOWN,,,18.0,IU,,QD,2020,Q3,Sedation,,2020,Q3,2,F,,20200901.0,20200605,20200915,PER,,US-DRREDDYS-USA/USA/20/0123649,DR REDDYS,"PATEL K, STUMMER L, PATEL K. STIFF?PERSON SYNDROME IN A PATIENT WITH COMORBID BIPOLAR AND PANIC DISORDERS: A CASE REPORT AND LITERATURE REVIEW. MENT HEALTH CLIN. 2020?10(3):95?99. DOI: 10.9740/MHC.2020.05.095.",58.0,YR,A,F,Y,,,20200915.0,,PH,US,US,2020,Q3,Adult
178716362,17871636,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,12.0,IU,,QD,2020,Q3,Immune-mediated myositis,,2020,Q3,2,F,,20200717.0,20200608,20200724,EXP,,CZ-BAUSCH-BL-2020-016306,BAUSCH AND LOMB,"SVARKO J, LOKOCOVA E, KOURKOVA E, ZAJICEK P. STATINY INDUKOVANA NEKROTIZUJICI AUTOIMUNITNI MYOPATIE JAKO NEOBVYKLA PRICINA EXTREMNICH HODNOT KARDIALNICH MARKERU U PACIENTA SE SVALOVOU SLABOSTI A OTOKY. CESKA REVMATOLOGIE. 2020?28(1):52?60.",75.0,YR,,M,Y,,,20200724.0,,HP,CZ,CZ,2020,Q3,Elderly
178729805,17872980,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2020,Q3,Eczema asteatotic,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,12.0,IU,INJECTION,QD,2020,Q3,Peripheral venous disease,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,INJECTION,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,INJECTION,QD,2020,Q3,Eczema asteatotic,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,10.0,IU,INJECTION,QD,2020,Q3,Peripheral venous disease,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,8.0,IU,INJECTION,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,8.0,IU,INJECTION,QD,2020,Q3,Eczema asteatotic,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,8.0,IU,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,8.0,IU,INJECTION,QD,2020,Q3,Peripheral venous disease,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Eczema asteatotic,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Peripheral venous disease,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,6.0,IU,INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,6.0,IU,INJECTION,,2020,Q3,Eczema asteatotic,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,6.0,IU,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,6.0,IU,INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Eczema asteatotic,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Peripheral venous disease,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,3.0,IU,INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,3.0,IU,INJECTION,,2020,Q3,Eczema asteatotic,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,3.0,IU,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178729805,17872980,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,3.0,IU,INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,5,F,20190508.0,20200815.0,20200608,20200820,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002880",BOEHRINGER INGELHEIM,,80.0,YR,,F,Y,36.7,KG,20200820.0,,MD,JP,JP,2020,Q3,Elderly
178759014,17875901,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 U,,,,,,,,,,,QD,2020,Q3,Blood creatinine increased,,2020,Q3,4,F,20200603.0,20200721.0,20200609,20200727,EXP,,ES-ROCHE-2616155,ROCHE,,71.0,YR,,M,Y,93.2,KG,20200727.0,,MD,ES,ES,2020,Q3,Elderly
178760782,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,2,F,202005.0,20200713.0,20200609,20200723,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200723.0,,MD,US,US,2020,Q3,Elderly
178760782,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hyperglycaemia,,2020,Q3,2,F,202005.0,20200713.0,20200609,20200723,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200723.0,,MD,US,US,2020,Q3,Elderly
178760782,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Insomnia,,2020,Q3,2,F,202005.0,20200713.0,20200609,20200723,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200723.0,,MD,US,US,2020,Q3,Elderly
178760782,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Loss of consciousness,,2020,Q3,2,F,202005.0,20200713.0,20200609,20200723,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200723.0,,MD,US,US,2020,Q3,Elderly
178760782,17876078,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Somnolence,,2020,Q3,2,F,202005.0,20200713.0,20200609,20200723,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2020-PIM-001794,ACADIA PHARMACEUTICALS,,69.0,YR,,F,Y,,,20200723.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Anaemia,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Dizziness,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Dyspnoea,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Fluid overload,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Haematocrit decreased,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Haemoglobin decreased,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Hypotension,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Incorrect dose administered,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Internal haemorrhage,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Mineral supplementation,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Muscle spasms,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Pain in extremity,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Red blood cell count decreased,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178773385,17877338,15,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 U, QAM",,,,,,,,,,,QD,2020,Q3,Transfusion,,2020,Q3,5,F,20200622.0,20200708.0,20200609,20200722,EXP,,US-ACTELION-A-NJ2020-205426,ACTELION,,73.0,YR,,M,Y,,,20200722.0,,MD,US,US,2020,Q3,Elderly
178782652,17878265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200514.0,20200715.0,20200609,20200717,EXP,,US-GILEAD-2020-0470883,GILEAD,,70.0,YR,E,M,Y,95.5,KG,20200717.0,,PH,US,US,2020,Q3,Elderly
178782652,17878265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,COVID-19 pneumonia,,2020,Q3,2,F,20200514.0,20200715.0,20200609,20200717,EXP,,US-GILEAD-2020-0470883,GILEAD,,70.0,YR,E,M,Y,95.5,KG,20200717.0,,PH,US,US,2020,Q3,Elderly
178782652,17878265,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,2,F,20200514.0,20200715.0,20200609,20200717,EXP,,US-GILEAD-2020-0470883,GILEAD,,70.0,YR,E,M,Y,95.5,KG,20200717.0,,PH,US,US,2020,Q3,Elderly
178812264,17881226,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,4,F,20200527.0,20200728.0,20200610,20200731,EXP,,US-GILEAD-2020-0470048,GILEAD,,69.0,YR,E,M,Y,,,20200731.0,,HP,US,US,2020,Q3,Elderly
178836653,17883665,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,COVID-19 pneumonia,,2020,Q3,3,F,20200325.0,20200714.0,20200611,20200721,EXP,,ES-ASTELLAS-2020US018491,ASTELLAS,,73.0,YR,,M,Y,,,20200721.0,,MD,ES,ES,2020,Q3,Elderly
178836653,17883665,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2020,Q3,Endocarditis noninfective,,2020,Q3,3,F,20200325.0,20200714.0,20200611,20200721,EXP,,ES-ASTELLAS-2020US018491,ASTELLAS,,73.0,YR,,M,Y,,,20200721.0,,MD,ES,ES,2020,Q3,Elderly
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Abdominal pain upper,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,CREST syndrome,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Fall,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hand fracture,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hiatus hernia,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Injection site bruising,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pain,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pelvic fracture,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Rheumatoid arthritis,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Upper limb fracture,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178919862,17891986,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, 0F527A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2017.0,20200814.0,20200612,20200825,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003127,ELI LILLY AND CO,,61.0,YR,,F,Y,96.0,KG,20200825.0,,CN,ES,ES,2020,Q3,Adult
178925972,17892597,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,20200531.0,20200630.0,20200612,20200702,EXP,,US-GILEAD-2020-0470641,GILEAD,,75.0,YR,E,M,Y,80.8,KG,20200702.0,,HP,US,US,2020,Q3,Elderly
178925972,17892597,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,2,F,20200531.0,20200630.0,20200612,20200702,EXP,,US-GILEAD-2020-0470641,GILEAD,,75.0,YR,E,M,Y,80.8,KG,20200702.0,,HP,US,US,2020,Q3,Elderly
178957343,17895734,23,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 UNITS, EVERY MONRING",10.0,IU,,,,,,5.0,IU,,QD,2020,Q3,Long QT syndrome,,2020,Q3,3,F,20200608.0,20200709.0,20200615,20200721,EXP,,"US-KARYOPHARM THERAPEUTICS, INC.-2020KPT000647",KARYOPHARM THERAPEUTICS,,47.0,YR,,M,Y,73.0,KG,20200721.0,,CN,US,US,2020,Q3,Adult
178969532,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178969532,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Condition aggravated,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178969532,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Decreased appetite,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178969532,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Dizziness,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178969532,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178969532,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,,,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178969532,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,,,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Condition aggravated,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178969532,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,,,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Decreased appetite,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178969532,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,,,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dizziness,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178969532,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,,,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,202005.0,20200701.0,20200615,20200710,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20200710.0,,CN,ES,ES,2020,Q3,Adult
178974444,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2020,Q3,Gastric pneumatosis,,2020,Q3,4,F,20200530.0,20200714.0,20200615,20200723,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20200723.0,,MD,JP,JP,2020,Q3,Adult
178974444,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2020,Q3,Gastric ulcer,,2020,Q3,4,F,20200530.0,20200714.0,20200615,20200723,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20200723.0,,MD,JP,JP,2020,Q3,Adult
178974444,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2020,Q3,Gastritis,,2020,Q3,4,F,20200530.0,20200714.0,20200615,20200723,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20200723.0,,MD,JP,JP,2020,Q3,Adult
178974444,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2020,Q3,Gastritis erosive,,2020,Q3,4,F,20200530.0,20200714.0,20200615,20200723,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20200723.0,,MD,JP,JP,2020,Q3,Adult
178974444,17897444,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,,, UNKNOWN,,,22.0,IU,,QD,2020,Q3,Portal venous gas,,2020,Q3,4,F,20200530.0,20200714.0,20200615,20200723,EXP,,JP-NOVOPROD-732754,NOVO NORDISK,,35.0,YR,,M,Y,95.9,KG,20200723.0,,MD,JP,JP,2020,Q3,Adult
179022037,17902203,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,7,F,20200527.0,20200720.0,20200616,20200729,EXP,,GB-ROCHE-2615238,ROCHE,,79.0,YR,,M,Y,73.1,KG,20200729.0,,MD,GB,GB,2020,Q3,Elderly
179022037,17902203,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Cytokine release syndrome,,2020,Q3,7,F,20200527.0,20200720.0,20200616,20200729,EXP,,GB-ROCHE-2615238,ROCHE,,79.0,YR,,M,Y,73.1,KG,20200729.0,,MD,GB,GB,2020,Q3,Elderly
179042023,17904202,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"15 INTERNATIONAL UNIT (15 UI), ONCE A DAY",75.0,IU,U,,,,,15.0,IU,,QD,2020,Q3,Therapeutic product ineffective,,2020,Q3,3,F,20200506.0,20200627.0,20200617,20200701,EXP,,CO-AUROBINDO-AUR-APL-2020-029750,AUROBINDO,,36.0,YR,,F,Y,52.0,KG,20200701.0,,PH,CO,CO,2020,Q3,Adult
179091642,17909164,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Alopecia,,2020,Q3,2,F,201510.0,20200922.0,20200617,20200928,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200928.0,,LW,US,US,2020,Q3,Adult
179091642,17909164,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hair colour changes,,2020,Q3,2,F,201510.0,20200922.0,20200617,20200928,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200928.0,,LW,US,US,2020,Q3,Adult
179091642,17909164,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hair disorder,,2020,Q3,2,F,201510.0,20200922.0,20200617,20200928,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200928.0,,LW,US,US,2020,Q3,Adult
179091642,17909164,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hair texture abnormal,,2020,Q3,2,F,201510.0,20200922.0,20200617,20200928,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200928.0,,LW,US,US,2020,Q3,Adult
179091642,17909164,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Madarosis,,2020,Q3,2,F,201510.0,20200922.0,20200617,20200928,PER,,US-PFIZER INC-2020235144,PFIZER,,56.0,YR,,F,Y,,,20200928.0,,LW,US,US,2020,Q3,Adult
179109464,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q3,Drug interaction,,2020,Q3,4,F,201808.0,20200831.0,20200618,20200904,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
179109464,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q3,Eye movement disorder,,2020,Q3,4,F,201808.0,20200831.0,20200618,20200904,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
179109464,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q3,Movement disorder,,2020,Q3,4,F,201808.0,20200831.0,20200618,20200904,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
179109464,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q3,Muscle spasms,,2020,Q3,4,F,201808.0,20200831.0,20200618,20200904,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
179109464,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q3,Oculogyric crisis,,2020,Q3,4,F,201808.0,20200831.0,20200618,20200904,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
179109464,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q3,Off label use,,2020,Q3,4,F,201808.0,20200831.0,20200618,20200904,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
179109464,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q3,Product use issue,,2020,Q3,4,F,201808.0,20200831.0,20200618,20200904,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
179109464,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q3,Seizure,,2020,Q3,4,F,201808.0,20200831.0,20200618,20200904,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
179109464,17910946,23,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD",,,,,,,,15.0,IU,,QD,2020,Q3,Status epilepticus,,2020,Q3,4,F,201808.0,20200831.0,20200618,20200904,EXP,,NVSC2020DE169310,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200904.0,,MD,DE,DE,2020,Q3,Elderly
179197772,17919777,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,5 UNITS,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,2,F,20200602.0,20200916.0,20200619,20200921,EXP,,US-GILEAD-2020-0473916,GILEAD,,48.0,YR,A,M,Y,113.38,KG,20200921.0,,PH,US,US,2020,Q3,Adult
179197912,17919791,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,24.0,IU,,QD,2020,Q3,Pancreatitis acute,,2020,Q3,2,F,20191023.0,20200720.0,20200619,20200724,EXP,,"CO-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-119365",BOEHRINGER INGELHEIM,,63.0,YR,,F,Y,76.0,KG,20200724.0,,MD,CO,CO,2020,Q3,Adult
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Acute respiratory distress syndrome,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Arthralgia,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Candida infection,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Cardiac failure acute,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Ecchymosis,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Erysipelas,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Escherichia infection,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Fungal infection,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Generalised oedema,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Product use in unapproved indication,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Serratia infection,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Spinal pain,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Subcutaneous haematoma,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Tooth infection,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179198162,17919816,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,100 IU/ML,,,,,,,,,,,,2020,Q3,Urosepsis,,2020,Q3,2,F,2019.0,20200715.0,20200619,20200724,EXP,,FR-SAMSUNG BIOEPIS-SB-2020-18910,SAMSUNG BIOEPIS,,78.0,YR,E,M,Y,85.0,KG,20200724.0,,MD,FR,FR,2020,Q3,Elderly
179279712,17927971,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,1.0,DF,INJECTION,QD,2020,Q3,Drug interaction,,2020,Q3,2,F,20200108.0,20200708.0,20200623,20200710,EXP,,IT-EMD SERONO-9170261,EMD SERONO INC,,81.0,YR,,M,Y,,,20200710.0,,MD,IT,IT,2020,Q3,Elderly
179279712,17927971,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,Y,,,,,1.0,DF,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,20200108.0,20200708.0,20200623,20200710,EXP,,IT-EMD SERONO-9170261,EMD SERONO INC,,81.0,YR,,M,Y,,,20200710.0,,MD,IT,IT,2020,Q3,Elderly
179386182,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2020,Q3,Anaemia,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2020,Q3,Electrolyte imbalance,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2020,Q3,Hyperkalaemia,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2020,Q3,Product monitoring error,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179386182,17938618,12,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT,0?0?16?0",,,U,,,,,300.0,IU,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200629.0,20200625,20200706,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20200706.0,,HP,DE,DE,2020,Q3,Elderly
179400342,17940034,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,2,F,20200614.0,20200710.0,20200624,20200715,EXP,,US-GILEAD-2020-0473153,GILEAD,,78.0,YR,E,F,Y,76.2,KG,20200715.0,,HP,US,US,2020,Q3,Elderly
179424402,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU UNK,,,U,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU UNK,,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU UNK,,,U,,,,,,,,,2020,Q3,Hyperkalaemia,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU UNK,,,U,,,,,,,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU UNK,,,U,,,,,,,,,2020,Q3,Product monitoring error,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179424402,17942440,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU UNK,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200707.0,20200624,20200715,EXP,,DE-ANIPHARMA-2020-DE-000141,ANI,,70.0,YR,,M,Y,78.0,KG,20200715.0,,PH,DE,DE,2020,Q3,Elderly
179425635,17942563,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Anaemia,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Electrolyte imbalance,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Hyperkalaemia,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Product monitoring error,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179425635,17942563,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Renal impairment,,2020,Q3,5,F,,20200715.0,20200625,20200717,EXP,,DE-PFIZER INC-2020243867,PFIZER,,70.0,YR,,M,Y,78.0,KG,20200717.0,,HP,DE,DE,2020,Q3,Elderly
179437972,17943797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Escherichia infection,,2020,Q3,2,F,201910.0,20200708.0,20200625,20200714,EXP,,US-ROCHE-2627386,ROCHE,,67.0,YR,,F,Y,,,20200714.0,,CN,US,US,2020,Q3,Elderly
179437972,17943797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,2,F,201910.0,20200708.0,20200625,20200714,EXP,,US-ROCHE-2627386,ROCHE,,67.0,YR,,F,Y,,,20200714.0,,CN,US,US,2020,Q3,Elderly
179437972,17943797,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,White blood cell count increased,,2020,Q3,2,F,201910.0,20200708.0,20200625,20200714,EXP,,US-ROCHE-2627386,ROCHE,,67.0,YR,,F,Y,,,20200714.0,,CN,US,US,2020,Q3,Elderly
179464842,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179464842,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179464842,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Fluid retention,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179464842,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179464842,17946484,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pancreatic disorder,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179464842,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179464842,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179464842,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Fluid retention,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179464842,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179464842,17946484,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pancreatic disorder,,2020,Q3,2,F,2020.0,20200811.0,20200626,20200819,EXP,,ES-AUROBINDO-AUR-APL-2020-031001,AUROBINDO,,56.0,YR,,M,Y,132.0,KG,20200819.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Fluid retention,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pancreatic disorder,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Fluid retention,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179488982,17948898,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE INCREASED,,,,, 0F580A,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pancreatic disorder,,2020,Q3,2,F,2020.0,20200813.0,20200626,20200821,EXP,,ES-BAUSCH-BL-2020-017852,BAUSCH AND LOMB,,56.0,YR,,M,Y,132.0,KG,20200821.0,,CN,ES,ES,2020,Q3,Adult
179529062,17952906,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?16?0",,,,,,,,300.0,IU,,,2020,Q3,Anaemia,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?16?0",,,,,,,,300.0,IU,,,2020,Q3,Electrolyte imbalance,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?16?0",,,,,,,,300.0,IU,,,2020,Q3,Hyperkalaemia,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?16?0",,,,,,,,300.0,IU,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?16?0",,,,,,,,300.0,IU,,,2020,Q3,Product monitoring error,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179529062,17952906,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?16?0",,,,,,,,300.0,IU,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200701.0,20200627,20200709,EXP,DE-BFARM-20006678,DE-ACCORD-186635,ACCORD,,70.0,YR,E,M,Y,78.0,KG,20200709.0,,HP,DE,DE,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Acidosis,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,C-reactive protein increased,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Food intolerance,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Glycosuria,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Hypophosphataemia,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Ketonuria,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Leukocytosis,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Metabolic acidosis,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Nausea,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Neutrophilia,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179569732,17956973,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,2,F,,20200622.0,20200629,20200701,EXP,,PT-EMD SERONO-E2B_90078253,EMD SERONO INC,"PEREIRA F, PINTO J, MEIRELES D, ALMEIDA P, PINHEIRO B, ARAUJO A. EUGLICAEMIC DIABETIC KETOACIDOSIS SGLT2 INHIBITORS MAY BE GUILTY. REVISTA PORTUGUESA DE DIABETES. 2019?14 (1SUPPL):47?122.",70.0,YR,,M,Y,,,20200701.0,,HP,PT,PT,2020,Q3,Elderly
179572512,17957251,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNIT, QD",,,,,,,,24.0,DF,,QD,2020,Q3,Confusional state,,2020,Q3,2,F,,20200630.0,20200629,20200703,EXP,,FR-PFIZER INC-2020245373,PFIZER,,75.0,YR,,M,Y,82.0,KG,20200703.0,,HP,FR,FR,2020,Q3,Elderly
179572512,17957251,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 UNIT, QD",,,,,,,,24.0,DF,,QD,2020,Q3,Fall,,2020,Q3,2,F,,20200630.0,20200629,20200703,EXP,,FR-PFIZER INC-2020245373,PFIZER,,75.0,YR,,M,Y,82.0,KG,20200703.0,,HP,FR,FR,2020,Q3,Elderly
179589604,17958960,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,Exposure during pregnancy,,2020,Q3,4,F,20200620.0,20200916.0,20200629,20200921,EXP,,US-FRESENIUS KABI-FK202006367,FRESENIUS KABI,,33.0,YR,,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Young Adult
179589604,17958960,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,Hypotension,,2020,Q3,4,F,20200620.0,20200916.0,20200629,20200921,EXP,,US-FRESENIUS KABI-FK202006367,FRESENIUS KABI,,33.0,YR,,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Young Adult
179589604,17958960,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,Product use issue,,2020,Q3,4,F,20200620.0,20200916.0,20200629,20200921,EXP,,US-FRESENIUS KABI-FK202006367,FRESENIUS KABI,,33.0,YR,,F,Y,,,20200921.0,,HP,US,US,2020,Q3,Young Adult
179654404,17965440,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Anaemia,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Electrolyte imbalance,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Hyperkalaemia,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Intentional product misuse,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Labelled drug-drug interaction medication error,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Product monitoring error,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179654404,17965440,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,,,2020,Q3,Renal impairment,,2020,Q3,4,F,,20200715.0,20200630,20200723,EXP,,DE-MYLANLABS-2020M1059330,MYLAN,,70.0,YR,,M,Y,78.0,KG,20200723.0,,HP,DE,DE,2020,Q3,Elderly
179658383,17965838,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Oesophageal carcinoma,,2020,Q3,3,F,20200627.0,20200804.0,20200701,20200807,EXP,,DE-ROCHE-2633635,ROCHE,,63.0,YR,,M,Y,72.0,KG,20200807.0,,MD,DE,DE,2020,Q3,Adult
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,36 IU,,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Anal incontinence,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Asthenia,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Boredom,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Malaise,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Product storage error,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pseudohypoglycaemia,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Psychiatric symptom,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179664993,17966499,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,Y,,,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Tremor,,2020,Q3,3,F,2020.0,20200727.0,20200630,20200803,EXP,,NVSC2020ES181551,NOVARTIS,,84.0,YR,,F,Y,80.0,KG,20200803.0,,HP,ES,ES,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Acute hepatic failure,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Ascites,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Asthenia,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Cerebral haemorrhage,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Chronic hepatitis B,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Diabetes mellitus,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Emphysema,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Enterococcal infection,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Hepatic cirrhosis,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Liver disorder,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Oedema,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Peritonitis bacterial,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Pleural effusion,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Streptococcal infection,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Thrombocytopenia,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179668061,17966806,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,30.0,IU,,BID,2020,Q3,Varices oesophageal,,2020,Q3,1,I,,20200624.0,20200701,20200701,EXP,,US-BAUSCH-BL-2020-018312,BAUSCH AND LOMB,,65.0,YR,,F,Y,46.5,KG,20200701.0,,MD,US,US,2020,Q3,Elderly
179673541,17967354,4,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,"INJECTION LIQUID, 100 UNITS / ML, THERAPY START DATE : ASKU, THERAPY END DATE: ASKU",,,,, UNKNOWN,,,,,,,2020,Q3,Drug reaction with eosinophilia and systemic symptoms,,2020,Q3,1,I,20200413.0,20200623.0,20200701,20200701,EXP,NL-LRB-00390453,NL-TEVA-2020-NL-1792934,TEVA,,73.0,YR,,M,Y,85.3,KG,20200701.0,,MD,NL,NL,2020,Q3,Elderly
179771591,17977159,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,U,,,,,12.0,IU,,QD,2020,Q3,Immune-mediated myositis,,2020,Q3,1,I,,20200701.0,20200702,20200702,EXP,,NVSC2020CZ186447,NOVARTIS,,75.0,YR,,,Y,,,20200703.0,,HP,CZ,CZ,2020,Q3,Elderly
179773622,17977362,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Other,"300 UNIT, PEN",,,,,,,,,,,QD,2020,Q3,Bladder neoplasm,,2020,Q3,2,F,20200604.0,20200701.0,20200702,20200706,EXP,,DE-ABBVIE-20K-062-3466093-00,ABBVIE,,71.0,YR,,F,Y,75.0,KG,20200705.0,,MD,DE,DE,2020,Q3,Elderly
179798332,17979833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT (56 IU),,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT (56 IU),,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT (56 IU),,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Fluid retention,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT (56 IU),,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Intentional product misuse,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT (56 IU),,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Medication error,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT (56 IU),,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 INTERNATIONAL UNIT (56 IU),,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pancreatic disorder,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Fluid retention,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Intentional product misuse,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Medication error,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179798332,17979833,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pancreatic disorder,,2020,Q3,2,F,2020.0,20200818.0,20200703,20200825,EXP,,ES-MYLANLABS-2020M1059652,MYLAN,,56.0,YR,,M,Y,132.0,KG,20200825.0,,HP,ES,ES,2020,Q3,Adult
179842644,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute respiratory distress syndrome,,2020,Q3,4,F,20200325.0,20200728.0,20200706,20200804,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20200804.0,,MD,DE,DE,2020,Q3,Adult
179842644,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,COVID-19 pneumonia,,2020,Q3,4,F,20200325.0,20200728.0,20200706,20200804,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20200804.0,,MD,DE,DE,2020,Q3,Adult
179842644,17984264,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Headache,,2020,Q3,4,F,20200325.0,20200728.0,20200706,20200804,EXP,,DE-ABBVIE-20K-062-3470530-00,ABBVIE,,53.0,YR,,F,Y,,,20200804.0,,MD,DE,DE,2020,Q3,Adult
179862381,17986238,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypersensitivity vasculitis,,2020,Q3,1,I,,20200706.0,20200706,20200706,EXP,,ES-ANIPHARMA-2020-ES-000076,ANI,"MARTIN GUERRA JM, MARTIN ASENJO M, NOVOA FERNANDEZ C, PRIETO DE PAULA JM.COTRIMOXAZOLE?INDUCED LEUKOCYTOCLASTIC VASCULITIS..REVISTA ESPANOLA DE GERIATRIA Y GERONTOLOGIA.2020?55(3):181?182.",80.0,YR,,M,Y,,,20200706.0,,HP,ES,ES,2020,Q3,Elderly
179876651,17987665,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Intestinal ischaemia,,2020,Q3,1,I,,20190706.0,20200707,20200707,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-214432,RANBAXY,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN?ASSOCIATED LACTIC ACIDOSIS PRESENTING LIKE ACUTE MESENTERIC ISCHEMIA. J EMERG MED. 2019?JUN 24:EPUB AHEAD OF PRINT]",60.0,YR,,F,Y,,,20200707.0,,MD,US,US,2020,Q3,Adult
179876651,17987665,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Lactic acidosis,,2020,Q3,1,I,,20190706.0,20200707,20200707,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2019R1-214432,RANBAXY,"ZHANG QC, HASTINGS C, JOHNSON K, SLAVEN E. METFORMIN?ASSOCIATED LACTIC ACIDOSIS PRESENTING LIKE ACUTE MESENTERIC ISCHEMIA. J EMERG MED. 2019?JUN 24:EPUB AHEAD OF PRINT]",60.0,YR,,F,Y,,,20200707.0,,MD,US,US,2020,Q3,Adult
179884263,17988426,2,C,GLARGINE INSULIN,INSULIN GLARGINE,1,Subcutaneous,25 UNIT DAILY AT TEN AM,,,,,,,,,,INJECTION,,2020,Q3,Ketoacidosis,,2020,Q3,3,F,20200628.0,20200731.0,20200707,20200810,EXP,,CN-ASTRAZENECA-2020SE83926,ASTRAZENECA,,51.0,YR,,M,Y,57.0,KG,20200810.0,,,CN,CN,2020,Q3,Adult
179890121,17989012,6,C,Insulin glargine 6 units,,2,,,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,20200702.0,,20200707,20200707,DIR,,,FDA-CTU,,53.0,YR,,M,N,85.5,KG,20200707.0,N,PH,US,US,2020,Q3,Adult
179890121,17989012,6,C,Insulin glargine 6 units,,2,,,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,20200702.0,,20200707,20200707,DIR,,,FDA-CTU,,53.0,YR,,M,N,85.5,KG,20200707.0,N,PH,US,US,2020,Q3,Adult
179895821,17989582,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200616.0,20200702.0,20200707,20200707,EXP,,US-GILEAD-2020-0479372,GILEAD,,48.0,YR,A,M,Y,110.9,KG,20200707.0,,PH,US,US,2020,Q3,Adult
179929611,17992961,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200629.0,20200702.0,20200707,20200707,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-053065,BRISTOL MYERS SQUIBB,,91.0,YR,,M,Y,,,20200707.0,,CN,US,US,2020,Q3,Elderly
179938081,17993808,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200703.0,,20200707,20200707,DIR,,,FDA-CTU,,46.0,YR,,M,N,159.8,KG,20200707.0,N,HP,US,US,2020,Q3,Adult
179939752,17993975,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INJECT 7?12 UNITS UNDER THE SKIN DAILY.,,,,,,,,1.0,DF,,QD,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,2,F,20180421.0,20200805.0,20200708,20200809,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-034346",BOEHRINGER INGELHEIM,,85.0,YR,,M,Y,68.04,KG,20200809.0,,CN,US,US,2020,Q3,Elderly
179955031,17995503,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Arthralgia,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,CA-TEVA-2020-CA-1797334,TEVA,,42.0,YR,,F,Y,,,20200708.0,,HP,CA,CA,2020,Q3,Adult
179955031,17995503,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,CA-TEVA-2020-CA-1797334,TEVA,,42.0,YR,,F,Y,,,20200708.0,,HP,CA,CA,2020,Q3,Adult
179955031,17995503,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,CA-TEVA-2020-CA-1797334,TEVA,,42.0,YR,,F,Y,,,20200708.0,,HP,CA,CA,2020,Q3,Adult
179955031,17995503,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Gait inability,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,CA-TEVA-2020-CA-1797334,TEVA,,42.0,YR,,F,Y,,,20200708.0,,HP,CA,CA,2020,Q3,Adult
179955031,17995503,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Headache,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,CA-TEVA-2020-CA-1797334,TEVA,,42.0,YR,,F,Y,,,20200708.0,,HP,CA,CA,2020,Q3,Adult
179955031,17995503,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Hypoaesthesia,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,CA-TEVA-2020-CA-1797334,TEVA,,42.0,YR,,F,Y,,,20200708.0,,HP,CA,CA,2020,Q3,Adult
179955031,17995503,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Lower respiratory tract infection,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,CA-TEVA-2020-CA-1797334,TEVA,,42.0,YR,,F,Y,,,20200708.0,,HP,CA,CA,2020,Q3,Adult
179955031,17995503,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Pharyngitis,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,CA-TEVA-2020-CA-1797334,TEVA,,42.0,YR,,F,Y,,,20200708.0,,HP,CA,CA,2020,Q3,Adult
179955031,17995503,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Toothache,,2020,Q3,1,I,,20200701.0,20200708,20200708,EXP,,CA-TEVA-2020-CA-1797334,TEVA,,42.0,YR,,F,Y,,,20200708.0,,HP,CA,CA,2020,Q3,Adult
179971791,17997179,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 DOSAGE FORM, QD (2X PER DAY BEFORE BREAKFAST AND BEFORE DINNER)",,,D,,,,210605.0,2.0,DF,INJECTION,QD,2020,Q3,Blood glucose abnormal,,2020,Q3,1,I,,20200602.0,20200708,20200708,EXP,,PL-MYLANLABS-2020M1053852,MYLAN,"GAJDA P, PASTERCZYK?BIELSKA K, DZIDA G.. PATIENTS PROFILES IN WHOM IT IS WORTH TO USE METFORMIN. MEDYCYNA FAKTOW. 2019?4(45):340?343",70.0,YR,,F,Y,31.0,KG,20200708.0,,MD,PL,PL,2020,Q3,Elderly
179971791,17997179,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 DOSAGE FORM, QD (2X PER DAY BEFORE BREAKFAST AND BEFORE DINNER)",,,D,,,,210605.0,2.0,DF,INJECTION,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200602.0,20200708,20200708,EXP,,PL-MYLANLABS-2020M1053852,MYLAN,"GAJDA P, PASTERCZYK?BIELSKA K, DZIDA G.. PATIENTS PROFILES IN WHOM IT IS WORTH TO USE METFORMIN. MEDYCYNA FAKTOW. 2019?4(45):340?343",70.0,YR,,F,Y,31.0,KG,20200708.0,,MD,PL,PL,2020,Q3,Elderly
179971791,17997179,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 DOSAGE FORM, QD (2X PER DAY BEFORE BREAKFAST AND BEFORE DINNER)",,,D,,,,210605.0,2.0,DF,INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,,20200602.0,20200708,20200708,EXP,,PL-MYLANLABS-2020M1053852,MYLAN,"GAJDA P, PASTERCZYK?BIELSKA K, DZIDA G.. PATIENTS PROFILES IN WHOM IT IS WORTH TO USE METFORMIN. MEDYCYNA FAKTOW. 2019?4(45):340?343",70.0,YR,,F,Y,31.0,KG,20200708.0,,MD,PL,PL,2020,Q3,Elderly
179971791,17997179,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 DOSAGE FORM, QD (2X PER DAY BEFORE BREAKFAST AND BEFORE DINNER)",,,D,,,,210605.0,2.0,DF,INJECTION,QD,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,,20200602.0,20200708,20200708,EXP,,PL-MYLANLABS-2020M1053852,MYLAN,"GAJDA P, PASTERCZYK?BIELSKA K, DZIDA G.. PATIENTS PROFILES IN WHOM IT IS WORTH TO USE METFORMIN. MEDYCYNA FAKTOW. 2019?4(45):340?343",70.0,YR,,F,Y,31.0,KG,20200708.0,,MD,PL,PL,2020,Q3,Elderly
179971791,17997179,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"2 DOSAGE FORM, QD (2X PER DAY BEFORE BREAKFAST AND BEFORE DINNER)",,,D,,,,210605.0,2.0,DF,INJECTION,QD,2020,Q3,Therapeutic product effect incomplete,,2020,Q3,1,I,,20200602.0,20200708,20200708,EXP,,PL-MYLANLABS-2020M1053852,MYLAN,"GAJDA P, PASTERCZYK?BIELSKA K, DZIDA G.. PATIENTS PROFILES IN WHOM IT IS WORTH TO USE METFORMIN. MEDYCYNA FAKTOW. 2019?4(45):340?343",70.0,YR,,F,Y,31.0,KG,20200708.0,,MD,PL,PL,2020,Q3,Elderly
179975183,17997518,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 U, QAM",,,,,,,,,,,QD,2020,Q3,Abscess limb,,2020,Q3,3,F,20200423.0,20200812.0,20200708,20200821,EXP,,US-ACTELION-A-US2020-206296,ACTELION,,61.0,YR,,F,Y,106.58,KG,20200821.0,,MD,US,US,2020,Q3,Adult
179975183,17997518,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 U, QAM",,,,,,,,,,,QD,2020,Q3,Diarrhoea,,2020,Q3,3,F,20200423.0,20200812.0,20200708,20200821,EXP,,US-ACTELION-A-US2020-206296,ACTELION,,61.0,YR,,F,Y,106.58,KG,20200821.0,,MD,US,US,2020,Q3,Adult
179975183,17997518,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 U, QAM",,,,,,,,,,,QD,2020,Q3,Malaise,,2020,Q3,3,F,20200423.0,20200812.0,20200708,20200821,EXP,,US-ACTELION-A-US2020-206296,ACTELION,,61.0,YR,,F,Y,106.58,KG,20200821.0,,MD,US,US,2020,Q3,Adult
179975183,17997518,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 U, QAM",,,,,,,,,,,QD,2020,Q3,Pancreatic cyst,,2020,Q3,3,F,20200423.0,20200812.0,20200708,20200821,EXP,,US-ACTELION-A-US2020-206296,ACTELION,,61.0,YR,,F,Y,106.58,KG,20200821.0,,MD,US,US,2020,Q3,Adult
179993961,17999396,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q3,Impaired healing,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187500,NOVARTIS,,63.0,YR,,M,Y,,,20200709.0,,HP,DE,DE,2020,Q3,Adult
179993961,17999396,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q3,Localised infection,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187500,NOVARTIS,,63.0,YR,,M,Y,,,20200709.0,,HP,DE,DE,2020,Q3,Adult
179993961,17999396,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q3,Peripheral arterial occlusive disease,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187500,NOVARTIS,,63.0,YR,,M,Y,,,20200709.0,,HP,DE,DE,2020,Q3,Adult
179993961,17999396,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q3,Ulcer,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187500,NOVARTIS,,63.0,YR,,M,Y,,,20200709.0,,HP,DE,DE,2020,Q3,Adult
179993961,17999396,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK MG, ACCORDING TO THE SCHEME",,,U,,,,,,,,,2020,Q3,Wound,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187500,NOVARTIS,,63.0,YR,,M,Y,,,20200709.0,,HP,DE,DE,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Abdominal discomfort,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Blood alkaline phosphatase increased,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Cholestasis,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Dry mouth,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Jaundice,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Neutrophil count increased,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Ocular icterus,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Portal tract inflammation,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180000581,18000058,4,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,White blood cell count increased,,2020,Q3,1,I,20200617.0,,20200709,20200709,DIR,,,FDA-CTU,,51.0,YR,,M,N,67.0,KG,20200709.0,N,MD,US,US,2020,Q3,Adult
180004601,18000460,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200708.0,,20200709,20200709,DIR,,,FDA-CTU,,66.0,YR,,F,N,85.9,KG,20200709.0,N,PH,US,US,2020,Q3,Elderly
180004601,18000460,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,20200708.0,,20200709,20200709,DIR,,,FDA-CTU,,66.0,YR,,F,N,85.9,KG,20200709.0,N,PH,US,US,2020,Q3,Elderly
180004601,18000460,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,20200708.0,,20200709,20200709,DIR,,,FDA-CTU,,66.0,YR,,F,N,85.9,KG,20200709.0,N,PH,US,US,2020,Q3,Elderly
180005431,18000543,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,20200702.0,,20200709,20200709,DIR,,,FDA-CTU,,61.0,YR,,M,N,111.0,KG,20200709.0,N,HP,US,US,2020,Q3,Adult
180005931,18000593,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2020,Q3,Cholestasis,,2020,Q3,1,I,20200323.0,20200629.0,20200709,20200709,EXP,FR-AFSSAPS-AM20200742,FR-MYLANLABS-2020M1060707,MYLAN,,76.0,YR,,M,Y,75.0,KG,20200709.0,,PH,FR,FR,2020,Q3,Elderly
180005931,18000593,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2020,Q3,Hypertransaminasaemia,,2020,Q3,1,I,20200323.0,20200629.0,20200709,20200709,EXP,FR-AFSSAPS-AM20200742,FR-MYLANLABS-2020M1060707,MYLAN,,76.0,YR,,M,Y,75.0,KG,20200709.0,,PH,FR,FR,2020,Q3,Elderly
180025371,18002537,5,SS,Insulin glargine,INSULIN GLARGINE,1,Parenteral,UNK,,,D,,,,,,,,,2020,Q3,Completed suicide,,2020,Q3,1,I,,20200630.0,20200710,20200710,EXP,,US-AUROBINDO-AUR-APL-2020-032476,AUROBINDO,,37.0,YR,,M,Y,,,20200710.0,,HP,US,US,2020,Q3,Adult
180025371,18002537,6,SS,Insulin glargine,INSULIN GLARGINE,1,Oral,UNK,,,D,,,,,,,,,2020,Q3,Completed suicide,,2020,Q3,1,I,,20200630.0,20200710,20200710,EXP,,US-AUROBINDO-AUR-APL-2020-032476,AUROBINDO,,37.0,YR,,M,Y,,,20200710.0,,HP,US,US,2020,Q3,Adult
180049071,18004907,5,C,insulin glargine 10 unit subcut qBedtime,,2,,,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,20200707.0,,20200709,20200709,DIR,,,FDA-CTU,,56.0,YR,,M,N,81.0,KG,20200709.0,N,PH,US,US,2020,Q3,Adult
180049071,18004907,5,C,insulin glargine 10 unit subcut qBedtime,,2,,,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,20200707.0,,20200709,20200709,DIR,,,FDA-CTU,,56.0,YR,,M,N,81.0,KG,20200709.0,N,PH,US,US,2020,Q3,Adult
180061131,18006113,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34?0?0?0",,,U,,,,,,,,,2020,Q3,Balance disorder,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187327,NOVARTIS,,75.0,YR,,M,Y,,,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180061131,18006113,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34?0?0?0",,,U,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187327,NOVARTIS,,75.0,YR,,M,Y,,,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180061131,18006113,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34?0?0?0",,,U,,,,,,,,,2020,Q3,Fracture,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187327,NOVARTIS,,75.0,YR,,M,Y,,,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180061131,18006113,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34?0?0?0",,,U,,,,,,,,,2020,Q3,Headache,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187327,NOVARTIS,,75.0,YR,,M,Y,,,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180061131,18006113,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 34?0?0?0",,,U,,,,,,,,,2020,Q3,Musculoskeletal pain,,2020,Q3,1,I,,20200701.0,20200709,20200709,EXP,,NVSC2020DE187327,NOVARTIS,,75.0,YR,,M,Y,,,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IU, QD (450 IE, 0?0?8?0)",,,U,U,,,,450.0,IU,,QD,2020,Q3,Confusional state,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IU, QD (450 IE, 0?0?8?0)",,,U,U,,,,450.0,IU,,QD,2020,Q3,Dehydration,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IU, QD (450 IE, 0?0?8?0)",,,U,U,,,,450.0,IU,,QD,2020,Q3,Fall,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IU, QD (450 IE, 0?0?8?0)",,,U,U,,,,450.0,IU,,QD,2020,Q3,General physical health deterioration,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IU, QD (450 IE, 0?0?8?0)",,,U,U,,,,450.0,IU,,QD,2020,Q3,Muscular weakness,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IU, QD (450 IE, 0?0?8?0)",,,U,U,,,,450.0,IU,,QD,2020,Q3,Somnolence,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 0?0?8?0",,,U,U,,,,,,,,2020,Q3,Confusional state,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 0?0?8?0",,,U,U,,,,,,,,2020,Q3,Dehydration,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 0?0?8?0",,,U,U,,,,,,,,2020,Q3,Fall,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 0?0?8?0",,,U,U,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 0?0?8?0",,,U,U,,,,,,,,2020,Q3,Muscular weakness,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180061532,18006153,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"450 IE, 0?0?8?0",,,U,U,,,,,,,,2020,Q3,Somnolence,,2020,Q3,2,F,20191212.0,20200911.0,20200709,20200916,EXP,,NVSC2020DE188690,NOVARTIS,,81.0,YR,,F,Y,40.0,KG,20200916.0,,HP,DE,DE,2020,Q3,Elderly
180072452,18007245,10,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,INJECTION,,2020,Q3,Fall,,2020,Q3,2,F,20200611.0,20200813.0,20200710,20200822,PER,,US-CELGENEUS-USA-20200702079,CELGENE,,81.0,YR,,M,Y,,,20200822.0,,MD,US,US,2020,Q3,Elderly
180072452,18007245,10,C,Insuline glargine,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,INJECTION,,2020,Q3,Head injury,,2020,Q3,2,F,20200611.0,20200813.0,20200710,20200822,PER,,US-CELGENEUS-USA-20200702079,CELGENE,,81.0,YR,,M,Y,,,20200822.0,,MD,US,US,2020,Q3,Elderly
180076501,18007650,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,210605.0,,,INJECTION,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,,20200701.0,20200710,20200710,EXP,,ES-MYLANLABS-2020M1061780,MYLAN,,75.0,YR,,F,Y,,,20200710.0,,CN,ES,ES,2020,Q3,Elderly
180094754,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Abdominal discomfort,,2020,Q3,4,F,20200818.0,20200825.0,20200710,20200901,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20200901.0,,HP,CO,CO,2020,Q3,Elderly
180094754,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Abdominal pain upper,,2020,Q3,4,F,20200818.0,20200825.0,20200710,20200901,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20200901.0,,HP,CO,CO,2020,Q3,Elderly
180094754,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Chills,,2020,Q3,4,F,20200818.0,20200825.0,20200710,20200901,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20200901.0,,HP,CO,CO,2020,Q3,Elderly
180094754,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Choking,,2020,Q3,4,F,20200818.0,20200825.0,20200710,20200901,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20200901.0,,HP,CO,CO,2020,Q3,Elderly
180094754,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hypertension,,2020,Q3,4,F,20200818.0,20200825.0,20200710,20200901,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20200901.0,,HP,CO,CO,2020,Q3,Elderly
180094754,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Inappropriate schedule of product administration,,2020,Q3,4,F,20200818.0,20200825.0,20200710,20200901,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20200901.0,,HP,CO,CO,2020,Q3,Elderly
180094754,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Incorrect product administration duration,,2020,Q3,4,F,20200818.0,20200825.0,20200710,20200901,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20200901.0,,HP,CO,CO,2020,Q3,Elderly
180094754,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Peripheral swelling,,2020,Q3,4,F,20200818.0,20200825.0,20200710,20200901,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20200901.0,,HP,CO,CO,2020,Q3,Elderly
180094754,18009475,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Product dose omission issue,,2020,Q3,4,F,20200818.0,20200825.0,20200710,20200901,EXP,,CO-BAYER-2019-233236,BAYER,,85.0,YR,E,F,Y,,,20200901.0,,HP,CO,CO,2020,Q3,Elderly
180100631,18010063,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK 0?0?0?12,,,U,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,DE-ADRED-04340-01,NVSC2020DE188542,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180100631,18010063,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK 0?0?0?12,,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,DE-ADRED-04340-01,NVSC2020DE188542,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180100631,18010063,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK 0?0?0?12,,,U,,,,,,,,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,DE-ADRED-04340-01,NVSC2020DE188542,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180100631,18010063,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK 0?0?0?12,,,U,,,,,,,,,2020,Q3,Incontinence,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,DE-ADRED-04340-01,NVSC2020DE188542,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180100631,18010063,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK 0?0?0?12,,,U,,,,,,,,,2020,Q3,Musculoskeletal chest pain,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,DE-ADRED-04340-01,NVSC2020DE188542,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180100631,18010063,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK 0?0?0?12,,,U,,,,,,,,,2020,Q3,Polyuria,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,DE-ADRED-04340-01,NVSC2020DE188542,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180100631,18010063,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK 0?0?0?12,,,U,,,,,,,,,2020,Q3,Product monitoring error,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,DE-ADRED-04340-01,NVSC2020DE188542,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180100631,18010063,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK 0?0?0?12,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,DE-ADRED-04340-01,NVSC2020DE188542,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180100631,18010063,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK 0?0?0?12,,,U,,,,,,,,,2020,Q3,Therapeutic drug monitoring analysis not performed,,2020,Q3,1,I,,20200702.0,20200710,20200710,EXP,DE-ADRED-04340-01,NVSC2020DE188542,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20200710.0,,HP,DE,DE,2020,Q3,Elderly
180125432,18012543,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180125432,18012543,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180125432,18012543,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Fluid retention,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180125432,18012543,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180125432,18012543,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"DOSE INCREASED, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pancreatic disorder,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180125432,18012543,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180125432,18012543,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180125432,18012543,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Fluid retention,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180125432,18012543,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Multiple use of single-use product,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180125432,18012543,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,56 IU,,,,, 0F580A,,,56.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pancreatic disorder,,2020,Q3,2,F,2020.0,20200813.0,20200713,20200818,EXP,,NVSC2020ES191067,NOVARTIS,,56.0,YR,,M,Y,132.0,KG,20200818.0,,HP,ES,ES,2020,Q3,Adult
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Amputation stump pain,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Debridement,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dizziness,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dyspepsia,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Gait inability,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional dose omission,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product misuse,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Skin discolouration,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Toe amputation,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vascular graft,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Visual impairment,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"26 INTERNATIONAL UNIT, ONCE A DAY",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vomiting,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Amputation stump pain,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Debridement,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dizziness,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dyspepsia,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Gait inability,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional dose omission,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product misuse,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Skin discolouration,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Toe amputation,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vascular graft,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Visual impairment,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180180801,18018080,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"28 INTERNATIONAL UNIT, ONCE A DAY",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vomiting,,2020,Q3,1,I,201705.0,20200703.0,20200713,20200713,EXP,,ES-AUROBINDO-AUR-APL-2020-034139,AUROBINDO,,66.0,YR,,F,Y,55.0,KG,20200714.0,,CN,ES,ES,2020,Q3,Elderly
180204491,18020449,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,25.0,IU,UNKNOWN,,2020,Q3,Calciphylaxis,,2020,Q3,1,I,,20200707.0,20200714,20200714,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-03206,HIKMA,"ADAPA S, NARAMALA S, GAYAM V, KODURI N, DAGGUBATI S, PATEL P, KONALA V. CALCIPHYLAXIS IN A PATIENT ON HOME HEMODIALYSIS. JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS? DOI: 10.1177/2324709620922718. 2020?8:1?7.",51.0,YR,,F,Y,,,20200714.0,,MD,US,US,2020,Q3,Adult
180215931,18021593,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypersensitivity vasculitis,,2020,Q3,1,I,,20200706.0,20200714,20200714,EXP,,ES-PAIPHARMA-2020-ES-000082,PHARMACEUTICAL ASSOC,"MARTIN GUERRA JM, MARTIN ASENJO M, NOVOA FERNANDEZ C, PRIETO DE PAULA JM.COTRIMOXAZOLE?INDUCED LEUKOCYTOCLASTIC VASCULITIS..REVISTA ESPANOLA DE GERIATRIA Y GERONTOLOGIA.2020?55(3):181?181.",80.0,YR,,M,Y,,,20200714.0,,HP,ES,ES,2020,Q3,Elderly
180231131,18023113,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 DOSAGE FORM, QD (24 UNIT, QD)",,,,,,,,24.0,DF,,QD,2020,Q3,Confusional state,,2020,Q3,1,I,,20200706.0,20200714,20200714,EXP,,FR-MYLANLABS-2020M1062663,MYLAN,,75.0,YR,,M,Y,82.0,KG,20200714.0,,HP,FR,FR,2020,Q3,Elderly
180231131,18023113,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 DOSAGE FORM, QD (24 UNIT, QD)",,,,,,,,24.0,DF,,QD,2020,Q3,Fall,,2020,Q3,1,I,,20200706.0,20200714,20200714,EXP,,FR-MYLANLABS-2020M1062663,MYLAN,,75.0,YR,,M,Y,82.0,KG,20200714.0,,HP,FR,FR,2020,Q3,Elderly
180231131,18023113,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 DOSAGE FORM, QD (24 UNIT, QD)",,,,,,,,24.0,DF,,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200706.0,20200714,20200714,EXP,,FR-MYLANLABS-2020M1062663,MYLAN,,75.0,YR,,M,Y,82.0,KG,20200714.0,,HP,FR,FR,2020,Q3,Elderly
180240881,18024088,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Cardiotoxicity,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03596,ALKEM,,79.0,YR,,F,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Elderly
180240881,18024088,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03596,ALKEM,,79.0,YR,,F,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Elderly
180240881,18024088,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Toxicity to various agents,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03596,ALKEM,,79.0,YR,,F,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Elderly
180241281,18024128,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Blood pressure systolic decreased,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03599,ALKEM,,67.0,YR,,M,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Elderly
180241281,18024128,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Cardiotoxicity,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03599,ALKEM,,67.0,YR,,M,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Elderly
180241281,18024128,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Heart rate decreased,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03599,ALKEM,,67.0,YR,,M,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Elderly
180241281,18024128,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03599,ALKEM,,67.0,YR,,M,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Elderly
180241281,18024128,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Overdose,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03599,ALKEM,,67.0,YR,,M,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Elderly
180241291,18024129,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Cardiotoxicity,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03598,ALKEM,,57.0,YR,,F,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Adult
180241291,18024129,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03598,ALKEM,,57.0,YR,,F,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Adult
180241291,18024129,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03598,ALKEM,,57.0,YR,,F,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Adult
180241291,18024129,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Overdose,,2020,Q3,1,I,,20200702.0,20200715,20200715,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-03598,ALKEM,,57.0,YR,,F,Y,,,20200715.0,,HP,AU,AU,2020,Q3,Adult
180249851,18024985,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200706.0,20200715,20200715,EXP,,CA-AUROBINDO-AUR-APL-2020-034516,AUROBINDO,,80.0,YR,,F,Y,,,20200715.0,,PH,CA,CA,2020,Q3,Elderly
180249851,18024985,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,SOLUTION,,2020,Q3,Speech disorder,,2020,Q3,1,I,,20200706.0,20200715,20200715,EXP,,CA-AUROBINDO-AUR-APL-2020-034516,AUROBINDO,,80.0,YR,,F,Y,,,20200715.0,,PH,CA,CA,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Amputation stump pain,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Debridement,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dizziness,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dyspepsia,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Gait inability,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional dose omission,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product misuse,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Skin discolouration,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Toe amputation,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vascular graft,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Visual impairment,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vomiting,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Amputation stump pain,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Debridement,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dizziness,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dyspepsia,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Gait inability,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional dose omission,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product misuse,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Skin discolouration,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Toe amputation,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vascular graft,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Visual impairment,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180271191,18027119,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F944A,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vomiting,,2020,Q3,1,I,201705.0,20200705.0,20200715,20200715,EXP,,ES-BAUSCH-BL-2020-019234,BAUSCH AND LOMB,,66.0,YR,,F,Y,55.0,KG,20200715.0,,CN,ES,ES,2020,Q3,Elderly
180277811,18027781,2,I,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",,,Y,U,,,,1.0,DF,,QD,2020,Q3,Drug interaction,,2020,Q3,1,I,20200108.0,20200618.0,20200716,20200716,EXP,,IT-AUROBINDO-AUR-APL-2020-030664,AUROBINDO,,81.0,YR,,M,Y,,,20200716.0,,MD,IT,IT,2020,Q3,Elderly
180277811,18027781,2,I,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",,,Y,U,,,,1.0,DF,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200108.0,20200618.0,20200716,20200716,EXP,,IT-AUROBINDO-AUR-APL-2020-030664,AUROBINDO,,81.0,YR,,M,Y,,,20200716.0,,MD,IT,IT,2020,Q3,Elderly
180296311,18029631,7,C,glargine insulin,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,1,I,20200714.0,,20200715,20200715,DIR,,,FDA-CTU,,62.0,YR,,M,N,91.2,KG,20200715.0,N,PH,US,US,2020,Q3,Adult
180296361,18029636,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, TOTAL",,,Y,,,,205692.0,1.0,DF,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200621.0,20200706.0,20200715,20200715,EXP,FR-AFSSAPS-TS20200538,FR-ELI_LILLY_AND_COMPANY-FR202007002599,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20200715.0,,MD,FR,FR,2020,Q3,Elderly
180296361,18029636,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, TOTAL",,,Y,,,,205692.0,1.0,DF,,,2020,Q3,Product administration error,,2020,Q3,1,I,20200621.0,20200706.0,20200715,20200715,EXP,FR-AFSSAPS-TS20200538,FR-ELI_LILLY_AND_COMPANY-FR202007002599,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20200715.0,,MD,FR,FR,2020,Q3,Elderly
180296361,18029636,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, TOTAL",,,Y,,,,205692.0,1.0,DF,,,2020,Q3,Seizure,,2020,Q3,1,I,20200621.0,20200706.0,20200715,20200715,EXP,FR-AFSSAPS-TS20200538,FR-ELI_LILLY_AND_COMPANY-FR202007002599,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20200715.0,,MD,FR,FR,2020,Q3,Elderly
180296361,18029636,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, TOTAL",,,Y,,,,205692.0,1.0,DF,,,2020,Q3,Wrong patient received product,,2020,Q3,1,I,20200621.0,20200706.0,20200715,20200715,EXP,FR-AFSSAPS-TS20200538,FR-ELI_LILLY_AND_COMPANY-FR202007002599,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20200715.0,,MD,FR,FR,2020,Q3,Elderly
180348393,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose fluctuation,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Cardiac disorder,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site bruising,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Osteoarthritis,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Urinary incontinence,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Vascular stent occlusion,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose fluctuation,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Cardiac disorder,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Injection site bruising,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Osteoarthritis,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Urinary incontinence,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180348393,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Vascular stent occlusion,,2020,Q3,3,F,,20200923.0,20200716,20200929,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20200930.0,,CN,ES,ES,2020,Q3,Adult
180401411,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401411,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Dialysis,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401411,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Disturbance in attention,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401411,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Inability to afford medication,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401411,18040141,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Liver dialysis,,2020,Q3,1,I,,20200713.0,20200717,20200717,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20200717.0,,CN,US,US,2020,Q3,Elderly
180401534,18040153,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2020,Q3,Acute myocardial infarction,,2020,Q3,4,F,202007.0,20200820.0,20200717,20200821,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20200821.0,,PH,US,US,2020,Q3,Elderly
180401534,18040153,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,4,F,202007.0,20200820.0,20200717,20200821,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20200821.0,,PH,US,US,2020,Q3,Elderly
180401534,18040153,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,4,F,202007.0,20200820.0,20200717,20200821,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20200821.0,,PH,US,US,2020,Q3,Elderly
180407401,18040740,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 DF, QD (24 UNIT, QD)",,,D,,,,,24.0,DF,,QD,2020,Q3,Confusional state,,2020,Q3,1,I,,20200706.0,20200717,20200717,EXP,,NVSC2020FR192407,NOVARTIS,,75.0,YR,,M,Y,82.0,KG,20200718.0,,HP,FR,FR,2020,Q3,Elderly
180407401,18040740,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 DF, QD (24 UNIT, QD)",,,D,,,,,24.0,DF,,QD,2020,Q3,Fall,,2020,Q3,1,I,,20200706.0,20200717,20200717,EXP,,NVSC2020FR192407,NOVARTIS,,75.0,YR,,M,Y,82.0,KG,20200718.0,,HP,FR,FR,2020,Q3,Elderly
180407401,18040740,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 DF, QD (24 UNIT, QD)",,,D,,,,,24.0,DF,,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200706.0,20200717,20200717,EXP,,NVSC2020FR192407,NOVARTIS,,75.0,YR,,M,Y,82.0,KG,20200718.0,,HP,FR,FR,2020,Q3,Elderly
180413661,18041366,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,Y,U,,,,1.0,DF,,QD,2020,Q3,Drug interaction,,2020,Q3,1,I,20200108.0,20200618.0,20200719,20200719,EXP,IT-MINISAL02-623139,IT-NOVOPROD-735819,NOVO NORDISK,,81.0,YR,,M,Y,,,20200719.0,,MD,IT,IT,2020,Q3,Elderly
180413661,18041366,1,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD",,,Y,U,,,,1.0,DF,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200108.0,20200618.0,20200719,20200719,EXP,IT-MINISAL02-623139,IT-NOVOPROD-735819,NOVO NORDISK,,81.0,YR,,M,Y,,,20200719.0,,MD,IT,IT,2020,Q3,Elderly
180427601,18042760,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200713.0,,20200717,20200717,DIR,,,FDA-CTU,,62.0,YR,,M,N,50.3,KG,20200717.0,Y,PH,US,US,2020,Q3,Adult
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Amputation stump pain,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dizziness,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dyspepsia,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Gait inability,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional dose omission,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product misuse,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Skin discolouration,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Visual impairment,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"26 IU, QD",,,,, 0F944A,,,26.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vomiting,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Amputation stump pain,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dizziness,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Dyspepsia,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Gait inability,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional dose omission,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product misuse,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Skin discolouration,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Visual impairment,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180427911,18042791,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 IU,QD",,,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Vomiting,,2020,Q3,1,I,201705.0,20200715.0,20200720,20200720,EXP,,NVSC2020ES200640,NOVARTIS,,66.0,YR,,F,Y,55.0,KG,20200720.0,,CN,ES,ES,2020,Q3,Elderly
180429481,18042948,10,C,insulin glargine 40 units sc bedtime,,2,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200718.0,,20200718,20200718,DIR,,,FDA-CTU,,62.0,YR,,F,N,88.4,KG,20200718.0,N,PH,US,US,2020,Q3,Adult
180440531,18044053,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200626.0,,20200718,20200718,DIR,,,FDA-CTU,,58.0,YR,,M,N,105.5,KG,20200716.0,N,MD,US,US,2020,Q3,Adult
180440531,18044053,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Sinus tachycardia,,2020,Q3,1,I,20200626.0,,20200718,20200718,DIR,,,FDA-CTU,,58.0,YR,,M,N,105.5,KG,20200716.0,N,MD,US,US,2020,Q3,Adult
180450201,18045020,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,Y,U,,,210605.0,1.0,DF,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200621.0,20200710.0,20200720,20200720,EXP,FR-AFSSAPS-TS20200538,FR-MYLANLABS-2020M1064170,MYLAN,,83.0,YR,,M,Y,,,20200720.0,,MD,FR,FR,2020,Q3,Elderly
180450201,18045020,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,Y,U,,,210605.0,1.0,DF,INJECTION,,2020,Q3,Product administration error,,2020,Q3,1,I,20200621.0,20200710.0,20200720,20200720,EXP,FR-AFSSAPS-TS20200538,FR-MYLANLABS-2020M1064170,MYLAN,,83.0,YR,,M,Y,,,20200720.0,,MD,FR,FR,2020,Q3,Elderly
180450201,18045020,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,Y,U,,,210605.0,1.0,DF,INJECTION,,2020,Q3,Seizure,,2020,Q3,1,I,20200621.0,20200710.0,20200720,20200720,EXP,FR-AFSSAPS-TS20200538,FR-MYLANLABS-2020M1064170,MYLAN,,83.0,YR,,M,Y,,,20200720.0,,MD,FR,FR,2020,Q3,Elderly
180450201,18045020,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,Y,U,,,210605.0,1.0,DF,INJECTION,,2020,Q3,Wrong patient received product,,2020,Q3,1,I,20200621.0,20200710.0,20200720,20200720,EXP,FR-AFSSAPS-TS20200538,FR-MYLANLABS-2020M1064170,MYLAN,,83.0,YR,,M,Y,,,20200720.0,,MD,FR,FR,2020,Q3,Elderly
180474401,18047440,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood creatine increased,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pollakiuria,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood creatine increased,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180474401,18047440,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,38 INTERNATIONAL UNIT,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pollakiuria,,2020,Q3,1,I,2020.0,20200713.0,20200721,20200721,EXP,,ES-AUROBINDO-AUR-APL-2020-035550,AUROBINDO,,70.0,YR,,M,Y,88.0,KG,20200721.0,,CN,ES,ES,2020,Q3,Elderly
180501641,18050164,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, QD",,,Y,U,,,,1.0,DF,INJECTION,QD,2020,Q3,Drug interaction,,2020,Q3,1,I,20200108.0,20200622.0,20200721,20200721,EXP,IT-MINISAL02-623139,IT-MYLANLABS-2020M1058934,MYLAN,,81.0,YR,,M,Y,,,20200721.0,,MD,IT,IT,2020,Q3,Elderly
180501641,18050164,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, QD",,,Y,U,,,,1.0,DF,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200108.0,20200622.0,20200721,20200721,EXP,IT-MINISAL02-623139,IT-MYLANLABS-2020M1058934,MYLAN,,81.0,YR,,M,Y,,,20200721.0,,MD,IT,IT,2020,Q3,Elderly
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"38 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Aortic aneurysm,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Arthralgia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Arthritis,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypertension,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Impaired healing,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Injection site pain,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Liver disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Metabolic syndrome,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Peripheral swelling,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Peripheral venous disease,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Sensorimotor disorder,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180558292,18055829,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"52 UNK, QN UNIT (AT 10 PM)",,,Y,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Weight increased,,2020,Q3,2,F,2016.0,20200803.0,20200722,20200806,EXP,,NVSC2020CZ205604,NOVARTIS,,62.0,YR,,M,Y,130.0,KG,20200806.0,,HP,CZ,CZ,2020,Q3,Adult
180584283,18058428,14,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY (EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Drug interaction,,2020,Q3,3,F,201808.0,20200827.0,20200723,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-035991,AUROBINDO,,68.0,YR,,M,Y,77.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Elderly
180584283,18058428,14,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY (EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Eye movement disorder,,2020,Q3,3,F,201808.0,20200827.0,20200723,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-035991,AUROBINDO,,68.0,YR,,M,Y,77.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Elderly
180584283,18058428,14,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY (EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Movement disorder,,2020,Q3,3,F,201808.0,20200827.0,20200723,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-035991,AUROBINDO,,68.0,YR,,M,Y,77.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Elderly
180584283,18058428,14,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY (EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Muscle spasms,,2020,Q3,3,F,201808.0,20200827.0,20200723,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-035991,AUROBINDO,,68.0,YR,,M,Y,77.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Elderly
180584283,18058428,14,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY (EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Oculogyric crisis,,2020,Q3,3,F,201808.0,20200827.0,20200723,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-035991,AUROBINDO,,68.0,YR,,M,Y,77.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Elderly
180584283,18058428,14,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY (EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Off label use,,2020,Q3,3,F,201808.0,20200827.0,20200723,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-035991,AUROBINDO,,68.0,YR,,M,Y,77.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Elderly
180584283,18058428,14,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY (EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Product use issue,,2020,Q3,3,F,201808.0,20200827.0,20200723,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-035991,AUROBINDO,,68.0,YR,,M,Y,77.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Elderly
180584283,18058428,14,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY (EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Seizure,,2020,Q3,3,F,201808.0,20200827.0,20200723,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-035991,AUROBINDO,,68.0,YR,,M,Y,77.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Elderly
180584283,18058428,14,I,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY (EVENING)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Status epilepticus,,2020,Q3,3,F,201808.0,20200827.0,20200723,20200902,EXP,,DE-AUROBINDO-AUR-APL-2020-035991,AUROBINDO,,68.0,YR,,M,Y,77.0,KG,20200902.0,,PH,DE,DE,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Discomfort,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Fall,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Hypotension,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Intentional product misuse,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Product dose omission issue,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Pulmonary oedema,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Renal disorder,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Renal failure,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Syncope,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180589191,18058919,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,,,,210605.0,,,INJECTION,,2020,Q3,Unresponsive to stimuli,,2020,Q3,1,I,202006.0,20200714.0,20200723,20200723,EXP,,ES-MYLANLABS-2020M1065092,MYLAN,,92.0,YR,,F,Y,50.0,KG,20200723.0,,CN,ES,ES,2020,Q3,Elderly
180591451,18059145,4,C,insulin glargine + lispro,,2,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase decreased,,2020,Q3,1,I,20200722.0,,20200723,20200723,DIR,,,FDA-CTU,,63.0,YR,,M,N,101.7,KG,20200723.0,N,PH,US,US,2020,Q3,Adult
180591451,18059145,4,C,insulin glargine + lispro,,2,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase decreased,,2020,Q3,1,I,20200722.0,,20200723,20200723,DIR,,,FDA-CTU,,63.0,YR,,M,N,101.7,KG,20200723.0,N,PH,US,US,2020,Q3,Adult
180591451,18059145,4,C,insulin glargine + lispro,,2,,,,,,,,,,,,,,2020,Q3,Hepatotoxicity,,2020,Q3,1,I,20200722.0,,20200723,20200723,DIR,,,FDA-CTU,,63.0,YR,,M,N,101.7,KG,20200723.0,N,PH,US,US,2020,Q3,Adult
180615581,18061558,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200713.0,20200717.0,20200723,20200723,EXP,,US-GILEAD-2020-0484363,GILEAD,,62.0,YR,A,M,Y,50.3,KG,20200723.0,,PH,US,US,2020,Q3,Adult
180616261,18061626,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q3,Anaemia,,2020,Q3,1,I,20180719.0,20180828.0,20200723,20200723,EXP,,DE-CELGENEUS-DEU-20180808778,CELGENE,,56.0,YR,,M,Y,152.0,KG,20200723.0,,MD,DE,DE,2020,Q3,Adult
180616261,18061626,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,20180719.0,20180828.0,20200723,20200723,EXP,,DE-CELGENEUS-DEU-20180808778,CELGENE,,56.0,YR,,M,Y,152.0,KG,20200723.0,,MD,DE,DE,2020,Q3,Adult
180616712,18061671,11,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (15 IE ABENDS)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Drug interaction,,2020,Q3,2,F,20200115.0,20200810.0,20200723,20200813,EXP,DE-EMA-DD-20200413-SHUKLA_V-080023,NVSC2020DE206330,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200813.0,,MD,DE,DE,2020,Q3,Elderly
180616712,18061671,11,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (15 IE ABENDS)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Eye movement disorder,,2020,Q3,2,F,20200115.0,20200810.0,20200723,20200813,EXP,DE-EMA-DD-20200413-SHUKLA_V-080023,NVSC2020DE206330,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200813.0,,MD,DE,DE,2020,Q3,Elderly
180616712,18061671,11,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (15 IE ABENDS)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Movement disorder,,2020,Q3,2,F,20200115.0,20200810.0,20200723,20200813,EXP,DE-EMA-DD-20200413-SHUKLA_V-080023,NVSC2020DE206330,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200813.0,,MD,DE,DE,2020,Q3,Elderly
180616712,18061671,11,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (15 IE ABENDS)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Off label use,,2020,Q3,2,F,20200115.0,20200810.0,20200723,20200813,EXP,DE-EMA-DD-20200413-SHUKLA_V-080023,NVSC2020DE206330,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200813.0,,MD,DE,DE,2020,Q3,Elderly
180616712,18061671,11,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (15 IE ABENDS)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Seizure,,2020,Q3,2,F,20200115.0,20200810.0,20200723,20200813,EXP,DE-EMA-DD-20200413-SHUKLA_V-080023,NVSC2020DE206330,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200813.0,,MD,DE,DE,2020,Q3,Elderly
180616712,18061671,11,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 IU, QD (15 IE ABENDS)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q3,Status epilepticus,,2020,Q3,2,F,20200115.0,20200810.0,20200723,20200813,EXP,DE-EMA-DD-20200413-SHUKLA_V-080023,NVSC2020DE206330,NOVARTIS,,69.0,YR,,M,Y,77.0,KG,20200813.0,,MD,DE,DE,2020,Q3,Elderly
180620721,18062072,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,30.0,IU,,,2020,Q3,Blindness,,2020,Q3,1,I,,20200715.0,20200723,20200723,EXP,,CA-TEVA-2020-CA-1803745,TEVA,,73.0,YR,,F,Y,,,20200723.0,,CN,CA,CA,2020,Q3,Elderly
180620721,18062072,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,30.0,IU,,,2020,Q3,Blood cholesterol increased,,2020,Q3,1,I,,20200715.0,20200723,20200723,EXP,,CA-TEVA-2020-CA-1803745,TEVA,,73.0,YR,,F,Y,,,20200723.0,,CN,CA,CA,2020,Q3,Elderly
180620721,18062072,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,30.0,IU,,,2020,Q3,Cataract,,2020,Q3,1,I,,20200715.0,20200723,20200723,EXP,,CA-TEVA-2020-CA-1803745,TEVA,,73.0,YR,,F,Y,,,20200723.0,,CN,CA,CA,2020,Q3,Elderly
180620721,18062072,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,30.0,IU,,,2020,Q3,Renal failure,,2020,Q3,1,I,,20200715.0,20200723,20200723,EXP,,CA-TEVA-2020-CA-1803745,TEVA,,73.0,YR,,F,Y,,,20200723.0,,CN,CA,CA,2020,Q3,Elderly
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Fatigue,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Leukopenia,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Polyneuropathy,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Product dispensing error,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Thrombocytopenia,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180620931,18062093,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 UNITS EVERY 24 HOURS,,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,20200528.0,20200717.0,20200723,20200723,EXP,,MX-ASTRAZENECA-2020SE91283,ASTRAZENECA,,63.0,YR,,F,Y,74.0,KG,20200723.0,,,MX,MX,2020,Q3,Adult
180642311,18064231,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,1,I,20200722.0,,20200723,20200723,DIR,,,FDA-CTU,,68.0,YR,,M,N,117.2,KG,20200723.0,N,PH,US,US,2020,Q3,Elderly
180647781,18064778,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Flushing,,2020,Q3,1,I,20200716.0,,20200723,20200723,DIR,,,FDA-CTU,,52.0,YR,,M,N,123.0,KG,20200720.0,Y,HP,US,US,2020,Q3,Adult
180647781,18064778,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hyperhidrosis,,2020,Q3,1,I,20200716.0,,20200723,20200723,DIR,,,FDA-CTU,,52.0,YR,,M,N,123.0,KG,20200720.0,Y,HP,US,US,2020,Q3,Adult
180647781,18064778,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypertension,,2020,Q3,1,I,20200716.0,,20200723,20200723,DIR,,,FDA-CTU,,52.0,YR,,M,N,123.0,KG,20200720.0,Y,HP,US,US,2020,Q3,Adult
180647781,18064778,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Oxygen saturation decreased,,2020,Q3,1,I,20200716.0,,20200723,20200723,DIR,,,FDA-CTU,,52.0,YR,,M,N,123.0,KG,20200720.0,Y,HP,US,US,2020,Q3,Adult
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Acute kidney injury,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Asthenia,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Constipation,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Contraindicated product administered,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Dehydration,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Drug clearance decreased,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Drug interaction,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Duplicate therapy error,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Fatigue,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,International normalised ratio increased,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Mobility decreased,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Myalgia,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Oedema peripheral,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Overdose,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Product administration error,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Product name confusion,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Toxicity to various agents,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180656435,18065643,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Urinary incontinence,,2020,Q3,5,F,,20200918.0,20200724,20200921,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20200921.0,,HP,CZ,CZ,2020,Q3,Elderly
180658651,18065865,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20191206.0,20191218.0,20200724,20200724,EXP,,US-ROCHE-2502743,ROCHE,,66.0,YR,,F,Y,81.3,KG,20200724.0,,MD,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
180658651,18065865,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,1,I,20191206.0,20191218.0,20200724,20200724,EXP,,US-ROCHE-2502743,ROCHE,,66.0,YR,,F,Y,81.3,KG,20200724.0,,MD,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
180666571,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood creatine increased,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK (DOSE INCREASED),,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Pollakiuria,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood creatine increased,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Feeling abnormal,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180666571,18066657,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,38 IU,,,,, 0F571A,,,38.0,IU,SOLUTION FOR INJECTION,,2020,Q3,Pollakiuria,,2020,Q3,1,I,2020.0,20200718.0,20200724,20200724,EXP,,ES-MYLANLABS-2020M1066083,MYLAN,,70.0,YR,,M,Y,88.0,KG,20200724.0,,CN,ES,ES,2020,Q3,Elderly
180669322,18066932,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE BEDTIME,,,,,,,,10.0,IU,,QD,2020,Q3,Renal disorder,,2020,Q3,2,F,2014.0,20200723.0,20200724,20200731,EXP,PT-EMA-DD-20200716-GONUGUNTLA_N1-135612,PT-BAUSCH-BL-2020-020773,BAUSCH AND LOMB,REIS A. MUITO PARA ALEM DA ENCEFALITE: UM RELATO DE CASO. REVISTA PORTUGUESA DE MEDICINA GERAL E FAMILIAR. 2017?33(2):141?147.,69.0,YR,,M,Y,,,20200731.0,,MD,PT,PT,2020,Q3,Elderly
180669322,18066932,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,BEFORE BEDTIME,,,,,,,,10.0,IU,,QD,2020,Q3,Toxicity to various agents,,2020,Q3,2,F,2014.0,20200723.0,20200724,20200731,EXP,PT-EMA-DD-20200716-GONUGUNTLA_N1-135612,PT-BAUSCH-BL-2020-020773,BAUSCH AND LOMB,REIS A. MUITO PARA ALEM DA ENCEFALITE: UM RELATO DE CASO. REVISTA PORTUGUESA DE MEDICINA GERAL E FAMILIAR. 2017?33(2):141?147.,69.0,YR,,M,Y,,,20200731.0,,MD,PT,PT,2020,Q3,Elderly
180672561,18067256,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"38 UNITS IN MORNING, 30 UNITS IN EVENING",,,Y,U,,,,,,INJECTION,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,2008.0,20200718.0,20200724,20200724,EXP,,DK-MYLANLABS-2020M1066155,MYLAN,,56.0,YR,,M,Y,,,20200724.0,,MD,DK,DK,2020,Q3,Adult
180672561,18067256,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"38 UNITS IN MORNING, 30 UNITS IN EVENING",,,Y,U,,,,,,INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,2008.0,20200718.0,20200724,20200724,EXP,,DK-MYLANLABS-2020M1066155,MYLAN,,56.0,YR,,M,Y,,,20200724.0,,MD,DK,DK,2020,Q3,Adult
180678721,18067872,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,, UNKNOWN,,,22.0,IU,UNKNOWN,QD,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200706.0,20200722.0,20200724,20200724,EXP,FR-AFSSAPS-LM20200380,FR-FRESENIUS KABI-FK202007535,FRESENIUS KABI,,59.0,YR,,M,Y,65.0,KG,20200724.0,,HP,NL,FR,2020,Q3,Adult
180713892,18071389,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Asthenia,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Drug interaction,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Duplicate therapy error,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Immobile,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,International normalised ratio increased,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Myalgia,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180713892,18071389,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Urinary incontinence,,2020,Q3,2,F,,20200814.0,20200727,20200825,EXP,,CZ-AUROBINDO-AUR-APL-2020-035999,AUROBINDO,ROSUVASTATIN/WARFARIN INTERACTION:RHABDOMYOLYSIS FOLLOWED BY MEDICATION ERROR AND OVERDOSE: CASE REPORT. 2020,74.0,YR,,M,Y,,,20200825.0,,HP,CZ,CZ,2020,Q3,Elderly
180739524,18073952,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30.5 UNITS, BOLUS 3?4?4 UNITS",,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30.5 UNITS, BOLUS 3?4?4 UNITS",,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Condition aggravated,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30.5 UNITS, BOLUS 3?4?4 UNITS",,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Disease progression,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30.5 UNITS, BOLUS 3?4?4 UNITS",,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30.5 UNITS, BOLUS 3?4?4 UNITS",,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Maternal exposure during pregnancy,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30.5 UNITS, BOLUS 3?4?4 UNITS",,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Premature baby,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30.5 UNITS, BOLUS 3?4?4 UNITS",,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Premature delivery,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Blood pressure increased,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Condition aggravated,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Disease progression,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Maternal exposure during pregnancy,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Premature baby,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180739524,18073952,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Premature delivery,,2020,Q3,4,F,,20200818.0,20200727,20200825,EXP,,SK-MYLANLABS-2020M1066428,MYLAN,,30.0,YR,,F,Y,,,20200825.0,,HP,SK,SK,2020,Q3,Young Adult
180784411,18078441,6,C,Insulin Glargine 15units HS,,2,,,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,1,I,20200725.0,,20200727,20200727,DIR,,,FDA-CTU,,66.0,YR,,M,N,98.3,KG,20200727.0,Y,PH,US,US,2020,Q3,Elderly
180801861,18080186,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML 0?0?0?12 UNITS?THERAPY START DATE: MAY 2014,,,,,,,,,,,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML 0?0?0?12 UNITS?THERAPY START DATE: MAY 2014,,,,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 U/ML 0?0?0?12 UNITS?THERAPY START DATE: MAY 2014,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 U/ML 0?0?0?60 UNITS?THERAPY START DATE: JUN 2018,,,,,,,,,,,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 U/ML 0?0?0?60 UNITS?THERAPY START DATE: JUN 2018,,,,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,300 U/ML 0?0?0?60 UNITS?THERAPY START DATE: JUN 2018,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,60 UNITS/DAILY?THERAPY START DATE: JUL 2019,,,,,,,,,,,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,60 UNITS/DAILY?THERAPY START DATE: JUL 2019,,,,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180801861,18080186,11,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,60 UNITS/DAILY?THERAPY START DATE: JUL 2019,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,201104.0,20200715.0,20200728,20200728,EXP,,CZ-EMD SERONO-9175035,EMD SERONO INC,UNKNOWN. COMBINATION THERAPY DULAGLUTIDE + BASAL INSULIN ANALOGUE ? A POSSIBLE STEP BACK FROM IIT. KAZUISTIKY V DIABETOLOGII. 18(2):37?39.,47.0,YR,A,M,Y,98.0,KG,20200728.0,,MD,CZ,CZ,2020,Q3,Adult
180803171,18080317,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200721.0,20200728,20200728,EXP,,AU-MYLANLABS-2020M1067573,MYLAN,"DE ZYLVA J, PADLEY J, BADBESS R, DEDIGAMA M. MULTIORGAN FAILURE FOLLOWING GASTROENTERITIS: A CASE REPORT. J?MED?CASE?REP 2020?14(1):74.",63.0,YR,,M,Y,,,20200728.0,,HP,AU,AU,2020,Q3,Adult
180832841,18083284,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Cardiogenic shock,,2020,Q3,1,I,,20200717.0,20200729,20200729,EXP,,AU-GENERIC HEALTH PTY. LTD.-2020-03809,LUPIN,,63.0,YR,,M,Y,,,20200729.0,,HP,AU,AU,2020,Q3,Adult
180832841,18083284,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200717.0,20200729,20200729,EXP,,AU-GENERIC HEALTH PTY. LTD.-2020-03809,LUPIN,,63.0,YR,,M,Y,,,20200729.0,,HP,AU,AU,2020,Q3,Adult
180832841,18083284,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Multiple organ dysfunction syndrome,,2020,Q3,1,I,,20200717.0,20200729,20200729,EXP,,AU-GENERIC HEALTH PTY. LTD.-2020-03809,LUPIN,,63.0,YR,,M,Y,,,20200729.0,,HP,AU,AU,2020,Q3,Adult
180832841,18083284,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,,20200717.0,20200729,20200729,EXP,,AU-GENERIC HEALTH PTY. LTD.-2020-03809,LUPIN,,63.0,YR,,M,Y,,,20200729.0,,HP,AU,AU,2020,Q3,Adult
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Acute kidney injury,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Alanine aminotransferase increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Asthenia,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Bedridden,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Blood creatine phosphokinase increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Blood creatinine increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Blood urea increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Constipation,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Contraindicated product administered,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Dehydration,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Drug clearance decreased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Drug interaction,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Fatigue,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Immobile,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Incorrect dose administered,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,International normalised ratio increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Mobility decreased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Myalgia,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Myoglobin blood increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Oedema peripheral,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Overdose,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Polyuria,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Product administration error,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Product name confusion,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Toxicity to various agents,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Transaminases increased,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180836905,18083690,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q3,Urinary incontinence,,2020,Q3,5,F,,20200922.0,20200729,20200929,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20200930.0,,HP,CZ,CZ,2020,Q3,Elderly
180856611,18085661,3,C,Insulin Glargine 35 units BID,,2,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200723.0,,20200728,20200728,DIR,,,FDA-CTU,,63.0,YR,,F,N,113.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Adult
180856611,18085661,3,C,Insulin Glargine 35 units BID,,2,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,20200723.0,,20200728,20200728,DIR,,,FDA-CTU,,63.0,YR,,F,N,113.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Adult
180856611,18085661,3,C,Insulin Glargine 35 units BID,,2,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200723.0,,20200728,20200728,DIR,,,FDA-CTU,,63.0,YR,,F,N,113.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Adult
180856611,18085661,3,C,Insulin Glargine 35 units BID,,2,,,,,,,,,,,,,,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,1,I,20200723.0,,20200728,20200728,DIR,,,FDA-CTU,,63.0,YR,,F,N,113.0,KG,20200728.0,Y,PH,US,US,2020,Q3,Adult
180859601,18085960,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200710.0,,20200729,20200729,DIR,,,FDA-CTU,,80.0,YR,,M,N,74.4,KG,20200729.0,N,PH,US,US,2020,Q3,Elderly
180859601,18085960,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Blood pressure decreased,,2020,Q3,1,I,20200710.0,,20200729,20200729,DIR,,,FDA-CTU,,80.0,YR,,M,N,74.4,KG,20200729.0,N,PH,US,US,2020,Q3,Elderly
180859601,18085960,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Disseminated intravascular coagulation,,2020,Q3,1,I,20200710.0,,20200729,20200729,DIR,,,FDA-CTU,,80.0,YR,,M,N,74.4,KG,20200729.0,N,PH,US,US,2020,Q3,Elderly
180859601,18085960,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Therapy non-responder,,2020,Q3,1,I,20200710.0,,20200729,20200729,DIR,,,FDA-CTU,,80.0,YR,,M,N,74.4,KG,20200729.0,N,PH,US,US,2020,Q3,Elderly
180875321,18087532,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Blood pressure increased,,2020,Q3,1,I,20200716.0,20200723.0,20200729,20200729,EXP,,US-GILEAD-2020-0486136,GILEAD,,52.0,YR,A,M,Y,123.0,KG,20200729.0,,HP,US,US,2020,Q3,Adult
180885471,18088547,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180885471,18088547,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Contraindicated product administered,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180885471,18088547,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180885471,18088547,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Polyuria,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180885471,18088547,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,1,I,,20200727.0,20200729,20200729,EXP,,NVSC2020CZ211240,NOVARTIS,"VODICKA M, SLANAF O, PISAR M, SALEK T. ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS. CESKA A SLOVENSKA FARMACIE. 2020?69(2):100?2",74.0,YR,,M,Y,,,20200729.0,,HP,CZ,CZ,2020,Q3,Elderly
180886251,18088625,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Empyema,,2020,Q3,1,I,,20200722.0,20200729,20200729,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037512",BOEHRINGER INGELHEIM,"MORITA S, KITAHARA C, KISHIMOTO S, MATSUNO S, URAKI S, TAKESHIMA K, ET AL?. EARLY DETECTION OF EUGLYCEMIC KETOACIDOSIS DURING THORACIC SURGERY ASSOCIATED WITH EMPAGLIFLOZIN IN A PATIENT WITH TYPE 2 DIABETES: A CASE REPORT. JOURNAL OF DIABETES INVESTIGATION. 2020?.",59.0,YR,,M,Y,69.0,KG,20200729.0,,MD,JP,JP,2020,Q3,Adult
180886251,18088625,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Euglycaemic diabetic ketoacidosis,,2020,Q3,1,I,,20200722.0,20200729,20200729,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037512",BOEHRINGER INGELHEIM,"MORITA S, KITAHARA C, KISHIMOTO S, MATSUNO S, URAKI S, TAKESHIMA K, ET AL?. EARLY DETECTION OF EUGLYCEMIC KETOACIDOSIS DURING THORACIC SURGERY ASSOCIATED WITH EMPAGLIFLOZIN IN A PATIENT WITH TYPE 2 DIABETES: A CASE REPORT. JOURNAL OF DIABETES INVESTIGATION. 2020?.",59.0,YR,,M,Y,69.0,KG,20200729.0,,MD,JP,JP,2020,Q3,Adult
180934301,18093430,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,210605.0,,,INJECTION,,2020,Q3,Abortion spontaneous,,2020,Q3,1,I,,20200715.0,20200730,20200730,EXP,,LT-MYLANLABS-2020M1065824,MYLAN,"STANKEVICIUS H,  SURGONTAITE D, KALINAUSKAS M,. ATIDETAS DVYNIO GIMIMAS KLINIKINIS ATVEJIS IR LITERATUROS APZVALGA. DELAYED?INITERVAL DELIVERY. CLINICAL CASE AND LITERATURE REVIEW. LIETUVOS AKSUERIJA IR GINEKOLOGIA. 2020?XXIII NR 2:139?144",38.0,YR,,F,Y,,,20200730.0,,MD,LT,LT,2020,Q3,Adult
180934301,18093430,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,210605.0,,,INJECTION,,2020,Q3,Maternal exposure during pregnancy,,2020,Q3,1,I,,20200715.0,20200730,20200730,EXP,,LT-MYLANLABS-2020M1065824,MYLAN,"STANKEVICIUS H,  SURGONTAITE D, KALINAUSKAS M,. ATIDETAS DVYNIO GIMIMAS KLINIKINIS ATVEJIS IR LITERATUROS APZVALGA. DELAYED?INITERVAL DELIVERY. CLINICAL CASE AND LITERATURE REVIEW. LIETUVOS AKSUERIJA IR GINEKOLOGIA. 2020?XXIII NR 2:139?144",38.0,YR,,F,Y,,,20200730.0,,MD,LT,LT,2020,Q3,Adult
180964001,18096400,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04025,ALKEM,,56.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Adult
180964001,18096400,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04025,ALKEM,,56.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Adult
180964001,18096400,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04025,ALKEM,,56.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Adult
180964001,18096400,4,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200716.0,20200731,20200731,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-04025,ALKEM,,56.0,YR,,F,Y,,,20200731.0,,HP,AU,AU,2020,Q3,Adult
180964402,18096440,53,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Constipation,,2020,Q3,2,F,20180126.0,20200218.0,20200731,20200817,EXP,,JP-ROCHE-2301429,ROCHE,,46.0,YR,,M,Y,79.0,KG,20200818.0,,MD,JP,JP,2020,Q3,Adult
180964402,18096440,53,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,20180126.0,20200218.0,20200731,20200817,EXP,,JP-ROCHE-2301429,ROCHE,,46.0,YR,,M,Y,79.0,KG,20200818.0,,MD,JP,JP,2020,Q3,Adult
180964402,18096440,53,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,White blood cell count decreased,,2020,Q3,2,F,20180126.0,20200218.0,20200731,20200817,EXP,,JP-ROCHE-2301429,ROCHE,,46.0,YR,,M,Y,79.0,KG,20200818.0,,MD,JP,JP,2020,Q3,Adult
180967293,18096729,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,25.0,IU,,QD,2020,Q3,Dizziness,,2020,Q3,3,F,,20200803.0,20200730,20200810,EXP,,"TR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037522",BOEHRINGER INGELHEIM,"ESENBOGA K, YAMANTURK Y, OZYUNCU N, TAN T, TUTAR E. EARLY REPOLARIZATION OR ACUTE CORONARY SYNDROME: A CASE REPORT OF ELECTROCARDIOGRAPHIC MIMICRY. MN KARDIYOLOJI. 2020?27(2):113?115.",58.0,YR,,M,Y,,,20200810.0,,MD,TR,TR,2020,Q3,Adult
180967293,18096729,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,25.0,IU,,QD,2020,Q3,Nausea,,2020,Q3,3,F,,20200803.0,20200730,20200810,EXP,,"TR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037522",BOEHRINGER INGELHEIM,"ESENBOGA K, YAMANTURK Y, OZYUNCU N, TAN T, TUTAR E. EARLY REPOLARIZATION OR ACUTE CORONARY SYNDROME: A CASE REPORT OF ELECTROCARDIOGRAPHIC MIMICRY. MN KARDIYOLOJI. 2020?27(2):113?115.",58.0,YR,,M,Y,,,20200810.0,,MD,TR,TR,2020,Q3,Adult
180967293,18096729,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,25.0,IU,,QD,2020,Q3,Vomiting,,2020,Q3,3,F,,20200803.0,20200730,20200810,EXP,,"TR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-037522",BOEHRINGER INGELHEIM,"ESENBOGA K, YAMANTURK Y, OZYUNCU N, TAN T, TUTAR E. EARLY REPOLARIZATION OR ACUTE CORONARY SYNDROME: A CASE REPORT OF ELECTROCARDIOGRAPHIC MIMICRY. MN KARDIYOLOJI. 2020?27(2):113?115.",58.0,YR,,M,Y,,,20200810.0,,MD,TR,TR,2020,Q3,Adult
180968801,18096880,9,C,Insulin Glargine 10 units SQ at HS,,2,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,20200728.0,,20200730,20200730,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.7,KG,20200730.0,Y,PH,US,US,2020,Q3,Adult
180968801,18096880,9,C,Insulin Glargine 10 units SQ at HS,,2,,,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,1,I,20200728.0,,20200730,20200730,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.7,KG,20200730.0,Y,PH,US,US,2020,Q3,Adult
180968801,18096880,9,C,Insulin Glargine 10 units SQ at HS,,2,,,,,,,,,,,,,,2020,Q3,Respiratory acidosis,,2020,Q3,1,I,20200728.0,,20200730,20200730,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.7,KG,20200730.0,Y,PH,US,US,2020,Q3,Adult
180968801,18096880,10,C,Insulin Glargine 15 units SQ BID,,2,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,20200728.0,,20200730,20200730,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.7,KG,20200730.0,Y,PH,US,US,2020,Q3,Adult
180968801,18096880,10,C,Insulin Glargine 15 units SQ BID,,2,,,,,,,,,,,,,,2020,Q3,Hypoxia,,2020,Q3,1,I,20200728.0,,20200730,20200730,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.7,KG,20200730.0,Y,PH,US,US,2020,Q3,Adult
180968801,18096880,10,C,Insulin Glargine 15 units SQ BID,,2,,,,,,,,,,,,,,2020,Q3,Respiratory acidosis,,2020,Q3,1,I,20200728.0,,20200730,20200730,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.7,KG,20200730.0,Y,PH,US,US,2020,Q3,Adult
180985311,18098531,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,30.0,IU,,,2020,Q3,Blindness,,2020,Q3,1,I,,20200727.0,20200731,20200731,EXP,,CA-BAUSCH-BL-2020-021431,BAUSCH AND LOMB,,73.0,YR,,F,Y,,,20200731.0,,CN,CA,CA,2020,Q3,Elderly
180985311,18098531,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,30.0,IU,,,2020,Q3,Blood cholesterol increased,,2020,Q3,1,I,,20200727.0,20200731,20200731,EXP,,CA-BAUSCH-BL-2020-021431,BAUSCH AND LOMB,,73.0,YR,,F,Y,,,20200731.0,,CN,CA,CA,2020,Q3,Elderly
180985311,18098531,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,30.0,IU,,,2020,Q3,Cataract,,2020,Q3,1,I,,20200727.0,20200731,20200731,EXP,,CA-BAUSCH-BL-2020-021431,BAUSCH AND LOMB,,73.0,YR,,F,Y,,,20200731.0,,CN,CA,CA,2020,Q3,Elderly
180985311,18098531,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,30.0,IU,,,2020,Q3,Renal failure,,2020,Q3,1,I,,20200727.0,20200731,20200731,EXP,,CA-BAUSCH-BL-2020-021431,BAUSCH AND LOMB,,73.0,YR,,F,Y,,,20200731.0,,CN,CA,CA,2020,Q3,Elderly
180992781,18099278,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,20200728.0,20200730.0,20200731,20200731,EXP,,US-GILEAD-2020-0487565,GILEAD,,63.0,YR,A,M,Y,72.7,KG,20200731.0,,PH,US,US,2020,Q3,Adult
181000232,18100023,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 IU, BID",,,,,,,,35.0,IU,,Q12H,2020,Q3,Alanine aminotransferase increased,,2020,Q3,2,F,20200723.0,20200817.0,20200731,20200819,EXP,,US-GILEAD-2020-0487474,GILEAD,,63.0,YR,A,F,Y,113.0,KG,20200819.0,,PH,US,US,2020,Q3,Adult
181000232,18100023,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 IU, BID",,,,,,,,35.0,IU,,Q12H,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,2,F,20200723.0,20200817.0,20200731,20200819,EXP,,US-GILEAD-2020-0487474,GILEAD,,63.0,YR,A,F,Y,113.0,KG,20200819.0,,PH,US,US,2020,Q3,Adult
181000232,18100023,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 IU, BID",,,,,,,,35.0,IU,,Q12H,2020,Q3,Blood creatinine increased,,2020,Q3,2,F,20200723.0,20200817.0,20200731,20200819,EXP,,US-GILEAD-2020-0487474,GILEAD,,63.0,YR,A,F,Y,113.0,KG,20200819.0,,PH,US,US,2020,Q3,Adult
181000232,18100023,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 IU, BID",,,,,,,,35.0,IU,,Q12H,2020,Q3,COVID-19,,2020,Q3,2,F,20200723.0,20200817.0,20200731,20200819,EXP,,US-GILEAD-2020-0487474,GILEAD,,63.0,YR,A,F,Y,113.0,KG,20200819.0,,PH,US,US,2020,Q3,Adult
181000232,18100023,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"35 IU, BID",,,,,,,,35.0,IU,,Q12H,2020,Q3,Glomerular filtration rate decreased,,2020,Q3,2,F,20200723.0,20200817.0,20200731,20200819,EXP,,US-GILEAD-2020-0487474,GILEAD,,63.0,YR,A,F,Y,113.0,KG,20200819.0,,PH,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Arthralgia,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Asthenia,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Blood urea increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Cardiac arrest,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Coma,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Coronary artery insufficiency,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Fatigue,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Headache,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Hypoaesthesia,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Lymphocyte count increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Lymphocyte percentage increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Myalgia,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Neck pain,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Obesity,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Pain in extremity,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Pulmonary embolism,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Respiratory depression,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Road traffic accident,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Spinal fusion surgery,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"34 UNIT, DAILY",5610.0,DF,D,, UNK,,,34.0,DF,,QD,2020,Q3,Toxicity to various agents,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Arthralgia,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Asthenia,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Blood urea increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Cardiac arrest,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Coma,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Coronary artery insufficiency,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Fatigue,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Headache,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Hypoaesthesia,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Lymphocyte count increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Lymphocyte percentage increased,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Myalgia,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Neck pain,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Obesity,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Pain in extremity,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Pulmonary embolism,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Respiratory depression,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Road traffic accident,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Spinal fusion surgery,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181001411,18100141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 UNIT, DAILY",5610.0,DF,D,, UNK,,,46.0,DF,,QD,2020,Q3,Toxicity to various agents,,2020,Q3,1,I,201807.0,20200511.0,20200731,20200731,EXP,,US-PURDUE-USA-2020-0160091,PURDUE,,61.0,YR,,F,Y,95.24,KG,20200731.0,,CN,US,US,2020,Q3,Adult
181003991,18100399,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 UNITS HS,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,1,I,20200725.0,20200728.0,20200731,20200731,EXP,,US-GILEAD-2020-0487417,GILEAD,,66.0,YR,E,M,Y,98.3,KG,20200731.0,,PH,US,US,2020,Q3,Elderly
181004992,18100499,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 UNITS,,,,,,,,,,INJECTION,,2020,Q3,Asthenia,,2020,Q3,2,F,20200718.0,20200818.0,20200731,20200831,EXP,,US-JNJFOC-20200741023,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,99.5,KG,20200831.0,,HP,US,US,2020,Q3,Elderly
181004992,18100499,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,14 UNITS,,,,,,,,,,INJECTION,,2020,Q3,Cerebrovascular accident,,2020,Q3,2,F,20200718.0,20200818.0,20200731,20200831,EXP,,US-JNJFOC-20200741023,JOHNSON AND JOHNSON,,79.0,YR,E,M,Y,99.5,KG,20200831.0,,HP,US,US,2020,Q3,Elderly
181030491,18103049,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200727.0,,20200731,20200731,DIR,,,FDA-CTU,,75.0,YR,,M,N,100.0,KG,20200731.0,N,PH,US,US,2020,Q3,Elderly
181033661,18103366,12,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Transaminases increased,,2020,Q3,1,I,20200728.0,,20200731,20200731,DIR,,,FDA-CTU,,69.0,YR,,F,N,102.0,KG,20200731.0,N,PH,US,US,2020,Q3,Elderly
181037281,18103728,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 MILLIGRAM, QD",,,U,U,,,,12.0,MG,INJECTION,QD,2020,Q3,Gait disturbance,,2020,Q3,1,I,,20200724.0,20200803,20200803,EXP,,CZ-MYLANLABS-2020M1068747,MYLAN,"SVARKO J, LOKOCOVA E, KOURKOVA E, ZAJICEK P. STATIN??INDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WITH MUSCLE WEAKNESS AND SWELLING. CESKA?REVMATOL 2020?28(1):52?60.",75.0,YR,,M,Y,,,20200803.0,,MD,CZ,CZ,2020,Q3,Elderly
181037281,18103728,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 MILLIGRAM, QD",,,U,U,,,,12.0,MG,INJECTION,QD,2020,Q3,Immune-mediated myositis,,2020,Q3,1,I,,20200724.0,20200803,20200803,EXP,,CZ-MYLANLABS-2020M1068747,MYLAN,"SVARKO J, LOKOCOVA E, KOURKOVA E, ZAJICEK P. STATIN??INDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WITH MUSCLE WEAKNESS AND SWELLING. CESKA?REVMATOL 2020?28(1):52?60.",75.0,YR,,M,Y,,,20200803.0,,MD,CZ,CZ,2020,Q3,Elderly
181037281,18103728,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 MILLIGRAM, QD",,,U,U,,,,12.0,MG,INJECTION,QD,2020,Q3,Loss of personal independence in daily activities,,2020,Q3,1,I,,20200724.0,20200803,20200803,EXP,,CZ-MYLANLABS-2020M1068747,MYLAN,"SVARKO J, LOKOCOVA E, KOURKOVA E, ZAJICEK P. STATIN??INDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WITH MUSCLE WEAKNESS AND SWELLING. CESKA?REVMATOL 2020?28(1):52?60.",75.0,YR,,M,Y,,,20200803.0,,MD,CZ,CZ,2020,Q3,Elderly
181073521,18107352,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,SOLUTION,QD,2020,Q3,Arthralgia,,2020,Q3,1,I,,20200727.0,20200804,20200804,EXP,,CA-BAUSCH-BL-2020-021529,BAUSCH AND LOMB,,42.0,YR,,F,Y,,,20200804.0,,HP,CA,CA,2020,Q3,Adult
181073521,18107352,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,SOLUTION,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200727.0,20200804,20200804,EXP,,CA-BAUSCH-BL-2020-021529,BAUSCH AND LOMB,,42.0,YR,,F,Y,,,20200804.0,,HP,CA,CA,2020,Q3,Adult
181073521,18107352,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,SOLUTION,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200727.0,20200804,20200804,EXP,,CA-BAUSCH-BL-2020-021529,BAUSCH AND LOMB,,42.0,YR,,F,Y,,,20200804.0,,HP,CA,CA,2020,Q3,Adult
181073521,18107352,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,SOLUTION,QD,2020,Q3,Gait inability,,2020,Q3,1,I,,20200727.0,20200804,20200804,EXP,,CA-BAUSCH-BL-2020-021529,BAUSCH AND LOMB,,42.0,YR,,F,Y,,,20200804.0,,HP,CA,CA,2020,Q3,Adult
181073521,18107352,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,SOLUTION,QD,2020,Q3,Headache,,2020,Q3,1,I,,20200727.0,20200804,20200804,EXP,,CA-BAUSCH-BL-2020-021529,BAUSCH AND LOMB,,42.0,YR,,F,Y,,,20200804.0,,HP,CA,CA,2020,Q3,Adult
181073521,18107352,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,SOLUTION,QD,2020,Q3,Hypoaesthesia,,2020,Q3,1,I,,20200727.0,20200804,20200804,EXP,,CA-BAUSCH-BL-2020-021529,BAUSCH AND LOMB,,42.0,YR,,F,Y,,,20200804.0,,HP,CA,CA,2020,Q3,Adult
181073521,18107352,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,SOLUTION,QD,2020,Q3,Lower respiratory tract infection,,2020,Q3,1,I,,20200727.0,20200804,20200804,EXP,,CA-BAUSCH-BL-2020-021529,BAUSCH AND LOMB,,42.0,YR,,F,Y,,,20200804.0,,HP,CA,CA,2020,Q3,Adult
181073521,18107352,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,SOLUTION,QD,2020,Q3,Pharyngitis,,2020,Q3,1,I,,20200727.0,20200804,20200804,EXP,,CA-BAUSCH-BL-2020-021529,BAUSCH AND LOMB,,42.0,YR,,F,Y,,,20200804.0,,HP,CA,CA,2020,Q3,Adult
181073521,18107352,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,SOLUTION SUBCUTANEOUS,,,U,,,,,,,SOLUTION,QD,2020,Q3,Toothache,,2020,Q3,1,I,,20200727.0,20200804,20200804,EXP,,CA-BAUSCH-BL-2020-021529,BAUSCH AND LOMB,,42.0,YR,,F,Y,,,20200804.0,,HP,CA,CA,2020,Q3,Adult
181088681,18108868,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypertension,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Increased appetite,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Infection,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Insulin-like growth factor increased,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Pain,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Weight increased,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q3,Hypertension,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q3,Increased appetite,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q3,Infection,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q3,Insulin-like growth factor increased,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q3,Pain,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181088681,18108868,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK, 1X/DAY",,,,,,,,,,SOLUTION FOR INJECTION,QD,2020,Q3,Weight increased,,2020,Q3,1,I,,20200728.0,20200804,20200804,EXP,,CA-PFIZER INC-2020289130,PFIZER,,64.0,YR,,M,Y,140.0,KG,20200804.0,,CN,CA,CA,2020,Q3,Adult
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Anxiety,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Arrhythmia,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Blood iron decreased,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Blood potassium decreased,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Blood sodium decreased,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Bronchitis,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Crying,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Fear,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Hypertension,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Insomnia,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Poor quality sleep,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Pulmonary valve incompetence,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181126091,18112609,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,INJECTION,,2020,Q3,Vomiting,,2020,Q3,1,I,2019.0,20200728.0,20200805,20200805,EXP,,CO-EMD SERONO-9178316,EMD SERONO INC,,75.0,YR,E,F,Y,52.0,KG,20200805.0,,CN,CO,CO,2020,Q3,Elderly
181133661,18113366,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,UNKNOWN,,2020,Q3,Enchondromatosis,,2020,Q3,1,I,,20200727.0,20200805,20200805,EXP,,DE-JNJFOC-20200741136,JOHNSON AND JOHNSON,,7.0,DEC,E,F,Y,130.0,KG,20200805.0,,MD,DE,DE,2020,Q3,Child
181148591,18114859,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200803.0,20200805,20200805,EXP,,CA-PFIZER INC-2020294534,PFIZER,,80.0,YR,,F,Y,,,20200805.0,,PH,CA,CA,2020,Q3,Elderly
181148591,18114859,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Speech disorder,,2020,Q3,1,I,,20200803.0,20200805,20200805,EXP,,CA-PFIZER INC-2020294534,PFIZER,,80.0,YR,,F,Y,,,20200805.0,,PH,CA,CA,2020,Q3,Elderly
181174891,18117489,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q3,Myalgia,,2020,Q3,1,I,20200707.0,20200708.0,20200805,20200805,PER,,US-RECORDATI RARE DISEASES-2088214,RECORDATI,,49.0,YR,,F,Y,,,20200805.0,,CN,US,US,2020,Q3,Adult
181174992,18117499,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,,,,,,12.0,IU,,QD,2020,Q3,Cardiac failure,,2020,Q3,2,F,201904.0,20200820.0,20200806,20200902,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-04191,LUPIN,,75.0,YR,,M,Y,,,20200902.0,,HP,CZ,CZ,2020,Q3,Elderly
181174992,18117499,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,,,,,,12.0,IU,,QD,2020,Q3,Gait disturbance,,2020,Q3,2,F,201904.0,20200820.0,20200806,20200902,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-04191,LUPIN,,75.0,YR,,M,Y,,,20200902.0,,HP,CZ,CZ,2020,Q3,Elderly
181174992,18117499,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,,,,,,12.0,IU,,QD,2020,Q3,Immune-mediated myositis,,2020,Q3,2,F,201904.0,20200820.0,20200806,20200902,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-04191,LUPIN,,75.0,YR,,M,Y,,,20200902.0,,HP,CZ,CZ,2020,Q3,Elderly
181174992,18117499,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,,,,,,12.0,IU,,QD,2020,Q3,Loss of personal independence in daily activities,,2020,Q3,2,F,201904.0,20200820.0,20200806,20200902,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-04191,LUPIN,,75.0,YR,,M,Y,,,20200902.0,,HP,CZ,CZ,2020,Q3,Elderly
181174992,18117499,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD",,,,,,,,12.0,IU,,QD,2020,Q3,Oedema peripheral,,2020,Q3,2,F,201904.0,20200820.0,20200806,20200902,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-04191,LUPIN,,75.0,YR,,M,Y,,,20200902.0,,HP,CZ,CZ,2020,Q3,Elderly
181194951,18119495,14,C,INSULIN GLARGINE (TOUJEO SOLOSTAR),,2,,,,,,,,,,,,,,2020,Q3,Constipation,,2020,Q3,1,I,,,20200806,20200806,DIR,,,FDA-CTU,,67.0,YR,,F,N,190.0,LBS,20200727.0,N,CN,US,US,2020,Q3,Elderly
181194951,18119495,14,C,INSULIN GLARGINE (TOUJEO SOLOSTAR),,2,,,,,,,,,,,,,,2020,Q3,Therapy change,,2020,Q3,1,I,,,20200806,20200806,DIR,,,FDA-CTU,,67.0,YR,,F,N,190.0,LBS,20200727.0,N,CN,US,US,2020,Q3,Elderly
181196041,18119604,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,IV BOLUS OF INSULIN AT 1UNIT/KG FOLLOWED BY INFUSION AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,IV BOLUS OF INSULIN AT 1UNIT/KG FOLLOWED BY INFUSION AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,IV BOLUS OF INSULIN AT 1UNIT/KG FOLLOWED BY INFUSION AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Encephalopathy,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,IV BOLUS OF INSULIN AT 1UNIT/KG FOLLOWED BY INFUSION AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Intentional overdose,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,IV BOLUS OF INSULIN AT 1UNIT/KG FOLLOWED BY INFUSION AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Lactic acidosis,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,IV BOLUS OF INSULIN AT 1UNIT/KG FOLLOWED BY INFUSION AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Multiple organ dysfunction syndrome,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,IV BOLUS OF INSULIN AT 1UNIT/KG FOLLOWED BY INFUSION AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Sinus tachycardia,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,IV BOLUS OF INSULIN AT 1UNIT/KG FOLLOWED BY INFUSION AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Suicide attempt,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous bolus,IV BOLUS OF INSULIN AT 1UNIT/KG FOLLOWED BY INFUSION AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Vasoplegia syndrome,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Encephalopathy,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Intentional overdose,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Lactic acidosis,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Multiple organ dysfunction syndrome,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Sinus tachycardia,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Suicide attempt,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181196041,18119604,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),IV INFUSION OF INSULIN AT 0.5 UNITS/KG/H TITRATED UP TO 5 UNITS/KG/H,,,D,,,,,,,INJECTION,,2020,Q3,Vasoplegia syndrome,,2020,Q3,1,I,,20200730.0,20200806,20200806,EXP,,US-MYLANLABS-2020M1070085,MYLAN,"SAHA BK, BONNIER A, CHONG W. RAPID REVERSAL OF VASOPLEGIA WITH METHYLENE BLUE IN CALCIUM CHANNEL BLOCKER POISONING. AFR?J?EMERG?MED 2020?NULL:NULL.",25.0,YR,,F,Y,,,20200806.0,,HP,US,US,2020,Q3,Young Adult
181197851,18119785,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200728.0,20200806,20200806,EXP,,AU-MICRO LABS LIMITED-ML2020-02301,MICRO LABS,"ZYLVA J, PADLEY J, BADBESS R, DEDIGAMA M. MULTIORGAN FAILURE FOLLOWING GASTROENTERITIS: A CASE REPORT. JOURNAL OF MEDICAL CASE REPORTS. 2020?14(1):74.",63.0,YR,,M,Y,,,20200806.0,,HP,AU,AU,2020,Q3,Adult
181228361,18122836,9,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2020,Q3,Cerebral haemorrhage,,2020,Q3,1,I,20190828.0,20190830.0,20200807,20200807,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20200807.0,,MD,JP,JP,2020,Q3,Elderly
181228361,18122836,9,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2020,Q3,Drug eruption,,2020,Q3,1,I,20190828.0,20190830.0,20200807,20200807,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20200807.0,,MD,JP,JP,2020,Q3,Elderly
181228361,18122836,9,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2020,Q3,Electrocardiogram QT prolonged,,2020,Q3,1,I,20190828.0,20190830.0,20200807,20200807,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20200807.0,,MD,JP,JP,2020,Q3,Elderly
181228361,18122836,9,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,"8 IU/DAY, UNKNOWN FREQ.",,,,,,,,8.0,IU,INJECTION,,2020,Q3,Liver disorder,,2020,Q3,1,I,20190828.0,20190830.0,20200807,20200807,EXP,,JP-ASTELLAS-2019JP018774,ASTELLAS,,76.0,YR,,F,Y,47.0,KG,20200807.0,,MD,JP,JP,2020,Q3,Elderly
181267471,18126747,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,1,I,,20200801.0,20200809,20200809,EXP,,CZ-AUROBINDO-AUR-APL-2020-038054,AUROBINDO,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE.. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200810.0,,MD,CZ,CZ,2020,Q3,Adult
181267471,18126747,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Injection site pain,,2020,Q3,1,I,,20200801.0,20200809,20200809,EXP,,CZ-AUROBINDO-AUR-APL-2020-038054,AUROBINDO,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE.. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200810.0,,MD,CZ,CZ,2020,Q3,Adult
181267471,18126747,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Weight increased,,2020,Q3,1,I,,20200801.0,20200809,20200809,EXP,,CZ-AUROBINDO-AUR-APL-2020-038054,AUROBINDO,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE.. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200810.0,,MD,CZ,CZ,2020,Q3,Adult
181282251,18128225,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,COVID-19 pneumonia,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Diabetes mellitus,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Inflammatory marker increased,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181282251,18128225,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,SARS-CoV-2 test positive,,2020,Q3,1,I,20200804.0,,20200807,20200807,DIR,,,FDA-CTU,,33.0,YR,,F,N,79.4,KG,20200807.0,Y,PH,US,US,2020,Q3,Young Adult
181283561,18128356,8,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200804.0,,20200809,20200809,DIR,,,FDA-CTU,,66.0,YR,,F,N,148.8,KG,20200809.0,N,PH,US,US,2020,Q3,Elderly
181284011,18128401,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, 0F638A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200806.0,20200810,20200810,EXP,,ES-AUROBINDO-AUR-APL-2020-038701,AUROBINDO,,74.0,YR,,M,Y,,,20200810.0,,CN,ES,ES,2020,Q3,Elderly
181284011,18128401,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, 0F638A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,2020.0,20200806.0,20200810,20200810,EXP,,ES-AUROBINDO-AUR-APL-2020-038701,AUROBINDO,,74.0,YR,,M,Y,,,20200810.0,,CN,ES,ES,2020,Q3,Elderly
181284011,18128401,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"22 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, 0F638A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product use issue,,2020,Q3,1,I,2020.0,20200806.0,20200810,20200810,EXP,,ES-AUROBINDO-AUR-APL-2020-038701,AUROBINDO,,74.0,YR,,M,Y,,,20200810.0,,CN,ES,ES,2020,Q3,Elderly
181284011,18128401,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, 0F638A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200806.0,20200810,20200810,EXP,,ES-AUROBINDO-AUR-APL-2020-038701,AUROBINDO,,74.0,YR,,M,Y,,,20200810.0,,CN,ES,ES,2020,Q3,Elderly
181284011,18128401,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, 0F638A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,2020.0,20200806.0,20200810,20200810,EXP,,ES-AUROBINDO-AUR-APL-2020-038701,AUROBINDO,,74.0,YR,,M,Y,,,20200810.0,,CN,ES,ES,2020,Q3,Elderly
181284011,18128401,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, 0F638A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product use issue,,2020,Q3,1,I,2020.0,20200806.0,20200810,20200810,EXP,,ES-AUROBINDO-AUR-APL-2020-038701,AUROBINDO,,74.0,YR,,M,Y,,,20200810.0,,CN,ES,ES,2020,Q3,Elderly
181296552,18129655,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,12 MILLIGRAM DAILY;,,,U,,,,,12.0,MG,,QD,2020,Q3,Gait disturbance,,2020,Q3,2,F,,20200819.0,20200810,20200820,EXP,,CZ-TEVA-2020-CZ-1812532,TEVA,SVARKO J. STATIN?INDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WITH MUSCLE WEAKNESS AND SWELLING.,75.0,YR,E,M,Y,,,20200820.0,,MD,CZ,CZ,2020,Q3,Elderly
181296552,18129655,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,12 MILLIGRAM DAILY;,,,U,,,,,12.0,MG,,QD,2020,Q3,Immune-mediated myositis,,2020,Q3,2,F,,20200819.0,20200810,20200820,EXP,,CZ-TEVA-2020-CZ-1812532,TEVA,SVARKO J. STATIN?INDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WITH MUSCLE WEAKNESS AND SWELLING.,75.0,YR,E,M,Y,,,20200820.0,,MD,CZ,CZ,2020,Q3,Elderly
181296552,18129655,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,12 MILLIGRAM DAILY;,,,U,,,,,12.0,MG,,QD,2020,Q3,Loss of personal independence in daily activities,,2020,Q3,2,F,,20200819.0,20200810,20200820,EXP,,CZ-TEVA-2020-CZ-1812532,TEVA,SVARKO J. STATIN?INDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WITH MUSCLE WEAKNESS AND SWELLING.,75.0,YR,E,M,Y,,,20200820.0,,MD,CZ,CZ,2020,Q3,Elderly
181296552,18129655,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,12 MILLIGRAM DAILY;,,,U,,,,,12.0,MG,,QD,2020,Q3,Oedema peripheral,,2020,Q3,2,F,,20200819.0,20200810,20200820,EXP,,CZ-TEVA-2020-CZ-1812532,TEVA,SVARKO J. STATIN?INDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WITH MUSCLE WEAKNESS AND SWELLING.,75.0,YR,E,M,Y,,,20200820.0,,MD,CZ,CZ,2020,Q3,Elderly
181315892,18131589,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 U,,,,,,,,,,,QD,2020,Q3,Cardiac arrest,,2020,Q3,2,F,20200728.0,20200807.0,20200810,20200817,EXP,,US-ROCHE-2654392,ROCHE,,43.0,YR,,M,Y,78.5,KG,20200817.0,,MD,US,US,2020,Q3,Adult
181315892,18131589,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 U,,,,,,,,,,,QD,2020,Q3,Quadriplegia,,2020,Q3,2,F,20200728.0,20200807.0,20200810,20200817,EXP,,US-ROCHE-2654392,ROCHE,,43.0,YR,,M,Y,78.5,KG,20200817.0,,MD,US,US,2020,Q3,Adult
181315892,18131589,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,10 U,,,,,,,,,,,QD,2020,Q3,Shock haemorrhagic,,2020,Q3,2,F,20200728.0,20200807.0,20200810,20200817,EXP,,US-ROCHE-2654392,ROCHE,,43.0,YR,,M,Y,78.5,KG,20200817.0,,MD,US,US,2020,Q3,Adult
181323011,18132301,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",673.0,DF,U,U,,,,1.0,DF,,QD,2020,Q3,Asthenia,,2020,Q3,1,I,20200622.0,20200803.0,20200811,20200811,EXP,,IT-AUROBINDO-AUR-APL-2020-038273,AUROBINDO,,75.0,YR,,F,Y,,,20200811.0,,MD,IT,IT,2020,Q3,Elderly
181323011,18132301,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",673.0,DF,U,U,,,,1.0,DF,,QD,2020,Q3,Bradyphrenia,,2020,Q3,1,I,20200622.0,20200803.0,20200811,20200811,EXP,,IT-AUROBINDO-AUR-APL-2020-038273,AUROBINDO,,75.0,YR,,F,Y,,,20200811.0,,MD,IT,IT,2020,Q3,Elderly
181323011,18132301,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",673.0,DF,U,U,,,,1.0,DF,,QD,2020,Q3,Drug interaction,,2020,Q3,1,I,20200622.0,20200803.0,20200811,20200811,EXP,,IT-AUROBINDO-AUR-APL-2020-038273,AUROBINDO,,75.0,YR,,F,Y,,,20200811.0,,MD,IT,IT,2020,Q3,Elderly
181323011,18132301,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",673.0,DF,U,U,,,,1.0,DF,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200622.0,20200803.0,20200811,20200811,EXP,,IT-AUROBINDO-AUR-APL-2020-038273,AUROBINDO,,75.0,YR,,F,Y,,,20200811.0,,MD,IT,IT,2020,Q3,Elderly
181323011,18132301,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, ONCE A DAY",673.0,DF,U,U,,,,1.0,DF,,QD,2020,Q3,Hypokinesia,,2020,Q3,1,I,20200622.0,20200803.0,20200811,20200811,EXP,,IT-AUROBINDO-AUR-APL-2020-038273,AUROBINDO,,75.0,YR,,F,Y,,,20200811.0,,MD,IT,IT,2020,Q3,Elderly
181324171,18132417,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2020,Q3,Acute myocardial infarction,,2020,Q3,1,I,202007.0,20200803.0,20200811,20200811,EXP,,CO-BAXTER-2020BAX015845,BAXTER,,62.0,YR,,F,Y,80.0,KG,20200811.0,,HP,CO,CO,2020,Q3,Adult
181324171,18132417,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,202007.0,20200803.0,20200811,20200811,EXP,,CO-BAXTER-2020BAX015845,BAXTER,,62.0,YR,,F,Y,80.0,KG,20200811.0,,HP,CO,CO,2020,Q3,Adult
181324171,18132417,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,20.0,IU,,,2020,Q3,Vomiting,,2020,Q3,1,I,202007.0,20200803.0,20200811,20200811,EXP,,CO-BAXTER-2020BAX015845,BAXTER,,62.0,YR,,F,Y,80.0,KG,20200811.0,,HP,CO,CO,2020,Q3,Adult
181329761,18132976,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,US-AUROBINDO-AUR-APL-2020-038513,AUROBINDO,,46.0,YR,,M,Y,,,20200811.0,,HP,US,US,2020,Q3,Adult
181329761,18132976,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,US-AUROBINDO-AUR-APL-2020-038513,AUROBINDO,,46.0,YR,,M,Y,,,20200811.0,,HP,US,US,2020,Q3,Adult
181329761,18132976,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Off label use,,2020,Q3,1,I,,20200805.0,20200811,20200811,EXP,,US-AUROBINDO-AUR-APL-2020-038513,AUROBINDO,,46.0,YR,,M,Y,,,20200811.0,,HP,US,US,2020,Q3,Adult
181364681,18136468,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Blood creatine phosphokinase increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Blood urea increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Incorrect dose administered,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,International normalised ratio increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Medication error,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Myoglobin blood increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Rhabdomyolysis,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181364681,18136468,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q3,Transaminases increased,,2020,Q3,1,I,,20200806.0,20200811,20200811,EXP,,NVSC2020CZ222167,NOVARTIS,"VODICKA M, SLANAR O, PISAR M, SALEK T. RHABDOMYOLYZA PO CHYBNEM UZIVANI ROSUVASTATINU KAZUISTIKA [ROSUVASTATIN?INDUCED RHABDOMYOLYSIS DUE TO MEDICATION ERRORS]. CES. SLOV. FARM. 2020?69:100?2",74.0,YR,,M,Y,,,20200811.0,,HP,CZ,CZ,2020,Q3,Elderly
181372111,18137211,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD",,,Y,U,,,,1.0,DF,,QD,2020,Q3,Asthenia,,2020,Q3,1,I,20200615.0,20200731.0,20200811,20200811,EXP,IT-MINISAL02-629082,IT-NOVOPROD-744393,NOVO NORDISK,,47.0,YR,,M,Y,,,20200811.0,,MD,IT,IT,2020,Q3,Adult
181372111,18137211,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD",,,Y,U,,,,1.0,DF,,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,20200615.0,20200731.0,20200811,20200811,EXP,IT-MINISAL02-629082,IT-NOVOPROD-744393,NOVO NORDISK,,47.0,YR,,M,Y,,,20200811.0,,MD,IT,IT,2020,Q3,Adult
181372111,18137211,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"1 DF, QD",,,Y,U,,,,1.0,DF,,QD,2020,Q3,Malaise,,2020,Q3,1,I,20200615.0,20200731.0,20200811,20200811,EXP,IT-MINISAL02-629082,IT-NOVOPROD-744393,NOVO NORDISK,,47.0,YR,,M,Y,,,20200811.0,,MD,IT,IT,2020,Q3,Adult
181391161,18139116,7,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Creatinine renal clearance decreased,,2020,Q3,1,I,20200810.0,,20200812,20200812,DIR,,,FDA-CTU,,63.0,YR,,M,N,107.5,KG,20200812.0,N,PH,US,US,2020,Q3,Adult
181391161,18139116,7,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Therapy cessation,,2020,Q3,1,I,20200810.0,,20200812,20200812,DIR,,,FDA-CTU,,63.0,YR,,M,N,107.5,KG,20200812.0,N,PH,US,US,2020,Q3,Adult
181419333,18141933,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,GENETICAL RECOMBINATION,,,,,,,,,,,,2020,Q3,Chronic kidney disease,,2020,Q3,3,F,20200322.0,20200929.0,20200812,20200930,EXP,,JP-ABBVIE-20K-087-3522495-00,ABBVIE,,69.0,YR,,M,Y,82.0,KG,20200930.0,,MD,JP,JP,2020,Q3,Elderly
181421771,18142177,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 DOSAGE FORM, QD",,,Y,U,,,210605.0,1.0,DF,,QD,2020,Q3,Asthenia,,2020,Q3,1,I,20200615.0,20200804.0,20200812,20200812,EXP,IT-MINISAL02-629082,IT-MYLANLABS-2020M1070105,MYLAN,,47.0,YR,,M,Y,,,20200812.0,,MD,IT,IT,2020,Q3,Adult
181421771,18142177,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 DOSAGE FORM, QD",,,Y,U,,,210605.0,1.0,DF,,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,20200615.0,20200804.0,20200812,20200812,EXP,IT-MINISAL02-629082,IT-MYLANLABS-2020M1070105,MYLAN,,47.0,YR,,M,Y,,,20200812.0,,MD,IT,IT,2020,Q3,Adult
181421771,18142177,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 DOSAGE FORM, QD",,,Y,U,,,210605.0,1.0,DF,,QD,2020,Q3,Malaise,,2020,Q3,1,I,20200615.0,20200804.0,20200812,20200812,EXP,IT-MINISAL02-629082,IT-MYLANLABS-2020M1070105,MYLAN,,47.0,YR,,M,Y,,,20200812.0,,MD,IT,IT,2020,Q3,Adult
181426661,18142666,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, QD (0?0?0?48 U)",,,Y,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,1,I,,20200805.0,20200812,20200812,EXP,,CZ-MYLANLABS-2020M1070229,MYLAN,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200812.0,,MD,CZ,CZ,2020,Q3,Adult
181426661,18142666,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, QD (0?0?0?48 U)",,,Y,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Injection site pain,,2020,Q3,1,I,,20200805.0,20200812,20200812,EXP,,CZ-MYLANLABS-2020M1070229,MYLAN,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200812.0,,MD,CZ,CZ,2020,Q3,Adult
181426661,18142666,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"48 INTERNATIONAL UNIT, QD (0?0?0?48 U)",,,Y,,,,,48.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Weight increased,,2020,Q3,1,I,,20200805.0,20200812,20200812,EXP,,CZ-MYLANLABS-2020M1070229,MYLAN,HIMMELOVA K. EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE. KAZUSITIKY V DIABETOLOGII. 2020?2:33?36,62.0,YR,,M,Y,,,20200812.0,,MD,CZ,CZ,2020,Q3,Adult
181432882,18143288,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,2,F,20200804.0,20200904.0,20200812,20200908,EXP,,US-GILEAD-2020-0489707,GILEAD,,33.0,YR,A,F,Y,79.4,KG,20200908.0,,PH,US,US,2020,Q3,Young Adult
181433771,18143377,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"58 UNIT, BID",,,,,,,,,,,BID,2020,Q3,Drug resistance,,2020,Q3,1,I,,20200731.0,20200813,20200813,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181433771,18143377,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNIT, QD",,,,,,,,,,,QD,2020,Q3,Drug resistance,,2020,Q3,1,I,,20200731.0,20200813,20200813,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181433771,18143377,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"35 UNIT, QD",,,,,,,,,,,QD,2020,Q3,Drug resistance,,2020,Q3,1,I,,20200731.0,20200813,20200813,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181445092,18144509,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"27 IU, 0?0?1?0",,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,2,F,,20200820.0,20200813,20200831,EXP,DE-BFARM-20008512,DE-ACCORD-195099,ACCORD,,84.0,YR,E,F,Y,80.0,KG,20200831.0,,CN,FR,DE,2020,Q3,Elderly
181445092,18144509,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"27 IU, 0?0?1?0",,,,,,,,,,,,2020,Q3,Abdominal pain lower,,2020,Q3,2,F,,20200820.0,20200813,20200831,EXP,DE-BFARM-20008512,DE-ACCORD-195099,ACCORD,,84.0,YR,E,F,Y,80.0,KG,20200831.0,,CN,FR,DE,2020,Q3,Elderly
181446492,18144649,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 KILO?INTERNATIONAL UNIT, QD",1362.0,KIU,U,U,,,210605.0,6.0,KIU,INJECTION,QD,2020,Q3,Asthenia,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181446492,18144649,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 KILO?INTERNATIONAL UNIT, QD",1362.0,KIU,U,U,,,210605.0,6.0,KIU,INJECTION,QD,2020,Q3,Bradyphrenia,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181446492,18144649,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 KILO?INTERNATIONAL UNIT, QD",1362.0,KIU,U,U,,,210605.0,6.0,KIU,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181446492,18144649,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 KILO?INTERNATIONAL UNIT, QD",1362.0,KIU,U,U,,,210605.0,6.0,KIU,INJECTION,QD,2020,Q3,Hypokinesia,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181446492,18144649,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 KILO?INTERNATIONAL UNIT, QD",1362.0,KIU,U,U,,,210605.0,6.0,KIU,INJECTION,QD,2020,Q3,Sopor,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181446492,18144649,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,1362.0,KIU,U,U,,,210605.0,,,INJECTION,,2020,Q3,Asthenia,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181446492,18144649,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,1362.0,KIU,U,U,,,210605.0,,,INJECTION,,2020,Q3,Bradyphrenia,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181446492,18144649,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,1362.0,KIU,U,U,,,210605.0,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181446492,18144649,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,1362.0,KIU,U,U,,,210605.0,,,INJECTION,,2020,Q3,Hypokinesia,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181446492,18144649,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,1362.0,KIU,U,U,,,210605.0,,,INJECTION,,2020,Q3,Sopor,,2020,Q3,2,F,20200615.0,20200807.0,20200813,20200814,EXP,IT-MINISAL02-629643,IT-MYLANLABS-2020M1070621,MYLAN,,82.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181458001,18145800,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"58 INTERNATIONAL UNIT, BID",,,,,,,,58.0,IU,,BID,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,US-MYLANLABS-2020M1070717,MYLAN,"LUNDHOLM MD, CHARNOGURSKY GA. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLIN?CASE?REP 2020?8(7):1238?1240.",65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181458001,18145800,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,REDUCED TO 10 UNITS DAILY,,,,,,,,,,,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,US-MYLANLABS-2020M1070717,MYLAN,"LUNDHOLM MD, CHARNOGURSKY GA. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLIN?CASE?REP 2020?8(7):1238?1240.",65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181458001,18145800,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,INCREASED TO 35 UNITS DAILY,,,,,,,,,,,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,US-MYLANLABS-2020M1070717,MYLAN,"LUNDHOLM MD, CHARNOGURSKY GA. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLIN?CASE?REP 2020?8(7):1238?1240.",65.0,YR,,M,Y,,,20200813.0,,HP,US,US,2020,Q3,Elderly
181458731,18145873,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,ACCORDING TO PLAN,,,U,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200807.0,20200813,20200813,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-040670",BOEHRINGER INGELHEIM,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181458731,18145873,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,ACCORDING TO PLAN,,,U,,,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200807.0,20200813,20200813,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-040670",BOEHRINGER INGELHEIM,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181458731,18145873,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,ACCORDING TO PLAN,,,U,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200807.0,20200813,20200813,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-040670",BOEHRINGER INGELHEIM,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181458731,18145873,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,ACCORDING TO PLAN,,,U,,,,,,,,,2020,Q3,Wound,,2020,Q3,1,I,,20200807.0,20200813,20200813,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-12-040670",BOEHRINGER INGELHEIM,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181460862,18146086,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK,0.01 TO 0.05 UNITS/KG BW/H",,,Y,U,,,210605.0,,,INJECTION,,2020,Q3,Drug ineffective,,2020,Q3,2,F,,20200804.0,20200813,20200819,EXP,,PL-MYLANLABS-2020M1070720,MYLAN,"SZYPOWSKA A, TOMASIK T. MEDYCYNA PRAKTYCZNA PEDIATRIA. CUKRZYCA NOWORODKOWA. 2020?3:84?112",4.0,WK,,M,Y,,,20200819.0,,HP,PL,PL,2020,Q3,Child
181460862,18146086,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK,0.01 TO 0.05 UNITS/KG BW/H",,,Y,U,,,210605.0,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,2,F,,20200804.0,20200813,20200819,EXP,,PL-MYLANLABS-2020M1070720,MYLAN,"SZYPOWSKA A, TOMASIK T. MEDYCYNA PRAKTYCZNA PEDIATRIA. CUKRZYCA NOWORODKOWA. 2020?3:84?112",4.0,WK,,M,Y,,,20200819.0,,HP,PL,PL,2020,Q3,Child
181467811,18146781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN)",,,U,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200810.0,20200813,20200813,EXP,,NVSC2020DE221709,NOVARTIS,,80.0,YR,,M,Y,74.0,KG,20200813.0,,HP,DE,DE,2020,Q3,Elderly
181467811,18146781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN)",,,U,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200810.0,20200813,20200813,EXP,,NVSC2020DE221709,NOVARTIS,,80.0,YR,,M,Y,74.0,KG,20200813.0,,HP,DE,DE,2020,Q3,Elderly
181467811,18146781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN)",,,U,,,,,,,,,2020,Q3,Localised infection,,2020,Q3,1,I,,20200810.0,20200813,20200813,EXP,,NVSC2020DE221709,NOVARTIS,,80.0,YR,,M,Y,74.0,KG,20200813.0,,HP,DE,DE,2020,Q3,Elderly
181467811,18146781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN)",,,U,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200810.0,20200813,20200813,EXP,,NVSC2020DE221709,NOVARTIS,,80.0,YR,,M,Y,74.0,KG,20200813.0,,HP,DE,DE,2020,Q3,Elderly
181467811,18146781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN)",,,U,,,,,,,,,2020,Q3,Productive cough,,2020,Q3,1,I,,20200810.0,20200813,20200813,EXP,,NVSC2020DE221709,NOVARTIS,,80.0,YR,,M,Y,74.0,KG,20200813.0,,HP,DE,DE,2020,Q3,Elderly
181467811,18146781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN)",,,U,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200810.0,20200813,20200813,EXP,,NVSC2020DE221709,NOVARTIS,,80.0,YR,,M,Y,74.0,KG,20200813.0,,HP,DE,DE,2020,Q3,Elderly
181467811,18146781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN)",,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,1,I,,20200810.0,20200813,20200813,EXP,,NVSC2020DE221709,NOVARTIS,,80.0,YR,,M,Y,74.0,KG,20200813.0,,HP,DE,DE,2020,Q3,Elderly
181479821,18147982,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ACCODRING TO PLAN",,,U,,,,205692.0,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008001583,ELI LILLY AND CO,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181479821,18147982,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ACCODRING TO PLAN",,,U,,,,205692.0,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008001583,ELI LILLY AND CO,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181479821,18147982,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ACCODRING TO PLAN",,,U,,,,205692.0,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008001583,ELI LILLY AND CO,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181479821,18147982,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, ACCODRING TO PLAN",,,U,,,,205692.0,,,,,2020,Q3,Wound,,2020,Q3,1,I,,20200804.0,20200813,20200813,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202008001583,ELI LILLY AND CO,,82.0,YR,,M,Y,133.4,KG,20200813.0,,PH,DE,DE,2020,Q3,Elderly
181483251,18148325,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"58 INTERNATIONAL UNIT, BID",,,Y,,,,,58.0,IU,,BID,2020,Q3,Acute myocardial infarction,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"58 INTERNATIONAL UNIT, BID",,,Y,,,,,58.0,IU,,BID,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"58 INTERNATIONAL UNIT, BID",,,Y,,,,,58.0,IU,,BID,2020,Q3,Pancytopenia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,Y,,,,,10.0,IU,,,2020,Q3,Acute myocardial infarction,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,Y,,,,,10.0,IU,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 INTERNATIONAL UNIT, QD",,,Y,,,,,10.0,IU,,,2020,Q3,Pancytopenia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"35 INTERNATIONAL UNIT, QD",,,Y,,,,,35.0,IU,,,2020,Q3,Acute myocardial infarction,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"35 INTERNATIONAL UNIT, QD",,,Y,,,,,35.0,IU,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181483251,18148325,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"35 INTERNATIONAL UNIT, QD",,,Y,,,,,35.0,IU,,,2020,Q3,Pancytopenia,,2020,Q3,1,I,,20200804.0,20200814,20200814,EXP,,US-APOTEX-2020AP016009,APOTEX,"LUNDHOLM MD, CHARNOGURSKY GA.. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.. CLINICAL CASE REPORT. 2020?8 (7):1?3",65.0,YR,,M,Y,,,20200814.0,,HP,US,US,2020,Q3,Elderly
181516051,18151605,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD (0?0?0?48 U)",,,Y,,,,,48.0,IU,,QD,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,1,I,,20200803.0,20200814,20200814,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ202008000544,ELI LILLY AND CO,HIMMELOVA K.EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE..KAZUSITIKY V DIABETOLOGII. 2020?2:33?36.DOI:UNK,62.0,YR,,M,Y,,,20200814.0,,MD,CZ,CZ,2020,Q3,Adult
181516051,18151605,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD (0?0?0?48 U)",,,Y,,,,,48.0,IU,,QD,2020,Q3,Injection site pain,,2020,Q3,1,I,,20200803.0,20200814,20200814,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ202008000544,ELI LILLY AND CO,HIMMELOVA K.EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE..KAZUSITIKY V DIABETOLOGII. 2020?2:33?36.DOI:UNK,62.0,YR,,M,Y,,,20200814.0,,MD,CZ,CZ,2020,Q3,Adult
181516051,18151605,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"48 IU, QD (0?0?0?48 U)",,,Y,,,,,48.0,IU,,QD,2020,Q3,Weight increased,,2020,Q3,1,I,,20200803.0,20200814,20200814,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ202008000544,ELI LILLY AND CO,HIMMELOVA K.EACH COIN HAS TWO SIDES AND TWO ARE MORE THAN ONE..KAZUSITIKY V DIABETOLOGII. 2020?2:33?36.DOI:UNK,62.0,YR,,M,Y,,,20200814.0,,MD,CZ,CZ,2020,Q3,Adult
181518271,18151827,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Haemoptysis,,2020,Q3,1,I,2020.0,20200805.0,20200814,20200814,EXP,IT-MINISAL02-629054,IT-VERTEX PHARMACEUTICALS-2020-016183,VERTEX,,15.0,YR,,M,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Youth
181522581,18152258,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, QD",673.0,DF,D,,,,210605.0,1.0,DF,INJECTION,QD,2020,Q3,Asthenia,,2020,Q3,1,I,20200622.0,20200807.0,20200814,20200814,EXP,IT-MINISAL02-629645,IT-MYLANLABS-2020M1070628,MYLAN,,75.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181522581,18152258,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, QD",673.0,DF,D,,,,210605.0,1.0,DF,INJECTION,QD,2020,Q3,Bradyphrenia,,2020,Q3,1,I,20200622.0,20200807.0,20200814,20200814,EXP,IT-MINISAL02-629645,IT-MYLANLABS-2020M1070628,MYLAN,,75.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181522581,18152258,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, QD",673.0,DF,D,,,,210605.0,1.0,DF,INJECTION,QD,2020,Q3,Drug interaction,,2020,Q3,1,I,20200622.0,20200807.0,20200814,20200814,EXP,IT-MINISAL02-629645,IT-MYLANLABS-2020M1070628,MYLAN,,75.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181522581,18152258,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, QD",673.0,DF,D,,,,210605.0,1.0,DF,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200622.0,20200807.0,20200814,20200814,EXP,IT-MINISAL02-629645,IT-MYLANLABS-2020M1070628,MYLAN,,75.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181522581,18152258,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DOSAGE FORM, QD",673.0,DF,D,,,,210605.0,1.0,DF,INJECTION,QD,2020,Q3,Hypokinesia,,2020,Q3,1,I,20200622.0,20200807.0,20200814,20200814,EXP,IT-MINISAL02-629645,IT-MYLANLABS-2020M1070628,MYLAN,,75.0,YR,,F,Y,,,20200814.0,,MD,IT,IT,2020,Q3,Elderly
181538292,18153829,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Myasthenia gravis crisis,,2020,Q3,2,F,,20200825.0,20200816,20200828,EXP,,NVSC2020US226171,NOVARTIS,"SALIK I, RODHOUSE HB, BARST S. MYASTHENIC CRISIS IN THE SETTING OF CORONAVIRUS DISEASE 2019 (COVID?19). JOURNAL OF CLINICAL ANESTHESIA. 2020?67:1?2",80.0,YR,,M,Y,,,20200828.0,,HP,US,US,2020,Q3,Elderly
181538292,18153829,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Product use in unapproved indication,,2020,Q3,2,F,,20200825.0,20200816,20200828,EXP,,NVSC2020US226171,NOVARTIS,"SALIK I, RODHOUSE HB, BARST S. MYASTHENIC CRISIS IN THE SETTING OF CORONAVIRUS DISEASE 2019 (COVID?19). JOURNAL OF CLINICAL ANESTHESIA. 2020?67:1?2",80.0,YR,,M,Y,,,20200828.0,,HP,US,US,2020,Q3,Elderly
181556771,18155677,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Fungal sepsis,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hydroureter,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Nephrotic syndrome,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Pyelonephritis,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181556771,18155677,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Urinary tract obstruction,,2020,Q3,1,I,20200725.0,,20200814,20200814,DIR,,,FDA-CTU,,57.0,YR,,F,N,98.2,KG,20200814.0,Y,PH,US,US,2020,Q3,Adult
181557031,18155703,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Accidental overdose,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181557031,18155703,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Blood lactic acid increased,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181557031,18155703,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Blood pH decreased,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181557031,18155703,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181557031,18155703,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U, UNKNOWN,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,,20200521.0,20200817,20200817,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-02397,ALKEM,,67.0,YR,,M,Y,,,20200817.0,,HP,AU,AU,2020,Q3,Elderly
181563111,18156311,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200805.0,20200817,20200817,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK049056,GLENMARK,"FINEGAN A, MABROUK U, NELSON LA.. GABAPENTIN?INDUCED BILATERAL LOWER EXTREMITY EDEMA IN A PATIENT WITH PERVASIVE DEVELOPMENTAL DISORDER AND SCHIZOAFFECTIVE DISORDER.. MENT HEALTH CLIN.. 2020?10 (4):250?253",46.0,YR,,M,Y,,,20200817.0,,PH,US,US,2020,Q3,Adult
181563111,18156311,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200805.0,20200817,20200817,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK049056,GLENMARK,"FINEGAN A, MABROUK U, NELSON LA.. GABAPENTIN?INDUCED BILATERAL LOWER EXTREMITY EDEMA IN A PATIENT WITH PERVASIVE DEVELOPMENTAL DISORDER AND SCHIZOAFFECTIVE DISORDER.. MENT HEALTH CLIN.. 2020?10 (4):250?253",46.0,YR,,M,Y,,,20200817.0,,PH,US,US,2020,Q3,Adult
181563111,18156311,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,1,I,,20200805.0,20200817,20200817,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK049056,GLENMARK,"FINEGAN A, MABROUK U, NELSON LA.. GABAPENTIN?INDUCED BILATERAL LOWER EXTREMITY EDEMA IN A PATIENT WITH PERVASIVE DEVELOPMENTAL DISORDER AND SCHIZOAFFECTIVE DISORDER.. MENT HEALTH CLIN.. 2020?10 (4):250?253",46.0,YR,,M,Y,,,20200817.0,,PH,US,US,2020,Q3,Adult
181593371,18159337,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE,",,,,,,,,,,TABLET,QD,2020,Q3,Disturbance in attention,,2020,Q3,1,I,,20200807.0,20200817,20200817,EXP,,DE-JNJFOC-20200810038,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,,,20200817.0,,PH,DE,DE,2020,Q3,Elderly
181593371,18159337,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE,",,,,,,,,,,TABLET,QD,2020,Q3,Drug level increased,,2020,Q3,1,I,,20200807.0,20200817,20200817,EXP,,DE-JNJFOC-20200810038,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,,,20200817.0,,PH,DE,DE,2020,Q3,Elderly
181593371,18159337,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE,",,,,,,,,,,TABLET,QD,2020,Q3,Encephalitis,,2020,Q3,1,I,,20200807.0,20200817,20200817,EXP,,DE-JNJFOC-20200810038,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,,,20200817.0,,PH,DE,DE,2020,Q3,Elderly
181593371,18159337,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE,",,,,,,,,,,TABLET,QD,2020,Q3,Fall,,2020,Q3,1,I,,20200807.0,20200817,20200817,EXP,,DE-JNJFOC-20200810038,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,,,20200817.0,,PH,DE,DE,2020,Q3,Elderly
181593371,18159337,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE,",,,,,,,,,,TABLET,QD,2020,Q3,Insomnia,,2020,Q3,1,I,,20200807.0,20200817,20200817,EXP,,DE-JNJFOC-20200810038,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,,,20200817.0,,PH,DE,DE,2020,Q3,Elderly
181593371,18159337,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE,",,,,,,,,,,TABLET,QD,2020,Q3,Restlessness,,2020,Q3,1,I,,20200807.0,20200817,20200817,EXP,,DE-JNJFOC-20200810038,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,,,20200817.0,,PH,DE,DE,2020,Q3,Elderly
181594101,18159410,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200805.0,20200818,20200818,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04754,LUPIN,,46.0,YR,,M,Y,,,20200818.0,,MD,US,US,2020,Q3,Adult
181594101,18159410,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200805.0,20200818,20200818,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04754,LUPIN,,46.0,YR,,M,Y,,,20200818.0,,MD,US,US,2020,Q3,Adult
181594101,18159410,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,1,I,,20200805.0,20200818,20200818,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04754,LUPIN,,46.0,YR,,M,Y,,,20200818.0,,MD,US,US,2020,Q3,Adult
181604521,18160452,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Eosinophilic pneumonia,,2020,Q3,1,I,20200305.0,20200812.0,20200817,20200817,EXP,,JP-PFIZER INC-2020310719,PFIZER,,73.0,YR,,M,Y,36.3,KG,20200817.0,,PH,JP,JP,2020,Q3,Elderly
181604521,18160452,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Steroid diabetes,,2020,Q3,1,I,20200305.0,20200812.0,20200817,20200817,EXP,,JP-PFIZER INC-2020310719,PFIZER,,73.0,YR,,M,Y,36.3,KG,20200817.0,,PH,JP,JP,2020,Q3,Elderly
181621791,18162179,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,673.0,DF,U,, UNKNOWN,,,1.0,DF,,,2020,Q3,Asthenia,,2020,Q3,1,I,20200622.0,20200810.0,20200818,20200818,EXP,IT-MINISAL02-629645,IT-TEVA-2020-IT-1814548,TEVA,,75.0,YR,E,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Elderly
181621791,18162179,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,673.0,DF,U,, UNKNOWN,,,1.0,DF,,,2020,Q3,Bradyphrenia,,2020,Q3,1,I,20200622.0,20200810.0,20200818,20200818,EXP,IT-MINISAL02-629645,IT-TEVA-2020-IT-1814548,TEVA,,75.0,YR,E,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Elderly
181621791,18162179,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,673.0,DF,U,, UNKNOWN,,,1.0,DF,,,2020,Q3,Drug interaction,,2020,Q3,1,I,20200622.0,20200810.0,20200818,20200818,EXP,IT-MINISAL02-629645,IT-TEVA-2020-IT-1814548,TEVA,,75.0,YR,E,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Elderly
181621791,18162179,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,673.0,DF,U,, UNKNOWN,,,1.0,DF,,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200622.0,20200810.0,20200818,20200818,EXP,IT-MINISAL02-629645,IT-TEVA-2020-IT-1814548,TEVA,,75.0,YR,E,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Elderly
181621791,18162179,2,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,673.0,DF,U,, UNKNOWN,,,1.0,DF,,,2020,Q3,Hypokinesia,,2020,Q3,1,I,20200622.0,20200810.0,20200818,20200818,EXP,IT-MINISAL02-629645,IT-TEVA-2020-IT-1814548,TEVA,,75.0,YR,E,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Elderly
181636001,18163600,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,FR-MYLANLABS-2020M1072181,MYLAN,,13.0,YR,,F,Y,50.0,KG,20200818.0,,HP,FR,FR,2020,Q3,Child
181636001,18163600,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Bundle branch block right,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,FR-MYLANLABS-2020M1072181,MYLAN,,13.0,YR,,F,Y,50.0,KG,20200818.0,,HP,FR,FR,2020,Q3,Child
181636001,18163600,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,FR-MYLANLABS-2020M1072181,MYLAN,,13.0,YR,,F,Y,50.0,KG,20200818.0,,HP,FR,FR,2020,Q3,Child
181636001,18163600,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Intentional overdose,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,FR-MYLANLABS-2020M1072181,MYLAN,,13.0,YR,,F,Y,50.0,KG,20200818.0,,HP,FR,FR,2020,Q3,Child
181636001,18163600,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Product administration error,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,FR-MYLANLABS-2020M1072181,MYLAN,,13.0,YR,,F,Y,50.0,KG,20200818.0,,HP,FR,FR,2020,Q3,Child
181636001,18163600,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Toxicity to various agents,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,FR-MYLANLABS-2020M1072181,MYLAN,,13.0,YR,,F,Y,50.0,KG,20200818.0,,HP,FR,FR,2020,Q3,Child
181636001,18163600,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q3,Vasoplegia syndrome,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,FR-MYLANLABS-2020M1072181,MYLAN,,13.0,YR,,F,Y,50.0,KG,20200818.0,,HP,FR,FR,2020,Q3,Child
181642981,18164298,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE, 1?0?0?0, TABLETTEN",,,,,,,,12.0,IU,TABLET,QD,2020,Q3,Disturbance in attention,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1070953,MYLAN,,73.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181642981,18164298,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE, 1?0?0?0, TABLETTEN",,,,,,,,12.0,IU,TABLET,QD,2020,Q3,Drug level increased,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1070953,MYLAN,,73.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181642981,18164298,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE, 1?0?0?0, TABLETTEN",,,,,,,,12.0,IU,TABLET,QD,2020,Q3,Encephalitis,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1070953,MYLAN,,73.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181642981,18164298,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE, 1?0?0?0, TABLETTEN",,,,,,,,12.0,IU,TABLET,QD,2020,Q3,Fall,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1070953,MYLAN,,73.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181642981,18164298,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE, 1?0?0?0, TABLETTEN",,,,,,,,12.0,IU,TABLET,QD,2020,Q3,Insomnia,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1070953,MYLAN,,73.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181642981,18164298,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"12 IE, 1?0?0?0, TABLETTEN",,,,,,,,12.0,IU,TABLET,QD,2020,Q3,Restlessness,,2020,Q3,1,I,,20200810.0,20200818,20200818,EXP,,DE-MYLANLABS-2020M1070953,MYLAN,,73.0,YR,,M,Y,,,20200818.0,,PH,DE,DE,2020,Q3,Elderly
181649761,18164976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, QD",,,D,,,,210605.0,30.0,IU,INJECTION,QD,2020,Q3,Cold sweat,,2020,Q3,1,I,20200705.0,20200814.0,20200818,20200818,EXP,IT-MINISAL02-630425,IT-MYLANLABS-2020M1072163,MYLAN,,31.0,YR,,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Young Adult
181649761,18164976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, QD",,,D,,,,210605.0,30.0,IU,INJECTION,QD,2020,Q3,Coma,,2020,Q3,1,I,20200705.0,20200814.0,20200818,20200818,EXP,IT-MINISAL02-630425,IT-MYLANLABS-2020M1072163,MYLAN,,31.0,YR,,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Young Adult
181649761,18164976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, QD",,,D,,,,210605.0,30.0,IU,INJECTION,QD,2020,Q3,Drug abuse,,2020,Q3,1,I,20200705.0,20200814.0,20200818,20200818,EXP,IT-MINISAL02-630425,IT-MYLANLABS-2020M1072163,MYLAN,,31.0,YR,,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Young Adult
181649761,18164976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, QD",,,D,,,,210605.0,30.0,IU,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200705.0,20200814.0,20200818,20200818,EXP,IT-MINISAL02-630425,IT-MYLANLABS-2020M1072163,MYLAN,,31.0,YR,,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Young Adult
181649761,18164976,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 INTERNATIONAL UNIT, QD",,,D,,,,210605.0,30.0,IU,INJECTION,QD,2020,Q3,Sedation,,2020,Q3,1,I,20200705.0,20200814.0,20200818,20200818,EXP,IT-MINISAL02-630425,IT-MYLANLABS-2020M1072163,MYLAN,,31.0,YR,,F,Y,,,20200818.0,,MD,IT,IT,2020,Q3,Young Adult
181673991,18167399,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200816.0,,20200818,20200818,DIR,,,FDA-CTU,,70.0,YR,,F,N,113.1,KG,20200818.0,N,PH,US,US,2020,Q3,Elderly
181674271,18167427,10,C,Glargine 10 units SQ daily,,2,,,,,,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,1,I,20200814.0,,20200818,20200818,DIR,,,FDA-CTU,,60.0,YR,,M,N,126.0,KG,20200818.0,N,PH,US,US,2020,Q3,Adult
181678981,18167898,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,1,I,,20190912.0,20200818,20200818,EXP,,US-OTSUKA-2019_032357,OTSUKA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC GERIATRICS. 2020?20(1):179",68.0,YR,,M,Y,,,20200818.0,,HP,US,US,2020,Q3,Elderly
181703051,18170305,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NACH PLAN,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Fall,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071317,MYLAN,,82.0,YR,,M,Y,133.4,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703051,18170305,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NACH PLAN,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071317,MYLAN,,82.0,YR,,M,Y,133.4,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703051,18170305,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NACH PLAN,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071317,MYLAN,,82.0,YR,,M,Y,133.4,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703051,18170305,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,NACH PLAN,,,U,U,,,210605.0,,,INJECTION,,2020,Q3,Wound,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071317,MYLAN,,82.0,YR,,M,Y,133.4,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703341,18170334,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,Y,U, 0F638A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703341,18170334,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,Y,U, 0F638A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Drug abuse,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703341,18170334,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,Y,U, 0F638A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703341,18170334,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,Y,U, 0F638A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product misuse,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703341,18170334,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"22 IU, QD",,,Y,U, 0F638A,,,22.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product use issue,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703341,18170334,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,U, 0F638A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Blood glucose increased,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703341,18170334,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,U, 0F638A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Drug abuse,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703341,18170334,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,U, 0F638A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703341,18170334,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,U, 0F638A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product misuse,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703341,18170334,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, QD",,,Y,U, 0F638A,,,20.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Intentional product use issue,,2020,Q3,1,I,2020.0,20200810.0,20200819,20200819,EXP,,ES-MYLANLABS-2020M1071248,MYLAN,,74.0,YR,,M,Y,,,20200819.0,,CN,ES,ES,2020,Q3,Elderly
181703401,18170340,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD,24 IE, 0?0?0?1, AMPULLEN",,,,,,,,,,,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071240,MYLAN,,79.0,YR,,F,Y,80.9,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703401,18170340,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD,24 IE, 0?0?0?1, AMPULLEN",,,,,,,,,,,QD,2020,Q3,Confusional state,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071240,MYLAN,,79.0,YR,,F,Y,80.9,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703401,18170340,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD,24 IE, 0?0?0?1, AMPULLEN",,,,,,,,,,,QD,2020,Q3,Disorientation,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071240,MYLAN,,79.0,YR,,F,Y,80.9,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703401,18170340,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD,24 IE, 0?0?0?1, AMPULLEN",,,,,,,,,,,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071240,MYLAN,,79.0,YR,,F,Y,80.9,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181703401,18170340,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, QD,24 IE, 0?0?0?1, AMPULLEN",,,,,,,,,,,QD,2020,Q3,Restlessness,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071240,MYLAN,,79.0,YR,,F,Y,80.9,KG,20200819.0,,PH,DE,DE,2020,Q3,Elderly
181707921,18170792,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN",,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071280,MYLAN,,80.0,YR,,M,Y,74.0,KG,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181707921,18170792,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN",,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071280,MYLAN,,80.0,YR,,M,Y,74.0,KG,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181707921,18170792,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN",,,,,,,,,,,,2020,Q3,Localised infection,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071280,MYLAN,,80.0,YR,,M,Y,74.0,KG,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181707921,18170792,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN",,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071280,MYLAN,,80.0,YR,,M,Y,74.0,KG,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181707921,18170792,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN",,,,,,,,,,,,2020,Q3,Productive cough,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071280,MYLAN,,80.0,YR,,M,Y,74.0,KG,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181707921,18170792,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN",,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071280,MYLAN,,80.0,YR,,M,Y,74.0,KG,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181707921,18170792,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"450 E/1.5ML, 0?0?16?0, FERTIGSPRITZEN",,,,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,1,I,,20200810.0,20200819,20200819,EXP,,DE-MYLANLABS-2020M1071280,MYLAN,,80.0,YR,,M,Y,74.0,KG,20200819.0,,MD,DE,DE,2020,Q3,Elderly
181722141,18172214,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",3222.0,IU,Y,U, ABJA005,,,18.0,IU,,QD,2020,Q3,Constipation,,2020,Q3,1,I,20200801.0,20200808.0,20200819,20200819,EXP,,CN-NOVOPROD-746791,NOVO NORDISK,,59.0,YR,,M,Y,70.0,KG,20200819.0,,HP,CN,CN,2020,Q3,Adult
181722141,18172214,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",3222.0,IU,Y,U, ABJA005,,,18.0,IU,,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200801.0,20200808.0,20200819,20200819,EXP,,CN-NOVOPROD-746791,NOVO NORDISK,,59.0,YR,,M,Y,70.0,KG,20200819.0,,HP,CN,CN,2020,Q3,Adult
181722141,18172214,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",3222.0,IU,Y,U, ABJA005,,,18.0,IU,,QD,2020,Q3,Hypoglycaemic coma,,2020,Q3,1,I,20200801.0,20200808.0,20200819,20200819,EXP,,CN-NOVOPROD-746791,NOVO NORDISK,,59.0,YR,,M,Y,70.0,KG,20200819.0,,HP,CN,CN,2020,Q3,Adult
181722141,18172214,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",3222.0,IU,Y,U, ABJA005,,,18.0,IU,,QD,2020,Q3,Pneumonitis,,2020,Q3,1,I,20200801.0,20200808.0,20200819,20200819,EXP,,CN-NOVOPROD-746791,NOVO NORDISK,,59.0,YR,,M,Y,70.0,KG,20200819.0,,HP,CN,CN,2020,Q3,Adult
181722141,18172214,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 U.,3222.0,IU,Y,U, ABJA005,,,,,,,2020,Q3,Constipation,,2020,Q3,1,I,20200801.0,20200808.0,20200819,20200819,EXP,,CN-NOVOPROD-746791,NOVO NORDISK,,59.0,YR,,M,Y,70.0,KG,20200819.0,,HP,CN,CN,2020,Q3,Adult
181722141,18172214,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 U.,3222.0,IU,Y,U, ABJA005,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200801.0,20200808.0,20200819,20200819,EXP,,CN-NOVOPROD-746791,NOVO NORDISK,,59.0,YR,,M,Y,70.0,KG,20200819.0,,HP,CN,CN,2020,Q3,Adult
181722141,18172214,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 U.,3222.0,IU,Y,U, ABJA005,,,,,,,2020,Q3,Hypoglycaemic coma,,2020,Q3,1,I,20200801.0,20200808.0,20200819,20200819,EXP,,CN-NOVOPROD-746791,NOVO NORDISK,,59.0,YR,,M,Y,70.0,KG,20200819.0,,HP,CN,CN,2020,Q3,Adult
181722141,18172214,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 U.,3222.0,IU,Y,U, ABJA005,,,,,,,2020,Q3,Pneumonitis,,2020,Q3,1,I,20200801.0,20200808.0,20200819,20200819,EXP,,CN-NOVOPROD-746791,NOVO NORDISK,,59.0,YR,,M,Y,70.0,KG,20200819.0,,HP,CN,CN,2020,Q3,Adult
181765641,18176564,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD",,,U,U,,,,,,,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200811.0,20200820,20200820,EXP,,US-MYLANLABS-2020M1072102,MYLAN,"ADAPA S, NARAMALA S, TIWANA HS, PATEL N, VERMA R, KODURI NM, ET AL. PERITONITIS FROM FACULTATIVE ANAEROBIC GRAM?NEGATIVE BACILLI LIKELY DUE TO TRANSLOCATION OF BACTERIA FROM GUT IN A PATIENT UNDERGOING PERITONEAL DIALYSIS. INFECT?DIS?REP 2020?12(1):16?18.",42.0,YR,,M,Y,,,20200820.0,,HP,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Accidental underdose,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Anger,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Anxiety,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Cataract,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Eye pain,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Injection site pain,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Iritis,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181784251,18178425,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"50 U, BID",,,U,,,,,50.0,IU,INJECTION,BID,2020,Q3,Weight decreased,,2020,Q3,1,I,20200724.0,20200724.0,20200820,20200820,PER,,US-ELI_LILLY_AND_COMPANY-US202007010918,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20200820.0,,CN,US,US,2020,Q3,Adult
181787631,18178763,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,,, UNKNOWN,,,6.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Anti-insulin antibody increased,,2020,Q3,1,I,,20161128.0,20200820,20200820,EXP,,JP-NOVOPROD-521819,NOVO NORDISK,"TOMOHIKO KIMURA E.,TAL. INSULIN ALLERGY BROUGHT OUT 8 YEARS AFTER STARTING INSULIN THERAPY IN A SUBJECT WITH TYPE 1 DIABETES MELLITUS. ACTA DIABETOLOGICA. 2020?57:1025?1026",64.0,YR,,F,Y,60.0,KG,20200820.0,,MD,JP,JP,2020,Q3,Adult
181787631,18178763,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,,, UNKNOWN,,,6.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,,20161128.0,20200820,20200820,EXP,,JP-NOVOPROD-521819,NOVO NORDISK,"TOMOHIKO KIMURA E.,TAL. INSULIN ALLERGY BROUGHT OUT 8 YEARS AFTER STARTING INSULIN THERAPY IN A SUBJECT WITH TYPE 1 DIABETES MELLITUS. ACTA DIABETOLOGICA. 2020?57:1025?1026",64.0,YR,,F,Y,60.0,KG,20200820.0,,MD,JP,JP,2020,Q3,Adult
181787631,18178763,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,,, UNKNOWN,,,6.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eczema nummular,,2020,Q3,1,I,,20161128.0,20200820,20200820,EXP,,JP-NOVOPROD-521819,NOVO NORDISK,"TOMOHIKO KIMURA E.,TAL. INSULIN ALLERGY BROUGHT OUT 8 YEARS AFTER STARTING INSULIN THERAPY IN A SUBJECT WITH TYPE 1 DIABETES MELLITUS. ACTA DIABETOLOGICA. 2020?57:1025?1026",64.0,YR,,F,Y,60.0,KG,20200820.0,,MD,JP,JP,2020,Q3,Adult
181787631,18178763,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"6 IU, QD",,,,, UNKNOWN,,,6.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Glycosylated haemoglobin increased,,2020,Q3,1,I,,20161128.0,20200820,20200820,EXP,,JP-NOVOPROD-521819,NOVO NORDISK,"TOMOHIKO KIMURA E.,TAL. INSULIN ALLERGY BROUGHT OUT 8 YEARS AFTER STARTING INSULIN THERAPY IN A SUBJECT WITH TYPE 1 DIABETES MELLITUS. ACTA DIABETOLOGICA. 2020?57:1025?1026",64.0,YR,,F,Y,60.0,KG,20200820.0,,MD,JP,JP,2020,Q3,Adult
181794411,18179441,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"15 UNITS, QD, INSULIN SLIDING SCALE",,,,,,,,15.0,DF,,QD,2020,Q3,Treatment failure,,2020,Q3,1,I,,20200813.0,20200820,20200820,PER,,US-009507513-2008USA008864,MERCK,"ADAPA S, NARAMALA S, TIWANA HS, PATEL N, VERMA R, KODURI NM, ETAL.. PERITONITIS FROM FACULTATIVE ANAEROBIC GRAM?NEGATIVE BACILLI LIKELY DUE TO TRANSLOCATION OF BACTERIA FROM GUT IN A PATIENT UNDERGOING PERITONEAL DIALYSIS. INFECTIOUS DISEASE REPORTS. 2020?12:8376:16?8",42.0,YR,,M,Y,,,20200820.0,,HP,US,US,2020,Q3,Adult
181796701,18179670,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 UNITS(S), EVERY MORNING, ON HOLD",,,,,,,,,,,,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,20200731.0,20200806.0,20200820,20200820,EXP,,CA-BAXTER-2020BAX016253,BAXTER,,61.0,YR,,M,Y,64.0,KG,20200820.0,,HP,CA,CA,2020,Q3,Adult
181796701,18179670,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 UNITS(S), EVERY MORNING, ON HOLD",,,,,,,,,,,,2020,Q3,Urticaria,,2020,Q3,1,I,20200731.0,20200806.0,20200820,20200820,EXP,,CA-BAXTER-2020BAX016253,BAXTER,,61.0,YR,,M,Y,64.0,KG,20200820.0,,HP,CA,CA,2020,Q3,Adult
181796701,18179670,9,C,insulin glargine,INSULIN GLARGINE,1,Unknown,14?16 UNITS DAILY,,,,,,,,,,,QD,2020,Q3,Drug hypersensitivity,,2020,Q3,1,I,20200731.0,20200806.0,20200820,20200820,EXP,,CA-BAXTER-2020BAX016253,BAXTER,,61.0,YR,,M,Y,64.0,KG,20200820.0,,HP,CA,CA,2020,Q3,Adult
181796701,18179670,9,C,insulin glargine,INSULIN GLARGINE,1,Unknown,14?16 UNITS DAILY,,,,,,,,,,,QD,2020,Q3,Urticaria,,2020,Q3,1,I,20200731.0,20200806.0,20200820,20200820,EXP,,CA-BAXTER-2020BAX016253,BAXTER,,61.0,YR,,M,Y,64.0,KG,20200820.0,,HP,CA,CA,2020,Q3,Adult
181798501,18179850,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,, UNKNOWN,,,,,,,2020,Q3,Cogwheel rigidity,,2020,Q3,1,I,,20200504.0,20200821,20200821,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-01807,ALKEM,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW.. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12",69.0,YR,,M,Y,,,20200821.0,,HP,US,US,2020,Q3,Elderly
181798501,18179850,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,, UNKNOWN,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200504.0,20200821,20200821,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-01807,ALKEM,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW.. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12",69.0,YR,,M,Y,,,20200821.0,,HP,US,US,2020,Q3,Elderly
181798501,18179850,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,, UNKNOWN,,,,,,,2020,Q3,Dystonia,,2020,Q3,1,I,,20200504.0,20200821,20200821,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-01807,ALKEM,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW.. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12",69.0,YR,,M,Y,,,20200821.0,,HP,US,US,2020,Q3,Elderly
181798501,18179850,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,, UNKNOWN,,,,,,,2020,Q3,Resting tremor,,2020,Q3,1,I,,20200504.0,20200821,20200821,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-01807,ALKEM,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW.. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12",69.0,YR,,M,Y,,,20200821.0,,HP,US,US,2020,Q3,Elderly
181798501,18179850,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,10 UNITS NIGHTLY,,,,, UNKNOWN,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,1,I,,20200504.0,20200821,20200821,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-01807,ALKEM,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW.. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. THE NURSE PRACTITIONER. 2020?45(5):11?12",69.0,YR,,M,Y,,,20200821.0,,HP,US,US,2020,Q3,Elderly
181798761,18179876,6,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,58.0,IU,,BID,2020,Q3,Acute myeloid leukaemia,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,6,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,58.0,IU,,BID,2020,Q3,Blood glucose increased,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,6,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,58.0,IU,,BID,2020,Q3,Drug resistance,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,6,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,58.0,IU,,BID,2020,Q3,Leukaemia recurrent,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181798761,18179876,6,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,58.0,IU,,BID,2020,Q3,Philadelphia chromosome positive,,2020,Q3,1,I,,20200811.0,20200821,20200821,EXP,,US-SHILPA MEDICARE LIMITED-SML-US-2020-00226,SHILPA MEDICARE,"LUNDHOLM M, GERALD C. DASATINIB?INDUCED HYPOGLYCEMIA IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA. CLINICAL CASE REPORTS. 2020 APR 02?8(7):1238?1240. DOI:10.1002/CCR3.2901",65.0,YR,E,M,Y,,,20200821.0,,MD,US,US,2020,Q3,Elderly
181809131,18180913,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,210605.0,,,,,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,,20200812.0,20200821,20200821,EXP,,SK-MYLANLABS-2020M1071700,MYLAN,MICHNOVA Z.? SZEPEOVA R.? HAVICEKOVA Z.? VOJTKOVA J.? MARCINEK J.? BANOVCIN P.ET.AL.. MAURIAC SYNDROME? A RARE COMPLICATION OF TYPE 1 DIABETES MELLITUS.. PEDIATRICS.. 2020?15 (3):185?187,14.0,YR,,M,Y,,,20200821.0,,MD,SK,SK,2020,Q3,Youth
181809131,18180913,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,210605.0,,,,,2020,Q3,Diabetic metabolic decompensation,,2020,Q3,1,I,,20200812.0,20200821,20200821,EXP,,SK-MYLANLABS-2020M1071700,MYLAN,MICHNOVA Z.? SZEPEOVA R.? HAVICEKOVA Z.? VOJTKOVA J.? MARCINEK J.? BANOVCIN P.ET.AL.. MAURIAC SYNDROME? A RARE COMPLICATION OF TYPE 1 DIABETES MELLITUS.. PEDIATRICS.. 2020?15 (3):185?187,14.0,YR,,M,Y,,,20200821.0,,MD,SK,SK,2020,Q3,Youth
181810251,18181025,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Ascites,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Osteonecrosis of jaw,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Tooth disorder,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Ascites,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Osteonecrosis of jaw,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Tooth disorder,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Ascites,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Osteonecrosis of jaw,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181810251,18181025,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Tooth disorder,,2020,Q3,1,I,201709.0,20181017.0,20200821,20200821,PER,,JP-AMGEN-JPNSP2018148746,AMGEN,,61.0,YR,A,M,Y,80.0,KG,20200821.0,,PH,JP,JP,2020,Q3,Adult
181815132,18181513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, 10?0?0?16",,,,,,,,,,,,2020,Q3,Cardiac failure,,2020,Q3,2,F,,20200812.0,20200821,20200827,EXP,,DE-MYLANLABS-2020M1071747,MYLAN,,89.0,YR,,F,Y,,,20200827.0,,MD,DE,DE,2020,Q3,Elderly
181815132,18181513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, 10?0?0?16",,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,2,F,,20200812.0,20200821,20200827,EXP,,DE-MYLANLABS-2020M1071747,MYLAN,,89.0,YR,,F,Y,,,20200827.0,,MD,DE,DE,2020,Q3,Elderly
181815132,18181513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, 10?0?0?16",,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,2,F,,20200812.0,20200821,20200827,EXP,,DE-MYLANLABS-2020M1071747,MYLAN,,89.0,YR,,F,Y,,,20200827.0,,MD,DE,DE,2020,Q3,Elderly
181815132,18181513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, 10?0?0?16",,,,,,,,,,,,2020,Q3,Oliguria,,2020,Q3,2,F,,20200812.0,20200821,20200827,EXP,,DE-MYLANLABS-2020M1071747,MYLAN,,89.0,YR,,F,Y,,,20200827.0,,MD,DE,DE,2020,Q3,Elderly
181815132,18181513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, 10?0?0?16",,,,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20200812.0,20200821,20200827,EXP,,DE-MYLANLABS-2020M1071747,MYLAN,,89.0,YR,,F,Y,,,20200827.0,,MD,DE,DE,2020,Q3,Elderly
181815132,18181513,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, 10?0?0?16",,,,,,,,,,,,2020,Q3,Tachycardia,,2020,Q3,2,F,,20200812.0,20200821,20200827,EXP,,DE-MYLANLABS-2020M1071747,MYLAN,,89.0,YR,,F,Y,,,20200827.0,,MD,DE,DE,2020,Q3,Elderly
181822941,18182294,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200813.0,20200821,20200821,EXP,,CA-TEVA-2020-CA-1815947,TEVA,,80.0,YR,E,F,Y,,,20200821.0,,PH,CA,CA,2020,Q3,Elderly
181822941,18182294,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Speech disorder,,2020,Q3,1,I,,20200813.0,20200821,20200821,EXP,,CA-TEVA-2020-CA-1815947,TEVA,,80.0,YR,E,F,Y,,,20200821.0,,PH,CA,CA,2020,Q3,Elderly
181832431,18183243,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Diabetic foot,,2020,Q3,1,I,20200707.0,20200812.0,20200821,20200821,EXP,,CO-BAXTER-2020BAX016550,BAXTER,,48.0,YR,,F,Y,64.0,KG,20200821.0,,HP,CO,CO,2020,Q3,Adult
181832431,18183243,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Postoperative wound infection,,2020,Q3,1,I,20200707.0,20200812.0,20200821,20200821,EXP,,CO-BAXTER-2020BAX016550,BAXTER,,48.0,YR,,F,Y,64.0,KG,20200821.0,,HP,CO,CO,2020,Q3,Adult
181832431,18183243,5,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200707.0,20200812.0,20200821,20200821,EXP,,CO-BAXTER-2020BAX016550,BAXTER,,48.0,YR,,F,Y,64.0,KG,20200821.0,,HP,CO,CO,2020,Q3,Adult
181878082,18187808,3,C,GLARGINE INSULINE,,2,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,2,F,20200724.0,20200910.0,20200824,20200914,EXP,,DE-ABBVIE-20K-062-3535510-00,ABBVIE,,69.0,YR,,M,Y,,,20200914.0,,CN,DE,DE,2020,Q3,Elderly
181878082,18187808,3,C,GLARGINE INSULINE,,2,,,,,,,,,,,,,,2020,Q3,Incontinence,,2020,Q3,2,F,20200724.0,20200910.0,20200824,20200914,EXP,,DE-ABBVIE-20K-062-3535510-00,ABBVIE,,69.0,YR,,M,Y,,,20200914.0,,CN,DE,DE,2020,Q3,Elderly
181878082,18187808,3,C,GLARGINE INSULINE,,2,,,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,2,F,20200724.0,20200910.0,20200824,20200914,EXP,,DE-ABBVIE-20K-062-3535510-00,ABBVIE,,69.0,YR,,M,Y,,,20200914.0,,CN,DE,DE,2020,Q3,Elderly
181928691,18192869,4,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Incorrect product administration duration,,2020,Q3,1,I,20200818.0,,20200825,20200825,DIR,,,FDA-CTU,,53.0,YR,,F,N,35.4,KG,20200825.0,Y,HP,US,US,2020,Q3,Adult
181958711,18195871,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypotension,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Ileus paralytic,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Mastication disorder,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Pain,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypotension,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Ileus paralytic,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Mastication disorder,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181958711,18195871,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"16 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Pain,,2020,Q3,1,I,,20200821.0,20200826,20200826,EXP,,ES-AUROBINDO-AUR-APL-2020-044941,AUROBINDO,,90.0,YR,,F,Y,90.0,KG,20200826.0,,CN,ES,ES,2020,Q3,Elderly
181965581,18196558,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Arthralgia,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Gait inability,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Headache,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Hypoaesthesia,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Lower respiratory tract infection,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Pharyngitis,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,QD,2020,Q3,Toothache,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,QD,2020,Q3,Arthralgia,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,QD,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,QD,2020,Q3,Gait inability,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,QD,2020,Q3,Headache,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,QD,2020,Q3,Hypoaesthesia,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,QD,2020,Q3,Lower respiratory tract infection,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,QD,2020,Q3,Pharyngitis,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181965581,18196558,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNKNOWN, SOLUTION SUBCUTANEOUS",,,U,,,,,,,,QD,2020,Q3,Toothache,,2020,Q3,1,I,,20190307.0,20200825,20200825,EXP,,CA-SAMSUNG BIOEPIS-SB-2019-05751,SAMSUNG BIOEPIS,,42.0,YR,A,F,Y,,,20200826.0,,HP,CA,CA,2020,Q3,Adult
181982031,18198203,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,2019.0,20200819.0,20200826,20200826,EXP,,AT-MYLANLABS-2020M1073337,MYLAN,E.KRIPPL. PREVENT AMPUTATIONS WITH A HOLISTIC THERAPY CONCEPT. J DIABETES FORUM. 2020?26?27,77.0,YR,,F,Y,87.0,KG,20200826.0,,MD,AT,AT,2020,Q3,Elderly
181982031,18198203,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Gangrene,,2020,Q3,1,I,2019.0,20200819.0,20200826,20200826,EXP,,AT-MYLANLABS-2020M1073337,MYLAN,E.KRIPPL. PREVENT AMPUTATIONS WITH A HOLISTIC THERAPY CONCEPT. J DIABETES FORUM. 2020?26?27,77.0,YR,,F,Y,87.0,KG,20200826.0,,MD,AT,AT,2020,Q3,Elderly
181982031,18198203,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Iron deficiency anaemia,,2020,Q3,1,I,2019.0,20200819.0,20200826,20200826,EXP,,AT-MYLANLABS-2020M1073337,MYLAN,E.KRIPPL. PREVENT AMPUTATIONS WITH A HOLISTIC THERAPY CONCEPT. J DIABETES FORUM. 2020?26?27,77.0,YR,,F,Y,87.0,KG,20200826.0,,MD,AT,AT,2020,Q3,Elderly
181982031,18198203,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,1,I,2019.0,20200819.0,20200826,20200826,EXP,,AT-MYLANLABS-2020M1073337,MYLAN,E.KRIPPL. PREVENT AMPUTATIONS WITH A HOLISTIC THERAPY CONCEPT. J DIABETES FORUM. 2020?26?27,77.0,YR,,F,Y,87.0,KG,20200826.0,,MD,AT,AT,2020,Q3,Elderly
181983451,18198345,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200818.0,20200826,20200826,EXP,,CA-APOTEX-2020AP016642,APOTEX,,80.0,YR,,F,Y,,,20200826.0,,CN,CA,CA,2020,Q3,Elderly
181983451,18198345,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Speech disorder,,2020,Q3,1,I,,20200818.0,20200826,20200826,EXP,,CA-APOTEX-2020AP016642,APOTEX,,80.0,YR,,F,Y,,,20200826.0,,CN,CA,CA,2020,Q3,Elderly
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Anonychia,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Cheilitis,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Drug eruption,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Lichenoid keratosis,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Nail discolouration,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Nail dystrophy,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Nail pterygium,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Onycholysis,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Paronychia,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
181985531,18198553,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q3,Post inflammatory pigmentation change,,2020,Q3,1,I,,20200819.0,20200826,20200826,EXP,,MA-MYLANLABS-2020M1074132,MYLAN,"BAYBAY H, SAADANI C, ELLOUDI S, DOUHI Z, RIMANI M, ACHOUR S, ET AL. LICHENOID DRUG ERUPTION WITH ANTITUBERCULOSIS DRUGS ASSOCIATED WITH AN ANONYCHIA. ANN?DERMATOL?VENEREOL 2020?147(6):456?460.",41.0,YR,,M,Y,,,20200826.0,,HP,MA,MA,2020,Q3,Adult
182017271,18201727,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,," OF571A,OF571A",,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,," OF571A,OF571A",,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,," OF571A,OF571A",,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,," OF571A,OF571A",,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypotension,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,," OF571A,OF571A",,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Ileus paralytic,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,," OF571A,OF571A",,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Mastication disorder,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,," OF571A,OF571A",,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Pain,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16IU, QD, REDUCED DOSE",,,Y,," OF571A,OF571A",,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16IU, QD, REDUCED DOSE",,,Y,," OF571A,OF571A",,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16IU, QD, REDUCED DOSE",,,Y,," OF571A,OF571A",,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16IU, QD, REDUCED DOSE",,,Y,," OF571A,OF571A",,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypotension,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16IU, QD, REDUCED DOSE",,,Y,," OF571A,OF571A",,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Ileus paralytic,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16IU, QD, REDUCED DOSE",,,Y,," OF571A,OF571A",,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Mastication disorder,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182017271,18201727,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16IU, QD, REDUCED DOSE",,,Y,," OF571A,OF571A",,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Pain,,2020,Q3,1,I,,20200821.0,20200827,20200827,EXP,,ES-BAUSCH-BL-2020-024155,BAUSCH AND LOMB,,90.0,YR,,F,Y,90.0,KG,20200827.0,,CN,ES,ES,2020,Q3,Elderly
182024031,18202403,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase decreased,,2020,Q3,1,I,20200824.0,,20200827,20200827,DIR,,,FDA-CTU,,69.0,YR,,F,N,81.0,KG,20200826.0,N,MD,US,US,2020,Q3,Elderly
182024031,18202403,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,1,I,20200824.0,,20200827,20200827,DIR,,,FDA-CTU,,69.0,YR,,F,N,81.0,KG,20200826.0,N,MD,US,US,2020,Q3,Elderly
182024031,18202403,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,20200824.0,,20200827,20200827,DIR,,,FDA-CTU,,69.0,YR,,F,N,81.0,KG,20200826.0,N,MD,US,US,2020,Q3,Elderly
182065841,18206584,10,C,insulin glargine 40 units,,2,,,,,,,,,,,,,,2020,Q3,Blood creatine increased,,2020,Q3,1,I,20200823.0,,20200827,20200827,DIR,,,FDA-CTU,,86.0,YR,,F,N,70.3,KG,20200827.0,Y,PH,US,US,2020,Q3,Elderly
182074681,18207468,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,20200720.0,20200819.0,20200828,20200828,EXP,,BR-NOVOPROD-749351,NOVO NORDISK,,67.0,YR,,M,Y,100.0,KG,20200828.0,,CN,BR,BR,2020,Q3,Elderly
182074681,18207468,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Visual impairment,,2020,Q3,1,I,20200720.0,20200819.0,20200828,20200828,EXP,,BR-NOVOPROD-749351,NOVO NORDISK,,67.0,YR,,M,Y,100.0,KG,20200828.0,,CN,BR,BR,2020,Q3,Elderly
182074681,18207468,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q3,Wrong technique in product usage process,,2020,Q3,1,I,20200720.0,20200819.0,20200828,20200828,EXP,,BR-NOVOPROD-749351,NOVO NORDISK,,67.0,YR,,M,Y,100.0,KG,20200828.0,,CN,BR,BR,2020,Q3,Elderly
182097123,18209712,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Thrombotic microangiopathy,,2020,Q3,3,F,20200818.0,20200918.0,20200828,20200923,EXP,,JP-009507513-2008JPN014013,MERCK,,71.0,YR,,F,Y,,,20200923.0,,MD,JP,JP,2020,Q3,Elderly
182106261,18210626,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Extra dose administered,,2020,Q3,1,I,20200818.0,20200825.0,20200829,20200829,EXP,,US-GILEAD-2020-0492426,GILEAD,,53.0,YR,A,F,Y,35.4,KG,20200829.0,,HP,US,US,2020,Q3,Adult
182114971,18211497,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,12.0,IU,,,2020,Q3,Cardiac failure,,2020,Q3,1,I,201904.0,20200820.0,20200831,20200831,EXP,,CZ-ACCORD-197857,ACCORD,"SVARKO J, LOKOCOVA E, KOURKOVA E, ZAJICEK P. STATIN?INDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WITH MUSCLE WEAKNESS AND SWELLING. CESKA REVMATOLOGIE. 2020?28(1):52?60.",75.0,YR,,M,Y,,,20200831.0,,MD,CZ,CZ,2020,Q3,Elderly
182114971,18211497,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,12.0,IU,,,2020,Q3,Immune-mediated myositis,,2020,Q3,1,I,201904.0,20200820.0,20200831,20200831,EXP,,CZ-ACCORD-197857,ACCORD,"SVARKO J, LOKOCOVA E, KOURKOVA E, ZAJICEK P. STATIN?INDUCED NECROTIZING AUTOIMMUNE MYOPATHY AS AN UNUSUAL CAUSE OF EXTREME ELEVATION OF CARDIAC MARKERS IN A PATIENT WITH MUSCLE WEAKNESS AND SWELLING. CESKA REVMATOLOGIE. 2020?28(1):52?60.",75.0,YR,,M,Y,,,20200831.0,,MD,CZ,CZ,2020,Q3,Elderly
182127282,18212728,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 U DAILY,,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,2,F,,20200903.0,20200831,20200908,EXP,,ES-ASTRAZENECA-2020SF08886,ASTRAZENECA,"VILAPLANA E V, BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M.. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020?DOI:10.1177/1078155220949639.",48.0,YR,,F,Y,,,20200908.0,,HP,ES,ES,2020,Q3,Adult
182127282,18212728,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 U DAILY,,,,,,,,,,,,2020,Q3,Gastrointestinal toxicity,,2020,Q3,2,F,,20200903.0,20200831,20200908,EXP,,ES-ASTRAZENECA-2020SF08886,ASTRAZENECA,"VILAPLANA E V, BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M.. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020?DOI:10.1177/1078155220949639.",48.0,YR,,F,Y,,,20200908.0,,HP,ES,ES,2020,Q3,Adult
182127282,18212728,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 U DAILY,,,,,,,,,,,,2020,Q3,Hepatic function abnormal,,2020,Q3,2,F,,20200903.0,20200831,20200908,EXP,,ES-ASTRAZENECA-2020SF08886,ASTRAZENECA,"VILAPLANA E V, BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M.. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020?DOI:10.1177/1078155220949639.",48.0,YR,,F,Y,,,20200908.0,,HP,ES,ES,2020,Q3,Adult
182127282,18212728,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 U DAILY,,,,,,,,,,,,2020,Q3,Pancreatitis acute,,2020,Q3,2,F,,20200903.0,20200831,20200908,EXP,,ES-ASTRAZENECA-2020SF08886,ASTRAZENECA,"VILAPLANA E V, BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M.. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020?DOI:10.1177/1078155220949639.",48.0,YR,,F,Y,,,20200908.0,,HP,ES,ES,2020,Q3,Adult
182127282,18212728,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 U DAILY,,,,,,,,,,,,2020,Q3,Potentiating drug interaction,,2020,Q3,2,F,,20200903.0,20200831,20200908,EXP,,ES-ASTRAZENECA-2020SF08886,ASTRAZENECA,"VILAPLANA E V, BORRELL C R, BUENO V C, ALVAREZ R, HERRANZ A, SANJURJO M.. ACUTE PANCREATITIS IN A PATIENT TREATED WITH IMATINIB AND GEFITINIB.. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2020?DOI:10.1177/1078155220949639.",48.0,YR,,F,Y,,,20200908.0,,HP,ES,ES,2020,Q3,Adult
182136261,18213626,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:56 UNITS;OTHER FREQUENCY:AM;?,,,,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,20200810.0,,20200831,20200831,DIR,,,FDA-CTU,,70.0,YR,,M,N,86.18,KG,20200826.0,N,PH,US,US,2020,Q3,Elderly
182136261,18213626,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:56 UNITS;OTHER FREQUENCY:AM;?,,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200810.0,,20200831,20200831,DIR,,,FDA-CTU,,70.0,YR,,M,N,86.18,KG,20200826.0,N,PH,US,US,2020,Q3,Elderly
182136261,18213626,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:56 UNITS;OTHER FREQUENCY:AM;?,,,,,,,,,,,,2020,Q3,Dizziness,,2020,Q3,1,I,20200810.0,,20200831,20200831,DIR,,,FDA-CTU,,70.0,YR,,M,N,86.18,KG,20200826.0,N,PH,US,US,2020,Q3,Elderly
182136261,18213626,2,SS,"INSULIN (INSULIN, GLARGINE, HUMAN 100 UNT/ML INJ)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:56 UNITS;OTHER FREQUENCY:AM;?,,,,,,,,,,,,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,20200810.0,,20200831,20200831,DIR,,,FDA-CTU,,70.0,YR,,M,N,86.18,KG,20200826.0,N,PH,US,US,2020,Q3,Elderly
182136712,18213671,98,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Diabetes mellitus,,2020,Q3,2,F,20190724.0,20200921.0,20200831,20200928,EXP,,NVSC2020ES234365,NOVARTIS,,70.0,YR,,M,Y,76.4,KG,20200928.0,,HP,ES,ES,2020,Q3,Elderly
182141071,18214107,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hepatic enzyme increased,,2020,Q3,1,I,20200819.0,,20200831,20200831,DIR,,,FDA-CTU,,18.0,YR,,M,N,61.2,KG,20200831.0,Y,PH,US,US,2020,Q3,Youth
182141071,18214107,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Therapy cessation,,2020,Q3,1,I,20200819.0,,20200831,20200831,DIR,,,FDA-CTU,,18.0,YR,,M,N,61.2,KG,20200831.0,Y,PH,US,US,2020,Q3,Youth
182176001,18217600,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Dizziness,,2020,Q3,1,I,,20200819.0,20200901,20200901,EXP,,CA-JNJFOC-20200837828,JOHNSON AND JOHNSON,,59.0,YR,A,F,Y,,,20200901.0,,HP,CA,CA,2020,Q3,Adult
182176001,18217600,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Gastrointestinal haemorrhage,,2020,Q3,1,I,,20200819.0,20200901,20200901,EXP,,CA-JNJFOC-20200837828,JOHNSON AND JOHNSON,,59.0,YR,A,F,Y,,,20200901.0,,HP,CA,CA,2020,Q3,Adult
182176001,18217600,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Haematochezia,,2020,Q3,1,I,,20200819.0,20200901,20200901,EXP,,CA-JNJFOC-20200837828,JOHNSON AND JOHNSON,,59.0,YR,A,F,Y,,,20200901.0,,HP,CA,CA,2020,Q3,Adult
182176001,18217600,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,,20200819.0,20200901,20200901,EXP,,CA-JNJFOC-20200837828,JOHNSON AND JOHNSON,,59.0,YR,A,F,Y,,,20200901.0,,HP,CA,CA,2020,Q3,Adult
182182932,18218293,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,2,F,20200823.0,20200922.0,20200901,20200924,EXP,,US-GILEAD-2020-0492628,GILEAD,,86.0,YR,E,F,Y,70.3,KG,20200924.0,,MD,US,US,2020,Q3,Elderly
182182932,18218293,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,2,F,20200823.0,20200922.0,20200901,20200924,EXP,,US-GILEAD-2020-0492628,GILEAD,,86.0,YR,E,F,Y,70.3,KG,20200924.0,,MD,US,US,2020,Q3,Elderly
182186871,18218687,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Blood potassium decreased,,2020,Q3,1,I,,20200828.0,20200901,20200901,EXP,,CA-PFIZER INC-2020335414,PFIZER,,65.0,YR,,F,Y,98.0,KG,20200901.0,,CN,CA,CA,2020,Q3,Elderly
182186871,18218687,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Cardiac dysfunction,,2020,Q3,1,I,,20200828.0,20200901,20200901,EXP,,CA-PFIZER INC-2020335414,PFIZER,,65.0,YR,,F,Y,98.0,KG,20200901.0,,CN,CA,CA,2020,Q3,Elderly
182186871,18218687,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200828.0,20200901,20200901,EXP,,CA-PFIZER INC-2020335414,PFIZER,,65.0,YR,,F,Y,98.0,KG,20200901.0,,CN,CA,CA,2020,Q3,Elderly
182186871,18218687,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200828.0,20200901,20200901,EXP,,CA-PFIZER INC-2020335414,PFIZER,,65.0,YR,,F,Y,98.0,KG,20200901.0,,CN,CA,CA,2020,Q3,Elderly
182186871,18218687,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200828.0,20200901,20200901,EXP,,CA-PFIZER INC-2020335414,PFIZER,,65.0,YR,,F,Y,98.0,KG,20200901.0,,CN,CA,CA,2020,Q3,Elderly
182186871,18218687,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Fatigue,,2020,Q3,1,I,,20200828.0,20200901,20200901,EXP,,CA-PFIZER INC-2020335414,PFIZER,,65.0,YR,,F,Y,98.0,KG,20200901.0,,CN,CA,CA,2020,Q3,Elderly
182186871,18218687,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Myocardial infarction,,2020,Q3,1,I,,20200828.0,20200901,20200901,EXP,,CA-PFIZER INC-2020335414,PFIZER,,65.0,YR,,F,Y,98.0,KG,20200901.0,,CN,CA,CA,2020,Q3,Elderly
182247921,18224792,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200825.0,20200903,20200903,EXP,,PK-DEXPHARM-20200771,DEXCEL,"INAYAT FAISAL? BOKHARI SYED RIZWAN A? ALMAS TALAL? ROSEN RAQUEL M?DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE.?AMERICAN JOURNAL OF THERAPEUTICS, (2020 AUG 14) .  ELECTRONIC PUBLICATION DATE: 14 AUG 2020 ?JOURNAL CODE: 9441347. E?ISSN: 1536?3686. L?ISSN: 1075?2765.??",42.0,YR,A,M,Y,,,20200903.0,,HP,PK,PK,2020,Q3,Adult
182266961,18226696,10,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Economic problem,,2020,Q3,1,I,20200901.0,,20200902,20200902,DIR,,,FDA-CTU,,71.0,YR,,F,N,,,20200902.0,Y,PH,US,US,2020,Q3,Elderly
182266961,18226696,10,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Therapy cessation,,2020,Q3,1,I,20200901.0,,20200902,20200902,DIR,,,FDA-CTU,,71.0,YR,,F,N,,,20200902.0,Y,PH,US,US,2020,Q3,Elderly
182288973,18228897,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,3,F,20191217.0,20200921.0,20200903,20200925,EXP,,CA-TAKEDA-2020TUS037089,TAKEDA,,74.0,YR,,F,Y,,,20200925.0,,CN,CA,CA,2020,Q3,Elderly
182288973,18228897,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Memory impairment,,2020,Q3,3,F,20191217.0,20200921.0,20200903,20200925,EXP,,CA-TAKEDA-2020TUS037089,TAKEDA,,74.0,YR,,F,Y,,,20200925.0,,CN,CA,CA,2020,Q3,Elderly
182288973,18228897,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Off label use,,2020,Q3,3,F,20191217.0,20200921.0,20200903,20200925,EXP,,CA-TAKEDA-2020TUS037089,TAKEDA,,74.0,YR,,F,Y,,,20200925.0,,CN,CA,CA,2020,Q3,Elderly
182288973,18228897,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Peripheral swelling,,2020,Q3,3,F,20191217.0,20200921.0,20200903,20200925,EXP,,CA-TAKEDA-2020TUS037089,TAKEDA,,74.0,YR,,F,Y,,,20200925.0,,CN,CA,CA,2020,Q3,Elderly
182302142,18230214,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q3,Pain,,2020,Q3,2,F,20200825.0,20200908.0,20200904,20200915,EXP,,AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-069839,BRISTOL MYERS SQUIBB,,52.0,YR,,M,Y,103.0,KG,20200915.0,,HP,AU,AU,2020,Q3,Adult
182305361,18230536,8,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,COVID-19,,2020,Q3,1,I,20200717.0,20200826.0,20200903,20200903,EXP,,CO-BAXTER-2020BAX017725,BAXTER,,62.0,YR,,M,Y,75.0,KG,20200903.0,,HP,CO,CO,2020,Q3,Adult
182305361,18230536,8,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Pneumonia bacterial,,2020,Q3,1,I,20200717.0,20200826.0,20200903,20200903,EXP,,CO-BAXTER-2020BAX017725,BAXTER,,62.0,YR,,M,Y,75.0,KG,20200903.0,,HP,CO,CO,2020,Q3,Adult
182305361,18230536,8,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Pulmonary oedema,,2020,Q3,1,I,20200717.0,20200826.0,20200903,20200903,EXP,,CO-BAXTER-2020BAX017725,BAXTER,,62.0,YR,,M,Y,75.0,KG,20200903.0,,HP,CO,CO,2020,Q3,Adult
182305361,18230536,8,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Pulmonary sepsis,,2020,Q3,1,I,20200717.0,20200826.0,20200903,20200903,EXP,,CO-BAXTER-2020BAX017725,BAXTER,,62.0,YR,,M,Y,75.0,KG,20200903.0,,HP,CO,CO,2020,Q3,Adult
182324222,18232422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q3,Demyelination,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q3,Seizure,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182324222,18232422,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,,,2020,Q3,Vasculitis,,2020,Q3,2,F,,20200828.0,20200904,20200908,EXP,,PK-UCBSA-2020034734,UCB,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AMERICAN JOURNAL OF THERAPEUTICS. 2020?1?2",42.0,YR,,M,Y,,,20200908.0,,MD,PK,PK,2020,Q3,Adult
182356461,18235646,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200828.0,20200905,20200905,EXP,,US-FDC LIMITED-2089431,FDC,"ADAPA S, NARAMALA S, TIWANA HS, PATEL N, VERMA R, KODURI NM ET AL. PERITONITIS FROM FACULTATIVE ANAEROBIC GRAM?NEGATIVE BACILLI LIKELY DUE TO TRANSLOCATION OF BACTERIA FROM GUT IN A PATIENT UNDERGOING PERITONEAL DIALYSIS. INFECTIOUS DISEASE REPORTS 12: 16?18, NO. 1, 2020. URL: HTTP://DOI.ORG/10.4081/IDR.2020.8376",42.0,YR,,M,Y,,,20200905.0,,HP,US,US,2020,Q3,Adult
182375843,18237584,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 UNITS, QHS",,,,,,,,12.0,IU,,,2020,Q3,Sepsis,,2020,Q3,3,F,20200831.0,20200910.0,20200907,20200922,EXP,,US-PFIZER INC-2020339572,PFIZER,,67.0,YR,,F,Y,47.4,KG,20200922.0,,HP,US,US,2020,Q3,Elderly
182388365,18238836,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,D,,,,,28.0,IU,,QD,2020,Q3,Asthenia,,2020,Q3,5,F,20170608.0,20200928.0,20200907,20200929,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20200929.0,,HP,ES,ES,2020,Q3,Adult
182388365,18238836,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,D,,,,,28.0,IU,,QD,2020,Q3,Drug interaction,,2020,Q3,5,F,20170608.0,20200928.0,20200907,20200929,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20200929.0,,HP,ES,ES,2020,Q3,Adult
182388365,18238836,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,D,,,,,28.0,IU,,QD,2020,Q3,Gastrointestinal toxicity,,2020,Q3,5,F,20170608.0,20200928.0,20200907,20200929,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20200929.0,,HP,ES,ES,2020,Q3,Adult
182388365,18238836,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,D,,,,,28.0,IU,,QD,2020,Q3,Malignant neoplasm progression,,2020,Q3,5,F,20170608.0,20200928.0,20200907,20200929,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20200929.0,,HP,ES,ES,2020,Q3,Adult
182388365,18238836,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,D,,,,,28.0,IU,,QD,2020,Q3,Neoplasm progression,,2020,Q3,5,F,20170608.0,20200928.0,20200907,20200929,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20200929.0,,HP,ES,ES,2020,Q3,Adult
182388365,18238836,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,D,,,,,28.0,IU,,QD,2020,Q3,Pancreatitis,,2020,Q3,5,F,20170608.0,20200928.0,20200907,20200929,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20200929.0,,HP,ES,ES,2020,Q3,Adult
182388365,18238836,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,D,,,,,28.0,IU,,QD,2020,Q3,Pancreatitis acute,,2020,Q3,5,F,20170608.0,20200928.0,20200907,20200929,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20200929.0,,HP,ES,ES,2020,Q3,Adult
182388365,18238836,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"28 IU, QD",,,D,,,,,28.0,IU,,QD,2020,Q3,Product use in unapproved indication,,2020,Q3,5,F,20170608.0,20200928.0,20200907,20200929,EXP,,NVSC2020ES230163,NOVARTIS,,48.0,YR,,F,Y,,,20200929.0,,HP,ES,ES,2020,Q3,Adult
182400631,18240063,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,,,,,2020,Q3,Cogwheel rigidity,,2020,Q3,1,I,,20200828.0,20200908,20200908,EXP,,US-FDC LIMITED-2089471,FDC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACTITIONER 45: 11?12, NO. 5, MAY 2020. URL: HTTP://DOI.ORG/10.1097/01.NPR.0000660368.67226.AD",69.0,YR,,M,Y,,,20200908.0,,MD,US,US,2020,Q3,Elderly
182400631,18240063,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200828.0,20200908,20200908,EXP,,US-FDC LIMITED-2089471,FDC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACTITIONER 45: 11?12, NO. 5, MAY 2020. URL: HTTP://DOI.ORG/10.1097/01.NPR.0000660368.67226.AD",69.0,YR,,M,Y,,,20200908.0,,MD,US,US,2020,Q3,Elderly
182400631,18240063,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,,,,,2020,Q3,Dystonia,,2020,Q3,1,I,,20200828.0,20200908,20200908,EXP,,US-FDC LIMITED-2089471,FDC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACTITIONER 45: 11?12, NO. 5, MAY 2020. URL: HTTP://DOI.ORG/10.1097/01.NPR.0000660368.67226.AD",69.0,YR,,M,Y,,,20200908.0,,MD,US,US,2020,Q3,Elderly
182400631,18240063,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,U,,,,,,,,2020,Q3,Resting tremor,,2020,Q3,1,I,,20200828.0,20200908,20200908,EXP,,US-FDC LIMITED-2089471,FDC,"CHAPPELL KB, SHAH SP, CUTSHALL BT, SANDS CW. CIPROFLOXACIN?RASAGILINE DRUG INTERACTION LEADING TO DOPAMINERGIC EFFECTS. NURSE PRACTITIONER 45: 11?12, NO. 5, MAY 2020. URL: HTTP://DOI.ORG/10.1097/01.NPR.0000660368.67226.AD",69.0,YR,,M,Y,,,20200908.0,,MD,US,US,2020,Q3,Elderly
182421171,18242117,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,18.0,IU,UNKNOWN,QD,2020,Q3,Atrial tachycardia,,2020,Q3,1,I,201707.0,20200831.0,20200908,20200908,EXP,FR-AFSSAPS-NY20201191,FR-FRESENIUS KABI-FK202009094,FRESENIUS KABI,,84.0,YR,,M,Y,82.0,KG,20200908.0,,HP,NL,FR,2020,Q3,Elderly
182421171,18242117,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,18.0,IU,UNKNOWN,QD,2020,Q3,Atrioventricular block,,2020,Q3,1,I,201707.0,20200831.0,20200908,20200908,EXP,FR-AFSSAPS-NY20201191,FR-FRESENIUS KABI-FK202009094,FRESENIUS KABI,,84.0,YR,,M,Y,82.0,KG,20200908.0,,HP,NL,FR,2020,Q3,Elderly
182421171,18242117,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, UNKNOWN,,,18.0,IU,UNKNOWN,QD,2020,Q3,Bundle branch block,,2020,Q3,1,I,201707.0,20200831.0,20200908,20200908,EXP,FR-AFSSAPS-NY20201191,FR-FRESENIUS KABI-FK202009094,FRESENIUS KABI,,84.0,YR,,M,Y,82.0,KG,20200908.0,,HP,NL,FR,2020,Q3,Elderly
182424751,18242475,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,2019.0,20200903.0,20200908,20200908,EXP,,AT-PFIZER INC-2020342107,PFIZER,"KRIPPL, E.. PREVENT AMPUTATIONS WITH A HOLISTIC THERAPY CONCEPT.. J DIABETES FORUM. 2020?26?27",77.0,YR,,F,Y,87.0,KG,20200908.0,,MD,AT,AT,2020,Q3,Elderly
182424751,18242475,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Gangrene,,2020,Q3,1,I,2019.0,20200903.0,20200908,20200908,EXP,,AT-PFIZER INC-2020342107,PFIZER,"KRIPPL, E.. PREVENT AMPUTATIONS WITH A HOLISTIC THERAPY CONCEPT.. J DIABETES FORUM. 2020?26?27",77.0,YR,,F,Y,87.0,KG,20200908.0,,MD,AT,AT,2020,Q3,Elderly
182424751,18242475,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Iron deficiency anaemia,,2020,Q3,1,I,2019.0,20200903.0,20200908,20200908,EXP,,AT-PFIZER INC-2020342107,PFIZER,"KRIPPL, E.. PREVENT AMPUTATIONS WITH A HOLISTIC THERAPY CONCEPT.. J DIABETES FORUM. 2020?26?27",77.0,YR,,F,Y,87.0,KG,20200908.0,,MD,AT,AT,2020,Q3,Elderly
182424751,18242475,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,1,I,2019.0,20200903.0,20200908,20200908,EXP,,AT-PFIZER INC-2020342107,PFIZER,"KRIPPL, E.. PREVENT AMPUTATIONS WITH A HOLISTIC THERAPY CONCEPT.. J DIABETES FORUM. 2020?26?27",77.0,YR,,F,Y,87.0,KG,20200908.0,,MD,AT,AT,2020,Q3,Elderly
182426391,18242639,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q3,Empyema,,2020,Q3,1,I,,20200828.0,20200908,20200908,EXP,JP-MLMSERVICE-20200812-2406399-1,JP-MYLANLABS-2020M1076838,MYLAN,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN?RES 2019?18(5):300?305.. 2019?18(5):300?305",77.0,YR,,F,Y,,,20200908.0,,MD,JP,JP,2020,Q3,Elderly
182426391,18242639,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q3,Nocardiosis,,2020,Q3,1,I,,20200828.0,20200908,20200908,EXP,JP-MLMSERVICE-20200812-2406399-1,JP-MYLANLABS-2020M1076838,MYLAN,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN?RES 2019?18(5):300?305.. 2019?18(5):300?305",77.0,YR,,F,Y,,,20200908.0,,MD,JP,JP,2020,Q3,Elderly
182426391,18242639,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q3,Pleural effusion,,2020,Q3,1,I,,20200828.0,20200908,20200908,EXP,JP-MLMSERVICE-20200812-2406399-1,JP-MYLANLABS-2020M1076838,MYLAN,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN?RES 2019?18(5):300?305.. 2019?18(5):300?305",77.0,YR,,F,Y,,,20200908.0,,MD,JP,JP,2020,Q3,Elderly
182426391,18242639,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,1,I,,20200828.0,20200908,20200908,EXP,JP-MLMSERVICE-20200812-2406399-1,JP-MYLANLABS-2020M1076838,MYLAN,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN?RES 2019?18(5):300?305.. 2019?18(5):300?305",77.0,YR,,F,Y,,,20200908.0,,MD,JP,JP,2020,Q3,Elderly
182426391,18242639,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q3,Subcutaneous abscess,,2020,Q3,1,I,,20200828.0,20200908,20200908,EXP,JP-MLMSERVICE-20200812-2406399-1,JP-MYLANLABS-2020M1076838,MYLAN,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN?RES 2019?18(5):300?305.. 2019?18(5):300?305",77.0,YR,,F,Y,,,20200908.0,,MD,JP,JP,2020,Q3,Elderly
182476691,18247669,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Condition aggravated,Condition aggravated,2020,Q3,1,I,,20200825.0,20200909,20200909,EXP,,PK-ALVOGEN-2020-ALVOGEN-114199,ALVOGEN,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020.",42.0,YR,,M,Y,,,20200909.0,,HP,PK,PK,2020,Q3,Adult
182476691,18247669,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Confusional state,Confusional state,2020,Q3,1,I,,20200825.0,20200909,20200909,EXP,,PK-ALVOGEN-2020-ALVOGEN-114199,ALVOGEN,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020.",42.0,YR,,M,Y,,,20200909.0,,HP,PK,PK,2020,Q3,Adult
182476691,18247669,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Drug interaction,Drug interaction,2020,Q3,1,I,,20200825.0,20200909,20200909,EXP,,PK-ALVOGEN-2020-ALVOGEN-114199,ALVOGEN,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020.",42.0,YR,,M,Y,,,20200909.0,,HP,PK,PK,2020,Q3,Adult
182476691,18247669,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Seizure cluster,Seizure cluster,2020,Q3,1,I,,20200825.0,20200909,20200909,EXP,,PK-ALVOGEN-2020-ALVOGEN-114199,ALVOGEN,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020.",42.0,YR,,M,Y,,,20200909.0,,HP,PK,PK,2020,Q3,Adult
182500171,18250017,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,20180129.0,20200826.0,20200909,20200909,EXP,,US-JNJFOC-20200842139,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20200909.0,,HP,US,US,2020,Q3,Adult
182500171,18250017,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Urinary tract infection,,2020,Q3,1,I,20180129.0,20200826.0,20200909,20200909,EXP,,US-JNJFOC-20200842139,JOHNSON AND JOHNSON,,49.0,YR,A,F,Y,,,20200909.0,,HP,US,US,2020,Q3,Adult
182500671,18250067,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Blood pressure fluctuation,,2020,Q3,1,I,20200617.0,20200907.0,20200910,20200910,EXP,,NVSC2020DE246594,NOVARTIS,,74.0,YR,,M,Y,,,20200910.0,,CN,DE,DE,2020,Q3,Elderly
182500671,18250067,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Disorientation,,2020,Q3,1,I,20200617.0,20200907.0,20200910,20200910,EXP,,NVSC2020DE246594,NOVARTIS,,74.0,YR,,M,Y,,,20200910.0,,CN,DE,DE,2020,Q3,Elderly
182500671,18250067,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Overdose,,2020,Q3,1,I,20200617.0,20200907.0,20200910,20200910,EXP,,NVSC2020DE246594,NOVARTIS,,74.0,YR,,M,Y,,,20200910.0,,CN,DE,DE,2020,Q3,Elderly
182500671,18250067,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Poisoning,,2020,Q3,1,I,20200617.0,20200907.0,20200910,20200910,EXP,,NVSC2020DE246594,NOVARTIS,,74.0,YR,,M,Y,,,20200910.0,,CN,DE,DE,2020,Q3,Elderly
182500671,18250067,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q3,Somnolence,,2020,Q3,1,I,20200617.0,20200907.0,20200910,20200910,EXP,,NVSC2020DE246594,NOVARTIS,,74.0,YR,,M,Y,,,20200910.0,,CN,DE,DE,2020,Q3,Elderly
182545161,18254516,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypotension,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Ileus paralytic,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Mastication disorder,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IU, QD",,,Y,U, OF571A,,,16.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Pain,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Constipation,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Eating disorder,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Hypotension,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Ileus paralytic,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Mastication disorder,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182545161,18254516,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, QD",,,Y,U, OF571A,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q3,Pain,,2020,Q3,1,I,,20200902.0,20200910,20200910,EXP,,ES-MYLANLABS-2020M1076712,MYLAN,,90.0,YR,,F,Y,90.0,KG,20200910.0,,CN,ES,ES,2020,Q3,Elderly
182549691,18254969,6,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,16U,,,Y,,,,,,,INJECTION,QD,2020,Q3,Blood glucose abnormal,,2020,Q3,1,I,201712.0,20200901.0,20200910,20200910,EXP,,CN-EMD SERONO-9184273,EMD SERONO INC,"JIAYING W, XIUHUI H, YAMEI X, SHASHA Z. A CASE OF LATENT AUTOIMMUNE DIABETES IN ADULTS WITH EXOGENOUS INSULIN AUTOIMMUNE SYNDROME. INT J IMMUNOL. 2020 MAR?2:235?237.",67.0,YR,E,F,Y,,,20200910.0,,MD,CN,CN,2020,Q3,Elderly
182549691,18254969,6,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,16U,,,Y,,,,,,,INJECTION,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,201712.0,20200901.0,20200910,20200910,EXP,,CN-EMD SERONO-9184273,EMD SERONO INC,"JIAYING W, XIUHUI H, YAMEI X, SHASHA Z. A CASE OF LATENT AUTOIMMUNE DIABETES IN ADULTS WITH EXOGENOUS INSULIN AUTOIMMUNE SYNDROME. INT J IMMUNOL. 2020 MAR?2:235?237.",67.0,YR,E,F,Y,,,20200910.0,,MD,CN,CN,2020,Q3,Elderly
182549691,18254969,7,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,10U (DOSAGE REDUCED),,,Y,,,,,,,INJECTION,QD,2020,Q3,Blood glucose abnormal,,2020,Q3,1,I,201712.0,20200901.0,20200910,20200910,EXP,,CN-EMD SERONO-9184273,EMD SERONO INC,"JIAYING W, XIUHUI H, YAMEI X, SHASHA Z. A CASE OF LATENT AUTOIMMUNE DIABETES IN ADULTS WITH EXOGENOUS INSULIN AUTOIMMUNE SYNDROME. INT J IMMUNOL. 2020 MAR?2:235?237.",67.0,YR,E,F,Y,,,20200910.0,,MD,CN,CN,2020,Q3,Elderly
182549691,18254969,7,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,10U (DOSAGE REDUCED),,,Y,,,,,,,INJECTION,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,201712.0,20200901.0,20200910,20200910,EXP,,CN-EMD SERONO-9184273,EMD SERONO INC,"JIAYING W, XIUHUI H, YAMEI X, SHASHA Z. A CASE OF LATENT AUTOIMMUNE DIABETES IN ADULTS WITH EXOGENOUS INSULIN AUTOIMMUNE SYNDROME. INT J IMMUNOL. 2020 MAR?2:235?237.",67.0,YR,E,F,Y,,,20200910.0,,MD,CN,CN,2020,Q3,Elderly
182549691,18254969,8,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,,,,Y,,,,,,,,,2020,Q3,Blood glucose abnormal,,2020,Q3,1,I,201712.0,20200901.0,20200910,20200910,EXP,,CN-EMD SERONO-9184273,EMD SERONO INC,"JIAYING W, XIUHUI H, YAMEI X, SHASHA Z. A CASE OF LATENT AUTOIMMUNE DIABETES IN ADULTS WITH EXOGENOUS INSULIN AUTOIMMUNE SYNDROME. INT J IMMUNOL. 2020 MAR?2:235?237.",67.0,YR,E,F,Y,,,20200910.0,,MD,CN,CN,2020,Q3,Elderly
182549691,18254969,8,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,,,,,Y,,,,,,,,,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,201712.0,20200901.0,20200910,20200910,EXP,,CN-EMD SERONO-9184273,EMD SERONO INC,"JIAYING W, XIUHUI H, YAMEI X, SHASHA Z. A CASE OF LATENT AUTOIMMUNE DIABETES IN ADULTS WITH EXOGENOUS INSULIN AUTOIMMUNE SYNDROME. INT J IMMUNOL. 2020 MAR?2:235?237.",67.0,YR,E,F,Y,,,20200910.0,,MD,CN,CN,2020,Q3,Elderly
182570001,18257000,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 INTERNATIONAL UNIT,,,U,,,,,30.0,IU,,,2020,Q3,Blindness,,2020,Q3,1,I,,20200831.0,20200911,20200911,EXP,,CA-APOTEX-2020AP017309,APOTEX,,73.0,YR,,F,Y,,,20200911.0,,CN,CA,CA,2020,Q3,Elderly
182570001,18257000,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 INTERNATIONAL UNIT,,,U,,,,,30.0,IU,,,2020,Q3,Blood cholesterol increased,,2020,Q3,1,I,,20200831.0,20200911,20200911,EXP,,CA-APOTEX-2020AP017309,APOTEX,,73.0,YR,,F,Y,,,20200911.0,,CN,CA,CA,2020,Q3,Elderly
182570001,18257000,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 INTERNATIONAL UNIT,,,U,,,,,30.0,IU,,,2020,Q3,Cataract,,2020,Q3,1,I,,20200831.0,20200911,20200911,EXP,,CA-APOTEX-2020AP017309,APOTEX,,73.0,YR,,F,Y,,,20200911.0,,CN,CA,CA,2020,Q3,Elderly
182570001,18257000,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,30 INTERNATIONAL UNIT,,,U,,,,,30.0,IU,,,2020,Q3,Renal failure,,2020,Q3,1,I,,20200831.0,20200911,20200911,EXP,,CA-APOTEX-2020AP017309,APOTEX,,73.0,YR,,F,Y,,,20200911.0,,CN,CA,CA,2020,Q3,Elderly
182570212,18257021,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,205692.0,,,INJECTION,,2020,Q3,Cerebral infarction,,2020,Q3,2,F,,20200908.0,20200911,20200918,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009002444,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20200918.0,,PH,JP,JP,2020,Q3,Elderly
182570251,18257025,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 U, DAILY, BEFORE SLEEP",,,,,,,,28.0,IU,,QD,2020,Q3,Cerebral infarction,,2020,Q3,1,I,2016.0,20200901.0,20200911,20200911,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003714,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20200911.0,,CN,CN,CN,2020,Q3,Adult
182570251,18257025,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 U, DAILY, BEFORE SLEEP",,,,,,,,28.0,IU,,QD,2020,Q3,Presbyopia,,2020,Q3,1,I,2016.0,20200901.0,20200911,20200911,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009003714,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20200911.0,,CN,CN,CN,2020,Q3,Adult
182588581,18258858,3,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200907.0,20200911,20200911,EXP,,"PK-BRECKENRIDGE PHARMACEUTICAL, INC.-2089675",BRECKENRIDGE,"^DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE^ BY FAISAL INAYAT, MBBS @ DEPARTMENT OF MEDICINE, ALLAMA IQBAL MEDICAL COLLEGE, LAHORE, PAKISTAN? SYED RIZWAN A. BOKHARI, MD AND  RAQUEL M. ROSEN, MD @ DIVISION OF NEPHROLOGY, BASSETT MEDICAL CENTER, COOPERSTOWN, NY? TALAL ALMAS, BS @ 3DEPARTMENT OF MEDICINE, ROYAL COLLEGE OF SURGEONS, DUBLIN, IRELAND",42.0,YR,,M,Y,,,20200911.0,,HP,US,PK,2020,Q3,Adult
182594462,18259446,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,2,F,20200908.0,20200924.0,20200911,20200925,EXP,,US-GILEAD-2020-0494634,GILEAD,,69.0,YR,E,M,Y,107.0,KG,20200925.0,,PH,US,US,2020,Q3,Elderly
182594462,18259446,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,2,F,20200908.0,20200924.0,20200911,20200925,EXP,,US-GILEAD-2020-0494634,GILEAD,,69.0,YR,E,M,Y,107.0,KG,20200925.0,,PH,US,US,2020,Q3,Elderly
182598811,18259881,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Asthenia,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Fall,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598811,18259881,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Hypovolaemia,,2020,Q3,1,I,,20200911.0,20200912,20200912,EXP,,NVSC2020DE249785,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,HP,DE,DE,2020,Q3,Elderly
182598831,18259883,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182598831,18259883,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q3,Hypovolaemia,,2020,Q3,1,I,,20200909.0,20200912,20200912,EXP,,NVSC2020DE249416,NOVARTIS,,89.0,YR,,F,Y,,,20200912.0,,CN,FR,DE,2020,Q3,Elderly
182619151,18261915,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,210605.0,,,,,2020,Q3,Gait disturbance,,2020,Q3,1,I,,20200903.0,20200914,20200914,EXP,,SE-MYLANLABS-2020M1078277,MYLAN,STARK J. SPONTANEOUS ILIOPSOAS TENDON RUPTURE: A CASE REPORT AND BRIEF REVIEW. ARCH?ORTHOP?TRAUMA?SURG 2020?NULL:NULL.,89.0,YR,,F,Y,,,20200914.0,,HP,SE,SE,2020,Q3,Elderly
182619151,18261915,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,210605.0,,,,,2020,Q3,Tendon rupture,,2020,Q3,1,I,,20200903.0,20200914,20200914,EXP,,SE-MYLANLABS-2020M1078277,MYLAN,STARK J. SPONTANEOUS ILIOPSOAS TENDON RUPTURE: A CASE REPORT AND BRIEF REVIEW. ARCH?ORTHOP?TRAUMA?SURG 2020?NULL:NULL.,89.0,YR,,F,Y,,,20200914.0,,HP,SE,SE,2020,Q3,Elderly
182635521,18263552,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 IE (0?0?0?1),,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200910.0,20200914,20200914,EXP,,NVSC2020DE249083,NOVARTIS,,91.0,YR,,F,Y,,,20200914.0,,HP,DE,DE,2020,Q3,Elderly
182635521,18263552,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 IE (0?0?0?1),,,U,,,,,,,,,2020,Q3,Haematemesis,,2020,Q3,1,I,,20200910.0,20200914,20200914,EXP,,NVSC2020DE249083,NOVARTIS,,91.0,YR,,F,Y,,,20200914.0,,HP,DE,DE,2020,Q3,Elderly
182635521,18263552,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,16 IE (0?0?0?1),,,U,,,,,,,,,2020,Q3,Pallor,,2020,Q3,1,I,,20200910.0,20200914,20200914,EXP,,NVSC2020DE249083,NOVARTIS,,91.0,YR,,F,Y,,,20200914.0,,HP,DE,DE,2020,Q3,Elderly
182640161,18264016,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (32 IE, 0?0?0?32, PEN)",,,U,,,,,,,,,2020,Q3,Haematochezia,,2020,Q3,1,I,,20200910.0,20200914,20200914,EXP,,NVSC2020DE249091,NOVARTIS,,72.0,YR,,F,Y,,,20200914.0,,HP,DE,DE,2020,Q3,Elderly
182640161,18264016,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (32 IE, 0?0?0?32, PEN)",,,U,,,,,,,,,2020,Q3,Swelling,,2020,Q3,1,I,,20200910.0,20200914,20200914,EXP,,NVSC2020DE249091,NOVARTIS,,72.0,YR,,F,Y,,,20200914.0,,HP,DE,DE,2020,Q3,Elderly
182664931,18266493,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Hypertensive urgency,,2020,Q3,1,I,,20200906.0,20200915,20200915,EXP,,IN-HETERO-HET2020IN01026,HETERO,,62.0,YR,,F,Y,,,20200915.0,,MD,IN,IN,2020,Q3,Adult
182666161,18266616,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 INTERNATIONAL UNIT, QD",89550.0,IU,U,U,,,210605.0,45.0,IU,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,20200613.0,20200909.0,20200915,20200915,EXP,IT-MINISAL02-625698,IT-MYLANLABS-2020M1078762,MYLAN,,23.0,YR,,M,Y,,,20200915.0,,PH,IT,IT,2020,Q3,Youth
182666161,18266616,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"45 INTERNATIONAL UNIT, QD",89550.0,IU,U,U,,,210605.0,45.0,IU,INJECTION,QD,2020,Q3,Sopor,,2020,Q3,1,I,20200613.0,20200909.0,20200915,20200915,EXP,IT-MINISAL02-625698,IT-MYLANLABS-2020M1078762,MYLAN,,23.0,YR,,M,Y,,,20200915.0,,PH,IT,IT,2020,Q3,Youth
182669681,18266968,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Disease recurrence,,2020,Q3,1,I,,20200904.0,20200915,20200915,EXP,,PK-ACCORD-200874,ACCORD,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020. DOI: 10.1097/MJT.0000000000001241.",42.0,YR,,M,Y,,,20200915.0,,MD,PK,PK,2020,Q3,Adult
182669681,18266968,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200904.0,20200915,20200915,EXP,,PK-ACCORD-200874,ACCORD,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020. DOI: 10.1097/MJT.0000000000001241.",42.0,YR,,M,Y,,,20200915.0,,MD,PK,PK,2020,Q3,Adult
182669681,18266968,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200904.0,20200915,20200915,EXP,,PK-ACCORD-200874,ACCORD,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020. DOI: 10.1097/MJT.0000000000001241.",42.0,YR,,M,Y,,,20200915.0,,MD,PK,PK,2020,Q3,Adult
182671631,18267163,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD (16 IE, 0?0?0?16, AMPULLEN)",,,U,,,,,,,,QD,2020,Q3,Depressed level of consciousness,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,DE-GLAXOSMITHKLINE-DE2020184326,GLAXOSMITHKLINE,,78.0,YR,,M,Y,,,20200915.0,,MD,DE,DE,2020,Q3,Elderly
182671631,18267163,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD (16 IE, 0?0?0?16, AMPULLEN)",,,U,,,,,,,,QD,2020,Q3,Fall,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,DE-GLAXOSMITHKLINE-DE2020184326,GLAXOSMITHKLINE,,78.0,YR,,M,Y,,,20200915.0,,MD,DE,DE,2020,Q3,Elderly
182671631,18267163,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD (16 IE, 0?0?0?16, AMPULLEN)",,,U,,,,,,,,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,DE-GLAXOSMITHKLINE-DE2020184326,GLAXOSMITHKLINE,,78.0,YR,,M,Y,,,20200915.0,,MD,DE,DE,2020,Q3,Elderly
182671631,18267163,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD (16 IE, 0?0?0?16, AMPULLEN)",,,U,,,,,,,,QD,2020,Q3,Loss of consciousness,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,DE-GLAXOSMITHKLINE-DE2020184326,GLAXOSMITHKLINE,,78.0,YR,,M,Y,,,20200915.0,,MD,DE,DE,2020,Q3,Elderly
182671631,18267163,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD (16 IE, 0?0?0?16, AMPULLEN)",,,U,,,,,,,,QD,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,DE-GLAXOSMITHKLINE-DE2020184326,GLAXOSMITHKLINE,,78.0,YR,,M,Y,,,20200915.0,,MD,DE,DE,2020,Q3,Elderly
182671631,18267163,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD (16 IE, 0?0?0?16, AMPULLEN)",,,U,,,,,,,,QD,2020,Q3,Somnolence,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,DE-GLAXOSMITHKLINE-DE2020184326,GLAXOSMITHKLINE,,78.0,YR,,M,Y,,,20200915.0,,MD,DE,DE,2020,Q3,Elderly
182672411,18267241,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200819.0,,20200915,20200915,DIR,,,FDA-CTU,,71.0,YR,,F,N,44.9,KG,20200915.0,Y,PH,US,US,2020,Q3,Elderly
182672411,18267241,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,20200819.0,,20200915,20200915,DIR,,,FDA-CTU,,71.0,YR,,F,N,44.9,KG,20200915.0,Y,PH,US,US,2020,Q3,Elderly
182672411,18267241,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Therapy interrupted,,2020,Q3,1,I,20200819.0,,20200915,20200915,DIR,,,FDA-CTU,,71.0,YR,,F,N,44.9,KG,20200915.0,Y,PH,US,US,2020,Q3,Elderly
182686901,18268690,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"4 INTERNATIONAL UNIT, TOTAL",4.0,IU,U,U,,,210605.0,4.0,IU,,,2020,Q3,Hypoglycaemic coma,,2020,Q3,1,I,20200518.0,20200904.0,20200915,20200915,EXP,IT-MINISAL02-631440,IT-MYLANLABS-2020M1077662,MYLAN,,87.0,YR,,M,Y,,,20200915.0,,MD,IT,IT,2020,Q3,Elderly
182701501,18270150,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"40 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,40.0,IU,,QD,2020,Q3,Haematoma,,2020,Q3,1,I,,20200909.0,20200916,20200916,EXP,,DE-AUROBINDO-AUR-APL-2020-047796,AUROBINDO,,76.0,YR,,M,Y,142.0,KG,20200916.0,,PH,DE,DE,2020,Q3,Elderly
182701501,18270150,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"40 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,40.0,IU,,QD,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,,20200909.0,20200916,20200916,EXP,,DE-AUROBINDO-AUR-APL-2020-047796,AUROBINDO,,76.0,YR,,M,Y,142.0,KG,20200916.0,,PH,DE,DE,2020,Q3,Elderly
182702231,18270223,4,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Ketoacidosis,,2020,Q3,1,I,20200823.0,20200909.0,20200915,20200915,EXP,,NL-ASTRAZENECA-2020SF16017,ASTRAZENECA,,55.0,YR,,F,Y,79.0,KG,20200915.0,,CN,NL,NL,2020,Q3,Adult
182702231,18270223,4,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Ketonuria,,2020,Q3,1,I,20200823.0,20200909.0,20200915,20200915,EXP,,NL-ASTRAZENECA-2020SF16017,ASTRAZENECA,,55.0,YR,,F,Y,79.0,KG,20200915.0,,CN,NL,NL,2020,Q3,Adult
182702851,18270285,18,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200909.0,20200916,20200916,EXP,,DE-AUROBINDO-AUR-APL-2020-047821,AUROBINDO,,62.0,YR,,M,Y,,,20200916.0,,MD,DE,DE,2020,Q3,Adult
182702851,18270285,18,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200909.0,20200916,20200916,EXP,,DE-AUROBINDO-AUR-APL-2020-047821,AUROBINDO,,62.0,YR,,M,Y,,,20200916.0,,MD,DE,DE,2020,Q3,Adult
182702851,18270285,18,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Dry skin,,2020,Q3,1,I,,20200909.0,20200916,20200916,EXP,,DE-AUROBINDO-AUR-APL-2020-047821,AUROBINDO,,62.0,YR,,M,Y,,,20200916.0,,MD,DE,DE,2020,Q3,Adult
182702851,18270285,18,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,,20200909.0,20200916,20200916,EXP,,DE-AUROBINDO-AUR-APL-2020-047821,AUROBINDO,,62.0,YR,,M,Y,,,20200916.0,,MD,DE,DE,2020,Q3,Adult
182702851,18270285,18,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200909.0,20200916,20200916,EXP,,DE-AUROBINDO-AUR-APL-2020-047821,AUROBINDO,,62.0,YR,,M,Y,,,20200916.0,,MD,DE,DE,2020,Q3,Adult
182702851,18270285,18,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Rash,,2020,Q3,1,I,,20200909.0,20200916,20200916,EXP,,DE-AUROBINDO-AUR-APL-2020-047821,AUROBINDO,,62.0,YR,,M,Y,,,20200916.0,,MD,DE,DE,2020,Q3,Adult
182705311,18270531,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NK IE, NACH SCHEMA)",,,U,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,NVSC2020DE251777,NOVARTIS,,76.0,YR,,M,Y,110.0,KG,20200915.0,,HP,DE,DE,2020,Q3,Elderly
182705311,18270531,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NK IE, NACH SCHEMA)",,,U,,,,,,,,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,NVSC2020DE251777,NOVARTIS,,76.0,YR,,M,Y,110.0,KG,20200915.0,,HP,DE,DE,2020,Q3,Elderly
182705311,18270531,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NK IE, NACH SCHEMA)",,,U,,,,,,,,,2020,Q3,Arrhythmia,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,NVSC2020DE251777,NOVARTIS,,76.0,YR,,M,Y,110.0,KG,20200915.0,,HP,DE,DE,2020,Q3,Elderly
182705311,18270531,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NK IE, NACH SCHEMA)",,,U,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,NVSC2020DE251777,NOVARTIS,,76.0,YR,,M,Y,110.0,KG,20200915.0,,HP,DE,DE,2020,Q3,Elderly
182705311,18270531,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NK IE, NACH SCHEMA)",,,U,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,NVSC2020DE251777,NOVARTIS,,76.0,YR,,M,Y,110.0,KG,20200915.0,,HP,DE,DE,2020,Q3,Elderly
182705311,18270531,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NK IE, NACH SCHEMA)",,,U,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200914.0,20200915,20200915,EXP,,NVSC2020DE251777,NOVARTIS,,76.0,YR,,M,Y,110.0,KG,20200915.0,,HP,DE,DE,2020,Q3,Elderly
182709501,18270950,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200908.0,20200915,20200915,EXP,,"PK-ARBOR PHARMACEUTICALS, LLC-US-2020ARB000746",ARBOR,"INAYAT F, BOKHARI SRA., ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020?1?2",42.0,YR,,M,Y,,,20200915.0,,MD,PK,US,2020,Q3,Adult
182709501,18270950,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200908.0,20200915,20200915,EXP,,"PK-ARBOR PHARMACEUTICALS, LLC-US-2020ARB000746",ARBOR,"INAYAT F, BOKHARI SRA., ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020?1?2",42.0,YR,,M,Y,,,20200915.0,,MD,PK,US,2020,Q3,Adult
182717091,18271709,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),16 INTERNATIONAL UNIT; BEFORE THE SLEEP,,,Y,,,,,16.0,IU,,,2020,Q3,Diabetes mellitus inadequate control,,2020,Q3,1,I,,20200908.0,20200916,20200916,EXP,,CN-009507513-2009CHN004839,MERCK,"HONG W, ZHAOJUN Y. CASE ANALYSIS OF INSULIN PREFILLER: DEEP KNOWLEDGE AND VIGOROUS ACTION, UNITY OF KNOWLEDGE WITH ACTION. CASE ANALYSIS. 2020?17 (9):62?4",61.0,YR,,F,Y,65.0,KG,20200916.0,,MD,CN,CN,2020,Q3,Adult
182717091,18271709,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),16 INTERNATIONAL UNIT; BEFORE THE SLEEP,,,Y,,,,,16.0,IU,,,2020,Q3,Therapy partial responder,,2020,Q3,1,I,,20200908.0,20200916,20200916,EXP,,CN-009507513-2009CHN004839,MERCK,"HONG W, ZHAOJUN Y. CASE ANALYSIS OF INSULIN PREFILLER: DEEP KNOWLEDGE AND VIGOROUS ACTION, UNITY OF KNOWLEDGE WITH ACTION. CASE ANALYSIS. 2020?17 (9):62?4",61.0,YR,,F,Y,65.0,KG,20200916.0,,MD,CN,CN,2020,Q3,Adult
182727611,18272761,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, QD/EVERY DAY",,,Y,U,,,,14.0,IU,INJECTION,QD,2020,Q3,Hyponatraemia,,2020,Q3,1,I,201809.0,20190412.0,20200916,20200916,EXP,FR-AFSSAPS-AN20181130,FR-MYLANLABS-2019M1036960,MYLAN,,71.0,YR,,F,Y,,,20200916.0,,HP,FR,FR,2020,Q3,Elderly
182727611,18272761,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, QD/EVERY DAY",,,Y,U,,,,14.0,IU,INJECTION,QD,2020,Q3,Inappropriate antidiuretic hormone secretion,,2020,Q3,1,I,201809.0,20190412.0,20200916,20200916,EXP,FR-AFSSAPS-AN20181130,FR-MYLANLABS-2019M1036960,MYLAN,,71.0,YR,,F,Y,,,20200916.0,,HP,FR,FR,2020,Q3,Elderly
182731311,18273131,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Diarrhoea,,2020,Q3,1,I,20200702.0,20200720.0,20200916,20200916,EXP,,JP-DSJP-DSJ-2020-120903,DAIICHI,,78.0,YR,,F,Y,39.0,KG,20200916.0,,MD,JP,JP,2020,Q3,Elderly
182731311,18273131,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Gastroenteritis,,2020,Q3,1,I,20200702.0,20200720.0,20200916,20200916,EXP,,JP-DSJP-DSJ-2020-120903,DAIICHI,,78.0,YR,,F,Y,39.0,KG,20200916.0,,MD,JP,JP,2020,Q3,Elderly
182731311,18273131,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,INJECTION,QD,2020,Q3,Nausea,,2020,Q3,1,I,20200702.0,20200720.0,20200916,20200916,EXP,,JP-DSJP-DSJ-2020-120903,DAIICHI,,78.0,YR,,F,Y,39.0,KG,20200916.0,,MD,JP,JP,2020,Q3,Elderly
182732521,18273252,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20140116.0,20200916,20200916,EXP,,US-AUROBINDO-AUR-APL-2014-00699,AUROBINDO,,55.0,YR,,M,Y,,,20200916.0,,HP,US,US,2020,Q3,Adult
182732521,18273252,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Lethargy,,2020,Q3,1,I,,20140116.0,20200916,20200916,EXP,,US-AUROBINDO-AUR-APL-2014-00699,AUROBINDO,,55.0,YR,,M,Y,,,20200916.0,,HP,US,US,2020,Q3,Adult
182732521,18273252,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Myoclonus,,2020,Q3,1,I,,20140116.0,20200916,20200916,EXP,,US-AUROBINDO-AUR-APL-2014-00699,AUROBINDO,,55.0,YR,,M,Y,,,20200916.0,,HP,US,US,2020,Q3,Adult
182732521,18273252,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,1,I,,20140116.0,20200916,20200916,EXP,,US-AUROBINDO-AUR-APL-2014-00699,AUROBINDO,,55.0,YR,,M,Y,,,20200916.0,,HP,US,US,2020,Q3,Adult
182732521,18273252,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Toxicity to various agents,,2020,Q3,1,I,,20140116.0,20200916,20200916,EXP,,US-AUROBINDO-AUR-APL-2014-00699,AUROBINDO,,55.0,YR,,M,Y,,,20200916.0,,HP,US,US,2020,Q3,Adult
182732521,18273252,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q3,Tremor,,2020,Q3,1,I,,20140116.0,20200916,20200916,EXP,,US-AUROBINDO-AUR-APL-2014-00699,AUROBINDO,,55.0,YR,,M,Y,,,20200916.0,,HP,US,US,2020,Q3,Adult
182761141,18276114,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT, ONCE A DAY, 0?0?14?0",,,U,,,,,300.0,IU,AMPOULES,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200910.0,20200917,20200917,EXP,,DE-AUROBINDO-AUR-APL-2020-047971,AUROBINDO,,71.0,YR,,M,Y,,,20200917.0,,MD,DE,DE,2020,Q3,Elderly
182761141,18276114,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"300 INTERNATIONAL UNIT, ONCE A DAY, 0?0?14?0",,,U,,,,,300.0,IU,AMPOULES,QD,2020,Q3,Haematochezia,,2020,Q3,1,I,,20200910.0,20200917,20200917,EXP,,DE-AUROBINDO-AUR-APL-2020-047971,AUROBINDO,,71.0,YR,,M,Y,,,20200917.0,,MD,DE,DE,2020,Q3,Elderly
182769841,18276984,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,,NVSC2020DE249807,NOVARTIS,,47.0,YR,,F,Y,45.0,KG,20200917.0,,HP,DE,DE,2020,Q3,Adult
182769841,18276984,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,,NVSC2020DE249807,NOVARTIS,,47.0,YR,,F,Y,45.0,KG,20200917.0,,HP,DE,DE,2020,Q3,Adult
182769841,18276984,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Dysphagia,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,,NVSC2020DE249807,NOVARTIS,,47.0,YR,,F,Y,45.0,KG,20200917.0,,HP,DE,DE,2020,Q3,Adult
182769841,18276984,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,,NVSC2020DE249807,NOVARTIS,,47.0,YR,,F,Y,45.0,KG,20200917.0,,HP,DE,DE,2020,Q3,Adult
182769841,18276984,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,,NVSC2020DE249807,NOVARTIS,,47.0,YR,,F,Y,45.0,KG,20200917.0,,HP,DE,DE,2020,Q3,Adult
182769841,18276984,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Thirst,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,,NVSC2020DE249807,NOVARTIS,,47.0,YR,,F,Y,45.0,KG,20200917.0,,HP,DE,DE,2020,Q3,Adult
182769841,18276984,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,,NVSC2020DE249807,NOVARTIS,,47.0,YR,,F,Y,45.0,KG,20200917.0,,HP,DE,DE,2020,Q3,Adult
182770081,18277008,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009857,DE-ACCORD-201451,ACCORD,,47.0,YR,A,F,Y,45.0,KG,20200917.0,,PH,DE,DE,2020,Q3,Adult
182770081,18277008,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009857,DE-ACCORD-201451,ACCORD,,47.0,YR,A,F,Y,45.0,KG,20200917.0,,PH,DE,DE,2020,Q3,Adult
182770081,18277008,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Dysphagia,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009857,DE-ACCORD-201451,ACCORD,,47.0,YR,A,F,Y,45.0,KG,20200917.0,,PH,DE,DE,2020,Q3,Adult
182770081,18277008,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009857,DE-ACCORD-201451,ACCORD,,47.0,YR,A,F,Y,45.0,KG,20200917.0,,PH,DE,DE,2020,Q3,Adult
182770081,18277008,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009857,DE-ACCORD-201451,ACCORD,,47.0,YR,A,F,Y,45.0,KG,20200917.0,,PH,DE,DE,2020,Q3,Adult
182770081,18277008,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Thirst,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009857,DE-ACCORD-201451,ACCORD,,47.0,YR,A,F,Y,45.0,KG,20200917.0,,PH,DE,DE,2020,Q3,Adult
182770081,18277008,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009857,DE-ACCORD-201451,ACCORD,,47.0,YR,A,F,Y,45.0,KG,20200917.0,,PH,DE,DE,2020,Q3,Adult
182781421,18278142,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009819,DE-ACCORD-201397,ACCORD,,62.0,YR,A,M,Y,,,20200917.0,,MD,DE,DE,2020,Q3,Adult
182781421,18278142,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009819,DE-ACCORD-201397,ACCORD,,62.0,YR,A,M,Y,,,20200917.0,,MD,DE,DE,2020,Q3,Adult
182781421,18278142,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Dry skin,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009819,DE-ACCORD-201397,ACCORD,,62.0,YR,A,M,Y,,,20200917.0,,MD,DE,DE,2020,Q3,Adult
182781421,18278142,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009819,DE-ACCORD-201397,ACCORD,,62.0,YR,A,M,Y,,,20200917.0,,MD,DE,DE,2020,Q3,Adult
182781421,18278142,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009819,DE-ACCORD-201397,ACCORD,,62.0,YR,A,M,Y,,,20200917.0,,MD,DE,DE,2020,Q3,Adult
182781421,18278142,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q3,Rash,,2020,Q3,1,I,,20200909.0,20200917,20200917,EXP,DE-BFARM-20009819,DE-ACCORD-201397,ACCORD,,62.0,YR,A,M,Y,,,20200917.0,,MD,DE,DE,2020,Q3,Adult
182789031,18278903,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,50.0,IU,,QD,2020,Q3,Drug ineffective,,2020,Q3,1,I,2018.0,20200825.0,20200917,20200917,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0544,BIODELIVERY SCIENCES INTERNATIONAL,,61.0,YR,A,M,Y,104.42,KG,20200917.0,,CN,US,US,2020,Q3,Adult
182789031,18278903,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,50.0,IU,,QD,2020,Q3,Product solubility abnormal,,2020,Q3,1,I,2018.0,20200825.0,20200917,20200917,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0544,BIODELIVERY SCIENCES INTERNATIONAL,,61.0,YR,A,M,Y,104.42,KG,20200917.0,,CN,US,US,2020,Q3,Adult
182789031,18278903,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,50.0,IU,,QD,2020,Q3,Therapeutic response decreased,,2020,Q3,1,I,2018.0,20200825.0,20200917,20200917,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0544,BIODELIVERY SCIENCES INTERNATIONAL,,61.0,YR,A,M,Y,104.42,KG,20200917.0,,CN,US,US,2020,Q3,Adult
182789031,18278903,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,50.0,IU,,QD,2020,Q3,Wrong technique in product usage process,,2020,Q3,1,I,2018.0,20200825.0,20200917,20200917,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0544,BIODELIVERY SCIENCES INTERNATIONAL,,61.0,YR,A,M,Y,104.42,KG,20200917.0,,CN,US,US,2020,Q3,Adult
182791571,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,U,,,,,,,,,2020,Q3,Depressed level of consciousness,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Elderly
182791571,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,U,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Elderly
182791571,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Elderly
182791571,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,U,,,,,,,,,2020,Q3,Loss of consciousness,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Elderly
182791571,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,U,,,,,,,,,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Elderly
182791571,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,U,,,,,,,,,2020,Q3,Somnolence,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Elderly
182792111,18279211,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q3,Drug ineffective for unapproved indication,,2020,Q3,1,I,201904.0,20200806.0,20200917,20200917,EXP,,NVSC2020CZ221252,NOVARTIS,,75.0,YR,,M,Y,,,20200917.0,,HP,CZ,CZ,2020,Q3,Elderly
182792111,18279211,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q3,Gait inability,,2020,Q3,1,I,201904.0,20200806.0,20200917,20200917,EXP,,NVSC2020CZ221252,NOVARTIS,,75.0,YR,,M,Y,,,20200917.0,,HP,CZ,CZ,2020,Q3,Elderly
182792111,18279211,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q3,Immune-mediated myositis,,2020,Q3,1,I,201904.0,20200806.0,20200917,20200917,EXP,,NVSC2020CZ221252,NOVARTIS,,75.0,YR,,M,Y,,,20200917.0,,HP,CZ,CZ,2020,Q3,Elderly
182792111,18279211,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q3,Muscular weakness,,2020,Q3,1,I,201904.0,20200806.0,20200917,20200917,EXP,,NVSC2020CZ221252,NOVARTIS,,75.0,YR,,M,Y,,,20200917.0,,HP,CZ,CZ,2020,Q3,Elderly
182792111,18279211,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q3,Pain in extremity,,2020,Q3,1,I,201904.0,20200806.0,20200917,20200917,EXP,,NVSC2020CZ221252,NOVARTIS,,75.0,YR,,M,Y,,,20200917.0,,HP,CZ,CZ,2020,Q3,Elderly
182792111,18279211,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 IU, QD",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q3,Peripheral swelling,,2020,Q3,1,I,201904.0,20200806.0,20200917,20200917,EXP,,NVSC2020CZ221252,NOVARTIS,,75.0,YR,,M,Y,,,20200917.0,,HP,CZ,CZ,2020,Q3,Elderly
182792571,18279257,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE,QD (0?0?1?0)",,,U,,,,,,,,QD,2020,Q3,Abdominal distension,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251785,NOVARTIS,,73.0,YR,,M,Y,69.0,KG,20200917.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
182792571,18279257,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE,QD (0?0?1?0)",,,U,,,,,,,,QD,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251785,NOVARTIS,,73.0,YR,,M,Y,69.0,KG,20200917.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
182792571,18279257,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE,QD (0?0?1?0)",,,U,,,,,,,,QD,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251785,NOVARTIS,,73.0,YR,,M,Y,69.0,KG,20200917.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
182792571,18279257,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE,QD (0?0?1?0)",,,U,,,,,,,,QD,2020,Q3,Haematemesis,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251785,NOVARTIS,,73.0,YR,,M,Y,69.0,KG,20200917.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
182792571,18279257,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE,QD (0?0?1?0)",,,U,,,,,,,,QD,2020,Q3,Mucosal haemorrhage,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251785,NOVARTIS,,73.0,YR,,M,Y,69.0,KG,20200917.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
182792571,18279257,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE,QD (0?0?1?0)",,,U,,,,,,,,QD,2020,Q3,Nausea,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251785,NOVARTIS,,73.0,YR,,M,Y,69.0,KG,20200917.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
182792571,18279257,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE,QD (0?0?1?0)",,,U,,,,,,,,QD,2020,Q3,Vomiting,,2020,Q3,1,I,,20200914.0,20200917,20200917,EXP,,NVSC2020DE251785,NOVARTIS,,73.0,YR,,M,Y,69.0,KG,20200917.0,,HP,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
182797151,18279715,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047800,AUROBINDO,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182797151,18279715,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047800,AUROBINDO,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182797151,18279715,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Dysphagia,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047800,AUROBINDO,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182797151,18279715,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047800,AUROBINDO,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182797151,18279715,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047800,AUROBINDO,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182797151,18279715,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Thirst,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047800,AUROBINDO,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182797151,18279715,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047800,AUROBINDO,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182798601,18279860,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,DE-ADRED-05580-01,NVSC2020DE251346,NOVARTIS,,62.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Adult
182798601,18279860,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,DE-ADRED-05580-01,NVSC2020DE251346,NOVARTIS,,62.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Adult
182798601,18279860,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Dry skin,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,DE-ADRED-05580-01,NVSC2020DE251346,NOVARTIS,,62.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Adult
182798601,18279860,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,DE-ADRED-05580-01,NVSC2020DE251346,NOVARTIS,,62.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Adult
182798601,18279860,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,DE-ADRED-05580-01,NVSC2020DE251346,NOVARTIS,,62.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Adult
182798601,18279860,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q3,Rash,,2020,Q3,1,I,,20200911.0,20200917,20200917,EXP,DE-ADRED-05580-01,NVSC2020DE251346,NOVARTIS,,62.0,YR,,M,Y,,,20200917.0,,HP,DE,DE,2020,Q3,Adult
182800341,18280034,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK IE, (ACCORDING TO SCHEME)",,,U,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047982,AUROBINDO,,76.0,YR,,M,Y,110.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182800341,18280034,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK IE, (ACCORDING TO SCHEME)",,,U,,,,,,,,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047982,AUROBINDO,,76.0,YR,,M,Y,110.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182800341,18280034,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK IE, (ACCORDING TO SCHEME)",,,U,,,,,,,,,2020,Q3,Arrhythmia,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047982,AUROBINDO,,76.0,YR,,M,Y,110.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182800341,18280034,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK IE, (ACCORDING TO SCHEME)",,,U,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047982,AUROBINDO,,76.0,YR,,M,Y,110.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182800341,18280034,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK IE, (ACCORDING TO SCHEME)",,,U,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047982,AUROBINDO,,76.0,YR,,M,Y,110.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182800341,18280034,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK IE, (ACCORDING TO SCHEME)",,,U,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047982,AUROBINDO,,76.0,YR,,M,Y,110.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182800411,18280041,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT (0?1?0?0),,,,,,,,14.0,IU,AMPOULES,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048090,AUROBINDO,,64.0,YR,,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182800411,18280041,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT (0?1?0?0),,,,,,,,14.0,IU,AMPOULES,,2020,Q3,Nausea,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048090,AUROBINDO,,64.0,YR,,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182800411,18280041,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,14 INTERNATIONAL UNIT (0?1?0?0),,,,,,,,14.0,IU,AMPOULES,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048090,AUROBINDO,,64.0,YR,,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182803691,18280369,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,4.0,IU,AMPOULES,QD,2020,Q3,Abdominal distension,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048210,AUROBINDO,,73.0,YR,,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182803691,18280369,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,4.0,IU,AMPOULES,QD,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048210,AUROBINDO,,73.0,YR,,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182803691,18280369,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,4.0,IU,AMPOULES,QD,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048210,AUROBINDO,,73.0,YR,,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182803691,18280369,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,4.0,IU,AMPOULES,QD,2020,Q3,Haematemesis,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048210,AUROBINDO,,73.0,YR,,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182803691,18280369,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,4.0,IU,AMPOULES,QD,2020,Q3,Mucosal haemorrhage,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048210,AUROBINDO,,73.0,YR,,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182803691,18280369,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,4.0,IU,AMPOULES,QD,2020,Q3,Nausea,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048210,AUROBINDO,,73.0,YR,,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182803691,18280369,10,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,4.0,IU,AMPOULES,QD,2020,Q3,Vomiting,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-048210,AUROBINDO,,73.0,YR,,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182811621,18281162,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2020,Q3,Asthenia,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811621,18281162,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2020,Q3,Hypovolaemia,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,DE-AUROBINDO-AUR-APL-2020-047794,AUROBINDO,,89.0,YR,,F,Y,,,20200918.0,,CN,DE,DE,2020,Q3,Elderly
182811741,18281174,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?1?0?0, AMPOULES",,,,,,,,,,,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20010006,DE-ACCORD-201519,ACCORD,,64.0,YR,A,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182811741,18281174,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?1?0?0, AMPOULES",,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20010006,DE-ACCORD-201519,ACCORD,,64.0,YR,A,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182811741,18281174,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, 0?1?0?0, AMPOULES",,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20010006,DE-ACCORD-201519,ACCORD,,64.0,YR,A,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182823991,18282399,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, 0?0?1?0, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q3,Abdominal distension,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20009918,DE-ACCORD-201508,ACCORD,,73.0,YR,E,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182823991,18282399,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, 0?0?1?0, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20009918,DE-ACCORD-201508,ACCORD,,73.0,YR,E,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182823991,18282399,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, 0?0?1?0, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20009918,DE-ACCORD-201508,ACCORD,,73.0,YR,E,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182823991,18282399,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, 0?0?1?0, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q3,Haematemesis,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20009918,DE-ACCORD-201508,ACCORD,,73.0,YR,E,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182823991,18282399,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, 0?0?1?0, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q3,Mucosal haemorrhage,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20009918,DE-ACCORD-201508,ACCORD,,73.0,YR,E,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182823991,18282399,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, 0?0?1?0, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q3,Nausea,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20009918,DE-ACCORD-201508,ACCORD,,73.0,YR,E,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182823991,18282399,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IU, 0?0?1?0, AMPOULES",,,,,,,,,,AMPOULES,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200910.0,20200918,20200918,EXP,DE-BFARM-20009918,DE-ACCORD-201508,ACCORD,,73.0,YR,E,M,Y,69.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182829181,18282918,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Eosinophilia,,2020,Q3,1,I,20200808.0,20200917.0,20200918,20200918,EXP,FR-AFSSAPS-AN20201025,FR-BAYER-2020-201142,BAYER,,79.0,YR,E,F,Y,72.0,KG,20200918.0,,HP,NL,FR,2020,Q3,Elderly
182829181,18282918,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hepatocellular injury,,2020,Q3,1,I,20200808.0,20200917.0,20200918,20200918,EXP,FR-AFSSAPS-AN20201025,FR-BAYER-2020-201142,BAYER,,79.0,YR,E,F,Y,72.0,KG,20200918.0,,HP,NL,FR,2020,Q3,Elderly
182829181,18282918,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Hypercreatininaemia,,2020,Q3,1,I,20200808.0,20200917.0,20200918,20200918,EXP,FR-AFSSAPS-AN20201025,FR-BAYER-2020-201142,BAYER,,79.0,YR,E,F,Y,72.0,KG,20200918.0,,HP,NL,FR,2020,Q3,Elderly
182829181,18282918,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Rash maculo-papular,,2020,Q3,1,I,20200808.0,20200917.0,20200918,20200918,EXP,FR-AFSSAPS-AN20201025,FR-BAYER-2020-201142,BAYER,,79.0,YR,E,F,Y,72.0,KG,20200918.0,,HP,NL,FR,2020,Q3,Elderly
182830101,18283010,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200804.0,20200916.0,20200918,20200918,EXP,DE-ADRED-05580-01,DE-PFIZER INC-2020360389,PFIZER,,62.0,YR,,M,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182830101,18283010,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,,,,,2020,Q3,Blood sodium decreased,,2020,Q3,1,I,20200804.0,20200916.0,20200918,20200918,EXP,DE-ADRED-05580-01,DE-PFIZER INC-2020360389,PFIZER,,62.0,YR,,M,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182830101,18283010,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,20200804.0,20200916.0,20200918,20200918,EXP,DE-ADRED-05580-01,DE-PFIZER INC-2020360389,PFIZER,,62.0,YR,,M,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182830101,18283010,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,,,,,2020,Q3,Dry skin,,2020,Q3,1,I,20200804.0,20200916.0,20200918,20200918,EXP,DE-ADRED-05580-01,DE-PFIZER INC-2020360389,PFIZER,,62.0,YR,,M,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182830101,18283010,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,,,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,20200804.0,20200916.0,20200918,20200918,EXP,DE-ADRED-05580-01,DE-PFIZER INC-2020360389,PFIZER,,62.0,YR,,M,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182830101,18283010,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,,,,,2020,Q3,Gamma-glutamyltransferase increased,,2020,Q3,1,I,20200804.0,20200916.0,20200918,20200918,EXP,DE-ADRED-05580-01,DE-PFIZER INC-2020360389,PFIZER,,62.0,YR,,M,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182830101,18283010,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,20200804.0,20200916.0,20200918,20200918,EXP,DE-ADRED-05580-01,DE-PFIZER INC-2020360389,PFIZER,,62.0,YR,,M,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182830101,18283010,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION)",,,,,,,,,,,,2020,Q3,Rash,,2020,Q3,1,I,20200804.0,20200916.0,20200918,20200918,EXP,DE-ADRED-05580-01,DE-PFIZER INC-2020360389,PFIZER,,62.0,YR,,M,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Adult
182830251,18283025,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, 1X/DAY",,,,,,,,40.0,IU,,QD,2020,Q3,Activated partial thromboplastin time shortened,,2020,Q3,1,I,20200716.0,20200916.0,20200918,20200918,EXP,,DE-PFIZER INC-2020360230,PFIZER,,76.0,YR,,M,Y,142.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182830251,18283025,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, 1X/DAY",,,,,,,,40.0,IU,,QD,2020,Q3,Glomerular filtration rate increased,,2020,Q3,1,I,20200716.0,20200916.0,20200918,20200918,EXP,,DE-PFIZER INC-2020360230,PFIZER,,76.0,YR,,M,Y,142.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182830251,18283025,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, 1X/DAY",,,,,,,,40.0,IU,,QD,2020,Q3,Haematoma,,2020,Q3,1,I,20200716.0,20200916.0,20200918,20200918,EXP,,DE-PFIZER INC-2020360230,PFIZER,,76.0,YR,,M,Y,142.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182830251,18283025,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, 1X/DAY",,,,,,,,40.0,IU,,QD,2020,Q3,Hyperglycaemia,,2020,Q3,1,I,20200716.0,20200916.0,20200918,20200918,EXP,,DE-PFIZER INC-2020360230,PFIZER,,76.0,YR,,M,Y,142.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182830251,18283025,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"40 IU, 1X/DAY",,,,,,,,40.0,IU,,QD,2020,Q3,Prothrombin level decreased,,2020,Q3,1,I,20200716.0,20200916.0,20200918,20200918,EXP,,DE-PFIZER INC-2020360230,PFIZER,,76.0,YR,,M,Y,142.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Elderly
182833851,18283385,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52127,HIKMA,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182833851,18283385,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52127,HIKMA,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182833851,18283385,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,Dysphagia,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52127,HIKMA,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182833851,18283385,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52127,HIKMA,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182833851,18283385,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52127,HIKMA,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182833851,18283385,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,Thirst,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52127,HIKMA,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182833851,18283385,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52127,HIKMA,,47.0,YR,,F,Y,45.0,KG,20200918.0,,PH,DE,DE,2020,Q3,Adult
182837111,18283711,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 I.U. IN THE NIGHT)",,,U,,,,,8.0,IU,,QD,2020,Q3,Confusional state,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-009507513-2009DEU005827,MERCK,,93.0,YR,,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Elderly
182837111,18283711,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 I.U. IN THE NIGHT)",,,U,,,,,8.0,IU,,QD,2020,Q3,Disorientation,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-009507513-2009DEU005827,MERCK,,93.0,YR,,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Elderly
182837111,18283711,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 I.U. IN THE NIGHT)",,,U,,,,,8.0,IU,,QD,2020,Q3,Fall,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-009507513-2009DEU005827,MERCK,,93.0,YR,,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Elderly
182837111,18283711,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 I.U. IN THE NIGHT)",,,U,,,,,8.0,IU,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-009507513-2009DEU005827,MERCK,,93.0,YR,,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Elderly
182837111,18283711,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 I.U. IN THE NIGHT)",,,U,,,,,8.0,IU,,QD,2020,Q3,Loss of consciousness,,2020,Q3,1,I,,20200915.0,20200918,20200918,EXP,,DE-009507513-2009DEU005827,MERCK,,93.0,YR,,F,Y,,,20200918.0,,MD,DE,DE,2020,Q3,Elderly
182848161,18284816,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Atelectasis,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Distributive shock,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Pleural effusion,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848161,18284816,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200831.0,20200914.0,20200919,20200919,PER,,US-AMGEN-USASP2020149787,AMGEN,,67.0,YR,E,F,Y,47.4,KG,20200918.0,,HP,US,US,2020,Q3,Elderly
182848701,18284870,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,PK-PRINSTON PHARMACEUTICAL INC.-2020PRN00310,PRINSTON PHARMACEUTICAL,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200918.0,,HP,PK,PK,2020,Q3,Adult
182848701,18284870,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200909.0,20200918,20200918,EXP,,PK-PRINSTON PHARMACEUTICAL INC.-2020PRN00310,PRINSTON PHARMACEUTICAL,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200918.0,,HP,PK,PK,2020,Q3,Adult
182859631,18285963,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?14?0, AMPOULES",,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200910.0,20200919,20200919,EXP,DE-BFARM-20009871,DE-ACCORD-201783,ACCORD,,71.0,YR,E,M,Y,,,20200919.0,,MD,DE,DE,2020,Q3,Elderly
182859631,18285963,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?14?0, AMPOULES",,,,,,,,,,,,2020,Q3,Haematochezia,,2020,Q3,1,I,,20200910.0,20200919,20200919,EXP,DE-BFARM-20009871,DE-ACCORD-201783,ACCORD,,71.0,YR,E,M,Y,,,20200919.0,,MD,DE,DE,2020,Q3,Elderly
182863721,18286372,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?14?0, AMPULLEN",,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200914.0,20200920,20200920,EXP,,NVSC2020DE252580,NOVARTIS,,71.0,YR,,M,Y,,,20200920.0,,HP,DE,DE,2020,Q3,Elderly
182863721,18286372,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?14?0, AMPULLEN",,,U,,,,,,,,,2020,Q3,Haematochezia,,2020,Q3,1,I,,20200914.0,20200920,20200920,EXP,,NVSC2020DE252580,NOVARTIS,,71.0,YR,,M,Y,,,20200920.0,,HP,DE,DE,2020,Q3,Elderly
182878741,18287874,1,PS,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,D, OF6833A,20221031.0,,0.5,ML,,BID,2020,Q3,Injection site pain,,2020,Q3,1,I,20200918.0,,20200918,20200918,DIR,,,FDA-CTU,,54.0,YR,,M,N,117.9,KG,20200918.0,N,PH,US,US,2020,Q3,Adult
182878741,18287874,1,PS,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,D, OF6833A,20221031.0,,0.5,ML,,BID,2020,Q3,Product quality issue,,2020,Q3,1,I,20200918.0,,20200918,20200918,DIR,,,FDA-CTU,,54.0,YR,,M,N,117.9,KG,20200918.0,N,PH,US,US,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Anaemia macrocytic,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Duodenal ulcer,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Gastritis erosive,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Hepatic failure,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Nausea,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Vomiting,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888301,18288830,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, QD, AMPOULE",,,U,,,,,,,,QD,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200914.0,20200921,20200921,EXP,,NVSC2020DE250564,NOVARTIS,,64.0,YR,,F,Y,,,20200921.0,,HP,DE,DE,2020,Q3,Adult
182888791,18288879,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,DE-BFARM-20009900,DE-ACCORD-201511,ACCORD,,76.0,YR,E,M,Y,110.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182888791,18288879,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,DE-BFARM-20009900,DE-ACCORD-201511,ACCORD,,76.0,YR,E,M,Y,110.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182888791,18288879,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Arrhythmia,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,DE-BFARM-20009900,DE-ACCORD-201511,ACCORD,,76.0,YR,E,M,Y,110.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182888791,18288879,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,DE-BFARM-20009900,DE-ACCORD-201511,ACCORD,,76.0,YR,E,M,Y,110.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182888791,18288879,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,DE-BFARM-20009900,DE-ACCORD-201511,ACCORD,,76.0,YR,E,M,Y,110.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182888791,18288879,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IU, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,DE-BFARM-20009900,DE-ACCORD-201511,ACCORD,,76.0,YR,E,M,Y,110.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182901031,18290103,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 I.U., 6 IN THE NIGHT, VIAL",,,U,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,,20200916.0,20200921,20200921,EXP,,DE-009507513-2009DEU006311,MERCK,,84.0,YR,,F,Y,85.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182901031,18290103,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 I.U., 6 IN THE NIGHT, VIAL",,,U,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200916.0,20200921,20200921,EXP,,DE-009507513-2009DEU006311,MERCK,,84.0,YR,,F,Y,85.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182901031,18290103,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 I.U., 6 IN THE NIGHT, VIAL",,,U,,,,,,,,,2020,Q3,Fatigue,,2020,Q3,1,I,,20200916.0,20200921,20200921,EXP,,DE-009507513-2009DEU006311,MERCK,,84.0,YR,,F,Y,85.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182901031,18290103,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 I.U., 6 IN THE NIGHT, VIAL",,,U,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200916.0,20200921,20200921,EXP,,DE-009507513-2009DEU006311,MERCK,,84.0,YR,,F,Y,85.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182901031,18290103,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 I.U., 6 IN THE NIGHT, VIAL",,,U,,,,,,,,,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200916.0,20200921,20200921,EXP,,DE-009507513-2009DEU006311,MERCK,,84.0,YR,,F,Y,85.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182901031,18290103,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 I.U., 6 IN THE NIGHT, VIAL",,,U,,,,,,,,,2020,Q3,Tachypnoea,,2020,Q3,1,I,,20200916.0,20200921,20200921,EXP,,DE-009507513-2009DEU006311,MERCK,,84.0,YR,,F,Y,85.0,KG,20200921.0,,PH,DE,DE,2020,Q3,Elderly
182908441,18290844,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,8.0,IU,,QD,2020,Q3,Confusional state,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005181,ELI LILLY AND CO,,93.0,YR,,F,Y,,,20200921.0,,MD,DE,DE,2020,Q3,Elderly
182908441,18290844,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,8.0,IU,,QD,2020,Q3,Disorientation,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005181,ELI LILLY AND CO,,93.0,YR,,F,Y,,,20200921.0,,MD,DE,DE,2020,Q3,Elderly
182908441,18290844,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,8.0,IU,,QD,2020,Q3,Fall,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005181,ELI LILLY AND CO,,93.0,YR,,F,Y,,,20200921.0,,MD,DE,DE,2020,Q3,Elderly
182908441,18290844,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,8.0,IU,,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005181,ELI LILLY AND CO,,93.0,YR,,F,Y,,,20200921.0,,MD,DE,DE,2020,Q3,Elderly
182908441,18290844,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,8.0,IU,,QD,2020,Q3,Loss of consciousness,,2020,Q3,1,I,,20200910.0,20200921,20200921,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005181,ELI LILLY AND CO,,93.0,YR,,F,Y,,,20200921.0,,MD,DE,DE,2020,Q3,Elderly
182916452,18291645,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (UNK IU AS PER SCHEME),,,,,,,,,,,,2020,Q3,Abdominal pain,,2020,Q3,2,F,20200809.0,20200928.0,20200921,20200928,EXP,DE-ADRED-05537-01,DE-PFIZER INC-2020362447,PFIZER,,76.0,YR,,M,Y,110.0,KG,20200928.0,,PH,DE,DE,2020,Q3,Elderly
182916452,18291645,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (UNK IU AS PER SCHEME),,,,,,,,,,,,2020,Q3,Abdominal pain upper,,2020,Q3,2,F,20200809.0,20200928.0,20200921,20200928,EXP,DE-ADRED-05537-01,DE-PFIZER INC-2020362447,PFIZER,,76.0,YR,,M,Y,110.0,KG,20200928.0,,PH,DE,DE,2020,Q3,Elderly
182916452,18291645,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (UNK IU AS PER SCHEME),,,,,,,,,,,,2020,Q3,Arrhythmia,,2020,Q3,2,F,20200809.0,20200928.0,20200921,20200928,EXP,DE-ADRED-05537-01,DE-PFIZER INC-2020362447,PFIZER,,76.0,YR,,M,Y,110.0,KG,20200928.0,,PH,DE,DE,2020,Q3,Elderly
182916452,18291645,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (UNK IU AS PER SCHEME),,,,,,,,,,,,2020,Q3,Death,,2020,Q3,2,F,20200809.0,20200928.0,20200921,20200928,EXP,DE-ADRED-05537-01,DE-PFIZER INC-2020362447,PFIZER,,76.0,YR,,M,Y,110.0,KG,20200928.0,,PH,DE,DE,2020,Q3,Elderly
182916452,18291645,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (UNK IU AS PER SCHEME),,,,,,,,,,,,2020,Q3,Diarrhoea,,2020,Q3,2,F,20200809.0,20200928.0,20200921,20200928,EXP,DE-ADRED-05537-01,DE-PFIZER INC-2020362447,PFIZER,,76.0,YR,,M,Y,110.0,KG,20200928.0,,PH,DE,DE,2020,Q3,Elderly
182916452,18291645,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (UNK IU AS PER SCHEME),,,,,,,,,,,,2020,Q3,Nausea,,2020,Q3,2,F,20200809.0,20200928.0,20200921,20200928,EXP,DE-ADRED-05537-01,DE-PFIZER INC-2020362447,PFIZER,,76.0,YR,,M,Y,110.0,KG,20200928.0,,PH,DE,DE,2020,Q3,Elderly
182916452,18291645,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (UNK IU AS PER SCHEME),,,,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,2,F,20200809.0,20200928.0,20200921,20200928,EXP,DE-ADRED-05537-01,DE-PFIZER INC-2020362447,PFIZER,,76.0,YR,,M,Y,110.0,KG,20200928.0,,PH,DE,DE,2020,Q3,Elderly
182916791,18291679,10,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200831.0,20200914.0,20200922,20200922,EXP,,US-BAXTER-2020BAX019200,BAXTER,,67.0,YR,,F,Y,47.4,KG,20200922.0,,MD,US,US,2020,Q3,Elderly
182919571,18291957,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,PK-ORCHID HEALTHCARE-2091005,ORCHID,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020 AUG 14.",42.0,YR,,M,Y,,,20200922.0,,MD,PK,PK,2020,Q3,Adult
182919571,18291957,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,PK-ORCHID HEALTHCARE-2091005,ORCHID,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020 AUG 14.",42.0,YR,,M,Y,,,20200922.0,,MD,PK,PK,2020,Q3,Adult
182919571,18291957,3,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,U,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,PK-ORCHID HEALTHCARE-2091005,ORCHID,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020 AUG 14.",42.0,YR,,M,Y,,,20200922.0,,MD,PK,PK,2020,Q3,Adult
182928471,18292847,14,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,1,I,20200916.0,,20200921,20200921,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.08,KG,20200921.0,N,PH,US,US,2020,Q3,Adult
182928471,18292847,14,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Blood lactate dehydrogenase increased,,2020,Q3,1,I,20200916.0,,20200921,20200921,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.08,KG,20200921.0,N,PH,US,US,2020,Q3,Adult
182928471,18292847,14,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Haptoglobin decreased,,2020,Q3,1,I,20200916.0,,20200921,20200921,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.08,KG,20200921.0,N,PH,US,US,2020,Q3,Adult
182928471,18292847,14,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Reticulocyte count increased,,2020,Q3,1,I,20200916.0,,20200921,20200921,DIR,,,FDA-CTU,,47.0,YR,,F,N,85.08,KG,20200921.0,N,PH,US,US,2020,Q3,Adult
182945501,18294550,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,PK-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00286,JUBILANT,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182945501,18294550,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,PK-JUBILANT CADISTA PHARMACEUTICALS-2020JUB00286,JUBILANT,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182967231,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200917.0,20200922,20200922,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20200922.0,,MD,DE,DE,2020,Q3,Adult
182967231,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2020,Q3,Anaemia macrocytic,,2020,Q3,1,I,,20200917.0,20200922,20200922,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20200922.0,,MD,DE,DE,2020,Q3,Adult
182967231,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2020,Q3,Circulatory collapse,,2020,Q3,1,I,,20200917.0,20200922,20200922,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20200922.0,,MD,DE,DE,2020,Q3,Adult
182967231,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2020,Q3,Contusion,,2020,Q3,1,I,,20200917.0,20200922,20200922,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20200922.0,,MD,DE,DE,2020,Q3,Adult
182967231,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2020,Q3,Dizziness,,2020,Q3,1,I,,20200917.0,20200922,20200922,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20200922.0,,MD,DE,DE,2020,Q3,Adult
182967231,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2020,Q3,Hepatic failure,,2020,Q3,1,I,,20200917.0,20200922,20200922,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20200922.0,,MD,DE,DE,2020,Q3,Adult
182967231,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2020,Q3,Liver function test increased,,2020,Q3,1,I,,20200917.0,20200922,20200922,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20200922.0,,MD,DE,DE,2020,Q3,Adult
182967231,18296723,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"24 IU, 1X/DAY 0?1?0?0 INJECTION / INFUSION SOLUTION",,,,,,,,24.0,IU,,QD,2020,Q3,White blood cell count decreased,,2020,Q3,1,I,,20200917.0,20200922,20200922,EXP,DE-ADRED-04739-03,DE-PFIZER INC-2020362521,PFIZER,,64.0,YR,,F,Y,,,20200922.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Abdominal pain,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Abdominal pain upper,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Anaemia macrocytic,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Duodenal ulcer,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Gastritis erosive,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,General physical health deterioration,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Hepatic function abnormal,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Nausea,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Product prescribing error,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Vomiting,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967322,18296732,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IU, 1X /DAY, 0?1?0?0, VIALS",,,,,,,,24.0,IU,,QD,2020,Q3,Weight decreased,,2020,Q3,2,F,,20200928.0,20200922,20200929,EXP,DE-ADRED-04739-04,DE-PFIZER INC-2020362098,PFIZER,,64.0,YR,,F,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
182967911,18296791,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,"PK-OXFORD PHARMACEUTICALS, LLC-2020OXF00110",OXFORD PHARMACEUTICALS,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182967911,18296791,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,"PK-OXFORD PHARMACEUTICALS, LLC-2020OXF00110",OXFORD PHARMACEUTICALS,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182968791,18296879,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,"PK-VIRTUS PHARMACEUTICALS, LLC-2020VTS00067",VIRTUS PHARMACEUTICALS,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182968791,18296879,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200909.0,20200922,20200922,EXP,,"PK-VIRTUS PHARMACEUTICALS, LLC-2020VTS00067",VIRTUS PHARMACEUTICALS,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020",42.0,YR,,M,Y,,,20200922.0,,HP,PK,PK,2020,Q3,Adult
182970811,18297081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE, 0?0?1?0, AMPOULES",,,,,,,,,,UNKNOWN,,2020,Q3,Abdominal distension,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,DE-FRESENIUS KABI-FK202009680,FRESENIUS KABI,,73.0,YR,,M,Y,69.0,KG,20200922.0,,HP,NL,DE,2020,Q3,Elderly
182970811,18297081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE, 0?0?1?0, AMPOULES",,,,,,,,,,UNKNOWN,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,DE-FRESENIUS KABI-FK202009680,FRESENIUS KABI,,73.0,YR,,M,Y,69.0,KG,20200922.0,,HP,NL,DE,2020,Q3,Elderly
182970811,18297081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE, 0?0?1?0, AMPOULES",,,,,,,,,,UNKNOWN,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,DE-FRESENIUS KABI-FK202009680,FRESENIUS KABI,,73.0,YR,,M,Y,69.0,KG,20200922.0,,HP,NL,DE,2020,Q3,Elderly
182970811,18297081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE, 0?0?1?0, AMPOULES",,,,,,,,,,UNKNOWN,,2020,Q3,Haematemesis,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,DE-FRESENIUS KABI-FK202009680,FRESENIUS KABI,,73.0,YR,,M,Y,69.0,KG,20200922.0,,HP,NL,DE,2020,Q3,Elderly
182970811,18297081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE, 0?0?1?0, AMPOULES",,,,,,,,,,UNKNOWN,,2020,Q3,Mucosal haemorrhage,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,DE-FRESENIUS KABI-FK202009680,FRESENIUS KABI,,73.0,YR,,M,Y,69.0,KG,20200922.0,,HP,NL,DE,2020,Q3,Elderly
182970811,18297081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE, 0?0?1?0, AMPOULES",,,,,,,,,,UNKNOWN,,2020,Q3,Nausea,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,DE-FRESENIUS KABI-FK202009680,FRESENIUS KABI,,73.0,YR,,M,Y,69.0,KG,20200922.0,,HP,NL,DE,2020,Q3,Elderly
182970811,18297081,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 IE, 0?0?1?0, AMPOULES",,,,,,,,,,UNKNOWN,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200916.0,20200922,20200922,EXP,,DE-FRESENIUS KABI-FK202009680,FRESENIUS KABI,,73.0,YR,,M,Y,69.0,KG,20200922.0,,HP,NL,DE,2020,Q3,Elderly
182995581,18299558,48,C,INSULIN GLARGINE (GENETICAL RECOMBINATION),INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Angina unstable,,2020,Q3,1,I,202008.0,20200917.0,20200923,20200923,EXP,,JP-GLAXOSMITHKLINE-JP2020JPN188231,GLAXOSMITHKLINE,,47.0,YR,,M,Y,95.0,KG,20200923.0,,CN,JP,JP,2020,Q3,Adult
182995781,18299578,13,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200911.0,,20200922,20200922,DIR,,,FDA-CTU,,61.0,YR,,M,N,121.8,KG,20200922.0,Y,PH,US,US,2020,Q3,Adult
182995781,18299578,13,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Haemodialysis,,2020,Q3,1,I,20200911.0,,20200922,20200922,DIR,,,FDA-CTU,,61.0,YR,,M,N,121.8,KG,20200922.0,Y,PH,US,US,2020,Q3,Adult
182995781,18299578,13,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Multiple organ dysfunction syndrome,,2020,Q3,1,I,20200911.0,,20200922,20200922,DIR,,,FDA-CTU,,61.0,YR,,M,N,121.8,KG,20200922.0,Y,PH,US,US,2020,Q3,Adult
182995781,18299578,13,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Palliative care,,2020,Q3,1,I,20200911.0,,20200922,20200922,DIR,,,FDA-CTU,,61.0,YR,,M,N,121.8,KG,20200922.0,Y,PH,US,US,2020,Q3,Adult
182995781,18299578,13,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,SARS-CoV-2 test positive,,2020,Q3,1,I,20200911.0,,20200922,20200922,DIR,,,FDA-CTU,,61.0,YR,,M,N,121.8,KG,20200922.0,Y,PH,US,US,2020,Q3,Adult
182995781,18299578,13,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,20200911.0,,20200922,20200922,DIR,,,FDA-CTU,,61.0,YR,,M,N,121.8,KG,20200922.0,Y,PH,US,US,2020,Q3,Adult
182995781,18299578,13,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Transaminases increased,,2020,Q3,1,I,20200911.0,,20200922,20200922,DIR,,,FDA-CTU,,61.0,YR,,M,N,121.8,KG,20200922.0,Y,PH,US,US,2020,Q3,Adult
183009491,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200914.0,20200923,20200923,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20200923.0,,HP,DE,DE,2020,Q3,Adult
183009491,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2020,Q3,Anaemia macrocytic,,2020,Q3,1,I,,20200914.0,20200923,20200923,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20200923.0,,HP,DE,DE,2020,Q3,Adult
183009491,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2020,Q3,Circulatory collapse,,2020,Q3,1,I,,20200914.0,20200923,20200923,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20200923.0,,HP,DE,DE,2020,Q3,Adult
183009491,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2020,Q3,Contusion,,2020,Q3,1,I,,20200914.0,20200923,20200923,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20200923.0,,HP,DE,DE,2020,Q3,Adult
183009491,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2020,Q3,Dizziness,,2020,Q3,1,I,,20200914.0,20200923,20200923,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20200923.0,,HP,DE,DE,2020,Q3,Adult
183009491,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2020,Q3,Hepatic failure,,2020,Q3,1,I,,20200914.0,20200923,20200923,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20200923.0,,HP,DE,DE,2020,Q3,Adult
183009491,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2020,Q3,Liver function test increased,,2020,Q3,1,I,,20200914.0,20200923,20200923,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20200923.0,,HP,DE,DE,2020,Q3,Adult
183009491,18300949,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"24 IU, QD (0?1?0?0), INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,24.0,IU,,QD,2020,Q3,White blood cell count decreased,,2020,Q3,1,I,,20200914.0,20200923,20200923,EXP,,NVSC2020DE253542,NOVARTIS,,64.0,YR,,F,Y,,,20200923.0,,HP,DE,DE,2020,Q3,Adult
183023171,18302317,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,,QD,2020,Q3,Abdominal distension,,2020,Q3,1,I,,20200910.0,20200923,20200923,PER,DE-ADRED-05546-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2020-00293,SHILPA MEDICARE,,73.0,YR,E,M,Y,69.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183023171,18302317,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,,QD,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200910.0,20200923,20200923,PER,DE-ADRED-05546-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2020-00293,SHILPA MEDICARE,,73.0,YR,E,M,Y,69.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183023171,18302317,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,,QD,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200910.0,20200923,20200923,PER,DE-ADRED-05546-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2020-00293,SHILPA MEDICARE,,73.0,YR,E,M,Y,69.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183023171,18302317,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,,QD,2020,Q3,Haematemesis,,2020,Q3,1,I,,20200910.0,20200923,20200923,PER,DE-ADRED-05546-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2020-00293,SHILPA MEDICARE,,73.0,YR,E,M,Y,69.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183023171,18302317,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,,QD,2020,Q3,Mucosal haemorrhage,,2020,Q3,1,I,,20200910.0,20200923,20200923,PER,DE-ADRED-05546-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2020-00293,SHILPA MEDICARE,,73.0,YR,E,M,Y,69.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183023171,18302317,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,,QD,2020,Q3,Nausea,,2020,Q3,1,I,,20200910.0,20200923,20200923,PER,DE-ADRED-05546-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2020-00293,SHILPA MEDICARE,,73.0,YR,E,M,Y,69.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183023171,18302317,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,,QD,2020,Q3,Vomiting,,2020,Q3,1,I,,20200910.0,20200923,20200923,PER,DE-ADRED-05546-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2020-00293,SHILPA MEDICARE,,73.0,YR,E,M,Y,69.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183029411,18302941,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20200911.0,20200922.0,20200923,20200923,EXP,,US-GILEAD-2020-0496065,GILEAD,,61.0,YR,A,M,Y,121.8,KG,20200923.0,,PH,US,US,2020,Q3,Adult
183044511,18304451,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,6.0,IU,,QD,2020,Q3,Cough,,2020,Q3,1,I,,20200911.0,20200923,20200923,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005720,ELI LILLY AND CO,,84.0,YR,,F,Y,85.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183044511,18304451,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,6.0,IU,,QD,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200911.0,20200923,20200923,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005720,ELI LILLY AND CO,,84.0,YR,,F,Y,85.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183044511,18304451,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,6.0,IU,,QD,2020,Q3,Fatigue,,2020,Q3,1,I,,20200911.0,20200923,20200923,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005720,ELI LILLY AND CO,,84.0,YR,,F,Y,85.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183044511,18304451,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,6.0,IU,,QD,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200911.0,20200923,20200923,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005720,ELI LILLY AND CO,,84.0,YR,,F,Y,85.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183044511,18304451,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,6.0,IU,,QD,2020,Q3,Pyrexia,,2020,Q3,1,I,,20200911.0,20200923,20200923,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005720,ELI LILLY AND CO,,84.0,YR,,F,Y,85.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183044511,18304451,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, DAILY",,,U,,,,205692.0,6.0,IU,,QD,2020,Q3,Tachypnoea,,2020,Q3,1,I,,20200911.0,20200923,20200923,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202009005720,ELI LILLY AND CO,,84.0,YR,,F,Y,85.0,KG,20200923.0,,PH,DE,DE,2020,Q3,Elderly
183053951,18305395,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2020,Q3,Eosinophilia,,2020,Q3,1,I,20200808.0,20200911.0,20200924,20200924,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20200924.0,,HP,NL,FR,2020,Q3,Elderly
183053951,18305395,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2020,Q3,Hepatocellular injury,,2020,Q3,1,I,20200808.0,20200911.0,20200924,20200924,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20200924.0,,HP,NL,FR,2020,Q3,Elderly
183053951,18305395,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2020,Q3,Hypercreatininaemia,,2020,Q3,1,I,20200808.0,20200911.0,20200924,20200924,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20200924.0,,HP,NL,FR,2020,Q3,Elderly
183053951,18305395,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2020,Q3,Rash maculo-papular,,2020,Q3,1,I,20200808.0,20200911.0,20200924,20200924,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20200924.0,,HP,NL,FR,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Acute respiratory distress syndrome,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Atrial fibrillation,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Blood albumin increased,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Blood glucose increased,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Blood urea increased,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Breast cancer metastatic,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Cough,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Death,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Decreased appetite,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Diaphragmatic paralysis,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Fatigue,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Haemoglobin decreased,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Herpes simplex,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Illness,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Infection,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Malignant neoplasm progression,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Metastases to central nervous system,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Mouth ulceration,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Oral infection,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Oral pain,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Oxygen consumption increased,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Phrenic nerve paralysis,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Polyuria,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Respiratory disorder,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Septic shock,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Somnolence,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Tachypnoea,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061291,18306129,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,1,I,20180918.0,20200918.0,20200924,20200924,EXP,,NVSC2020US256484,NOVARTIS,,74.0,YR,,F,Y,64.85,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183061352,18306135,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q3,Nephropathy,,2020,Q3,2,F,20200914.0,20200925.0,20200924,20200930,EXP,,NVSC2020RU252695,NOVARTIS,,30.0,YR,,M,Y,69.0,KG,20200930.0,,MD,RU,RU,2020,Q3,Young Adult
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Bedridden,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Constipation,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Contraindicated product administered,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Drug clearance decreased,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,International normalised ratio increased,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Overdose,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Product administration error,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Product name confusion,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Rhabdomyolysis,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183064011,18306401,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,44.0,IU,,,2020,Q3,Toxicity to various agents,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,CZ-EMA-DD-20200915-ABDUL_J-115130,CZ-ACCORD-202142,ACCORD,,74.0,YR,,M,Y,,,20200924.0,,HP,CZ,CZ,2020,Q3,Elderly
183066421,18306642,3,C,insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200910.0,20200924,20200924,EXP,,PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-262011,RANBAXY,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020?1?2",42.0,YR,,M,Y,,,20200924.0,,HP,PK,PK,2020,Q3,Adult
183066421,18306642,3,C,insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200910.0,20200924,20200924,EXP,,PK-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-262011,RANBAXY,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE. AM J THER. 2020?1?2",42.0,YR,,M,Y,,,20200924.0,,HP,PK,PK,2020,Q3,Adult
183076031,18307603,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200914.0,20200924,20200924,EXP,DE-ADRED-05580-01,DE-009507513-2009DEU005362,MERCK,,62.0,YR,,M,Y,,,20200924.0,,MD,DE,DE,2020,Q3,Adult
183076031,18307603,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200914.0,20200924,20200924,EXP,DE-ADRED-05580-01,DE-009507513-2009DEU005362,MERCK,,62.0,YR,,M,Y,,,20200924.0,,MD,DE,DE,2020,Q3,Adult
183076031,18307603,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,,,,,,,,,,2020,Q3,Dry skin,,2020,Q3,1,I,,20200914.0,20200924,20200924,EXP,DE-ADRED-05580-01,DE-009507513-2009DEU005362,MERCK,,62.0,YR,,M,Y,,,20200924.0,,MD,DE,DE,2020,Q3,Adult
183076031,18307603,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,,,,,,,,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,,20200914.0,20200924,20200924,EXP,DE-ADRED-05580-01,DE-009507513-2009DEU005362,MERCK,,62.0,YR,,M,Y,,,20200924.0,,MD,DE,DE,2020,Q3,Adult
183076031,18307603,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200914.0,20200924,20200924,EXP,DE-ADRED-05580-01,DE-009507513-2009DEU005362,MERCK,,62.0,YR,,M,Y,,,20200924.0,,MD,DE,DE,2020,Q3,Adult
183076031,18307603,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,,,,,,,,,,2020,Q3,Rash,,2020,Q3,1,I,,20200914.0,20200924,20200924,EXP,DE-ADRED-05580-01,DE-009507513-2009DEU005362,MERCK,,62.0,YR,,M,Y,,,20200924.0,,MD,DE,DE,2020,Q3,Adult
183080511,18308051,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK UNK, UNKNOWN",,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200831.0,20200914.0,20200924,20200924,EXP,,US-ENDO PHARMACEUTICALS INC-2020-006195,ENDO,,67.0,YR,,F,Y,47.39,KG,20200924.0,,CN,US,US,2020,Q3,Elderly
183082021,18308202,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,UNKNOWN,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,,DE-FRESENIUS KABI-FK202009735,FRESENIUS KABI,,47.0,YR,,F,Y,45.0,KG,20200924.0,,HP,NL,DE,2020,Q3,Adult
183082021,18308202,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,UNKNOWN,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,,DE-FRESENIUS KABI-FK202009735,FRESENIUS KABI,,47.0,YR,,F,Y,45.0,KG,20200924.0,,HP,NL,DE,2020,Q3,Adult
183082021,18308202,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,UNKNOWN,,2020,Q3,Dysphagia,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,,DE-FRESENIUS KABI-FK202009735,FRESENIUS KABI,,47.0,YR,,F,Y,45.0,KG,20200924.0,,HP,NL,DE,2020,Q3,Adult
183082021,18308202,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,UNKNOWN,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,,DE-FRESENIUS KABI-FK202009735,FRESENIUS KABI,,47.0,YR,,F,Y,45.0,KG,20200924.0,,HP,NL,DE,2020,Q3,Adult
183082021,18308202,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,UNKNOWN,,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,,DE-FRESENIUS KABI-FK202009735,FRESENIUS KABI,,47.0,YR,,F,Y,45.0,KG,20200924.0,,HP,NL,DE,2020,Q3,Adult
183082021,18308202,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,UNKNOWN,,2020,Q3,Thirst,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,,DE-FRESENIUS KABI-FK202009735,FRESENIUS KABI,,47.0,YR,,F,Y,45.0,KG,20200924.0,,HP,NL,DE,2020,Q3,Adult
183082021,18308202,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,UNKNOWN,,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200916.0,20200924,20200924,EXP,,DE-FRESENIUS KABI-FK202009735,FRESENIUS KABI,,47.0,YR,,F,Y,45.0,KG,20200924.0,,HP,NL,DE,2020,Q3,Adult
183105172,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,D,,,,,,,INJECTION,QD,2020,Q3,Cardiac dysfunction,,2020,Q3,2,F,20200729.0,20200925.0,20200924,20200928,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20200928.0,,MD,CN,CN,2020,Q3,Adult
183105172,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,D,,,,,,,INJECTION,QD,2020,Q3,Chest discomfort,,2020,Q3,2,F,20200729.0,20200925.0,20200924,20200928,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20200928.0,,MD,CN,CN,2020,Q3,Adult
183105172,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,D,,,,,,,INJECTION,QD,2020,Q3,Coronary artery disease,,2020,Q3,2,F,20200729.0,20200925.0,20200924,20200928,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20200928.0,,MD,CN,CN,2020,Q3,Adult
183105172,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,D,,,,,,,INJECTION,QD,2020,Q3,Discomfort,,2020,Q3,2,F,20200729.0,20200925.0,20200924,20200928,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20200928.0,,MD,CN,CN,2020,Q3,Adult
183105172,18310517,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 UNK, QD(14 UNITS QN)",,,D,,,,,,,INJECTION,QD,2020,Q3,Myocardial infarction,,2020,Q3,2,F,20200729.0,20200925.0,20200924,20200928,EXP,,NVSC2020CN259632,NOVARTIS,,48.0,YR,,M,Y,72.0,KG,20200928.0,,MD,CN,CN,2020,Q3,Adult
183109741,18310974,1,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q3,Dizziness,,2020,Q3,1,I,20190820.0,20190823.0,20200925,20200925,EXP,,US-ALVOGEN-2020-ALVOGEN-113206,ALVOGEN,,63.0,YR,,F,Y,86.17,KG,20200925.0,,MD,US,US,2020,Q3,Adult
183109741,18310974,1,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q3,Feeling abnormal,,2020,Q3,1,I,20190820.0,20190823.0,20200925,20200925,EXP,,US-ALVOGEN-2020-ALVOGEN-113206,ALVOGEN,,63.0,YR,,F,Y,86.17,KG,20200925.0,,MD,US,US,2020,Q3,Adult
183109741,18310974,1,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q3,Product use in unapproved indication,,2020,Q3,1,I,20190820.0,20190823.0,20200925,20200925,EXP,,US-ALVOGEN-2020-ALVOGEN-113206,ALVOGEN,,63.0,YR,,F,Y,86.17,KG,20200925.0,,MD,US,US,2020,Q3,Adult
183123801,18312380,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Atrioventricular block first degree,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,US-MYLANLABS-2020M1081402,MYLAN,"GOLDBERGER D, WEISS S, SACKS O. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLIN?TOXICOL?(PHILA) 2020?58(6):626 ABSTR. 261.",74.0,YR,,F,Y,,,20200925.0,,HP,US,US,2020,Q3,Elderly
183123801,18312380,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Atrioventricular block second degree,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,US-MYLANLABS-2020M1081402,MYLAN,"GOLDBERGER D, WEISS S, SACKS O. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLIN?TOXICOL?(PHILA) 2020?58(6):626 ABSTR. 261.",74.0,YR,,F,Y,,,20200925.0,,HP,US,US,2020,Q3,Elderly
183123801,18312380,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Bezoar,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,US-MYLANLABS-2020M1081402,MYLAN,"GOLDBERGER D, WEISS S, SACKS O. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLIN?TOXICOL?(PHILA) 2020?58(6):626 ABSTR. 261.",74.0,YR,,F,Y,,,20200925.0,,HP,US,US,2020,Q3,Elderly
183123801,18312380,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,US-MYLANLABS-2020M1081402,MYLAN,"GOLDBERGER D, WEISS S, SACKS O. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLIN?TOXICOL?(PHILA) 2020?58(6):626 ABSTR. 261.",74.0,YR,,F,Y,,,20200925.0,,HP,US,US,2020,Q3,Elderly
183123801,18312380,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Intentional overdose,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,US-MYLANLABS-2020M1081402,MYLAN,"GOLDBERGER D, WEISS S, SACKS O. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLIN?TOXICOL?(PHILA) 2020?58(6):626 ABSTR. 261.",74.0,YR,,F,Y,,,20200925.0,,HP,US,US,2020,Q3,Elderly
183123801,18312380,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Pulseless electrical activity,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,US-MYLANLABS-2020M1081402,MYLAN,"GOLDBERGER D, WEISS S, SACKS O. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLIN?TOXICOL?(PHILA) 2020?58(6):626 ABSTR. 261.",74.0,YR,,F,Y,,,20200925.0,,HP,US,US,2020,Q3,Elderly
183123801,18312380,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Somnolence,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,US-MYLANLABS-2020M1081402,MYLAN,"GOLDBERGER D, WEISS S, SACKS O. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLIN?TOXICOL?(PHILA) 2020?58(6):626 ABSTR. 261.",74.0,YR,,F,Y,,,20200925.0,,HP,US,US,2020,Q3,Elderly
183123801,18312380,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,US-MYLANLABS-2020M1081402,MYLAN,"GOLDBERGER D, WEISS S, SACKS O. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLIN?TOXICOL?(PHILA) 2020?58(6):626 ABSTR. 261.",74.0,YR,,F,Y,,,20200925.0,,HP,US,US,2020,Q3,Elderly
183129201,18312920,16,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Liver function test increased,,2020,Q3,1,I,20200925.0,,20200925,20200925,DIR,,,FDA-CTU,,87.0,YR,,M,N,80.3,KG,20200925.0,N,PH,US,US,2020,Q3,Elderly
183131081,18313108,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,UNKNOWN,,2020,Q3,Abdominal distension,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52144,HIKMA,,73.0,YR,,M,Y,69.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Elderly
183131081,18313108,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,UNKNOWN,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52144,HIKMA,,73.0,YR,,M,Y,69.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Elderly
183131081,18313108,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,UNKNOWN,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52144,HIKMA,,73.0,YR,,M,Y,69.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Elderly
183131081,18313108,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,UNKNOWN,,2020,Q3,Haematemesis,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52144,HIKMA,,73.0,YR,,M,Y,69.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Elderly
183131081,18313108,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,UNKNOWN,,2020,Q3,Mucosal haemorrhage,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52144,HIKMA,,73.0,YR,,M,Y,69.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Elderly
183131081,18313108,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,UNKNOWN,,2020,Q3,Nausea,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52144,HIKMA,,73.0,YR,,M,Y,69.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Elderly
183131081,18313108,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,4.0,IU,UNKNOWN,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200916.0,20200925,20200925,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-20-52144,HIKMA,,73.0,YR,,M,Y,69.0,KG,20200925.0,,PH,DE,DE,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Aortic valve incompetence,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Asthenia,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Cardiac index decreased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Decreased appetite,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Dysarthria,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Fall,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Femur fracture,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Haematoma,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Haemoglobin decreased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Hypersomnia,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Hypotension,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Klebsiella test positive,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Lethargy,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Liver function test abnormal,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Liver function test increased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Muscle strain,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Pain in extremity,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Peripheral swelling,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Renal disorder,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Retroperitoneal haemorrhage,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Skin laceration,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Therapy non-responder,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Urinary retention,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Urinary tract infection,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Urosepsis,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,Weight decreased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183142571,18314257,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 U/ML, QD",,,,,,,,300.0,IU,,QD,2020,Q3,White blood cell count increased,,2020,Q3,1,I,2020.0,20200227.0,20200925,20200925,EXP,,US-JNJFOC-A-US2020-202748,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,105.78,KG,20200925.0,,HP,US,US,2020,Q3,Elderly
183150831,18315083,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IU, ACCORDING TO PLAN, AMPOULES",,,,,,,,,,,,2020,Q3,Anaemia,,2020,Q3,1,I,,20200917.0,20200926,20200926,EXP,,DE-TEVA-2020-DE-1830685,TEVA,,85.0,YR,E,M,Y,,,20200926.0,,MD,DE,DE,2020,Q3,Elderly
183150831,18315083,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IU, ACCORDING TO PLAN, AMPOULES",,,,,,,,,,,,2020,Q3,Angina pectoris,,2020,Q3,1,I,,20200917.0,20200926,20200926,EXP,,DE-TEVA-2020-DE-1830685,TEVA,,85.0,YR,E,M,Y,,,20200926.0,,MD,DE,DE,2020,Q3,Elderly
183150831,18315083,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IU, ACCORDING TO PLAN, AMPOULES",,,,,,,,,,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200917.0,20200926,20200926,EXP,,DE-TEVA-2020-DE-1830685,TEVA,,85.0,YR,E,M,Y,,,20200926.0,,MD,DE,DE,2020,Q3,Elderly
183150831,18315083,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IU, ACCORDING TO PLAN, AMPOULES",,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200917.0,20200926,20200926,EXP,,DE-TEVA-2020-DE-1830685,TEVA,,85.0,YR,E,M,Y,,,20200926.0,,MD,DE,DE,2020,Q3,Elderly
183150831,18315083,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IU, ACCORDING TO PLAN, AMPOULES",,,,,,,,,,,,2020,Q3,Haematuria,,2020,Q3,1,I,,20200917.0,20200926,20200926,EXP,,DE-TEVA-2020-DE-1830685,TEVA,,85.0,YR,E,M,Y,,,20200926.0,,MD,DE,DE,2020,Q3,Elderly
183150831,18315083,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"100 IU, ACCORDING TO PLAN, AMPOULES",,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200917.0,20200926,20200926,EXP,,DE-TEVA-2020-DE-1830685,TEVA,,85.0,YR,E,M,Y,,,20200926.0,,MD,DE,DE,2020,Q3,Elderly
183162801,18316280,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Depressive symptom,,2020,Q3,1,I,,20200603.0,20200927,20200927,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-02670,LUPIN,,68.0,YR,,M,Y,,,20200927.0,,HP,US,US,2020,Q3,Elderly
183162801,18316280,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Drug ineffective,,2020,Q3,1,I,,20200603.0,20200927,20200927,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-02670,LUPIN,,68.0,YR,,M,Y,,,20200927.0,,HP,US,US,2020,Q3,Elderly
183162801,18316280,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Neutropenia,,2020,Q3,1,I,,20200603.0,20200927,20200927,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-02670,LUPIN,,68.0,YR,,M,Y,,,20200927.0,,HP,US,US,2020,Q3,Elderly
183162801,18316280,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q3,Suicidal ideation,,2020,Q3,1,I,,20200603.0,20200927,20200927,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-02670,LUPIN,,68.0,YR,,M,Y,,,20200927.0,,HP,US,US,2020,Q3,Elderly
183179231,18317923,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2020,Q3,Eosinophilia,,2020,Q3,1,I,20200808.0,20200914.0,20200928,20200928,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20200928.0,,CN,GB,FR,2020,Q3,Elderly
183179231,18317923,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2020,Q3,Hepatocellular injury,,2020,Q3,1,I,20200808.0,20200914.0,20200928,20200928,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20200928.0,,CN,GB,FR,2020,Q3,Elderly
183179231,18317923,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2020,Q3,Hypercreatininaemia,,2020,Q3,1,I,20200808.0,20200914.0,20200928,20200928,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20200928.0,,CN,GB,FR,2020,Q3,Elderly
183179231,18317923,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2020,Q3,Rash maculo-papular,,2020,Q3,1,I,20200808.0,20200914.0,20200928,20200928,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20200928.0,,CN,GB,FR,2020,Q3,Elderly
183208411,18320841,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Confusional state,,2020,Q3,1,I,,20200915.0,20200929,20200929,EXP,,PK-MICRO LABS LIMITED-ML2020-02829,MICRO LABS,"INAYAT F, BOKHARI S, ALMAS T, ROSEN R. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE.. AM?J?THER. 2020?1?2.",42.0,YR,,M,Y,,,20200929.0,,MD,PK,PK,2020,Q3,Adult
183208411,18320841,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Drug interaction,,2020,Q3,1,I,,20200915.0,20200929,20200929,EXP,,PK-MICRO LABS LIMITED-ML2020-02829,MICRO LABS,"INAYAT F, BOKHARI S, ALMAS T, ROSEN R. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE.. AM?J?THER. 2020?1?2.",42.0,YR,,M,Y,,,20200929.0,,MD,PK,PK,2020,Q3,Adult
183208411,18320841,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Seizure,,2020,Q3,1,I,,20200915.0,20200929,20200929,EXP,,PK-MICRO LABS LIMITED-ML2020-02829,MICRO LABS,"INAYAT F, BOKHARI S, ALMAS T, ROSEN R. DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE.. AM?J?THER. 2020?1?2.",42.0,YR,,M,Y,,,20200929.0,,MD,PK,PK,2020,Q3,Adult
183232891,18323289,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DAILY",,,,,,,,,,,QD,2020,Q3,Blood glucose abnormal,,2020,Q3,1,I,,20200923.0,20200929,20200929,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009011471,ELI LILLY AND CO,,62.0,YR,,M,Y,71.0,KG,20200929.0,,CN,CN,CN,2020,Q3,Adult
183232891,18323289,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DAILY",,,,,,,,,,,QD,2020,Q3,Hydronephrosis,,2020,Q3,1,I,,20200923.0,20200929,20200929,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009011471,ELI LILLY AND CO,,62.0,YR,,M,Y,71.0,KG,20200929.0,,CN,CN,CN,2020,Q3,Adult
183232891,18323289,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DAILY",,,,,,,,,,,QD,2020,Q3,Hypophagia,,2020,Q3,1,I,,20200923.0,20200929,20200929,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009011471,ELI LILLY AND CO,,62.0,YR,,M,Y,71.0,KG,20200929.0,,CN,CN,CN,2020,Q3,Adult
183232891,18323289,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, DAILY",,,,,,,,,,,QD,2020,Q3,Injection site pain,,2020,Q3,1,I,,20200923.0,20200929,20200929,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202009011471,ELI LILLY AND CO,,62.0,YR,,M,Y,71.0,KG,20200929.0,,CN,CN,CN,2020,Q3,Adult
183239801,18323980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE, NACH PLAN, AMPULLEN",,,,,,,,100.0,IU,INJECTION,,2020,Q3,Anaemia,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081224,MYLAN,,85.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Elderly
183239801,18323980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE, NACH PLAN, AMPULLEN",,,,,,,,100.0,IU,INJECTION,,2020,Q3,Angina pectoris,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081224,MYLAN,,85.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Elderly
183239801,18323980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE, NACH PLAN, AMPULLEN",,,,,,,,100.0,IU,INJECTION,,2020,Q3,Dyspnoea,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081224,MYLAN,,85.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Elderly
183239801,18323980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE, NACH PLAN, AMPULLEN",,,,,,,,100.0,IU,INJECTION,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081224,MYLAN,,85.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Elderly
183239801,18323980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE, NACH PLAN, AMPULLEN",,,,,,,,100.0,IU,INJECTION,,2020,Q3,Haematuria,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081224,MYLAN,,85.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Elderly
183239801,18323980,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"100 IE, NACH PLAN, AMPULLEN",,,,,,,,100.0,IU,INJECTION,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081224,MYLAN,,85.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Elderly
183240921,18324092,13,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200927.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183240921,18324092,13,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Hypoperfusion,,2020,Q3,1,I,20200927.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183240921,18324092,13,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Hypovolaemia,,2020,Q3,1,I,20200927.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183240921,18324092,13,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Large intestine perforation,,2020,Q3,1,I,20200927.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Acute respiratory failure,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Colectomy,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Ileostomy,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Large intestine perforation,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Pneumonia,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183240991,18324099,12,C,"Insulin (glargine, lispro, and sliding?scale regular)",,2,,,,,,,,,,,,,,2020,Q3,Sepsis,,2020,Q3,1,I,20200926.0,,20200929,20200929,DIR,,,FDA-CTU,,70.0,YR,,M,N,140.0,KG,20200929.0,N,PH,US,US,2020,Q3,Elderly
183242361,18324236,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IE, NACH SCHEMA",,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081276,MYLAN,,47.0,YR,,F,Y,45.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Adult
183242361,18324236,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IE, NACH SCHEMA",,,,,,,,,,,,2020,Q3,Dehydration,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081276,MYLAN,,47.0,YR,,F,Y,45.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Adult
183242361,18324236,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IE, NACH SCHEMA",,,,,,,,,,,,2020,Q3,Dysphagia,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081276,MYLAN,,47.0,YR,,F,Y,45.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Adult
183242361,18324236,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IE, NACH SCHEMA",,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081276,MYLAN,,47.0,YR,,F,Y,45.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Adult
183242361,18324236,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IE, NACH SCHEMA",,,,,,,,,,,,2020,Q3,Oropharyngeal pain,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081276,MYLAN,,47.0,YR,,F,Y,45.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Adult
183242361,18324236,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IE, NACH SCHEMA",,,,,,,,,,,,2020,Q3,Thirst,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081276,MYLAN,,47.0,YR,,F,Y,45.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Adult
183242361,18324236,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"NK IE, NACH SCHEMA",,,,,,,,,,,,2020,Q3,Weight decreased,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081276,MYLAN,,47.0,YR,,F,Y,45.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Adult
183260041,18326004,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081503,MYLAN,,62.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
183260041,18326004,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,,,,,,,,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081503,MYLAN,,62.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
183260041,18326004,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,,,,,,,,,,2020,Q3,Dry skin,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081503,MYLAN,,62.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
183260041,18326004,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,,,,,,,,,,2020,Q3,Dyspnoea exertional,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081503,MYLAN,,62.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
183260041,18326004,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,,,,,,,,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081503,MYLAN,,62.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
183260041,18326004,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,,,,,,,,,,2020,Q3,Rash,,2020,Q3,1,I,,20200921.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1081503,MYLAN,,62.0,YR,,M,Y,,,20200929.0,,MD,DE,DE,2020,Q3,Adult
183263271,18326327,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?8?0, AMPULLEN",,,,,,,,1.0,IU,,,2020,Q3,Condition aggravated,,2020,Q3,1,I,202004.0,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082186,MYLAN,,87.0,YR,,F,Y,,,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183263271,18326327,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?8?0, AMPULLEN",,,,,,,,1.0,IU,,,2020,Q3,Dyspnoea,,2020,Q3,1,I,202004.0,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082186,MYLAN,,87.0,YR,,F,Y,,,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183263271,18326327,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?8?0, AMPULLEN",,,,,,,,1.0,IU,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,202004.0,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082186,MYLAN,,87.0,YR,,F,Y,,,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183263271,18326327,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?8?0, AMPULLEN",,,,,,,,1.0,IU,,,2020,Q3,Oedema peripheral,,2020,Q3,1,I,202004.0,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082186,MYLAN,,87.0,YR,,F,Y,,,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183263271,18326327,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0?0?8?0, AMPULLEN",,,,,,,,1.0,IU,,,2020,Q3,Weight increased,,2020,Q3,1,I,202004.0,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082186,MYLAN,,87.0,YR,,F,Y,,,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183266631,18326663,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, QD, 0?0?1?0, AMPULLEN",,,,,,,,4.0,IU,,QD,2020,Q3,Abdominal distension,,2020,Q3,1,I,,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082060,MYLAN,,73.0,YR,,M,Y,69.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183266631,18326663,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, QD, 0?0?1?0, AMPULLEN",,,,,,,,4.0,IU,,QD,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082060,MYLAN,,73.0,YR,,M,Y,69.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183266631,18326663,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, QD, 0?0?1?0, AMPULLEN",,,,,,,,4.0,IU,,QD,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082060,MYLAN,,73.0,YR,,M,Y,69.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183266631,18326663,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, QD, 0?0?1?0, AMPULLEN",,,,,,,,4.0,IU,,QD,2020,Q3,Haematemesis,,2020,Q3,1,I,,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082060,MYLAN,,73.0,YR,,M,Y,69.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183266631,18326663,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, QD, 0?0?1?0, AMPULLEN",,,,,,,,4.0,IU,,QD,2020,Q3,Mucosal haemorrhage,,2020,Q3,1,I,,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082060,MYLAN,,73.0,YR,,M,Y,69.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183266631,18326663,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, QD, 0?0?1?0, AMPULLEN",,,,,,,,4.0,IU,,QD,2020,Q3,Nausea,,2020,Q3,1,I,,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082060,MYLAN,,73.0,YR,,M,Y,69.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183266631,18326663,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 INTERNATIONAL UNIT, QD, 0?0?1?0, AMPULLEN",,,,,,,,4.0,IU,,QD,2020,Q3,Vomiting,,2020,Q3,1,I,,20200922.0,20200929,20200929,EXP,,DE-MYLANLABS-2020M1082060,MYLAN,,73.0,YR,,M,Y,69.0,KG,20200929.0,,PH,DE,DE,2020,Q3,Elderly
183277451,18327745,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK (NK MG, ACCORDING TO THE SCHEME)",,,,,,,,,,,,2020,Q3,Angina pectoris,,2020,Q3,1,I,,20200923.0,20200930,20200930,EXP,,DE-AUROBINDO-AUR-APL-2020-049765,AUROBINDO,,43.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Adult
183277451,18327745,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK (NK MG, ACCORDING TO THE SCHEME)",,,,,,,,,,,,2020,Q3,Electrolyte imbalance,,2020,Q3,1,I,,20200923.0,20200930,20200930,EXP,,DE-AUROBINDO-AUR-APL-2020-049765,AUROBINDO,,43.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Adult
183277451,18327745,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK (NK MG, ACCORDING TO THE SCHEME)",,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200923.0,20200930,20200930,EXP,,DE-AUROBINDO-AUR-APL-2020-049765,AUROBINDO,,43.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Adult
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Alanine aminotransferase increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Aspartate aminotransferase increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Band neutrophil count increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood bilirubin increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood calcium decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood creatinine increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood glucose decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood magnesium increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood sodium increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Blood urea increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Bradycardia,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Carbon dioxide decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Cardiac disorder,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Dialysis,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Glomerular filtration rate,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Haematocrit decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Haemodialysis,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Haemoglobin decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Hypochromasia,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Hypokalaemia,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Hyponatraemia,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Hypotension,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Lymphocyte count decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Macrocytosis,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Mean cell volume decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Mean platelet volume decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Metabolic acidosis,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Metamyelocyte count increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Monocyte count decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Neutrophil count increased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Neutrophil toxic granulation present,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Platelet count decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Pupil fixed,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Red blood cell count decreased,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Respiratory failure,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183285551,18328555,22,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q3,Unresponsive to stimuli,,2020,Q3,1,I,20200922.0,,20200929,20200929,DIR,,,FDA-CTU,,66.0,YR,,M,N,80.0,KG,20200929.0,Y,PH,US,US,2020,Q3,Elderly
183300861,18330086,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2020,Q3,Eosinophilia,,2020,Q3,1,I,20200808.0,20200921.0,20200930,20200930,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20200930.0,,MD,FR,FR,2020,Q3,Elderly
183300861,18330086,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2020,Q3,Hepatocellular injury,,2020,Q3,1,I,20200808.0,20200921.0,20200930,20200930,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20200930.0,,MD,FR,FR,2020,Q3,Elderly
183300861,18330086,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2020,Q3,Hypercreatininaemia,,2020,Q3,1,I,20200808.0,20200921.0,20200930,20200930,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20200930.0,,MD,FR,FR,2020,Q3,Elderly
183300861,18330086,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2020,Q3,Rash maculo-papular,,2020,Q3,1,I,20200808.0,20200921.0,20200930,20200930,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20200930.0,,MD,FR,FR,2020,Q3,Elderly
183304311,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,,,,,,,,,,2020,Q3,Depressed level of consciousness,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304311,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,,,,,,,,,,2020,Q3,Fall,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304311,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,,,,,,,,,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304311,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,,,,,,,,,,2020,Q3,Loss of consciousness,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304311,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,,,,,,,,,,2020,Q3,Product prescribing error,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304311,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0?0?0?16, AMPULLEN",,,,,,,,,,,,2020,Q3,Somnolence,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304331,18330433,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 IE, ZUR NACHT)",,,U,U,,,210605.0,8.0,IU,INJECTION,QD,2020,Q3,Confusional state,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081879,MYLAN,,93.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304331,18330433,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 IE, ZUR NACHT)",,,U,U,,,210605.0,8.0,IU,INJECTION,QD,2020,Q3,Disorientation,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081879,MYLAN,,93.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304331,18330433,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 IE, ZUR NACHT)",,,U,U,,,210605.0,8.0,IU,INJECTION,QD,2020,Q3,Fall,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081879,MYLAN,,93.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304331,18330433,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 IE, ZUR NACHT)",,,U,U,,,210605.0,8.0,IU,INJECTION,QD,2020,Q3,Hypoglycaemia,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081879,MYLAN,,93.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183304331,18330433,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 INTERNATIONAL UNIT, QD (8 IE, ZUR NACHT)",,,U,U,,,210605.0,8.0,IU,INJECTION,QD,2020,Q3,Loss of consciousness,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081879,MYLAN,,93.0,YR,,F,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183305151,18330515,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, NACH SCHEMA",,,,,,,,,,INJECTION,,2020,Q3,Abdominal pain,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081812,MYLAN,,76.0,YR,,M,Y,110.0,KG,20200930.0,,PH,DE,DE,2020,Q3,Elderly
183305151,18330515,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, NACH SCHEMA",,,,,,,,,,INJECTION,,2020,Q3,Abdominal pain upper,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081812,MYLAN,,76.0,YR,,M,Y,110.0,KG,20200930.0,,PH,DE,DE,2020,Q3,Elderly
183305151,18330515,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, NACH SCHEMA",,,,,,,,,,INJECTION,,2020,Q3,Arrhythmia,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081812,MYLAN,,76.0,YR,,M,Y,110.0,KG,20200930.0,,PH,DE,DE,2020,Q3,Elderly
183305151,18330515,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, NACH SCHEMA",,,,,,,,,,INJECTION,,2020,Q3,Diarrhoea,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081812,MYLAN,,76.0,YR,,M,Y,110.0,KG,20200930.0,,PH,DE,DE,2020,Q3,Elderly
183305151,18330515,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, NACH SCHEMA",,,,,,,,,,INJECTION,,2020,Q3,Nausea,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081812,MYLAN,,76.0,YR,,M,Y,110.0,KG,20200930.0,,PH,DE,DE,2020,Q3,Elderly
183305151,18330515,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"NK IE, NACH SCHEMA",,,,,,,,,,INJECTION,,2020,Q3,Vomiting,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081812,MYLAN,,76.0,YR,,M,Y,110.0,KG,20200930.0,,PH,DE,DE,2020,Q3,Elderly
183305951,18330595,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?14?0, AMPULLEN",,,,,,,,300.0,IU,INJECTION,,2020,Q3,General physical health deterioration,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081773,MYLAN,,71.0,YR,,M,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183305951,18330595,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"300 IE, 0?0?14?0, AMPULLEN",,,,,,,,300.0,IU,INJECTION,,2020,Q3,Haematochezia,,2020,Q3,1,I,,20200922.0,20200930,20200930,EXP,,DE-MYLANLABS-2020M1081773,MYLAN,,71.0,YR,,M,Y,,,20200930.0,,MD,DE,DE,2020,Q3,Elderly
183313381,18331338,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"260 U, QD",158329.2,IU,,,,,,260.0,IU,INJECTION,QD,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183313381,18331338,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"260 U, QD",158329.2,IU,,,,,,260.0,IU,INJECTION,QD,2020,Q3,Dehydration,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183313381,18331338,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"260 U, QD",158329.2,IU,,,,,,260.0,IU,INJECTION,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183313381,18331338,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"260 U, QD",158329.2,IU,,,,,,260.0,IU,INJECTION,QD,2020,Q3,Hypertension,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183313381,18331338,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"260 U, QD",158329.2,IU,,,,,,260.0,IU,INJECTION,QD,2020,Q3,Maternal exposure during pregnancy,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183313381,18331338,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"290 U, QD",158329.2,IU,,,,,,290.0,IU,INJECTION,QD,2020,Q3,Acute kidney injury,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183313381,18331338,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"290 U, QD",158329.2,IU,,,,,,290.0,IU,INJECTION,QD,2020,Q3,Dehydration,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183313381,18331338,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"290 U, QD",158329.2,IU,,,,,,290.0,IU,INJECTION,QD,2020,Q3,Diabetic ketoacidosis,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183313381,18331338,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"290 U, QD",158329.2,IU,,,,,,290.0,IU,INJECTION,QD,2020,Q3,Hypertension,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183313381,18331338,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"290 U, QD",158329.2,IU,,,,,,290.0,IU,INJECTION,QD,2020,Q3,Maternal exposure during pregnancy,,2020,Q3,1,I,20160726.0,20200924.0,20200930,20200930,EXP,GB-EMA-DD-20171214-ASHWINIHVP-151556,GB-MYLANLABS-2020M1082653,MYLAN,,36.0,YR,,F,Y,94.2,KG,20200930.0,,CN,GB,GB,2020,Q3,Adult
183319021,18331902,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q3,Cardiac arrest,,2020,Q3,1,I,,20200929.0,20200930,20200930,EXP,,US-GILEAD-2020-0496881,GILEAD,,66.0,YR,E,M,Y,80.0,KG,20200930.0,,PH,US,US,2020,Q3,Elderly
183319561,18331956,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Depression,,2020,Q3,1,I,20131114.0,20200928.0,20200930,20200930,EXP,,US-PFIZER INC-2020375339,PFIZER,,65.0,YR,,F,Y,,,20200930.0,,LW,US,US,2020,Q3,Elderly
183319561,18331956,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,End stage renal disease,,2020,Q3,1,I,20131114.0,20200928.0,20200930,20200930,EXP,,US-PFIZER INC-2020375339,PFIZER,,65.0,YR,,F,Y,,,20200930.0,,LW,US,US,2020,Q3,Elderly
183319561,18331956,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q3,Renal failure,,2020,Q3,1,I,20131114.0,20200928.0,20200930,20200930,EXP,,US-PFIZER INC-2020375339,PFIZER,,65.0,YR,,F,Y,,,20200930.0,,LW,US,US,2020,Q3,Elderly
65814262,6581426,31,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Blister,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,31,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Conjunctivitis,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,31,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Lip erosion,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,31,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Nikolsky's sign,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,31,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Ocular hyperaemia,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,31,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Pruritus,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,31,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Purpura,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,31,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Stevens-Johnson syndrome,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
65814262,6581426,31,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q3,Swollen tongue,,2020,Q3,2,F,20041104.0,20080410.0,20080314,20080418,EXP,,DE-ABBOTT-08P-062-0441584-00,ABBOTT,,71.0,YR,,F,Y,,,20080418.0,,,COUNTRY NOT SPECIFIED,DE,2020,Q3,Elderly
73953123,7395312,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,,,,,2020,Q3,Respiratory tract infection viral,,2020,Q3,3,F,20100512.0,20111117.0,20100521,20111122,EXP,,AU-JNJFOC-20100505705,CENTOCOR,,49.0,YR,A,M,Y,107.0,KG,20111122.0,,MD,AU,AU,2020,Q3,Adult
74867202,7486720,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 UNITS; FREQUENCY NOT PROVIDED,,,,,,,,,,,,2020,Q3,Nephrotic syndrome,,2020,Q3,2,F,20100707.0,20100819.0,20100719,20100825,EXP,,US-WYE-H16060110,WYETH,,48.0,YR,,M,Y,117.0,KG,20100825.0,,MD,US,US,2020,Q3,Adult
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Anxiety,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Blood pressure systolic increased,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Erosive duodenitis,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Gait disturbance,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Ileus,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Iron deficiency anaemia,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Myopathy,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Respiratory rate increased,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Rhabdomyolysis,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86221351,8622135,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,70 U,,,,,,,,,,,,2020,Q3,Tearfulness,,2020,Q3,1,I,,20120519.0,20120604,20120604,EXP,,IPC201205-000227,IPCA,,79.0,YR,E,M,N,,,20120601.0,,HP,US,,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Anxiety,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Blood pressure systolic increased,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Erosive duodenitis,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Gait disturbance,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Ileus,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Iron deficiency anaemia,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Myopathy,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Renal impairment,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Respiratory rate increased,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Rhabdomyolysis,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
86909902,8690990,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"70 U, UNK",,,,U,,,,,,,,2020,Q3,Tearfulness,,2020,Q3,2,F,,20130724.0,20120730,20131106,EXP,,US-009507513-1207USA010587,MERCK,,79.0,YR,,M,Y,,,20131106.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q3,Elderly
112686755,11268675,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,,,SOLUTION,BID,2020,Q4,Haematuria,,2020,Q4,5,F,20130618.0,20201025.0,20150714,20201029,PER,,US-JNJFOC-20150616435,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20201029.0,,CN,US,US,2020,Q4,Elderly
112686755,11268675,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,,,SOLUTION,BID,2020,Q4,Rectal haemorrhage,,2020,Q4,5,F,20130618.0,20201025.0,20150714,20201029,PER,,US-JNJFOC-20150616435,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20201029.0,,CN,US,US,2020,Q4,Elderly
112686755,11268675,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,,,SOLUTION,BID,2020,Q4,Uterine haemorrhage,,2020,Q4,5,F,20130618.0,20201025.0,20150714,20201029,PER,,US-JNJFOC-20150616435,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20201029.0,,CN,US,US,2020,Q4,Elderly
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Blood creatinine increased,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Depressed level of consciousness,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Hypokalaemia,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Hypomagnesaemia,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Hypotension,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Intentional overdose,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Nodal arrhythmia,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Somnolence,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Suicide attempt,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),1 U/KG/HOUR,,,Y,U,,,,,,INJECTION,,2020,Q4,Vomiting,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Blood creatinine increased,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Depressed level of consciousness,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Hypokalaemia,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Hypomagnesaemia,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Hypotension,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Intentional overdose,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Nodal arrhythmia,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Somnolence,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Suicide attempt,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),TITRATED UP BY 1 U/ KG/HOUR APPROXIMATELY EVERY 15 MINUTES,,,Y,U,,,,,,INJECTION,,2020,Q4,Vomiting,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Blood creatinine increased,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Depressed level of consciousness,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Hypokalaemia,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Hypomagnesaemia,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Hypotension,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Intentional overdose,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Nodal arrhythmia,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Somnolence,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Suicide attempt,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
115991492,11599149,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),MAXIMUM OF 10 U/KG/ HOUR OVER THE 2 HOURS AFTER ARRIVAL TO THE TERTIARY FACILITY,,,Y,U,,,,,,INJECTION,,2020,Q4,Vomiting,,2020,Q4,2,F,,20201103.0,20151006,20201110,EXP,,US-MYLANLABS-2015M1033308,MYLAN,"CORCORAN JN, JACOBY KJ, OLIVES TD, BANGH SA, COLE JB. PERSISTENT HYPERINSULINEMIA FOLLOWING HIGH-DOSE INSULIN THERAPY: A CASE REPORT. J-MED-TOXICOL 2020;16(4):465-469.",51.0,YR,,M,Y,100.0,KG,20201110.0,,HP,US,US,2020,Q4,Adult
118150763,11815076,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 DF,QD",,,U,,,,,12.0,DF,,QD,2020,Q4,Blindness,,2020,Q4,3,F,,20201211.0,20151209,20201218,EXP,,US-SA-2015SA163763,SANOFI AVENTIS,,70.0,YR,,F,Y,,,20201218.0,,CN,US,US,2020,Q4,Elderly
118150763,11815076,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 DF,QD",,,U,,,,,12.0,DF,,QD,2020,Q4,Blood glucose increased,,2020,Q4,3,F,,20201211.0,20151209,20201218,EXP,,US-SA-2015SA163763,SANOFI AVENTIS,,70.0,YR,,F,Y,,,20201218.0,,CN,US,US,2020,Q4,Elderly
118150763,11815076,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 DF,QD",,,U,,,,,12.0,DF,,QD,2020,Q4,Expired product administered,,2020,Q4,3,F,,20201211.0,20151209,20201218,EXP,,US-SA-2015SA163763,SANOFI AVENTIS,,70.0,YR,,F,Y,,,20201218.0,,CN,US,US,2020,Q4,Elderly
118150763,11815076,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 DF,QD",,,U,,,,,12.0,DF,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,,20201211.0,20151209,20201218,EXP,,US-SA-2015SA163763,SANOFI AVENTIS,,70.0,YR,,F,Y,,,20201218.0,,CN,US,US,2020,Q4,Elderly
118150763,11815076,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 DF,QD",,,U,,,,,12.0,DF,,QD,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,3,F,,20201211.0,20151209,20201218,EXP,,US-SA-2015SA163763,SANOFI AVENTIS,,70.0,YR,,F,Y,,,20201218.0,,CN,US,US,2020,Q4,Elderly
118150763,11815076,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 DF,QD",,,U,,,,,12.0,DF,,QD,2020,Q4,Visual impairment,,2020,Q4,3,F,,20201211.0,20151209,20201218,EXP,,US-SA-2015SA163763,SANOFI AVENTIS,,70.0,YR,,F,Y,,,20201218.0,,CN,US,US,2020,Q4,Elderly
122327952,12232795,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Agranulocytosis,,2020,Q4,2,F,,20201204.0,20160402,20201216,PER,,US-LUPIN PHARMACEUTICALS INC.-2015-01903,LUPIN,,45.0,YR,,M,Y,,,20201216.0,,PH,US,US,2020,Q4,Adult
124117324,12411732,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Agranulocytosis,Agranulocytosis,2020,Q4,4,F,,20201210.0,20160527,20201217,PER,,US-DRREDDYS-USA/USA/16/0080123,DR REDDYS,MANCANO M. ZIPROSIDONE-INDUCED TRANSIENT AGRANULOCYTOSIS DELAYED ONSET OF CARDIAC ADVERSE EFFECTS WITH FINGOLIMOD TELMISARTAN-INDUCED MYOTOXICITY SEVERE DILATED CARDIOMYOPATHY INDUCED BY ADALIMUMAB AND USTEKINUMAB. HOSPITAL PHARMACY. 2015;50(10):855-858. DOI:UNKNOWN,45.0,YR,A,M,Y,,,20201217.0,,HP,US,US,2020,Q4,Adult
124124016,12412401,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Agranulocytosis,Agranulocytosis,2020,Q4,6,F,,20201210.0,20160527,20201215,EXP,,US-PFIZER INC-2016274551,PFIZER,"ISKANDAR, J.. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2015;35(3):347-348",45.0,YR,,M,Y,,,20201215.0,,MD,US,US,2020,Q4,Adult
124124026,12412402,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Agranulocytosis,Agranulocytosis,2020,Q4,6,F,,20201208.0,20160527,20201215,EXP,,US-PFIZER INC-2016274629,PFIZER,"ISKANDAR, J.. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2015;35(3):347-348",45.0,YR,,M,Y,,,20201215.0,,MD,US,US,2020,Q4,Adult
125119553,12511955,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,80.0,IU,INJECTION,,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,3,F,20141028.0,20201210.0,20160630,20201214,PER,,US-JNJFOC-20160507595,JOHNSON AND JOHNSON,,77.0,YR,E,F,Y,,,20201214.0,,CN,US,US,2020,Q4,Elderly
126305602,12630560,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"80 IU, QD",,,,,,,,80.0,IU,,QD,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,2,F,20141028.0,20201210.0,20160808,20201216,EXP,,US-BAYER-2016-092876,BAYER,,77.0,YR,E,F,Y,,,20201216.0,,CN,US,US,2020,Q4,Elderly
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Adverse drug reaction,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Arthralgia,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Condition aggravated,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Drug ineffective,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Gait inability,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Headache,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoaesthesia,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Lower respiratory tract infection,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Pharyngitis,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
1367540215,13675402,9,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Toothache,,2020,Q4,15,F,,20201216.0,20170621,20201228,EXP,,CA-APOTEX-2017AP012984,APOTEX,,42.0,YR,,F,Y,,,20201228.0,,CN,CA,CA,2020,Q4,Adult
136979857,13697985,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, (UNIT PM)",,,,,,,,20.0,IU,,,2020,Q4,Alopecia,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
136979857,13697985,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, (UNIT PM)",,,,,,,,20.0,IU,,,2020,Q4,Hair colour changes,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
136979857,13697985,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, (UNIT PM)",,,,,,,,20.0,IU,,,2020,Q4,Hair disorder,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
136979857,13697985,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, (UNIT PM)",,,,,,,,20.0,IU,,,2020,Q4,Hair texture abnormal,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
136979857,13697985,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20 IU, (UNIT PM)",,,,,,,,20.0,IU,,,2020,Q4,Madarosis,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
136979857,13697985,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, UNK",,,,,,,,100.0,IU,,,2020,Q4,Alopecia,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
136979857,13697985,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, UNK",,,,,,,,100.0,IU,,,2020,Q4,Hair colour changes,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
136979857,13697985,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, UNK",,,,,,,,100.0,IU,,,2020,Q4,Hair disorder,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
136979857,13697985,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, UNK",,,,,,,,100.0,IU,,,2020,Q4,Hair texture abnormal,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
136979857,13697985,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"100 IU, UNK",,,,,,,,100.0,IU,,,2020,Q4,Madarosis,,2020,Q4,7,F,201401.0,20201021.0,20170628,20201022,PER,,US-PFIZER INC-2017281177,PFIZER,,64.0,YR,,F,Y,,,20201022.0,,LW,US,US,2020,Q4,Adult
138556847,13855684,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Blood potassium increased,,2020,Q4,7,F,2017.0,20201120.0,20170810,20201127,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,,F,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
138556847,13855684,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Constipation,,2020,Q4,7,F,2017.0,20201120.0,20170810,20201127,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,,F,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
138556847,13855684,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Drug intolerance,,2020,Q4,7,F,2017.0,20201120.0,20170810,20201127,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,,F,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
138556847,13855684,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,7,F,2017.0,20201120.0,20170810,20201127,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,,F,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
138556847,13855684,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Femur fracture,,2020,Q4,7,F,2017.0,20201120.0,20170810,20201127,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,,F,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
138556847,13855684,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hip fracture,,2020,Q4,7,F,2017.0,20201120.0,20170810,20201127,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,,F,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
138556847,13855684,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Postoperative wound infection,,2020,Q4,7,F,2017.0,20201120.0,20170810,20201127,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,,F,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
138556847,13855684,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Product preparation error,,2020,Q4,7,F,2017.0,20201120.0,20170810,20201127,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,,F,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
138556847,13855684,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Urinary tract infection staphylococcal,,2020,Q4,7,F,2017.0,20201120.0,20170810,20201127,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2017-06833,VIFOR,,87.0,YR,,F,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
141626765,14162676,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Cellulitis,,2020,Q4,5,F,20170319.0,20200928.0,20171106,20201006,EXP,,GB-AUROBINDO-AUR-APL-2017-42976,AUROBINDO,,65.0,YR,,F,Y,96.0,KG,20201006.0,,CN,GB,GB,2020,Q4,Elderly
141626765,14162676,8,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,5,F,20170319.0,20200928.0,20171106,20201006,EXP,,GB-AUROBINDO-AUR-APL-2017-42976,AUROBINDO,,65.0,YR,,F,Y,96.0,KG,20201006.0,,CN,GB,GB,2020,Q4,Elderly
141626765,14162676,9,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (),,,U,U,,,,,,,,2020,Q4,Cellulitis,,2020,Q4,5,F,20170319.0,20200928.0,20171106,20201006,EXP,,GB-AUROBINDO-AUR-APL-2017-42976,AUROBINDO,,65.0,YR,,F,Y,96.0,KG,20201006.0,,CN,GB,GB,2020,Q4,Elderly
141626765,14162676,9,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK (),,,U,U,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,5,F,20170319.0,20200928.0,20171106,20201006,EXP,,GB-AUROBINDO-AUR-APL-2017-42976,AUROBINDO,,65.0,YR,,F,Y,96.0,KG,20201006.0,,CN,GB,GB,2020,Q4,Elderly
142618344,14261834,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Anaphylactic reaction,,2020,Q4,4,F,,20201028.0,20171208,20201106,EXP,,CA-APOTEX-2017AP022094,APOTEX,,70.0,YR,,F,Y,,,20201106.0,,CN,CA,CA,2020,Q4,Elderly
142618344,14261834,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Drug intolerance,,2020,Q4,4,F,,20201028.0,20171208,20201106,EXP,,CA-APOTEX-2017AP022094,APOTEX,,70.0,YR,,F,Y,,,20201106.0,,CN,CA,CA,2020,Q4,Elderly
143745452,14374545,10,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Cellulitis,,2020,Q4,2,F,20170319.0,20200928.0,20180111,20201006,EXP,,GB-AUROBINDO-AUR-APL-2018-001404,AUROBINDO,,65.0,YR,,F,Y,96.0,KG,20201006.0,,CN,GB,GB,2020,Q4,Elderly
143745452,14374545,10,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,2,F,20170319.0,20200928.0,20180111,20201006,EXP,,GB-AUROBINDO-AUR-APL-2018-001404,AUROBINDO,,65.0,YR,,F,Y,96.0,KG,20201006.0,,CN,GB,GB,2020,Q4,Elderly
147005253,14700525,28,C,INSULIN GLARGINE BS[BIOSIMILAR,,2,Transdermal,,,,U,,,,,,,,QD,2020,Q4,Anaemia,,2020,Q4,3,F,20161201.0,20201112.0,20180330,20201119,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-001330",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,80.1,KG,20201119.0,,MD,JP,JP,2020,Q4,Elderly
147005253,14700525,28,C,INSULIN GLARGINE BS[BIOSIMILAR,,2,Transdermal,,,,U,,,,,,,,QD,2020,Q4,Diabetic gangrene,,2020,Q4,3,F,20161201.0,20201112.0,20180330,20201119,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-001330",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,80.1,KG,20201119.0,,MD,JP,JP,2020,Q4,Elderly
147005253,14700525,28,C,INSULIN GLARGINE BS[BIOSIMILAR,,2,Transdermal,,,,U,,,,,,,,QD,2020,Q4,Hypophosphataemia,,2020,Q4,3,F,20161201.0,20201112.0,20180330,20201119,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-001330",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,80.1,KG,20201119.0,,MD,JP,JP,2020,Q4,Elderly
147005253,14700525,28,C,INSULIN GLARGINE BS[BIOSIMILAR,,2,Transdermal,,,,U,,,,,,,,QD,2020,Q4,Renal artery stenosis,,2020,Q4,3,F,20161201.0,20201112.0,20180330,20201119,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2017-NB-001330",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,80.1,KG,20201119.0,,MD,JP,JP,2020,Q4,Elderly
148588742,14858874,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,MONTH,,,,,,,,20.0,IU,,,2020,Q4,Alopecia,,2020,Q4,2,F,201401.0,20201020.0,20180508,20201028,PER,,US-TEVA-785787USA,TEVA,,64.0,YR,A,F,Y,,,20201028.0,,LW,US,US,2020,Q4,Adult
148588742,14858874,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,MONTH,,,,,,,,20.0,IU,,,2020,Q4,Hair colour changes,,2020,Q4,2,F,201401.0,20201020.0,20180508,20201028,PER,,US-TEVA-785787USA,TEVA,,64.0,YR,A,F,Y,,,20201028.0,,LW,US,US,2020,Q4,Adult
148588742,14858874,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,MONTH,,,,,,,,20.0,IU,,,2020,Q4,Hair texture abnormal,,2020,Q4,2,F,201401.0,20201020.0,20180508,20201028,PER,,US-TEVA-785787USA,TEVA,,64.0,YR,A,F,Y,,,20201028.0,,LW,US,US,2020,Q4,Adult
148588742,14858874,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,MONTH,,,,,,,,20.0,IU,,,2020,Q4,Madarosis,,2020,Q4,2,F,201401.0,20201020.0,20180508,20201028,PER,,US-TEVA-785787USA,TEVA,,64.0,YR,A,F,Y,,,20201028.0,,LW,US,US,2020,Q4,Adult
154836083,15483608,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Electrocardiogram QT prolonged,,2020,Q4,3,F,20180926.0,20201218.0,20181010,20201228,PER,,US-009507513-1810USA001529,MERCK,,69.0,YR,,M,Y,93.9,KG,20201228.0,,CN,US,US,2020,Q4,Elderly
157819553,15781955,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q4,Drug-induced liver injury,,2020,Q4,3,F,20181206.0,20190701.0,20190102,20201021,EXP,,GE-JNJFOC-20181219197,JOHNSON AND JOHNSON,,59.0,YR,A,M,Y,69.2,KG,20201021.0,,MD,GE,GE,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Blood creatine phosphokinase increased,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Bronchitis,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Bronchopulmonary aspergillosis,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Cerumen impaction,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Chronic graft versus host disease,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Constipation,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Dermal cyst,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Duodenal ulcer,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Encephalitis viral,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Febrile neutropenia,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Hepatic enzyme increased,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Insomnia,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Neutropenia,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Papule,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Patella fracture,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Pulmonary artery thrombosis,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Renal failure,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Sepsis,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Stasis dermatitis,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Substance-induced psychotic disorder,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
1578879412,15788794,116,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,INJECTION,,2020,Q4,Transplantation complication,,2020,Q4,12,F,20170321.0,20201113.0,20190104,20201119,EXP,,JP-ASTELLAS-2017JP004936AA,ASTELLAS,,58.0,YR,,M,Y,57.0,KG,20201119.0,,MD,JP,JP,2020,Q4,Adult
157974173,15797417,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,,20.0,IU,,QD,2020,Q4,Blood glucose abnormal,,2020,Q4,3,F,2012.0,20201125.0,20190108,20201207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201901000706,ELI LILLY AND CO,,69.0,YR,,F,Y,60.0,KG,20201207.0,,CN,CN,CN,2020,Q4,Elderly
157974173,15797417,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,,20.0,IU,,QD,2020,Q4,Blood glucose increased,,2020,Q4,3,F,2012.0,20201125.0,20190108,20201207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201901000706,ELI LILLY AND CO,,69.0,YR,,F,Y,60.0,KG,20201207.0,,CN,CN,CN,2020,Q4,Elderly
157974173,15797417,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,,20.0,IU,,QD,2020,Q4,Protein urine,,2020,Q4,3,F,2012.0,20201125.0,20190108,20201207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201901000706,ELI LILLY AND CO,,69.0,YR,,F,Y,60.0,KG,20201207.0,,CN,CN,CN,2020,Q4,Elderly
157974173,15797417,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,,20.0,IU,,QD,2020,Q4,Retinal detachment,,2020,Q4,3,F,2012.0,20201125.0,20190108,20201207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201901000706,ELI LILLY AND CO,,69.0,YR,,F,Y,60.0,KG,20201207.0,,CN,CN,CN,2020,Q4,Elderly
157974173,15797417,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,,,,,,20.0,IU,,QD,2020,Q4,Visual impairment,,2020,Q4,3,F,2012.0,20201125.0,20190108,20201207,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201901000706,ELI LILLY AND CO,,69.0,YR,,F,Y,60.0,KG,20201207.0,,CN,CN,CN,2020,Q4,Elderly
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Coronary artery occlusion,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Hyperparathyroidism secondary,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Nephropathy,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Rebound acid hypersecretion,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
159945633,15994563,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Renal injury,,2020,Q4,3,F,2015.0,20201111.0,20190222,20201116,EXP,,US-ASTRAZENECA-2019SE10576,ASTRAZENECA,,36.0,YR,,M,Y,79.4,KG,20201116.0,,,US,US,2020,Q4,Adult
160271417,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q4,Cellulitis,,2020,Q4,7,F,20181225.0,20201104.0,20190303,20201110,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20201110.0,,HP,DE,DE,2020,Q4,Adult
160271417,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q4,Lymphangitis,,2020,Q4,7,F,20181225.0,20201104.0,20190303,20201110,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20201110.0,,HP,DE,DE,2020,Q4,Adult
160271417,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q4,Necrosis,,2020,Q4,7,F,20181225.0,20201104.0,20190303,20201110,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20201110.0,,HP,DE,DE,2020,Q4,Adult
160271417,16027141,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"30 IU, QD",,,U,,,,,30.0,IU,,QD,2020,Q4,Soft tissue infection,,2020,Q4,7,F,20181225.0,20201104.0,20190303,20201110,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019559,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,130.0,KG,20201110.0,,HP,DE,DE,2020,Q4,Adult
160748354,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2020,Q4,Acute coronary syndrome,,2020,Q4,4,F,20171110.0,20201006.0,20190314,20201013,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20201010.0,,MD,CA,CA,2020,Q4,Elderly
160748354,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,4,F,20171110.0,20201006.0,20190314,20201013,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20201010.0,,MD,CA,CA,2020,Q4,Elderly
160748354,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2020,Q4,Chest pain,,2020,Q4,4,F,20171110.0,20201006.0,20190314,20201013,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20201010.0,,MD,CA,CA,2020,Q4,Elderly
160748354,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,4,F,20171110.0,20201006.0,20190314,20201013,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20201010.0,,MD,CA,CA,2020,Q4,Elderly
160748354,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,4,F,20171110.0,20201006.0,20190314,20201013,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20201010.0,,MD,CA,CA,2020,Q4,Elderly
160748354,16074835,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"12 UNK, UNKNOWN",,,,,,,,,,,,2020,Q4,Syncope,,2020,Q4,4,F,20171110.0,20201006.0,20190314,20201013,EXP,,PHHY2019CA055398,NOVARTIS,,65.0,YR,,F,Y,119.1,KG,20201010.0,,MD,CA,CA,2020,Q4,Elderly
1619976610,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2020,Q4,Cutaneous sarcoidosis,,2020,Q4,10,F,20190404.0,20201224.0,20190415,20201230,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20201230.0,,HP,BR,BR,2020,Q4,Elderly
1619976610,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2020,Q4,Epiglottic oedema,,2020,Q4,10,F,20190404.0,20201224.0,20190415,20201230,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20201230.0,,HP,BR,BR,2020,Q4,Elderly
1619976610,16199766,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM: 25 UNIT NO'S,,,U,,,,,1.0,DF,,,2020,Q4,Sarcoidosis,,2020,Q4,10,F,20190404.0,20201224.0,20190415,20201230,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20201230.0,,HP,BR,BR,2020,Q4,Elderly
1619976610,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q4,Cutaneous sarcoidosis,,2020,Q4,10,F,20190404.0,20201224.0,20190415,20201230,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20201230.0,,HP,BR,BR,2020,Q4,Elderly
1619976610,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q4,Epiglottic oedema,,2020,Q4,10,F,20190404.0,20201224.0,20190415,20201230,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20201230.0,,HP,BR,BR,2020,Q4,Elderly
1619976610,16199766,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,,,2020,Q4,Sarcoidosis,,2020,Q4,10,F,20190404.0,20201224.0,20190415,20201230,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20201230.0,,HP,BR,BR,2020,Q4,Elderly
1627846010,16278460,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,29 UNITS,,,,,,,,,,INJECTION,,2020,Q4,Anaemia,,2020,Q4,10,F,20190417.0,20200226.0,20190506,20201028,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20201028.0,,HP,US,US,2020,Q4,Elderly
1627846010,16278460,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,29 UNITS,,,,,,,,,,INJECTION,,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,10,F,20190417.0,20200226.0,20190506,20201028,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20201028.0,,HP,US,US,2020,Q4,Elderly
1627846010,16278460,13,C,Glargine Insulin,INSULIN GLARGINE,1,Subcutaneous,29 UNITS,,,,,,,,,,INJECTION,,2020,Q4,Hepatic failure,,2020,Q4,10,F,20190417.0,20200226.0,20190506,20201028,EXP,,US-CELGENEUS-USA-20190411233,CELGENE,,74.0,YR,,M,Y,,,20201028.0,,HP,US,US,2020,Q4,Elderly
162981142,16298114,19,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20091117.0,20201215.0,20190510,20201223,EXP,,US-ASTRAZENECA-2019SE63998,ASTRAZENECA,,21909.0,DY,,M,Y,122.5,KG,20201223.0,,,US,US,2020,Q4,Elderly
162981142,16298114,19,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20091117.0,20201215.0,20190510,20201223,EXP,,US-ASTRAZENECA-2019SE63998,ASTRAZENECA,,21909.0,DY,,M,Y,122.5,KG,20201223.0,,,US,US,2020,Q4,Elderly
162981142,16298114,19,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,20091117.0,20201215.0,20190510,20201223,EXP,,US-ASTRAZENECA-2019SE63998,ASTRAZENECA,,21909.0,DY,,M,Y,122.5,KG,20201223.0,,,US,US,2020,Q4,Elderly
162981142,16298114,19,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Gastrooesophageal reflux disease,,2020,Q4,2,F,20091117.0,20201215.0,20190510,20201223,EXP,,US-ASTRAZENECA-2019SE63998,ASTRAZENECA,,21909.0,DY,,M,Y,122.5,KG,20201223.0,,,US,US,2020,Q4,Elderly
162981142,16298114,19,C,GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,20091117.0,20201215.0,20190510,20201223,EXP,,US-ASTRAZENECA-2019SE63998,ASTRAZENECA,,21909.0,DY,,M,Y,122.5,KG,20201223.0,,,US,US,2020,Q4,Elderly
163699747,16369974,68,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Mucosal inflammation,,2020,Q4,7,F,20190517.0,20201228.0,20190530,20201229,EXP,,IT-ROCHE-2326430,ROCHE,,56.0,YR,,F,Y,67.0,KG,20201229.0,,MD,IT,IT,2020,Q4,Adult
167281035,16728103,44,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION,,2020,Q4,Anaphylactic reaction,,2020,Q4,5,F,,20201124.0,20190822,20201202,EXP,,CA-AUROBINDO-AUR-APL-2019-054279,AUROBINDO,,70.0,YR,,F,Y,,,20201202.0,,HP,CA,CA,2020,Q4,Elderly
167281035,16728103,44,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION,,2020,Q4,Drug intolerance,,2020,Q4,5,F,,20201124.0,20190822,20201202,EXP,,CA-AUROBINDO-AUR-APL-2019-054279,AUROBINDO,,70.0,YR,,F,Y,,,20201202.0,,HP,CA,CA,2020,Q4,Elderly
167597325,16759732,36,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"21 IU, QN, IH",,,,,,,,21.0,IU,,,2020,Q4,Interstitial lung disease,,2020,Q4,5,F,20190815.0,20201106.0,20190830,20201116,EXP,,CN-TESAROUBC-2019-TSO03011-CN,GLAXOSMITHKLINE,,51.0,YR,,F,Y,66.5,KG,20201116.0,,MD,CN,CN,2020,Q4,Adult
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Abscess limb,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cellulitis,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cellulitis of male external genital organ,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fournier's gangrene,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Groin abscess,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Necrotising fasciitis,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Necrotising soft tissue infection,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Perineal abscess,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Peritoneal abscess,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Rectal abscess,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Scrotal abscess,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168768184,16876818,16,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Subcutaneous abscess,,2020,Q4,4,F,20171228.0,20200930.0,20191002,20201007,EXP,,US-ASTRAZENECA-2019SF36617,ASTRAZENECA,,26896.0,DY,,M,Y,130.6,KG,20201007.0,,,US,US,2020,Q4,Elderly
168825515,16882551,11,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Unknown,,,,U,,,,,8.0,IU,,,2020,Q4,Angina pectoris,,2020,Q4,5,F,20181104.0,20201116.0,20191003,20201123,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-104902",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,106.7,KG,20201123.0,,MD,JP,JP,2020,Q4,Adult
169324974,16932497,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Leukopenia,,2020,Q4,4,F,20190723.0,20201205.0,20191017,20201216,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20201216.0,,MD,PL,PL,2020,Q4,Adult
169324974,16932497,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Neutropenia,,2020,Q4,4,F,20190723.0,20201205.0,20191017,20201216,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20201216.0,,MD,PL,PL,2020,Q4,Adult
169610134,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q4,Anxiety,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q4,Condition aggravated,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q4,Diet noncompliance,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q4,Hypoglycaemia,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q4,Hypothyroidism,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q4,Pollakiuria,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,19.0IU UNKNOWN,,,Y,, 9F165A,,,19.0,IU,,,2020,Q4,Weight decreased,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q4,Anxiety,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q4,Condition aggravated,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q4,Diet noncompliance,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q4,Hypoglycaemia,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q4,Hypothyroidism,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q4,Pollakiuria,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18.0IU UNKNOWN,,,Y,, 9F43LA,,,18.0,IU,,,2020,Q4,Weight decreased,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q4,Anxiety,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q4,Condition aggravated,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q4,Diet noncompliance,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q4,Glycosylated haemoglobin increased,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q4,Hypoglycaemia,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q4,Hypothyroidism,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q4,Pollakiuria,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
169610134,16961013,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,15.0IU UNKNOWN,,,Y,, 9F250A,,,15.0,IU,,,2020,Q4,Weight decreased,,2020,Q4,4,F,20181221.0,20201218.0,20191025,20201225,EXP,,ES-ASTRAZENECA-2019SF47843,ASTRAZENECA,,61.0,YR,,F,Y,,,20201225.0,,CN,ES,ES,2020,Q4,Adult
170224212,17022421,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,2,F,20191021.0,20191101.0,20191112,20201020,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20201020.0,,MD,IT,IT,2020,Q4,Elderly
170224212,17022421,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2020,Q4,Loss of consciousness,,2020,Q4,2,F,20191021.0,20191101.0,20191112,20201020,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20201020.0,,MD,IT,IT,2020,Q4,Elderly
170224212,17022421,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2020,Q4,Neurological symptom,,2020,Q4,2,F,20191021.0,20191101.0,20191112,20201020,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20201020.0,,MD,IT,IT,2020,Q4,Elderly
170224212,17022421,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2020,Q4,Respiratory arrest,,2020,Q4,2,F,20191021.0,20191101.0,20191112,20201020,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20201020.0,,MD,IT,IT,2020,Q4,Elderly
171017658,17101765,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q4,Gastrooesophageal reflux disease,,2020,Q4,8,F,201907.0,20201210.0,20191202,20201220,EXP,,JP-NOVOPROD-699040,NOVO NORDISK,,80.0,YR,,M,Y,49.6,KG,20201220.0,,MD,JP,JP,2020,Q4,Elderly
171017658,17101765,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q4,Rectal cancer,,2020,Q4,8,F,201907.0,20201210.0,20191202,20201220,EXP,,JP-NOVOPROD-699040,NOVO NORDISK,,80.0,YR,,M,Y,49.6,KG,20201220.0,,MD,JP,JP,2020,Q4,Elderly
171017658,17101765,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q4,Sepsis,,2020,Q4,8,F,201907.0,20201210.0,20191202,20201220,EXP,,JP-NOVOPROD-699040,NOVO NORDISK,,80.0,YR,,M,Y,49.6,KG,20201220.0,,MD,JP,JP,2020,Q4,Elderly
171017658,17101765,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, UNKNOWN,,,,,,,2020,Q4,Superior mesenteric artery syndrome,,2020,Q4,8,F,201907.0,20201210.0,20191202,20201220,EXP,,JP-NOVOPROD-699040,NOVO NORDISK,,80.0,YR,,M,Y,49.6,KG,20201220.0,,MD,JP,JP,2020,Q4,Elderly
172046435,17204643,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Dementia,,2020,Q4,5,F,20190725.0,20201021.0,20191226,20201029,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20201029.0,,CN,CA,CA,2020,Q4,Elderly
172046435,17204643,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,5,F,20190725.0,20201021.0,20191226,20201029,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20201029.0,,CN,CA,CA,2020,Q4,Elderly
172046435,17204643,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,5,F,20190725.0,20201021.0,20191226,20201029,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20201029.0,,CN,CA,CA,2020,Q4,Elderly
172046435,17204643,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hot flush,,2020,Q4,5,F,20190725.0,20201021.0,20191226,20201029,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20201029.0,,CN,CA,CA,2020,Q4,Elderly
172046435,17204643,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Kidney infection,,2020,Q4,5,F,20190725.0,20201021.0,20191226,20201029,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20201029.0,,CN,CA,CA,2020,Q4,Elderly
172046435,17204643,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,5,F,20190725.0,20201021.0,20191226,20201029,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20201029.0,,CN,CA,CA,2020,Q4,Elderly
172046435,17204643,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Sleep apnoea syndrome,,2020,Q4,5,F,20190725.0,20201021.0,20191226,20201029,EXP,,CA-TAKEDA-2019TUS047228,TAKEDA,,73.0,YR,,F,Y,,,20201029.0,,CN,CA,CA,2020,Q4,Elderly
173344123,17334412,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U, UNKNOWN,,,,,,,2020,Q4,Maternal exposure during pregnancy,,2020,Q4,3,F,,20201214.0,20200128,20201221,EXP,,DE-DRREDDYS-GER/GER/20/0118923,DR REDDYS,"DATHE K, FRANK J, PADBERG S, HULTZSCH S, MEIXNER K, BECK E ET AL.. NEGLIGIBLE RISK OF PRENATAL DUCTUS ARTERIOSUS CLOSURE OR FETAL RENAL IMPAIRMENT AFTER THIRDTRIMESTER PARACETAMOL USE: EVALUATION OF THE GERMAN EMBRYOTOX COHORT. BJOJ: AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2019;126:1560-7. DOI:10.1111\1471-2D0528.15872",38.0,WK,I,F,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
173344123,17334412,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U, UNKNOWN,,,,,,,2020,Q4,Off label use,,2020,Q4,3,F,,20201214.0,20200128,20201221,EXP,,DE-DRREDDYS-GER/GER/20/0118923,DR REDDYS,"DATHE K, FRANK J, PADBERG S, HULTZSCH S, MEIXNER K, BECK E ET AL.. NEGLIGIBLE RISK OF PRENATAL DUCTUS ARTERIOSUS CLOSURE OR FETAL RENAL IMPAIRMENT AFTER THIRDTRIMESTER PARACETAMOL USE: EVALUATION OF THE GERMAN EMBRYOTOX COHORT. BJOJ: AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2019;126:1560-7. DOI:10.1111\1471-2D0528.15872",38.0,WK,I,F,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
173344123,17334412,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U, UNKNOWN,,,,,,,2020,Q4,Oligohydramnios,,2020,Q4,3,F,,20201214.0,20200128,20201221,EXP,,DE-DRREDDYS-GER/GER/20/0118923,DR REDDYS,"DATHE K, FRANK J, PADBERG S, HULTZSCH S, MEIXNER K, BECK E ET AL.. NEGLIGIBLE RISK OF PRENATAL DUCTUS ARTERIOSUS CLOSURE OR FETAL RENAL IMPAIRMENT AFTER THIRDTRIMESTER PARACETAMOL USE: EVALUATION OF THE GERMAN EMBRYOTOX COHORT. BJOJ: AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2019;126:1560-7. DOI:10.1111\1471-2D0528.15872",38.0,WK,I,F,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
173344123,17334412,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U, UNKNOWN,,,,,,,2020,Q4,Product use issue,,2020,Q4,3,F,,20201214.0,20200128,20201221,EXP,,DE-DRREDDYS-GER/GER/20/0118923,DR REDDYS,"DATHE K, FRANK J, PADBERG S, HULTZSCH S, MEIXNER K, BECK E ET AL.. NEGLIGIBLE RISK OF PRENATAL DUCTUS ARTERIOSUS CLOSURE OR FETAL RENAL IMPAIRMENT AFTER THIRDTRIMESTER PARACETAMOL USE: EVALUATION OF THE GERMAN EMBRYOTOX COHORT. BJOJ: AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2019;126:1560-7. DOI:10.1111\1471-2D0528.15872",38.0,WK,I,F,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
174008457,17400845,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2020,Q4,Dyspnoea,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
174008457,17400845,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2020,Q4,Ear haemorrhage,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
174008457,17400845,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2020,Q4,Enzyme level increased,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
174008457,17400845,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2020,Q4,Off label use,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
174008457,17400845,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,100 UNIT/ML (3ML) INSULIN PEN INTO THE SKIN NIGHTLY FOR 90 DAYS,,,,,,,,20.0,IU,,,2020,Q4,Product dispensing error,,2020,Q4,7,F,2020.0,20201123.0,20200211,20201128,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20201127.0,,HP,US,US,2020,Q4,Elderly
174330522,17433052,11,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,2,F,20180122.0,20201220.0,20200219,20201231,EXP,,JP-CLINIGEN GROUP PLC/ CLINIGEN HEALTHCARE LTD-JP-CLGN-20-00077,CLINIGEN,,70.0,YR,,M,Y,53.5,KG,20201231.0,,MD,JP,JP,2020,Q4,Elderly
174330522,17433052,11,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Myelosuppression,,2020,Q4,2,F,20180122.0,20201220.0,20200219,20201231,EXP,,JP-CLINIGEN GROUP PLC/ CLINIGEN HEALTHCARE LTD-JP-CLGN-20-00077,CLINIGEN,,70.0,YR,,M,Y,53.5,KG,20201231.0,,MD,JP,JP,2020,Q4,Elderly
174929163,17492916,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hydrocephalus,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hydrocephalus,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
174929163,17492916,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,3,F,20191127.0,20200909.0,20200303,20201108,EXP,,NL-JNJFOC-20200301000,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,,,20201109.0,,MD,NL,NL,2020,Q4,Elderly
175453538,17545353,12,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Differentiation syndrome,,2020,Q4,8,F,20200216.0,20201106.0,20200316,20201112,EXP,,ES-CELGENEUS-ESP-20200301108,CELGENE,,80.0,YR,,F,Y,66.0,KG,20201112.0,,MD,ES,ES,2020,Q4,Elderly
175453538,17545353,12,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Renal failure,,2020,Q4,8,F,20200216.0,20201106.0,20200316,20201112,EXP,,ES-CELGENEUS-ESP-20200301108,CELGENE,,80.0,YR,,F,Y,66.0,KG,20201112.0,,MD,ES,ES,2020,Q4,Elderly
175490993,17549099,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Aspiration,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Fall,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hydrocephalus,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,15,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Aspiration,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Fall,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hydrocephalus,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175490993,17549099,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,3,F,20191127.0,20201107.0,20200317,20201119,EXP,,NL-AUROBINDO-AUR-APL-2020-012562,AUROBINDO,,74.0,YR,,F,Y,,,20201119.0,,CN,US,NL,2020,Q4,Elderly
175623035,17562303,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,5,F,,20201202.0,20200319,20201208,EXP,,US-PFIZER INC-2020115287,PFIZER,"MALIK, M.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12 (1):10.1159/000505907",41.0,YR,,F,Y,,,20201208.0,,MD,US,US,2020,Q4,Adult
175623035,17562303,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Posterior reversible encephalopathy syndrome,,2020,Q4,5,F,,20201202.0,20200319,20201208,EXP,,US-PFIZER INC-2020115287,PFIZER,"MALIK, M.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12 (1):10.1159/000505907",41.0,YR,,F,Y,,,20201208.0,,MD,US,US,2020,Q4,Adult
175623035,17562303,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,5,F,,20201202.0,20200319,20201208,EXP,,US-PFIZER INC-2020115287,PFIZER,"MALIK, M.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12 (1):10.1159/000505907",41.0,YR,,F,Y,,,20201208.0,,MD,US,US,2020,Q4,Adult
175785914,17578591,7,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q4,Erythema multiforme,,2020,Q4,4,F,20190610.0,20201109.0,20200325,20201123,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20201123.0,,HP,NL,ES,2020,Q4,Elderly
175785914,17578591,7,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q4,Pyrexia,,2020,Q4,4,F,20190610.0,20201109.0,20200325,20201123,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20201123.0,,HP,NL,ES,2020,Q4,Elderly
175785914,17578591,7,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q4,Toxic skin eruption,,2020,Q4,4,F,20190610.0,20201109.0,20200325,20201123,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20201123.0,,HP,NL,ES,2020,Q4,Elderly
175785914,17578591,8,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q4,Erythema multiforme,,2020,Q4,4,F,20190610.0,20201109.0,20200325,20201123,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20201123.0,,HP,NL,ES,2020,Q4,Elderly
175785914,17578591,8,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q4,Pyrexia,,2020,Q4,4,F,20190610.0,20201109.0,20200325,20201123,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20201123.0,,HP,NL,ES,2020,Q4,Elderly
175785914,17578591,8,SS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"20 IU, PER DAY",,,U,,,,,20.0,IU,,,2020,Q4,Toxic skin eruption,,2020,Q4,4,F,20190610.0,20201109.0,20200325,20201123,EXP,,ES-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-241547,RANBAXY,,73.0,YR,,F,Y,,,20201123.0,,HP,NL,ES,2020,Q4,Elderly
175870952,17587095,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Aspiration,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hydrocephalus,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Aspiration,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hydrocephalus,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Aspiration,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hydrocephalus,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
175870952,17587095,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,2,F,20191127.0,20201016.0,20200326,20201019,EXP,,NL-MYLANLABS-2020M1031749,MYLAN,,74.0,YR,,F,Y,,,20201019.0,,CN,US,NL,2020,Q4,Elderly
176011242,17601124,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q4,Posterior reversible encephalopathy syndrome,,2020,Q4,2,F,,20201202.0,20200331,20201211,EXP,,US-DRREDDYS-USA/USA/20/0121287,DR REDDYS,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68. DOI: 10.1159/000505907.",41.0,YR,A,F,Y,,,20201211.0,,MD,US,US,2020,Q4,Adult
176011242,17601124,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,, UNKNOWN,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,2,F,,20201202.0,20200331,20201211,EXP,,US-DRREDDYS-USA/USA/20/0121287,DR REDDYS,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12:63-68. DOI: 10.1159/000505907.",41.0,YR,A,F,Y,,,20201211.0,,MD,US,US,2020,Q4,Adult
1760743430,17607434,13,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Drug interaction,,2020,Q4,30,F,201808.0,20201013.0,20200331,20201015,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20201015.0,,CN,DE,DE,2020,Q4,Elderly
1760743430,17607434,13,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Eye movement disorder,,2020,Q4,30,F,201808.0,20201013.0,20200331,20201015,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20201015.0,,CN,DE,DE,2020,Q4,Elderly
1760743430,17607434,13,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Movement disorder,,2020,Q4,30,F,201808.0,20201013.0,20200331,20201015,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20201015.0,,CN,DE,DE,2020,Q4,Elderly
1760743430,17607434,13,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Muscle spasms,,2020,Q4,30,F,201808.0,20201013.0,20200331,20201015,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20201015.0,,CN,DE,DE,2020,Q4,Elderly
1760743430,17607434,13,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Oculogyric crisis,,2020,Q4,30,F,201808.0,20201013.0,20200331,20201015,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20201015.0,,CN,DE,DE,2020,Q4,Elderly
1760743430,17607434,13,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Off label use,,2020,Q4,30,F,201808.0,20201013.0,20200331,20201015,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20201015.0,,CN,DE,DE,2020,Q4,Elderly
1760743430,17607434,13,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Product use issue,,2020,Q4,30,F,201808.0,20201013.0,20200331,20201015,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20201015.0,,CN,DE,DE,2020,Q4,Elderly
1760743430,17607434,13,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Seizure,,2020,Q4,30,F,201808.0,20201013.0,20200331,20201015,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20201015.0,,CN,DE,DE,2020,Q4,Elderly
1760743430,17607434,13,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Status epilepticus,,2020,Q4,30,F,201808.0,20201013.0,20200331,20201015,EXP,,DE-PFIZER INC-2020134407,PFIZER,,69.0,YR,,M,Y,77.0,KG,20201015.0,,CN,DE,DE,2020,Q4,Elderly
176341662,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Arthralgia,,2020,Q4,2,F,,20201221.0,20200406,20201228,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20201228.0,,HP,CA,CA,2020,Q4,Young Adult
176341662,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood creatine phosphokinase increased,,2020,Q4,2,F,,20201221.0,20200406,20201228,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20201228.0,,HP,CA,CA,2020,Q4,Young Adult
176341662,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Mobility decreased,,2020,Q4,2,F,,20201221.0,20200406,20201228,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20201228.0,,HP,CA,CA,2020,Q4,Young Adult
176341662,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Myalgia,,2020,Q4,2,F,,20201221.0,20200406,20201228,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20201228.0,,HP,CA,CA,2020,Q4,Young Adult
176341662,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Myositis,,2020,Q4,2,F,,20201221.0,20200406,20201228,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20201228.0,,HP,CA,CA,2020,Q4,Young Adult
176341662,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Pain,,2020,Q4,2,F,,20201221.0,20200406,20201228,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20201228.0,,HP,CA,CA,2020,Q4,Young Adult
176341662,17634166,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Rhabdomyolysis,,2020,Q4,2,F,,20201221.0,20200406,20201228,EXP,,NVSC2020CA091852,NOVARTIS,,34.0,YR,,F,Y,,,20201228.0,,HP,CA,CA,2020,Q4,Young Adult
1763573816,17635738,25,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Drug interaction,,2020,Q4,16,F,201808.0,20201207.0,20200406,20201217,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,69.0,YR,,M,Y,77.0,KG,20201217.0,,PH,DE,DE,2020,Q4,Elderly
1763573816,17635738,25,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Eye movement disorder,,2020,Q4,16,F,201808.0,20201207.0,20200406,20201217,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,69.0,YR,,M,Y,77.0,KG,20201217.0,,PH,DE,DE,2020,Q4,Elderly
1763573816,17635738,25,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Movement disorder,,2020,Q4,16,F,201808.0,20201207.0,20200406,20201217,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,69.0,YR,,M,Y,77.0,KG,20201217.0,,PH,DE,DE,2020,Q4,Elderly
1763573816,17635738,25,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Muscle spasms,,2020,Q4,16,F,201808.0,20201207.0,20200406,20201217,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,69.0,YR,,M,Y,77.0,KG,20201217.0,,PH,DE,DE,2020,Q4,Elderly
1763573816,17635738,25,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Oculogyric crisis,,2020,Q4,16,F,201808.0,20201207.0,20200406,20201217,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,69.0,YR,,M,Y,77.0,KG,20201217.0,,PH,DE,DE,2020,Q4,Elderly
1763573816,17635738,25,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Off label use,,2020,Q4,16,F,201808.0,20201207.0,20200406,20201217,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,69.0,YR,,M,Y,77.0,KG,20201217.0,,PH,DE,DE,2020,Q4,Elderly
1763573816,17635738,25,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Product use issue,,2020,Q4,16,F,201808.0,20201207.0,20200406,20201217,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,69.0,YR,,M,Y,77.0,KG,20201217.0,,PH,DE,DE,2020,Q4,Elderly
1763573816,17635738,25,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Seizure,,2020,Q4,16,F,201808.0,20201207.0,20200406,20201217,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,69.0,YR,,M,Y,77.0,KG,20201217.0,,PH,DE,DE,2020,Q4,Elderly
1763573816,17635738,25,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, DAILY, IN THE EVENING",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Status epilepticus,,2020,Q4,16,F,201808.0,20201207.0,20200406,20201217,EXP,DE-BFARM-20003581,DE-009507513-2004DEU000601,MERCK,,69.0,YR,,M,Y,77.0,KG,20201217.0,,PH,DE,DE,2020,Q4,Elderly
176382832,17638283,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,2,F,20181106.0,20200325.0,20200407,20201020,EXP,IT-MINISAL02-538310,IT-JNJFOC-20200343241,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20201020.0,,PH,IT,IT,2020,Q4,Elderly
176382832,17638283,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,2,F,20181106.0,20200325.0,20200407,20201020,EXP,IT-MINISAL02-538310,IT-JNJFOC-20200343241,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20201020.0,,PH,IT,IT,2020,Q4,Elderly
176382832,17638283,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Melaena,,2020,Q4,2,F,20181106.0,20200325.0,20200407,20201020,EXP,IT-MINISAL02-538310,IT-JNJFOC-20200343241,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,,,20201020.0,,PH,IT,IT,2020,Q4,Elderly
176484972,17648497,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Posterior reversible encephalopathy syndrome,,2020,Q4,2,F,,20201202.0,20200408,20201216,EXP,,US-BAUSCH-BL-2020-009496,BAUSCH AND LOMB,"MALIK M, MAJEED M, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020 FEB 12;12:63-68. DOI:10.1159/000505907",41.0,YR,,F,Y,,,20201216.0,,MD,US,US,2020,Q4,Adult
176527712,17652771,48,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20191022.0,20201015.0,20200409,20201020,EXP,,US-ASTRAZENECA-2020SE47985,ASTRAZENECA,,23098.0,DY,,M,Y,,,20201020.0,,,US,US,2020,Q4,Elderly
176527712,17652771,48,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,20191022.0,20201015.0,20200409,20201020,EXP,,US-ASTRAZENECA-2020SE47985,ASTRAZENECA,,23098.0,DY,,M,Y,,,20201020.0,,,US,US,2020,Q4,Elderly
176527712,17652771,48,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,2,F,20191022.0,20201015.0,20200409,20201020,EXP,,US-ASTRAZENECA-2020SE47985,ASTRAZENECA,,23098.0,DY,,M,Y,,,20201020.0,,,US,US,2020,Q4,Elderly
176527712,17652771,48,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Rebound acid hypersecretion,,2020,Q4,2,F,20191022.0,20201015.0,20200409,20201020,EXP,,US-ASTRAZENECA-2020SE47985,ASTRAZENECA,,23098.0,DY,,M,Y,,,20201020.0,,,US,US,2020,Q4,Elderly
176527712,17652771,48,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,20191022.0,20201015.0,20200409,20201020,EXP,,US-ASTRAZENECA-2020SE47985,ASTRAZENECA,,23098.0,DY,,M,Y,,,20201020.0,,,US,US,2020,Q4,Elderly
176811302,17681130,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176811302,17681130,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,2,F,20120707.0,20201109.0,20200417,20201117,EXP,,US-ASTRAZENECA-2020SE50856,ASTRAZENECA,,10842.0,DY,,F,Y,,,20201117.0,,,US,US,2020,Q4,Elderly
176890086,17689008,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Depressed mood,,2020,Q4,6,F,202006.0,20201223.0,20200421,20201230,PER,,US-VERTEX PHARMACEUTICALS-2020-004716,VERTEX,,33.0,YR,,F,Y,57.0,KG,20201230.0,,CN,US,US,2020,Q4,Young Adult
176890086,17689008,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,6,F,202006.0,20201223.0,20200421,20201230,PER,,US-VERTEX PHARMACEUTICALS-2020-004716,VERTEX,,33.0,YR,,F,Y,57.0,KG,20201230.0,,CN,US,US,2020,Q4,Young Adult
176890086,17689008,28,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Weight increased,,2020,Q4,6,F,202006.0,20201223.0,20200421,20201230,PER,,US-VERTEX PHARMACEUTICALS-2020-004716,VERTEX,,33.0,YR,,F,Y,57.0,KG,20201230.0,,CN,US,US,2020,Q4,Young Adult
177034582,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,2014.0,20201210.0,20200424,20201215,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20201215.0,,,US,US,2020,Q4,Adult
177034582,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,2014.0,20201210.0,20200424,20201215,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20201215.0,,,US,US,2020,Q4,Adult
177034582,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,2,F,2014.0,20201210.0,20200424,20201215,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20201215.0,,,US,US,2020,Q4,Adult
177034582,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,2014.0,20201210.0,20200424,20201215,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20201215.0,,,US,US,2020,Q4,Adult
177034582,17703458,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,2014.0,20201210.0,20200424,20201215,EXP,,US-ASTRAZENECA-2020SE53993,ASTRAZENECA,,57.0,YR,,M,Y,119.7,KG,20201215.0,,,US,US,2020,Q4,Adult
177044213,17704421,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Upper gastrointestinal haemorrhage,,2020,Q4,3,F,20191027.0,20201019.0,20200424,20201027,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-032858,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,127.3,KG,20201027.0,,HP,US,US,2020,Q4,Elderly
1771825014,17718250,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 INTERNATIONAL UNIT, DAILY)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Drug interaction,,2020,Q4,14,F,201808.0,20201002.0,20200428,20201008,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,69.0,YR,,M,Y,77.0,KG,20201008.0,,MD,DE,DE,2020,Q4,Elderly
1771825014,17718250,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 INTERNATIONAL UNIT, DAILY)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Eye movement disorder,,2020,Q4,14,F,201808.0,20201002.0,20200428,20201008,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,69.0,YR,,M,Y,77.0,KG,20201008.0,,MD,DE,DE,2020,Q4,Elderly
1771825014,17718250,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 INTERNATIONAL UNIT, DAILY)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Movement disorder,,2020,Q4,14,F,201808.0,20201002.0,20200428,20201008,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,69.0,YR,,M,Y,77.0,KG,20201008.0,,MD,DE,DE,2020,Q4,Elderly
1771825014,17718250,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 INTERNATIONAL UNIT, DAILY)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Muscle spasms,,2020,Q4,14,F,201808.0,20201002.0,20200428,20201008,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,69.0,YR,,M,Y,77.0,KG,20201008.0,,MD,DE,DE,2020,Q4,Elderly
1771825014,17718250,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 INTERNATIONAL UNIT, DAILY)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Oculogyric crisis,,2020,Q4,14,F,201808.0,20201002.0,20200428,20201008,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,69.0,YR,,M,Y,77.0,KG,20201008.0,,MD,DE,DE,2020,Q4,Elderly
1771825014,17718250,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 INTERNATIONAL UNIT, DAILY)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Off label use,,2020,Q4,14,F,201808.0,20201002.0,20200428,20201008,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,69.0,YR,,M,Y,77.0,KG,20201008.0,,MD,DE,DE,2020,Q4,Elderly
1771825014,17718250,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 INTERNATIONAL UNIT, DAILY)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Product use issue,,2020,Q4,14,F,201808.0,20201002.0,20200428,20201008,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,69.0,YR,,M,Y,77.0,KG,20201008.0,,MD,DE,DE,2020,Q4,Elderly
1771825014,17718250,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 INTERNATIONAL UNIT, DAILY)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Seizure,,2020,Q4,14,F,201808.0,20201002.0,20200428,20201008,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,69.0,YR,,M,Y,77.0,KG,20201008.0,,MD,DE,DE,2020,Q4,Elderly
1771825014,17718250,12,I,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD (15 INTERNATIONAL UNIT, DAILY)",,,,,,,,15.0,IU,INJECTION,QD,2020,Q4,Status epilepticus,,2020,Q4,14,F,201808.0,20201002.0,20200428,20201008,EXP,DE-BFARM-20003581,DE-MYLANLABS-2020M1041505,MYLAN,,69.0,YR,,M,Y,77.0,KG,20201008.0,,MD,DE,DE,2020,Q4,Elderly
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Crying,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Depressed mood,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Dyskinesia,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Gait disturbance,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Impaired gastric emptying,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Impaired quality of life,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Limb discomfort,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Limb operation,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Malaise,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Memory impairment,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Mood altered,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Muscle rigidity,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Muscular weakness,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,On and off phenomenon,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Panic reaction,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Procedural pain,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Protein total increased,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Psychiatric symptom,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Serum ferritin increased,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Sleep disorder due to a general medical condition,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Stoma site erythema,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Stoma site infection,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Stress,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Tension,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Therapeutic response shortened,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Transferrin decreased,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Tremor,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Urinary tract infection,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177488644,17748864,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Weight decreased,,2020,Q4,4,F,20191117.0,20201116.0,20200506,20201124,EXP,,NL-ABBVIE-19K-114-3013608-00,ABBVIE,,61.0,YR,,F,Y,110.0,KG,20201123.0,,CN,NL,NL,2020,Q4,Adult
177490974,17749097,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,4,F,20170903.0,20201020.0,20200506,20201027,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-023205",BOEHRINGER INGELHEIM,,58.0,YR,A,M,Y,110.0,KG,20201027.0,,MD,US,US,2020,Q4,Adult
178025783,17802578,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Aspiration,,2020,Q4,3,F,20191127.0,20201005.0,20200519,20201118,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20201118.0,,HP,NL,NL,2020,Q4,Elderly
178025783,17802578,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Cerebral haemorrhage,,2020,Q4,3,F,20191127.0,20201005.0,20200519,20201118,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20201118.0,,HP,NL,NL,2020,Q4,Elderly
178025783,17802578,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Fall,,2020,Q4,3,F,20191127.0,20201005.0,20200519,20201118,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20201118.0,,HP,NL,NL,2020,Q4,Elderly
178025783,17802578,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hydrocephalus,,2020,Q4,3,F,20191127.0,20201005.0,20200519,20201118,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20201118.0,,HP,NL,NL,2020,Q4,Elderly
178025783,17802578,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,3,F,20191127.0,20201005.0,20200519,20201118,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20201118.0,,HP,NL,NL,2020,Q4,Elderly
178025783,17802578,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,3,F,20191127.0,20201005.0,20200519,20201118,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20201118.0,,HP,NL,NL,2020,Q4,Elderly
178025783,17802578,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,3,F,20191127.0,20201005.0,20200519,20201118,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20201118.0,,HP,NL,NL,2020,Q4,Elderly
178025783,17802578,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,3,F,20191127.0,20201005.0,20200519,20201118,EXP,,NVSC2020NL135283,NOVARTIS,,74.0,YR,,F,Y,,,20201118.0,,HP,NL,NL,2020,Q4,Elderly
178163612,17816361,9,C,INSULIN GLARGINE BS (BIOSIMILAR 2),,2,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2020,Q4,Encephalopathy,,2020,Q4,2,F,2019.0,20201111.0,20200522,20201119,EXP,,JP-ASTRAZENECA-2020SE65567,ASTRAZENECA,,70.0,YR,,M,Y,,,20201119.0,,PH,JP,JP,2020,Q4,Elderly
178163612,17816361,9,C,INSULIN GLARGINE BS (BIOSIMILAR 2),,2,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,INJECTION,,2020,Q4,Paraneoplastic neurological syndrome,,2020,Q4,2,F,2019.0,20201111.0,20200522,20201119,EXP,,JP-ASTRAZENECA-2020SE65567,ASTRAZENECA,,70.0,YR,,M,Y,,,20201119.0,,PH,JP,JP,2020,Q4,Elderly
178414272,17841427,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20200516.0,20201005.0,20200529,20201013,EXP,,US-GILEAD-2020-0468705,GILEAD,,69.0,YR,E,M,Y,135.56,KG,20201013.0,,HP,US,US,2020,Q4,Elderly
178414272,17841427,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Blood creatinine increased,,2020,Q4,2,F,20200516.0,20201005.0,20200529,20201013,EXP,,US-GILEAD-2020-0468705,GILEAD,,69.0,YR,E,M,Y,135.56,KG,20201013.0,,HP,US,US,2020,Q4,Elderly
178414272,17841427,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Blood urea increased,,2020,Q4,2,F,20200516.0,20201005.0,20200529,20201013,EXP,,US-GILEAD-2020-0468705,GILEAD,,69.0,YR,E,M,Y,135.56,KG,20201013.0,,HP,US,US,2020,Q4,Elderly
178733265,17873326,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,80 UNIT SUB-Q QDAY,,,,,,,,,,,QD,2020,Q4,Fournier's gangrene,,2020,Q4,5,F,20180429.0,20201029.0,20200608,20201105,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-028625",BOEHRINGER INGELHEIM,,45.0,YR,A,,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
178733265,17873326,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,80 UNIT SUB-Q QDAY,,,,,,,,,,,QD,2020,Q4,Necrotising fasciitis,,2020,Q4,5,F,20180429.0,20201029.0,20200608,20201105,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-028625",BOEHRINGER INGELHEIM,,45.0,YR,A,,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
178759016,17875901,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,26 U,,,,,,,,,,,QD,2020,Q4,Blood creatinine increased,,2020,Q4,6,F,20200603.0,20201118.0,20200609,20201123,EXP,,ES-ROCHE-2616155,ROCHE,,71.0,YR,,M,Y,93.2,KG,20201123.0,,MD,ES,ES,2020,Q4,Elderly
178829415,17882941,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q4,Cardiac failure,,2020,Q4,5,F,201904.0,20201003.0,20200610,20201008,EXP,,CZ-AUROBINDO-AUR-APL-2020-027986,AUROBINDO,,75.0,YR,,M,Y,,,20201008.0,,HP,CZ,CZ,2020,Q4,Elderly
178829415,17882941,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q4,Gait inability,,2020,Q4,5,F,201904.0,20201003.0,20200610,20201008,EXP,,CZ-AUROBINDO-AUR-APL-2020-027986,AUROBINDO,,75.0,YR,,M,Y,,,20201008.0,,HP,CZ,CZ,2020,Q4,Elderly
178829415,17882941,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q4,Immune-mediated myositis,,2020,Q4,5,F,201904.0,20201003.0,20200610,20201008,EXP,,CZ-AUROBINDO-AUR-APL-2020-027986,AUROBINDO,,75.0,YR,,M,Y,,,20201008.0,,HP,CZ,CZ,2020,Q4,Elderly
178829415,17882941,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q4,Muscular weakness,,2020,Q4,5,F,201904.0,20201003.0,20200610,20201008,EXP,,CZ-AUROBINDO-AUR-APL-2020-027986,AUROBINDO,,75.0,YR,,M,Y,,,20201008.0,,HP,CZ,CZ,2020,Q4,Elderly
178829415,17882941,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q4,Pain in extremity,,2020,Q4,5,F,201904.0,20201003.0,20200610,20201008,EXP,,CZ-AUROBINDO-AUR-APL-2020-027986,AUROBINDO,,75.0,YR,,M,Y,,,20201008.0,,HP,CZ,CZ,2020,Q4,Elderly
178829415,17882941,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,12.0,IU,INJECTION,QD,2020,Q4,Peripheral swelling,,2020,Q4,5,F,201904.0,20201003.0,20200610,20201008,EXP,,CZ-AUROBINDO-AUR-APL-2020-027986,AUROBINDO,,75.0,YR,,M,Y,,,20201008.0,,HP,CZ,CZ,2020,Q4,Elderly
178969533,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Balance disorder,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Condition aggravated,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Decreased appetite,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Dizziness,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,47 IU,,,,, 9F444A,,,47.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Postprandial hypoglycaemia,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,, 9F444A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Balance disorder,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,, 9F444A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,, 9F444A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Condition aggravated,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,, 9F444A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Decreased appetite,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,, 9F444A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Dizziness,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
178969533,17896953,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"49 INTERNATIONAL UNIT, DAILY (INCREASE OF 2 IU OF TOUJEO)",,,,, 9F444A,,,49.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Postprandial hypoglycaemia,,2020,Q4,3,F,202005.0,20201207.0,20200615,20201216,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202006003943,ELI LILLY AND CO,,55.0,YR,,M,Y,109.0,KG,20201216.0,,CN,ES,ES,2020,Q4,Adult
179698862,17969886,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU INTERNATINAL UNITS,,,,,,,,,,INJECTION,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,2,F,,20201013.0,20200701,20201021,EXP,,JP-ASTRAZENECA-2020SE80401,ASTRAZENECA,"ISHIGURO A, ET AL.. D-4 A CASE OF TYPE 1 DIABETES MELLITUS WHO PRESENTED WITH A SHOCK STATE DUE TO COMPLICATIONS OF DKA AND HHS WHILE ON ORAL ADMINISTRATION OF SGLT2 INHIBITOR.. THE 94TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY 2020;74.",49.0,YR,,M,Y,74.7,KG,20201021.0,,MD,JP,JP,2020,Q4,Adult
179698862,17969886,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,28 IU INTERNATINAL UNITS,,,,,,,,,,INJECTION,,2020,Q4,Hyperglycaemic hyperosmolar nonketotic syndrome,,2020,Q4,2,F,,20201013.0,20200701,20201021,EXP,,JP-ASTRAZENECA-2020SE80401,ASTRAZENECA,"ISHIGURO A, ET AL.. D-4 A CASE OF TYPE 1 DIABETES MELLITUS WHO PRESENTED WITH A SHOCK STATE DUE TO COMPLICATIONS OF DKA AND HHS WHILE ON ORAL ADMINISTRATION OF SGLT2 INHIBITOR.. THE 94TH CHUBU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY 2020;74.",49.0,YR,,M,Y,74.7,KG,20201021.0,,MD,JP,JP,2020,Q4,Adult
180077813,18007781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,34 UNITS,,,,,,,,,,,QD,2020,Q4,Salivary hypersecretion,,2020,Q4,3,F,20200408.0,20201014.0,20200710,20201023,PER,,US-VERTEX PHARMACEUTICALS-2020-014329,VERTEX,,41.0,YR,,M,Y,91.0,KG,20201023.0,,PH,US,US,2020,Q4,Adult
180077813,18007781,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,34 UNITS,,,,,,,,,,,QD,2020,Q4,Weight increased,,2020,Q4,3,F,20200408.0,20201014.0,20200710,20201023,PER,,US-VERTEX PHARMACEUTICALS-2020-014329,VERTEX,,41.0,YR,,M,Y,91.0,KG,20201023.0,,PH,US,US,2020,Q4,Adult
180200242,18020024,6,C,INSUL GLARGINE,,2,Unknown,UNK,,,,,,,,,,,,2020,Q4,Blood pressure increased,,2020,Q4,2,F,,20200710.0,20200714,20201126,PER,,IR-LUPIN PHARMACEUTICALS INC.-2020-03202,LUPIN,,59.0,YR,,M,Y,,,20201126.0,,MD,IR,IR,2020,Q4,Adult
180200242,18020024,6,C,INSUL GLARGINE,,2,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hypertension,,2020,Q4,2,F,,20200710.0,20200714,20201126,PER,,IR-LUPIN PHARMACEUTICALS INC.-2020-03202,LUPIN,,59.0,YR,,M,Y,,,20201126.0,,MD,IR,IR,2020,Q4,Adult
180306923,18030692,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,3,F,20200708.0,20201013.0,20200715,20201014,EXP,,US-GILEAD-2020-0483267,GILEAD,,55.0,YR,A,M,Y,121.0,KG,20201014.0,,PH,US,US,2020,Q4,Adult
180348394,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Cardiac disorder,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Injection site bruising,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Osteoarthritis,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Urinary incontinence,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Vascular stent occlusion,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Cardiac disorder,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Injection site bruising,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Osteoarthritis,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Urinary incontinence,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Vascular stent occlusion,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED",,,,, 0F715A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED",,,,, 0F715A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED",,,,, 0F715A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Cardiac disorder,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED",,,,, 0F715A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Injection site bruising,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED",,,,, 0F715A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Osteoarthritis,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED",,,,, 0F715A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Urinary incontinence,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180348394,18034839,4,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DOSE INCREASED",,,,, 0F715A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Vascular stent occlusion,,2020,Q4,4,F,,20201219.0,20200716,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-034909,AUROBINDO,,62.0,YR,,M,Y,93.0,KG,20201225.0,,CN,ES,ES,2020,Q4,Adult
180452784,18045278,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2020,Q4,Carcinoembryonic antigen increased,,2020,Q4,4,F,20200612.0,20201005.0,20200720,20201013,EXP,,JP-JNJFOC-20200715479,JOHNSON AND JOHNSON,,67.0,YR,E,F,Y,,,20201013.0,,MD,JP,JP,2020,Q4,Elderly
180452784,18045278,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,INJECTION,QD,2020,Q4,Pancreatic cyst,,2020,Q4,4,F,20200612.0,20201005.0,20200720,20201013,EXP,,JP-JNJFOC-20200715479,JOHNSON AND JOHNSON,,67.0,YR,E,F,Y,,,20201013.0,,MD,JP,JP,2020,Q4,Elderly
180511202,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Cardiac disorder,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Injection site bruising,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Osteoarthritis,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Urinary incontinence,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,18 INTERNATIONAL UNIT,,,,, 0F527A,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Vascular stent occlusion,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Cardiac disorder,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Injection site bruising,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Osteoarthritis,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Urinary incontinence,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180511202,18051120,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 INTERNATIONAL UNIT,,,,,,,,20.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Vascular stent occlusion,,2020,Q4,2,F,2020.0,20201005.0,20200721,20201008,EXP,,ES-MYLANLABS-2020M1064631,MYLAN,,62.0,YR,,M,Y,93.0,KG,20201008.0,,CN,ES,ES,2020,Q4,Adult
180636452,18063645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,2,F,2020.0,20201005.0,20200724,20201015,EXP,,ES-BAUSCH-BL-2020-020361,BAUSCH AND LOMB,,78.0,YR,,M,Y,90.7,KG,20201015.0,,CN,ES,ES,2020,Q4,Elderly
180636452,18063645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,2,F,2020.0,20201005.0,20200724,20201015,EXP,,ES-BAUSCH-BL-2020-020361,BAUSCH AND LOMB,,78.0,YR,,M,Y,90.7,KG,20201015.0,,CN,ES,ES,2020,Q4,Elderly
180636452,18063645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diet noncompliance,,2020,Q4,2,F,2020.0,20201005.0,20200724,20201015,EXP,,ES-BAUSCH-BL-2020-020361,BAUSCH AND LOMB,,78.0,YR,,M,Y,90.7,KG,20201015.0,,CN,ES,ES,2020,Q4,Elderly
180636452,18063645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Gait inability,,2020,Q4,2,F,2020.0,20201005.0,20200724,20201015,EXP,,ES-BAUSCH-BL-2020-020361,BAUSCH AND LOMB,,78.0,YR,,M,Y,90.7,KG,20201015.0,,CN,ES,ES,2020,Q4,Elderly
180636452,18063645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,2,F,2020.0,20201005.0,20200724,20201015,EXP,,ES-BAUSCH-BL-2020-020361,BAUSCH AND LOMB,,78.0,YR,,M,Y,90.7,KG,20201015.0,,CN,ES,ES,2020,Q4,Elderly
180636452,18063645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Malaise,,2020,Q4,2,F,2020.0,20201005.0,20200724,20201015,EXP,,ES-BAUSCH-BL-2020-020361,BAUSCH AND LOMB,,78.0,YR,,M,Y,90.7,KG,20201015.0,,CN,ES,ES,2020,Q4,Elderly
180636452,18063645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Nervousness,,2020,Q4,2,F,2020.0,20201005.0,20200724,20201015,EXP,,ES-BAUSCH-BL-2020-020361,BAUSCH AND LOMB,,78.0,YR,,M,Y,90.7,KG,20201015.0,,CN,ES,ES,2020,Q4,Elderly
180636452,18063645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Pain in extremity,,2020,Q4,2,F,2020.0,20201005.0,20200724,20201015,EXP,,ES-BAUSCH-BL-2020-020361,BAUSCH AND LOMB,,78.0,YR,,M,Y,90.7,KG,20201015.0,,CN,ES,ES,2020,Q4,Elderly
180636452,18063645,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product dose omission in error,,2020,Q4,2,F,2020.0,20201005.0,20200724,20201015,EXP,,ES-BAUSCH-BL-2020-020361,BAUSCH AND LOMB,,78.0,YR,,M,Y,90.7,KG,20201015.0,,CN,ES,ES,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Asthenia,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Constipation,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Contraindicated product administered,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Dehydration,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Drug clearance decreased,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Duplicate therapy error,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Fatigue,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,International normalised ratio increased,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Medication error,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Mobility decreased,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Myalgia,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Oedema peripheral,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Overdose,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Product administration error,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Product name confusion,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Rhabdomyolysis,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180656436,18065643,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 IU, QD",,,U,,,,,44.0,IU,,QD,2020,Q4,Urinary incontinence,,2020,Q4,6,F,,20201123.0,20200724,20201126,EXP,,NVSC2020CZ205071,NOVARTIS,,74.0,YR,,M,Y,,,20201126.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Asthenia,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Bedridden,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Constipation,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Contraindicated product administered,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Dehydration,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Drug clearance decreased,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Duplicate therapy error,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Fatigue,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,International normalised ratio increased,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Labelled drug-drug interaction medication error,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Medication error,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Mobility decreased,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Myalgia,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Oedema peripheral,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Overdose,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Product administration error,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Product name confusion,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Rhabdomyolysis,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180735805,18073580,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"44 INTERNATIONAL UNIT, QD",,,U,U,,,,44.0,IU,,QD,2020,Q4,Urinary incontinence,,2020,Q4,5,F,,20201204.0,20200727,20201210,EXP,,CZ-MYLANLABS-2020M1066289,MYLAN,,74.0,YR,,M,Y,,,20201210.0,,HP,CZ,CZ,2020,Q4,Elderly
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Arrhythmia supraventricular,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Decubitus ulcer,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Leukocytosis,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Normochromic normocytic anaemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pneumonia bacterial,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Sepsis syndrome,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Shock,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,22,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Staphylococcal infection,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Arrhythmia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Arrhythmia supraventricular,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Decubitus ulcer,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Leukocytosis,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Normochromic normocytic anaemia,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pneumonia bacterial,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Sepsis syndrome,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Shock,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180779326,18077932,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Staphylococcal infection,,2020,Q4,6,F,20200630.0,20201014.0,20200727,20201117,EXP,,US-GILEAD-2020-0485701,GILEAD,,63.0,YR,A,F,Y,53.0,KG,20201117.0,,HP,US,US,2020,Q4,Adult
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Alanine aminotransferase increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Asthenia,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Bedridden,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Blood creatine phosphokinase increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Blood creatinine increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Blood urea increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Constipation,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Contraindicated product administered,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Dehydration,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Drug clearance decreased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Fatigue,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Immobile,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Incorrect dose administered,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,International normalised ratio increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Medication error,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Mobility decreased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Myalgia,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Myoglobin blood increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Oedema peripheral,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Overdose,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Polyuria,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Product administration error,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Product name confusion,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Rhabdomyolysis,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Transaminases increased,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180836906,18083690,16,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,44.0,IU,,QD,2020,Q4,Urinary incontinence,,2020,Q4,6,F,,20201120.0,20200729,20201130,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,,74.0,YR,,M,Y,,,20201130.0,,HP,CZ,CZ,2020,Q4,Elderly
180877613,18087761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,210605.0,,,INJECTION,,2020,Q4,Blood insulin abnormal,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,210605.0,,,INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,210605.0,,,INJECTION,,2020,Q4,Drug ineffective,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,210605.0,,,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,210605.0,,,INJECTION,,2020,Q4,Insulin C-peptide abnormal,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,210605.0,,,INJECTION,,2020,Q4,Product administration interrupted,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180877613,18087761,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,INSULIN GLARGINE AND LISPRO (TOTAL DOSE - 60 UNITS/DAY),,,Y,,,,210605.0,,,INJECTION,,2020,Q4,Treatment noncompliance,,2020,Q4,3,F,201908.0,20201002.0,20200729,20201006,EXP,,PT-MYLANLABS-2020M1028391,MYLAN,,43.0,YR,,F,Y,,,20201006.0,,CN,PT,PT,2020,Q4,Adult
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Bedridden,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Constipation,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Contraindicated product administered,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Drug clearance decreased,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,International normalised ratio increased,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Overdose,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Product administration error,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Product name confusion,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Rhabdomyolysis,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180893492,18089349,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"44 INTERNATIONAL UNIT, QD",,,,,,,,44.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,2,F,,20200922.0,20200730,20201005,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,,74.0,YR,,M,Y,,,20201005.0,,HP,CZ,CZ,2020,Q4,Elderly
180895853,18089585,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 IU, QD",,,,,,,,,,,,2020,Q4,Gastroenteritis Escherichia coli,,2020,Q4,3,F,20200713.0,20200923.0,20200729,20201001,PER,,NL-TAIHO ONCOLOGY  INC-IM-2020-00561,TAIHO ONCOLOGY INC,,73.0,YR,,M,Y,94.0,KG,20201001.0,,MD,NL,NL,2020,Q4,Elderly
180899874,18089987,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Hypoglycaemia,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,6,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,12.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Weight increased,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Hypoglycaemia,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180899874,18089987,7,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, ONCE A DAY",,,Y,U,,,,60.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Weight increased,,2020,Q4,4,F,201104.0,20201001.0,20200730,20201009,EXP,,CZ-AUROBINDO-AUR-APL-2020-036834,AUROBINDO,,47.0,YR,,M,Y,,,20201009.0,,HP,CZ,CZ,2020,Q4,Adult
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Haemorrhage intracranial,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Lethargy,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Seizure,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
180986318,18098631,23,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Urinary tract infection,,2020,Q4,8,F,20200226.0,20201102.0,20200731,20201112,EXP,,US-ROCHE-2650965,ROCHE,,66.0,YR,,F,Y,104.0,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Asthenia,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood pressure decreased,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Dizziness,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Feeling abnormal,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Fibromyalgia,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Gait inability,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Glaucoma,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypersensitivity,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoaesthesia,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypotension,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Ocular hyperaemia,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Osteoarthritis,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Pain in extremity,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Paraesthesia,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Rheumatic disorder,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Swelling,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Swollen tongue,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Tremor,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181096763,18109676,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Unevaluable event,,2020,Q4,3,F,202007.0,20201019.0,20200804,20201026,EXP,,NVSC2020ES212214,NOVARTIS,,71.0,YR,,F,Y,96.0,KG,20201026.0,,HP,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Asthenia,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood pressure decreased,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Dizziness,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Feeling abnormal,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Fibromyalgia,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Gait inability,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Glaucoma,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypersensitivity,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoaesthesia,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypotension,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Ocular hyperaemia,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Osteoarthritis,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Pain in extremity,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Paraesthesia,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Rheumatic disorder,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Swelling,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Swollen tongue,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Tremor,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181125003,18112500,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Unevaluable event,,2020,Q4,3,F,202007.0,20201015.0,20200805,20201026,EXP,,ES-AUROBINDO-AUR-APL-2020-037153,AUROBINDO,,71.0,YR,,F,Y,96.0,KG,20201023.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Asthenia,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Blood pressure decreased,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Dizziness,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Feeling abnormal,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Fibromyalgia,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Gait inability,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Glaucoma,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypersensitivity,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoaesthesia,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Ocular hyperaemia,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Osteoarthritis,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Pain in extremity,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Paraesthesia,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Rheumatic disorder,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Swelling,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Swollen tongue,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Tremor,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181252133,18125213,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,Y,U, 0F557A,,,,,SOLUTION FOR INJECTION,,2020,Q4,Unevaluable event,,2020,Q4,3,F,202007.0,20201026.0,20200807,20201030,EXP,,ES-MYLANLABS-2020M1069726,MYLAN,,71.0,YR,,F,Y,96.0,KG,20201030.0,,CN,ES,ES,2020,Q4,Elderly
181462223,18146222,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, OTHER",,,,,,,210605.0,6.0,IU,INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, OTHER",,,,,,,210605.0,6.0,IU,INJECTION,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, OTHER",,,,,,,210605.0,6.0,IU,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, OTHER",,,,,,,210605.0,6.0,IU,INJECTION,,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, OTHER",,,,,,,210605.0,6.0,IU,INJECTION,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"6 IU, OTHER",,,,,,,210605.0,6.0,IU,INJECTION,,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"38 IU, OTHER",,,,,,,210605.0,38.0,IU,INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"38 IU, OTHER",,,,,,,210605.0,38.0,IU,INJECTION,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"38 IU, OTHER",,,,,,,210605.0,38.0,IU,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"38 IU, OTHER",,,,,,,210605.0,38.0,IU,INJECTION,,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"38 IU, OTHER",,,,,,,210605.0,38.0,IU,INJECTION,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"38 IU, OTHER",,,,,,,210605.0,38.0,IU,INJECTION,,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, OTHER",,,,,,,210605.0,34.0,IU,INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, OTHER",,,,,,,210605.0,34.0,IU,INJECTION,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, OTHER",,,,,,,210605.0,34.0,IU,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, OTHER",,,,,,,210605.0,34.0,IU,INJECTION,,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, OTHER",,,,,,,210605.0,34.0,IU,INJECTION,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"34 IU, OTHER",,,,,,,210605.0,34.0,IU,INJECTION,,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, OTHER",,,,,,,210605.0,14.0,IU,INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, OTHER",,,,,,,210605.0,14.0,IU,INJECTION,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, OTHER",,,,,,,210605.0,14.0,IU,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, OTHER",,,,,,,210605.0,14.0,IU,INJECTION,,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, OTHER",,,,,,,210605.0,14.0,IU,INJECTION,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 IU, OTHER",,,,,,,210605.0,14.0,IU,INJECTION,,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, OTHER",,,,,,,210605.0,22.0,IU,INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, OTHER",,,,,,,210605.0,22.0,IU,INJECTION,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, OTHER",,,,,,,210605.0,22.0,IU,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, OTHER",,,,,,,210605.0,22.0,IU,INJECTION,,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, OTHER",,,,,,,210605.0,22.0,IU,INJECTION,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"22 IU, OTHER",,,,,,,210605.0,22.0,IU,INJECTION,,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD (0-0-0-12 IU)",,,,,,,210605.0,12.0,IU,INJECTION,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD (0-0-0-12 IU)",,,,,,,210605.0,12.0,IU,INJECTION,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD (0-0-0-12 IU)",,,,,,,210605.0,12.0,IU,INJECTION,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD (0-0-0-12 IU)",,,,,,,210605.0,12.0,IU,INJECTION,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD (0-0-0-12 IU)",,,,,,,210605.0,12.0,IU,INJECTION,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"12 INTERNATIONAL UNIT, QD (0-0-0-12 IU)",,,,,,,210605.0,12.0,IU,INJECTION,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, QD (0-0-060 IU)",,,,,,,210605.0,60.0,IU,INJECTION,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, QD (0-0-060 IU)",,,,,,,210605.0,60.0,IU,INJECTION,QD,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, QD (0-0-060 IU)",,,,,,,210605.0,60.0,IU,INJECTION,QD,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, QD (0-0-060 IU)",,,,,,,210605.0,60.0,IU,INJECTION,QD,2020,Q4,Pancreatitis,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, QD (0-0-060 IU)",,,,,,,210605.0,60.0,IU,INJECTION,QD,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181462223,18146222,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"60 INTERNATIONAL UNIT, QD (0-0-060 IU)",,,,,,,210605.0,60.0,IU,INJECTION,QD,2020,Q4,Weight increased,,2020,Q4,3,F,201408.0,20201012.0,20200813,20201015,EXP,,CZ-MYLANLABS-2019M1044117,MYLAN,MAULE P.. DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - A POSSIBLE STEP BACK FROM. KASUISTIKY V DIABETOLOGII.. 2020;(18)2:37-39,47.0,YR,,M,Y,,,20201015.0,,MD,CZ,CZ,2020,Q4,Adult
181571483,18157148,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU INTERNATIONAL UNIT(S), 1/DAY, LONG-ACTING",,,,,,,,,,INJECTION,,2020,Q4,Decreased appetite,,2020,Q4,3,F,20190323.0,20201203.0,20200817,20201208,EXP,,JP-ASTRAZENECA-2020SE99896,ASTRAZENECA,,17224.0,DY,,M,Y,52.0,KG,20201208.0,,MD,JP,JP,2020,Q4,Elderly
181571483,18157148,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU INTERNATIONAL UNIT(S), 1/DAY, LONG-ACTING",,,,,,,,,,INJECTION,,2020,Q4,Dehydration,,2020,Q4,3,F,20190323.0,20201203.0,20200817,20201208,EXP,,JP-ASTRAZENECA-2020SE99896,ASTRAZENECA,,17224.0,DY,,M,Y,52.0,KG,20201208.0,,MD,JP,JP,2020,Q4,Elderly
181571483,18157148,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU INTERNATIONAL UNIT(S), 1/DAY, LONG-ACTING",,,,,,,,,,INJECTION,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,3,F,20190323.0,20201203.0,20200817,20201208,EXP,,JP-ASTRAZENECA-2020SE99896,ASTRAZENECA,,17224.0,DY,,M,Y,52.0,KG,20201208.0,,MD,JP,JP,2020,Q4,Elderly
181571483,18157148,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU INTERNATIONAL UNIT(S), 1/DAY, LONG-ACTING",,,,,,,,,,INJECTION,,2020,Q4,General physical health deterioration,,2020,Q4,3,F,20190323.0,20201203.0,20200817,20201208,EXP,,JP-ASTRAZENECA-2020SE99896,ASTRAZENECA,,17224.0,DY,,M,Y,52.0,KG,20201208.0,,MD,JP,JP,2020,Q4,Elderly
181571483,18157148,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU INTERNATIONAL UNIT(S), 1/DAY, LONG-ACTING",,,,,,,,,,INJECTION,,2020,Q4,Hypophagia,,2020,Q4,3,F,20190323.0,20201203.0,20200817,20201208,EXP,,JP-ASTRAZENECA-2020SE99896,ASTRAZENECA,,17224.0,DY,,M,Y,52.0,KG,20201208.0,,MD,JP,JP,2020,Q4,Elderly
181571483,18157148,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU INTERNATIONAL UNIT(S), 1/DAY, LONG-ACTING",,,,,,,,,,INJECTION,,2020,Q4,Infection,,2020,Q4,3,F,20190323.0,20201203.0,20200817,20201208,EXP,,JP-ASTRAZENECA-2020SE99896,ASTRAZENECA,,17224.0,DY,,M,Y,52.0,KG,20201208.0,,MD,JP,JP,2020,Q4,Elderly
181579082,18157908,85,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,85,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Anxiety,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,85,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,85,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,85,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Emotional distress,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,85,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,85,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Nephrolithiasis,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,85,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pain,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
181579082,18157908,85,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,2,F,20140930.0,20201023.0,20200817,20201030,EXP,,US-GILEAD-2020-0489137,GILEAD,,44.0,YR,A,M,Y,84.35,KG,20201030.0,,LW,US,US,2020,Q4,Adult
182008735,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,5,F,,20201102.0,20200827,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Young Adult
182008735,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,5,F,,20201102.0,20200827,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Young Adult
182008735,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Gastrointestinal disorder,,2020,Q4,5,F,,20201102.0,20200827,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Young Adult
182008735,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Lymphoma,,2020,Q4,5,F,,20201102.0,20200827,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Young Adult
182008735,18200873,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Therapy non-responder,,2020,Q4,5,F,,20201102.0,20200827,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-044564,AUROBINDO,,26.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Young Adult
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diet noncompliance,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Gait inability,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Malaise,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Nervousness,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Pain in extremity,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product dose omission in error,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182163592,18216359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product use issue,,2020,Q4,2,F,2020.0,20201003.0,20200901,20201012,EXP,,ES-AUROBINDO-AUR-APL-2020-035551,AUROBINDO,,78.0,YR,,M,Y,90.7,KG,20201012.0,,CN,ES,ES,2020,Q4,Elderly
182283517,18228351,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Central nervous system leukaemia,,2020,Q4,7,F,20200823.0,20201111.0,20200903,20201116,EXP,,DE-CELGENEUS-DEU-20200807250,CELGENE,,77.0,YR,,M,Y,88.0,KG,20201116.0,,HP,DE,DE,2020,Q4,Elderly
182283517,18228351,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Genital infection fungal,,2020,Q4,7,F,20200823.0,20201111.0,20200903,20201116,EXP,,DE-CELGENEUS-DEU-20200807250,CELGENE,,77.0,YR,,M,Y,88.0,KG,20201116.0,,HP,DE,DE,2020,Q4,Elderly
182283517,18228351,12,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Sepsis,,2020,Q4,7,F,20200823.0,20201111.0,20200903,20201116,EXP,,DE-CELGENEUS-DEU-20200807250,CELGENE,,77.0,YR,,M,Y,88.0,KG,20201116.0,,HP,DE,DE,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diet noncompliance,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Gait inability,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Malaise,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Nervousness,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Pain in extremity,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product dose omission in error,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182477472,18247747,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product use issue,,2020,Q4,2,F,2020.0,20201016.0,20200909,20201020,EXP,,ES-MYLANLABS-2020M1076346,MYLAN,,78.0,YR,,M,Y,90.7,KG,20201020.0,,CN,ES,ES,2020,Q4,Elderly
182482783,18248278,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,210605.0,,,,,2020,Q4,Drug ineffective,,2020,Q4,3,F,,20201012.0,20200909,20201015,EXP,,DE-MYLANLABS-2020M1076367,MYLAN,,26.0,YR,,M,Y,,,20201015.0,,CN,DE,DE,2020,Q4,Young Adult
182482783,18248278,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,210605.0,,,,,2020,Q4,Gastrointestinal disorder,,2020,Q4,3,F,,20201012.0,20200909,20201015,EXP,,DE-MYLANLABS-2020M1076367,MYLAN,,26.0,YR,,M,Y,,,20201015.0,,CN,DE,DE,2020,Q4,Young Adult
182482783,18248278,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,210605.0,,,,,2020,Q4,Lymphoma,,2020,Q4,3,F,,20201012.0,20200909,20201015,EXP,,DE-MYLANLABS-2020M1076367,MYLAN,,26.0,YR,,M,Y,,,20201015.0,,CN,DE,DE,2020,Q4,Young Adult
182482783,18248278,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,210605.0,,,,,2020,Q4,Therapy non-responder,,2020,Q4,3,F,,20201012.0,20200909,20201015,EXP,,DE-MYLANLABS-2020M1076367,MYLAN,,26.0,YR,,M,Y,,,20201015.0,,CN,DE,DE,2020,Q4,Young Adult
182635977,18263597,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 INTERNATIONAL UNIT, QD",,,,,,,,28.0,IU,,QD,2020,Q4,Asthenia,,2020,Q4,7,F,20170608.0,20201012.0,20200914,20201015,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,,57.0,YR,,F,Y,,,20201015.0,,MD,ES,ES,2020,Q4,Adult
182635977,18263597,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 INTERNATIONAL UNIT, QD",,,,,,,,28.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,7,F,20170608.0,20201012.0,20200914,20201015,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,,57.0,YR,,F,Y,,,20201015.0,,MD,ES,ES,2020,Q4,Adult
182635977,18263597,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 INTERNATIONAL UNIT, QD",,,,,,,,28.0,IU,,QD,2020,Q4,Gastrointestinal toxicity,,2020,Q4,7,F,20170608.0,20201012.0,20200914,20201015,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,,57.0,YR,,F,Y,,,20201015.0,,MD,ES,ES,2020,Q4,Adult
182635977,18263597,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 INTERNATIONAL UNIT, QD",,,,,,,,28.0,IU,,QD,2020,Q4,Malignant neoplasm progression,,2020,Q4,7,F,20170608.0,20201012.0,20200914,20201015,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,,57.0,YR,,F,Y,,,20201015.0,,MD,ES,ES,2020,Q4,Adult
182635977,18263597,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 INTERNATIONAL UNIT, QD",,,,,,,,28.0,IU,,QD,2020,Q4,Off label use,,2020,Q4,7,F,20170608.0,20201012.0,20200914,20201015,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,,57.0,YR,,F,Y,,,20201015.0,,MD,ES,ES,2020,Q4,Adult
182635977,18263597,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 INTERNATIONAL UNIT, QD",,,,,,,,28.0,IU,,QD,2020,Q4,Pancreatitis acute,,2020,Q4,7,F,20170608.0,20201012.0,20200914,20201015,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,,57.0,YR,,F,Y,,,20201015.0,,MD,ES,ES,2020,Q4,Adult
182635977,18263597,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"28 INTERNATIONAL UNIT, QD",,,,,,,,28.0,IU,,QD,2020,Q4,Product use in unapproved indication,,2020,Q4,7,F,20170608.0,20201012.0,20200914,20201015,EXP,,ES-MYLANLABS-2020M1077486,MYLAN,,57.0,YR,,F,Y,,,20201015.0,,MD,ES,ES,2020,Q4,Adult
182665333,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q4,Hyperglycaemia,,2020,Q4,3,F,20200907.0,20201021.0,20200915,20201026,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
182665333,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,3,F,20200907.0,20201021.0,20200915,20201026,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
182665333,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q4,Neutropenia,,2020,Q4,3,F,20200907.0,20201021.0,20200915,20201026,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
182665333,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q4,Toxic epidermal necrolysis,,2020,Q4,3,F,20200907.0,20201021.0,20200915,20201026,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
182665333,18266533,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, AT BEDTIME (QHS)",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q4,Toxicity to various agents,,2020,Q4,3,F,20200907.0,20201021.0,20200915,20201026,EXP,,US-ASTELLAS-2020US030491,ASTELLAS,,72.0,YR,,F,Y,,,20201026.0,,CN,US,US,2020,Q4,Elderly
182697272,18269727,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Empyema,,2020,Q4,2,F,,20201013.0,20200915,20201016,EXP,,JP-TEVA-2020-JP-1827254,TEVA,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN-RES 2019;18(5):300-305.",77.0,YR,E,F,Y,,,20201016.0,,MD,JP,JP,2020,Q4,Elderly
182697272,18269727,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Nocardiosis,,2020,Q4,2,F,,20201013.0,20200915,20201016,EXP,,JP-TEVA-2020-JP-1827254,TEVA,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN-RES 2019;18(5):300-305.",77.0,YR,E,F,Y,,,20201016.0,,MD,JP,JP,2020,Q4,Elderly
182697272,18269727,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Pleural effusion,,2020,Q4,2,F,,20201013.0,20200915,20201016,EXP,,JP-TEVA-2020-JP-1827254,TEVA,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN-RES 2019;18(5):300-305.",77.0,YR,E,F,Y,,,20201016.0,,MD,JP,JP,2020,Q4,Elderly
182697272,18269727,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,2,F,,20201013.0,20200915,20201016,EXP,,JP-TEVA-2020-JP-1827254,TEVA,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN-RES 2019;18(5):300-305.",77.0,YR,E,F,Y,,,20201016.0,,MD,JP,JP,2020,Q4,Elderly
182697272,18269727,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Subcutaneous abscess,,2020,Q4,2,F,,20201013.0,20200915,20201016,EXP,,JP-TEVA-2020-JP-1827254,TEVA,"TAKEMORI C, NISHII M, TSURUTA A, SEKIMUKAI A, YAMAMOTO A, IMADO T, ET AL. A CASE OF DISSEMINATED NOCARDIOSIS IN AN IMMUNOCOMPROMISED PATIENT. [JAPANESE]. SKIN-RES 2019;18(5):300-305.",77.0,YR,E,F,Y,,,20201016.0,,MD,JP,JP,2020,Q4,Elderly
182710472,18271047,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Disease recurrence,,2020,Q4,2,F,,20200930.0,20200916,20201013,EXP,,PK-LUPIN PHARMACEUTICALS INC.-2020-05900,LUPIN,,42.0,YR,,M,Y,,,20201013.0,,MD,US,PK,2020,Q4,Adult
182710472,18271047,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Drug interaction,,2020,Q4,2,F,,20200930.0,20200916,20201013,EXP,,PK-LUPIN PHARMACEUTICALS INC.-2020-05900,LUPIN,,42.0,YR,,M,Y,,,20201013.0,,MD,US,PK,2020,Q4,Adult
182710472,18271047,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, QD",,,,,,,,,,,QD,2020,Q4,Seizure,,2020,Q4,2,F,,20200930.0,20200916,20201013,EXP,,PK-LUPIN PHARMACEUTICALS INC.-2020-05900,LUPIN,,42.0,YR,,M,Y,,,20201013.0,,MD,US,PK,2020,Q4,Adult
182720999,18272099,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,100.0,IU,INJECTION,,2020,Q4,Hypertensive emergency,,2020,Q4,9,F,20200830.0,20201228.0,20200916,20201230,EXP,,US-ASTELLAS-2020US031974,ASTELLAS,,66.0,YR,,M,Y,116.0,KG,20201230.0,,MD,US,US,2020,Q4,Elderly
182721512,18272151,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Asthenia,,2020,Q4,2,F,20200725.0,20201025.0,20200916,20201102,EXP,PT-INFARMED-F202008-437,PT-TEVA-2020-PT-1826738,TEVA,,84.0,YR,E,F,Y,,,20201102.0,,PH,PT,PT,2020,Q4,Elderly
182721512,18272151,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Fatigue,,2020,Q4,2,F,20200725.0,20201025.0,20200916,20201102,EXP,PT-INFARMED-F202008-437,PT-TEVA-2020-PT-1826738,TEVA,,84.0,YR,E,F,Y,,,20201102.0,,PH,PT,PT,2020,Q4,Elderly
182721512,18272151,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,, UNKNOWN,,,,,,,2020,Q4,Hyperglycaemia,,2020,Q4,2,F,20200725.0,20201025.0,20200916,20201102,EXP,PT-INFARMED-F202008-437,PT-TEVA-2020-PT-1826738,TEVA,,84.0,YR,E,F,Y,,,20201102.0,,PH,PT,PT,2020,Q4,Elderly
182727612,18272761,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, QD/EVERY DAY",,,Y,U,,,,14.0,IU,INJECTION,QD,2020,Q4,Hyponatraemia,,2020,Q4,2,F,201809.0,20201207.0,20200916,20201215,EXP,FR-AFSSAPS-AN20181130,FR-MYLANLABS-2019M1036960,MYLAN,,71.0,YR,,F,Y,,,20201215.0,,HP,FR,FR,2020,Q4,Elderly
182727612,18272761,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 INTERNATIONAL UNIT, QD/EVERY DAY",,,Y,U,,,,14.0,IU,INJECTION,QD,2020,Q4,Inappropriate antidiuretic hormone secretion,,2020,Q4,2,F,201809.0,20201207.0,20200916,20201215,EXP,FR-AFSSAPS-AN20181130,FR-MYLANLABS-2019M1036960,MYLAN,,71.0,YR,,F,Y,,,20201215.0,,HP,FR,FR,2020,Q4,Elderly
182729162,18272916,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNITS,,,,,,,,,,,QD,2020,Q4,Product adhesion issue,,2020,Q4,2,F,2020.0,20200929.0,20200916,20201103,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0440,BIODELIVERY SCIENCES INTERNATIONAL,,72.0,YR,E,M,Y,90.8,KG,20201103.0,,CN,US,US,2020,Q4,Elderly
182729162,18272916,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNITS,,,,,,,,,,,QD,2020,Q4,Product physical consistency issue,,2020,Q4,2,F,2020.0,20200929.0,20200916,20201103,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0440,BIODELIVERY SCIENCES INTERNATIONAL,,72.0,YR,E,M,Y,90.8,KG,20201103.0,,CN,US,US,2020,Q4,Elderly
182729162,18272916,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNITS,,,,,,,,,,,QD,2020,Q4,Product solubility abnormal,,2020,Q4,2,F,2020.0,20200929.0,20200916,20201103,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0440,BIODELIVERY SCIENCES INTERNATIONAL,,72.0,YR,E,M,Y,90.8,KG,20201103.0,,CN,US,US,2020,Q4,Elderly
182729162,18272916,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,12 UNITS,,,,,,,,,,,QD,2020,Q4,Wrong technique in product usage process,,2020,Q4,2,F,2020.0,20200929.0,20200916,20201103,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0440,BIODELIVERY SCIENCES INTERNATIONAL,,72.0,YR,E,M,Y,90.8,KG,20201103.0,,CN,US,US,2020,Q4,Elderly
182791572,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,U,,,,,,,,,2020,Q4,Depressed level of consciousness,,2020,Q4,2,F,,20201105.0,20200917,20201113,EXP,DE-ADRED-05209-02,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
182791572,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,2,F,,20201105.0,20200917,20201113,EXP,DE-ADRED-05209-02,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
182791572,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,2,F,,20201105.0,20200917,20201113,EXP,DE-ADRED-05209-02,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
182791572,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,U,,,,,,,,,2020,Q4,Loss of consciousness,,2020,Q4,2,F,,20201105.0,20200917,20201113,EXP,DE-ADRED-05209-02,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
182791572,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,U,,,,,,,,,2020,Q4,Product prescribing error,,2020,Q4,2,F,,20201105.0,20200917,20201113,EXP,DE-ADRED-05209-02,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
182791572,18279157,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,U,,,,,,,,,2020,Q4,Somnolence,,2020,Q4,2,F,,20201105.0,20200917,20201113,EXP,DE-ADRED-05209-02,NVSC2020DE251768,NOVARTIS,,78.0,YR,,M,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
182800952,18280095,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,2,F,20200819.0,20200915.0,20200917,20201007,EXP,,US-GILEAD-2020-0495305,GILEAD,,71.0,YR,E,F,Y,44.9,KG,20201007.0,,PH,US,US,2020,Q4,Elderly
182800952,18280095,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,2,F,20200819.0,20200915.0,20200917,20201007,EXP,,US-GILEAD-2020-0495305,GILEAD,,71.0,YR,E,F,Y,44.9,KG,20201007.0,,PH,US,US,2020,Q4,Elderly
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Balance disorder,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Blood creatine phosphokinase increased,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Cogwheel rigidity,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Gait disturbance,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypertonia,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Myocarditis,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Neuroleptic malignant syndrome,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Nystagmus,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Somnolence,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182832342,18283234,25,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,2,F,202007.0,20201007.0,20200918,20201013,EXP,,CA-MYLANLABS-2020M1068968,MYLAN,,51.0,YR,,M,Y,94.2,KG,20201013.0,,MD,CA,CA,2020,Q4,Adult
182843814,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,4,F,,20201005.0,20200918,20201007,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20201007.0,,HP,DE,DE,2020,Q4,Young Adult
182843814,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,4,F,,20201005.0,20200918,20201007,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20201007.0,,HP,DE,DE,2020,Q4,Young Adult
182843814,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,4,F,,20201005.0,20200918,20201007,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20201007.0,,HP,DE,DE,2020,Q4,Young Adult
182843814,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Gastrointestinal disorder,,2020,Q4,4,F,,20201005.0,20200918,20201007,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20201007.0,,HP,DE,DE,2020,Q4,Young Adult
182843814,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Lymphoma,,2020,Q4,4,F,,20201005.0,20200918,20201007,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20201007.0,,HP,DE,DE,2020,Q4,Young Adult
182843814,18284381,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Therapy non-responder,,2020,Q4,4,F,,20201005.0,20200918,20201007,EXP,,NVSC2020DE247971,NOVARTIS,,26.0,YR,,M,Y,,,20201007.0,,HP,DE,DE,2020,Q4,Young Adult
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Breath sounds,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Cheilitis,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Eosinophilia,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Glossitis,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Hepatocellular injury,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Hypercreatininaemia,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Intra-abdominal fluid collection,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Rash maculo-papular,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182853354,18285335,14,C,Insuline Glargine,INSULIN GLARGINE,1,Unknown,"UNK,INCONNUE",,,,,,,,,,,,2020,Q4,Splenomegaly,,2020,Q4,4,F,202008.0,20201214.0,20200919,20201223,EXP,,FR-AUROBINDO-AUR-APL-2020-048123,AUROBINDO,,79.0,YR,,F,Y,72.0,KG,20201224.0,,MD,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Breath sounds,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Cheilitis,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Eosinophilia,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Glossitis,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Hepatocellular injury,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Hypercreatininaemia,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Intra-abdominal fluid collection,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Rash maculo-papular,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
182900816,18290081,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (INCONNUE),,,,,,,,,,,,2020,Q4,Splenomegaly,,2020,Q4,6,F,202008.0,20201221.0,20200921,20201228,EXP,FR-AFSSAPS-AN20201025,NVSC2020FR252711,NOVARTIS,,79.0,YR,,F,Y,72.0,KG,20201228.0,,HP,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Breath sounds,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cheilitis,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Eosinophilia,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Glossitis,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hepatocellular injury,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypercreatininaemia,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Intra-abdominal fluid collection,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Rash maculo-papular,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183024173,18302417,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Splenomegaly,,2020,Q4,3,F,202008.0,20201202.0,20200923,20201208,EXP,FR-AFSSAPS-AN20201025,FR-JNJFOC-20200924658,JOHNSON AND JOHNSON,,79.0,YR,E,F,Y,72.0,KG,20201209.0,,MD,FR,FR,2020,Q4,Elderly
183053952,18305395,10,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2020,Q4,Eosinophilia,,2020,Q4,2,F,20200808.0,20201203.0,20200924,20201216,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20201216.0,,HP,NL,FR,2020,Q4,Elderly
183053952,18305395,10,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2020,Q4,Hepatocellular injury,,2020,Q4,2,F,20200808.0,20201203.0,20200924,20201216,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20201216.0,,HP,NL,FR,2020,Q4,Elderly
183053952,18305395,10,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2020,Q4,Hypercreatininaemia,,2020,Q4,2,F,20200808.0,20201203.0,20200924,20201216,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20201216.0,,HP,NL,FR,2020,Q4,Elderly
183053952,18305395,10,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,Unknown,INCONNUE (),,,,,,,,,,,,2020,Q4,Rash maculo-papular,,2020,Q4,2,F,20200808.0,20201203.0,20200924,20201216,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-261519,RANBAXY,,79.0,YR,,F,Y,72.0,KG,20201216.0,,HP,NL,FR,2020,Q4,Elderly
183098872,18309887,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Blood lactate dehydrogenase increased,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
183098872,18309887,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Haemolytic anaemia,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
183098872,18309887,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Haptoglobin decreased,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
183098872,18309887,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Intentional product use issue,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
183098872,18309887,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Reticulocyte count increased,,2020,Q4,2,F,20200916.0,20201007.0,20200924,20201012,EXP,,US-GILEAD-2020-0496198,GILEAD,,47.0,YR,A,F,Y,85.1,KG,20201012.0,,PH,US,US,2020,Q4,Adult
1831150112,18311501,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (HIGH DOSE),,,D,,,,,,,,,2020,Q4,Atrioventricular block first degree,,2020,Q4,12,F,,20201112.0,20200925,20201118,EXP,,US-PFIZER INC-2020369062,PFIZER,"GOLDBERGER, D.. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLINICAL TOXICOLOGY. 2020;58(6):626",74.0,YR,,F,Y,,,20201118.0,,MD,US,US,2020,Q4,Elderly
1831150112,18311501,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (HIGH DOSE),,,D,,,,,,,,,2020,Q4,Atrioventricular block second degree,,2020,Q4,12,F,,20201112.0,20200925,20201118,EXP,,US-PFIZER INC-2020369062,PFIZER,"GOLDBERGER, D.. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLINICAL TOXICOLOGY. 2020;58(6):626",74.0,YR,,F,Y,,,20201118.0,,MD,US,US,2020,Q4,Elderly
1831150112,18311501,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (HIGH DOSE),,,D,,,,,,,,,2020,Q4,Bezoar,,2020,Q4,12,F,,20201112.0,20200925,20201118,EXP,,US-PFIZER INC-2020369062,PFIZER,"GOLDBERGER, D.. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLINICAL TOXICOLOGY. 2020;58(6):626",74.0,YR,,F,Y,,,20201118.0,,MD,US,US,2020,Q4,Elderly
1831150112,18311501,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (HIGH DOSE),,,D,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,12,F,,20201112.0,20200925,20201118,EXP,,US-PFIZER INC-2020369062,PFIZER,"GOLDBERGER, D.. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLINICAL TOXICOLOGY. 2020;58(6):626",74.0,YR,,F,Y,,,20201118.0,,MD,US,US,2020,Q4,Elderly
1831150112,18311501,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (HIGH DOSE),,,D,,,,,,,,,2020,Q4,Intentional overdose,,2020,Q4,12,F,,20201112.0,20200925,20201118,EXP,,US-PFIZER INC-2020369062,PFIZER,"GOLDBERGER, D.. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLINICAL TOXICOLOGY. 2020;58(6):626",74.0,YR,,F,Y,,,20201118.0,,MD,US,US,2020,Q4,Elderly
1831150112,18311501,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (HIGH DOSE),,,D,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,12,F,,20201112.0,20200925,20201118,EXP,,US-PFIZER INC-2020369062,PFIZER,"GOLDBERGER, D.. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLINICAL TOXICOLOGY. 2020;58(6):626",74.0,YR,,F,Y,,,20201118.0,,MD,US,US,2020,Q4,Elderly
1831150112,18311501,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (HIGH DOSE),,,D,,,,,,,,,2020,Q4,Somnolence,,2020,Q4,12,F,,20201112.0,20200925,20201118,EXP,,US-PFIZER INC-2020369062,PFIZER,"GOLDBERGER, D.. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLINICAL TOXICOLOGY. 2020;58(6):626",74.0,YR,,F,Y,,,20201118.0,,MD,US,US,2020,Q4,Elderly
1831150112,18311501,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK (HIGH DOSE),,,D,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,12,F,,20201112.0,20200925,20201118,EXP,,US-PFIZER INC-2020369062,PFIZER,"GOLDBERGER, D.. MASSIVE POLYPHARMACY OVERDOSE RESULTING IN DILTIAZEM PHARMACOBEZOAR FORMATION. CLINICAL TOXICOLOGY. 2020;58(6):626",74.0,YR,,F,Y,,,20201118.0,,MD,US,US,2020,Q4,Elderly
183179232,18317923,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2020,Q4,Eosinophilia,,2020,Q4,2,F,20200808.0,20201204.0,20200928,20201214,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20201214.0,,CN,GB,FR,2020,Q4,Elderly
183179232,18317923,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2020,Q4,Hepatocellular injury,,2020,Q4,2,F,20200808.0,20201204.0,20200928,20201214,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20201214.0,,CN,GB,FR,2020,Q4,Elderly
183179232,18317923,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2020,Q4,Hypercreatininaemia,,2020,Q4,2,F,20200808.0,20201204.0,20200928,20201214,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20201214.0,,CN,GB,FR,2020,Q4,Elderly
183179232,18317923,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,, UNK,,,,,FORMULATION UNKNOWN,,2020,Q4,Rash maculo-papular,,2020,Q4,2,F,20200808.0,20201204.0,20200928,20201214,EXP,,FR-ASTELLAS-2020US033375,ASTELLAS,,79.0,YR,,F,Y,,,20201214.0,,CN,GB,FR,2020,Q4,Elderly
183208752,18320875,20,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20131114.0,20201013.0,20200928,20201015,EXP,,US-PFIZER INC-2019230250,PFIZER,,65.0,YR,,F,Y,,,20201015.0,,HP,US,US,2020,Q4,Elderly
183208752,18320875,20,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,20131114.0,20201013.0,20200928,20201015,EXP,,US-PFIZER INC-2019230250,PFIZER,,65.0,YR,,F,Y,,,20201015.0,,HP,US,US,2020,Q4,Elderly
183300862,18330086,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2020,Q4,Eosinophilia,,2020,Q4,2,F,20200808.0,20201207.0,20200930,20201215,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20201215.0,,MD,FR,FR,2020,Q4,Elderly
183300862,18330086,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2020,Q4,Hepatocellular injury,,2020,Q4,2,F,20200808.0,20201207.0,20200930,20201215,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20201215.0,,MD,FR,FR,2020,Q4,Elderly
183300862,18330086,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2020,Q4,Hypercreatininaemia,,2020,Q4,2,F,20200808.0,20201207.0,20200930,20201215,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20201215.0,,MD,FR,FR,2020,Q4,Elderly
183300862,18330086,9,C,INSULINE GLARGINE ((BACTERIE/ESCHERICHIA COLI)),INSULIN GLARGINE,1,,UNKNOWN,,,,, UNKNOWN,,,,,,,2020,Q4,Rash maculo-papular,,2020,Q4,2,F,20200808.0,20201207.0,20200930,20201215,EXP,FR-AFSSAPS-AN20201025,FR-TEVA-2020-FR-1832185,TEVA,,79.0,YR,E,F,Y,72.0,KG,20201215.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Breath sounds,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Cheilitis,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Eosinophilia,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Glossitis,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Hepatocellular injury,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Hypercreatininaemia,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Intra-abdominal fluid collection,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Rash maculo-papular,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183303773,18330377,12,C,INSULINE GLARGINE,INSULIN GLARGINE,1,,INCONNUE,,,,,,,,,,,,2020,Q4,Splenomegaly,,2020,Q4,3,F,202008.0,20201208.0,20200930,20201217,EXP,FR-AFSSAPS-AN20201025,FR-MYLANLABS-2020M1081955,MYLAN,,79.0,YR,,F,Y,72.0,KG,20201217.0,,MD,FR,FR,2020,Q4,Elderly
183304312,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Depressed level of consciousness,,2020,Q4,2,F,,20201118.0,20200930,20201124,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20201124.0,,MD,DE,DE,2020,Q4,Elderly
183304312,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Fall,,2020,Q4,2,F,,20201118.0,20200930,20201124,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20201124.0,,MD,DE,DE,2020,Q4,Elderly
183304312,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,General physical health deterioration,,2020,Q4,2,F,,20201118.0,20200930,20201124,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20201124.0,,MD,DE,DE,2020,Q4,Elderly
183304312,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Loss of consciousness,,2020,Q4,2,F,,20201118.0,20200930,20201124,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20201124.0,,MD,DE,DE,2020,Q4,Elderly
183304312,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Product prescribing error,,2020,Q4,2,F,,20201118.0,20200930,20201124,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20201124.0,,MD,DE,DE,2020,Q4,Elderly
183304312,18330431,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"16 IE, 0-0-0-16, AMPULLEN",,,,,,,,,,INJECTION,,2020,Q4,Somnolence,,2020,Q4,2,F,,20201118.0,20200930,20201124,EXP,,DE-MYLANLABS-2020M1081878,MYLAN,,78.0,YR,,M,Y,,,20201124.0,,MD,DE,DE,2020,Q4,Elderly
183307644,18330764,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,4,F,20200926.0,20201124.0,20200930,20201218,EXP,,US-GILEAD-2020-0496822,GILEAD,,70.0,YR,E,M,Y,,,20201218.0,,PH,US,US,2020,Q4,Elderly
183307644,18330764,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,4,F,20200926.0,20201124.0,20200930,20201218,EXP,,US-GILEAD-2020-0496822,GILEAD,,70.0,YR,E,M,Y,,,20201218.0,,PH,US,US,2020,Q4,Elderly
183307644,18330764,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Large intestine perforation,,2020,Q4,4,F,20200926.0,20201124.0,20200930,20201218,EXP,,US-GILEAD-2020-0496822,GILEAD,,70.0,YR,E,M,Y,,,20201218.0,,PH,US,US,2020,Q4,Elderly
183351971,18335197,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, AMPULLEN",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,Cough,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082309,MYLAN,,84.0,YR,,F,Y,85.0,KG,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183351971,18335197,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, AMPULLEN",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082309,MYLAN,,84.0,YR,,F,Y,85.0,KG,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183351971,18335197,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, AMPULLEN",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,Fatigue,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082309,MYLAN,,84.0,YR,,F,Y,85.0,KG,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183351971,18335197,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, AMPULLEN",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082309,MYLAN,,84.0,YR,,F,Y,85.0,KG,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183351971,18335197,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, AMPULLEN",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,Pyrexia,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082309,MYLAN,,84.0,YR,,F,Y,85.0,KG,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183351971,18335197,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-6, AMPULLEN",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20200924.0,20201001,20201001,EXP,,DE-MYLANLABS-2020M1082309,MYLAN,,84.0,YR,,F,Y,85.0,KG,20201001.0,,PH,DE,DE,2020,Q4,Elderly
183364822,18336482,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,2,F,,20201105.0,20201001,20201113,EXP,DE-EMA-DD-20200915-PRABHAKAR_D-181703,DE-EMD SERONO-E2B_90080394,EMD SERONO INC,"DONATH H, HESS U, KIESLICH M, THEIS M, OHLENSCHL?GER U, SCHUBERT R, WOELKE S, ZIELEN S. DIABETES IN PATIENTS WITH ATAXIA TELANGIECTASIA: A NATIONAL COHORT STUDY. FRONT PEDIATR. 2020;8:317. DOI:10.3389/FPED.2020.00317.",26.0,YR,A,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Young Adult
183364822,18336482,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q4,Gastrointestinal disorder,,2020,Q4,2,F,,20201105.0,20201001,20201113,EXP,DE-EMA-DD-20200915-PRABHAKAR_D-181703,DE-EMD SERONO-E2B_90080394,EMD SERONO INC,"DONATH H, HESS U, KIESLICH M, THEIS M, OHLENSCHL?GER U, SCHUBERT R, WOELKE S, ZIELEN S. DIABETES IN PATIENTS WITH ATAXIA TELANGIECTASIA: A NATIONAL COHORT STUDY. FRONT PEDIATR. 2020;8:317. DOI:10.3389/FPED.2020.00317.",26.0,YR,A,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Young Adult
183364822,18336482,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q4,Lymphoma,,2020,Q4,2,F,,20201105.0,20201001,20201113,EXP,DE-EMA-DD-20200915-PRABHAKAR_D-181703,DE-EMD SERONO-E2B_90080394,EMD SERONO INC,"DONATH H, HESS U, KIESLICH M, THEIS M, OHLENSCHL?GER U, SCHUBERT R, WOELKE S, ZIELEN S. DIABETES IN PATIENTS WITH ATAXIA TELANGIECTASIA: A NATIONAL COHORT STUDY. FRONT PEDIATR. 2020;8:317. DOI:10.3389/FPED.2020.00317.",26.0,YR,A,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Young Adult
183364822,18336482,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,,,,,,2020,Q4,Therapy non-responder,,2020,Q4,2,F,,20201105.0,20201001,20201113,EXP,DE-EMA-DD-20200915-PRABHAKAR_D-181703,DE-EMD SERONO-E2B_90080394,EMD SERONO INC,"DONATH H, HESS U, KIESLICH M, THEIS M, OHLENSCHL?GER U, SCHUBERT R, WOELKE S, ZIELEN S. DIABETES IN PATIENTS WITH ATAXIA TELANGIECTASIA: A NATIONAL COHORT STUDY. FRONT PEDIATR. 2020;8:317. DOI:10.3389/FPED.2020.00317.",26.0,YR,A,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Young Adult
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Hypernatraemia,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Hypertriglyceridaemia,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Leukocytosis,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183379191,18337919,21,C,Insulin Glargine/Lispro,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200914.0,,20201001,20201001,DIR,,,FDA-CTU,,63.0,YR,,M,N,91.0,KG,20201001.0,Y,PH,US,US,2020,Q4,Adult
183384632,18338463,8,C,OPTISULIN [INSULIN GLARGINE],INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,,, UNKNOWN,,,24.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20200709.0,20201022.0,20201002,20201104,EXP,,AU-NOVOPROD-755708,NOVO NORDISK,,65.0,YR,,F,Y,96.5,KG,20201104.0,,MD,AU,AU,2020,Q4,Elderly
183384632,18338463,8,C,OPTISULIN [INSULIN GLARGINE],INSULIN GLARGINE,1,Unknown,"24 IU, QD",,,,, UNKNOWN,,,24.0,IU,,QD,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,2,F,20200709.0,20201022.0,20201002,20201104,EXP,,AU-NOVOPROD-755708,NOVO NORDISK,,65.0,YR,,F,Y,96.5,KG,20201104.0,,MD,AU,AU,2020,Q4,Elderly
183387931,18338793,19,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200921.0,,20201002,20201002,DIR,,,FDA-CTU,,60.0,YR,,M,N,75.0,KG,20201002.0,Y,PH,US,US,2020,Q4,Adult
183387931,18338793,19,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Acute respiratory distress syndrome,,2020,Q4,1,I,20200921.0,,20201002,20201002,DIR,,,FDA-CTU,,60.0,YR,,M,N,75.0,KG,20201002.0,Y,PH,US,US,2020,Q4,Adult
183387931,18338793,19,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Bacterial infection,,2020,Q4,1,I,20200921.0,,20201002,20201002,DIR,,,FDA-CTU,,60.0,YR,,M,N,75.0,KG,20201002.0,Y,PH,US,US,2020,Q4,Adult
183394161,18339416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK (NK MG, NACH SCHEMA)",,,U,,,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,NVSC2020DE261870,NOVARTIS,,43.0,YR,,F,Y,,,20201002.0,,HP,DE,DE,2020,Q4,Adult
183394161,18339416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK (NK MG, NACH SCHEMA)",,,U,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,NVSC2020DE261870,NOVARTIS,,43.0,YR,,F,Y,,,20201002.0,,HP,DE,DE,2020,Q4,Adult
183394161,18339416,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK (NK MG, NACH SCHEMA)",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200925.0,20201002,20201002,EXP,,NVSC2020DE261870,NOVARTIS,,43.0,YR,,F,Y,,,20201002.0,,HP,DE,DE,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Blood electrolytes decreased,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Blood iron decreased,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Cardiac valve disease,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Coeliac disease,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Product use issue,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Somnolence,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Underdose,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183397871,18339787,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Weight decreased,,2020,Q4,1,I,,20200924.0,20201002,20201002,EXP,,CA-ASTRAZENECA-2020SF23886,ASTRAZENECA,,59.0,YR,,M,Y,54.0,KG,20201002.0,,CN,CA,CA,2020,Q4,Adult
183406092,18340609,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2020,Q4,Cystitis,,2020,Q4,2,F,201602.0,20201125.0,20201002,20201125,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-017266,BRISTOL MYERS SQUIBB,"OKUYAMA S, TAKASU A, OGURI N, HONDA H, OKAMOTO T, SHIRATORI Y, ET AL. LIVER DISORDER DUE TO PD-1 INHIBITORS IN THE CLINICAL SETTING. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2019;7(8):137-8",78.0,YR,,F,Y,48.0,KG,20201125.0,,MD,JP,JP,2020,Q4,Elderly
183406092,18340609,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,2,F,201602.0,20201125.0,20201002,20201125,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-017266,BRISTOL MYERS SQUIBB,"OKUYAMA S, TAKASU A, OGURI N, HONDA H, OKAMOTO T, SHIRATORI Y, ET AL. LIVER DISORDER DUE TO PD-1 INHIBITORS IN THE CLINICAL SETTING. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2019;7(8):137-8",78.0,YR,,F,Y,48.0,KG,20201125.0,,MD,JP,JP,2020,Q4,Elderly
183406092,18340609,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2020,Q4,Hepatic function abnormal,,2020,Q4,2,F,201602.0,20201125.0,20201002,20201125,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-017266,BRISTOL MYERS SQUIBB,"OKUYAMA S, TAKASU A, OGURI N, HONDA H, OKAMOTO T, SHIRATORI Y, ET AL. LIVER DISORDER DUE TO PD-1 INHIBITORS IN THE CLINICAL SETTING. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2019;7(8):137-8",78.0,YR,,F,Y,48.0,KG,20201125.0,,MD,JP,JP,2020,Q4,Elderly
183406092,18340609,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2020,Q4,Hypothyroidism,,2020,Q4,2,F,201602.0,20201125.0,20201002,20201125,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-017266,BRISTOL MYERS SQUIBB,"OKUYAMA S, TAKASU A, OGURI N, HONDA H, OKAMOTO T, SHIRATORI Y, ET AL. LIVER DISORDER DUE TO PD-1 INHIBITORS IN THE CLINICAL SETTING. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2019;7(8):137-8",78.0,YR,,F,Y,48.0,KG,20201125.0,,MD,JP,JP,2020,Q4,Elderly
183406092,18340609,5,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,INJECTION,,2020,Q4,Liver disorder,,2020,Q4,2,F,201602.0,20201125.0,20201002,20201125,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-017266,BRISTOL MYERS SQUIBB,"OKUYAMA S, TAKASU A, OGURI N, HONDA H, OKAMOTO T, SHIRATORI Y, ET AL. LIVER DISORDER DUE TO PD-1 INHIBITORS IN THE CLINICAL SETTING. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2019;7(8):137-8",78.0,YR,,F,Y,48.0,KG,20201125.0,,MD,JP,JP,2020,Q4,Elderly
183464611,18346461,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,20131114.0,20200928.0,20201005,20201005,EXP,,US-TAKEDA-2020TUS041139,TAKEDA,,65.0,YR,,F,Y,,,20201005.0,,LW,US,US,2020,Q4,Elderly
183464611,18346461,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,1,I,20131114.0,20200928.0,20201005,20201005,EXP,,US-TAKEDA-2020TUS041139,TAKEDA,,65.0,YR,,F,Y,,,20201005.0,,LW,US,US,2020,Q4,Elderly
183464611,18346461,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,1,I,20131114.0,20200928.0,20201005,20201005,EXP,,US-TAKEDA-2020TUS041139,TAKEDA,,65.0,YR,,F,Y,,,20201005.0,,LW,US,US,2020,Q4,Elderly
183468351,18346835,6,C,insulin glargine,INSULIN GLARGINE,1,,"NK MG, NACH SCHEMA (NK MG, ACCORDING TO SCHEME)",,,,, UNKNOWN,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-DRREDDYS-GER/GER/20/0127558,DR REDDYS,,43.0,YR,A,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183468351,18346835,6,C,insulin glargine,INSULIN GLARGINE,1,,"NK MG, NACH SCHEMA (NK MG, ACCORDING TO SCHEME)",,,,, UNKNOWN,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-DRREDDYS-GER/GER/20/0127558,DR REDDYS,,43.0,YR,A,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183468351,18346835,6,C,insulin glargine,INSULIN GLARGINE,1,,"NK MG, NACH SCHEMA (NK MG, ACCORDING TO SCHEME)",,,,, UNKNOWN,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-DRREDDYS-GER/GER/20/0127558,DR REDDYS,,43.0,YR,A,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183469041,18346904,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,1,I,20200914.0,20201001.0,20201005,20201005,EXP,,US-GILEAD-2020-0497321,GILEAD,,63.0,YR,A,M,Y,91.0,KG,20201005.0,,PH,US,US,2020,Q4,Adult
183469041,18346904,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,20200914.0,20201001.0,20201005,20201005,EXP,,US-GILEAD-2020-0497321,GILEAD,,63.0,YR,A,M,Y,91.0,KG,20201005.0,,PH,US,US,2020,Q4,Adult
183469041,18346904,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200914.0,20201001.0,20201005,20201005,EXP,,US-GILEAD-2020-0497321,GILEAD,,63.0,YR,A,M,Y,91.0,KG,20201005.0,,PH,US,US,2020,Q4,Adult
183481744,18348174,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 DF, QD",,,D,,,,,14.0,DF,INJECTION,QD,2020,Q4,Cardiac tamponade,,2020,Q4,4,F,20200822.0,20201222.0,20201006,20201229,EXP,,NVSC2020IL266793,NOVARTIS,,59.0,YR,,F,Y,70.0,KG,20201229.0,,MD,IL,IL,2020,Q4,Adult
183481744,18348174,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 DF, QD",,,D,,,,,14.0,DF,INJECTION,QD,2020,Q4,Dyspnoea,,2020,Q4,4,F,20200822.0,20201222.0,20201006,20201229,EXP,,NVSC2020IL266793,NOVARTIS,,59.0,YR,,F,Y,70.0,KG,20201229.0,,MD,IL,IL,2020,Q4,Adult
183481744,18348174,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 DF, QD",,,D,,,,,14.0,DF,INJECTION,QD,2020,Q4,Fatigue,,2020,Q4,4,F,20200822.0,20201222.0,20201006,20201229,EXP,,NVSC2020IL266793,NOVARTIS,,59.0,YR,,F,Y,70.0,KG,20201229.0,,MD,IL,IL,2020,Q4,Adult
183481744,18348174,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 DF, QD",,,D,,,,,14.0,DF,INJECTION,QD,2020,Q4,Malaise,,2020,Q4,4,F,20200822.0,20201222.0,20201006,20201229,EXP,,NVSC2020IL266793,NOVARTIS,,59.0,YR,,F,Y,70.0,KG,20201229.0,,MD,IL,IL,2020,Q4,Adult
183481744,18348174,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 DF, QD",,,D,,,,,14.0,DF,INJECTION,QD,2020,Q4,Malignant pleural effusion,,2020,Q4,4,F,20200822.0,20201222.0,20201006,20201229,EXP,,NVSC2020IL266793,NOVARTIS,,59.0,YR,,F,Y,70.0,KG,20201229.0,,MD,IL,IL,2020,Q4,Adult
183481744,18348174,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 DF, QD",,,D,,,,,14.0,DF,INJECTION,QD,2020,Q4,Pneumonitis,,2020,Q4,4,F,20200822.0,20201222.0,20201006,20201229,EXP,,NVSC2020IL266793,NOVARTIS,,59.0,YR,,F,Y,70.0,KG,20201229.0,,MD,IL,IL,2020,Q4,Adult
183493971,18349397,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-PFIZER INC-2020378620,PFIZER,,43.0,YR,,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183493971,18349397,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-PFIZER INC-2020378620,PFIZER,,43.0,YR,,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183493971,18349397,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-PFIZER INC-2020378620,PFIZER,,43.0,YR,,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183493971,18349397,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"UNK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Product use issue,,2020,Q4,1,I,,20200930.0,20201006,20201006,EXP,,DE-PFIZER INC-2020378620,PFIZER,,43.0,YR,,F,Y,,,20201006.0,,MD,DE,DE,2020,Q4,Adult
183505501,18350550,12,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,1,I,,20200929.0,20201006,20201006,EXP,,PK-PAIPHARMA-2020-PK-000007,PHARMACEUTICAL ASSOC,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM.DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE..AMERICAN JOURNAL OF THERAPEUTICS.2020;.",42.0,YR,,M,Y,,,20201006.0,,MD,PK,PK,2020,Q4,Adult
183505501,18350550,12,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Seizure,,2020,Q4,1,I,,20200929.0,20201006,20201006,EXP,,PK-PAIPHARMA-2020-PK-000007,PHARMACEUTICAL ASSOC,"INAYAT F, BOKHARI SRA, ALMAS T, ROSEN RM.DRUG INTERACTION BETWEEN SEVELAMER AND LEVETIRACETAM: THE FIRST CLINICAL EXPERIENCE..AMERICAN JOURNAL OF THERAPEUTICS.2020;.",42.0,YR,,M,Y,,,20201006.0,,MD,PK,PK,2020,Q4,Adult
183520824,18352082,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,DOSE AND FREQUENCY UNKNOWN,,,,,,,,,,,,2020,Q4,Drug reaction with eosinophilia and systemic symptoms,,2020,Q4,4,F,20200803.0,20201021.0,20201006,20201104,EXP,FR-AFSSAPS-AM20200963,FR-JNJFOC-20200941182,JOHNSON AND JOHNSON,,41.0,YR,A,F,Y,79.9,KG,20201104.0,,HP,FR,FR,2020,Q4,Adult
183522971,18352297,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,20200921.0,20201002.0,20201006,20201006,EXP,,US-GILEAD-2020-0497511,GILEAD,,60.0,YR,A,M,Y,75.0,KG,20201006.0,,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acute cardiac event,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood creatine increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood lactic acid increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood magnesium increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood phosphorus increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood potassium increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood urea increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Carbon dioxide decreased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Haemodialysis,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hyperlipidaemia,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hypertension,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540581,18354058,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,53.0,YR,,F,N,129.0,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Anisocytosis,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Bacteraemia,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Haemodialysis,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Macrocytosis,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Microcytosis,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Platelet morphology abnormal,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Polychromasia,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Procalcitonin increased,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Red blood cell nucleated morphology,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540631,18354063,9,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200704.0,,20201006,20201006,DIR,,,FDA-CTU,,52.0,YR,,M,N,79.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood lactate dehydrogenase increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood magnesium increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Blood potassium increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Haemodialysis,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Haemoglobin decreased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Platelet count decreased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Red blood cell count decreased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183540741,18354074,10,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,White blood cell count increased,,2020,Q4,1,I,20200708.0,,20201006,20201006,DIR,,,FDA-CTU,,54.0,YR,,M,N,213.6,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541081,18354108,16,C,Insulin glargine/lispro/regular,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200705.0,,20201006,20201006,DIR,,,FDA-CTU,,60.0,YR,,F,N,83.1,KG,20201006.0,Y,PH,US,US,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Arthralgia,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Bacterial toxaemia,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Clostridium difficile infection,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Gait disturbance,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hepatic failure,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Myalgia,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pain in extremity,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183541115,18354111,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,5,F,20200930.0,20201120.0,20201006,20201127,EXP,,AU-BEH-2020123166,CSL BEHRING,,41.0,YR,A,F,Y,58.0,KG,20201127.0,,HP,AU,AU,2020,Q4,Adult
183546313,18354631,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,6.0,IU,UNKNOWN,,2020,Q4,Acute kidney injury,,2020,Q4,3,F,20200713.0,20201012.0,20201007,20201020,EXP,IT-MINISAL02-635484,IT-FRESENIUS KABI-FK202010229,FRESENIUS KABI,,77.0,YR,,M,Y,80.0,KG,20201020.0,,HP,NL,IT,2020,Q4,Elderly
183546313,18354631,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,6.0,IU,UNKNOWN,,2020,Q4,Rhabdomyolysis,,2020,Q4,3,F,20200713.0,20201012.0,20201007,20201020,EXP,IT-MINISAL02-635484,IT-FRESENIUS KABI-FK202010229,FRESENIUS KABI,,77.0,YR,,M,Y,80.0,KG,20201020.0,,HP,NL,IT,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Band neutrophil count increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Basophil percentage increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Bilirubin conjugated increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Blood albumin decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Blood alkaline phosphatase increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Blood bilirubin increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Blood phosphorus decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Eosinophil count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Eosinophil percentage decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Fibrin D dimer increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Haematocrit decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Haemoglobin decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Lymphocyte count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Lymphocyte percentage decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Mean cell haemoglobin increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Mean cell volume increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Monocyte count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Monocyte percentage decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Neutrophil count increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Platelet morphology abnormal,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Procalcitonin increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Protein total decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Red blood cell count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Red blood cell nucleated morphology present,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Respiratory acidosis,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,Serum ferritin increased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183546981,18354698,8,C,Insulin glargine/lispro,,2,,,,,,,,,,,,,,2020,Q4,White blood cell count decreased,,2020,Q4,1,I,20200705.0,,20201007,20201007,DIR,,,FDA-CTU,,69.0,YR,,M,N,69.6,KG,20201007.0,Y,PH,US,US,2020,Q4,Elderly
183595051,18359505,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20200103.0,20201008,20201008,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-00168,LUPIN,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019;199:9,63.0,YR,,M,Y,,,20201008.0,,HP,US,US,2020,Q4,Adult
183596131,18359613,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS DAILY,,,U,U,,,,,,,QD,2020,Q4,Drug interaction,,2020,Q4,1,I,,20200929.0,20201008,20201008,EXP,NZ-MLMSERVICE-20200921-2491519-1,NZ-MYLANLABS-2020M1084032,MYLAN,,15.0,YR,,M,Y,49.2,KG,20201008.0,,HP,NZ,NZ,2020,Q4,Youth
183596131,18359613,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,10 UNITS DAILY,,,U,U,,,,,,,QD,2020,Q4,Hyperglycaemic hyperosmolar nonketotic syndrome,,2020,Q4,1,I,,20200929.0,20201008,20201008,EXP,NZ-MLMSERVICE-20200921-2491519-1,NZ-MYLANLABS-2020M1084032,MYLAN,,15.0,YR,,M,Y,49.2,KG,20201008.0,,HP,NZ,NZ,2020,Q4,Youth
183618591,18361859,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183618591,18361859,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Bacteraemia,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183618591,18361859,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183618591,18361859,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183618591,18361859,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,1,I,20200704.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497913,GILEAD,,52.0,YR,A,M,Y,79.5,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Burning sensation,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Chromaturia,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Decreased appetite,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Decreased immune responsiveness,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Dizziness,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Drug intolerance,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Influenza,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Malignant neoplasm progression,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Necrosis,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Neuroendocrine tumour,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Pain,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Pruritus,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Skin ulcer,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Sleep disorder,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Somnolence,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Stomatitis,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Urticaria,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183624492,18362449,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Weight decreased,,2020,Q4,2,F,20180301.0,20200925.0,20201008,20201020,EXP,,PHHY2018CO003635,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20201020.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
183630061,18363006,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183630061,18363006,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Respiratory disorder,,2020,Q4,1,I,2020.0,20201006.0,20201008,20201008,EXP,,US-GILEAD-2020-0497917,GILEAD,,60.0,YR,A,F,Y,83.1,KG,20201008.0,,PH,US,US,2020,Q4,Adult
183639741,18363974,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Torulopsis infection,,2020,Q4,1,I,,20200928.0,20201009,20201009,EXP,,PT-JNJFOC-20200953691,JOHNSON AND JOHNSON,"RODRIGUES R, ALVES T, SOUSA R, REIGOT R, GONCALVE J, FIGUEIREDO A, CARVALHO A, NOGUEIRA J. ATYPICAL FUNGUS WITH NEW ORAL ANTIDIABETICS. MEDICINA INTERNA. 2020;27(SPECIAL EDITION):527-528.",85.0,YR,E,M,Y,,,20201008.0,,MD,PT,PT,2020,Q4,Elderly
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Headache,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Hyperglycaemic hyperosmolar nonketotic syndrome,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Irritability,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Lethargy,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Nocturia,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Polydipsia,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Polyuria,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Tremor,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183656852,18365685,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 UNITS, DAILY",,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,2,F,,20201029.0,20201009,20201109,EXP,,NZ-STRIDES ARCOLAB LIMITED-2020SP011945,STRIDES,,15.0,YR,,M,Y,49.2,KG,20201109.0,,HP,NZ,NZ,2020,Q4,Youth
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fournier's gangrene,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hyperparathyroidism secondary,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Necrotising fasciitis,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Perineal abscess,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Perineal cellulitis,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Peritonitis,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal failure,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183670102,18367010,4,C,GLARGINE INSULIN,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Scrotal abscess,,2020,Q4,2,F,20150624.0,20201028.0,20201009,20201105,EXP,,US-ASTRAZENECA-2020SF27970,ASTRAZENECA,,21690.0,DY,,M,Y,88.5,KG,20201105.0,,,US,US,2020,Q4,Elderly
183671531,18367153,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200705.0,20201007.0,20201009,20201009,EXP,,US-GILEAD-2020-0498028,GILEAD,,69.0,YR,E,M,Y,69.6,KG,20201009.0,,PH,US,US,2020,Q4,Elderly
183671531,18367153,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,20200705.0,20201007.0,20201009,20201009,EXP,,US-GILEAD-2020-0498028,GILEAD,,69.0,YR,E,M,Y,69.6,KG,20201009.0,,PH,US,US,2020,Q4,Elderly
183671531,18367153,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,COVID-19 pneumonia,,2020,Q4,1,I,20200705.0,20201007.0,20201009,20201009,EXP,,US-GILEAD-2020-0498028,GILEAD,,69.0,YR,E,M,Y,69.6,KG,20201009.0,,PH,US,US,2020,Q4,Elderly
183671531,18367153,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,20200705.0,20201007.0,20201009,20201009,EXP,,US-GILEAD-2020-0498028,GILEAD,,69.0,YR,E,M,Y,69.6,KG,20201009.0,,PH,US,US,2020,Q4,Elderly
183671531,18367153,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200705.0,20201007.0,20201009,20201009,EXP,,US-GILEAD-2020-0498028,GILEAD,,69.0,YR,E,M,Y,69.6,KG,20201009.0,,PH,US,US,2020,Q4,Elderly
183671531,18367153,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200705.0,20201007.0,20201009,20201009,EXP,,US-GILEAD-2020-0498028,GILEAD,,69.0,YR,E,M,Y,69.6,KG,20201009.0,,PH,US,US,2020,Q4,Elderly
183671531,18367153,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,20200705.0,20201007.0,20201009,20201009,EXP,,US-GILEAD-2020-0498028,GILEAD,,69.0,YR,E,M,Y,69.6,KG,20201009.0,,PH,US,US,2020,Q4,Elderly
183671531,18367153,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Respiratory acidosis,,2020,Q4,1,I,20200705.0,20201007.0,20201009,20201009,EXP,,US-GILEAD-2020-0498028,GILEAD,,69.0,YR,E,M,Y,69.6,KG,20201009.0,,PH,US,US,2020,Q4,Elderly
183678861,18367886,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acidosis,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183678861,18367886,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183678861,18367886,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Cardiac disorder,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183678861,18367886,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183678861,18367886,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,2020.0,20201006.0,20201009,20201009,EXP,,US-GILEAD-2020-0497903,GILEAD,,53.0,YR,A,F,Y,129.0,KG,20201009.0,,PH,US,US,2020,Q4,Adult
183679722,18367972,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,2,F,20200708.0,20201204.0,20201009,20201207,EXP,,US-GILEAD-2020-0497905,GILEAD,,54.0,YR,A,M,Y,213.6,KG,20201207.0,,PH,US,US,2020,Q4,Adult
183688331,18368833,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 INTERNATIONAL UNIT,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 INTERNATIONAL UNIT,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 INTERNATIONAL UNIT,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 INTERNATIONAL UNIT,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,12 INTERNATIONAL UNIT,,,,,,,,12.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Weight increased,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 INTERNATIONAL UNIT,,,,,,,,60.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 INTERNATIONAL UNIT,,,,,,,,60.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diabetic metabolic decompensation,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 INTERNATIONAL UNIT,,,,,,,,60.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 INTERNATIONAL UNIT,,,,,,,,60.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Therapeutic product effect incomplete,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183688331,18368833,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,60 INTERNATIONAL UNIT,,,,,,,,60.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Weight increased,,2020,Q4,1,I,2011.0,20200715.0,20201010,20201010,EXP,,CZ-TAKEDA-2020TEU006429,TAKEDA,MAULE P. KOMBINACNI LECBA DULAGLUTID AND BAZALNI INZULINOVY ANALOG - MOZNY KROK ZPET Z IIT [DULAGLUTIDE AND BASAL INSULIN ANALOGUE COMBINATION THERAPY - POSSIBLE STEP BACK FROM IIT]. KAZUISTIKY V DIABETOLOGII. 2020;18(2):37-9,47.0,YR,,M,Y,,,20201010.0,,MD,CZ,CZ,2020,Q4,Adult
183697852,18369785,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Diabetes mellitus,,2020,Q4,2,F,20190724.0,20201030.0,20201012,20201104,EXP,,ES-PFIZER INC-2020372192,PFIZER,,70.0,YR,,M,Y,76.4,KG,20201104.0,,MD,ES,ES,2020,Q4,Elderly
183712641,18371264,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"0.29 IU/KG, QD",,,U,U,,,,0.29,IU/KG,,QD,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,2017.0,20200928.0,20201012,20201012,EXP,,TW-NOVOPROD-757746,NOVO NORDISK,"YI-YIN LEE, CHENG-WEI LIN AND I-WEN CHEN. EXOGENOUS INSULIN INJECTION-INDUCED STIFF-PERSON SYNDROME IN A PATIENT WITH LATENT AUTOIMMUNE DIABETES: A CASE REPORT AND LITERATURE REVIEW. FRONTIERS IN ENDOCRINOLOGY. 2020;11:1-6",43.0,YR,,M,Y,,,20201012.0,,MD,TW,TW,2020,Q4,Adult
183712641,18371264,10,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"0.29 IU/KG, QD",,,U,U,,,,0.29,IU/KG,,QD,2020,Q4,Treatment noncompliance,,2020,Q4,1,I,2017.0,20200928.0,20201012,20201012,EXP,,TW-NOVOPROD-757746,NOVO NORDISK,"YI-YIN LEE, CHENG-WEI LIN AND I-WEN CHEN. EXOGENOUS INSULIN INJECTION-INDUCED STIFF-PERSON SYNDROME IN A PATIENT WITH LATENT AUTOIMMUNE DIABETES: A CASE REPORT AND LITERATURE REVIEW. FRONTIERS IN ENDOCRINOLOGY. 2020;11:1-6",43.0,YR,,M,Y,,,20201012.0,,MD,TW,TW,2020,Q4,Adult
183723921,18372392,6,C,insulin glargine,INSULIN GLARGINE,1,,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Angina pectoris,,2020,Q4,1,I,,20201004.0,20201012,20201012,EXP,,DE-TEVA-2020-DE-1836386,TEVA,,43.0,YR,A,F,Y,,,20201012.0,,MD,DE,DE,2020,Q4,Adult
183723921,18372392,6,C,insulin glargine,INSULIN GLARGINE,1,,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201004.0,20201012,20201012,EXP,,DE-TEVA-2020-DE-1836386,TEVA,,43.0,YR,A,F,Y,,,20201012.0,,MD,DE,DE,2020,Q4,Adult
183723921,18372392,6,C,insulin glargine,INSULIN GLARGINE,1,,"NK MG, ACCORDING TO THE SCHEME",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201004.0,20201012,20201012,EXP,,DE-TEVA-2020-DE-1836386,TEVA,,43.0,YR,A,F,Y,,,20201012.0,,MD,DE,DE,2020,Q4,Adult
183740514,18374051,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2020,Q4,Acute kidney injury,,2020,Q4,4,F,20201005.0,20201219.0,20201012,20201224,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-082607,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,110.0,KG,20201224.0,,HP,DE,DE,2020,Q4,Elderly
183756321,18375632,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,1,I,2020.0,20200715.0,20201013,20201013,EXP,,NVSC2020ES202579,NOVARTIS,,78.0,YR,,M,Y,90.7,KG,20201013.0,,HP,ES,ES,2020,Q4,Elderly
183756321,18375632,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,2020.0,20200715.0,20201013,20201013,EXP,,NVSC2020ES202579,NOVARTIS,,78.0,YR,,M,Y,90.7,KG,20201013.0,,HP,ES,ES,2020,Q4,Elderly
183756321,18375632,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Gait inability,,2020,Q4,1,I,2020.0,20200715.0,20201013,20201013,EXP,,NVSC2020ES202579,NOVARTIS,,78.0,YR,,M,Y,90.7,KG,20201013.0,,HP,ES,ES,2020,Q4,Elderly
183756321,18375632,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,1,I,2020.0,20200715.0,20201013,20201013,EXP,,NVSC2020ES202579,NOVARTIS,,78.0,YR,,M,Y,90.7,KG,20201013.0,,HP,ES,ES,2020,Q4,Elderly
183756321,18375632,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Malaise,,2020,Q4,1,I,2020.0,20200715.0,20201013,20201013,EXP,,NVSC2020ES202579,NOVARTIS,,78.0,YR,,M,Y,90.7,KG,20201013.0,,HP,ES,ES,2020,Q4,Elderly
183756321,18375632,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Nervousness,,2020,Q4,1,I,2020.0,20200715.0,20201013,20201013,EXP,,NVSC2020ES202579,NOVARTIS,,78.0,YR,,M,Y,90.7,KG,20201013.0,,HP,ES,ES,2020,Q4,Elderly
183756321,18375632,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Pain in extremity,,2020,Q4,1,I,2020.0,20200715.0,20201013,20201013,EXP,,NVSC2020ES202579,NOVARTIS,,78.0,YR,,M,Y,90.7,KG,20201013.0,,HP,ES,ES,2020,Q4,Elderly
183756321,18375632,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product dose omission in error,,2020,Q4,1,I,2020.0,20200715.0,20201013,20201013,EXP,,NVSC2020ES202579,NOVARTIS,,78.0,YR,,M,Y,90.7,KG,20201013.0,,HP,ES,ES,2020,Q4,Elderly
183756321,18375632,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, DF557A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product use issue,,2020,Q4,1,I,2020.0,20200715.0,20201013,20201013,EXP,,NVSC2020ES202579,NOVARTIS,,78.0,YR,,M,Y,90.7,KG,20201013.0,,HP,ES,ES,2020,Q4,Elderly
183793771,18379377,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),DOSE: 6 IE/HOUR,,,U,U,,,,,,INJECTION,,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201007.0,20201013,20201013,EXP,,DK-MYLANLABS-2020M1086709,MYLAN,"MARINA D, MATHIESEN ER, KLOSE M, PEDERSEN BW, RINGHOLM L. CO-EXISTENCE OF STARVATION KETOACIDOSIS AND HYPERTHYROIDISM IN EARLY PREGNANCY: A CASE REPORT. ACTA-DIABETOL 2020;57(10):1267-1270.",30.0,YR,,F,Y,,,20201013.0,,HP,DK,DK,2020,Q4,Young Adult
183793771,18379377,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),DOSE: 6 IE/HOUR,,,U,U,,,,,,INJECTION,,2020,Q4,Maternal exposure during pregnancy,,2020,Q4,1,I,,20201007.0,20201013,20201013,EXP,,DK-MYLANLABS-2020M1086709,MYLAN,"MARINA D, MATHIESEN ER, KLOSE M, PEDERSEN BW, RINGHOLM L. CO-EXISTENCE OF STARVATION KETOACIDOSIS AND HYPERTHYROIDISM IN EARLY PREGNANCY: A CASE REPORT. ACTA-DIABETOL 2020;57(10):1267-1270.",30.0,YR,,F,Y,,,20201013.0,,HP,DK,DK,2020,Q4,Young Adult
183793771,18379377,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),DOSE: 6 IE/HOUR,,,U,U,,,,,,INJECTION,,2020,Q4,Normal newborn,,2020,Q4,1,I,,20201007.0,20201013,20201013,EXP,,DK-MYLANLABS-2020M1086709,MYLAN,"MARINA D, MATHIESEN ER, KLOSE M, PEDERSEN BW, RINGHOLM L. CO-EXISTENCE OF STARVATION KETOACIDOSIS AND HYPERTHYROIDISM IN EARLY PREGNANCY: A CASE REPORT. ACTA-DIABETOL 2020;57(10):1267-1270.",30.0,YR,,F,Y,,,20201013.0,,HP,DK,DK,2020,Q4,Young Adult
183793771,18379377,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),DOSE: 6 IE/HOUR,,,U,U,,,,,,INJECTION,,2020,Q4,Off label use,,2020,Q4,1,I,,20201007.0,20201013,20201013,EXP,,DK-MYLANLABS-2020M1086709,MYLAN,"MARINA D, MATHIESEN ER, KLOSE M, PEDERSEN BW, RINGHOLM L. CO-EXISTENCE OF STARVATION KETOACIDOSIS AND HYPERTHYROIDISM IN EARLY PREGNANCY: A CASE REPORT. ACTA-DIABETOL 2020;57(10):1267-1270.",30.0,YR,,F,Y,,,20201013.0,,HP,DK,DK,2020,Q4,Young Adult
183793771,18379377,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"DOSE: 0-3IE/HOUR, BASED ON GLUCOSE LEVEL",,,U,U,,,,,,INJECTION,,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201007.0,20201013,20201013,EXP,,DK-MYLANLABS-2020M1086709,MYLAN,"MARINA D, MATHIESEN ER, KLOSE M, PEDERSEN BW, RINGHOLM L. CO-EXISTENCE OF STARVATION KETOACIDOSIS AND HYPERTHYROIDISM IN EARLY PREGNANCY: A CASE REPORT. ACTA-DIABETOL 2020;57(10):1267-1270.",30.0,YR,,F,Y,,,20201013.0,,HP,DK,DK,2020,Q4,Young Adult
183793771,18379377,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"DOSE: 0-3IE/HOUR, BASED ON GLUCOSE LEVEL",,,U,U,,,,,,INJECTION,,2020,Q4,Maternal exposure during pregnancy,,2020,Q4,1,I,,20201007.0,20201013,20201013,EXP,,DK-MYLANLABS-2020M1086709,MYLAN,"MARINA D, MATHIESEN ER, KLOSE M, PEDERSEN BW, RINGHOLM L. CO-EXISTENCE OF STARVATION KETOACIDOSIS AND HYPERTHYROIDISM IN EARLY PREGNANCY: A CASE REPORT. ACTA-DIABETOL 2020;57(10):1267-1270.",30.0,YR,,F,Y,,,20201013.0,,HP,DK,DK,2020,Q4,Young Adult
183793771,18379377,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"DOSE: 0-3IE/HOUR, BASED ON GLUCOSE LEVEL",,,U,U,,,,,,INJECTION,,2020,Q4,Normal newborn,,2020,Q4,1,I,,20201007.0,20201013,20201013,EXP,,DK-MYLANLABS-2020M1086709,MYLAN,"MARINA D, MATHIESEN ER, KLOSE M, PEDERSEN BW, RINGHOLM L. CO-EXISTENCE OF STARVATION KETOACIDOSIS AND HYPERTHYROIDISM IN EARLY PREGNANCY: A CASE REPORT. ACTA-DIABETOL 2020;57(10):1267-1270.",30.0,YR,,F,Y,,,20201013.0,,HP,DK,DK,2020,Q4,Young Adult
183793771,18379377,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),"DOSE: 0-3IE/HOUR, BASED ON GLUCOSE LEVEL",,,U,U,,,,,,INJECTION,,2020,Q4,Off label use,,2020,Q4,1,I,,20201007.0,20201013,20201013,EXP,,DK-MYLANLABS-2020M1086709,MYLAN,"MARINA D, MATHIESEN ER, KLOSE M, PEDERSEN BW, RINGHOLM L. CO-EXISTENCE OF STARVATION KETOACIDOSIS AND HYPERTHYROIDISM IN EARLY PREGNANCY: A CASE REPORT. ACTA-DIABETOL 2020;57(10):1267-1270.",30.0,YR,,F,Y,,,20201013.0,,HP,DK,DK,2020,Q4,Young Adult
183803181,18380318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FROM 5 YEARS,,,U,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201003.0,20201014,20201014,EXP,,GR-EMD SERONO-9190824,EMD SERONO INC,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, NTALAOUTIS A, SAMARAS A, LAZARI E, VLASTARAKOS P, GIANNAS R, IORDANIDIS S, GEORGALI A, GIANNIKOPOULOS G. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MYTH OR REALITY?.. POSTED ANNOUNCEMENTS (POSTER).. 2020;75.",82.0,YR,E,M,Y,,,20201014.0,,HP,GR,GR,2020,Q4,Elderly
183803181,18380318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FROM 5 YEARS,,,U,,,,,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,,20201003.0,20201014,20201014,EXP,,GR-EMD SERONO-9190824,EMD SERONO INC,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, NTALAOUTIS A, SAMARAS A, LAZARI E, VLASTARAKOS P, GIANNAS R, IORDANIDIS S, GEORGALI A, GIANNIKOPOULOS G. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MYTH OR REALITY?.. POSTED ANNOUNCEMENTS (POSTER).. 2020;75.",82.0,YR,E,M,Y,,,20201014.0,,HP,GR,GR,2020,Q4,Elderly
183803181,18380318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FROM 5 YEARS,,,U,,,,,,,,,2020,Q4,Aortic bruit,,2020,Q4,1,I,,20201003.0,20201014,20201014,EXP,,GR-EMD SERONO-9190824,EMD SERONO INC,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, NTALAOUTIS A, SAMARAS A, LAZARI E, VLASTARAKOS P, GIANNAS R, IORDANIDIS S, GEORGALI A, GIANNIKOPOULOS G. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MYTH OR REALITY?.. POSTED ANNOUNCEMENTS (POSTER).. 2020;75.",82.0,YR,E,M,Y,,,20201014.0,,HP,GR,GR,2020,Q4,Elderly
183803181,18380318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FROM 5 YEARS,,,U,,,,,,,,,2020,Q4,Breath sounds abnormal,,2020,Q4,1,I,,20201003.0,20201014,20201014,EXP,,GR-EMD SERONO-9190824,EMD SERONO INC,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, NTALAOUTIS A, SAMARAS A, LAZARI E, VLASTARAKOS P, GIANNAS R, IORDANIDIS S, GEORGALI A, GIANNIKOPOULOS G. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MYTH OR REALITY?.. POSTED ANNOUNCEMENTS (POSTER).. 2020;75.",82.0,YR,E,M,Y,,,20201014.0,,HP,GR,GR,2020,Q4,Elderly
183803181,18380318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FROM 5 YEARS,,,U,,,,,,,,,2020,Q4,Bundle branch block right,,2020,Q4,1,I,,20201003.0,20201014,20201014,EXP,,GR-EMD SERONO-9190824,EMD SERONO INC,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, NTALAOUTIS A, SAMARAS A, LAZARI E, VLASTARAKOS P, GIANNAS R, IORDANIDIS S, GEORGALI A, GIANNIKOPOULOS G. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MYTH OR REALITY?.. POSTED ANNOUNCEMENTS (POSTER).. 2020;75.",82.0,YR,E,M,Y,,,20201014.0,,HP,GR,GR,2020,Q4,Elderly
183803181,18380318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FROM 5 YEARS,,,U,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,1,I,,20201003.0,20201014,20201014,EXP,,GR-EMD SERONO-9190824,EMD SERONO INC,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, NTALAOUTIS A, SAMARAS A, LAZARI E, VLASTARAKOS P, GIANNAS R, IORDANIDIS S, GEORGALI A, GIANNIKOPOULOS G. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MYTH OR REALITY?.. POSTED ANNOUNCEMENTS (POSTER).. 2020;75.",82.0,YR,E,M,Y,,,20201014.0,,HP,GR,GR,2020,Q4,Elderly
183803181,18380318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FROM 5 YEARS,,,U,,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,,20201003.0,20201014,20201014,EXP,,GR-EMD SERONO-9190824,EMD SERONO INC,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, NTALAOUTIS A, SAMARAS A, LAZARI E, VLASTARAKOS P, GIANNAS R, IORDANIDIS S, GEORGALI A, GIANNIKOPOULOS G. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MYTH OR REALITY?.. POSTED ANNOUNCEMENTS (POSTER).. 2020;75.",82.0,YR,E,M,Y,,,20201014.0,,HP,GR,GR,2020,Q4,Elderly
183803181,18380318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FROM 5 YEARS,,,U,,,,,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201003.0,20201014,20201014,EXP,,GR-EMD SERONO-9190824,EMD SERONO INC,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, NTALAOUTIS A, SAMARAS A, LAZARI E, VLASTARAKOS P, GIANNAS R, IORDANIDIS S, GEORGALI A, GIANNIKOPOULOS G. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MYTH OR REALITY?.. POSTED ANNOUNCEMENTS (POSTER).. 2020;75.",82.0,YR,E,M,Y,,,20201014.0,,HP,GR,GR,2020,Q4,Elderly
183803181,18380318,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,FROM 5 YEARS,,,U,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201003.0,20201014,20201014,EXP,,GR-EMD SERONO-9190824,EMD SERONO INC,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, NTALAOUTIS A, SAMARAS A, LAZARI E, VLASTARAKOS P, GIANNAS R, IORDANIDIS S, GEORGALI A, GIANNIKOPOULOS G. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES MYTH OR REALITY?.. POSTED ANNOUNCEMENTS (POSTER).. 2020;75.",82.0,YR,E,M,Y,,,20201014.0,,HP,GR,GR,2020,Q4,Elderly
183840721,18384072,6,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"20 INTERNATIONAL UNIT, ONCE A DAY",8220.0,IU,Y,,,,,20.0,IU,,QD,2020,Q4,Lower gastrointestinal haemorrhage,,2020,Q4,1,I,20191124.0,20201007.0,20201015,20201015,EXP,,ES-AUROBINDO-AUR-APL-2020-051927,AUROBINDO,,77.0,YR,,F,Y,,,20201015.0,,MD,ES,ES,2020,Q4,Elderly
183868411,18386841,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20200915.0,,20201015,20201015,DIR,,,FDA-CTU,,75.0,YR,,F,N,117.3,KG,20201015.0,N,PH,US,US,2020,Q4,Elderly
183868411,18386841,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Liver function test increased,,2020,Q4,1,I,20200915.0,,20201015,20201015,DIR,,,FDA-CTU,,75.0,YR,,F,N,117.3,KG,20201015.0,N,PH,US,US,2020,Q4,Elderly
183868411,18386841,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,20200915.0,,20201015,20201015,DIR,,,FDA-CTU,,75.0,YR,,F,N,117.3,KG,20201015.0,N,PH,US,US,2020,Q4,Elderly
183868411,18386841,5,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Therapy cessation,,2020,Q4,1,I,20200915.0,,20201015,20201015,DIR,,,FDA-CTU,,75.0,YR,,F,N,117.3,KG,20201015.0,N,PH,US,US,2020,Q4,Elderly
183969672,18396967,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Diabetes mellitus,,2020,Q4,2,F,202010.0,20201014.0,20201019,20201024,EXP,,US-UCBSA-2020040475,UCB,,53.0,YR,,F,Y,,,20201024.0,,CN,US,US,2020,Q4,Adult
183969672,18396967,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Myocardial infarction,,2020,Q4,2,F,202010.0,20201014.0,20201019,20201024,EXP,,US-UCBSA-2020040475,UCB,,53.0,YR,,F,Y,,,20201024.0,,CN,US,US,2020,Q4,Adult
183969681,18396968,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,20201016.0,,20201018,20201018,DIR,,,FDA-CTU,,70.0,YR,,F,N,109.0,KG,20201018.0,N,PH,US,US,2020,Q4,Elderly
183969681,18396968,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,20201016.0,,20201018,20201018,DIR,,,FDA-CTU,,70.0,YR,,F,N,109.0,KG,20201018.0,N,PH,US,US,2020,Q4,Elderly
183985881,18398588,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Coronary artery disease,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Ejection fraction decreased,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
183985881,18398588,11,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypertension,,2020,Q4,1,I,20200825.0,,20201019,20201019,DIR,,,FDA-CTU,,85.0,YR,,M,N,80.9,KG,20201019.0,Y,PH,US,US,2020,Q4,Elderly
184006722,18400672,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 UNITS, ONCE DAILY EVERY MORNING",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q4,Anaemia,,2020,Q4,2,F,20201010.0,20201123.0,20201019,20201127,EXP,,US-ASTELLAS-2020US036516,ASTELLAS,,79.0,YR,,M,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
184006722,18400672,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"28 UNITS, ONCE DAILY EVERY MORNING",,,,,,,,,,FORMULATION UNKNOWN,QD,2020,Q4,Cardiac disorder,,2020,Q4,2,F,20201010.0,20201123.0,20201019,20201127,EXP,,US-ASTELLAS-2020US036516,ASTELLAS,,79.0,YR,,M,Y,,,20201127.0,,CN,US,US,2020,Q4,Elderly
184032021,18403202,9,C,INSULINE GLARGINE 100E/ML INJVLST / ABASAGLAR INJVLST 100E/ML PEN 3ML,,2,,"20 E ONCE A DAY, UNIT DOSE: 20 IU,",,,,, UNKNOWN,,,20.0,IU,,,2020,Q4,Bradycardia,,2020,Q4,1,I,20200911.0,20201012.0,20201020,20201020,EXP,NL-LRB-00414824,NL-TEVA-2020-NL-1839194,TEVA,,53.0,YR,A,F,Y,117.0,KG,20201020.0,,MD,NL,NL,2020,Q4,Adult
184032021,18403202,9,C,INSULINE GLARGINE 100E/ML INJVLST / ABASAGLAR INJVLST 100E/ML PEN 3ML,,2,,"20 E ONCE A DAY, UNIT DOSE: 20 IU,",,,,, UNKNOWN,,,20.0,IU,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,20200911.0,20201012.0,20201020,20201020,EXP,NL-LRB-00414824,NL-TEVA-2020-NL-1839194,TEVA,,53.0,YR,A,F,Y,117.0,KG,20201020.0,,MD,NL,NL,2020,Q4,Adult
184076001,18407600,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypertension,,2020,Q4,1,I,20200301.0,20201016.0,20201020,20201020,EXP,,FR-MYLANLABS-2020M1088026,MYLAN,,68.0,YR,,M,Y,104.0,KG,20201020.0,,MD,FR,FR,2020,Q4,Elderly
184105771,18410577,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,GR-MYLANLABS-2020M1088052,MYLAN,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, LAZARI I, VLASTARAKOS P, GIANNAS R, ET AL.. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES: MYTH OR REALITY?. POSTED ANNOUNCEMENTS (POSTER).. 2020;75",82.0,YR,,,Y,,,20201021.0,,HP,GR,GR,2020,Q4,Elderly
184105771,18410577,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,GR-MYLANLABS-2020M1088052,MYLAN,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, LAZARI I, VLASTARAKOS P, GIANNAS R, ET AL.. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES: MYTH OR REALITY?. POSTED ANNOUNCEMENTS (POSTER).. 2020;75",82.0,YR,,,Y,,,20201021.0,,HP,GR,GR,2020,Q4,Elderly
184105771,18410577,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Aortic bruit,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,GR-MYLANLABS-2020M1088052,MYLAN,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, LAZARI I, VLASTARAKOS P, GIANNAS R, ET AL.. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES: MYTH OR REALITY?. POSTED ANNOUNCEMENTS (POSTER).. 2020;75",82.0,YR,,,Y,,,20201021.0,,HP,GR,GR,2020,Q4,Elderly
184105771,18410577,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Breath sounds abnormal,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,GR-MYLANLABS-2020M1088052,MYLAN,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, LAZARI I, VLASTARAKOS P, GIANNAS R, ET AL.. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES: MYTH OR REALITY?. POSTED ANNOUNCEMENTS (POSTER).. 2020;75",82.0,YR,,,Y,,,20201021.0,,HP,GR,GR,2020,Q4,Elderly
184105771,18410577,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Bundle branch block right,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,GR-MYLANLABS-2020M1088052,MYLAN,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, LAZARI I, VLASTARAKOS P, GIANNAS R, ET AL.. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES: MYTH OR REALITY?. POSTED ANNOUNCEMENTS (POSTER).. 2020;75",82.0,YR,,,Y,,,20201021.0,,HP,GR,GR,2020,Q4,Elderly
184105771,18410577,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Confusional state,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,GR-MYLANLABS-2020M1088052,MYLAN,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, LAZARI I, VLASTARAKOS P, GIANNAS R, ET AL.. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES: MYTH OR REALITY?. POSTED ANNOUNCEMENTS (POSTER).. 2020;75",82.0,YR,,,Y,,,20201021.0,,HP,GR,GR,2020,Q4,Elderly
184105771,18410577,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,GR-MYLANLABS-2020M1088052,MYLAN,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, LAZARI I, VLASTARAKOS P, GIANNAS R, ET AL.. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES: MYTH OR REALITY?. POSTED ANNOUNCEMENTS (POSTER).. 2020;75",82.0,YR,,,Y,,,20201021.0,,HP,GR,GR,2020,Q4,Elderly
184105771,18410577,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Tachypnoea,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,GR-MYLANLABS-2020M1088052,MYLAN,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, LAZARI I, VLASTARAKOS P, GIANNAS R, ET AL.. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES: MYTH OR REALITY?. POSTED ANNOUNCEMENTS (POSTER).. 2020;75",82.0,YR,,,Y,,,20201021.0,,HP,GR,GR,2020,Q4,Elderly
184105771,18410577,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201016.0,20201021,20201021,EXP,,GR-MYLANLABS-2020M1088052,MYLAN,"FEIDAKIS A, TRITZALI M, ADAMIDOU S, LAZARI I, VLASTARAKOS P, GIANNAS R, ET AL.. DIABETIC KETOACIDOSIS IN AN ELDERLY PATIENT WITH TYPE 2 DIABETES: MYTH OR REALITY?. POSTED ANNOUNCEMENTS (POSTER).. 2020;75",82.0,YR,,,Y,,,20201021.0,,HP,GR,GR,2020,Q4,Elderly
184126792,18412679,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS PER TIME,,,,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,2,F,20201002.0,20201021.0,20201022,20201029,EXP,,CN-ASTRAZENECA-2020SF35406,ASTRAZENECA,,17591.0,DY,,M,Y,75.0,KG,20201029.0,,,CN,CN,2020,Q4,Elderly
184126792,18412679,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS PER TIME,,,,,,,,,,,,2020,Q4,Diarrhoea,,2020,Q4,2,F,20201002.0,20201021.0,20201022,20201029,EXP,,CN-ASTRAZENECA-2020SF35406,ASTRAZENECA,,17591.0,DY,,M,Y,75.0,KG,20201029.0,,,CN,CN,2020,Q4,Elderly
184126792,18412679,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS PER TIME,,,,,,,,,,,,2020,Q4,Dyspepsia,,2020,Q4,2,F,20201002.0,20201021.0,20201022,20201029,EXP,,CN-ASTRAZENECA-2020SF35406,ASTRAZENECA,,17591.0,DY,,M,Y,75.0,KG,20201029.0,,,CN,CN,2020,Q4,Elderly
184126792,18412679,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS PER TIME,,,,,,,,,,,,2020,Q4,Eructation,,2020,Q4,2,F,20201002.0,20201021.0,20201022,20201029,EXP,,CN-ASTRAZENECA-2020SF35406,ASTRAZENECA,,17591.0,DY,,M,Y,75.0,KG,20201029.0,,,CN,CN,2020,Q4,Elderly
184126792,18412679,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS PER TIME,,,,,,,,,,,,2020,Q4,Gait disturbance,,2020,Q4,2,F,20201002.0,20201021.0,20201022,20201029,EXP,,CN-ASTRAZENECA-2020SF35406,ASTRAZENECA,,17591.0,DY,,M,Y,75.0,KG,20201029.0,,,CN,CN,2020,Q4,Elderly
184126792,18412679,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS PER TIME,,,,,,,,,,,,2020,Q4,Hypovolaemic shock,,2020,Q4,2,F,20201002.0,20201021.0,20201022,20201029,EXP,,CN-ASTRAZENECA-2020SF35406,ASTRAZENECA,,17591.0,DY,,M,Y,75.0,KG,20201029.0,,,CN,CN,2020,Q4,Elderly
184126792,18412679,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS PER TIME,,,,,,,,,,,,2020,Q4,Muscular weakness,,2020,Q4,2,F,20201002.0,20201021.0,20201022,20201029,EXP,,CN-ASTRAZENECA-2020SF35406,ASTRAZENECA,,17591.0,DY,,M,Y,75.0,KG,20201029.0,,,CN,CN,2020,Q4,Elderly
184126792,18412679,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 UNITS PER TIME,,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,2,F,20201002.0,20201021.0,20201022,20201029,EXP,,CN-ASTRAZENECA-2020SF35406,ASTRAZENECA,,17591.0,DY,,M,Y,75.0,KG,20201029.0,,,CN,CN,2020,Q4,Elderly
184139351,18413935,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201011.0,20201022,20201022,EXP,,US-INDICUS PHARMA-000724,INDICUS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. C41 CRITICAL CARE CASE REPORTS: TOXICOLOGY AND POISONINGS. ANY J REAL. CRIT CARE MED 2019;199:A4805,63.0,YR,,M,Y,,,20201022.0,,MD,QA,US,2020,Q4,Adult
184139351,18413935,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20201011.0,20201022,20201022,EXP,,US-INDICUS PHARMA-000724,INDICUS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. C41 CRITICAL CARE CASE REPORTS: TOXICOLOGY AND POISONINGS. ANY J REAL. CRIT CARE MED 2019;199:A4805,63.0,YR,,M,Y,,,20201022.0,,MD,QA,US,2020,Q4,Adult
184139351,18413935,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Leukocytosis,,2020,Q4,1,I,,20201011.0,20201022,20201022,EXP,,US-INDICUS PHARMA-000724,INDICUS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. C41 CRITICAL CARE CASE REPORTS: TOXICOLOGY AND POISONINGS. ANY J REAL. CRIT CARE MED 2019;199:A4805,63.0,YR,,M,Y,,,20201022.0,,MD,QA,US,2020,Q4,Adult
184139351,18413935,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Osmolar gap,,2020,Q4,1,I,,20201011.0,20201022,20201022,EXP,,US-INDICUS PHARMA-000724,INDICUS,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. C41 CRITICAL CARE CASE REPORTS: TOXICOLOGY AND POISONINGS. ANY J REAL. CRIT CARE MED 2019;199:A4805,63.0,YR,,M,Y,,,20201022.0,,MD,QA,US,2020,Q4,Adult
184141131,18414113,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201011.0,20201022,20201022,EXP,,US-INVENTIA-000432,INVENTIA HEALTHCARE,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. C41 CRITICAL CARE CASE REPORTS: TOXICOLOGY AND POISONINGS. ANY J REAL. CRIT CARE MED 2019;199:A4805,63.0,YR,,M,Y,,,20201022.0,,MD,QA,US,2020,Q4,Adult
184141131,18414113,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20201011.0,20201022,20201022,EXP,,US-INVENTIA-000432,INVENTIA HEALTHCARE,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. C41 CRITICAL CARE CASE REPORTS: TOXICOLOGY AND POISONINGS. ANY J REAL. CRIT CARE MED 2019;199:A4805,63.0,YR,,M,Y,,,20201022.0,,MD,QA,US,2020,Q4,Adult
184141131,18414113,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Leukocytosis,,2020,Q4,1,I,,20201011.0,20201022,20201022,EXP,,US-INVENTIA-000432,INVENTIA HEALTHCARE,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. C41 CRITICAL CARE CASE REPORTS: TOXICOLOGY AND POISONINGS. ANY J REAL. CRIT CARE MED 2019;199:A4805,63.0,YR,,M,Y,,,20201022.0,,MD,QA,US,2020,Q4,Adult
184141131,18414113,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Osmolar gap,,2020,Q4,1,I,,20201011.0,20201022,20201022,EXP,,US-INVENTIA-000432,INVENTIA HEALTHCARE,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS. C41 CRITICAL CARE CASE REPORTS: TOXICOLOGY AND POISONINGS. ANY J REAL. CRIT CARE MED 2019;199:A4805,63.0,YR,,M,Y,,,20201022.0,,MD,QA,US,2020,Q4,Adult
184143031,18414303,17,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,,,20201021,20201021,DIR,,,FDA-CTU,,77.0,YR,,M,N,97.4,KG,20201021.0,N,PH,US,US,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Colitis ischaemic,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Constipation,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Dysuria,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Eczema asteatotic,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Enterocolitis haemorrhagic,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Hepatic function abnormal,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Hyperkalaemia,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Neutrophil count decreased,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Oedema peripheral,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Oral herpes,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184145163,18414516,17,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN FREQ., 1 BOTTLE, INJECTION",,,,,,,,,,INJECTION,,2020,Q4,Pyrexia,,2020,Q4,3,F,20190220.0,20201215.0,20201022,20201222,EXP,,JP-ASTELLAS-2020JP015707,ASTELLAS,"IMANAKA T, UEDA H, FUJIMURA K, SAITO T, NAGATA O, TAKAYA R, ET AL.. A CASE OF CONCOMITANT USE OF GILTERITINIB AND CHEMOTHERAPY FOR FLT-ITD MUTATION POSITIVE ACUTE MYELOID LEUKEMIA. THE 59TH CHUGOKU-SHIKOKU REGINAL MEETING OF JAPANESE SOCIETY OF HEMATOLOGY PROGR. 2020;37",82.0,YR,,F,Y,51.0,KG,20201222.0,,MD,JP,JP,2020,Q4,Elderly
184151471,18415147,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Liver function test increased,,2020,Q4,1,I,20201012.0,,20201022,20201022,DIR,,,FDA-CTU,,69.0,YR,,M,N,96.6,KG,20201022.0,N,PH,US,US,2020,Q4,Elderly
184166522,18416652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Aggression,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Communication disorder,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Confusional state,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Disorientation,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184166522,18416652,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,U,,,210605.0,,,,,2020,Q4,Irritability,,2020,Q4,2,F,,20201104.0,20201022,20201111,EXP,,GR-MYLANLABS-2020M1088712,MYLAN,,65.0,YR,,F,Y,,,20201111.0,,CN,GR,GR,2020,Q4,Elderly
184188063,18418806,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,N,,,,205692.0,,,,,2020,Q4,Hypoglycaemic encephalopathy,,2020,Q4,3,F,20200512.0,20201119.0,20201023,20201201,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010005391,ELI LILLY AND CO,AZUMA. K ET AL..A CASE OF HYPOGLYCEMIC ENCEPHALOPATHY WHICH SUSPECTED OVERDOSE OF PREVIOUSLY USED INSULIN SELF-INJECTION.THE 94TH CHUBU BRANCH MEETING OF JAPAN DIABETES MELLITUS SOCIETY 2020;:77.,57.0,YR,,F,Y,,,20201201.0,,MD,JP,JP,2020,Q4,Adult
184188063,18418806,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,N,,,,205692.0,,,,,2020,Q4,Wrong drug,,2020,Q4,3,F,20200512.0,20201119.0,20201023,20201201,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010005391,ELI LILLY AND CO,AZUMA. K ET AL..A CASE OF HYPOGLYCEMIC ENCEPHALOPATHY WHICH SUSPECTED OVERDOSE OF PREVIOUSLY USED INSULIN SELF-INJECTION.THE 94TH CHUBU BRANCH MEETING OF JAPAN DIABETES MELLITUS SOCIETY 2020;:77.,57.0,YR,,F,Y,,,20201201.0,,MD,JP,JP,2020,Q4,Adult
184201991,18420199,47,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Hypomagnesaemia,,2020,Q4,1,I,20200722.0,20200825.0,20201023,20201023,EXP,ES-VELOXIS PHARMACEUTICALS-2020VELES-000724,NVSC2020ES236352,NOVARTIS,,68.0,YR,,M,Y,62.6,KG,20201023.0,,HP,ES,ES,2020,Q4,Elderly
184201991,18420199,47,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,20200722.0,20200825.0,20201023,20201023,EXP,ES-VELOXIS PHARMACEUTICALS-2020VELES-000724,NVSC2020ES236352,NOVARTIS,,68.0,YR,,M,Y,62.6,KG,20201023.0,,HP,ES,ES,2020,Q4,Elderly
184201991,18420199,48,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Hypomagnesaemia,,2020,Q4,1,I,20200722.0,20200825.0,20201023,20201023,EXP,ES-VELOXIS PHARMACEUTICALS-2020VELES-000724,NVSC2020ES236352,NOVARTIS,,68.0,YR,,M,Y,62.6,KG,20201023.0,,HP,ES,ES,2020,Q4,Elderly
184201991,18420199,48,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,20200722.0,20200825.0,20201023,20201023,EXP,ES-VELOXIS PHARMACEUTICALS-2020VELES-000724,NVSC2020ES236352,NOVARTIS,,68.0,YR,,M,Y,62.6,KG,20201023.0,,HP,ES,ES,2020,Q4,Elderly
184292521,18429252,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNK, 10 UNITS",,,U,,,,,,,INJECTION,,2020,Q4,Cardiac ventricular thrombosis,,2020,Q4,1,I,20200828.0,20201019.0,20201026,20201026,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20201026.0,,MD,CN,CN,2020,Q4,Adult
184292521,18429252,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 UNK, 10 UNITS",,,U,,,,,,,INJECTION,,2020,Q4,Ventricular arrhythmia,,2020,Q4,1,I,20200828.0,20201019.0,20201026,20201026,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20201026.0,,MD,CN,CN,2020,Q4,Adult
184294223,18429422,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Hypomagnesaemia,,2020,Q4,3,F,20200722.0,20201117.0,20201026,20201120,EXP,,ES-PFIZER INC-2020338723,PFIZER,,68.0,YR,,M,Y,62.6,KG,20201120.0,,MD,ES,ES,2020,Q4,Elderly
184294223,18429422,44,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Renal impairment,,2020,Q4,3,F,20200722.0,20201117.0,20201026,20201120,EXP,,ES-PFIZER INC-2020338723,PFIZER,,68.0,YR,,M,Y,62.6,KG,20201120.0,,MD,ES,ES,2020,Q4,Elderly
184294223,18429422,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypomagnesaemia,,2020,Q4,3,F,20200722.0,20201117.0,20201026,20201120,EXP,,ES-PFIZER INC-2020338723,PFIZER,,68.0,YR,,M,Y,62.6,KG,20201120.0,,MD,ES,ES,2020,Q4,Elderly
184294223,18429422,45,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,3,F,20200722.0,20201117.0,20201026,20201120,EXP,,ES-PFIZER INC-2020338723,PFIZER,,68.0,YR,,M,Y,62.6,KG,20201120.0,,MD,ES,ES,2020,Q4,Elderly
184297002,18429700,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Blood bilirubin increased,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,International normalised ratio increased,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297002,18429700,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,2,F,202009.0,20201119.0,20201026,20201125,EXP,,US-GILEAD-2020-0501216,GILEAD,,64.0,YR,,M,Y,93.6,KG,20201125.0,,PH,US,US,2020,Q4,Adult
184297282,18429728,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,2,F,20201018.0,20201124.0,20201026,20201201,EXP,,US-GILEAD-2020-0501205,GILEAD,,86.0,YR,E,M,Y,92.9,KG,20201201.0,,PH,US,US,2020,Q4,Elderly
184297282,18429728,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Expired product administered,,2020,Q4,2,F,20201018.0,20201124.0,20201026,20201201,EXP,,US-GILEAD-2020-0501205,GILEAD,,86.0,YR,E,M,Y,92.9,KG,20201201.0,,PH,US,US,2020,Q4,Elderly
184297282,18429728,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pulseless electrical activity,,2020,Q4,2,F,20201018.0,20201124.0,20201026,20201201,EXP,,US-GILEAD-2020-0501205,GILEAD,,86.0,YR,E,M,Y,92.9,KG,20201201.0,,PH,US,US,2020,Q4,Elderly
184297282,18429728,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,2,F,20201018.0,20201124.0,20201026,20201201,EXP,,US-GILEAD-2020-0501205,GILEAD,,86.0,YR,E,M,Y,92.9,KG,20201201.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Apnoeic attack,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Areflexia,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Endotracheal intubation,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Extubation,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypoxic-ischaemic encephalopathy,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Mechanical ventilation,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184297292,18429729,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pulse absent,,2020,Q4,2,F,20200929.0,20201124.0,20201026,20201127,EXP,,US-GILEAD-2020-0501211,GILEAD,,95.0,YR,E,F,Y,85.4,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
184314951,18431495,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Posterior reversible encephalopathy syndrome,,2020,Q4,1,I,,20201019.0,20201027,20201027,EXP,,US-MYLANLABS-2020M1089668,MYLAN,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE-REP-NEUROL 2020;12(1):63-68.",41.0,YR,,F,Y,,,20201027.0,,MD,US,US,2020,Q4,Adult
184314951,18431495,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,U,,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,,20201019.0,20201027,20201027,EXP,,US-MYLANLABS-2020M1089668,MYLAN,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE-REP-NEUROL 2020;12(1):63-68.",41.0,YR,,F,Y,,,20201027.0,,MD,US,US,2020,Q4,Adult
184334672,18433467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Contraindicated product administered,,2020,Q4,2,F,,20201116.0,20201027,20201124,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-056954",BOEHRINGER INGELHEIM,A CASE OF A WOMAN IN HER 70S WITH REPEATED DKA SUCCESSFULLY PREVENTED DKA RELAPSE FOR OVER ONE AND A HALF YEAR THROUGH MULTIDISCIPLINARY INTERVENTION FOR HOME CARE MAINTENANCE AFTER EDUCATION BY PHARMACISTS. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2020 AUG 24; 63(1): 206-,74.0,YR,E,F,Y,,,20201124.0,,,COUNTRY NOT SPECIFIED,JP,2020,Q4,Elderly
184334672,18433467,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,2,F,,20201116.0,20201027,20201124,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-056954",BOEHRINGER INGELHEIM,A CASE OF A WOMAN IN HER 70S WITH REPEATED DKA SUCCESSFULLY PREVENTED DKA RELAPSE FOR OVER ONE AND A HALF YEAR THROUGH MULTIDISCIPLINARY INTERVENTION FOR HOME CARE MAINTENANCE AFTER EDUCATION BY PHARMACISTS. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2020 AUG 24; 63(1): 206-,74.0,YR,E,F,Y,,,20201124.0,,,COUNTRY NOT SPECIFIED,JP,2020,Q4,Elderly
184344481,18434448,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Intracardiac,"44 INTERNATIONAL UNIT, QD (BEFORE EACH MEAL)",,,,,,,,44.0,IU,,QD,2020,Q4,Off label use,,2020,Q4,1,I,,20201019.0,20201028,20201028,EXP,,CO-LUPIN PHARMACEUTICALS INC.-2020-07907,LUPIN,,40.0,YR,,M,Y,,,20201028.0,,HP,CO,CO,2020,Q4,Adult
184366111,18436611,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE,,,D,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201021.0,20201028,20201028,EXP,,US-MYLANLABS-2020M1090464,MYLAN,"TILLETT Z, ISLAM MI, PATEL M, SILL J. METHYLENE BLUE LEADS TO RAPID CORRECTION OF VASOPRESSOR RESISTANT HYPOTENSION IN CALCIUM CHANNEL BLOCKER OVERDOSE. CHEST 2020;158 (SUPPL.)(4):A893-A894.",26.0,YR,,F,Y,,,20201028.0,,HP,US,US,2020,Q4,Young Adult
184366111,18436611,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE,,,D,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,,20201021.0,20201028,20201028,EXP,,US-MYLANLABS-2020M1090464,MYLAN,"TILLETT Z, ISLAM MI, PATEL M, SILL J. METHYLENE BLUE LEADS TO RAPID CORRECTION OF VASOPRESSOR RESISTANT HYPOTENSION IN CALCIUM CHANNEL BLOCKER OVERDOSE. CHEST 2020;158 (SUPPL.)(4):A893-A894.",26.0,YR,,F,Y,,,20201028.0,,HP,US,US,2020,Q4,Young Adult
184366111,18436611,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE,,,D,,,,,,,,,2020,Q4,Intentional overdose,,2020,Q4,1,I,,20201021.0,20201028,20201028,EXP,,US-MYLANLABS-2020M1090464,MYLAN,"TILLETT Z, ISLAM MI, PATEL M, SILL J. METHYLENE BLUE LEADS TO RAPID CORRECTION OF VASOPRESSOR RESISTANT HYPOTENSION IN CALCIUM CHANNEL BLOCKER OVERDOSE. CHEST 2020;158 (SUPPL.)(4):A893-A894.",26.0,YR,,F,Y,,,20201028.0,,HP,US,US,2020,Q4,Young Adult
184366111,18436611,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE,,,D,,,,,,,,,2020,Q4,Shock,,2020,Q4,1,I,,20201021.0,20201028,20201028,EXP,,US-MYLANLABS-2020M1090464,MYLAN,"TILLETT Z, ISLAM MI, PATEL M, SILL J. METHYLENE BLUE LEADS TO RAPID CORRECTION OF VASOPRESSOR RESISTANT HYPOTENSION IN CALCIUM CHANNEL BLOCKER OVERDOSE. CHEST 2020;158 (SUPPL.)(4):A893-A894.",26.0,YR,,F,Y,,,20201028.0,,HP,US,US,2020,Q4,Young Adult
184366111,18436611,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE,,,D,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201021.0,20201028,20201028,EXP,,US-MYLANLABS-2020M1090464,MYLAN,"TILLETT Z, ISLAM MI, PATEL M, SILL J. METHYLENE BLUE LEADS TO RAPID CORRECTION OF VASOPRESSOR RESISTANT HYPOTENSION IN CALCIUM CHANNEL BLOCKER OVERDOSE. CHEST 2020;158 (SUPPL.)(4):A893-A894.",26.0,YR,,F,Y,,,20201028.0,,HP,US,US,2020,Q4,Young Adult
184366111,18436611,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,HIGH DOSE,,,D,,,,,,,,,2020,Q4,Vasodilatation,,2020,Q4,1,I,,20201021.0,20201028,20201028,EXP,,US-MYLANLABS-2020M1090464,MYLAN,"TILLETT Z, ISLAM MI, PATEL M, SILL J. METHYLENE BLUE LEADS TO RAPID CORRECTION OF VASOPRESSOR RESISTANT HYPOTENSION IN CALCIUM CHANNEL BLOCKER OVERDOSE. CHEST 2020;158 (SUPPL.)(4):A893-A894.",26.0,YR,,F,Y,,,20201028.0,,HP,US,US,2020,Q4,Young Adult
184369943,18436994,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Blood bilirubin increased,,2020,Q4,3,F,20200913.0,20201105.0,20201028,20201116,EXP,,US-PFIZER INC-2020401804,PFIZER,,60.0,YR,,M,Y,120.3,KG,20201116.0,,HP,US,US,2020,Q4,Adult
184369943,18436994,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,3,F,20200913.0,20201105.0,20201028,20201116,EXP,,US-PFIZER INC-2020401804,PFIZER,,60.0,YR,,M,Y,120.3,KG,20201116.0,,HP,US,US,2020,Q4,Adult
184369943,18436994,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Encephalopathy,,2020,Q4,3,F,20200913.0,20201105.0,20201028,20201116,EXP,,US-PFIZER INC-2020401804,PFIZER,,60.0,YR,,M,Y,120.3,KG,20201116.0,,HP,US,US,2020,Q4,Adult
184369943,18436994,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,3,F,20200913.0,20201105.0,20201028,20201116,EXP,,US-PFIZER INC-2020401804,PFIZER,,60.0,YR,,M,Y,120.3,KG,20201116.0,,HP,US,US,2020,Q4,Adult
184369943,18436994,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Muscular weakness,,2020,Q4,3,F,20200913.0,20201105.0,20201028,20201116,EXP,,US-PFIZER INC-2020401804,PFIZER,,60.0,YR,,M,Y,120.3,KG,20201116.0,,HP,US,US,2020,Q4,Adult
184369943,18436994,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pulmonary oedema,,2020,Q4,3,F,20200913.0,20201105.0,20201028,20201116,EXP,,US-PFIZER INC-2020401804,PFIZER,,60.0,YR,,M,Y,120.3,KG,20201116.0,,HP,US,US,2020,Q4,Adult
184369943,18436994,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,3,F,20200913.0,20201105.0,20201028,20201116,EXP,,US-PFIZER INC-2020401804,PFIZER,,60.0,YR,,M,Y,120.3,KG,20201116.0,,HP,US,US,2020,Q4,Adult
184369943,18436994,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Venoocclusive liver disease,,2020,Q4,3,F,20200913.0,20201105.0,20201028,20201116,EXP,,US-PFIZER INC-2020401804,PFIZER,,60.0,YR,,M,Y,120.3,KG,20201116.0,,HP,US,US,2020,Q4,Adult
184376991,18437699,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,210605.0,,,,,2020,Q4,Drug ineffective for unapproved indication,,2020,Q4,1,I,,20201021.0,20201028,20201028,EXP,,US-MYLANLABS-2020M1090735,MYLAN,"MILLS K, OMAR A, ABE T. A RARE CASE OF COMPLETE HEART BLOCK AS THE INITIAL MANIFESTATION OF ACUTE KIDNEY INJURY. CHEST 2020;158(4):A248.",73.0,YR,,M,Y,,,20201028.0,,HP,US,US,2020,Q4,Elderly
184376991,18437699,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,210605.0,,,,,2020,Q4,Off label use,,2020,Q4,1,I,,20201021.0,20201028,20201028,EXP,,US-MYLANLABS-2020M1090735,MYLAN,"MILLS K, OMAR A, ABE T. A RARE CASE OF COMPLETE HEART BLOCK AS THE INITIAL MANIFESTATION OF ACUTE KIDNEY INJURY. CHEST 2020;158(4):A248.",73.0,YR,,M,Y,,,20201028.0,,HP,US,US,2020,Q4,Elderly
184391296,18439129,25,C,INSULIN GLARGINE BIOMEP,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,6,F,20201018.0,20201211.0,20201028,20201215,EXP,,US-GILEAD-2020-0501671,GILEAD,,77.0,YR,E,F,Y,59.41,KG,20201215.0,,HP,US,US,2020,Q4,Elderly
184391421,18439142,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Streptococcal infection,,2020,Q4,1,I,20200927.0,20201012.0,20201028,20201028,EXP,,US-GILEAD-2020-0498852,GILEAD,,78.0,YR,E,M,Y,97.0,KG,20201028.0,,HP,US,US,2020,Q4,Elderly
184394892,18439489,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,205692.0,6.0,IU,,QD,2020,Q4,Cutaneous amyloidosis,,2020,Q4,2,F,,20201104.0,20201028,20201116,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010008562AA,ELI LILLY AND CO,"NAKAMURA E, ET AL..A CASE IN WHICH A WOMAN IN HER 70S WHO REPEATED DKA WAS ABLE TO PREVENT DKA RELAPSE FOR MORE THAN A YEAR AND A HALF THROUGH MULTIDISCIPLINARY INTERVENTION TO MAINTAIN HOME CARE, TRIGGERED BY PHARMACISTS MEDICAL TREATMENT GUIDANCE..JOURNAL OF THE JAPAN DIABETES SOCIETY 2020;63 (S1):S206.",74.0,YR,,F,Y,,,20201116.0,,PH,JP,JP,2020,Q4,Elderly
184394892,18439489,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"6 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,205692.0,6.0,IU,,QD,2020,Q4,Diabetic ketoacidosis,,2020,Q4,2,F,,20201104.0,20201028,20201116,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010008562AA,ELI LILLY AND CO,"NAKAMURA E, ET AL..A CASE IN WHICH A WOMAN IN HER 70S WHO REPEATED DKA WAS ABLE TO PREVENT DKA RELAPSE FOR MORE THAN A YEAR AND A HALF THROUGH MULTIDISCIPLINARY INTERVENTION TO MAINTAIN HOME CARE, TRIGGERED BY PHARMACISTS MEDICAL TREATMENT GUIDANCE..JOURNAL OF THE JAPAN DIABETES SOCIETY 2020;63 (S1):S206.",74.0,YR,,F,Y,,,20201116.0,,PH,JP,JP,2020,Q4,Elderly
184417041,18441704,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201020.0,20201029,20201029,EXP,,US-JNJFOC-20201042257,JOHNSON AND JOHNSON,"TITLE: HICCUPS: YOU GOT TO BE KIDNEY ME! YEAR: 2020 VOLUME: 8 ISSUE:  AUTHOR AFFILIATION: (NGUYEN, DEEB) INTERNAL MEDICINE RESIDENT, UNIVERSITY OF MIAMI JFK GME, ATLANTIS, FL, UNITED STATES(RATHAKRISHNAN) DEPARTMENT OF INTERNAL MEDICINE, HOSPITALIST, WEST PALM BEACH VETERANS AFFAIRS MEDICAL CENTER, WEST PALM BEACH, FL, UNITED STATES JOURNAL NAME: SAGE OPEN MEDICAL CASE REPORTS",62.0,YR,A,M,Y,,,20201029.0,,HP,US,US,2020,Q4,Adult
184417041,18441704,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Hiccups,,2020,Q4,1,I,,20201020.0,20201029,20201029,EXP,,US-JNJFOC-20201042257,JOHNSON AND JOHNSON,"TITLE: HICCUPS: YOU GOT TO BE KIDNEY ME! YEAR: 2020 VOLUME: 8 ISSUE:  AUTHOR AFFILIATION: (NGUYEN, DEEB) INTERNAL MEDICINE RESIDENT, UNIVERSITY OF MIAMI JFK GME, ATLANTIS, FL, UNITED STATES(RATHAKRISHNAN) DEPARTMENT OF INTERNAL MEDICINE, HOSPITALIST, WEST PALM BEACH VETERANS AFFAIRS MEDICAL CENTER, WEST PALM BEACH, FL, UNITED STATES JOURNAL NAME: SAGE OPEN MEDICAL CASE REPORTS",62.0,YR,A,M,Y,,,20201029.0,,HP,US,US,2020,Q4,Adult
184417591,18441759,3,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Acute myocardial infarction,,2020,Q4,1,I,20200913.0,20201022.0,20201029,20201029,EXP,,CO-BAXTER-2020BAX021683,BAXTER,,64.0,YR,,F,Y,71.4,KG,20201029.0,,HP,CO,CO,2020,Q4,Adult
184417591,18441759,3,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Brain oedema,,2020,Q4,1,I,20200913.0,20201022.0,20201029,20201029,EXP,,CO-BAXTER-2020BAX021683,BAXTER,,64.0,YR,,F,Y,71.4,KG,20201029.0,,HP,CO,CO,2020,Q4,Adult
184417591,18441759,3,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Cardiac disorder,,2020,Q4,1,I,20200913.0,20201022.0,20201029,20201029,EXP,,CO-BAXTER-2020BAX021683,BAXTER,,64.0,YR,,F,Y,71.4,KG,20201029.0,,HP,CO,CO,2020,Q4,Adult
184417591,18441759,3,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Cerebrovascular accident,,2020,Q4,1,I,20200913.0,20201022.0,20201029,20201029,EXP,,CO-BAXTER-2020BAX021683,BAXTER,,64.0,YR,,F,Y,71.4,KG,20201029.0,,HP,CO,CO,2020,Q4,Adult
184417591,18441759,3,C,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Urinary tract infection,,2020,Q4,1,I,20200913.0,20201022.0,20201029,20201029,EXP,,CO-BAXTER-2020BAX021683,BAXTER,,64.0,YR,,F,Y,71.4,KG,20201029.0,,HP,CO,CO,2020,Q4,Adult
184417652,18441765,15,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q4,Diabetes mellitus,,2020,Q4,2,F,20170810.0,20201026.0,20201029,20201104,EXP,,JP-FERRINGPH-2020FE07540,FERRING,,76.0,YR,,M,Y,,,20201104.0,,MD,JP,JP,2020,Q4,Elderly
184417652,18441765,15,C,INSULIN GLARGINE BS,INSULIN GLARGINE,1,,UNK,,,,,,,,,,INJECTION,,2020,Q4,Infusion related reaction,,2020,Q4,2,F,20170810.0,20201026.0,20201029,20201104,EXP,,JP-FERRINGPH-2020FE07540,FERRING,,76.0,YR,,M,Y,,,20201104.0,,MD,JP,JP,2020,Q4,Elderly
184419161,18441916,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,TEXT:UNKNOWN-FREQ:UNKNOWN,,,,,,,,,,,,2020,Q4,Face oedema,,2020,Q4,1,I,20041204.0,20201026.0,20201029,20201029,PER,,US-009507513-2010USA009800,MERCK,,60.0,YR,,F,Y,,,20201029.0,,PH,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Aggression,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Headache,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hyperreflexia,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hypertonia,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Mental status changes,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Posterior reversible encephalopathy syndrome,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Tremor,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Vasogenic cerebral oedema,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184457651,18445765,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201023.0,20201030,20201030,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013108,STRIDES,"MALIK MT, MAJEED MF, ZAND R.. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REPORTS IN NEUROLOGY. 2020;12(1):63-68",41.0,YR,,F,Y,,,20201030.0,,MD,US,US,2020,Q4,Adult
184463802,18446380,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184463802,18446380,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2020,Q4,Infective pulmonary exacerbation of cystic fibrosis,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184463802,18446380,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2020,Q4,Lower respiratory tract infection fungal,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184463802,18446380,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2020,Q4,Pneumonia bacterial,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184463802,18446380,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,8 UNITS,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,2,F,20201007.0,20201123.0,20201030,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021228,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184464561,18446456,15,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201021.0,20201030,20201030,EXP,,ES-BAXTER-2020BAX021863,BAXTER,,75.0,YR,,M,Y,86.4,KG,20201030.0,,MD,ES,ES,2020,Q4,Elderly
184464561,18446456,15,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201021.0,20201030,20201030,EXP,,ES-BAXTER-2020BAX021863,BAXTER,,75.0,YR,,M,Y,86.4,KG,20201030.0,,MD,ES,ES,2020,Q4,Elderly
184464561,18446456,15,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201021.0,20201030,20201030,EXP,,ES-BAXTER-2020BAX021863,BAXTER,,75.0,YR,,M,Y,86.4,KG,20201030.0,,MD,ES,ES,2020,Q4,Elderly
184464561,18446456,15,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201021.0,20201030,20201030,EXP,,ES-BAXTER-2020BAX021863,BAXTER,,75.0,YR,,M,Y,86.4,KG,20201030.0,,MD,ES,ES,2020,Q4,Elderly
184464561,18446456,15,SS,insulin glargine,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201021.0,20201030,20201030,EXP,,ES-BAXTER-2020BAX021863,BAXTER,,75.0,YR,,M,Y,86.4,KG,20201030.0,,MD,ES,ES,2020,Q4,Elderly
184516051,18451605,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, 0-0-0-1, AMPOULES",,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201027.0,20201102,20201102,EXP,DE-BFARM-20011622,DE-ACCORD-206907,ACCORD,,86.0,YR,E,M,Y,,,20201102.0,,MD,DE,DE,2020,Q4,Elderly
184516051,18451605,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, 0-0-0-1, AMPOULES",,,,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201027.0,20201102,20201102,EXP,DE-BFARM-20011622,DE-ACCORD-206907,ACCORD,,86.0,YR,E,M,Y,,,20201102.0,,MD,DE,DE,2020,Q4,Elderly
184516051,18451605,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, 0-0-0-1, AMPOULES",,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201027.0,20201102,20201102,EXP,DE-BFARM-20011622,DE-ACCORD-206907,ACCORD,,86.0,YR,E,M,Y,,,20201102.0,,MD,DE,DE,2020,Q4,Elderly
184516051,18451605,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, 0-0-0-1, AMPOULES",,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201027.0,20201102,20201102,EXP,DE-BFARM-20011622,DE-ACCORD-206907,ACCORD,,86.0,YR,E,M,Y,,,20201102.0,,MD,DE,DE,2020,Q4,Elderly
184516051,18451605,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, 0-0-0-1, AMPOULES",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201027.0,20201102,20201102,EXP,DE-BFARM-20011622,DE-ACCORD-206907,ACCORD,,86.0,YR,E,M,Y,,,20201102.0,,MD,DE,DE,2020,Q4,Elderly
184516051,18451605,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, 0-0-0-1, AMPOULES",,,,,,,,,,,,2020,Q4,Musculoskeletal pain,,2020,Q4,1,I,,20201027.0,20201102,20201102,EXP,DE-BFARM-20011622,DE-ACCORD-206907,ACCORD,,86.0,YR,E,M,Y,,,20201102.0,,MD,DE,DE,2020,Q4,Elderly
184516051,18451605,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, 0-0-0-1, AMPOULES",,,,,,,,,,,,2020,Q4,Neck pain,,2020,Q4,1,I,,20201027.0,20201102,20201102,EXP,DE-BFARM-20011622,DE-ACCORD-206907,ACCORD,,86.0,YR,E,M,Y,,,20201102.0,,MD,DE,DE,2020,Q4,Elderly
184519291,18451929,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 INTERNATIONAL UNIT,,,,,,,,13.0,IU,,,2020,Q4,Cutaneous amyloidosis,,2020,Q4,1,I,,20201021.0,20201102,20201102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010009820,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20201102.0,,MD,JP,JP,2020,Q4,Elderly
184519291,18451929,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,13 INTERNATIONAL UNIT,,,,,,,,13.0,IU,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,,20201021.0,20201102,20201102,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202010009820,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20201102.0,,MD,JP,JP,2020,Q4,Elderly
184536962,18453696,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 UNITS, Q24H",,,,,,,,,,,QD,2020,Q4,Acute respiratory failure,,2020,Q4,2,F,202010.0,20201123.0,20201102,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021230,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184536962,18453696,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 UNITS, Q24H",,,,,,,,,,,QD,2020,Q4,Pneumonia,,2020,Q4,2,F,202010.0,20201123.0,20201102,20201202,EXP,,US-VERTEX PHARMACEUTICALS-2020-021230,VERTEX,,26.0,YR,,M,Y,,,20201202.0,,PH,US,US,2020,Q4,Young Adult
184546661,18454666,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Posterior reversible encephalopathy syndrome,,2020,Q4,1,I,,20201019.0,20201103,20201103,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-266030,RANBAXY,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REP NEUROL. 2020;12:63-68",41.0,YR,,F,Y,,,20201103.0,,MD,US,US,2020,Q4,Adult
184546661,18454666,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,,20201019.0,20201103,20201103,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-266030,RANBAXY,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE REP NEUROL. 2020;12:63-68",41.0,YR,,F,Y,,,20201103.0,,MD,US,US,2020,Q4,Adult
184576521,18457652,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,,,,D,,,,,,,,,2020,Q4,Exposure via breast milk,,2020,Q4,1,I,,20201026.0,20201103,20201103,EXP,,US-MYLANLABS-2020M1092014,MYLAN,,1.0,DY,,F,Y,,,20201103.0,,HP,US,US,2020,Q4,Child
184576521,18457652,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,,,,D,,,,,,,,,2020,Q4,Foetal exposure during pregnancy,,2020,Q4,1,I,,20201026.0,20201103,20201103,EXP,,US-MYLANLABS-2020M1092014,MYLAN,,1.0,DY,,F,Y,,,20201103.0,,HP,US,US,2020,Q4,Child
184576521,18457652,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,,,,D,,,,,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,,20201026.0,20201103,20201103,EXP,,US-MYLANLABS-2020M1092014,MYLAN,,1.0,DY,,F,Y,,,20201103.0,,HP,US,US,2020,Q4,Child
184576521,18457652,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Transplacental,,,,D,,,,,,,,,2020,Q4,Respiratory distress,,2020,Q4,1,I,,20201026.0,20201103,20201103,EXP,,US-MYLANLABS-2020M1092014,MYLAN,,1.0,DY,,F,Y,,,20201103.0,,HP,US,US,2020,Q4,Child
184597284,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2020,Q4,Cerebral infarction,,2020,Q4,4,F,20200926.0,20201218.0,20201103,20201223,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20201223.0,,PH,JP,JP,2020,Q4,Elderly
184597284,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2020,Q4,Hypernatraemia,,2020,Q4,4,F,20200926.0,20201218.0,20201103,20201223,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20201223.0,,PH,JP,JP,2020,Q4,Elderly
184597284,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2020,Q4,Interstitial lung disease,,2020,Q4,4,F,20200926.0,20201218.0,20201103,20201223,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20201223.0,,PH,JP,JP,2020,Q4,Elderly
184597284,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2020,Q4,Osmotic demyelination syndrome,,2020,Q4,4,F,20200926.0,20201218.0,20201103,20201223,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20201223.0,,PH,JP,JP,2020,Q4,Elderly
184597284,18459728,13,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2020,Q4,Pneumonia bacterial,,2020,Q4,4,F,20200926.0,20201218.0,20201103,20201223,EXP,,JP-CELGENEUS-JPN-20201100119,CELGENE,,77.0,YR,,M,Y,47.08,KG,20201223.0,,PH,JP,JP,2020,Q4,Elderly
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Gallbladder oedema,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Gastroenteritis,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Intestinal angioedema,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Oedematous pancreatitis,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Retroperitoneal oedema,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184611471,18461147,2,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20191226.0,20201104,20201104,EXP,,US-SCIEGEN-2019SCILIT00396,SCIEGEN,,60.0,YR,A,F,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184616131,18461613,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184616131,18461613,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cardiac failure,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184616131,18461613,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cardioversion,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184616131,18461613,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184616131,18461613,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Weight decreased,,2020,Q4,1,I,201608.0,20201026.0,20201104,20201104,EXP,,"HR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-057616",BOEHRINGER INGELHEIM,,51.0,YR,A,M,Y,155.0,KG,20201104.0,,,COUNTRY NOT SPECIFIED,HR,2020,Q4,Adult
184620301,18462030,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"42 ARBITRARY UNITS, QD",,,,,,,,,,,QD,2020,Q4,VIth nerve paralysis,,2020,Q4,1,I,20200304.0,20200723.0,20201104,20201104,EXP,,GB-NOVOPROD-743351,NOVO NORDISK,,60.0,YR,,M,Y,102.0,KG,20201104.0,,CN,GB,GB,2020,Q4,Adult
184646531,18464653,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, 1X/DAY(25 UNITS BY SUBCUTANEOUS ROUTE AT BEDTIME)",,,,,,,,25.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Escherichia infection,,2020,Q4,1,I,,20160425.0,20201104,20201104,PER,,US-PFIZER INC-2016232636,PFIZER,,43.0,YR,,M,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184646531,18464653,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, 1X/DAY(25 UNITS BY SUBCUTANEOUS ROUTE AT BEDTIME)",,,,,,,,25.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Limb injury,,2020,Q4,1,I,,20160425.0,20201104,20201104,PER,,US-PFIZER INC-2016232636,PFIZER,,43.0,YR,,M,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184646531,18464653,26,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 IU, 1X/DAY(25 UNITS BY SUBCUTANEOUS ROUTE AT BEDTIME)",,,,,,,,25.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Sepsis,,2020,Q4,1,I,,20160425.0,20201104,20201104,PER,,US-PFIZER INC-2016232636,PFIZER,,43.0,YR,,M,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184646531,18464653,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY(18 UNITS BY SUBCUTANEOUS ROUTE A BEDTIME)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Escherichia infection,,2020,Q4,1,I,,20160425.0,20201104,20201104,PER,,US-PFIZER INC-2016232636,PFIZER,,43.0,YR,,M,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184646531,18464653,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY(18 UNITS BY SUBCUTANEOUS ROUTE A BEDTIME)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Limb injury,,2020,Q4,1,I,,20160425.0,20201104,20201104,PER,,US-PFIZER INC-2016232636,PFIZER,,43.0,YR,,M,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184646531,18464653,27,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, DAILY(18 UNITS BY SUBCUTANEOUS ROUTE A BEDTIME)",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Sepsis,,2020,Q4,1,I,,20160425.0,20201104,20201104,PER,,US-PFIZER INC-2016232636,PFIZER,,43.0,YR,,M,Y,,,20201104.0,,MD,US,US,2020,Q4,Adult
184652761,18465276,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"44 IU, 0-0-0-1, AMPOULES",,,,,,,,44.0,IU,,QD,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201103.0,20201104,20201104,EXP,,DE-009507513-2011DEU001020,MERCK,,78.0,YR,,M,Y,87.0,KG,20201104.0,,MD,DE,DE,2020,Q4,Elderly
184652761,18465276,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"44 IU, 0-0-0-1, AMPOULES",,,,,,,,44.0,IU,,QD,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201103.0,20201104,20201104,EXP,,DE-009507513-2011DEU001020,MERCK,,78.0,YR,,M,Y,87.0,KG,20201104.0,,MD,DE,DE,2020,Q4,Elderly
184652761,18465276,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"44 IU, 0-0-0-1, AMPOULES",,,,,,,,44.0,IU,,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201103.0,20201104,20201104,EXP,,DE-009507513-2011DEU001020,MERCK,,78.0,YR,,M,Y,87.0,KG,20201104.0,,MD,DE,DE,2020,Q4,Elderly
184652761,18465276,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"44 IU, 0-0-0-1, AMPOULES",,,,,,,,44.0,IU,,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201103.0,20201104,20201104,EXP,,DE-009507513-2011DEU001020,MERCK,,78.0,YR,,M,Y,87.0,KG,20201104.0,,MD,DE,DE,2020,Q4,Elderly
184652761,18465276,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"44 IU, 0-0-0-1, AMPOULES",,,,,,,,44.0,IU,,QD,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201103.0,20201104,20201104,EXP,,DE-009507513-2011DEU001020,MERCK,,78.0,YR,,M,Y,87.0,KG,20201104.0,,MD,DE,DE,2020,Q4,Elderly
184672531,18467253,17,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,20201028.0,,20201104,20201104,DIR,,,FDA-CTU,,76.0,YR,,F,N,126.0,KG,20201104.0,N,PH,US,US,2020,Q4,Elderly
184672951,18467295,2,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Liver function test increased,,2020,Q4,1,I,20201014.0,,20201104,20201104,DIR,,,FDA-CTU,,46.0,YR,,F,N,62.1,KG,20201104.0,N,PH,US,US,2020,Q4,Adult
184674181,18467418,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,,,,QD,2020,Q4,Asthenia,,2020,Q4,1,I,20200715.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184674181,18467418,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,,,,QD,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,20200715.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184674181,18467418,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,,,,QD,2020,Q4,Fatigue,,2020,Q4,1,I,20200715.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184674181,18467418,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,,,,QD,2020,Q4,Nausea,,2020,Q4,1,I,20200715.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184674181,18467418,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,,,,QD,2020,Q4,Polydipsia,,2020,Q4,1,I,20200715.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184674181,18467418,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,,,,QD,2020,Q4,Polyuria,,2020,Q4,1,I,20200715.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184674181,18467418,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,,,,QD,2020,Q4,Therapy cessation,,2020,Q4,1,I,20200715.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184674181,18467418,1,PS,"INSULIN (INSULIN, GLARGINE, HUMAN 300 UNT/ML INJ, SOLOSTAR, 3ML)",INSULIN GLARGINE,1,Subcutaneous,?          OTHER DOSE:45 UNITS;?,,,,,,,,,,,QD,2020,Q4,Vomiting,,2020,Q4,1,I,20200715.0,,20201104,20201104,DIR,,,FDA-CTU,,63.0,YR,,M,N,72.12,KG,20201021.0,N,PH,US,US,2020,Q4,Adult
184683782,18468378,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Posterior reversible encephalopathy syndrome,,2020,Q4,2,F,,20201204.0,20201105,20201214,EXP,,US-TEVA-2020-US-1843898,TEVA,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE-REP-NEUROL 2020;12(1):63-68.",41.0,YR,A,F,Y,,,20201214.0,,MD,US,US,2020,Q4,Adult
184683782,18468378,7,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,2,F,,20201204.0,20201105,20201214,EXP,,US-TEVA-2020-US-1843898,TEVA,"MALIK MT, MAJEED MF, ZAND R. SEROTONIN SYNDROME PRESENTING AS A POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. CASE-REP-NEUROL 2020;12(1):63-68.",41.0,YR,A,F,Y,,,20201214.0,,MD,US,US,2020,Q4,Adult
184686821,18468682,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,INJECTION,,2020,Q4,Anuria,,2020,Q4,1,I,,20201030.0,20201105,20201105,EXP,,US-MYLANLABS-2020M1092874,MYLAN,"EDELMAN ER, BUTALA NM, AVERY LL, LUNDQUIST AL, DIGHE AS. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. N-ENGL-J-MED 2020;383(13):1263-1275.",54.0,YR,,M,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
184686821,18468682,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,INJECTION,,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201030.0,20201105,20201105,EXP,,US-MYLANLABS-2020M1092874,MYLAN,"EDELMAN ER, BUTALA NM, AVERY LL, LUNDQUIST AL, DIGHE AS. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. N-ENGL-J-MED 2020;383(13):1263-1275.",54.0,YR,,M,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
184686821,18468682,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,INJECTION,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201030.0,20201105,20201105,EXP,,US-MYLANLABS-2020M1092874,MYLAN,"EDELMAN ER, BUTALA NM, AVERY LL, LUNDQUIST AL, DIGHE AS. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. N-ENGL-J-MED 2020;383(13):1263-1275.",54.0,YR,,M,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
184686821,18468682,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,INJECTION,,2020,Q4,Hypercalcaemia,,2020,Q4,1,I,,20201030.0,20201105,20201105,EXP,,US-MYLANLABS-2020M1092874,MYLAN,"EDELMAN ER, BUTALA NM, AVERY LL, LUNDQUIST AL, DIGHE AS. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. N-ENGL-J-MED 2020;383(13):1263-1275.",54.0,YR,,M,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
184686821,18468682,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,INJECTION,,2020,Q4,Hypertension,,2020,Q4,1,I,,20201030.0,20201105,20201105,EXP,,US-MYLANLABS-2020M1092874,MYLAN,"EDELMAN ER, BUTALA NM, AVERY LL, LUNDQUIST AL, DIGHE AS. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. N-ENGL-J-MED 2020;383(13):1263-1275.",54.0,YR,,M,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
184686821,18468682,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,INJECTION,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,,20201030.0,20201105,20201105,EXP,,US-MYLANLABS-2020M1092874,MYLAN,"EDELMAN ER, BUTALA NM, AVERY LL, LUNDQUIST AL, DIGHE AS. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. N-ENGL-J-MED 2020;383(13):1263-1275.",54.0,YR,,M,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
184686821,18468682,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,INJECTION,,2020,Q4,Metabolic alkalosis,,2020,Q4,1,I,,20201030.0,20201105,20201105,EXP,,US-MYLANLABS-2020M1092874,MYLAN,"EDELMAN ER, BUTALA NM, AVERY LL, LUNDQUIST AL, DIGHE AS. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. N-ENGL-J-MED 2020;383(13):1263-1275.",54.0,YR,,M,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
184686821,18468682,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,INJECTION,,2020,Q4,Renal failure,,2020,Q4,1,I,,20201030.0,20201105,20201105,EXP,,US-MYLANLABS-2020M1092874,MYLAN,"EDELMAN ER, BUTALA NM, AVERY LL, LUNDQUIST AL, DIGHE AS. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. N-ENGL-J-MED 2020;383(13):1263-1275.",54.0,YR,,M,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
184686821,18468682,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,D,,,,,,,INJECTION,,2020,Q4,Rhabdomyolysis,,2020,Q4,1,I,,20201030.0,20201105,20201105,EXP,,US-MYLANLABS-2020M1092874,MYLAN,"EDELMAN ER, BUTALA NM, AVERY LL, LUNDQUIST AL, DIGHE AS. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. N-ENGL-J-MED 2020;383(13):1263-1275.",54.0,YR,,M,Y,,,20201105.0,,MD,US,US,2020,Q4,Adult
184725791,18472579,60,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Burkholderia test positive,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,60,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Product contamination microbial,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,60,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Product quality issue,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,60,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Recalled product administered,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,60,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Respiratory disorder,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,60,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Sputum culture positive,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184725791,18472579,60,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Syncope,,2020,Q4,1,I,20200930.0,,20201104,20201104,DIR,,,FDA-CTU,,54.0,YR,,M,N,103.8,KG,20201029.0,N,PH,US,AU,2020,Q4,Adult
184732751,18473275,23,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Metabolic encephalopathy,,2020,Q4,1,I,20201005.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,102.0,KG,20201028.0,N,PH,US,US,2020,Q4,Elderly
184732751,18473275,23,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pancreatitis,,2020,Q4,1,I,20201005.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,102.0,KG,20201028.0,N,PH,US,US,2020,Q4,Elderly
184732751,18473275,23,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Product contamination,,2020,Q4,1,I,20201005.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,102.0,KG,20201028.0,N,PH,US,US,2020,Q4,Elderly
184732751,18473275,23,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Recalled product administered,,2020,Q4,1,I,20201005.0,,20201104,20201104,DIR,,,FDA-CTU,,69.0,YR,,M,N,102.0,KG,20201028.0,N,PH,US,US,2020,Q4,Elderly
184737911,18473791,2,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201026.0,20201106,20201106,EXP,,US-AMNEAL PHARMACEUTICALS-2020-AMRX-03471,AMNEAL,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE. 2020;99(41):E22492",63.0,YR,,M,Y,,,20201106.0,,PH,QA,US,2020,Q4,Adult
184737911,18473791,2,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20201026.0,20201106,20201106,EXP,,US-AMNEAL PHARMACEUTICALS-2020-AMRX-03471,AMNEAL,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE. 2020;99(41):E22492",63.0,YR,,M,Y,,,20201106.0,,PH,QA,US,2020,Q4,Adult
184737911,18473791,2,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Osmolar gap increased,,2020,Q4,1,I,,20201026.0,20201106,20201106,EXP,,US-AMNEAL PHARMACEUTICALS-2020-AMRX-03471,AMNEAL,"ELSHAFEI MN, ALAMIN M, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS CASE REPORT AND A LITERATURE REVIEW HIGHLIGHTING AN APPARENTLY UNUSUAL ASSOCIATION. MEDICINE. 2020;99(41):E22492",63.0,YR,,M,Y,,,20201106.0,,PH,QA,US,2020,Q4,Adult
184745621,18474562,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (10 IE, 0-1-0-0, AMPULLEN)",,,U,,,,,1.0,DF,,QD,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201029.0,20201106,20201106,EXP,,NVSC2020DE291382,NOVARTIS,,64.0,YR,,F,Y,,,20201106.0,,HP,DE,DE,2020,Q4,Adult
184745621,18474562,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (10 IE, 0-1-0-0, AMPULLEN)",,,U,,,,,1.0,DF,,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201029.0,20201106,20201106,EXP,,NVSC2020DE291382,NOVARTIS,,64.0,YR,,F,Y,,,20201106.0,,HP,DE,DE,2020,Q4,Adult
184745621,18474562,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (10 IE, 0-1-0-0, AMPULLEN)",,,U,,,,,1.0,DF,,QD,2020,Q4,Nausea,,2020,Q4,1,I,,20201029.0,20201106,20201106,EXP,,NVSC2020DE291382,NOVARTIS,,64.0,YR,,F,Y,,,20201106.0,,HP,DE,DE,2020,Q4,Adult
184745621,18474562,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (10 IE, 0-1-0-0, AMPULLEN)",,,U,,,,,1.0,DF,,QD,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201029.0,20201106,20201106,EXP,,NVSC2020DE291382,NOVARTIS,,64.0,YR,,F,Y,,,20201106.0,,HP,DE,DE,2020,Q4,Adult
184745621,18474562,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 DF, QD (10 IE, 0-1-0-0, AMPULLEN)",,,U,,,,,1.0,DF,,QD,2020,Q4,Vomiting,,2020,Q4,1,I,,20201029.0,20201106,20201106,EXP,,NVSC2020DE291382,NOVARTIS,,64.0,YR,,F,Y,,,20201106.0,,HP,DE,DE,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,Anuria,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,Arrhythmia,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,General physical health deterioration,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,Hypercalcaemia,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,Hypertension,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,Hypokalaemia,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,Metabolic alkalosis,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,Pseudoaldosteronism,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,Renal failure,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184745714,18474571,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,INJECTION,,2020,Q4,Rhabdomyolysis,,2020,Q4,4,F,,20201111.0,20201106,20201118,EXP,,US-PFIZER INC-2020432401,PFIZER,"EDELMAN, E.. CASE 30-2020: A 54-YEAR-OLD MAN WITH SUDDEN CARDIAC ARREST. NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1263-1275",54.0,YR,,M,Y,,,20201118.0,,MD,US,US,2020,Q4,Adult
184762113,18476211,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,10 U,,,,,,,,,,,,2020,Q4,Bradycardia,,2020,Q4,3,F,202010.0,20201217.0,20201106,20201222,EXP,,PT-GILEAD-2020-0502547,GILEAD,,71.0,YR,E,M,Y,,,20201222.0,,PH,PT,PT,2020,Q4,Elderly
184764191,18476419,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"34 IE, 0-0-0-1",,,,,,,,,,,,2020,Q4,Contusion,,2020,Q4,1,I,,20201030.0,20201107,20201107,EXP,DE-BFARM-20011825,DE-ACCORD-207459,ACCORD,,85.0,YR,E,F,Y,,,20201107.0,,MD,DE,DE,2020,Q4,Elderly
184764191,18476419,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"34 IE, 0-0-0-1",,,,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,,20201030.0,20201107,20201107,EXP,DE-BFARM-20011825,DE-ACCORD-207459,ACCORD,,85.0,YR,E,F,Y,,,20201107.0,,MD,DE,DE,2020,Q4,Elderly
184764191,18476419,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"34 IE, 0-0-0-1",,,,,,,,,,,,2020,Q4,Haematoma,,2020,Q4,1,I,,20201030.0,20201107,20201107,EXP,DE-BFARM-20011825,DE-ACCORD-207459,ACCORD,,85.0,YR,E,F,Y,,,20201107.0,,MD,DE,DE,2020,Q4,Elderly
184764191,18476419,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"34 IE, 0-0-0-1",,,,,,,,,,,,2020,Q4,Syncope,,2020,Q4,1,I,,20201030.0,20201107,20201107,EXP,DE-BFARM-20011825,DE-ACCORD-207459,ACCORD,,85.0,YR,E,F,Y,,,20201107.0,,MD,DE,DE,2020,Q4,Elderly
184765211,18476521,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Acute respiratory distress syndrome,,2020,Q4,1,I,20200508.0,20200508.0,20201106,20201106,EXP,,US-GILEAD-2020-0466462,GILEAD,,61.0,YR,A,M,Y,81.5,KG,20201106.0,,MD,US,US,2020,Q4,Adult
184765211,18476521,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,COVID-19,,2020,Q4,1,I,20200508.0,20200508.0,20201106,20201106,EXP,,US-GILEAD-2020-0466462,GILEAD,,61.0,YR,A,M,Y,81.5,KG,20201106.0,,MD,US,US,2020,Q4,Adult
184765211,18476521,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypercapnia,,2020,Q4,1,I,20200508.0,20200508.0,20201106,20201106,EXP,,US-GILEAD-2020-0466462,GILEAD,,61.0,YR,A,M,Y,81.5,KG,20201106.0,,MD,US,US,2020,Q4,Adult
184765211,18476521,50,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200508.0,20200508.0,20201106,20201106,EXP,,US-GILEAD-2020-0466462,GILEAD,,61.0,YR,A,M,Y,81.5,KG,20201106.0,,MD,US,US,2020,Q4,Adult
184769121,18476912,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IE, QD",,,U,,,,,,,,QD,2020,Q4,Abdominal pain lower,,2020,Q4,1,I,,20201030.0,20201107,20201107,EXP,,NVSC2020DE294113,NOVARTIS,,76.0,YR,,F,Y,,,20201107.0,,HP,DE,DE,2020,Q4,Elderly
184769121,18476912,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IE, QD",,,U,,,,,,,,QD,2020,Q4,Diarrhoea,,2020,Q4,1,I,,20201030.0,20201107,20201107,EXP,,NVSC2020DE294113,NOVARTIS,,76.0,YR,,F,Y,,,20201107.0,,HP,DE,DE,2020,Q4,Elderly
184769121,18476912,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"8 IE, QD",,,U,,,,,,,,QD,2020,Q4,Nausea,,2020,Q4,1,I,,20201030.0,20201107,20201107,EXP,,NVSC2020DE294113,NOVARTIS,,76.0,YR,,F,Y,,,20201107.0,,HP,DE,DE,2020,Q4,Elderly
184793151,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201027.0,20201109,20201109,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20201109.0,,MD,DE,DE,2020,Q4,Adult
184793151,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201027.0,20201109,20201109,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20201109.0,,MD,DE,DE,2020,Q4,Adult
184793151,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2020,Q4,Nausea,,2020,Q4,1,I,,20201027.0,20201109,20201109,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20201109.0,,MD,DE,DE,2020,Q4,Adult
184793151,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201027.0,20201109,20201109,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20201109.0,,MD,DE,DE,2020,Q4,Adult
184793151,18479315,7,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,10.0,IU,AMPOULES,QD,2020,Q4,Vomiting,,2020,Q4,1,I,,20201027.0,20201109,20201109,EXP,,DE-AUROBINDO-AUR-APL-2020-054924,AUROBINDO,,64.0,YR,,F,Y,,,20201109.0,,MD,DE,DE,2020,Q4,Adult
184794881,18479488,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,U,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201029.0,20201109,20201109,EXP,,NVSC2020DE291344,NOVARTIS,,86.0,YR,,M,Y,,,20201109.0,,HP,DE,DE,2020,Q4,Elderly
184794881,18479488,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,U,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201029.0,20201109,20201109,EXP,,NVSC2020DE291344,NOVARTIS,,86.0,YR,,M,Y,,,20201109.0,,HP,DE,DE,2020,Q4,Elderly
184794881,18479488,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,U,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201029.0,20201109,20201109,EXP,,NVSC2020DE291344,NOVARTIS,,86.0,YR,,M,Y,,,20201109.0,,HP,DE,DE,2020,Q4,Elderly
184794881,18479488,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,U,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201029.0,20201109,20201109,EXP,,NVSC2020DE291344,NOVARTIS,,86.0,YR,,M,Y,,,20201109.0,,HP,DE,DE,2020,Q4,Elderly
184794881,18479488,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201029.0,20201109,20201109,EXP,,NVSC2020DE291344,NOVARTIS,,86.0,YR,,M,Y,,,20201109.0,,HP,DE,DE,2020,Q4,Elderly
184794881,18479488,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,U,,,,,,,,,2020,Q4,Musculoskeletal pain,,2020,Q4,1,I,,20201029.0,20201109,20201109,EXP,,NVSC2020DE291344,NOVARTIS,,86.0,YR,,M,Y,,,20201109.0,,HP,DE,DE,2020,Q4,Elderly
184794881,18479488,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,U,,,,,,,,,2020,Q4,Neck pain,,2020,Q4,1,I,,20201029.0,20201109,20201109,EXP,,NVSC2020DE291344,NOVARTIS,,86.0,YR,,M,Y,,,20201109.0,,HP,DE,DE,2020,Q4,Elderly
184795873,18479587,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"54 IU, QD",,,,,,,,54.0,IU,,QD,2020,Q4,Asthenia,,2020,Q4,3,F,20200929.0,20201112.0,20201109,20201123,EXP,,CO-NOVOPROD-758875,NOVO NORDISK,,33.0,YR,,F,Y,68.0,KG,20201123.0,,CN,CO,CO,2020,Q4,Young Adult
184795873,18479587,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"54 IU, QD",,,,,,,,54.0,IU,,QD,2020,Q4,Fatigue,,2020,Q4,3,F,20200929.0,20201112.0,20201109,20201123,EXP,,CO-NOVOPROD-758875,NOVO NORDISK,,33.0,YR,,F,Y,68.0,KG,20201123.0,,CN,CO,CO,2020,Q4,Young Adult
184795873,18479587,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"54 IU, QD",,,,,,,,54.0,IU,,QD,2020,Q4,Nausea,,2020,Q4,3,F,20200929.0,20201112.0,20201109,20201123,EXP,,CO-NOVOPROD-758875,NOVO NORDISK,,33.0,YR,,F,Y,68.0,KG,20201123.0,,CN,CO,CO,2020,Q4,Young Adult
184795873,18479587,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"54 IU, QD",,,,,,,,54.0,IU,,QD,2020,Q4,Vomiting,,2020,Q4,3,F,20200929.0,20201112.0,20201109,20201123,EXP,,CO-NOVOPROD-758875,NOVO NORDISK,,33.0,YR,,F,Y,68.0,KG,20201123.0,,CN,CO,CO,2020,Q4,Young Adult
184796901,18479690,2,C,insulin glargine,INSULIN GLARGINE,1,,UNKNOWN,,,U,,,,,,,,,2020,Q4,Hypertensive urgency,,2020,Q4,1,I,,20201031.0,20201109,20201109,EXP,,IN-TORRENT-00002646,TORRENT,,62.0,YR,A,F,Y,,,20201109.0,,HP,IN,IN,2020,Q4,Adult
184797903,18479790,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"20.0,U,",,,,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,3,F,20201028.0,20201124.0,20201109,20201203,EXP,,BR-NOVOPROD-764252,NOVO NORDISK,,83.0,YR,,M,Y,96.0,KG,20201203.0,,MD,BR,BR,2020,Q4,Elderly
184807611,18480761,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201102.0,20201109,20201109,EXP,,US-MYLANLABS-2020M1093801,MYLAN,"NGUYEN V, DEEB K, RATHAKRISHNAN R. HICCUPS: YOU GOT TO BE KIDNEY ME!. SAGE-OPEN-MED-CASE-REP 2020;NULL:NULL.",62.0,YR,,M,Y,,,20201109.0,,HP,US,US,2020,Q4,Adult
184807611,18480761,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Drug abuse,,2020,Q4,1,I,,20201102.0,20201109,20201109,EXP,,US-MYLANLABS-2020M1093801,MYLAN,"NGUYEN V, DEEB K, RATHAKRISHNAN R. HICCUPS: YOU GOT TO BE KIDNEY ME!. SAGE-OPEN-MED-CASE-REP 2020;NULL:NULL.",62.0,YR,,M,Y,,,20201109.0,,HP,US,US,2020,Q4,Adult
184807611,18480761,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,U,,,,,,,,2020,Q4,Hiccups,,2020,Q4,1,I,,20201102.0,20201109,20201109,EXP,,US-MYLANLABS-2020M1093801,MYLAN,"NGUYEN V, DEEB K, RATHAKRISHNAN R. HICCUPS: YOU GOT TO BE KIDNEY ME!. SAGE-OPEN-MED-CASE-REP 2020;NULL:NULL.",62.0,YR,,M,Y,,,20201109.0,,HP,US,US,2020,Q4,Adult
184809951,18480995,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q4,Food interaction,,2020,Q4,1,I,,20201102.0,20201109,20201109,EXP,,US-FRESENIUS KABI-FK202011808,FRESENIUS KABI,"NGUYEN V, DEEB K, RATHAKRISHNAN R. HICCUPS: YOU GOT TO BE KIDNEY ME!. SAGE OPEN MEDICAL CASE REPORTS. 2020 SEP 30;8:.",62.0,YR,,M,Y,,,20201109.0,,HP,US,US,2020,Q4,Adult
184809951,18480995,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,,,,,,,,UNKNOWN,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201102.0,20201109,20201109,EXP,,US-FRESENIUS KABI-FK202011808,FRESENIUS KABI,"NGUYEN V, DEEB K, RATHAKRISHNAN R. HICCUPS: YOU GOT TO BE KIDNEY ME!. SAGE OPEN MEDICAL CASE REPORTS. 2020 SEP 30;8:.",62.0,YR,,M,Y,,,20201109.0,,HP,US,US,2020,Q4,Adult
184810602,18481060,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,15.0,DF,,QD,2020,Q4,Serotonin syndrome,,2020,Q4,2,F,2018.0,20201106.0,20201109,20201117,EXP,,US-ABBVIE-20K-163-3641643-00,ABBVIE,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020 JAN 01;1-7.",74.0,YR,,M,Y,75.0,KG,20201117.0,,HP,COUNTRY NOT SPECIFIED,US,2020,Q4,Elderly
184811261,18481126,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,,20201027.0,20201109,20201109,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202010011882,ELI LILLY AND CO,,32.0,YR,,M,Y,77.5,KG,20201109.0,,CN,CN,CN,2020,Q4,Young Adult
184821221,18482122,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INJECT 70 UNITAT BEDTIME,,,,,,,,,,,QD,2020,Q4,Scrotal abscess,,2020,Q4,1,I,,20201103.0,20201109,20201109,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-059336",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20201110.0,,MD,US,US,2020,Q4,Elderly
184821221,18482122,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,INJECT 70 UNITAT BEDTIME,,,,,,,,,,,QD,2020,Q4,Testicular abscess,,2020,Q4,1,I,,20201103.0,20201109,20201109,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-059336",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20201110.0,,MD,US,US,2020,Q4,Elderly
184839371,18483937,8,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,,,2020,Q4,Agranulocytosis,,2020,Q4,1,I,20201008.0,20201102.0,20201109,20201109,EXP,,CH-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-092463,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,,,20201109.0,,MD,CH,CH,2020,Q4,Elderly
184870901,18487090,1,PS,Insulin glargine,INSULIN GLARGINE,1,Oral,"6 IE, 1-0-1-0",,,U,,,,205692.0,6.0,IU,,BID,2020,Q4,Arrhythmia,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013435,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870901,18487090,1,PS,Insulin glargine,INSULIN GLARGINE,1,Oral,"6 IE, 1-0-1-0",,,U,,,,205692.0,6.0,IU,,BID,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013435,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870901,18487090,1,PS,Insulin glargine,INSULIN GLARGINE,1,Oral,"6 IE, 1-0-1-0",,,U,,,,205692.0,6.0,IU,,BID,2020,Q4,Depressed level of consciousness,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013435,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870901,18487090,1,PS,Insulin glargine,INSULIN GLARGINE,1,Oral,"6 IE, 1-0-1-0",,,U,,,,205692.0,6.0,IU,,BID,2020,Q4,Disorientation,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013435,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870901,18487090,1,PS,Insulin glargine,INSULIN GLARGINE,1,Oral,"6 IE, 1-0-1-0",,,U,,,,205692.0,6.0,IU,,BID,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013435,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870901,18487090,1,PS,Insulin glargine,INSULIN GLARGINE,1,Oral,"6 IE, 1-0-1-0",,,U,,,,205692.0,6.0,IU,,BID,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013435,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870901,18487090,1,PS,Insulin glargine,INSULIN GLARGINE,1,Oral,"6 IE, 1-0-1-0",,,U,,,,205692.0,6.0,IU,,BID,2020,Q4,Off label use,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013435,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870971,18487097,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, 0-1-0-0",,,U,,,,205692.0,40.0,IU,,,2020,Q4,Fall,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013440,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870971,18487097,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, 0-1-0-0",,,U,,,,205692.0,40.0,IU,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013440,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870971,18487097,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, 0-1-0-0",,,U,,,,205692.0,40.0,IU,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013440,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184870971,18487097,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"40 INTERNATIONAL UNIT, 0-1-0-0",,,U,,,,205692.0,40.0,IU,,,2020,Q4,Loss of consciousness,,2020,Q4,1,I,,20201030.0,20201110,20201110,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202010013440,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20201110.0,,MD,DE,DE,2020,Q4,Elderly
184879612,18487961,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,,,2020,Q4,Agranulocytosis,Agranulocytosis,2020,Q4,2,F,20201008.0,20201203.0,20201111,20201216,EXP,CH-SM-2020-16742,CH-ALVOGEN-2020-ALVOGEN-115130,ALVOGEN,,65.0,YR,,M,Y,,,20201216.0,,CN,SZ,CH,2020,Q4,Elderly
184879631,18487963,33,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,7 U,,,,,,,,,,INJECTION,,2020,Q4,Bacteraemia,,2020,Q4,1,I,20170824.0,20170829.0,20201111,20201111,EXP,,US-JNJFOC-20170910422,JOHNSON AND JOHNSON,,69.0,YR,E,M,Y,,,20201111.0,,MD,US,US,2020,Q4,Elderly
184879631,18487963,33,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,7 U,,,,,,,,,,INJECTION,,2020,Q4,Gastrointestinal haemorrhage,,2020,Q4,1,I,20170824.0,20170829.0,20201111,20201111,EXP,,US-JNJFOC-20170910422,JOHNSON AND JOHNSON,,69.0,YR,E,M,Y,,,20201111.0,,MD,US,US,2020,Q4,Elderly
184879631,18487963,33,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,7 U,,,,,,,,,,INJECTION,,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,1,I,20170824.0,20170829.0,20201111,20201111,EXP,,US-JNJFOC-20170910422,JOHNSON AND JOHNSON,,69.0,YR,E,M,Y,,,20201111.0,,MD,US,US,2020,Q4,Elderly
184891231,18489123,2,C,INSULIN GLARGINEGENETICAL RECOMBINATION),,2,Subcutaneous,"14 INTERNATIONAL UNIT, QD",,,,,,,,14.0,IU,INJECTION,QD,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,20190814.0,20200205.0,20201111,20201111,EXP,,JP-JNJFOC-20200216252,JOHNSON AND JOHNSON,"TANAKA S, MIWA Y, TAGUCHI Y, OGASAWARA J, MUROYA Y, HONJYO  SET AL., O-010 KETOACIDOSIS DEVELOPED IN 3 ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS WHILE ON ORAL SGLT2 INHIBITORS, THE 57TH KANTO KOUSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY, 2020.1.18;71",77.0,YR,E,M,Y,,,20201111.0,,MD,JP,JP,2020,Q4,Elderly
184891231,18489123,2,C,INSULIN GLARGINEGENETICAL RECOMBINATION),,2,Subcutaneous,"14 INTERNATIONAL UNIT, QD",,,,,,,,14.0,IU,INJECTION,QD,2020,Q4,Pneumonia,,2020,Q4,1,I,20190814.0,20200205.0,20201111,20201111,EXP,,JP-JNJFOC-20200216252,JOHNSON AND JOHNSON,"TANAKA S, MIWA Y, TAGUCHI Y, OGASAWARA J, MUROYA Y, HONJYO  SET AL., O-010 KETOACIDOSIS DEVELOPED IN 3 ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS WHILE ON ORAL SGLT2 INHIBITORS, THE 57TH KANTO KOUSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY, 2020.1.18;71",77.0,YR,E,M,Y,,,20201111.0,,MD,JP,JP,2020,Q4,Elderly
184891231,18489123,2,C,INSULIN GLARGINEGENETICAL RECOMBINATION),,2,Subcutaneous,"14 INTERNATIONAL UNIT, QD",,,,,,,,14.0,IU,INJECTION,QD,2020,Q4,Pulmonary artery thrombosis,,2020,Q4,1,I,20190814.0,20200205.0,20201111,20201111,EXP,,JP-JNJFOC-20200216252,JOHNSON AND JOHNSON,"TANAKA S, MIWA Y, TAGUCHI Y, OGASAWARA J, MUROYA Y, HONJYO  SET AL., O-010 KETOACIDOSIS DEVELOPED IN 3 ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS WHILE ON ORAL SGLT2 INHIBITORS, THE 57TH KANTO KOUSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY, 2020.1.18;71",77.0,YR,E,M,Y,,,20201111.0,,MD,JP,JP,2020,Q4,Elderly
184891231,18489123,2,C,INSULIN GLARGINEGENETICAL RECOMBINATION),,2,Subcutaneous,"14 INTERNATIONAL UNIT, QD",,,,,,,,14.0,IU,INJECTION,QD,2020,Q4,Septic shock,,2020,Q4,1,I,20190814.0,20200205.0,20201111,20201111,EXP,,JP-JNJFOC-20200216252,JOHNSON AND JOHNSON,"TANAKA S, MIWA Y, TAGUCHI Y, OGASAWARA J, MUROYA Y, HONJYO  SET AL., O-010 KETOACIDOSIS DEVELOPED IN 3 ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS WHILE ON ORAL SGLT2 INHIBITORS, THE 57TH KANTO KOUSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY, 2020.1.18;71",77.0,YR,E,M,Y,,,20201111.0,,MD,JP,JP,2020,Q4,Elderly
184891231,18489123,3,C,INSULIN GLARGINEGENETICAL RECOMBINATION),,2,Subcutaneous,"2 INTERNATIONAL UNIT, QD",,,,,,,,2.0,IU,INJECTION,QD,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,20190814.0,20200205.0,20201111,20201111,EXP,,JP-JNJFOC-20200216252,JOHNSON AND JOHNSON,"TANAKA S, MIWA Y, TAGUCHI Y, OGASAWARA J, MUROYA Y, HONJYO  SET AL., O-010 KETOACIDOSIS DEVELOPED IN 3 ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS WHILE ON ORAL SGLT2 INHIBITORS, THE 57TH KANTO KOUSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY, 2020.1.18;71",77.0,YR,E,M,Y,,,20201111.0,,MD,JP,JP,2020,Q4,Elderly
184891231,18489123,3,C,INSULIN GLARGINEGENETICAL RECOMBINATION),,2,Subcutaneous,"2 INTERNATIONAL UNIT, QD",,,,,,,,2.0,IU,INJECTION,QD,2020,Q4,Pneumonia,,2020,Q4,1,I,20190814.0,20200205.0,20201111,20201111,EXP,,JP-JNJFOC-20200216252,JOHNSON AND JOHNSON,"TANAKA S, MIWA Y, TAGUCHI Y, OGASAWARA J, MUROYA Y, HONJYO  SET AL., O-010 KETOACIDOSIS DEVELOPED IN 3 ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS WHILE ON ORAL SGLT2 INHIBITORS, THE 57TH KANTO KOUSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY, 2020.1.18;71",77.0,YR,E,M,Y,,,20201111.0,,MD,JP,JP,2020,Q4,Elderly
184891231,18489123,3,C,INSULIN GLARGINEGENETICAL RECOMBINATION),,2,Subcutaneous,"2 INTERNATIONAL UNIT, QD",,,,,,,,2.0,IU,INJECTION,QD,2020,Q4,Pulmonary artery thrombosis,,2020,Q4,1,I,20190814.0,20200205.0,20201111,20201111,EXP,,JP-JNJFOC-20200216252,JOHNSON AND JOHNSON,"TANAKA S, MIWA Y, TAGUCHI Y, OGASAWARA J, MUROYA Y, HONJYO  SET AL., O-010 KETOACIDOSIS DEVELOPED IN 3 ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS WHILE ON ORAL SGLT2 INHIBITORS, THE 57TH KANTO KOUSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY, 2020.1.18;71",77.0,YR,E,M,Y,,,20201111.0,,MD,JP,JP,2020,Q4,Elderly
184891231,18489123,3,C,INSULIN GLARGINEGENETICAL RECOMBINATION),,2,Subcutaneous,"2 INTERNATIONAL UNIT, QD",,,,,,,,2.0,IU,INJECTION,QD,2020,Q4,Septic shock,,2020,Q4,1,I,20190814.0,20200205.0,20201111,20201111,EXP,,JP-JNJFOC-20200216252,JOHNSON AND JOHNSON,"TANAKA S, MIWA Y, TAGUCHI Y, OGASAWARA J, MUROYA Y, HONJYO  SET AL., O-010 KETOACIDOSIS DEVELOPED IN 3 ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS WHILE ON ORAL SGLT2 INHIBITORS, THE 57TH KANTO KOUSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY, 2020.1.18;71",77.0,YR,E,M,Y,,,20201111.0,,MD,JP,JP,2020,Q4,Elderly
184892761,18489276,3,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"24 UNITS, DAILY",,,U,,,,,,,,,2020,Q4,Increased insulin requirement,,2020,Q4,1,I,,20201027.0,20201111,20201111,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-267311,RANBAXY,"WEI ET, KOH E, KELLY MS, WRIGHT LA, TYLEE TS. PATIENT ERRORS IN USE OF INJECTABLE ANTIDIABETIC MEDICATIONS: A NEED FOR IMPROVED CLINIC-BASED EDUCATION. J AM PHARMACISTS ASSOC. 2020;60 (5), MAR 4:E76-E80",55.0,YR,,M,Y,,,20201111.0,,PH,US,US,2020,Q4,Adult
184896381,18489638,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, OF687A,,,50.0,IU,,,2020,Q4,Anaemia,,2020,Q4,1,I,201912.0,20201030.0,20201111,20201111,EXP,,ES-AUROBINDO-AUR-APL-2020-055357,AUROBINDO,,85.0,YR,,F,Y,96.0,KG,20201111.0,,CN,ES,ES,2020,Q4,Elderly
184896381,18489638,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, OF687A,,,50.0,IU,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,201912.0,20201030.0,20201111,20201111,EXP,,ES-AUROBINDO-AUR-APL-2020-055357,AUROBINDO,,85.0,YR,,F,Y,96.0,KG,20201111.0,,CN,ES,ES,2020,Q4,Elderly
184896381,18489638,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, OF687A,,,50.0,IU,,,2020,Q4,Diarrhoea,,2020,Q4,1,I,201912.0,20201030.0,20201111,20201111,EXP,,ES-AUROBINDO-AUR-APL-2020-055357,AUROBINDO,,85.0,YR,,F,Y,96.0,KG,20201111.0,,CN,ES,ES,2020,Q4,Elderly
184896381,18489638,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, OF687A,,,50.0,IU,,,2020,Q4,Haematochezia,,2020,Q4,1,I,201912.0,20201030.0,20201111,20201111,EXP,,ES-AUROBINDO-AUR-APL-2020-055357,AUROBINDO,,85.0,YR,,F,Y,96.0,KG,20201111.0,,CN,ES,ES,2020,Q4,Elderly
184896381,18489638,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,50 INTERNATIONAL UNIT,,,,, OF687A,,,50.0,IU,,,2020,Q4,Haemorrhage,,2020,Q4,1,I,201912.0,20201030.0,20201111,20201111,EXP,,ES-AUROBINDO-AUR-APL-2020-055357,AUROBINDO,,85.0,YR,,F,Y,96.0,KG,20201111.0,,CN,ES,ES,2020,Q4,Elderly
184904111,18490411,5,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Immune thrombocytopenia,,2020,Q4,1,I,,20201027.0,20201111,20201111,EXP,,US-CROSSMEDIKA SA-2095802,CROSSMEDIKA,"MOORE J, BAER M R, GROVER B E, ET AL. (SEPTEMBER 17, 2020) MOXIFLOXACIN-INDUCED THROMBOCYTOPENIA MEDIATED BY MOXIFLOXACIN-DEPENDENT IGM AND IGG ANTIPLATELET ANTIBODIES: A CASE REPORT. CUREUS 12(9): E10507. DOI 10.7759/CUREUS.10507",55.0,YR,,F,Y,,,20201111.0,,HP,US,US,2020,Q4,Adult
184907051,18490705,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201109.0,20201111,20201111,EXP,,NVSC2020ES300295,NOVARTIS,,75.0,YR,,M,Y,86.4,KG,20201111.0,,HP,ES,ES,2020,Q4,Elderly
184907051,18490705,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201109.0,20201111,20201111,EXP,,NVSC2020ES300295,NOVARTIS,,75.0,YR,,M,Y,86.4,KG,20201111.0,,HP,ES,ES,2020,Q4,Elderly
184907051,18490705,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201109.0,20201111,20201111,EXP,,NVSC2020ES300295,NOVARTIS,,75.0,YR,,M,Y,86.4,KG,20201111.0,,HP,ES,ES,2020,Q4,Elderly
184907051,18490705,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201109.0,20201111,20201111,EXP,,NVSC2020ES300295,NOVARTIS,,75.0,YR,,M,Y,86.4,KG,20201111.0,,HP,ES,ES,2020,Q4,Elderly
184907051,18490705,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201109.0,20201111,20201111,EXP,,NVSC2020ES300295,NOVARTIS,,75.0,YR,,M,Y,86.4,KG,20201111.0,,HP,ES,ES,2020,Q4,Elderly
184907691,18490769,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hypervolaemia,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184907691,18490769,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184907691,18490769,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184907691,18490769,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184907691,18490769,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20200806.0,20201111,20201111,PER,US-MLMSERVICE-20200731-2417155-1,US-STRIDES ARCOLAB LIMITED-2020SP009202,STRIDES,,46.0,YR,,M,Y,,,20201111.0,,,NL,US,2020,Q4,Adult
184915833,18491583,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,,2020,Q4,Acute respiratory distress syndrome,,2020,Q4,3,F,20200714.0,20201118.0,20201111,20201126,EXP,,GR-BIOVITRUM-2020GR5845,BIOVITRUM,,62.0,YR,,F,Y,90.0,KG,20201126.0,,MD,GR,GR,2020,Q4,Adult
184915833,18491583,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,,2020,Q4,Nosocomial infection,,2020,Q4,3,F,20200714.0,20201118.0,20201111,20201126,EXP,,GR-BIOVITRUM-2020GR5845,BIOVITRUM,,62.0,YR,,F,Y,90.0,KG,20201126.0,,MD,GR,GR,2020,Q4,Adult
184915833,18491583,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,18.0,IU,,,2020,Q4,Shock,,2020,Q4,3,F,20200714.0,20201118.0,20201111,20201126,EXP,,GR-BIOVITRUM-2020GR5845,BIOVITRUM,,62.0,YR,,F,Y,90.0,KG,20201126.0,,MD,GR,GR,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Anxiety,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Cardiac arrest,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Cardiac disorder,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Cardiac operation,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Constipation,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Diabetes mellitus,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Drug dependence,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Fluid retention,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Immobile,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Insomnia,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Kidney transplant rejection,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Overdose,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Respiratory disorder,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184917661,18491766,15,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,U, UNKNOWN,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,2018.0,20200624.0,20201111,20201111,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20201111.0,,CN,US,US,2020,Q4,Adult
184928982,18492898,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 IU (INTERNATIONAL UNIT),,,,,,,,26.0,IU,INJECTION,QD,2020,Q4,Bacterial sepsis,,2020,Q4,2,F,20201104.0,20201105.0,20201111,20201112,EXP,,US-CELGENEUS-USA-20201101512,CELGENE,,73.0,YR,,M,Y,87.7,KG,20201112.0,,HP,US,US,2020,Q4,Elderly
184928982,18492898,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 IU (INTERNATIONAL UNIT),,,,,,,,26.0,IU,INJECTION,QD,2020,Q4,Cholecystitis acute,,2020,Q4,2,F,20201104.0,20201105.0,20201111,20201112,EXP,,US-CELGENEUS-USA-20201101512,CELGENE,,73.0,YR,,M,Y,87.7,KG,20201112.0,,HP,US,US,2020,Q4,Elderly
184928982,18492898,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 IU (INTERNATIONAL UNIT),,,,,,,,26.0,IU,INJECTION,QD,2020,Q4,Encephalopathy,,2020,Q4,2,F,20201104.0,20201105.0,20201111,20201112,EXP,,US-CELGENEUS-USA-20201101512,CELGENE,,73.0,YR,,M,Y,87.7,KG,20201112.0,,HP,US,US,2020,Q4,Elderly
184928982,18492898,3,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,26 IU (INTERNATIONAL UNIT),,,,,,,,26.0,IU,INJECTION,QD,2020,Q4,Septic shock,,2020,Q4,2,F,20201104.0,20201105.0,20201111,20201112,EXP,,US-CELGENEUS-USA-20201101512,CELGENE,,73.0,YR,,M,Y,87.7,KG,20201112.0,,HP,US,US,2020,Q4,Elderly
184938361,18493836,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"34 INTERNATIONAL UNIT, ONCE A DAY, 0-0-0-1",,,U,,,,,34.0,IU,,QD,2020,Q4,Contusion,,2020,Q4,1,I,,20201102.0,20201111,20201111,EXP,,DE-AUROBINDO-AUR-APL-2020-055580,AUROBINDO,,85.0,YR,,F,Y,,,20201112.0,,MD,DE,DE,2020,Q4,Elderly
184938361,18493836,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"34 INTERNATIONAL UNIT, ONCE A DAY, 0-0-0-1",,,U,,,,,34.0,IU,,QD,2020,Q4,Dehydration,,2020,Q4,1,I,,20201102.0,20201111,20201111,EXP,,DE-AUROBINDO-AUR-APL-2020-055580,AUROBINDO,,85.0,YR,,F,Y,,,20201112.0,,MD,DE,DE,2020,Q4,Elderly
184938361,18493836,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"34 INTERNATIONAL UNIT, ONCE A DAY, 0-0-0-1",,,U,,,,,34.0,IU,,QD,2020,Q4,Haematoma,,2020,Q4,1,I,,20201102.0,20201111,20201111,EXP,,DE-AUROBINDO-AUR-APL-2020-055580,AUROBINDO,,85.0,YR,,F,Y,,,20201112.0,,MD,DE,DE,2020,Q4,Elderly
184938361,18493836,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"34 INTERNATIONAL UNIT, ONCE A DAY, 0-0-0-1",,,U,,,,,34.0,IU,,QD,2020,Q4,Syncope,,2020,Q4,1,I,,20201102.0,20201111,20201111,EXP,,DE-AUROBINDO-AUR-APL-2020-055580,AUROBINDO,,85.0,YR,,F,Y,,,20201112.0,,MD,DE,DE,2020,Q4,Elderly
184948111,18494811,26,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Burkholderia test positive,,2020,Q4,1,I,20201102.0,,20201111,20201111,DIR,,,FDA-CTU,,81.0,YR,,F,N,74.2,KG,20201105.0,N,PH,US,US,2020,Q4,Elderly
184948111,18494811,26,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Product contamination microbial,,2020,Q4,1,I,20201102.0,,20201111,20201111,DIR,,,FDA-CTU,,81.0,YR,,F,N,74.2,KG,20201105.0,N,PH,US,US,2020,Q4,Elderly
184948111,18494811,26,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Product quality issue,,2020,Q4,1,I,20201102.0,,20201111,20201111,DIR,,,FDA-CTU,,81.0,YR,,F,N,74.2,KG,20201105.0,N,PH,US,US,2020,Q4,Elderly
184948111,18494811,26,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Recalled product,,2020,Q4,1,I,20201102.0,,20201111,20201111,DIR,,,FDA-CTU,,81.0,YR,,F,N,74.2,KG,20201105.0,N,PH,US,US,2020,Q4,Elderly
184951291,18495129,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201105.0,20201112,20201112,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011002918,ELI LILLY AND CO,,75.0,YR,,M,Y,86.4,KG,20201112.0,,MD,ES,ES,2020,Q4,Elderly
184951291,18495129,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201105.0,20201112,20201112,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011002918,ELI LILLY AND CO,,75.0,YR,,M,Y,86.4,KG,20201112.0,,MD,ES,ES,2020,Q4,Elderly
184951291,18495129,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201105.0,20201112,20201112,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011002918,ELI LILLY AND CO,,75.0,YR,,M,Y,86.4,KG,20201112.0,,MD,ES,ES,2020,Q4,Elderly
184951291,18495129,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201105.0,20201112,20201112,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011002918,ELI LILLY AND CO,,75.0,YR,,M,Y,86.4,KG,20201112.0,,MD,ES,ES,2020,Q4,Elderly
184951291,18495129,1,PS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK, UNKNOWN",,,U,,,,205692.0,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201105.0,20201112,20201112,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011002918,ELI LILLY AND CO,,75.0,YR,,M,Y,86.4,KG,20201112.0,,MD,ES,ES,2020,Q4,Elderly
184951491,18495149,7,C,Insulin Glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cytokine release syndrome,,2020,Q4,1,I,20200925.0,,20201111,20201111,DIR,,,FDA-CTU,,64.0,YR,,F,N,57.15,KG,20201111.0,N,HP,US,US,2020,Q4,Adult
184953231,18495323,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU (50 IU),,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Anaemia,,2020,Q4,1,I,201912.0,20201105.0,20201112,20201112,EXP,,NVSC2020ES297989,NOVARTIS,,85.0,YR,,F,Y,96.0,KG,20201112.0,,HP,ES,ES,2020,Q4,Elderly
184953231,18495323,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU (50 IU),,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,201912.0,20201105.0,20201112,20201112,EXP,,NVSC2020ES297989,NOVARTIS,,85.0,YR,,F,Y,96.0,KG,20201112.0,,HP,ES,ES,2020,Q4,Elderly
184953231,18495323,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU (50 IU),,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,201912.0,20201105.0,20201112,20201112,EXP,,NVSC2020ES297989,NOVARTIS,,85.0,YR,,F,Y,96.0,KG,20201112.0,,HP,ES,ES,2020,Q4,Elderly
184953231,18495323,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU (50 IU),,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Haematochezia,,2020,Q4,1,I,201912.0,20201105.0,20201112,20201112,EXP,,NVSC2020ES297989,NOVARTIS,,85.0,YR,,F,Y,96.0,KG,20201112.0,,HP,ES,ES,2020,Q4,Elderly
184953231,18495323,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU (50 IU),,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Haemorrhage,,2020,Q4,1,I,201912.0,20201105.0,20201112,20201112,EXP,,NVSC2020ES297989,NOVARTIS,,85.0,YR,,F,Y,96.0,KG,20201112.0,,HP,ES,ES,2020,Q4,Elderly
184955471,18495547,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IE, 0-1-0-0, AMPOULES",,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201105.0,20201112,20201112,EXP,DE-ADRED-05639-01,DE-009507513-2011DEU003741,MERCK,,81.0,YR,,F,Y,,,20201112.0,,MD,DE,DE,2020,Q4,Elderly
184955471,18495547,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IE, 0-1-0-0, AMPOULES",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201105.0,20201112,20201112,EXP,DE-ADRED-05639-01,DE-009507513-2011DEU003741,MERCK,,81.0,YR,,F,Y,,,20201112.0,,MD,DE,DE,2020,Q4,Elderly
184955471,18495547,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IE, 0-1-0-0, AMPOULES",,,U,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201105.0,20201112,20201112,EXP,DE-ADRED-05639-01,DE-009507513-2011DEU003741,MERCK,,81.0,YR,,F,Y,,,20201112.0,,MD,DE,DE,2020,Q4,Elderly
184955471,18495547,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40 IE, 0-1-0-0, AMPOULES",,,U,,,,,,,,,2020,Q4,Loss of consciousness,,2020,Q4,1,I,,20201105.0,20201112,20201112,EXP,DE-ADRED-05639-01,DE-009507513-2011DEU003741,MERCK,,81.0,YR,,F,Y,,,20201112.0,,MD,DE,DE,2020,Q4,Elderly
184965701,18496570,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNIT/ML. 12 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,,,2020,Q4,Abdominal tenderness,,2020,Q4,1,I,20180806.0,20201102.0,20201112,20201112,EXP,,US-009507513-2011USA000730,MERCK,,19977.0,DY,,M,Y,92.1,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
184965701,18496570,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNIT/ML. 12 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,,,2020,Q4,Chest pain,,2020,Q4,1,I,20180806.0,20201102.0,20201112,20201112,EXP,,US-009507513-2011USA000730,MERCK,,19977.0,DY,,M,Y,92.1,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
184965701,18496570,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNIT/ML. 12 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,,,2020,Q4,Constipation,,2020,Q4,1,I,20180806.0,20201102.0,20201112,20201112,EXP,,US-009507513-2011USA000730,MERCK,,19977.0,DY,,M,Y,92.1,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
184965701,18496570,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNIT/ML. 12 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,20180806.0,20201102.0,20201112,20201112,EXP,,US-009507513-2011USA000730,MERCK,,19977.0,DY,,M,Y,92.1,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
184965701,18496570,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNIT/ML. 12 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,,,2020,Q4,Hyperkalaemia,,2020,Q4,1,I,20180806.0,20201102.0,20201112,20201112,EXP,,US-009507513-2011USA000730,MERCK,,19977.0,DY,,M,Y,92.1,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
184965701,18496570,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNIT/ML. 12 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,,,2020,Q4,Ketoacidosis,,2020,Q4,1,I,20180806.0,20201102.0,20201112,20201112,EXP,,US-009507513-2011USA000730,MERCK,,19977.0,DY,,M,Y,92.1,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
184965701,18496570,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNIT/ML. 12 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,,,2020,Q4,Large intestinal obstruction,,2020,Q4,1,I,20180806.0,20201102.0,20201112,20201112,EXP,,US-009507513-2011USA000730,MERCK,,19977.0,DY,,M,Y,92.1,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
184965701,18496570,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,100 UNIT/ML. 12 UNITS INTO THE SKIN EVERY MORNING,,,,,,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,20180806.0,20201102.0,20201112,20201112,EXP,,US-009507513-2011USA000730,MERCK,,19977.0,DY,,M,Y,92.1,KG,20201112.0,,MD,US,US,2020,Q4,Elderly
184971391,18497139,4,SS,INSULIN GLARGINEGENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Altered state of consciousness,,2020,Q4,1,I,,20201104.0,20201112,20201112,EXP,,JP-JNJFOC-20201118175,JOHNSON AND JOHNSON,"AKANE HORI, SAYAKA TANAKA, KEIICHI KIMURA, FUSA TSUNETA, KENTO YAMAMOTO, ATSUSHI YOSHIKAWA, KOHEI OKITA. 8-19 A CASE OF MARKED HYPERGLYCAEMIA AND METABOLIC ACIDOSIS NOTED AFTER HOSPITAL ADMISSION FOR DISTURBED CONSCIOUSNESS DURING TREATMENT FOR DIABETES MELLITUS. THE 57TH KINKI REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY [HELD ONLINE]. 2020.10.17,18,19,20,21,22,23,24,25,26,27,28,29,30,31;135",46.0,YR,A,M,Y,,,20201112.0,,MD,JP,JP,2020,Q4,Adult
184971391,18497139,4,SS,INSULIN GLARGINEGENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,,20201104.0,20201112,20201112,EXP,,JP-JNJFOC-20201118175,JOHNSON AND JOHNSON,"AKANE HORI, SAYAKA TANAKA, KEIICHI KIMURA, FUSA TSUNETA, KENTO YAMAMOTO, ATSUSHI YOSHIKAWA, KOHEI OKITA. 8-19 A CASE OF MARKED HYPERGLYCAEMIA AND METABOLIC ACIDOSIS NOTED AFTER HOSPITAL ADMISSION FOR DISTURBED CONSCIOUSNESS DURING TREATMENT FOR DIABETES MELLITUS. THE 57TH KINKI REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY [HELD ONLINE]. 2020.10.17,18,19,20,21,22,23,24,25,26,27,28,29,30,31;135",46.0,YR,A,M,Y,,,20201112.0,,MD,JP,JP,2020,Q4,Adult
184971391,18497139,4,SS,INSULIN GLARGINEGENETICAL RECOMBINATION),INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Seizure,,2020,Q4,1,I,,20201104.0,20201112,20201112,EXP,,JP-JNJFOC-20201118175,JOHNSON AND JOHNSON,"AKANE HORI, SAYAKA TANAKA, KEIICHI KIMURA, FUSA TSUNETA, KENTO YAMAMOTO, ATSUSHI YOSHIKAWA, KOHEI OKITA. 8-19 A CASE OF MARKED HYPERGLYCAEMIA AND METABOLIC ACIDOSIS NOTED AFTER HOSPITAL ADMISSION FOR DISTURBED CONSCIOUSNESS DURING TREATMENT FOR DIABETES MELLITUS. THE 57TH KINKI REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY [HELD ONLINE]. 2020.10.17,18,19,20,21,22,23,24,25,26,27,28,29,30,31;135",46.0,YR,A,M,Y,,,20201112.0,,MD,JP,JP,2020,Q4,Adult
184981831,18498183,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,U,,,,,,,AMPOULES,,2020,Q4,Anuria,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,U,,,,,,,AMPOULES,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,U,,,,,,,AMPOULES,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,U,,,,,,,AMPOULES,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,U,,,,,,,AMPOULES,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184981831,18498183,5,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,U,,,,,,,AMPOULES,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20201113.0,,PH,DE,DE,2020,Q4,Elderly
184983251,18498325,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0-0-0-1, AMPULLEN",,,,, UNKNOWN,,,24.0,IU,,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201103.0,20201113,20201113,PER,,DE-DRREDDYS-GER/GER/20/0128740,DR REDDYS,,79.0,YR,E,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Elderly
184983251,18498325,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0-0-0-1, AMPULLEN",,,,, UNKNOWN,,,24.0,IU,,QD,2020,Q4,Musculoskeletal pain,,2020,Q4,1,I,,20201103.0,20201113,20201113,PER,,DE-DRREDDYS-GER/GER/20/0128740,DR REDDYS,,79.0,YR,E,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Elderly
184983251,18498325,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0-0-0-1, AMPULLEN",,,,, UNKNOWN,,,24.0,IU,,QD,2020,Q4,Pain,,2020,Q4,1,I,,20201103.0,20201113,20201113,PER,,DE-DRREDDYS-GER/GER/20/0128740,DR REDDYS,,79.0,YR,E,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Elderly
184983251,18498325,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0-0-0-1, AMPULLEN",,,,, UNKNOWN,,,24.0,IU,,QD,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201103.0,20201113,20201113,PER,,DE-DRREDDYS-GER/GER/20/0128740,DR REDDYS,,79.0,YR,E,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Elderly
184995921,18499592,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU (INTERNATIONAL UNIT) DAILY;  0-0-0-1, AMPOULES",,,,,,,,24.0,IU,,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,DE-TEVA-2020-DE-1847643,TEVA,,79.0,YR,E,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Elderly
184995921,18499592,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU (INTERNATIONAL UNIT) DAILY;  0-0-0-1, AMPOULES",,,,,,,,24.0,IU,,QD,2020,Q4,Musculoskeletal pain,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,DE-TEVA-2020-DE-1847643,TEVA,,79.0,YR,E,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Elderly
184995921,18499592,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU (INTERNATIONAL UNIT) DAILY;  0-0-0-1, AMPOULES",,,,,,,,24.0,IU,,QD,2020,Q4,Pain,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,DE-TEVA-2020-DE-1847643,TEVA,,79.0,YR,E,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Elderly
184995921,18499592,4,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"24 IU (INTERNATIONAL UNIT) DAILY;  0-0-0-1, AMPOULES",,,,,,,,24.0,IU,,QD,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,DE-TEVA-2020-DE-1847643,TEVA,,79.0,YR,E,M,Y,,,20201113.0,,MD,DE,DE,2020,Q4,Elderly
184997041,18499704,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-08805,LUPIN,,62.0,YR,,M,Y,,,20201113.0,,HP,US,US,2020,Q4,Adult
184997041,18499704,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Food interaction,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-08805,LUPIN,,62.0,YR,,M,Y,,,20201113.0,,HP,US,US,2020,Q4,Adult
184997041,18499704,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hiccups,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-08805,LUPIN,,62.0,YR,,M,Y,,,20201113.0,,HP,US,US,2020,Q4,Adult
184997041,18499704,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Renal tubular disorder,,2020,Q4,1,I,,20201102.0,20201113,20201113,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-08805,LUPIN,,62.0,YR,,M,Y,,,20201113.0,,HP,US,US,2020,Q4,Adult
184997462,18499746,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,INJECTION,,2020,Q4,Gastric disorder,,2020,Q4,2,F,20201005.0,20201113.0,20201112,20201119,EXP,,CN-CELGENEUS-CHN-20201003175,CELGENE,,77.0,YR,,M,Y,,,20201119.0,,HP,CN,CN,2020,Q4,Elderly
184997462,18499746,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,INJECTION,,2020,Q4,Impaired gastric emptying,,2020,Q4,2,F,20201005.0,20201113.0,20201112,20201119,EXP,,CN-CELGENEUS-CHN-20201003175,CELGENE,,77.0,YR,,M,Y,,,20201119.0,,HP,CN,CN,2020,Q4,Elderly
184997462,18499746,9,C,Insulin Glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,INJECTION,,2020,Q4,Soft tissue injury,,2020,Q4,2,F,20201005.0,20201113.0,20201112,20201119,EXP,,CN-CELGENEUS-CHN-20201003175,CELGENE,,77.0,YR,,M,Y,,,20201119.0,,HP,CN,CN,2020,Q4,Elderly
184997822,18499782,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 UNIT?ONCE/DAY,,,,,,,,,,,,2020,Q4,Serotonin syndrome,Serotonin syndrome,2020,Q4,2,F,20180212.0,20201113.0,20201113,20201126,EXP,,US-ACCORD-207926,ACCORD,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REP PSYCHIATRY. 2020 OCT 7;2020:8860434",74.0,YR,,M,Y,75.0,KG,20201126.0,,HP,US,US,2020,Q4,Elderly
185000811,18500081,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 UNITS BEFORE BREAKFAST,,,Y,,,,,,,,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,,20201104.0,20201113,20201113,EXP,,US-009507513-2011USA004970,MERCK,"SHAH S,. COMPARISON OF GLUCOSE EXCURSION IN PATIENT WITH T2DM AFTER THE EFFECTS OF TREATMENT WITH DULAGLUTIDE INJECTION BY USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM A CASE REPORT!. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES. 2019;39 (1):S30-1",52.0,YR,,M,Y,,,20201113.0,,HP,US,US,2020,Q4,Adult
185000811,18500081,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,24 UNITS BEFORE BREAKFAST,,,Y,,,,,,,,,2020,Q4,Drug ineffective,,2020,Q4,1,I,,20201104.0,20201113,20201113,EXP,,US-009507513-2011USA004970,MERCK,"SHAH S,. COMPARISON OF GLUCOSE EXCURSION IN PATIENT WITH T2DM AFTER THE EFFECTS OF TREATMENT WITH DULAGLUTIDE INJECTION BY USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM A CASE REPORT!. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES. 2019;39 (1):S30-1",52.0,YR,,M,Y,,,20201113.0,,HP,US,US,2020,Q4,Adult
185005221,18500522,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Asphyxia,,2020,Q4,1,I,,20201101.0,20201113,20201113,EXP,,FR-INDICUS PHARMA-000729,INDICUS,"ARBOUCHE N, FARRUGIA A, WALCH A, RAUL JS, KINTZ P. SPECIFIC INTERPRETATION OF HAIR CONCENTRATIONS IN 2 FATAL METFORMIN INTOXICATION CASES. LEG MED (TOKYO). 2020 OCT 22:101803.",57.0,YR,,M,Y,,,20201113.0,,HP,FR,FR,2020,Q4,Adult
185005221,18500522,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,,20201101.0,20201113,20201113,EXP,,FR-INDICUS PHARMA-000729,INDICUS,"ARBOUCHE N, FARRUGIA A, WALCH A, RAUL JS, KINTZ P. SPECIFIC INTERPRETATION OF HAIR CONCENTRATIONS IN 2 FATAL METFORMIN INTOXICATION CASES. LEG MED (TOKYO). 2020 OCT 22:101803.",57.0,YR,,M,Y,,,20201113.0,,HP,FR,FR,2020,Q4,Adult
185005221,18500522,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Overdose,,2020,Q4,1,I,,20201101.0,20201113,20201113,EXP,,FR-INDICUS PHARMA-000729,INDICUS,"ARBOUCHE N, FARRUGIA A, WALCH A, RAUL JS, KINTZ P. SPECIFIC INTERPRETATION OF HAIR CONCENTRATIONS IN 2 FATAL METFORMIN INTOXICATION CASES. LEG MED (TOKYO). 2020 OCT 22:101803.",57.0,YR,,M,Y,,,20201113.0,,HP,FR,FR,2020,Q4,Adult
185005221,18500522,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20201101.0,20201113,20201113,EXP,,FR-INDICUS PHARMA-000729,INDICUS,"ARBOUCHE N, FARRUGIA A, WALCH A, RAUL JS, KINTZ P. SPECIFIC INTERPRETATION OF HAIR CONCENTRATIONS IN 2 FATAL METFORMIN INTOXICATION CASES. LEG MED (TOKYO). 2020 OCT 22:101803.",57.0,YR,,M,Y,,,20201113.0,,HP,FR,FR,2020,Q4,Adult
185005671,18500567,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Asphyxia,,2020,Q4,1,I,,20201101.0,20201113,20201113,EXP,,FR-INVENTIA-000437,INVENTIA HEALTHCARE,"ARBOUCHE N, FARRUGIA A, WALCH A, RAUL JS, KINTZ P. SPECIFIC INTERPRETATION OF HAIR CONCENTRATIONS IN 2 FATAL METFORMIN INTOXICATION CASES. LEG MED (TOKYO). 2020 OCT 22:101803.",57.0,YR,,M,Y,,,20201113.0,,HP,FR,FR,2020,Q4,Adult
185005671,18500567,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,,20201101.0,20201113,20201113,EXP,,FR-INVENTIA-000437,INVENTIA HEALTHCARE,"ARBOUCHE N, FARRUGIA A, WALCH A, RAUL JS, KINTZ P. SPECIFIC INTERPRETATION OF HAIR CONCENTRATIONS IN 2 FATAL METFORMIN INTOXICATION CASES. LEG MED (TOKYO). 2020 OCT 22:101803.",57.0,YR,,M,Y,,,20201113.0,,HP,FR,FR,2020,Q4,Adult
185005671,18500567,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Overdose,,2020,Q4,1,I,,20201101.0,20201113,20201113,EXP,,FR-INVENTIA-000437,INVENTIA HEALTHCARE,"ARBOUCHE N, FARRUGIA A, WALCH A, RAUL JS, KINTZ P. SPECIFIC INTERPRETATION OF HAIR CONCENTRATIONS IN 2 FATAL METFORMIN INTOXICATION CASES. LEG MED (TOKYO). 2020 OCT 22:101803.",57.0,YR,,M,Y,,,20201113.0,,HP,FR,FR,2020,Q4,Adult
185005671,18500567,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20201101.0,20201113,20201113,EXP,,FR-INVENTIA-000437,INVENTIA HEALTHCARE,"ARBOUCHE N, FARRUGIA A, WALCH A, RAUL JS, KINTZ P. SPECIFIC INTERPRETATION OF HAIR CONCENTRATIONS IN 2 FATAL METFORMIN INTOXICATION CASES. LEG MED (TOKYO). 2020 OCT 22:101803.",57.0,YR,,M,Y,,,20201113.0,,HP,FR,FR,2020,Q4,Adult
185008452,18500845,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DAILY",,,,,,,205692.0,4.0,IU,INJECTION,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,2,F,,20201125.0,20201113,20201203,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202011002645,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20201203.0,,HP,JP,JP,2020,Q4,Elderly
185008452,18500845,1,PS,Insulin Glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, DAILY",,,,,,,205692.0,4.0,IU,INJECTION,QD,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,2,F,,20201125.0,20201113,20201203,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202011002645,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20201203.0,,HP,JP,JP,2020,Q4,Elderly
185013341,18501334,35,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,COVID-19,,2020,Q4,1,I,20201025.0,20201110.0,20201113,20201113,EXP,,FR-PFIZER INC-2020444518,PFIZER,,79.0,YR,,M,Y,,,20201113.0,,MD,FR,FR,2020,Q4,Elderly
185019511,18501951,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"(1 IE, 0-0-0-70, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"(1 IE, 0-0-0-70, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"(1 IE, 0-0-0-70, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"(1 IE, 0-0-0-70, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"(1 IE, 0-0-0-70, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185019511,18501951,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"(1 IE, 0-0-0-70, AMPULLEN)",,,U,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201105.0,20201113,20201113,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20201113.0,,HP,DE,DE,2020,Q4,Elderly
185035511,18503551,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Anaemia,,2020,Q4,1,I,201912.0,20201102.0,20201113,20201113,EXP,,ES-BAUSCH-BL-2020-032292,BAUSCH AND LOMB,,85.0,YR,,F,Y,96.0,KG,20201113.0,,CN,ES,ES,2020,Q4,Elderly
185035511,18503551,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,201912.0,20201102.0,20201113,20201113,EXP,,ES-BAUSCH-BL-2020-032292,BAUSCH AND LOMB,,85.0,YR,,F,Y,96.0,KG,20201113.0,,CN,ES,ES,2020,Q4,Elderly
185035511,18503551,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,201912.0,20201102.0,20201113,20201113,EXP,,ES-BAUSCH-BL-2020-032292,BAUSCH AND LOMB,,85.0,YR,,F,Y,96.0,KG,20201113.0,,CN,ES,ES,2020,Q4,Elderly
185035511,18503551,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Haematochezia,,2020,Q4,1,I,201912.0,20201102.0,20201113,20201113,EXP,,ES-BAUSCH-BL-2020-032292,BAUSCH AND LOMB,,85.0,YR,,F,Y,96.0,KG,20201113.0,,CN,ES,ES,2020,Q4,Elderly
185035511,18503551,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Haemorrhage,,2020,Q4,1,I,201912.0,20201102.0,20201113,20201113,EXP,,ES-BAUSCH-BL-2020-032292,BAUSCH AND LOMB,,85.0,YR,,F,Y,96.0,KG,20201113.0,,CN,ES,ES,2020,Q4,Elderly
185036771,18503677,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, BID (6 IE, 1-0-1-0)",,,,,,,,,,,BID,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,,20201109.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1094643,MYLAN,,84.0,YR,,F,Y,75.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185036771,18503677,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, BID (6 IE, 1-0-1-0)",,,,,,,,,,,BID,2020,Q4,Dehydration,,2020,Q4,1,I,,20201109.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1094643,MYLAN,,84.0,YR,,F,Y,75.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185036771,18503677,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, BID (6 IE, 1-0-1-0)",,,,,,,,,,,BID,2020,Q4,Depressed level of consciousness,,2020,Q4,1,I,,20201109.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1094643,MYLAN,,84.0,YR,,F,Y,75.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185036771,18503677,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, BID (6 IE, 1-0-1-0)",,,,,,,,,,,BID,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1094643,MYLAN,,84.0,YR,,F,Y,75.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185036771,18503677,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, BID (6 IE, 1-0-1-0)",,,,,,,,,,,BID,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201109.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1094643,MYLAN,,84.0,YR,,F,Y,75.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185036771,18503677,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, BID (6 IE, 1-0-1-0)",,,,,,,,,,,BID,2020,Q4,Renal failure,,2020,Q4,1,I,,20201109.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1094643,MYLAN,,84.0,YR,,F,Y,75.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185036771,18503677,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, BID (6 IE, 1-0-1-0)",,,,,,,,,,,BID,2020,Q4,Thirst,,2020,Q4,1,I,,20201109.0,20201113,20201113,EXP,,DE-MYLANLABS-2020M1094643,MYLAN,,84.0,YR,,F,Y,75.0,KG,20201113.0,,PH,DE,DE,2020,Q4,Elderly
185038281,18503828,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201110.0,20201113,20201113,EXP,,ES-ASTRAZENECA-2020SF47907,ASTRAZENECA,,75.0,YR,,M,Y,86.4,KG,20201113.0,,MD,ES,ES,2020,Q4,Elderly
185038281,18503828,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201110.0,20201113,20201113,EXP,,ES-ASTRAZENECA-2020SF47907,ASTRAZENECA,,75.0,YR,,M,Y,86.4,KG,20201113.0,,MD,ES,ES,2020,Q4,Elderly
185038281,18503828,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201110.0,20201113,20201113,EXP,,ES-ASTRAZENECA-2020SF47907,ASTRAZENECA,,75.0,YR,,M,Y,86.4,KG,20201113.0,,MD,ES,ES,2020,Q4,Elderly
185038281,18503828,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201110.0,20201113,20201113,EXP,,ES-ASTRAZENECA-2020SF47907,ASTRAZENECA,,75.0,YR,,M,Y,86.4,KG,20201113.0,,MD,ES,ES,2020,Q4,Elderly
185038281,18503828,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201110.0,20201113,20201113,EXP,,ES-ASTRAZENECA-2020SF47907,ASTRAZENECA,,75.0,YR,,M,Y,86.4,KG,20201113.0,,MD,ES,ES,2020,Q4,Elderly
185039692,18503969,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, DAILY",,,U,, 0F662,,,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Anxiety,,2020,Q4,2,F,20201030.0,20201116.0,20201113,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011004459,ELI LILLY AND CO,,82.0,YR,,F,Y,58.0,KG,20201125.0,,CN,ES,ES,2020,Q4,Elderly
185039692,18503969,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, DAILY",,,U,, 0F662,,,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Blood glucose increased,,2020,Q4,2,F,20201030.0,20201116.0,20201113,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011004459,ELI LILLY AND CO,,82.0,YR,,F,Y,58.0,KG,20201125.0,,CN,ES,ES,2020,Q4,Elderly
185039692,18503969,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, DAILY",,,U,, 0F662,,,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Chest pain,,2020,Q4,2,F,20201030.0,20201116.0,20201113,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011004459,ELI LILLY AND CO,,82.0,YR,,F,Y,58.0,KG,20201125.0,,CN,ES,ES,2020,Q4,Elderly
185039692,18503969,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, DAILY",,,U,, 0F662,,,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Hyperglycaemia,,2020,Q4,2,F,20201030.0,20201116.0,20201113,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011004459,ELI LILLY AND CO,,82.0,YR,,F,Y,58.0,KG,20201125.0,,CN,ES,ES,2020,Q4,Elderly
185039692,18503969,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, DAILY",,,U,, 0F662,,,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,20201030.0,20201116.0,20201113,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011004459,ELI LILLY AND CO,,82.0,YR,,F,Y,58.0,KG,20201125.0,,CN,ES,ES,2020,Q4,Elderly
185039692,18503969,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, DAILY",,,U,, 0F662,,,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Hypertension,,2020,Q4,2,F,20201030.0,20201116.0,20201113,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011004459,ELI LILLY AND CO,,82.0,YR,,F,Y,58.0,KG,20201125.0,,CN,ES,ES,2020,Q4,Elderly
185039692,18503969,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"32 INTERNATIONAL UNIT, DAILY",,,U,, 0F662,,,32.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Infarction,,2020,Q4,2,F,20201030.0,20201116.0,20201113,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011004459,ELI LILLY AND CO,,82.0,YR,,F,Y,58.0,KG,20201125.0,,CN,ES,ES,2020,Q4,Elderly
185044881,18504488,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (24 IE, 0-0-0-1, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201105.0,20201114,20201114,EXP,,NVSC2020DE298917,NOVARTIS,,79.0,YR,,M,Y,,,20201114.0,,HP,DE,DE,2020,Q4,Elderly
185044881,18504488,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (24 IE, 0-0-0-1, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Musculoskeletal pain,,2020,Q4,1,I,,20201105.0,20201114,20201114,EXP,,NVSC2020DE298917,NOVARTIS,,79.0,YR,,M,Y,,,20201114.0,,HP,DE,DE,2020,Q4,Elderly
185044881,18504488,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (24 IE, 0-0-0-1, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Pain,,2020,Q4,1,I,,20201105.0,20201114,20201114,EXP,,NVSC2020DE298917,NOVARTIS,,79.0,YR,,M,Y,,,20201114.0,,HP,DE,DE,2020,Q4,Elderly
185044881,18504488,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (24 IE, 0-0-0-1, AMPULLEN)",,,U,,,,,,,,,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201105.0,20201114,20201114,EXP,,NVSC2020DE298917,NOVARTIS,,79.0,YR,,M,Y,,,20201114.0,,HP,DE,DE,2020,Q4,Elderly
185045041,18504504,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD (14 IE, 1-0-0-0)",,,U,,,,,14.0,IU,,QD,2020,Q4,Anaemia,,2020,Q4,1,I,,20201105.0,20201114,20201114,EXP,,NVSC2020DE299254,NOVARTIS,,78.0,YR,,F,Y,,,20201114.0,,HP,DE,DE,2020,Q4,Elderly
185045041,18504504,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD (14 IE, 1-0-0-0)",,,U,,,,,14.0,IU,,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201105.0,20201114,20201114,EXP,,NVSC2020DE299254,NOVARTIS,,78.0,YR,,F,Y,,,20201114.0,,HP,DE,DE,2020,Q4,Elderly
185045041,18504504,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"14 IU, QD (14 IE, 1-0-0-0)",,,U,,,,,14.0,IU,,QD,2020,Q4,Musculoskeletal pain,,2020,Q4,1,I,,20201105.0,20201114,20201114,EXP,,NVSC2020DE299254,NOVARTIS,,78.0,YR,,F,Y,,,20201114.0,,HP,DE,DE,2020,Q4,Elderly
185050781,18505078,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 ABSENT,,,U,,,,,28.0,DF,,,2020,Q4,Conjunctivitis,,2020,Q4,1,I,20190701.0,20190801.0,20201116,20201116,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-077207,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,,,20201116.0,,HP,FR,FR,2020,Q4,Elderly
185050781,18505078,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 ABSENT,,,U,,,,,28.0,DF,,,2020,Q4,Myalgia,,2020,Q4,1,I,20190701.0,20190801.0,20201116,20201116,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-077207,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,,,20201116.0,,HP,FR,FR,2020,Q4,Elderly
185050781,18505078,10,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Subcutaneous,28 ABSENT,,,U,,,,,28.0,DF,,,2020,Q4,Steroid diabetes,,2020,Q4,1,I,20190701.0,20190801.0,20201116,20201116,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-077207,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,,,20201116.0,,HP,FR,FR,2020,Q4,Elderly
185057651,18505765,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Varicose vein ruptured,,2020,Q4,1,I,,20201103.0,20201116,20201116,EXP,,CO-EMD SERONO-9197112,EMD SERONO INC,,52.0,YR,A,M,Y,120.0,KG,20201116.0,,MD,CO,CO,2020,Q4,Adult
185060051,18506005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,,,,,,,,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185060051,18506005,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201105.0,20201116,20201116,EXP,,DE-EMD SERONO-E2B_90081157,EMD SERONO INC,,69.0,YR,E,F,Y,,,20201116.0,,PH,DE,DE,2020,Q4,Elderly
185063861,18506386,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Hypersensitivity,,2020,Q4,1,I,20201109.0,20201110.0,20201116,20201116,EXP,,NVSC2020TH301396,NOVARTIS,,62.0,YR,,M,Y,71.1,KG,20201116.0,,HP,TH,TH,2020,Q4,Adult
185072691,18507269,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, 1X/DAY (20 UNITS, SUBCUTANEOUS, BEDTIME, # 10 ML, 3 REFILL(S))",,,,,,,,20.0,IU,,QD,2020,Q4,Feeling abnormal,,2020,Q4,1,I,,20161011.0,20201116,20201116,PER,,US-PFIZER INC-2016476742,PFIZER,,53.0,YR,,F,Y,51.7,KG,20201116.0,,MD,US,US,2020,Q4,Adult
185072691,18507269,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"20 IU, 1X/DAY (20 UNITS, SUBCUTANEOUS, BEDTIME, # 10 ML, 3 REFILL(S))",,,,,,,,20.0,IU,,QD,2020,Q4,Sleep disorder,,2020,Q4,1,I,,20161011.0,20201116,20201116,PER,,US-PFIZER INC-2016476742,PFIZER,,53.0,YR,,F,Y,51.7,KG,20201116.0,,MD,US,US,2020,Q4,Adult
185108842,18510884,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,FREQUENCY: BEDTIME,,,,,,,,20.0,IU,,,2020,Q4,Cardiac failure,,2020,Q4,2,F,20200926.0,20201209.0,20201117,20201211,EXP,,US-JNJFOC-20200951620,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,61.2,KG,20201211.0,,MD,US,US,2020,Q4,Elderly
185110671,18511067,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Anaemia,,2020,Q4,1,I,201912.0,20201109.0,20201117,20201117,EXP,,ES-MYLANLABS-2020M1093948,MYLAN,,85.0,YR,,F,Y,96.0,KG,20201117.0,,CN,ES,ES,2020,Q4,Elderly
185110671,18511067,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,201912.0,20201109.0,20201117,20201117,EXP,,ES-MYLANLABS-2020M1093948,MYLAN,,85.0,YR,,F,Y,96.0,KG,20201117.0,,CN,ES,ES,2020,Q4,Elderly
185110671,18511067,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,201912.0,20201109.0,20201117,20201117,EXP,,ES-MYLANLABS-2020M1093948,MYLAN,,85.0,YR,,F,Y,96.0,KG,20201117.0,,CN,ES,ES,2020,Q4,Elderly
185110671,18511067,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Haematochezia,,2020,Q4,1,I,201912.0,20201109.0,20201117,20201117,EXP,,ES-MYLANLABS-2020M1093948,MYLAN,,85.0,YR,,F,Y,96.0,KG,20201117.0,,CN,ES,ES,2020,Q4,Elderly
185110671,18511067,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 IU,,,,, OF687A,,,50.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Haemorrhage,,2020,Q4,1,I,201912.0,20201109.0,20201117,20201117,EXP,,ES-MYLANLABS-2020M1093948,MYLAN,,85.0,YR,,F,Y,96.0,KG,20201117.0,,CN,ES,ES,2020,Q4,Elderly
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Drug abuse,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hiccups,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hypocalcaemia,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Intercapillary glomerulosclerosis,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Kidney fibrosis,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Nephropathy toxic,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Renal cyst,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Renal tubular injury,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Sleep disorder,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185111521,18511152,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201106.0,20201117,20201117,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP013932,STRIDES,"NGUYEN V, DEEB K, RATHAKRISHNAN R.. HICCUPS: YOU GOT TO BE KIDNEY ME!.. SAGE OPEN MEDICAL CASE REPORTS. 2020;8:1-4",62.0,YR,,M,Y,,,20201117.0,,HP,US,US,2020,Q4,Adult
185124701,18512470,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 DOSAGE UNITS, QD",,,,,,,,15.0,DF,,QD,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201106.0,20201117,20201117,EXP,,US-AMNEAL PHARMACEUTICALS-2020-AMRX-03608,AMNEAL,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REP. PSYCHIATRY. 2020",75.0,YR,,M,Y,75.0,KG,20201117.0,,HP,US,US,2020,Q4,Elderly
185126551,18512655,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT (10 IE, 0-1-0-0, AMPOULES)",,,,,,,,10.0,IU,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094277,MYLAN,,64.0,YR,,F,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Adult
185126551,18512655,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT (10 IE, 0-1-0-0, AMPOULES)",,,,,,,,10.0,IU,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094277,MYLAN,,64.0,YR,,F,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Adult
185126551,18512655,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT (10 IE, 0-1-0-0, AMPOULES)",,,,,,,,10.0,IU,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094277,MYLAN,,64.0,YR,,F,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Adult
185126551,18512655,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT (10 IE, 0-1-0-0, AMPOULES)",,,,,,,,10.0,IU,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094277,MYLAN,,64.0,YR,,F,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Adult
185126551,18512655,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT (10 IE, 0-1-0-0, AMPOULES)",,,,,,,,10.0,IU,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094277,MYLAN,,64.0,YR,,F,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Adult
185126651,18512665,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,,,,,,18.0,IU,,QD,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094249,MYLAN,,86.0,YR,,M,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Elderly
185126651,18512665,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,,,,,,18.0,IU,,QD,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094249,MYLAN,,86.0,YR,,M,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Elderly
185126651,18512665,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,,,,,,18.0,IU,,QD,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094249,MYLAN,,86.0,YR,,M,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Elderly
185126651,18512665,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,,,,,,18.0,IU,,QD,2020,Q4,Dizziness,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094249,MYLAN,,86.0,YR,,M,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Elderly
185126651,18512665,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,,,,,,18.0,IU,,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094249,MYLAN,,86.0,YR,,M,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Elderly
185126651,18512665,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,,,,,,18.0,IU,,QD,2020,Q4,Musculoskeletal pain,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094249,MYLAN,,86.0,YR,,M,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Elderly
185126651,18512665,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IE, 0-0-0-1, AMPULLEN",,,,,,,,18.0,IU,,QD,2020,Q4,Neck pain,,2020,Q4,1,I,,20201109.0,20201117,20201117,EXP,,DE-MYLANLABS-2020M1094249,MYLAN,,86.0,YR,,M,Y,,,20201117.0,,MD,DE,DE,2020,Q4,Elderly
185166551,18516655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70, AMPOULES",,,,,,,,,,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70, AMPOULES",,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70, AMPOULES",,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70, AMPOULES",,,,,,,,,,,,2020,Q4,Electrolyte imbalance,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70, AMPOULES",,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185166551,18516655,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"1 IE, 0-0-0-70, AMPOULES",,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201103.0,20201118,20201118,EXP,DE-ADRED-05691-01,DE-BAUSCH-BL-2020-032607,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201118.0,,PH,DE,DE,2020,Q4,Elderly
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Basophil percentage decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Blood albumin decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Blood bicarbonate increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Blood calcium decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Blood chloride decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Blood fibrinogen increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Blood lactate dehydrogenase increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Blood potassium decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Blood sodium decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,C-reactive protein increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Eosinophil percentage decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Fibrin D dimer increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Lymphocyte count decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Lymphocyte percentage decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Mean cell haemoglobin concentration decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Mean cell haemoglobin decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Mean platelet volume increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Monocyte percentage decreased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Neutrophil count increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Neutrophil percentage increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185174691,18517469,8,C,Insulin glargine 10 units SQ bedtime,,2,,,,,,,,,,,,,,2020,Q4,Serum ferritin increased,,2020,Q4,1,I,20201117.0,,20201118,20201118,DIR,,,FDA-CTU,,39.0,YR,,M,N,197.7,KG,20201118.0,Y,PH,US,US,2020,Q4,Adult
185175271,18517527,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200820.0,20201116.0,20201118,20201118,EXP,,ES-PFIZER INC-2020454285,PFIZER,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185175271,18517527,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200820.0,20201116.0,20201118,20201118,EXP,,ES-PFIZER INC-2020454285,PFIZER,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185175271,18517527,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200820.0,20201116.0,20201118,20201118,EXP,,ES-PFIZER INC-2020454285,PFIZER,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185175271,18517527,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200820.0,20201116.0,20201118,20201118,EXP,,ES-PFIZER INC-2020454285,PFIZER,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185175271,18517527,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200820.0,20201116.0,20201118,20201118,EXP,,ES-PFIZER INC-2020454285,PFIZER,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185175271,18517527,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Lymphocyte count decreased,,2020,Q4,1,I,20200820.0,20201116.0,20201118,20201118,EXP,,ES-PFIZER INC-2020454285,PFIZER,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185175271,18517527,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Neutrophil count increased,,2020,Q4,1,I,20200820.0,20201116.0,20201118,20201118,EXP,,ES-PFIZER INC-2020454285,PFIZER,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185175271,18517527,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,White blood cell count increased,,2020,Q4,1,I,20200820.0,20201116.0,20201118,20201118,EXP,,ES-PFIZER INC-2020454285,PFIZER,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185181491,18518149,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0-0-0-1, AMPULLEN",,,,,,,,24.0,IU,,QD,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-MYLANLABS-2020M1094768,MYLAN,,79.0,YR,,M,Y,,,20201118.0,,MD,DE,DE,2020,Q4,Elderly
185181491,18518149,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0-0-0-1, AMPULLEN",,,,,,,,24.0,IU,,QD,2020,Q4,Musculoskeletal pain,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-MYLANLABS-2020M1094768,MYLAN,,79.0,YR,,M,Y,,,20201118.0,,MD,DE,DE,2020,Q4,Elderly
185181491,18518149,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0-0-0-1, AMPULLEN",,,,,,,,24.0,IU,,QD,2020,Q4,Pain,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-MYLANLABS-2020M1094768,MYLAN,,79.0,YR,,M,Y,,,20201118.0,,MD,DE,DE,2020,Q4,Elderly
185181491,18518149,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 IE, 0-0-0-1, AMPULLEN",,,,,,,,24.0,IU,,QD,2020,Q4,Pain in extremity,,2020,Q4,1,I,,20201109.0,20201118,20201118,EXP,,DE-MYLANLABS-2020M1094768,MYLAN,,79.0,YR,,M,Y,,,20201118.0,,MD,DE,DE,2020,Q4,Elderly
185184581,18518458,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201108.0,20201118,20201118,EXP,,ES-BAUSCH-BL-2020-033191,BAUSCH AND LOMB,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185184581,18518458,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201108.0,20201118,20201118,EXP,,ES-BAUSCH-BL-2020-033191,BAUSCH AND LOMB,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185184581,18518458,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201108.0,20201118,20201118,EXP,,ES-BAUSCH-BL-2020-033191,BAUSCH AND LOMB,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185184581,18518458,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201108.0,20201118,20201118,EXP,,ES-BAUSCH-BL-2020-033191,BAUSCH AND LOMB,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185184581,18518458,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201108.0,20201118,20201118,EXP,,ES-BAUSCH-BL-2020-033191,BAUSCH AND LOMB,,75.0,YR,,M,Y,86.4,KG,20201118.0,,MD,ES,ES,2020,Q4,Elderly
185198481,18519848,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,,,UNKNOWN,QD,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20190515.0,20190522.0,20201119,20201119,EXP,,US-JNJFOC-20190531665,JOHNSON AND JOHNSON,,81.0,YR,E,M,Y,98.06,KG,20201119.0,,MD,US,US,2020,Q4,Elderly
185199671,18519967,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Clostridium difficile colitis,,2020,Q4,1,I,20190626.0,20190702.0,20201119,20201119,EXP,,US-JNJFOC-20190709130,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,95.34,KG,20201119.0,,MD,US,US,2020,Q4,Elderly
185200181,18520018,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,D,,,,,,,,,2020,Q4,Systemic inflammatory response syndrome,,2020,Q4,1,I,20181016.0,20181023.0,20201119,20201119,EXP,,US-JNJFOC-20181036201,JOHNSON AND JOHNSON,,81.0,YR,E,M,Y,104.42,KG,20201119.0,,MD,US,US,2020,Q4,Elderly
185224031,18522403,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201109.0,20201119,20201119,PER,,ES-IGSA-BIG0012055,GRIFOLS,,75.0,YR,,M,Y,86.4,KG,20201119.0,,MD,ES,ES,2020,Q4,Elderly
185224031,18522403,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201109.0,20201119,20201119,PER,,ES-IGSA-BIG0012055,GRIFOLS,,75.0,YR,,M,Y,86.4,KG,20201119.0,,MD,ES,ES,2020,Q4,Elderly
185224031,18522403,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201109.0,20201119,20201119,PER,,ES-IGSA-BIG0012055,GRIFOLS,,75.0,YR,,M,Y,86.4,KG,20201119.0,,MD,ES,ES,2020,Q4,Elderly
185224031,18522403,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201109.0,20201119,20201119,PER,,ES-IGSA-BIG0012055,GRIFOLS,,75.0,YR,,M,Y,86.4,KG,20201119.0,,MD,ES,ES,2020,Q4,Elderly
185224031,18522403,22,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201109.0,20201119,20201119,PER,,ES-IGSA-BIG0012055,GRIFOLS,,75.0,YR,,M,Y,86.4,KG,20201119.0,,MD,ES,ES,2020,Q4,Elderly
185224291,18522429,11,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201105.0,20201119,20201119,EXP,,ES-AUROBINDO-AUR-APL-2020-056326,AUROBINDO,,75.0,YR,,M,Y,86.4,KG,20201117.0,,MD,ES,ES,2020,Q4,Elderly
185224291,18522429,11,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201105.0,20201119,20201119,EXP,,ES-AUROBINDO-AUR-APL-2020-056326,AUROBINDO,,75.0,YR,,M,Y,86.4,KG,20201117.0,,MD,ES,ES,2020,Q4,Elderly
185224291,18522429,11,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201105.0,20201119,20201119,EXP,,ES-AUROBINDO-AUR-APL-2020-056326,AUROBINDO,,75.0,YR,,M,Y,86.4,KG,20201117.0,,MD,ES,ES,2020,Q4,Elderly
185224291,18522429,11,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201105.0,20201119,20201119,EXP,,ES-AUROBINDO-AUR-APL-2020-056326,AUROBINDO,,75.0,YR,,M,Y,86.4,KG,20201117.0,,MD,ES,ES,2020,Q4,Elderly
185224291,18522429,11,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201105.0,20201119,20201119,EXP,,ES-AUROBINDO-AUR-APL-2020-056326,AUROBINDO,,75.0,YR,,M,Y,86.4,KG,20201117.0,,MD,ES,ES,2020,Q4,Elderly
185228591,18522859,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,QD,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201109.0,20201119,20201119,EXP,,DE-PFIZER INC-2020456508,PFIZER,,64.0,YR,,F,Y,,,20201119.0,,MD,DE,DE,2020,Q4,Adult
185228591,18522859,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,QD,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201109.0,20201119,20201119,EXP,,DE-PFIZER INC-2020456508,PFIZER,,64.0,YR,,F,Y,,,20201119.0,,MD,DE,DE,2020,Q4,Adult
185228591,18522859,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,QD,2020,Q4,Nausea,,2020,Q4,1,I,,20201109.0,20201119,20201119,EXP,,DE-PFIZER INC-2020456508,PFIZER,,64.0,YR,,F,Y,,,20201119.0,,MD,DE,DE,2020,Q4,Adult
185228591,18522859,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,QD,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201109.0,20201119,20201119,EXP,,DE-PFIZER INC-2020456508,PFIZER,,64.0,YR,,F,Y,,,20201119.0,,MD,DE,DE,2020,Q4,Adult
185228591,18522859,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"10 INTERNATIONAL UNIT, QD",,,,,,,,10.0,IU,,QD,2020,Q4,Vomiting,,2020,Q4,1,I,,20201109.0,20201119,20201119,EXP,,DE-PFIZER INC-2020456508,PFIZER,,64.0,YR,,F,Y,,,20201119.0,,MD,DE,DE,2020,Q4,Adult
185253392,18525339,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Death,,2020,Q4,2,F,20201117.0,20201201.0,20201119,20201203,EXP,,US-GILEAD-2020-0505237,GILEAD,,39.0,YR,A,M,Y,197.7,KG,20201203.0,,PH,US,US,2020,Q4,Adult
185257041,18525704,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT?STARTED 15 YEARS AGO,,,,,,,,,,,,2020,Q4,Memory impairment,Memory impairment,2020,Q4,1,I,,20200107.0,20201119,20201119,PER,,US-ALVOGEN-2020-ALVOGEN-107581,ALVOGEN,,65.0,YR,,F,Y,81.65,KG,20201120.0,,MD,US,US,2020,Q4,Elderly
185257041,18525704,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT?STARTED 15 YEARS AGO,,,,,,,,,,,,2020,Q4,Myalgia,Myalgia,2020,Q4,1,I,,20200107.0,20201119,20201119,PER,,US-ALVOGEN-2020-ALVOGEN-107581,ALVOGEN,,65.0,YR,,F,Y,81.65,KG,20201120.0,,MD,US,US,2020,Q4,Elderly
185257041,18525704,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT?STARTED 15 YEARS AGO,,,,,,,,,,,,2020,Q4,Off label use,Off label use,2020,Q4,1,I,,20200107.0,20201119,20201119,PER,,US-ALVOGEN-2020-ALVOGEN-107581,ALVOGEN,,65.0,YR,,F,Y,81.65,KG,20201120.0,,MD,US,US,2020,Q4,Elderly
185265562,18526556,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"15 IU, 1X/DAY",,,,,,,,15.0,IU,,QD,2020,Q4,Serotonin syndrome,,2020,Q4,2,F,20180212.0,20201120.0,20201120,20201125,EXP,,US-PFIZER INC-2020453543,PFIZER,"PANDYA, D.. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020;10.1155/2020/8860434",74.0,YR,,M,Y,75.0,KG,20201125.0,,PH,US,US,2020,Q4,Elderly
185265562,18526556,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"15 IU, 1X/DAY",,,,,,,,15.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,2,F,20180212.0,20201120.0,20201120,20201125,EXP,,US-PFIZER INC-2020453543,PFIZER,"PANDYA, D.. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020;10.1155/2020/8860434",74.0,YR,,M,Y,75.0,KG,20201125.0,,PH,US,US,2020,Q4,Elderly
185299031,18529903,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,50 UNITS DAILY,,,Y,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,20190911.0,20191022.0,20201120,20201120,PER,,US-NOVOPROD-693269,NOVO NORDISK,,54.0,YR,,F,Y,126.05,KG,20201120.0,,PH,US,US,2020,Q4,Adult
185299031,18529903,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,45 UNITS DAILY,,,Y,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,20190911.0,20191022.0,20201120,20201120,PER,,US-NOVOPROD-693269,NOVO NORDISK,,54.0,YR,,F,Y,126.05,KG,20201120.0,,PH,US,US,2020,Q4,Adult
185310231,18531023,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 INTERNATIONAL UNIT DAILY,,,,, UNKNOWN,,,15.0,IU,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201113.0,20201122,20201122,EXP,US-MLMSERVICE-20201109-2572995-1,US-EMCURE PHARMACEUTICALS LTD-2020-EPL-001907,EMCURE,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020",74.0,YR,,M,Y,75.0,KG,20201120.0,,PH,US,US,2020,Q4,Elderly
185310231,18531023,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 INTERNATIONAL UNIT DAILY,,,,, UNKNOWN,,,15.0,IU,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,20180212.0,20201113.0,20201122,20201122,EXP,US-MLMSERVICE-20201109-2572995-1,US-EMCURE PHARMACEUTICALS LTD-2020-EPL-001907,EMCURE,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020",74.0,YR,,M,Y,75.0,KG,20201120.0,,PH,US,US,2020,Q4,Elderly
185318251,18531825,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IU,,,U,,,,,15.0,IU,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201113.0,20201123,20201123,EXP,,US-HETERO-HET2020US01253,HETERO,,74.0,YR,,M,Y,75.0,KG,20201123.0,,HP,IN,US,2020,Q4,Elderly
185318251,18531825,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,15 IU,,,U,,,,,15.0,IU,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,20180212.0,20201113.0,20201123,20201123,EXP,,US-HETERO-HET2020US01253,HETERO,,74.0,YR,,M,Y,75.0,KG,20201123.0,,HP,IN,US,2020,Q4,Elderly
185330171,18533017,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cholelithiasis,,2020,Q4,1,I,20201122.0,,20201122,20201122,DIR,,,FDA-CTU,,52.0,YR,,F,N,99.0,KG,20201122.0,N,PH,US,US,2020,Q4,Adult
185330171,18533017,15,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pancreatitis acute,,2020,Q4,1,I,20201122.0,,20201122,20201122,DIR,,,FDA-CTU,,52.0,YR,,F,N,99.0,KG,20201122.0,N,PH,US,US,2020,Q4,Adult
185330741,18533074,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201110.0,20201123,20201123,EXP,,ES-JNJFOC-20201117022,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,86.4,KG,20201123.0,,MD,ES,ES,2020,Q4,Elderly
185330741,18533074,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201110.0,20201123,20201123,EXP,,ES-JNJFOC-20201117022,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,86.4,KG,20201123.0,,MD,ES,ES,2020,Q4,Elderly
185330741,18533074,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201110.0,20201123,20201123,EXP,,ES-JNJFOC-20201117022,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,86.4,KG,20201123.0,,MD,ES,ES,2020,Q4,Elderly
185330741,18533074,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201110.0,20201123,20201123,EXP,,ES-JNJFOC-20201117022,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,86.4,KG,20201123.0,,MD,ES,ES,2020,Q4,Elderly
185330741,18533074,12,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,,,,UNKNOWN,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201110.0,20201123,20201123,EXP,,ES-JNJFOC-20201117022,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,86.4,KG,20201123.0,,MD,ES,ES,2020,Q4,Elderly
185331631,18533163,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201113.0,20201123,20201123,EXP,,US-TORRENT-00010543,TORRENT,,74.0,YR,E,M,Y,75.0,KG,20201123.0,,PH,US,US,2020,Q4,Elderly
185331631,18533163,11,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,20180212.0,20201113.0,20201123,20201123,EXP,,US-TORRENT-00010543,TORRENT,,74.0,YR,E,M,Y,75.0,KG,20201123.0,,PH,US,US,2020,Q4,Elderly
185352441,18535244,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU QD,,,U,,,,,,,,,2020,Q4,Chills,,2020,Q4,1,I,,20201117.0,20201123,20201123,EXP,,DE-ANIPHARMA-2020-DE-000287,ANI,,91.0,YR,,M,Y,93.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185352441,18535244,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU QD,,,U,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,,20201117.0,20201123,20201123,EXP,,DE-ANIPHARMA-2020-DE-000287,ANI,,91.0,YR,,M,Y,93.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185352441,18535244,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU QD,,,U,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,,20201117.0,20201123,20201123,EXP,,DE-ANIPHARMA-2020-DE-000287,ANI,,91.0,YR,,M,Y,93.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185352441,18535244,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,35 IU QD,,,U,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,1,I,,20201117.0,20201123,20201123,EXP,,DE-ANIPHARMA-2020-DE-000287,ANI,,91.0,YR,,M,Y,93.0,KG,20201123.0,,PH,DE,DE,2020,Q4,Elderly
185373522,18537352,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,15.0,IU,,QD,2020,Q4,Serotonin syndrome,,2020,Q4,2,F,20180212.0,20201130.0,20201124,20201209,EXP,,US-AUROBINDO-AUR-APL-2020-057315,AUROBINDO,,74.0,YR,,M,Y,75.0,KG,20201209.0,,HP,US,US,2020,Q4,Elderly
185373522,18537352,14,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, ONCE A DAY",,,U,,,,,15.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,2,F,20180212.0,20201130.0,20201124,20201209,EXP,,US-AUROBINDO-AUR-APL-2020-057315,AUROBINDO,,74.0,YR,,M,Y,75.0,KG,20201209.0,,HP,US,US,2020,Q4,Elderly
185375781,18537578,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201113.0,20201124,20201124,PER,,US-DRREDDYS-USA/USA/20/0129193,DR REDDYS,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020:ARTICLE NUMBER 8860434. DOI: 10.1155/2020/8860434.",74.0,YR,E,M,Y,75.0,KG,20201124.0,,PH,US,US,2020,Q4,Elderly
185375781,18537578,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,20180212.0,20201113.0,20201124,20201124,PER,,US-DRREDDYS-USA/USA/20/0129193,DR REDDYS,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020:ARTICLE NUMBER 8860434. DOI: 10.1155/2020/8860434.",74.0,YR,E,M,Y,75.0,KG,20201124.0,,PH,US,US,2020,Q4,Elderly
185380443,18538044,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Muscular weakness,,2020,Q4,3,F,20191008.0,20201202.0,20201123,20201203,EXP,,US-GILEAD-2019-0432608,GILEAD,,81.0,YR,E,M,Y,86.9,KG,20201203.0,,MD,US,US,2020,Q4,Elderly
185380443,18538044,38,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Toxic encephalopathy,,2020,Q4,3,F,20191008.0,20201202.0,20201123,20201203,EXP,,US-GILEAD-2019-0432608,GILEAD,,81.0,YR,E,M,Y,86.9,KG,20201203.0,,MD,US,US,2020,Q4,Elderly
185402581,18540258,8,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,PER DAY,,,,,,,,9.0,IU,,,2020,Q4,Delirium,,2020,Q4,1,I,20201115.0,20201119.0,20201124,20201124,EXP,,CO-BAXTER-2020BAX023733,BAXTER,,80.0,YR,,F,Y,50.0,KG,20201124.0,,HP,CO,CO,2020,Q4,Elderly
185440911,18544091,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,15.0,IU,UNKNOWN,QD,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201113.0,20201125,20201125,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52669,HIKMA,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020:ARTICLE NUMBER 8860434. DOI: 10.1155/2020/8860434.",74.0,YR,,M,Y,75.0,KG,20201125.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Elderly
185440911,18544091,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,15.0,IU,UNKNOWN,QD,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,20180212.0,20201113.0,20201125,20201125,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52669,HIKMA,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020:ARTICLE NUMBER 8860434. DOI: 10.1155/2020/8860434.",74.0,YR,,M,Y,75.0,KG,20201125.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Elderly
185449512,18544951,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,,,2020,Q4,Ketosis,,2020,Q4,2,F,20201018.0,20201211.0,20201125,20201214,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-063467",BOEHRINGER INGELHEIM,,75.0,YR,E,F,Y,,,20201214.0,,PH,JP,JP,2020,Q4,Elderly
185450521,18545052,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201110.0,20201125,20201125,EXP,,ES-COVIS PHARMA B.V.-2020COV00551,COVIS,,75.0,YR,,M,Y,86.0,KG,20201124.0,,CN,ES,ES,2020,Q4,Elderly
185450521,18545052,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201110.0,20201125,20201125,EXP,,ES-COVIS PHARMA B.V.-2020COV00551,COVIS,,75.0,YR,,M,Y,86.0,KG,20201124.0,,CN,ES,ES,2020,Q4,Elderly
185450521,18545052,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201110.0,20201125,20201125,EXP,,ES-COVIS PHARMA B.V.-2020COV00551,COVIS,,75.0,YR,,M,Y,86.0,KG,20201124.0,,CN,ES,ES,2020,Q4,Elderly
185450521,18545052,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201110.0,20201125,20201125,EXP,,ES-COVIS PHARMA B.V.-2020COV00551,COVIS,,75.0,YR,,M,Y,86.0,KG,20201124.0,,CN,ES,ES,2020,Q4,Elderly
185450521,18545052,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201110.0,20201125,20201125,EXP,,ES-COVIS PHARMA B.V.-2020COV00551,COVIS,,75.0,YR,,M,Y,86.0,KG,20201124.0,,CN,ES,ES,2020,Q4,Elderly
185454011,18545401,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,22.0,IU,UNKNOWN,,2020,Q4,Psoriasis,,2020,Q4,1,I,202008.0,20201118.0,20201125,20201125,EXP,FR-AFSSAPS-AM20201179,FR-JNJFOC-20201130863,JOHNSON AND JOHNSON,,59.0,YR,A,F,Y,62.0,KG,20201125.0,,MD,FR,FR,2020,Q4,Adult
185457241,18545724,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40IU, 0-1-0-0, AMPOULES",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,Fall,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096365,MYLAN,,81.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185457241,18545724,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40IU, 0-1-0-0, AMPOULES",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096365,MYLAN,,81.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185457241,18545724,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40IU, 0-1-0-0, AMPOULES",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096365,MYLAN,,81.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185457241,18545724,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"40IU, 0-1-0-0, AMPOULES",,,U,U,,,210605.0,,,INJECTION,,2020,Q4,Loss of consciousness,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096365,MYLAN,,81.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185458491,18545849,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"34 IE, 0-0-0-1",,,,,,,,34.0,IU,,QD,2020,Q4,Contusion,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096415,MYLAN,,85.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185458491,18545849,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"34 IE, 0-0-0-1",,,,,,,,34.0,IU,,QD,2020,Q4,Dehydration,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096415,MYLAN,,85.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185458491,18545849,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"34 IE, 0-0-0-1",,,,,,,,34.0,IU,,QD,2020,Q4,Haematoma,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096415,MYLAN,,85.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185458491,18545849,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"34 IE, 0-0-0-1",,,,,,,,34.0,IU,,QD,2020,Q4,Syncope,,2020,Q4,1,I,,20201118.0,20201125,20201125,EXP,,DE-MYLANLABS-2020M1096415,MYLAN,,85.0,YR,,F,Y,,,20201125.0,,MD,DE,DE,2020,Q4,Elderly
185459391,18545939,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,THE MAN RECEIVED 15 UNIT OF INSULIN-GLARGINE,,,U,U,,,,,,,,2020,Q4,Off label use,,2020,Q4,1,I,20180212.0,20201118.0,20201125,20201125,EXP,,US-MYLANLABS-2020M1097367,MYLAN,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE-REP-PSYCHIATRY 2020;NULL:NULL.",74.0,YR,,M,Y,75.0,KG,20201125.0,,HP,US,US,2020,Q4,Elderly
185459391,18545939,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,THE MAN RECEIVED 15 UNIT OF INSULIN-GLARGINE,,,U,U,,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201118.0,20201125,20201125,EXP,,US-MYLANLABS-2020M1097367,MYLAN,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE-REP-PSYCHIATRY 2020;NULL:NULL.",74.0,YR,,M,Y,75.0,KG,20201125.0,,HP,US,US,2020,Q4,Elderly
185467832,18546783,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Deep vein thrombosis,,2020,Q4,2,F,20200716.0,20201130.0,20201125,20201203,EXP,,AE-GILEAD-2020-0505807,GILEAD,,46.0,YR,A,M,Y,67.0,KG,20201203.0,,MD,AE,AE,2020,Q4,Adult
185467832,18546783,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,2,F,20200716.0,20201130.0,20201125,20201203,EXP,,AE-GILEAD-2020-0505807,GILEAD,,46.0,YR,A,M,Y,67.0,KG,20201203.0,,MD,AE,AE,2020,Q4,Adult
185467832,18546783,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,20200716.0,20201130.0,20201125,20201203,EXP,,AE-GILEAD-2020-0505807,GILEAD,,46.0,YR,A,M,Y,67.0,KG,20201203.0,,MD,AE,AE,2020,Q4,Adult
185467832,18546783,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,2,F,20200716.0,20201130.0,20201125,20201203,EXP,,AE-GILEAD-2020-0505807,GILEAD,,46.0,YR,A,M,Y,67.0,KG,20201203.0,,MD,AE,AE,2020,Q4,Adult
185467832,18546783,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,2,F,20200716.0,20201130.0,20201125,20201203,EXP,,AE-GILEAD-2020-0505807,GILEAD,,46.0,YR,A,M,Y,67.0,KG,20201203.0,,MD,AE,AE,2020,Q4,Adult
185467832,18546783,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,2,F,20200716.0,20201130.0,20201125,20201203,EXP,,AE-GILEAD-2020-0505807,GILEAD,,46.0,YR,A,M,Y,67.0,KG,20201203.0,,MD,AE,AE,2020,Q4,Adult
185469961,18546996,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, DAILY",,,,,,,,24.0,IU,,QD,2020,Q4,Blood glucose increased,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202011007930,ELI LILLY AND CO,,20.0,YR,,F,Y,50.0,KG,20201125.0,,CN,CN,CN,2020,Q4,Youth
185469961,18546996,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 U, DAILY",,,,,,,,24.0,IU,,QD,2020,Q4,Ketosis,,2020,Q4,1,I,,20201117.0,20201125,20201125,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202011007930,ELI LILLY AND CO,,20.0,YR,,F,Y,50.0,KG,20201125.0,,CN,CN,CN,2020,Q4,Youth
185469991,18546999,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Blood iron decreased,,2020,Q4,1,I,202009.0,20201113.0,20201125,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011006312,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20201125.0,,CN,ES,ES,2020,Q4,Adult
185469991,18546999,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,202009.0,20201113.0,20201125,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011006312,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20201125.0,,CN,ES,ES,2020,Q4,Adult
185469991,18546999,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Dysstasia,,2020,Q4,1,I,202009.0,20201113.0,20201125,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011006312,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20201125.0,,CN,ES,ES,2020,Q4,Adult
185469991,18546999,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Fatigue,,2020,Q4,1,I,202009.0,20201113.0,20201125,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011006312,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20201125.0,,CN,ES,ES,2020,Q4,Adult
185469991,18546999,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,202009.0,20201113.0,20201125,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011006312,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20201125.0,,CN,ES,ES,2020,Q4,Adult
185469991,18546999,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Injection site reaction,,2020,Q4,1,I,202009.0,20201113.0,20201125,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011006312,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20201125.0,,CN,ES,ES,2020,Q4,Adult
185469991,18546999,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Lethargy,,2020,Q4,1,I,202009.0,20201113.0,20201125,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011006312,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20201125.0,,CN,ES,ES,2020,Q4,Adult
185469991,18546999,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Pain,,2020,Q4,1,I,202009.0,20201113.0,20201125,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011006312,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20201125.0,,CN,ES,ES,2020,Q4,Adult
185469991,18546999,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY",,,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2020,Q4,Tremor,,2020,Q4,1,I,202009.0,20201113.0,20201125,20201125,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011006312,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20201125.0,,CN,ES,ES,2020,Q4,Adult
185471841,18547184,8,C,Insulin glargine,INSULIN GLARGINE,1,,15 UNIT ONCE PER DAY,,,,,,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,,20201111.0,20201126,20201126,EXP,,US-UNICHEM PHARMACEUTICALS (USA) INC-UCM202011-001353,UNICHEM,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020;2020:. DOI:10.1155/2020/8860434",74.0,YR,E,M,Y,75.0,KG,20201126.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Elderly
185484741,18548474,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 INTERNATIONAL UNIT, DAILY",,,Y,,,,205692.0,5.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,20201103.0,20201113.0,20201125,20201125,EXP,IT-MINISAL02-642681,IT-ELI_LILLY_AND_COMPANY-IT202011007012,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20201125.0,,MD,IT,IT,2020,Q4,Elderly
185484741,18548474,1,PS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 INTERNATIONAL UNIT, DAILY",,,Y,,,,205692.0,5.0,IU,,QD,2020,Q4,Sopor,,2020,Q4,1,I,20201103.0,20201113.0,20201125,20201125,EXP,IT-MINISAL02-642681,IT-ELI_LILLY_AND_COMPANY-IT202011007012,ELI LILLY AND CO,,90.0,YR,,F,Y,,,20201125.0,,MD,IT,IT,2020,Q4,Elderly
185492781,18549278,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q4,Depressive symptom,,2020,Q4,1,I,20180212.0,20201113.0,20201126,20201126,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09349,LUPIN,,74.0,YR,,M,Y,75.0,KG,20201126.0,,HP,US,US,2020,Q4,Elderly
185492781,18549278,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q4,Drug interaction,,2020,Q4,1,I,20180212.0,20201113.0,20201126,20201126,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09349,LUPIN,,74.0,YR,,M,Y,75.0,KG,20201126.0,,HP,US,US,2020,Q4,Elderly
185492781,18549278,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q4,Hypocalcaemia,,2020,Q4,1,I,20180212.0,20201113.0,20201126,20201126,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09349,LUPIN,,74.0,YR,,M,Y,75.0,KG,20201126.0,,HP,US,US,2020,Q4,Elderly
185492781,18549278,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q4,Migraine,,2020,Q4,1,I,20180212.0,20201113.0,20201126,20201126,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09349,LUPIN,,74.0,YR,,M,Y,75.0,KG,20201126.0,,HP,US,US,2020,Q4,Elderly
185492781,18549278,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q4,Neurological symptom,,2020,Q4,1,I,20180212.0,20201113.0,20201126,20201126,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09349,LUPIN,,74.0,YR,,M,Y,75.0,KG,20201126.0,,HP,US,US,2020,Q4,Elderly
185492781,18549278,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q4,Poor quality sleep,,2020,Q4,1,I,20180212.0,20201113.0,20201126,20201126,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09349,LUPIN,,74.0,YR,,M,Y,75.0,KG,20201126.0,,HP,US,US,2020,Q4,Elderly
185492781,18549278,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201113.0,20201126,20201126,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09349,LUPIN,,74.0,YR,,M,Y,75.0,KG,20201126.0,,HP,US,US,2020,Q4,Elderly
185492781,18549278,13,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 INTERNATIONAL UNIT, QD",,,,,,,,15.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,20180212.0,20201113.0,20201126,20201126,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-09349,LUPIN,,74.0,YR,,M,Y,75.0,KG,20201126.0,,HP,US,US,2020,Q4,Elderly
185494421,18549442,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,42 INTERNATIONAL UNIT,,,,, 0F662A,,,42.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Abdominal distension,,2020,Q4,1,I,,20201118.0,20201126,20201126,EXP,,ES-AUROBINDO-AUR-APL-2020-058171,AUROBINDO,,35.0,YR,,F,Y,,,20201126.0,,CN,ES,ES,2020,Q4,Adult
185494421,18549442,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,42 INTERNATIONAL UNIT,,,,, 0F662A,,,42.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201118.0,20201126,20201126,EXP,,ES-AUROBINDO-AUR-APL-2020-058171,AUROBINDO,,35.0,YR,,F,Y,,,20201126.0,,CN,ES,ES,2020,Q4,Adult
185500141,18550014,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,42 IU,,,,, 0F662A,,,42.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Abdominal distension,,2020,Q4,1,I,,20201120.0,20201126,20201126,EXP,,NVSC2020ES310284,NOVARTIS,,35.0,YR,,F,Y,,,20201126.0,,HP,ES,ES,2020,Q4,Adult
185500141,18550014,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,42 IU,,,,, 0F662A,,,42.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201120.0,20201126,20201126,EXP,,NVSC2020ES310284,NOVARTIS,,35.0,YR,,F,Y,,,20201126.0,,HP,ES,ES,2020,Q4,Adult
185546011,18554601,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,QD,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201113.0,20201127,20201127,EXP,,US-BAUSCH-BL-2020-033838,BAUSCH AND LOMB,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020 OCT 08;1-7. DOI:10.1155/2020/8860434",74.0,YR,,M,Y,75.0,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
185546011,18554601,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,QD,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,20180212.0,20201113.0,20201127,20201127,EXP,,US-BAUSCH-BL-2020-033838,BAUSCH AND LOMB,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020 OCT 08;1-7. DOI:10.1155/2020/8860434",74.0,YR,,M,Y,75.0,KG,20201127.0,,PH,US,US,2020,Q4,Elderly
185572651,18557265,2,C,insulin glargine,INSULIN GLARGINE,1,Unknown,100 IU / ML PER 3ML,,,,,,,,100.0,IU,,,2020,Q4,Acute coronary syndrome,,2020,Q4,1,I,20201026.0,20201123.0,20201129,20201129,EXP,,CO-BAXTER-2020BAX024086,BAXTER,,56.0,YR,,F,Y,87.0,KG,20201129.0,,HP,CO,CO,2020,Q4,Adult
185586001,18558600,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"15 DOSAGE FORM, QD (15 UNITS)",,,D,,,,,15.0,DF,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201118.0,20201130,20201130,EXP,,US-APOTEX-2020AP022548,APOTEX,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020;2020(202088604):1-7",74.0,YR,,M,Y,75.0,KG,20201130.0,,HP,US,US,2020,Q4,Elderly
185614341,18561434,2,C,insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Hypertensive urgency,,2020,Q4,1,I,,20201117.0,20201201,20201201,EXP,,IN-SUN PHARMACEUTICAL INDUSTRIES LTD-2020R1-268983,RANBAXY,,62.0,YR,,F,Y,,,20201201.0,,HP,IN,IN,2020,Q4,Adult
185616751,18561675,4,C,INSUL GLARGINE,,2,,,,,,,,,,,,,,2020,Q4,Antibiotic therapy,,2020,Q4,1,I,20200319.0,20200420.0,20201130,20201130,EXP,,US-ROCHE-2588076,ROCHE,,48.0,YR,,M,Y,95.34,KG,20201130.0,,PH,US,US,2020,Q4,Adult
185616751,18561675,4,C,INSUL GLARGINE,,2,,,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,1,I,20200319.0,20200420.0,20201130,20201130,EXP,,US-ROCHE-2588076,ROCHE,,48.0,YR,,M,Y,95.34,KG,20201130.0,,PH,US,US,2020,Q4,Adult
185616751,18561675,4,C,INSUL GLARGINE,,2,,,,,,,,,,,,,,2020,Q4,Thrombocytopenia,,2020,Q4,1,I,20200319.0,20200420.0,20201130,20201130,EXP,,US-ROCHE-2588076,ROCHE,,48.0,YR,,M,Y,95.34,KG,20201130.0,,PH,US,US,2020,Q4,Adult
185633221,18563322,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,,2020,Q4,Drug interaction,,2020,Q4,1,I,20180212.0,20201118.0,20201201,20201201,EXP,,US-DEXPHARM-20201053,DEXCEL,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020;2020:1-7.   DOI: 10.1155/2020/8860434.",74.0,YR,E,M,Y,75.0,KG,20201201.0,,HP,US,US,2020,Q4,Elderly
185633221,18563322,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201118.0,20201201,20201201,EXP,,US-DEXPHARM-20201053,DEXCEL,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020;2020:1-7.   DOI: 10.1155/2020/8860434.",74.0,YR,E,M,Y,75.0,KG,20201201.0,,HP,US,US,2020,Q4,Elderly
185633221,18563322,12,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,15.0,IU,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,20180212.0,20201118.0,20201201,20201201,EXP,,US-DEXPHARM-20201053,DEXCEL,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M. CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME. CASE REPORTS IN PSYCHIATRY. 2020;2020:1-7.   DOI: 10.1155/2020/8860434.",74.0,YR,E,M,Y,75.0,KG,20201201.0,,HP,US,US,2020,Q4,Elderly
185635511,18563551,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201130.0,20201201,20201201,EXP,,ES-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0714,BIODELIVERY SCIENCES INTERNATIONAL,,75.0,YR,E,M,Y,86.4,KG,20201201.0,,MD,ES,ES,2020,Q4,Elderly
185635511,18563551,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201130.0,20201201,20201201,EXP,,ES-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0714,BIODELIVERY SCIENCES INTERNATIONAL,,75.0,YR,E,M,Y,86.4,KG,20201201.0,,MD,ES,ES,2020,Q4,Elderly
185635511,18563551,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201130.0,20201201,20201201,EXP,,ES-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0714,BIODELIVERY SCIENCES INTERNATIONAL,,75.0,YR,E,M,Y,86.4,KG,20201201.0,,MD,ES,ES,2020,Q4,Elderly
185635511,18563551,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201130.0,20201201,20201201,EXP,,ES-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0714,BIODELIVERY SCIENCES INTERNATIONAL,,75.0,YR,E,M,Y,86.4,KG,20201201.0,,MD,ES,ES,2020,Q4,Elderly
185635511,18563551,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201130.0,20201201,20201201,EXP,,ES-BIODELIVERY SCIENCES INTERNATIONAL-2020BDSI0714,BIODELIVERY SCIENCES INTERNATIONAL,,75.0,YR,E,M,Y,86.4,KG,20201201.0,,MD,ES,ES,2020,Q4,Elderly
185645212,18564521,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, 1X/DAY",,,,,,,,4.0,IU,,QD,2020,Q4,Diabetic nephropathy,,2020,Q4,2,F,20150618.0,20201214.0,20201201,20201216,EXP,,JP-PFIZER INC-2020470048,PFIZER,,67.0,YR,,M,Y,48.7,KG,20201216.0,,MD,JP,JP,2020,Q4,Elderly
185645212,18564521,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, 1X/DAY",,,,,,,,4.0,IU,,QD,2020,Q4,End stage renal disease,,2020,Q4,2,F,20150618.0,20201214.0,20201201,20201216,EXP,,JP-PFIZER INC-2020470048,PFIZER,,67.0,YR,,M,Y,48.7,KG,20201216.0,,MD,JP,JP,2020,Q4,Elderly
185645212,18564521,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, 1X/DAY",,,,,,,,4.0,IU,,QD,2020,Q4,Gangrene,,2020,Q4,2,F,20150618.0,20201214.0,20201201,20201216,EXP,,JP-PFIZER INC-2020470048,PFIZER,,67.0,YR,,M,Y,48.7,KG,20201216.0,,MD,JP,JP,2020,Q4,Elderly
185645212,18564521,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, 1X/DAY",,,,,,,,4.0,IU,,QD,2020,Q4,Off label use,,2020,Q4,2,F,20150618.0,20201214.0,20201201,20201216,EXP,,JP-PFIZER INC-2020470048,PFIZER,,67.0,YR,,M,Y,48.7,KG,20201216.0,,MD,JP,JP,2020,Q4,Elderly
185645212,18564521,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, 1X/DAY",,,,,,,,4.0,IU,,QD,2020,Q4,Peripheral arterial occlusive disease,,2020,Q4,2,F,20150618.0,20201214.0,20201201,20201216,EXP,,JP-PFIZER INC-2020470048,PFIZER,,67.0,YR,,M,Y,48.7,KG,20201216.0,,MD,JP,JP,2020,Q4,Elderly
185645212,18564521,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"4 UNITS, 1X/DAY",,,,,,,,4.0,IU,,QD,2020,Q4,Sepsis,,2020,Q4,2,F,20150618.0,20201214.0,20201201,20201216,EXP,,JP-PFIZER INC-2020470048,PFIZER,,67.0,YR,,M,Y,48.7,KG,20201216.0,,MD,JP,JP,2020,Q4,Elderly
185668771,18566877,4,C,GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,,20201124.0,20201201,20201201,EXP,,GR-ASTRAZENECA-2020SF55437,ASTRAZENECA,,52.0,YR,,F,Y,,,20201201.0,,MD,GR,GR,2020,Q4,Adult
185668771,18566877,4,C,GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Pyrexia,,2020,Q4,1,I,,20201124.0,20201201,20201201,EXP,,GR-ASTRAZENECA-2020SF55437,ASTRAZENECA,,52.0,YR,,F,Y,,,20201201.0,,MD,GR,GR,2020,Q4,Adult
185672601,18567260,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,15 UNITS ONCE/DAY,,,,, UNKNOWN,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,20180212.0,20201117.0,20201202,20201202,EXP,US-MLMSERVICE-20201109-2572995-1,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-08394,ALKEM,,74.0,YR,,M,Y,75.0,KG,20201202.0,,HP,GB,US,2020,Q4,Elderly
185672601,18567260,11,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,15 UNITS ONCE/DAY,,,,, UNKNOWN,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,20180212.0,20201117.0,20201202,20201202,EXP,US-MLMSERVICE-20201109-2572995-1,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2020-08394,ALKEM,,74.0,YR,,M,Y,75.0,KG,20201202.0,,HP,GB,US,2020,Q4,Elderly
185702922,18570292,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 UNITS,,,D,,,,210605.0,,,INJECTION,,2020,Q4,Acute respiratory distress syndrome,,2020,Q4,2,F,,20201120.0,20201202,20201202,EXP,,US-MYLANLABS-2020M1098075,MYLAN,"SINGH S, FOSTER A, KHAN Z, SIDDIQUI A, ATERE M, NFONOYIM JM. COVID-19-INDUCED DIABETIC KETOACIDOSIS AND ACUTE RESPIRATORY DISTRESS SYNDROME IN AN OBESE 24-YEAR-OLD TYPE I DIABETIC. AM-J-CASE-REP 2020;NULL:NULL.",24.0,YR,,M,Y,,,20201202.0,,HP,US,US,2020,Q4,Young Adult
185702922,18570292,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 UNITS,,,D,,,,210605.0,,,INJECTION,,2020,Q4,Bradycardia,,2020,Q4,2,F,,20201120.0,20201202,20201202,EXP,,US-MYLANLABS-2020M1098075,MYLAN,"SINGH S, FOSTER A, KHAN Z, SIDDIQUI A, ATERE M, NFONOYIM JM. COVID-19-INDUCED DIABETIC KETOACIDOSIS AND ACUTE RESPIRATORY DISTRESS SYNDROME IN AN OBESE 24-YEAR-OLD TYPE I DIABETIC. AM-J-CASE-REP 2020;NULL:NULL.",24.0,YR,,M,Y,,,20201202.0,,HP,US,US,2020,Q4,Young Adult
185702922,18570292,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 UNITS,,,D,,,,210605.0,,,INJECTION,,2020,Q4,Hypotension,,2020,Q4,2,F,,20201120.0,20201202,20201202,EXP,,US-MYLANLABS-2020M1098075,MYLAN,"SINGH S, FOSTER A, KHAN Z, SIDDIQUI A, ATERE M, NFONOYIM JM. COVID-19-INDUCED DIABETIC KETOACIDOSIS AND ACUTE RESPIRATORY DISTRESS SYNDROME IN AN OBESE 24-YEAR-OLD TYPE I DIABETIC. AM-J-CASE-REP 2020;NULL:NULL.",24.0,YR,,M,Y,,,20201202.0,,HP,US,US,2020,Q4,Young Adult
185702922,18570292,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 UNITS,,,D,,,,210605.0,,,INJECTION,,2020,Q4,Off label use,,2020,Q4,2,F,,20201120.0,20201202,20201202,EXP,,US-MYLANLABS-2020M1098075,MYLAN,"SINGH S, FOSTER A, KHAN Z, SIDDIQUI A, ATERE M, NFONOYIM JM. COVID-19-INDUCED DIABETIC KETOACIDOSIS AND ACUTE RESPIRATORY DISTRESS SYNDROME IN AN OBESE 24-YEAR-OLD TYPE I DIABETIC. AM-J-CASE-REP 2020;NULL:NULL.",24.0,YR,,M,Y,,,20201202.0,,HP,US,US,2020,Q4,Young Adult
185702922,18570292,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 UNITS,,,D,,,,210605.0,,,INJECTION,,2020,Q4,Pulse absent,,2020,Q4,2,F,,20201120.0,20201202,20201202,EXP,,US-MYLANLABS-2020M1098075,MYLAN,"SINGH S, FOSTER A, KHAN Z, SIDDIQUI A, ATERE M, NFONOYIM JM. COVID-19-INDUCED DIABETIC KETOACIDOSIS AND ACUTE RESPIRATORY DISTRESS SYNDROME IN AN OBESE 24-YEAR-OLD TYPE I DIABETIC. AM-J-CASE-REP 2020;NULL:NULL.",24.0,YR,,M,Y,,,20201202.0,,HP,US,US,2020,Q4,Young Adult
185702922,18570292,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),6 UNITS,,,D,,,,210605.0,,,INJECTION,,2020,Q4,Respiratory failure,,2020,Q4,2,F,,20201120.0,20201202,20201202,EXP,,US-MYLANLABS-2020M1098075,MYLAN,"SINGH S, FOSTER A, KHAN Z, SIDDIQUI A, ATERE M, NFONOYIM JM. COVID-19-INDUCED DIABETIC KETOACIDOSIS AND ACUTE RESPIRATORY DISTRESS SYNDROME IN AN OBESE 24-YEAR-OLD TYPE I DIABETIC. AM-J-CASE-REP 2020;NULL:NULL.",24.0,YR,,M,Y,,,20201202.0,,HP,US,US,2020,Q4,Young Adult
185723042,18572304,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,20 IU,,,,,,,,20.0,IU,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,2,F,20201123.0,20201211.0,20201202,20201215,PER,,US-GILEAD-2020-0506625,GILEAD,,72.0,YR,E,F,Y,64.0,KG,20201215.0,,PH,US,US,2020,Q4,Elderly
185743841,18574384,9,C,Insulin glargine,INSULIN GLARGINE,1,,15 UNITS ONCE DAILY,,,,,,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,,20201202.0,20201203,20201203,EXP,,US-CELLTRION-2020-US-024238,CELLTRION,"PANDYA D, TRAN M, VERDUZCO-GUTIERREZ M..CLINICAL RELEVANCE OF PHARMACOGENETICS IN SEROTONIN SYNDROME..CASE REPORTS IN PSYCHIATRY.2020;8860434.",74.0,YR,,M,Y,75.0,KG,20201203.0,,HP,US,US,2020,Q4,Elderly
185748731,18574873,6,C,insulin glargine subcutaneous injection,,2,,,,,,,,,,,,,,2020,Q4,Hypoaesthesia oral,,2020,Q4,1,I,20201201.0,,20201203,20201203,DIR,,,FDA-CTU,,86.0,YR,,F,N,87.5,KG,20201203.0,Y,PH,US,US,2020,Q4,Elderly
185748731,18574873,6,C,insulin glargine subcutaneous injection,,2,,,,,,,,,,,,,,2020,Q4,Tongue oedema,,2020,Q4,1,I,20201201.0,,20201203,20201203,DIR,,,FDA-CTU,,86.0,YR,,F,N,87.5,KG,20201203.0,Y,PH,US,US,2020,Q4,Elderly
185775241,18577524,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Agitation,,2020,Q4,1,I,,20201126.0,20201204,20201204,EXP,,GR-EMD SERONO-9203035,EMD SERONO INC,,65.0,YR,E,F,Y,,,20201204.0,,HP,GR,GR,2020,Q4,Elderly
185775241,18577524,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Confusional state,,2020,Q4,1,I,,20201126.0,20201204,20201204,EXP,,GR-EMD SERONO-9203035,EMD SERONO INC,,65.0,YR,E,F,Y,,,20201204.0,,HP,GR,GR,2020,Q4,Elderly
185809851,18580985,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,20200909.0,20201127.0,20201204,20201204,EXP,,SE-BAUSCH-BL-2020-035311,BAUSCH AND LOMB,,61.0,YR,,M,Y,101.0,KG,20201204.0,,MD,SE,SE,2020,Q4,Adult
185809851,18580985,9,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,20200909.0,20201127.0,20201204,20201204,EXP,,SE-BAUSCH-BL-2020-035311,BAUSCH AND LOMB,,61.0,YR,,M,Y,101.0,KG,20201204.0,,MD,SE,SE,2020,Q4,Adult
185812072,18581207,128,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cellulitis,,2020,Q4,2,F,20161106.0,20201202.0,20201204,20201210,EXP,,US-ASTRAZENECA-2020SF58511,ASTRAZENECA,,15524.0,DY,,M,Y,108.9,KG,20201210.0,,,US,US,2020,Q4,Elderly
185812072,18581207,128,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fournier's gangrene,,2020,Q4,2,F,20161106.0,20201202.0,20201204,20201210,EXP,,US-ASTRAZENECA-2020SF58511,ASTRAZENECA,,15524.0,DY,,M,Y,108.9,KG,20201210.0,,,US,US,2020,Q4,Elderly
185812072,18581207,128,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Perineal abscess,,2020,Q4,2,F,20161106.0,20201202.0,20201204,20201210,EXP,,US-ASTRAZENECA-2020SF58511,ASTRAZENECA,,15524.0,DY,,M,Y,108.9,KG,20201210.0,,,US,US,2020,Q4,Elderly
185812072,18581207,128,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Perineal cellulitis,,2020,Q4,2,F,20161106.0,20201202.0,20201204,20201210,EXP,,US-ASTRAZENECA-2020SF58511,ASTRAZENECA,,15524.0,DY,,M,Y,108.9,KG,20201210.0,,,US,US,2020,Q4,Elderly
185812072,18581207,128,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Rectal abscess,,2020,Q4,2,F,20161106.0,20201202.0,20201204,20201210,EXP,,US-ASTRAZENECA-2020SF58511,ASTRAZENECA,,15524.0,DY,,M,Y,108.9,KG,20201210.0,,,US,US,2020,Q4,Elderly
185812072,18581207,128,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Scrotal abscess,,2020,Q4,2,F,20161106.0,20201202.0,20201204,20201210,EXP,,US-ASTRAZENECA-2020SF58511,ASTRAZENECA,,15524.0,DY,,M,Y,108.9,KG,20201210.0,,,US,US,2020,Q4,Elderly
185812072,18581207,128,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Sepsis,,2020,Q4,2,F,20161106.0,20201202.0,20201204,20201210,EXP,,US-ASTRAZENECA-2020SF58511,ASTRAZENECA,,15524.0,DY,,M,Y,108.9,KG,20201210.0,,,US,US,2020,Q4,Elderly
185812072,18581207,128,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Septic shock,,2020,Q4,2,F,20161106.0,20201202.0,20201204,20201210,EXP,,US-ASTRAZENECA-2020SF58511,ASTRAZENECA,,15524.0,DY,,M,Y,108.9,KG,20201210.0,,,US,US,2020,Q4,Elderly
185813281,18581328,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Cyanosis,,2020,Q4,1,I,20200823.0,20201126.0,20201204,20201204,EXP,,ES-MYLANLABS-2020M1098562,MYLAN,,75.0,YR,,M,Y,86.4,KG,20201204.0,,MD,ES,ES,2020,Q4,Elderly
185813281,18581328,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hypokalaemia,,2020,Q4,1,I,20200823.0,20201126.0,20201204,20201204,EXP,,ES-MYLANLABS-2020M1098562,MYLAN,,75.0,YR,,M,Y,86.4,KG,20201204.0,,MD,ES,ES,2020,Q4,Elderly
185813281,18581328,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hyponatraemia,,2020,Q4,1,I,20200823.0,20201126.0,20201204,20201204,EXP,,ES-MYLANLABS-2020M1098562,MYLAN,,75.0,YR,,M,Y,86.4,KG,20201204.0,,MD,ES,ES,2020,Q4,Elderly
185813281,18581328,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Hypoxia,,2020,Q4,1,I,20200823.0,20201126.0,20201204,20201204,EXP,,ES-MYLANLABS-2020M1098562,MYLAN,,75.0,YR,,M,Y,86.4,KG,20201204.0,,MD,ES,ES,2020,Q4,Elderly
185813281,18581328,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,D,,,,,,,,,2020,Q4,Klebsiella infection,,2020,Q4,1,I,20200823.0,20201126.0,20201204,20201204,EXP,,ES-MYLANLABS-2020M1098562,MYLAN,,75.0,YR,,M,Y,86.4,KG,20201204.0,,MD,ES,ES,2020,Q4,Elderly
185817041,18581704,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F662A,,,42.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Abdominal distension,,2020,Q4,1,I,,20201123.0,20201204,20201204,EXP,,ES-BAUSCH-BL-2020-034624,BAUSCH AND LOMB,,35.0,YR,,F,Y,,,20201204.0,,CN,ES,ES,2020,Q4,Adult
185817041,18581704,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,, 0F662A,,,42.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201123.0,20201204,20201204,EXP,,ES-BAUSCH-BL-2020-034624,BAUSCH AND LOMB,,35.0,YR,,F,Y,,,20201204.0,,CN,ES,ES,2020,Q4,Adult
185823971,18582397,20,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Drug interaction,,2020,Q4,1,I,2011.0,20201127.0,20201205,20201205,EXP,,ES-AUROBINDO-AUR-APL-2020-059465,AUROBINDO,,72.0,YR,,F,Y,,,20201205.0,,MD,ES,ES,2020,Q4,Elderly
185823971,18582397,20,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,U,,,,,,,,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,2011.0,20201127.0,20201205,20201205,EXP,,ES-AUROBINDO-AUR-APL-2020-059465,AUROBINDO,,72.0,YR,,F,Y,,,20201205.0,,MD,ES,ES,2020,Q4,Elderly
185833012,18583301,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,3 MILLILITER,,,,,,,,3.0,ML,,,2020,Q4,Bradycardia,,2020,Q4,2,F,20201130.0,20201203.0,20201206,20201208,PER,,US-AMGEN INC.-USACT2020195995,AMGEN,,67.0,YR,E,M,Y,125.91,KG,20201208.0,,MD,US,US,2020,Q4,Elderly
185848581,18584858,10,C,glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20201203.0,,20201205,20201205,DIR,,,FDA-CTU,,75.0,YR,,F,N,103.5,KG,20201205.0,N,PH,US,US,2020,Q4,Elderly
185848581,18584858,10,C,glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Respiratory disorder,,2020,Q4,1,I,20201203.0,,20201205,20201205,DIR,,,FDA-CTU,,75.0,YR,,F,N,103.5,KG,20201205.0,N,PH,US,US,2020,Q4,Elderly
185858851,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Malaise,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Pancreatic disorder,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"24 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,24.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Postprandial hypoglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose fluctuation,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Malaise,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Pancreatic disorder,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185858851,18585885,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"25 INTERNATIONAL UNIT, UNKNOWN",,,,, OF662A,,,25.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Postprandial hypoglycaemia,,2020,Q4,1,I,,20201123.0,20201207,20201207,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20201207.0,,CN,ES,ES,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Acute respiratory failure,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Atelectasis,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Chills,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Haemoptysis,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Headache,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pain,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pulmonary fibrosis,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Pulmonary oedema,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185868001,18586800,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Respiratory failure,,2020,Q4,1,I,20201202.0,,20201207,20201207,DIR,,,FDA-CTU,,73.0,YR,,M,N,95.1,KG,20201207.0,N,HP,US,US,2020,Q4,Elderly
185917492,18591749,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,Rash pruritic,,2020,Q4,2,F,20201204.0,20201229.0,20201208,20201231,PER,,US-GILEAD-2020-0507880,GILEAD,,56.0,YR,A,M,Y,59.2,KG,20201231.0,,PH,US,US,2020,Q4,Adult
185917541,18591754,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,General physical health deterioration,,2020,Q4,1,I,20201112.0,20201127.0,20201208,20201208,EXP,,CH-ASTRAZENECA-2020SF62766,ASTRAZENECA,,74.0,YR,,M,Y,,,20201208.0,,MD,CH,CH,2020,Q4,Elderly
185917541,18591754,11,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Thrombocytopenia,,2020,Q4,1,I,20201112.0,20201127.0,20201208,20201208,EXP,,CH-ASTRAZENECA-2020SF62766,ASTRAZENECA,,74.0,YR,,M,Y,,,20201208.0,,MD,CH,CH,2020,Q4,Elderly
185951001,18595100,8,C,"Insulin (glargine, lispro and regular)",,2,,,,,,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,20201207.0,,20201209,20201209,DIR,,,FDA-CTU,,80.0,YR,,F,N,83.9,KG,20201209.0,Y,PH,US,US,2020,Q4,Elderly
185953592,18595359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Aggression,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Agitation,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Communication disorder,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Disorientation,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185953592,18595359,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2020,Q4,Mental disorder,,2020,Q4,2,F,,20201202.0,20201209,20201215,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,UNKNOWN.SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA..UNKNOWN 2020;:31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
185959644,18595964,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Bacteraemia,,2020,Q4,4,F,20200406.0,20201217.0,20201209,20201221,EXP,,ES-CELGENEUS-ESP-20201104636,CELGENE,,69.0,YR,,M,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
185959644,18595964,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Escherichia bacteraemia,,2020,Q4,4,F,20200406.0,20201217.0,20201209,20201221,EXP,,ES-CELGENEUS-ESP-20201104636,CELGENE,,69.0,YR,,M,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
185959644,18595964,6,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,UNKNOWN,,2020,Q4,Klebsiella infection,,2020,Q4,4,F,20200406.0,20201217.0,20201209,20201221,EXP,,ES-CELGENEUS-ESP-20201104636,CELGENE,,69.0,YR,,M,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186001081,18600108,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,INCONNUE,,,,,,,,,,,,2020,Q4,Eosinophilia,,2020,Q4,1,I,20200808.0,20201130.0,20201210,20201210,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102061,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,72.0,KG,20201210.0,,MD,FR,FR,2020,Q4,Elderly
186001081,18600108,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,INCONNUE,,,,,,,,,,,,2020,Q4,Hepatocellular injury,,2020,Q4,1,I,20200808.0,20201130.0,20201210,20201210,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102061,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,72.0,KG,20201210.0,,MD,FR,FR,2020,Q4,Elderly
186001081,18600108,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,INCONNUE,,,,,,,,,,,,2020,Q4,Hypercreatininaemia,,2020,Q4,1,I,20200808.0,20201130.0,20201210,20201210,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102061,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,72.0,KG,20201210.0,,MD,FR,FR,2020,Q4,Elderly
186001081,18600108,9,C,INSULINE GLARGINE,INSULIN GLARGINE,1,Unknown,INCONNUE,,,,,,,,,,,,2020,Q4,Rash maculo-papular,,2020,Q4,1,I,20200808.0,20201130.0,20201210,20201210,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-102061,BRISTOL MYERS SQUIBB,,79.0,YR,,F,Y,72.0,KG,20201210.0,,MD,FR,FR,2020,Q4,Elderly
186001251,18600125,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 INTERNATIONAL UNIT, QD",,,Y,U,,,210605.0,5.0,IU,INJECTION,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,20201103.0,20201201.0,20201210,20201210,EXP,IT-MINISAL02-642681,IT-MYLANLABS-2020M1099736,MYLAN,,90.0,YR,,F,Y,,,20201210.0,,MD,IT,IT,2020,Q4,Elderly
186001251,18600125,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 INTERNATIONAL UNIT, QD",,,Y,U,,,210605.0,5.0,IU,INJECTION,QD,2020,Q4,Sopor,,2020,Q4,1,I,20201103.0,20201201.0,20201210,20201210,EXP,IT-MINISAL02-642681,IT-MYLANLABS-2020M1099736,MYLAN,,90.0,YR,,F,Y,,,20201210.0,,MD,IT,IT,2020,Q4,Elderly
186008971,18600897,35,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,,,,,,,,,2020,Q4,COVID-19,,2020,Q4,1,I,20201025.0,20201202.0,20201210,20201210,EXP,,FR-MYLANLABS-2020M1100253,MYLAN,,79.0,YR,,M,Y,,,20201210.0,,MD,FR,FR,2020,Q4,Elderly
186009031,18600903,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,42 INTERNATIONAL UNIT (42 IU),,,,, 0F662A,,,42.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Abdominal distension,,2020,Q4,1,I,,20201202.0,20201210,20201210,EXP,,ES-MYLANLABS-2020M1100138,MYLAN,,35.0,YR,,F,Y,,,20201210.0,,CN,ES,ES,2020,Q4,Adult
186009031,18600903,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,42 INTERNATIONAL UNIT (42 IU),,,,, 0F662A,,,42.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201202.0,20201210,20201210,EXP,,ES-MYLANLABS-2020M1100138,MYLAN,,35.0,YR,,F,Y,,,20201210.0,,CN,ES,ES,2020,Q4,Adult
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Chills,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Dehydration,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Infusion related reaction,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Rhabdomyolysis,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Syncope,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Urinary incontinence,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186010051,18601005,6,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,20201124.0,,20201210,20201210,DIR,,,FDA-CTU,,69.0,YR,,M,N,101.5,KG,20201210.0,N,PH,US,US,2020,Q4,Elderly
186018461,18601846,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD (30 UNITS, ONCE DAILY)",,,,,,,,,,,QD,2020,Q4,Metastases to bone,,2020,Q4,1,I,2020.0,20201009.0,20201210,20201210,EXP,,NVSC2020CO277817,NOVARTIS,,70.0,YR,,F,Y,54.0,KG,20201210.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
186018461,18601846,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD (30 UNITS, ONCE DAILY)",,,,,,,,,,,QD,2020,Q4,SARS-CoV-2 test positive,,2020,Q4,1,I,2020.0,20201009.0,20201210,20201210,EXP,,NVSC2020CO277817,NOVARTIS,,70.0,YR,,F,Y,54.0,KG,20201210.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
186018461,18601846,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, QD (30 UNITS, ONCE DAILY)",,,,,,,,,,,QD,2020,Q4,Treatment failure,,2020,Q4,1,I,2020.0,20201009.0,20201210,20201210,EXP,,NVSC2020CO277817,NOVARTIS,,70.0,YR,,F,Y,54.0,KG,20201210.0,,CN,COUNTRY NOT SPECIFIED,CO,2020,Q4,Elderly
186045371,18604537,27,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cardio-respiratory arrest,,2020,Q4,1,I,,,20201210,20201210,DIR,,,FDA-CTU,,76.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Elderly
186045371,18604537,27,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,1,I,,,20201210,20201210,DIR,,,FDA-CTU,,76.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Elderly
186045371,18604537,27,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Seizure,,2020,Q4,1,I,,,20201210,20201210,DIR,,,FDA-CTU,,76.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Elderly
186118461,18611846,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,15 UNK,,,,,,,,,,,,2020,Q4,Cardiac failure congestive,,2020,Q4,1,I,20201027.0,20201208.0,20201214,20201214,PER,,US-AMGEN-USACT2020200392,AMGEN,,60.0,YR,A,M,Y,111.36,KG,20201214.0,,MD,US,US,2020,Q4,Adult
186158441,18615844,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,2018.0,20201207.0,20201214,20201214,EXP,,NVSC2020ES325804,NOVARTIS,,77.0,YR,,M,Y,,,20201215.0,,HP,ES,ES,2020,Q4,Elderly
186158441,18615844,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,2018.0,20201207.0,20201214,20201214,EXP,,NVSC2020ES325804,NOVARTIS,,77.0,YR,,M,Y,,,20201215.0,,HP,ES,ES,2020,Q4,Elderly
186158441,18615844,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Parkinson's disease,,2020,Q4,1,I,2018.0,20201207.0,20201214,20201214,EXP,,NVSC2020ES325804,NOVARTIS,,77.0,YR,,M,Y,,,20201215.0,,HP,ES,ES,2020,Q4,Elderly
186158441,18615844,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,46 IU,,,,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product storage error,,2020,Q4,1,I,2018.0,20201207.0,20201214,20201214,EXP,,NVSC2020ES325804,NOVARTIS,,77.0,YR,,M,Y,,,20201215.0,,HP,ES,ES,2020,Q4,Elderly
186158441,18615844,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,48 IU,,,,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,2018.0,20201207.0,20201214,20201214,EXP,,NVSC2020ES325804,NOVARTIS,,77.0,YR,,M,Y,,,20201215.0,,HP,ES,ES,2020,Q4,Elderly
186158441,18615844,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,48 IU,,,,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,2018.0,20201207.0,20201214,20201214,EXP,,NVSC2020ES325804,NOVARTIS,,77.0,YR,,M,Y,,,20201215.0,,HP,ES,ES,2020,Q4,Elderly
186158441,18615844,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,48 IU,,,,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Parkinson's disease,,2020,Q4,1,I,2018.0,20201207.0,20201214,20201214,EXP,,NVSC2020ES325804,NOVARTIS,,77.0,YR,,M,Y,,,20201215.0,,HP,ES,ES,2020,Q4,Elderly
186158441,18615844,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,48 IU,,,,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product storage error,,2020,Q4,1,I,2018.0,20201207.0,20201214,20201214,EXP,,NVSC2020ES325804,NOVARTIS,,77.0,YR,,M,Y,,,20201215.0,,HP,ES,ES,2020,Q4,Elderly
186166481,18616648,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,48 INTERNATIONAL UNIT,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186166481,18616648,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,48 INTERNATIONAL UNIT,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186166481,18616648,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,48 INTERNATIONAL UNIT,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diet noncompliance,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186166481,18616648,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,48 INTERNATIONAL UNIT,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Parkinson's disease,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186166481,18616648,2,SS,Insulin glargine,INSULIN GLARGINE,1,Unknown,48 INTERNATIONAL UNIT,,,D,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product storage error,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186166481,18616648,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 INTERNATIONAL UNIT,,,D,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186166481,18616648,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 INTERNATIONAL UNIT,,,D,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186166481,18616648,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 INTERNATIONAL UNIT,,,D,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diet noncompliance,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186166481,18616648,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 INTERNATIONAL UNIT,,,D,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Parkinson's disease,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186166481,18616648,3,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,46 INTERNATIONAL UNIT,,,D,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product storage error,,2020,Q4,1,I,2018.0,20201204.0,20201215,20201215,EXP,,ES-AUROBINDO-AUR-APL-2020-060595,AUROBINDO,,77.0,YR,,M,Y,,,20201215.0,,CN,ES,ES,2020,Q4,Elderly
186177881,18617788,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Agitation,,2020,Q4,1,I,,20201201.0,20201215,20201215,EXP,,GR-BAUSCH-BL-2020-035509,BAUSCH AND LOMB,UNKNOWN. UNKNOWN. UNKNOWN. 2020;31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
186177881,18617788,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Confusional state,,2020,Q4,1,I,,20201201.0,20201215,20201215,EXP,,GR-BAUSCH-BL-2020-035509,BAUSCH AND LOMB,UNKNOWN. UNKNOWN. UNKNOWN. 2020;31.,65.0,YR,,F,Y,,,20201215.0,,HP,GR,GR,2020,Q4,Elderly
186179961,18617996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, QD",,,U,U,,,,10.0,IU,,QD,2020,Q4,Asthenia,,2020,Q4,1,I,202011.0,20201204.0,20201215,20201215,EXP,,CN-NOVOPROD-772865,NOVO NORDISK,,79.0,YR,,F,Y,,,20201215.0,,CN,CN,CN,2020,Q4,Elderly
186179961,18617996,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"10 IU, QD",,,U,U,,,,10.0,IU,,QD,2020,Q4,Blood glucose increased,,2020,Q4,1,I,202011.0,20201204.0,20201215,20201215,EXP,,CN-NOVOPROD-772865,NOVO NORDISK,,79.0,YR,,F,Y,,,20201215.0,,CN,CN,CN,2020,Q4,Elderly
186193481,18619348,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"50 INTERNATIONAL UNIT, QD (INJECTION VIAL)",,,Y,, UNKNOWN,,,50.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201027.0,20201215,20201215,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08403,LUPIN,,50.0,YR,,F,Y,,,20201215.0,,MD,US,US,2020,Q4,Adult
186193481,18619348,7,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,Y,, UNKNOWN,,,40.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201027.0,20201215,20201215,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08403,LUPIN,,50.0,YR,,F,Y,,,20201215.0,,MD,US,US,2020,Q4,Adult
186193481,18619348,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,"14 INTERNATIONAL UNIT, QD",,,Y,, UNKNOWN,,,14.0,IU,,QD,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201027.0,20201215,20201215,PER,,US-LUPIN PHARMACEUTICALS INC.-2020-08403,LUPIN,,50.0,YR,,F,Y,,,20201215.0,,MD,US,US,2020,Q4,Adult
186195011,18619501,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20170612.0,20201207.0,20201215,20201215,EXP,,US-ASTRAZENECA-2020SF64312,ASTRAZENECA,,15905.0,DY,,F,Y,86.2,KG,20201215.0,,,US,US,2020,Q4,Elderly
186195011,18619501,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Chronic kidney disease,,2020,Q4,1,I,20170612.0,20201207.0,20201215,20201215,EXP,,US-ASTRAZENECA-2020SF64312,ASTRAZENECA,,15905.0,DY,,F,Y,86.2,KG,20201215.0,,,US,US,2020,Q4,Elderly
186195011,18619501,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,End stage renal disease,,2020,Q4,1,I,20170612.0,20201207.0,20201215,20201215,EXP,,US-ASTRAZENECA-2020SF64312,ASTRAZENECA,,15905.0,DY,,F,Y,86.2,KG,20201215.0,,,US,US,2020,Q4,Elderly
186195011,18619501,24,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Nephrogenic anaemia,,2020,Q4,1,I,20170612.0,20201207.0,20201215,20201215,EXP,,US-ASTRAZENECA-2020SF64312,ASTRAZENECA,,15905.0,DY,,F,Y,86.2,KG,20201215.0,,,US,US,2020,Q4,Elderly
186197072,18619707,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,"1 DF, DAILY (ONE INJECTION AFTER DINNER EVERY DAY)",,,,,,,,1.0,DF,INJECTION,,2020,Q4,No adverse event,,2020,Q4,2,F,,20201216.0,20201215,20201222,EXP,,AR-PFIZER INC-2020491681,PFIZER,,78.0,YR,,F,Y,,,20201222.0,,CN,AR,AR,2020,Q4,Elderly
186232162,18623216,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 IU, 1X/DAY(AT NIGHT)",,,,,,,,18.0,IU,,QD,2020,Q4,BRASH syndrome,,2020,Q4,2,F,,20201216.0,20201216,20201223,EXP,,US-PFIZER INC-2020493659,PFIZER,"ARIF, A.. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST DEBAKEY CARDIOVASCULAR JOURNAL. 2020;16(3):241-244",55.0,YR,,F,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186246102,18624610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,INJECTION,,2020,Q4,Aggression,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,INJECTION,,2020,Q4,Agitation,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,INJECTION,,2020,Q4,Communication disorder,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,INJECTION,,2020,Q4,Confusional state,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,INJECTION,,2020,Q4,Disorientation,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,INJECTION,,2020,Q4,Hyperhidrosis,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186246102,18624610,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,INJECTION,,2020,Q4,Mental disorder,,2020,Q4,2,F,,20201209.0,20201216,20201222,EXP,,GR-MYLANLABS-2020M1103138,MYLAN,SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201222.0,,HP,GR,GR,2020,Q4,Elderly
186265951,18626595,12,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,15 UNIT ONCE/DAY,,,,, UNKNOWN,,,,,UNKNOWN,,2020,Q4,Serotonin syndrome,,2020,Q4,1,I,,20201203.0,20201217,20201217,EXP,,US-SCIEGEN-2020SCILIT00488,SCIEGEN,,75.0,YR,E,M,Y,75.0,KG,20201217.0,,HP,US,US,2020,Q4,Elderly
186273211,18627321,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNK,,2020,Q4,Asphyxia,,2020,Q4,1,I,,20201202.0,20201217,20201217,EXP,,FR-GRANULES-FR-2020GRALIT00093,GRANULES INDIA,,57.0,YR,A,M,Y,,,20201217.0,,HP,FR,FR,2020,Q4,Adult
186273211,18627321,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNK,,2020,Q4,Cyanosis,,2020,Q4,1,I,,20201202.0,20201217,20201217,EXP,,FR-GRANULES-FR-2020GRALIT00093,GRANULES INDIA,,57.0,YR,A,M,Y,,,20201217.0,,HP,FR,FR,2020,Q4,Adult
186273211,18627321,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNK,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201202.0,20201217,20201217,EXP,,FR-GRANULES-FR-2020GRALIT00093,GRANULES INDIA,,57.0,YR,A,M,Y,,,20201217.0,,HP,FR,FR,2020,Q4,Adult
186273211,18627321,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNK,,2020,Q4,Overdose,,2020,Q4,1,I,,20201202.0,20201217,20201217,EXP,,FR-GRANULES-FR-2020GRALIT00093,GRANULES INDIA,,57.0,YR,A,M,Y,,,20201217.0,,HP,FR,FR,2020,Q4,Adult
186273211,18627321,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,, UNKNOWN,,,,,UNK,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20201202.0,20201217,20201217,EXP,,FR-GRANULES-FR-2020GRALIT00093,GRANULES INDIA,,57.0,YR,A,M,Y,,,20201217.0,,HP,FR,FR,2020,Q4,Adult
186296481,18629648,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 INTERNATIONAL UNIT,,,D,,,,210605.0,20.0,IU,,,2020,Q4,Drug abuse,,2020,Q4,1,I,19960314.0,20191206.0,20201217,20201217,EXP,,AT-MYLANLABS-2019M1122306,MYLAN,,31.0,YR,,M,Y,,,20201217.0,,PH,AT,AT,2020,Q4,Young Adult
186296481,18629648,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 INTERNATIONAL UNIT,,,D,,,,210605.0,20.0,IU,,,2020,Q4,Hepatic neoplasm,,2020,Q4,1,I,19960314.0,20191206.0,20201217,20201217,EXP,,AT-MYLANLABS-2019M1122306,MYLAN,,31.0,YR,,M,Y,,,20201217.0,,PH,AT,AT,2020,Q4,Young Adult
186296481,18629648,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 INTERNATIONAL UNIT,,,D,,,,210605.0,20.0,IU,,,2020,Q4,Intentional product misuse,,2020,Q4,1,I,19960314.0,20191206.0,20201217,20201217,EXP,,AT-MYLANLABS-2019M1122306,MYLAN,,31.0,YR,,M,Y,,,20201217.0,,PH,AT,AT,2020,Q4,Young Adult
186296481,18629648,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 INTERNATIONAL UNIT,,,D,,,,210605.0,20.0,IU,,,2020,Q4,Intra-abdominal haemorrhage,,2020,Q4,1,I,19960314.0,20191206.0,20201217,20201217,EXP,,AT-MYLANLABS-2019M1122306,MYLAN,,31.0,YR,,M,Y,,,20201217.0,,PH,AT,AT,2020,Q4,Young Adult
186296481,18629648,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 INTERNATIONAL UNIT,,,D,,,,210605.0,20.0,IU,,,2020,Q4,Multiple organ dysfunction syndrome,,2020,Q4,1,I,19960314.0,20191206.0,20201217,20201217,EXP,,AT-MYLANLABS-2019M1122306,MYLAN,,31.0,YR,,M,Y,,,20201217.0,,PH,AT,AT,2020,Q4,Young Adult
186296481,18629648,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,20 INTERNATIONAL UNIT,,,D,,,,210605.0,20.0,IU,,,2020,Q4,Poisoning,,2020,Q4,1,I,19960314.0,20191206.0,20201217,20201217,EXP,,AT-MYLANLABS-2019M1122306,MYLAN,,31.0,YR,,M,Y,,,20201217.0,,PH,AT,AT,2020,Q4,Young Adult
186297521,18629752,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186297521,18629752,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186297521,18629752,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186297521,18629752,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201210.0,20201217,20201217,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202012005931,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20201217.0,,MD,DE,DE,2020,Q4,Adult
186308661,18630866,8,C,Insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Atrial fibrillation,,2020,Q4,1,I,20201207.0,20201209.0,20201217,20201217,EXP,,US-ELI_LILLY_AND_COMPANY-US202012005262,ELI LILLY AND CO,,80.0,YR,,F,Y,83.9,KG,20201217.0,,PH,US,US,2020,Q4,Elderly
186315011,18631501,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,,,,,18.0,IU,,,2020,Q4,BRASH syndrome,,2020,Q4,1,I,,20201209.0,20201217,20201217,EXP,,US-BAUSCH-BL-2020-036965,BAUSCH AND LOMB,"ARIF A, KHAN M, MASRI A, MBA B, AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST DEBAKEY CARDIOVASC. 2020;16(3):241-244. DOI:10.14797/MDCJ-16-3-241",55.0,YR,,F,Y,,,20201217.0,,MD,US,US,2020,Q4,Adult
186315991,18631599,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186315991,18631599,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186315991,18631599,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186315991,18631599,8,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK (ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION)",,,,,,,,,,INJECTION,,2020,Q4,Fall,,2020,Q4,1,I,,20201210.0,20201218,20201218,EXP,,DE-AUROBINDO-AUR-APL-2020-061412,AUROBINDO,,55.0,YR,,M,Y,,,20201218.0,,MD,DE,DE,2020,Q4,Adult
186325621,18632562,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (5 IE, 0-0-1-0, INJEKTIONS-/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201211.0,20201218,20201218,EXP,,NVSC2020DE330872,NOVARTIS,,68.0,YR,,F,Y,,,20201218.0,,HP,DE,DE,2020,Q4,Elderly
186325621,18632562,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (5 IE, 0-0-1-0, INJEKTIONS-/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,,20201211.0,20201218,20201218,EXP,,NVSC2020DE330872,NOVARTIS,,68.0,YR,,F,Y,,,20201218.0,,HP,DE,DE,2020,Q4,Elderly
186325621,18632562,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (5 IE, 0-0-1-0, INJEKTIONS-/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,1,I,,20201211.0,20201218,20201218,EXP,,NVSC2020DE330872,NOVARTIS,,68.0,YR,,F,Y,,,20201218.0,,HP,DE,DE,2020,Q4,Elderly
186325621,18632562,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK (5 IE, 0-0-1-0, INJEKTIONS-/INFUSIONSL?SUNG)",,,U,,,,,,,,,2020,Q4,Urinary hesitation,,2020,Q4,1,I,,20201211.0,20201218,20201218,EXP,,NVSC2020DE330872,NOVARTIS,,68.0,YR,,F,Y,,,20201218.0,,HP,DE,DE,2020,Q4,Elderly
186360371,18636037,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNK,,,,,UNKNOWN,,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,20201107.0,20201214.0,20201218,20201218,EXP,FR-AFSSAPS-LM20200718,FR-FRESENIUS KABI-FK202013345,FRESENIUS KABI,,77.0,YR,,F,Y,99.6,KG,20201218.0,,HP,NL,FR,2020,Q4,Elderly
186360371,18636037,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNK,,,,,UNKNOWN,,2020,Q4,Incorrect dose administered,,2020,Q4,1,I,20201107.0,20201214.0,20201218,20201218,EXP,FR-AFSSAPS-LM20200718,FR-FRESENIUS KABI-FK202013345,FRESENIUS KABI,,77.0,YR,,F,Y,99.6,KG,20201218.0,,HP,NL,FR,2020,Q4,Elderly
186360371,18636037,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,, UNK,,,,,UNKNOWN,,2020,Q4,Wrong product administered,,2020,Q4,1,I,20201107.0,20201214.0,20201218,20201218,EXP,FR-AFSSAPS-LM20200718,FR-FRESENIUS KABI-FK202013345,FRESENIUS KABI,,77.0,YR,,F,Y,99.6,KG,20201218.0,,HP,NL,FR,2020,Q4,Elderly
186369311,18636931,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Chronic gastritis,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,ES-AUROBINDO-AUR-APL-2020-061469,AUROBINDO,,69.0,YR,,F,Y,,,20201219.0,,MD,ES,ES,2020,Q4,Elderly
186369311,18636931,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,ES-AUROBINDO-AUR-APL-2020-061469,AUROBINDO,,69.0,YR,,F,Y,,,20201219.0,,MD,ES,ES,2020,Q4,Elderly
186369311,18636931,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Drug intolerance,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,ES-AUROBINDO-AUR-APL-2020-061469,AUROBINDO,,69.0,YR,,F,Y,,,20201219.0,,MD,ES,ES,2020,Q4,Elderly
186369311,18636931,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Dyslipidaemia,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,ES-AUROBINDO-AUR-APL-2020-061469,AUROBINDO,,69.0,YR,,F,Y,,,20201219.0,,MD,ES,ES,2020,Q4,Elderly
186369311,18636931,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hepatic steatosis,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,ES-AUROBINDO-AUR-APL-2020-061469,AUROBINDO,,69.0,YR,,F,Y,,,20201219.0,,MD,ES,ES,2020,Q4,Elderly
186369311,18636931,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypertension,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,ES-AUROBINDO-AUR-APL-2020-061469,AUROBINDO,,69.0,YR,,F,Y,,,20201219.0,,MD,ES,ES,2020,Q4,Elderly
186369311,18636931,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,U,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Overweight,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,ES-AUROBINDO-AUR-APL-2020-061469,AUROBINDO,,69.0,YR,,F,Y,,,20201219.0,,MD,ES,ES,2020,Q4,Elderly
186371991,18637199,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, PAUSIERT(PAUSED)",,,U,,,,,,,AMPOULES,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186371991,18637199,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, PAUSIERT(PAUSED)",,,U,,,,,,,AMPOULES,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186371991,18637199,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, PAUSIERT(PAUSED)",,,U,,,,,,,AMPOULES,,2020,Q4,Nausea,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186371991,18637199,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, PAUSIERT(PAUSED)",,,U,,,,,,,AMPOULES,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186371991,18637199,9,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"UNK, PAUSIERT(PAUSED)",,,U,,,,,,,AMPOULES,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201210.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061396,AUROBINDO,,64.0,YR,,F,Y,88.0,KG,20201219.0,,MD,DE,DE,2020,Q4,Adult
186380111,18638011,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 INTERNATIONAL UNIT, ONCE A DAY (0-0-1-0)",,,U,,,,,5.0,IU,SOLUTION FOR INFUSION,QD,2020,Q4,Anuria,,2020,Q4,1,I,,20201209.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061134,AUROBINDO,,68.0,YR,,F,Y,,,20201219.0,,MD,DE,DE,2020,Q4,Elderly
186380111,18638011,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 INTERNATIONAL UNIT, ONCE A DAY (0-0-1-0)",,,U,,,,,5.0,IU,SOLUTION FOR INFUSION,QD,2020,Q4,Cough,,2020,Q4,1,I,,20201209.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061134,AUROBINDO,,68.0,YR,,F,Y,,,20201219.0,,MD,DE,DE,2020,Q4,Elderly
186380111,18638011,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 INTERNATIONAL UNIT, ONCE A DAY (0-0-1-0)",,,U,,,,,5.0,IU,SOLUTION FOR INFUSION,QD,2020,Q4,Oedema peripheral,,2020,Q4,1,I,,20201209.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061134,AUROBINDO,,68.0,YR,,F,Y,,,20201219.0,,MD,DE,DE,2020,Q4,Elderly
186380111,18638011,11,C,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"5 INTERNATIONAL UNIT, ONCE A DAY (0-0-1-0)",,,U,,,,,5.0,IU,SOLUTION FOR INFUSION,QD,2020,Q4,Urinary hesitation,,2020,Q4,1,I,,20201209.0,20201219,20201219,EXP,,DE-AUROBINDO-AUR-APL-2020-061134,AUROBINDO,,68.0,YR,,F,Y,,,20201219.0,,MD,DE,DE,2020,Q4,Elderly
186386471,18638647,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,U,, UNKNOWN,,,18.0,IU,,,2020,Q4,BRASH syndrome,,2020,Q4,1,I,,20201211.0,20201219,20201219,EXP,,US-DRREDDYS-USA/USA/20/0130084,DR REDDYS,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST DEBAKEY CARDIOVASCULAR JOURNAL. 2020;16(3):241-4. DOI:10.14797/MDCJ-16-3-241.",55.0,YR,A,F,Y,,,20201219.0,,MD,US,US,2020,Q4,Adult
186386901,18638690,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Glucose-6-phosphate dehydrogenase deficiency,,2020,Q4,1,I,,20201209.0,20201219,20201219,EXP,,QA-ACCORD-211417,ACCORD,"OBEIDAT K, YASSIN MA CAN HYDROXYCHLOROQUINE CAUSE G6PD-RELATED HEMOLYSIS? A CASE STUDY. DUBAI MEDICAL JOURNAL. 2020. DOI: 10.1159/000511688.",64.0,YR,,M,Y,,,20201219.0,,HP,QA,QA,2020,Q4,Adult
186386901,18638690,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Haemolysis,,2020,Q4,1,I,,20201209.0,20201219,20201219,EXP,,QA-ACCORD-211417,ACCORD,"OBEIDAT K, YASSIN MA CAN HYDROXYCHLOROQUINE CAUSE G6PD-RELATED HEMOLYSIS? A CASE STUDY. DUBAI MEDICAL JOURNAL. 2020. DOI: 10.1159/000511688.",64.0,YR,,M,Y,,,20201219.0,,HP,QA,QA,2020,Q4,Adult
186386901,18638690,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Normochromic normocytic anaemia,,2020,Q4,1,I,,20201209.0,20201219,20201219,EXP,,QA-ACCORD-211417,ACCORD,"OBEIDAT K, YASSIN MA CAN HYDROXYCHLOROQUINE CAUSE G6PD-RELATED HEMOLYSIS? A CASE STUDY. DUBAI MEDICAL JOURNAL. 2020. DOI: 10.1159/000511688.",64.0,YR,,M,Y,,,20201219.0,,HP,QA,QA,2020,Q4,Adult
186391891,18639189,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Aggression,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Agitation,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Communication disorder,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Confusional state,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Disorientation,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hyperhidrosis,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186391891,18639189,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Mental disorder,,2020,Q4,1,I,,20201209.0,20201218,20201218,EXP,,GR-009507513-2012GRC004399,MERCK,UNKNOWN. SUDDEN MENTAL SYNDROME DUE TO HYPOGLYCAEMIA. UNKNOWN. 2020;31,65.0,YR,,F,Y,,,20201218.0,,HP,GR,GR,2020,Q4,Elderly
186407241,18640724,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Constipation,,2020,Q4,1,I,20201125.0,20201214.0,20201221,20201221,PER,,ES-AMGEN-ESPSP2020203619,AMGEN,,73.0,YR,E,M,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186407241,18640724,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,,,2020,Q4,Hyperglycaemia,,2020,Q4,1,I,20201125.0,20201214.0,20201221,20201221,PER,,ES-AMGEN-ESPSP2020203619,AMGEN,,73.0,YR,E,M,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186410831,18641083,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Asymptomatic COVID-19,,2020,Q4,1,I,2020.0,20201210.0,20201221,20201221,EXP,,CO-EMD SERONO-9206489,EMD SERONO INC,,70.0,YR,E,F,Y,45.0,KG,20201221.0,,CN,CO,CO,2020,Q4,Elderly
186410831,18641083,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Breast cancer metastatic,,2020,Q4,1,I,2020.0,20201210.0,20201221,20201221,EXP,,CO-EMD SERONO-9206489,EMD SERONO INC,,70.0,YR,E,F,Y,45.0,KG,20201221.0,,CN,CO,CO,2020,Q4,Elderly
186410831,18641083,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Metastases to bone,,2020,Q4,1,I,2020.0,20201210.0,20201221,20201221,EXP,,CO-EMD SERONO-9206489,EMD SERONO INC,,70.0,YR,E,F,Y,45.0,KG,20201221.0,,CN,CO,CO,2020,Q4,Elderly
186417711,18641771,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,AT NIGHT,,,,,,,,18.0,IU,,,2020,Q4,BRASH syndrome,,2020,Q4,1,I,,20201211.0,20201221,20201221,EXP,,US-ACCORD-211682,ACCORD,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST DEBAKEY CARDIOVASCULAR JOURNAL. 2020;16(3):241-4. DOI:10.14797/MDCJ-16-3-241.",55.0,YR,,F,Y,,,20201221.0,,MD,US,US,2020,Q4,Adult
186417961,18641796,5,C,insulin glargine 10units subq daily,,2,,,,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186417961,18641796,5,C,insulin glargine 10units subq daily,,2,,,,,,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186417961,18641796,5,C,insulin glargine 10units subq daily,,2,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186417961,18641796,5,C,insulin glargine 10units subq daily,,2,,,,,,,,,,,,,,2020,Q4,Heart rate increased,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186417961,18641796,5,C,insulin glargine 10units subq daily,,2,,,,,,,,,,,,,,2020,Q4,Pneumonia,,2020,Q4,1,I,20201129.0,,20201219,20201219,DIR,,,FDA-CTU,,37.0,YR,,F,N,94.2,KG,20201219.0,N,PH,US,US,2020,Q4,Adult
186423131,18642313,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186423131,18642313,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186423131,18642313,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186423131,18642313,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186423131,18642313,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201210.0,20201221,20201221,EXP,DE-BFARM-20013295,DE-ACCORD-211502,ACCORD,,64.0,YR,A,F,Y,88.0,KG,20201221.0,,MD,DE,DE,2020,Q4,Adult
186425621,18642562,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Chronic gastritis,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,,NVSC2020ES332811,NOVARTIS,,69.0,YR,,F,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186425621,18642562,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,,NVSC2020ES332811,NOVARTIS,,69.0,YR,,F,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186425621,18642562,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Drug intolerance,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,,NVSC2020ES332811,NOVARTIS,,69.0,YR,,F,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186425621,18642562,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Dyslipidaemia,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,,NVSC2020ES332811,NOVARTIS,,69.0,YR,,F,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186425621,18642562,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hepatic steatosis,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,,NVSC2020ES332811,NOVARTIS,,69.0,YR,,F,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186425621,18642562,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypertension,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,,NVSC2020ES332811,NOVARTIS,,69.0,YR,,F,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186425621,18642562,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Overweight,,2020,Q4,1,I,,20201214.0,20201221,20201221,EXP,,NVSC2020ES332811,NOVARTIS,,69.0,YR,,F,Y,,,20201221.0,,HP,ES,ES,2020,Q4,Elderly
186428521,18642852,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Alanine aminotransferase increased,,2020,Q4,1,I,,20200828.0,20201221,20201221,PER,,DE-LUPIN PHARMACEUTICALS INC.-2020-05737,LUPIN,,42.0,YR,,M,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
186428521,18642852,8,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Aspartate aminotransferase increased,,2020,Q4,1,I,,20200828.0,20201221,20201221,PER,,DE-LUPIN PHARMACEUTICALS INC.-2020-05737,LUPIN,,42.0,YR,,M,Y,,,20201221.0,,HP,DE,DE,2020,Q4,Adult
186429351,18642935,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,14U NIGHT,,,,, UNKNOWN,,,,,,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,201004.0,20201210.0,20201221,20201221,EXP,,BR-NOVOPROD-774845,NOVO NORDISK,,38.0,YR,,M,Y,,,20201221.0,,MD,BR,BR,2020,Q4,Adult
186429351,18642935,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,14U NIGHT,,,,, UNKNOWN,,,,,,,2020,Q4,Depression,,2020,Q4,1,I,201004.0,20201210.0,20201221,20201221,EXP,,BR-NOVOPROD-774845,NOVO NORDISK,,38.0,YR,,M,Y,,,20201221.0,,MD,BR,BR,2020,Q4,Adult
186429351,18642935,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,14U NIGHT,,,,, UNKNOWN,,,,,,,2020,Q4,Hyperglycaemic seizure,,2020,Q4,1,I,201004.0,20201210.0,20201221,20201221,EXP,,BR-NOVOPROD-774845,NOVO NORDISK,,38.0,YR,,M,Y,,,20201221.0,,MD,BR,BR,2020,Q4,Adult
186429351,18642935,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,14U NIGHT,,,,, UNKNOWN,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,201004.0,20201210.0,20201221,20201221,EXP,,BR-NOVOPROD-774845,NOVO NORDISK,,38.0,YR,,M,Y,,,20201221.0,,MD,BR,BR,2020,Q4,Adult
186429351,18642935,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,14U NIGHT,,,,, UNKNOWN,,,,,,,2020,Q4,Insomnia,,2020,Q4,1,I,201004.0,20201210.0,20201221,20201221,EXP,,BR-NOVOPROD-774845,NOVO NORDISK,,38.0,YR,,M,Y,,,20201221.0,,MD,BR,BR,2020,Q4,Adult
186438411,18643841,12,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Bradycardia,,2020,Q4,1,I,,,20201221,20201221,DIR,,,FDA-CTU,,90.0,YR,,F,N,,,,N,MD,US,US,2020,Q4,Elderly
186439001,18643900,6,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Bradycardia,,2020,Q4,1,I,,,20201221,20201221,DIR,,,FDA-CTU,,29.0,YR,,M,N,,,,N,MD,US,US,2020,Q4,Young Adult
186455581,18645558,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Blood glucose abnormal,,2020,Q4,1,I,,20201217.0,20201221,20201221,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202012009537,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20201221.0,,CN,CN,CN,2020,Q4,Adult
186468541,18646854,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186468541,18646854,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186468541,18646854,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186468541,18646854,8,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"ACCORDING TO INSULIN SCHEDULE, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201210.0,20201222,20201222,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2020-10472,LUPIN,,55.0,YR,,M,Y,,,20201222.0,,CN,NL,DE,2020,Q4,Adult
186470451,18647045,5,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,AT NIGHT,,,U,,,,,18.0,IU,UNKNOWN,QD,2020,Q4,BRASH syndrome,,2020,Q4,1,I,,20201211.0,20201222,20201222,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52866,HIKMA,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST DEBAKEY CARDIOVASCULAR JOURNAL. 2020;16(3):241-4. DOI:10.14797/MDCJ-16-3-241.",55.0,YR,,F,Y,,,20201222.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Adult
186473631,18647363,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,D,,,,,,,,,2020,Q4,Suspected suicide,,2020,Q4,1,I,,20201214.0,20201222,20201222,EXP,,US-009507513-2012USA008667,MERCK,,61.0,YR,,M,Y,,,20201222.0,,HP,US,US,2020,Q4,Adult
186491102,18649110,2,SS,INSULIN GLARGINE RECOMBINANT,INSULIN GLARGINE,1,Subcutaneous,16.00IU,,,,,,,,,,,,2020,Q4,Hospitalisation,,2020,Q4,2,F,,20201223.0,20201222,20201230,EXP,,JP-NOVOPROD-775035,NOVO NORDISK,,75.0,YR,,,Y,,,20201230.0,,MD,JP,JP,2020,Q4,Elderly
186498122,18649812,1,PS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,D,,,,210605.0,,,,,2020,Q4,Drug ineffective,,2020,Q4,2,F,,20201210.0,20201222,20201224,EXP,,DE-MYLANLABS-2020M1103762,MYLAN,,17.0,MON,,M,Y,,,20201224.0,,HP,DE,DE,2020,Q4,Youth
186498122,18649812,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,D,,,,210605.0,,,,,2020,Q4,Drug ineffective,,2020,Q4,2,F,,20201210.0,20201222,20201224,EXP,,DE-MYLANLABS-2020M1103762,MYLAN,,17.0,MON,,M,Y,,,20201224.0,,HP,DE,DE,2020,Q4,Youth
186513631,18651363,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (18 UNITS AT NIGHT),,,U,,,,,,,,,2020,Q4,Bradycardia,,2020,Q4,1,I,,20201222.0,20201222,20201222,EXP,,NVSC2020US339819,NOVARTIS,"ARIF WA, KHAN SM, MASRI A, MBA B, AYUB TM, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST DEBAKEY CARDIOVASCULAR JOURNAL. 2020;16(3):241-4",55.0,YR,,F,Y,,,20201222.0,,HP,US,US,2020,Q4,Adult
186513631,18651363,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK (18 UNITS AT NIGHT),,,U,,,,,,,,,2020,Q4,Hypotension,,2020,Q4,1,I,,20201222.0,20201222,20201222,EXP,,NVSC2020US339819,NOVARTIS,"ARIF WA, KHAN SM, MASRI A, MBA B, AYUB TM, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST DEBAKEY CARDIOVASCULAR JOURNAL. 2020;16(3):241-4",55.0,YR,,F,Y,,,20201222.0,,HP,US,US,2020,Q4,Adult
186524991,18652499,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Abdominal pain,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186524991,18652499,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Abdominal pain upper,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186524991,18652499,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Nausea,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186524991,18652499,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Product prescribing error,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186524991,18652499,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"PAUSED, AMPOULES",,,,,,,,,,,,2020,Q4,Vomiting,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,,DE-009507513-2012DEU008583,MERCK,,64.0,YR,,F,Y,88.0,KG,20201223.0,,MD,DE,DE,2020,Q4,Adult
186544821,18654482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,2020.0,20201203.0,20201223,20201223,PER,,US-009507513-2012USA002695,MERCK,,60.0,YR,,M,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186544821,18654482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,2020.0,20201203.0,20201223,20201223,PER,,US-009507513-2012USA002695,MERCK,,60.0,YR,,M,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186544821,18654482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Dyspnoea,,2020,Q4,1,I,2020.0,20201203.0,20201223,20201223,PER,,US-009507513-2012USA002695,MERCK,,60.0,YR,,M,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186544821,18654482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,2020.0,20201203.0,20201223,20201223,PER,,US-009507513-2012USA002695,MERCK,,60.0,YR,,M,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186544821,18654482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fatigue,,2020,Q4,1,I,2020.0,20201203.0,20201223,20201223,PER,,US-009507513-2012USA002695,MERCK,,60.0,YR,,M,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186544821,18654482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Feeling abnormal,,2020,Q4,1,I,2020.0,20201203.0,20201223,20201223,PER,,US-009507513-2012USA002695,MERCK,,60.0,YR,,M,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186544821,18654482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Hypercalcaemia,,2020,Q4,1,I,2020.0,20201203.0,20201223,20201223,PER,,US-009507513-2012USA002695,MERCK,,60.0,YR,,M,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186544821,18654482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Inappropriate schedule of product administration,,2020,Q4,1,I,2020.0,20201203.0,20201223,20201223,PER,,US-009507513-2012USA002695,MERCK,,60.0,YR,,M,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186544821,18654482,10,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Vocal cord paralysis,,2020,Q4,1,I,2020.0,20201203.0,20201223,20201223,PER,,US-009507513-2012USA002695,MERCK,,60.0,YR,,M,Y,,,20201223.0,,MD,US,US,2020,Q4,Adult
186569391,18656939,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,,20201214.0,20201224,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-062085,AUROBINDO,,72.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186569391,18656939,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Intentional product use issue,,2020,Q4,1,I,,20201214.0,20201224,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-062085,AUROBINDO,,72.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186569391,18656939,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Lung neoplasm,,2020,Q4,1,I,,20201214.0,20201224,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-062085,AUROBINDO,,72.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186569391,18656939,2,SS,Insulin glargine,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Trigger finger,,2020,Q4,1,I,,20201214.0,20201224,20201224,EXP,,ES-AUROBINDO-AUR-APL-2020-062085,AUROBINDO,,72.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186574881,18657488,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IE, 0-0-1-0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q4,Anuria,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,DE-ADRED-06088-01,DE-009507513-2012DEU008405,MERCK,,68.0,YR,,F,Y,,,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186574881,18657488,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IE, 0-0-1-0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q4,Cough,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,DE-ADRED-06088-01,DE-009507513-2012DEU008405,MERCK,,68.0,YR,,F,Y,,,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186574881,18657488,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IE, 0-0-1-0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q4,Oedema peripheral,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,DE-ADRED-06088-01,DE-009507513-2012DEU008405,MERCK,,68.0,YR,,F,Y,,,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186574881,18657488,4,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"5 IE, 0-0-1-0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2020,Q4,Urinary hesitation,,2020,Q4,1,I,,20201217.0,20201223,20201223,EXP,DE-ADRED-06088-01,DE-009507513-2012DEU008405,MERCK,,68.0,YR,,F,Y,,,20201223.0,,MD,DE,DE,2020,Q4,Elderly
186599391,18659939,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Acute kidney injury,,2020,Q4,1,I,,20201012.0,20201224,20201224,EXP,,US-ALKEM LABORATORIES LIMITED-QA-ALKEM-2020-07143,ALKEM,"ELSHAFEI MN, ALAMIN N, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS. MEDICINE. 2020;99:41:E22492",63.0,YR,,M,Y,,,20201224.0,,HP,QA,QA,2020,Q4,Adult
186599391,18659939,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Hypertension,,2020,Q4,1,I,,20201012.0,20201224,20201224,EXP,,US-ALKEM LABORATORIES LIMITED-QA-ALKEM-2020-07143,ALKEM,"ELSHAFEI MN, ALAMIN N, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS. MEDICINE. 2020;99:41:E22492",63.0,YR,,M,Y,,,20201224.0,,HP,QA,QA,2020,Q4,Adult
186599391,18659939,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Hypoglycaemia,,2020,Q4,1,I,,20201012.0,20201224,20201224,EXP,,US-ALKEM LABORATORIES LIMITED-QA-ALKEM-2020-07143,ALKEM,"ELSHAFEI MN, ALAMIN N, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS. MEDICINE. 2020;99:41:E22492",63.0,YR,,M,Y,,,20201224.0,,HP,QA,QA,2020,Q4,Adult
186599391,18659939,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Hypothermia,,2020,Q4,1,I,,20201012.0,20201224,20201224,EXP,,US-ALKEM LABORATORIES LIMITED-QA-ALKEM-2020-07143,ALKEM,"ELSHAFEI MN, ALAMIN N, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS. MEDICINE. 2020;99:41:E22492",63.0,YR,,M,Y,,,20201224.0,,HP,QA,QA,2020,Q4,Adult
186599391,18659939,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Lactic acidosis,,2020,Q4,1,I,,20201012.0,20201224,20201224,EXP,,US-ALKEM LABORATORIES LIMITED-QA-ALKEM-2020-07143,ALKEM,"ELSHAFEI MN, ALAMIN N, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS. MEDICINE. 2020;99:41:E22492",63.0,YR,,M,Y,,,20201224.0,,HP,QA,QA,2020,Q4,Adult
186599391,18659939,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Leukocytosis,,2020,Q4,1,I,,20201012.0,20201224,20201224,EXP,,US-ALKEM LABORATORIES LIMITED-QA-ALKEM-2020-07143,ALKEM,"ELSHAFEI MN, ALAMIN N, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS. MEDICINE. 2020;99:41:E22492",63.0,YR,,M,Y,,,20201224.0,,HP,QA,QA,2020,Q4,Adult
186599391,18659939,2,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Tachycardia,,2020,Q4,1,I,,20201012.0,20201224,20201224,EXP,,US-ALKEM LABORATORIES LIMITED-QA-ALKEM-2020-07143,ALKEM,"ELSHAFEI MN, ALAMIN N, MOHAMED MFH. OSMOLAR-GAP IN THE SETTING OF METFORMIN ASSOCIATED LACTIC ACIDOSIS. MEDICINE. 2020;99:41:E22492",63.0,YR,,M,Y,,,20201224.0,,HP,QA,QA,2020,Q4,Adult
186611921,18661192,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,,20201216.0,20201224,20201224,EXP,,NVSC2020ES335022,NOVARTIS,,72.0,YR,,M,Y,,,20201224.0,,HP,ES,ES,2020,Q4,Elderly
186611921,18661192,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Intentional product use issue,,2020,Q4,1,I,,20201216.0,20201224,20201224,EXP,,NVSC2020ES335022,NOVARTIS,,72.0,YR,,M,Y,,,20201224.0,,HP,ES,ES,2020,Q4,Elderly
186611921,18661192,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Lung neoplasm,,2020,Q4,1,I,,20201216.0,20201224,20201224,EXP,,NVSC2020ES335022,NOVARTIS,,72.0,YR,,M,Y,,,20201224.0,,HP,ES,ES,2020,Q4,Elderly
186611921,18661192,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Trigger finger,,2020,Q4,1,I,,20201216.0,20201224,20201224,EXP,,NVSC2020ES335022,NOVARTIS,,72.0,YR,,M,Y,,,20201224.0,,HP,ES,ES,2020,Q4,Elderly
186636961,18663696,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 INTERNATIONAL UNIT, 48 IU",,,,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186636961,18663696,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 INTERNATIONAL UNIT, 48 IU",,,,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186636961,18663696,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 INTERNATIONAL UNIT, 48 IU",,,,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diet noncompliance,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186636961,18663696,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 INTERNATIONAL UNIT, 48 IU",,,,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Parkinson's disease,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186636961,18663696,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,,"48 INTERNATIONAL UNIT, 48 IU",,,,,,,,48.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product storage error,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186636961,18663696,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, 46 IU",,,,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Blood glucose increased,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186636961,18663696,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, 46 IU",,,,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diarrhoea,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186636961,18663696,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, 46 IU",,,,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Diet noncompliance,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186636961,18663696,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, 46 IU",,,,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Parkinson's disease,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186636961,18663696,3,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"46 INTERNATIONAL UNIT, 46 IU",,,,, 0F715A,,,46.0,IU,SOLUTION FOR INJECTION,,2020,Q4,Product storage error,,2020,Q4,1,I,2018.0,20201209.0,20201224,20201224,EXP,,ES-MYLANLABS-2020M1103834,MYLAN,,77.0,YR,,M,Y,,,20201224.0,,CN,ES,ES,2020,Q4,Elderly
186643391,18664339,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Chronic gastritis,,2020,Q4,1,I,,20201212.0,20201225,20201225,EXP,,ES-BAUSCH-BL-2020-037407,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201225.0,,MD,ES,ES,2020,Q4,Elderly
186643391,18664339,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,,20201212.0,20201225,20201225,EXP,,ES-BAUSCH-BL-2020-037407,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201225.0,,MD,ES,ES,2020,Q4,Elderly
186643391,18664339,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Drug intolerance,,2020,Q4,1,I,,20201212.0,20201225,20201225,EXP,,ES-BAUSCH-BL-2020-037407,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201225.0,,MD,ES,ES,2020,Q4,Elderly
186643391,18664339,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Dyslipidaemia,,2020,Q4,1,I,,20201212.0,20201225,20201225,EXP,,ES-BAUSCH-BL-2020-037407,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201225.0,,MD,ES,ES,2020,Q4,Elderly
186643391,18664339,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hepatic steatosis,,2020,Q4,1,I,,20201212.0,20201225,20201225,EXP,,ES-BAUSCH-BL-2020-037407,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201225.0,,MD,ES,ES,2020,Q4,Elderly
186643391,18664339,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Hypertension,,2020,Q4,1,I,,20201212.0,20201225,20201225,EXP,,ES-BAUSCH-BL-2020-037407,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201225.0,,MD,ES,ES,2020,Q4,Elderly
186643391,18664339,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,U,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Overweight,,2020,Q4,1,I,,20201212.0,20201225,20201225,EXP,,ES-BAUSCH-BL-2020-037407,BAUSCH AND LOMB,,69.0,YR,,F,Y,,,20201225.0,,MD,ES,ES,2020,Q4,Elderly
186643651,18664365,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,ACCORDING TO INSULIN SCHEDULE,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643651,18664365,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,ACCORDING TO INSULIN SCHEDULE,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643651,18664365,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,ACCORDING TO INSULIN SCHEDULE,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643651,18664365,8,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,ACCORDING TO INSULIN SCHEDULE,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2020,Q4,Fall,,2020,Q4,1,I,,20201216.0,20201225,20201225,EXP,,DE-TEVA-2020-DE-1860870,TEVA,,55.0,YR,A,M,Y,,,20201225.0,,MD,DE,DE,2020,Q4,Adult
186643801,18664380,13,C,Insulin glargine,INSULIN GLARGINE,1,Unknown,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Febrile neutropenia,,2020,Q4,1,I,,20200909.0,20201225,20201225,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2020-05980,ALKEM,,38.0,YR,,F,Y,,,20201225.0,,HP,AU,AU,2020,Q4,Adult
186644411,18664441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL-BOLUS,,,,,,,,,,,,2020,Q4,Haemolysis,,2020,Q4,1,I,,20201214.0,20201225,20201225,EXP,,QA-LUPIN PHARMACEUTICALS INC.-2020-10778,LUPIN,,64.0,YR,,M,Y,,,20201225.0,,HP,QA,QA,2020,Q4,Adult
186644411,18664441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL-BOLUS,,,,,,,,,,,,2020,Q4,Normochromic normocytic anaemia,,2020,Q4,1,I,,20201214.0,20201225,20201225,EXP,,QA-LUPIN PHARMACEUTICALS INC.-2020-10778,LUPIN,,64.0,YR,,M,Y,,,20201225.0,,HP,QA,QA,2020,Q4,Adult
186644411,18664441,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,BASAL-BOLUS,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,1,I,,20201214.0,20201225,20201225,EXP,,QA-LUPIN PHARMACEUTICALS INC.-2020-10778,LUPIN,,64.0,YR,,M,Y,,,20201225.0,,HP,QA,QA,2020,Q4,Adult
186672031,18667203,8,C,Basal-bolus (glargine/aspart) insulin,,2,Unknown,UNK,,,,,,,,,,,,2020,Q4,Haemolysis,,2020,Q4,1,I,,20201214.0,20201228,20201228,EXP,,QA-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-272665,RANBAXY,"OBEIDAT K, YASSIN MA.. CAN HYDROXYCHLOROQUINE CAUSE G6PD-RELATED HEMOLYSIS? A CASE STUDY. DUBAI MED J. 2020;3:140-142",64.0,YR,,M,Y,,,20201228.0,,HP,QA,QA,2020,Q4,Adult
186672031,18667203,8,C,Basal-bolus (glargine/aspart) insulin,,2,Unknown,UNK,,,,,,,,,,,,2020,Q4,Off label use,,2020,Q4,1,I,,20201214.0,20201228,20201228,EXP,,QA-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-272665,RANBAXY,"OBEIDAT K, YASSIN MA.. CAN HYDROXYCHLOROQUINE CAUSE G6PD-RELATED HEMOLYSIS? A CASE STUDY. DUBAI MED J. 2020;3:140-142",64.0,YR,,M,Y,,,20201228.0,,HP,QA,QA,2020,Q4,Adult
186685461,18668546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2020,Q4,Acute kidney injury,Acute kidney injury,2020,Q4,1,I,,20201026.0,20201228,20201228,EXP,,US-ALS-000112,ALIGNSCIENCE PHARMA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2020;201:A4805,63.0,YR,A,M,Y,,,20201228.0,,HP,US,US,2020,Q4,Adult
186685461,18668546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2020,Q4,Condition aggravated,Condition aggravated,2020,Q4,1,I,,20201026.0,20201228,20201228,EXP,,US-ALS-000112,ALIGNSCIENCE PHARMA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2020;201:A4805,63.0,YR,A,M,Y,,,20201228.0,,HP,US,US,2020,Q4,Adult
186685461,18668546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2020,Q4,Drug level above therapeutic,Drug level above therapeutic,2020,Q4,1,I,,20201026.0,20201228,20201228,EXP,,US-ALS-000112,ALIGNSCIENCE PHARMA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2020;201:A4805,63.0,YR,A,M,Y,,,20201228.0,,HP,US,US,2020,Q4,Adult
186685461,18668546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2020,Q4,Hypertension,Hypertension,2020,Q4,1,I,,20201026.0,20201228,20201228,EXP,,US-ALS-000112,ALIGNSCIENCE PHARMA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2020;201:A4805,63.0,YR,A,M,Y,,,20201228.0,,HP,US,US,2020,Q4,Adult
186685461,18668546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2020,Q4,Hypoglycaemia,Hypoglycaemia,2020,Q4,1,I,,20201026.0,20201228,20201228,EXP,,US-ALS-000112,ALIGNSCIENCE PHARMA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2020;201:A4805,63.0,YR,A,M,Y,,,20201228.0,,HP,US,US,2020,Q4,Adult
186685461,18668546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2020,Q4,Hypothermia,Hypothermia,2020,Q4,1,I,,20201026.0,20201228,20201228,EXP,,US-ALS-000112,ALIGNSCIENCE PHARMA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2020;201:A4805,63.0,YR,A,M,Y,,,20201228.0,,HP,US,US,2020,Q4,Adult
186685461,18668546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2020,Q4,Lactic acidosis,Lactic acidosis,2020,Q4,1,I,,20201026.0,20201228,20201228,EXP,,US-ALS-000112,ALIGNSCIENCE PHARMA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2020;201:A4805,63.0,YR,A,M,Y,,,20201228.0,,HP,US,US,2020,Q4,Adult
186685461,18668546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2020,Q4,Mental disorder,Mental disorder,2020,Q4,1,I,,20201026.0,20201228,20201228,EXP,,US-ALS-000112,ALIGNSCIENCE PHARMA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2020;201:A4805,63.0,YR,A,M,Y,,,20201228.0,,HP,US,US,2020,Q4,Adult
186685461,18668546,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,,,,U,,,,,,,,,2020,Q4,Osmolar gap,Osmolar gap,2020,Q4,1,I,,20201026.0,20201228,20201228,EXP,,US-ALS-000112,ALIGNSCIENCE PHARMA,RAOOF S. METFORMIN ASSOCIATED LACTIC ACIDOSIS AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2020;201:A4805,63.0,YR,A,M,Y,,,20201228.0,,HP,US,US,2020,Q4,Adult
186692831,18669283,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Diabetes mellitus inadequate control,,2020,Q4,1,I,,20201216.0,20201228,20201228,EXP,,ES-BAUSCH-BL-2020-037768,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20201228.0,,CN,ES,ES,2020,Q4,Elderly
186692831,18669283,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Intentional product use issue,,2020,Q4,1,I,,20201216.0,20201228,20201228,EXP,,ES-BAUSCH-BL-2020-037768,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20201228.0,,CN,ES,ES,2020,Q4,Elderly
186692831,18669283,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Lung neoplasm,,2020,Q4,1,I,,20201216.0,20201228,20201228,EXP,,ES-BAUSCH-BL-2020-037768,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20201228.0,,CN,ES,ES,2020,Q4,Elderly
186692831,18669283,2,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,,,,,,,,,,,SOLUTION FOR INJECTION,,2020,Q4,Trigger finger,,2020,Q4,1,I,,20201216.0,20201228,20201228,EXP,,ES-BAUSCH-BL-2020-037768,BAUSCH AND LOMB,,72.0,YR,,M,Y,,,20201228.0,,CN,ES,ES,2020,Q4,Elderly
186711601,18671160,7,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH INSULINPLAN, INJEKTIONS-/INFUSIONSLSUNG",,,U,,,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,7,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH INSULINPLAN, INJEKTIONS-/INFUSIONSLSUNG",,,U,,,,,,,,,2020,Q4,Dizziness,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,7,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH INSULINPLAN, INJEKTIONS-/INFUSIONSLSUNG",,,U,,,,,,,,,2020,Q4,Electrocardiogram abnormal,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186711601,18671160,7,C,insulin glargine,INSULIN GLARGINE,1,Subcutaneous,"NACH INSULINPLAN, INJEKTIONS-/INFUSIONSLSUNG",,,U,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,,20201217.0,20201228,20201228,EXP,DE-ADRED-06077-01,DE-TORRENT-00019241,TORRENT,,55.0,YR,A,M,Y,,,20201228.0,,MD,DE,DE,2020,Q4,Adult
186733931,18673393,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,5 UNIT AT BED TIME,,,U,, UNKNOWN,,,5.0,DF,,QD,2020,Q4,Acute kidney injury,,2020,Q4,1,I,20200108.0,20200125.0,20201229,20201229,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000071,VELOXIS PHARMACEUTICALS,,54.0,YR,,F,Y,111.6,KG,20201229.0,,MD,US,US,2020,Q4,Adult
186733931,18673393,19,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,5 UNIT AT BED TIME,,,U,, UNKNOWN,,,5.0,DF,,QD,2020,Q4,Transplant rejection,,2020,Q4,1,I,20200108.0,20200125.0,20201229,20201229,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-000071,VELOXIS PHARMACEUTICALS,,54.0,YR,,F,Y,111.6,KG,20201229.0,,MD,US,US,2020,Q4,Adult
186751461,18675146,4,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, EXTENDED RELEASE (ER)",,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201229,20201229,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051141,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",46.0,YR,,F,Y,,,20201229.0,,MD,US,US,2020,Q4,Adult
186751461,18675146,5,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,"UNK, ROUTE: ASPIRATION (WITH INGESTION); EXTENDED RELEASE (ER)",,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201229,20201229,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051141,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",46.0,YR,,F,Y,,,20201229.0,,MD,US,US,2020,Q4,Adult
186751461,18675146,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,"UNK, EXTENDED RELEASE (ER)",,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201229,20201229,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051141,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",46.0,YR,,F,Y,,,20201229.0,,MD,US,US,2020,Q4,Adult
186766081,18676608,10,C,"Insulin (glargine, regular and lispro)",,2,,,,,,,,,,,,,,2020,Q4,Diabetic ketoacidosis,,2020,Q4,1,I,20201223.0,,20201229,20201229,DIR,,,FDA-CTU,,67.0,YR,,F,N,86.7,KG,20201229.0,Y,PH,US,US,2020,Q4,Elderly
186766081,18676608,10,C,"Insulin (glargine, regular and lispro)",,2,,,,,,,,,,,,,,2020,Q4,Dyspnoea exertional,,2020,Q4,1,I,20201223.0,,20201229,20201229,DIR,,,FDA-CTU,,67.0,YR,,F,N,86.7,KG,20201229.0,Y,PH,US,US,2020,Q4,Elderly
186766081,18676608,10,C,"Insulin (glargine, regular and lispro)",,2,,,,,,,,,,,,,,2020,Q4,Pulmonary congestion,,2020,Q4,1,I,20201223.0,,20201229,20201229,DIR,,,FDA-CTU,,67.0,YR,,F,N,86.7,KG,20201229.0,Y,PH,US,US,2020,Q4,Elderly
186787941,18678794,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201221.0,20201229,20201229,EXP,,US-PFIZER INC-2020508678,PFIZER,,57.0,YR,,M,Y,,,20201229.0,,MD,US,US,2020,Q4,Adult
186787941,18678794,14,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,UNK,,,,, UNKNOWN,,,,,,,2020,Q4,Inappropriate antidiuretic hormone secretion,,2020,Q4,1,I,,20201221.0,20201229,20201229,EXP,,US-PFIZER INC-2020508678,PFIZER,,57.0,YR,,M,Y,,,20201229.0,,MD,US,US,2020,Q4,Adult
186800191,18680019,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201224.0,20201230,20201230,EXP,,US-ASTRAZENECA-2020SF74309,ASTRAZENECA,,61.0,YR,,M,Y,,,20201230.0,,HP,US,US,2020,Q4,Adult
186800191,18680019,6,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20201224.0,20201230,20201230,EXP,,US-ASTRAZENECA-2020SF74309,ASTRAZENECA,,61.0,YR,,M,Y,,,20201230.0,,HP,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Complications of transplanted kidney,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Human ehrlichiosis,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Inappropriate antidiuretic hormone secretion,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Leukopenia,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Thrombocytopenia,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Transaminases increased,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186800891,18680089,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,,,,,,,,,2020,Q4,Transplant rejection,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-DRREDDYS-USA/USA/20/0130485,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186813811,18681381,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Blood creatinine increased,,2020,Q4,1,I,20201228.0,,20201229,20201229,DIR,,,FDA-CTU,,48.0,YR,,M,N,99.0,KG,20201229.0,N,PH,US,US,2020,Q4,Adult
186813811,18681381,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Infusion related reaction,,2020,Q4,1,I,20201228.0,,20201229,20201229,DIR,,,FDA-CTU,,48.0,YR,,M,N,99.0,KG,20201229.0,N,PH,US,US,2020,Q4,Adult
186827401,18682740,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2020,Q4,Condition aggravated,,2020,Q4,1,I,,20201221.0,20201229,20201229,EXP,,US-DRREDDYS-USA/USA/20/0130487,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186827401,18682740,18,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,U,, UNKNOWN,,,,,,,2020,Q4,Inappropriate antidiuretic hormone secretion,,2020,Q4,1,I,,20201221.0,20201229,20201229,EXP,,US-DRREDDYS-USA/USA/20/0130487,DR REDDYS,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,A,M,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Complications of transplanted kidney,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Human ehrlichiosis,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Inappropriate antidiuretic hormone secretion,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Leukopenia,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Thrombocytopenia,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Transaminases increased,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186832321,18683232,21,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,,,,,,,,,,2020,Q4,Transplant rejection,,2020,Q4,1,I,,20201222.0,20201230,20201230,EXP,,US-STRIDES ARCOLAB LIMITED-2020SP016365,STRIDES,,57.0,YR,,M,Y,,,20201230.0,,,NL,US,2020,Q4,Adult
186840611,18684061,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, QD, 18 UNITS AT NIGHT",,,U,U,,,,18.0,IU,INJECTION,QD,2020,Q4,BRASH syndrome,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-MYLANLABS-2020M1106352,MYLAN,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST-DEBAKEY-CARDIOVASC-J 2020;16(3):241-244.",55.0,YR,,F,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186840611,18684061,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, QD, 18 UNITS AT NIGHT",,,U,U,,,,18.0,IU,INJECTION,QD,2020,Q4,Hypotension,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-MYLANLABS-2020M1106352,MYLAN,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST-DEBAKEY-CARDIOVASC-J 2020;16(3):241-244.",55.0,YR,,F,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186840611,18684061,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, QD, 18 UNITS AT NIGHT",,,U,U,,,,18.0,IU,INJECTION,QD,2020,Q4,Pleural effusion,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-MYLANLABS-2020M1106352,MYLAN,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST-DEBAKEY-CARDIOVASC-J 2020;16(3):241-244.",55.0,YR,,F,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186840611,18684061,7,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"18 INTERNATIONAL UNIT, QD, 18 UNITS AT NIGHT",,,U,U,,,,18.0,IU,INJECTION,QD,2020,Q4,Pulmonary congestion,,2020,Q4,1,I,,20201221.0,20201230,20201230,EXP,,US-MYLANLABS-2020M1106352,MYLAN,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION. METHODIST-DEBAKEY-CARDIOVASC-J 2020;16(3):241-244.",55.0,YR,,F,Y,,,20201230.0,,MD,US,US,2020,Q4,Adult
186862541,18686254,5,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201228.0,20201231,20201231,EXP,,US-BAYER-2020-287440,BAYER,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020;58:12:1360-1541",61.0,YR,A,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186862541,18686254,5,SS,INSULINE GLARGINE,INSULIN GLARGINE,1,Intravenous (not otherwise specified),,,,,,,,,,,,,2020,Q4,Toxicity to various agents,,2020,Q4,1,I,,20201228.0,20201231,20201231,EXP,,US-BAYER-2020-287440,BAYER,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS? NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020;58:12:1360-1541",61.0,YR,A,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186873351,18687335,13,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Oral,UNK; EXTENDED RELEASE (ER),,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201231,20201231,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051223,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",61.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186873351,18687335,14,SS,INSULIN GLARGINE,INSULIN GLARGINE,1,Parenteral,UNK; EXTENDED RELEASE (ER),,,U,,,,,,,,,2020,Q4,Completed suicide,,2020,Q4,1,I,,20201223.0,20201231,20201231,EXP,,US-GLENMARK PHARMACEUTICALS-2020GMK051223,GLENMARK,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY.. 2020;58 (12):1360-1541",61.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186874881,18687488,6,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Subcutaneous,"UNK UNK, Q.H.S. (18 UNITS AT NIGHT)",,,D,,,,,,,,QD,2020,Q4,BRASH syndrome,,2020,Q4,1,I,,20201221.0,20201231,20201231,EXP,,US-APOTEX-2020AP025035,APOTEX,"ARIF AW, KHAN MS, MASRI A, MBA B, TALHA AYUB M, DOUKKY R.. BRASH SYNDROME WITH HYPERKALEMIA: AN UNDER-RECOGNIZED CLINICAL CONDITION.. METHODIST-DEBAKEY-CARDIOVASC-J. 2020;16(3):241-244",55.0,YR,,F,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Complications of transplanted kidney,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Human ehrlichiosis,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Inappropriate antidiuretic hormone secretion,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Leukopenia,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Liver function test abnormal,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Thrombocytopenia,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186882391,18688239,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNK,,,U,, UNKNOWN,,,,,,,2020,Q4,Transplant rejection,,2020,Q4,1,I,,20201222.0,20201231,20201231,EXP,,US-VELOXIS PHARMACEUTICALS-2020VELUS-001079,VELOXIS PHARMACEUTICALS,,57.0,YR,,M,Y,,,20201231.0,,MD,US,US,2020,Q4,Adult
186885191,18688519,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2020,Q4,Anaemia,,2020,Q4,1,I,,20201221.0,20201231,20201231,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52965,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20201231.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Adult
186885191,18688519,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2020,Q4,Human ehrlichiosis,,2020,Q4,1,I,,20201221.0,20201231,20201231,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52965,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20201231.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Adult
186885191,18688519,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2020,Q4,Inappropriate antidiuretic hormone secretion,,2020,Q4,1,I,,20201221.0,20201231,20201231,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52965,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20201231.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Adult
186885191,18688519,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2020,Q4,Leukopenia,,2020,Q4,1,I,,20201221.0,20201231,20201231,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52965,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20201231.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Adult
186885191,18688519,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2020,Q4,Renal impairment,,2020,Q4,1,I,,20201221.0,20201231,20201231,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52965,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20201231.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Adult
186885191,18688519,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2020,Q4,Renal tubular necrosis,,2020,Q4,1,I,,20201221.0,20201231,20201231,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52965,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20201231.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Adult
186885191,18688519,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2020,Q4,Thrombocytopenia,,2020,Q4,1,I,,20201221.0,20201231,20201231,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52965,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20201231.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Adult
186885191,18688519,20,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,UNKNOWN,,,U,,,,,,,UNKNOWN,,2020,Q4,Transaminases increased,,2020,Q4,1,I,,20201221.0,20201231,20201231,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-20-52965,HIKMA,"HASSAN W, TALWAR M, BALARAMAN V, MOLNAR MZ. EHRLICHIOSIS INFECTION MIMICKING THROMBOTIC MICROANGIOPATHY SYNDROME EARLY AFTER KIDNEY TRANSPLANTATION. TRANSPLANT INFECTIOUS DISEASE. 2020;22(5):ARTICLE NUMBER E13305. DOI: 10.1111/TID.13305.",57.0,YR,,M,Y,,,20201231.0,,,COUNTRY NOT SPECIFIED,US,2020,Q4,Adult
186886361,18688636,10,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,International normalised ratio increased,,2020,Q4,1,I,20201226.0,,20201231,20201231,DIR,,,FDA-CTU,,62.0,YR,,M,N,76.95,KG,20201231.0,N,PH,US,US,2020,Q4,Adult
186886361,18688636,10,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Prothrombin time prolonged,,2020,Q4,1,I,20201226.0,,20201231,20201231,DIR,,,FDA-CTU,,62.0,YR,,M,N,76.95,KG,20201231.0,N,PH,US,US,2020,Q4,Adult
186886491,18688649,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,20201225.0,,20201231,20201231,DIR,,,FDA-CTU,,70.0,YR,,M,N,70.0,KG,20201231.0,Y,PH,US,US,2020,Q4,Elderly
186886491,18688649,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,COVID-19,,2020,Q4,1,I,20201225.0,,20201231,20201231,DIR,,,FDA-CTU,,70.0,YR,,M,N,70.0,KG,20201231.0,Y,PH,US,US,2020,Q4,Elderly
186886491,18688649,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Cervical vertebral fracture,,2020,Q4,1,I,20201225.0,,20201231,20201231,DIR,,,FDA-CTU,,70.0,YR,,M,N,70.0,KG,20201231.0,Y,PH,US,US,2020,Q4,Elderly
186886491,18688649,9,C,insulin glargine,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Fall,,2020,Q4,1,I,20201225.0,,20201231,20201231,DIR,,,FDA-CTU,,70.0,YR,,M,N,70.0,KG,20201231.0,Y,PH,US,US,2020,Q4,Elderly
186886611,18688661,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Dysstasia,,2020,Q4,1,I,20201223.0,,20201231,20201231,DIR,,,FDA-CTU,,77.0,YR,,F,N,59.85,KG,20201231.0,N,CN,US,US,2020,Q4,Elderly
186886621,18688662,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Dysstasia,,2020,Q4,1,I,20201223.0,,20201231,20201231,DIR,,,FDA-CTU,,77.0,YR,,F,N,59.85,KG,20201231.0,N,CN,US,US,2020,Q4,Elderly
186886621,18688662,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Gait disturbance,,2020,Q4,1,I,20201223.0,,20201231,20201231,DIR,,,FDA-CTU,,77.0,YR,,F,N,59.85,KG,20201231.0,N,CN,US,US,2020,Q4,Elderly
186886621,18688662,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Loss of personal independence in daily activities,,2020,Q4,1,I,20201223.0,,20201231,20201231,DIR,,,FDA-CTU,,77.0,YR,,F,N,59.85,KG,20201231.0,N,CN,US,US,2020,Q4,Elderly
186886961,18688696,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Asthenia,,2020,Q4,1,I,20201223.0,,20201231,20201231,DIR,,,FDA-CTU,,77.0,YR,,F,N,59.85,KG,20201231.0,N,CN,US,US,2020,Q4,Elderly
186886961,18688696,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Confusional state,,2020,Q4,1,I,20201223.0,,20201231,20201231,DIR,,,FDA-CTU,,77.0,YR,,F,N,59.85,KG,20201231.0,N,CN,US,US,2020,Q4,Elderly
186886961,18688696,3,C,INSULIN GLARGINE,INSULIN GLARGINE,1,,,,,,,,,,,,,,2020,Q4,Micturition disorder,,2020,Q4,1,I,20201223.0,,20201231,20201231,DIR,,,FDA-CTU,,77.0,YR,,F,N,59.85,KG,20201231.0,N,CN,US,US,2020,Q4,Elderly
186896291,18689629,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Euglycaemic diabetic ketoacidosis,,2020,Q4,1,I,,20201229.0,20201231,20201231,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-073117",BOEHRINGER INGELHEIM,"JOSHI M, LIEB D, GRESENS A, JENKINS E, ARE SGLT-2 INHIBITORS SAFE IN PATIENTS UNDERGOING BARIATRIC SURGERY?. ENDOCRINE PRACTICE. 2020; 26(2): 118-",36.0,YR,A,M,Y,,,20201231.0,,HP,US,US,2020,Q4,Adult
186896291,18689629,2,C,INSULIN GLARGINE,INSULIN GLARGINE,1,Unknown,,,,,,,,,,,,,2020,Q4,Metabolic acidosis,,2020,Q4,1,I,,20201229.0,20201231,20201231,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-073117",BOEHRINGER INGELHEIM,"JOSHI M, LIEB D, GRESENS A, JENKINS E, ARE SGLT-2 INHIBITORS SAFE IN PATIENTS UNDERGOING BARIATRIC SURGERY?. ENDOCRINE PRACTICE. 2020; 26(2): 118-",36.0,YR,A,M,Y,,,20201231.0,,HP,US,US,2020,Q4,Adult
